STUDYID|DOMAIN|USUBJID|FASEQ|FATESTCD|FATEST|FAOBJ|FACAT|FAORRES|FAORRESU|FASTRESC|FASTRESN|FASTRESU|FALOC|FALAT|FALOBXFL|FABLFL|FAEVAL|VISITNUM|VISIT|VISITDY|TAETORD|EPOCH|FADTC|FADY
e|FA|35f5401f-575a-44dc-9141-8084716a5b70|1|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|mol/day|[?]|1|mL/dose|ESOPHAGUS, MIDDLE THIRD|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-10-20|10
e|FA|35f5401f-575a-44dc-9141-8084716a5b70|2|STROKTYP|Stroke Type|[?]|GERD|[?]|Gy/min|[?]|1|g/L|DUODENUM|IPSILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|4|FOLLOW-UP|2020-10-20|10
e|FA|35f5401f-575a-44dc-9141-8084716a5b70|3|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|umol/L|[?]|1|km|METACARPOPHALANGEAL JOINT 3|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|FOLLOW-UP|2020-11-04|25
e|FA|35f5401f-575a-44dc-9141-8084716a5b70|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|Log10 ELISA unit|[?]|1|ug/g/h|FLANK|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2020-11-04|25
e|FA|35f5401f-575a-44dc-9141-8084716a5b70|5|DFIBER|Dietary Fiber|[?]|GERD|[?]|L/h/m2|[?]|1|h*%|ANTRUM PYLORI|LATERAL|Y||INTERVIEWER|3|Visit_3|40|5|FOLLOW-UP|2020-11-19|40
e|FA|35f5401f-575a-44dc-9141-8084716a5b70|6|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|kg|[?]|1|/200 HPFs|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|RIGHT|Y||CHILD|3|Visit_3|40|2|FOLLOW-UP|2020-11-19|40
e|FA|35f5401f-575a-44dc-9141-8084716a5b70|7|LOCONSET|Localization of Onset|[?]|GERD|[?]|um/day|[?]|1|g/L|AXILLARY VEIN|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2020-12-14|65
e|FA|35f5401f-575a-44dc-9141-8084716a5b70|8|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|Bq/mL|[?]|1|U/mg|PERIURETHRAL REGION|UNILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|7|WASHOUT|2020-12-14|65
e|FA|35f5401f-575a-44dc-9141-8084716a5b70|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|BLOCKS|[?]|1|ug/g/h|ESOPHAGUS, CERVICAL|UNILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|WASHOUT|2021-01-08|90
e|FA|35f5401f-575a-44dc-9141-8084716a5b70|10|DFIBER|Dietary Fiber|[?]|GERD|[?]|mL/g/h|[?]|1|h*%|THIRD DIAGONAL BRANCH ARTERY|LEFT|||INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2021-01-08|90
e|FA|8a863a88-67d8-4e50-bafa-c3146591f046|1|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|amu|[?]|1|TRANSDUCING UNIT/mL|PANCREATIC DUCT|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|TREATMENT|2020-12-29|10
e|FA|8a863a88-67d8-4e50-bafa-c3146591f046|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ug/mL/h|[?]|1|mg/g/min|RETROCRURAL LYMPH NODE|RIGHT|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|4|SCREENING|2020-12-29|10
e|FA|8a863a88-67d8-4e50-bafa-c3146591f046|3|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|mCi/kg|[?]|1|mL/h|FLEXOR CARPI ULNARIS MUSCLE|LATERAL|Y||VENDOR|2|Visit_2|25|3|SCREENING|2021-01-13|25
e|FA|8a863a88-67d8-4e50-bafa-c3146591f046|4|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|L/L|[?]|1|10^6 CFU|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|BILATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|FOLLOW-UP|2021-01-13|25
e|FA|8a863a88-67d8-4e50-bafa-c3146591f046|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|MET*min|[?]|1|mg/g/min|LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT|RIGHT|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2021-01-28|40
e|FA|8a863a88-67d8-4e50-bafa-c3146591f046|6|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|foz_us|[?]|1|g/L|PROXIMAL PHALANX 3 OF THE HAND|UNILATERAL||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2021-01-28|40
e|FA|8a863a88-67d8-4e50-bafa-c3146591f046|7|RLDEV|Relationship to Device|[?]|GERD|[?]|mV|[?]|1|mL/min/mmHg|INTERTROCHANTERIC REGION|BILATERAL|||SPOUSE|4|Visit_4|65|7|FOLLOW-UP|2021-02-22|65
e|FA|8a863a88-67d8-4e50-bafa-c3146591f046|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/mmol|[?]|1|mg/g/min|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|BILATERAL|Y||CHILD|4|Visit_4|65|7|TREATMENT|2021-02-22|65
e|FA|8a863a88-67d8-4e50-bafa-c3146591f046|9|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|v/v|[?]|1|mL/cm3/min|C3 VERTEBRA|BILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|FOLLOW-UP|2021-03-19|90
e|FA|8a863a88-67d8-4e50-bafa-c3146591f046|10|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|g/cm2|[?]|1|m2|SECOND RIGHT POSTEROLATERAL ARTERY|RIGHT|||FRIEND|5|Visit_5|90|7|WASHOUT|2021-03-19|90
e|FA|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|lx|[?]|1|Pa|PREAURICULAR LYMPH NODE|LEFT|||PARENT|1|Visit_1|10|1|TREATMENT|2020-08-03|10
e|FA|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|mEq/day|[?]|1|TRANSDUCING UNIT/mL|FEMALE GENITALIA|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-08-03|10
e|FA|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|/ms|[?]|1|mg/g/min|MITRAL VALVE ANNULUS|LATERAL|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-08-18|25
e|FA|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|4|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|10^3 CFU/mL|[?]|1|uL/kg/day|DORSALIS PEDIS ARTERY|CONTRALATERAL||Y|CAREGIVER|2|Visit_2|25|3|TREATMENT|2020-08-18|25
e|FA|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|5|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|ug/min|[?]|1|SACHET|CEPHALIC VEIN|BILATERAL|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-09-02|40
e|FA|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|6|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|U/g/h|[?]|1|mAmp|PORTAL VEIN BIFURCATION|RIGHT|||FRIEND|3|Visit_3|40|2|FOLLOW-UP|2020-09-02|40
e|FA|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|7|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/mL|[?]|1|mL|URACHAL TRACT|LEFT|Y||SPOUSE|4|Visit_4|65|5|FOLLOW-UP|2020-09-27|65
e|FA|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|8|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|ug/day|[?]|1|IU/mg|SCIATIC NERVE|CONTRALATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-09-27|65
e|FA|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|9|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|dB|[?]|1|g/day|BRACHIOCEPHALIC ARTERY|BILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2020-10-22|90
e|FA|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|log10 PFU/mL|[?]|1|10^6 U|PARASPINAL REGION|LEFT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-10-22|90
e|FA|0558cb35-f542-4f9a-a7e7-18b1d71be69c|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|MET|[?]|1|mg/g/min|TOOTH|BILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-12-20|10
e|FA|0558cb35-f542-4f9a-a7e7-18b1d71be69c|2|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|GBq/g|[?]|1|MPS U|METACARPOPHALANGEAL JOINT 3|UNILATERAL|||PARENT|1|Visit_1|10|7|TREATMENT|2020-12-20|10
e|FA|0558cb35-f542-4f9a-a7e7-18b1d71be69c|3|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|min/day|[?]|1|PFU/dose|ABDUCTOR HALLUCIS MUSCLE|RIGHT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2021-01-04|25
e|FA|0558cb35-f542-4f9a-a7e7-18b1d71be69c|4|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|U/mg|[?]|1|NEEDLE GAUGE|T10 VERTEBRA|BILATERAL||Y|PARENT|2|Visit_2|25|4|TREATMENT|2021-01-04|25
e|FA|0558cb35-f542-4f9a-a7e7-18b1d71be69c|5|STROKTYP|Stroke Type|[?]|GERD|[?]|mmHg*min/L|[?]|1|g/L|MITRAL VALVE, ANTERIOR ANNULUS|CONTRALATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2021-01-19|40
e|FA|0558cb35-f542-4f9a-a7e7-18b1d71be69c|6|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|Bq/mg|ARM|LATERAL|||FRIEND|3|Visit_3|40|6|TREATMENT|2021-01-19|40
e|FA|0558cb35-f542-4f9a-a7e7-18b1d71be69c|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|CYLINDER|[?]|1|%(v/v)|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|IPSILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2021-02-13|65
e|FA|0558cb35-f542-4f9a-a7e7-18b1d71be69c|8|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|Bq/uL|[?]|1|PACK|RETINAL ARTERY|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-02-13|65
e|FA|0558cb35-f542-4f9a-a7e7-18b1d71be69c|9|LENRSCT|Length of Resection|[?]|GERD|[?]|pt_us|[?]|1|psi|SKIN OF THE HAND|RIGHT|||DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2021-03-10|90
e|FA|0558cb35-f542-4f9a-a7e7-18b1d71be69c|10|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|MnFI|[?]|1|cmH2O/mL|SUPERIOR PUBIC RAMUS|IPSILATERAL|||PARENT|5|Visit_5|90|5|SCREENING|2021-03-10|90
e|FA|a9cf4d21-c2a8-4f32-b932-f05d2d317400|1|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|/2500 WBC|[?]|1|mIU/L|BLADDER, FUNDUS|RIGHT|||PARENT|1|Visit_1|10|2|WASHOUT|2020-07-03|10
e|FA|a9cf4d21-c2a8-4f32-b932-f05d2d317400|2|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|Gy/min|[?]|1|IU/mg|ORBICULARIS OCULI MUSCLE|IPSILATERAL|||VENDOR|1|Visit_1|10|3|TREATMENT|2020-07-03|10
e|FA|a9cf4d21-c2a8-4f32-b932-f05d2d317400|3|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|BU|[?]|1|BP|LEFT MAIN CORONARY ARTERY BIFURCATION|UNILATERAL|||CAREGIVER|2|Visit_2|25|4|FOLLOW-UP|2020-07-18|25
e|FA|a9cf4d21-c2a8-4f32-b932-f05d2d317400|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|L/day|[?]|1|10^6 IU/mL|DUODENUM|LEFT|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-07-18|25
e|FA|a9cf4d21-c2a8-4f32-b932-f05d2d317400|5|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|anti-Xa IU/mL|[?]|1|ug/kg/h|DISTANT LYMPH NODE|LEFT|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2020-08-02|40
e|FA|a9cf4d21-c2a8-4f32-b932-f05d2d317400|6|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|aMFI|HEART, LEFT VENTRICULAR OUTFLOW TRACT|BILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2020-08-02|40
e|FA|a9cf4d21-c2a8-4f32-b932-f05d2d317400|7|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|mol/mL|[?]|1|Hz/s|THYROID GLAND, RIGHT LOBE|CONTRALATERAL|||FAMILY MEMBER|4|Visit_4|65|5|FOLLOW-UP|2020-08-27|65
e|FA|a9cf4d21-c2a8-4f32-b932-f05d2d317400|8|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|vp/dose|ARTERY|LEFT||Y|CAREGIVER|4|Visit_4|65|2|WASHOUT|2020-08-27|65
e|FA|a9cf4d21-c2a8-4f32-b932-f05d2d317400|9|SEV|Severity/Intensity|[?]|GERD|[?]|uL/mL|[?]|1|Pa|DISTANT LYMPH NODE|LATERAL|||ADJUDICATOR|5|Visit_5|90|3|FOLLOW-UP|2020-09-21|90
e|FA|a9cf4d21-c2a8-4f32-b932-f05d2d317400|10|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|Hz/s|LOWER GASTROINTESTINAL TRACT LYMPH NODE|BILATERAL|||INVESTIGATOR|5|Visit_5|90|6|WASHOUT|2020-09-21|90
e|FA|0389257f-50de-4a05-8f2a-69c068374337|1|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|um/s|[?]|1|mg/h|WRIST JOINT|RIGHT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|WASHOUT|2020-10-08|10
e|FA|0389257f-50de-4a05-8f2a-69c068374337|2|DFATT|Dietary Fat, Total|[?]|GERD|[?]|s*kPa|[?]|1|Bq/mg|CHOROID PLEXUS|UNILATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|3|FOLLOW-UP|2020-10-08|10
e|FA|0389257f-50de-4a05-8f2a-69c068374337|3|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/day|[?]|1|umol|PULMONARY TRUNK|CONTRALATERAL|||CAREGIVER|2|Visit_2|25|4|FOLLOW-UP|2020-10-23|25
e|FA|0389257f-50de-4a05-8f2a-69c068374337|4|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mEq/kg|[?]|1|oz eq|FEMUR|BILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|SCREENING|2020-10-23|25
e|FA|0389257f-50de-4a05-8f2a-69c068374337|5|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|fmol/L/sec|[?]|1|gtt|THORACIC CAVITY|CONTRALATERAL|||SPOUSE|3|Visit_3|40|1|WASHOUT|2020-11-07|40
e|FA|0389257f-50de-4a05-8f2a-69c068374337|6|DCAL|Dietary Calories|[?]|GERD|[?]|hPa|[?]|1|EIA unit|METATARSOPHALANGEAL JOINT 5|BILATERAL|||ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-11-07|40
e|FA|0389257f-50de-4a05-8f2a-69c068374337|7|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|ug/g/day|[?]|1|uCi/kg|COMMON FEMORAL VEIN|LEFT|||SIBLING|4|Visit_4|65|6|WASHOUT|2020-12-02|65
e|FA|0389257f-50de-4a05-8f2a-69c068374337|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|Bq/ug|[?]|1|CUP|CANINE TOOTH|BILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-12-02|65
e|FA|0389257f-50de-4a05-8f2a-69c068374337|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|g/g|[?]|1|mg/g/min|APPENDIX|BILATERAL|||CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-12-27|90
e|FA|0389257f-50de-4a05-8f2a-69c068374337|10|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|10^6 IU/mL|TRICUSPID VALVE, ANTERIOR CUSP|UNILATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|2|WASHOUT|2020-12-27|90
e|FA|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|1|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|LENS|[?]|1|Hz/s|PANCREAS, EXOCRINE|LEFT|||PROXY|1|Visit_1|10|1|TREATMENT|2020-12-15|10
e|FA|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|2|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|pg/cell|[?]|1|g/day|PORTAL LYMPH NODE|CONTRALATERAL|||PROXY|1|Visit_1|10|1|TREATMENT|2020-12-15|10
e|FA|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|3|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|days/month|[?]|1|mAmp|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|LATERAL|||FRIEND|2|Visit_2|25|6|TREATMENT|2020-12-30|25
e|FA|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mEq/mL|[?]|1|mg/g/min|METACARPAL 1 BASE|IPSILATERAL|||ADJUDICATOR|2|Visit_2|25|1|FOLLOW-UP|2020-12-30|25
e|FA|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|5|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|DROP|MESENTERY|CONTRALATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|SCREENING|2021-01-14|40
e|FA|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|PIXEL|[?]|1|Pa|CUBOID BONE|LEFT|Y||DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2021-01-14|40
e|FA|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|7|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|hr/day|[?]|1|Ci/ug|FOOT PHALANX|LATERAL|||INTERVIEWER|4|Visit_4|65|4|SCREENING|2021-02-08|65
e|FA|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|8|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|PIXELS/cm|[?]|1|mEq|URACHAL TRACT|BILATERAL||Y|CAREGIVER|4|Visit_4|65|5|TREATMENT|2021-02-08|65
e|FA|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|9|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|BP|[?]|1|mAmp|C6 VERTEBRA|LEFT|Y||PARENT|5|Visit_5|90|7|WASHOUT|2021-03-05|90
e|FA|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|CFU/mL|[?]|1|mg/g/min|LIMB, LOWER|LATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|5|WASHOUT|2021-03-05|90
e|FA|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|1|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|Tbsp|[?]|1|g/day|SCAPHOID BONE|IPSILATERAL|Y||CHILD|1|Visit_1|10|6|TREATMENT|2020-12-22|10
e|FA|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|g|[?]|1|mg/g/min|LUNG, LEFT UPPER LOBE|LEFT||Y|DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-12-22|10
e|FA|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|3|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|mmAL|[?]|1|SCOOPFUL|VASTUS INTERMEDIUS MUSCLE|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2021-01-06|25
e|FA|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|4|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mEq/mL|[?]|1|U/10^12 RBC|DIGIT|LATERAL|Y||SIBLING|2|Visit_2|25|2|WASHOUT|2021-01-06|25
e|FA|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|5|VOL|Volume|[?]|GERD|[?]|U/mL|[?]|1|vp/dose|INTERPHALANGEAL THUMB JOINT|IPSILATERAL|||SPOUSE|3|Visit_3|40|5|TREATMENT|2021-01-21|40
e|FA|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|6|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|dB|[?]|1|mAmp|SPINAL CORD|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|FOLLOW-UP|2021-01-21|40
e|FA|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|7|DPROT|Dietary Protein|[?]|GERD|[?]|MPL U|[?]|1|10^4 CFU/mL|PALATINE BONE|CONTRALATERAL|Y||DOMESTIC PARTNER|4|Visit_4|65|5|TREATMENT|2021-02-15|65
e|FA|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|8|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mL/cage|[?]|1|ohm|PROSTATE GLAND, MIDDLE LOBE|LEFT||Y|FRIEND|4|Visit_4|65|1|WASHOUT|2021-02-15|65
e|FA|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|9|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|mN|[?]|1|Bq/L|FOREHEAD|RIGHT||Y|DOMESTIC PARTNER|5|Visit_5|90|7|SCREENING|2021-03-12|90
e|FA|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|10|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|g/m2/day|[?]|1|HOURS|PARAPHARYNGEAL LYMPH NODE|BILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|1|SCREENING|2021-03-12|90
e|FA|ad402b62-0625-431b-9bd7-ffd6124610f3|1|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|umol/min|[?]|1|/kg|INTRAHEPATIC LARGE BILE DUCT|IPSILATERAL|||STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-09-25|10
e|FA|ad402b62-0625-431b-9bd7-ffd6124610f3|2|ACNDEV|Action Taken With Device|[?]|GERD|[?]|log10 PFU|[?]|1|100 IU/mL|PONS VAROLII|RIGHT||Y|PARENT|1|Visit_1|10|5|WASHOUT|2020-09-25|10
e|FA|ad402b62-0625-431b-9bd7-ffd6124610f3|3|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|cy/cm|[?]|1|MBq|ABDUCTOR HALLUCIS MUSCLE|BILATERAL|||CHILD|2|Visit_2|25|3|FOLLOW-UP|2020-10-10|25
e|FA|ad402b62-0625-431b-9bd7-ffd6124610f3|4|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|bel|[?]|1|L/h/m2|VERTEBRAL ARTERY|CONTRALATERAL|||INVESTIGATOR|2|Visit_2|25|4|SCREENING|2020-10-10|25
e|FA|ad402b62-0625-431b-9bd7-ffd6124610f3|5|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|10^9/L|[?]|1|uCi/kg|CORONARY SINUS|RIGHT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-10-25|40
e|FA|ad402b62-0625-431b-9bd7-ffd6124610f3|6|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|nmol/L|[?]|1|fmol|SUBTALAR JOINT|LEFT|Y|Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|FOLLOW-UP|2020-10-25|40
e|FA|ad402b62-0625-431b-9bd7-ffd6124610f3|7|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|nmol/mol|[?]|1|mL/h|MID-CIRCUMFLEX ARTERY|CONTRALATERAL|Y||SIBLING|4|Visit_4|65|4|FOLLOW-UP|2020-11-19|65
e|FA|ad402b62-0625-431b-9bd7-ffd6124610f3|8|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|foz_us|[?]|1|Gy/h|ILIOTIBIAL BAND|RIGHT|Y||INTERVIEWER|4|Visit_4|65|3|TREATMENT|2020-11-19|65
e|FA|ad402b62-0625-431b-9bd7-ffd6124610f3|9|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|Farad|[?]|1|mm/h|LUNG|BILATERAL|||INVESTIGATOR|5|Visit_5|90|1|SCREENING|2020-12-14|90
e|FA|ad402b62-0625-431b-9bd7-ffd6124610f3|10|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|NFIU|[?]|1|SCOOPFUL|L3-L4 INTERVERTEBRAL SPACE|CONTRALATERAL|||PARENT|5|Visit_5|90|6|TREATMENT|2020-12-14|90
e|FA|d76b0f55-541c-491d-9162-4c133c9509f1|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ug/kg/min|[?]|1|mg/g/min|GALLBLADDER|BILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|5|SCREENING|2020-05-24|10
e|FA|d76b0f55-541c-491d-9162-4c133c9509f1|2|CALBURN|Calories Burned|[?]|GERD|[?]|mL/min/mmHg|[?]|1|/kg|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|Y||STUDY SUBJECT|1|Visit_1|10|1|WASHOUT|2020-05-24|10
e|FA|d76b0f55-541c-491d-9162-4c133c9509f1|3|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|Ci/g|[?]|1|mEq/g|OROPHARYNX|BILATERAL|||FAMILY MEMBER|2|Visit_2|25|5|TREATMENT|2020-06-08|25
e|FA|d76b0f55-541c-491d-9162-4c133c9509f1|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|ug/kg/h|[?]|1|mL/dose|PITUITARY GLAND|IPSILATERAL||Y|GUARDIAN|2|Visit_2|25|2|FOLLOW-UP|2020-06-08|25
e|FA|d76b0f55-541c-491d-9162-4c133c9509f1|5|CALBURN|Calories Burned|[?]|GERD|[?]|tuberculin unit|[?]|1|/kg|PULMONARY VALVE, ANTERIOR CUSP|UNILATERAL|||VENDOR|3|Visit_3|40|6|TREATMENT|2020-06-23|40
e|FA|d76b0f55-541c-491d-9162-4c133c9509f1|6|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|mL/min|[?]|1|TRANSDUCING UNIT/mL|HIP ADDUCTORS|RIGHT|Y|Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|WASHOUT|2020-06-23|40
e|FA|d76b0f55-541c-491d-9162-4c133c9509f1|7|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|ELISA unit|[?]|1|g/dL|ELBOW JOINT|UNILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-07-18|65
e|FA|d76b0f55-541c-491d-9162-4c133c9509f1|8|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mL/(min*100mL)|[?]|1|100 IU/mL|NUCLEUS ACCUMBENS|IPSILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2020-07-18|65
e|FA|d76b0f55-541c-491d-9162-4c133c9509f1|9|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|ng/day|LIVER, LEFT LOBE|BILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|WASHOUT|2020-08-12|90
e|FA|d76b0f55-541c-491d-9162-4c133c9509f1|10|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|mV*min|[?]|1|SACHET|L5-S1 INTERVERTEBRAL SPACE|RIGHT||Y|INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2020-08-12|90
e|FA|146059d8-5652-41cd-b484-c6e5d8ea540f|1|EVENTFRQ|Event Frequency|[?]|GERD|[?]|MONTHS|[?]|1|ug/kg/h|MIDDLE PHALANX 4 OF THE HAND|IPSILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|5|SCREENING|2020-08-26|10
e|FA|146059d8-5652-41cd-b484-c6e5d8ea540f|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/dose|[?]|1|mg/g/min|SPLENIC VEIN|LEFT|||SIGNIFICANT OTHER|1|Visit_1|10|6|SCREENING|2020-08-26|10
e|FA|146059d8-5652-41cd-b484-c6e5d8ea540f|3|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|10^3 DNA copies/mL|[?]|1|/kg|MIDDLE PHALANX 5 OF THE HAND|LEFT|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|WASHOUT|2020-09-10|25
e|FA|146059d8-5652-41cd-b484-c6e5d8ea540f|4|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|mmol/s|[?]|1|DRUM|RENAL PELVIS|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|WASHOUT|2020-09-10|25
e|FA|146059d8-5652-41cd-b484-c6e5d8ea540f|5|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|ug/h|[?]|1|g/dL|PORTAL LYMPH NODE|BILATERAL||Y|SIBLING|3|Visit_3|40|4|SCREENING|2020-09-25|40
e|FA|146059d8-5652-41cd-b484-c6e5d8ea540f|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|10^9/g|[?]|1|Shock Wave|EXTERNAL ILIAC ARTERY|CONTRALATERAL||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-09-25|40
e|FA|146059d8-5652-41cd-b484-c6e5d8ea540f|7|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|mmol|[?]|1|10^9 CFU/mL|CORNEAL EPITHELIUM|BILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|4|SCREENING|2020-10-20|65
e|FA|146059d8-5652-41cd-b484-c6e5d8ea540f|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|nCi|[?]|1|mg/g/min|EAR|LEFT|Y|Y|SIBLING|4|Visit_4|65|3|TREATMENT|2020-10-20|65
e|FA|146059d8-5652-41cd-b484-c6e5d8ea540f|9|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|PLUG|[?]|1|SCOOPFUL|VAS DEFERENS|LATERAL|||FRIEND|5|Visit_5|90|7|SCREENING|2020-11-14|90
e|FA|146059d8-5652-41cd-b484-c6e5d8ea540f|10|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|/10^3|[?]|1|L|SEMINAL VESICLE|CONTRALATERAL|Y||INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2020-11-14|90
e|FA|3d5f1964-b65c-4a0a-bb5b-1689308754d8|1|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|10^6 organisms|[?]|1|fmol|URETHRA|IPSILATERAL|||CAREGIVER|1|Visit_1|10|6|FOLLOW-UP|2020-11-04|10
e|FA|3d5f1964-b65c-4a0a-bb5b-1689308754d8|2|STRCTNUM|Number of Strictures|[?]|GERD|[?]|mL/kg/day|[?]|1|SACHET|MITRAL VALVE|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|WASHOUT|2020-11-04|10
e|FA|3d5f1964-b65c-4a0a-bb5b-1689308754d8|3|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|L/s/kPa|[?]|1|L|ADDUCTOR MAGNUS MUSCLE|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2020-11-19|25
e|FA|3d5f1964-b65c-4a0a-bb5b-1689308754d8|4|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|MBq/uL|[?]|1|DRUM|EXTENSOR HALLUCIS BREVIS MUSCLE|IPSILATERAL||Y|SIBLING|2|Visit_2|25|4|WASHOUT|2020-11-19|25
e|FA|3d5f1964-b65c-4a0a-bb5b-1689308754d8|5|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|Shock Wave|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT|||GUARDIAN|3|Visit_3|40|5|FOLLOW-UP|2020-12-04|40
e|FA|3d5f1964-b65c-4a0a-bb5b-1689308754d8|6|DIAMETER|Diameter|[?]|GERD|[?]|%(v/v)|[?]|1|cm|T5 VERTEBRA|LATERAL|Y|Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|FOLLOW-UP|2020-12-04|40
e|FA|3d5f1964-b65c-4a0a-bb5b-1689308754d8|7|OBJNUM|Number of Objects|[?]|GERD|[?]|10^6/L|[?]|1|mL/100g/min|INCUS|RIGHT||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2020-12-29|65
e|FA|3d5f1964-b65c-4a0a-bb5b-1689308754d8|8|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|/LPF|[?]|1|10^6 U|FOREBRAIN|LATERAL|Y||INTERVIEWER|4|Visit_4|65|1|WASHOUT|2020-12-29|65
e|FA|3d5f1964-b65c-4a0a-bb5b-1689308754d8|9|TOXGR|Toxicity Grade|[?]|GERD|[?]|vp/dose|[?]|1|aMFI|EYE|LEFT|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2021-01-23|90
e|FA|3d5f1964-b65c-4a0a-bb5b-1689308754d8|10|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|g/day|[?]|1|Log10 ELISA unit|PALM|LEFT|||PARENT|5|Visit_5|90|2|TREATMENT|2021-01-23|90
e|FA|129dc836-068a-463e-b789-a0d05c60605d|1|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|pmol/day|[?]|1|IU/mmol|UTERUS|BILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-07-06|10
e|FA|129dc836-068a-463e-b789-a0d05c60605d|2|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|mAmp|BRAIN VENTRICLE, LATERAL|LATERAL|||SPOUSE|1|Visit_1|10|3|SCREENING|2020-07-06|10
e|FA|129dc836-068a-463e-b789-a0d05c60605d|3|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|um/s|[?]|1|SCOOPFUL|ESOPHAGEAL LYMPH NODE|CONTRALATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-07-21|25
e|FA|129dc836-068a-463e-b789-a0d05c60605d|4|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|10^3 DNA copies/mL|[?]|1|/200 HPFs|RECTO-UTERINE POUCH|LEFT|||ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-07-21|25
e|FA|129dc836-068a-463e-b789-a0d05c60605d|5|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|mmHg*min/L|[?]|1|g/day|CARPOMETACARPAL JOINT 4|BILATERAL|||PROXY|3|Visit_3|40|1|FOLLOW-UP|2020-08-05|40
e|FA|129dc836-068a-463e-b789-a0d05c60605d|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|g/cage/wk|[?]|1|PACK|NUCLEUS ACCUMBENS|UNILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|2|TREATMENT|2020-08-05|40
e|FA|129dc836-068a-463e-b789-a0d05c60605d|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|kcal|[?]|1|%(v/v)|KIDNEY, UPPER LOBE|CONTRALATERAL|||CAREGIVER|4|Visit_4|65|3|WASHOUT|2020-08-30|65
e|FA|129dc836-068a-463e-b789-a0d05c60605d|8|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|DAYS|[?]|1|Ci/ug|TRANSVERSE TARSAL JOINT|IPSILATERAL|Y||PARENT|4|Visit_4|65|6|SCREENING|2020-08-30|65
e|FA|129dc836-068a-463e-b789-a0d05c60605d|9|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|GPS U|[?]|1|BP|KIDNEY, UPPER LOBE|LATERAL|||FAMILY MEMBER|5|Visit_5|90|3|SCREENING|2020-09-24|90
e|FA|129dc836-068a-463e-b789-a0d05c60605d|10|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|mg/dL|[?]|1|BAG|BRAIN VENTRICLE, LATERAL|UNILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|2|TREATMENT|2020-09-24|90
e|FA|9ef8a6d4-8326-4050-be85-e9f8983f55c1|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|mEq/ug|[?]|1|SCOOPFUL|VULVA|LATERAL|Y||INTERVIEWER|1|Visit_1|10|3|TREATMENT|2020-11-07|10
e|FA|9ef8a6d4-8326-4050-be85-e9f8983f55c1|2|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|IU/kg|[?]|1|HOURS|PERONEAL ARTERY|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-11-07|10
e|FA|9ef8a6d4-8326-4050-be85-e9f8983f55c1|3|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|Linear ft*LB|[?]|1|10^6/L|ULNA SHAFT|UNILATERAL|Y||CAREGIVER|2|Visit_2|25|2|SCREENING|2020-11-22|25
e|FA|9ef8a6d4-8326-4050-be85-e9f8983f55c1|4|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|IU/day|[?]|1|/kg|HEPATIC ARTERY|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|FOLLOW-UP|2020-11-22|25
e|FA|9ef8a6d4-8326-4050-be85-e9f8983f55c1|5|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|10^4 CFU/mL|CORONARY ARTERY|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|FOLLOW-UP|2020-12-07|40
e|FA|9ef8a6d4-8326-4050-be85-e9f8983f55c1|6|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|mL/m2|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|RIGHT||Y|CHILD|3|Visit_3|40|5|TREATMENT|2020-12-07|40
e|FA|9ef8a6d4-8326-4050-be85-e9f8983f55c1|7|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|PRESSOR UNITS|[?]|1|ohm|TENTORIUM CEREBELLI|IPSILATERAL|||PARENT|4|Visit_4|65|3|SCREENING|2021-01-01|65
e|FA|9ef8a6d4-8326-4050-be85-e9f8983f55c1|8|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mm/2h|[?]|1|Weber|DISTAL LAD ARTERY|CONTRALATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2021-01-01|65
e|FA|9ef8a6d4-8326-4050-be85-e9f8983f55c1|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mV|[?]|1|%(v/v)|TROCHLEAR NERVE|LATERAL|||ADJUDICATOR|5|Visit_5|90|2|TREATMENT|2021-01-26|90
e|FA|9ef8a6d4-8326-4050-be85-e9f8983f55c1|10|EVENTFRQ|Event Frequency|[?]|GERD|[?]|L/s/kPa|[?]|1|ug/kg/h|AORTIC ARCH|IPSILATERAL|||CHILD|5|Visit_5|90|6|WASHOUT|2021-01-26|90
e|FA|b91c4469-b3be-467f-8512-b73cf561e168|1|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|DAgU|[?]|1|ng/day|ORAL CAVITY|LATERAL|Y||CAREGIVER|1|Visit_1|10|2|SCREENING|2020-05-18|10
e|FA|b91c4469-b3be-467f-8512-b73cf561e168|2|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|U/10^12 RBC|[?]|1|AU/mL|FEMUR SHAFT|LATERAL||Y|VENDOR|1|Visit_1|10|3|TREATMENT|2020-05-18|10
e|FA|b91c4469-b3be-467f-8512-b73cf561e168|3|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|IU|[?]|1|QUANTITY SUFFICIENT|SOLEUS MUSCLE|RIGHT|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-06-02|25
e|FA|b91c4469-b3be-467f-8512-b73cf561e168|4|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|g/L|[?]|1|mg/h|ESOPHAGUS, LOWER THIRD|CONTRALATERAL|||INTERVIEWER|2|Visit_2|25|3|SCREENING|2020-06-02|25
e|FA|b91c4469-b3be-467f-8512-b73cf561e168|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|L/min/m2|[?]|1|ug/g/h|MALLEUS|BILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|FOLLOW-UP|2020-06-17|40
e|FA|b91c4469-b3be-467f-8512-b73cf561e168|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|Pa|LARGE INTESTINE|BILATERAL|Y||GUARDIAN|3|Visit_3|40|1|TREATMENT|2020-06-17|40
e|FA|b91c4469-b3be-467f-8512-b73cf561e168|7|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|L/h/m2|SAPHENOUS VEIN|LEFT|Y||VENDOR|4|Visit_4|65|6|TREATMENT|2020-07-12|65
e|FA|b91c4469-b3be-467f-8512-b73cf561e168|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/cm3/min|[?]|1|%(v/v)|PELVIC LYMPH NODE|LATERAL|Y|Y|PROXY|4|Visit_4|65|1|SCREENING|2020-07-12|65
e|FA|b91c4469-b3be-467f-8512-b73cf561e168|9|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|gtt|[?]|1|AU/mL|TEMPORAL ARTERY|CONTRALATERAL|||CAREGIVER|5|Visit_5|90|7|TREATMENT|2020-08-06|90
e|FA|b91c4469-b3be-467f-8512-b73cf561e168|10|AGETRT1|Age At First Treatment|[?]|GERD|[?]|nmol|[?]|1|mL/mmHg/min/L|TUNICA INTIMA|LATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|TREATMENT|2020-08-06|90
e|FA|3637e1e0-8c0c-45cc-b139-e812a589f940|1|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|/5x10^4 WBC|[?]|1|BP|ABDUCTOR HALLUCIS MUSCLE|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|3|TREATMENT|2020-08-30|10
e|FA|3637e1e0-8c0c-45cc-b139-e812a589f940|2|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|MnFI|[?]|1|AU/mL|POPLITEAL VEIN|CONTRALATERAL|||SPOUSE|1|Visit_1|10|7|TREATMENT|2020-08-30|10
e|FA|3637e1e0-8c0c-45cc-b139-e812a589f940|3|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mL|[?]|1|m2|INTESTINE|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|SCREENING|2020-09-14|25
e|FA|3637e1e0-8c0c-45cc-b139-e812a589f940|4|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|Siemens|[?]|1|HOURS|VAS DEFERENS|RIGHT|||FAMILY MEMBER|2|Visit_2|25|3|TREATMENT|2020-09-14|25
e|FA|3637e1e0-8c0c-45cc-b139-e812a589f940|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|GPS U|[?]|1|U/mg|ILEUM, TERMINAL|RIGHT|||SIBLING|3|Visit_3|40|4|FOLLOW-UP|2020-09-29|40
e|FA|3637e1e0-8c0c-45cc-b139-e812a589f940|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|/sec|[?]|1|QUANTITY SUFFICIENT|SUBMENTAL LYMPH NODE|LATERAL||Y|GUARDIAN|3|Visit_3|40|7|TREATMENT|2020-09-29|40
e|FA|3637e1e0-8c0c-45cc-b139-e812a589f940|7|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mL|[?]|1|BOWL|VAGINAL WALL|RIGHT|||ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2020-10-24|65
e|FA|3637e1e0-8c0c-45cc-b139-e812a589f940|8|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|ngEq/L|[?]|1|g/L|CERVICAL SPINE|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-10-24|65
e|FA|3637e1e0-8c0c-45cc-b139-e812a589f940|9|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|mL/kg/min|[?]|1|mmHg/L/min|SUBGLOTTIS|LATERAL|Y||SPOUSE|5|Visit_5|90|1|TREATMENT|2020-11-18|90
e|FA|3637e1e0-8c0c-45cc-b139-e812a589f940|10|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|MnFI|[?]|1|AU/mL|SKIN AROUND THE EYE|IPSILATERAL|||CAREGIVER|5|Visit_5|90|5|SCREENING|2020-11-18|90
e|FA|23385974-5fcd-4c36-b9fa-2fbb3841f182|1|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|mL/breath|[?]|1|anti-Xa IU/mL|L4-L5 INTERVERTEBRAL SPACE|LATERAL|||STUDY SUBJECT|1|Visit_1|10|5|WASHOUT|2020-11-27|10
e|FA|23385974-5fcd-4c36-b9fa-2fbb3841f182|2|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|uL/kg/day|FEMORO-POPLITEAL PERIPHERAL ARTERY|RIGHT|Y||PROXY|1|Visit_1|10|2|FOLLOW-UP|2020-11-27|10
e|FA|23385974-5fcd-4c36-b9fa-2fbb3841f182|3|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|pL|[?]|1|mg/dose|SCALP|RIGHT|||SPOUSE|2|Visit_2|25|6|TREATMENT|2020-12-12|25
e|FA|23385974-5fcd-4c36-b9fa-2fbb3841f182|4|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|ohm|[?]|1|BOWL|ENDOCARDIUM|RIGHT|||PARENT|2|Visit_2|25|2|TREATMENT|2020-12-12|25
e|FA|23385974-5fcd-4c36-b9fa-2fbb3841f182|5|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mL/h|[?]|1|gtt|POSTERIOR POLE OF THE EYE|IPSILATERAL|||CHILD|3|Visit_3|40|7|TREATMENT|2020-12-27|40
e|FA|23385974-5fcd-4c36-b9fa-2fbb3841f182|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mEq|[?]|1|CUP|EYE|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2020-12-27|40
e|FA|23385974-5fcd-4c36-b9fa-2fbb3841f182|7|DFRUIT|Dietary Fruit|[?]|GERD|[?]|ug/cm2|[?]|1|10^6 CFU/mL|CEREBRAL HEMISPHERE, LEFT|LATERAL|||CAREGIVER|4|Visit_4|65|5|TREATMENT|2021-01-21|65
e|FA|23385974-5fcd-4c36-b9fa-2fbb3841f182|8|STRCTNUM|Number of Strictures|[?]|GERD|[?]|deg/s|[?]|1|SACHET|URETHRA, PENILE|LATERAL|||PROXY|4|Visit_4|65|4|FOLLOW-UP|2021-01-21|65
e|FA|23385974-5fcd-4c36-b9fa-2fbb3841f182|9|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|NFIU|[?]|1|in|INTERPHALANGEAL JOINT 3|UNILATERAL|Y||SIBLING|5|Visit_5|90|6|TREATMENT|2021-02-15|90
e|FA|23385974-5fcd-4c36-b9fa-2fbb3841f182|10|SEV|Severity/Intensity|[?]|GERD|[?]|% INHIBITION|[?]|1|Pa|BRAIN VENTRICLE, LATERAL|IPSILATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2021-02-15|90
e|FA|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|1|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mL/g/min|[?]|1|U/mg|COLON, RIGHT|IPSILATERAL|Y||GUARDIAN|1|Visit_1|10|2|WASHOUT|2020-12-06|10
e|FA|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|2|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|kIU|[?]|1|mL/100g/min|PERIURETERAL REGION|RIGHT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|WASHOUT|2020-12-06|10
e|FA|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|3|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|log10 CFU/g|[?]|1|m2|SUBTALAR JOINT|UNILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|5|FOLLOW-UP|2020-12-21|25
e|FA|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|4|PPTFCT|Precipitating Factor|[?]|GERD|[?]|Absorbance U/mL|[?]|1|EIA unit|FEMALE REPRODUCTIVE SYSTEM|IPSILATERAL|||CHILD|2|Visit_2|25|3|FOLLOW-UP|2020-12-21|25
e|FA|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mm/2h|[?]|1|mg/g/min|FEMORAL HEAD|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|5|WASHOUT|2021-01-05|40
e|FA|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|6|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/L|[?]|1|uL/kg/day|SCAPULA|CONTRALATERAL|||FRIEND|3|Visit_3|40|5|SCREENING|2021-01-05|40
e|FA|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|7|PPTFCT|Precipitating Factor|[?]|GERD|[?]|nmol/mL/min|[?]|1|EIA unit|THORACIC ARTERY|LEFT||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|WASHOUT|2021-01-30|65
e|FA|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|8|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|mg/kg|[?]|1|SCOOPFUL|CHIN|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|SCREENING|2021-01-30|65
e|FA|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|9|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|kg/cm2|[?]|1|Gy/h|BREAST|CONTRALATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|5|SCREENING|2021-02-24|90
e|FA|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|10|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|mg/cm2|[?]|1|mEq|GASTRIC CARDIA|LATERAL|Y||FRIEND|5|Visit_5|90|5|TREATMENT|2021-02-24|90
e|FA|f1327e16-08c6-4ef0-852e-13c095a94c00|1|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|ppb|[?]|1|10^6 IU/mL|DORSAL MOTOR NUCLEUS|RIGHT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|WASHOUT|2020-05-26|10
e|FA|f1327e16-08c6-4ef0-852e-13c095a94c00|2|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|TRACE|[?]|1|umol|PERIFACIAL LYMPH NODE|BILATERAL||Y|GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-05-26|10
e|FA|f1327e16-08c6-4ef0-852e-13c095a94c00|3|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|U.CARR|[?]|1|uCi/kg|PARACAVAL LYMPH NODE|LEFT|Y|Y|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-06-10|25
e|FA|f1327e16-08c6-4ef0-852e-13c095a94c00|4|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|Sv|[?]|1|g/cage/day|SUBGLOTTIS|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2020-06-10|25
e|FA|f1327e16-08c6-4ef0-852e-13c095a94c00|5|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|RNA copies/mL|[?]|1|/500 WBC|PROXIMAL INTERPHALANGEAL JOINT 4|RIGHT||Y|GUARDIAN|3|Visit_3|40|2|SCREENING|2020-06-25|40
e|FA|f1327e16-08c6-4ef0-852e-13c095a94c00|6|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mmol/g|[?]|1|ohm|ANTERIOR TIBIAL VEIN|BILATERAL|||PARENT|3|Visit_3|40|2|SCREENING|2020-06-25|40
e|FA|f1327e16-08c6-4ef0-852e-13c095a94c00|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ng|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 2|CONTRALATERAL|||INTERVIEWER|4|Visit_4|65|6|TREATMENT|2020-07-20|65
e|FA|f1327e16-08c6-4ef0-852e-13c095a94c00|8|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mmol/L|[?]|1|U/10^12 RBC|SACROILIAC JOINT|LEFT|||STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-07-20|65
e|FA|f1327e16-08c6-4ef0-852e-13c095a94c00|9|EVENTNUM|Number of Events|[?]|GERD|[?]|mU/g|[?]|1|U/10^12 RBC|ADDUCTOR POLLICIS MUSCLE|UNILATERAL|||FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2020-08-14|90
e|FA|f1327e16-08c6-4ef0-852e-13c095a94c00|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mg/mL/min|[?]|1|mL|HAND DIGIT 4|LEFT|||INVESTIGATOR|5|Visit_5|90|1|SCREENING|2020-08-14|90
e|FA|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|Gravitational Unit|[?]|1|10^6 U|ANUS|BILATERAL|||PARENT|1|Visit_1|10|1|SCREENING|2021-01-15|10
e|FA|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|in|[?]|1|g/day|FEMORAL ARTERY|CONTRALATERAL|||PROXY|1|Visit_1|10|4|TREATMENT|2021-01-15|10
e|FA|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|3|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|L/h|[?]|1|umol|BUCCAL LYMPH NODE|CONTRALATERAL|||PROXY|2|Visit_2|25|5|TREATMENT|2021-01-30|25
e|FA|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|4|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|mmol/g|[?]|1|oz eq|FINGERNAIL|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|SCREENING|2021-01-30|25
e|FA|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|5|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|Ci|[?]|1|L/h/m2|SUBGLOTTIS|RIGHT|||SIBLING|3|Visit_3|40|2|SCREENING|2021-02-14|40
e|FA|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|PACK|PORTAL VEIN|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2021-02-14|40
e|FA|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|PRESSOR UNITS|[?]|1|Pa|CALCANEUS|RIGHT|||PROXY|4|Visit_4|65|4|TREATMENT|2021-03-11|65
e|FA|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|foz_us|[?]|1|mg/g/min|MEDIASTINUM, ANTERIOR|UNILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2021-03-11|65
e|FA|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|9|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|10^3 copies/mL|[?]|1|Log10 ELISA unit|SALIVARY GLAND|LEFT|||CAREGIVER|5|Visit_5|90|3|WASHOUT|2021-04-05|90
e|FA|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|10|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|cm H2O|OPPONENS POLLICIS MUSCLE|IPSILATERAL|Y||VENDOR|5|Visit_5|90|2|WASHOUT|2021-04-05|90
e|FA|e8065021-c163-41c8-8a76-5f0c1c3a06c4|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|mg/g/min|COLON LYMPH NODE|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|SCREENING|2020-12-08|10
e|FA|e8065021-c163-41c8-8a76-5f0c1c3a06c4|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|mg/g/min|HYOID BONE|BILATERAL|||PROXY|1|Visit_1|10|6|TREATMENT|2020-12-08|10
e|FA|e8065021-c163-41c8-8a76-5f0c1c3a06c4|3|STROKTYP|Stroke Type|[?]|GERD|[?]|PIXEL|[?]|1|g/L|LEFT MAIN CORONARY ARTERY BODY|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|WASHOUT|2020-12-23|25
e|FA|e8065021-c163-41c8-8a76-5f0c1c3a06c4|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|U/kg/min|[?]|1|10^6 IU/mL|DENTAL ARCH|LATERAL|||PARENT|2|Visit_2|25|4|FOLLOW-UP|2020-12-23|25
e|FA|e8065021-c163-41c8-8a76-5f0c1c3a06c4|5|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|Torr|[?]|1|/kg|ACCESSORY RENAL ARTERY|LEFT|||INTERVIEWER|3|Visit_3|40|7|TREATMENT|2021-01-07|40
e|FA|e8065021-c163-41c8-8a76-5f0c1c3a06c4|6|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|RING|[?]|1|ng/day|PANCREAS, HEAD|CONTRALATERAL|||INTERVIEWER|3|Visit_3|40|4|SCREENING|2021-01-07|40
e|FA|e8065021-c163-41c8-8a76-5f0c1c3a06c4|7|DMG|Dietary Magnesium|[?]|GERD|[?]|log10 copies/mL|[?]|1|TRANSDUCING UNIT/mL|PERICARDIAL CAVITY|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|2|WASHOUT|2021-02-01|65
e|FA|e8065021-c163-41c8-8a76-5f0c1c3a06c4|8|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|ug/day|[?]|1|10^6 U|RADIAL ARTERY|LEFT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2021-02-01|65
e|FA|e8065021-c163-41c8-8a76-5f0c1c3a06c4|9|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|cs|[?]|1|mL/100g/min|ULNAR NERVE|IPSILATERAL|||VENDOR|5|Visit_5|90|3|TREATMENT|2021-02-26|90
e|FA|e8065021-c163-41c8-8a76-5f0c1c3a06c4|10|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|SUPPOSITORY|[?]|1|IU/mmol|ESOPHAGUS, CERVICAL|BILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|6|FOLLOW-UP|2021-02-26|90
e|FA|854a9218-995e-47f4-87ab-e58d20f56d19|1|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|MAC50|[?]|1|EIA unit|ABDUCENS NERVE|UNILATERAL||Y|ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-11-23|10
e|FA|854a9218-995e-47f4-87ab-e58d20f56d19|2|STRCTNUM|Number of Strictures|[?]|GERD|[?]|EP U|[?]|1|SACHET|ALVEOLUS|IPSILATERAL|Y||SPOUSE|1|Visit_1|10|6|TREATMENT|2020-11-23|10
e|FA|854a9218-995e-47f4-87ab-e58d20f56d19|3|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|mL/dL|[?]|1|mL/h|PULMONARY VALVE, ANTERIOR CUSP|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|SCREENING|2020-12-08|25
e|FA|854a9218-995e-47f4-87ab-e58d20f56d19|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|nmol/L|[?]|1|mg/g/min|SKIN OF THE SOLE|IPSILATERAL|||PROXY|2|Visit_2|25|7|WASHOUT|2020-12-08|25
e|FA|854a9218-995e-47f4-87ab-e58d20f56d19|5|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|ug/m2|[?]|1|TRANSDUCING UNIT/mL|LIVER, RIGHT LOBE|CONTRALATERAL|||SPOUSE|3|Visit_3|40|7|TREATMENT|2020-12-23|40
e|FA|854a9218-995e-47f4-87ab-e58d20f56d19|6|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|cm/min|[?]|1|gtt|EPIGLOTTIS|UNILATERAL||Y|GUARDIAN|3|Visit_3|40|4|FOLLOW-UP|2020-12-23|40
e|FA|854a9218-995e-47f4-87ab-e58d20f56d19|7|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|/4.0 mL|[?]|1|mL/m2|POSTERIOR TIBIAL VEIN|LATERAL|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2021-01-17|65
e|FA|854a9218-995e-47f4-87ab-e58d20f56d19|8|EVENTFRQ|Event Frequency|[?]|GERD|[?]|NEEDLE GAUGE|[?]|1|ug/kg/h|C3 VERTEBRA|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|WASHOUT|2021-01-17|65
e|FA|854a9218-995e-47f4-87ab-e58d20f56d19|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|oz|[?]|1|10^6 IU/mL|SACRAL TUBEROSITY|IPSILATERAL|||FRIEND|5|Visit_5|90|6|TREATMENT|2021-02-11|90
e|FA|854a9218-995e-47f4-87ab-e58d20f56d19|10|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|SPRAY|[?]|1|BOWL|ADDUCTOR BREVIS MUSCLE|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|SCREENING|2021-02-11|90
e|FA|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|1|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|WEEKS|[?]|1|umol|TESTIS|IPSILATERAL|||FRIEND|1|Visit_1|10|3|FOLLOW-UP|2020-06-21|10
e|FA|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|2|DMG|Dietary Magnesium|[?]|GERD|[?]|mmol/g|[?]|1|TRANSDUCING UNIT/mL|TRIANGULAR-HAMATE JOINT|BILATERAL|||ADJUDICATOR|1|Visit_1|10|3|WASHOUT|2020-06-21|10
e|FA|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|3|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|/10^4|[?]|1|U/mmol|MEDIASTINUM, SUPERIOR|IPSILATERAL|Y||DOMESTIC PARTNER|2|Visit_2|25|7|TREATMENT|2020-07-06|25
e|FA|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|4|LOCONSET|Localization of Onset|[?]|GERD|[?]|kg/L|[?]|1|g/L|SUPRATENTORIAL BRAIN|UNILATERAL||Y|INTERVIEWER|2|Visit_2|25|7|FOLLOW-UP|2020-07-06|25
e|FA|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|10^4/hpf|[?]|1|Pa|BRAIN VENTRICLE|CONTRALATERAL|Y||INTERVIEWER|3|Visit_3|40|7|WASHOUT|2020-07-21|40
e|FA|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|6|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|m/sec2|[?]|1|Shock Wave|RAMUS INTERMEDIUS ARTERY|LATERAL||Y|SIBLING|3|Visit_3|40|5|WASHOUT|2020-07-21|40
e|FA|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|7|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|cL|[?]|1|cm H2O|ADDUCTOR BREVIS MUSCLE|RIGHT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2020-08-15|65
e|FA|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|8|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|umol/L/h|[?]|1|mg/dose|RETINAL NERVE FIBER LAYER|CONTRALATERAL|||SPOUSE|4|Visit_4|65|1|TREATMENT|2020-08-15|65
e|FA|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|9|DCAL|Dietary Calories|[?]|GERD|[?]|tuberculin unit|[?]|1|EIA unit|CAPITATE-LUNATE JOINT|CONTRALATERAL|Y|Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|FOLLOW-UP|2020-09-09|90
e|FA|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Hz/s|[?]|1|mg/g/min|CAPITATE BONE|UNILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|FOLLOW-UP|2020-09-09|90
e|FA|08944dcd-a62d-4932-bb15-a8f15cc73229|1|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|Linear ft*LB|[?]|1|cm|HEART, RIGHT VENTRICLE|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2020-12-23|10
e|FA|08944dcd-a62d-4932-bb15-a8f15cc73229|2|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|IU/L|[?]|1|SCOOPFUL|RETINAL PIGMENTED EPITHELIAL LAYER|BILATERAL|||PROXY|1|Visit_1|10|5|TREATMENT|2020-12-23|10
e|FA|08944dcd-a62d-4932-bb15-a8f15cc73229|3|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/cage/wk|[?]|1|10^9 CFU/mL|KNEE JOINT TENDONS|UNILATERAL|Y||INTERVIEWER|2|Visit_2|25|2|TREATMENT|2021-01-07|25
e|FA|08944dcd-a62d-4932-bb15-a8f15cc73229|4|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|Farad|[?]|1|g/dL|GLUTEUS MAXIMUS|UNILATERAL|||GUARDIAN|2|Visit_2|25|4|WASHOUT|2021-01-07|25
e|FA|08944dcd-a62d-4932-bb15-a8f15cc73229|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|USP U|[?]|1|%(v/v)|PERICARDIAL CAVITY|LEFT|Y||STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2021-01-22|40
e|FA|08944dcd-a62d-4932-bb15-a8f15cc73229|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mL*cmH2O|[?]|1|%(v/v)|FOREBRAIN|BILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|7|WASHOUT|2021-01-22|40
e|FA|08944dcd-a62d-4932-bb15-a8f15cc73229|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|keV|[?]|1|mg/g/min|WRIST JOINT FLEXOR MUSCLES|IPSILATERAL|Y|Y|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-02-16|65
e|FA|08944dcd-a62d-4932-bb15-a8f15cc73229|8|SEV|Severity/Intensity|[?]|GERD|[?]|L/h|[?]|1|Pa|CAROTID ARTERY|IPSILATERAL|||SPOUSE|4|Visit_4|65|2|TREATMENT|2021-02-16|65
e|FA|08944dcd-a62d-4932-bb15-a8f15cc73229|9|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|mL/h|THYROID GLAND, RIGHT LOBE|RIGHT|||INDEPENDENT ASSESSOR|5|Visit_5|90|3|WASHOUT|2021-03-13|90
e|FA|08944dcd-a62d-4932-bb15-a8f15cc73229|10|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|log10 CFU/mL|[?]|1|EIA unit|RETINAL ARTERY|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2021-03-13|90
e|FA|1d7df560-695a-41fe-9226-4cc206b05f48|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/kg/h|[?]|1|mg/g/min|DISTAL PHALANX 2 OF THE HAND|LATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-12-09|10
e|FA|1d7df560-695a-41fe-9226-4cc206b05f48|2|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|mol/L|[?]|1|DRUM|ESOPHAGUS, CERVICAL|RIGHT|||INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-12-09|10
e|FA|1d7df560-695a-41fe-9226-4cc206b05f48|3|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|10^3 DNA copies/mL|[?]|1|uCi/kg|RETINAL PIGMENTED EPITHELIAL LAYER|RIGHT||Y|DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-12-24|25
e|FA|1d7df560-695a-41fe-9226-4cc206b05f48|4|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|mmol/kg|[?]|1|ng|INTERPHALANGEAL JOINT 3 OF THE FOOT|LEFT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|FOLLOW-UP|2020-12-24|25
e|FA|1d7df560-695a-41fe-9226-4cc206b05f48|5|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|cd*s/m2|[?]|1|/500 WBC|PANCREATIC DUCT|CONTRALATERAL|||GUARDIAN|3|Visit_3|40|6|FOLLOW-UP|2021-01-08|40
e|FA|1d7df560-695a-41fe-9226-4cc206b05f48|6|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|mEq|[?]|1|L|OSTIOMEATAL COMPLEX|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|FOLLOW-UP|2021-01-08|40
e|FA|1d7df560-695a-41fe-9226-4cc206b05f48|7|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|nmol/kg/day|[?]|1|ng|RENAL PELVIS|LEFT|||PROXY|4|Visit_4|65|5|TREATMENT|2021-02-02|65
e|FA|1d7df560-695a-41fe-9226-4cc206b05f48|8|OBJTYPE|Type of Object|[?]|GERD|[?]|CAN|[?]|1|ng|CERVICAL VERTEBRA|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2021-02-02|65
e|FA|1d7df560-695a-41fe-9226-4cc206b05f48|9|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|hr/day|[?]|1|aMFI|PRIMARY VISUAL CORTEX|LATERAL|Y|Y|PARENT|5|Visit_5|90|2|TREATMENT|2021-02-27|90
e|FA|1d7df560-695a-41fe-9226-4cc206b05f48|10|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mL|[?]|1|ug/kg/h|PANCREAS, HEAD|RIGHT|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|WASHOUT|2021-02-27|90
e|FA|12c802a8-862c-45a4-b12c-a6f920772534|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|%(v/v)|DISTANT LYMPH NODE|CONTRALATERAL|||FRIEND|1|Visit_1|10|3|TREATMENT|2020-06-17|10
e|FA|12c802a8-862c-45a4-b12c-a6f920772534|2|EXTRSCT|Extent of Resection|[?]|GERD|[?]|kPa|[?]|1|Weber|SUPERIOR PUBIC RAMUS|BILATERAL|Y||INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-06-17|10
e|FA|12c802a8-862c-45a4-b12c-a6f920772534|3|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|% INHIBITION|[?]|1|fmol|PALATINE BONE|IPSILATERAL|||GUARDIAN|2|Visit_2|25|2|TREATMENT|2020-07-02|25
e|FA|12c802a8-862c-45a4-b12c-a6f920772534|4|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|10^6 U|[?]|1|TRANSDUCING UNIT/mL|NASAL BONE|BILATERAL||Y|VENDOR|2|Visit_2|25|4|WASHOUT|2020-07-02|25
e|FA|12c802a8-862c-45a4-b12c-a6f920772534|5|SEV|Severity/Intensity|[?]|GERD|[?]|GLOBULE|[?]|1|Pa|ABDOMINAL AORTA|LEFT||Y|FRIEND|3|Visit_3|40|3|TREATMENT|2020-07-17|40
e|FA|12c802a8-862c-45a4-b12c-a6f920772534|6|DCAL|Dietary Calories|[?]|GERD|[?]|MPL U/mL|[?]|1|EIA unit|AXIAL SKELETON|LEFT|Y|Y|VENDOR|3|Visit_3|40|1|TREATMENT|2020-07-17|40
e|FA|12c802a8-862c-45a4-b12c-a6f920772534|7|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|CYLINDER|[?]|1|BP|AMYGDALA|LATERAL||Y|FRIEND|4|Visit_4|65|5|TREATMENT|2020-08-11|65
e|FA|12c802a8-862c-45a4-b12c-a6f920772534|8|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|mL/g/min|[?]|1|g/L|HAND|RIGHT||Y|SIGNIFICANT OTHER|4|Visit_4|65|6|FOLLOW-UP|2020-08-11|65
e|FA|12c802a8-862c-45a4-b12c-a6f920772534|9|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|MPS U|[?]|1|mL/min/mmHg|ILEUM WALL|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|FOLLOW-UP|2020-09-05|90
e|FA|12c802a8-862c-45a4-b12c-a6f920772534|10|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|ng|PANCREAS, BODY|BILATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|7|TREATMENT|2020-09-05|90
e|FA|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|1|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|10^7 CFU|[?]|1|g/L|SPLENIC VEIN|RIGHT|||SPOUSE|1|Visit_1|10|3|TREATMENT|2020-11-23|10
e|FA|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|2|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|vg/kg|[?]|1|SCOOPFUL|COCCYGEAL VERTEBRA|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-11-23|10
e|FA|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|3|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|BAG|COMMON FEMORAL ARTERY|RIGHT|Y|Y|INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-12-08|25
e|FA|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|4|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|uIU/dL|[?]|1|uCi/kg|HAND DIGIT 4|LEFT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|6|SCREENING|2020-12-08|25
e|FA|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|5|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|ug/animal|[?]|1|DRUM|METACARPOPHALANGEAL JOINT 4|BILATERAL|Y|Y|DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-12-23|40
e|FA|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|6|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|uV2|[?]|1|ohm|HAND DIGIT 1|LEFT|||CHILD|3|Visit_3|40|4|TREATMENT|2020-12-23|40
e|FA|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|g/m2/day|[?]|1|PFU/dose|PREPUTIAL GLAND|LEFT||Y|SPOUSE|4|Visit_4|65|3|TREATMENT|2021-01-17|65
e|FA|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|8|LENRSCT|Length of Resection|[?]|GERD|[?]|ug/dL|[?]|1|psi|LATERAL SECOND DIAGONAL BRANCH ARTERY|IPSILATERAL|Y||VENDOR|4|Visit_4|65|3|FOLLOW-UP|2021-01-17|65
e|FA|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|9|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|mIU/L|BUCCAL LYMPH NODE|LATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|TREATMENT|2021-02-11|90
e|FA|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|10|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|Gy/h|[?]|1|g/dL|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|IPSILATERAL|||PARENT|5|Visit_5|90|5|TREATMENT|2021-02-11|90
e|FA|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|1|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|mL/cage|[?]|1|gtt|OCCIPITAL SCALP|LATERAL||Y|STUDY SUBJECT|1|Visit_1|10|4|WASHOUT|2020-08-16|10
e|FA|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|2|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|DRUM|[?]|1|Weber|PINEAL GLAND|LEFT|||INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-08-16|10
e|FA|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|3|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|bel|[?]|1|/500 WBC|HYPOPHARYNX|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|WASHOUT|2020-08-31|25
e|FA|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|4|LESNUM|Number of Lesions|[?]|GERD|[?]|U/L|[?]|1|ng/day|PLEURAL CAVITY|LATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|FOLLOW-UP|2020-08-31|25
e|FA|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|5|DCAL|Dietary Calories|[?]|GERD|[?]|um|[?]|1|EIA unit|SCAPHOID-RADIUS JOINT|UNILATERAL|||CAREGIVER|3|Visit_3|40|3|WASHOUT|2020-09-15|40
e|FA|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|6|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|ng/day|WARDS TRIANGLE|LEFT|||INVESTIGATOR|3|Visit_3|40|2|WASHOUT|2020-09-15|40
e|FA|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|7|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|uCi/L|[?]|1|TRANSDUCING UNIT/mL|HYOID BONE|CONTRALATERAL|Y||CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-10-10|65
e|FA|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|8|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|nmol BCE/L|[?]|1|10^6 U|FUNDUS OF THE STOMACH|LEFT|||GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-10-10|65
e|FA|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|9|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|HOMEOPATHIC DILUTION|[?]|1|vp/dose|HEART, RIGHT ATRIAL APPENDAGE|LATERAL|||SPOUSE|5|Visit_5|90|6|FOLLOW-UP|2020-11-04|90
e|FA|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|10|SEV|Severity/Intensity|[?]|GERD|[?]|U/kg|[?]|1|Pa|PRIMARY VISUAL CORTEX|IPSILATERAL|||SIBLING|5|Visit_5|90|1|TREATMENT|2020-11-04|90
e|FA|96114171-59a0-4543-b3ec-c7796ae8ee92|1|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|umol/L/sec|[?]|1|10^6 U|COMMON ILIAC ARTERY|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-11-24|10
e|FA|96114171-59a0-4543-b3ec-c7796ae8ee92|2|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|mOsm|[?]|1|mm/h|OLECRANON|BILATERAL|||FRIEND|1|Visit_1|10|4|TREATMENT|2020-11-24|10
e|FA|96114171-59a0-4543-b3ec-c7796ae8ee92|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|nmol/day|[?]|1|mg/g/min|TRICUSPID VALVE, SEPTAL CUSP|IPSILATERAL|||INVESTIGATOR|2|Visit_2|25|7|FOLLOW-UP|2020-12-09|25
e|FA|96114171-59a0-4543-b3ec-c7796ae8ee92|4|SEV|Severity/Intensity|[?]|GERD|[?]|kV|[?]|1|Pa|CENTRAL NERVOUS SYSTEM|LATERAL|||CAREGIVER|2|Visit_2|25|5|WASHOUT|2020-12-09|25
e|FA|96114171-59a0-4543-b3ec-c7796ae8ee92|5|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|ug/min|[?]|1|BOWL|MEDIASTINUM, ANTERIOR|LEFT|||FRIEND|3|Visit_3|40|2|TREATMENT|2020-12-24|40
e|FA|96114171-59a0-4543-b3ec-c7796ae8ee92|6|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|tsp|[?]|1|EIA unit|THYROID GLAND ISTHMUS|RIGHT|||INDEPENDENT ASSESSOR|3|Visit_3|40|2|FOLLOW-UP|2020-12-24|40
e|FA|96114171-59a0-4543-b3ec-c7796ae8ee92|7|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|U/L|[?]|1|mm/h|CELIAC LYMPH NODE|BILATERAL||Y|VENDOR|4|Visit_4|65|5|TREATMENT|2021-01-18|65
e|FA|96114171-59a0-4543-b3ec-c7796ae8ee92|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|%(v/v)|TRICUSPID VALVE|IPSILATERAL|||FRIEND|4|Visit_4|65|6|FOLLOW-UP|2021-01-18|65
e|FA|96114171-59a0-4543-b3ec-c7796ae8ee92|9|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|msec|[?]|1|HOURS|PROSTATE GLAND, POSTERIOR LOBE|IPSILATERAL|Y||GUARDIAN|5|Visit_5|90|6|TREATMENT|2021-02-12|90
e|FA|96114171-59a0-4543-b3ec-c7796ae8ee92|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|U/g Hb|[?]|1|oz eq|LEFT MAIN CORONARY ARTERY BODY|IPSILATERAL|||SPOUSE|5|Visit_5|90|1|FOLLOW-UP|2021-02-12|90
e|FA|0070d42d-c864-4a83-a3c9-4c8ca7de51de|1|DFATT|Dietary Fat, Total|[?]|GERD|[?]|fmol/L/sec|[?]|1|Bq/mg|CORPUS CALLOSUM|CONTRALATERAL|||PARENT|1|Visit_1|10|7|FOLLOW-UP|2020-08-15|10
e|FA|0070d42d-c864-4a83-a3c9-4c8ca7de51de|2|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|ukat|[?]|1|PACK|COLON, TRANSVERSE|LATERAL|||INTERVIEWER|1|Visit_1|10|5|SCREENING|2020-08-15|10
e|FA|0070d42d-c864-4a83-a3c9-4c8ca7de51de|3|SEV|Severity/Intensity|[?]|GERD|[?]|10^7 CFU|[?]|1|Pa|FASCIA|RIGHT||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|7|SCREENING|2020-08-30|25
e|FA|0070d42d-c864-4a83-a3c9-4c8ca7de51de|4|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|MESF|[?]|1|10^9 CFU/g|STERNOCLAVICULAR JOINT|RIGHT|Y|Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-08-30|25
e|FA|0070d42d-c864-4a83-a3c9-4c8ca7de51de|5|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/dose|[?]|1|g/day|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|FOLLOW-UP|2020-09-14|40
e|FA|0070d42d-c864-4a83-a3c9-4c8ca7de51de|6|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|kUSP|[?]|1|mL|INFRACLAVICULAR LYMPH NODE|CONTRALATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|1|WASHOUT|2020-09-14|40
e|FA|0070d42d-c864-4a83-a3c9-4c8ca7de51de|7|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|10^4 CFU/mL|RIGHT CORONARY ARTERY OSTIUM|LEFT|||INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2020-10-09|65
e|FA|0070d42d-c864-4a83-a3c9-4c8ca7de51de|8|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|oz eq|ANKLE JOINT ANTERIOR FLEXOR TENDONS|IPSILATERAL|Y|Y|PROXY|4|Visit_4|65|1|TREATMENT|2020-10-09|65
e|FA|0070d42d-c864-4a83-a3c9-4c8ca7de51de|9|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|kg/mol|[?]|1|in|PELVIC LYMPH NODE|UNILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|FOLLOW-UP|2020-11-03|90
e|FA|0070d42d-c864-4a83-a3c9-4c8ca7de51de|10|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|uL/dose|[?]|1|umol|SMALL INTESTINE|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-11-03|90
e|FA|a2ec3389-6f5f-44a3-a6dd-f6177a805791|1|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|Log10 ELISA unit|[?]|1|g/day|FLEXOR POLLICIS LONGUS MUSCLE|LATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-10-17|10
e|FA|a2ec3389-6f5f-44a3-a6dd-f6177a805791|2|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|10^8/L|[?]|1|mg/h|PERIPANCREATIC LYMPH NODE|LEFT|||PARENT|1|Visit_1|10|4|SCREENING|2020-10-17|10
e|FA|a2ec3389-6f5f-44a3-a6dd-f6177a805791|3|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|FIU|[?]|1|mL/mmHg/min/L|OROPHARYNX|RIGHT|||ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-11-01|25
e|FA|a2ec3389-6f5f-44a3-a6dd-f6177a805791|4|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|anti-Xa IU|[?]|1|TRANSDUCING UNIT/mL|INCISOR|LEFT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-11-01|25
e|FA|a2ec3389-6f5f-44a3-a6dd-f6177a805791|5|SPEED|Speed|[?]|GERD|[?]|fmol/g|[?]|1|mEq/g|RIB 5|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|5|TREATMENT|2020-11-16|40
e|FA|a2ec3389-6f5f-44a3-a6dd-f6177a805791|6|LOCONSET|Localization of Onset|[?]|GERD|[?]|IU/mmol|[?]|1|g/L|BLADDER|LEFT|Y||STUDY SUBJECT|3|Visit_3|40|2|SCREENING|2020-11-16|40
e|FA|a2ec3389-6f5f-44a3-a6dd-f6177a805791|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|%(v/v)|PERIPHERAL NERVE|IPSILATERAL|Y||CAREGIVER|4|Visit_4|65|3|WASHOUT|2020-12-11|65
e|FA|a2ec3389-6f5f-44a3-a6dd-f6177a805791|8|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|mL/min/mmHg|[?]|1|TRANSDUCING UNIT/mL|OCCIPITAL LYMPH NODE|LATERAL|||VENDOR|4|Visit_4|65|1|WASHOUT|2020-12-11|65
e|FA|a2ec3389-6f5f-44a3-a6dd-f6177a805791|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Mile|[?]|1|mg/g/min|INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-01-05|90
e|FA|a2ec3389-6f5f-44a3-a6dd-f6177a805791|10|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|K|[?]|1|mg/dose|SKIN OF THE LIP|LATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|3|FOLLOW-UP|2021-01-05|90
e|FA|cc562042-9641-460d-862e-d6923dd4207d|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|Pa|LIVER, LEFT LOBE|UNILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-05-27|10
e|FA|cc562042-9641-460d-862e-d6923dd4207d|2|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|kg/mol|[?]|1|Shock Wave|PRELARYNGEAL LYMPH NODE|CONTRALATERAL|||PROXY|1|Visit_1|10|6|WASHOUT|2020-05-27|10
e|FA|cc562042-9641-460d-862e-d6923dd4207d|3|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|Joule|[?]|1|Log10 ELISA unit|HEPATOBILIARY SYSTEM|LATERAL|Y|Y|INVESTIGATOR|2|Visit_2|25|4|WASHOUT|2020-06-11|25
e|FA|cc562042-9641-460d-862e-d6923dd4207d|4|LESNUM|Number of Lesions|[?]|GERD|[?]|Pack Year|[?]|1|ng/day|THYMUS GLAND|CONTRALATERAL|Y||INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2020-06-11|25
e|FA|cc562042-9641-460d-862e-d6923dd4207d|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|kcal|[?]|1|%(v/v)|FEMORAL NECK|UNILATERAL|||SPOUSE|3|Visit_3|40|2|TREATMENT|2020-06-26|40
e|FA|cc562042-9641-460d-862e-d6923dd4207d|6|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|anti-Xa IU/mL|AXILLARY LYMPH NODE LEVEL I|RIGHT|||VENDOR|3|Visit_3|40|4|WASHOUT|2020-06-26|40
e|FA|cc562042-9641-460d-862e-d6923dd4207d|7|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|mEq/dL|[?]|1|BOWL|ACHILLES TENDON|BILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2020-07-21|65
e|FA|cc562042-9641-460d-862e-d6923dd4207d|8|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|MET|[?]|1|AU/mL|TIBIALIS POSTERIOR MUSCLE|CONTRALATERAL|Y|Y|DOMESTIC PARTNER|4|Visit_4|65|5|TREATMENT|2020-07-21|65
e|FA|cc562042-9641-460d-862e-d6923dd4207d|9|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|TRACE|[?]|1|oz eq|HYMENAL RING|IPSILATERAL|||CAREGIVER|5|Visit_5|90|2|WASHOUT|2020-08-15|90
e|FA|cc562042-9641-460d-862e-d6923dd4207d|10|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|pptr|[?]|1|Shock Wave|SECOND RIGHT POSTEROLATERAL ARTERY|LEFT|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-08-15|90
e|FA|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/g/h|[?]|1|mg/g/min|PERITONEAL CAVITY|CONTRALATERAL|Y|Y|PARENT|1|Visit_1|10|2|TREATMENT|2020-07-30|10
e|FA|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|2|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|tuberculin unit/mL|[?]|1|mg/dose|FINGER EXTENSOR MUSCLES|BILATERAL|Y||INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-07-30|10
e|FA|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|3|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|mL|CLITORIS|LEFT|||INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-08-14|25
e|FA|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^6 RNA copies/mL|[?]|1|%(v/v)|OPPONENS POLLICIS MUSCLE|IPSILATERAL||Y|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-08-14|25
e|FA|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|5|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|pkat|[?]|1|mL/cm3/min|TOENAIL|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|FOLLOW-UP|2020-08-29|40
e|FA|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|6|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ng|[?]|1|umol|SKIN OF THE SOLE|IPSILATERAL|Y||SIBLING|3|Visit_3|40|5|TREATMENT|2020-08-29|40
e|FA|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|7|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|CAPSULE|[?]|1|cm H2O|PYRAMIDAL TRACTS, INTERNAL CAPSULE|UNILATERAL||Y|DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2020-09-23|65
e|FA|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|8|QOLIMP|QOL Impact|[?]|GERD|[?]|/500 WBC|[?]|1|10^6/L|FIRST RIGHT POSTEROLATERAL ARTERY|LEFT|||INTERVIEWER|4|Visit_4|65|2|FOLLOW-UP|2020-09-23|65
e|FA|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|9|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|Ci/ug|[?]|1|ohm|BRACHIAL PLEXUS|CONTRALATERAL|Y|Y|GUARDIAN|5|Visit_5|90|3|TREATMENT|2020-10-18|90
e|FA|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|10|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|cm/s|[?]|1|BAG|LOCUS CERULEUS|CONTRALATERAL|||FAMILY MEMBER|5|Visit_5|90|1|SCREENING|2020-10-18|90
e|FA|d90f2824-692e-403f-b1ca-5b6462c93a75|1|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|gtt|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|RIGHT||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-07-15|10
e|FA|d90f2824-692e-403f-b1ca-5b6462c93a75|2|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|RATIO|[?]|1|U/mmol|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LEFT|Y|Y|DOMESTIC PARTNER|1|Visit_1|10|7|SCREENING|2020-07-15|10
e|FA|d90f2824-692e-403f-b1ca-5b6462c93a75|3|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|IU/kg|[?]|1|g/day|GASTROINTESTINAL TRACT, LOWER|LATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|2|TREATMENT|2020-07-30|25
e|FA|d90f2824-692e-403f-b1ca-5b6462c93a75|4|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mL/kg/day|[?]|1|NEEDLE GAUGE|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|BILATERAL||Y|PARENT|2|Visit_2|25|5|TREATMENT|2020-07-30|25
e|FA|d90f2824-692e-403f-b1ca-5b6462c93a75|5|DFATT|Dietary Fat, Total|[?]|GERD|[?]|nCi|[?]|1|Bq/mg|SCAPHOID-TRAPEZOID JOINT|CONTRALATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2020-08-14|40
e|FA|d90f2824-692e-403f-b1ca-5b6462c93a75|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|QUANTITY SUFFICIENT|RECTOVAGINAL SPACE|RIGHT|||PARENT|3|Visit_3|40|6|WASHOUT|2020-08-14|40
e|FA|d90f2824-692e-403f-b1ca-5b6462c93a75|7|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|10^9 CFU/g|[?]|1|10^6 U|OBTURATOR MUSCLE|LATERAL|||PROXY|4|Visit_4|65|4|WASHOUT|2020-09-08|65
e|FA|d90f2824-692e-403f-b1ca-5b6462c93a75|8|LOCONSET|Localization of Onset|[?]|GERD|[?]|IU/day|[?]|1|g/L|INTERPHALANGEAL JOINT 3|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|WASHOUT|2020-09-08|65
e|FA|d90f2824-692e-403f-b1ca-5b6462c93a75|9|STROKTYP|Stroke Type|[?]|GERD|[?]|nU/cL|[?]|1|g/L|PROSTATE GLAND|LATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|TREATMENT|2020-10-03|90
e|FA|d90f2824-692e-403f-b1ca-5b6462c93a75|10|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|min/day|[?]|1|SCOOPFUL|LEFT ATRIOVENTRICULAR ARTERY|UNILATERAL|||SIBLING|5|Visit_5|90|7|TREATMENT|2020-10-03|90
e|FA|ee0e55e1-6107-4a3c-85b4-cb48300153e8|1|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|dyn|[?]|1|IU/mmol|HEEL OF THE HAND|UNILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|WASHOUT|2020-05-25|10
e|FA|ee0e55e1-6107-4a3c-85b4-cb48300153e8|2|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/mmol|[?]|1|km|OCCIPITAL SCALP|BILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|3|FOLLOW-UP|2020-05-25|10
e|FA|ee0e55e1-6107-4a3c-85b4-cb48300153e8|3|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|C|[?]|1|Gy/h|XIPHOID PROCESS|UNILATERAL|||FRIEND|2|Visit_2|25|1|FOLLOW-UP|2020-06-09|25
e|FA|ee0e55e1-6107-4a3c-85b4-cb48300153e8|4|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|10^7 CFU/mL|[?]|1|AU/mL|ANUS|RIGHT|Y|Y|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-06-09|25
e|FA|ee0e55e1-6107-4a3c-85b4-cb48300153e8|5|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|%|[?]|1|gtt|SACRAL VERTEBRA|RIGHT|||PARENT|3|Visit_3|40|7|TREATMENT|2020-06-24|40
e|FA|ee0e55e1-6107-4a3c-85b4-cb48300153e8|6|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|U/mmol|[?]|1|U/10^12 RBC|MITRAL VALVE ANNULUS|CONTRALATERAL|||VENDOR|3|Visit_3|40|7|TREATMENT|2020-06-24|40
e|FA|ee0e55e1-6107-4a3c-85b4-cb48300153e8|7|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|10^6 RNA copies/mL|[?]|1|mL/m2|SYNOVIAL FLUID|BILATERAL|||PROXY|4|Visit_4|65|4|SCREENING|2020-07-19|65
e|FA|ee0e55e1-6107-4a3c-85b4-cb48300153e8|8|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/mL|[?]|1|MPS U|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|UNILATERAL|||INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-07-19|65
e|FA|ee0e55e1-6107-4a3c-85b4-cb48300153e8|9|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|uEq|[?]|1|Gy/h|ELBOW JOINT|IPSILATERAL||Y|CHILD|5|Visit_5|90|2|SCREENING|2020-08-13|90
e|FA|ee0e55e1-6107-4a3c-85b4-cb48300153e8|10|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|10^3 organisms/g|[?]|1|mm/h|PYRAMIDAL TRACTS, INTERNAL CAPSULE|CONTRALATERAL|Y|Y|INTERVIEWER|5|Visit_5|90|4|FOLLOW-UP|2020-08-13|90
e|FA|6aa37bb3-85aa-427f-9e56-a776257f1548|1|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|anti-Xa IU/mL|[?]|1|mL/cm3/min|OLECRANON|CONTRALATERAL|||VENDOR|1|Visit_1|10|2|TREATMENT|2020-11-14|10
e|FA|6aa37bb3-85aa-427f-9e56-a776257f1548|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|MET*h|[?]|1|Pa|INTERPHALANGEAL JOINT 1|UNILATERAL|Y||ADJUDICATOR|1|Visit_1|10|1|WASHOUT|2020-11-14|10
e|FA|6aa37bb3-85aa-427f-9e56-a776257f1548|3|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|Gy|[?]|1|g/day|APPENDICULAR SKELETON|IPSILATERAL|Y||DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-11-29|25
e|FA|6aa37bb3-85aa-427f-9e56-a776257f1548|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|/10^4|[?]|1|mg/g/min|CORPUS CALLOSUM, BODY|LATERAL|||SPOUSE|2|Visit_2|25|2|FOLLOW-UP|2020-11-29|25
e|FA|6aa37bb3-85aa-427f-9e56-a776257f1548|5|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|MAC50|[?]|1|/kg|PARASYMPATHETIC GANGLIA|UNILATERAL|||INTERVIEWER|3|Visit_3|40|7|FOLLOW-UP|2020-12-14|40
e|FA|6aa37bb3-85aa-427f-9e56-a776257f1548|6|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|Shock Wave|[?]|1|SCOOPFUL|HAIR|IPSILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|7|TREATMENT|2020-12-14|40
e|FA|6aa37bb3-85aa-427f-9e56-a776257f1548|7|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|copies/uL|[?]|1|DROP|RADIUS SHAFT|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|WASHOUT|2021-01-08|65
e|FA|6aa37bb3-85aa-427f-9e56-a776257f1548|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|IU/mg|[?]|1|Pa|SUBMANDIBULAR GLAND|LATERAL||Y|PARENT|4|Visit_4|65|2|FOLLOW-UP|2021-01-08|65
e|FA|6aa37bb3-85aa-427f-9e56-a776257f1548|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|mL/dose|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|||GUARDIAN|5|Visit_5|90|4|WASHOUT|2021-02-02|90
e|FA|6aa37bb3-85aa-427f-9e56-a776257f1548|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|umol/L/sec|[?]|1|Pa|COLON WALL|CONTRALATERAL|||FRIEND|5|Visit_5|90|3|TREATMENT|2021-02-02|90
e|FA|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|1|TOXGR|Toxicity Grade|[?]|GERD|[?]|ug/animal|[?]|1|aMFI|AXILLARY LYMPH NODE LEVEL I|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-05-18|10
e|FA|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|2|DISTANCE|Distance|[?]|GERD|[?]|log10 IU/mL|[?]|1|BOWL|BONE MARROW|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|1|FOLLOW-UP|2020-05-18|10
e|FA|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|3|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|fmol/g|[?]|1|PFU/dose|OLFACTORY NERVE|LATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2020-06-02|25
e|FA|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|4|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|TABLET|[?]|1|Log10 ELISA unit|URETHRA|BILATERAL|||INTERVIEWER|2|Visit_2|25|7|TREATMENT|2020-06-02|25
e|FA|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|5|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|log10 PFU/mL|[?]|1|SACHET|CALCANEUS|RIGHT||Y|DOMESTIC PARTNER|3|Visit_3|40|2|SCREENING|2020-06-17|40
e|FA|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|6|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|/40 HPFs|[?]|1|ug/kg/h|VAGINA|LEFT|||INTERVIEWER|3|Visit_3|40|7|FOLLOW-UP|2020-06-17|40
e|FA|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|7|STRCTNUM|Number of Strictures|[?]|GERD|[?]|log10 copies/mL|[?]|1|SACHET|INTERPHALANGEAL JOINT 5 OF THE FOOT|LEFT|||ADJUDICATION COMMITTEE|4|Visit_4|65|1|WASHOUT|2020-07-12|65
e|FA|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|8|TOTNUM|Total Number|[?]|GERD|[?]|mL/m2/h|[?]|1|/200 HPFs|MUCOSA|LATERAL||Y|INVESTIGATOR|4|Visit_4|65|7|WASHOUT|2020-07-12|65
e|FA|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|9|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|in|T7 VERTEBRA|LEFT|Y||SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2020-08-06|90
e|FA|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|10|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mmHg/sec|[?]|1|mAmp|KNEE JOINT TENDONS|BILATERAL|Y|Y|STUDY SUBJECT|5|Visit_5|90|5|FOLLOW-UP|2020-08-06|90
e|FA|940d4614-b41a-44d3-b878-6e19ee22f24b|1|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|g/animal/day|[?]|1|Shock Wave|C3 VERTEBRA|LATERAL|Y||SIBLING|1|Visit_1|10|5|SCREENING|2020-07-06|10
e|FA|940d4614-b41a-44d3-b878-6e19ee22f24b|2|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|QUANTITY SUFFICIENT|THORACIC SPINE|LEFT|||CHILD|1|Visit_1|10|5|TREATMENT|2020-07-06|10
e|FA|940d4614-b41a-44d3-b878-6e19ee22f24b|3|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|CCID 50/mL|[?]|1|psi|MEDIAL FEMORAL CONDYLE|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-07-21|25
e|FA|940d4614-b41a-44d3-b878-6e19ee22f24b|4|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|IU/dL|[?]|1|BAG|C5 VERTEBRA|UNILATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2020-07-21|25
e|FA|940d4614-b41a-44d3-b878-6e19ee22f24b|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|/kg|[?]|1|%(v/v)|BUCCAL LYMPH NODE|UNILATERAL|Y||CHILD|3|Visit_3|40|1|FOLLOW-UP|2020-08-05|40
e|FA|940d4614-b41a-44d3-b878-6e19ee22f24b|6|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|APL U/mL|[?]|1|NEEDLE GAUGE|POPLITEAL LYMPH NODE|BILATERAL|||FRIEND|3|Visit_3|40|1|FOLLOW-UP|2020-08-05|40
e|FA|940d4614-b41a-44d3-b878-6e19ee22f24b|7|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|MBq/uL|[?]|1|oz eq|SKIN OF THE INGUINAL REGION|RIGHT||Y|FRIEND|4|Visit_4|65|2|TREATMENT|2020-08-30|65
e|FA|940d4614-b41a-44d3-b878-6e19ee22f24b|8|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|cy/cm|[?]|1|/500 WBC|ANAL CANAL|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|6|SCREENING|2020-08-30|65
e|FA|940d4614-b41a-44d3-b878-6e19ee22f24b|9|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|/mm2|[?]|1|uCi/kg|OMENTUM|UNILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2020-09-24|90
e|FA|940d4614-b41a-44d3-b878-6e19ee22f24b|10|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mmAL|[?]|1|L/h/m2|CANINE TOOTH|IPSILATERAL|||INVESTIGATOR|5|Visit_5|90|4|WASHOUT|2020-09-24|90
e|FA|e2edd4f0-926b-4514-bf3f-7449f248343f|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|C|[?]|1|%(v/v)|ACETABULUM|RIGHT|||CHILD|1|Visit_1|10|7|TREATMENT|2020-11-01|10
e|FA|e2edd4f0-926b-4514-bf3f-7449f248343f|2|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|ug/L/h|[?]|1|/500 WBC|RAMUS INTERMEDIUS ARTERY|IPSILATERAL||Y|INTERVIEWER|1|Visit_1|10|7|FOLLOW-UP|2020-11-01|10
e|FA|e2edd4f0-926b-4514-bf3f-7449f248343f|3|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|kg/cm|[?]|1|/kg|INFERIOR VENA CAVA|CONTRALATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-11-16|25
e|FA|e2edd4f0-926b-4514-bf3f-7449f248343f|4|SPEED|Speed|[?]|GERD|[?]|10^7 TCID 50/dose|[?]|1|mEq/g|C6 VERTEBRA|LATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|6|FOLLOW-UP|2020-11-16|25
e|FA|e2edd4f0-926b-4514-bf3f-7449f248343f|5|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|mU/g|[?]|1|AU/mL|HUMERAL EPICONDYLE|IPSILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|6|SCREENING|2020-12-01|40
e|FA|e2edd4f0-926b-4514-bf3f-7449f248343f|6|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|LOZENGE|[?]|1|gtt|C1 VERTEBRA|LEFT||Y|STUDY SUBJECT|3|Visit_3|40|3|SCREENING|2020-12-01|40
e|FA|e2edd4f0-926b-4514-bf3f-7449f248343f|7|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|Arbitrary U|[?]|1|IU/mmol|NIPPLE|RIGHT|Y||GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-12-26|65
e|FA|e2edd4f0-926b-4514-bf3f-7449f248343f|8|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|10^6 U|[?]|1|ng|QUADRICEPS MUSCLE|LATERAL|||CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-12-26|65
e|FA|e2edd4f0-926b-4514-bf3f-7449f248343f|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU|[?]|1|ug/g/h|METATARSOPHALANGEAL JOINT 4|RIGHT|||SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2021-01-20|90
e|FA|e2edd4f0-926b-4514-bf3f-7449f248343f|10|SEV|Severity/Intensity|[?]|GERD|[?]|IU/dL|[?]|1|Pa|PARASYMPATHETIC GANGLIA|UNILATERAL|||FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-01-20|90
e|FA|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|1|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|USP U|[?]|1|/200 HPFs|GASTROCNEMIUS MUSCLE, LATERAL HEAD|CONTRALATERAL|||PARENT|1|Visit_1|10|5|WASHOUT|2020-06-28|10
e|FA|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|CAPLET|[?]|1|%(v/v)|ANAL CANAL|IPSILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|7|TREATMENT|2020-06-28|10
e|FA|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|3|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|Gauss|[?]|1|mL/mmHg/min/L|GINGIVA|IPSILATERAL|Y||ADJUDICATOR|2|Visit_2|25|4|SCREENING|2020-07-13|25
e|FA|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|4|PPTFCT|Precipitating Factor|[?]|GERD|[?]|dpm/mL|[?]|1|EIA unit|PARALARYNGEAL LYMPH NODE|IPSILATERAL|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|2|FOLLOW-UP|2020-07-13|25
e|FA|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|5|DGRAIN|Dietary Grain|[?]|GERD|[?]|mol/day|[?]|1|10^9 CFU/g|INTERPHALANGEAL JOINT 2 OF THE FOOT|CONTRALATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|2|TREATMENT|2020-07-28|40
e|FA|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|6|DFRUIT|Dietary Fruit|[?]|GERD|[?]|10^9 organisms/mL|[?]|1|10^6 CFU/mL|DENTAL ARCH|IPSILATERAL|||GUARDIAN|3|Visit_3|40|5|FOLLOW-UP|2020-07-28|40
e|FA|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|7|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|DNA copies/ug|[?]|1|IU/mmol|OLFACTORY MUCOSA|IPSILATERAL|||PARENT|4|Visit_4|65|2|WASHOUT|2020-08-22|65
e|FA|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|8|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|TRANSDUCING UNIT/mL|[?]|1|anti-Xa IU/mL|OBTURATOR MUSCLE|LEFT|||ADJUDICATION COMMITTEE|4|Visit_4|65|1|TREATMENT|2020-08-22|65
e|FA|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|9|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|grain|[?]|1|L/h/m2|WARDS TRIANGLE|LATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|WASHOUT|2020-09-16|90
e|FA|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|10|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mL/cm3/min|[?]|1|ohm|SAPHENOUS VEIN|CONTRALATERAL|||INTERVIEWER|5|Visit_5|90|4|TREATMENT|2020-09-16|90
e|FA|493a53ef-01ab-470c-9bbe-7c2aa48b946b|1|DCAL|Dietary Calories|[?]|GERD|[?]|um/day|[?]|1|EIA unit|EYE|IPSILATERAL||Y|STUDY SUBJECT|1|Visit_1|10|4|WASHOUT|2020-07-13|10
e|FA|493a53ef-01ab-470c-9bbe-7c2aa48b946b|2|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|mmHg/L/min|[?]|1|ug/m2/h|HARD PALATE|UNILATERAL||Y|VENDOR|1|Visit_1|10|1|TREATMENT|2020-07-13|10
e|FA|493a53ef-01ab-470c-9bbe-7c2aa48b946b|3|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|umol/mg/min|[?]|1|mL/h|STERNAL MANUBRIUM|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|FOLLOW-UP|2020-07-28|25
e|FA|493a53ef-01ab-470c-9bbe-7c2aa48b946b|4|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|DRUM|ILEUM LYMPH NODE|BILATERAL|||STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-07-28|25
e|FA|493a53ef-01ab-470c-9bbe-7c2aa48b946b|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Bq/ug|[?]|1|mg/g/min|PERINEUM|RIGHT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|FOLLOW-UP|2020-08-12|40
e|FA|493a53ef-01ab-470c-9bbe-7c2aa48b946b|6|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|vg/kg|[?]|1|U/mmol|GREAT TROCHANTER|LATERAL|||STUDY SUBJECT|3|Visit_3|40|3|SCREENING|2020-08-12|40
e|FA|493a53ef-01ab-470c-9bbe-7c2aa48b946b|7|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|L/kg|[?]|1|Log10 ELISA unit|FIBULA|LATERAL|Y||PROXY|4|Visit_4|65|7|TREATMENT|2020-09-06|65
e|FA|493a53ef-01ab-470c-9bbe-7c2aa48b946b|8|TOTNUM|Total Number|[?]|GERD|[?]|mg/h|[?]|1|/200 HPFs|FEMORAL NECK|CONTRALATERAL|||SIBLING|4|Visit_4|65|1|TREATMENT|2020-09-06|65
e|FA|493a53ef-01ab-470c-9bbe-7c2aa48b946b|9|DMEAT|Dietary Meat|[?]|GERD|[?]|mg/kg/h|[?]|1|10^6 organisms/mL|PROXIMAL PHALANX 3 OF THE HAND|IPSILATERAL|||SIBLING|5|Visit_5|90|5|SCREENING|2020-10-01|90
e|FA|493a53ef-01ab-470c-9bbe-7c2aa48b946b|10|OBJTYPE|Type of Object|[?]|GERD|[?]|CCID 50/dose|[?]|1|ng|CALF|CONTRALATERAL||Y|SIBLING|5|Visit_5|90|4|TREATMENT|2020-10-01|90
e|FA|ba33de14-b676-4389-a863-a7fa3edb8543|1|TRTSETT|Treatment Setting|[?]|GERD|[?]|100 IU/mL|[?]|1|Coulomb|TRIANGULAR-LUNATE JOINT|LATERAL|||SPOUSE|1|Visit_1|10|7|WASHOUT|2020-11-03|10
e|FA|ba33de14-b676-4389-a863-a7fa3edb8543|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|POINT|[?]|1|%(v/v)|L3-L4 INTERVERTEBRAL SPACE|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|5|TREATMENT|2020-11-03|10
e|FA|ba33de14-b676-4389-a863-a7fa3edb8543|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|BAG|[?]|1|mg/h|ULNAR NERVE|CONTRALATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2020-11-18|25
e|FA|ba33de14-b676-4389-a863-a7fa3edb8543|4|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|Bq/ug|[?]|1|mg/dose|METATARSOPHALANGEAL JOINT 2|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|SCREENING|2020-11-18|25
e|FA|ba33de14-b676-4389-a863-a7fa3edb8543|5|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|cm|[?]|1|MBq|POSTERIOR CERVICAL LYMPH NODE|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-12-03|40
e|FA|ba33de14-b676-4389-a863-a7fa3edb8543|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|%(v/v)|AZYGOS VEIN|LEFT|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-12-03|40
e|FA|ba33de14-b676-4389-a863-a7fa3edb8543|7|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|MESF|[?]|1|10^4 CFU/mL|INTRAHEPATIC BILE DUCT|IPSILATERAL|||ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-12-28|65
e|FA|ba33de14-b676-4389-a863-a7fa3edb8543|8|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|mEq|KIDNEY, HILUM|LEFT|||SIBLING|4|Visit_4|65|7|WASHOUT|2020-12-28|65
e|FA|ba33de14-b676-4389-a863-a7fa3edb8543|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/L|[?]|1|mg/g/min|MITRAL VALVE|BILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2021-01-22|90
e|FA|ba33de14-b676-4389-a863-a7fa3edb8543|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mmol/s|[?]|1|10^6 U|APPENDIX|LEFT|||VENDOR|5|Visit_5|90|6|TREATMENT|2021-01-22|90
e|FA|24801f05-79be-433d-8124-85580bc14c4f|1|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|10^6 U|[?]|1|Hz/s|FRONTAL SINUS|LEFT|||FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-09-09|10
e|FA|24801f05-79be-433d-8124-85580bc14c4f|2|DFATT|Dietary Fat, Total|[?]|GERD|[?]|kg/mol|[?]|1|Bq/mg|RADIAL ARTERY|LATERAL||Y|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-09-09|10
e|FA|24801f05-79be-433d-8124-85580bc14c4f|3|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|cP|[?]|1|Hz/s|L3 VERTEBRA|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|WASHOUT|2020-09-24|25
e|FA|24801f05-79be-433d-8124-85580bc14c4f|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Siemens|[?]|1|mg/g/min|CORNEAL ENDOTHELIUM|UNILATERAL||Y|CHILD|2|Visit_2|25|7|TREATMENT|2020-09-24|25
e|FA|24801f05-79be-433d-8124-85580bc14c4f|5|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|SCOOPFUL|[?]|1|mmHg/L/min|THORAX|CONTRALATERAL||Y|PROXY|3|Visit_3|40|5|SCREENING|2020-10-09|40
e|FA|24801f05-79be-433d-8124-85580bc14c4f|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|AMPULE|[?]|1|Pa|ORBIT|UNILATERAL|||STUDY SUBJECT|3|Visit_3|40|4|TREATMENT|2020-10-09|40
e|FA|24801f05-79be-433d-8124-85580bc14c4f|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|pL|[?]|1|umol|INTERPHALANGEAL JOINT 3 OF THE FOOT|IPSILATERAL|||PROXY|4|Visit_4|65|6|TREATMENT|2020-11-03|65
e|FA|24801f05-79be-433d-8124-85580bc14c4f|8|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|g/dL|ILIOPSOAS MUSCLE|LATERAL|||INTERVIEWER|4|Visit_4|65|5|SCREENING|2020-11-03|65
e|FA|24801f05-79be-433d-8124-85580bc14c4f|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|F|[?]|1|mg/g/min|CANINE TOOTH|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|FOLLOW-UP|2020-11-28|90
e|FA|24801f05-79be-433d-8124-85580bc14c4f|10|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|CAPSULE|[?]|1|uCi/kg|SIGMOID SINUS|IPSILATERAL|||FRIEND|5|Visit_5|90|4|TREATMENT|2020-11-28|90
e|FA|02df80f9-2337-4abd-9452-41cd83dec8ba|1|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|L/min|[?]|1|MPS U|PANCREAS, BODY|CONTRALATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|7|FOLLOW-UP|2020-08-04|10
e|FA|02df80f9-2337-4abd-9452-41cd83dec8ba|2|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|10^6 organisms/g|[?]|1|L/h/m2|FEMORAL HEAD|LATERAL|||GUARDIAN|1|Visit_1|10|6|WASHOUT|2020-08-04|10
e|FA|02df80f9-2337-4abd-9452-41cd83dec8ba|3|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mEq/L|[?]|1|L/h/m2|FINGER|UNILATERAL||Y|SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2020-08-19|25
e|FA|02df80f9-2337-4abd-9452-41cd83dec8ba|4|EVENTNUM|Number of Events|[?]|GERD|[?]|tsp eq|[?]|1|U/10^12 RBC|RIGHT POSTERIOR DESCENDING ARTERY|LEFT|||PARENT|2|Visit_2|25|2|TREATMENT|2020-08-19|25
e|FA|02df80f9-2337-4abd-9452-41cd83dec8ba|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|nkat|[?]|1|ug/g/h|MALLEUS|CONTRALATERAL||Y|SIGNIFICANT OTHER|3|Visit_3|40|4|TREATMENT|2020-09-03|40
e|FA|02df80f9-2337-4abd-9452-41cd83dec8ba|6|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|mL/m2|GLOTTIS|RIGHT|||ADJUDICATOR|3|Visit_3|40|5|SCREENING|2020-09-03|40
e|FA|02df80f9-2337-4abd-9452-41cd83dec8ba|7|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|nmol/L|[?]|1|mmHg/L/min|EYE, ANTERIOR SEGMENT|IPSILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|3|FOLLOW-UP|2020-09-28|65
e|FA|02df80f9-2337-4abd-9452-41cd83dec8ba|8|DPROT|Dietary Protein|[?]|GERD|[?]|pt_br|[?]|1|10^4 CFU/mL|PRESACRAL SPACE|UNILATERAL|||VENDOR|4|Visit_4|65|7|FOLLOW-UP|2020-09-28|65
e|FA|02df80f9-2337-4abd-9452-41cd83dec8ba|9|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|Bq/L|[?]|1|mm|UNCINATE PROCESS OF PANCREAS|UNILATERAL||Y|GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-10-23|90
e|FA|02df80f9-2337-4abd-9452-41cd83dec8ba|10|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|vg/mL|[?]|1|g/L|AXIAL SKELETON|RIGHT||Y|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2020-10-23|90
e|FA|d9eea93b-f9f9-466c-aa8a-a250baff18ef|1|LDIAM|Longest Diameter|[?]|GERD|[?]|nmol/kg/day|[?]|1|Shock Wave|L2-L3 INTERVERTEBRAL SPACE|LEFT|||INVESTIGATOR|1|Visit_1|10|6|SCREENING|2020-08-03|10
e|FA|d9eea93b-f9f9-466c-aa8a-a250baff18ef|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|EIA unit|[?]|1|mg/g/min|AORTIC VALVE, NON-CORONARY CUSP|IPSILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|6|SCREENING|2020-08-03|10
e|FA|d9eea93b-f9f9-466c-aa8a-a250baff18ef|3|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|%|[?]|1|ug/m2/h|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2020-08-18|25
e|FA|d9eea93b-f9f9-466c-aa8a-a250baff18ef|4|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|/min|[?]|1|mL/min/mmHg|GLOMERULUS|UNILATERAL||Y|PROXY|2|Visit_2|25|5|TREATMENT|2020-08-18|25
e|FA|d9eea93b-f9f9-466c-aa8a-a250baff18ef|5|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|IU|[?]|1|m2|PUPIL|UNILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|WASHOUT|2020-09-02|40
e|FA|d9eea93b-f9f9-466c-aa8a-a250baff18ef|6|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|Ci/kg|[?]|1|Log10 ELISA unit|ANKLE JOINT|LATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|FOLLOW-UP|2020-09-02|40
e|FA|d9eea93b-f9f9-466c-aa8a-a250baff18ef|7|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|km|ILIAC LYMPH NODE|RIGHT|||STUDY SUBJECT|4|Visit_4|65|3|FOLLOW-UP|2020-09-27|65
e|FA|d9eea93b-f9f9-466c-aa8a-a250baff18ef|8|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|Shock Wave|FALLOPIAN TUBE|UNILATERAL|||SPOUSE|4|Visit_4|65|2|SCREENING|2020-09-27|65
e|FA|d9eea93b-f9f9-466c-aa8a-a250baff18ef|9|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT/mL|[?]|1|DRUM|WALDEYER'S TONSILLAR RING|LEFT|Y|Y|FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2020-10-22|90
e|FA|d9eea93b-f9f9-466c-aa8a-a250baff18ef|10|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|EID 50/mL|[?]|1|ng/day|BONE MARROW|IPSILATERAL||Y|GUARDIAN|5|Visit_5|90|3|FOLLOW-UP|2020-10-22|90
e|FA|35a59f6a-2712-4d1b-a954-f1418d4b9168|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Ci/ug|[?]|1|mg/g/min|ISCHIORECTAL FOSSA|LATERAL|||STUDY SUBJECT|1|Visit_1|10|3|TREATMENT|2020-11-05|10
e|FA|35a59f6a-2712-4d1b-a954-f1418d4b9168|2|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|uEq/L|[?]|1|ug/m2/h|ISCHIUM|BILATERAL|Y||INTERVIEWER|1|Visit_1|10|3|TREATMENT|2020-11-05|10
e|FA|35a59f6a-2712-4d1b-a954-f1418d4b9168|3|DMEAT|Dietary Meat|[?]|GERD|[?]|Linear ft*LB|[?]|1|10^6 organisms/mL|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|RIGHT|||SPOUSE|2|Visit_2|25|3|TREATMENT|2020-11-20|25
e|FA|35a59f6a-2712-4d1b-a954-f1418d4b9168|4|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|LB|[?]|1|U/10^12 RBC|GRACILIS MUSCLE|UNILATERAL|Y||STUDY SUBJECT|2|Visit_2|25|2|SCREENING|2020-11-20|25
e|FA|35a59f6a-2712-4d1b-a954-f1418d4b9168|5|DMG|Dietary Magnesium|[?]|GERD|[?]|um2|[?]|1|TRANSDUCING UNIT/mL|SUPRASPINATUS MUSCLE|RIGHT|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-12-05|40
e|FA|35a59f6a-2712-4d1b-a954-f1418d4b9168|6|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|pmol/dL|[?]|1|BOWL|L2-L3 INTERVERTEBRAL SPACE|BILATERAL||Y|GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-12-05|40
e|FA|35a59f6a-2712-4d1b-a954-f1418d4b9168|7|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|nmol BCE/nmol|[?]|1|fmol|SUBSTANTIA NIGRA|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|SCREENING|2020-12-30|65
e|FA|35a59f6a-2712-4d1b-a954-f1418d4b9168|8|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|g/m2|[?]|1|g/cage/day|RIB 3|LATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|4|FOLLOW-UP|2020-12-30|65
e|FA|35a59f6a-2712-4d1b-a954-f1418d4b9168|9|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|deg/mm|[?]|1|cm|GALLBLADDER|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|2|TREATMENT|2021-01-24|90
e|FA|35a59f6a-2712-4d1b-a954-f1418d4b9168|10|DVEG|Dietary Vegetable|[?]|GERD|[?]|cs|[?]|1|Ci/ug|MALE REPRODUCTIVE SYSTEM|CONTRALATERAL|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2021-01-24|90
e|FA|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|1|TRTSETT|Treatment Setting|[?]|GERD|[?]|Hounsfield Unit|[?]|1|Coulomb|EAR|LATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|3|FOLLOW-UP|2020-11-10|10
e|FA|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|2|SEV|Severity/Intensity|[?]|GERD|[?]|VOXEL|[?]|1|Pa|EYE, VITREOUS CHAMBER|LEFT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-11-10|10
e|FA|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|umol/L/min|[?]|1|mg/h|SUPERIOR VENA CAVA|LATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|FOLLOW-UP|2020-11-25|25
e|FA|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|4|TRTSETT|Treatment Setting|[?]|GERD|[?]|pkat/L|[?]|1|Coulomb|URINARY SYSTEM|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-11-25|25
e|FA|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|uL|[?]|1|mg/g/min|EYE|UNILATERAL|Y||FRIEND|3|Visit_3|40|2|TREATMENT|2020-12-10|40
e|FA|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|6|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|10^4 CFU|[?]|1|mL/h|LEG SKIN|RIGHT|Y||CAREGIVER|3|Visit_3|40|4|WASHOUT|2020-12-10|40
e|FA|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|7|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|tsp eq|[?]|1|gtt|HIP JOINT|UNILATERAL|||SPOUSE|4|Visit_4|65|6|SCREENING|2021-01-04|65
e|FA|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|8|SPEED|Speed|[?]|GERD|[?]|10^6/hpf|[?]|1|mEq/g|INTERPHALANGEAL JOINT 4 OF THE HAND|IPSILATERAL|Y||SPOUSE|4|Visit_4|65|5|SCREENING|2021-01-04|65
e|FA|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|9|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|mL/min/mmHg|[?]|1|HOURS|NOSE|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|WASHOUT|2021-01-29|90
e|FA|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|IU/mg|[?]|1|oz eq|BUCCAL LYMPH NODE|IPSILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|6|WASHOUT|2021-01-29|90
e|FA|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|1|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|10^9 organisms/g|[?]|1|PACK|PALATINE BONE|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-05-13|10
e|FA|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|HEP|[?]|1|g/day|SUBGLOTTIS|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-05-13|10
e|FA|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|3|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|cmH2O*s/mL|[?]|1|mL/dose|INTERPHALANGEAL JOINT 4 OF THE HAND|LEFT|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|SCREENING|2020-05-28|25
e|FA|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|4|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|C|[?]|1|10^9 CFU/mL|TRACHEA|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2020-05-28|25
e|FA|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|5|AGETRT1|Age At First Treatment|[?]|GERD|[?]|10^9 CFU|[?]|1|mL/mmHg/min/L|LIP|RIGHT|||FAMILY MEMBER|3|Visit_3|40|1|SCREENING|2020-06-12|40
e|FA|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|6|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|aMFI|[?]|1|MPS U|RECTOSIGMOID JUNCTION|CONTRALATERAL|||GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-06-12|40
e|FA|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|7|CALBURN|Calories Burned|[?]|GERD|[?]|nmol/mol|[?]|1|/kg|EYELID|LATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-07-07|65
e|FA|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^9 CFU/g|[?]|1|mg/g/min|SCAPHOID-TRAPEZOID JOINT|UNILATERAL|||FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2020-07-07|65
e|FA|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|9|SEV|Severity/Intensity|[?]|GERD|[?]|pkat|[?]|1|Pa|T4 VERTEBRA|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-08-01|90
e|FA|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|10|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|cd*s/m2|[?]|1|uCi/kg|LACRIMAL GLAND|IPSILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|2|WASHOUT|2020-08-01|90
e|FA|d041952e-4aa6-4b37-9cec-127adce2eabb|1|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|BOLUS|[?]|1|10^6/L|SYMPATHETIC GANGLIA|RIGHT|||PARENT|1|Visit_1|10|6|SCREENING|2020-10-09|10
e|FA|d041952e-4aa6-4b37-9cec-127adce2eabb|2|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|dB|[?]|1|/500 WBC|TIBIOTARSAL JOINT|LATERAL||Y|CAREGIVER|1|Visit_1|10|5|SCREENING|2020-10-09|10
e|FA|d041952e-4aa6-4b37-9cec-127adce2eabb|3|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|/HPF|[?]|1|NEEDLE GAUGE|SKULL, BASE|LATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|WASHOUT|2020-10-24|25
e|FA|d041952e-4aa6-4b37-9cec-127adce2eabb|4|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|Coulomb|[?]|1|ohm|MEDIASTINUM, MIDDLE|BILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|1|FOLLOW-UP|2020-10-24|25
e|FA|d041952e-4aa6-4b37-9cec-127adce2eabb|5|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|EIA unit|CARPOMETACARPAL JOINT 1|IPSILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|4|SCREENING|2020-11-08|40
e|FA|d041952e-4aa6-4b37-9cec-127adce2eabb|6|LESNUM|Number of Lesions|[?]|GERD|[?]|GLOBULE|[?]|1|ng/day|LEFT VENTRICULAR MID ANTERIOR SEGMENT|LEFT|||STUDY SUBJECT|3|Visit_3|40|4|TREATMENT|2020-11-08|40
e|FA|d041952e-4aa6-4b37-9cec-127adce2eabb|7|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|GBq|[?]|1|HOURS|HEAD AND NECK|IPSILATERAL|Y||GUARDIAN|4|Visit_4|65|1|FOLLOW-UP|2020-12-03|65
e|FA|d041952e-4aa6-4b37-9cec-127adce2eabb|8|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|Ci/uL|[?]|1|mAmp|ABDOMINAL CAVITY|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-12-03|65
e|FA|d041952e-4aa6-4b37-9cec-127adce2eabb|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|mIU/L|[?]|1|mL/dose|SEBACEOUS GLAND|IPSILATERAL||Y|INVESTIGATOR|5|Visit_5|90|1|FOLLOW-UP|2020-12-28|90
e|FA|d041952e-4aa6-4b37-9cec-127adce2eabb|10|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|HOMEOPATHIC DILUTION|[?]|1|g/day|HAND|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|WASHOUT|2020-12-28|90
e|FA|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|/month|[?]|1|%(v/v)|SKIN OF THE BENDING JOINT|IPSILATERAL|||INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-06-09|10
e|FA|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|2|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|um/day|[?]|1|mg/h|COLON, SPLENIC FLEXURE|LEFT|||CHILD|1|Visit_1|10|1|TREATMENT|2020-06-09|10
e|FA|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|3|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|RNA copies/mL|[?]|1|cm H2O|MIDDLE PHALANX 2 OF THE HAND|LEFT|||SIGNIFICANT OTHER|2|Visit_2|25|7|FOLLOW-UP|2020-06-24|25
e|FA|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|4|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|/100 WBC|[?]|1|Coulomb|HEART, APEX|BILATERAL|Y||CHILD|2|Visit_2|25|6|TREATMENT|2020-06-24|25
e|FA|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|5|LESNUM|Number of Lesions|[?]|GERD|[?]|BAR|[?]|1|ng/day|INGUINAL REGION|RIGHT|||INTERVIEWER|3|Visit_3|40|1|FOLLOW-UP|2020-07-09|40
e|FA|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|6|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|g/dL|CALCANEUS|BILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|TREATMENT|2020-07-09|40
e|FA|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|7|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|um2|[?]|1|Gy/h|POPLITEAL ARTERY BELOW KNEE|LATERAL|Y|Y|ADJUDICATION COMMITTEE|4|Visit_4|65|3|SCREENING|2020-08-03|65
e|FA|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|8|LENRSCT|Length of Resection|[?]|GERD|[?]|PACKAGE|[?]|1|psi|TRICUSPID VALVE, POSTERIOR ANNULUS|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-08-03|65
e|FA|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|9|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|g/dL|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|IPSILATERAL|||PROXY|5|Visit_5|90|1|FOLLOW-UP|2020-08-28|90
e|FA|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|10|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|g/day|ASCENDING AORTA, SINOTUBULAR JUNCTION|CONTRALATERAL|Y|Y|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-08-28|90
e|FA|9fc393da-4665-4be5-a869-856c45ddcf13|1|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|/min|[?]|1|mEq|SUBGLOTTIS|RIGHT|Y||INVESTIGATOR|1|Visit_1|10|4|SCREENING|2020-06-18|10
e|FA|9fc393da-4665-4be5-a869-856c45ddcf13|2|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mL|[?]|1|psi|NASOPHARYNX|IPSILATERAL|||GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-06-18|10
e|FA|9fc393da-4665-4be5-a869-856c45ddcf13|3|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|dL|[?]|1|mm/h|FLEXOR HALLUCIS BREVIS MUSCLE|IPSILATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|4|SCREENING|2020-07-03|25
e|FA|9fc393da-4665-4be5-a869-856c45ddcf13|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|GBq/g|[?]|1|NEEDLE GAUGE|URACHAL TRACT|RIGHT||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|5|WASHOUT|2020-07-03|25
e|FA|9fc393da-4665-4be5-a869-856c45ddcf13|5|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|mEq/ug|[?]|1|mL/100g/min|PROSTATE GLAND|CONTRALATERAL|||VENDOR|3|Visit_3|40|1|WASHOUT|2020-07-18|40
e|FA|9fc393da-4665-4be5-a869-856c45ddcf13|6|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|MHz|[?]|1|/500 WBC|NASOPHARYNX|LATERAL|Y||CHILD|3|Visit_3|40|4|TREATMENT|2020-07-18|40
e|FA|9fc393da-4665-4be5-a869-856c45ddcf13|7|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|log10 IU/mL|[?]|1|Log10 ELISA unit|UTERUS|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-08-12|65
e|FA|9fc393da-4665-4be5-a869-856c45ddcf13|8|SEV|Severity/Intensity|[?]|GERD|[?]|kg/L|[?]|1|Pa|PHARYNX|IPSILATERAL||Y|SPOUSE|4|Visit_4|65|3|SCREENING|2020-08-12|65
e|FA|9fc393da-4665-4be5-a869-856c45ddcf13|9|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|ohm|KIDNEY, CORTEX|UNILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-09-06|90
e|FA|9fc393da-4665-4be5-a869-856c45ddcf13|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|g/U|[?]|1|%(v/v)|HILAR|LATERAL|||STUDY SUBJECT|5|Visit_5|90|2|SCREENING|2020-09-06|90
e|FA|cddc1541-4de9-45e7-bb61-15a2d5baca6f|1|SEV|Severity/Intensity|[?]|GERD|[?]|g/animal/day|[?]|1|Pa|CEREBRAL SUBCORTEX|IPSILATERAL|||SPOUSE|1|Visit_1|10|3|TREATMENT|2021-01-19|10
e|FA|cddc1541-4de9-45e7-bb61-15a2d5baca6f|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|/100 HPFs|[?]|1|mg/g/min|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|IPSILATERAL|||ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2021-01-19|10
e|FA|cddc1541-4de9-45e7-bb61-15a2d5baca6f|3|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|U/g/min|[?]|1|TRANSDUCING UNIT/mL|BLADDER|LATERAL|||FRIEND|2|Visit_2|25|3|WASHOUT|2021-02-03|25
e|FA|cddc1541-4de9-45e7-bb61-15a2d5baca6f|4|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|V/sec|[?]|1|mg/dose|TARSAL JOINT|LATERAL||Y|CHILD|2|Visit_2|25|7|SCREENING|2021-02-03|25
e|FA|cddc1541-4de9-45e7-bb61-15a2d5baca6f|5|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|mL/cm H2O|[?]|1|L/h/m2|PENIS|CONTRALATERAL|||VENDOR|3|Visit_3|40|3|TREATMENT|2021-02-18|40
e|FA|cddc1541-4de9-45e7-bb61-15a2d5baca6f|6|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|TCID 50/dose|[?]|1|aMFI|BLADDER|RIGHT||Y|CHILD|3|Visit_3|40|7|SCREENING|2021-02-18|40
e|FA|cddc1541-4de9-45e7-bb61-15a2d5baca6f|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 2|LEFT|||STUDY SUBJECT|4|Visit_4|65|2|FOLLOW-UP|2021-03-15|65
e|FA|cddc1541-4de9-45e7-bb61-15a2d5baca6f|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|NEBULE|[?]|1|%(v/v)|URETHRA, ANTERIOR|UNILATERAL|||INVESTIGATOR|4|Visit_4|65|2|WASHOUT|2021-03-15|65
e|FA|cddc1541-4de9-45e7-bb61-15a2d5baca6f|9|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|%/s|[?]|1|Bq/L|HIP|LATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|4|SCREENING|2021-04-09|90
e|FA|cddc1541-4de9-45e7-bb61-15a2d5baca6f|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|MET|[?]|1|km|FOREBRAIN|LATERAL|||SPOUSE|5|Visit_5|90|1|SCREENING|2021-04-09|90
e|FA|303c6dbe-59f9-4016-baa1-8506c0c1ee09|1|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|log10 CFU/mL|[?]|1|ug/m2/h|ELBOW EXTENSOR MUSCLES|BILATERAL|||INVESTIGATOR|1|Visit_1|10|3|SCREENING|2020-12-26|10
e|FA|303c6dbe-59f9-4016-baa1-8506c0c1ee09|2|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|U/mg|NASAL BONE|LATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2020-12-26|10
e|FA|303c6dbe-59f9-4016-baa1-8506c0c1ee09|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|U/g/min|[?]|1|Shock Wave|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|LATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2021-01-10|25
e|FA|303c6dbe-59f9-4016-baa1-8506c0c1ee09|4|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|umol/h/mmol|[?]|1|mg/dose|POPLITEAL ARTERY BELOW KNEE|UNILATERAL|||VENDOR|2|Visit_2|25|3|FOLLOW-UP|2021-01-10|25
e|FA|303c6dbe-59f9-4016-baa1-8506c0c1ee09|5|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|10^7/L|[?]|1|10^6 IU/mL|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|BILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|4|FOLLOW-UP|2021-01-25|40
e|FA|303c6dbe-59f9-4016-baa1-8506c0c1ee09|6|DMG|Dietary Magnesium|[?]|GERD|[?]|/500 WBC|[?]|1|TRANSDUCING UNIT/mL|LUNATE BONE|LATERAL|||INTERVIEWER|3|Visit_3|40|1|SCREENING|2021-01-25|40
e|FA|303c6dbe-59f9-4016-baa1-8506c0c1ee09|7|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|yd|[?]|1|Bq/L|PROSTATE GLAND|LEFT|||SIGNIFICANT OTHER|4|Visit_4|65|3|WASHOUT|2021-02-19|65
e|FA|303c6dbe-59f9-4016-baa1-8506c0c1ee09|8|SEV|Severity/Intensity|[?]|GERD|[?]|mg/cm2|[?]|1|Pa|ANASTOMOSIS|IPSILATERAL||Y|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2021-02-19|65
e|FA|303c6dbe-59f9-4016-baa1-8506c0c1ee09|9|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|GLOBULE|[?]|1|mmHg/L/min|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|LATERAL|||CHILD|5|Visit_5|90|2|TREATMENT|2021-03-16|90
e|FA|303c6dbe-59f9-4016-baa1-8506c0c1ee09|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/cage/day|[?]|1|mg/g/min|PARS COMPACTA|LATERAL|||SIBLING|5|Visit_5|90|4|FOLLOW-UP|2021-03-16|90
e|FA|fee3c810-3d76-4db4-9272-6b4e8fd14088|1|VOL|Volume|[?]|GERD|[?]|/LPF|[?]|1|vp/dose|ANKLE JOINT|RIGHT|||FAMILY MEMBER|1|Visit_1|10|3|SCREENING|2020-12-15|10
e|FA|fee3c810-3d76-4db4-9272-6b4e8fd14088|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|Pa|PROFUNDA FEMORIS ARTERY|IPSILATERAL||Y|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2020-12-15|10
e|FA|fee3c810-3d76-4db4-9272-6b4e8fd14088|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/m2|[?]|1|mg/g/min|RIB 9|RIGHT|Y||CAREGIVER|2|Visit_2|25|2|TREATMENT|2020-12-30|25
e|FA|fee3c810-3d76-4db4-9272-6b4e8fd14088|4|PPTFCT|Precipitating Factor|[?]|GERD|[?]|Gravitational Unit|[?]|1|EIA unit|PALPEBRAL FISSURE|CONTRALATERAL|||SPOUSE|2|Visit_2|25|4|TREATMENT|2020-12-30|25
e|FA|fee3c810-3d76-4db4-9272-6b4e8fd14088|5|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|EIA unit|MEDIASTINUM, POSTERIOR|CONTRALATERAL||Y|PROXY|3|Visit_3|40|2|TREATMENT|2021-01-14|40
e|FA|fee3c810-3d76-4db4-9272-6b4e8fd14088|6|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|mL/cm|[?]|1|Log10 ELISA unit|FALLOPIAN TUBE|LEFT||Y|FAMILY MEMBER|3|Visit_3|40|4|WASHOUT|2021-01-14|40
e|FA|fee3c810-3d76-4db4-9272-6b4e8fd14088|7|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|/4.0 mL|[?]|1|PACK|PARALARYNGEAL LYMPH NODE|LEFT|Y||PARENT|4|Visit_4|65|5|WASHOUT|2021-02-08|65
e|FA|fee3c810-3d76-4db4-9272-6b4e8fd14088|8|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|F|[?]|1|ug/g/h|PARAMETRIUM|CONTRALATERAL||Y|CHILD|4|Visit_4|65|6|SCREENING|2021-02-08|65
e|FA|fee3c810-3d76-4db4-9272-6b4e8fd14088|9|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|Weber|DIGIT|CONTRALATERAL|Y||PARENT|5|Visit_5|90|6|TREATMENT|2021-03-05|90
e|FA|fee3c810-3d76-4db4-9272-6b4e8fd14088|10|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|mL/cm H2O|[?]|1|Shock Wave|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|LEFT|Y||FRIEND|5|Visit_5|90|2|TREATMENT|2021-03-05|90
e|FA|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|1|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|AU/mL|[?]|1|10^6/L|VASTUS INTERMEDIUS MUSCLE|IPSILATERAL|Y||PARENT|1|Visit_1|10|1|TREATMENT|2020-07-08|10
e|FA|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|2|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|Ci/mg|[?]|1|PACK|HAIR|LEFT|||SIGNIFICANT OTHER|1|Visit_1|10|4|SCREENING|2020-07-08|10
e|FA|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|3|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|L/h/m2|[?]|1|umol|GREATER CURVATURE OF THE STOMACH|CONTRALATERAL|Y||FRIEND|2|Visit_2|25|6|TREATMENT|2020-07-23|25
e|FA|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|4|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|PFU/dose|[?]|1|cm H2O|RECTUS FEMORIS MUSCLE|LATERAL||Y|CAREGIVER|2|Visit_2|25|6|TREATMENT|2020-07-23|25
e|FA|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|5|TOXGR|Toxicity Grade|[?]|GERD|[?]|FIU|[?]|1|aMFI|RIGHT ATRIAL ENDOCARDIUM|IPSILATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-08-07|40
e|FA|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|DIOPTER|[?]|1|QUANTITY SUFFICIENT|SUPRARENAL AORTA|BILATERAL|||VENDOR|3|Visit_3|40|4|TREATMENT|2020-08-07|40
e|FA|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|7|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|g/day|HAMATE BONE|IPSILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2020-09-01|65
e|FA|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|8|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|pmol/L|[?]|1|Hz/s|LACRIMAL GLAND|LEFT||Y|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-09-01|65
e|FA|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|9|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/g|[?]|1|PACK|L2 VERTEBRA|LEFT||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|WASHOUT|2020-09-26|90
e|FA|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|10|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|pg/cell|[?]|1|L|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|LEFT|Y||PARENT|5|Visit_5|90|3|WASHOUT|2020-09-26|90
e|FA|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|mL/cm|[?]|1|L|FEMORAL LYMPH NODE|LEFT||Y|DOMESTIC PARTNER|1|Visit_1|10|1|SCREENING|2020-08-01|10
e|FA|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|2|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|Pa|[?]|1|uCi/kg|NIPPLE|IPSILATERAL|Y||ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-08-01|10
e|FA|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|3|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|ug/mol|[?]|1|CUP|OBTURATOR MUSCLE|LEFT|Y||PROXY|2|Visit_2|25|6|TREATMENT|2020-08-16|25
e|FA|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|deg2|[?]|1|PFU/dose|SHOULDER|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|WASHOUT|2020-08-16|25
e|FA|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|5|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|mL/g/min|[?]|1|ohm|LATISSIMUS DORSI MUSCLE|CONTRALATERAL|Y||SIBLING|3|Visit_3|40|7|SCREENING|2020-08-31|40
e|FA|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|6|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|oz|[?]|1|uCi/kg|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|UNILATERAL||Y|SPOUSE|3|Visit_3|40|5|TREATMENT|2020-08-31|40
e|FA|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Ci/ug|[?]|1|mg/g/min|FIRST RIGHT POSTEROLATERAL ARTERY|BILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|6|SCREENING|2020-09-25|65
e|FA|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|8|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|kcal|[?]|1|cm H2O|FOOT DIGIT 3|RIGHT|Y||SPOUSE|4|Visit_4|65|7|SCREENING|2020-09-25|65
e|FA|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|9|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg|[?]|1|mL/h|RIB 6|UNILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2020-10-20|90
e|FA|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|10|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|cmH2O/mL|PRESACRAL LYMPH NODE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2020-10-20|90
e|FA|47fad45a-9a4c-47ee-a863-089d979523b5|1|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|mm|HUMERUS SHAFT|LATERAL|||INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-10-07|10
e|FA|47fad45a-9a4c-47ee-a863-089d979523b5|2|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|BOLUS|[?]|1|ug/m2/h|LIVER, LEFT LOBE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-10-07|10
e|FA|47fad45a-9a4c-47ee-a863-089d979523b5|3|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|NEBULE|[?]|1|km|PORTA HEPATIS LYMPH NODE|IPSILATERAL|||PROXY|2|Visit_2|25|7|TREATMENT|2020-10-22|25
e|FA|47fad45a-9a4c-47ee-a863-089d979523b5|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|DROP|[?]|1|10^6 IU/mL|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LATERAL|||STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-10-22|25
e|FA|47fad45a-9a4c-47ee-a863-089d979523b5|5|SERVNUM|Number of Servings|[?]|GERD|[?]|10^9 CFU|[?]|1|Hz/s|STERNUM|CONTRALATERAL|||CHILD|3|Visit_3|40|3|SCREENING|2020-11-06|40
e|FA|47fad45a-9a4c-47ee-a863-089d979523b5|6|DFIBER|Dietary Fiber|[?]|GERD|[?]|SBE/mL|[?]|1|h*%|GASTROINTESTINAL TRACT, LOWER|RIGHT|Y||ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-11-06|40
e|FA|47fad45a-9a4c-47ee-a863-089d979523b5|7|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|WAFER|[?]|1|umol|SUPERIOR VENA CAVA|LEFT|Y||FRIEND|4|Visit_4|65|5|TREATMENT|2020-12-01|65
e|FA|47fad45a-9a4c-47ee-a863-089d979523b5|8|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|Shock Wave|POSTERIOR POLE OF THE EYE|UNILATERAL||Y|VENDOR|4|Visit_4|65|6|TREATMENT|2020-12-01|65
e|FA|47fad45a-9a4c-47ee-a863-089d979523b5|9|SEV|Severity/Intensity|[?]|GERD|[?]|PRESSOR UNITS|[?]|1|Pa|OPTIC NERVE|LEFT|||GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-12-26|90
e|FA|47fad45a-9a4c-47ee-a863-089d979523b5|10|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/mL|[?]|1|mm|ENTORHINAL CORTEX|IPSILATERAL|||CAREGIVER|5|Visit_5|90|5|FOLLOW-UP|2020-12-26|90
e|FA|317b8b6d-9638-44a3-816f-7f3fca1e01a3|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Coulomb|[?]|1|Pa|SUPERFICIAL LYMPH NODE|BILATERAL|||ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-05-23|10
e|FA|317b8b6d-9638-44a3-816f-7f3fca1e01a3|2|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|CAPFUL|[?]|1|10^6/L|SARTORIUS MUSCLE|IPSILATERAL|Y||SPOUSE|1|Visit_1|10|3|SCREENING|2020-05-23|10
e|FA|317b8b6d-9638-44a3-816f-7f3fca1e01a3|3|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|m2|[?]|1|Log10 ELISA unit|PRONATOR TERES MUSCLE|CONTRALATERAL|||FRIEND|2|Visit_2|25|6|FOLLOW-UP|2020-06-07|25
e|FA|317b8b6d-9638-44a3-816f-7f3fca1e01a3|4|SERVNUM|Number of Servings|[?]|GERD|[?]|mol/L|[?]|1|Hz/s|AORTIC VALVE, NON-CORONARY CUSP|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|FOLLOW-UP|2020-06-07|25
e|FA|317b8b6d-9638-44a3-816f-7f3fca1e01a3|5|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|min|[?]|1|mL|OLFACTORY MUCOSA|BILATERAL|Y|Y|CHILD|3|Visit_3|40|2|TREATMENT|2020-06-22|40
e|FA|317b8b6d-9638-44a3-816f-7f3fca1e01a3|6|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|ft|[?]|1|vp/dose|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|IPSILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-06-22|40
e|FA|317b8b6d-9638-44a3-816f-7f3fca1e01a3|7|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|/month|[?]|1|IU/mg|ANTRUM PYLORI|LEFT|||FRIEND|4|Visit_4|65|4|TREATMENT|2020-07-17|65
e|FA|317b8b6d-9638-44a3-816f-7f3fca1e01a3|8|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|Weber|PRELARYNGEAL LYMPH NODE|BILATERAL|||VENDOR|4|Visit_4|65|3|SCREENING|2020-07-17|65
e|FA|317b8b6d-9638-44a3-816f-7f3fca1e01a3|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|pg/L|[?]|1|%(v/v)|SPLENIC HILAR LYMPH NODE|LATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|FOLLOW-UP|2020-08-11|90
e|FA|317b8b6d-9638-44a3-816f-7f3fca1e01a3|10|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|PHERESIS UNIT|[?]|1|Coulomb|CORRUGATOR SUPERCILII MUSCLE|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-08-11|90
e|FA|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|1|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|VIRTUAL PIXEL|[?]|1|BAG|MEDIASTINAL LYMPH NODE|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|5|SCREENING|2020-07-10|10
e|FA|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|2|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|IU/L|[?]|1|EIA unit|TEMPLE|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|SCREENING|2020-07-10|10
e|FA|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|3|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|ug/m2|[?]|1|km|CAUDAL VERTEBRA|BILATERAL|Y|Y|STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-07-25|25
e|FA|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|4|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|10^9 CFU/mL|ADDUCTOR MAGNUS MUSCLE|CONTRALATERAL|||INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-07-25|25
e|FA|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|5|DCAL|Dietary Calories|[?]|GERD|[?]|/LSQN|[?]|1|EIA unit|ARM|RIGHT|||STUDY SUBJECT|3|Visit_3|40|6|TREATMENT|2020-08-09|40
e|FA|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|6|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|uL/kg/day|[?]|1|BAG|MIDDLE PHALANX 2 OF THE HAND|IPSILATERAL|Y|Y|SIBLING|3|Visit_3|40|3|TREATMENT|2020-08-09|40
e|FA|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|7|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|MPL U/mL|[?]|1|10^6 CFU|HEART, LEFT VENTRICULAR WALL|BILATERAL||Y|FRIEND|4|Visit_4|65|6|TREATMENT|2020-09-03|65
e|FA|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|nmol/mol|[?]|1|mg/g/min|HEPATIC ARTERY|IPSILATERAL||Y|PARENT|4|Visit_4|65|3|WASHOUT|2020-09-03|65
e|FA|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|fL|[?]|1|mL|EYELID|LATERAL||Y|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-09-28|90
e|FA|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|10|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|U/g/day|[?]|1|cm H2O|L5 VERTEBRA|IPSILATERAL|Y||SIGNIFICANT OTHER|5|Visit_5|90|3|FOLLOW-UP|2020-09-28|90
e|FA|e7cee930-54f6-482e-b782-01aed0f0db06|1|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|nsec|[?]|1|Bq/mg|ULNA SHAFT|UNILATERAL|||INTERVIEWER|1|Visit_1|10|6|TREATMENT|2021-01-07|10
e|FA|e7cee930-54f6-482e-b782-01aed0f0db06|2|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|mJoule/cm2|[?]|1|vp/dose|ASCENDING AORTA, SINOTUBULAR JUNCTION|CONTRALATERAL|||GUARDIAN|1|Visit_1|10|4|TREATMENT|2021-01-07|10
e|FA|e7cee930-54f6-482e-b782-01aed0f0db06|3|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|min/day|[?]|1|mL/m2|EPIGASTRIC LYMPH NODE|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2021-01-22|25
e|FA|e7cee930-54f6-482e-b782-01aed0f0db06|4|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/mmol|[?]|1|Shock Wave|CARPOMETACARPAL JOINT|IPSILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|7|SCREENING|2021-01-22|25
e|FA|e7cee930-54f6-482e-b782-01aed0f0db06|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|mEq/g|[?]|1|U/mg|CORPUS LUTEUM|IPSILATERAL|||FAMILY MEMBER|3|Visit_3|40|4|FOLLOW-UP|2021-02-06|40
e|FA|e7cee930-54f6-482e-b782-01aed0f0db06|6|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|MnFI|[?]|1|MBq|RIB 6|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|TREATMENT|2021-02-06|40
e|FA|e7cee930-54f6-482e-b782-01aed0f0db06|7|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mg/dL|[?]|1|NEEDLE GAUGE|MESENTERIC LYMPH NODE|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2021-03-03|65
e|FA|e7cee930-54f6-482e-b782-01aed0f0db06|8|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|umol/L/min|[?]|1|BAG|MOTOR CORTEX|RIGHT|||PROXY|4|Visit_4|65|5|FOLLOW-UP|2021-03-03|65
e|FA|e7cee930-54f6-482e-b782-01aed0f0db06|9|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|mg/dose|FOREBRAIN|UNILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2021-03-28|90
e|FA|e7cee930-54f6-482e-b782-01aed0f0db06|10|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|BEAM BREAKS|[?]|1|anti-Xa IU/mL|OSTIOMEATAL COMPLEX|BILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2021-03-28|90
e|FA|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|1|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|BEAM BREAKS|[?]|1|mAmp|MAXILLA|LEFT|Y||CHILD|1|Visit_1|10|7|TREATMENT|2021-01-21|10
e|FA|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|2|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|mEq/L|[?]|1|km|ILEUM, TERMINAL|UNILATERAL|Y||INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2021-01-21|10
e|FA|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|3|EXTRSCT|Extent of Resection|[?]|GERD|[?]|nmol BCE/mmol|[?]|1|Weber|FOOT DIGIT 5|RIGHT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2021-02-05|25
e|FA|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|4|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|g/day|[?]|1|CUP|BLOOD|CONTRALATERAL||Y|SIBLING|2|Visit_2|25|6|FOLLOW-UP|2021-02-05|25
e|FA|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|h/wk|[?]|1|U/mg|OPTIC NERVE|LATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2021-02-20|40
e|FA|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|NFIU|[?]|1|mg/g/min|UVEA|UNILATERAL|||SPOUSE|3|Visit_3|40|4|TREATMENT|2021-02-20|40
e|FA|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|7|EVENTFRQ|Event Frequency|[?]|GERD|[?]|amp|[?]|1|ug/kg/h|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|CONTRALATERAL|||FRIEND|4|Visit_4|65|1|FOLLOW-UP|2021-03-17|65
e|FA|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|8|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|mL/cage|[?]|1|Ci/ug|EXTENSOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|5|FOLLOW-UP|2021-03-17|65
e|FA|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|9|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mmol/g|[?]|1|fmol|EPIGLOTTIS|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|2|SCREENING|2021-04-11|90
e|FA|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|10|DGRAIN|Dietary Grain|[?]|GERD|[?]|fmol/g|[?]|1|10^9 CFU/g|RIGHT ATRIAL ENDOCARDIUM|CONTRALATERAL|||VENDOR|5|Visit_5|90|5|TREATMENT|2021-04-11|90
e|FA|f754ae7d-0776-41c0-988c-8cf2879d85da|1|TOXGR|Toxicity Grade|[?]|GERD|[?]|10^12/L|[?]|1|aMFI|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-09-17|10
e|FA|f754ae7d-0776-41c0-988c-8cf2879d85da|2|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|DNA copies/mL|[?]|1|Gy/h|COLON, SPLENIC FLEXURE|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|WASHOUT|2020-09-17|10
e|FA|f754ae7d-0776-41c0-988c-8cf2879d85da|3|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|IU/g|[?]|1|Log10 ELISA unit|AORTIC VALVE, RIGHT CORONARY CUSP|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|5|FOLLOW-UP|2020-10-02|25
e|FA|f754ae7d-0776-41c0-988c-8cf2879d85da|4|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/mL/min|[?]|1|g/dL|POSTERIOR TIBIAL ARTERY|IPSILATERAL|||CAREGIVER|2|Visit_2|25|5|TREATMENT|2020-10-02|25
e|FA|f754ae7d-0776-41c0-988c-8cf2879d85da|5|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|NEEDLE GAUGE|[?]|1|MPS U|SHOULDER JOINT TENDONS|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-10-17|40
e|FA|f754ae7d-0776-41c0-988c-8cf2879d85da|6|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|aMFI|[?]|1|L|LIVER LOBE|LATERAL|Y|Y|STUDY SUBJECT|3|Visit_3|40|5|SCREENING|2020-10-17|40
e|FA|f754ae7d-0776-41c0-988c-8cf2879d85da|7|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|DRUM|[?]|1|BAG|SCROTUM|UNILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-11-11|65
e|FA|f754ae7d-0776-41c0-988c-8cf2879d85da|8|DCAL|Dietary Calories|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|EIA unit|PENIS, BODY|LEFT||Y|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2020-11-11|65
e|FA|f754ae7d-0776-41c0-988c-8cf2879d85da|9|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/kg/week|[?]|1|mIU/L|CEREBRAL ARTERY|LATERAL|||PARENT|5|Visit_5|90|1|TREATMENT|2020-12-06|90
e|FA|f754ae7d-0776-41c0-988c-8cf2879d85da|10|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|Weber|DORSALIS PEDIS ARTERY|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-12-06|90
e|FA|8a8d8c31-ae36-4a64-90da-ba5eb473e420|1|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/dose|[?]|1|mL/h|FRONTAL LOBE|LATERAL|||PROXY|1|Visit_1|10|2|TREATMENT|2020-06-25|10
e|FA|8a8d8c31-ae36-4a64-90da-ba5eb473e420|2|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|ukat|[?]|1|AU/mL|LUMBAR REGION|LEFT|Y||SIBLING|1|Visit_1|10|4|TREATMENT|2020-06-25|10
e|FA|8a8d8c31-ae36-4a64-90da-ba5eb473e420|3|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|L/h/m2|[?]|1|umol|KIDNEY, LOWER LOBE|RIGHT|Y||FRIEND|2|Visit_2|25|5|SCREENING|2020-07-10|25
e|FA|8a8d8c31-ae36-4a64-90da-ba5eb473e420|4|TOTNUM|Total Number|[?]|GERD|[?]|mm/sec|[?]|1|/200 HPFs|FLEXOR CARPI RADIALIS MUSCLE|RIGHT||Y|GUARDIAN|2|Visit_2|25|6|FOLLOW-UP|2020-07-10|25
e|FA|8a8d8c31-ae36-4a64-90da-ba5eb473e420|5|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|RATIO|[?]|1|mg/dose|MUSCULOSKELETAL SYSTEM|UNILATERAL|||SIBLING|3|Visit_3|40|2|WASHOUT|2020-07-25|40
e|FA|8a8d8c31-ae36-4a64-90da-ba5eb473e420|6|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|um/s|[?]|1|mL/cm3/min|SUPRASPINATUS MUSCLE|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|4|SCREENING|2020-07-25|40
e|FA|8a8d8c31-ae36-4a64-90da-ba5eb473e420|7|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|g/dL|ARTERY|IPSILATERAL|||ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2020-08-19|65
e|FA|8a8d8c31-ae36-4a64-90da-ba5eb473e420|8|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|Ci/mg|[?]|1|mL/h|CELIAC LYMPH NODE|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-08-19|65
e|FA|8a8d8c31-ae36-4a64-90da-ba5eb473e420|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU|[?]|1|10^6 IU/mL|LEFT MAIN CORONARY ARTERY BODY|BILATERAL||Y|INVESTIGATOR|5|Visit_5|90|3|SCREENING|2020-09-13|90
e|FA|8a8d8c31-ae36-4a64-90da-ba5eb473e420|10|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|MPS U|LOWER GASTROINTESTINAL TRACT LYMPH NODE|BILATERAL|||FRIEND|5|Visit_5|90|4|WASHOUT|2020-09-13|90
e|FA|482e40c9-2908-4269-b93c-61c311e9fde3|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|DNA copies/ug|[?]|1|km|PUPIL|CONTRALATERAL|||STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2020-07-16|10
e|FA|482e40c9-2908-4269-b93c-61c311e9fde3|2|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|APL U|[?]|1|/200 HPFs|CERVICAL LYMPH NODE|UNILATERAL|||STUDY SUBJECT|1|Visit_1|10|1|SCREENING|2020-07-16|10
e|FA|482e40c9-2908-4269-b93c-61c311e9fde3|3|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|/month|[?]|1|10^6 CFU|KIDNEY, CORTEX|BILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2020-07-31|25
e|FA|482e40c9-2908-4269-b93c-61c311e9fde3|4|EVENTFRQ|Event Frequency|[?]|GERD|[?]|/4.0 mL|[?]|1|ug/kg/h|ISCHIAL TUBEROSITY|UNILATERAL|||PARENT|2|Visit_2|25|6|FOLLOW-UP|2020-07-31|25
e|FA|482e40c9-2908-4269-b93c-61c311e9fde3|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|Pa|TRAPEZOID BONE|BILATERAL|||INTERVIEWER|3|Visit_3|40|5|SCREENING|2020-08-15|40
e|FA|482e40c9-2908-4269-b93c-61c311e9fde3|6|EXCDUR|Exercise Duration|[?]|GERD|[?]|/day|[?]|1|mm|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|CONTRALATERAL|||SIBLING|3|Visit_3|40|5|FOLLOW-UP|2020-08-15|40
e|FA|482e40c9-2908-4269-b93c-61c311e9fde3|7|DGRAIN|Dietary Grain|[?]|GERD|[?]|uL/dose|[?]|1|10^9 CFU/g|LEPTOMENINGES|LEFT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2020-09-09|65
e|FA|482e40c9-2908-4269-b93c-61c311e9fde3|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Ejaculate U|[?]|1|mg/g/min|GASTROINTESTINAL TRACT, UPPER, WALL|CONTRALATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2020-09-09|65
e|FA|482e40c9-2908-4269-b93c-61c311e9fde3|9|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|PHERESIS UNIT|[?]|1|TRANSDUCING UNIT/mL|TRICUSPID VALVE, POSTERIOR CUSP|RIGHT|Y||GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-10-04|90
e|FA|482e40c9-2908-4269-b93c-61c311e9fde3|10|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/L|[?]|1|mL/100g/min|EXTENSOR HALLUCIS BREVIS MUSCLE|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|4|TREATMENT|2020-10-04|90
e|FA|f7cfb281-0556-4316-9373-65edf63c4b23|1|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/mL|[?]|1|uCi/kg|TAIL|CONTRALATERAL||Y|PROXY|1|Visit_1|10|5|TREATMENT|2020-06-29|10
e|FA|f7cfb281-0556-4316-9373-65edf63c4b23|2|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|mg/h|GUT-ASSOCIATED LYMPHOID TISSUE|RIGHT|||PROXY|1|Visit_1|10|6|TREATMENT|2020-06-29|10
e|FA|f7cfb281-0556-4316-9373-65edf63c4b23|3|STROKTYP|Stroke Type|[?]|GERD|[?]|mL/mmHg/min/L|[?]|1|g/L|PANCREATIC DUCT|LEFT|Y|Y|PARENT|2|Visit_2|25|5|TREATMENT|2020-07-14|25
e|FA|f7cfb281-0556-4316-9373-65edf63c4b23|4|SEV|Severity/Intensity|[?]|GERD|[?]|pkat/L|[?]|1|Pa|PARAPHARYNGEAL LYMPH NODE|LATERAL|||FRIEND|2|Visit_2|25|7|WASHOUT|2020-07-14|25
e|FA|f7cfb281-0556-4316-9373-65edf63c4b23|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|pptr|[?]|1|mL/animal/day|MAIN BRONCHUS, RIGHT|RIGHT|||DOMESTIC PARTNER|3|Visit_3|40|2|WASHOUT|2020-07-29|40
e|FA|f7cfb281-0556-4316-9373-65edf63c4b23|6|DFIBER|Dietary Fiber|[?]|GERD|[?]|mm|[?]|1|h*%|INFRATENTORIAL BRAIN|UNILATERAL||Y|INVESTIGATOR|3|Visit_3|40|6|TREATMENT|2020-07-29|40
e|FA|f7cfb281-0556-4316-9373-65edf63c4b23|7|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|kIU|[?]|1|AU/mL|METACARPAL 1 BASE|IPSILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-08-23|65
e|FA|f7cfb281-0556-4316-9373-65edf63c4b23|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|bel|[?]|1|%(v/v)|PRECUNEUS|UNILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2020-08-23|65
e|FA|f7cfb281-0556-4316-9373-65edf63c4b23|9|SERVNUM|Number of Servings|[?]|GERD|[?]|10^6 U|[?]|1|Hz/s|VAGINAL WALL|RIGHT|Y|Y|VENDOR|5|Visit_5|90|6|TREATMENT|2020-09-17|90
e|FA|f7cfb281-0556-4316-9373-65edf63c4b23|10|SERVNUM|Number of Servings|[?]|GERD|[?]|Pack Year|[?]|1|Hz/s|PENIS|BILATERAL|||ADJUDICATOR|5|Visit_5|90|4|FOLLOW-UP|2020-09-17|90
e|FA|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|1|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa|[?]|1|ug/g/h|RAMUS INTERMEDIUS ARTERY|BILATERAL|||PARENT|1|Visit_1|10|3|TREATMENT|2021-01-10|10
e|FA|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|2|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|MPS U|[?]|1|10^9 CFU/mL|SUBMENTAL LYMPH NODE|BILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|6|WASHOUT|2021-01-10|10
e|FA|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|3|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|MBq|CRANIAL NERVE|UNILATERAL|||FAMILY MEMBER|2|Visit_2|25|3|TREATMENT|2021-01-25|25
e|FA|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|breaths/min|[?]|1|Pa|GASTRIC CURVATURE LYMPH NODE|LEFT|||VENDOR|2|Visit_2|25|5|TREATMENT|2021-01-25|25
e|FA|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|5|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|MESF|[?]|1|/200 HPFs|ENDOMETRIAL CAVITY|CONTRALATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2021-02-09|40
e|FA|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|6|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|PATCH|[?]|1|10^6 IU/mL|INTERPHALANGEAL JOINT 2|LEFT|Y|Y|SPOUSE|3|Visit_3|40|4|FOLLOW-UP|2021-02-09|40
e|FA|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|7|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|hPa|[?]|1|QUANTITY SUFFICIENT|LACRIMAL GLAND|BILATERAL||Y|SIBLING|4|Visit_4|65|7|SCREENING|2021-03-06|65
e|FA|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|8|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mL/s/m2|[?]|1|U/mg|AXILLARY LYMPH NODE|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|WASHOUT|2021-03-06|65
e|FA|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|9|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|mol/mol|[?]|1|mAmp|ASCENDING AORTA|UNILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|7|WASHOUT|2021-03-31|90
e|FA|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/L|[?]|1|mg/g/min|GINGIVAL MUCOSA|LEFT|||PROXY|5|Visit_5|90|1|TREATMENT|2021-03-31|90
e|FA|9ed8a578-a82a-423a-81ca-ee87f98d62f7|1|TRTSETT|Treatment Setting|[?]|GERD|[?]|K|[?]|1|Coulomb|ASCENDING AORTA|UNILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-09-02|10
e|FA|9ed8a578-a82a-423a-81ca-ee87f98d62f7|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mL|[?]|1|g/day|ORAL CAVITY|BILATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-09-02|10
e|FA|9ed8a578-a82a-423a-81ca-ee87f98d62f7|3|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|cmH2O/mL|[?]|1|10^6/L|POSTERIOR CERVICAL LYMPH NODE|BILATERAL|Y||FAMILY MEMBER|2|Visit_2|25|3|TREATMENT|2020-09-17|25
e|FA|9ed8a578-a82a-423a-81ca-ee87f98d62f7|4|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|days/wk|[?]|1|mAmp|FEMALE GENITALIA|LATERAL||Y|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-09-17|25
e|FA|9ed8a578-a82a-423a-81ca-ee87f98d62f7|5|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|PUFF|[?]|1|fmol|OPHTHALMIC ARTERY|LEFT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2020-10-02|40
e|FA|9ed8a578-a82a-423a-81ca-ee87f98d62f7|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|/2500 WBC|[?]|1|mg/g/min|EAR|UNILATERAL|Y||SIBLING|3|Visit_3|40|7|SCREENING|2020-10-02|40
e|FA|9ed8a578-a82a-423a-81ca-ee87f98d62f7|7|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|Absorbance U/mL|[?]|1|ug/g/h|ELBOW EXTENSOR MUSCLES|LATERAL|||ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2020-10-27|65
e|FA|9ed8a578-a82a-423a-81ca-ee87f98d62f7|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/day|[?]|1|%(v/v)|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|UNILATERAL||Y|INVESTIGATOR|4|Visit_4|65|1|SCREENING|2020-10-27|65
e|FA|9ed8a578-a82a-423a-81ca-ee87f98d62f7|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|mg/g/min|RIGHT VENTRICULAR ENDOCARDIUM|UNILATERAL|||PROXY|5|Visit_5|90|6|TREATMENT|2020-11-21|90
e|FA|9ed8a578-a82a-423a-81ca-ee87f98d62f7|10|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mL/m2/day|[?]|1|PFU/dose|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|CONTRALATERAL|||CAREGIVER|5|Visit_5|90|6|WASHOUT|2020-11-21|90
e|FA|2214af46-1072-4328-bf3d-f4fe9cd97d9b|1|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|ugEq|[?]|1|TRANSDUCING UNIT/mL|ASCENDING AORTA|IPSILATERAL||Y|VENDOR|1|Visit_1|10|6|SCREENING|2020-10-18|10
e|FA|2214af46-1072-4328-bf3d-f4fe9cd97d9b|2|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|nkat/g Hb|[?]|1|uL/kg/day|KIDNEY, UPPER LOBE|BILATERAL|||CAREGIVER|1|Visit_1|10|6|SCREENING|2020-10-18|10
e|FA|2214af46-1072-4328-bf3d-f4fe9cd97d9b|3|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^8/L|[?]|1|mL|ABDOMINAL CAVITY|RIGHT||Y|INVESTIGATOR|2|Visit_2|25|6|TREATMENT|2020-11-02|25
e|FA|2214af46-1072-4328-bf3d-f4fe9cd97d9b|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|STEPS|[?]|1|%(v/v)|LOWER JUGULAR LYMPH NODE|RIGHT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-11-02|25
e|FA|2214af46-1072-4328-bf3d-f4fe9cd97d9b|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|L/h/m2|[?]|1|mg/g/min|SUBLINGUAL REGION|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-11-17|40
e|FA|2214af46-1072-4328-bf3d-f4fe9cd97d9b|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|TABLET|[?]|1|Pa|HAIR ROOT|UNILATERAL|||FRIEND|3|Visit_3|40|6|FOLLOW-UP|2020-11-17|40
e|FA|2214af46-1072-4328-bf3d-f4fe9cd97d9b|7|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|m2|TRAPEZIUM-TRAPEZOID JOINT|IPSILATERAL|Y|Y|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-12-12|65
e|FA|2214af46-1072-4328-bf3d-f4fe9cd97d9b|8|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|log EID 50/dose|[?]|1|IU/mmol|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LATERAL||Y|SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2020-12-12|65
e|FA|2214af46-1072-4328-bf3d-f4fe9cd97d9b|9|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|umol/L|[?]|1|m2|COMMON ILIAC ARTERY|IPSILATERAL|||CHILD|5|Visit_5|90|3|TREATMENT|2021-01-06|90
e|FA|2214af46-1072-4328-bf3d-f4fe9cd97d9b|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|g|[?]|1|10^6 U|PANCREATIC DUCT|CONTRALATERAL|||DOMESTIC PARTNER|5|Visit_5|90|6|SCREENING|2021-01-06|90
e|FA|7e56eb43-62a6-45ac-9476-1d0655595a04|1|ACNDEV|Action Taken With Device|[?]|GERD|[?]|/100 HPFs|[?]|1|100 IU/mL|INTERTROCHANTERIC REGION|CONTRALATERAL|||FAMILY MEMBER|1|Visit_1|10|6|SCREENING|2021-01-24|10
e|FA|7e56eb43-62a6-45ac-9476-1d0655595a04|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|m|[?]|1|g/day|PERIPHERAL NERVE|UNILATERAL|||INTERVIEWER|1|Visit_1|10|1|WASHOUT|2021-01-24|10
e|FA|7e56eb43-62a6-45ac-9476-1d0655595a04|3|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|mL/100g/min|[?]|1|10^4 CFU/mL|LIP, LOWER|BILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|WASHOUT|2021-02-08|25
e|FA|7e56eb43-62a6-45ac-9476-1d0655595a04|4|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|pt_br|[?]|1|BP|COMMON FEMORAL ARTERY|LATERAL|||SIBLING|2|Visit_2|25|2|TREATMENT|2021-02-08|25
e|FA|7e56eb43-62a6-45ac-9476-1d0655595a04|5|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|10^4/L|[?]|1|AU/mL|SUPERIOR SAGITTAL SINUS|IPSILATERAL|Y||SPOUSE|3|Visit_3|40|7|TREATMENT|2021-02-23|40
e|FA|7e56eb43-62a6-45ac-9476-1d0655595a04|6|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|ug/min|[?]|1|umol|HEPATIC ARTERY|BILATERAL|||VENDOR|3|Visit_3|40|5|TREATMENT|2021-02-23|40
e|FA|7e56eb43-62a6-45ac-9476-1d0655595a04|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|Pa|CEREBRAL ARTERY|RIGHT|||ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2021-03-20|65
e|FA|7e56eb43-62a6-45ac-9476-1d0655595a04|8|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|mg/dose|LUNG|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|1|FOLLOW-UP|2021-03-20|65
e|FA|7e56eb43-62a6-45ac-9476-1d0655595a04|9|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/mL|[?]|1|10^6/L|PENIS, GLANS|BILATERAL|Y|Y|GUARDIAN|5|Visit_5|90|3|WASHOUT|2021-04-14|90
e|FA|7e56eb43-62a6-45ac-9476-1d0655595a04|10|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|copies/uL|[?]|1|uCi/kg|ANAL CANAL|RIGHT||Y|CAREGIVER|5|Visit_5|90|2|TREATMENT|2021-04-14|90
e|FA|73a8e85a-0b5f-496b-b164-afc4d1f02de2|1|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|pkat|[?]|1|10^6 IU/mL|ESOPHAGUS, CERVICAL|RIGHT|Y|Y|STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-06-29|10
e|FA|73a8e85a-0b5f-496b-b164-afc4d1f02de2|2|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|mol|[?]|1|mg/dose|METATARSOPHALANGEAL JOINT 4|BILATERAL|||ADJUDICATOR|1|Visit_1|10|2|WASHOUT|2020-06-29|10
e|FA|73a8e85a-0b5f-496b-b164-afc4d1f02de2|3|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|pptr|[?]|1|/kg|MITRAL VALVE, POSTERIOR ANNULUS|IPSILATERAL|||PROXY|2|Visit_2|25|6|TREATMENT|2020-07-14|25
e|FA|73a8e85a-0b5f-496b-b164-afc4d1f02de2|4|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|ug/g/day|[?]|1|anti-Xa IU/mL|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|WASHOUT|2020-07-14|25
e|FA|73a8e85a-0b5f-496b-b164-afc4d1f02de2|5|EXTRSCT|Extent of Resection|[?]|GERD|[?]|PACKAGE|[?]|1|Weber|RETROAURICULAR LYMPH NODE|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|WASHOUT|2020-07-29|40
e|FA|73a8e85a-0b5f-496b-b164-afc4d1f02de2|6|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|NEBULE|[?]|1|g/dL|LUNATE BONE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-07-29|40
e|FA|73a8e85a-0b5f-496b-b164-afc4d1f02de2|7|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|foz_us|[?]|1|mg/dose|TOOTH|LEFT|Y||SPOUSE|4|Visit_4|65|3|WASHOUT|2020-08-23|65
e|FA|73a8e85a-0b5f-496b-b164-afc4d1f02de2|8|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|Bq/g|[?]|1|g/day|GASTROCNEMIUS MUSCLE|UNILATERAL|||STUDY SUBJECT|4|Visit_4|65|2|FOLLOW-UP|2020-08-23|65
e|FA|73a8e85a-0b5f-496b-b164-afc4d1f02de2|9|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/kg/h|[?]|1|10^9 CFU/mL|OCCIPITAL SCALP|RIGHT|Y||FAMILY MEMBER|5|Visit_5|90|2|TREATMENT|2020-09-17|90
e|FA|73a8e85a-0b5f-496b-b164-afc4d1f02de2|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|psi|[?]|1|%(v/v)|OPPONENS POLLICIS MUSCLE|UNILATERAL|||ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-09-17|90
e|FA|84f74359-c79b-4f1c-8119-a4993b071973|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|%(v/v)|INTERVENTRICULAR SEPTUM|LEFT|Y||SIBLING|1|Visit_1|10|1|FOLLOW-UP|2020-05-12|10
e|FA|84f74359-c79b-4f1c-8119-a4993b071973|2|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|oz eq|MUCOSA OF THE LIP|UNILATERAL||Y|CHILD|1|Visit_1|10|7|TREATMENT|2020-05-12|10
e|FA|84f74359-c79b-4f1c-8119-a4993b071973|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|NEEDLE GAUGE|[?]|1|mg/g/min|LEFT VENTRICULAR APEX SEGMENT|LATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|WASHOUT|2020-05-27|25
e|FA|84f74359-c79b-4f1c-8119-a4993b071973|4|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|CAPLET|[?]|1|m2|INSULAR CORTEX|LEFT||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2020-05-27|25
e|FA|84f74359-c79b-4f1c-8119-a4993b071973|5|DMG|Dietary Magnesium|[?]|GERD|[?]|U/kg|[?]|1|TRANSDUCING UNIT/mL|GASTRIC CURVATURE LYMPH NODE|BILATERAL|Y||SPOUSE|3|Visit_3|40|1|FOLLOW-UP|2020-06-11|40
e|FA|84f74359-c79b-4f1c-8119-a4993b071973|6|ESTWT|Estimated Weight|[?]|GERD|[?]|RFU|[?]|1|g/day|HEART, VENTRICLE|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2020-06-11|40
e|FA|84f74359-c79b-4f1c-8119-a4993b071973|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|DAgU/mL|[?]|1|mg/g/min|METACARPOPHALANGEAL JOINT 3|RIGHT|||SIBLING|4|Visit_4|65|3|TREATMENT|2020-07-06|65
e|FA|84f74359-c79b-4f1c-8119-a4993b071973|8|AGETRT1|Age At First Treatment|[?]|GERD|[?]|mCi/L|[?]|1|mL/mmHg/min/L|LIVER, QUADRATE LOBE|RIGHT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|WASHOUT|2020-07-06|65
e|FA|84f74359-c79b-4f1c-8119-a4993b071973|9|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|cd*s/m2|[?]|1|BOWL|HYMENAL RING|RIGHT||Y|ADJUDICATOR|5|Visit_5|90|4|WASHOUT|2020-07-31|90
e|FA|84f74359-c79b-4f1c-8119-a4993b071973|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|genEq|[?]|1|mg/g/min|PONS VAROLII|LATERAL|||CAREGIVER|5|Visit_5|90|3|TREATMENT|2020-07-31|90
e|FA|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|1|OBJTYPE|Type of Object|[?]|GERD|[?]|g/animal/wk|[?]|1|ng|LEFT CIRCUMFLEX ARTERY OSTIUM|BILATERAL||Y|CHILD|1|Visit_1|10|6|SCREENING|2020-11-06|10
e|FA|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|2|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|mV|[?]|1|10^6 organisms/mL|ELBOW FLEXOR MUSCLES|IPSILATERAL|||PARENT|1|Visit_1|10|1|TREATMENT|2020-11-06|10
e|FA|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|mmHg/sec|[?]|1|Shock Wave|CAPITATE-LUNATE JOINT|UNILATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|WASHOUT|2020-11-21|25
e|FA|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|4|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|C|[?]|1|umol|CARPOMETACARPAL JOINT|LEFT|Y|Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|SCREENING|2020-11-21|25
e|FA|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|5|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|/4.0 mL|[?]|1|umol|FEMORAL HEAD|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|SCREENING|2020-12-06|40
e|FA|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|6|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|cs|[?]|1|cm H2O|RESPIRATORY SYSTEM|LATERAL|||GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-12-06|40
e|FA|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|7|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|lm|[?]|1|10^6 U|UMBILICAL CORD|BILATERAL|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|SCREENING|2020-12-31|65
e|FA|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|cd|[?]|1|mg/g/min|INTERTROCHANTERIC REGION|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-12-31|65
e|FA|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|9|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|Enzyme U/L|[?]|1|mL/cm3/min|FALCIFORM LIGAMENT|IPSILATERAL|||FRIEND|5|Visit_5|90|7|TREATMENT|2021-01-25|90
e|FA|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|10|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|cd|[?]|1|mL/dose|GLOTTIS|UNILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|SCREENING|2021-01-25|90
e|FA|cd0c969e-61c6-4c65-ac19-4ee247f5009a|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|damol/L|[?]|1|%(v/v)|CEREBELLUM|CONTRALATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-09-09|10
e|FA|cd0c969e-61c6-4c65-ac19-4ee247f5009a|2|EXTRSCT|Extent of Resection|[?]|GERD|[?]|scm|[?]|1|Weber|CAPITATE-HAMATE JOINT|LATERAL|Y|Y|INVESTIGATOR|1|Visit_1|10|3|SCREENING|2020-09-09|10
e|FA|cd0c969e-61c6-4c65-ac19-4ee247f5009a|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/mL/min|[?]|1|mg/g/min|OLFACTORY NERVE|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|SCREENING|2020-09-24|25
e|FA|cd0c969e-61c6-4c65-ac19-4ee247f5009a|4|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|TRANSDUCING UNIT/mL|PLEURA|LATERAL||Y|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-09-24|25
e|FA|cd0c969e-61c6-4c65-ac19-4ee247f5009a|5|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|mL/day|[?]|1|mL/min/mmHg|VULVA|RIGHT|Y||SPOUSE|3|Visit_3|40|6|WASHOUT|2020-10-09|40
e|FA|cd0c969e-61c6-4c65-ac19-4ee247f5009a|6|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|RFU|[?]|1|g/day|HAMATE BONE|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-10-09|40
e|FA|cd0c969e-61c6-4c65-ac19-4ee247f5009a|7|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|Ci/L|[?]|1|fmol|INTRAHEPATIC LARGE BILE DUCT|CONTRALATERAL|||INVESTIGATOR|4|Visit_4|65|6|TREATMENT|2020-11-03|65
e|FA|cd0c969e-61c6-4c65-ac19-4ee247f5009a|8|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|STRIP|[?]|1|/500 WBC|NOSTRIL|BILATERAL|||ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2020-11-03|65
e|FA|cd0c969e-61c6-4c65-ac19-4ee247f5009a|9|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|10^3 CFU|[?]|1|L/h/m2|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|UNILATERAL||Y|CHILD|5|Visit_5|90|5|TREATMENT|2020-11-28|90
e|FA|cd0c969e-61c6-4c65-ac19-4ee247f5009a|10|ESTWT|Estimated Weight|[?]|GERD|[?]|mL/animal/day|[?]|1|g/day|DISTAL CIRCUMFLEX ARTERY|RIGHT|Y||CHILD|5|Visit_5|90|6|TREATMENT|2020-11-28|90
e|FA|1fff484d-0a68-42cd-8eff-bc4fe4da945c|1|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|mL/100g/min|[?]|1|umol|PROXIMAL URETHRA|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2021-01-28|10
e|FA|1fff484d-0a68-42cd-8eff-bc4fe4da945c|2|DVEG|Dietary Vegetable|[?]|GERD|[?]|U/g Hb|[?]|1|Ci/ug|LUMBAR SPINE|RIGHT||Y|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2021-01-28|10
e|FA|1fff484d-0a68-42cd-8eff-bc4fe4da945c|3|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|U/mmol|TRAPEZOID-CAPITATE JOINT|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|2|SCREENING|2021-02-12|25
e|FA|1fff484d-0a68-42cd-8eff-bc4fe4da945c|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|log10 CCID 50/dose|[?]|1|ug/g/h|ORBICULARIS OCULI MUSCLE|IPSILATERAL|||GUARDIAN|2|Visit_2|25|5|WASHOUT|2021-02-12|25
e|FA|1fff484d-0a68-42cd-8eff-bc4fe4da945c|5|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|/LPF|[?]|1|100 IU/mL|PARANASAL SINUS|CONTRALATERAL|||CAREGIVER|3|Visit_3|40|1|TREATMENT|2021-02-27|40
e|FA|1fff484d-0a68-42cd-8eff-bc4fe4da945c|6|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|cm H2O|SHOULDER JOINT TENDONS|CONTRALATERAL|||FRIEND|3|Visit_3|40|2|TREATMENT|2021-02-27|40
e|FA|1fff484d-0a68-42cd-8eff-bc4fe4da945c|7|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|mol|[?]|1|mL|SKIN OF THE PALM|LEFT||Y|CAREGIVER|4|Visit_4|65|7|SCREENING|2021-03-24|65
e|FA|1fff484d-0a68-42cd-8eff-bc4fe4da945c|8|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|/100 HPFs|[?]|1|mmHg/L/min|HIP JOINT|LEFT|Y|Y|ADJUDICATION COMMITTEE|4|Visit_4|65|7|TREATMENT|2021-03-24|65
e|FA|1fff484d-0a68-42cd-8eff-bc4fe4da945c|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|L/h|[?]|1|mg/g/min|ANAL VERGE|RIGHT|||STUDY SUBJECT|5|Visit_5|90|5|SCREENING|2021-04-18|90
e|FA|1fff484d-0a68-42cd-8eff-bc4fe4da945c|10|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|ng|[?]|1|g/L|AZYGOS VEIN|IPSILATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|2|WASHOUT|2021-04-18|90
e|FA|e2c20e9a-0ac5-4907-96de-472bee70bd79|1|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|m2|[?]|1|fmol|PARASPINAL REGION|LEFT||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|WASHOUT|2020-12-04|10
e|FA|e2c20e9a-0ac5-4907-96de-472bee70bd79|2|DMEAT|Dietary Meat|[?]|GERD|[?]|CCID 50/mL|[?]|1|10^6 organisms/mL|GENITAL TUBERCLE|CONTRALATERAL|||VENDOR|1|Visit_1|10|1|TREATMENT|2020-12-04|10
e|FA|e2c20e9a-0ac5-4907-96de-472bee70bd79|3|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|ELISA unit|[?]|1|PACK|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|RIGHT|||INVESTIGATOR|2|Visit_2|25|6|TREATMENT|2020-12-19|25
e|FA|e2c20e9a-0ac5-4907-96de-472bee70bd79|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|log10 PFU|[?]|1|mg/g/min|CARPOMETACARPAL JOINT 5|RIGHT|||VENDOR|2|Visit_2|25|7|FOLLOW-UP|2020-12-19|25
e|FA|e2c20e9a-0ac5-4907-96de-472bee70bd79|5|DISTANCE|Distance|[?]|GERD|[?]|SFC/10^6 PBMC|[?]|1|BOWL|ASCENDING AORTA, SINOTUBULAR JUNCTION|CONTRALATERAL|||CHILD|3|Visit_3|40|3|WASHOUT|2021-01-03|40
e|FA|e2c20e9a-0ac5-4907-96de-472bee70bd79|6|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|Hounsfield Unit|[?]|1|oz eq|LEG|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|1|WASHOUT|2021-01-03|40
e|FA|e2c20e9a-0ac5-4907-96de-472bee70bd79|7|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|F|[?]|1|fmol|RIB 12|UNILATERAL|||PROXY|4|Visit_4|65|1|FOLLOW-UP|2021-01-28|65
e|FA|e2c20e9a-0ac5-4907-96de-472bee70bd79|8|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mV*min|[?]|1|fmol|DISTAL INTERPHALANGEAL JOINT 2|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|FOLLOW-UP|2021-01-28|65
e|FA|e2c20e9a-0ac5-4907-96de-472bee70bd79|9|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|mL/cage|[?]|1|EIA unit|T9 VERTEBRA|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2021-02-22|90
e|FA|e2c20e9a-0ac5-4907-96de-472bee70bd79|10|TOXGR|Toxicity Grade|[?]|GERD|[?]|U/mg|[?]|1|aMFI|CORPUS CALLOSUM|LATERAL|||SPOUSE|5|Visit_5|90|3|WASHOUT|2021-02-22|90
e|FA|6064ca8c-b723-4d05-914a-bb547d86fcc5|1|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|10^6 U|THROAT|IPSILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-06-02|10
e|FA|6064ca8c-b723-4d05-914a-bb547d86fcc5|2|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|/sec|[?]|1|Hz/s|SCAPHOID-LUNATE JOINT|IPSILATERAL|||VENDOR|1|Visit_1|10|3|TREATMENT|2020-06-02|10
e|FA|6064ca8c-b723-4d05-914a-bb547d86fcc5|3|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|mL/m2/day|[?]|1|g/day|ADRENAL GLAND|UNILATERAL|||GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-06-17|25
e|FA|6064ca8c-b723-4d05-914a-bb547d86fcc5|4|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|dmol|[?]|1|ng/day|OROPHARYNX|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-06-17|25
e|FA|6064ca8c-b723-4d05-914a-bb547d86fcc5|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|Arbitrary U|[?]|1|%(v/v)|EXTENSOR DIGITORUM BREVIS MUSCLE|UNILATERAL|||GUARDIAN|3|Visit_3|40|3|SCREENING|2020-07-02|40
e|FA|6064ca8c-b723-4d05-914a-bb547d86fcc5|6|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|oz eq|[?]|1|TRANSDUCING UNIT/mL|LARGE INTESTINE|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|WASHOUT|2020-07-02|40
e|FA|6064ca8c-b723-4d05-914a-bb547d86fcc5|7|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|kg/mol|[?]|1|BOWL|LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT|RIGHT|||FRIEND|4|Visit_4|65|1|TREATMENT|2020-07-27|65
e|FA|6064ca8c-b723-4d05-914a-bb547d86fcc5|8|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|mL/h|EAR|RIGHT|||PROXY|4|Visit_4|65|5|TREATMENT|2020-07-27|65
e|FA|6064ca8c-b723-4d05-914a-bb547d86fcc5|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|PA|[?]|1|%(v/v)|ACCESSORY RENAL ARTERY|BILATERAL||Y|SIBLING|5|Visit_5|90|1|WASHOUT|2020-08-21|90
e|FA|6064ca8c-b723-4d05-914a-bb547d86fcc5|10|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|PACK|[?]|1|uL/kg/day|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|IPSILATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2020-08-21|90
e|FA|8effbbff-acda-4718-89f1-e30a418f6bae|1|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|U.CARR|[?]|1|Coulomb|UPPER RESPIRATORY SYSTEM|UNILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|WASHOUT|2020-11-06|10
e|FA|8effbbff-acda-4718-89f1-e30a418f6bae|2|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|mL/kg/h|[?]|1|g/dL|ANASTOMOSIS|BILATERAL|Y||ADJUDICATOR|1|Visit_1|10|5|SCREENING|2020-11-06|10
e|FA|8effbbff-acda-4718-89f1-e30a418f6bae|3|SEV|Severity/Intensity|[?]|GERD|[?]|PFU/dose|[?]|1|Pa|PANCREAS|CONTRALATERAL||Y|FRIEND|2|Visit_2|25|7|TREATMENT|2020-11-21|25
e|FA|8effbbff-acda-4718-89f1-e30a418f6bae|4|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|/ms|[?]|1|U/mg|ANKLE MORTISE|BILATERAL|||CHILD|2|Visit_2|25|4|WASHOUT|2020-11-21|25
e|FA|8effbbff-acda-4718-89f1-e30a418f6bae|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|%(v/v)|METACARPAL BONE 5|LEFT|||SPOUSE|3|Visit_3|40|5|SCREENING|2020-12-06|40
e|FA|8effbbff-acda-4718-89f1-e30a418f6bae|6|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|kN/cm2|[?]|1|g/L|PHARYNGEAL TONSIL|LATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|FOLLOW-UP|2020-12-06|40
e|FA|8effbbff-acda-4718-89f1-e30a418f6bae|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|h*%|[?]|1|PFU/dose|FLEXOR HALLUCIS BREVIS MUSCLE|BILATERAL|||PARENT|4|Visit_4|65|5|TREATMENT|2020-12-31|65
e|FA|8effbbff-acda-4718-89f1-e30a418f6bae|8|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|/LSQN|[?]|1|DRUM|HAND PHALANX|BILATERAL|||FRIEND|4|Visit_4|65|2|SCREENING|2020-12-31|65
e|FA|8effbbff-acda-4718-89f1-e30a418f6bae|9|LESNUM|Number of Lesions|[?]|GERD|[?]|LOZENGE|[?]|1|ng/day|HIPPOCAMPUS|LATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2021-01-25|90
e|FA|8effbbff-acda-4718-89f1-e30a418f6bae|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|eq|[?]|1|mL|T7 VERTEBRA|RIGHT|||SIBLING|5|Visit_5|90|6|TREATMENT|2021-01-25|90
e|FA|859b16a5-f6a2-40cc-8e01-18c112b1969e|1|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|IU/kg/h|[?]|1|Gy/h|THORACIC CAVITY|BILATERAL|||GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-08-18|10
e|FA|859b16a5-f6a2-40cc-8e01-18c112b1969e|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/m2|[?]|1|mg/g/min|SECOND DIAGONAL BRANCH ARTERY|BILATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-08-18|10
e|FA|859b16a5-f6a2-40cc-8e01-18c112b1969e|3|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|PLUG|[?]|1|uCi/kg|THYROID GLAND ISTHMUS|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|TREATMENT|2020-09-02|25
e|FA|859b16a5-f6a2-40cc-8e01-18c112b1969e|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|kg|[?]|1|mg/g/min|CARPOMETACARPAL JOINT|LEFT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-09-02|25
e|FA|859b16a5-f6a2-40cc-8e01-18c112b1969e|5|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|10^6 U|COSTOCHONDRAL JOINT 7|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-09-17|40
e|FA|859b16a5-f6a2-40cc-8e01-18c112b1969e|6|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/min|[?]|1|fmol|AORTOCAVAL LYMPH NODE|LEFT||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|1|TREATMENT|2020-09-17|40
e|FA|859b16a5-f6a2-40cc-8e01-18c112b1969e|7|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|100 IU/mL|ESOPHAGUS, UPPER THIRD|UNILATERAL|||ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2020-10-12|65
e|FA|859b16a5-f6a2-40cc-8e01-18c112b1969e|8|VOL|Volume|[?]|GERD|[?]|mg/g/min|[?]|1|vp/dose|FOOT DIGIT 1|BILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|1|WASHOUT|2020-10-12|65
e|FA|859b16a5-f6a2-40cc-8e01-18c112b1969e|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit|[?]|1|mg/g/min|DIAPHRAGMATIC LYMPH NODE|LEFT|||ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2020-11-06|90
e|FA|859b16a5-f6a2-40cc-8e01-18c112b1969e|10|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|umol/kg/min|[?]|1|SACHET|PATELLA|LATERAL|||SPOUSE|5|Visit_5|90|7|SCREENING|2020-11-06|90
e|FA|36b457ef-4cf6-4043-a836-49368ebf3f1c|1|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|mL/kg|[?]|1|MPS U|HAND DIGIT 5|RIGHT|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-08-16|10
e|FA|36b457ef-4cf6-4043-a836-49368ebf3f1c|2|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|TABLET|[?]|1|10^6 organisms/mL|POSTERIOR POLE OF THE EYE|UNILATERAL|||INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-08-16|10
e|FA|36b457ef-4cf6-4043-a836-49368ebf3f1c|3|ESTWT|Estimated Weight|[?]|GERD|[?]|min*mg/mL|[?]|1|g/day|ILEUM, TERMINAL|UNILATERAL|||FRIEND|2|Visit_2|25|5|TREATMENT|2020-08-31|25
e|FA|36b457ef-4cf6-4043-a836-49368ebf3f1c|4|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|Pack Year|[?]|1|ug/m2/h|FALLOPIAN TUBE|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-08-31|25
e|FA|36b457ef-4cf6-4043-a836-49368ebf3f1c|5|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|C|[?]|1|mm/h|CORPUS CALLOSUM, SPLENIUM|LATERAL||Y|INTERVIEWER|3|Visit_3|40|1|WASHOUT|2020-09-15|40
e|FA|36b457ef-4cf6-4043-a836-49368ebf3f1c|6|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|gtt|AORTIC VALVE|BILATERAL|Y||PARENT|3|Visit_3|40|7|TREATMENT|2020-09-15|40
e|FA|36b457ef-4cf6-4043-a836-49368ebf3f1c|7|DVEG|Dietary Vegetable|[?]|GERD|[?]|mmol/L|[?]|1|Ci/ug|METATARSOPHALANGEAL JOINT 3|BILATERAL||Y|PARENT|4|Visit_4|65|2|SCREENING|2020-10-10|65
e|FA|36b457ef-4cf6-4043-a836-49368ebf3f1c|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|WEEKS|[?]|1|PFU/dose|THIRD POSTEROLATERAL DESCENDING ARTERY|CONTRALATERAL|||SIBLING|4|Visit_4|65|3|WASHOUT|2020-10-10|65
e|FA|36b457ef-4cf6-4043-a836-49368ebf3f1c|9|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|ohm|[?]|1|ng/day|COLON WALL|UNILATERAL|||GUARDIAN|5|Visit_5|90|6|WASHOUT|2020-11-04|90
e|FA|36b457ef-4cf6-4043-a836-49368ebf3f1c|10|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|Weber|[?]|1|mAmp|GASTROINTESTINAL TRACT, WALL|LEFT|||ADJUDICATION COMMITTEE|5|Visit_5|90|5|TREATMENT|2020-11-04|90
e|FA|31f33e38-bba6-4c8a-b563-14afaabae5d7|1|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|10^6 CFU/mL|ILIAC CREST|LATERAL|||SIBLING|1|Visit_1|10|1|FOLLOW-UP|2020-07-01|10
e|FA|31f33e38-bba6-4c8a-b563-14afaabae5d7|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|kPa/L/sec|[?]|1|mg/g/min|PROSTATE GLAND, MIDDLE LOBE|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|SCREENING|2020-07-01|10
e|FA|31f33e38-bba6-4c8a-b563-14afaabae5d7|3|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|min*mg/mL|[?]|1|DROP|GONAD|UNILATERAL|||VENDOR|2|Visit_2|25|7|SCREENING|2020-07-16|25
e|FA|31f33e38-bba6-4c8a-b563-14afaabae5d7|4|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|g/cage/wk|[?]|1|SCOOPFUL|HIPPOCAMPUS|UNILATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2020-07-16|25
e|FA|31f33e38-bba6-4c8a-b563-14afaabae5d7|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/L/h|[?]|1|mg/g/min|PAROTID GLAND LYMPH NODE|RIGHT||Y|SIGNIFICANT OTHER|3|Visit_3|40|5|TREATMENT|2020-07-31|40
e|FA|31f33e38-bba6-4c8a-b563-14afaabae5d7|6|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|Log10 ELISA unit/dose|[?]|1|IU/mg|MID-CIRCUMFLEX ARTERY|CONTRALATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|1|SCREENING|2020-07-31|40
e|FA|31f33e38-bba6-4c8a-b563-14afaabae5d7|7|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|g/cm2|[?]|1|MBq|TOE|RIGHT|||ADJUDICATOR|4|Visit_4|65|5|FOLLOW-UP|2020-08-25|65
e|FA|31f33e38-bba6-4c8a-b563-14afaabae5d7|8|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|ug/h|[?]|1|BAG|PROXIMAL PHALANX 2 OF THE HAND|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2020-08-25|65
e|FA|31f33e38-bba6-4c8a-b563-14afaabae5d7|9|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|U/10^12 RBC|[?]|1|ng|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL|Y||GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-09-19|90
e|FA|31f33e38-bba6-4c8a-b563-14afaabae5d7|10|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|mV*min|[?]|1|Bq/mg|CORPUS CALLOSUM, SPLENIUM|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|SCREENING|2020-09-19|90
e|FA|6794dffe-333b-425b-8883-26f6e5ba0797|1|SERVNUM|Number of Servings|[?]|GERD|[?]|breaths/min|[?]|1|Hz/s|HEART, RIGHT VENTRICLE|CONTRALATERAL||Y|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-07-09|10
e|FA|6794dffe-333b-425b-8883-26f6e5ba0797|2|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|pmol/L/h|[?]|1|in|COCCYX|RIGHT|||VENDOR|1|Visit_1|10|2|FOLLOW-UP|2020-07-09|10
e|FA|6794dffe-333b-425b-8883-26f6e5ba0797|3|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/min|[?]|1|mg/dose|PINEAL GLAND|UNILATERAL|Y||VENDOR|2|Visit_2|25|7|SCREENING|2020-07-24|25
e|FA|6794dffe-333b-425b-8883-26f6e5ba0797|4|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|BE/mL|[?]|1|mm|ABDUCTOR HALLUCIS MUSCLE|LATERAL||Y|CHILD|2|Visit_2|25|7|TREATMENT|2020-07-24|25
e|FA|6794dffe-333b-425b-8883-26f6e5ba0797|5|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|L/h/m2|[?]|1|HOURS|INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|||ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-08-08|40
e|FA|6794dffe-333b-425b-8883-26f6e5ba0797|6|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|uL/dose|[?]|1|U/mmol|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-08-08|40
e|FA|6794dffe-333b-425b-8883-26f6e5ba0797|7|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/m2|[?]|1|cm|MENINGES|LEFT|||CAREGIVER|4|Visit_4|65|1|SCREENING|2020-09-02|65
e|FA|6794dffe-333b-425b-8883-26f6e5ba0797|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|um|[?]|1|10^6 U|THORAX|LEFT|||ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-09-02|65
e|FA|6794dffe-333b-425b-8883-26f6e5ba0797|9|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|mL/animal/wk|[?]|1|Shock Wave|LATERAL HUMERAL EPICONDYLE|BILATERAL|||FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2020-09-27|90
e|FA|6794dffe-333b-425b-8883-26f6e5ba0797|10|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|FEU|[?]|1|HOURS|OROPHARYNX|LATERAL||Y|FAMILY MEMBER|5|Visit_5|90|6|WASHOUT|2020-09-27|90
e|FA|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|1|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|DNA copies/mL|[?]|1|BOWL|LUNG, HILUM|RIGHT|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|WASHOUT|2020-06-07|10
e|FA|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|2|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|mg/m2/day|[?]|1|ug/g/h|URETHRAL SPHINCTER|RIGHT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|WASHOUT|2020-06-07|10
e|FA|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|3|LOCONSET|Localization of Onset|[?]|GERD|[?]|MAC50|[?]|1|g/L|MESENTERIC LYMPH NODE|IPSILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-06-22|25
e|FA|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|4|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|pmol/10^10 cells|[?]|1|10^9 CFU/mL|SPLENIC HILAR LYMPH NODE|UNILATERAL|||FAMILY MEMBER|2|Visit_2|25|3|TREATMENT|2020-06-22|25
e|FA|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|5|STRCTNUM|Number of Strictures|[?]|GERD|[?]|10^3 RNA copies/mL|[?]|1|SACHET|DISTAL PHALANX 4 OF THE HAND|LEFT||Y|INVESTIGATOR|3|Visit_3|40|2|FOLLOW-UP|2020-07-07|40
e|FA|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|6|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|ppm|[?]|1|DROP|HAIR BULB|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|FOLLOW-UP|2020-07-07|40
e|FA|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|7|DCAL|Dietary Calories|[?]|GERD|[?]|Ci|[?]|1|EIA unit|CAPITATE-HAMATE JOINT|BILATERAL|||FRIEND|4|Visit_4|65|7|FOLLOW-UP|2020-08-01|65
e|FA|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|8|DPROT|Dietary Protein|[?]|GERD|[?]|cmHg|[?]|1|10^4 CFU/mL|ABDUCTOR POLLICIS BREVIS MUSCLE|BILATERAL||Y|PARENT|4|Visit_4|65|6|TREATMENT|2020-08-01|65
e|FA|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|9|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|oz|[?]|1|AU/mL|ILEUM WALL|UNILATERAL|Y|Y|CAREGIVER|5|Visit_5|90|7|TREATMENT|2020-08-26|90
e|FA|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|10|EXCDUR|Exercise Duration|[?]|GERD|[?]|TRANSDUCING UNIT|[?]|1|mm|T8 VERTEBRA|CONTRALATERAL|||GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-08-26|90
e|FA|45897452-8f5a-458d-9a43-13237460ba48|1|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|U/g Hb|[?]|1|PACK|ILEUM, TERMINAL|CONTRALATERAL||Y|PROXY|1|Visit_1|10|6|TREATMENT|2020-11-11|10
e|FA|45897452-8f5a-458d-9a43-13237460ba48|2|EXCDUR|Exercise Duration|[?]|GERD|[?]|10^9 CFU|[?]|1|mm|MUSCULOSKELETAL SYSTEM|CONTRALATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|6|FOLLOW-UP|2020-11-11|10
e|FA|45897452-8f5a-458d-9a43-13237460ba48|3|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|%(w/w)|[?]|1|10^6 U|TESTIS|LEFT|||VENDOR|2|Visit_2|25|4|TREATMENT|2020-11-26|25
e|FA|45897452-8f5a-458d-9a43-13237460ba48|4|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|DISK|[?]|1|psi|GASTROCNEMIUS MUSCLE, LATERAL HEAD|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-11-26|25
e|FA|45897452-8f5a-458d-9a43-13237460ba48|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/m2/h|[?]|1|mg/g/min|INGUINAL REGION|RIGHT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-12-11|40
e|FA|45897452-8f5a-458d-9a43-13237460ba48|6|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|pt_us|[?]|1|BOWL|DELTOID MUSCLE|CONTRALATERAL|||CHILD|3|Visit_3|40|7|TREATMENT|2020-12-11|40
e|FA|45897452-8f5a-458d-9a43-13237460ba48|7|TRTSETT|Treatment Setting|[?]|GERD|[?]|vg/kg|[?]|1|Coulomb|PARANASAL SINUS|CONTRALATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2021-01-05|65
e|FA|45897452-8f5a-458d-9a43-13237460ba48|8|SEV|Severity/Intensity|[?]|GERD|[?]|umol/kg/min|[?]|1|Pa|PARACAVAL LYMPH NODE|CONTRALATERAL||Y|INVESTIGATOR|4|Visit_4|65|1|WASHOUT|2021-01-05|65
e|FA|45897452-8f5a-458d-9a43-13237460ba48|9|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|mL/m2/day|[?]|1|BOWL|TAIL|LEFT|||SIGNIFICANT OTHER|5|Visit_5|90|5|WASHOUT|2021-01-30|90
e|FA|45897452-8f5a-458d-9a43-13237460ba48|10|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|uOsm|[?]|1|anti-Xa IU/mL|KIDNEY, LOWER LOBE|UNILATERAL||Y|ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2021-01-30|90
e|FA|16eb981f-2118-4658-a83f-93d925c410c9|1|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|min*mg/mL|[?]|1|10^4 CFU/mL|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-12-16|10
e|FA|16eb981f-2118-4658-a83f-93d925c410c9|2|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|/wk|[?]|1|CUP|LEFT VENTRICULAR MID INFERIOR SEGMENT|CONTRALATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|5|SCREENING|2020-12-16|10
e|FA|16eb981f-2118-4658-a83f-93d925c410c9|3|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|fraction of 1|[?]|1|PACK|RECTUS FEMORIS MUSCLE|IPSILATERAL|Y||PARENT|2|Visit_2|25|6|TREATMENT|2020-12-31|25
e|FA|16eb981f-2118-4658-a83f-93d925c410c9|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|deg/s|[?]|1|mL/dose|ISCHIUM|LATERAL|||CHILD|2|Visit_2|25|5|TREATMENT|2020-12-31|25
e|FA|16eb981f-2118-4658-a83f-93d925c410c9|5|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|uEq/L|[?]|1|in|HEART, APEX|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|WASHOUT|2021-01-15|40
e|FA|16eb981f-2118-4658-a83f-93d925c410c9|6|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|mV2/Hz|[?]|1|BAG|METATARSOPHALANGEAL JOINT 1|CONTRALATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|6|SCREENING|2021-01-15|40
e|FA|16eb981f-2118-4658-a83f-93d925c410c9|7|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|grain|[?]|1|/200 HPFs|PERICARDIUM|IPSILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|7|TREATMENT|2021-02-09|65
e|FA|16eb981f-2118-4658-a83f-93d925c410c9|8|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|mmol|[?]|1|IU/mg|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|||SPOUSE|4|Visit_4|65|2|TREATMENT|2021-02-09|65
e|FA|16eb981f-2118-4658-a83f-93d925c410c9|9|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|mkat|[?]|1|mL/cm3/min|LUMBAR SPINE|RIGHT|Y||SPOUSE|5|Visit_5|90|7|TREATMENT|2021-03-06|90
e|FA|16eb981f-2118-4658-a83f-93d925c410c9|10|SEV|Severity/Intensity|[?]|GERD|[?]|Gauss|[?]|1|Pa|LIVER, LEFT LOBE|CONTRALATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|SCREENING|2021-03-06|90
e|FA|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|1|PPTFCT|Precipitating Factor|[?]|GERD|[?]|ag|[?]|1|EIA unit|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|LATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|4|SCREENING|2021-01-11|10
e|FA|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|2|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|% INHIBITION|[?]|1|SACHET|HAIR|CONTRALATERAL|||CAREGIVER|1|Visit_1|10|1|TREATMENT|2021-01-11|10
e|FA|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|3|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|v/v|[?]|1|mL/cm3/min|CARDIAC VALVE|BILATERAL|||FRIEND|2|Visit_2|25|4|TREATMENT|2021-01-26|25
e|FA|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|4|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|U/mg|[?]|1|U/mg|OPTIC NERVE|UNILATERAL||Y|PROXY|2|Visit_2|25|4|TREATMENT|2021-01-26|25
e|FA|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|5|DIAMETER|Diameter|[?]|GERD|[?]|EID 50/dose|[?]|1|cm|WARDS TRIANGLE|RIGHT|||SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2021-02-10|40
e|FA|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|6|VOL|Volume|[?]|GERD|[?]|MPS U|[?]|1|vp/dose|UTERINE ARTERY|IPSILATERAL||Y|SPOUSE|3|Visit_3|40|4|WASHOUT|2021-02-10|40
e|FA|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|7|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|mCi|[?]|1|mg/h|INTRATHORACIC LYMPH NODE|IPSILATERAL||Y|GUARDIAN|4|Visit_4|65|2|FOLLOW-UP|2021-03-07|65
e|FA|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|10^3 RNA copies/mL|[?]|1|%(v/v)|RECTUM|LEFT|||INDEPENDENT ASSESSOR|4|Visit_4|65|2|WASHOUT|2021-03-07|65
e|FA|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/day|[?]|1|mg/g/min|OCCIPITAL LOBE|LEFT|Y||FAMILY MEMBER|5|Visit_5|90|7|SCREENING|2021-04-01|90
e|FA|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|10|SPEED|Speed|[?]|GERD|[?]|kg/L|[?]|1|mEq/g|RADIAL NERVE|RIGHT|Y|Y|ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2021-04-01|90
e|FA|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|1|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|kHz|[?]|1|mL/m2|SACRUM|CONTRALATERAL|Y||FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2021-01-29|10
e|FA|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|2|SEV|Severity/Intensity|[?]|GERD|[?]|mL/beat|[?]|1|Pa|CHEEK|LATERAL|||DOMESTIC PARTNER|1|Visit_1|10|2|WASHOUT|2021-01-29|10
e|FA|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|3|DCAL|Dietary Calories|[?]|GERD|[?]|IU/mg|[?]|1|EIA unit|SUBMANDIBULAR LYMPH NODE|UNILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2021-02-13|25
e|FA|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|/day|[?]|1|mg/g/min|STERNAL MANUBRIUM|CONTRALATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|1|WASHOUT|2021-02-13|25
e|FA|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|5|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|ug/min|[?]|1|ohm|CORONARY ARTERY, RIGHT|IPSILATERAL|||ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2021-02-28|40
e|FA|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|6|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|mgEq|[?]|1|mmHg/L/min|GASTROCNEMIUS MUSCLE|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2021-02-28|40
e|FA|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|7|EVENTFRQ|Event Frequency|[?]|GERD|[?]|PELLET|[?]|1|ug/kg/h|DISTAL INTERPHALANGEAL JOINT 2|IPSILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2021-03-25|65
e|FA|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|8|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|PA|[?]|1|gtt|AORTIC VALVE, NON-CORONARY CUSP|IPSILATERAL|||STUDY SUBJECT|4|Visit_4|65|4|FOLLOW-UP|2021-03-25|65
e|FA|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|9|CALBURN|Calories Burned|[?]|GERD|[?]|h*%|[?]|1|/kg|LUMBAR REGION|RIGHT|||FRIEND|5|Visit_5|90|6|TREATMENT|2021-04-19|90
e|FA|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mol/mg|[?]|1|%(v/v)|CEREBRUM|IPSILATERAL|||INTERVIEWER|5|Visit_5|90|3|SCREENING|2021-04-19|90
e|FA|874f491c-5d55-4738-86b7-b1200b16d106|1|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|PATCH|[?]|1|Coulomb|FRONTAL LOBE|RIGHT|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2021-01-08|10
e|FA|874f491c-5d55-4738-86b7-b1200b16d106|2|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|mL*cmH2O|[?]|1|mEq|METACARPOPHALANGEAL JOINT 1|BILATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2021-01-08|10
e|FA|874f491c-5d55-4738-86b7-b1200b16d106|3|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|ug/g/h|[?]|1|cm H2O|AORTIC VALVE, NON-CORONARY CUSP|IPSILATERAL|||FAMILY MEMBER|2|Visit_2|25|4|TREATMENT|2021-01-23|25
e|FA|874f491c-5d55-4738-86b7-b1200b16d106|4|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|mCi/kg|[?]|1|EIA unit|PERIURETHRAL REGION|RIGHT||Y|INVESTIGATOR|2|Visit_2|25|1|WASHOUT|2021-01-23|25
e|FA|874f491c-5d55-4738-86b7-b1200b16d106|5|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|CFU/mL|[?]|1|10^6 IU/mL|AORTIC ARCH|LATERAL||Y|FRIEND|3|Visit_3|40|2|TREATMENT|2021-02-07|40
e|FA|874f491c-5d55-4738-86b7-b1200b16d106|6|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mg/day|[?]|1|Weber|HAIR ROOT|UNILATERAL|||INVESTIGATOR|3|Visit_3|40|5|TREATMENT|2021-02-07|40
e|FA|874f491c-5d55-4738-86b7-b1200b16d106|7|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mOsm/L|[?]|1|U/10^12 RBC|TRICUSPID VALVE, POSTERIOR ANNULUS|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-03-04|65
e|FA|874f491c-5d55-4738-86b7-b1200b16d106|8|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|mmHg|[?]|1|AU/mL|CORNEAL STROMA|UNILATERAL|Y||FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2021-03-04|65
e|FA|874f491c-5d55-4738-86b7-b1200b16d106|9|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|FEU|[?]|1|g/dL|HEART, APEX|LEFT|||INDEPENDENT ASSESSOR|5|Visit_5|90|4|TREATMENT|2021-03-29|90
e|FA|874f491c-5d55-4738-86b7-b1200b16d106|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Enzyme U|[?]|1|mg/g/min|MYOMETRIUM|LATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2021-03-29|90
e|FA|281ccdef-794c-49ad-9616-6f6f68dd4543|1|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|log10 IU/mL|[?]|1|mL/dose|MIDDLE PHALANX 3 OF THE HAND|BILATERAL|Y||FAMILY MEMBER|1|Visit_1|10|3|SCREENING|2020-06-04|10
e|FA|281ccdef-794c-49ad-9616-6f6f68dd4543|2|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|10^7 PFU|[?]|1|DROP|DISTAL PHALANX 5 OF THE HAND|UNILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-06-04|10
e|FA|281ccdef-794c-49ad-9616-6f6f68dd4543|3|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|LENS|[?]|1|m2|CRANIAL CAVITY|UNILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-06-19|25
e|FA|281ccdef-794c-49ad-9616-6f6f68dd4543|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/mL|[?]|1|ug/g/h|TARSAL JOINT|UNILATERAL||Y|CAREGIVER|2|Visit_2|25|3|WASHOUT|2020-06-19|25
e|FA|281ccdef-794c-49ad-9616-6f6f68dd4543|5|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|Bq/mL|[?]|1|mL/dose|HIP|BILATERAL|Y|Y|FAMILY MEMBER|3|Visit_3|40|1|SCREENING|2020-07-04|40
e|FA|281ccdef-794c-49ad-9616-6f6f68dd4543|6|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|mmol/s|[?]|1|IU/mg|CARPAL BONE|RIGHT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-07-04|40
e|FA|281ccdef-794c-49ad-9616-6f6f68dd4543|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|mg/g/min|HAND PHALANX|RIGHT|Y||ADJUDICATOR|4|Visit_4|65|2|WASHOUT|2020-07-29|65
e|FA|281ccdef-794c-49ad-9616-6f6f68dd4543|8|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|umol/dL|[?]|1|TRANSDUCING UNIT/mL|GASTROCNEMIUS MUSCLE|CONTRALATERAL||Y|ADJUDICATOR|4|Visit_4|65|1|FOLLOW-UP|2020-07-29|65
e|FA|281ccdef-794c-49ad-9616-6f6f68dd4543|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|MBP|[?]|1|mg/g/min|MENINGES|LEFT|||CHILD|5|Visit_5|90|5|SCREENING|2020-08-23|90
e|FA|281ccdef-794c-49ad-9616-6f6f68dd4543|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|BOTTLE|[?]|1|U/mmol|CALF|RIGHT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|FOLLOW-UP|2020-08-23|90
e|FA|b1179e10-e8fe-472c-a511-d6d460571857|1|ESTWT|Estimated Weight|[?]|GERD|[?]|g/animal/day|[?]|1|g/day|SENSORIMOTOR CORTEX|UNILATERAL|Y||INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-08-02|10
e|FA|b1179e10-e8fe-472c-a511-d6d460571857|2|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|DIOPTER|[?]|1|MPS U|OLFACTORY BULB|CONTRALATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|1|TREATMENT|2020-08-02|10
e|FA|b1179e10-e8fe-472c-a511-d6d460571857|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|Pa|INCISOR|BILATERAL|||INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2020-08-17|25
e|FA|b1179e10-e8fe-472c-a511-d6d460571857|4|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mL/s/m2|[?]|1|U/10^12 RBC|FOOT DIGIT 3|IPSILATERAL|||SPOUSE|2|Visit_2|25|1|SCREENING|2020-08-17|25
e|FA|b1179e10-e8fe-472c-a511-d6d460571857|5|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|MONTHS|[?]|1|mL/m2|ORAL CAVITY|LATERAL|||ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-09-01|40
e|FA|b1179e10-e8fe-472c-a511-d6d460571857|6|EXTRSCT|Extent of Resection|[?]|GERD|[?]|PATCH|[?]|1|Weber|AXILLARY LYMPH NODE|RIGHT|||SIBLING|3|Visit_3|40|5|TREATMENT|2020-09-01|40
e|FA|b1179e10-e8fe-472c-a511-d6d460571857|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|Pa|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL|||FRIEND|4|Visit_4|65|1|FOLLOW-UP|2020-09-26|65
e|FA|b1179e10-e8fe-472c-a511-d6d460571857|8|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|km|[?]|1|ug/m2/h|HINDLIMB|BILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-09-26|65
e|FA|b1179e10-e8fe-472c-a511-d6d460571857|9|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|umol/L|[?]|1|L|ARM SKIN|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|SCREENING|2020-10-21|90
e|FA|b1179e10-e8fe-472c-a511-d6d460571857|10|SEV|Severity/Intensity|[?]|GERD|[?]|10^8/L|[?]|1|Pa|TRAPEZIUM-TRAPEZOID JOINT|UNILATERAL||Y|ADJUDICATOR|5|Visit_5|90|7|SCREENING|2020-10-21|90
e|FA|6362cf42-f286-4151-bdf7-38fcc5639eed|1|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|PACK|[?]|1|IU/mmol|PRESACRAL LYMPH NODE|BILATERAL||Y|VENDOR|1|Visit_1|10|6|SCREENING|2020-09-07|10
e|FA|6362cf42-f286-4151-bdf7-38fcc5639eed|2|DISTANCE|Distance|[?]|GERD|[?]|genEq|[?]|1|BOWL|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|RIGHT|Y||INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-09-07|10
e|FA|6362cf42-f286-4151-bdf7-38fcc5639eed|3|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|DDU|[?]|1|10^9 CFU/g|OBTURATOR EXTERNUS MUSCLE|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2020-09-22|25
e|FA|6362cf42-f286-4151-bdf7-38fcc5639eed|4|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|ug/L/h|[?]|1|ng/day|PROXIMAL PHALANX 3 OF THE HAND|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-09-22|25
e|FA|6362cf42-f286-4151-bdf7-38fcc5639eed|5|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|deg2|[?]|1|g/L|HAIR ROOT|IPSILATERAL|||STUDY SUBJECT|3|Visit_3|40|5|WASHOUT|2020-10-07|40
e|FA|6362cf42-f286-4151-bdf7-38fcc5639eed|6|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mmHg*min/L|[?]|1|U/mg|CORONARY ARTERY, LEFT|CONTRALATERAL|||FAMILY MEMBER|3|Visit_3|40|3|FOLLOW-UP|2020-10-07|40
e|FA|6362cf42-f286-4151-bdf7-38fcc5639eed|7|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|ohm|CRANIAL CAVITY|LATERAL|||INTERVIEWER|4|Visit_4|65|3|FOLLOW-UP|2020-11-01|65
e|FA|6362cf42-f286-4151-bdf7-38fcc5639eed|8|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|DAYS|[?]|1|psi|INTERPHALANGEAL JOINT 1|BILATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2020-11-01|65
e|FA|6362cf42-f286-4151-bdf7-38fcc5639eed|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/kg/week|[?]|1|Pa|DISTAL INTERPHALANGEAL JOINT 4|LEFT|||CHILD|5|Visit_5|90|3|TREATMENT|2020-11-26|90
e|FA|6362cf42-f286-4151-bdf7-38fcc5639eed|10|SERVNUM|Number of Servings|[?]|GERD|[?]|/min|[?]|1|Hz/s|T5 VERTEBRA|BILATERAL|Y||STUDY SUBJECT|5|Visit_5|90|2|SCREENING|2020-11-26|90
e|FA|8e28e3ab-0060-43f7-b033-c16bd77c0e29|1|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|PFU|[?]|1|vp/dose|LEPTOMENINGES|LATERAL||Y|SIBLING|1|Visit_1|10|3|TREATMENT|2020-11-30|10
e|FA|8e28e3ab-0060-43f7-b033-c16bd77c0e29|2|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|Joule|[?]|1|mm/h|ILEUM|LEFT|||ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-11-30|10
e|FA|8e28e3ab-0060-43f7-b033-c16bd77c0e29|3|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mg/min|[?]|1|U/10^12 RBC|SUBTALAR JOINT|UNILATERAL|Y|Y|SPOUSE|2|Visit_2|25|1|TREATMENT|2020-12-15|25
e|FA|8e28e3ab-0060-43f7-b033-c16bd77c0e29|4|STRCTNUM|Number of Strictures|[?]|GERD|[?]|/100 WBC|[?]|1|SACHET|FOOT DIGIT 5|RIGHT|||FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-12-15|25
e|FA|8e28e3ab-0060-43f7-b033-c16bd77c0e29|5|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|umol/dL|[?]|1|DROP|AORTA|BILATERAL|||INVESTIGATOR|3|Visit_3|40|3|FOLLOW-UP|2020-12-30|40
e|FA|8e28e3ab-0060-43f7-b033-c16bd77c0e29|6|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|nmol/L/min|[?]|1|10^6 U|URACHAL TRACT|IPSILATERAL||Y|PROXY|3|Visit_3|40|2|SCREENING|2020-12-30|40
e|FA|8e28e3ab-0060-43f7-b033-c16bd77c0e29|7|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|10^3 CFU/mL|[?]|1|Gy/h|LEG|LATERAL|||INVESTIGATOR|4|Visit_4|65|6|SCREENING|2021-01-24|65
e|FA|8e28e3ab-0060-43f7-b033-c16bd77c0e29|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|PFU|[?]|1|CUP|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|BILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-01-24|65
e|FA|8e28e3ab-0060-43f7-b033-c16bd77c0e29|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/m2|[?]|1|mg/g/min|SUDORIFEROUS GLAND|CONTRALATERAL|||FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-02-18|90
e|FA|8e28e3ab-0060-43f7-b033-c16bd77c0e29|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|ug/L FEU|[?]|1|mL|T7 VERTEBRA|RIGHT|||GUARDIAN|5|Visit_5|90|5|SCREENING|2021-02-18|90
e|FA|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|1|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|deg/mm|[?]|1|mL/h|WRIST JOINT|RIGHT|Y||SIBLING|1|Visit_1|10|7|SCREENING|2020-06-27|10
e|FA|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|kg/m2|[?]|1|Pa|NUCLEUS ACCUMBENS|LATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-06-27|10
e|FA|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|3|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mL|[?]|1|mIU/L|SUPRASPINATUS MUSCLE|LEFT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-07-12|25
e|FA|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|kBq|[?]|1|10^6 IU/mL|BREAST|BILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2020-07-12|25
e|FA|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/g/min|[?]|1|mg/g/min|BACK|CONTRALATERAL|Y|Y|CHILD|3|Visit_3|40|3|TREATMENT|2020-07-27|40
e|FA|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|6|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|mEq/ug|[?]|1|oz eq|INFRATENTORIAL BRAIN|BILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|3|SCREENING|2020-07-27|40
e|FA|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|7|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|mg/min|[?]|1|Ci/ug|SHOULDER|UNILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-08-21|65
e|FA|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|8|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|mmAL|[?]|1|mL/min/mmHg|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|Y||SPOUSE|4|Visit_4|65|4|WASHOUT|2020-08-21|65
e|FA|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|mg/g/min|GLOTTIS|BILATERAL|Y||SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2020-09-15|90
e|FA|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|10|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|mL/min/mmHg|CORPUS CALLOSUM|CONTRALATERAL|||STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-09-15|90
e|FA|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|1|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|/wk|[?]|1|QUANTITY SUFFICIENT|SUPERFICIAL FEMORAL ARTERY|IPSILATERAL||Y|SPOUSE|1|Visit_1|10|2|FOLLOW-UP|2020-06-22|10
e|FA|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|2|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|umol/L|[?]|1|DROP|PLEURA|LEFT|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|FOLLOW-UP|2020-06-22|10
e|FA|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|3|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|steps/min|[?]|1|mm/h|DELTOID MUSCLE|UNILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-07-07|25
e|FA|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|4|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|usec|[?]|1|g/day|RIB 9|UNILATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|1|SCREENING|2020-07-07|25
e|FA|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|5|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|mL/cage|[?]|1|10^6 CFU|PROXIMAL LAD ARTERY|LATERAL|||PROXY|3|Visit_3|40|4|WASHOUT|2020-07-22|40
e|FA|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|BEAM BREAKS|[?]|1|%(v/v)|FACIAL NERVE|CONTRALATERAL||Y|PARENT|3|Visit_3|40|4|WASHOUT|2020-07-22|40
e|FA|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|7|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|PIXELS/cm|[?]|1|mm/h|PROSTATE GLAND, MIDDLE LOBE|RIGHT||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-08-16|65
e|FA|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|8|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|mg/kg/h|[?]|1|fmol|BUCCAL MUCOSA|BILATERAL|Y||INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2020-08-16|65
e|FA|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|9|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|K|[?]|1|uCi/kg|ANTERIOR SUPERIOR ILIAC SPINE|IPSILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|TREATMENT|2020-09-10|90
e|FA|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|nm|[?]|1|10^6 U|SOLE|UNILATERAL||Y|SIBLING|5|Visit_5|90|5|SCREENING|2020-09-10|90
e|FA|43880587-c397-402d-886b-9b666e3fe455|1|EVENTFRQ|Event Frequency|[?]|GERD|[?]|U/g/h|[?]|1|ug/kg/h|PINEAL GLAND|LEFT||Y|INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-07-21|10
e|FA|43880587-c397-402d-886b-9b666e3fe455|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|min*mg/mL|[?]|1|mg/g/min|CONJUNCTIVA|LEFT||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-07-21|10
e|FA|43880587-c397-402d-886b-9b666e3fe455|3|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|fg|[?]|1|mL/mmHg/min/L|LOCUS CERULEUS|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2020-08-05|25
e|FA|43880587-c397-402d-886b-9b666e3fe455|4|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|mL/100g/min|BLADDER|IPSILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|SCREENING|2020-08-05|25
e|FA|43880587-c397-402d-886b-9b666e3fe455|5|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|mg/mol|[?]|1|psi|PARALARYNGEAL LYMPH NODE|RIGHT|||FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2020-08-20|40
e|FA|43880587-c397-402d-886b-9b666e3fe455|6|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|TROCHE|[?]|1|PFU/dose|INGUINAL LYMPH NODE|BILATERAL|||SIBLING|3|Visit_3|40|5|FOLLOW-UP|2020-08-20|40
e|FA|43880587-c397-402d-886b-9b666e3fe455|7|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|ELISA unit|[?]|1|/200 HPFs|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|LEFT||Y|FRIEND|4|Visit_4|65|6|SCREENING|2020-09-14|65
e|FA|43880587-c397-402d-886b-9b666e3fe455|8|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|log10 CFU/mL|[?]|1|10^4 CFU/mL|HILAR|UNILATERAL|||FRIEND|4|Visit_4|65|5|FOLLOW-UP|2020-09-14|65
e|FA|43880587-c397-402d-886b-9b666e3fe455|9|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|DRINK|[?]|1|mL/cm3/min|ULNA SHAFT|LATERAL|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|5|FOLLOW-UP|2020-10-09|90
e|FA|43880587-c397-402d-886b-9b666e3fe455|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|DRINK|[?]|1|10^6 U|PORTAL LYMPH NODE|IPSILATERAL|Y|Y|SIBLING|5|Visit_5|90|5|SCREENING|2020-10-09|90
e|FA|807f83d2-9364-4ee4-855d-304f3e252555|1|EXCDUR|Exercise Duration|[?]|GERD|[?]|MET*min|[?]|1|mm|BULBAR CONJUNCTIVA|RIGHT|||DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-05-14|10
e|FA|807f83d2-9364-4ee4-855d-304f3e252555|2|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|g/g/day|[?]|1|BOWL|INTESTINE|RIGHT||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-05-14|10
e|FA|807f83d2-9364-4ee4-855d-304f3e252555|3|DPROT|Dietary Protein|[?]|GERD|[?]|SFC/10^6 PBMC|[?]|1|10^4 CFU/mL|AORTIC VALVE, LEFT CORONARY CUSP|RIGHT|||SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2020-05-29|25
e|FA|807f83d2-9364-4ee4-855d-304f3e252555|4|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|10^3/L|[?]|1|mL/h|BRACHIAL ARTERY|IPSILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-05-29|25
e|FA|807f83d2-9364-4ee4-855d-304f3e252555|5|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|mAnson U/mL|[?]|1|10^6 IU/mL|MESENTERIC ARTERY|RIGHT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|FOLLOW-UP|2020-06-13|40
e|FA|807f83d2-9364-4ee4-855d-304f3e252555|6|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|WEEKS|[?]|1|g/L|SKIN OF THE KNEE|BILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|7|FOLLOW-UP|2020-06-13|40
e|FA|807f83d2-9364-4ee4-855d-304f3e252555|7|DVEG|Dietary Vegetable|[?]|GERD|[?]|rpm|[?]|1|Ci/ug|TROCHANTER|UNILATERAL|Y|Y|SIBLING|4|Visit_4|65|4|TREATMENT|2020-07-08|65
e|FA|807f83d2-9364-4ee4-855d-304f3e252555|8|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|IU/mL|[?]|1|g/day|CEREBRAL SUBCORTEX|LEFT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2020-07-08|65
e|FA|807f83d2-9364-4ee4-855d-304f3e252555|9|DFIBER|Dietary Fiber|[?]|GERD|[?]|OD Unit|[?]|1|h*%|FEMUR SHAFT|UNILATERAL|||FRIEND|5|Visit_5|90|7|TREATMENT|2020-08-02|90
e|FA|807f83d2-9364-4ee4-855d-304f3e252555|10|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|mmol/mol|[?]|1|in|HAND DIGIT 1|UNILATERAL||Y|PROXY|5|Visit_5|90|2|FOLLOW-UP|2020-08-02|90
e|FA|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|1|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|DAgU/mL|[?]|1|mL/m2|FEMORAL NECK|BILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-12-09|10
e|FA|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|2|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ag|[?]|1|mL|VASTUS INTERMEDIUS MUSCLE|IPSILATERAL|||CHILD|1|Visit_1|10|2|TREATMENT|2020-12-09|10
e|FA|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|3|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|IU/g|[?]|1|aMFI|INTERPHALANGEAL JOINT OF THE HAND|RIGHT|||FAMILY MEMBER|2|Visit_2|25|5|SCREENING|2020-12-24|25
e|FA|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|4|VOL|Volume|[?]|GERD|[?]|TRANSDUCING UNIT/mL|[?]|1|vp/dose|C1 VERTEBRA|RIGHT|||SIBLING|2|Visit_2|25|6|TREATMENT|2020-12-24|25
e|FA|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|5|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|uL/dose|[?]|1|NEEDLE GAUGE|KIDNEY, UPPER LOBE|IPSILATERAL|||INTERVIEWER|3|Visit_3|40|7|TREATMENT|2021-01-08|40
e|FA|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|cup eq|[?]|1|%(v/v)|COSTOCHONDRAL JOINT 1|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2021-01-08|40
e|FA|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|7|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|dpm/mL|[?]|1|m2|SUPERIOR PUBIC RAMUS|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|SCREENING|2021-02-02|65
e|FA|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|8|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|U/10^12 RBC|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|CONTRALATERAL|Y||INTERVIEWER|4|Visit_4|65|5|TREATMENT|2021-02-02|65
e|FA|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|9|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|mm/h|AXILLARY LYMPH NODE|IPSILATERAL|||FRIEND|5|Visit_5|90|5|FOLLOW-UP|2021-02-27|90
e|FA|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/g/h|[?]|1|mg/g/min|GASTRIC CURVATURE LYMPH NODE|LEFT|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2021-02-27|90
e|FA|81c33633-6ade-45fe-a78e-0e853d8aa9c2|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^11/L|[?]|1|mg/g/min|CILIARY BODY|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|TREATMENT|2020-08-15|10
e|FA|81c33633-6ade-45fe-a78e-0e853d8aa9c2|2|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|genEq|[?]|1|/kg|FOOT|LATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-08-15|10
e|FA|81c33633-6ade-45fe-a78e-0e853d8aa9c2|3|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|GBq/mg|[?]|1|IU/mg|BONE MARROW|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|3|FOLLOW-UP|2020-08-30|25
e|FA|81c33633-6ade-45fe-a78e-0e853d8aa9c2|4|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|h*%|[?]|1|TRANSDUCING UNIT/mL|URETER|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-08-30|25
e|FA|81c33633-6ade-45fe-a78e-0e853d8aa9c2|5|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mL/min/1.73m2|[?]|1|100 IU/mL|PULMONARY VALVE, ANTERIOR CUSP|LATERAL||Y|SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2020-09-14|40
e|FA|81c33633-6ade-45fe-a78e-0e853d8aa9c2|6|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|pg|[?]|1|10^6 U|SKIN OF THE FACE|RIGHT|Y||CHILD|3|Visit_3|40|3|SCREENING|2020-09-14|40
e|FA|81c33633-6ade-45fe-a78e-0e853d8aa9c2|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|Pa|[?]|1|U/mg|COLON, RECTOSIGMOID|UNILATERAL||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|FOLLOW-UP|2020-10-09|65
e|FA|81c33633-6ade-45fe-a78e-0e853d8aa9c2|8|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|BP|[?]|1|Shock Wave|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|LATERAL|Y||SPOUSE|4|Visit_4|65|7|WASHOUT|2020-10-09|65
e|FA|81c33633-6ade-45fe-a78e-0e853d8aa9c2|9|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mg|[?]|1|aMFI|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|LATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-11-03|90
e|FA|81c33633-6ade-45fe-a78e-0e853d8aa9c2|10|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|mmol/mol|[?]|1|Bq/L|SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-11-03|90
e|FA|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|1|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|kN/cm2|[?]|1|Hz/s|AXILLARY VEIN|LEFT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|WASHOUT|2020-08-01|10
e|FA|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|2|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/kg/min|[?]|1|in|SKIN OF THE BUTTOCK|LEFT|||ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-08-01|10
e|FA|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|3|OBJNUM|Number of Objects|[?]|GERD|[?]|IU/mL|[?]|1|mL/100g/min|BILE DUCT|BILATERAL||Y|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-08-16|25
e|FA|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|1/(s*kPa)|[?]|1|mL/dose|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-08-16|25
e|FA|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|5|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|umol|[?]|1|umol|CHEST|RIGHT||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-08-31|40
e|FA|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|6|SEV|Severity/Intensity|[?]|GERD|[?]|10^9 CFU/g|[?]|1|Pa|L2 VERTEBRA|RIGHT|||CLINICAL STUDY SPONSOR|3|Visit_3|40|1|FOLLOW-UP|2020-08-31|40
e|FA|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|7|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|ug/m2/h|PORTAL VEIN|RIGHT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|WASHOUT|2020-09-25|65
e|FA|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|8|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|nmol/L/h|[?]|1|mm/h|MESENTERIC LYMPH NODE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-09-25|65
e|FA|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|9|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|mm|AORTIC VALVE|RIGHT|Y||FAMILY MEMBER|5|Visit_5|90|2|TREATMENT|2020-10-20|90
e|FA|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|10|OBJTYPE|Type of Object|[?]|GERD|[?]|mL/day|[?]|1|ng|MAXILLARY SINUS|LEFT|Y||FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2020-10-20|90
e|FA|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|1|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|mL/min|[?]|1|mIU/L|CARDIAC WALL|UNILATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|5|FOLLOW-UP|2020-09-01|10
e|FA|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|2|SPEED|Speed|[?]|GERD|[?]|uCi/kg|[?]|1|mEq/g|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|UNILATERAL|Y||GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-09-01|10
e|FA|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/g/h|[?]|1|mg/g/min|ILIAC FOSSA|LATERAL|Y||FAMILY MEMBER|2|Visit_2|25|1|SCREENING|2020-09-16|25
e|FA|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|4|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|U/kg/h|[?]|1|m2|PYRAMIDAL TRACTS, INTERNAL CAPSULE|RIGHT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|SCREENING|2020-09-16|25
e|FA|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|5|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|mmHg|[?]|1|mm/h|BONE|BILATERAL|||FRIEND|3|Visit_3|40|1|SCREENING|2020-10-01|40
e|FA|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|6|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|log10 CFU/mL|[?]|1|mEq|HEEL OF THE HAND|CONTRALATERAL|Y|Y|SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2020-10-01|40
e|FA|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|7|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|copies/ug|[?]|1|Shock Wave|UNCINATE PROCESS OF PANCREAS|LATERAL|||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-10-26|65
e|FA|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|8|STROKTYP|Stroke Type|[?]|GERD|[?]|MONTHS|[?]|1|g/L|PROXIMAL PHALANX 2 OF THE HAND|BILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-10-26|65
e|FA|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|TAMPON|[?]|1|mL/dose|LEG SKIN|RIGHT|||CAREGIVER|5|Visit_5|90|1|TREATMENT|2020-11-20|90
e|FA|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|U/kg/min|[?]|1|%(v/v)|RIB 10|IPSILATERAL|Y||STUDY SUBJECT|5|Visit_5|90|7|WASHOUT|2020-11-20|90
e|FA|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|1|EVENTNUM|Number of Events|[?]|GERD|[?]|mAmp|[?]|1|U/10^12 RBC|AXILLARY LYMPH NODE LEVEL III|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2021-01-27|10
e|FA|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|2|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mL/cage|[?]|1|10^6 U|SKIN AROUND THE MOUTH|LATERAL|Y|Y|DOMESTIC PARTNER|1|Visit_1|10|3|WASHOUT|2021-01-27|10
e|FA|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|3|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|10^7 CFU|[?]|1|cmH2O/mL|SUBSTANTIA NIGRA|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|7|WASHOUT|2021-02-11|25
e|FA|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|4|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|Bq/L|[?]|1|mIU/L|HIP ADDUCTORS|LEFT|||STUDY SUBJECT|2|Visit_2|25|2|FOLLOW-UP|2021-02-11|25
e|FA|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|5|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|10^6/hpf|[?]|1|g/day|PLEURA|LEFT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2021-02-26|40
e|FA|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|6|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|mol/day|[?]|1|mL/mmHg/min/L|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|BILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2021-02-26|40
e|FA|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|7|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|umol/L/min|[?]|1|MBq|PROXIMAL URETHRA|BILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2021-03-23|65
e|FA|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|8|EXCDUR|Exercise Duration|[?]|GERD|[?]|mmol|[?]|1|mm|THORAX|IPSILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|FOLLOW-UP|2021-03-23|65
e|FA|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|9|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|mL/animal|[?]|1|MBq|EPIGASTRIC LYMPH NODE|LATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|1|FOLLOW-UP|2021-04-17|90
e|FA|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|10|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|cm H2O|OROPHARYNX|LEFT|||DOMESTIC PARTNER|5|Visit_5|90|2|FOLLOW-UP|2021-04-17|90
e|FA|21740641-69bb-49a9-a86d-2444914f6d12|1|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|BOWL|[?]|1|ng/day|FAT PAD|CONTRALATERAL|||INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-05-17|10
e|FA|21740641-69bb-49a9-a86d-2444914f6d12|2|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|mg/L|[?]|1|Shock Wave|POSTERIOR CINGULATE CORTEX|RIGHT||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-05-17|10
e|FA|21740641-69bb-49a9-a86d-2444914f6d12|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/h/mmol|[?]|1|mg/g/min|LEFT VENTRICULAR APEX SEGMENT|UNILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|WASHOUT|2020-06-01|25
e|FA|21740641-69bb-49a9-a86d-2444914f6d12|4|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|MET|[?]|1|mm/h|PULMONARY VALVE, LEFT CUSP|LEFT|||INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-06-01|25
e|FA|21740641-69bb-49a9-a86d-2444914f6d12|5|SEV|Severity/Intensity|[?]|GERD|[?]|10^9 CFU/mL|[?]|1|Pa|PERIURETERAL REGION|LEFT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-06-16|40
e|FA|21740641-69bb-49a9-a86d-2444914f6d12|6|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|mm3/mm2/year|[?]|1|in|BRAIN STEM|RIGHT|||VENDOR|3|Visit_3|40|6|TREATMENT|2020-06-16|40
e|FA|21740641-69bb-49a9-a86d-2444914f6d12|7|SEV|Severity/Intensity|[?]|GERD|[?]|pmol/day|[?]|1|Pa|MESENTERIC LYMPH NODE|RIGHT|||PROXY|4|Visit_4|65|5|FOLLOW-UP|2020-07-11|65
e|FA|21740641-69bb-49a9-a86d-2444914f6d12|8|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|U/mg|[?]|1|mm/h|SKIN OF THE BENDING JOINT|LATERAL|||SIBLING|4|Visit_4|65|6|WASHOUT|2020-07-11|65
e|FA|21740641-69bb-49a9-a86d-2444914f6d12|9|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|10^3 RNA copies/mL|[?]|1|g/L|UNCINATE PROCESS OF PANCREAS|RIGHT|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-08-05|90
e|FA|21740641-69bb-49a9-a86d-2444914f6d12|10|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|Bq|[?]|1|mg/dose|COLON, SPLENIC FLEXURE|IPSILATERAL||Y|GUARDIAN|5|Visit_5|90|5|TREATMENT|2020-08-05|90
e|FA|c3984f41-30a0-49a4-a8bd-f36fad4621a8|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ngEq/L|[?]|1|%(v/v)|C2 VERTEBRA|BILATERAL|||PROXY|1|Visit_1|10|3|TREATMENT|2020-06-18|10
e|FA|c3984f41-30a0-49a4-a8bd-f36fad4621a8|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Newton|[?]|1|%(v/v)|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|WASHOUT|2020-06-18|10
e|FA|c3984f41-30a0-49a4-a8bd-f36fad4621a8|3|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|ngEq/L|[?]|1|km|SUPRARENAL AORTA|RIGHT|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|FOLLOW-UP|2020-07-03|25
e|FA|c3984f41-30a0-49a4-a8bd-f36fad4621a8|4|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|Pa|[?]|1|g/L|FAT PAD|RIGHT|Y||VENDOR|2|Visit_2|25|2|TREATMENT|2020-07-03|25
e|FA|c3984f41-30a0-49a4-a8bd-f36fad4621a8|5|DCAL|Dietary Calories|[?]|GERD|[?]|mg/L FEU|[?]|1|EIA unit|METACARPOPHALANGEAL JOINT 3|RIGHT|||PARENT|3|Visit_3|40|2|WASHOUT|2020-07-18|40
e|FA|c3984f41-30a0-49a4-a8bd-f36fad4621a8|6|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|PA|[?]|1|mm|CORPUS UTERI|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|7|FOLLOW-UP|2020-07-18|40
e|FA|c3984f41-30a0-49a4-a8bd-f36fad4621a8|7|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|mL|[?]|1|SACHET|SALIVARY GLAND, SUBLINGUAL|RIGHT|||DOMESTIC PARTNER|4|Visit_4|65|2|SCREENING|2020-08-12|65
e|FA|c3984f41-30a0-49a4-a8bd-f36fad4621a8|8|AGETRT1|Age At First Treatment|[?]|GERD|[?]|nmol|[?]|1|mL/mmHg/min/L|RENAL PELVIS|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-08-12|65
e|FA|c3984f41-30a0-49a4-a8bd-f36fad4621a8|9|LDIAM|Longest Diameter|[?]|GERD|[?]|mol/L|[?]|1|Shock Wave|HAND PHALANX|LEFT|Y||STUDY SUBJECT|5|Visit_5|90|1|FOLLOW-UP|2020-09-06|90
e|FA|c3984f41-30a0-49a4-a8bd-f36fad4621a8|10|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|DPM|[?]|1|10^6 IU/mL|EPIGLOTTIS|UNILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2020-09-06|90
e|FA|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|1|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|ug/kg/h|[?]|1|Bq/L|SKIN AROUND THE MOUTH|CONTRALATERAL|||CAREGIVER|1|Visit_1|10|2|TREATMENT|2021-01-21|10
e|FA|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|2|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|breaths/30s|[?]|1|HOURS|FLOOR OF MOUTH|BILATERAL|||INTERVIEWER|1|Visit_1|10|6|TREATMENT|2021-01-21|10
e|FA|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|3|STROKTYP|Stroke Type|[?]|GERD|[?]|%/min|[?]|1|g/L|BRACHIAL ARTERY|IPSILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|2|WASHOUT|2021-02-05|25
e|FA|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|4|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|ft3|[?]|1|m2|OCULOMOTOR NERVE|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|TREATMENT|2021-02-05|25
e|FA|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|5|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|amp|[?]|1|in|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|CONTRALATERAL|||GUARDIAN|3|Visit_3|40|4|WASHOUT|2021-02-20|40
e|FA|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|6|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|CONTAINER|[?]|1|10^9 CFU/mL|GLUTEAL MUSCLE|LATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2021-02-20|40
e|FA|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|7|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|/ms|[?]|1|uL/kg/day|SUBLINGUAL REGION|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|FOLLOW-UP|2021-03-17|65
e|FA|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|8|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|10^10/L|[?]|1|mL/cm3/min|CILIARY BODY|CONTRALATERAL|||PROXY|4|Visit_4|65|3|WASHOUT|2021-03-17|65
e|FA|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|IU/mg|[?]|1|ug/g/h|BRACHIALIS MUSCLE|LATERAL|||INTERVIEWER|5|Visit_5|90|6|TREATMENT|2021-04-11|90
e|FA|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|s*kPa|[?]|1|oz eq|ILIUM|UNILATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|3|SCREENING|2021-04-11|90
e|FA|0f85b859-187d-4c6b-8873-33c0f18d3e3c|1|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|CFU/mL|[?]|1|IU/mmol|VAGINA|LEFT|||INTERVIEWER|1|Visit_1|10|6|FOLLOW-UP|2020-07-24|10
e|FA|0f85b859-187d-4c6b-8873-33c0f18d3e3c|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/kg/min|[?]|1|mg/g/min|OBTURATOR MUSCLE|BILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|FOLLOW-UP|2020-07-24|10
e|FA|0f85b859-187d-4c6b-8873-33c0f18d3e3c|3|DFATT|Dietary Fat, Total|[?]|GERD|[?]|10^6 RNA copies/mL|[?]|1|Bq/mg|TRIANGULAR BONE|RIGHT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|FOLLOW-UP|2020-08-08|25
e|FA|0f85b859-187d-4c6b-8873-33c0f18d3e3c|4|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|FEU|[?]|1|Shock Wave|SYNOVIAL FLUID|RIGHT||Y|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-08-08|25
e|FA|0f85b859-187d-4c6b-8873-33c0f18d3e3c|5|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^4/L|[?]|1|oz eq|DISTAL FEMUR R1|LATERAL|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|2|TREATMENT|2020-08-23|40
e|FA|0f85b859-187d-4c6b-8873-33c0f18d3e3c|6|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|vp/dose|[?]|1|mL/h|JAW|UNILATERAL||Y|STUDY SUBJECT|3|Visit_3|40|6|WASHOUT|2020-08-23|40
e|FA|0f85b859-187d-4c6b-8873-33c0f18d3e3c|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|10^3 RNA copies/mL|[?]|1|PFU/dose|PULMONARY VALVE, ANTERIOR CUSP|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|TREATMENT|2020-09-17|65
e|FA|0f85b859-187d-4c6b-8873-33c0f18d3e3c|8|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|APS U|[?]|1|anti-Xa IU/mL|ANASTOMOSIS|BILATERAL||Y|PARENT|4|Visit_4|65|2|TREATMENT|2020-09-17|65
e|FA|0f85b859-187d-4c6b-8873-33c0f18d3e3c|9|SPEED|Speed|[?]|GERD|[?]|mN|[?]|1|mEq/g|COSTOCHONDRAL JOINT 1|RIGHT|Y||SIBLING|5|Visit_5|90|3|TREATMENT|2020-10-12|90
e|FA|0f85b859-187d-4c6b-8873-33c0f18d3e3c|10|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|ng/mol|[?]|1|mEq|ULNA SHAFT|RIGHT||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-10-12|90
e|FA|5e383a9d-dc97-4352-8add-d55a1a566b9f|1|DGRAIN|Dietary Grain|[?]|GERD|[?]|GBq/mg|[?]|1|10^9 CFU/g|RETINA|RIGHT|||GUARDIAN|1|Visit_1|10|3|FOLLOW-UP|2020-09-27|10
e|FA|5e383a9d-dc97-4352-8add-d55a1a566b9f|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^8 PFU|[?]|1|mg/g/min|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|IPSILATERAL|||FRIEND|1|Visit_1|10|5|TREATMENT|2020-09-27|10
e|FA|5e383a9d-dc97-4352-8add-d55a1a566b9f|3|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|cm2|[?]|1|g/L|PORTAL LYMPH NODE|CONTRALATERAL|Y||SIBLING|2|Visit_2|25|3|SCREENING|2020-10-12|25
e|FA|5e383a9d-dc97-4352-8add-d55a1a566b9f|4|DFIBER|Dietary Fiber|[?]|GERD|[?]|Bq/mL|[?]|1|h*%|MESENTERY|LEFT|||INVESTIGATOR|2|Visit_2|25|6|TREATMENT|2020-10-12|25
e|FA|5e383a9d-dc97-4352-8add-d55a1a566b9f|5|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|Anson U|[?]|1|Shock Wave|LUNG, RIGHT LOWER LOBE|IPSILATERAL|||ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2020-10-27|40
e|FA|5e383a9d-dc97-4352-8add-d55a1a566b9f|6|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|mg/L|[?]|1|Shock Wave|ABDUCTOR HALLUCIS MUSCLE|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|SCREENING|2020-10-27|40
e|FA|5e383a9d-dc97-4352-8add-d55a1a566b9f|7|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|POUCH|[?]|1|10^9 CFU/mL|HARD PALATE|LEFT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|SCREENING|2020-11-21|65
e|FA|5e383a9d-dc97-4352-8add-d55a1a566b9f|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|mg/g/min|LUMBAR SPINE|UNILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|4|WASHOUT|2020-11-21|65
e|FA|5e383a9d-dc97-4352-8add-d55a1a566b9f|9|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|cg|[?]|1|NEEDLE GAUGE|PROXIMAL INTERPHALANGEAL JOINT 5|CONTRALATERAL|||INTERVIEWER|5|Visit_5|90|3|FOLLOW-UP|2020-12-16|90
e|FA|5e383a9d-dc97-4352-8add-d55a1a566b9f|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|DNA copies/ug|[?]|1|%(v/v)|METACARPOPHALANGEAL JOINT 5|LATERAL|Y|Y|SIBLING|5|Visit_5|90|5|TREATMENT|2020-12-16|90
e|FA|3eda746b-fb97-4950-a528-1d4ae5d3653a|1|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|ECL unit|[?]|1|in|COLON WALL|LATERAL|Y||VENDOR|1|Visit_1|10|3|TREATMENT|2020-06-13|10
e|FA|3eda746b-fb97-4950-a528-1d4ae5d3653a|2|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|msec|[?]|1|mL/cm3/min|ENDOMETRIUM|RIGHT|||GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-06-13|10
e|FA|3eda746b-fb97-4950-a528-1d4ae5d3653a|3|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|FIU|[?]|1|cm H2O|FLEXOR HALLUCIS LONGUS MUSCLE|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2020-06-28|25
e|FA|3eda746b-fb97-4950-a528-1d4ae5d3653a|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|uV*sec|[?]|1|Pa|FINGER EXTENSOR MUSCLES|UNILATERAL|||STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2020-06-28|25
e|FA|3eda746b-fb97-4950-a528-1d4ae5d3653a|5|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|kPa/L/sec|[?]|1|mAmp|TESTIS|LEFT|||INTERVIEWER|3|Visit_3|40|2|TREATMENT|2020-07-13|40
e|FA|3eda746b-fb97-4950-a528-1d4ae5d3653a|6|DMEAT|Dietary Meat|[?]|GERD|[?]|MBq|[?]|1|10^6 organisms/mL|HAIR BULB|BILATERAL|Y|Y|SPOUSE|3|Visit_3|40|5|TREATMENT|2020-07-13|40
e|FA|3eda746b-fb97-4950-a528-1d4ae5d3653a|7|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|uU/L|[?]|1|Coulomb|RAPHE|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|2|TREATMENT|2020-08-07|65
e|FA|3eda746b-fb97-4950-a528-1d4ae5d3653a|8|EXTRSCT|Extent of Resection|[?]|GERD|[?]|ft2|[?]|1|Weber|MYOMETRIUM|LEFT|||STUDY SUBJECT|4|Visit_4|65|7|WASHOUT|2020-08-07|65
e|FA|3eda746b-fb97-4950-a528-1d4ae5d3653a|9|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|cd|[?]|1|IU/mmol|SUBMANDIBULAR GLAND|LATERAL|||FRIEND|5|Visit_5|90|1|TREATMENT|2020-09-01|90
e|FA|3eda746b-fb97-4950-a528-1d4ae5d3653a|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|Bq|[?]|1|10^6 U|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|LEFT||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|FOLLOW-UP|2020-09-01|90
e|FA|a3b72841-3401-4dcc-9d06-75438b408d0b|1|STROKTYP|Stroke Type|[?]|GERD|[?]|g/animal/day|[?]|1|g/L|CAUDATE NUCLEUS|BILATERAL|Y||SPOUSE|1|Visit_1|10|2|TREATMENT|2020-11-05|10
e|FA|a3b72841-3401-4dcc-9d06-75438b408d0b|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|SYRINGE|[?]|1|mg/g/min|SUDORIFEROUS GLAND|CONTRALATERAL|||SIBLING|1|Visit_1|10|1|WASHOUT|2020-11-05|10
e|FA|a3b72841-3401-4dcc-9d06-75438b408d0b|3|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|mL/dose|PATELLA|IPSILATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-11-20|25
e|FA|a3b72841-3401-4dcc-9d06-75438b408d0b|4|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|uEq|[?]|1|10^6 U|VOCAL CORD|LEFT|||PARENT|2|Visit_2|25|4|FOLLOW-UP|2020-11-20|25
e|FA|a3b72841-3401-4dcc-9d06-75438b408d0b|5|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/mL|[?]|1|IU/mmol|RETINAL NERVE FIBER LAYER|LEFT|||SIGNIFICANT OTHER|3|Visit_3|40|5|TREATMENT|2020-12-05|40
e|FA|a3b72841-3401-4dcc-9d06-75438b408d0b|6|DMG|Dietary Magnesium|[?]|GERD|[?]|nm|[?]|1|TRANSDUCING UNIT/mL|BICEPS FEMORIS MUSCLE|UNILATERAL||Y|STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2020-12-05|40
e|FA|a3b72841-3401-4dcc-9d06-75438b408d0b|7|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|g/cage/day|REGIONAL LYMPH NODE|LATERAL|||PARENT|4|Visit_4|65|1|TREATMENT|2020-12-30|65
e|FA|a3b72841-3401-4dcc-9d06-75438b408d0b|8|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|tuberculin unit/mL|[?]|1|ohm|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|RIGHT|||CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-12-30|65
e|FA|a3b72841-3401-4dcc-9d06-75438b408d0b|9|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|mg/L FEU|[?]|1|ohm|FEMUR|CONTRALATERAL|||PROXY|5|Visit_5|90|5|TREATMENT|2021-01-24|90
e|FA|a3b72841-3401-4dcc-9d06-75438b408d0b|10|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|m/sec|[?]|1|fmol|POSTERIOR CERVICAL LYMPH NODE|RIGHT|||SIGNIFICANT OTHER|5|Visit_5|90|3|FOLLOW-UP|2021-01-24|90
e|FA|4393406e-bda5-42e4-a752-a8121004b7ef|1|TOXGR|Toxicity Grade|[?]|GERD|[?]|foz_br|[?]|1|aMFI|FINGER EXTENSOR TENDONS|UNILATERAL||Y|STUDY SUBJECT|1|Visit_1|10|4|TREATMENT|2020-10-28|10
e|FA|4393406e-bda5-42e4-a752-a8121004b7ef|2|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|mL/kg/day|[?]|1|mL/cm3/min|CLAVICLE|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|4|WASHOUT|2020-10-28|10
e|FA|4393406e-bda5-42e4-a752-a8121004b7ef|3|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|cm H2O|[?]|1|U/mmol|GASTROINTESTINAL TRACT, LOWER, WALL|LEFT|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|7|WASHOUT|2020-11-12|25
e|FA|4393406e-bda5-42e4-a752-a8121004b7ef|4|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|MPS U|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|BILATERAL|||ADJUDICATOR|2|Visit_2|25|1|SCREENING|2020-11-12|25
e|FA|4393406e-bda5-42e4-a752-a8121004b7ef|5|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|POUCH|[?]|1|cm|TYMPANIC MEMBRANE|UNILATERAL||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|6|WASHOUT|2020-11-27|40
e|FA|4393406e-bda5-42e4-a752-a8121004b7ef|6|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|umol|BRACHIAL LYMPH NODE|BILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|6|TREATMENT|2020-11-27|40
e|FA|4393406e-bda5-42e4-a752-a8121004b7ef|7|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mg|[?]|1|Weber|TRACHEOBRONCHIAL TREE|BILATERAL|||SPOUSE|4|Visit_4|65|7|SCREENING|2020-12-22|65
e|FA|4393406e-bda5-42e4-a752-a8121004b7ef|8|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|Osm|[?]|1|L/h/m2|URINARY SYSTEM|CONTRALATERAL|||VENDOR|4|Visit_4|65|6|TREATMENT|2020-12-22|65
e|FA|4393406e-bda5-42e4-a752-a8121004b7ef|9|SEV|Severity/Intensity|[?]|GERD|[?]|Absorbance U|[?]|1|Pa|INTERVENTRICULAR SEPTUM|BILATERAL|||GUARDIAN|5|Visit_5|90|3|TREATMENT|2021-01-16|90
e|FA|4393406e-bda5-42e4-a752-a8121004b7ef|10|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|10^12/L|[?]|1|EIA unit|CORONARY ARTERY, LEFT|BILATERAL|Y||SPOUSE|5|Visit_5|90|3|WASHOUT|2021-01-16|90
e|FA|d70f5903-3d94-422b-8f69-212f015b54c9|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|RATIO|[?]|1|SCOOPFUL|RIB 4|LEFT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|3|FOLLOW-UP|2020-05-19|10
e|FA|d70f5903-3d94-422b-8f69-212f015b54c9|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|%(v/v)|DISTAL LAD ARTERY|RIGHT||Y|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-05-19|10
e|FA|d70f5903-3d94-422b-8f69-212f015b54c9|3|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|EID 50/mL|[?]|1|mL|GASTROINTESTINAL TRACT, UPPER|LATERAL|||STUDY SUBJECT|2|Visit_2|25|1|FOLLOW-UP|2020-06-03|25
e|FA|d70f5903-3d94-422b-8f69-212f015b54c9|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ukat/L|[?]|1|U/mmol|FLEXOR CARPI ULNARIS MUSCLE|LATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2020-06-03|25
e|FA|d70f5903-3d94-422b-8f69-212f015b54c9|5|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|nmol/mL/min|[?]|1|uCi/kg|VEIN|RIGHT|||FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2020-06-18|40
e|FA|d70f5903-3d94-422b-8f69-212f015b54c9|6|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|Bq/kg|[?]|1|mg/dose|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|BILATERAL|||SPOUSE|3|Visit_3|40|6|TREATMENT|2020-06-18|40
e|FA|d70f5903-3d94-422b-8f69-212f015b54c9|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|PFU/mL|[?]|1|mg/g/min|ANKLE JOINT|CONTRALATERAL|||STUDY SUBJECT|4|Visit_4|65|5|WASHOUT|2020-07-13|65
e|FA|d70f5903-3d94-422b-8f69-212f015b54c9|8|SPEED|Speed|[?]|GERD|[?]|IU/day|[?]|1|mEq/g|ORBICULARIS OCULI MUSCLE|LEFT||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|1|SCREENING|2020-07-13|65
e|FA|d70f5903-3d94-422b-8f69-212f015b54c9|9|DFRUIT|Dietary Fruit|[?]|GERD|[?]|U/mL|[?]|1|10^6 CFU/mL|CARDIOVASCULAR SYSTEM|LATERAL||Y|SIBLING|5|Visit_5|90|2|FOLLOW-UP|2020-08-07|90
e|FA|d70f5903-3d94-422b-8f69-212f015b54c9|10|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|10^9/L|[?]|1|cmH2O/mL|TEMPORAL LOBE|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|FOLLOW-UP|2020-08-07|90
e|FA|ef772266-faf1-4904-8ac3-19cbc3ea7d36|1|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|ug/kg/min|[?]|1|Bq/L|GASTROINTESTINAL TRACT, LOWER|UNILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|FOLLOW-UP|2021-01-06|10
e|FA|ef772266-faf1-4904-8ac3-19cbc3ea7d36|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ug/dL|[?]|1|mg/g/min|CEREBRAL HEMISPHERE, LEFT|UNILATERAL||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|WASHOUT|2021-01-06|10
e|FA|ef772266-faf1-4904-8ac3-19cbc3ea7d36|3|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|mAmp|[?]|1|ug/m2/h|STERNUM|IPSILATERAL||Y|CHILD|2|Visit_2|25|4|TREATMENT|2021-01-21|25
e|FA|ef772266-faf1-4904-8ac3-19cbc3ea7d36|4|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|ug/dL|[?]|1|g/cage/day|NAIL|CONTRALATERAL|||ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2021-01-21|25
e|FA|ef772266-faf1-4904-8ac3-19cbc3ea7d36|5|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|1/(s*kPa)|[?]|1|PACK|LUNG, RIGHT MIDDLE LOBE|CONTRALATERAL||Y|INVESTIGATOR|3|Visit_3|40|1|SCREENING|2021-02-05|40
e|FA|ef772266-faf1-4904-8ac3-19cbc3ea7d36|6|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|steps/min|[?]|1|Bq/L|INTESTINE|LATERAL||Y|CHILD|3|Visit_3|40|3|WASHOUT|2021-02-05|40
e|FA|ef772266-faf1-4904-8ac3-19cbc3ea7d36|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|OD Unit|[?]|1|Pa|PELVIC LYMPH NODE|IPSILATERAL|Y||DOMESTIC PARTNER|4|Visit_4|65|5|WASHOUT|2021-03-02|65
e|FA|ef772266-faf1-4904-8ac3-19cbc3ea7d36|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mgEq|[?]|1|mg/g/min|T2 VERTEBRA|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|FOLLOW-UP|2021-03-02|65
e|FA|ef772266-faf1-4904-8ac3-19cbc3ea7d36|9|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|L/h/m2|RIB 10|BILATERAL|||GUARDIAN|5|Visit_5|90|1|SCREENING|2021-03-27|90
e|FA|ef772266-faf1-4904-8ac3-19cbc3ea7d36|10|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|mOsm/kg|[?]|1|10^6 CFU|OVARIAN FOLLICLE|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|WASHOUT|2021-03-27|90
e|FA|c0f9c36c-1ae5-4f80-b936-0afe3f661746|1|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|1/(s*kPa)|[?]|1|DRUM|UTERINE ARTERY|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-07-14|10
e|FA|c0f9c36c-1ae5-4f80-b936-0afe3f661746|2|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|g/cage/wk|[?]|1|NEEDLE GAUGE|ADDUCTOR LONGUS MUSCLE|IPSILATERAL||Y|GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-07-14|10
e|FA|c0f9c36c-1ae5-4f80-b936-0afe3f661746|3|SEV|Severity/Intensity|[?]|GERD|[?]|fmol|[?]|1|Pa|INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL||Y|VENDOR|2|Visit_2|25|7|SCREENING|2020-07-29|25
e|FA|c0f9c36c-1ae5-4f80-b936-0afe3f661746|4|DPROT|Dietary Protein|[?]|GERD|[?]|Ci/L|[?]|1|10^4 CFU/mL|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|LEFT||Y|FAMILY MEMBER|2|Visit_2|25|1|WASHOUT|2020-07-29|25
e|FA|c0f9c36c-1ae5-4f80-b936-0afe3f661746|5|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|IU/mg|CARPAL BONE|IPSILATERAL|Y|Y|INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-08-13|40
e|FA|c0f9c36c-1ae5-4f80-b936-0afe3f661746|6|DFIBER|Dietary Fiber|[?]|GERD|[?]|ug/mol|[?]|1|h*%|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|LEFT|||DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-08-13|40
e|FA|c0f9c36c-1ae5-4f80-b936-0afe3f661746|7|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|YEARS|[?]|1|mL/h|WRIST JOINT EXTENSOR MUSCLES|BILATERAL||Y|PARENT|4|Visit_4|65|1|TREATMENT|2020-09-07|65
e|FA|c0f9c36c-1ae5-4f80-b936-0afe3f661746|8|EVENTFRQ|Event Frequency|[?]|GERD|[?]|10^9/dose|[?]|1|ug/kg/h|BRACHIOCEPHALIC ARTERY|LEFT|||SIGNIFICANT OTHER|4|Visit_4|65|5|TREATMENT|2020-09-07|65
e|FA|c0f9c36c-1ae5-4f80-b936-0afe3f661746|9|SEV|Severity/Intensity|[?]|GERD|[?]|MBq/uL|[?]|1|Pa|TEMPORAL BONE|LEFT|||INTERVIEWER|5|Visit_5|90|2|TREATMENT|2020-10-02|90
e|FA|c0f9c36c-1ae5-4f80-b936-0afe3f661746|10|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|mL/mmHg/min/L|MEDIASTINUM, ANTERIOR|LEFT|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|WASHOUT|2020-10-02|90
e|FA|f17b5630-e782-4135-8a50-4a9bb2fe63b1|1|TOTNUM|Total Number|[?]|GERD|[?]|U/kg|[?]|1|/200 HPFs|ADDUCTOR LONGUS MUSCLE|IPSILATERAL|||INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-11-29|10
e|FA|f17b5630-e782-4135-8a50-4a9bb2fe63b1|2|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|umol/mg/min|[?]|1|ug/kg/h|PERITONEAL CAVITY|LEFT|Y||SIBLING|1|Visit_1|10|3|TREATMENT|2020-11-29|10
e|FA|f17b5630-e782-4135-8a50-4a9bb2fe63b1|3|VOL|Volume|[?]|GERD|[?]|Gy|[?]|1|vp/dose|PECTORALIS MAJOR MUSCLE|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2020-12-14|25
e|FA|f17b5630-e782-4135-8a50-4a9bb2fe63b1|4|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|LB|[?]|1|umol|PYLORIC SPHINCTER|CONTRALATERAL|||FAMILY MEMBER|2|Visit_2|25|7|TREATMENT|2020-12-14|25
e|FA|f17b5630-e782-4135-8a50-4a9bb2fe63b1|5|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|IU/mmol|[?]|1|h*%|DISTAL INTERPHALANGEAL JOINT 5|RIGHT|||INTERVIEWER|3|Visit_3|40|4|TREATMENT|2020-12-29|40
e|FA|f17b5630-e782-4135-8a50-4a9bb2fe63b1|6|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|DAgU/mL|[?]|1|10^6 U|PROXIMAL INTERPHALANGEAL JOINT 2|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|FOLLOW-UP|2020-12-29|40
e|FA|f17b5630-e782-4135-8a50-4a9bb2fe63b1|7|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|SCOOPFUL|[?]|1|in|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|LEFT||Y|CAREGIVER|4|Visit_4|65|4|TREATMENT|2021-01-23|65
e|FA|f17b5630-e782-4135-8a50-4a9bb2fe63b1|8|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|Gy/min|[?]|1|vp/dose|INTERNAL MAMMARY LYMPH NODE|CONTRALATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2021-01-23|65
e|FA|f17b5630-e782-4135-8a50-4a9bb2fe63b1|9|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|s^-1(%O2)^-1|[?]|1|BOWL|TONSIL|RIGHT|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|5|FOLLOW-UP|2021-02-17|90
e|FA|f17b5630-e782-4135-8a50-4a9bb2fe63b1|10|SEV|Severity/Intensity|[?]|GERD|[?]|%/min|[?]|1|Pa|LEG SKIN|UNILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2021-02-17|90
e|FA|8bdb40c9-1e44-45ae-bf08-81ea635fd762|1|SEV|Severity/Intensity|[?]|GERD|[?]|NEEDLE GAUGE|[?]|1|Pa|TRIGEMINAL NERVE|IPSILATERAL|Y|Y|FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2021-01-02|10
e|FA|8bdb40c9-1e44-45ae-bf08-81ea635fd762|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|kDa|[?]|1|g/day|CAPITATE-LUNATE JOINT|IPSILATERAL|||GUARDIAN|1|Visit_1|10|3|TREATMENT|2021-01-02|10
e|FA|8bdb40c9-1e44-45ae-bf08-81ea635fd762|3|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|log10 CFU/mL|[?]|1|ug/m2/h|EPICARDIUM|UNILATERAL|Y||VENDOR|2|Visit_2|25|3|SCREENING|2021-01-17|25
e|FA|8bdb40c9-1e44-45ae-bf08-81ea635fd762|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/kg|[?]|1|mg/g/min|PHARYNX|IPSILATERAL|Y||PROXY|2|Visit_2|25|7|SCREENING|2021-01-17|25
e|FA|8bdb40c9-1e44-45ae-bf08-81ea635fd762|5|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|AgU/mL|[?]|1|CUP|SKIN OF THE FINGER|LATERAL|Y||SPOUSE|3|Visit_3|40|5|FOLLOW-UP|2021-02-01|40
e|FA|8bdb40c9-1e44-45ae-bf08-81ea635fd762|6|LESNUM|Number of Lesions|[?]|GERD|[?]|ugEq|[?]|1|ng/day|BLADDER, NECK|IPSILATERAL|Y|Y|INVESTIGATOR|3|Visit_3|40|2|TREATMENT|2021-02-01|40
e|FA|8bdb40c9-1e44-45ae-bf08-81ea635fd762|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|U/g|[?]|1|Pa|COSTOCHONDRAL JOINT 1|IPSILATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|4|FOLLOW-UP|2021-02-26|65
e|FA|8bdb40c9-1e44-45ae-bf08-81ea635fd762|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|fL|[?]|1|mg/g/min|CERVIX UTERI|LEFT||Y|CAREGIVER|4|Visit_4|65|4|TREATMENT|2021-02-26|65
e|FA|8bdb40c9-1e44-45ae-bf08-81ea635fd762|9|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|Anson U|[?]|1|fmol|FOOT DIGIT 3|LEFT|||INVESTIGATOR|5|Visit_5|90|2|SCREENING|2021-03-23|90
e|FA|8bdb40c9-1e44-45ae-bf08-81ea635fd762|10|EVENTNUM|Number of Events|[?]|GERD|[?]|pptr|[?]|1|U/10^12 RBC|LUNG, LEFT UPPER LOBE|LATERAL|||SPOUSE|5|Visit_5|90|7|TREATMENT|2021-03-23|90
e|FA|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|1|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|cmH2O*s2/mL|[?]|1|mL/mmHg/min/L|INTRATHORACIC LYMPH NODE|CONTRALATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|5|SCREENING|2021-01-16|10
e|FA|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|2|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit|[?]|1|10^6 organisms/mL|OPHTHALMIC ARTERY|UNILATERAL|||FRIEND|1|Visit_1|10|2|SCREENING|2021-01-16|10
e|FA|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|3|DPROT|Dietary Protein|[?]|GERD|[?]|kcal/day|[?]|1|10^4 CFU/mL|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|RIGHT|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|WASHOUT|2021-01-31|25
e|FA|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|cd/m2|[?]|1|MBq|ELBOW JOINT|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2021-01-31|25
e|FA|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|5|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|cm H2O|[?]|1|mEq|INTERPHALANGEAL JOINT 4 OF THE HAND|LATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|1|TREATMENT|2021-02-15|40
e|FA|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|6|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|kg/cm|[?]|1|IU/mg|SUPRARENAL AORTA|BILATERAL||Y|SPOUSE|3|Visit_3|40|7|FOLLOW-UP|2021-02-15|40
e|FA|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|7|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|10^7 TCID 50/dose|[?]|1|mm/h|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|LEFT||Y|PARENT|4|Visit_4|65|6|SCREENING|2021-03-12|65
e|FA|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|Siemens|[?]|1|CUP|SUBGLOTTIS|IPSILATERAL||Y|FAMILY MEMBER|4|Visit_4|65|2|FOLLOW-UP|2021-03-12|65
e|FA|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|9|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|cm/s|[?]|1|oz eq|KNEE JOINT TENDONS|LATERAL|||CAREGIVER|5|Visit_5|90|4|FOLLOW-UP|2021-04-06|90
e|FA|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|10|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|FFU|[?]|1|10^6 CFU/mL|SUBMENTAL LYMPH NODE|UNILATERAL|Y|Y|PROXY|5|Visit_5|90|2|WASHOUT|2021-04-06|90
e|FA|296f8314-5a07-47b5-8796-31afe709b379|1|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|fL|[?]|1|NEEDLE GAUGE|KIDNEY, LOWER LOBE|LATERAL|||PARENT|1|Visit_1|10|5|TREATMENT|2020-07-08|10
e|FA|296f8314-5a07-47b5-8796-31afe709b379|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|copies/mL|[?]|1|TRANSDUCING UNIT/mL|GLOBUS PALLIDUS|RIGHT|||INDEPENDENT ASSESSOR|1|Visit_1|10|4|WASHOUT|2020-07-08|10
e|FA|296f8314-5a07-47b5-8796-31afe709b379|3|LOCONSET|Localization of Onset|[?]|GERD|[?]|mL/kg/min|[?]|1|g/L|VASTUS INTERMEDIUS MUSCLE|UNILATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2020-07-23|25
e|FA|296f8314-5a07-47b5-8796-31afe709b379|4|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|mph|[?]|1|AU/mL|ESOPHAGUS, MIDDLE THIRD|RIGHT|Y||GUARDIAN|2|Visit_2|25|4|TREATMENT|2020-07-23|25
e|FA|296f8314-5a07-47b5-8796-31afe709b379|5|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|mU|[?]|1|g/L|GASTROCNEMIUS MUSCLE, LATERAL HEAD|UNILATERAL|||CAREGIVER|3|Visit_3|40|6|FOLLOW-UP|2020-08-07|40
e|FA|296f8314-5a07-47b5-8796-31afe709b379|6|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|Hz/s|[?]|1|100 IU/mL|CEREBRAL HEMISPHERE, RIGHT|UNILATERAL||Y|PROXY|3|Visit_3|40|7|WASHOUT|2020-08-07|40
e|FA|296f8314-5a07-47b5-8796-31afe709b379|7|LOCONSET|Localization of Onset|[?]|GERD|[?]|mL/cm3/min|[?]|1|g/L|GASTROCNEMIUS MUSCLE, LATERAL HEAD|UNILATERAL|||GUARDIAN|4|Visit_4|65|2|FOLLOW-UP|2020-09-01|65
e|FA|296f8314-5a07-47b5-8796-31afe709b379|8|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|F|[?]|1|L|SKIN OF THE AXILLA|IPSILATERAL|||FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2020-09-01|65
e|FA|296f8314-5a07-47b5-8796-31afe709b379|9|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|dpm/100mg|[?]|1|g/day|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|LATERAL|||INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2020-09-26|90
e|FA|296f8314-5a07-47b5-8796-31afe709b379|10|DCAL|Dietary Calories|[?]|GERD|[?]|Torr|[?]|1|EIA unit|BILE DUCT|CONTRALATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|2|SCREENING|2020-09-26|90
e|FA|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|1|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|foz_br|[?]|1|DRUM|OPTIC NERVE|CONTRALATERAL|||FRIEND|1|Visit_1|10|7|TREATMENT|2020-12-13|10
e|FA|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|2|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|STRIP|[?]|1|BP|WRIST JOINT EXTENSOR TENDONS|CONTRALATERAL|||PROXY|1|Visit_1|10|6|FOLLOW-UP|2020-12-13|10
e|FA|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|3|LDIAM|Longest Diameter|[?]|GERD|[?]|NEEDLE GAUGE|[?]|1|Shock Wave|LATERAL SECOND DIAGONAL BRANCH ARTERY|RIGHT|||DOMESTIC PARTNER|2|Visit_2|25|5|WASHOUT|2020-12-28|25
e|FA|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|4|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|mg/m2/min|[?]|1|DROP|ACROMIOCLAVICULAR JOINT|CONTRALATERAL|||INVESTIGATOR|2|Visit_2|25|2|SCREENING|2020-12-28|25
e|FA|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|5|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|pmol/L|[?]|1|Gy/h|SPLENIC HILAR LYMPH NODE|RIGHT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|SCREENING|2021-01-12|40
e|FA|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Linear ft*LB|[?]|1|%(v/v)|HIP|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2021-01-12|40
e|FA|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|7|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mU/L|[?]|1|L/h/m2|ASCENDING AORTA, SINOTUBULAR JUNCTION|RIGHT|Y||FAMILY MEMBER|4|Visit_4|65|6|FOLLOW-UP|2021-02-06|65
e|FA|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|8|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|mg/mL/day|[?]|1|SCOOPFUL|ENDOMETRIUM|IPSILATERAL||Y|SPOUSE|4|Visit_4|65|1|TREATMENT|2021-02-06|65
e|FA|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|9|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|amp|[?]|1|mm|BULBAR CONJUNCTIVA|UNILATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|7|TREATMENT|2021-03-03|90
e|FA|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|10|DVEG|Dietary Vegetable|[?]|GERD|[?]|Enzyme U/m2|[?]|1|Ci/ug|PARATHYROID GLAND|BILATERAL|Y||INVESTIGATOR|5|Visit_5|90|2|SCREENING|2021-03-03|90
e|FA|b06043ae-8251-4df8-ab6d-0ceb269c1a42|1|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|gtt|[?]|1|m2|PARATRACHEAL LYMPH NODE|CONTRALATERAL||Y|PROXY|1|Visit_1|10|5|SCREENING|2021-01-25|10
e|FA|b06043ae-8251-4df8-ab6d-0ceb269c1a42|2|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|10^6 IU/mL|BUCCAL MUCOSA|LATERAL|||CHILD|1|Visit_1|10|1|TREATMENT|2021-01-25|10
e|FA|b06043ae-8251-4df8-ab6d-0ceb269c1a42|3|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|cm|[?]|1|fmol|AXIAL SKELETON|CONTRALATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2021-02-09|25
e|FA|b06043ae-8251-4df8-ab6d-0ceb269c1a42|4|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|h*%|[?]|1|g/cage/day|CORRUGATOR SUPERCILII MUSCLE|RIGHT||Y|PROXY|2|Visit_2|25|1|WASHOUT|2021-02-09|25
e|FA|b06043ae-8251-4df8-ab6d-0ceb269c1a42|5|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|nmol/g|[?]|1|NEEDLE GAUGE|WRIST JOINT FLEXOR TENDONS|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|5|SCREENING|2021-02-24|40
e|FA|b06043ae-8251-4df8-ab6d-0ceb269c1a42|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|PHERESIS UNIT|[?]|1|Shock Wave|MALE GENITALIA|LATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2021-02-24|40
e|FA|b06043ae-8251-4df8-ab6d-0ceb269c1a42|7|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|10^6 organisms/mg|[?]|1|Shock Wave|SKIN OF THE LOWER LIMB|RIGHT|||GUARDIAN|4|Visit_4|65|4|WASHOUT|2021-03-21|65
e|FA|b06043ae-8251-4df8-ab6d-0ceb269c1a42|8|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|uCi/L|[?]|1|10^9 CFU/g|PANCREAS, HEAD|BILATERAL|Y||GUARDIAN|4|Visit_4|65|5|SCREENING|2021-03-21|65
e|FA|b06043ae-8251-4df8-ab6d-0ceb269c1a42|9|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|10^7/L|[?]|1|h*%|DIAPHRAGMATIC LYMPH NODE|CONTRALATERAL||Y|PROXY|5|Visit_5|90|7|TREATMENT|2021-04-15|90
e|FA|b06043ae-8251-4df8-ab6d-0ceb269c1a42|10|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|U/dL|[?]|1|anti-Xa IU/mL|BILIARY TRACT|LATERAL||Y|CAREGIVER|5|Visit_5|90|4|WASHOUT|2021-04-15|90
e|FA|d4fb5b9e-e244-4818-be3d-dbb57faacd43|1|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|mU/L|[?]|1|mm|EYE|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|FOLLOW-UP|2020-11-07|10
e|FA|d4fb5b9e-e244-4818-be3d-dbb57faacd43|2|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|mIU/L|SUBSCAPULARIS MUSCLE|RIGHT|Y|Y|CHILD|1|Visit_1|10|3|WASHOUT|2020-11-07|10
e|FA|d4fb5b9e-e244-4818-be3d-dbb57faacd43|3|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|mL/g/h|[?]|1|IU/mmol|POSTERIOR INFERIOR CEREBELLAR ARTERY|LATERAL|||CHILD|2|Visit_2|25|6|TREATMENT|2020-11-22|25
e|FA|d4fb5b9e-e244-4818-be3d-dbb57faacd43|4|ESTWT|Estimated Weight|[?]|GERD|[?]|mEq/mmol|[?]|1|g/day|ASCENDING AORTA, SINUS OF VALSALVA|UNILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|6|FOLLOW-UP|2020-11-22|25
e|FA|d4fb5b9e-e244-4818-be3d-dbb57faacd43|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|%(v/v)|AORTIC VALVE, LEFT CORONARY CUSP|CONTRALATERAL|Y||INTERVIEWER|3|Visit_3|40|3|SCREENING|2020-12-07|40
e|FA|d4fb5b9e-e244-4818-be3d-dbb57faacd43|6|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|nmol/mL/min|[?]|1|U/mg|RADIUS|LATERAL|Y||ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2020-12-07|40
e|FA|d4fb5b9e-e244-4818-be3d-dbb57faacd43|7|SEV|Severity/Intensity|[?]|GERD|[?]|mol|[?]|1|Pa|INTERATRIAL SEPTUM|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|5|SCREENING|2021-01-01|65
e|FA|d4fb5b9e-e244-4818-be3d-dbb57faacd43|8|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|BAU|[?]|1|Log10 ELISA unit|DISTAL LAD ARTERY|IPSILATERAL||Y|CHILD|4|Visit_4|65|2|TREATMENT|2021-01-01|65
e|FA|d4fb5b9e-e244-4818-be3d-dbb57faacd43|9|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|Tesla|[?]|1|L|GASTROCNEMIUS MUSCLE, LATERAL HEAD|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|WASHOUT|2021-01-26|90
e|FA|d4fb5b9e-e244-4818-be3d-dbb57faacd43|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|MPL U|[?]|1|10^6 U|CALCANEUS|BILATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2021-01-26|90
e|FA|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^6 DNA copies/mL|[?]|1|%(v/v)|HEART, VENTRICULAR WALL|LEFT|Y||DOMESTIC PARTNER|1|Visit_1|10|4|WASHOUT|2020-07-13|10
e|FA|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|2|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|mL/m2|[?]|1|EIA unit|PELVIC BONE|LEFT||Y|INTERVIEWER|1|Visit_1|10|2|FOLLOW-UP|2020-07-13|10
e|FA|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|mg/m2/h|[?]|1|Shock Wave|BASILIC VEIN|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-07-28|25
e|FA|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|4|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|um2|[?]|1|/200 HPFs|INTERNAL ILIAC LYMPH NODE|RIGHT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-07-28|25
e|FA|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|5|DISTANCE|Distance|[?]|GERD|[?]|fmol|[?]|1|BOWL|CELIAC ARTERY|UNILATERAL||Y|INTERVIEWER|3|Visit_3|40|4|WASHOUT|2020-08-12|40
e|FA|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|mL/cm|[?]|1|Shock Wave|BRACHIORADIALIS MUSCLE|RIGHT|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|FOLLOW-UP|2020-08-12|40
e|FA|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|7|EVENTNUM|Number of Events|[?]|GERD|[?]|10^3 organisms/mL|[?]|1|U/10^12 RBC|FUNDUS OF THE STOMACH|IPSILATERAL|Y||PROXY|4|Visit_4|65|5|FOLLOW-UP|2020-09-06|65
e|FA|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|8|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|PLUG|[?]|1|ug/m2/h|PUTAMEN|LEFT|||PARENT|4|Visit_4|65|4|FOLLOW-UP|2020-09-06|65
e|FA|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|9|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|cal|[?]|1|cmH2O/mL|URETHRA|IPSILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2020-10-01|90
e|FA|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|10|DFIBER|Dietary Fiber|[?]|GERD|[?]|HOMEOPATHIC DILUTION|[?]|1|h*%|LUNG, RIGHT|LATERAL|||VENDOR|5|Visit_5|90|1|WASHOUT|2020-10-01|90
e|FA|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|1|QOLIMP|QOL Impact|[?]|GERD|[?]|g/L|[?]|1|10^6/L|OLECRANON|BILATERAL|Y||CAREGIVER|1|Visit_1|10|6|SCREENING|2021-01-14|10
e|FA|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|2|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|/200 HPFs|[?]|1|uL/kg/day|TENTORIUM CEREBELLI|UNILATERAL|Y|Y|SIBLING|1|Visit_1|10|5|WASHOUT|2021-01-14|10
e|FA|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|3|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|log10 IU/mL|[?]|1|Bq/L|METACARPAL 1 BASE|RIGHT|||CAREGIVER|2|Visit_2|25|5|TREATMENT|2021-01-29|25
e|FA|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|4|DISTANCE|Distance|[?]|GERD|[?]|ug/m2/min|[?]|1|BOWL|GONAD|LEFT||Y|FAMILY MEMBER|2|Visit_2|25|2|FOLLOW-UP|2021-01-29|25
e|FA|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|10^3 CFU/mL|[?]|1|mL/animal/day|TIBIALIS POSTERIOR MUSCLE|UNILATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|6|WASHOUT|2021-02-13|40
e|FA|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|6|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms|[?]|1|EIA unit|FOREBRAIN|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2021-02-13|40
e|FA|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|7|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|MnFI|[?]|1|IU/mmol|HYMENAL RING|RIGHT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2021-03-10|65
e|FA|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|8|QOLIMP|QOL Impact|[?]|GERD|[?]|ELISA unit/mL|[?]|1|10^6/L|ORBIT|BILATERAL|Y||VENDOR|4|Visit_4|65|4|WASHOUT|2021-03-10|65
e|FA|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit/dose|[?]|1|%(v/v)|FINGER FLEXOR TENDONS|BILATERAL|Y||PARENT|5|Visit_5|90|7|TREATMENT|2021-04-04|90
e|FA|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|10|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|PACK|[?]|1|uL/kg/day|FOREARM|LATERAL|||GUARDIAN|5|Visit_5|90|5|TREATMENT|2021-04-04|90
e|FA|b1215705-4c22-43bd-aa65-58bd8745f081|1|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|HOURS|TRUNK|LATERAL|||SIBLING|1|Visit_1|10|3|TREATMENT|2020-07-15|10
e|FA|b1215705-4c22-43bd-aa65-58bd8745f081|2|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|AU/mL|HUMERUS SHAFT|LEFT|Y|Y|STUDY SUBJECT|1|Visit_1|10|4|TREATMENT|2020-07-15|10
e|FA|b1215705-4c22-43bd-aa65-58bd8745f081|3|TOXGR|Toxicity Grade|[?]|GERD|[?]|pm|[?]|1|aMFI|EXTENSOR DIGITORUM BREVIS MUSCLE|UNILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-07-30|25
e|FA|b1215705-4c22-43bd-aa65-58bd8745f081|4|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|mol/day|[?]|1|DROP|OLFACTORY MUCOSA|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-07-30|25
e|FA|b1215705-4c22-43bd-aa65-58bd8745f081|5|AGETRT1|Age At First Treatment|[?]|GERD|[?]|Ci/ug|[?]|1|mL/mmHg/min/L|TEMPLE|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2020-08-14|40
e|FA|b1215705-4c22-43bd-aa65-58bd8745f081|6|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|Farad|[?]|1|mL/mmHg/min/L|NECK|BILATERAL||Y|SIBLING|3|Visit_3|40|7|SCREENING|2020-08-14|40
e|FA|b1215705-4c22-43bd-aa65-58bd8745f081|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|mg/g/min|EYELASH|LATERAL|||GUARDIAN|4|Visit_4|65|7|TREATMENT|2020-09-08|65
e|FA|b1215705-4c22-43bd-aa65-58bd8745f081|8|DPROT|Dietary Protein|[?]|GERD|[?]|cycle/min|[?]|1|10^4 CFU/mL|HEART, APEX|LATERAL|Y||FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-09-08|65
e|FA|b1215705-4c22-43bd-aa65-58bd8745f081|9|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|pmol/dL|[?]|1|10^6 U|LUNG LOBE|BILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-10-03|90
e|FA|b1215705-4c22-43bd-aa65-58bd8745f081|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|Joule|[?]|1|U/mmol|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|RIGHT|||SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2020-10-03|90
e|FA|b99c6528-af4e-42f5-8d2d-18943b57d55a|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|Roentgen|[?]|1|SCOOPFUL|BONE|UNILATERAL|||VENDOR|1|Visit_1|10|5|SCREENING|2020-10-25|10
e|FA|b99c6528-af4e-42f5-8d2d-18943b57d55a|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|mL/g/h|[?]|1|TRANSDUCING UNIT/mL|TRUNK|UNILATERAL|||INVESTIGATOR|1|Visit_1|10|5|WASHOUT|2020-10-25|10
e|FA|b99c6528-af4e-42f5-8d2d-18943b57d55a|3|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|mg/mL/day|[?]|1|g/L|CORONARY VEIN|RIGHT|Y||PROXY|2|Visit_2|25|7|TREATMENT|2020-11-09|25
e|FA|b99c6528-af4e-42f5-8d2d-18943b57d55a|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/mL/min|[?]|1|NEEDLE GAUGE|ANTERIOR HORN OF THE LATERAL VENTRICLE|BILATERAL|||PARENT|2|Visit_2|25|5|TREATMENT|2020-11-09|25
e|FA|b99c6528-af4e-42f5-8d2d-18943b57d55a|5|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mEq/L|[?]|1|CUP|PANCREAS, BODY|UNILATERAL|||PROXY|3|Visit_3|40|6|FOLLOW-UP|2020-11-24|40
e|FA|b99c6528-af4e-42f5-8d2d-18943b57d55a|6|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|mg/mol|[?]|1|/200 HPFs|ILIAC LYMPH NODE|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|FOLLOW-UP|2020-11-24|40
e|FA|b99c6528-af4e-42f5-8d2d-18943b57d55a|7|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|SACHET|[?]|1|100 IU/mL|SUPRACLAVICULAR LYMPH NODE|LATERAL|Y|Y|INDEPENDENT ASSESSOR|4|Visit_4|65|2|FOLLOW-UP|2020-12-19|65
e|FA|b99c6528-af4e-42f5-8d2d-18943b57d55a|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/kg/min|[?]|1|mg/g/min|TOE|LEFT|Y||INTERVIEWER|4|Visit_4|65|5|SCREENING|2020-12-19|65
e|FA|b99c6528-af4e-42f5-8d2d-18943b57d55a|9|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|ms/mmHg|[?]|1|Gy/h|INTERPHALANGEAL JOINT 4|UNILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2021-01-13|90
e|FA|b99c6528-af4e-42f5-8d2d-18943b57d55a|10|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|nmol/L|[?]|1|mL/h|FACIAL BONE|LEFT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|WASHOUT|2021-01-13|90
e|FA|6848e438-51ca-4a7d-8f81-26c375969a64|1|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|%/s|[?]|1|mEq/g|AORTA|LEFT|||ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-11-12|10
e|FA|6848e438-51ca-4a7d-8f81-26c375969a64|2|DCAL|Dietary Calories|[?]|GERD|[?]|OD Unit|[?]|1|EIA unit|T5 VERTEBRA|LEFT|Y||STUDY SUBJECT|1|Visit_1|10|4|TREATMENT|2020-11-12|10
e|FA|6848e438-51ca-4a7d-8f81-26c375969a64|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|VIAL|[?]|1|Pa|URETHRA, ANTERIOR|LEFT|Y|Y|SIBLING|2|Visit_2|25|3|FOLLOW-UP|2020-11-27|25
e|FA|6848e438-51ca-4a7d-8f81-26c375969a64|4|DFRUIT|Dietary Fruit|[?]|GERD|[?]|ft2|[?]|1|10^6 CFU/mL|ISCHIAL TUBEROSITY|UNILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2020-11-27|25
e|FA|6848e438-51ca-4a7d-8f81-26c375969a64|5|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|log10 PFU/mL|[?]|1|L|SOLE|UNILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-12-12|40
e|FA|6848e438-51ca-4a7d-8f81-26c375969a64|6|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|pt_br|[?]|1|m2|LEFT CIRCUMFLEX CORONARY ARTERY|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2020-12-12|40
e|FA|6848e438-51ca-4a7d-8f81-26c375969a64|7|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|Torr|[?]|1|mg/dose|INFRARENAL AORTA|IPSILATERAL||Y|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-01-06|65
e|FA|6848e438-51ca-4a7d-8f81-26c375969a64|8|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|cL|[?]|1|oz eq|SHIN|IPSILATERAL|||SPOUSE|4|Visit_4|65|3|TREATMENT|2021-01-06|65
e|FA|6848e438-51ca-4a7d-8f81-26c375969a64|9|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|nU/cL|[?]|1|PFU/dose|INTRAHEPATIC BILE DUCT|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2021-01-31|90
e|FA|6848e438-51ca-4a7d-8f81-26c375969a64|10|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|10^3/L|[?]|1|vp/dose|PERITONEUM|LATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2021-01-31|90
e|FA|a6e11c33-7905-42d2-bda9-671d756d4c51|1|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|TAMPON|[?]|1|10^6 U|FOOT DIGIT 2|LEFT|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2020-08-06|10
e|FA|a6e11c33-7905-42d2-bda9-671d756d4c51|2|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|DDU|[?]|1|h*%|INTERVENTRICULAR SEPTUM|IPSILATERAL|Y||SIBLING|1|Visit_1|10|2|TREATMENT|2020-08-06|10
e|FA|a6e11c33-7905-42d2-bda9-671d756d4c51|3|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|mg/m2/min|[?]|1|L/h/m2|TRAPEZOID-CAPITATE JOINT|CONTRALATERAL|||INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-08-21|25
e|FA|a6e11c33-7905-42d2-bda9-671d756d4c51|4|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|YEARS|[?]|1|fmol|RETROAURICULAR LYMPH NODE|IPSILATERAL|Y||VENDOR|2|Visit_2|25|2|TREATMENT|2020-08-21|25
e|FA|a6e11c33-7905-42d2-bda9-671d756d4c51|5|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|uU/L|[?]|1|BP|CELIAC ARTERY|UNILATERAL|||STUDY SUBJECT|3|Visit_3|40|6|TREATMENT|2020-09-05|40
e|FA|a6e11c33-7905-42d2-bda9-671d756d4c51|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|mol/L|[?]|1|PACK|L5-S1 INTERVERTEBRAL SPACE|CONTRALATERAL|||DOMESTIC PARTNER|3|Visit_3|40|1|WASHOUT|2020-09-05|40
e|FA|a6e11c33-7905-42d2-bda9-671d756d4c51|7|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|km|HAND PHALANX|UNILATERAL|Y||CHILD|4|Visit_4|65|7|WASHOUT|2020-09-30|65
e|FA|a6e11c33-7905-42d2-bda9-671d756d4c51|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|nkat/g Hb|[?]|1|PFU/dose|KNEE JOINT|LATERAL|||VENDOR|4|Visit_4|65|5|TREATMENT|2020-09-30|65
e|FA|a6e11c33-7905-42d2-bda9-671d756d4c51|9|OBJTYPE|Type of Object|[?]|GERD|[?]|cm2|[?]|1|ng|LOWER JUGULAR LYMPH NODE|CONTRALATERAL|||STUDY SUBJECT|5|Visit_5|90|7|WASHOUT|2020-10-25|90
e|FA|a6e11c33-7905-42d2-bda9-671d756d4c51|10|SEV|Severity/Intensity|[?]|GERD|[?]|P|[?]|1|Pa|SKIN OF THE CHEST|LATERAL|||VENDOR|5|Visit_5|90|5|SCREENING|2020-10-25|90
e|FA|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mm|[?]|1|10^6 U|RIGHT VENTRICULAR BRANCH|BILATERAL|||PROXY|1|Visit_1|10|5|TREATMENT|2020-11-12|10
e|FA|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|keV|[?]|1|Pa|METACARPOPHALANGEAL JOINT 1|UNILATERAL||Y|FRIEND|1|Visit_1|10|2|TREATMENT|2020-11-12|10
e|FA|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|3|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|JDF Unit|[?]|1|mL/dose|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|2|SCREENING|2020-11-27|25
e|FA|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|4|SPEED|Speed|[?]|GERD|[?]|mm/sec|[?]|1|mEq/g|CHOROID PLEXUS|LATERAL|||VENDOR|2|Visit_2|25|7|TREATMENT|2020-11-27|25
e|FA|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|5|RLDEV|Relationship to Device|[?]|GERD|[?]|uU/dL|[?]|1|mL/min/mmHg|5TH LUMBAR SPINOUS PROCESS|UNILATERAL|||CHILD|3|Visit_3|40|5|TREATMENT|2020-12-12|40
e|FA|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|6|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|mEq/g|CARPOMETACARPAL JOINT|RIGHT|||SIBLING|3|Visit_3|40|7|TREATMENT|2020-12-12|40
e|FA|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|7|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|umol/kg/min|[?]|1|Gy/h|JAW|IPSILATERAL|||PARENT|4|Visit_4|65|6|SCREENING|2021-01-06|65
e|FA|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|HOMEOPATHIC DILUTION|[?]|1|mL|CORPUS LUTEUM|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-01-06|65
e|FA|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|cmol|[?]|1|mL/dose|FALCIFORM LIGAMENT|BILATERAL|Y|Y|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2021-01-31|90
e|FA|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|10|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|10^9 organisms|[?]|1|mmHg/L/min|SPINOUS PROCESS|IPSILATERAL|||FRIEND|5|Visit_5|90|6|TREATMENT|2021-01-31|90
e|FA|8ef37b54-b463-43a4-879f-3ad653c4fef4|1|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|IU/dL|[?]|1|cmH2O/mL|LESSER TROCHANTER|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-09-11|10
e|FA|8ef37b54-b463-43a4-879f-3ad653c4fef4|2|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|um|[?]|1|ohm|HAIR FOLLICLE|IPSILATERAL|||FRIEND|1|Visit_1|10|4|TREATMENT|2020-09-11|10
e|FA|8ef37b54-b463-43a4-879f-3ad653c4fef4|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|/cmH2O|[?]|1|%(v/v)|PARATHYROID GLAND|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2020-09-26|25
e|FA|8ef37b54-b463-43a4-879f-3ad653c4fef4|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|/h|[?]|1|mg/g/min|C3 VERTEBRA|IPSILATERAL|Y||GUARDIAN|2|Visit_2|25|4|WASHOUT|2020-09-26|25
e|FA|8ef37b54-b463-43a4-879f-3ad653c4fef4|5|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|%(v/v)|[?]|1|m2|ILEUM WALL|LEFT|Y||CHILD|3|Visit_3|40|3|TREATMENT|2020-10-11|40
e|FA|8ef37b54-b463-43a4-879f-3ad653c4fef4|6|SEV|Severity/Intensity|[?]|GERD|[?]|OD Unit|[?]|1|Pa|STRIATUM|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-10-11|40
e|FA|8ef37b54-b463-43a4-879f-3ad653c4fef4|7|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|L/kg|[?]|1|mm|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|LEFT|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|6|SCREENING|2020-11-05|65
e|FA|8ef37b54-b463-43a4-879f-3ad653c4fef4|8|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|gtt|[?]|1|mEq|METACARPAL BONE 1|LATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2020-11-05|65
e|FA|8ef37b54-b463-43a4-879f-3ad653c4fef4|9|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|U/kg/day|[?]|1|g/day|MIDDLE PHALANX 3 OF THE HAND|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-11-30|90
e|FA|8ef37b54-b463-43a4-879f-3ad653c4fef4|10|DGRAIN|Dietary Grain|[?]|GERD|[?]|g/animal/wk|[?]|1|10^9 CFU/g|PALM|RIGHT|Y||STUDY SUBJECT|5|Visit_5|90|5|WASHOUT|2020-11-30|90
e|FA|cf10035c-4d44-4512-810b-c267d1c8821b|1|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|g/day|MEDIASTINAL LYMPH NODE|LEFT|Y||SIBLING|1|Visit_1|10|4|TREATMENT|2020-05-27|10
e|FA|cf10035c-4d44-4512-810b-c267d1c8821b|2|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|log10 PFU/mL|[?]|1|IU/mg|BRACHIAL PLEXUS|LATERAL|||FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-05-27|10
e|FA|cf10035c-4d44-4512-810b-c267d1c8821b|3|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|mmol/g|[?]|1|BAG|BLADDER, FUNDUS|RIGHT|Y||CHILD|2|Visit_2|25|2|TREATMENT|2020-06-11|25
e|FA|cf10035c-4d44-4512-810b-c267d1c8821b|4|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|uEq|[?]|1|psi|BASAL GANGLIA|LATERAL||Y|FRIEND|2|Visit_2|25|5|TREATMENT|2020-06-11|25
e|FA|cf10035c-4d44-4512-810b-c267d1c8821b|5|RLDEV|Relationship to Device|[?]|GERD|[?]|APS U|[?]|1|mL/min/mmHg|NAIL BED|IPSILATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|7|SCREENING|2020-06-26|40
e|FA|cf10035c-4d44-4512-810b-c267d1c8821b|6|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|g/dL|[?]|1|Log10 ELISA unit|ESOPHAGUS, UPPER THIRD|LATERAL|||SIBLING|3|Visit_3|40|4|SCREENING|2020-06-26|40
e|FA|cf10035c-4d44-4512-810b-c267d1c8821b|7|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg|[?]|1|/kg|COSTOCHONDRAL JOINT 7|LEFT||Y|GUARDIAN|4|Visit_4|65|1|TREATMENT|2020-07-21|65
e|FA|cf10035c-4d44-4512-810b-c267d1c8821b|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit/dose|[?]|1|%(v/v)|CAPITATE BONE|BILATERAL|Y|Y|SIGNIFICANT OTHER|4|Visit_4|65|7|FOLLOW-UP|2020-07-21|65
e|FA|cf10035c-4d44-4512-810b-c267d1c8821b|9|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|NEBULE|[?]|1|mEq|OBTURATOR EXTERNUS MUSCLE|CONTRALATERAL|||GUARDIAN|5|Visit_5|90|1|FOLLOW-UP|2020-08-15|90
e|FA|cf10035c-4d44-4512-810b-c267d1c8821b|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|U/mL|[?]|1|%(v/v)|PONS VAROLII|LATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|FOLLOW-UP|2020-08-15|90
e|FA|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|1|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|BOWL|[?]|1|/200 HPFs|STOMACH|CONTRALATERAL||Y|VENDOR|1|Visit_1|10|6|TREATMENT|2020-08-01|10
e|FA|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|2|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|Bq/kg|[?]|1|mL/h|GINGIVA|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|SCREENING|2020-08-01|10
e|FA|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|3|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|mL/cm|[?]|1|fmol|SKIN AROUND THE EYE|RIGHT|||VENDOR|2|Visit_2|25|7|WASHOUT|2020-08-16|25
e|FA|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|4|LENRSCT|Length of Resection|[?]|GERD|[?]|mEq/day|[?]|1|psi|EXTRAHEPATIC BILE DUCT|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|7|FOLLOW-UP|2020-08-16|25
e|FA|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|5|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|aMFI|BRAIN STEM|LATERAL|||STUDY SUBJECT|3|Visit_3|40|4|TREATMENT|2020-08-31|40
e|FA|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|10^4/L|[?]|1|ug/g/h|HAND DIGIT 3|LATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|2|SCREENING|2020-08-31|40
e|FA|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|7|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|log10 TCID 50/mL|[?]|1|10^9 CFU/mL|INTRAHEPATIC BILE DUCT|LEFT||Y|PARENT|4|Visit_4|65|1|WASHOUT|2020-09-25|65
e|FA|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|8|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|DRUM|[?]|1|mL/mmHg/min/L|AXILLARY LYMPH NODE LEVEL I|BILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2020-09-25|65
e|FA|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|9|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|/month|[?]|1|km|WRIST JOINT EXTENSOR TENDONS|CONTRALATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|3|WASHOUT|2020-10-20|90
e|FA|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|10|DMEAT|Dietary Meat|[?]|GERD|[?]|mg/m2/h|[?]|1|10^6 organisms/mL|OPPONENS POLLICIS MUSCLE|UNILATERAL|||CAREGIVER|5|Visit_5|90|2|TREATMENT|2020-10-20|90
e|FA|a1e0035a-3328-4966-8664-82e53a44eb59|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|uCi|[?]|1|%(v/v)|ILIOTIBIAL BAND|CONTRALATERAL|||CAREGIVER|1|Visit_1|10|4|WASHOUT|2020-08-10|10
e|FA|a1e0035a-3328-4966-8664-82e53a44eb59|2|DFATT|Dietary Fat, Total|[?]|GERD|[?]|kcal/day|[?]|1|Bq/mg|HYOID BONE|UNILATERAL|Y|Y|GUARDIAN|1|Visit_1|10|5|FOLLOW-UP|2020-08-10|10
e|FA|a1e0035a-3328-4966-8664-82e53a44eb59|3|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mL/animal/wk|[?]|1|mAmp|HUMERAL EPICONDYLE|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-08-25|25
e|FA|a1e0035a-3328-4966-8664-82e53a44eb59|4|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|L/s|[?]|1|10^6 U|PUTAMEN|BILATERAL|Y||ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-08-25|25
e|FA|a1e0035a-3328-4966-8664-82e53a44eb59|5|DCAL|Dietary Calories|[?]|GERD|[?]|ukat/L|[?]|1|EIA unit|EXTERNAL ILIAC ARTERY|BILATERAL|Y|Y|ADJUDICATOR|3|Visit_3|40|4|WASHOUT|2020-09-09|40
e|FA|a1e0035a-3328-4966-8664-82e53a44eb59|6|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mL/g/min|[?]|1|U/mg|TRAPEZOID-CAPITATE JOINT|CONTRALATERAL||Y|SPOUSE|3|Visit_3|40|1|WASHOUT|2020-09-09|40
e|FA|a1e0035a-3328-4966-8664-82e53a44eb59|7|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|fmol/L|[?]|1|ug/m2/h|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|UNILATERAL|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2020-10-04|65
e|FA|a1e0035a-3328-4966-8664-82e53a44eb59|8|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|g/kg|[?]|1|/500 WBC|EXTENSOR HALLUCIS BREVIS MUSCLE|LATERAL|||PROXY|4|Visit_4|65|1|FOLLOW-UP|2020-10-04|65
e|FA|a1e0035a-3328-4966-8664-82e53a44eb59|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/L|[?]|1|mg/g/min|FEMORO-POPLITEAL PERIPHERAL ARTERY|IPSILATERAL|||INTERVIEWER|5|Visit_5|90|1|SCREENING|2020-10-29|90
e|FA|a1e0035a-3328-4966-8664-82e53a44eb59|10|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|Bq/ug|[?]|1|psi|LEFT VENTRICULAR APICAL LATERAL SEGMENT|LATERAL|Y||INVESTIGATOR|5|Visit_5|90|4|FOLLOW-UP|2020-10-29|90
e|FA|771377fd-724f-4056-b2ea-84e1adab1f47|1|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|ug/m2/h|COLON WALL|UNILATERAL|Y||STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2020-11-08|10
e|FA|771377fd-724f-4056-b2ea-84e1adab1f47|2|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/(min*100mL)|[?]|1|mL/animal/day|ESOPHAGUS, CERVICAL|LATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|7|TREATMENT|2020-11-08|10
e|FA|771377fd-724f-4056-b2ea-84e1adab1f47|3|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/dL|[?]|1|PACK|TRAPEZIUM-TRAPEZOID JOINT|LATERAL|||PARENT|2|Visit_2|25|6|TREATMENT|2020-11-23|25
e|FA|771377fd-724f-4056-b2ea-84e1adab1f47|4|OBJNUM|Number of Objects|[?]|GERD|[?]|mL*cmH2O|[?]|1|mL/100g/min|CANINE TOOTH|RIGHT|||DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2020-11-23|25
e|FA|771377fd-724f-4056-b2ea-84e1adab1f47|5|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/dose|[?]|1|g/day|ILIOTIBIAL BAND|BILATERAL|||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-12-08|40
e|FA|771377fd-724f-4056-b2ea-84e1adab1f47|6|QOLIMP|QOL Impact|[?]|GERD|[?]|10^6/hpf|[?]|1|10^6/L|FOOT|BILATERAL|||PROXY|3|Visit_3|40|2|WASHOUT|2020-12-08|40
e|FA|771377fd-724f-4056-b2ea-84e1adab1f47|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Gy|[?]|1|Pa|VASTUS LATERALIS MUSCLE|LEFT|||SIBLING|4|Visit_4|65|7|TREATMENT|2021-01-02|65
e|FA|771377fd-724f-4056-b2ea-84e1adab1f47|8|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|MASK|[?]|1|10^4 CFU/mL|URETER|BILATERAL|Y||FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2021-01-02|65
e|FA|771377fd-724f-4056-b2ea-84e1adab1f47|9|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mEq/g|[?]|1|10^6 U|BRACHIAL VEIN|BILATERAL||Y|CAREGIVER|5|Visit_5|90|6|TREATMENT|2021-01-27|90
e|FA|771377fd-724f-4056-b2ea-84e1adab1f47|10|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|mL/cm3/min|[?]|1|IU/mmol|AORTOCAVAL LYMPH NODE|LEFT|||PARENT|5|Visit_5|90|4|WASHOUT|2021-01-27|90
e|FA|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|1|DFIBER|Dietary Fiber|[?]|GERD|[?]|nm|[?]|1|h*%|ARTERY|LEFT||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-08-23|10
e|FA|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|2|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|mmAL|[?]|1|ug/kg/h|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|CONTRALATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|1|WASHOUT|2020-08-23|10
e|FA|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|10^9/dose|[?]|1|Shock Wave|PREAURICULAR LYMPH NODE|LATERAL|||INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2020-09-07|25
e|FA|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|4|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|h/wk|[?]|1|mmHg/L/min|LYMPH NODE|CONTRALATERAL||Y|VENDOR|2|Visit_2|25|2|TREATMENT|2020-09-07|25
e|FA|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|5|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/g|[?]|1|g/dL|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|RIGHT|Y||PROXY|3|Visit_3|40|1|FOLLOW-UP|2020-09-22|40
e|FA|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|6|OBJTYPE|Type of Object|[?]|GERD|[?]|PA|[?]|1|ng|URETHRA, PROSTATIC|LEFT|||SIBLING|3|Visit_3|40|5|TREATMENT|2020-09-22|40
e|FA|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|7|TRTSETT|Treatment Setting|[?]|GERD|[?]|MnFI|[?]|1|Coulomb|AORTIC VALVE ANNULUS|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|FOLLOW-UP|2020-10-17|65
e|FA|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|8|ACNDEV|Action Taken With Device|[?]|GERD|[?]|nm|[?]|1|100 IU/mL|CHIN|IPSILATERAL||Y|INTERVIEWER|4|Visit_4|65|1|TREATMENT|2020-10-17|65
e|FA|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|9|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|BOX|[?]|1|gtt|CALCANEUS|LEFT|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|FOLLOW-UP|2020-11-11|90
e|FA|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|10|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|mOsm/L|[?]|1|AU/mL|C1 VERTEBRA|UNILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|7|WASHOUT|2020-11-11|90
e|FA|3aea0861-8f67-4717-93ce-c1e322f151d9|1|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|km|[?]|1|mAmp|PAW|UNILATERAL|Y||INTERVIEWER|1|Visit_1|10|6|TREATMENT|2020-08-14|10
e|FA|3aea0861-8f67-4717-93ce-c1e322f151d9|2|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|nmol/L|[?]|1|umol|PALPEBRAL FISSURE|RIGHT|||INDEPENDENT ASSESSOR|1|Visit_1|10|1|SCREENING|2020-08-14|10
e|FA|3aea0861-8f67-4717-93ce-c1e322f151d9|3|OBJTYPE|Type of Object|[?]|GERD|[?]|h/wk|[?]|1|ng|INFERIOR VENA CAVA|LATERAL||Y|PARENT|2|Visit_2|25|5|SCREENING|2020-08-29|25
e|FA|3aea0861-8f67-4717-93ce-c1e322f151d9|4|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|QUANTITY SUFFICIENT|[?]|1|cmH2O/mL|LIVER LOBE|UNILATERAL|||STUDY SUBJECT|2|Visit_2|25|6|SCREENING|2020-08-29|25
e|FA|3aea0861-8f67-4717-93ce-c1e322f151d9|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|10^6 DNA copies/mL|[?]|1|U/mg|TYMPANIC MEMBRANE|LEFT|||CHILD|3|Visit_3|40|6|FOLLOW-UP|2020-09-13|40
e|FA|3aea0861-8f67-4717-93ce-c1e322f151d9|6|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|log10 IU/mL|[?]|1|TRANSDUCING UNIT/mL|ULNAR NERVE|LEFT|Y|Y|DOMESTIC PARTNER|3|Visit_3|40|5|FOLLOW-UP|2020-09-13|40
e|FA|3aea0861-8f67-4717-93ce-c1e322f151d9|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|mL/g/h|[?]|1|umol|OROPHARYNX|BILATERAL|Y||SPOUSE|4|Visit_4|65|1|TREATMENT|2020-10-08|65
e|FA|3aea0861-8f67-4717-93ce-c1e322f151d9|8|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|L|COLON, HEPATIC FLEXURE|IPSILATERAL|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2020-10-08|65
e|FA|3aea0861-8f67-4717-93ce-c1e322f151d9|9|DVEG|Dietary Vegetable|[?]|GERD|[?]|ug/h|[?]|1|Ci/ug|TONGUE|UNILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2020-11-02|90
e|FA|3aea0861-8f67-4717-93ce-c1e322f151d9|10|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|oz eq|[?]|1|mm/h|XIPHOID PROCESS|LATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|SCREENING|2020-11-02|90
e|FA|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|1|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|ELISA unit|[?]|1|BOWL|ORBICULARIS OCULI MUSCLE|UNILATERAL|||SPOUSE|1|Visit_1|10|3|TREATMENT|2020-10-05|10
e|FA|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|2|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|EVENTS|[?]|1|mL/dose|CARPOMETACARPAL JOINT 2|BILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|5|WASHOUT|2020-10-05|10
e|FA|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|3|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|km/h|[?]|1|IU/mmol|GREATER CURVATURE OF THE STOMACH|UNILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2020-10-20|25
e|FA|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|IU/g|[?]|1|10^6 IU/mL|PARASPINAL REGION|LATERAL|||SPOUSE|2|Visit_2|25|5|FOLLOW-UP|2020-10-20|25
e|FA|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|5|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|L/L|[?]|1|Shock Wave|CALCANEUS|LEFT|||INTERVIEWER|3|Visit_3|40|1|WASHOUT|2020-11-04|40
e|FA|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|6|SERVNUM|Number of Servings|[?]|GERD|[?]|fmol|[?]|1|Hz/s|ABDUCTOR HALLUCIS MUSCLE|UNILATERAL|||INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-11-04|40
e|FA|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|7|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|Ci/L|[?]|1|aMFI|URETHRA, POSTERIOR|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|FOLLOW-UP|2020-11-29|65
e|FA|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|8|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|pg/L|[?]|1|L|AXILLARY LYMPH NODE|LEFT|||CAREGIVER|4|Visit_4|65|5|SCREENING|2020-11-29|65
e|FA|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|9|SEV|Severity/Intensity|[?]|GERD|[?]|nmol/L|[?]|1|Pa|LEFT MAIN CORONARY ARTERY OSTIUM|UNILATERAL||Y|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2020-12-24|90
e|FA|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mJoule/cm2|[?]|1|oz eq|COLON, TRANSVERSE|BILATERAL||Y|CHILD|5|Visit_5|90|1|TREATMENT|2020-12-24|90
e|FA|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|1|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|ug/m2/day|[?]|1|mEq|ILEUM, TERMINAL|LEFT||Y|INVESTIGATOR|1|Visit_1|10|1|SCREENING|2020-12-30|10
e|FA|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|2|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|kBq/uL|[?]|1|10^6 CFU/mL|FEMORO-POPLITEAL PERIPHERAL ARTERY|UNILATERAL||Y|VENDOR|1|Visit_1|10|5|SCREENING|2020-12-30|10
e|FA|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|3|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|GLOBULE|[?]|1|mEq/g|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|LEFT|||SIGNIFICANT OTHER|2|Visit_2|25|5|SCREENING|2021-01-14|25
e|FA|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|4|SERVNUM|Number of Servings|[?]|GERD|[?]|APS U|[?]|1|Hz/s|THYROID GLAND, RIGHT LOBE|UNILATERAL|Y||ADJUDICATOR|2|Visit_2|25|1|FOLLOW-UP|2021-01-14|25
e|FA|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|5|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|/kg|PLACENTA|BILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2021-01-29|40
e|FA|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|6|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|/40 HPFs|[?]|1|g/L|MEDIASTINAL LYMPH NODE|CONTRALATERAL|||GUARDIAN|3|Visit_3|40|7|FOLLOW-UP|2021-01-29|40
e|FA|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|7|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|ag|[?]|1|/kg|PROXIMAL INTERPHALANGEAL JOINT 5|LEFT||Y|SPOUSE|4|Visit_4|65|1|TREATMENT|2021-02-23|65
e|FA|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|8|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|10^6/L|L4-L5 INTERVERTEBRAL SPACE|LEFT|||CAREGIVER|4|Visit_4|65|6|FOLLOW-UP|2021-02-23|65
e|FA|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mm/2h|[?]|1|%(v/v)|METATARSOPHALANGEAL JOINT 2|CONTRALATERAL|||PROXY|5|Visit_5|90|1|TREATMENT|2021-03-20|90
e|FA|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|10|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|/mm|[?]|1|cm|NUCHAL LYMPH NODE|RIGHT|||SPOUSE|5|Visit_5|90|6|TREATMENT|2021-03-20|90
e|FA|39f51bd8-5edc-4434-92d4-7d8b683a6c32|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/min|[?]|1|mg/g/min|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|LATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-09-19|10
e|FA|39f51bd8-5edc-4434-92d4-7d8b683a6c32|2|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|mL|EYELASH|LEFT|||PARENT|1|Visit_1|10|6|FOLLOW-UP|2020-09-19|10
e|FA|39f51bd8-5edc-4434-92d4-7d8b683a6c32|3|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|days/month|[?]|1|ug/kg/h|INTERPHALANGEAL JOINT 2|BILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|5|SCREENING|2020-10-04|25
e|FA|39f51bd8-5edc-4434-92d4-7d8b683a6c32|4|ESTWT|Estimated Weight|[?]|GERD|[?]|dL|[?]|1|g/day|THALAMUS|LEFT|Y||PROXY|2|Visit_2|25|4|TREATMENT|2020-10-04|25
e|FA|39f51bd8-5edc-4434-92d4-7d8b683a6c32|5|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|ug/L DDU|[?]|1|U/10^12 RBC|PERIUMBILICAL REGION|IPSILATERAL|Y||PARENT|3|Visit_3|40|6|WASHOUT|2020-10-19|40
e|FA|39f51bd8-5edc-4434-92d4-7d8b683a6c32|6|OBJTYPE|Type of Object|[?]|GERD|[?]|fmol|[?]|1|ng|HEART, LEFT VENTRICLE|LATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|FOLLOW-UP|2020-10-19|40
e|FA|39f51bd8-5edc-4434-92d4-7d8b683a6c32|7|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|uIU/dL|[?]|1|SCOOPFUL|VAGUS NERVE|RIGHT|||PROXY|4|Visit_4|65|1|TREATMENT|2020-11-13|65
e|FA|39f51bd8-5edc-4434-92d4-7d8b683a6c32|8|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|ug/m2/h|[?]|1|mL/min/mmHg|GLUTEAL MUSCLE|RIGHT|||ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2020-11-13|65
e|FA|39f51bd8-5edc-4434-92d4-7d8b683a6c32|9|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|Bq/L|[?]|1|L|AXILLARY LYMPH NODE|LATERAL|Y|Y|CAREGIVER|5|Visit_5|90|3|TREATMENT|2020-12-08|90
e|FA|39f51bd8-5edc-4434-92d4-7d8b683a6c32|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|IU/kg|[?]|1|mg/g/min|NUCLEUS ACCUMBENS|IPSILATERAL|||FRIEND|5|Visit_5|90|2|TREATMENT|2020-12-08|90
e|FA|80565a22-8cec-46a2-abd7-91daf0767035|1|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|MBP|[?]|1|EIA unit|MUSCLE|CONTRALATERAL|Y|Y|CAREGIVER|1|Visit_1|10|5|TREATMENT|2021-01-28|10
e|FA|80565a22-8cec-46a2-abd7-91daf0767035|2|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|BOWL|ANAL CANAL|UNILATERAL|Y||STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2021-01-28|10
e|FA|80565a22-8cec-46a2-abd7-91daf0767035|3|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|mEq/ug|[?]|1|10^9 CFU/mL|PARATHYROID GLAND|UNILATERAL|||GUARDIAN|2|Visit_2|25|7|SCREENING|2021-02-12|25
e|FA|80565a22-8cec-46a2-abd7-91daf0767035|4|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mg/L FEU|[?]|1|Weber|MID-CIRCUMFLEX ARTERY|IPSILATERAL|||FAMILY MEMBER|2|Visit_2|25|1|SCREENING|2021-02-12|25
e|FA|80565a22-8cec-46a2-abd7-91daf0767035|5|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|RFU|[?]|1|U/10^12 RBC|GINGIVAL MUCOSA|CONTRALATERAL|Y||SPOUSE|3|Visit_3|40|7|WASHOUT|2021-02-27|40
e|FA|80565a22-8cec-46a2-abd7-91daf0767035|6|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|SBE/mL|[?]|1|umol|C3 VERTEBRA|UNILATERAL|||PARENT|3|Visit_3|40|7|TREATMENT|2021-02-27|40
e|FA|80565a22-8cec-46a2-abd7-91daf0767035|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mg/g/min|[?]|1|%(v/v)|AXILLARY LYMPH NODE|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|SCREENING|2021-03-24|65
e|FA|80565a22-8cec-46a2-abd7-91daf0767035|8|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|tuberculin unit|[?]|1|m2|FLEXOR DIGITORUM PROFUNDUS MUSCLE|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|6|FOLLOW-UP|2021-03-24|65
e|FA|80565a22-8cec-46a2-abd7-91daf0767035|9|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|nmol|[?]|1|/200 HPFs|HAMATE BONE|RIGHT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|TREATMENT|2021-04-18|90
e|FA|80565a22-8cec-46a2-abd7-91daf0767035|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|U/kg/h|[?]|1|Pa|CORPUS CALLOSUM|RIGHT|||PROXY|5|Visit_5|90|7|TREATMENT|2021-04-18|90
e|FA|585a254e-c36b-44cf-b8a9-335fb98e0fd2|1|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|RFU|[?]|1|MPS U|SACRUM|LATERAL|||ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-10-19|10
e|FA|585a254e-c36b-44cf-b8a9-335fb98e0fd2|2|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|mg/h|ABDOMINAL AORTA|BILATERAL|||GUARDIAN|1|Visit_1|10|3|TREATMENT|2020-10-19|10
e|FA|585a254e-c36b-44cf-b8a9-335fb98e0fd2|3|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|dpm/mg|[?]|1|mAmp|RIB 1|IPSILATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-11-03|25
e|FA|585a254e-c36b-44cf-b8a9-335fb98e0fd2|4|EXTRSCT|Extent of Resection|[?]|GERD|[?]|10^3 copies/mL|[?]|1|Weber|SKIN OF THE TRUNK|IPSILATERAL|||FRIEND|2|Visit_2|25|5|TREATMENT|2020-11-03|25
e|FA|585a254e-c36b-44cf-b8a9-335fb98e0fd2|5|EXTRSCT|Extent of Resection|[?]|GERD|[?]|U/mL|[?]|1|Weber|HEART, LEFT ATRIAL APPENDAGE|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|5|FOLLOW-UP|2020-11-18|40
e|FA|585a254e-c36b-44cf-b8a9-335fb98e0fd2|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|10^7/L|[?]|1|CUP|SACROILIAC JOINT|LATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|WASHOUT|2020-11-18|40
e|FA|585a254e-c36b-44cf-b8a9-335fb98e0fd2|7|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|VOXEL|[?]|1|BOWL|CORONARY ARTERY|CONTRALATERAL|||STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2020-12-13|65
e|FA|585a254e-c36b-44cf-b8a9-335fb98e0fd2|8|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|L/day|[?]|1|uL/kg/day|PARAVERTEBRAL GANGLIA|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|3|WASHOUT|2020-12-13|65
e|FA|585a254e-c36b-44cf-b8a9-335fb98e0fd2|9|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mL/min/1.73m2|[?]|1|NEEDLE GAUGE|SOFT TISSUE|CONTRALATERAL|||GUARDIAN|5|Visit_5|90|3|FOLLOW-UP|2021-01-07|90
e|FA|585a254e-c36b-44cf-b8a9-335fb98e0fd2|10|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|mL/kg|[?]|1|IU/mmol|CELIAC ARTERY|IPSILATERAL|||CHILD|5|Visit_5|90|5|TREATMENT|2021-01-07|90
e|FA|9ee3632d-4e99-4a46-b0b9-237467d97ca0|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|CFU/mL|[?]|1|km|NECK|RIGHT|Y||CHILD|1|Visit_1|10|3|FOLLOW-UP|2020-09-09|10
e|FA|9ee3632d-4e99-4a46-b0b9-237467d97ca0|2|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|gtt|[?]|1|MPS U|ILEUM LYMPH NODE|IPSILATERAL|||SPOUSE|1|Visit_1|10|7|SCREENING|2020-09-09|10
e|FA|9ee3632d-4e99-4a46-b0b9-237467d97ca0|3|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|ppth|[?]|1|mL/h|PLEURA|LATERAL|||STUDY SUBJECT|2|Visit_2|25|7|WASHOUT|2020-09-24|25
e|FA|9ee3632d-4e99-4a46-b0b9-237467d97ca0|4|DGRAIN|Dietary Grain|[?]|GERD|[?]|DAYS|[?]|1|10^9 CFU/g|RIGHT VENTRICULAR ENDOCARDIUM|RIGHT|||ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-09-24|25
e|FA|9ee3632d-4e99-4a46-b0b9-237467d97ca0|5|SEV|Severity/Intensity|[?]|GERD|[?]|L/min|[?]|1|Pa|PERIPANCREATIC LYMPH NODE|CONTRALATERAL|||FAMILY MEMBER|3|Visit_3|40|4|SCREENING|2020-10-09|40
e|FA|9ee3632d-4e99-4a46-b0b9-237467d97ca0|6|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|ug|[?]|1|in|LUNG LOBE|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|WASHOUT|2020-10-09|40
e|FA|9ee3632d-4e99-4a46-b0b9-237467d97ca0|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|g/day|[?]|1|umol|THORAX|LEFT|||INDEPENDENT ASSESSOR|4|Visit_4|65|2|WASHOUT|2020-11-03|65
e|FA|9ee3632d-4e99-4a46-b0b9-237467d97ca0|8|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|cg|[?]|1|mEq/g|FIBULAR VEIN|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|SCREENING|2020-11-03|65
e|FA|9ee3632d-4e99-4a46-b0b9-237467d97ca0|9|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|mol/L|[?]|1|10^6 CFU/mL|SUBSTANTIA NIGRA|RIGHT||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|WASHOUT|2020-11-28|90
e|FA|9ee3632d-4e99-4a46-b0b9-237467d97ca0|10|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mm|[?]|1|PFU/dose|LARYNX|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-11-28|90
e|FA|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|pm|[?]|1|SCOOPFUL|MEDIAN OR LOWER CERVICAL LYMPH NODE|BILATERAL|Y||FRIEND|1|Visit_1|10|4|TREATMENT|2020-06-16|10
e|FA|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|2|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|mAmp|CHIN|CONTRALATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|5|FOLLOW-UP|2020-06-16|10
e|FA|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|3|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|mOsm/L|[?]|1|NEEDLE GAUGE|HEPATIC ARTERY|BILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|5|SCREENING|2020-07-01|25
e|FA|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|4|VOL|Volume|[?]|GERD|[?]|g/animal/wk|[?]|1|vp/dose|HEART, RIGHT ATRIAL APPENDAGE|IPSILATERAL|Y|Y|INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-07-01|25
e|FA|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|5|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|g/g|[?]|1|vp/dose|AXIAL SKELETON|CONTRALATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|4|TREATMENT|2020-07-16|40
e|FA|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mN|[?]|1|mg/g/min|FINGER|LEFT|Y|Y|ADJUDICATION COMMITTEE|3|Visit_3|40|7|SCREENING|2020-07-16|40
e|FA|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|7|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|L/h/m2|[?]|1|km|HEART, APEX|CONTRALATERAL|||DOMESTIC PARTNER|4|Visit_4|65|4|TREATMENT|2020-08-10|65
e|FA|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|8|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|nmol/kg/day|[?]|1|10^6 IU/mL|CARPOMETACARPAL JOINT 1|BILATERAL|||STUDY SUBJECT|4|Visit_4|65|7|FOLLOW-UP|2020-08-10|65
e|FA|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|9|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms|[?]|1|h*%|SPINOUS PROCESS|CONTRALATERAL||Y|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2020-09-04|90
e|FA|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|10|PPTFCT|Precipitating Factor|[?]|GERD|[?]|10^12/L|[?]|1|EIA unit|PECTORALIS MAJOR MUSCLE|BILATERAL|Y|Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|4|TREATMENT|2020-09-04|90
e|FA|34b2090b-13ac-4fb2-8d87-eca2839a62f2|1|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|U/mmol|[?]|1|g/dL|FOOT|CONTRALATERAL|Y|Y|PARENT|1|Visit_1|10|6|SCREENING|2020-06-07|10
e|FA|34b2090b-13ac-4fb2-8d87-eca2839a62f2|2|SEV|Severity/Intensity|[?]|GERD|[?]|DNA copies/ug|[?]|1|Pa|PERITONEAL CAVITY|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2020-06-07|10
e|FA|34b2090b-13ac-4fb2-8d87-eca2839a62f2|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|mg/min|[?]|1|mg/h|MEDIASTINUM, MIDDLE|RIGHT|Y||FRIEND|2|Visit_2|25|1|TREATMENT|2020-06-22|25
e|FA|34b2090b-13ac-4fb2-8d87-eca2839a62f2|4|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|breaths/30s|[?]|1|EIA unit|LIP, LOWER|BILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|5|FOLLOW-UP|2020-06-22|25
e|FA|34b2090b-13ac-4fb2-8d87-eca2839a62f2|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|CIGAR|[?]|1|%(v/v)|THIRD POSTEROLATERAL DESCENDING ARTERY|RIGHT|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|WASHOUT|2020-07-07|40
e|FA|34b2090b-13ac-4fb2-8d87-eca2839a62f2|6|TOXGR|Toxicity Grade|[?]|GERD|[?]|mOsm|[?]|1|aMFI|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|BILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|1|TREATMENT|2020-07-07|40
e|FA|34b2090b-13ac-4fb2-8d87-eca2839a62f2|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|steps/min|[?]|1|mg/g/min|T6 VERTEBRA|BILATERAL|||FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2020-08-01|65
e|FA|34b2090b-13ac-4fb2-8d87-eca2839a62f2|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|CUP|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|RIGHT|||SIGNIFICANT OTHER|4|Visit_4|65|7|TREATMENT|2020-08-01|65
e|FA|34b2090b-13ac-4fb2-8d87-eca2839a62f2|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|MPL U|[?]|1|Pa|PANCREAS, BODY|BILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|2|TREATMENT|2020-08-26|90
e|FA|34b2090b-13ac-4fb2-8d87-eca2839a62f2|10|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|mL/cm3/min|ARM SKIN|IPSILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|2|FOLLOW-UP|2020-08-26|90
e|FA|bfc19b4b-51bb-4056-9195-8bd2db53a497|1|LESNUM|Number of Lesions|[?]|GERD|[?]|DAgU/mL|[?]|1|ng/day|SUBGLOTTIS|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-07-26|10
e|FA|bfc19b4b-51bb-4056-9195-8bd2db53a497|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|mL/kg/min|[?]|1|TRANSDUCING UNIT/mL|AORTIC VALVE ANNULUS|LATERAL|||GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-07-26|10
e|FA|bfc19b4b-51bb-4056-9195-8bd2db53a497|3|ACNDEV|Action Taken With Device|[?]|GERD|[?]|mL/min/mmHg|[?]|1|100 IU/mL|DISTAL RIGHT CORONARY ARTERY CONDUIT|CONTRALATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-08-10|25
e|FA|bfc19b4b-51bb-4056-9195-8bd2db53a497|4|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|mg/kg/week|[?]|1|L/h/m2|BLOOD VESSEL|LATERAL|Y||PROXY|2|Visit_2|25|6|SCREENING|2020-08-10|25
e|FA|bfc19b4b-51bb-4056-9195-8bd2db53a497|5|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|h/wk|[?]|1|TRANSDUCING UNIT/mL|PREFRONTAL CORTEX|LATERAL|||SPOUSE|3|Visit_3|40|1|TREATMENT|2020-08-25|40
e|FA|bfc19b4b-51bb-4056-9195-8bd2db53a497|6|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|TROCHE|[?]|1|U/mmol|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|CONTRALATERAL|||PROXY|3|Visit_3|40|3|FOLLOW-UP|2020-08-25|40
e|FA|bfc19b4b-51bb-4056-9195-8bd2db53a497|7|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|MESF|[?]|1|mL/m2|MITRAL VALVE, POSTERIOR ANNULUS|CONTRALATERAL|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2020-09-19|65
e|FA|bfc19b4b-51bb-4056-9195-8bd2db53a497|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|genEq|[?]|1|mL|LEPTOMENINGES|UNILATERAL|||GUARDIAN|4|Visit_4|65|3|TREATMENT|2020-09-19|65
e|FA|bfc19b4b-51bb-4056-9195-8bd2db53a497|9|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|dram|[?]|1|CUP|RESPIRATORY SYSTEM|LEFT||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|FOLLOW-UP|2020-10-14|90
e|FA|bfc19b4b-51bb-4056-9195-8bd2db53a497|10|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|log10 TCID 50/uL|[?]|1|g/day|RIB 3|BILATERAL|||FRIEND|5|Visit_5|90|1|WASHOUT|2020-10-14|90
e|FA|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|EVENTS|[?]|1|mg/g/min|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|CONTRALATERAL|||PROXY|1|Visit_1|10|6|WASHOUT|2020-09-21|10
e|FA|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|2|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|cmH2O*s2/mL|[?]|1|10^6 IU/mL|POSTERIOR SUPERIOR ILIAC SPINE|BILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-09-21|10
e|FA|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|3|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|Weber|[?]|1|L/h/m2|HAND|LATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|WASHOUT|2020-10-06|25
e|FA|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|4|TOTNUM|Total Number|[?]|GERD|[?]|mL/kg/day|[?]|1|/200 HPFs|ANTERIOR TIBIAL VEIN|CONTRALATERAL||Y|GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-10-06|25
e|FA|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|5|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|Log10 ELISA unit|FOOT DIGIT 5|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|4|WASHOUT|2020-10-21|40
e|FA|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|ug/g/h|BLADDER, TRIGONE|LATERAL|||VENDOR|3|Visit_3|40|3|WASHOUT|2020-10-21|40
e|FA|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|7|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|BAU/mL|[?]|1|Shock Wave|ARTERY|LEFT|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-11-15|65
e|FA|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|8|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|ng|INFRACLAVICULAR LYMPH NODE|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2020-11-15|65
e|FA|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|9|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|mEq/day|[?]|1|g/cage/day|METACARPAL 1 BASE|RIGHT|||PROXY|5|Visit_5|90|7|TREATMENT|2020-12-10|90
e|FA|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/mL|[?]|1|U/mmol|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|BILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|6|SCREENING|2020-12-10|90
e|FA|64a70103-14bf-42f4-808b-fbdecec8bd4f|1|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|SYRINGE|[?]|1|BAG|STERNAL MANUBRIUM|BILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|4|FOLLOW-UP|2020-09-09|10
e|FA|64a70103-14bf-42f4-808b-fbdecec8bd4f|2|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU|[?]|1|L|ETHMOID SINUS|CONTRALATERAL||Y|FRIEND|1|Visit_1|10|4|FOLLOW-UP|2020-09-09|10
e|FA|64a70103-14bf-42f4-808b-fbdecec8bd4f|3|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|h*%|SCAPHOID-TRAPEZIUM JOINT|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-09-24|25
e|FA|64a70103-14bf-42f4-808b-fbdecec8bd4f|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|mL/dose|[?]|1|10^6 IU/mL|INTERPHALANGEAL JOINT 5 OF THE HAND|CONTRALATERAL|||PROXY|2|Visit_2|25|6|FOLLOW-UP|2020-09-24|25
e|FA|64a70103-14bf-42f4-808b-fbdecec8bd4f|5|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|10^9 organisms/g|[?]|1|uL/kg/day|CELIAC ARTERY|RIGHT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2020-10-09|40
e|FA|64a70103-14bf-42f4-808b-fbdecec8bd4f|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|L/L|[?]|1|mg/g/min|FEMORAL HEAD|UNILATERAL|||VENDOR|3|Visit_3|40|4|FOLLOW-UP|2020-10-09|40
e|FA|64a70103-14bf-42f4-808b-fbdecec8bd4f|7|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|TRANSDUCING UNIT/mL|FLEXOR DIGITORUM PROFUNDUS MUSCLE|IPSILATERAL||Y|GUARDIAN|4|Visit_4|65|4|SCREENING|2020-11-03|65
e|FA|64a70103-14bf-42f4-808b-fbdecec8bd4f|8|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|foz_us|[?]|1|cm H2O|NAIL|UNILATERAL|||CHILD|4|Visit_4|65|1|TREATMENT|2020-11-03|65
e|FA|64a70103-14bf-42f4-808b-fbdecec8bd4f|9|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|nU/cL|[?]|1|mEq/g|RIGHT VENTRICULAR ENDOCARDIUM|CONTRALATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-11-28|90
e|FA|64a70103-14bf-42f4-808b-fbdecec8bd4f|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|CONTAINER|[?]|1|QUANTITY SUFFICIENT|PYRAMIDAL TRACTS, INTERNAL CAPSULE|LATERAL|||DOMESTIC PARTNER|5|Visit_5|90|5|FOLLOW-UP|2020-11-28|90
e|FA|00f3949b-b14a-47c5-942c-2ab71e03e40f|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^3 copies/mL|[?]|1|%(v/v)|HEAD OF THE HUMERUS|LEFT|||CHILD|1|Visit_1|10|5|SCREENING|2021-01-19|10
e|FA|00f3949b-b14a-47c5-942c-2ab71e03e40f|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|log EID 50/dose|[?]|1|mg/g/min|PRESACRAL SPACE|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|WASHOUT|2021-01-19|10
e|FA|00f3949b-b14a-47c5-942c-2ab71e03e40f|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|APL U/mL|[?]|1|mg/h|AXILLARY ARTERY|LATERAL|||SPOUSE|2|Visit_2|25|7|TREATMENT|2021-02-03|25
e|FA|00f3949b-b14a-47c5-942c-2ab71e03e40f|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|uIU/dL|[?]|1|mg/g/min|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|IPSILATERAL|||PARENT|2|Visit_2|25|5|FOLLOW-UP|2021-02-03|25
e|FA|00f3949b-b14a-47c5-942c-2ab71e03e40f|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/day|[?]|1|Pa|INSULAR CORTEX|LATERAL|||SIBLING|3|Visit_3|40|6|TREATMENT|2021-02-18|40
e|FA|00f3949b-b14a-47c5-942c-2ab71e03e40f|6|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|cm H2O|PRONATOR QUADRATUS MUSCLE|RIGHT|||PARENT|3|Visit_3|40|5|SCREENING|2021-02-18|40
e|FA|00f3949b-b14a-47c5-942c-2ab71e03e40f|7|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|IU|[?]|1|ug/g/h|PANCREAS, EXOCRINE|UNILATERAL|||PARENT|4|Visit_4|65|4|SCREENING|2021-03-15|65
e|FA|00f3949b-b14a-47c5-942c-2ab71e03e40f|8|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|eq|[?]|1|g/cage/day|CORPUS STRIATUM|LATERAL|||FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2021-03-15|65
e|FA|00f3949b-b14a-47c5-942c-2ab71e03e40f|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|GLOBULE|[?]|1|mL/dose|PRIMARY VISUAL CORTEX|RIGHT||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|TREATMENT|2021-04-09|90
e|FA|00f3949b-b14a-47c5-942c-2ab71e03e40f|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|10^6/hpf|[?]|1|%(v/v)|RADIUS|LEFT|||INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2021-04-09|90
e|FA|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|1|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms|[?]|1|10^6 organisms/mL|PRIMARY VISUAL CORTEX|UNILATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|5|WASHOUT|2020-12-27|10
e|FA|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|2|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|in2|[?]|1|mg/h|BLADDER, NECK|BILATERAL||Y|INTERVIEWER|1|Visit_1|10|5|FOLLOW-UP|2020-12-27|10
e|FA|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|3|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|nCi|[?]|1|DROP|CINGULATE CORTEX|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|WASHOUT|2021-01-11|25
e|FA|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|4|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|cm|BICEPS FEMORIS MUSCLE|CONTRALATERAL|||ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2021-01-11|25
e|FA|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mEq/kg|[?]|1|Pa|SALIVARY GLAND|LEFT|||SPOUSE|3|Visit_3|40|4|WASHOUT|2021-01-26|40
e|FA|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|6|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/g|[?]|1|cm H2O|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL|||FRIEND|3|Visit_3|40|5|SCREENING|2021-01-26|40
e|FA|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|7|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|10^5/L|[?]|1|g/day|LIVER, RIGHT LOBE|IPSILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|7|TREATMENT|2021-02-20|65
e|FA|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|8|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|mL/cm3/min|LACRIMAL GLAND|LATERAL|||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2021-02-20|65
e|FA|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|9|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|Watt|[?]|1|g/day|CARDIAC VALVE|LATERAL|||INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2021-03-17|90
e|FA|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|10|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|log10 IU/mL|[?]|1|BOWL|CORNEA|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2021-03-17|90
e|FA|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|1|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|MASK|[?]|1|U/mg|TEMPORAL LOBE|LATERAL|||SIBLING|1|Visit_1|10|3|WASHOUT|2020-07-19|10
e|FA|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|2|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|MESF|[?]|1|L|INTERPHALANGEAL JOINT 5 OF THE FOOT|UNILATERAL|||FRIEND|1|Visit_1|10|6|TREATMENT|2020-07-19|10
e|FA|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|U/mg|TRACHEA|RIGHT|Y||FRIEND|2|Visit_2|25|5|TREATMENT|2020-08-03|25
e|FA|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|4|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|pkat/L|[?]|1|Shock Wave|GENITAL TUBERCLE|LEFT|||INTERVIEWER|2|Visit_2|25|7|TREATMENT|2020-08-03|25
e|FA|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|mg/g/min|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|UNILATERAL|Y||FRIEND|3|Visit_3|40|2|FOLLOW-UP|2020-08-18|40
e|FA|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|6|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|nmol/L/h|[?]|1|g/cage/day|SUPRACLAVICULAR LYMPH NODE|IPSILATERAL|||VENDOR|3|Visit_3|40|7|TREATMENT|2020-08-18|40
e|FA|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|7|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|nmol BCE/L|[?]|1|DROP|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|SCREENING|2020-09-12|65
e|FA|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|8|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|MBq|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|BILATERAL|||FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2020-09-12|65
e|FA|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|9|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|10^6 CFU/mL|TYMPANIC MEMBRANE|LEFT||Y|STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2020-10-07|90
e|FA|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|10|SEV|Severity/Intensity|[?]|GERD|[?]|mCi/kg|[?]|1|Pa|COLON, ASCENDING|BILATERAL|Y||SPOUSE|5|Visit_5|90|3|FOLLOW-UP|2020-10-07|90
e|FA|44ca1fe6-76d2-4a94-9854-1ddbde638803|1|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|EU|[?]|1|U/mmol|GLOMERULUS|RIGHT|||PARENT|1|Visit_1|10|5|FOLLOW-UP|2020-07-19|10
e|FA|44ca1fe6-76d2-4a94-9854-1ddbde638803|2|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|cm H2O|[?]|1|100 IU/mL|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|LATERAL|Y|Y|STUDY SUBJECT|1|Visit_1|10|2|FOLLOW-UP|2020-07-19|10
e|FA|44ca1fe6-76d2-4a94-9854-1ddbde638803|3|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|/2000 RBC|[?]|1|MPS U|PECTORALIS MAJOR MUSCLE|CONTRALATERAL|||VENDOR|2|Visit_2|25|4|TREATMENT|2020-08-03|25
e|FA|44ca1fe6-76d2-4a94-9854-1ddbde638803|4|SEV|Severity/Intensity|[?]|GERD|[?]|cL|[?]|1|Pa|ENTORHINAL CORTEX|LEFT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|SCREENING|2020-08-03|25
e|FA|44ca1fe6-76d2-4a94-9854-1ddbde638803|5|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|BISCUIT|[?]|1|mm/h|VEIN|RIGHT|||PARENT|3|Visit_3|40|7|WASHOUT|2020-08-18|40
e|FA|44ca1fe6-76d2-4a94-9854-1ddbde638803|6|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|mEq/g|SKIN OF THE FACE|BILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-08-18|40
e|FA|44ca1fe6-76d2-4a94-9854-1ddbde638803|7|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|10^7 CFU|[?]|1|ug/kg/h|THIRD OBTUSE MARGINAL BRANCH ARTERY|LEFT|||GUARDIAN|4|Visit_4|65|6|SCREENING|2020-09-12|65
e|FA|44ca1fe6-76d2-4a94-9854-1ddbde638803|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|cmH2O*s2/mL|[?]|1|%(v/v)|C3 VERTEBRA|LEFT|||PROXY|4|Visit_4|65|2|SCREENING|2020-09-12|65
e|FA|44ca1fe6-76d2-4a94-9854-1ddbde638803|9|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|CAPLET|[?]|1|mm|DISTAL INTERPHALANGEAL JOINT 2|BILATERAL|Y||GUARDIAN|5|Visit_5|90|1|FOLLOW-UP|2020-10-07|90
e|FA|44ca1fe6-76d2-4a94-9854-1ddbde638803|10|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|RFU|[?]|1|gtt|LENS|RIGHT||Y|SIBLING|5|Visit_5|90|6|SCREENING|2020-10-07|90
e|FA|edc935ed-3b94-43fa-9b7f-facf6eb6780e|1|DCAL|Dietary Calories|[?]|GERD|[?]|Pack Year|[?]|1|EIA unit|C3 VERTEBRA|UNILATERAL|||INVESTIGATOR|1|Visit_1|10|3|FOLLOW-UP|2020-12-04|10
e|FA|edc935ed-3b94-43fa-9b7f-facf6eb6780e|2|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|Siemens|[?]|1|anti-Xa IU/mL|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|BILATERAL|||GUARDIAN|1|Visit_1|10|5|TREATMENT|2020-12-04|10
e|FA|edc935ed-3b94-43fa-9b7f-facf6eb6780e|3|STRCTNUM|Number of Strictures|[?]|GERD|[?]|CIGARETTE|[?]|1|SACHET|ULNAR NERVE|UNILATERAL|||CHILD|2|Visit_2|25|5|TREATMENT|2020-12-19|25
e|FA|edc935ed-3b94-43fa-9b7f-facf6eb6780e|4|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|mEq/day|[?]|1|anti-Xa IU/mL|PULMONARY VALVE, ANTERIOR CUSP|LATERAL|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2020-12-19|25
e|FA|edc935ed-3b94-43fa-9b7f-facf6eb6780e|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mm2|[?]|1|mg/g/min|FOOT DIGIT 1|RIGHT|Y||SIBLING|3|Visit_3|40|3|TREATMENT|2021-01-03|40
e|FA|edc935ed-3b94-43fa-9b7f-facf6eb6780e|6|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|Bq|[?]|1|/kg|DORSAL MOTOR NUCLEUS|BILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2021-01-03|40
e|FA|edc935ed-3b94-43fa-9b7f-facf6eb6780e|7|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT|[?]|1|Bq/mg|MEDIASTINUM, MIDDLE|RIGHT|||SIBLING|4|Visit_4|65|4|WASHOUT|2021-01-28|65
e|FA|edc935ed-3b94-43fa-9b7f-facf6eb6780e|8|TRTSETT|Treatment Setting|[?]|GERD|[?]|umol/L/h|[?]|1|Coulomb|ANKLE JOINT|UNILATERAL|||STUDY SUBJECT|4|Visit_4|65|1|FOLLOW-UP|2021-01-28|65
e|FA|edc935ed-3b94-43fa-9b7f-facf6eb6780e|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|uL/kg/day|[?]|1|%(v/v)|GALLBLADDER|LATERAL|Y||PROXY|5|Visit_5|90|3|TREATMENT|2021-02-22|90
e|FA|edc935ed-3b94-43fa-9b7f-facf6eb6780e|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|nmol BCE/L|[?]|1|mg/g/min|BLADDER, TRIGONE|IPSILATERAL|||GUARDIAN|5|Visit_5|90|6|FOLLOW-UP|2021-02-22|90
e|FA|f997ad2a-e9b1-4341-96d5-caef4bcb7196|1|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|mEq/uL|[?]|1|mm/h|MEDIASTINUM, MIDDLE|LATERAL|||GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-06-08|10
e|FA|f997ad2a-e9b1-4341-96d5-caef4bcb7196|2|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|DAgU|[?]|1|mIU/L|THORACIC CAVITY|UNILATERAL||Y|VENDOR|1|Visit_1|10|4|SCREENING|2020-06-08|10
e|FA|f997ad2a-e9b1-4341-96d5-caef4bcb7196|3|SERVNUM|Number of Servings|[?]|GERD|[?]|psi|[?]|1|Hz/s|CEREBELLUM|LATERAL|Y||FRIEND|2|Visit_2|25|6|WASHOUT|2020-06-23|25
e|FA|f997ad2a-e9b1-4341-96d5-caef4bcb7196|4|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|cm|HAND DIGIT 5|UNILATERAL|||SIBLING|2|Visit_2|25|2|FOLLOW-UP|2020-06-23|25
e|FA|f997ad2a-e9b1-4341-96d5-caef4bcb7196|5|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|mmol2/L2|[?]|1|MBq|PULMONARY VALVE, LEFT CUSP|CONTRALATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-07-08|40
e|FA|f997ad2a-e9b1-4341-96d5-caef4bcb7196|6|STROKTYP|Stroke Type|[?]|GERD|[?]|mg/kg/h|[?]|1|g/L|THROAT|CONTRALATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|2|SCREENING|2020-07-08|40
e|FA|f997ad2a-e9b1-4341-96d5-caef4bcb7196|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|NEEDLE GAUGE|[?]|1|U/mmol|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|RIGHT|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-08-02|65
e|FA|f997ad2a-e9b1-4341-96d5-caef4bcb7196|8|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|L/h/m2|[?]|1|uL/kg/day|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|RIGHT|||CHILD|4|Visit_4|65|1|SCREENING|2020-08-02|65
e|FA|f997ad2a-e9b1-4341-96d5-caef4bcb7196|9|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|L/day|[?]|1|10^6 U|FLEXOR DIGITORUM PROFUNDUS MUSCLE|BILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|5|TREATMENT|2020-08-27|90
e|FA|f997ad2a-e9b1-4341-96d5-caef4bcb7196|10|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|h*%|GLOSSOPHARYNGEAL NERVE|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-08-27|90
e|FA|5a56874f-10e4-4cd0-842f-19552a04d1bd|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mOsm/L|[?]|1|mg/g/min|L1 VERTEBRA|CONTRALATERAL||Y|INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-06-20|10
e|FA|5a56874f-10e4-4cd0-842f-19552a04d1bd|2|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|BP|[?]|1|ng|POPLITEAL VEIN|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|FOLLOW-UP|2020-06-20|10
e|FA|5a56874f-10e4-4cd0-842f-19552a04d1bd|3|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|10^11/L|[?]|1|Hz/s|INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|SCREENING|2020-07-05|25
e|FA|5a56874f-10e4-4cd0-842f-19552a04d1bd|4|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|mg/kg/h|[?]|1|BP|LUMBAR REGION|LEFT|||FAMILY MEMBER|2|Visit_2|25|7|TREATMENT|2020-07-05|25
e|FA|5a56874f-10e4-4cd0-842f-19552a04d1bd|5|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|um2|[?]|1|TRANSDUCING UNIT/mL|LEG|UNILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|WASHOUT|2020-07-20|40
e|FA|5a56874f-10e4-4cd0-842f-19552a04d1bd|6|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|10^9/L|[?]|1|HOURS|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|RIGHT||Y|INTERVIEWER|3|Visit_3|40|1|SCREENING|2020-07-20|40
e|FA|5a56874f-10e4-4cd0-842f-19552a04d1bd|7|SEV|Severity/Intensity|[?]|GERD|[?]|cup eq|[?]|1|Pa|POPLITEAL LYMPH NODE|UNILATERAL||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|6|WASHOUT|2020-08-14|65
e|FA|5a56874f-10e4-4cd0-842f-19552a04d1bd|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^7 PFU|[?]|1|mg/g/min|COSTOCHONDRAL JOINT 1|CONTRALATERAL|||GUARDIAN|4|Visit_4|65|6|FOLLOW-UP|2020-08-14|65
e|FA|5a56874f-10e4-4cd0-842f-19552a04d1bd|9|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|mg/kg/h|[?]|1|10^6 CFU|TUNICA INTIMA|RIGHT|Y||INVESTIGATOR|5|Visit_5|90|6|FOLLOW-UP|2020-09-08|90
e|FA|5a56874f-10e4-4cd0-842f-19552a04d1bd|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|amu|[?]|1|oz eq|ASCENDING AORTA|CONTRALATERAL||Y|GUARDIAN|5|Visit_5|90|3|FOLLOW-UP|2020-09-08|90
e|FA|f1d4ebe5-fc72-447b-8872-67e971ff471b|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|%(v/v)|HIP JOINT|LATERAL|||SIBLING|1|Visit_1|10|5|TREATMENT|2020-11-08|10
e|FA|f1d4ebe5-fc72-447b-8872-67e971ff471b|2|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|pg|[?]|1|/500 WBC|L4-L5 INTERVERTEBRAL SPACE|IPSILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|3|WASHOUT|2020-11-08|10
e|FA|f1d4ebe5-fc72-447b-8872-67e971ff471b|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|mmol/mol|[?]|1|Shock Wave|COMMON FEMORAL VEIN|RIGHT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|SCREENING|2020-11-23|25
e|FA|f1d4ebe5-fc72-447b-8872-67e971ff471b|4|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|h/wk|[?]|1|mL/cm3/min|PUPIL|LEFT|Y|Y|ADJUDICATOR|2|Visit_2|25|5|SCREENING|2020-11-23|25
e|FA|f1d4ebe5-fc72-447b-8872-67e971ff471b|5|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|ft2|[?]|1|Hz/s|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|UNILATERAL||Y|SIBLING|3|Visit_3|40|1|SCREENING|2020-12-08|40
e|FA|f1d4ebe5-fc72-447b-8872-67e971ff471b|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/min|[?]|1|PACK|LIVER, LEFT LOBE|LEFT|||PROXY|3|Visit_3|40|1|WASHOUT|2020-12-08|40
e|FA|f1d4ebe5-fc72-447b-8872-67e971ff471b|7|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|Hz|[?]|1|PACK|ARTERY|BILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|5|SCREENING|2021-01-02|65
e|FA|f1d4ebe5-fc72-447b-8872-67e971ff471b|8|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|pt_us|[?]|1|mm/h|GLOBUS PALLIDUS|LEFT|||PROXY|4|Visit_4|65|6|SCREENING|2021-01-02|65
e|FA|f1d4ebe5-fc72-447b-8872-67e971ff471b|9|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|mL/m2|PAW|CONTRALATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2021-01-27|90
e|FA|f1d4ebe5-fc72-447b-8872-67e971ff471b|10|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|mU/g|[?]|1|IU/mg|TALUS|CONTRALATERAL|||CHILD|5|Visit_5|90|6|TREATMENT|2021-01-27|90
e|FA|2a141b73-e336-4701-9067-8d51d532596b|1|DVEG|Dietary Vegetable|[?]|GERD|[?]|ft2|[?]|1|Ci/ug|LIVER, LEFT LOBE|BILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-06-12|10
e|FA|2a141b73-e336-4701-9067-8d51d532596b|2|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|Tbsp|[?]|1|mL/100g/min|MUSCULOSKELETAL SYSTEM|BILATERAL|||STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2020-06-12|10
e|FA|2a141b73-e336-4701-9067-8d51d532596b|3|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|%|[?]|1|Bq/L|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|IPSILATERAL|Y||ADJUDICATOR|2|Visit_2|25|4|FOLLOW-UP|2020-06-27|25
e|FA|2a141b73-e336-4701-9067-8d51d532596b|4|PPTFCT|Precipitating Factor|[?]|GERD|[?]|msec|[?]|1|EIA unit|BRAIN, PERIVENTRICULAR REGION|UNILATERAL|||VENDOR|2|Visit_2|25|6|SCREENING|2020-06-27|25
e|FA|2a141b73-e336-4701-9067-8d51d532596b|5|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|U/mg|[?]|1|anti-Xa IU/mL|EYELID|IPSILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-07-12|40
e|FA|2a141b73-e336-4701-9067-8d51d532596b|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|nmol/g|[?]|1|mg/g/min|FLEXOR HALLUCIS BREVIS MUSCLE|LATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-07-12|40
e|FA|2a141b73-e336-4701-9067-8d51d532596b|7|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|10^7/L|[?]|1|gtt|PLACENTA|LEFT|||INDEPENDENT ASSESSOR|4|Visit_4|65|4|WASHOUT|2020-08-06|65
e|FA|2a141b73-e336-4701-9067-8d51d532596b|8|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|/kg|[?]|1|mL/cm3/min|CORONARY SINUS|IPSILATERAL|||STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2020-08-06|65
e|FA|2a141b73-e336-4701-9067-8d51d532596b|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/m2/min|[?]|1|Pa|RIB 5|LATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-08-31|90
e|FA|2a141b73-e336-4701-9067-8d51d532596b|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|oz eq|TRICUSPID VALVE, POSTERIOR ANNULUS|CONTRALATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2020-08-31|90
e|FA|4adf9a2c-3c43-4289-8156-1a109791580c|1|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mL/100g/min|[?]|1|NEEDLE GAUGE|LEFT VENTRICULAR MID INFERIOR SEGMENT|LEFT|||CHILD|1|Visit_1|10|5|WASHOUT|2020-11-22|10
e|FA|4adf9a2c-3c43-4289-8156-1a109791580c|2|LDIAM|Longest Diameter|[?]|GERD|[?]|ka_u/dL|[?]|1|Shock Wave|TRAPEZIUS MUSCLE|BILATERAL|||SPOUSE|1|Visit_1|10|6|TREATMENT|2020-11-22|10
e|FA|4adf9a2c-3c43-4289-8156-1a109791580c|3|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mg/min|[?]|1|U/10^12 RBC|EXTERNAL ILIAC ARTERY|UNILATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|6|SCREENING|2020-12-07|25
e|FA|4adf9a2c-3c43-4289-8156-1a109791580c|4|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|log10 copies/mL|[?]|1|uCi/kg|MALE REPRODUCTIVE SYSTEM|BILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-12-07|25
e|FA|4adf9a2c-3c43-4289-8156-1a109791580c|5|DPROT|Dietary Protein|[?]|GERD|[?]|ukat|[?]|1|10^4 CFU/mL|LACRIMAL GLAND|BILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2020-12-22|40
e|FA|4adf9a2c-3c43-4289-8156-1a109791580c|6|SEV|Severity/Intensity|[?]|GERD|[?]|TRANSDUCING UNIT/mL|[?]|1|Pa|ABDOMINAL WALL|RIGHT||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-12-22|40
e|FA|4adf9a2c-3c43-4289-8156-1a109791580c|7|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|pmol/L|[?]|1|mEq/g|PRETRACHEAL LYMPH NODE|LATERAL||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|SCREENING|2021-01-16|65
e|FA|4adf9a2c-3c43-4289-8156-1a109791580c|8|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|mg/dose|[?]|1|cmH2O/mL|PERIUMBILICAL REGION|CONTRALATERAL|||CHILD|4|Visit_4|65|2|FOLLOW-UP|2021-01-16|65
e|FA|4adf9a2c-3c43-4289-8156-1a109791580c|9|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|%(w/v)|[?]|1|cm H2O|SEMINAL VESICLE|CONTRALATERAL|Y||SIBLING|5|Visit_5|90|2|TREATMENT|2021-02-10|90
e|FA|4adf9a2c-3c43-4289-8156-1a109791580c|10|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|ft|[?]|1|CUP|C7 VERTEBRA|LEFT|||ADJUDICATOR|5|Visit_5|90|4|TREATMENT|2021-02-10|90
e|FA|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|1|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|10^3 copies/mL|[?]|1|g/cage/day|COLON, RIGHT|IPSILATERAL|||VENDOR|1|Visit_1|10|5|SCREENING|2020-05-23|10
e|FA|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|2|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|10^4/hpf|[?]|1|mg/h|FIRST RIGHT POSTEROLATERAL ARTERY|LATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|SCREENING|2020-05-23|10
e|FA|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|3|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|umol/L/sec|[?]|1|10^9 CFU/mL|KIDNEY|LATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|SCREENING|2020-06-07|25
e|FA|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|DNA copies/ug|[?]|1|mg/g/min|SINUS|LATERAL||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2020-06-07|25
e|FA|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|5|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|m/sec|[?]|1|/500 WBC|TARSUS BONE|UNILATERAL|||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-06-22|40
e|FA|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|6|SERVNUM|Number of Servings|[?]|GERD|[?]|PFU/mL|[?]|1|Hz/s|PERITONEUM|IPSILATERAL||Y|SPOUSE|3|Visit_3|40|1|SCREENING|2020-06-22|40
e|FA|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|7|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|10^12 IU/L|[?]|1|mAmp|PULMONARY VALVE, RIGHT CUSP|BILATERAL|Y|Y|INVESTIGATOR|4|Visit_4|65|2|SCREENING|2020-07-17|65
e|FA|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|8|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|10^5/hpf|[?]|1|EIA unit|T8 VERTEBRA|RIGHT|||SIBLING|4|Visit_4|65|4|FOLLOW-UP|2020-07-17|65
e|FA|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|9|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|/500 WBC|[?]|1|10^9 CFU/g|PROSTATE GLAND, POSTERIOR LOBE|IPSILATERAL||Y|VENDOR|5|Visit_5|90|1|SCREENING|2020-08-11|90
e|FA|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|10|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|Enzyme U/L|[?]|1|BOWL|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|RIGHT|||SPOUSE|5|Visit_5|90|4|TREATMENT|2020-08-11|90
e|FA|1b2eda86-2d2c-4fdc-a88e-409ea5180603|1|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|GPL U|[?]|1|mL/cm3/min|LINGULA OF THE LUNG|LEFT|||CAREGIVER|1|Visit_1|10|2|TREATMENT|2020-05-19|10
e|FA|1b2eda86-2d2c-4fdc-a88e-409ea5180603|2|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa/L|[?]|1|mAmp|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|UNILATERAL|Y||SPOUSE|1|Visit_1|10|7|TREATMENT|2020-05-19|10
e|FA|1b2eda86-2d2c-4fdc-a88e-409ea5180603|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ks|[?]|1|mg/g/min|MITRAL VALVE, POSTERIOR ANNULUS|LEFT|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-06-03|25
e|FA|1b2eda86-2d2c-4fdc-a88e-409ea5180603|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|mg/g/min|BLADDER, DOME|UNILATERAL|||FAMILY MEMBER|2|Visit_2|25|7|TREATMENT|2020-06-03|25
e|FA|1b2eda86-2d2c-4fdc-a88e-409ea5180603|5|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|mL|JEJUNUM|CONTRALATERAL|Y||PARENT|3|Visit_3|40|5|FOLLOW-UP|2020-06-18|40
e|FA|1b2eda86-2d2c-4fdc-a88e-409ea5180603|6|DGRAIN|Dietary Grain|[?]|GERD|[?]|ks|[?]|1|10^9 CFU/g|NUCHAL LYMPH NODE|UNILATERAL|Y||SIGNIFICANT OTHER|3|Visit_3|40|4|TREATMENT|2020-06-18|40
e|FA|1b2eda86-2d2c-4fdc-a88e-409ea5180603|7|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|titer|[?]|1|mL/mmHg/min/L|DISTAL EXTRAHEPATIC BILE DUCT REGION|RIGHT|||ADJUDICATION COMMITTEE|4|Visit_4|65|6|FOLLOW-UP|2020-07-13|65
e|FA|1b2eda86-2d2c-4fdc-a88e-409ea5180603|8|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|TRACE|[?]|1|g/cage/day|CALF MUSCULAR VEIN|LEFT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-07-13|65
e|FA|1b2eda86-2d2c-4fdc-a88e-409ea5180603|9|RLDEV|Relationship to Device|[?]|GERD|[?]|GPS U|[?]|1|mL/min/mmHg|ENDOMETRIUM|LEFT|||CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-08-07|90
e|FA|1b2eda86-2d2c-4fdc-a88e-409ea5180603|10|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|keV|[?]|1|TRANSDUCING UNIT/mL|FEMALE REPRODUCTIVE SYSTEM|CONTRALATERAL|||CAREGIVER|5|Visit_5|90|1|TREATMENT|2020-08-07|90
e|FA|fc02184a-dfba-4964-be3a-cfa5f5d7200e|1|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|L/kg|[?]|1|vp/dose|FACIAL NERVE|LATERAL|||VENDOR|1|Visit_1|10|4|TREATMENT|2020-05-26|10
e|FA|fc02184a-dfba-4964-be3a-cfa5f5d7200e|2|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|uU/dL|[?]|1|Coulomb|CORRUGATOR SUPERCILII MUSCLE|BILATERAL|||ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-05-26|10
e|FA|fc02184a-dfba-4964-be3a-cfa5f5d7200e|3|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|100 IU/mL|[?]|1|Gy/h|RIB 5|BILATERAL||Y|PARENT|2|Visit_2|25|2|TREATMENT|2020-06-10|25
e|FA|fc02184a-dfba-4964-be3a-cfa5f5d7200e|4|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|IU/kg|[?]|1|L/h/m2|PREAURICULAR LYMPH NODE|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|6|FOLLOW-UP|2020-06-10|25
e|FA|fc02184a-dfba-4964-be3a-cfa5f5d7200e|5|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|DAYS|[?]|1|mL/mmHg/min/L|RIB 4|BILATERAL|Y||VENDOR|3|Visit_3|40|1|TREATMENT|2020-06-25|40
e|FA|fc02184a-dfba-4964-be3a-cfa5f5d7200e|6|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|kg|[?]|1|EIA unit|CORPUS UTERI|LATERAL||Y|INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-06-25|40
e|FA|fc02184a-dfba-4964-be3a-cfa5f5d7200e|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|AFU|[?]|1|%(v/v)|SYNOVIAL FLUID|BILATERAL||Y|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-07-20|65
e|FA|fc02184a-dfba-4964-be3a-cfa5f5d7200e|8|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|Osm|[?]|1|BAG|MUSCLE|LATERAL|||STUDY SUBJECT|4|Visit_4|65|6|WASHOUT|2020-07-20|65
e|FA|fc02184a-dfba-4964-be3a-cfa5f5d7200e|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|Pa|PARANASAL SINUS|CONTRALATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2020-08-14|90
e|FA|fc02184a-dfba-4964-be3a-cfa5f5d7200e|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|10^6 U|SUPERFICIAL FEMORAL ARTERY|UNILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-08-14|90
e|FA|37c59cfa-b952-4d16-a675-5e3b3a2e0288|1|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|mL/100g/min|STERNAL MANUBRIUM|IPSILATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|1|FOLLOW-UP|2020-05-29|10
e|FA|37c59cfa-b952-4d16-a675-5e3b3a2e0288|2|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|MBP|[?]|1|ug/m2/h|DISTAL INTERPHALANGEAL JOINT 5|LEFT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-05-29|10
e|FA|37c59cfa-b952-4d16-a675-5e3b3a2e0288|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|U/kg/h|[?]|1|U/mg|MIDDLE PHALANX 5 OF THE HAND|LEFT|||CAREGIVER|2|Visit_2|25|1|TREATMENT|2020-06-13|25
e|FA|37c59cfa-b952-4d16-a675-5e3b3a2e0288|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|nmol/mol|[?]|1|mg/g/min|DENTAL ARCH|LATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-06-13|25
e|FA|37c59cfa-b952-4d16-a675-5e3b3a2e0288|5|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|Gy/min|[?]|1|10^6 U|ILEUM, TERMINAL|CONTRALATERAL|||SIBLING|3|Visit_3|40|3|WASHOUT|2020-06-28|40
e|FA|37c59cfa-b952-4d16-a675-5e3b3a2e0288|6|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|g/day|[?]|1|oz eq|COMMON FEMORAL VEIN|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2020-06-28|40
e|FA|37c59cfa-b952-4d16-a675-5e3b3a2e0288|7|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|umol/day|[?]|1|HOURS|COLON, RIGHT|RIGHT|Y|Y|PROXY|4|Visit_4|65|2|WASHOUT|2020-07-23|65
e|FA|37c59cfa-b952-4d16-a675-5e3b3a2e0288|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|amu|[?]|1|PFU/dose|L2-L3 INTERVERTEBRAL SPACE|CONTRALATERAL||Y|GUARDIAN|4|Visit_4|65|4|WASHOUT|2020-07-23|65
e|FA|37c59cfa-b952-4d16-a675-5e3b3a2e0288|9|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|mL/cm3/min|ADDUCTOR BREVIS MUSCLE|IPSILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2020-08-17|90
e|FA|37c59cfa-b952-4d16-a675-5e3b3a2e0288|10|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|pg/cell|[?]|1|anti-Xa IU/mL|FLEXOR POLLICIS LONGUS MUSCLE|RIGHT|||SPOUSE|5|Visit_5|90|7|WASHOUT|2020-08-17|90
e|FA|11130b2c-e9fd-4a50-87ee-5dfa19199eba|1|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|deg|[?]|1|gtt|LIVER|UNILATERAL|||GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-12-03|10
e|FA|11130b2c-e9fd-4a50-87ee-5dfa19199eba|2|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|cm|RETROCRURAL LYMPH NODE|UNILATERAL|Y||VENDOR|1|Visit_1|10|7|TREATMENT|2020-12-03|10
e|FA|11130b2c-e9fd-4a50-87ee-5dfa19199eba|3|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|mg/dL|[?]|1|10^9 CFU/g|MASTOID PROCESS|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-12-18|25
e|FA|11130b2c-e9fd-4a50-87ee-5dfa19199eba|4|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mg/g/min|[?]|1|ug/kg/h|DISTAL INTERPHALANGEAL JOINT 4|LEFT||Y|SIBLING|2|Visit_2|25|3|FOLLOW-UP|2020-12-18|25
e|FA|11130b2c-e9fd-4a50-87ee-5dfa19199eba|5|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|U/L|[?]|1|cmH2O/mL|METACARPAL BONE 1|BILATERAL|||PROXY|3|Visit_3|40|6|SCREENING|2021-01-02|40
e|FA|11130b2c-e9fd-4a50-87ee-5dfa19199eba|6|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|RING|[?]|1|uL/kg/day|VAS DEFERENS|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2021-01-02|40
e|FA|11130b2c-e9fd-4a50-87ee-5dfa19199eba|7|TOXGR|Toxicity Grade|[?]|GERD|[?]|fL|[?]|1|aMFI|METACARPOPHALANGEAL JOINT 2|UNILATERAL|||FRIEND|4|Visit_4|65|6|TREATMENT|2021-01-27|65
e|FA|11130b2c-e9fd-4a50-87ee-5dfa19199eba|8|TRTSETT|Treatment Setting|[?]|GERD|[?]|FEU|[?]|1|Coulomb|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|CONTRALATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|7|WASHOUT|2021-01-27|65
e|FA|11130b2c-e9fd-4a50-87ee-5dfa19199eba|9|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|g/cage/day|[?]|1|mm/h|CAUDATE NUCLEUS|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2021-02-21|90
e|FA|11130b2c-e9fd-4a50-87ee-5dfa19199eba|10|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|mOsm|[?]|1|BP|CHOROID PLEXUS|LATERAL|||SIBLING|5|Visit_5|90|4|FOLLOW-UP|2021-02-21|90
e|FA|08e4310f-f868-4858-a321-f33a21a771e8|1|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|V|[?]|1|mmHg/L/min|INCUS|RIGHT|||VENDOR|1|Visit_1|10|1|TREATMENT|2020-05-15|10
e|FA|08e4310f-f868-4858-a321-f33a21a771e8|2|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|APS U|[?]|1|NEEDLE GAUGE|THIRD POSTEROLATERAL DESCENDING ARTERY|CONTRALATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-05-15|10
e|FA|08e4310f-f868-4858-a321-f33a21a771e8|3|EXCDUR|Exercise Duration|[?]|GERD|[?]|mU/g|[?]|1|mm|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|LEFT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2020-05-30|25
e|FA|08e4310f-f868-4858-a321-f33a21a771e8|4|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|usec|[?]|1|U/10^12 RBC|PALM|LEFT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-05-30|25
e|FA|08e4310f-f868-4858-a321-f33a21a771e8|5|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|U/g/h|[?]|1|MPS U|OCULOMOTOR NERVE|UNILATERAL|||PROXY|3|Visit_3|40|5|TREATMENT|2020-06-14|40
e|FA|08e4310f-f868-4858-a321-f33a21a771e8|6|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mol/day|[?]|1|NEEDLE GAUGE|INFERIOR PUBIC RAMUS|CONTRALATERAL||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-06-14|40
e|FA|08e4310f-f868-4858-a321-f33a21a771e8|7|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|mg/L|[?]|1|BP|PREAURICULAR LYMPH NODE|CONTRALATERAL|||CAREGIVER|4|Visit_4|65|4|SCREENING|2020-07-09|65
e|FA|08e4310f-f868-4858-a321-f33a21a771e8|8|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|U/m2/h|[?]|1|mIU/L|SCROTUM|CONTRALATERAL|||PARENT|4|Visit_4|65|1|TREATMENT|2020-07-09|65
e|FA|08e4310f-f868-4858-a321-f33a21a771e8|9|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|RING|[?]|1|g/cage/day|PERICARDIAL LYMPH NODE|BILATERAL|Y||CHILD|5|Visit_5|90|7|SCREENING|2020-08-03|90
e|FA|08e4310f-f868-4858-a321-f33a21a771e8|10|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|mmol2/L2|[?]|1|ug/m2/h|TOE|LATERAL|Y||CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-08-03|90
e|FA|29edf133-8b5b-46d5-bf7a-f75af4658417|1|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|dL|[?]|1|QUANTITY SUFFICIENT|SKIN AROUND THE EYE|LEFT||Y|GUARDIAN|1|Visit_1|10|2|FOLLOW-UP|2020-08-22|10
e|FA|29edf133-8b5b-46d5-bf7a-f75af4658417|2|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|MPS U|GREATER CURVATURE OF THE STOMACH|LEFT||Y|VENDOR|1|Visit_1|10|2|SCREENING|2020-08-22|10
e|FA|29edf133-8b5b-46d5-bf7a-f75af4658417|3|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|g/animal/day|[?]|1|Gy/h|T3 VERTEBRA|IPSILATERAL|||SIBLING|2|Visit_2|25|6|WASHOUT|2020-09-06|25
e|FA|29edf133-8b5b-46d5-bf7a-f75af4658417|4|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|nmol/mL/min|[?]|1|Hz/s|SUPERFICIAL LYMPH NODE|RIGHT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-09-06|25
e|FA|29edf133-8b5b-46d5-bf7a-f75af4658417|5|TOTNUM|Total Number|[?]|GERD|[?]|U/kg|[?]|1|/200 HPFs|BRAIN, THIRD VENTRICLE|IPSILATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-09-21|40
e|FA|29edf133-8b5b-46d5-bf7a-f75af4658417|6|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|cm H2O|[?]|1|cm|ILIOTIBIAL BAND|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|SCREENING|2020-09-21|40
e|FA|29edf133-8b5b-46d5-bf7a-f75af4658417|7|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU|[?]|1|gtt|HAND DIGIT 5|LATERAL|Y|Y|SIBLING|4|Visit_4|65|4|TREATMENT|2020-10-16|65
e|FA|29edf133-8b5b-46d5-bf7a-f75af4658417|8|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|deg2|[?]|1|/500 WBC|T6 VERTEBRA|LEFT||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|FOLLOW-UP|2020-10-16|65
e|FA|29edf133-8b5b-46d5-bf7a-f75af4658417|9|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|mV2/Hz|[?]|1|mL/cm3/min|ABDOMINAL AORTA|CONTRALATERAL|||FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2020-11-10|90
e|FA|29edf133-8b5b-46d5-bf7a-f75af4658417|10|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|BOWL|[?]|1|mmHg/L/min|CORONARY ARTERY, LEFT|LATERAL|Y||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2020-11-10|90
e|FA|49756233-e18f-4187-8d48-3b6b4fa7e5c2|1|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|/min|[?]|1|Hz/s|ETHMOID BONE|IPSILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|SCREENING|2020-08-09|10
e|FA|49756233-e18f-4187-8d48-3b6b4fa7e5c2|2|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|GBq/ug|[?]|1|L/h/m2|RETROPHARYNGEAL LYMPH NODE|BILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-08-09|10
e|FA|49756233-e18f-4187-8d48-3b6b4fa7e5c2|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^9/L|[?]|1|mg/g/min|ANTERIOR INFERIOR CEREBELLAR ARTERY|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-08-24|25
e|FA|49756233-e18f-4187-8d48-3b6b4fa7e5c2|4|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|log10 TCID 50/mL|[?]|1|10^6 U|BICEPS BRACHII MUSCLE|CONTRALATERAL|||FAMILY MEMBER|2|Visit_2|25|5|TREATMENT|2020-08-24|25
e|FA|49756233-e18f-4187-8d48-3b6b4fa7e5c2|5|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|DROP|[?]|1|gtt|SOFT TISSUE|CONTRALATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|7|FOLLOW-UP|2020-09-08|40
e|FA|49756233-e18f-4187-8d48-3b6b4fa7e5c2|6|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|Ci/L|[?]|1|mIU/L|ANAL VERGE|LATERAL|||DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-09-08|40
e|FA|49756233-e18f-4187-8d48-3b6b4fa7e5c2|7|SEV|Severity/Intensity|[?]|GERD|[?]|mL/cage/day|[?]|1|Pa|THYROID GLAND ISTHMUS|BILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-10-03|65
e|FA|49756233-e18f-4187-8d48-3b6b4fa7e5c2|8|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|MET*h|[?]|1|gtt|CARPOMETACARPAL JOINT 4|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|6|FOLLOW-UP|2020-10-03|65
e|FA|49756233-e18f-4187-8d48-3b6b4fa7e5c2|9|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|Bq/kg|[?]|1|CUP|LIVER FISSURE|RIGHT|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2020-10-28|90
e|FA|49756233-e18f-4187-8d48-3b6b4fa7e5c2|10|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|IU/mmol|CENTRAL NERVOUS SYSTEM|IPSILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|FOLLOW-UP|2020-10-28|90
e|FA|7a046104-7215-4708-9d85-66683ceb8fe8|1|DFATT|Dietary Fat, Total|[?]|GERD|[?]|Bq/mg|[?]|1|Bq/mg|UTERUS|RIGHT|Y||SPOUSE|1|Visit_1|10|2|TREATMENT|2020-10-16|10
e|FA|7a046104-7215-4708-9d85-66683ceb8fe8|2|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|Rad|[?]|1|PACK|LIMB, LOWER|LATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-10-16|10
e|FA|7a046104-7215-4708-9d85-66683ceb8fe8|3|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|mol/L|[?]|1|BAG|T8 VERTEBRA|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2020-10-31|25
e|FA|7a046104-7215-4708-9d85-66683ceb8fe8|4|SEV|Severity/Intensity|[?]|GERD|[?]|10^6 organisms/g|[?]|1|Pa|BRACHIAL ARTERY|LEFT|||PARENT|2|Visit_2|25|6|FOLLOW-UP|2020-10-31|25
e|FA|7a046104-7215-4708-9d85-66683ceb8fe8|5|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|log EID 50/dose|[?]|1|HOURS|URETHRA, POSTERIOR|UNILATERAL|Y||STUDY SUBJECT|3|Visit_3|40|7|SCREENING|2020-11-15|40
e|FA|7a046104-7215-4708-9d85-66683ceb8fe8|6|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|DAgU|[?]|1|g/cage/day|TIBIA SHAFT|CONTRALATERAL|||INTERVIEWER|3|Visit_3|40|3|SCREENING|2020-11-15|40
e|FA|7a046104-7215-4708-9d85-66683ceb8fe8|7|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|Gy/h|PARASPINAL REGION|CONTRALATERAL||Y|SIBLING|4|Visit_4|65|4|FOLLOW-UP|2020-12-10|65
e|FA|7a046104-7215-4708-9d85-66683ceb8fe8|8|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|cup eq|[?]|1|10^6/L|RIB 10|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|WASHOUT|2020-12-10|65
e|FA|7a046104-7215-4708-9d85-66683ceb8fe8|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|%(v/v)|SKIN FOLD|IPSILATERAL|Y|Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2021-01-04|90
e|FA|7a046104-7215-4708-9d85-66683ceb8fe8|10|QOLIMP|QOL Impact|[?]|GERD|[?]|U/g/min|[?]|1|10^6/L|COLON, LEFT|UNILATERAL|Y||CAREGIVER|5|Visit_5|90|5|WASHOUT|2021-01-04|90
e|FA|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|DNA copies/ug|[?]|1|L|ESOPHAGUS, LOWER THIRD|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|WASHOUT|2021-01-26|10
e|FA|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|2|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|APS U|[?]|1|/kg|INTERPHALANGEAL JOINT 5 OF THE FOOT|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|FOLLOW-UP|2021-01-26|10
e|FA|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|3|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|g/day|DELTOID MUSCLE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2021-02-10|25
e|FA|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|copies/mL|[?]|1|mg/g/min|LEFT POSTERIOR DESCENDING ARTERY|LEFT||Y|VENDOR|2|Visit_2|25|1|WASHOUT|2021-02-10|25
e|FA|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|5|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|vp/dose|ASCENDING AORTA, SINUS OF VALSALVA|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2021-02-25|40
e|FA|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|6|TRTSETT|Treatment Setting|[?]|GERD|[?]|mmol|[?]|1|Coulomb|ANKLE MORTISE|LEFT|||SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2021-02-25|40
e|FA|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|7|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mmHg|[?]|1|mL|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|UNILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|7|TREATMENT|2021-03-22|65
e|FA|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|HOMEOPATHIC DILUTION|[?]|1|Pa|STERNUM|RIGHT|||GUARDIAN|4|Visit_4|65|5|WASHOUT|2021-03-22|65
e|FA|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|9|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|psec|[?]|1|U/mg|TIBIALIS POSTERIOR MUSCLE|UNILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2021-04-16|90
e|FA|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|10|DIAMETER|Diameter|[?]|GERD|[?]|RNA copies/mL|[?]|1|cm|BONE|CONTRALATERAL|||SPOUSE|5|Visit_5|90|2|TREATMENT|2021-04-16|90
e|FA|bcbe7d50-2ebe-483a-9d71-dce4094f864e|1|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|SCOOPFUL|[?]|1|ng/day|METACARPOPHALANGEAL JOINT 2|IPSILATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-05-25|10
e|FA|bcbe7d50-2ebe-483a-9d71-dce4094f864e|2|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|10^6 organisms/mL|POSTERIOR INFERIOR CEREBELLAR ARTERY|LEFT|||SIBLING|1|Visit_1|10|2|TREATMENT|2020-05-25|10
e|FA|bcbe7d50-2ebe-483a-9d71-dce4094f864e|3|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|Hz/s|[?]|1|IU/mg|PULMONARY ARTERY BRANCH|RIGHT|||FRIEND|2|Visit_2|25|4|TREATMENT|2020-06-09|25
e|FA|bcbe7d50-2ebe-483a-9d71-dce4094f864e|4|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|Bq/mg|EYELASH|BILATERAL|||GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-06-09|25
e|FA|bcbe7d50-2ebe-483a-9d71-dce4094f864e|5|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|SPRAY|[?]|1|BP|INTERPHALANGEAL OF THE FOOT|UNILATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|5|SCREENING|2020-06-24|40
e|FA|bcbe7d50-2ebe-483a-9d71-dce4094f864e|6|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|/2000 RBC|[?]|1|PACK|LIMB, LOWER|RIGHT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|WASHOUT|2020-06-24|40
e|FA|bcbe7d50-2ebe-483a-9d71-dce4094f864e|7|RLDEV|Relationship to Device|[?]|GERD|[?]|mg/animal|[?]|1|mL/min/mmHg|LIVER LOBE|IPSILATERAL|||VENDOR|4|Visit_4|65|6|TREATMENT|2020-07-19|65
e|FA|bcbe7d50-2ebe-483a-9d71-dce4094f864e|8|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|mL/100g/min|[?]|1|10^6/L|RIGHT ATRIAL ENDOCARDIUM|UNILATERAL|Y|Y|DOMESTIC PARTNER|4|Visit_4|65|1|SCREENING|2020-07-19|65
e|FA|bcbe7d50-2ebe-483a-9d71-dce4094f864e|9|SEV|Severity/Intensity|[?]|GERD|[?]|m2|[?]|1|Pa|CELIAC ARTERY|RIGHT||Y|SIBLING|5|Visit_5|90|1|SCREENING|2020-08-13|90
e|FA|bcbe7d50-2ebe-483a-9d71-dce4094f864e|10|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|10^11/L|[?]|1|IU/mg|PREPUTIAL GLAND|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|TREATMENT|2020-08-13|90
e|FA|2550ba24-7bcf-41e2-9eae-536e13d4b345|1|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|Weber|[?]|1|U/mmol|CORPUS STRIATUM|LATERAL|Y||VENDOR|1|Visit_1|10|7|TREATMENT|2021-01-20|10
e|FA|2550ba24-7bcf-41e2-9eae-536e13d4b345|2|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|1/(s*kPa)|[?]|1|U/mg|FAT PAD|BILATERAL|||CHILD|1|Visit_1|10|6|FOLLOW-UP|2021-01-20|10
e|FA|2550ba24-7bcf-41e2-9eae-536e13d4b345|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Absorbance U|[?]|1|mg/g/min|THIRD POSTEROLATERAL DESCENDING ARTERY|BILATERAL||Y|VENDOR|2|Visit_2|25|1|TREATMENT|2021-02-04|25
e|FA|2550ba24-7bcf-41e2-9eae-536e13d4b345|4|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|uSiemens|[?]|1|Log10 ELISA unit|LATERAL SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2021-02-04|25
e|FA|2550ba24-7bcf-41e2-9eae-536e13d4b345|5|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mm/h|[?]|1|10^6 U|SKIN OF THE ELBOW|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2021-02-19|40
e|FA|2550ba24-7bcf-41e2-9eae-536e13d4b345|6|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|COAT|[?]|1|cm H2O|FIRST DIAGONAL BRANCH ARTERY|IPSILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|WASHOUT|2021-02-19|40
e|FA|2550ba24-7bcf-41e2-9eae-536e13d4b345|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|K|[?]|1|mg/g/min|FLEXOR CARPI ULNARIS MUSCLE|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-03-16|65
e|FA|2550ba24-7bcf-41e2-9eae-536e13d4b345|8|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|PUFF|[?]|1|10^6 CFU|RADIUS|LEFT|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|3|SCREENING|2021-03-16|65
e|FA|2550ba24-7bcf-41e2-9eae-536e13d4b345|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|m/sec|[?]|1|%(v/v)|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2021-04-10|90
e|FA|2550ba24-7bcf-41e2-9eae-536e13d4b345|10|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|mMU/mL|[?]|1|TRANSDUCING UNIT/mL|DISTAL PHALANX 4 OF THE HAND|RIGHT|Y|Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|SCREENING|2021-04-10|90
e|FA|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|1|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mL/animal|[?]|1|cm H2O|INGUINAL REGION|IPSILATERAL||Y|STUDY SUBJECT|1|Visit_1|10|4|SCREENING|2020-08-14|10
e|FA|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|vp/dose|[?]|1|mg/g/min|EYELASH|UNILATERAL|Y|Y|PROXY|1|Visit_1|10|2|WASHOUT|2020-08-14|10
e|FA|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|3|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|days/wk|[?]|1|mL/h|HYPOGLOSSAL NERVE|BILATERAL|Y|Y|PROXY|2|Visit_2|25|5|TREATMENT|2020-08-29|25
e|FA|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/g|[?]|1|mg/g/min|HIP|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-08-29|25
e|FA|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|TUBE|[?]|1|mg/g/min|INFRACLAVICULAR LYMPH NODE|LATERAL|||INVESTIGATOR|3|Visit_3|40|5|SCREENING|2020-09-13|40
e|FA|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|6|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|10^4 CFU|[?]|1|g/day|HUMERUS SHAFT|LEFT||Y|INTERVIEWER|3|Visit_3|40|5|TREATMENT|2020-09-13|40
e|FA|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|7|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|TRANSDUCING UNIT/mL|TEMPORAL ARTERY|IPSILATERAL|||SIBLING|4|Visit_4|65|4|TREATMENT|2020-10-08|65
e|FA|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|8|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|IMPLANT|[?]|1|cm|CORONARY SINUS|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|WASHOUT|2020-10-08|65
e|FA|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|yd|[?]|1|mg/g/min|CARPAL BONE|RIGHT|Y||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|TREATMENT|2020-11-02|90
e|FA|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|10|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|mL/kg/h|[?]|1|BOWL|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT|Y|Y|GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-11-02|90
e|FA|6ec23671-252e-4dc9-b919-88254fce68a5|1|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|g/day|[?]|1|in|LATERAL FIRST DIAGONAL BRANCH ARTERY|LATERAL|||PARENT|1|Visit_1|10|4|TREATMENT|2020-07-28|10
e|FA|6ec23671-252e-4dc9-b919-88254fce68a5|2|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|TAMPON|[?]|1|mm/h|L5 VERTEBRA|CONTRALATERAL|||SPOUSE|1|Visit_1|10|4|TREATMENT|2020-07-28|10
e|FA|6ec23671-252e-4dc9-b919-88254fce68a5|3|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|log10 PFU/mL|[?]|1|/200 HPFs|DISTAL INTERPHALANGEAL JOINT 5|RIGHT|||SPOUSE|2|Visit_2|25|6|SCREENING|2020-08-12|25
e|FA|6ec23671-252e-4dc9-b919-88254fce68a5|4|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mU|[?]|1|km|PORTACAVAL LYMPH NODE|LATERAL||Y|CHILD|2|Visit_2|25|6|FOLLOW-UP|2020-08-12|25
e|FA|6ec23671-252e-4dc9-b919-88254fce68a5|5|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|Bq|[?]|1|mg/dose|SKIN OF THE HEAD|IPSILATERAL|Y||SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2020-08-27|40
e|FA|6ec23671-252e-4dc9-b919-88254fce68a5|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mm2|[?]|1|mg/g/min|PYRAMIDAL TRACTS, BRAINSTEM|LEFT|||SPOUSE|3|Visit_3|40|5|SCREENING|2020-08-27|40
e|FA|6ec23671-252e-4dc9-b919-88254fce68a5|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|uL/kg/day|[?]|1|%(v/v)|NAVICULAR BONE|LATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|7|WASHOUT|2020-09-21|65
e|FA|6ec23671-252e-4dc9-b919-88254fce68a5|8|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|mol/mol|[?]|1|ug/kg/h|KIDNEY, HILUM|BILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2020-09-21|65
e|FA|6ec23671-252e-4dc9-b919-88254fce68a5|9|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|mm3/mm2/year|[?]|1|m2|FUNDUS OF THE EYE|IPSILATERAL|||INTERVIEWER|5|Visit_5|90|3|FOLLOW-UP|2020-10-16|90
e|FA|6ec23671-252e-4dc9-b919-88254fce68a5|10|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|Bq/g|[?]|1|g/L|ESOPHAGEAL LYMPH NODE|LATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-10-16|90
e|FA|db59e5e1-ccda-480b-8955-da5157e16c4a|1|DMG|Dietary Magnesium|[?]|GERD|[?]|%/min|[?]|1|TRANSDUCING UNIT/mL|HEART, RIGHT ATRIAL APPENDAGE|LATERAL|Y|Y|GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-05-14|10
e|FA|db59e5e1-ccda-480b-8955-da5157e16c4a|2|LENRSCT|Length of Resection|[?]|GERD|[?]|pmol|[?]|1|psi|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|BILATERAL||Y|INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-05-14|10
e|FA|db59e5e1-ccda-480b-8955-da5157e16c4a|3|STROKTYP|Stroke Type|[?]|GERD|[?]|PA|[?]|1|g/L|HAND DIGIT 4|BILATERAL|Y||INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-05-29|25
e|FA|db59e5e1-ccda-480b-8955-da5157e16c4a|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|ng|[?]|1|mL/dose|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|IPSILATERAL|||FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-05-29|25
e|FA|db59e5e1-ccda-480b-8955-da5157e16c4a|5|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|MBq/uL|[?]|1|mAmp|VASTUS MEDIALIS MUSCLE|LEFT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-06-13|40
e|FA|db59e5e1-ccda-480b-8955-da5157e16c4a|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|mg/m2|[?]|1|ug/g/h|LUNG, HILUM|CONTRALATERAL|||PARENT|3|Visit_3|40|2|SCREENING|2020-06-13|40
e|FA|db59e5e1-ccda-480b-8955-da5157e16c4a|7|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|uIU/L|[?]|1|m2|MEDIAN OR LOWER CERVICAL LYMPH NODE|RIGHT|||INVESTIGATOR|4|Visit_4|65|4|FOLLOW-UP|2020-07-08|65
e|FA|db59e5e1-ccda-480b-8955-da5157e16c4a|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|CUP|[?]|1|Pa|ADDUCTOR LONGUS MUSCLE|LEFT|||FAMILY MEMBER|4|Visit_4|65|7|WASHOUT|2020-07-08|65
e|FA|db59e5e1-ccda-480b-8955-da5157e16c4a|9|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|DRINK|[?]|1|umol|SUPERIOR PUBIC RAMUS|BILATERAL|||FRIEND|5|Visit_5|90|2|WASHOUT|2020-08-02|90
e|FA|db59e5e1-ccda-480b-8955-da5157e16c4a|10|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|kN/cm2|[?]|1|L|HEART, VENTRICLE|BILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|2|TREATMENT|2020-08-02|90
e|FA|1dce856e-b7cb-4899-b27f-87ab8d918df4|1|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|pg/dL|[?]|1|ohm|BLADDER WALL|LEFT|Y||FRIEND|1|Visit_1|10|3|TREATMENT|2020-09-12|10
e|FA|1dce856e-b7cb-4899-b27f-87ab8d918df4|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/animal|[?]|1|mg/g/min|PELVIS|LEFT|||CHILD|1|Visit_1|10|6|TREATMENT|2020-09-12|10
e|FA|1dce856e-b7cb-4899-b27f-87ab8d918df4|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|g/g/day|[?]|1|mg/g/min|ACCESSORY RENAL ARTERY|RIGHT|||INTERVIEWER|2|Visit_2|25|2|TREATMENT|2020-09-27|25
e|FA|1dce856e-b7cb-4899-b27f-87ab8d918df4|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|U/g|[?]|1|Pa|PINEAL GLAND|CONTRALATERAL||Y|CAREGIVER|2|Visit_2|25|5|TREATMENT|2020-09-27|25
e|FA|1dce856e-b7cb-4899-b27f-87ab8d918df4|5|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|PA|[?]|1|DROP|TALUS|LATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|7|TREATMENT|2020-10-12|40
e|FA|1dce856e-b7cb-4899-b27f-87ab8d918df4|6|SEV|Severity/Intensity|[?]|GERD|[?]|ppth|[?]|1|Pa|RIB 1|LATERAL|||INTERVIEWER|3|Visit_3|40|7|FOLLOW-UP|2020-10-12|40
e|FA|1dce856e-b7cb-4899-b27f-87ab8d918df4|7|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|PACKAGE|[?]|1|100 IU/mL|ANKLE JOINT ANTERIOR FLEXOR TENDONS|CONTRALATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|5|TREATMENT|2020-11-06|65
e|FA|1dce856e-b7cb-4899-b27f-87ab8d918df4|8|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|mgEq|[?]|1|U/mg|CARPOMETACARPAL JOINT 1|RIGHT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-11-06|65
e|FA|1dce856e-b7cb-4899-b27f-87ab8d918df4|9|DISTANCE|Distance|[?]|GERD|[?]|uSiemens|[?]|1|BOWL|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|RIGHT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2020-12-01|90
e|FA|1dce856e-b7cb-4899-b27f-87ab8d918df4|10|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|dyn|[?]|1|Bq/L|TARSAL JOINT|RIGHT|||INDEPENDENT ASSESSOR|5|Visit_5|90|5|FOLLOW-UP|2020-12-01|90
e|FA|7449180b-e226-4e97-a059-8760f6523f77|1|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ELISA unit|[?]|1|oz eq|CUBOID BONE|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-07-04|10
e|FA|7449180b-e226-4e97-a059-8760f6523f77|2|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|10^3 organisms/g|[?]|1|uCi/kg|PYRAMIDAL TRACTS, BRAINSTEM|RIGHT||Y|FRIEND|1|Visit_1|10|5|TREATMENT|2020-07-04|10
e|FA|7449180b-e226-4e97-a059-8760f6523f77|3|STROKTYP|Stroke Type|[?]|GERD|[?]|10^6 CFU|[?]|1|g/L|AXILLARY LYMPH NODE LEVEL I|LEFT||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|1|FOLLOW-UP|2020-07-19|25
e|FA|7449180b-e226-4e97-a059-8760f6523f77|4|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|/day|[?]|1|EIA unit|FORELIMB|RIGHT|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-07-19|25
e|FA|7449180b-e226-4e97-a059-8760f6523f77|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mmHg/L/min|[?]|1|mg/g/min|LIVER, LEFT LOBE|LATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-08-03|40
e|FA|7449180b-e226-4e97-a059-8760f6523f77|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|CUP|INTRAHEPATIC BILE DUCT|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|6|FOLLOW-UP|2020-08-03|40
e|FA|7449180b-e226-4e97-a059-8760f6523f77|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|pkat/L|[?]|1|mg/g/min|CORPUS LUTEUM|CONTRALATERAL|||CAREGIVER|4|Visit_4|65|6|FOLLOW-UP|2020-08-28|65
e|FA|7449180b-e226-4e97-a059-8760f6523f77|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Ci/L|[?]|1|mg/g/min|SPHENOID SINUS|BILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|WASHOUT|2020-08-28|65
e|FA|7449180b-e226-4e97-a059-8760f6523f77|9|TOTNUM|Total Number|[?]|GERD|[?]|mg/dL|[?]|1|/200 HPFs|ALVEOLUS|LEFT|||PROXY|5|Visit_5|90|7|TREATMENT|2020-09-22|90
e|FA|7449180b-e226-4e97-a059-8760f6523f77|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|MPS U|[?]|1|mg/g/min|THYMUS GLAND|CONTRALATERAL|Y||SIGNIFICANT OTHER|5|Visit_5|90|3|SCREENING|2020-09-22|90
e|FA|f077c497-b0f0-4a20-b448-608b0cc6ab36|1|DMEAT|Dietary Meat|[?]|GERD|[?]|kBq|[?]|1|10^6 organisms/mL|UPPER URINARY SYSTEM|LEFT|Y||INVESTIGATOR|1|Visit_1|10|3|SCREENING|2020-06-08|10
e|FA|f077c497-b0f0-4a20-b448-608b0cc6ab36|2|STROKTYP|Stroke Type|[?]|GERD|[?]|mOsm/L|[?]|1|g/L|PANCREAS, BODY|RIGHT|Y||STUDY SUBJECT|1|Visit_1|10|3|TREATMENT|2020-06-08|10
e|FA|f077c497-b0f0-4a20-b448-608b0cc6ab36|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|IU/kg/h|[?]|1|10^6 U|BRONCHUS|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|SCREENING|2020-06-23|25
e|FA|f077c497-b0f0-4a20-b448-608b0cc6ab36|4|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|Watt|[?]|1|10^9 CFU/mL|CORNEAL ENDOTHELIUM|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-06-23|25
e|FA|f077c497-b0f0-4a20-b448-608b0cc6ab36|5|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|cd|[?]|1|gtt|PENIS, RADIX|BILATERAL|||FAMILY MEMBER|3|Visit_3|40|3|FOLLOW-UP|2020-07-08|40
e|FA|f077c497-b0f0-4a20-b448-608b0cc6ab36|6|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU|[?]|1|Bq/L|CLAW|RIGHT|||GUARDIAN|3|Visit_3|40|1|FOLLOW-UP|2020-07-08|40
e|FA|f077c497-b0f0-4a20-b448-608b0cc6ab36|7|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|uL/kg/day|ESOPHAGEAL LYMPH NODE|RIGHT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2020-08-02|65
e|FA|f077c497-b0f0-4a20-b448-608b0cc6ab36|8|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|uCi/kg|SPLEEN, HILUM|RIGHT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2020-08-02|65
e|FA|f077c497-b0f0-4a20-b448-608b0cc6ab36|9|AGETRT1|Age At First Treatment|[?]|GERD|[?]|mOsm|[?]|1|mL/mmHg/min/L|CARDIAC WALL|BILATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2020-08-27|90
e|FA|f077c497-b0f0-4a20-b448-608b0cc6ab36|10|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|CAPLET|[?]|1|IU/mg|PANCREATIC DUCT|BILATERAL||Y|STUDY SUBJECT|5|Visit_5|90|1|TREATMENT|2020-08-27|90
e|FA|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|1|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|TRACE|[?]|1|mIU/L|GASTROINTESTINAL TRACT, LOWER|UNILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-06-12|10
e|FA|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/min|[?]|1|mg/g/min|FINGER|UNILATERAL||Y|SPOUSE|1|Visit_1|10|1|TREATMENT|2020-06-12|10
e|FA|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|nmol/day|[?]|1|U/mg|BODY OF STOMACH|RIGHT|||GUARDIAN|2|Visit_2|25|4|TREATMENT|2020-06-27|25
e|FA|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|4|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|10^6 U|[?]|1|IU/mg|MALE REPRODUCTIVE SYSTEM|IPSILATERAL|Y|Y|ADJUDICATOR|2|Visit_2|25|4|FOLLOW-UP|2020-06-27|25
e|FA|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|5|DIAMETER|Diameter|[?]|GERD|[?]|EID 50/mL|[?]|1|cm|THYMUS GLAND|BILATERAL|||SPOUSE|3|Visit_3|40|6|SCREENING|2020-07-12|40
e|FA|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|6|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|um/s|[?]|1|NEEDLE GAUGE|C2 VERTEBRA|BILATERAL|||VENDOR|3|Visit_3|40|7|TREATMENT|2020-07-12|40
e|FA|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|7|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|MET*h|[?]|1|10^6/L|RIB 4|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2020-08-06|65
e|FA|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|8|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|mL*cmH2O|[?]|1|mIU/L|CARDIOVASCULAR SYSTEM|RIGHT|Y||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-08-06|65
e|FA|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|9|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|deg/mm|[?]|1|QUANTITY SUFFICIENT|C5 VERTEBRA|CONTRALATERAL|Y|Y|FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2020-08-31|90
e|FA|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|10|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|amol|[?]|1|uCi/kg|FEMUR SHAFT|RIGHT|Y||FRIEND|5|Visit_5|90|1|SCREENING|2020-08-31|90
e|FA|3f7c46ac-fe30-4ef3-a581-99c064a85efa|1|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|cd*s/m2|[?]|1|10^4 CFU/mL|ATRIOVENTRICULAR VALVE|BILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|SCREENING|2021-01-11|10
e|FA|3f7c46ac-fe30-4ef3-a581-99c064a85efa|2|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU|[?]|1|SACHET|C1 VERTEBRA|BILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2021-01-11|10
e|FA|3f7c46ac-fe30-4ef3-a581-99c064a85efa|3|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|cm H2O|GINGIVA|IPSILATERAL|Y||INVESTIGATOR|2|Visit_2|25|4|SCREENING|2021-01-26|25
e|FA|3f7c46ac-fe30-4ef3-a581-99c064a85efa|4|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|CFU/g|[?]|1|mAmp|L5 VERTEBRA|LEFT|||CAREGIVER|2|Visit_2|25|4|FOLLOW-UP|2021-01-26|25
e|FA|3f7c46ac-fe30-4ef3-a581-99c064a85efa|5|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|U/m2|[?]|1|10^6 U|OVARIAN FOLLICLE|LATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|SCREENING|2021-02-10|40
e|FA|3f7c46ac-fe30-4ef3-a581-99c064a85efa|6|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|mL/mmHg/min/L|METACARPAL BONE 1|IPSILATERAL|||FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2021-02-10|40
e|FA|3f7c46ac-fe30-4ef3-a581-99c064a85efa|7|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|cm|[?]|1|U/10^12 RBC|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|BILATERAL||Y|PROXY|4|Visit_4|65|7|TREATMENT|2021-03-07|65
e|FA|3f7c46ac-fe30-4ef3-a581-99c064a85efa|8|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/mol|[?]|1|g/dL|RECTUS FEMORIS MUSCLE|CONTRALATERAL||Y|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-03-07|65
e|FA|3f7c46ac-fe30-4ef3-a581-99c064a85efa|9|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|Weber|[?]|1|umol|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|IPSILATERAL|||ADJUDICATOR|5|Visit_5|90|3|FOLLOW-UP|2021-04-01|90
e|FA|3f7c46ac-fe30-4ef3-a581-99c064a85efa|10|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|grain|[?]|1|CUP|ANTRUM PYLORI|RIGHT|||GUARDIAN|5|Visit_5|90|2|TREATMENT|2021-04-01|90
e|FA|8d944400-df75-4ec7-8fb4-239eb0f6de9d|1|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|FINGERTIP UNIT|[?]|1|cmH2O/mL|MALE REPRODUCTIVE SYSTEM|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-09-22|10
e|FA|8d944400-df75-4ec7-8fb4-239eb0f6de9d|2|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|uV*sec|[?]|1|/500 WBC|OCCIPITAL LOBE|UNILATERAL||Y|INDEPENDENT ASSESSOR|1|Visit_1|10|4|FOLLOW-UP|2020-09-22|10
e|FA|8d944400-df75-4ec7-8fb4-239eb0f6de9d|3|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|Bq|[?]|1|10^6 U|FRONTAL LOBE|BILATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|3|SCREENING|2020-10-07|25
e|FA|8d944400-df75-4ec7-8fb4-239eb0f6de9d|4|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|log10 CFU/mL|[?]|1|cm|C1 VERTEBRA|IPSILATERAL|Y|Y|INVESTIGATOR|2|Visit_2|25|3|SCREENING|2020-10-07|25
e|FA|8d944400-df75-4ec7-8fb4-239eb0f6de9d|5|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|POINT|[?]|1|Bq/L|PARAPHARYNGEAL LYMPH NODE|IPSILATERAL||Y|PROXY|3|Visit_3|40|6|TREATMENT|2020-10-22|40
e|FA|8d944400-df75-4ec7-8fb4-239eb0f6de9d|6|DFIBER|Dietary Fiber|[?]|GERD|[?]|mmol|[?]|1|h*%|EAR|CONTRALATERAL|Y|Y|DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-10-22|40
e|FA|8d944400-df75-4ec7-8fb4-239eb0f6de9d|7|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|ug/L|[?]|1|mL/cm3/min|SCAPHOID-LUNATE JOINT|RIGHT|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2020-11-16|65
e|FA|8d944400-df75-4ec7-8fb4-239eb0f6de9d|8|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|Ci|[?]|1|mL/cm3/min|FALCIFORM LIGAMENT|UNILATERAL||Y|SPOUSE|4|Visit_4|65|5|TREATMENT|2020-11-16|65
e|FA|8d944400-df75-4ec7-8fb4-239eb0f6de9d|9|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|psec|[?]|1|AU/mL|SEMINAL VESICLE|RIGHT||Y|ADJUDICATOR|5|Visit_5|90|3|FOLLOW-UP|2020-12-11|90
e|FA|8d944400-df75-4ec7-8fb4-239eb0f6de9d|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|nkat/L|[?]|1|U/mg|HEART, RIGHT VENTRICULAR WALL|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|FOLLOW-UP|2020-12-11|90
e|FA|7b201f93-bd8c-4507-a7b7-27a02e364647|1|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|g/animal/day|[?]|1|MBq|RECTUS FEMORIS MUSCLE|LEFT|||PARENT|1|Visit_1|10|5|TREATMENT|2020-12-23|10
e|FA|7b201f93-bd8c-4507-a7b7-27a02e364647|2|ESTWT|Estimated Weight|[?]|GERD|[?]|mmHg/sec|[?]|1|g/day|RADIAL NERVE|RIGHT|||INVESTIGATOR|1|Visit_1|10|4|WASHOUT|2020-12-23|10
e|FA|7b201f93-bd8c-4507-a7b7-27a02e364647|3|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|pkat|[?]|1|BOWL|ENTORHINAL CORTEX|UNILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2021-01-07|25
e|FA|7b201f93-bd8c-4507-a7b7-27a02e364647|4|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|ppth|[?]|1|ohm|POSTERIOR POLE OF THE EYE|LATERAL||Y|VENDOR|2|Visit_2|25|1|FOLLOW-UP|2021-01-07|25
e|FA|7b201f93-bd8c-4507-a7b7-27a02e364647|5|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|DPM|[?]|1|m2|OROPHARYNX|RIGHT|Y|Y|ADJUDICATOR|3|Visit_3|40|3|SCREENING|2021-01-22|40
e|FA|7b201f93-bd8c-4507-a7b7-27a02e364647|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/mg|[?]|1|mg/g/min|TRIGEMINAL NERVE|IPSILATERAL||Y|VENDOR|3|Visit_3|40|5|WASHOUT|2021-01-22|40
e|FA|7b201f93-bd8c-4507-a7b7-27a02e364647|7|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|10^6/L|[?]|1|Log10 ELISA unit|MUSCLE|RIGHT|Y||INTERVIEWER|4|Visit_4|65|3|FOLLOW-UP|2021-02-16|65
e|FA|7b201f93-bd8c-4507-a7b7-27a02e364647|8|QOLIMP|QOL Impact|[?]|GERD|[?]|DNA copies/ug|[?]|1|10^6/L|THORACIC LYMPH NODE|IPSILATERAL|||INTERVIEWER|4|Visit_4|65|2|TREATMENT|2021-02-16|65
e|FA|7b201f93-bd8c-4507-a7b7-27a02e364647|9|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|nkat/L|[?]|1|mL/h|LEG|UNILATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2021-03-13|90
e|FA|7b201f93-bd8c-4507-a7b7-27a02e364647|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|Gravitational Unit|[?]|1|%(v/v)|INTERPHALANGEAL THUMB JOINT|IPSILATERAL|||CAREGIVER|5|Visit_5|90|4|WASHOUT|2021-03-13|90
e|FA|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|1|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|ug/dL|[?]|1|mL/m2|VERTEBRA|UNILATERAL|Y||SIBLING|1|Visit_1|10|6|FOLLOW-UP|2020-08-05|10
e|FA|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|2|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|h*%|SALIVARY GLAND|IPSILATERAL|Y|Y|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-08-05|10
e|FA|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|3|DVEG|Dietary Vegetable|[?]|GERD|[?]|mL/kg/day|[?]|1|Ci/ug|SCAPHOID-TRAPEZOID JOINT|CONTRALATERAL|||SPOUSE|2|Visit_2|25|3|FOLLOW-UP|2020-08-20|25
e|FA|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|4|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|mAmp|SMALL SAPHENOUS VEIN|BILATERAL|||VENDOR|2|Visit_2|25|6|TREATMENT|2020-08-20|25
e|FA|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|5|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|cycle/min|[?]|1|Bq/L|METACARPOPHALANGEAL JOINT 1|IPSILATERAL|Y|Y|CAREGIVER|3|Visit_3|40|5|TREATMENT|2020-09-04|40
e|FA|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|6|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|EIA unit|GREATER CURVATURE OF THE STOMACH|LEFT|Y||FAMILY MEMBER|3|Visit_3|40|6|FOLLOW-UP|2020-09-04|40
e|FA|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|7|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|BP|[?]|1|g/day|L4-L5 INTERVERTEBRAL SPACE|CONTRALATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|1|FOLLOW-UP|2020-09-29|65
e|FA|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT/mL|[?]|1|%(v/v)|POPLITEAL ARTERY BELOW KNEE|RIGHT|||SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2020-09-29|65
e|FA|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|9|LDIAM|Longest Diameter|[?]|GERD|[?]|uU/L|[?]|1|Shock Wave|SKIN OF THE FOREARM|IPSILATERAL||Y|CAREGIVER|5|Visit_5|90|1|FOLLOW-UP|2020-10-24|90
e|FA|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|10|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|dB|[?]|1|gtt|ISCHIUM|LEFT|||SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-10-24|90
e|FA|3611b798-9b3d-4173-b23e-3017939847e0|1|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|pmol/day|[?]|1|mmHg/L/min|PYLORIC SPHINCTER|UNILATERAL||Y|ADJUDICATOR|1|Visit_1|10|5|SCREENING|2020-08-03|10
e|FA|3611b798-9b3d-4173-b23e-3017939847e0|2|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|lm|[?]|1|BAG|EPIGASTRIC REGION|LEFT|Y||VENDOR|1|Visit_1|10|4|TREATMENT|2020-08-03|10
e|FA|3611b798-9b3d-4173-b23e-3017939847e0|3|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|EVENTS|[?]|1|PFU/dose|DISTANT LYMPH NODE|RIGHT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-08-18|25
e|FA|3611b798-9b3d-4173-b23e-3017939847e0|4|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|min/day|[?]|1|10^9 CFU/mL|OBTURATOR EXTERNUS MUSCLE|RIGHT|||INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-08-18|25
e|FA|3611b798-9b3d-4173-b23e-3017939847e0|5|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|U/g/min|[?]|1|mL/h|ACHILLES TENDON|BILATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|3|FOLLOW-UP|2020-09-02|40
e|FA|3611b798-9b3d-4173-b23e-3017939847e0|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|GPL U|[?]|1|ug/g/h|SUBGLOTTIS|RIGHT|||GUARDIAN|3|Visit_3|40|7|TREATMENT|2020-09-02|40
e|FA|3611b798-9b3d-4173-b23e-3017939847e0|7|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|mCi/L|[?]|1|mL/h|HAIR FOLLICLE|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|SCREENING|2020-09-27|65
e|FA|3611b798-9b3d-4173-b23e-3017939847e0|8|DVEG|Dietary Vegetable|[?]|GERD|[?]|U/kg/min|[?]|1|Ci/ug|OPTIC DISC|UNILATERAL|||STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2020-09-27|65
e|FA|3611b798-9b3d-4173-b23e-3017939847e0|9|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mL/min/mmHg|[?]|1|U/10^12 RBC|METACARPAL BONE 1|LEFT|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-10-22|90
e|FA|3611b798-9b3d-4173-b23e-3017939847e0|10|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|U/g Hb|[?]|1|uL/kg/day|CORONARY ARTERY, RIGHT|LEFT|||INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-10-22|90
e|FA|f651799b-9723-4c2c-88d1-de2f347e9a69|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|kcal|[?]|1|mg/g/min|STERNAL MANUBRIUM|LATERAL|Y|Y|VENDOR|1|Visit_1|10|4|WASHOUT|2020-06-24|10
e|FA|f651799b-9723-4c2c-88d1-de2f347e9a69|2|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|FINGERTIP UNIT|[?]|1|CUP|METATARSOPHALANGEAL JOINT|RIGHT|||PARENT|1|Visit_1|10|7|WASHOUT|2020-06-24|10
e|FA|f651799b-9723-4c2c-88d1-de2f347e9a69|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|AgU/mL|[?]|1|mg/g/min|METATARSAL BONE|LEFT|||INTERVIEWER|2|Visit_2|25|4|FOLLOW-UP|2020-07-09|25
e|FA|f651799b-9723-4c2c-88d1-de2f347e9a69|4|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/g|[?]|1|cmH2O/mL|SKIN OF THE CHEST|IPSILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|7|SCREENING|2020-07-09|25
e|FA|f651799b-9723-4c2c-88d1-de2f347e9a69|5|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|g/kg|[?]|1|oz eq|FEMALE REPRODUCTIVE SYSTEM|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-07-24|40
e|FA|f651799b-9723-4c2c-88d1-de2f347e9a69|6|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|ks|[?]|1|HOURS|ANTERIOR SUPERIOR ILIAC SPINE|BILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-07-24|40
e|FA|f651799b-9723-4c2c-88d1-de2f347e9a69|7|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|aMFI|LIVER|LEFT|||ADJUDICATION COMMITTEE|4|Visit_4|65|5|FOLLOW-UP|2020-08-18|65
e|FA|f651799b-9723-4c2c-88d1-de2f347e9a69|8|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|AgU/mL|[?]|1|MPS U|EXTRAHEPATIC BILE DUCT|CONTRALATERAL|Y||DOMESTIC PARTNER|4|Visit_4|65|7|FOLLOW-UP|2020-08-18|65
e|FA|f651799b-9723-4c2c-88d1-de2f347e9a69|9|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|mL/kg/min|[?]|1|SACHET|OCCIPITAL LYMPH NODE|RIGHT|||CHILD|5|Visit_5|90|4|TREATMENT|2020-09-12|90
e|FA|f651799b-9723-4c2c-88d1-de2f347e9a69|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/day|[?]|1|Pa|ESOPHAGUS, CERVICAL|IPSILATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|7|TREATMENT|2020-09-12|90
e|FA|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|copies/uL|[?]|1|CUP|CARDIAC WALL|RIGHT|||GUARDIAN|1|Visit_1|10|2|FOLLOW-UP|2020-10-19|10
e|FA|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|2|EXTRSCT|Extent of Resection|[?]|GERD|[?]|10^3 CFU|[?]|1|Weber|LEPTOMENINGES|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|FOLLOW-UP|2020-10-19|10
e|FA|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|3|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|kat|[?]|1|AU/mL|HAND DIGIT 3|BILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-11-03|25
e|FA|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|4|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|nU/cL|[?]|1|ohm|BICEPS BRACHII MUSCLE|RIGHT||Y|VENDOR|2|Visit_2|25|3|FOLLOW-UP|2020-11-03|25
e|FA|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|5|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mg/animal|[?]|1|gtt|INTERNAL ILIAC LYMPH NODE|LEFT|||SIBLING|3|Visit_3|40|3|WASHOUT|2020-11-18|40
e|FA|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|6|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|mol/mol|[?]|1|ng|POSTERIOR SUPERIOR ILIAC SPINE|LEFT||Y|STUDY SUBJECT|3|Visit_3|40|6|SCREENING|2020-11-18|40
e|FA|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/day|[?]|1|mg/g/min|MESENTERY|BILATERAL|||INTERVIEWER|4|Visit_4|65|3|WASHOUT|2020-12-13|65
e|FA|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|8|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|km/h|[?]|1|Bq/mg|FRONTAL LOBE|UNILATERAL|Y|Y|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-12-13|65
e|FA|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mg/m2/h|[?]|1|mL|ORAL MUCOSA|LATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|FOLLOW-UP|2021-01-07|90
e|FA|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|10|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|U/dL|[?]|1|ohm|INTERPHALANGEAL JOINT 5|RIGHT|||PROXY|5|Visit_5|90|1|SCREENING|2021-01-07|90
e|FA|29b16c31-df0e-493c-a777-46113b904879|1|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|/7.5 mL|[?]|1|10^4 CFU/mL|SHOULDER JOINT TENDONS|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-06-07|10
e|FA|29b16c31-df0e-493c-a777-46113b904879|2|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|hPa|[?]|1|Hz/s|MALE REPRODUCTIVE SYSTEM|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|2|FOLLOW-UP|2020-06-07|10
e|FA|29b16c31-df0e-493c-a777-46113b904879|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|L/s|[?]|1|mg/g/min|CHEST WALL|CONTRALATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|4|SCREENING|2020-06-22|25
e|FA|29b16c31-df0e-493c-a777-46113b904879|4|DFATT|Dietary Fat, Total|[?]|GERD|[?]|/5x10^4 WBC|[?]|1|Bq/mg|GINGIVA|CONTRALATERAL|||CHILD|2|Visit_2|25|4|WASHOUT|2020-06-22|25
e|FA|29b16c31-df0e-493c-a777-46113b904879|5|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|INHALATION|[?]|1|mL/cm3/min|THROAT|BILATERAL|||PROXY|3|Visit_3|40|2|TREATMENT|2020-07-07|40
e|FA|29b16c31-df0e-493c-a777-46113b904879|6|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/g|[?]|1|BOWL|NAIL|LEFT|Y||PROXY|3|Visit_3|40|1|SCREENING|2020-07-07|40
e|FA|29b16c31-df0e-493c-a777-46113b904879|7|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|Bq/mg|DISTAL FEMUR R1|RIGHT||Y|VENDOR|4|Visit_4|65|4|FOLLOW-UP|2020-08-01|65
e|FA|29b16c31-df0e-493c-a777-46113b904879|8|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|mg/day|[?]|1|mmHg/L/min|FINGER FLEXOR TENDONS|RIGHT|||INVESTIGATOR|4|Visit_4|65|2|WASHOUT|2020-08-01|65
e|FA|29b16c31-df0e-493c-a777-46113b904879|9|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|Sv|[?]|1|10^6 organisms/mL|COLON, RIGHT|RIGHT||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-08-26|90
e|FA|29b16c31-df0e-493c-a777-46113b904879|10|DVEG|Dietary Vegetable|[?]|GERD|[?]|YEARS|[?]|1|Ci/ug|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|IPSILATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|6|SCREENING|2020-08-26|90
e|FA|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|1|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|STEPS|[?]|1|uCi/kg|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|IPSILATERAL|Y|Y|PROXY|1|Visit_1|10|4|TREATMENT|2020-07-31|10
e|FA|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|2|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|10^6 CFU|FIBULAR VEIN|LEFT|Y||INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-07-31|10
e|FA|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|3|SEV|Severity/Intensity|[?]|GERD|[?]|Antibody Unit|[?]|1|Pa|VASTUS INTERMEDIUS MUSCLE|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|TREATMENT|2020-08-15|25
e|FA|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|4|SEV|Severity/Intensity|[?]|GERD|[?]|mmAL|[?]|1|Pa|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-08-15|25
e|FA|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|5|PPTFCT|Precipitating Factor|[?]|GERD|[?]|cs|[?]|1|EIA unit|EPIGASTRIC LYMPH NODE|LATERAL|||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-08-30|40
e|FA|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|6|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|100 IU/mL|PULMONARY VALVE, LEFT CUSP|LATERAL||Y|FRIEND|3|Visit_3|40|7|WASHOUT|2020-08-30|40
e|FA|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|7|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|fmol/g|[?]|1|L|THORACIC SPINE|IPSILATERAL||Y|INVESTIGATOR|4|Visit_4|65|2|SCREENING|2020-09-24|65
e|FA|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|8|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|mL*cmH2O|[?]|1|in|HAIR SHAFT|IPSILATERAL||Y|SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-09-24|65
e|FA|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|9|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|mL/100g/min|T7 VERTEBRA|UNILATERAL||Y|FRIEND|5|Visit_5|90|2|FOLLOW-UP|2020-10-19|90
e|FA|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|10|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|Hz|[?]|1|cm H2O|HEART|BILATERAL|||FRIEND|5|Visit_5|90|6|SCREENING|2020-10-19|90
e|FA|118914c8-9f6a-47c8-b427-296a99547756|1|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|min|[?]|1|Log10 ELISA unit|PALATINE BONE|LATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-10-25|10
e|FA|118914c8-9f6a-47c8-b427-296a99547756|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|PFU/dose|[?]|1|mg/g/min|CAPITATE-LUNATE JOINT|LEFT|||PROXY|1|Visit_1|10|5|SCREENING|2020-10-25|10
e|FA|118914c8-9f6a-47c8-b427-296a99547756|3|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|U/g/h|[?]|1|mL/h|MITRAL VALVE, POSTERIOR ANNULUS|RIGHT|Y||VENDOR|2|Visit_2|25|4|TREATMENT|2020-11-09|25
e|FA|118914c8-9f6a-47c8-b427-296a99547756|4|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|DNA copies/ug|[?]|1|mL|ACUTE MARGINAL ARTERY|BILATERAL|||STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-11-09|25
e|FA|118914c8-9f6a-47c8-b427-296a99547756|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|pg/dL|[?]|1|U/mg|DISTAL RADIOULNAR JOINT|BILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|5|SCREENING|2020-11-24|40
e|FA|118914c8-9f6a-47c8-b427-296a99547756|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|Pa|MUSCULOSKELETAL SYSTEM|IPSILATERAL|Y||SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2020-11-24|40
e|FA|118914c8-9f6a-47c8-b427-296a99547756|7|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mol/day|[?]|1|mL|URINARY SYSTEM|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|5|FOLLOW-UP|2020-12-19|65
e|FA|118914c8-9f6a-47c8-b427-296a99547756|8|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|mg/dL|[?]|1|mmHg/L/min|ESOPHAGUS, UPPER THIRD|BILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|1|WASHOUT|2020-12-19|65
e|FA|118914c8-9f6a-47c8-b427-296a99547756|9|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|BU|[?]|1|ug/m2/h|PUTAMEN|LATERAL|||VENDOR|5|Visit_5|90|5|TREATMENT|2021-01-13|90
e|FA|118914c8-9f6a-47c8-b427-296a99547756|10|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|VOXEL|[?]|1|g/dL|HEART, APEX|CONTRALATERAL|Y||PARENT|5|Visit_5|90|1|SCREENING|2021-01-13|90
e|FA|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|1|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|g/cm2|[?]|1|m2|TENTORIUM CEREBELLI|IPSILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|6|WASHOUT|2020-12-09|10
e|FA|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|2|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mol/day|[?]|1|ohm|METATARSOPHALANGEAL JOINT 5|UNILATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-12-09|10
e|FA|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|3|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|Enzyme U/L|[?]|1|IU/mg|SIGMOID SINUS|IPSILATERAL||Y|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-12-24|25
e|FA|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|IU/day|[?]|1|%(v/v)|PERICARDIAL CAVITY|LEFT|||FAMILY MEMBER|2|Visit_2|25|5|SCREENING|2020-12-24|25
e|FA|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|TAMPON|[?]|1|%(v/v)|PYRAMIDAL TRACTS, INTERNAL CAPSULE|UNILATERAL|Y|Y|GUARDIAN|3|Visit_3|40|7|WASHOUT|2021-01-08|40
e|FA|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|6|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|cm2|[?]|1|AU/mL|TUNICA INTIMA|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|FOLLOW-UP|2021-01-08|40
e|FA|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|7|SEV|Severity/Intensity|[?]|GERD|[?]|IU/kg/h|[?]|1|Pa|HAND DIGIT 2|RIGHT|||FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2021-02-02|65
e|FA|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|8|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/dL|[?]|1|PACK|KIDNEY, HILUM|LATERAL|Y||CHILD|4|Visit_4|65|5|TREATMENT|2021-02-02|65
e|FA|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Watt|[?]|1|%(v/v)|EPICARDIUM|LEFT|||STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2021-02-27|90
e|FA|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|10|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|Bq/mL|[?]|1|CUP|L2 VERTEBRA|UNILATERAL||Y|FAMILY MEMBER|5|Visit_5|90|5|TREATMENT|2021-02-27|90
e|FA|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|1|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|CFU/g|[?]|1|Ci/ug|ESOPHAGEAL LYMPH NODE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2021-01-08|10
e|FA|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|2|ESTWT|Estimated Weight|[?]|GERD|[?]|kg/cm|[?]|1|g/day|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|LATERAL|Y||GUARDIAN|1|Visit_1|10|2|FOLLOW-UP|2021-01-08|10
e|FA|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mEq/mL|[?]|1|%(v/v)|INTERPHALANGEAL JOINT 5|IPSILATERAL|||INVESTIGATOR|2|Visit_2|25|5|SCREENING|2021-01-23|25
e|FA|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|4|ACNDEV|Action Taken With Device|[?]|GERD|[?]|CAPLET|[?]|1|100 IU/mL|MYOMETRIUM|IPSILATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|7|WASHOUT|2021-01-23|25
e|FA|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|5|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|USP U|[?]|1|MPS U|MASTOID PROCESS|IPSILATERAL|Y||SIGNIFICANT OTHER|3|Visit_3|40|6|FOLLOW-UP|2021-02-07|40
e|FA|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|6|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|mL/m2|[?]|1|BOWL|SCAPULA|UNILATERAL|||SPOUSE|3|Visit_3|40|4|FOLLOW-UP|2021-02-07|40
e|FA|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|7|ESTWT|Estimated Weight|[?]|GERD|[?]|oz|[?]|1|g/day|TRACHEOBRONCHIAL TREE|CONTRALATERAL|||VENDOR|4|Visit_4|65|4|TREATMENT|2021-03-04|65
e|FA|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|8|DMEAT|Dietary Meat|[?]|GERD|[?]|U/m2/min|[?]|1|10^6 organisms/mL|TIBIALIS ANTERIOR MUSCLE|CONTRALATERAL|||ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2021-03-04|65
e|FA|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|9|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|mm|[?]|1|in|POSTEROLATERAL SEGMENTAL ARTERY|LATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|TREATMENT|2021-03-29|90
e|FA|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^7/L|[?]|1|mg/g/min|LUMBAR REGION|LATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2021-03-29|90
e|FA|7a5ae465-03b9-4006-a29e-94822ed857aa|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|mg/g/min|FACET JOINT|IPSILATERAL|||SIBLING|1|Visit_1|10|1|SCREENING|2020-07-02|10
e|FA|7a5ae465-03b9-4006-a29e-94822ed857aa|2|CALBURN|Calories Burned|[?]|GERD|[?]|ug/kg|[?]|1|/kg|ABDUCENS NERVE|IPSILATERAL||Y|SPOUSE|1|Visit_1|10|3|TREATMENT|2020-07-02|10
e|FA|7a5ae465-03b9-4006-a29e-94822ed857aa|3|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|10^9/L|[?]|1|mL/m2|DIAPHRAGMATIC LYMPH NODE|IPSILATERAL|||PROXY|2|Visit_2|25|1|SCREENING|2020-07-17|25
e|FA|7a5ae465-03b9-4006-a29e-94822ed857aa|4|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|U/kg/day|[?]|1|mm/h|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|UNILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-07-17|25
e|FA|7a5ae465-03b9-4006-a29e-94822ed857aa|5|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|pkat/L|[?]|1|HOURS|SUPRAGLOTTIS|CONTRALATERAL|||VENDOR|3|Visit_3|40|7|SCREENING|2020-08-01|40
e|FA|7a5ae465-03b9-4006-a29e-94822ed857aa|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|RFU|[?]|1|Pa|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|LEFT||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|5|FOLLOW-UP|2020-08-01|40
e|FA|7a5ae465-03b9-4006-a29e-94822ed857aa|7|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|Linear ft*LB|[?]|1|mm|LIVER FISSURE|BILATERAL|Y||PROXY|4|Visit_4|65|1|WASHOUT|2020-08-26|65
e|FA|7a5ae465-03b9-4006-a29e-94822ed857aa|8|EVENTFRQ|Event Frequency|[?]|GERD|[?]|kN/cm2|[?]|1|ug/kg/h|APPENDICEAL TIP|CONTRALATERAL|Y||INTERVIEWER|4|Visit_4|65|6|FOLLOW-UP|2020-08-26|65
e|FA|7a5ae465-03b9-4006-a29e-94822ed857aa|9|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|kHz|[?]|1|U/10^12 RBC|LUMBAR SPINE|UNILATERAL|Y||FRIEND|5|Visit_5|90|1|TREATMENT|2020-09-20|90
e|FA|7a5ae465-03b9-4006-a29e-94822ed857aa|10|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|amol|[?]|1|mL/cm3/min|CORNEAL EPITHELIUM|IPSILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|1|FOLLOW-UP|2020-09-20|90
e|FA|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|1|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|kcal|[?]|1|EIA unit|COCCYGEAL VERTEBRA|LATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|6|WASHOUT|2020-09-22|10
e|FA|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|2|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|fL|[?]|1|BOWL|TRIGEMINAL NERVE|BILATERAL||Y|CAREGIVER|1|Visit_1|10|2|TREATMENT|2020-09-22|10
e|FA|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|3|EVENTNUM|Number of Events|[?]|GERD|[?]|h/wk|[?]|1|U/10^12 RBC|HEPATOBILIARY SYSTEM|UNILATERAL|Y||CHILD|2|Visit_2|25|2|WASHOUT|2020-10-07|25
e|FA|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|4|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|s/h|[?]|1|DROP|PARACOLIC GUTTER|CONTRALATERAL|||VENDOR|2|Visit_2|25|3|TREATMENT|2020-10-07|25
e|FA|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|5|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|nkat/g Hb|[?]|1|oz eq|TRIANGULAR-HAMATE JOINT|IPSILATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|5|WASHOUT|2020-10-22|40
e|FA|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|6|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|/kg|[?]|1|/kg|URETHRA, ANTERIOR|IPSILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-10-22|40
e|FA|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|7|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|Watt|[?]|1|BAG|NUCLEUS ACCUMBENS|IPSILATERAL|||VENDOR|4|Visit_4|65|6|WASHOUT|2020-11-16|65
e|FA|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|8|EXCDUR|Exercise Duration|[?]|GERD|[?]|TRANSDUCING UNIT|[?]|1|mm|SUPERFICIAL FEMORAL ARTERY|LATERAL||Y|SPOUSE|4|Visit_4|65|1|TREATMENT|2020-11-16|65
e|FA|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|9|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|L/L|[?]|1|HOURS|SPLENIC LYMPH NODE|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-12-11|90
e|FA|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|10|OBJTYPE|Type of Object|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|ng|EPIDIDYMIS|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|SCREENING|2020-12-11|90
e|FA|2e4cd860-734a-40b0-bde5-ca08297415a9|1|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|QUANTITY SUFFICIENT|[?]|1|DRUM|PROXIMAL CIRCUMFLEX ARTERY|UNILATERAL|||SPOUSE|1|Visit_1|10|4|SCREENING|2020-11-25|10
e|FA|2e4cd860-734a-40b0-bde5-ca08297415a9|2|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|FIU|[?]|1|vp/dose|SKIN OF THE CHIN|IPSILATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|4|FOLLOW-UP|2020-11-25|10
e|FA|2e4cd860-734a-40b0-bde5-ca08297415a9|3|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|s*kPa|[?]|1|CUP|ANASTOMOSIS|UNILATERAL||Y|SPOUSE|2|Visit_2|25|5|TREATMENT|2020-12-10|25
e|FA|2e4cd860-734a-40b0-bde5-ca08297415a9|4|DMEAT|Dietary Meat|[?]|GERD|[?]|10^3 organisms/mL|[?]|1|10^6 organisms/mL|HUMERUS SHAFT|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2020-12-10|25
e|FA|2e4cd860-734a-40b0-bde5-ca08297415a9|5|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|fmol|[?]|1|IU/mg|VASTUS INTERMEDIUS MUSCLE|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-12-25|40
e|FA|2e4cd860-734a-40b0-bde5-ca08297415a9|6|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|PHERESIS UNIT|[?]|1|vp/dose|RIB 11|IPSILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2020-12-25|40
e|FA|2e4cd860-734a-40b0-bde5-ca08297415a9|7|AGETRT1|Age At First Treatment|[?]|GERD|[?]|mg/day|[?]|1|mL/mmHg/min/L|NAIL|CONTRALATERAL|Y||FRIEND|4|Visit_4|65|6|TREATMENT|2021-01-19|65
e|FA|2e4cd860-734a-40b0-bde5-ca08297415a9|8|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|g/L|PALPEBRAL CONJUNCTIVA|CONTRALATERAL|Y|Y|PROXY|4|Visit_4|65|7|WASHOUT|2021-01-19|65
e|FA|2e4cd860-734a-40b0-bde5-ca08297415a9|9|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|amu|[?]|1|BOWL|POPLITEAL ARTERY BELOW KNEE|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|FOLLOW-UP|2021-02-13|90
e|FA|2e4cd860-734a-40b0-bde5-ca08297415a9|10|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|Ci/ug|[?]|1|/500 WBC|LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT|BILATERAL|Y||SIBLING|5|Visit_5|90|2|TREATMENT|2021-02-13|90
e|FA|3f1854fb-d14e-4699-888b-d5042fa9327c|1|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|SACHET|[?]|1|U/10^12 RBC|SACRAL TUBEROSITY|CONTRALATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|5|TREATMENT|2020-08-04|10
e|FA|3f1854fb-d14e-4699-888b-d5042fa9327c|2|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|L/day|[?]|1|10^6 U|ACHILLES TENDON|UNILATERAL|||SIBLING|1|Visit_1|10|5|FOLLOW-UP|2020-08-04|10
e|FA|3f1854fb-d14e-4699-888b-d5042fa9327c|3|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|cpm|[?]|1|mAmp|INTERPHALANGEAL JOINT 5|IPSILATERAL|||INTERVIEWER|2|Visit_2|25|5|SCREENING|2020-08-19|25
e|FA|3f1854fb-d14e-4699-888b-d5042fa9327c|4|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|cy/cm|[?]|1|g/L|PULMONARY ARTERY BRANCH|BILATERAL|||FAMILY MEMBER|2|Visit_2|25|3|FOLLOW-UP|2020-08-19|25
e|FA|3f1854fb-d14e-4699-888b-d5042fa9327c|5|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|10^6 organisms|[?]|1|MPS U|ILEUM|LATERAL|Y|Y|INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2020-09-03|40
e|FA|3f1854fb-d14e-4699-888b-d5042fa9327c|6|DFRUIT|Dietary Fruit|[?]|GERD|[?]|U.CARR|[?]|1|10^6 CFU/mL|NUCHAL LYMPH NODE|LATERAL||Y|FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2020-09-03|40
e|FA|3f1854fb-d14e-4699-888b-d5042fa9327c|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/kg|[?]|1|Pa|PROXIMAL PHALANX 4 OF THE HAND|CONTRALATERAL|||FAMILY MEMBER|4|Visit_4|65|7|TREATMENT|2020-09-28|65
e|FA|3f1854fb-d14e-4699-888b-d5042fa9327c|8|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|EID 50/dose|[?]|1|cm H2O|ILEUM, TERMINAL|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|WASHOUT|2020-09-28|65
e|FA|3f1854fb-d14e-4699-888b-d5042fa9327c|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|cg|[?]|1|10^6 IU/mL|LIP|CONTRALATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-10-23|90
e|FA|3f1854fb-d14e-4699-888b-d5042fa9327c|10|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|%(w/w)|[?]|1|NEEDLE GAUGE|LUNG, RIGHT MIDDLE LOBE|LEFT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-10-23|90
e|FA|f6e37eba-e224-47f3-baa0-59dfdfb47b70|1|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|POINT|[?]|1|fmol|ARM SKIN|CONTRALATERAL|Y||VENDOR|1|Visit_1|10|4|WASHOUT|2020-12-10|10
e|FA|f6e37eba-e224-47f3-baa0-59dfdfb47b70|2|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/L|[?]|1|NEEDLE GAUGE|AXILLARY ARTERY|LEFT|||SIBLING|1|Visit_1|10|1|TREATMENT|2020-12-10|10
e|FA|f6e37eba-e224-47f3-baa0-59dfdfb47b70|3|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|ukat/10^12 RBC|[?]|1|10^6 CFU/mL|UPPER URINARY SYSTEM|LEFT|||GUARDIAN|2|Visit_2|25|2|TREATMENT|2020-12-25|25
e|FA|f6e37eba-e224-47f3-baa0-59dfdfb47b70|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|pL|[?]|1|%(v/v)|ILIAC LYMPH NODE|LATERAL|Y||CAREGIVER|2|Visit_2|25|7|TREATMENT|2020-12-25|25
e|FA|f6e37eba-e224-47f3-baa0-59dfdfb47b70|5|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|CIGARETTE|[?]|1|DROP|LUNG LOBE|LATERAL||Y|SPOUSE|3|Visit_3|40|6|TREATMENT|2021-01-09|40
e|FA|f6e37eba-e224-47f3-baa0-59dfdfb47b70|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ug/kg/day|[?]|1|%(v/v)|AORTIC VALVE, NON-CORONARY CUSP|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|WASHOUT|2021-01-09|40
e|FA|f6e37eba-e224-47f3-baa0-59dfdfb47b70|7|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|umol/kg/min|[?]|1|m2|MIDDLE PHALANX 2 OF THE HAND|RIGHT|||PROXY|4|Visit_4|65|4|TREATMENT|2021-02-03|65
e|FA|f6e37eba-e224-47f3-baa0-59dfdfb47b70|8|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|/sec|[?]|1|IU/mmol|FACIAL NERVE|LATERAL|||INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2021-02-03|65
e|FA|f6e37eba-e224-47f3-baa0-59dfdfb47b70|9|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|copies/mL|[?]|1|QUANTITY SUFFICIENT|CERVIX UTERI|LATERAL|Y|Y|DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2021-02-28|90
e|FA|f6e37eba-e224-47f3-baa0-59dfdfb47b70|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|Ci/L|[?]|1|U/mg|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|4|FOLLOW-UP|2021-02-28|90
e|FA|8298b45d-16ff-42ef-8404-0f3ce628f9e5|1|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|g/kg|[?]|1|/500 WBC|SKIN OF THE AXILLA|LATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|1|TREATMENT|2020-07-31|10
e|FA|8298b45d-16ff-42ef-8404-0f3ce628f9e5|2|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|10^12/L|[?]|1|BOWL|BLADDER, FUNDUS|LEFT|||FRIEND|1|Visit_1|10|6|TREATMENT|2020-07-31|10
e|FA|8298b45d-16ff-42ef-8404-0f3ce628f9e5|3|SERVNUM|Number of Servings|[?]|GERD|[?]|ms/mmHg|[?]|1|Hz/s|MANDIBLE|CONTRALATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-08-15|25
e|FA|8298b45d-16ff-42ef-8404-0f3ce628f9e5|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT|[?]|1|mg/g/min|EYELID|CONTRALATERAL|||CHILD|2|Visit_2|25|1|SCREENING|2020-08-15|25
e|FA|8298b45d-16ff-42ef-8404-0f3ce628f9e5|5|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|U/L|[?]|1|PACK|LEG SKIN|UNILATERAL|||PROXY|3|Visit_3|40|5|TREATMENT|2020-08-30|40
e|FA|8298b45d-16ff-42ef-8404-0f3ce628f9e5|6|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|dB|[?]|1|ohm|GASTROINTESTINAL TRACT, WALL|LATERAL|||ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-08-30|40
e|FA|8298b45d-16ff-42ef-8404-0f3ce628f9e5|7|TRTSETT|Treatment Setting|[?]|GERD|[?]|um/s|[?]|1|Coulomb|RIB 7|UNILATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|5|FOLLOW-UP|2020-09-24|65
e|FA|8298b45d-16ff-42ef-8404-0f3ce628f9e5|8|LDIAM|Longest Diameter|[?]|GERD|[?]|umol|[?]|1|Shock Wave|HINDLIMB|BILATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-09-24|65
e|FA|8298b45d-16ff-42ef-8404-0f3ce628f9e5|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|CONTAINER|[?]|1|mg/g/min|MUCOSA|CONTRALATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|3|WASHOUT|2020-10-19|90
e|FA|8298b45d-16ff-42ef-8404-0f3ce628f9e5|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|IU/kg/h|[?]|1|%(v/v)|POSTERIOR SUPERIOR ILIAC SPINE|LATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|5|FOLLOW-UP|2020-10-19|90
e|FA|ee5c6623-5cb4-4f18-99b0-6373328abc1d|1|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|IU/mmol|[?]|1|10^6 CFU|CERVIX UTERI|LEFT|Y||VENDOR|1|Visit_1|10|1|TREATMENT|2020-06-11|10
e|FA|ee5c6623-5cb4-4f18-99b0-6373328abc1d|2|SEV|Severity/Intensity|[?]|GERD|[?]|HOMEOPATHIC DILUTION|[?]|1|Pa|SCAPHOID-LUNATE JOINT|LATERAL|Y||FRIEND|1|Visit_1|10|2|TREATMENT|2020-06-11|10
e|FA|ee5c6623-5cb4-4f18-99b0-6373328abc1d|3|DFRUIT|Dietary Fruit|[?]|GERD|[?]|10^6 copies/mL|[?]|1|10^6 CFU/mL|ATRIOVENTRICULAR VALVE|CONTRALATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|SCREENING|2020-06-26|25
e|FA|ee5c6623-5cb4-4f18-99b0-6373328abc1d|4|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|EID 50/dose|[?]|1|Gy/h|PUBIC BONE|UNILATERAL|||INTERVIEWER|2|Visit_2|25|4|WASHOUT|2020-06-26|25
e|FA|ee5c6623-5cb4-4f18-99b0-6373328abc1d|5|RLDEV|Relationship to Device|[?]|GERD|[?]|log10 IU/mL|[?]|1|mL/min/mmHg|SIGMOID SINUS|LEFT|||SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2020-07-11|40
e|FA|ee5c6623-5cb4-4f18-99b0-6373328abc1d|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|umol/kg/min|[?]|1|%(v/v)|EAR, OUTER|LEFT|||PARENT|3|Visit_3|40|3|SCREENING|2020-07-11|40
e|FA|ee5c6623-5cb4-4f18-99b0-6373328abc1d|7|LOCONSET|Localization of Onset|[?]|GERD|[?]|mm/min|[?]|1|g/L|AXILLARY VEIN|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-08-05|65
e|FA|ee5c6623-5cb4-4f18-99b0-6373328abc1d|8|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|foz_us|[?]|1|mL/mmHg/min/L|ANKLE JOINT ANTERIOR FLEXOR TENDONS|CONTRALATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|4|WASHOUT|2020-08-05|65
e|FA|ee5c6623-5cb4-4f18-99b0-6373328abc1d|9|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|mol/L|[?]|1|DRUM|GREATER CURVATURE OF THE STOMACH|RIGHT|||SIGNIFICANT OTHER|5|Visit_5|90|6|SCREENING|2020-08-30|90
e|FA|ee5c6623-5cb4-4f18-99b0-6373328abc1d|10|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|uU/L|[?]|1|mg/h|AORTIC VALVE ANNULUS|CONTRALATERAL|Y||SPOUSE|5|Visit_5|90|3|TREATMENT|2020-08-30|90
e|FA|f8d6576b-b300-4c5f-8f5a-6bb35250d576|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|PATCH|[?]|1|CUP|GUT-ASSOCIATED LYMPHOID TISSUE|LATERAL|||FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2020-06-25|10
e|FA|f8d6576b-b300-4c5f-8f5a-6bb35250d576|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|pptr|[?]|1|mEq/g|GASTROINTESTINAL TRACT|LEFT||Y|VENDOR|1|Visit_1|10|7|TREATMENT|2020-06-25|10
e|FA|f8d6576b-b300-4c5f-8f5a-6bb35250d576|3|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|FFU|[?]|1|DROP|TROCHANTER|BILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-07-10|25
e|FA|f8d6576b-b300-4c5f-8f5a-6bb35250d576|4|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|/day|[?]|1|/500 WBC|ISCHIUM|LATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2020-07-10|25
e|FA|f8d6576b-b300-4c5f-8f5a-6bb35250d576|5|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|GBq/ug|[?]|1|Shock Wave|NASOPHARYNX|BILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|FOLLOW-UP|2020-07-25|40
e|FA|f8d6576b-b300-4c5f-8f5a-6bb35250d576|6|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|VIAL|[?]|1|m2|PORTAL LYMPH NODE|IPSILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-07-25|40
e|FA|f8d6576b-b300-4c5f-8f5a-6bb35250d576|7|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|Sv|[?]|1|/200 HPFs|HAIR BULB|LATERAL|||SPOUSE|4|Visit_4|65|1|FOLLOW-UP|2020-08-19|65
e|FA|f8d6576b-b300-4c5f-8f5a-6bb35250d576|8|SEV|Severity/Intensity|[?]|GERD|[?]|scm|[?]|1|Pa|METACARPAL BONE 4|BILATERAL|Y|Y|PARENT|4|Visit_4|65|7|TREATMENT|2020-08-19|65
e|FA|f8d6576b-b300-4c5f-8f5a-6bb35250d576|9|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|cs|[?]|1|PACK|ANTERIOR SUPERIOR ILIAC SPINE|LEFT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-09-13|90
e|FA|f8d6576b-b300-4c5f-8f5a-6bb35250d576|10|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|EIA unit|[?]|1|IU/mmol|PALATINE BONE|BILATERAL||Y|CAREGIVER|5|Visit_5|90|6|TREATMENT|2020-09-13|90
e|FA|8635a6b3-d16e-432c-90bf-53f1494dbe5e|1|SEV|Severity/Intensity|[?]|GERD|[?]|/10^4|[?]|1|Pa|LATERAL FIRST DIAGONAL BRANCH ARTERY|LATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|FOLLOW-UP|2020-10-26|10
e|FA|8635a6b3-d16e-432c-90bf-53f1494dbe5e|2|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|MHz|[?]|1|MBq|RAPHE|LATERAL||Y|CHILD|1|Visit_1|10|5|SCREENING|2020-10-26|10
e|FA|8635a6b3-d16e-432c-90bf-53f1494dbe5e|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|VOXEL|[?]|1|Pa|METATARSAL BONE|UNILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-11-10|25
e|FA|8635a6b3-d16e-432c-90bf-53f1494dbe5e|4|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|mV/sec|[?]|1|SACHET|HILAR|RIGHT|Y||PARENT|2|Visit_2|25|7|TREATMENT|2020-11-10|25
e|FA|8635a6b3-d16e-432c-90bf-53f1494dbe5e|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|ug/g/h|LOWER RESPIRATORY SYSTEM|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-11-25|40
e|FA|8635a6b3-d16e-432c-90bf-53f1494dbe5e|6|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|POINT|[?]|1|HOURS|JEJUNUM|IPSILATERAL|Y||VENDOR|3|Visit_3|40|3|WASHOUT|2020-11-25|40
e|FA|8635a6b3-d16e-432c-90bf-53f1494dbe5e|7|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|days/wk|[?]|1|mEq|METACARPAL BONE 1|UNILATERAL|Y|Y|PARENT|4|Visit_4|65|7|FOLLOW-UP|2020-12-20|65
e|FA|8635a6b3-d16e-432c-90bf-53f1494dbe5e|8|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|U/kg|[?]|1|PACK|CARDIAC WALL|RIGHT|||SPOUSE|4|Visit_4|65|5|SCREENING|2020-12-20|65
e|FA|8635a6b3-d16e-432c-90bf-53f1494dbe5e|9|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|GBq/mg|[?]|1|10^6 organisms/mL|EYE, VITREOUS CHAMBER|IPSILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|SCREENING|2021-01-14|90
e|FA|8635a6b3-d16e-432c-90bf-53f1494dbe5e|10|EXTRSCT|Extent of Resection|[?]|GERD|[?]|10^6 organisms/g|[?]|1|Weber|HYMENAL RING|RIGHT|Y|Y|SIBLING|5|Visit_5|90|7|TREATMENT|2021-01-14|90
e|FA|2cda4297-410a-49e4-949c-deb3dc4c6656|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/min|[?]|1|Pa|METACARPOPHALANGEAL JOINT 5|CONTRALATERAL|||CHILD|1|Visit_1|10|4|TREATMENT|2020-06-20|10
e|FA|2cda4297-410a-49e4-949c-deb3dc4c6656|2|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|Roentgen|[?]|1|Coulomb|ILIAC LYMPH NODE|IPSILATERAL|||GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-06-20|10
e|FA|2cda4297-410a-49e4-949c-deb3dc4c6656|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|fraction of 1|[?]|1|Pa|INTERNAL MAMMARY LYMPH NODE|CONTRALATERAL|||INTERVIEWER|2|Visit_2|25|5|WASHOUT|2020-07-05|25
e|FA|2cda4297-410a-49e4-949c-deb3dc4c6656|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|GPL U/mL|[?]|1|ug/g/h|COMMON FEMORAL VEIN|LEFT||Y|FRIEND|2|Visit_2|25|3|SCREENING|2020-07-05|25
e|FA|2cda4297-410a-49e4-949c-deb3dc4c6656|5|DGRAIN|Dietary Grain|[?]|GERD|[?]|OI50|[?]|1|10^9 CFU/g|URETHRA, ANTERIOR|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|WASHOUT|2020-07-20|40
e|FA|2cda4297-410a-49e4-949c-deb3dc4c6656|6|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|dpm/mg|[?]|1|mL/h|CORPUS UTERI|LEFT|||VENDOR|3|Visit_3|40|4|TREATMENT|2020-07-20|40
e|FA|2cda4297-410a-49e4-949c-deb3dc4c6656|7|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|ng/dL|[?]|1|10^9 CFU/g|MUSCLE|CONTRALATERAL|||FRIEND|4|Visit_4|65|7|FOLLOW-UP|2020-08-14|65
e|FA|2cda4297-410a-49e4-949c-deb3dc4c6656|8|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|/kg|POSTERIOR CINGULATE CORTEX|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-08-14|65
e|FA|2cda4297-410a-49e4-949c-deb3dc4c6656|9|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/L|[?]|1|mIU/L|CLAVICLE|CONTRALATERAL|Y||SPOUSE|5|Visit_5|90|3|TREATMENT|2020-09-08|90
e|FA|2cda4297-410a-49e4-949c-deb3dc4c6656|10|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|pmol/10^9 cells|[?]|1|10^6/L|SKIN OF THE LIP|LATERAL|||STUDY SUBJECT|5|Visit_5|90|5|WASHOUT|2020-09-08|90
e|FA|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|Ejaculate U|[?]|1|L|JEJUNUM|IPSILATERAL||Y|FRIEND|1|Visit_1|10|4|WASHOUT|2021-01-29|10
e|FA|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|2|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|vg/mL|[?]|1|mm/h|FEMORO-POPLITEAL PERIPHERAL ARTERY|RIGHT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|SCREENING|2021-01-29|10
e|FA|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|3|SEV|Severity/Intensity|[?]|GERD|[?]|10^5/L|[?]|1|Pa|FLEXOR DIGITORUM LONGUS MUSCLE|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|FOLLOW-UP|2021-02-13|25
e|FA|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Bq/L|[?]|1|mg/g/min|PYLORIC SPHINCTER|LATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|1|SCREENING|2021-02-13|25
e|FA|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|5|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/uL|[?]|1|vp/dose|HEPATIC VEIN|IPSILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2021-02-28|40
e|FA|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|6|DGRAIN|Dietary Grain|[?]|GERD|[?]|U/mg|[?]|1|10^9 CFU/g|T12 VERTEBRA|CONTRALATERAL||Y|SIBLING|3|Visit_3|40|2|WASHOUT|2021-02-28|40
e|FA|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|7|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|usec|[?]|1|Shock Wave|INFERIOR VENA CAVA|BILATERAL|Y||SPOUSE|4|Visit_4|65|6|SCREENING|2021-03-25|65
e|FA|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|8|DMEAT|Dietary Meat|[?]|GERD|[?]|U/kg/min|[?]|1|10^6 organisms/mL|LATERAL THIRD DIAGONAL BRANCH ARTERY|RIGHT|Y|Y|CHILD|4|Visit_4|65|7|TREATMENT|2021-03-25|65
e|FA|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|9|DCAL|Dietary Calories|[?]|GERD|[?]|mU|[?]|1|EIA unit|SPLEEN|BILATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|1|WASHOUT|2021-04-19|90
e|FA|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|10|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|DROP|ESOPHAGEAL LYMPH NODE|LEFT|Y||VENDOR|5|Visit_5|90|4|SCREENING|2021-04-19|90
e|FA|9e82141b-e2b9-42c7-b813-b79bda2bd216|1|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|/MBP|[?]|1|MBq|TIBIALIS ANTERIOR MUSCLE|RIGHT||Y|CHILD|1|Visit_1|10|7|TREATMENT|2020-05-31|10
e|FA|9e82141b-e2b9-42c7-b813-b79bda2bd216|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/dose|[?]|1|mg/g/min|FACIAL BONE|UNILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-05-31|10
e|FA|9e82141b-e2b9-42c7-b813-b79bda2bd216|3|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|amu|[?]|1|AU/mL|URETERIC ORIFICE|BILATERAL|||STUDY SUBJECT|2|Visit_2|25|3|FOLLOW-UP|2020-06-15|25
e|FA|9e82141b-e2b9-42c7-b813-b79bda2bd216|4|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|ug/kg/min|[?]|1|mm|BLADDER, TRIGONE|LEFT|Y|Y|PARENT|2|Visit_2|25|3|WASHOUT|2020-06-15|25
e|FA|9e82141b-e2b9-42c7-b813-b79bda2bd216|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|tsp|[?]|1|%(v/v)|ACETABULUM|RIGHT|||ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-06-30|40
e|FA|9e82141b-e2b9-42c7-b813-b79bda2bd216|6|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|/sec|[?]|1|ug/kg/h|DISTAL RADIOULNAR JOINT|UNILATERAL|||CHILD|3|Visit_3|40|4|TREATMENT|2020-06-30|40
e|FA|9e82141b-e2b9-42c7-b813-b79bda2bd216|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|sec|[?]|1|U/mmol|L5-S1 INTERVERTEBRAL SPACE|UNILATERAL|||FAMILY MEMBER|4|Visit_4|65|4|WASHOUT|2020-07-25|65
e|FA|9e82141b-e2b9-42c7-b813-b79bda2bd216|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|Farad|[?]|1|%(v/v)|TONSIL|RIGHT|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2020-07-25|65
e|FA|9e82141b-e2b9-42c7-b813-b79bda2bd216|9|DIAMETER|Diameter|[?]|GERD|[?]|PIXELS/in|[?]|1|cm|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|UNILATERAL|||FRIEND|5|Visit_5|90|2|FOLLOW-UP|2020-08-19|90
e|FA|9e82141b-e2b9-42c7-b813-b79bda2bd216|10|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|IU/g Hb|[?]|1|gtt|SALIVARY GLAND|UNILATERAL|||PROXY|5|Visit_5|90|7|WASHOUT|2020-08-19|90
e|FA|4b432c61-c620-4c5e-8aad-411facc0f4db|1|SEV|Severity/Intensity|[?]|GERD|[?]|cy/cm|[?]|1|Pa|T7 VERTEBRA|LEFT||Y|VENDOR|1|Visit_1|10|6|WASHOUT|2020-09-14|10
e|FA|4b432c61-c620-4c5e-8aad-411facc0f4db|2|SPEED|Speed|[?]|GERD|[?]|/ms|[?]|1|mEq/g|OVARIAN FOLLICLE|LATERAL|||CHILD|1|Visit_1|10|4|TREATMENT|2020-09-14|10
e|FA|4b432c61-c620-4c5e-8aad-411facc0f4db|3|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|g/U|[?]|1|mL/animal/day|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|LEFT|||SIGNIFICANT OTHER|2|Visit_2|25|7|SCREENING|2020-09-29|25
e|FA|4b432c61-c620-4c5e-8aad-411facc0f4db|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|mg/g/min|HEART, RIGHT VENTRICLE|UNILATERAL|||STUDY SUBJECT|2|Visit_2|25|7|FOLLOW-UP|2020-09-29|25
e|FA|4b432c61-c620-4c5e-8aad-411facc0f4db|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|PRESSOR UNITS|[?]|1|mg/g/min|HAND DIGIT 3|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|2|WASHOUT|2020-10-14|40
e|FA|4b432c61-c620-4c5e-8aad-411facc0f4db|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cm/s|[?]|1|mg/g/min|EYE, VITREOUS CHAMBER|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|SCREENING|2020-10-14|40
e|FA|4b432c61-c620-4c5e-8aad-411facc0f4db|7|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|Bq/L|OBTURATOR INTERNUS MUSCLE|LEFT|||INTERVIEWER|4|Visit_4|65|2|TREATMENT|2020-11-08|65
e|FA|4b432c61-c620-4c5e-8aad-411facc0f4db|8|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|ug/L/h|[?]|1|L|SKULL|IPSILATERAL|Y||GUARDIAN|4|Visit_4|65|6|WASHOUT|2020-11-08|65
e|FA|4b432c61-c620-4c5e-8aad-411facc0f4db|9|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|V|[?]|1|g/dL|LIVER FISSURE|IPSILATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2020-12-03|90
e|FA|4b432c61-c620-4c5e-8aad-411facc0f4db|10|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|%|[?]|1|10^6 CFU/mL|SOFT TISSUE|IPSILATERAL|||CAREGIVER|5|Visit_5|90|7|TREATMENT|2020-12-03|90
e|FA|1a1e6863-26da-4b5d-b82a-5703e3e9056e|1|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|CARTRIDGE|[?]|1|Log10 ELISA unit|SCAPHOID-LUNATE JOINT|UNILATERAL|||CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-12-26|10
e|FA|1a1e6863-26da-4b5d-b82a-5703e3e9056e|2|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|gpELISA unit/mL|[?]|1|Hz/s|CAPITATE-HAMATE JOINT|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|TREATMENT|2020-12-26|10
e|FA|1a1e6863-26da-4b5d-b82a-5703e3e9056e|3|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|bel|[?]|1|mL/dose|GREAT VESSELS|CONTRALATERAL|Y||FRIEND|2|Visit_2|25|4|TREATMENT|2021-01-10|25
e|FA|1a1e6863-26da-4b5d-b82a-5703e3e9056e|4|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|10^9 organisms|[?]|1|anti-Xa IU/mL|CRANIAL CAVITY|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2021-01-10|25
e|FA|1a1e6863-26da-4b5d-b82a-5703e3e9056e|5|TOTNUM|Total Number|[?]|GERD|[?]|PNU/mL|[?]|1|/200 HPFs|ESOPHAGUS, UPPER THIRD|BILATERAL|||VENDOR|3|Visit_3|40|2|FOLLOW-UP|2021-01-25|40
e|FA|1a1e6863-26da-4b5d-b82a-5703e3e9056e|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|/mm2|[?]|1|mg/g/min|L1 VERTEBRA|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|FOLLOW-UP|2021-01-25|40
e|FA|1a1e6863-26da-4b5d-b82a-5703e3e9056e|7|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|rpm|[?]|1|g/cage/day|SHOULDER|BILATERAL|Y|Y|SPOUSE|4|Visit_4|65|3|FOLLOW-UP|2021-02-19|65
e|FA|1a1e6863-26da-4b5d-b82a-5703e3e9056e|8|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|IU/kg/h|[?]|1|10^4 CFU/mL|NOSE|IPSILATERAL|Y||CHILD|4|Visit_4|65|7|TREATMENT|2021-02-19|65
e|FA|1a1e6863-26da-4b5d-b82a-5703e3e9056e|9|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|uIU/dL|[?]|1|U/mg|ANTERIOR HORN OF THE LATERAL VENTRICLE|LATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|WASHOUT|2021-03-16|90
e|FA|1a1e6863-26da-4b5d-b82a-5703e3e9056e|10|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|mg/g/min|[?]|1|mEq|HUMERAL EPICONDYLE|RIGHT|||INTERVIEWER|5|Visit_5|90|4|SCREENING|2021-03-16|90
e|FA|8c8053d1-adae-4d45-870e-cf4ad2475c74|1|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|uIU/dL|[?]|1|umol|BODY|BILATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|3|WASHOUT|2020-05-11|10
e|FA|8c8053d1-adae-4d45-870e-cf4ad2475c74|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/beat|[?]|1|mg/g/min|LEFT ATRIOVENTRICULAR ARTERY|LEFT|||PROXY|1|Visit_1|10|3|FOLLOW-UP|2020-05-11|10
e|FA|8c8053d1-adae-4d45-870e-cf4ad2475c74|3|ESTWT|Estimated Weight|[?]|GERD|[?]|ukat/10^12 RBC|[?]|1|g/day|RETROPERITONEUM|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|3|FOLLOW-UP|2020-05-26|25
e|FA|8c8053d1-adae-4d45-870e-cf4ad2475c74|4|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|GBq|[?]|1|in|BLOOD|LEFT||Y|DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2020-05-26|25
e|FA|8c8053d1-adae-4d45-870e-cf4ad2475c74|5|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|10^8 PFU|[?]|1|mL/100g/min|GASTROINTESTINAL TRACT, UPPER, WALL|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|5|FOLLOW-UP|2020-06-10|40
e|FA|8c8053d1-adae-4d45-870e-cf4ad2475c74|6|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|nCi|[?]|1|oz eq|ATRIOVENTRICULAR VALVE|LEFT|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|2|SCREENING|2020-06-10|40
e|FA|8c8053d1-adae-4d45-870e-cf4ad2475c74|7|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|10^6 CFU|HEEL OF THE FOOT|IPSILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|3|WASHOUT|2020-07-05|65
e|FA|8c8053d1-adae-4d45-870e-cf4ad2475c74|8|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|kg/m2|[?]|1|Bq/mg|HAND DIGIT 4|BILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|FOLLOW-UP|2020-07-05|65
e|FA|8c8053d1-adae-4d45-870e-cf4ad2475c74|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mol/g|[?]|1|Pa|LINGULA OF THE LUNG|RIGHT||Y|PROXY|5|Visit_5|90|7|WASHOUT|2020-07-30|90
e|FA|8c8053d1-adae-4d45-870e-cf4ad2475c74|10|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|10^7 PFU|[?]|1|IU/mmol|CARPOMETACARPAL JOINT|UNILATERAL|||CHILD|5|Visit_5|90|4|TREATMENT|2020-07-30|90
e|FA|c3b911a8-116e-4940-80a2-7128db004f4a|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|dyn|[?]|1|mg/g/min|L3 VERTEBRA|IPSILATERAL|Y|Y|ADJUDICATOR|1|Visit_1|10|3|SCREENING|2020-11-19|10
e|FA|c3b911a8-116e-4940-80a2-7128db004f4a|2|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|Arbitrary U|[?]|1|h*%|HINDLIMB|UNILATERAL|Y||GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-11-19|10
e|FA|c3b911a8-116e-4940-80a2-7128db004f4a|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|gMFI|[?]|1|%(v/v)|METATARSOPHALANGEAL JOINT 5|RIGHT|||INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-12-04|25
e|FA|c3b911a8-116e-4940-80a2-7128db004f4a|4|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|pmol/g|[?]|1|mL/h|UTERINE ARTERY|LATERAL|||FRIEND|2|Visit_2|25|7|WASHOUT|2020-12-04|25
e|FA|c3b911a8-116e-4940-80a2-7128db004f4a|5|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|ug/kg/min|[?]|1|MPS U|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|RIGHT|||FAMILY MEMBER|3|Visit_3|40|7|WASHOUT|2020-12-19|40
e|FA|c3b911a8-116e-4940-80a2-7128db004f4a|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|CYLINDER|[?]|1|Pa|HEEL OF THE FOOT|LATERAL|||STUDY SUBJECT|3|Visit_3|40|6|WASHOUT|2020-12-19|40
e|FA|c3b911a8-116e-4940-80a2-7128db004f4a|7|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|10^6 U|UMBILICUS|IPSILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|6|WASHOUT|2021-01-13|65
e|FA|c3b911a8-116e-4940-80a2-7128db004f4a|8|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|Shock Wave|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2021-01-13|65
e|FA|c3b911a8-116e-4940-80a2-7128db004f4a|9|DMG|Dietary Magnesium|[?]|GERD|[?]|mJoule/cm2|[?]|1|TRANSDUCING UNIT/mL|MESENTERIC VEIN|LATERAL|||STUDY SUBJECT|5|Visit_5|90|5|WASHOUT|2021-02-07|90
e|FA|c3b911a8-116e-4940-80a2-7128db004f4a|10|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|U/kg/day|[?]|1|m2|MUCOSA|LATERAL||Y|GUARDIAN|5|Visit_5|90|5|SCREENING|2021-02-07|90
e|FA|401d66ba-bc00-4495-ba5d-796068dd1fd6|1|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|cmH2O/mL|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|BILATERAL|||INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-06-11|10
e|FA|401d66ba-bc00-4495-ba5d-796068dd1fd6|2|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|umol|METACARPOPHALANGEAL JOINT 2|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|FOLLOW-UP|2020-06-11|10
e|FA|401d66ba-bc00-4495-ba5d-796068dd1fd6|3|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|log10 PFU/mL|[?]|1|uCi/kg|FEMORAL NECK|BILATERAL||Y|INTERVIEWER|2|Visit_2|25|4|WASHOUT|2020-06-26|25
e|FA|401d66ba-bc00-4495-ba5d-796068dd1fd6|4|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|BU/mL|[?]|1|mg/dose|DORSALIS PEDIS ARTERY|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2020-06-26|25
e|FA|401d66ba-bc00-4495-ba5d-796068dd1fd6|5|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|Bq/kg|[?]|1|Ci/ug|ORAL CAVITY|LEFT||Y|FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-07-11|40
e|FA|401d66ba-bc00-4495-ba5d-796068dd1fd6|6|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|s/h|[?]|1|HOURS|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|LATERAL|Y||SIBLING|3|Visit_3|40|7|TREATMENT|2020-07-11|40
e|FA|401d66ba-bc00-4495-ba5d-796068dd1fd6|7|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mV2/Hz|[?]|1|Weber|VERTEBRAL ARTERY|LEFT|||INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2020-08-05|65
e|FA|401d66ba-bc00-4495-ba5d-796068dd1fd6|8|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|mL*cmH2O|[?]|1|ug/g/h|FORELIMB|LATERAL||Y|PROXY|4|Visit_4|65|4|TREATMENT|2020-08-05|65
e|FA|401d66ba-bc00-4495-ba5d-796068dd1fd6|9|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mol/mL|[?]|1|10^6 U|MEDIAN BASILIC VEIN|IPSILATERAL|Y||FRIEND|5|Visit_5|90|3|TREATMENT|2020-08-30|90
e|FA|401d66ba-bc00-4495-ba5d-796068dd1fd6|10|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|umol|LESSER TROCHANTER|CONTRALATERAL|||DOMESTIC PARTNER|5|Visit_5|90|2|SCREENING|2020-08-30|90
e|FA|f8113725-4deb-48a1-876a-ba168a6d2cee|1|CALBURN|Calories Burned|[?]|GERD|[?]|10^6/L|[?]|1|/kg|PERONEAL ARTERY|UNILATERAL|Y|Y|CAREGIVER|1|Visit_1|10|4|TREATMENT|2021-01-22|10
e|FA|f8113725-4deb-48a1-876a-ba168a6d2cee|2|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|Ci/mL|[?]|1|QUANTITY SUFFICIENT|CAUDAL VERTEBRA|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|6|WASHOUT|2021-01-22|10
e|FA|f8113725-4deb-48a1-876a-ba168a6d2cee|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|nmol/L|[?]|1|Pa|PERONEAL ARTERY|LATERAL|Y||INVESTIGATOR|2|Visit_2|25|7|SCREENING|2021-02-06|25
e|FA|f8113725-4deb-48a1-876a-ba168a6d2cee|4|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|rpm|[?]|1|MPS U|APPENDIX|BILATERAL|||CHILD|2|Visit_2|25|4|FOLLOW-UP|2021-02-06|25
e|FA|f8113725-4deb-48a1-876a-ba168a6d2cee|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^12 IU/L|[?]|1|mg/g/min|VASTUS INTERMEDIUS MUSCLE|RIGHT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|SCREENING|2021-02-21|40
e|FA|f8113725-4deb-48a1-876a-ba168a6d2cee|6|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|nmol/L/h|[?]|1|g/day|FEMORO-POPLITEAL PERIPHERAL ARTERY|IPSILATERAL|||PROXY|3|Visit_3|40|3|TREATMENT|2021-02-21|40
e|FA|f8113725-4deb-48a1-876a-ba168a6d2cee|7|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|mm/h|SKIN OF THE BUTTOCK|LEFT|Y||SIBLING|4|Visit_4|65|5|TREATMENT|2021-03-18|65
e|FA|f8113725-4deb-48a1-876a-ba168a6d2cee|8|DVEG|Dietary Vegetable|[?]|GERD|[?]|BAR|[?]|1|Ci/ug|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|RIGHT||Y|INVESTIGATOR|4|Visit_4|65|3|FOLLOW-UP|2021-03-18|65
e|FA|f8113725-4deb-48a1-876a-ba168a6d2cee|9|DFIBER|Dietary Fiber|[?]|GERD|[?]|FINGERTIP UNIT|[?]|1|h*%|SOLE|LEFT|||STUDY SUBJECT|5|Visit_5|90|6|SCREENING|2021-04-12|90
e|FA|f8113725-4deb-48a1-876a-ba168a6d2cee|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|L/min/m2|[?]|1|mL|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|LATERAL|Y||INTERVIEWER|5|Visit_5|90|6|FOLLOW-UP|2021-04-12|90
e|FA|f056c174-b6da-4df6-bf95-2e31911939fb|1|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|mL/min|[?]|1|mL/min/mmHg|ACCESSORY RENAL ARTERY|CONTRALATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-12-16|10
e|FA|f056c174-b6da-4df6-bf95-2e31911939fb|2|DISTANCE|Distance|[?]|GERD|[?]|mL/g/day|[?]|1|BOWL|INTERPHALANGEAL JOINT 1 OF THE FOOT|RIGHT|||SIBLING|1|Visit_1|10|2|TREATMENT|2020-12-16|10
e|FA|f056c174-b6da-4df6-bf95-2e31911939fb|3|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|DAgU|[?]|1|AU/mL|OCCIPITAL SCALP|BILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-12-31|25
e|FA|f056c174-b6da-4df6-bf95-2e31911939fb|4|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|ug/dL|[?]|1|fmol|PHARYNGEAL TONSIL|LATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|1|FOLLOW-UP|2020-12-31|25
e|FA|f056c174-b6da-4df6-bf95-2e31911939fb|5|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|genEq|[?]|1|gtt|LYMPH NODE|LATERAL|Y||VENDOR|3|Visit_3|40|3|TREATMENT|2021-01-15|40
e|FA|f056c174-b6da-4df6-bf95-2e31911939fb|6|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|mCi|[?]|1|mmHg/L/min|MUCOSA|LEFT|||CHILD|3|Visit_3|40|4|FOLLOW-UP|2021-01-15|40
e|FA|f056c174-b6da-4df6-bf95-2e31911939fb|7|PPTFCT|Precipitating Factor|[?]|GERD|[?]|mOsm/kg|[?]|1|EIA unit|MITRAL VALVE ANNULUS|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-02-09|65
e|FA|f056c174-b6da-4df6-bf95-2e31911939fb|8|DGRAIN|Dietary Grain|[?]|GERD|[?]|amu|[?]|1|10^9 CFU/g|MALE GENITALIA|BILATERAL|||INVESTIGATOR|4|Visit_4|65|2|FOLLOW-UP|2021-02-09|65
e|FA|f056c174-b6da-4df6-bf95-2e31911939fb|9|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|DPM|[?]|1|anti-Xa IU/mL|TOOTH|LEFT|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2021-03-06|90
e|FA|f056c174-b6da-4df6-bf95-2e31911939fb|10|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|g/L|PULMONARY ARTERY BRANCH|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|WASHOUT|2021-03-06|90
e|FA|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|1|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|/7.5 mL|[?]|1|U/mmol|PALPEBRAL CONJUNCTIVA|UNILATERAL|Y||ADJUDICATOR|1|Visit_1|10|2|SCREENING|2020-09-16|10
e|FA|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|2|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|10^7 PFU|[?]|1|ohm|MESENTERIC VEIN|LEFT||Y|SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-09-16|10
e|FA|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|3|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|U/dL|[?]|1|L|PULMONARY VALVE, ANTERIOR CUSP|IPSILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|4|SCREENING|2020-10-01|25
e|FA|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|4|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mL|[?]|1|mL/100g/min|DISTANT LYMPH NODE|UNILATERAL||Y|PROXY|2|Visit_2|25|4|FOLLOW-UP|2020-10-01|25
e|FA|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|5|EXTRSCT|Extent of Resection|[?]|GERD|[?]|ug/g/min|[?]|1|Weber|ILEUM, TERMINAL|RIGHT||Y|INVESTIGATOR|3|Visit_3|40|4|WASHOUT|2020-10-16|40
e|FA|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|6|PPTFCT|Precipitating Factor|[?]|GERD|[?]|Enzyme U|[?]|1|EIA unit|COLON, TRANSVERSE|BILATERAL|||FRIEND|3|Visit_3|40|5|TREATMENT|2020-10-16|40
e|FA|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|7|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|TROCHE|[?]|1|10^6 U|CARDIOVASCULAR SYSTEM|IPSILATERAL|Y|Y|SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-11-10|65
e|FA|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|8|CALBURN|Calories Burned|[?]|GERD|[?]|scm|[?]|1|/kg|ACCESSORY RENAL ARTERY|RIGHT|||SIBLING|4|Visit_4|65|3|TREATMENT|2020-11-10|65
e|FA|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|9|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|cm/min|[?]|1|EIA unit|COMMON FEMORAL VEIN|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2020-12-05|90
e|FA|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/h|[?]|1|mg/g/min|INTRATHORACIC LYMPH NODE|UNILATERAL|||FAMILY MEMBER|5|Visit_5|90|2|WASHOUT|2020-12-05|90
e|FA|57b7f30f-5f2a-425d-8bf2-fd5915cac481|1|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|h/wk|[?]|1|fmol|GANGLION|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|5|TREATMENT|2021-01-18|10
e|FA|57b7f30f-5f2a-425d-8bf2-fd5915cac481|2|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|10^4/L|[?]|1|Coulomb|EPIGASTRIC LYMPH NODE|BILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2021-01-18|10
e|FA|57b7f30f-5f2a-425d-8bf2-fd5915cac481|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|GBq/g|[?]|1|Shock Wave|INFERIOR PUBIC RAMUS|LATERAL|||STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2021-02-02|25
e|FA|57b7f30f-5f2a-425d-8bf2-fd5915cac481|4|LOCONSET|Localization of Onset|[?]|GERD|[?]|DPM|[?]|1|g/L|PAROTID GLAND|RIGHT|Y||CAREGIVER|2|Visit_2|25|4|TREATMENT|2021-02-02|25
e|FA|57b7f30f-5f2a-425d-8bf2-fd5915cac481|5|OBJTYPE|Type of Object|[?]|GERD|[?]|Absorbance U/min|[?]|1|ng|INTERPHALANGEAL JOINT 5 OF THE HAND|UNILATERAL|Y|Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|WASHOUT|2021-02-17|40
e|FA|57b7f30f-5f2a-425d-8bf2-fd5915cac481|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|dpm/mg|[?]|1|%(v/v)|ATRIOVENTRICULAR VALVE|BILATERAL|||FAMILY MEMBER|3|Visit_3|40|2|FOLLOW-UP|2021-02-17|40
e|FA|57b7f30f-5f2a-425d-8bf2-fd5915cac481|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/g|[?]|1|mg/g/min|LIMB, UPPER|BILATERAL||Y|FRIEND|4|Visit_4|65|1|SCREENING|2021-03-14|65
e|FA|57b7f30f-5f2a-425d-8bf2-fd5915cac481|8|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|min|[?]|1|TRANSDUCING UNIT/mL|INSULAR CORTEX|RIGHT||Y|INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2021-03-14|65
e|FA|57b7f30f-5f2a-425d-8bf2-fd5915cac481|9|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|10^3/hpf|[?]|1|mm/h|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|FOLLOW-UP|2021-04-08|90
e|FA|57b7f30f-5f2a-425d-8bf2-fd5915cac481|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mmHg*min/L|[?]|1|Pa|SKIN OF THE CHEST|CONTRALATERAL|Y|Y|INTERVIEWER|5|Visit_5|90|5|TREATMENT|2021-04-08|90
e|FA|02d9a74a-abc8-4b47-a4d4-a196d339f621|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Gy/h|[?]|1|mg/g/min|TRICUSPID VALVE, SEPTAL CUSP|IPSILATERAL|Y||INVESTIGATOR|1|Visit_1|10|3|WASHOUT|2020-09-14|10
e|FA|02d9a74a-abc8-4b47-a4d4-a196d339f621|2|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|mmHg/sec|[?]|1|mg/dose|INTESTINE|LEFT|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-09-14|10
e|FA|02d9a74a-abc8-4b47-a4d4-a196d339f621|3|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|MET|[?]|1|NEEDLE GAUGE|PARACAVAL LYMPH NODE|LEFT|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-09-29|25
e|FA|02d9a74a-abc8-4b47-a4d4-a196d339f621|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|cm H2O|[?]|1|%(v/v)|HAMATE BONE|LEFT||Y|PROXY|2|Visit_2|25|5|WASHOUT|2020-09-29|25
e|FA|02d9a74a-abc8-4b47-a4d4-a196d339f621|5|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|g/cage/day|AORTOCAVAL LYMPH NODE|BILATERAL|||CHILD|3|Visit_3|40|1|SCREENING|2020-10-14|40
e|FA|02d9a74a-abc8-4b47-a4d4-a196d339f621|6|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|10^7 CFU|[?]|1|TRANSDUCING UNIT/mL|ANTERIOR HORN OF THE LATERAL VENTRICLE|LEFT||Y|CAREGIVER|3|Visit_3|40|1|TREATMENT|2020-10-14|40
e|FA|02d9a74a-abc8-4b47-a4d4-a196d339f621|7|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|MBq/uL|[?]|1|oz eq|PENIS, GLANS|UNILATERAL|||FRIEND|4|Visit_4|65|6|FOLLOW-UP|2020-11-08|65
e|FA|02d9a74a-abc8-4b47-a4d4-a196d339f621|8|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|PELLET|[?]|1|fmol|POSTERIOR TIBIAL VEIN|CONTRALATERAL|Y||CAREGIVER|4|Visit_4|65|4|WASHOUT|2020-11-08|65
e|FA|02d9a74a-abc8-4b47-a4d4-a196d339f621|9|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|vp/mL|[?]|1|TRANSDUCING UNIT/mL|MANDIBLE|LEFT|||SIGNIFICANT OTHER|5|Visit_5|90|3|FOLLOW-UP|2020-12-03|90
e|FA|02d9a74a-abc8-4b47-a4d4-a196d339f621|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|QUANTITY SUFFICIENT|[?]|1|%(v/v)|THYROID GLAND, RIGHT LOBE|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-12-03|90
e|FA|81480f83-206f-40c0-a5a4-f75b31cda363|1|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|oz eq|[?]|1|mL/dose|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-11-22|10
e|FA|81480f83-206f-40c0-a5a4-f75b31cda363|2|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|mg/mol|[?]|1|Bq/L|CENTRAL NERVOUS SYSTEM|IPSILATERAL||Y|CAREGIVER|1|Visit_1|10|4|WASHOUT|2020-11-22|10
e|FA|81480f83-206f-40c0-a5a4-f75b31cda363|3|SEV|Severity/Intensity|[?]|GERD|[?]|10^4/L|[?]|1|Pa|IRIS|IPSILATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|FOLLOW-UP|2020-12-07|25
e|FA|81480f83-206f-40c0-a5a4-f75b31cda363|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|in2|[?]|1|PFU/dose|T3 VERTEBRA|IPSILATERAL||Y|FRIEND|2|Visit_2|25|3|WASHOUT|2020-12-07|25
e|FA|81480f83-206f-40c0-a5a4-f75b31cda363|5|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|pg|[?]|1|Shock Wave|T2 VERTEBRA|UNILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-12-22|40
e|FA|81480f83-206f-40c0-a5a4-f75b31cda363|6|TRTSETT|Treatment Setting|[?]|GERD|[?]|copies/ug|[?]|1|Coulomb|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|UNILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|2|TREATMENT|2020-12-22|40
e|FA|81480f83-206f-40c0-a5a4-f75b31cda363|7|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|Antibody Unit|[?]|1|BOWL|DISTANT LYMPH NODE|BILATERAL||Y|CAREGIVER|4|Visit_4|65|6|TREATMENT|2021-01-16|65
e|FA|81480f83-206f-40c0-a5a4-f75b31cda363|8|TOTNUM|Total Number|[?]|GERD|[?]|mmHg*min/L|[?]|1|/200 HPFs|OCCIPITAL LOBE|UNILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|7|FOLLOW-UP|2021-01-16|65
e|FA|81480f83-206f-40c0-a5a4-f75b31cda363|9|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Bq/L|[?]|1|mm/h|MEDIASTINUM, MIDDLE|IPSILATERAL|||SPOUSE|5|Visit_5|90|7|SCREENING|2021-02-10|90
e|FA|81480f83-206f-40c0-a5a4-f75b31cda363|10|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|mL/h|LUMBAR REGION|BILATERAL|Y||FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-02-10|90
e|FA|2b183b69-3ed8-4356-b9e2-0988128de3f2|1|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|m2|METACARPOPHALANGEAL JOINT 3|LATERAL|Y||VENDOR|1|Visit_1|10|4|TREATMENT|2020-10-16|10
e|FA|2b183b69-3ed8-4356-b9e2-0988128de3f2|2|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|BOWL|HEART, RIGHT VENTRICLE|BILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-10-16|10
e|FA|2b183b69-3ed8-4356-b9e2-0988128de3f2|3|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|CIGAR|[?]|1|cm H2O|PROXIMAL URETHRA|UNILATERAL|Y|Y|VENDOR|2|Visit_2|25|6|WASHOUT|2020-10-31|25
e|FA|2b183b69-3ed8-4356-b9e2-0988128de3f2|4|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|amu|[?]|1|Weber|METACARPAL BONE 4|UNILATERAL|Y||SIBLING|2|Visit_2|25|6|WASHOUT|2020-10-31|25
e|FA|2b183b69-3ed8-4356-b9e2-0988128de3f2|5|EXCDUR|Exercise Duration|[?]|GERD|[?]|FINGERTIP UNIT|[?]|1|mm|FLEXOR CARPI ULNARIS MUSCLE|CONTRALATERAL|||PROXY|3|Visit_3|40|7|SCREENING|2020-11-15|40
e|FA|2b183b69-3ed8-4356-b9e2-0988128de3f2|6|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|mL/g/h|[?]|1|Bq/L|CALCANEUS|LATERAL|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|2|TREATMENT|2020-11-15|40
e|FA|2b183b69-3ed8-4356-b9e2-0988128de3f2|7|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|ug/mol|[?]|1|km|POPLITEAL ARTERY BELOW KNEE|CONTRALATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2020-12-10|65
e|FA|2b183b69-3ed8-4356-b9e2-0988128de3f2|8|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|BEAM BREAKS|[?]|1|HOURS|RIB 11|RIGHT|||INVESTIGATOR|4|Visit_4|65|1|FOLLOW-UP|2020-12-10|65
e|FA|2b183b69-3ed8-4356-b9e2-0988128de3f2|9|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|MAC50|[?]|1|/kg|AXILLARY LYMPH NODE LEVEL II|BILATERAL||Y|VENDOR|5|Visit_5|90|4|TREATMENT|2021-01-04|90
e|FA|2b183b69-3ed8-4356-b9e2-0988128de3f2|10|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|fL|[?]|1|ug/g/h|CEPHALIC VEIN|BILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2021-01-04|90
e|FA|6ed8a749-81c0-4998-817d-efc86cfaa091|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PIXELS/cm|[?]|1|mg/g/min|LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT|RIGHT||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2020-06-05|10
e|FA|6ed8a749-81c0-4998-817d-efc86cfaa091|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|lx|[?]|1|%(v/v)|LIVER, LEFT LOBE|BILATERAL|Y||ADJUDICATOR|1|Visit_1|10|5|WASHOUT|2020-06-05|10
e|FA|6ed8a749-81c0-4998-817d-efc86cfaa091|3|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|/40 HPFs|[?]|1|mL/m2|SUBGLOTTIS|RIGHT||Y|INTERVIEWER|2|Visit_2|25|2|SCREENING|2020-06-20|25
e|FA|6ed8a749-81c0-4998-817d-efc86cfaa091|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|umol/mg/min|[?]|1|%(v/v)|LUNG, LEFT LOWER LOBE|UNILATERAL|Y||SIBLING|2|Visit_2|25|3|TREATMENT|2020-06-20|25
e|FA|6ed8a749-81c0-4998-817d-efc86cfaa091|5|DFATT|Dietary Fat, Total|[?]|GERD|[?]|mg/kg/day|[?]|1|Bq/mg|VENA CAVA|LATERAL||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2020-07-05|40
e|FA|6ed8a749-81c0-4998-817d-efc86cfaa091|6|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|GBq/mg|[?]|1|BOWL|CLAW|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|FOLLOW-UP|2020-07-05|40
e|FA|6ed8a749-81c0-4998-817d-efc86cfaa091|7|OBJTYPE|Type of Object|[?]|GERD|[?]|K|[?]|1|ng|CONJUNCTIVA|BILATERAL|||SIBLING|4|Visit_4|65|5|WASHOUT|2020-07-30|65
e|FA|6ed8a749-81c0-4998-817d-efc86cfaa091|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|GBq/ug|[?]|1|mg/g/min|HIPPOCAMPUS|RIGHT|||INVESTIGATOR|4|Visit_4|65|7|SCREENING|2020-07-30|65
e|FA|6ed8a749-81c0-4998-817d-efc86cfaa091|9|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|LB|[?]|1|10^9 CFU/g|SACRAL TUBEROSITY|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-08-24|90
e|FA|6ed8a749-81c0-4998-817d-efc86cfaa091|10|SERVNUM|Number of Servings|[?]|GERD|[?]|RFU|[?]|1|Hz/s|INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2020-08-24|90
e|FA|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|1|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|nkat/g Hb|[?]|1|DROP|SKIN OF THE FINGER|UNILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2021-01-18|10
e|FA|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|2|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|mgEq|[?]|1|mIU/L|GREATER CURVATURE OF THE STOMACH|RIGHT|Y|Y|CHILD|1|Visit_1|10|4|TREATMENT|2021-01-18|10
e|FA|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/dL|[?]|1|Pa|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|CONTRALATERAL|||FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2021-02-02|25
e|FA|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|4|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|PNU/mL|[?]|1|fmol|RADIUS|CONTRALATERAL|Y||PARENT|2|Visit_2|25|2|TREATMENT|2021-02-02|25
e|FA|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|msec|[?]|1|Pa|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|UNILATERAL|||INTERVIEWER|3|Visit_3|40|4|TREATMENT|2021-02-17|40
e|FA|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|6|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|AU/mL|BUCCAL LYMPH NODE|BILATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|3|FOLLOW-UP|2021-02-17|40
e|FA|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|7|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|breaths/min|[?]|1|IU/mg|VERTEBRAL ARTERY|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2021-03-14|65
e|FA|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|8|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/min|[?]|1|cm|SHOULDER JOINT TENDONS|UNILATERAL|Y||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2021-03-14|65
e|FA|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|9|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|mL/mmHg/min/L|[?]|1|AU/mL|EYE, ANTERIOR SEGMENT|LEFT|||PARENT|5|Visit_5|90|4|TREATMENT|2021-04-08|90
e|FA|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|10|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|pmol/dL|[?]|1|TRANSDUCING UNIT/mL|LATISSIMUS DORSI MUSCLE|BILATERAL|Y|Y|VENDOR|5|Visit_5|90|6|TREATMENT|2021-04-08|90
e|FA|e6162980-e240-4924-a13a-dde28b2345cd|1|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|MONTHS|[?]|1|umol|PRONATOR QUADRATUS MUSCLE|LATERAL||Y|SIBLING|1|Visit_1|10|5|TREATMENT|2020-08-11|10
e|FA|e6162980-e240-4924-a13a-dde28b2345cd|2|ESTWT|Estimated Weight|[?]|GERD|[?]|uOsm|[?]|1|g/day|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|1|FOLLOW-UP|2020-08-11|10
e|FA|e6162980-e240-4924-a13a-dde28b2345cd|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mOsm/L|[?]|1|mg/g/min|ILIAC VEIN|LATERAL|Y||SPOUSE|2|Visit_2|25|6|WASHOUT|2020-08-26|25
e|FA|e6162980-e240-4924-a13a-dde28b2345cd|4|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|TROCHE|[?]|1|TRANSDUCING UNIT/mL|APPENDICULAR SKELETON|CONTRALATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|WASHOUT|2020-08-26|25
e|FA|e6162980-e240-4924-a13a-dde28b2345cd|5|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|mg/kg/week|[?]|1|BAG|EPIDIDYMIS|LATERAL|||CAREGIVER|3|Visit_3|40|5|TREATMENT|2020-09-10|40
e|FA|e6162980-e240-4924-a13a-dde28b2345cd|6|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/mmol|[?]|1|10^6 IU/mL|WARDS TRIANGLE|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2020-09-10|40
e|FA|e6162980-e240-4924-a13a-dde28b2345cd|7|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|Anson U|[?]|1|vp/dose|HILAR LYMPH NODE|RIGHT|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2020-10-05|65
e|FA|e6162980-e240-4924-a13a-dde28b2345cd|8|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|kg/L|[?]|1|U/mg|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|LATERAL|||FAMILY MEMBER|4|Visit_4|65|6|FOLLOW-UP|2020-10-05|65
e|FA|e6162980-e240-4924-a13a-dde28b2345cd|9|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|mg/animal|[?]|1|BOWL|HEEL OF THE FOOT|UNILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|7|FOLLOW-UP|2020-10-30|90
e|FA|e6162980-e240-4924-a13a-dde28b2345cd|10|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|U/m2|[?]|1|L/h/m2|EPITROCHLEAR LYMPH NODE|BILATERAL|||STUDY SUBJECT|5|Visit_5|90|1|TREATMENT|2020-10-30|90
e|FA|3dc9c666-8be3-4cfa-88d4-b18647e08d00|1|DMEAT|Dietary Meat|[?]|GERD|[?]|umol/mol|[?]|1|10^6 organisms/mL|THIGH|BILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2020-06-13|10
e|FA|3dc9c666-8be3-4cfa-88d4-b18647e08d00|2|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|cycle/min|[?]|1|psi|TROCHLEAR NERVE|RIGHT||Y|INDEPENDENT ASSESSOR|1|Visit_1|10|2|FOLLOW-UP|2020-06-13|10
e|FA|3dc9c666-8be3-4cfa-88d4-b18647e08d00|3|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|uEq|[?]|1|PFU/dose|SKIN OF THE TRUNK|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|TREATMENT|2020-06-28|25
e|FA|3dc9c666-8be3-4cfa-88d4-b18647e08d00|4|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/L|[?]|1|SACHET|LEFT VENTRICULAR MID ANTERIOR SEGMENT|LEFT|Y|Y|CHILD|2|Visit_2|25|7|TREATMENT|2020-06-28|25
e|FA|3dc9c666-8be3-4cfa-88d4-b18647e08d00|5|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|pg/cell|[?]|1|PFU/dose|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|LEFT|||SPOUSE|3|Visit_3|40|1|TREATMENT|2020-07-13|40
e|FA|3dc9c666-8be3-4cfa-88d4-b18647e08d00|6|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|mmol/day|[?]|1|IU/mmol|OCULOMOTOR NERVE|IPSILATERAL|Y||VENDOR|3|Visit_3|40|6|SCREENING|2020-07-13|40
e|FA|3dc9c666-8be3-4cfa-88d4-b18647e08d00|7|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|10^10/L|[?]|1|ug/m2/h|LUNG, HILUM|LATERAL|Y||SIBLING|4|Visit_4|65|6|TREATMENT|2020-08-07|65
e|FA|3dc9c666-8be3-4cfa-88d4-b18647e08d00|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|/HPF|[?]|1|mg/g/min|URETHRAL SPHINCTER|LEFT||Y|CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-08-07|65
e|FA|3dc9c666-8be3-4cfa-88d4-b18647e08d00|9|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|g/U|[?]|1|10^6 organisms/mL|GASTROINTESTINAL SYSTEM|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-09-01|90
e|FA|3dc9c666-8be3-4cfa-88d4-b18647e08d00|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|CARTRIDGE|[?]|1|km|BODY OF STOMACH|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|SCREENING|2020-09-01|90
e|FA|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|1|LOCONSET|Localization of Onset|[?]|GERD|[?]|pg/cell|[?]|1|g/L|LEFT MAIN CORONARY ARTERY BIFURCATION|CONTRALATERAL|Y|Y|PARENT|1|Visit_1|10|7|TREATMENT|2021-01-23|10
e|FA|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|2|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|h*%|[?]|1|EIA unit|BLOOD|UNILATERAL|||INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2021-01-23|10
e|FA|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ug/L|[?]|1|%(v/v)|LEFT CIRCUMFLEX ARTERY OSTIUM|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|WASHOUT|2021-02-07|25
e|FA|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|4|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|breaths/min|[?]|1|BP|SCAPULA|RIGHT|||CHILD|2|Visit_2|25|5|WASHOUT|2021-02-07|25
e|FA|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|5|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|BOLUS|[?]|1|DROP|POPLITEAL LYMPH NODE|BILATERAL||Y|PARENT|3|Visit_3|40|7|SCREENING|2021-02-22|40
e|FA|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|6|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|g/U|[?]|1|gtt|PROFUNDA FEMORIS VEIN|LEFT||Y|SIBLING|3|Visit_3|40|1|TREATMENT|2021-02-22|40
e|FA|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|7|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mL/min/mmHg|[?]|1|10^6 U|PERIANAL REGION|UNILATERAL|Y||CAREGIVER|4|Visit_4|65|4|SCREENING|2021-03-19|65
e|FA|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|8|ACNDEV|Action Taken With Device|[?]|GERD|[?]|mg2/dL2|[?]|1|100 IU/mL|ADRENAL GLAND|IPSILATERAL|Y||CHILD|4|Visit_4|65|1|FOLLOW-UP|2021-03-19|65
e|FA|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|cP|[?]|1|Pa|THIRD RIGHT POSTEROLATERAL ARTERY|CONTRALATERAL|||STUDY SUBJECT|5|Visit_5|90|3|FOLLOW-UP|2021-04-13|90
e|FA|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|10|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|um/s|[?]|1|PACK|PAROTID GLAND|BILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|4|TREATMENT|2021-04-13|90
e|FA|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|/min|[?]|1|Pa|AORTOCAVAL LYMPH NODE|CONTRALATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|1|WASHOUT|2020-11-19|10
e|FA|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|2|DPROT|Dietary Protein|[?]|GERD|[?]|nmol/L/h|[?]|1|10^4 CFU/mL|AORTIC VALVE, RIGHT CORONARY CUSP|IPSILATERAL|||VENDOR|1|Visit_1|10|6|TREATMENT|2020-11-19|10
e|FA|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|3|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mg|[?]|1|aMFI|AORTO-ILIAC PERIPHERAL ARTERY|BILATERAL|Y|Y|CAREGIVER|2|Visit_2|25|2|FOLLOW-UP|2020-12-04|25
e|FA|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|4|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|10^6/Ejaculate U|[?]|1|psi|SKIN OF THE NECK|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-12-04|25
e|FA|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|5|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|h*%|TRACHEA|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2020-12-19|40
e|FA|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|6|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|mmHg*min/L|[?]|1|aMFI|HEAD AND NECK|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|WASHOUT|2020-12-19|40
e|FA|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|7|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|kV|[?]|1|10^9 CFU/g|CORPUS CALLOSUM, BODY|UNILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|4|SCREENING|2021-01-13|65
e|FA|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|8|CALBURN|Calories Burned|[?]|GERD|[?]|days/month|[?]|1|/kg|SCROTUM|BILATERAL|||GUARDIAN|4|Visit_4|65|6|SCREENING|2021-01-13|65
e|FA|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|9|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|U/dL|[?]|1|cm H2O|MESENTERIC VEIN|IPSILATERAL|||VENDOR|5|Visit_5|90|3|FOLLOW-UP|2021-02-07|90
e|FA|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|10|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|ug/L|[?]|1|BAG|FOREBRAIN|RIGHT|||INTERVIEWER|5|Visit_5|90|7|SCREENING|2021-02-07|90
e|FA|2738b933-c71d-4239-a093-6b4aa7cc41df|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|mL/g/h|[?]|1|SCOOPFUL|PREPUTIAL GLAND|BILATERAL|||INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-05-28|10
e|FA|2738b933-c71d-4239-a093-6b4aa7cc41df|2|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|100 IU/mL|[?]|1|cm H2O|ADDUCTOR POLLICIS MUSCLE|UNILATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|2|FOLLOW-UP|2020-05-28|10
e|FA|2738b933-c71d-4239-a093-6b4aa7cc41df|3|DVEG|Dietary Vegetable|[?]|GERD|[?]|Bq/mg|[?]|1|Ci/ug|ANTERIOR INFERIOR CEREBELLAR ARTERY|BILATERAL|||GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-06-12|25
e|FA|2738b933-c71d-4239-a093-6b4aa7cc41df|4|DMG|Dietary Magnesium|[?]|GERD|[?]|CARTRIDGE|[?]|1|TRANSDUCING UNIT/mL|ELBOW FLEXOR MUSCLES|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|TREATMENT|2020-06-12|25
e|FA|2738b933-c71d-4239-a093-6b4aa7cc41df|5|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mg/mL/day|[?]|1|L/h/m2|JAW|IPSILATERAL|Y||PARENT|3|Visit_3|40|1|WASHOUT|2020-06-27|40
e|FA|2738b933-c71d-4239-a093-6b4aa7cc41df|6|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mmol/kg|[?]|1|mAmp|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|RIGHT|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|5|SCREENING|2020-06-27|40
e|FA|2738b933-c71d-4239-a093-6b4aa7cc41df|7|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|L/h|[?]|1|umol|PUPIL|RIGHT|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|2|SCREENING|2020-07-22|65
e|FA|2738b933-c71d-4239-a093-6b4aa7cc41df|8|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|MBP|[?]|1|BOWL|MIDDLE PHALANX 5 OF THE HAND|RIGHT||Y|CAREGIVER|4|Visit_4|65|2|TREATMENT|2020-07-22|65
e|FA|2738b933-c71d-4239-a093-6b4aa7cc41df|9|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|nL|[?]|1|NEEDLE GAUGE|PENIS, RADIX|BILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2020-08-16|90
e|FA|2738b933-c71d-4239-a093-6b4aa7cc41df|10|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|nsec|[?]|1|SCOOPFUL|FIBULA|RIGHT|||CHILD|5|Visit_5|90|6|TREATMENT|2020-08-16|90
e|FA|68b9ff4e-9694-4545-a752-4d3ac0e89fda|1|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|/10^3|[?]|1|TRANSDUCING UNIT/mL|LEFT MAIN CORONARY ARTERY OSTIUM|UNILATERAL||Y|INTERVIEWER|1|Visit_1|10|2|TREATMENT|2021-01-08|10
e|FA|68b9ff4e-9694-4545-a752-4d3ac0e89fda|2|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|PACK|PROXIMAL INTERPHALANGEAL JOINT 5|CONTRALATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|WASHOUT|2021-01-08|10
e|FA|68b9ff4e-9694-4545-a752-4d3ac0e89fda|3|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|fmol|[?]|1|AU/mL|PROXIMAL PHALANX 5 OF THE HAND|LEFT|||SIBLING|2|Visit_2|25|7|TREATMENT|2021-01-23|25
e|FA|68b9ff4e-9694-4545-a752-4d3ac0e89fda|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|MET*h|[?]|1|PFU/dose|FIRST DIAGONAL BRANCH ARTERY|BILATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2021-01-23|25
e|FA|68b9ff4e-9694-4545-a752-4d3ac0e89fda|5|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|cmol|[?]|1|10^6 organisms/mL|CORNEAL EPITHELIUM|LATERAL|||SIBLING|3|Visit_3|40|1|SCREENING|2021-02-07|40
e|FA|68b9ff4e-9694-4545-a752-4d3ac0e89fda|6|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|sec|[?]|1|Log10 ELISA unit|SPINAL ACCESSORY NERVE|LATERAL||Y|INTERVIEWER|3|Visit_3|40|1|TREATMENT|2021-02-07|40
e|FA|68b9ff4e-9694-4545-a752-4d3ac0e89fda|7|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|mol/day|[?]|1|mL/100g/min|T5 VERTEBRA|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|SCREENING|2021-03-04|65
e|FA|68b9ff4e-9694-4545-a752-4d3ac0e89fda|8|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|PUFF|[?]|1|100 IU/mL|QUADRICEPS MUSCLE|IPSILATERAL|Y||SIBLING|4|Visit_4|65|1|TREATMENT|2021-03-04|65
e|FA|68b9ff4e-9694-4545-a752-4d3ac0e89fda|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PNU/mL|[?]|1|mg/g/min|TARSUS BONE|LEFT|Y||SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2021-03-29|90
e|FA|68b9ff4e-9694-4545-a752-4d3ac0e89fda|10|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|ms2|[?]|1|uCi/kg|EAR, INNER|LATERAL||Y|CHILD|5|Visit_5|90|3|TREATMENT|2021-03-29|90
e|FA|0f0ec179-5100-4a3d-9f93-54140aca7d30|1|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|/2500 WBC|[?]|1|L/h/m2|C2 VERTEBRA|UNILATERAL||Y|SPOUSE|1|Visit_1|10|1|WASHOUT|2020-08-25|10
e|FA|0f0ec179-5100-4a3d-9f93-54140aca7d30|2|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|DISK|[?]|1|in|IRIS|CONTRALATERAL|||PROXY|1|Visit_1|10|4|FOLLOW-UP|2020-08-25|10
e|FA|0f0ec179-5100-4a3d-9f93-54140aca7d30|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|10^6 DNA copies/mL|[?]|1|U/mg|PROSTATE GLAND, MIDDLE LOBE|BILATERAL|||FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-09-09|25
e|FA|0f0ec179-5100-4a3d-9f93-54140aca7d30|4|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|STRIP|[?]|1|mm|SUPRACLAVICULAR LYMPH NODE|UNILATERAL|Y||ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-09-09|25
e|FA|0f0ec179-5100-4a3d-9f93-54140aca7d30|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|g|[?]|1|Pa|RIB 8|LATERAL|||VENDOR|3|Visit_3|40|7|TREATMENT|2020-09-24|40
e|FA|0f0ec179-5100-4a3d-9f93-54140aca7d30|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|APL U/mL|[?]|1|mg/g/min|PRIMARY VISUAL CORTEX|CONTRALATERAL||Y|SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2020-09-24|40
e|FA|0f0ec179-5100-4a3d-9f93-54140aca7d30|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mol|[?]|1|mg/g/min|SCAPHOID-TRAPEZOID JOINT|IPSILATERAL||Y|ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2020-10-19|65
e|FA|0f0ec179-5100-4a3d-9f93-54140aca7d30|8|OBJNUM|Number of Objects|[?]|GERD|[?]|/LPF|[?]|1|mL/100g/min|ISCHIORECTAL FOSSA|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|5|TREATMENT|2020-10-19|65
e|FA|0f0ec179-5100-4a3d-9f93-54140aca7d30|9|SEV|Severity/Intensity|[?]|GERD|[?]|IU/dL|[?]|1|Pa|MEDIASTINAL LYMPH NODE|BILATERAL||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2020-11-13|90
e|FA|0f0ec179-5100-4a3d-9f93-54140aca7d30|10|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|uCi/kg|[?]|1|BOWL|MENINGES|LATERAL|||PROXY|5|Visit_5|90|6|FOLLOW-UP|2020-11-13|90
e|FA|6affe43d-e455-40af-8478-dc38019e89e1|1|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|cP|[?]|1|ohm|INTERPHALANGEAL JOINT 5 OF THE FOOT|BILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|3|SCREENING|2020-06-17|10
e|FA|6affe43d-e455-40af-8478-dc38019e89e1|2|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|gtt|[?]|1|g/dL|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LEFT|||GUARDIAN|1|Visit_1|10|7|FOLLOW-UP|2020-06-17|10
e|FA|6affe43d-e455-40af-8478-dc38019e89e1|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mCi|[?]|1|%(v/v)|SKIN OF THE CHIN|BILATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|7|FOLLOW-UP|2020-07-02|25
e|FA|6affe43d-e455-40af-8478-dc38019e89e1|4|LESNUM|Number of Lesions|[?]|GERD|[?]|/10^4|[?]|1|ng/day|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|UNILATERAL|||VENDOR|2|Visit_2|25|1|WASHOUT|2020-07-02|25
e|FA|6affe43d-e455-40af-8478-dc38019e89e1|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|VOXEL|[?]|1|mg/g/min|HYPOGLOSSAL NERVE|CONTRALATERAL|||SIBLING|3|Visit_3|40|3|WASHOUT|2020-07-17|40
e|FA|6affe43d-e455-40af-8478-dc38019e89e1|6|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|Hz/s|[?]|1|cm H2O|ORBIT|IPSILATERAL||Y|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-07-17|40
e|FA|6affe43d-e455-40af-8478-dc38019e89e1|7|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|DDU|[?]|1|cm H2O|PARACAVAL LYMPH NODE|RIGHT|||CAREGIVER|4|Visit_4|65|2|SCREENING|2020-08-11|65
e|FA|6affe43d-e455-40af-8478-dc38019e89e1|8|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|U/dL|[?]|1|mL/animal/day|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|CONTRALATERAL|||INTERVIEWER|4|Visit_4|65|6|TREATMENT|2020-08-11|65
e|FA|6affe43d-e455-40af-8478-dc38019e89e1|9|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|mg/animal|[?]|1|10^6 CFU|CEREBRAL HEMISPHERE, LEFT|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|SCREENING|2020-09-05|90
e|FA|6affe43d-e455-40af-8478-dc38019e89e1|10|SEV|Severity/Intensity|[?]|GERD|[?]|CAN|[?]|1|Pa|PARAVERTEBRAL GANGLIA|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|SCREENING|2020-09-05|90
e|FA|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/kg/day|[?]|1|Pa|INTERTROCHANTERIC REGION|CONTRALATERAL|||VENDOR|1|Visit_1|10|7|SCREENING|2020-06-07|10
e|FA|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|2|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|g/animal|[?]|1|10^6 IU/mL|HILAR|LEFT|||FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-06-07|10
e|FA|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|3|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|MASK|[?]|1|Log10 ELISA unit|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|UNILATERAL|||PROXY|2|Visit_2|25|1|FOLLOW-UP|2020-06-22|25
e|FA|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|FIU|[?]|1|%(v/v)|OLFACTORY MUCOSA|LATERAL|||STUDY SUBJECT|2|Visit_2|25|2|FOLLOW-UP|2020-06-22|25
e|FA|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|5|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|PFU/animal|[?]|1|BAG|FLEXOR HALLUCIS LONGUS MUSCLE|BILATERAL|||GUARDIAN|3|Visit_3|40|2|FOLLOW-UP|2020-07-07|40
e|FA|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|6|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|ft|[?]|1|gtt|LEFT POSTEROLATERAL DESCENDING ARTERY|UNILATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|5|TREATMENT|2020-07-07|40
e|FA|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|kN/cm2|[?]|1|PFU/dose|UPPER RESPIRATORY SYSTEM|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|SCREENING|2020-08-01|65
e|FA|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|8|LENRSCT|Length of Resection|[?]|GERD|[?]|umol/L/min|[?]|1|psi|FOOT PHALANX|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|1|WASHOUT|2020-08-01|65
e|FA|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|9|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|in2|[?]|1|Shock Wave|VAGUS NERVE|IPSILATERAL|||PROXY|5|Visit_5|90|3|SCREENING|2020-08-26|90
e|FA|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|10|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|MET*min|[?]|1|HOURS|PITUITARY GLAND|RIGHT|||DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-08-26|90
e|FA|e0258c95-7bcc-4b54-895c-f290a1364b5c|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|rpm|[?]|1|L|HEART, RIGHT VENTRICLE|LATERAL|||INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-12-27|10
e|FA|e0258c95-7bcc-4b54-895c-f290a1364b5c|2|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|TAMPON|[?]|1|umol|PERIHILAR LYMPH NODE|UNILATERAL|||SPOUSE|1|Visit_1|10|4|TREATMENT|2020-12-27|10
e|FA|e0258c95-7bcc-4b54-895c-f290a1364b5c|3|DMEAT|Dietary Meat|[?]|GERD|[?]|cm/min|[?]|1|10^6 organisms/mL|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|LEFT|||INVESTIGATOR|2|Visit_2|25|1|FOLLOW-UP|2021-01-11|25
e|FA|e0258c95-7bcc-4b54-895c-f290a1364b5c|4|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|h/wk|[?]|1|mAmp|GASTROINTESTINAL TRACT|CONTRALATERAL|Y|Y|VENDOR|2|Visit_2|25|7|FOLLOW-UP|2021-01-11|25
e|FA|e0258c95-7bcc-4b54-895c-f290a1364b5c|5|ACNDEV|Action Taken With Device|[?]|GERD|[?]|kHz|[?]|1|100 IU/mL|LEFT VENTRICULAR APICAL LATERAL SEGMENT|IPSILATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|2|TREATMENT|2021-01-26|40
e|FA|e0258c95-7bcc-4b54-895c-f290a1364b5c|6|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|kN/cm2|[?]|1|fmol|LIP, UPPER|RIGHT|||STUDY SUBJECT|3|Visit_3|40|4|WASHOUT|2021-01-26|40
e|FA|e0258c95-7bcc-4b54-895c-f290a1364b5c|7|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|nmol/L/h|[?]|1|SCOOPFUL|LOWER RESPIRATORY SYSTEM|UNILATERAL||Y|SPOUSE|4|Visit_4|65|4|TREATMENT|2021-02-20|65
e|FA|e0258c95-7bcc-4b54-895c-f290a1364b5c|8|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|ft|[?]|1|cm H2O|PYLORIC SPHINCTER|LEFT|||SPOUSE|4|Visit_4|65|3|TREATMENT|2021-02-20|65
e|FA|e0258c95-7bcc-4b54-895c-f290a1364b5c|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|IU|[?]|1|Pa|BICEPS BRACHII MUSCLE|UNILATERAL|||CHILD|5|Visit_5|90|3|TREATMENT|2021-03-17|90
e|FA|e0258c95-7bcc-4b54-895c-f290a1364b5c|10|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|mkat|[?]|1|g/day|FLEXOR CARPI RADIALIS MUSCLE|RIGHT|||CAREGIVER|5|Visit_5|90|4|TREATMENT|2021-03-17|90
e|FA|7218f9ae-0119-4633-a8d3-7d98b2ae1671|1|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|scm|[?]|1|mg/h|RECTUS FEMORIS MUSCLE|LATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2021-01-13|10
e|FA|7218f9ae-0119-4633-a8d3-7d98b2ae1671|2|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|umol|LIVER, QUADRATE LOBE|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|SCREENING|2021-01-13|10
e|FA|7218f9ae-0119-4633-a8d3-7d98b2ae1671|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|WAFER|[?]|1|Pa|PITUITARY GLAND|UNILATERAL|||SPOUSE|2|Visit_2|25|1|FOLLOW-UP|2021-01-28|25
e|FA|7218f9ae-0119-4633-a8d3-7d98b2ae1671|4|DMG|Dietary Magnesium|[?]|GERD|[?]|10^3 organisms/g|[?]|1|TRANSDUCING UNIT/mL|PARAVERTEBRAL GANGLIA|RIGHT|||CAREGIVER|2|Visit_2|25|1|FOLLOW-UP|2021-01-28|25
e|FA|7218f9ae-0119-4633-a8d3-7d98b2ae1671|5|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|10^6 RNA copies/mL|[?]|1|Bq/mg|HUMERUS|LATERAL||Y|SIBLING|3|Visit_3|40|7|TREATMENT|2021-02-12|40
e|FA|7218f9ae-0119-4633-a8d3-7d98b2ae1671|6|OBJTYPE|Type of Object|[?]|GERD|[?]|AMPULE|[?]|1|ng|T5 VERTEBRA|CONTRALATERAL|||PROXY|3|Visit_3|40|7|TREATMENT|2021-02-12|40
e|FA|7218f9ae-0119-4633-a8d3-7d98b2ae1671|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|Pa|GREATER CURVATURE OF THE STOMACH|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2021-03-09|65
e|FA|7218f9ae-0119-4633-a8d3-7d98b2ae1671|8|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|BU/mL|[?]|1|ohm|PHARYNX|LATERAL|||PROXY|4|Visit_4|65|5|TREATMENT|2021-03-09|65
e|FA|7218f9ae-0119-4633-a8d3-7d98b2ae1671|9|QOLIMP|QOL Impact|[?]|GERD|[?]|g/m2|[?]|1|10^6/L|ELBOW EXTENSOR MUSCLES|UNILATERAL|||PROXY|5|Visit_5|90|6|TREATMENT|2021-04-03|90
e|FA|7218f9ae-0119-4633-a8d3-7d98b2ae1671|10|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|/kg|FRONTAL LOBE|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|5|FOLLOW-UP|2021-04-03|90
e|FA|f8c938ff-21c8-4d0b-9335-08d2865543ab|1|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|HEP|[?]|1|QUANTITY SUFFICIENT|VERTEBRAL ARTERY|CONTRALATERAL||Y|PROXY|1|Visit_1|10|2|WASHOUT|2020-05-11|10
e|FA|f8c938ff-21c8-4d0b-9335-08d2865543ab|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/animal/wk|[?]|1|%(v/v)|HEART, RIGHT VENTRICULAR FREE WALL|CONTRALATERAL||Y|SPOUSE|1|Visit_1|10|7|WASHOUT|2020-05-11|10
e|FA|f8c938ff-21c8-4d0b-9335-08d2865543ab|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|SYRINGE|[?]|1|%(v/v)|ILIAC LYMPH NODE|BILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|4|FOLLOW-UP|2020-05-26|25
e|FA|f8c938ff-21c8-4d0b-9335-08d2865543ab|4|DPROT|Dietary Protein|[?]|GERD|[?]|mmHg*min/L|[?]|1|10^4 CFU/mL|BRAIN VENTRICLE, LATERAL|UNILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2020-05-26|25
e|FA|f8c938ff-21c8-4d0b-9335-08d2865543ab|5|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|Roentgen|[?]|1|Ci/ug|BODY OF STOMACH|BILATERAL|||INTERVIEWER|3|Visit_3|40|4|SCREENING|2020-06-10|40
e|FA|f8c938ff-21c8-4d0b-9335-08d2865543ab|6|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/g|[?]|1|Log10 ELISA unit|METATARSOPHALANGEAL JOINT|LEFT|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|FOLLOW-UP|2020-06-10|40
e|FA|f8c938ff-21c8-4d0b-9335-08d2865543ab|7|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mL/breath|[?]|1|CUP|GREAT SAPHENOUS VEIN|RIGHT||Y|CAREGIVER|4|Visit_4|65|3|SCREENING|2020-07-05|65
e|FA|f8c938ff-21c8-4d0b-9335-08d2865543ab|8|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|PACKET|[?]|1|mm/h|SOFT TISSUE|LEFT||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-07-05|65
e|FA|f8c938ff-21c8-4d0b-9335-08d2865543ab|9|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|m3|[?]|1|Shock Wave|LOWER JUGULAR LYMPH NODE|CONTRALATERAL|||VENDOR|5|Visit_5|90|2|WASHOUT|2020-07-30|90
e|FA|f8c938ff-21c8-4d0b-9335-08d2865543ab|10|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|umol/min|[?]|1|HOURS|GLOTTIS|LEFT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|WASHOUT|2020-07-30|90
e|FA|7176f852-7392-4636-800f-3aad48e93065|1|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|MPL U|[?]|1|Shock Wave|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|UNILATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2021-01-16|10
e|FA|7176f852-7392-4636-800f-3aad48e93065|2|DFATT|Dietary Fat, Total|[?]|GERD|[?]|U/g|[?]|1|Bq/mg|HUMERAL EPICONDYLE|IPSILATERAL||Y|SIBLING|1|Visit_1|10|1|TREATMENT|2021-01-16|10
e|FA|7176f852-7392-4636-800f-3aad48e93065|3|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|ug/dL|[?]|1|IU/mmol|MITRAL VALVE, ANTERIOR CUSP|RIGHT|Y||FRIEND|2|Visit_2|25|3|FOLLOW-UP|2021-01-31|25
e|FA|7176f852-7392-4636-800f-3aad48e93065|4|TRTSETT|Treatment Setting|[?]|GERD|[?]|U/m2|[?]|1|Coulomb|MEDIASTINUM, ANTERIOR|LEFT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2021-01-31|25
e|FA|7176f852-7392-4636-800f-3aad48e93065|5|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|mU/g|[?]|1|mL/min/mmHg|PECTORALIS MINOR MUSCLE|LATERAL|||INVESTIGATOR|3|Visit_3|40|3|WASHOUT|2021-02-15|40
e|FA|7176f852-7392-4636-800f-3aad48e93065|6|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|TRANSDUCING UNIT/mL|SUPERIOR PUBIC RAMUS|CONTRALATERAL|Y||CHILD|3|Visit_3|40|7|WASHOUT|2021-02-15|40
e|FA|7176f852-7392-4636-800f-3aad48e93065|7|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|oz eq|[?]|1|mL/dose|KIDNEY, MEDULLA|RIGHT|||DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2021-03-12|65
e|FA|7176f852-7392-4636-800f-3aad48e93065|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|BEAM BREAKS|[?]|1|Pa|BRAIN, THIRD VENTRICLE|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|SCREENING|2021-03-12|65
e|FA|7176f852-7392-4636-800f-3aad48e93065|9|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|mN|[?]|1|BOWL|RETINA|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2021-04-06|90
e|FA|7176f852-7392-4636-800f-3aad48e93065|10|SEV|Severity/Intensity|[?]|GERD|[?]|g/animal|[?]|1|Pa|FOOT|CONTRALATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2021-04-06|90
e|FA|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|1|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|OI50|[?]|1|mg/dose|EXTERNAL ILIAC ARTERY|LATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|1|TREATMENT|2020-10-08|10
e|FA|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|2|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|DISK|[?]|1|cm H2O|T2 VERTEBRA|IPSILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|6|WASHOUT|2020-10-08|10
e|FA|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|3|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|mEq/ug|[?]|1|BP|LOCUS CERULEUS|IPSILATERAL|Y||FAMILY MEMBER|2|Visit_2|25|5|SCREENING|2020-10-23|25
e|FA|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|4|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|gpELISA unit/mL|[?]|1|DROP|LUNG, LEFT|LATERAL||Y|GUARDIAN|2|Visit_2|25|6|WASHOUT|2020-10-23|25
e|FA|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|U/mmol|INCUS|RIGHT|||SPOUSE|3|Visit_3|40|2|TREATMENT|2020-11-07|40
e|FA|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|6|TRTSETT|Treatment Setting|[?]|GERD|[?]|kcal/day|[?]|1|Coulomb|INTRATHORACIC LYMPH NODE|LEFT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|SCREENING|2020-11-07|40
e|FA|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|7|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|dpm/mL|[?]|1|SCOOPFUL|AXILLA|LEFT|Y||SIBLING|4|Visit_4|65|6|FOLLOW-UP|2020-12-02|65
e|FA|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|8|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|in2|[?]|1|SACHET|DUCTUS ARTERIOSUS|UNILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-12-02|65
e|FA|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|9|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|/500 WBC|RIB 1|LEFT||Y|INVESTIGATOR|5|Visit_5|90|4|WASHOUT|2020-12-27|90
e|FA|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|10|TOXGR|Toxicity Grade|[?]|GERD|[?]|uV*sec|[?]|1|aMFI|MEDIASTINUM, POSTERIOR|UNILATERAL|||SIBLING|5|Visit_5|90|2|TREATMENT|2020-12-27|90
e|FA|69e41d6b-57f7-48b0-be7a-29fca953f8d9|1|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|TRANSDUCING UNIT/mL|AXILLARY VEIN|LATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|3|TREATMENT|2020-10-28|10
e|FA|69e41d6b-57f7-48b0-be7a-29fca953f8d9|2|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|tuberculin unit/mL|[?]|1|EIA unit|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|IPSILATERAL|Y||SIBLING|1|Visit_1|10|7|TREATMENT|2020-10-28|10
e|FA|69e41d6b-57f7-48b0-be7a-29fca953f8d9|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|1/(s*kPa)|[?]|1|mg/g/min|ENDOCERVIX|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-11-12|25
e|FA|69e41d6b-57f7-48b0-be7a-29fca953f8d9|4|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|hr/day|[?]|1|L/h/m2|INTESTINE|RIGHT|||INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-11-12|25
e|FA|69e41d6b-57f7-48b0-be7a-29fca953f8d9|5|RLDEV|Relationship to Device|[?]|GERD|[?]|kg/cm|[?]|1|mL/min/mmHg|URETHRAL SPHINCTER|IPSILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|SCREENING|2020-11-27|40
e|FA|69e41d6b-57f7-48b0-be7a-29fca953f8d9|6|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|FINGERTIP UNIT|[?]|1|AU/mL|POSTEROLATERAL SEGMENTAL ARTERY|CONTRALATERAL|||DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-11-27|40
e|FA|69e41d6b-57f7-48b0-be7a-29fca953f8d9|7|SEV|Severity/Intensity|[?]|GERD|[?]|PFU/mL|[?]|1|Pa|FEMUR SHAFT|IPSILATERAL|||FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2020-12-22|65
e|FA|69e41d6b-57f7-48b0-be7a-29fca953f8d9|8|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|mm/sec|[?]|1|mm/h|TARSAL JOINT|BILATERAL|||SIBLING|4|Visit_4|65|5|WASHOUT|2020-12-22|65
e|FA|69e41d6b-57f7-48b0-be7a-29fca953f8d9|9|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|cpm|[?]|1|PACK|LIMB|RIGHT|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|TREATMENT|2021-01-16|90
e|FA|69e41d6b-57f7-48b0-be7a-29fca953f8d9|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|MnFI|[?]|1|mg/g/min|SAPHENOUS VEIN|LEFT|||INDEPENDENT ASSESSOR|5|Visit_5|90|1|FOLLOW-UP|2021-01-16|90
e|FA|a38eb4fc-2422-4d4a-a435-58ae9bf42589|1|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|amu|[?]|1|BOWL|GLOTTIS|LATERAL|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|SCREENING|2020-11-23|10
e|FA|a38eb4fc-2422-4d4a-a435-58ae9bf42589|2|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|g/m2|[?]|1|PACK|NOSTRIL|LEFT|||CHILD|1|Visit_1|10|6|TREATMENT|2020-11-23|10
e|FA|a38eb4fc-2422-4d4a-a435-58ae9bf42589|3|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|uL|[?]|1|DRUM|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|RIGHT|||DOMESTIC PARTNER|2|Visit_2|25|3|SCREENING|2020-12-08|25
e|FA|a38eb4fc-2422-4d4a-a435-58ae9bf42589|4|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|Gy|[?]|1|mm|RIB 6|CONTRALATERAL|||FRIEND|2|Visit_2|25|3|WASHOUT|2020-12-08|25
e|FA|a38eb4fc-2422-4d4a-a435-58ae9bf42589|5|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|Ci/uL|[?]|1|10^6 U|T10 VERTEBRA|RIGHT|||INTERVIEWER|3|Visit_3|40|7|FOLLOW-UP|2020-12-23|40
e|FA|a38eb4fc-2422-4d4a-a435-58ae9bf42589|6|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|ohm|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|IPSILATERAL|||FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-12-23|40
e|FA|a38eb4fc-2422-4d4a-a435-58ae9bf42589|7|DPROT|Dietary Protein|[?]|GERD|[?]|mg/kg/day|[?]|1|10^4 CFU/mL|BRAIN STEM|IPSILATERAL||Y|SIGNIFICANT OTHER|4|Visit_4|65|6|WASHOUT|2021-01-17|65
e|FA|a38eb4fc-2422-4d4a-a435-58ae9bf42589|8|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mOsm/kg|[?]|1|10^6 U|HEEL OF THE FOOT|RIGHT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|FOLLOW-UP|2021-01-17|65
e|FA|a38eb4fc-2422-4d4a-a435-58ae9bf42589|9|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|mg/g/h|[?]|1|Shock Wave|CARDIAC WALL|LEFT|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2021-02-11|90
e|FA|a38eb4fc-2422-4d4a-a435-58ae9bf42589|10|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|mg/m2/day|[?]|1|IU/mg|GASTRIC CURVATURE LYMPH NODE|CONTRALATERAL|||PARENT|5|Visit_5|90|6|TREATMENT|2021-02-11|90
e|FA|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|1|SEV|Severity/Intensity|[?]|GERD|[?]|fg|[?]|1|Pa|ETHMOID SINUS|RIGHT|||VENDOR|1|Visit_1|10|3|WASHOUT|2020-09-26|10
e|FA|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|mg/g/min|ACUTE MARGINAL ARTERY|CONTRALATERAL|Y|Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2020-09-26|10
e|FA|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|3|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|kBq|[?]|1|anti-Xa IU/mL|LUNG LOBE|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2020-10-11|25
e|FA|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PA|[?]|1|mg/g/min|RENAL PELVIS|UNILATERAL||Y|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-10-11|25
e|FA|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|5|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|gtt|[?]|1|fmol|RIGHT VENTRICULAR ENDOCARDIUM|IPSILATERAL|||INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-10-26|40
e|FA|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|6|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|Antibody Unit|[?]|1|BP|BODY|BILATERAL|Y||VENDOR|3|Visit_3|40|3|FOLLOW-UP|2020-10-26|40
e|FA|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|7|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|PFU/dose|[?]|1|gtt|GRACILIS MUSCLE|LEFT|Y|Y|PARENT|4|Visit_4|65|4|SCREENING|2020-11-20|65
e|FA|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|dpm/mL|[?]|1|Pa|CHOROID PLEXUS|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2020-11-20|65
e|FA|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|9|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|10^9 organisms/mL|[?]|1|mL/m2|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|BILATERAL|Y||INVESTIGATOR|5|Visit_5|90|1|FOLLOW-UP|2020-12-15|90
e|FA|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|10|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|mMU/mL|[?]|1|aMFI|COLON|IPSILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-12-15|90
e|FA|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|1|DISTANCE|Distance|[?]|GERD|[?]|mol/L|[?]|1|BOWL|LIVER, LEFT LOBE|RIGHT|Y|Y|SPOUSE|1|Visit_1|10|4|WASHOUT|2021-01-01|10
e|FA|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|2|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mEq/mL|[?]|1|oz eq|CORONARY ARTERY, RIGHT|UNILATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|3|TREATMENT|2021-01-01|10
e|FA|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|3|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|g/cage/wk|[?]|1|Weber|SKIN OF THE HEAD|IPSILATERAL|Y|Y|VENDOR|2|Visit_2|25|2|TREATMENT|2021-01-16|25
e|FA|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|4|ESTWT|Estimated Weight|[?]|GERD|[?]|kHz|[?]|1|g/day|MEDIASTINUM|RIGHT|||DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2021-01-16|25
e|FA|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|5|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|ug/dose|[?]|1|TRANSDUCING UNIT/mL|T11 VERTEBRA|LATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2021-01-31|40
e|FA|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|6|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|deg/s|[?]|1|mL/m2|METACARPOPHALANGEAL JOINT 5|UNILATERAL|||CAREGIVER|3|Visit_3|40|2|FOLLOW-UP|2021-01-31|40
e|FA|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|7|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|Enzyme U/g Hb|[?]|1|mL/animal/day|SECOND DIAGONAL BRANCH ARTERY|LEFT|||GUARDIAN|4|Visit_4|65|5|TREATMENT|2021-02-25|65
e|FA|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|10^6 U|[?]|1|10^6 U|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|RIGHT|Y||VENDOR|4|Visit_4|65|7|TREATMENT|2021-02-25|65
e|FA|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|9|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mL/animal|[?]|1|10^6 U|GASTROCNEMIUS MUSCLE, LATERAL HEAD|UNILATERAL|||STUDY SUBJECT|5|Visit_5|90|3|FOLLOW-UP|2021-03-22|90
e|FA|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|10|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|BOLUS|[?]|1|10^9 CFU/mL|LYMPH NODE HILUM|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-03-22|90
e|FA|dd518f55-0280-445d-a29f-10f09b21fd53|1|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|QUANTITY SUFFICIENT|[?]|1|PACK|SCAPHOID-TRAPEZOID JOINT|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|SCREENING|2020-05-18|10
e|FA|dd518f55-0280-445d-a29f-10f09b21fd53|2|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|mL/dose|GALLBLADDER|LEFT||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2020-05-18|10
e|FA|dd518f55-0280-445d-a29f-10f09b21fd53|3|EXCDUR|Exercise Duration|[?]|GERD|[?]|JAR|[?]|1|mm|AORTIC VALVE, LEFT CORONARY CUSP|UNILATERAL|Y||INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-06-02|25
e|FA|dd518f55-0280-445d-a29f-10f09b21fd53|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|Torr|[?]|1|%(v/v)|LUNG, RIGHT|BILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-06-02|25
e|FA|dd518f55-0280-445d-a29f-10f09b21fd53|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/kg/week|[?]|1|%(v/v)|T11 VERTEBRA|RIGHT|||INVESTIGATOR|3|Visit_3|40|6|TREATMENT|2020-06-17|40
e|FA|dd518f55-0280-445d-a29f-10f09b21fd53|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|APL U/mL|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 4|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|SCREENING|2020-06-17|40
e|FA|dd518f55-0280-445d-a29f-10f09b21fd53|7|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|um/s|[?]|1|anti-Xa IU/mL|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|LATERAL|||INVESTIGATOR|4|Visit_4|65|7|WASHOUT|2020-07-12|65
e|FA|dd518f55-0280-445d-a29f-10f09b21fd53|8|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|JDF Unit|[?]|1|DROP|OROPHARYNX|IPSILATERAL|||PARENT|4|Visit_4|65|1|TREATMENT|2020-07-12|65
e|FA|dd518f55-0280-445d-a29f-10f09b21fd53|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|dpm/mg|[?]|1|10^6 IU/mL|LUNG, RIGHT MIDDLE LOBE|BILATERAL|Y|Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|WASHOUT|2020-08-06|90
e|FA|dd518f55-0280-445d-a29f-10f09b21fd53|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit/dose|[?]|1|mg/g/min|SEMITENDINOSUS MUSCLE|LEFT||Y|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2020-08-06|90
e|FA|49a972da-dfad-438e-b5bc-26ee6b955a59|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|RATIO|[?]|1|mg/g/min|FALCIFORM LIGAMENT|BILATERAL|||INVESTIGATOR|1|Visit_1|10|4|FOLLOW-UP|2020-06-24|10
e|FA|49a972da-dfad-438e-b5bc-26ee6b955a59|2|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|psec|[?]|1|CUP|LAD SEPTAL PERFORATOR ARTERY|LEFT|||CAREGIVER|1|Visit_1|10|5|SCREENING|2020-06-24|10
e|FA|49a972da-dfad-438e-b5bc-26ee6b955a59|3|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|cmH2O*s/mL|[?]|1|10^6 CFU|ASCENDING AORTA, SINOTUBULAR JUNCTION|UNILATERAL||Y|ADJUDICATOR|2|Visit_2|25|2|WASHOUT|2020-07-09|25
e|FA|49a972da-dfad-438e-b5bc-26ee6b955a59|4|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|BOX|[?]|1|/200 HPFs|TOENAIL|LATERAL|||STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-07-09|25
e|FA|49a972da-dfad-438e-b5bc-26ee6b955a59|5|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Absorbance U|[?]|1|mm/h|AORTIC VALVE, NON-CORONARY CUSP|LEFT|||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-07-24|40
e|FA|49a972da-dfad-438e-b5bc-26ee6b955a59|6|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|umol/dL|[?]|1|uCi/kg|FAT PAD|UNILATERAL|||VENDOR|3|Visit_3|40|3|SCREENING|2020-07-24|40
e|FA|49a972da-dfad-438e-b5bc-26ee6b955a59|7|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|FINGERTIP UNIT|[?]|1|Gy/h|L5 VERTEBRA|LEFT||Y|INVESTIGATOR|4|Visit_4|65|4|WASHOUT|2020-08-18|65
e|FA|49a972da-dfad-438e-b5bc-26ee6b955a59|8|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|vp/dose|[?]|1|psi|AORTIC VALVE|IPSILATERAL|Y||GUARDIAN|4|Visit_4|65|7|TREATMENT|2020-08-18|65
e|FA|49a972da-dfad-438e-b5bc-26ee6b955a59|9|SEV|Severity/Intensity|[?]|GERD|[?]|mL/day|[?]|1|Pa|NASAL BONE|RIGHT|||FRIEND|5|Visit_5|90|3|WASHOUT|2020-09-12|90
e|FA|49a972da-dfad-438e-b5bc-26ee6b955a59|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cP|[?]|1|mg/g/min|INTERPHALANGEAL JOINT 5 OF THE HAND|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-09-12|90
e|FA|502a42a7-2ed6-46b9-9b10-728f849334b6|1|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|ukat/10^12 RBC|[?]|1|g/dL|INGUINAL LYMPH NODE|IPSILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|SCREENING|2020-11-21|10
e|FA|502a42a7-2ed6-46b9-9b10-728f849334b6|2|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|/cmH2O|[?]|1|CUP|INTERPHALANGEAL JOINT 3 OF THE FOOT|LEFT|||PROXY|1|Visit_1|10|7|FOLLOW-UP|2020-11-21|10
e|FA|502a42a7-2ed6-46b9-9b10-728f849334b6|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|dpm/0.5 mL|[?]|1|mg/g/min|METACARPOPHALANGEAL JOINT 4|CONTRALATERAL||Y|PROXY|2|Visit_2|25|7|TREATMENT|2020-12-06|25
e|FA|502a42a7-2ed6-46b9-9b10-728f849334b6|4|LESNUM|Number of Lesions|[?]|GERD|[?]|mL/sec/1.73m2|[?]|1|ng/day|FEMALE GENITALIA|CONTRALATERAL|Y||PROXY|2|Visit_2|25|7|WASHOUT|2020-12-06|25
e|FA|502a42a7-2ed6-46b9-9b10-728f849334b6|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/g Hb|[?]|1|%(v/v)|TROCHLEAR NERVE|RIGHT|||PARENT|3|Visit_3|40|6|WASHOUT|2020-12-21|40
e|FA|502a42a7-2ed6-46b9-9b10-728f849334b6|6|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|10^6/hpf|[?]|1|mL/cm3/min|PYRAMIDAL TRACTS, BRAINSTEM|LATERAL|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|2|TREATMENT|2020-12-21|40
e|FA|502a42a7-2ed6-46b9-9b10-728f849334b6|7|DFRUIT|Dietary Fruit|[?]|GERD|[?]|uU/dL|[?]|1|10^6 CFU/mL|ESOPHAGUS, MIDDLE THIRD|CONTRALATERAL||Y|PROXY|4|Visit_4|65|6|FOLLOW-UP|2021-01-15|65
e|FA|502a42a7-2ed6-46b9-9b10-728f849334b6|8|LESNUM|Number of Lesions|[?]|GERD|[?]|g/animal|[?]|1|ng/day|RAPHE|UNILATERAL|||CAREGIVER|4|Visit_4|65|4|SCREENING|2021-01-15|65
e|FA|502a42a7-2ed6-46b9-9b10-728f849334b6|9|RLDEV|Relationship to Device|[?]|GERD|[?]|pmol/day|[?]|1|mL/min/mmHg|RETROPERITONEAL LYMPH NODE|LATERAL|||CHILD|5|Visit_5|90|3|TREATMENT|2021-02-09|90
e|FA|502a42a7-2ed6-46b9-9b10-728f849334b6|10|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|IU/g|[?]|1|mIU/L|HAIR|CONTRALATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|SCREENING|2021-02-09|90
e|FA|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|1|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|EP U|[?]|1|ng|ENDOMETRIUM|LEFT|Y||ADJUDICATOR|1|Visit_1|10|6|FOLLOW-UP|2020-10-26|10
e|FA|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|2|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|mg/dose|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|UNILATERAL||Y|VENDOR|1|Visit_1|10|4|WASHOUT|2020-10-26|10
e|FA|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|3|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|tsp|[?]|1|mL/mmHg/min/L|HEEL OF THE FOOT|RIGHT|||INTERVIEWER|2|Visit_2|25|2|WASHOUT|2020-11-10|25
e|FA|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|4|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|uCi/L|[?]|1|gtt|PARA-AORTIC LYMPH NODE|UNILATERAL|Y||CAREGIVER|2|Visit_2|25|5|TREATMENT|2020-11-10|25
e|FA|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|SBE/mL|[?]|1|U/mmol|CORONARY ARTERY|UNILATERAL|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-11-25|40
e|FA|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|6|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Newton|[?]|1|mm/h|RIB 11|UNILATERAL|Y|Y|INTERVIEWER|3|Visit_3|40|1|TREATMENT|2020-11-25|40
e|FA|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|7|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|Bq/kg|[?]|1|mL/h|LIVER, CAUDATE LOBE|RIGHT||Y|INTERVIEWER|4|Visit_4|65|7|FOLLOW-UP|2020-12-20|65
e|FA|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|8|SEV|Severity/Intensity|[?]|GERD|[?]|U/kg/h|[?]|1|Pa|FLEXOR CARPI RADIALIS MUSCLE|CONTRALATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2020-12-20|65
e|FA|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|9|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|mU/g|[?]|1|CUP|MESENTERY|LEFT||Y|SPOUSE|5|Visit_5|90|3|TREATMENT|2021-01-14|90
e|FA|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|10|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|cmHg|[?]|1|BOWL|RENAL FOSSA|BILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|WASHOUT|2021-01-14|90
e|FA|40c048ea-d637-426b-8afe-2da3a6961528|1|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|APL U/mL|[?]|1|DROP|L3-L4 INTERVERTEBRAL SPACE|BILATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-07-13|10
e|FA|40c048ea-d637-426b-8afe-2da3a6961528|2|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|CUP|UVEA|LEFT||Y|GUARDIAN|1|Visit_1|10|4|FOLLOW-UP|2020-07-13|10
e|FA|40c048ea-d637-426b-8afe-2da3a6961528|3|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|PFU/animal|[?]|1|cm H2O|COSTAL CARTILAGE|RIGHT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|WASHOUT|2020-07-28|25
e|FA|40c048ea-d637-426b-8afe-2da3a6961528|4|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg/min/L|[?]|1|CUP|ANKLE JOINT ANTERIOR FLEXOR TENDONS|LATERAL|||SIBLING|2|Visit_2|25|4|TREATMENT|2020-07-28|25
e|FA|40c048ea-d637-426b-8afe-2da3a6961528|5|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|um|[?]|1|mL/cm3/min|PROSTATE GLAND|LATERAL|||CHILD|3|Visit_3|40|1|WASHOUT|2020-08-12|40
e|FA|40c048ea-d637-426b-8afe-2da3a6961528|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|%(v/v)|SIGMOID SINUS|CONTRALATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2020-08-12|40
e|FA|40c048ea-d637-426b-8afe-2da3a6961528|7|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|genEq|[?]|1|10^6 IU/mL|SUBSCAPULARIS MUSCLE|LATERAL||Y|SPOUSE|4|Visit_4|65|7|TREATMENT|2020-09-06|65
e|FA|40c048ea-d637-426b-8afe-2da3a6961528|8|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|g/cage/day|[?]|1|mL/h|PREAURICULAR LYMPH NODE|UNILATERAL||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2020-09-06|65
e|FA|40c048ea-d637-426b-8afe-2da3a6961528|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|IU/dL|[?]|1|%(v/v)|SKIN OF THE FOREARM|LEFT|||CHILD|5|Visit_5|90|2|FOLLOW-UP|2020-10-01|90
e|FA|40c048ea-d637-426b-8afe-2da3a6961528|10|SEV|Severity/Intensity|[?]|GERD|[?]|mm3/mm2/year|[?]|1|Pa|LUNG, RIGHT LOWER LOBE|LATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-10-01|90
e|FA|4d03b209-bd53-47f5-8251-f9fb2074bc38|1|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|10^7 PFU|[?]|1|Shock Wave|STERNOCLAVICULAR JOINT|RIGHT|||FRIEND|1|Visit_1|10|5|TREATMENT|2021-01-02|10
e|FA|4d03b209-bd53-47f5-8251-f9fb2074bc38|2|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|Bq/mg|[?]|1|L/h/m2|NAIL|UNILATERAL|||INTERVIEWER|1|Visit_1|10|7|SCREENING|2021-01-02|10
e|FA|4d03b209-bd53-47f5-8251-f9fb2074bc38|3|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|U/dL|[?]|1|mAmp|HUMERUS SHAFT|LATERAL|||CAREGIVER|2|Visit_2|25|4|SCREENING|2021-01-17|25
e|FA|4d03b209-bd53-47f5-8251-f9fb2074bc38|4|LDIAM|Longest Diameter|[?]|GERD|[?]|log10 TCID 50/uL|[?]|1|Shock Wave|SPINAL CORD|UNILATERAL|Y||STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2021-01-17|25
e|FA|4d03b209-bd53-47f5-8251-f9fb2074bc38|5|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|1/(s*kPa)|[?]|1|PFU/dose|FOOT DIGIT 1|IPSILATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|2|WASHOUT|2021-02-01|40
e|FA|4d03b209-bd53-47f5-8251-f9fb2074bc38|6|LESNUM|Number of Lesions|[?]|GERD|[?]|steps/min|[?]|1|ng/day|FEMORAL LYMPH NODE|RIGHT|Y||FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2021-02-01|40
e|FA|4d03b209-bd53-47f5-8251-f9fb2074bc38|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^3 copies/mL|[?]|1|mg/g/min|GASTROINTESTINAL TRACT, LOWER, WALL|CONTRALATERAL|||INTERVIEWER|4|Visit_4|65|5|TREATMENT|2021-02-26|65
e|FA|4d03b209-bd53-47f5-8251-f9fb2074bc38|8|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|ms/mmHg|[?]|1|/500 WBC|URETHRA, PENILE|RIGHT|||ADJUDICATION COMMITTEE|4|Visit_4|65|7|FOLLOW-UP|2021-02-26|65
e|FA|4d03b209-bd53-47f5-8251-f9fb2074bc38|9|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|cmH2O*s/mL|[?]|1|ug/kg/h|PYRAMIDAL TRACTS, INTERNAL CAPSULE|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2021-03-23|90
e|FA|4d03b209-bd53-47f5-8251-f9fb2074bc38|10|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|dmol|[?]|1|10^9 CFU/g|L2 VERTEBRA|UNILATERAL|||INTERVIEWER|5|Visit_5|90|7|TREATMENT|2021-03-23|90
e|FA|35f01eda-1acb-4700-8285-c8cd4b69b524|1|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mmol/g|[?]|1|PFU/dose|ACCESSORY RENAL ARTERY|LEFT|||VENDOR|1|Visit_1|10|7|SCREENING|2020-09-30|10
e|FA|35f01eda-1acb-4700-8285-c8cd4b69b524|2|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|10^4 CFU/mL|C7 VERTEBRA|CONTRALATERAL|||DOMESTIC PARTNER|1|Visit_1|10|2|WASHOUT|2020-09-30|10
e|FA|35f01eda-1acb-4700-8285-c8cd4b69b524|3|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|/mm2|[?]|1|gtt|CEREBRAL VEIN|RIGHT|||SPOUSE|2|Visit_2|25|7|WASHOUT|2020-10-15|25
e|FA|35f01eda-1acb-4700-8285-c8cd4b69b524|4|DPROT|Dietary Protein|[?]|GERD|[?]|ng/dL|[?]|1|10^4 CFU/mL|LEG SKIN|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2020-10-15|25
e|FA|35f01eda-1acb-4700-8285-c8cd4b69b524|5|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|mCi|[?]|1|IU/mmol|RAPHE|LEFT||Y|ADJUDICATOR|3|Visit_3|40|2|FOLLOW-UP|2020-10-30|40
e|FA|35f01eda-1acb-4700-8285-c8cd4b69b524|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|pkat|[?]|1|mg/g/min|PANCREAS, ENDOCRINE|BILATERAL|Y||GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-10-30|40
e|FA|35f01eda-1acb-4700-8285-c8cd4b69b524|7|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|ug/g/min|[?]|1|Gy/h|MID-JUGULAR LYMPH NODE|UNILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|SCREENING|2020-11-24|65
e|FA|35f01eda-1acb-4700-8285-c8cd4b69b524|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|oz eq|[?]|1|mg/g/min|FEMALE REPRODUCTIVE SYSTEM|UNILATERAL|||INTERVIEWER|4|Visit_4|65|2|TREATMENT|2020-11-24|65
e|FA|35f01eda-1acb-4700-8285-c8cd4b69b524|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol/day|[?]|1|mg/g/min|BONE MARROW|LATERAL|||CAREGIVER|5|Visit_5|90|1|TREATMENT|2020-12-19|90
e|FA|35f01eda-1acb-4700-8285-c8cd4b69b524|10|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|mL/day|[?]|1|mL/m2|HEART|LEFT|||PARENT|5|Visit_5|90|1|WASHOUT|2020-12-19|90
e|FA|9df97277-7d07-4020-bae0-dfa982f21c8d|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|U/g/min|[?]|1|10^6 U|FOOT DIGIT 4|UNILATERAL|Y|Y|VENDOR|1|Visit_1|10|5|TREATMENT|2020-11-02|10
e|FA|9df97277-7d07-4020-bae0-dfa982f21c8d|2|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|uEq|[?]|1|Bq/L|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|RIGHT|||INDEPENDENT ASSESSOR|1|Visit_1|10|4|SCREENING|2020-11-02|10
e|FA|9df97277-7d07-4020-bae0-dfa982f21c8d|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/h|[?]|1|%(v/v)|WARDS TRIANGLE|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-11-17|25
e|FA|9df97277-7d07-4020-bae0-dfa982f21c8d|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/animal|[?]|1|mg/g/min|PERIURETHRAL REGION|RIGHT|Y||VENDOR|2|Visit_2|25|2|FOLLOW-UP|2020-11-17|25
e|FA|9df97277-7d07-4020-bae0-dfa982f21c8d|5|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|MPS U|[?]|1|g/dL|THYMUS GLAND|LEFT||Y|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-12-02|40
e|FA|9df97277-7d07-4020-bae0-dfa982f21c8d|6|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|10^4 CFU/mL|ARM SKIN|LEFT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-12-02|40
e|FA|9df97277-7d07-4020-bae0-dfa982f21c8d|7|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|mL/(min*100mL)|[?]|1|m2|SPLEEN, HILUM|CONTRALATERAL|||ADJUDICATOR|4|Visit_4|65|4|FOLLOW-UP|2020-12-27|65
e|FA|9df97277-7d07-4020-bae0-dfa982f21c8d|8|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|s*kPa|[?]|1|gtt|MITRAL VALVE|CONTRALATERAL||Y|FRIEND|4|Visit_4|65|6|WASHOUT|2020-12-27|65
e|FA|9df97277-7d07-4020-bae0-dfa982f21c8d|9|SEV|Severity/Intensity|[?]|GERD|[?]|uOsm|[?]|1|Pa|SUBTALAR JOINT|IPSILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2021-01-21|90
e|FA|9df97277-7d07-4020-bae0-dfa982f21c8d|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|L/h|[?]|1|Pa|BACK|CONTRALATERAL|||INTERVIEWER|5|Visit_5|90|2|TREATMENT|2021-01-21|90
e|FA|d1b522d5-557a-4361-a9da-292aa601fbc3|1|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|titer|[?]|1|10^6 U|MAIN BRONCHUS, RIGHT|LATERAL|||FRIEND|1|Visit_1|10|3|TREATMENT|2020-10-09|10
e|FA|d1b522d5-557a-4361-a9da-292aa601fbc3|2|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|mL/min/1.73m2|[?]|1|g/day|EPIDIDYMIS|LATERAL||Y|CHILD|1|Visit_1|10|7|TREATMENT|2020-10-09|10
e|FA|d1b522d5-557a-4361-a9da-292aa601fbc3|3|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|uU/L|[?]|1|g/day|CERVICAL VERTEBRA|BILATERAL|Y||FAMILY MEMBER|2|Visit_2|25|5|TREATMENT|2020-10-24|25
e|FA|d1b522d5-557a-4361-a9da-292aa601fbc3|4|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|U/10^12 RBC|OBTURATOR EXTERNUS MUSCLE|LEFT|Y||GUARDIAN|2|Visit_2|25|4|TREATMENT|2020-10-24|25
e|FA|d1b522d5-557a-4361-a9da-292aa601fbc3|5|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|gpELISA unit/mL|[?]|1|mEq|MIDDLE PHALANX 4 OF THE HAND|UNILATERAL|||SIBLING|3|Visit_3|40|5|FOLLOW-UP|2020-11-08|40
e|FA|d1b522d5-557a-4361-a9da-292aa601fbc3|6|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|mL/g/min|[?]|1|ng/day|MIDDLE PHALANX 3 OF THE HAND|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|5|TREATMENT|2020-11-08|40
e|FA|d1b522d5-557a-4361-a9da-292aa601fbc3|7|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|ug/L/h|[?]|1|g/day|LIMB|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|WASHOUT|2020-12-03|65
e|FA|d1b522d5-557a-4361-a9da-292aa601fbc3|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ngEq/L|[?]|1|%(v/v)|LATERAL RAMUS INTERMEDIUS ARTERY|IPSILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|7|TREATMENT|2020-12-03|65
e|FA|d1b522d5-557a-4361-a9da-292aa601fbc3|9|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|mL/s|[?]|1|mL/min/mmHg|THORACIC SPINE|LATERAL||Y|INTERVIEWER|5|Visit_5|90|3|WASHOUT|2020-12-28|90
e|FA|d1b522d5-557a-4361-a9da-292aa601fbc3|10|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mL/h|[?]|1|uL/kg/day|ENDOCERVIX|LEFT|||PARENT|5|Visit_5|90|1|TREATMENT|2020-12-28|90
e|FA|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|1|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|SFC/10^6 PBMC|[?]|1|cm|RAMUS INTERMEDIUS ARTERY|LEFT||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|WASHOUT|2020-07-27|10
e|FA|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|2|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|PLUG|[?]|1|fmol|EYE|IPSILATERAL||Y|FAMILY MEMBER|1|Visit_1|10|7|FOLLOW-UP|2020-07-27|10
e|FA|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|3|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|v/v|[?]|1|mL/cm3/min|PROCERUS MUSCLE|LEFT|||ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-08-11|25
e|FA|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|4|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa/L|[?]|1|fmol|LYMPH NODE|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-08-11|25
e|FA|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|5|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|/sec|[?]|1|cmH2O/mL|SKIN OF THE FINGER|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2020-08-26|40
e|FA|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|6|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|mg/g/h|[?]|1|10^6 IU/mL|PROSTATE GLAND, MIDDLE LOBE|BILATERAL|Y||GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-08-26|40
e|FA|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|7|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|nkat/g Hb|[?]|1|mL/min/mmHg|TOENAIL|LATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|3|TREATMENT|2020-09-20|65
e|FA|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|8|RLDEV|Relationship to Device|[?]|GERD|[?]|ukat/10^12 RBC|[?]|1|mL/min/mmHg|COLON, RECTOSIGMOID|CONTRALATERAL|||FAMILY MEMBER|4|Visit_4|65|2|WASHOUT|2020-09-20|65
e|FA|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|9|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|km|[?]|1|g/day|GRACILIS MUSCLE|CONTRALATERAL|Y||VENDOR|5|Visit_5|90|1|TREATMENT|2020-10-15|90
e|FA|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|kBq/uL|[?]|1|km|SKIN OF THE TRUNK|CONTRALATERAL|||PARENT|5|Visit_5|90|3|WASHOUT|2020-10-15|90
e|FA|da2d0844-3608-4927-9103-cb7c52dd2c96|1|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|ng/dL|[?]|1|EIA unit|LIP, UPPER|CONTRALATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2021-01-26|10
e|FA|da2d0844-3608-4927-9103-cb7c52dd2c96|2|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|mg/dose|[?]|1|Log10 ELISA unit|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|IPSILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|3|FOLLOW-UP|2021-01-26|10
e|FA|da2d0844-3608-4927-9103-cb7c52dd2c96|3|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|genEq/mL|[?]|1|BAG|SUPERIOR VENA CAVA|BILATERAL||Y|FAMILY MEMBER|2|Visit_2|25|4|WASHOUT|2021-02-10|25
e|FA|da2d0844-3608-4927-9103-cb7c52dd2c96|4|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|Weber|[?]|1|CUP|RETROPERITONEUM|RIGHT|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2021-02-10|25
e|FA|da2d0844-3608-4927-9103-cb7c52dd2c96|5|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|C|[?]|1|TRANSDUCING UNIT/mL|PARACOLIC GUTTER|LATERAL|Y||ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2021-02-25|40
e|FA|da2d0844-3608-4927-9103-cb7c52dd2c96|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|Henry|[?]|1|PACK|LEFT VENTRICULAR APICAL LATERAL SEGMENT|CONTRALATERAL|Y||ADJUDICATOR|3|Visit_3|40|2|FOLLOW-UP|2021-02-25|40
e|FA|da2d0844-3608-4927-9103-cb7c52dd2c96|7|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|nU/cL|[?]|1|10^4 CFU/mL|POSTERIOR INFERIOR CEREBELLAR ARTERY|IPSILATERAL|||SPOUSE|4|Visit_4|65|3|FOLLOW-UP|2021-03-22|65
e|FA|da2d0844-3608-4927-9103-cb7c52dd2c96|8|LENRSCT|Length of Resection|[?]|GERD|[?]|mmAL|[?]|1|psi|MITRAL VALVE|UNILATERAL|||FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2021-03-22|65
e|FA|da2d0844-3608-4927-9103-cb7c52dd2c96|9|SEV|Severity/Intensity|[?]|GERD|[?]|TRACE|[?]|1|Pa|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT|||SPOUSE|5|Visit_5|90|2|TREATMENT|2021-04-16|90
e|FA|da2d0844-3608-4927-9103-cb7c52dd2c96|10|DIAMETER|Diameter|[?]|GERD|[?]|U/10^12 RBC|[?]|1|cm|SKIN OF THE KNEE|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2021-04-16|90
e|FA|30b6f8a7-4512-462d-a162-45c3dad853e5|1|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms|[?]|1|umol|RETINAL ARTERY|CONTRALATERAL|Y||CHILD|1|Visit_1|10|3|SCREENING|2020-12-02|10
e|FA|30b6f8a7-4512-462d-a162-45c3dad853e5|2|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|ngEq/L|[?]|1|mL/dose|PENIS, RADIX|LEFT|Y||SIBLING|1|Visit_1|10|2|FOLLOW-UP|2020-12-02|10
e|FA|30b6f8a7-4512-462d-a162-45c3dad853e5|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/g|[?]|1|mg/g/min|LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT|LATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2020-12-17|25
e|FA|30b6f8a7-4512-462d-a162-45c3dad853e5|4|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|m3|[?]|1|cmH2O/mL|FACIAL NERVE|BILATERAL|Y||INVESTIGATOR|2|Visit_2|25|7|FOLLOW-UP|2020-12-17|25
e|FA|30b6f8a7-4512-462d-a162-45c3dad853e5|5|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|10^6 organisms/mL|VASTUS MEDIALIS MUSCLE|UNILATERAL|||GUARDIAN|3|Visit_3|40|4|WASHOUT|2021-01-01|40
e|FA|30b6f8a7-4512-462d-a162-45c3dad853e5|6|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|10^3 copies/mL|[?]|1|ohm|ACETABULUM|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|1|TREATMENT|2021-01-01|40
e|FA|30b6f8a7-4512-462d-a162-45c3dad853e5|7|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|m/sec|[?]|1|NEEDLE GAUGE|SACRAL VERTEBRA|BILATERAL|Y||PARENT|4|Visit_4|65|7|FOLLOW-UP|2021-01-26|65
e|FA|30b6f8a7-4512-462d-a162-45c3dad853e5|8|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|fg|[?]|1|SCOOPFUL|HUMERAL EPICONDYLE|LATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|FOLLOW-UP|2021-01-26|65
e|FA|30b6f8a7-4512-462d-a162-45c3dad853e5|9|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|/month|[?]|1|IU/mg|THYROID GLAND, RIGHT LOBE|CONTRALATERAL|||GUARDIAN|5|Visit_5|90|4|TREATMENT|2021-02-20|90
e|FA|30b6f8a7-4512-462d-a162-45c3dad853e5|10|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|U/g/min|[?]|1|uL/kg/day|INTERATRIAL SEPTUM|IPSILATERAL|||FAMILY MEMBER|5|Visit_5|90|5|TREATMENT|2021-02-20|90
e|FA|1a3808b9-6004-4133-8f59-49905d04655e|1|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|nmol/mol|[?]|1|cmH2O/mL|CORONARY ARTERY, RIGHT|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|WASHOUT|2020-11-07|10
e|FA|1a3808b9-6004-4133-8f59-49905d04655e|2|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|mL/dL|[?]|1|10^6 CFU|UVEA|IPSILATERAL|||ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-11-07|10
e|FA|1a3808b9-6004-4133-8f59-49905d04655e|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|in|[?]|1|mg/g/min|CORPUS STRIATUM|RIGHT|||CHILD|2|Visit_2|25|7|FOLLOW-UP|2020-11-22|25
e|FA|1a3808b9-6004-4133-8f59-49905d04655e|4|DFATT|Dietary Fat, Total|[?]|GERD|[?]|bel|[?]|1|Bq/mg|PARALARYNGEAL LYMPH NODE|LATERAL|||CAREGIVER|2|Visit_2|25|6|TREATMENT|2020-11-22|25
e|FA|1a3808b9-6004-4133-8f59-49905d04655e|5|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|10^6 CFU|SUBCLAVIAN ARTERY|CONTRALATERAL|||STUDY SUBJECT|3|Visit_3|40|5|FOLLOW-UP|2020-12-07|40
e|FA|1a3808b9-6004-4133-8f59-49905d04655e|6|TRTSETT|Treatment Setting|[?]|GERD|[?]|BAG|[?]|1|Coulomb|FACIAL NERVE|LATERAL|||FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-12-07|40
e|FA|1a3808b9-6004-4133-8f59-49905d04655e|7|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|L/s/kPa|[?]|1|ohm|MASTOID PROCESS|BILATERAL||Y|GUARDIAN|4|Visit_4|65|7|FOLLOW-UP|2021-01-01|65
e|FA|1a3808b9-6004-4133-8f59-49905d04655e|8|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|RING|[?]|1|Shock Wave|METACARPAL BONE 4|LEFT|Y||CAREGIVER|4|Visit_4|65|1|FOLLOW-UP|2021-01-01|65
e|FA|1a3808b9-6004-4133-8f59-49905d04655e|9|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mg/g/min|[?]|1|L/h/m2|FEMALE REPRODUCTIVE SYSTEM|CONTRALATERAL|Y||FAMILY MEMBER|5|Visit_5|90|5|TREATMENT|2021-01-26|90
e|FA|1a3808b9-6004-4133-8f59-49905d04655e|10|DFRUIT|Dietary Fruit|[?]|GERD|[?]|MPL U/mL|[?]|1|10^6 CFU/mL|TRIANGULAR BONE|LATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2021-01-26|90
e|FA|5c91894d-c756-4ade-9fc4-2a64d4acc53f|1|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|uL|[?]|1|IU/mg|SECOND OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2021-01-19|10
e|FA|5c91894d-c756-4ade-9fc4-2a64d4acc53f|2|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|uV|[?]|1|cmH2O/mL|HUMERUS|LATERAL||Y|INTERVIEWER|1|Visit_1|10|5|WASHOUT|2021-01-19|10
e|FA|5c91894d-c756-4ade-9fc4-2a64d4acc53f|3|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|mV2/Hz|[?]|1|DROP|LENS|UNILATERAL||Y|PROXY|2|Visit_2|25|5|TREATMENT|2021-02-03|25
e|FA|5c91894d-c756-4ade-9fc4-2a64d4acc53f|4|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|DAYS|[?]|1|g/day|PUBIC BONE|LATERAL|Y||INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2021-02-03|25
e|FA|5c91894d-c756-4ade-9fc4-2a64d4acc53f|5|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|nmol BCE/L|[?]|1|HOURS|POSTERIOR TIBIAL ARTERY|RIGHT|||STUDY SUBJECT|3|Visit_3|40|7|FOLLOW-UP|2021-02-18|40
e|FA|5c91894d-c756-4ade-9fc4-2a64d4acc53f|6|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|tsp|[?]|1|Gy/h|FALCIFORM LIGAMENT|RIGHT||Y|STUDY SUBJECT|3|Visit_3|40|7|TREATMENT|2021-02-18|40
e|FA|5c91894d-c756-4ade-9fc4-2a64d4acc53f|7|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|g/m2|[?]|1|uL/kg/day|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|SCREENING|2021-03-15|65
e|FA|5c91894d-c756-4ade-9fc4-2a64d4acc53f|8|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|SBE/mL|[?]|1|mg/dose|LATERAL THIRD DIAGONAL BRANCH ARTERY|UNILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|2|FOLLOW-UP|2021-03-15|65
e|FA|5c91894d-c756-4ade-9fc4-2a64d4acc53f|9|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|mL/(min*100mL)|[?]|1|Log10 ELISA unit|HAIR FOLLICLE|UNILATERAL|Y||FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-04-09|90
e|FA|5c91894d-c756-4ade-9fc4-2a64d4acc53f|10|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|SPRAY|[?]|1|EIA unit|OCULOMOTOR NERVE|RIGHT|||VENDOR|5|Visit_5|90|3|WASHOUT|2021-04-09|90
e|FA|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|1|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|cs|[?]|1|g/L|OLFACTORY NERVE|RIGHT||Y|SIGNIFICANT OTHER|1|Visit_1|10|5|SCREENING|2020-07-15|10
e|FA|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|2|PPTFCT|Precipitating Factor|[?]|GERD|[?]|uU/L|[?]|1|EIA unit|FOREHEAD|CONTRALATERAL||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2020-07-15|10
e|FA|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|MBq|[?]|1|10^6 U|BREAST|UNILATERAL|||VENDOR|2|Visit_2|25|5|WASHOUT|2020-07-30|25
e|FA|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|4|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|Log10 ELISA unit|CAROTID ARTERY|UNILATERAL|Y||CHILD|2|Visit_2|25|3|TREATMENT|2020-07-30|25
e|FA|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|5|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|POINT|[?]|1|/200 HPFs|TYMPANIC MEMBRANE|IPSILATERAL|||PROXY|3|Visit_3|40|4|TREATMENT|2020-08-14|40
e|FA|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|6|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|ng/L|[?]|1|mEq|PECTORALIS MAJOR MUSCLE|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|1|FOLLOW-UP|2020-08-14|40
e|FA|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^8/L|[?]|1|%(v/v)|SALIVARY GLAND, SUBLINGUAL|RIGHT|||INDEPENDENT ASSESSOR|4|Visit_4|65|4|FOLLOW-UP|2020-09-08|65
e|FA|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|8|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|10^4 CFU/mL|LIMB|LEFT||Y|FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-09-08|65
e|FA|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|9|RLDEV|Relationship to Device|[?]|GERD|[?]|cm2|[?]|1|mL/min/mmHg|ADDUCTOR POLLICIS MUSCLE|CONTRALATERAL|||FRIEND|5|Visit_5|90|7|TREATMENT|2020-10-03|90
e|FA|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|nmol|[?]|1|mg/g/min|DURAL VENOUS SINUS|IPSILATERAL|Y||SIGNIFICANT OTHER|5|Visit_5|90|2|SCREENING|2020-10-03|90
e|FA|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|1|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|Gy/min|[?]|1|mL/h|LINGULA OF THE LUNG|CONTRALATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|2|SCREENING|2020-09-15|10
e|FA|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|2|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mm/sec|[?]|1|oz eq|THORACIC AORTA|IPSILATERAL|||PARENT|1|Visit_1|10|4|WASHOUT|2020-09-15|10
e|FA|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|3|TOTNUM|Total Number|[?]|GERD|[?]|mL/g/h|[?]|1|/200 HPFs|SUPRAPUBIC REGION|IPSILATERAL|||GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-09-30|25
e|FA|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|4|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|Bq/mg|[?]|1|mm|PERICARDIAL LYMPH NODE|LEFT|Y|Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2020-09-30|25
e|FA|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|5|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|OD Unit|[?]|1|ng|CORONARY ARTERY|LEFT|||GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-10-15|40
e|FA|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|6|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|uU/L|[?]|1|TRANSDUCING UNIT/mL|INTERPHALANGEAL JOINT 1|RIGHT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2020-10-15|40
e|FA|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|7|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|PELLET|[?]|1|SACHET|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|4|WASHOUT|2020-11-09|65
e|FA|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|8|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|Tesla|[?]|1|EIA unit|CEREBRAL HEMISPHERE, LEFT|BILATERAL|||GUARDIAN|4|Visit_4|65|5|TREATMENT|2020-11-09|65
e|FA|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|9|VOL|Volume|[?]|GERD|[?]|10^6 organisms/g|[?]|1|vp/dose|MEDIASTINUM, MIDDLE|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|FOLLOW-UP|2020-12-04|90
e|FA|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|10|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|ug/kg/h|[?]|1|DROP|ANKLE JOINT|LEFT|Y||INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2020-12-04|90
e|FA|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|1|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|10^6 DNA copies/mL|[?]|1|Ci/ug|SUBCLAVIAN VEIN|IPSILATERAL|Y|Y|CAREGIVER|1|Visit_1|10|2|TREATMENT|2020-06-10|10
e|FA|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|2|SERVNUM|Number of Servings|[?]|GERD|[?]|Linear ft*LB|[?]|1|Hz/s|INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|SCREENING|2020-06-10|10
e|FA|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|3|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|PFU|[?]|1|MPS U|PREFRONTAL CORTEX|BILATERAL|||FAMILY MEMBER|2|Visit_2|25|2|FOLLOW-UP|2020-06-25|25
e|FA|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|/VF|[?]|1|MBq|HEART|LEFT|||STUDY SUBJECT|2|Visit_2|25|5|SCREENING|2020-06-25|25
e|FA|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|5|CALBURN|Calories Burned|[?]|GERD|[?]|10^3 RNA copies/mL|[?]|1|/kg|RECTUS FEMORIS MUSCLE|CONTRALATERAL|Y|Y|INTERVIEWER|3|Visit_3|40|2|SCREENING|2020-07-10|40
e|FA|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|6|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|cm|[?]|1|mL/animal/day|ELBOW JOINT|LEFT|||ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2020-07-10|40
e|FA|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|10^6/Ejaculate U|[?]|1|U/mg|MID-CIRCUMFLEX ARTERY|LEFT|Y||FRIEND|4|Visit_4|65|3|TREATMENT|2020-08-04|65
e|FA|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|8|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|ug/kg/day|[?]|1|g/dL|TESTIS|RIGHT|Y|Y|ADJUDICATOR|4|Visit_4|65|7|SCREENING|2020-08-04|65
e|FA|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|9|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|GBq|[?]|1|QUANTITY SUFFICIENT|GASTROINTESTINAL SYSTEM|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-08-29|90
e|FA|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|10|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|ug/kg/h|ABDUCTOR HALLUCIS MUSCLE|LATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|4|WASHOUT|2020-08-29|90
e|FA|37610314-f803-4ffa-a584-ebfe09267a0d|1|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|/min|[?]|1|mm|LOWER JUGULAR LYMPH NODE|IPSILATERAL|||CAREGIVER|1|Visit_1|10|3|TREATMENT|2020-06-30|10
e|FA|37610314-f803-4ffa-a584-ebfe09267a0d|2|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|mm/h|RIB 6|IPSILATERAL||Y|SPOUSE|1|Visit_1|10|4|TREATMENT|2020-06-30|10
e|FA|37610314-f803-4ffa-a584-ebfe09267a0d|3|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|mL*cmH2O|[?]|1|L|SKIN OF THE FACE|BILATERAL|Y||FRIEND|2|Visit_2|25|7|WASHOUT|2020-07-15|25
e|FA|37610314-f803-4ffa-a584-ebfe09267a0d|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mEq|[?]|1|%(v/v)|FIRST OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|Y|Y|PROXY|2|Visit_2|25|7|TREATMENT|2020-07-15|25
e|FA|37610314-f803-4ffa-a584-ebfe09267a0d|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/L DDU|[?]|1|mL/animal/day|HEART, RIGHT ATRIUM|RIGHT|||CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-07-30|40
e|FA|37610314-f803-4ffa-a584-ebfe09267a0d|6|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|MAC50|[?]|1|mL/h|PALATINE BONE|LATERAL|||GUARDIAN|3|Visit_3|40|6|WASHOUT|2020-07-30|40
e|FA|37610314-f803-4ffa-a584-ebfe09267a0d|7|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|dmol|[?]|1|NEEDLE GAUGE|INFRACLAVICULAR LYMPH NODE|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|FOLLOW-UP|2020-08-24|65
e|FA|37610314-f803-4ffa-a584-ebfe09267a0d|8|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|nmol BCE/nmol|[?]|1|10^6 CFU|DISTAL EXTRAHEPATIC BILE DUCT REGION|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-08-24|65
e|FA|37610314-f803-4ffa-a584-ebfe09267a0d|9|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|ms/mmHg|[?]|1|MPS U|SKIN OF THE NECK|LEFT|Y||PARENT|5|Visit_5|90|2|WASHOUT|2020-09-18|90
e|FA|37610314-f803-4ffa-a584-ebfe09267a0d|10|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|ELISA unit|[?]|1|mL/animal/day|RETINAL PIGMENTED EPITHELIAL LAYER|RIGHT||Y|PROXY|5|Visit_5|90|6|FOLLOW-UP|2020-09-18|90
e|FA|760ec5ce-3ae7-4268-9f76-b83085ad3754|1|SEV|Severity/Intensity|[?]|GERD|[?]|mV|[?]|1|Pa|SUPERIOR PUBIC RAMUS|RIGHT|||INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-09-24|10
e|FA|760ec5ce-3ae7-4268-9f76-b83085ad3754|2|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|10^12/L|[?]|1|cmH2O/mL|HEART, LEFT VENTRICULAR WALL|LATERAL|Y||CHILD|1|Visit_1|10|6|TREATMENT|2020-09-24|10
e|FA|760ec5ce-3ae7-4268-9f76-b83085ad3754|3|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|m|[?]|1|mIU/L|THIRD RIGHT POSTEROLATERAL ARTERY|LEFT|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|4|WASHOUT|2020-10-09|25
e|FA|760ec5ce-3ae7-4268-9f76-b83085ad3754|4|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|copies/ug|[?]|1|PACK|PROXIMAL INTERPHALANGEAL JOINT 2|RIGHT|||STUDY SUBJECT|2|Visit_2|25|5|WASHOUT|2020-10-09|25
e|FA|760ec5ce-3ae7-4268-9f76-b83085ad3754|5|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|Ci/ug|[?]|1|NEEDLE GAUGE|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|LATERAL|Y|Y|DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-10-24|40
e|FA|760ec5ce-3ae7-4268-9f76-b83085ad3754|6|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|/2000 RBC|[?]|1|/500 WBC|PLEURAL CAVITY|LATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|6|WASHOUT|2020-10-24|40
e|FA|760ec5ce-3ae7-4268-9f76-b83085ad3754|7|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|BE/mL|[?]|1|ng|VEIN|IPSILATERAL|||STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2020-11-18|65
e|FA|760ec5ce-3ae7-4268-9f76-b83085ad3754|8|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|RFU|[?]|1|g/day|PERIANAL REGION|LATERAL|Y||ADJUDICATOR|4|Visit_4|65|5|WASHOUT|2020-11-18|65
e|FA|760ec5ce-3ae7-4268-9f76-b83085ad3754|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^12 IU/L|[?]|1|%(v/v)|REGIONAL LYMPH NODE|IPSILATERAL|Y||SPOUSE|5|Visit_5|90|1|SCREENING|2020-12-13|90
e|FA|760ec5ce-3ae7-4268-9f76-b83085ad3754|10|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|mmol/kg|[?]|1|Bq/mg|BRACHIAL VEIN|BILATERAL||Y|INTERVIEWER|5|Visit_5|90|3|TREATMENT|2020-12-13|90
e|FA|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|1|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|10^6/Ejaculate U|[?]|1|ohm|LEFT POSTEROLATERAL DESCENDING ARTERY|RIGHT|Y|Y|ADJUDICATOR|1|Visit_1|10|7|FOLLOW-UP|2020-06-15|10
e|FA|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ngEq/L|[?]|1|mg/g/min|GASTROINTESTINAL TRACT|LATERAL|||CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-06-15|10
e|FA|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|3|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|CAN|[?]|1|IU/mmol|SHOULDER JOINT|LATERAL|Y||FRIEND|2|Visit_2|25|6|TREATMENT|2020-06-30|25
e|FA|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|4|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|psi|[?]|1|mL/m2|HAMATE BONE|LATERAL|||FAMILY MEMBER|2|Visit_2|25|5|TREATMENT|2020-06-30|25
e|FA|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/mmol|[?]|1|mg/g/min|ESOPHAGUS, CERVICAL|UNILATERAL|||PROXY|3|Visit_3|40|1|SCREENING|2020-07-15|40
e|FA|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|6|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|mL/dL|[?]|1|IU/mg|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-07-15|40
e|FA|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|7|LOCONSET|Localization of Onset|[?]|GERD|[?]|10^9 CFU/g|[?]|1|g/L|ISCHIUM|BILATERAL||Y|SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-08-09|65
e|FA|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^6/Ejaculate U|[?]|1|%(v/v)|POSTERIOR TIBIAL VEIN|LEFT|||VENDOR|4|Visit_4|65|3|TREATMENT|2020-08-09|65
e|FA|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|cm|[?]|1|mg/g/min|OBTURATOR INTERNUS MUSCLE|UNILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|7|FOLLOW-UP|2020-09-03|90
e|FA|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|10|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|%/s|[?]|1|cmH2O/mL|SCAPHOID-TRAPEZIUM JOINT|LEFT|||PROXY|5|Visit_5|90|4|FOLLOW-UP|2020-09-03|90
e|FA|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|dpm/0.5 mL|[?]|1|%(v/v)|MUSCULOSKELETAL SYSTEM|UNILATERAL|||PARENT|1|Visit_1|10|3|TREATMENT|2021-01-24|10
e|FA|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|2|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|g/g|[?]|1|MBq|SECOND OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|Y|Y|VENDOR|1|Visit_1|10|6|WASHOUT|2021-01-24|10
e|FA|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|3|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|uEq|[?]|1|fmol|FIRST RIGHT POSTEROLATERAL ARTERY|IPSILATERAL|||CAREGIVER|2|Visit_2|25|6|FOLLOW-UP|2021-02-08|25
e|FA|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|4|CALBURN|Calories Burned|[?]|GERD|[?]|nmol|[?]|1|/kg|TRAPEZOID BONE|LEFT|||INDEPENDENT ASSESSOR|2|Visit_2|25|5|SCREENING|2021-02-08|25
e|FA|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mmHg|[?]|1|mg/g/min|LIMB|CONTRALATERAL|||VENDOR|3|Visit_3|40|6|WASHOUT|2021-02-23|40
e|FA|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|6|PPTFCT|Precipitating Factor|[?]|GERD|[?]|amu|[?]|1|EIA unit|SKIN OF THE BUTTOCK|BILATERAL||Y|INTERVIEWER|3|Visit_3|40|5|WASHOUT|2021-02-23|40
e|FA|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|7|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|U/kg/day|[?]|1|ug/g/h|AORTIC ARCH|UNILATERAL|Y||INTERVIEWER|4|Visit_4|65|5|TREATMENT|2021-03-20|65
e|FA|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|8|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|usec|[?]|1|g/L|SUBCLAVIAN VEIN|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2021-03-20|65
e|FA|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|9|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|IU/mmol|[?]|1|mEq|L5 VERTEBRA|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|TREATMENT|2021-04-14|90
e|FA|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|10|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|mmHg*min/L|[?]|1|SCOOPFUL|BRACHIORADIALIS MUSCLE|RIGHT|||PROXY|5|Visit_5|90|2|TREATMENT|2021-04-14|90
e|FA|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|1|OBJTYPE|Type of Object|[?]|GERD|[?]|ng/day|[?]|1|ng|CELIAC LYMPH NODE|IPSILATERAL|||SPOUSE|1|Visit_1|10|1|TREATMENT|2020-11-13|10
e|FA|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|2|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|hPa|[?]|1|SCOOPFUL|INTERNAL ILIAC LYMPH NODE|LATERAL|||SIBLING|1|Visit_1|10|1|TREATMENT|2020-11-13|10
e|FA|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/m2/day|[?]|1|mg/g/min|PRECUNEUS|IPSILATERAL|||ADJUDICATOR|2|Visit_2|25|2|FOLLOW-UP|2020-11-28|25
e|FA|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|4|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|10^10/L|[?]|1|L/h/m2|ACROMIOCLAVICULAR JOINT|UNILATERAL|||CAREGIVER|2|Visit_2|25|5|FOLLOW-UP|2020-11-28|25
e|FA|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|5|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|min|[?]|1|ng|PITUITARY GLAND|BILATERAL|||GUARDIAN|3|Visit_3|40|7|TREATMENT|2020-12-13|40
e|FA|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|6|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|10^6 CFU|TIBIA SHAFT|UNILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|1|FOLLOW-UP|2020-12-13|40
e|FA|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|7|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|Ci/uL|[?]|1|L|ENDOMETRIAL CAVITY|LATERAL|Y||DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2021-01-07|65
e|FA|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|8|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|kBq|[?]|1|SCOOPFUL|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|LATERAL|||PARENT|4|Visit_4|65|7|WASHOUT|2021-01-07|65
e|FA|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|9|DFRUIT|Dietary Fruit|[?]|GERD|[?]|s/h|[?]|1|10^6 CFU/mL|PYRAMIDAL TRACTS, BRAINSTEM|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2021-02-01|90
e|FA|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|10|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|uEq/L|[?]|1|Bq/mg|SUBMANDIBULAR LYMPH NODE|UNILATERAL|Y||CAREGIVER|5|Visit_5|90|3|WASHOUT|2021-02-01|90
e|FA|d7b41e15-6725-4433-8a35-72629e342b47|1|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|dpm/mL|[?]|1|mmHg/L/min|SUBARACHNOID SPACE|LEFT|Y|Y|SPOUSE|1|Visit_1|10|7|TREATMENT|2020-09-14|10
e|FA|d7b41e15-6725-4433-8a35-72629e342b47|2|LENRSCT|Length of Resection|[?]|GERD|[?]|msec|[?]|1|psi|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|LATERAL|||GUARDIAN|1|Visit_1|10|2|FOLLOW-UP|2020-09-14|10
e|FA|d7b41e15-6725-4433-8a35-72629e342b47|3|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|BAU|[?]|1|Shock Wave|KIDNEY, LOWER LOBE|LATERAL|||SIBLING|2|Visit_2|25|6|TREATMENT|2020-09-29|25
e|FA|d7b41e15-6725-4433-8a35-72629e342b47|4|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|mL/(min*100mL)|[?]|1|DRUM|CECUM|CONTRALATERAL|||INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-09-29|25
e|FA|d7b41e15-6725-4433-8a35-72629e342b47|5|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|1/(s*kPa)|[?]|1|in|RADIUS SHAFT|LEFT|||SIBLING|3|Visit_3|40|7|TREATMENT|2020-10-14|40
e|FA|d7b41e15-6725-4433-8a35-72629e342b47|6|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|CAPFUL|[?]|1|mL/cm3/min|SHOULDER JOINT TENDONS|LATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|WASHOUT|2020-10-14|40
e|FA|d7b41e15-6725-4433-8a35-72629e342b47|7|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|Enzyme U/g Hb|[?]|1|mL/m2|BLADDER, TRIGONE|LEFT||Y|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-11-08|65
e|FA|d7b41e15-6725-4433-8a35-72629e342b47|8|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|cGy|[?]|1|AU/mL|L1 VERTEBRA|BILATERAL|||PARENT|4|Visit_4|65|4|TREATMENT|2020-11-08|65
e|FA|d7b41e15-6725-4433-8a35-72629e342b47|9|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|mkat|[?]|1|EIA unit|GLUTEAL MUSCLE|BILATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|1|SCREENING|2020-12-03|90
e|FA|d7b41e15-6725-4433-8a35-72629e342b47|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|oz eq|GLUTEUS MAXIMUS|IPSILATERAL|||VENDOR|5|Visit_5|90|3|WASHOUT|2020-12-03|90
e|FA|aeddc1ed-545c-405e-b1f7-08131961f5ff|1|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|msec|[?]|1|mEq/g|PERONEAL ARTERY|CONTRALATERAL|||CHILD|1|Visit_1|10|4|TREATMENT|2020-10-15|10
e|FA|aeddc1ed-545c-405e-b1f7-08131961f5ff|2|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|IU/g|[?]|1|mm/h|TEMPORAL ARTERY|RIGHT|Y||PARENT|1|Visit_1|10|7|TREATMENT|2020-10-15|10
e|FA|aeddc1ed-545c-405e-b1f7-08131961f5ff|3|AGETRT1|Age At First Treatment|[?]|GERD|[?]|CFU/g|[?]|1|mL/mmHg/min/L|AORTIC VALVE ANNULUS|RIGHT|||INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-10-30|25
e|FA|aeddc1ed-545c-405e-b1f7-08131961f5ff|4|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|U/kg|[?]|1|mL|LATERAL HUMERAL EPICONDYLE|IPSILATERAL|Y|Y|INDEPENDENT ASSESSOR|2|Visit_2|25|7|SCREENING|2020-10-30|25
e|FA|aeddc1ed-545c-405e-b1f7-08131961f5ff|5|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|MPS U|[?]|1|mg/h|LATISSIMUS DORSI MUSCLE|RIGHT|Y||CHILD|3|Visit_3|40|5|TREATMENT|2020-11-14|40
e|FA|aeddc1ed-545c-405e-b1f7-08131961f5ff|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mg/cm2|[?]|1|CUP|CALCANEUS|RIGHT|||DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-11-14|40
e|FA|aeddc1ed-545c-405e-b1f7-08131961f5ff|7|ACNDEV|Action Taken With Device|[?]|GERD|[?]|10^3 organisms|[?]|1|100 IU/mL|THIRD RIGHT POSTEROLATERAL ARTERY|LATERAL|Y||INTERVIEWER|4|Visit_4|65|2|TREATMENT|2020-12-09|65
e|FA|aeddc1ed-545c-405e-b1f7-08131961f5ff|8|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|/500 WBC|[?]|1|NEEDLE GAUGE|FACIAL NERVE|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2020-12-09|65
e|FA|aeddc1ed-545c-405e-b1f7-08131961f5ff|9|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|TRANSDUCING UNIT/mL|T9 VERTEBRA|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|SCREENING|2021-01-03|90
e|FA|aeddc1ed-545c-405e-b1f7-08131961f5ff|10|EVENTNUM|Number of Events|[?]|GERD|[?]|ppb|[?]|1|U/10^12 RBC|GASTRIC CURVATURE LYMPH NODE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|SCREENING|2021-01-03|90
e|FA|3effe272-6a68-4163-a4f3-bd269af6061c|1|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|mg/mL/day|[?]|1|EIA unit|T1 VERTEBRA|LATERAL|||SIBLING|1|Visit_1|10|2|TREATMENT|2021-01-15|10
e|FA|3effe272-6a68-4163-a4f3-bd269af6061c|2|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|mL/cm H2O|[?]|1|IU/mg|DUODENUM|UNILATERAL|||PARENT|1|Visit_1|10|5|TREATMENT|2021-01-15|10
e|FA|3effe272-6a68-4163-a4f3-bd269af6061c|3|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|g/m2/day|[?]|1|BOWL|AORTA|UNILATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|WASHOUT|2021-01-30|25
e|FA|3effe272-6a68-4163-a4f3-bd269af6061c|4|DIAMETER|Diameter|[?]|GERD|[?]|10^6 IU/mL|[?]|1|cm|PROXIMAL CIRCUMFLEX ARTERY|RIGHT|||SIBLING|2|Visit_2|25|7|WASHOUT|2021-01-30|25
e|FA|3effe272-6a68-4163-a4f3-bd269af6061c|5|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit|[?]|1|aMFI|FLEXOR HALLUCIS LONGUS MUSCLE|BILATERAL|||INVESTIGATOR|3|Visit_3|40|1|FOLLOW-UP|2021-02-14|40
e|FA|3effe272-6a68-4163-a4f3-bd269af6061c|6|QOLIMP|QOL Impact|[?]|GERD|[?]|mV2/Hz|[?]|1|10^6/L|SKIN OF THE ELBOW|RIGHT|||GUARDIAN|3|Visit_3|40|5|SCREENING|2021-02-14|40
e|FA|3effe272-6a68-4163-a4f3-bd269af6061c|7|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|10^6/L|[?]|1|mmHg/L/min|LIVER LOBE|UNILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2021-03-11|65
e|FA|3effe272-6a68-4163-a4f3-bd269af6061c|8|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|rpm|[?]|1|ug/g/h|MID-LAD ARTERY|LATERAL|||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2021-03-11|65
e|FA|3effe272-6a68-4163-a4f3-bd269af6061c|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|TABLET|[?]|1|Pa|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|UNILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-04-05|90
e|FA|3effe272-6a68-4163-a4f3-bd269af6061c|10|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|RING|[?]|1|DROP|FOREBRAIN|BILATERAL|||INTERVIEWER|5|Visit_5|90|7|WASHOUT|2021-04-05|90
e|FA|8153c765-a92a-4b0f-9ef3-6ca925337f54|1|TOTNUM|Total Number|[?]|GERD|[?]|cm/min|[?]|1|/200 HPFs|WRIST JOINT EXTENSOR MUSCLES|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2020-09-29|10
e|FA|8153c765-a92a-4b0f-9ef3-6ca925337f54|2|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|MPL U/mL|[?]|1|U/mg|LEFT VENTRICULAR MID ANTERIOR SEGMENT|LEFT|||CHILD|1|Visit_1|10|5|WASHOUT|2020-09-29|10
e|FA|8153c765-a92a-4b0f-9ef3-6ca925337f54|3|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|anti-Xa IU|[?]|1|TRANSDUCING UNIT/mL|EXTERNAL ILIAC LYMPH NODE|LEFT|||INTERVIEWER|2|Visit_2|25|7|SCREENING|2020-10-14|25
e|FA|8153c765-a92a-4b0f-9ef3-6ca925337f54|4|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|sec|[?]|1|10^6 organisms/mL|COSTOCHONDRAL JOINT 1|UNILATERAL||Y|FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-10-14|25
e|FA|8153c765-a92a-4b0f-9ef3-6ca925337f54|5|SEV|Severity/Intensity|[?]|GERD|[?]|kcal/day|[?]|1|Pa|TROCHLEAR NERVE|RIGHT||Y|GUARDIAN|3|Visit_3|40|3|SCREENING|2020-10-29|40
e|FA|8153c765-a92a-4b0f-9ef3-6ca925337f54|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|Tbsp|[?]|1|PACK|SUPRAGLOTTIS|BILATERAL|||GUARDIAN|3|Visit_3|40|7|TREATMENT|2020-10-29|40
e|FA|8153c765-a92a-4b0f-9ef3-6ca925337f54|7|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|m|[?]|1|mL/min/mmHg|PENIS, GLANS|LATERAL|||CAREGIVER|4|Visit_4|65|2|TREATMENT|2020-11-23|65
e|FA|8153c765-a92a-4b0f-9ef3-6ca925337f54|8|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|h*%|[?]|1|U/mg|BULBAR CONJUNCTIVA|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|7|SCREENING|2020-11-23|65
e|FA|8153c765-a92a-4b0f-9ef3-6ca925337f54|9|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|Coulomb|[?]|1|mL/h|LIVER FISSURE|IPSILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2020-12-18|90
e|FA|8153c765-a92a-4b0f-9ef3-6ca925337f54|10|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|hPa|[?]|1|fmol|TEMPORAL ARTERY|IPSILATERAL|||ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-12-18|90
e|FA|8d27cdcf-768e-4630-95b5-da554f6f3b56|1|SEV|Severity/Intensity|[?]|GERD|[?]|L/min|[?]|1|Pa|NASAL SEPTUM|BILATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|7|SCREENING|2020-10-30|10
e|FA|8d27cdcf-768e-4630-95b5-da554f6f3b56|2|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|deg/s|[?]|1|mIU/L|VAGINA|UNILATERAL|||INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-10-30|10
e|FA|8d27cdcf-768e-4630-95b5-da554f6f3b56|3|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|LOZENGE|[?]|1|Log10 ELISA unit|INTERPHALANGEAL JOINT 5|IPSILATERAL|||STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2020-11-14|25
e|FA|8d27cdcf-768e-4630-95b5-da554f6f3b56|4|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|uOsm|[?]|1|mL/mmHg/min/L|AORTIC VALVE ANNULUS|RIGHT|||STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-11-14|25
e|FA|8d27cdcf-768e-4630-95b5-da554f6f3b56|5|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|IU/mmol|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|LATERAL|||DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-11-29|40
e|FA|8d27cdcf-768e-4630-95b5-da554f6f3b56|6|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|mU/g|[?]|1|Bq/L|PARASYMPATHETIC GANGLIA|UNILATERAL|||SPOUSE|3|Visit_3|40|1|SCREENING|2020-11-29|40
e|FA|8d27cdcf-768e-4630-95b5-da554f6f3b56|7|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|ohm|DISTAL COMMON BILE DUCT|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-12-24|65
e|FA|8d27cdcf-768e-4630-95b5-da554f6f3b56|8|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|cd*s/m2|[?]|1|AU/mL|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|BILATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|7|TREATMENT|2020-12-24|65
e|FA|8d27cdcf-768e-4630-95b5-da554f6f3b56|9|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|U/g/h|[?]|1|mEq|AZYGOS VEIN|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|6|SCREENING|2021-01-18|90
e|FA|8d27cdcf-768e-4630-95b5-da554f6f3b56|10|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|/cmH2O|[?]|1|SCOOPFUL|FOREARM|BILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-01-18|90
e|FA|5c2791ff-aaf6-413f-9827-6e97e2273388|1|EXTRSCT|Extent of Resection|[?]|GERD|[?]|U/g Hb|[?]|1|Weber|HEPATOBILIARY SYSTEM|CONTRALATERAL|||CAREGIVER|1|Visit_1|10|6|WASHOUT|2020-09-06|10
e|FA|5c2791ff-aaf6-413f-9827-6e97e2273388|2|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|g/day|[?]|1|IU/mg|MAIN BRONCHUS, RIGHT|CONTRALATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|5|WASHOUT|2020-09-06|10
e|FA|5c2791ff-aaf6-413f-9827-6e97e2273388|3|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|CYLINDER|[?]|1|mL/dose|SUPRAPUBIC REGION|UNILATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-09-21|25
e|FA|5c2791ff-aaf6-413f-9827-6e97e2273388|4|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|m/sec|[?]|1|mmHg/L/min|RIB 12|LATERAL|||CHILD|2|Visit_2|25|6|TREATMENT|2020-09-21|25
e|FA|5c2791ff-aaf6-413f-9827-6e97e2273388|5|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|uOsm|[?]|1|10^6/L|CARDIAC VALVE|IPSILATERAL||Y|INTERVIEWER|3|Visit_3|40|2|SCREENING|2020-10-06|40
e|FA|5c2791ff-aaf6-413f-9827-6e97e2273388|6|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|U/mg|[?]|1|U/mg|COCCYGEAL VERTEBRA|LEFT|Y|Y|FRIEND|3|Visit_3|40|2|SCREENING|2020-10-06|40
e|FA|5c2791ff-aaf6-413f-9827-6e97e2273388|7|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|10^6 CFU/mL|FUNDUS UTERI|IPSILATERAL|Y|Y|SPOUSE|4|Visit_4|65|4|FOLLOW-UP|2020-10-31|65
e|FA|5c2791ff-aaf6-413f-9827-6e97e2273388|8|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|Bq/mg|[?]|1|mL/dose|TIBIOTARSAL JOINT|BILATERAL||Y|SIBLING|4|Visit_4|65|2|SCREENING|2020-10-31|65
e|FA|5c2791ff-aaf6-413f-9827-6e97e2273388|9|DISTANCE|Distance|[?]|GERD|[?]|VOXEL|[?]|1|BOWL|LEPTOMENINGES|LEFT|||CAREGIVER|5|Visit_5|90|6|FOLLOW-UP|2020-11-25|90
e|FA|5c2791ff-aaf6-413f-9827-6e97e2273388|10|VOL|Volume|[?]|GERD|[?]|g/mol|[?]|1|vp/dose|BRACHIAL VEIN|LATERAL|Y||FAMILY MEMBER|5|Visit_5|90|5|TREATMENT|2020-11-25|90
e|FA|b336d8c2-7bca-404e-aea3-5148d559ea99|1|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|pg/cell|[?]|1|mg/h|EYE BULGE|LEFT|||VENDOR|1|Visit_1|10|1|SCREENING|2020-09-19|10
e|FA|b336d8c2-7bca-404e-aea3-5148d559ea99|2|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|TROCHE|[?]|1|aMFI|PRETRACHEAL LYMPH NODE|LEFT||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|SCREENING|2020-09-19|10
e|FA|b336d8c2-7bca-404e-aea3-5148d559ea99|3|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|CFU/mL|[?]|1|g/L|BUTTOCK|CONTRALATERAL||Y|PROXY|2|Visit_2|25|7|WASHOUT|2020-10-04|25
e|FA|b336d8c2-7bca-404e-aea3-5148d559ea99|4|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|dram|[?]|1|anti-Xa IU/mL|COLON LYMPH NODE|LEFT|Y||VENDOR|2|Visit_2|25|6|SCREENING|2020-10-04|25
e|FA|b336d8c2-7bca-404e-aea3-5148d559ea99|5|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|IU/kg/h|[?]|1|m2|SUPERIOR SAGITTAL SINUS|LATERAL|||CHILD|3|Visit_3|40|5|TREATMENT|2020-10-19|40
e|FA|b336d8c2-7bca-404e-aea3-5148d559ea99|6|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|ug/kg/h|[?]|1|Hz/s|MEDIASTINUM, SUPERIOR|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2020-10-19|40
e|FA|b336d8c2-7bca-404e-aea3-5148d559ea99|7|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|mEq|METACARPAL BONE 5|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-11-13|65
e|FA|b336d8c2-7bca-404e-aea3-5148d559ea99|8|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|BOWL|[?]|1|L/h/m2|SUPRARENAL AORTA|BILATERAL|||ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2020-11-13|65
e|FA|b336d8c2-7bca-404e-aea3-5148d559ea99|9|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|DROP|[?]|1|g/dL|OPTIC NERVE|CONTRALATERAL|||INTERVIEWER|5|Visit_5|90|5|TREATMENT|2020-12-08|90
e|FA|b336d8c2-7bca-404e-aea3-5148d559ea99|10|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mJoule/cm2|[?]|1|ohm|AXILLARY LYMPH NODE LEVEL III|LATERAL|||STUDY SUBJECT|5|Visit_5|90|7|SCREENING|2020-12-08|90
e|FA|702b2f8f-63b9-44c1-a46d-1a41bc837c32|1|STRCTNUM|Number of Strictures|[?]|GERD|[?]|fL|[?]|1|SACHET|ADRENAL GLAND|RIGHT|||SPOUSE|1|Visit_1|10|4|TREATMENT|2020-06-17|10
e|FA|702b2f8f-63b9-44c1-a46d-1a41bc837c32|2|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|g/m2|[?]|1|Shock Wave|GLOSSOPHARYNGEAL NERVE|BILATERAL||Y|PARENT|1|Visit_1|10|3|SCREENING|2020-06-17|10
e|FA|702b2f8f-63b9-44c1-a46d-1a41bc837c32|3|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|ug/L|[?]|1|ug/g/h|HUMERUS|RIGHT|||CHILD|2|Visit_2|25|7|TREATMENT|2020-07-02|25
e|FA|702b2f8f-63b9-44c1-a46d-1a41bc837c32|4|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|uEq/L|[?]|1|mL|ANTERIOR INFERIOR CEREBELLAR ARTERY|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|6|SCREENING|2020-07-02|25
e|FA|702b2f8f-63b9-44c1-a46d-1a41bc837c32|5|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|/VF|[?]|1|km|ADDUCTOR MAGNUS MUSCLE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-07-17|40
e|FA|702b2f8f-63b9-44c1-a46d-1a41bc837c32|6|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|mAmp|[?]|1|IU/mmol|CARDIAC VALVE|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|2|WASHOUT|2020-07-17|40
e|FA|702b2f8f-63b9-44c1-a46d-1a41bc837c32|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|nmol/L|[?]|1|%(v/v)|HEART, LEFT VENTRICULAR WALL|LATERAL|||CHILD|4|Visit_4|65|3|TREATMENT|2020-08-11|65
e|FA|702b2f8f-63b9-44c1-a46d-1a41bc837c32|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|PHERESIS UNIT|[?]|1|Pa|ANTERIOR SUPERIOR ILIAC SPINE|BILATERAL|||SIBLING|4|Visit_4|65|6|TREATMENT|2020-08-11|65
e|FA|702b2f8f-63b9-44c1-a46d-1a41bc837c32|9|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa/L|[?]|1|DRUM|INTERPHALANGEAL JOINT 4|IPSILATERAL|Y|Y|INTERVIEWER|5|Visit_5|90|4|TREATMENT|2020-09-05|90
e|FA|702b2f8f-63b9-44c1-a46d-1a41bc837c32|10|SEV|Severity/Intensity|[?]|GERD|[?]|ELISA unit/dose|[?]|1|Pa|VAGUS NERVE|CONTRALATERAL|Y|Y|ADJUDICATION COMMITTEE|5|Visit_5|90|7|TREATMENT|2020-09-05|90
e|FA|1261eee1-f073-4419-b0b7-28abd0ec1513|1|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|g/m2/day|[?]|1|Hz/s|FLOOR OF MOUTH|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|WASHOUT|2020-10-01|10
e|FA|1261eee1-f073-4419-b0b7-28abd0ec1513|2|LOCONSET|Localization of Onset|[?]|GERD|[?]|pptr|[?]|1|g/L|STERNEBRA|RIGHT|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|2|TREATMENT|2020-10-01|10
e|FA|1261eee1-f073-4419-b0b7-28abd0ec1513|3|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|g/g|[?]|1|10^9 CFU/g|ENDOMETRIUM|LATERAL||Y|PROXY|2|Visit_2|25|2|TREATMENT|2020-10-16|25
e|FA|1261eee1-f073-4419-b0b7-28abd0ec1513|4|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|KIT|[?]|1|DRUM|ACCESSORY RENAL ARTERY|UNILATERAL|Y||ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-10-16|25
e|FA|1261eee1-f073-4419-b0b7-28abd0ec1513|5|SEV|Severity/Intensity|[?]|GERD|[?]|nU/cL|[?]|1|Pa|PALPEBRAL FISSURE|CONTRALATERAL||Y|CAREGIVER|3|Visit_3|40|1|FOLLOW-UP|2020-10-31|40
e|FA|1261eee1-f073-4419-b0b7-28abd0ec1513|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cy/cm|[?]|1|mg/g/min|PULMONARY ARTERY BRANCH|CONTRALATERAL|Y||SPOUSE|3|Visit_3|40|2|TREATMENT|2020-10-31|40
e|FA|1261eee1-f073-4419-b0b7-28abd0ec1513|7|DFATT|Dietary Fat, Total|[?]|GERD|[?]|/day|[?]|1|Bq/mg|PROXIMAL URETHRA|LEFT||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2020-11-25|65
e|FA|1261eee1-f073-4419-b0b7-28abd0ec1513|8|SEV|Severity/Intensity|[?]|GERD|[?]|GPL U|[?]|1|Pa|PLACENTA|IPSILATERAL|Y||PARENT|4|Visit_4|65|4|SCREENING|2020-11-25|65
e|FA|1261eee1-f073-4419-b0b7-28abd0ec1513|9|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/mL|[?]|1|10^9 CFU/mL|BRAIN VENTRICLE, LATERAL|LATERAL|||PARENT|5|Visit_5|90|4|TREATMENT|2020-12-20|90
e|FA|1261eee1-f073-4419-b0b7-28abd0ec1513|10|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|mmol/g|[?]|1|g/day|RECTOVAGINAL SPACE|CONTRALATERAL|||FRIEND|5|Visit_5|90|6|TREATMENT|2020-12-20|90
e|FA|46eefdf3-c314-4e61-963c-ce7f48c636e5|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mkat|[?]|1|mg/g/min|SINUS|LEFT|||SIBLING|1|Visit_1|10|3|FOLLOW-UP|2020-12-29|10
e|FA|46eefdf3-c314-4e61-963c-ce7f48c636e5|2|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|10^3 RNA copies/mL|[?]|1|SCOOPFUL|MID-LAD ARTERY|RIGHT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-12-29|10
e|FA|46eefdf3-c314-4e61-963c-ce7f48c636e5|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mol/mol|[?]|1|Pa|METACARPOPHALANGEAL JOINT 3|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|FOLLOW-UP|2021-01-13|25
e|FA|46eefdf3-c314-4e61-963c-ce7f48c636e5|4|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|tsp|[?]|1|ug/m2/h|C7 VERTEBRA|IPSILATERAL|Y||ADJUDICATOR|2|Visit_2|25|6|WASHOUT|2021-01-13|25
e|FA|46eefdf3-c314-4e61-963c-ce7f48c636e5|5|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|mOsm/L|[?]|1|cmH2O/mL|LESSER TROCHANTER|LATERAL|Y||STUDY SUBJECT|3|Visit_3|40|7|TREATMENT|2021-01-28|40
e|FA|46eefdf3-c314-4e61-963c-ce7f48c636e5|6|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|AMPULE|[?]|1|10^4 CFU/mL|VASTUS INTERMEDIUS MUSCLE|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2021-01-28|40
e|FA|46eefdf3-c314-4e61-963c-ce7f48c636e5|7|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|vg/dose|[?]|1|mL|COLON, ASCENDING|LEFT|Y||SIBLING|4|Visit_4|65|3|TREATMENT|2021-02-22|65
e|FA|46eefdf3-c314-4e61-963c-ce7f48c636e5|8|EXCDUR|Exercise Duration|[?]|GERD|[?]|pmol/g|[?]|1|mm|VASTUS INTERMEDIUS MUSCLE|LATERAL|||FRIEND|4|Visit_4|65|6|SCREENING|2021-02-22|65
e|FA|46eefdf3-c314-4e61-963c-ce7f48c636e5|9|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|kg|[?]|1|DROP|LEFT ATRIOVENTRICULAR ARTERY|LATERAL|Y||ADJUDICATOR|5|Visit_5|90|3|WASHOUT|2021-03-19|90
e|FA|46eefdf3-c314-4e61-963c-ce7f48c636e5|10|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|10^9 organisms/g|[?]|1|L|COMMON ILIAC ARTERY|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|SCREENING|2021-03-19|90
e|FA|f632159b-8c91-4f0d-81cb-e5b9195588c9|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|VOXEL|[?]|1|mg/g/min|COLON WALL|IPSILATERAL|||CAREGIVER|1|Visit_1|10|7|TREATMENT|2021-01-12|10
e|FA|f632159b-8c91-4f0d-81cb-e5b9195588c9|2|DISTANCE|Distance|[?]|GERD|[?]|U/m2/h|[?]|1|BOWL|THIRD POSTEROLATERAL DESCENDING ARTERY|RIGHT|||STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2021-01-12|10
e|FA|f632159b-8c91-4f0d-81cb-e5b9195588c9|3|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|DAYS|[?]|1|Weber|SPHENOID SINUS|LEFT|||FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2021-01-27|25
e|FA|f632159b-8c91-4f0d-81cb-e5b9195588c9|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|hr/day|[?]|1|mg/g/min|POSTERIOR POLE OF THE EYE|IPSILATERAL|||STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2021-01-27|25
e|FA|f632159b-8c91-4f0d-81cb-e5b9195588c9|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Antibody Unit|[?]|1|mg/g/min|SPLEEN, HILUM|UNILATERAL|Y||STUDY SUBJECT|3|Visit_3|40|5|TREATMENT|2021-02-11|40
e|FA|f632159b-8c91-4f0d-81cb-e5b9195588c9|6|DVEG|Dietary Vegetable|[?]|GERD|[?]|10^6 copies/mL|[?]|1|Ci/ug|SUPRACLAVICULAR FOSSA|RIGHT||Y|INTERVIEWER|3|Visit_3|40|4|WASHOUT|2021-02-11|40
e|FA|f632159b-8c91-4f0d-81cb-e5b9195588c9|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|m3|[?]|1|U/mg|PALATE|BILATERAL|||ADJUDICATOR|4|Visit_4|65|1|WASHOUT|2021-03-08|65
e|FA|f632159b-8c91-4f0d-81cb-e5b9195588c9|8|VOL|Volume|[?]|GERD|[?]|DAgU/mL|[?]|1|vp/dose|LEFT POSTEROLATERAL DESCENDING ARTERY|CONTRALATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|7|TREATMENT|2021-03-08|65
e|FA|f632159b-8c91-4f0d-81cb-e5b9195588c9|9|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|m/sec2|[?]|1|mL/h|FEMORO-POPLITEAL PERIPHERAL ARTERY|LEFT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|SCREENING|2021-04-02|90
e|FA|f632159b-8c91-4f0d-81cb-e5b9195588c9|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|CFU/mL|[?]|1|10^6 U|HAMSTRING MUSCLE|LEFT|||STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2021-04-02|90
e|FA|898a9d2f-338b-41bf-8ac0-c4a025481349|1|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|L/s/kPa|[?]|1|DROP|CEREBRUM|LATERAL|||FAMILY MEMBER|1|Visit_1|10|6|TREATMENT|2020-05-24|10
e|FA|898a9d2f-338b-41bf-8ac0-c4a025481349|2|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|HOURS|[?]|1|10^9 CFU/mL|TIBIAL-CRURAL PERIPHERAL ARTERY|LEFT||Y|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-05-24|10
e|FA|898a9d2f-338b-41bf-8ac0-c4a025481349|3|LDIAM|Longest Diameter|[?]|GERD|[?]|STRIP|[?]|1|Shock Wave|INTERATRIAL SEPTUM|BILATERAL|||PROXY|2|Visit_2|25|7|TREATMENT|2020-06-08|25
e|FA|898a9d2f-338b-41bf-8ac0-c4a025481349|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|cmol|[?]|1|MBq|T8 VERTEBRA|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|FOLLOW-UP|2020-06-08|25
e|FA|898a9d2f-338b-41bf-8ac0-c4a025481349|5|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|mCi/kg|[?]|1|g/L|INTRAHEPATIC BILE DUCT|LATERAL|||VENDOR|3|Visit_3|40|7|WASHOUT|2020-06-23|40
e|FA|898a9d2f-338b-41bf-8ac0-c4a025481349|6|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mmol/min/kPa|[?]|1|cm H2O|SPLEEN, HILUM|UNILATERAL|||SIBLING|3|Visit_3|40|5|TREATMENT|2020-06-23|40
e|FA|898a9d2f-338b-41bf-8ac0-c4a025481349|7|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|/4.0 mL|[?]|1|Weber|LEFT MAIN CORONARY ARTERY BIFURCATION|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|TREATMENT|2020-07-18|65
e|FA|898a9d2f-338b-41bf-8ac0-c4a025481349|8|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|mMU/mL|[?]|1|ug/m2/h|GALLBLADDER|BILATERAL||Y|SIBLING|4|Visit_4|65|6|TREATMENT|2020-07-18|65
e|FA|898a9d2f-338b-41bf-8ac0-c4a025481349|9|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|km|[?]|1|L|PISIFORM BONE|IPSILATERAL|Y|Y|INTERVIEWER|5|Visit_5|90|3|SCREENING|2020-08-12|90
e|FA|898a9d2f-338b-41bf-8ac0-c4a025481349|10|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|pt_us|[?]|1|BOWL|CAUDAL VERTEBRA|UNILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|6|WASHOUT|2020-08-12|90
e|FA|db3824aa-375d-4e40-a14b-af0e4460914e|1|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|U/mg|RIGHT ATRIAL ENDOCARDIUM|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-05-20|10
e|FA|db3824aa-375d-4e40-a14b-af0e4460914e|2|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|ng|AORTIC VALVE, LEFT CORONARY CUSP|BILATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|2|SCREENING|2020-05-20|10
e|FA|db3824aa-375d-4e40-a14b-af0e4460914e|3|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|Bq/mL|[?]|1|MPS U|KIDNEY, CORTEX|CONTRALATERAL|||CHILD|2|Visit_2|25|5|SCREENING|2020-06-04|25
e|FA|db3824aa-375d-4e40-a14b-af0e4460914e|4|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/dose|[?]|1|Bq/L|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|LATERAL|||INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-06-04|25
e|FA|db3824aa-375d-4e40-a14b-af0e4460914e|5|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|mmHg/L/min|[?]|1|MBq|RENAL PELVIS|CONTRALATERAL|||CHILD|3|Visit_3|40|5|TREATMENT|2020-06-19|40
e|FA|db3824aa-375d-4e40-a14b-af0e4460914e|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|IU/mmol|[?]|1|%(v/v)|SCAPHOID-LUNATE JOINT|LEFT|||SIBLING|3|Visit_3|40|1|WASHOUT|2020-06-19|40
e|FA|db3824aa-375d-4e40-a14b-af0e4460914e|7|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|10^6/hpf|[?]|1|Gy/h|ENDOMETRIUM|LEFT|||PROXY|4|Visit_4|65|5|TREATMENT|2020-07-14|65
e|FA|db3824aa-375d-4e40-a14b-af0e4460914e|8|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|ug/h|[?]|1|L|BULBAR CONJUNCTIVA|UNILATERAL||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2020-07-14|65
e|FA|db3824aa-375d-4e40-a14b-af0e4460914e|9|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|SACHET|FLEXOR CARPI ULNARIS MUSCLE|BILATERAL|Y|Y|ADJUDICATION COMMITTEE|5|Visit_5|90|3|TREATMENT|2020-08-08|90
e|FA|db3824aa-375d-4e40-a14b-af0e4460914e|10|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT|[?]|1|ug/g/h|LIVER, QUADRATE LOBE|LEFT|||FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2020-08-08|90
e|FA|0ea6be64-32f8-4e10-b993-687ea200e4e9|1|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|ug/m2/min|[?]|1|fmol|POPLITEAL VEIN|BILATERAL|Y||GUARDIAN|1|Visit_1|10|5|WASHOUT|2021-01-28|10
e|FA|0ea6be64-32f8-4e10-b993-687ea200e4e9|2|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|g/cage/wk|[?]|1|10^6 organisms/mL|FEMORAL HEAD|CONTRALATERAL|||INTERVIEWER|1|Visit_1|10|4|WASHOUT|2021-01-28|10
e|FA|0ea6be64-32f8-4e10-b993-687ea200e4e9|3|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|vg/mL|[?]|1|mEq|THYROID GLAND, RIGHT LOBE|IPSILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2021-02-12|25
e|FA|0ea6be64-32f8-4e10-b993-687ea200e4e9|4|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|g/m2|[?]|1|g/L|METATARSOPHALANGEAL JOINT 1|IPSILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2021-02-12|25
e|FA|0ea6be64-32f8-4e10-b993-687ea200e4e9|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cs|[?]|1|mg/g/min|UMBILICAL CORD|UNILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2021-02-27|40
e|FA|0ea6be64-32f8-4e10-b993-687ea200e4e9|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|umol|[?]|1|Shock Wave|MEDIAL FEMORAL CONDYLE|IPSILATERAL|||PARENT|3|Visit_3|40|3|SCREENING|2021-02-27|40
e|FA|0ea6be64-32f8-4e10-b993-687ea200e4e9|7|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|Absorbance U/mL|[?]|1|g/day|SKIN OF THE HEAD|LEFT|||INDEPENDENT ASSESSOR|4|Visit_4|65|7|WASHOUT|2021-03-24|65
e|FA|0ea6be64-32f8-4e10-b993-687ea200e4e9|8|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|Bq|[?]|1|mg/dose|THROAT|LATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2021-03-24|65
e|FA|0ea6be64-32f8-4e10-b993-687ea200e4e9|9|SEV|Severity/Intensity|[?]|GERD|[?]|cGy|[?]|1|Pa|SECOND RIGHT POSTEROLATERAL ARTERY|BILATERAL||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2021-04-18|90
e|FA|0ea6be64-32f8-4e10-b993-687ea200e4e9|10|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|10^6 DNA copies/mL|[?]|1|BOWL|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|WASHOUT|2021-04-18|90
e|FA|18504c4e-41c8-4c1a-a479-d179ccd318e3|1|SPEED|Speed|[?]|GERD|[?]|mmol/L|[?]|1|mEq/g|DUODENUM|BILATERAL|Y||INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-06-22|10
e|FA|18504c4e-41c8-4c1a-a479-d179ccd318e3|2|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6/hpf|[?]|1|g/dL|RESPIRATORY SYSTEM|LATERAL||Y|PROXY|1|Visit_1|10|2|TREATMENT|2020-06-22|10
e|FA|18504c4e-41c8-4c1a-a479-d179ccd318e3|3|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|10^6 CFU/mL|SUBCARINAL LYMPH NODE|BILATERAL|||SPOUSE|2|Visit_2|25|3|SCREENING|2020-07-07|25
e|FA|18504c4e-41c8-4c1a-a479-d179ccd318e3|4|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|amol|[?]|1|uCi/kg|COLON, SPLENIC FLEXURE|IPSILATERAL|||CAREGIVER|2|Visit_2|25|3|TREATMENT|2020-07-07|25
e|FA|18504c4e-41c8-4c1a-a479-d179ccd318e3|5|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mg/kg/week|[?]|1|L/h/m2|HEPATIC VEIN|RIGHT|||CAREGIVER|3|Visit_3|40|6|SCREENING|2020-07-22|40
e|FA|18504c4e-41c8-4c1a-a479-d179ccd318e3|6|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|copies/ug|[?]|1|EIA unit|FOOT DIGIT 5|RIGHT||Y|CHILD|3|Visit_3|40|6|FOLLOW-UP|2020-07-22|40
e|FA|18504c4e-41c8-4c1a-a479-d179ccd318e3|7|LDIAM|Longest Diameter|[?]|GERD|[?]|L/kg|[?]|1|Shock Wave|MEDIASTINUM, SUPERIOR|RIGHT|||SIGNIFICANT OTHER|4|Visit_4|65|3|TREATMENT|2020-08-16|65
e|FA|18504c4e-41c8-4c1a-a479-d179ccd318e3|8|DMG|Dietary Magnesium|[?]|GERD|[?]|Osm|[?]|1|TRANSDUCING UNIT/mL|ANAL CANAL|CONTRALATERAL||Y|ADJUDICATOR|4|Visit_4|65|7|FOLLOW-UP|2020-08-16|65
e|FA|18504c4e-41c8-4c1a-a479-d179ccd318e3|9|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|tsp|[?]|1|oz eq|MIDDLE PHALANX 5 OF THE HAND|IPSILATERAL||Y|SIBLING|5|Visit_5|90|7|FOLLOW-UP|2020-09-10|90
e|FA|18504c4e-41c8-4c1a-a479-d179ccd318e3|10|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|mEq/mL|[?]|1|Shock Wave|PANCREAS, HEAD|UNILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|TREATMENT|2020-09-10|90
e|FA|7f211d8a-7478-4082-8d95-4ace9ceee919|1|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|fmol/L/sec|[?]|1|g/cage/day|FEMALE REPRODUCTIVE SYSTEM|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-08-19|10
e|FA|7f211d8a-7478-4082-8d95-4ace9ceee919|2|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|mmHg|[?]|1|10^9 CFU/g|SUBCARINAL LYMPH NODE|LEFT||Y|CHILD|1|Visit_1|10|6|TREATMENT|2020-08-19|10
e|FA|7f211d8a-7478-4082-8d95-4ace9ceee919|3|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|DAgU/mL|[?]|1|U/mmol|MID-LAD ARTERY|CONTRALATERAL|||ADJUDICATOR|2|Visit_2|25|7|WASHOUT|2020-09-03|25
e|FA|7f211d8a-7478-4082-8d95-4ace9ceee919|4|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|v/v|[?]|1|g/cage/day|TIBIOTARSAL JOINT|LEFT||Y|PROXY|2|Visit_2|25|2|FOLLOW-UP|2020-09-03|25
e|FA|7f211d8a-7478-4082-8d95-4ace9ceee919|5|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|10^11/L|[?]|1|MPS U|METACARPAL BONE 1|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|SCREENING|2020-09-18|40
e|FA|7f211d8a-7478-4082-8d95-4ace9ceee919|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mmol2/L2|[?]|1|%(v/v)|HIP ADDUCTORS|LATERAL|Y||PARENT|3|Visit_3|40|3|FOLLOW-UP|2020-09-18|40
e|FA|7f211d8a-7478-4082-8d95-4ace9ceee919|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|U/g Hb|[?]|1|U/mg|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|BILATERAL|Y||SPOUSE|4|Visit_4|65|4|FOLLOW-UP|2020-10-13|65
e|FA|7f211d8a-7478-4082-8d95-4ace9ceee919|8|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|SQU/mL|[?]|1|Coulomb|FEMORAL VEIN|BILATERAL|||VENDOR|4|Visit_4|65|1|TREATMENT|2020-10-13|65
e|FA|7f211d8a-7478-4082-8d95-4ace9ceee919|9|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|NEEDLE GAUGE|[?]|1|/500 WBC|ANUS|IPSILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|6|FOLLOW-UP|2020-11-07|90
e|FA|7f211d8a-7478-4082-8d95-4ace9ceee919|10|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|ka_u/dL|[?]|1|Bq/L|HUMERUS|LEFT|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|WASHOUT|2020-11-07|90
e|FA|0739e140-bcac-4df9-9629-bd0748d1fdd6|1|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|mg/kg/day|[?]|1|BP|TRIANGULAR-LUNATE JOINT|BILATERAL|||CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-10-09|10
e|FA|0739e140-bcac-4df9-9629-bd0748d1fdd6|2|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|mL/min/mmHg|THROAT|LEFT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|FOLLOW-UP|2020-10-09|10
e|FA|0739e140-bcac-4df9-9629-bd0748d1fdd6|3|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|log10 TCID 50/uL|[?]|1|uL/kg/day|NAVICULAR BONE|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|WASHOUT|2020-10-24|25
e|FA|0739e140-bcac-4df9-9629-bd0748d1fdd6|4|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|100 IU/mL|[?]|1|mmHg/L/min|VENOUS SINUS|LATERAL||Y|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-10-24|25
e|FA|0739e140-bcac-4df9-9629-bd0748d1fdd6|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Gauss|[?]|1|mg/g/min|PERICARDIAL WALL|BILATERAL|||SIBLING|3|Visit_3|40|1|FOLLOW-UP|2020-11-08|40
e|FA|0739e140-bcac-4df9-9629-bd0748d1fdd6|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|keV|[?]|1|Pa|BICEPS FEMORIS MUSCLE|LEFT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|WASHOUT|2020-11-08|40
e|FA|0739e140-bcac-4df9-9629-bd0748d1fdd6|7|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|10^6 CFU/mL|COCCYX|LEFT|||SPOUSE|4|Visit_4|65|2|TREATMENT|2020-12-03|65
e|FA|0739e140-bcac-4df9-9629-bd0748d1fdd6|8|SEV|Severity/Intensity|[?]|GERD|[?]|Log10 ELISA unit|[?]|1|Pa|TRICEPS BRACHII MUSCLE|RIGHT|Y|Y|INDEPENDENT ASSESSOR|4|Visit_4|65|5|SCREENING|2020-12-03|65
e|FA|0739e140-bcac-4df9-9629-bd0748d1fdd6|9|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|10^6 organisms|[?]|1|IU/mg|NASAL CAVITY|LEFT||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|6|SCREENING|2020-12-28|90
e|FA|0739e140-bcac-4df9-9629-bd0748d1fdd6|10|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|10^6/hpf|[?]|1|g/cage/day|DISTAL EXTRAHEPATIC BILE DUCT REGION|BILATERAL|Y||FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2020-12-28|90
e|FA|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|1|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|/sec|[?]|1|Gy/h|SCIATIC NERVE|BILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-12-21|10
e|FA|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|2|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|/500 WBC|GREATER CURVATURE OF THE STOMACH|IPSILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|FOLLOW-UP|2020-12-21|10
e|FA|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|3|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|vp/dose|DISTANT LYMPH NODE|CONTRALATERAL|||STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2021-01-05|25
e|FA|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|4|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|log10 PFU/mL|[?]|1|HOURS|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|RIGHT||Y|SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2021-01-05|25
e|FA|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|5|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/g|[?]|1|10^6/L|SUPRASPINATUS MUSCLE|LEFT|Y|Y|INTERVIEWER|3|Visit_3|40|1|SCREENING|2021-01-20|40
e|FA|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|6|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|10^5/L|[?]|1|10^6 U|TIBIOTARSAL JOINT|RIGHT|Y||PARENT|3|Visit_3|40|7|WASHOUT|2021-01-20|40
e|FA|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|7|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|10^12/L|[?]|1|g/dL|HUMERAL EPICONDYLE|CONTRALATERAL|||CHILD|4|Visit_4|65|5|SCREENING|2021-02-14|65
e|FA|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|PIXELS/cm|[?]|1|PFU/dose|LIMB|CONTRALATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|1|SCREENING|2021-02-14|65
e|FA|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|9|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|kUSP|[?]|1|mg/dose|INTERPHALANGEAL JOINT 1|IPSILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|FOLLOW-UP|2021-03-11|90
e|FA|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|m3|[?]|1|mg/g/min|MEDULLA OBLONGATA|RIGHT|||CAREGIVER|5|Visit_5|90|4|WASHOUT|2021-03-11|90
e|FA|f24b931a-2cdd-4432-a1dd-69c7286f4690|1|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|nmol/mL/min|[?]|1|m2|INFERIOR PUBIC RAMUS|BILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|6|WASHOUT|2020-05-15|10
e|FA|f24b931a-2cdd-4432-a1dd-69c7286f4690|2|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|mol/day|[?]|1|U/mmol|SPLEEN, HILUM|LEFT|||STUDY SUBJECT|1|Visit_1|10|1|TREATMENT|2020-05-15|10
e|FA|f24b931a-2cdd-4432-a1dd-69c7286f4690|3|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|damol/L|[?]|1|mL/h|CORPUS CALLOSUM, BODY|LEFT|||ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-05-30|25
e|FA|f24b931a-2cdd-4432-a1dd-69c7286f4690|4|RLDEV|Relationship to Device|[?]|GERD|[?]|10^6/hpf|[?]|1|mL/min/mmHg|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|RIGHT|||INVESTIGATOR|2|Visit_2|25|6|FOLLOW-UP|2020-05-30|25
e|FA|f24b931a-2cdd-4432-a1dd-69c7286f4690|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|pL|[?]|1|mL/animal/day|THORACIC SPINE|CONTRALATERAL||Y|VENDOR|3|Visit_3|40|5|TREATMENT|2020-06-14|40
e|FA|f24b931a-2cdd-4432-a1dd-69c7286f4690|6|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|vp/mL|[?]|1|g/day|ORBICULARIS OCULI MUSCLE|IPSILATERAL|Y||INTERVIEWER|3|Visit_3|40|5|TREATMENT|2020-06-14|40
e|FA|f24b931a-2cdd-4432-a1dd-69c7286f4690|7|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|BLOCKS|[?]|1|mL/mmHg/min/L|EXTRAOCULAR MUSCLE|LATERAL|||FAMILY MEMBER|4|Visit_4|65|1|WASHOUT|2020-07-09|65
e|FA|f24b931a-2cdd-4432-a1dd-69c7286f4690|8|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|g/L|TRANSVERSE TARSAL JOINT|RIGHT|||SPOUSE|4|Visit_4|65|5|SCREENING|2020-07-09|65
e|FA|f24b931a-2cdd-4432-a1dd-69c7286f4690|9|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|g/animal/day|[?]|1|100 IU/mL|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LEFT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-08-03|90
e|FA|f24b931a-2cdd-4432-a1dd-69c7286f4690|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^3 DNA copies/mL|[?]|1|mg/g/min|TOOTH|RIGHT|Y|Y|CHILD|5|Visit_5|90|3|WASHOUT|2020-08-03|90
e|FA|d394120d-7630-4fcf-a336-482599d88296|1|DVEG|Dietary Vegetable|[?]|GERD|[?]|/5x10^4 WBC|[?]|1|Ci/ug|FOOT PHALANX|LEFT||Y|VENDOR|1|Visit_1|10|1|TREATMENT|2021-01-22|10
e|FA|d394120d-7630-4fcf-a336-482599d88296|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms|[?]|1|mEq/g|METATARSOPHALANGEAL JOINT 4|IPSILATERAL||Y|PROXY|1|Visit_1|10|7|TREATMENT|2021-01-22|10
e|FA|d394120d-7630-4fcf-a336-482599d88296|3|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms|[?]|1|10^9 CFU/mL|INTERVENTRICULAR SEPTUM|CONTRALATERAL||Y|ADJUDICATOR|2|Visit_2|25|7|WASHOUT|2021-02-06|25
e|FA|d394120d-7630-4fcf-a336-482599d88296|4|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|pmol/dL|[?]|1|km|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|BILATERAL|||FRIEND|2|Visit_2|25|3|TREATMENT|2021-02-06|25
e|FA|d394120d-7630-4fcf-a336-482599d88296|5|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|mL/kg/h|[?]|1|10^6 IU/mL|GINGIVAL MUCOSA|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|3|FOLLOW-UP|2021-02-21|40
e|FA|d394120d-7630-4fcf-a336-482599d88296|6|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|ug/m2/day|[?]|1|10^6 U|SUPRAPUBIC REGION|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|2|SCREENING|2021-02-21|40
e|FA|d394120d-7630-4fcf-a336-482599d88296|7|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|Tesla|[?]|1|AU/mL|DELTOID MUSCLE|IPSILATERAL|||SPOUSE|4|Visit_4|65|5|TREATMENT|2021-03-18|65
e|FA|d394120d-7630-4fcf-a336-482599d88296|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|IU/kg|[?]|1|mg/g/min|SKIN OF THE AXILLA|UNILATERAL|Y||PROXY|4|Visit_4|65|6|TREATMENT|2021-03-18|65
e|FA|d394120d-7630-4fcf-a336-482599d88296|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|Pa|EYELID|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-04-12|90
e|FA|d394120d-7630-4fcf-a336-482599d88296|10|LOCONSET|Localization of Onset|[?]|GERD|[?]|min|[?]|1|g/L|TONSIL|LEFT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|6|TREATMENT|2021-04-12|90
e|FA|bcda1d95-58ed-4991-9395-0b98efc1d9a1|1|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|DNA copies/ug|[?]|1|psi|CEPHALIC VEIN|BILATERAL|||SIBLING|1|Visit_1|10|3|TREATMENT|2020-10-21|10
e|FA|bcda1d95-58ed-4991-9395-0b98efc1d9a1|2|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|ug/g/min|[?]|1|/500 WBC|ILIOTIBIAL BAND|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|WASHOUT|2020-10-21|10
e|FA|bcda1d95-58ed-4991-9395-0b98efc1d9a1|3|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|mL/min/1.73m2|[?]|1|ug/m2/h|T11 VERTEBRA|CONTRALATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|1|FOLLOW-UP|2020-11-05|25
e|FA|bcda1d95-58ed-4991-9395-0b98efc1d9a1|4|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|cm H2O|LUNG LOBE|RIGHT|||GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-11-05|25
e|FA|bcda1d95-58ed-4991-9395-0b98efc1d9a1|5|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|Ci/g|[?]|1|g/day|LUNG|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-11-20|40
e|FA|bcda1d95-58ed-4991-9395-0b98efc1d9a1|6|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|vp/dose|PROSTATE GLAND, LATERAL LOBE|LATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-11-20|40
e|FA|bcda1d95-58ed-4991-9395-0b98efc1d9a1|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mmol2/L2|[?]|1|%(v/v)|PANCREAS, EXOCRINE|UNILATERAL|Y||VENDOR|4|Visit_4|65|4|TREATMENT|2020-12-15|65
e|FA|bcda1d95-58ed-4991-9395-0b98efc1d9a1|8|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|DNA copies/mL|[?]|1|TRANSDUCING UNIT/mL|ANKLE MORTISE|UNILATERAL|||VENDOR|4|Visit_4|65|2|SCREENING|2020-12-15|65
e|FA|bcda1d95-58ed-4991-9395-0b98efc1d9a1|9|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|DNA copies/ug|[?]|1|fmol|METATARSOPHALANGEAL JOINT 2|RIGHT|||SIBLING|5|Visit_5|90|7|TREATMENT|2021-01-09|90
e|FA|bcda1d95-58ed-4991-9395-0b98efc1d9a1|10|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|kHz|[?]|1|/500 WBC|LIMB|BILATERAL|Y||CAREGIVER|5|Visit_5|90|7|WASHOUT|2021-01-09|90
e|FA|6999bd5c-0790-42b8-a4ff-e538776b0fb0|1|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|nmol/kg/day|[?]|1|cm H2O|WRIST JOINT FLEXOR TENDONS|UNILATERAL|Y||ADJUDICATOR|1|Visit_1|10|7|SCREENING|2020-08-15|10
e|FA|6999bd5c-0790-42b8-a4ff-e538776b0fb0|2|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|vg/mL|[?]|1|BP|SKIN OF THE LIP|RIGHT|||PROXY|1|Visit_1|10|5|TREATMENT|2020-08-15|10
e|FA|6999bd5c-0790-42b8-a4ff-e538776b0fb0|3|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|mL/cage|[?]|1|CUP|FLOOR OF MOUTH|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-08-30|25
e|FA|6999bd5c-0790-42b8-a4ff-e538776b0fb0|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mL|[?]|1|mg/g/min|HUMERUS|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-08-30|25
e|FA|6999bd5c-0790-42b8-a4ff-e538776b0fb0|5|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|/7.5 mL|[?]|1|Shock Wave|PERIANAL REGION|LATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-09-14|40
e|FA|6999bd5c-0790-42b8-a4ff-e538776b0fb0|6|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|DIOPTER|[?]|1|cm H2O|GREAT SAPHENOUS VEIN|LEFT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|FOLLOW-UP|2020-09-14|40
e|FA|6999bd5c-0790-42b8-a4ff-e538776b0fb0|7|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|cup eq|[?]|1|mm/h|EXTERNAL ILIAC ARTERY|BILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|FOLLOW-UP|2020-10-09|65
e|FA|6999bd5c-0790-42b8-a4ff-e538776b0fb0|8|SEV|Severity/Intensity|[?]|GERD|[?]|ug/day|[?]|1|Pa|BONE MARROW|IPSILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|2|SCREENING|2020-10-09|65
e|FA|6999bd5c-0790-42b8-a4ff-e538776b0fb0|9|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|mL/kg/day|[?]|1|mm/h|DISTAL INTERPHALANGEAL JOINT 5|CONTRALATERAL|Y||GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-11-03|90
e|FA|6999bd5c-0790-42b8-a4ff-e538776b0fb0|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|log10 PFU/mL|[?]|1|10^6 U|CLAW|BILATERAL|||CHILD|5|Visit_5|90|7|TREATMENT|2020-11-03|90
e|FA|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|1|LOCONSET|Localization of Onset|[?]|GERD|[?]|/min|[?]|1|g/L|CAUDAL VERTEBRA|UNILATERAL|||CHILD|1|Visit_1|10|7|WASHOUT|2020-12-21|10
e|FA|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|2|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|MPL U/mL|[?]|1|PFU/dose|FOOT DIGIT 5|LATERAL||Y|SIBLING|1|Visit_1|10|3|SCREENING|2020-12-21|10
e|FA|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|L/h|[?]|1|%(v/v)|AORTIC VALVE, NON-CORONARY CUSP|LEFT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2021-01-05|25
e|FA|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|4|TRTSETT|Treatment Setting|[?]|GERD|[?]|g/cage|[?]|1|Coulomb|FEMORO-POPLITEAL PERIPHERAL ARTERY|LEFT|Y|Y|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2021-01-05|25
e|FA|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|5|LDIAM|Longest Diameter|[?]|GERD|[?]|10^3 DNA copies/mL|[?]|1|Shock Wave|SKIN OF THE PALM|LATERAL|||VENDOR|3|Visit_3|40|5|TREATMENT|2021-01-20|40
e|FA|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|6|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|mL/dL|[?]|1|10^4 CFU/mL|CEPHALIC VEIN|LATERAL|||INTERVIEWER|3|Visit_3|40|2|TREATMENT|2021-01-20|40
e|FA|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|7|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|ug/g/day|[?]|1|ug/m2/h|PROXIMAL INTERPHALANGEAL JOINT 5|LATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2021-02-14|65
e|FA|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|8|LDIAM|Longest Diameter|[?]|GERD|[?]|L/min/m2|[?]|1|Shock Wave|HEART, VENTRICLE|RIGHT||Y|SPOUSE|4|Visit_4|65|6|TREATMENT|2021-02-14|65
e|FA|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|10^6 DNA copies/mL|[?]|1|Pa|FASCIA|UNILATERAL|Y||STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2021-03-11|90
e|FA|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|10|OBJNUM|Number of Objects|[?]|GERD|[?]|FEU|[?]|1|mL/100g/min|OPHTHALMIC ARTERY|RIGHT|Y||DOMESTIC PARTNER|5|Visit_5|90|2|FOLLOW-UP|2021-03-11|90
e|FA|59b0fee3-2294-448e-9837-38bd6b5c794b|1|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|Ci/ug|[?]|1|BAG|POPLITEAL ARTERY BELOW KNEE|IPSILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2021-01-01|10
e|FA|59b0fee3-2294-448e-9837-38bd6b5c794b|2|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|mg/kg/week|[?]|1|uCi/kg|C7 VERTEBRA|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2021-01-01|10
e|FA|59b0fee3-2294-448e-9837-38bd6b5c794b|3|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|K|[?]|1|cm|INTERPHALANGEAL OF THE FOOT|UNILATERAL|Y|Y|FRIEND|2|Visit_2|25|7|TREATMENT|2021-01-16|25
e|FA|59b0fee3-2294-448e-9837-38bd6b5c794b|4|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|ag|[?]|1|SACHET|LEG SKIN|LEFT|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|TREATMENT|2021-01-16|25
e|FA|59b0fee3-2294-448e-9837-38bd6b5c794b|5|DFATT|Dietary Fat, Total|[?]|GERD|[?]|mg/g/min|[?]|1|Bq/mg|NASAL SEPTUM|CONTRALATERAL|||FAMILY MEMBER|3|Visit_3|40|4|WASHOUT|2021-01-31|40
e|FA|59b0fee3-2294-448e-9837-38bd6b5c794b|6|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|10^9/dose|[?]|1|Log10 ELISA unit|INTERPHALANGEAL JOINT 2 OF THE HAND|LATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|5|TREATMENT|2021-01-31|40
e|FA|59b0fee3-2294-448e-9837-38bd6b5c794b|7|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|mmol2/L2|[?]|1|mAmp|LOWER GASTROINTESTINAL TRACT LYMPH NODE|BILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2021-02-25|65
e|FA|59b0fee3-2294-448e-9837-38bd6b5c794b|8|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mN|[?]|1|mAmp|BICEPS FEMORIS MUSCLE|LEFT|Y||ADJUDICATOR|4|Visit_4|65|4|SCREENING|2021-02-25|65
e|FA|59b0fee3-2294-448e-9837-38bd6b5c794b|9|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|g/cage|[?]|1|NEEDLE GAUGE|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|BILATERAL|Y||SPOUSE|5|Visit_5|90|7|TREATMENT|2021-03-22|90
e|FA|59b0fee3-2294-448e-9837-38bd6b5c794b|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|m2|[?]|1|%(v/v)|GASTROINTESTINAL TRACT, LOWER, WALL|UNILATERAL||Y|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2021-03-22|90
e|FA|d9bdb1e3-4630-423f-be01-4873bce30422|1|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|10^6 copies/mL|[?]|1|g/cage/day|GASTROCNEMIUS MUSCLE|LEFT|||SPOUSE|1|Visit_1|10|6|TREATMENT|2020-12-22|10
e|FA|d9bdb1e3-4630-423f-be01-4873bce30422|2|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|JDF Unit|[?]|1|mL/h|ILIAC VEIN|RIGHT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-12-22|10
e|FA|d9bdb1e3-4630-423f-be01-4873bce30422|3|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|fmol/L|[?]|1|mL/100g/min|HIP ADDUCTORS|IPSILATERAL|Y|Y|ADJUDICATOR|2|Visit_2|25|7|SCREENING|2021-01-06|25
e|FA|d9bdb1e3-4630-423f-be01-4873bce30422|4|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT/mL|[?]|1|ng|SUPRAGLOTTIS|LEFT|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2021-01-06|25
e|FA|d9bdb1e3-4630-423f-be01-4873bce30422|5|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|EP U|[?]|1|Shock Wave|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|RIGHT|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2021-01-21|40
e|FA|d9bdb1e3-4630-423f-be01-4873bce30422|6|LESNUM|Number of Lesions|[?]|GERD|[?]|L/min|[?]|1|ng/day|PROSTATE GLAND, MIDDLE LOBE|BILATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2021-01-21|40
e|FA|d9bdb1e3-4630-423f-be01-4873bce30422|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mAmp|[?]|1|mg/g/min|MID-CIRCUMFLEX ARTERY|BILATERAL|||FRIEND|4|Visit_4|65|2|TREATMENT|2021-02-15|65
e|FA|d9bdb1e3-4630-423f-be01-4873bce30422|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|g/cage/day|[?]|1|mL|UTERUS|UNILATERAL|Y||SIBLING|4|Visit_4|65|3|TREATMENT|2021-02-15|65
e|FA|d9bdb1e3-4630-423f-be01-4873bce30422|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|g/kg|[?]|1|ug/g/h|FIBULAR VEIN|UNILATERAL|||INTERVIEWER|5|Visit_5|90|1|FOLLOW-UP|2021-03-12|90
e|FA|d9bdb1e3-4630-423f-be01-4873bce30422|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|PATCH|[?]|1|mg/g/min|LOCUS CERULEUS|IPSILATERAL|||PARENT|5|Visit_5|90|4|FOLLOW-UP|2021-03-12|90
e|FA|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|1|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|mg/g/min|[?]|1|mL/dose|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL||Y|CAREGIVER|1|Visit_1|10|5|WASHOUT|2020-06-25|10
e|FA|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|2|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|mL/h|[?]|1|Bq/mg|UTERUS|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-06-25|10
e|FA|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|3|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|Ci/ug|[?]|1|mm/h|PERIURETERAL REGION|LATERAL|||PARENT|2|Visit_2|25|1|SCREENING|2020-07-10|25
e|FA|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|TAMPON|[?]|1|mg/g/min|CARPOMETACARPAL JOINT 2|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|WASHOUT|2020-07-10|25
e|FA|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|5|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|10^4 CFU|[?]|1|m2|LIVER, LEFT LOBE|UNILATERAL|Y|Y|ADJUDICATOR|3|Visit_3|40|4|WASHOUT|2020-07-25|40
e|FA|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|6|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|mm3/mm2/year|[?]|1|SCOOPFUL|ANTERIOR SUPERIOR ILIAC SPINE|UNILATERAL||Y|FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2020-07-25|40
e|FA|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|7|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|g/animal|[?]|1|100 IU/mL|PAROTID GLAND|BILATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|4|WASHOUT|2020-08-19|65
e|FA|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|8|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|AgU/mL|[?]|1|DRUM|TRACHEOBRONCHIAL TREE|LATERAL|Y|Y|CHILD|4|Visit_4|65|4|WASHOUT|2020-08-19|65
e|FA|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|9|SERVNUM|Number of Servings|[?]|GERD|[?]|mL/m2|[?]|1|Hz/s|VEIN|UNILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|7|SCREENING|2020-09-13|90
e|FA|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ppm|[?]|1|mg/g/min|INTERPHALANGEAL JOINT 3|UNILATERAL|Y||PARENT|5|Visit_5|90|1|SCREENING|2020-09-13|90
e|FA|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|HOMEOPATHIC DILUTION|[?]|1|Pa|PALATINE BONE|RIGHT|||ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-08-04|10
e|FA|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|2|LENRSCT|Length of Resection|[?]|GERD|[?]|cd/m2|[?]|1|psi|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-08-04|10
e|FA|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|3|ACNDEV|Action Taken With Device|[?]|GERD|[?]|10^6/hpf|[?]|1|100 IU/mL|TRANSVERSE TARSAL JOINT|UNILATERAL|||CAREGIVER|2|Visit_2|25|3|FOLLOW-UP|2020-08-19|25
e|FA|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|4|VOL|Volume|[?]|GERD|[?]|kg/cm|[?]|1|vp/dose|ESOPHAGEAL LYMPH NODE|LATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|5|SCREENING|2020-08-19|25
e|FA|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|5|AGETRT1|Age At First Treatment|[?]|GERD|[?]|nmol/L/h|[?]|1|mL/mmHg/min/L|SUBSTANTIA NIGRA|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|WASHOUT|2020-09-03|40
e|FA|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|6|DISTANCE|Distance|[?]|GERD|[?]|mm3/mm2/year|[?]|1|BOWL|INGUINAL LYMPH NODE|LEFT|||CHILD|3|Visit_3|40|3|TREATMENT|2020-09-03|40
e|FA|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|7|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|mL/day|[?]|1|ng|SEMINAL VESICLE|RIGHT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2020-09-28|65
e|FA|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|8|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mg/m2/h|[?]|1|U/10^12 RBC|COLON WALL|LATERAL|Y||GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-09-28|65
e|FA|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|9|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|10^6/L|[?]|1|mg/h|TRAPEZOID-CAPITATE JOINT|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|TREATMENT|2020-10-23|90
e|FA|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|10|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|mL/sec/1.73m2|[?]|1|mAmp|ALVEOLUS|RIGHT|Y|Y|CAREGIVER|5|Visit_5|90|1|WASHOUT|2020-10-23|90
e|FA|933c3a61-59a0-4cfb-ae17-45bc48229323|1|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|10^4 CFU/mL|T2 VERTEBRA|LATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|FOLLOW-UP|2020-09-09|10
e|FA|933c3a61-59a0-4cfb-ae17-45bc48229323|2|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|psec|[?]|1|mm/h|CLITORIS|LEFT|Y||FAMILY MEMBER|1|Visit_1|10|2|WASHOUT|2020-09-09|10
e|FA|933c3a61-59a0-4cfb-ae17-45bc48229323|3|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|BOX|[?]|1|10^6 CFU/mL|PROSTATE GLAND, LATERAL LOBE|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-09-24|25
e|FA|933c3a61-59a0-4cfb-ae17-45bc48229323|4|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|mAnson U/mL|[?]|1|uCi/kg|DISTAL INTERPHALANGEAL JOINT 5|IPSILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2020-09-24|25
e|FA|933c3a61-59a0-4cfb-ae17-45bc48229323|5|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|MPS U|PERIUMBILICAL REGION|LATERAL|Y||GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-10-09|40
e|FA|933c3a61-59a0-4cfb-ae17-45bc48229323|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Osm|[?]|1|%(v/v)|PENIS, RADIX|IPSILATERAL|||FRIEND|3|Visit_3|40|6|WASHOUT|2020-10-09|40
e|FA|933c3a61-59a0-4cfb-ae17-45bc48229323|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|nkat/L|[?]|1|umol|ISCHIUM|RIGHT|||ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-11-03|65
e|FA|933c3a61-59a0-4cfb-ae17-45bc48229323|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|%(w/w)|[?]|1|mg/g/min|SUDORIFEROUS GLAND|BILATERAL|||VENDOR|4|Visit_4|65|3|TREATMENT|2020-11-03|65
e|FA|933c3a61-59a0-4cfb-ae17-45bc48229323|9|LESNUM|Number of Lesions|[?]|GERD|[?]|uIU/dL|[?]|1|ng/day|INTERNAL ILIAC LYMPH NODE|UNILATERAL|||CAREGIVER|5|Visit_5|90|4|FOLLOW-UP|2020-11-28|90
e|FA|933c3a61-59a0-4cfb-ae17-45bc48229323|10|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|10^9/dose|[?]|1|cm H2O|ESOPHAGUS, LOWER THIRD|UNILATERAL|||SIBLING|5|Visit_5|90|4|WASHOUT|2020-11-28|90
e|FA|58d871e3-ef99-48da-ab12-fdfdc2e01da6|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|ug|[?]|1|10^6 U|TRICUSPID VALVE, SEPTAL CUSP|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|4|WASHOUT|2020-10-26|10
e|FA|58d871e3-ef99-48da-ab12-fdfdc2e01da6|2|LESNUM|Number of Lesions|[?]|GERD|[?]|IU/g|[?]|1|ng/day|ACROMIOCLAVICULAR JOINT|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|TREATMENT|2020-10-26|10
e|FA|58d871e3-ef99-48da-ab12-fdfdc2e01da6|3|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|km/h|[?]|1|km|METACARPAL BONE 3|RIGHT||Y|SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2020-11-10|25
e|FA|58d871e3-ef99-48da-ab12-fdfdc2e01da6|4|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|CIGARETTE|[?]|1|aMFI|THORAX|IPSILATERAL||Y|VENDOR|2|Visit_2|25|3|WASHOUT|2020-11-10|25
e|FA|58d871e3-ef99-48da-ab12-fdfdc2e01da6|5|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|uL|[?]|1|Gy/h|INFRARENAL AORTA|IPSILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2020-11-25|40
e|FA|58d871e3-ef99-48da-ab12-fdfdc2e01da6|6|RLDEV|Relationship to Device|[?]|GERD|[?]|10^6/L|[?]|1|mL/min/mmHg|OROPHARYNX|LEFT|||CHILD|3|Visit_3|40|3|TREATMENT|2020-11-25|40
e|FA|58d871e3-ef99-48da-ab12-fdfdc2e01da6|7|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|10^5/L|[?]|1|10^6 U|TRAPEZIUS MUSCLE|IPSILATERAL|||GUARDIAN|4|Visit_4|65|2|TREATMENT|2020-12-20|65
e|FA|58d871e3-ef99-48da-ab12-fdfdc2e01da6|8|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|log EID 50/dose|[?]|1|10^6 IU/mL|FOOT|LATERAL|||INTERVIEWER|4|Visit_4|65|6|SCREENING|2020-12-20|65
e|FA|58d871e3-ef99-48da-ab12-fdfdc2e01da6|9|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|mU|[?]|1|g/dL|BRACHIORADIALIS MUSCLE|UNILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|3|FOLLOW-UP|2021-01-14|90
e|FA|58d871e3-ef99-48da-ab12-fdfdc2e01da6|10|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|Hounsfield Unit|[?]|1|Shock Wave|PERIFACIAL LYMPH NODE|LEFT|Y||SPOUSE|5|Visit_5|90|5|SCREENING|2021-01-14|90
e|FA|ac66129e-3244-4cd8-a235-43b4bfb7dace|1|DCAL|Dietary Calories|[?]|GERD|[?]|10^7 PFU|[?]|1|EIA unit|DIAPHRAGM|UNILATERAL|Y|Y|SIBLING|1|Visit_1|10|5|SCREENING|2020-10-29|10
e|FA|ac66129e-3244-4cd8-a235-43b4bfb7dace|2|DCAL|Dietary Calories|[?]|GERD|[?]|amol|[?]|1|EIA unit|RECTOSIGMOID JUNCTION|CONTRALATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-10-29|10
e|FA|ac66129e-3244-4cd8-a235-43b4bfb7dace|3|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|umol/day|[?]|1|umol|PERIUMBILICAL REGION|BILATERAL|Y||GUARDIAN|2|Visit_2|25|3|FOLLOW-UP|2020-11-13|25
e|FA|ac66129e-3244-4cd8-a235-43b4bfb7dace|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^4 CFU|[?]|1|mg/g/min|INGUINAL LYMPH NODE|CONTRALATERAL||Y|SIGNIFICANT OTHER|2|Visit_2|25|4|SCREENING|2020-11-13|25
e|FA|ac66129e-3244-4cd8-a235-43b4bfb7dace|5|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|Newton|[?]|1|NEEDLE GAUGE|SHOULDER|UNILATERAL|||ADJUDICATOR|3|Visit_3|40|3|SCREENING|2020-11-28|40
e|FA|ac66129e-3244-4cd8-a235-43b4bfb7dace|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/mL|[?]|1|mg/g/min|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-11-28|40
e|FA|ac66129e-3244-4cd8-a235-43b4bfb7dace|7|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|pmol/dL|[?]|1|m2|ESOPHAGUS, CERVICAL|LEFT||Y|SIGNIFICANT OTHER|4|Visit_4|65|5|FOLLOW-UP|2020-12-23|65
e|FA|ac66129e-3244-4cd8-a235-43b4bfb7dace|8|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT|[?]|1|mL/mmHg/min/L|HEEL OF THE FOOT|IPSILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|2|TREATMENT|2020-12-23|65
e|FA|ac66129e-3244-4cd8-a235-43b4bfb7dace|9|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|/100 HPFs|[?]|1|SACHET|SKIN OF THE LOWER LIMB|CONTRALATERAL|Y||GUARDIAN|5|Visit_5|90|7|TREATMENT|2021-01-17|90
e|FA|ac66129e-3244-4cd8-a235-43b4bfb7dace|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|Pa|TROCHLEAR NERVE|LATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|7|TREATMENT|2021-01-17|90
e|FA|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|FFU|[?]|1|%(v/v)|SUPRASPINATUS MUSCLE|LATERAL|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-09-02|10
e|FA|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|2|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|mmHg/L/min|ILEUM LYMPH NODE|RIGHT|||CAREGIVER|1|Visit_1|10|4|TREATMENT|2020-09-02|10
e|FA|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|3|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|Bq/kg|[?]|1|mAmp|PERIANAL REGION|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|4|SCREENING|2020-09-17|25
e|FA|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|4|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|fmol|THIRD DIAGONAL BRANCH ARTERY|CONTRALATERAL|||FAMILY MEMBER|2|Visit_2|25|3|TREATMENT|2020-09-17|25
e|FA|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|5|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|dpm/mg|[?]|1|L/h/m2|PENIS, BODY|LEFT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2020-10-02|40
e|FA|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|ug/m2/day|[?]|1|QUANTITY SUFFICIENT|SPLENIC HILAR LYMPH NODE|RIGHT|||ADJUDICATOR|3|Visit_3|40|4|WASHOUT|2020-10-02|40
e|FA|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|7|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/L|[?]|1|L|GREAT TROCHANTER|IPSILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-10-27|65
e|FA|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|hr/day|[?]|1|mg/g/min|FOREARM|CONTRALATERAL|||CAREGIVER|4|Visit_4|65|1|SCREENING|2020-10-27|65
e|FA|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|9|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|Frames/s|[?]|1|TRANSDUCING UNIT/mL|LUMBRICAL MUSCLES OF THE HAND|UNILATERAL|||INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2020-11-21|90
e|FA|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|10|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|10^3 copies/mL|[?]|1|BOWL|METATARSAL BONE|IPSILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-11-21|90
e|FA|3d59a754-10bb-4847-93ea-433b43265a2f|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|pg/dL|[?]|1|mg/g/min|AORTOCAVAL LYMPH NODE|CONTRALATERAL||Y|INTERVIEWER|1|Visit_1|10|3|FOLLOW-UP|2020-10-24|10
e|FA|3d59a754-10bb-4847-93ea-433b43265a2f|2|SERVNUM|Number of Servings|[?]|GERD|[?]|steps/min|[?]|1|Hz/s|DIAPHRAGMATIC LYMPH NODE|BILATERAL|Y||INTERVIEWER|1|Visit_1|10|4|FOLLOW-UP|2020-10-24|10
e|FA|3d59a754-10bb-4847-93ea-433b43265a2f|3|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|SFC/10^6 PBMC|[?]|1|cm H2O|RETINAL ARTERY|UNILATERAL||Y|SPOUSE|2|Visit_2|25|7|WASHOUT|2020-11-08|25
e|FA|3d59a754-10bb-4847-93ea-433b43265a2f|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|breaths/30s|[?]|1|%(v/v)|METATARSOPHALANGEAL JOINT 2|IPSILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|SCREENING|2020-11-08|25
e|FA|3d59a754-10bb-4847-93ea-433b43265a2f|5|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|GPS U|[?]|1|umol|HEART, LEFT ATRIAL APPENDAGE|LEFT|Y||DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-11-23|40
e|FA|3d59a754-10bb-4847-93ea-433b43265a2f|6|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|cs|[?]|1|NEEDLE GAUGE|INTERPHALANGEAL JOINT 2|LEFT|||SIGNIFICANT OTHER|3|Visit_3|40|5|TREATMENT|2020-11-23|40
e|FA|3d59a754-10bb-4847-93ea-433b43265a2f|7|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|BLOCKS|[?]|1|mEq/g|PARACOLIC GUTTER|IPSILATERAL|Y|Y|INTERVIEWER|4|Visit_4|65|7|WASHOUT|2020-12-18|65
e|FA|3d59a754-10bb-4847-93ea-433b43265a2f|8|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|DISK|[?]|1|mL/h|PROXIMAL PHALANX 4 OF THE HAND|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|SCREENING|2020-12-18|65
e|FA|3d59a754-10bb-4847-93ea-433b43265a2f|9|STRCTNUM|Number of Strictures|[?]|GERD|[?]|HOMEOPATHIC DILUTION|[?]|1|SACHET|HIP ADDUCTORS|IPSILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|WASHOUT|2021-01-12|90
e|FA|3d59a754-10bb-4847-93ea-433b43265a2f|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|L/min/m2|[?]|1|%(v/v)|FINGER EXTENSOR TENDONS|UNILATERAL|||CAREGIVER|5|Visit_5|90|1|TREATMENT|2021-01-12|90
e|FA|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|1|DFRUIT|Dietary Fruit|[?]|GERD|[?]|DDU|[?]|1|10^6 CFU/mL|LEG|UNILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|WASHOUT|2021-01-20|10
e|FA|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|2|LENRSCT|Length of Resection|[?]|GERD|[?]|mL/m2/min|[?]|1|psi|SAPHENOUS VEIN|LATERAL|||GUARDIAN|1|Visit_1|10|1|TREATMENT|2021-01-20|10
e|FA|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|3|ACNDEV|Action Taken With Device|[?]|GERD|[?]|JAR|[?]|1|100 IU/mL|AORTIC VALVE, LEFT CORONARY CUSP|CONTRALATERAL|||INTERVIEWER|2|Visit_2|25|5|TREATMENT|2021-02-04|25
e|FA|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|4|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|m|[?]|1|mL|HEART, LEFT VENTRICLE|UNILATERAL|Y||INVESTIGATOR|2|Visit_2|25|5|SCREENING|2021-02-04|25
e|FA|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|5|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|mg/cm2|[?]|1|IU/mmol|PROSTATE GLAND, LATERAL LOBE|LEFT|||INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2021-02-19|40
e|FA|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|6|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|umol|[?]|1|U/10^12 RBC|TRAPEZIUS MUSCLE|LATERAL|||GUARDIAN|3|Visit_3|40|5|TREATMENT|2021-02-19|40
e|FA|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|7|DFIBER|Dietary Fiber|[?]|GERD|[?]|ELISA unit|[?]|1|h*%|GASTROINTESTINAL TRACT, LOWER, WALL|LEFT|||ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2021-03-16|65
e|FA|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|8|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|IMPLANT|[?]|1|QUANTITY SUFFICIENT|SCAPHOID-CAPITATE JOINT|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2021-03-16|65
e|FA|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|9|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|uV|[?]|1|SCOOPFUL|MUCOSA OF THE LIP|LATERAL|||GUARDIAN|5|Visit_5|90|4|TREATMENT|2021-04-10|90
e|FA|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|10|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/g|[?]|1|HOURS|BUTTOCK|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|3|SCREENING|2021-04-10|90
e|FA|89209495-c485-4eb7-b858-8dc5490d2b64|1|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|MBP|[?]|1|100 IU/mL|ANKLE JOINT|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|FOLLOW-UP|2020-09-07|10
e|FA|89209495-c485-4eb7-b858-8dc5490d2b64|2|CALBURN|Calories Burned|[?]|GERD|[?]|/10^3|[?]|1|/kg|PARS COMPACTA|LEFT|||PARENT|1|Visit_1|10|1|FOLLOW-UP|2020-09-07|10
e|FA|89209495-c485-4eb7-b858-8dc5490d2b64|3|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|m/sec2|[?]|1|DROP|GASTROINTESTINAL TRACT, UPPER|RIGHT|Y|Y|INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-09-22|25
e|FA|89209495-c485-4eb7-b858-8dc5490d2b64|4|STRCTNUM|Number of Strictures|[?]|GERD|[?]|ELISA unit/mL|[?]|1|SACHET|T9 VERTEBRA|RIGHT|||GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-09-22|25
e|FA|89209495-c485-4eb7-b858-8dc5490d2b64|5|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|ukat/L|[?]|1|g/day|DURAL VENOUS SINUS|LATERAL|||VENDOR|3|Visit_3|40|5|WASHOUT|2020-10-07|40
e|FA|89209495-c485-4eb7-b858-8dc5490d2b64|6|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|/10^3|[?]|1|mL/min/mmHg|POSTERIOR TIBIAL ARTERY|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|2|FOLLOW-UP|2020-10-07|40
e|FA|89209495-c485-4eb7-b858-8dc5490d2b64|7|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|fL|[?]|1|DRUM|MEDIASTINUM, SUPERIOR|LATERAL|||ADJUDICATOR|4|Visit_4|65|5|SCREENING|2020-11-01|65
e|FA|89209495-c485-4eb7-b858-8dc5490d2b64|8|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/g/h|[?]|1|mg/dose|ESOPHAGUS, MIDDLE THIRD|IPSILATERAL||Y|FRIEND|4|Visit_4|65|3|WASHOUT|2020-11-01|65
e|FA|89209495-c485-4eb7-b858-8dc5490d2b64|9|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|DRINK|[?]|1|mIU/L|ESOPHAGUS, THORACIC|IPSILATERAL|||SPOUSE|5|Visit_5|90|1|SCREENING|2020-11-26|90
e|FA|89209495-c485-4eb7-b858-8dc5490d2b64|10|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|anti-Xa IU|[?]|1|10^6/L|SCAPHOID-RADIUS JOINT|LEFT|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-11-26|90
e|FA|d80522bb-f146-4270-a6e1-326fde50d9ca|1|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|s*kPa|[?]|1|g/L|MENINGES|RIGHT|||CHILD|1|Visit_1|10|7|FOLLOW-UP|2020-12-31|10
e|FA|d80522bb-f146-4270-a6e1-326fde50d9ca|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|GBq/g|[?]|1|mEq/g|SUPERIOR VENA CAVA|UNILATERAL|||FRIEND|1|Visit_1|10|2|SCREENING|2020-12-31|10
e|FA|d80522bb-f146-4270-a6e1-326fde50d9ca|3|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|COAT|[?]|1|mAmp|SUPRARENAL AORTA|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|WASHOUT|2021-01-15|25
e|FA|d80522bb-f146-4270-a6e1-326fde50d9ca|4|SEV|Severity/Intensity|[?]|GERD|[?]|TAMPON|[?]|1|Pa|ARM|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2021-01-15|25
e|FA|d80522bb-f146-4270-a6e1-326fde50d9ca|5|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|IU/L|[?]|1|SACHET|CORPUS UTERI|IPSILATERAL|||GUARDIAN|3|Visit_3|40|1|WASHOUT|2021-01-30|40
e|FA|d80522bb-f146-4270-a6e1-326fde50d9ca|6|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|Henry|[?]|1|cm H2O|CORPUS STRIATUM|LATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2021-01-30|40
e|FA|d80522bb-f146-4270-a6e1-326fde50d9ca|7|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|U/kg|[?]|1|mm|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2021-02-24|65
e|FA|d80522bb-f146-4270-a6e1-326fde50d9ca|8|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mOsm/L|[?]|1|NEEDLE GAUGE|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|WASHOUT|2021-02-24|65
e|FA|d80522bb-f146-4270-a6e1-326fde50d9ca|9|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|CAPFUL|[?]|1|L/h/m2|URETHRA, POSTERIOR|IPSILATERAL|||CAREGIVER|5|Visit_5|90|3|TREATMENT|2021-03-21|90
e|FA|d80522bb-f146-4270-a6e1-326fde50d9ca|10|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/mL|[?]|1|vp/dose|SCAPHOID-TRAPEZIUM JOINT|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|SCREENING|2021-03-21|90
e|FA|3982a462-95f6-4e71-93e5-9df777770067|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/mol|[?]|1|mg/g/min|SHIN|BILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-12-25|10
e|FA|3982a462-95f6-4e71-93e5-9df777770067|2|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|IU/g Hb|[?]|1|psi|RECTOVAGINAL SPACE|CONTRALATERAL|||VENDOR|1|Visit_1|10|6|SCREENING|2020-12-25|10
e|FA|3982a462-95f6-4e71-93e5-9df777770067|3|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/m2|[?]|1|mL/mmHg/min/L|OLFACTORY BULB|CONTRALATERAL|Y||FRIEND|2|Visit_2|25|1|TREATMENT|2021-01-09|25
e|FA|3982a462-95f6-4e71-93e5-9df777770067|4|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/g/min|[?]|1|/500 WBC|PROXIMAL INTERPHALANGEAL JOINT 3|LATERAL|||CAREGIVER|2|Visit_2|25|2|TREATMENT|2021-01-09|25
e|FA|3982a462-95f6-4e71-93e5-9df777770067|5|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|/day|[?]|1|BOWL|ENTORHINAL CORTEX|UNILATERAL|Y||SPOUSE|3|Visit_3|40|3|TREATMENT|2021-01-24|40
e|FA|3982a462-95f6-4e71-93e5-9df777770067|6|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|vp/mL|[?]|1|Gy/h|BICEPS BRACHII MUSCLE|CONTRALATERAL|||ADJUDICATOR|3|Visit_3|40|3|SCREENING|2021-01-24|40
e|FA|3982a462-95f6-4e71-93e5-9df777770067|7|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|copies/ug|[?]|1|Log10 ELISA unit|GENITALIA|RIGHT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|FOLLOW-UP|2021-02-18|65
e|FA|3982a462-95f6-4e71-93e5-9df777770067|8|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mg|[?]|1|BP|MEDIASTINUM, POSTERIOR|LEFT|Y||CAREGIVER|4|Visit_4|65|1|TREATMENT|2021-02-18|65
e|FA|3982a462-95f6-4e71-93e5-9df777770067|9|DCAL|Dietary Calories|[?]|GERD|[?]|FIU|[?]|1|EIA unit|AORTIC VALVE, NON-CORONARY CUSP|BILATERAL|Y||FRIEND|5|Visit_5|90|4|TREATMENT|2021-03-15|90
e|FA|3982a462-95f6-4e71-93e5-9df777770067|10|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|10^7 TCID 50/dose|[?]|1|Weber|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|Y||INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2021-03-15|90
e|FA|f3a3a6ca-2344-4cee-a6a5-59beee9304df|1|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|/500 WBC|ULNAR NERVE|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|WASHOUT|2020-11-09|10
e|FA|f3a3a6ca-2344-4cee-a6a5-59beee9304df|2|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|SBE/mL|[?]|1|h*%|INFERIOR PUBIC RAMUS|LEFT|||CAREGIVER|1|Visit_1|10|3|FOLLOW-UP|2020-11-09|10
e|FA|f3a3a6ca-2344-4cee-a6a5-59beee9304df|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|%(v/v)|HUMERUS|LATERAL|||FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-11-24|25
e|FA|f3a3a6ca-2344-4cee-a6a5-59beee9304df|4|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|IMPLANT|[?]|1|mm/h|PISIFORM BONE|BILATERAL||Y|ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-11-24|25
e|FA|f3a3a6ca-2344-4cee-a6a5-59beee9304df|5|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|L/min|[?]|1|mL/m2|INFRATENTORIAL BRAIN|RIGHT||Y|INTERVIEWER|3|Visit_3|40|4|WASHOUT|2020-12-09|40
e|FA|f3a3a6ca-2344-4cee-a6a5-59beee9304df|6|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|AMPULE|[?]|1|g/day|RIB 6|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|3|WASHOUT|2020-12-09|40
e|FA|f3a3a6ca-2344-4cee-a6a5-59beee9304df|7|LDIAM|Longest Diameter|[?]|GERD|[?]|PACKAGE|[?]|1|Shock Wave|UPPER URINARY SYSTEM|LATERAL|||FRIEND|4|Visit_4|65|5|SCREENING|2021-01-03|65
e|FA|f3a3a6ca-2344-4cee-a6a5-59beee9304df|8|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|cm H2O|INTERPHALANGEAL OF THE FOOT|BILATERAL|||GUARDIAN|4|Visit_4|65|5|TREATMENT|2021-01-03|65
e|FA|f3a3a6ca-2344-4cee-a6a5-59beee9304df|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|C|[?]|1|%(v/v)|COCCYGEAL VERTEBRA|LATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2021-01-28|90
e|FA|f3a3a6ca-2344-4cee-a6a5-59beee9304df|10|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|cd/m2|[?]|1|mL/animal/day|CHEST WALL|BILATERAL||Y|SIBLING|5|Visit_5|90|6|TREATMENT|2021-01-28|90
e|FA|175cfd82-a6fe-463b-81e5-07ae9e1253db|1|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|mL/mmHg/min/L|[?]|1|mm/h|MITRAL VALVE, POSTERIOR ANNULUS|LEFT|||FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-05-26|10
e|FA|175cfd82-a6fe-463b-81e5-07ae9e1253db|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/m2|[?]|1|mg/g/min|TIBIA|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|SCREENING|2020-05-26|10
e|FA|175cfd82-a6fe-463b-81e5-07ae9e1253db|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|g/mol|[?]|1|mg/g/min|NASAL SEPTUM|CONTRALATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|4|FOLLOW-UP|2020-06-10|25
e|FA|175cfd82-a6fe-463b-81e5-07ae9e1253db|4|TOTNUM|Total Number|[?]|GERD|[?]|nkat/g Hb|[?]|1|/200 HPFs|LACRIMAL BONE|RIGHT|||FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-06-10|25
e|FA|175cfd82-a6fe-463b-81e5-07ae9e1253db|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ukat/L|[?]|1|mg/g/min|L4-L5 INTERVERTEBRAL SPACE|CONTRALATERAL||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2020-06-25|40
e|FA|175cfd82-a6fe-463b-81e5-07ae9e1253db|6|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|g/dL|MIDDLE PHALANX 5 OF THE HAND|UNILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|6|SCREENING|2020-06-25|40
e|FA|175cfd82-a6fe-463b-81e5-07ae9e1253db|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/(min*100mL)|[?]|1|U/mmol|GREAT SAPHENOUS VEIN|RIGHT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-07-20|65
e|FA|175cfd82-a6fe-463b-81e5-07ae9e1253db|8|LDIAM|Longest Diameter|[?]|GERD|[?]|MASK|[?]|1|Shock Wave|HEART, ATRIUM|BILATERAL||Y|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2020-07-20|65
e|FA|175cfd82-a6fe-463b-81e5-07ae9e1253db|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|uCi/kg|[?]|1|10^6 IU/mL|CHEEK|LATERAL|||GUARDIAN|5|Visit_5|90|4|TREATMENT|2020-08-14|90
e|FA|175cfd82-a6fe-463b-81e5-07ae9e1253db|10|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|U/kg|[?]|1|PACK|LEFT MAIN CORONARY ARTERY BODY|UNILATERAL|||PROXY|5|Visit_5|90|7|TREATMENT|2020-08-14|90
e|FA|e19b469c-40d5-4506-8233-a86bebde880d|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|mU/L|[?]|1|mL/animal/day|LATERAL SECOND DIAGONAL BRANCH ARTERY|LEFT||Y|FRIEND|1|Visit_1|10|1|TREATMENT|2021-01-22|10
e|FA|e19b469c-40d5-4506-8233-a86bebde880d|2|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|Ci/uL|[?]|1|g/cage/day|ABDOMINAL REGION|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|1|FOLLOW-UP|2021-01-22|10
e|FA|e19b469c-40d5-4506-8233-a86bebde880d|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|gMFI|[?]|1|%(v/v)|LIVER, QUADRATE LOBE|CONTRALATERAL|Y||FRIEND|2|Visit_2|25|4|FOLLOW-UP|2021-02-06|25
e|FA|e19b469c-40d5-4506-8233-a86bebde880d|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/g/h|[?]|1|Pa|SECOND RIGHT POSTEROLATERAL ARTERY|UNILATERAL|Y|Y|CHILD|2|Visit_2|25|1|SCREENING|2021-02-06|25
e|FA|e19b469c-40d5-4506-8233-a86bebde880d|5|CALBURN|Calories Burned|[?]|GERD|[?]|Bq|[?]|1|/kg|TEMPORAL LOBE|UNILATERAL|||INVESTIGATOR|3|Visit_3|40|2|TREATMENT|2021-02-21|40
e|FA|e19b469c-40d5-4506-8233-a86bebde880d|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|AMPULE|[?]|1|%(v/v)|KIDNEY, CORTEX|UNILATERAL|Y||VENDOR|3|Visit_3|40|1|TREATMENT|2021-02-21|40
e|FA|e19b469c-40d5-4506-8233-a86bebde880d|7|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|mol/day|[?]|1|Shock Wave|WRIST JOINT EXTENSOR TENDONS|RIGHT|||CHILD|4|Visit_4|65|4|TREATMENT|2021-03-18|65
e|FA|e19b469c-40d5-4506-8233-a86bebde880d|8|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|cm/s|[?]|1|mL/cm3/min|LIP|BILATERAL|||GUARDIAN|4|Visit_4|65|5|FOLLOW-UP|2021-03-18|65
e|FA|e19b469c-40d5-4506-8233-a86bebde880d|9|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|ks|[?]|1|mIU/L|DIGIT|LATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|TREATMENT|2021-04-12|90
e|FA|e19b469c-40d5-4506-8233-a86bebde880d|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|mEq/mmol|[?]|1|U/mg|FACET JOINT|BILATERAL|||INTERVIEWER|5|Visit_5|90|6|TREATMENT|2021-04-12|90
e|FA|f280a4a5-9826-4d77-adf1-992284cb3314|1|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|cmH2O*s2/mL|[?]|1|mmHg/L/min|EARLOBE|LEFT|||PARENT|1|Visit_1|10|3|TREATMENT|2020-12-19|10
e|FA|f280a4a5-9826-4d77-adf1-992284cb3314|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|g/animal/wk|[?]|1|TRANSDUCING UNIT/mL|BRACHIAL PLEXUS|BILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|TREATMENT|2020-12-19|10
e|FA|f280a4a5-9826-4d77-adf1-992284cb3314|3|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|GBq/g|[?]|1|Log10 ELISA unit|BRONCHUS|IPSILATERAL|||STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2021-01-03|25
e|FA|f280a4a5-9826-4d77-adf1-992284cb3314|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PIXELS/cm|[?]|1|mg/g/min|SUBMANDIBULAR LYMPH NODE|RIGHT||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2021-01-03|25
e|FA|f280a4a5-9826-4d77-adf1-992284cb3314|5|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/dose|[?]|1|Shock Wave|T7 VERTEBRA|UNILATERAL|Y||PARENT|3|Visit_3|40|2|TREATMENT|2021-01-18|40
e|FA|f280a4a5-9826-4d77-adf1-992284cb3314|6|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|DRUM|[?]|1|fmol|GASTROINTESTINAL TRACT, LOWER, WALL|UNILATERAL||Y|GUARDIAN|3|Visit_3|40|5|TREATMENT|2021-01-18|40
e|FA|f280a4a5-9826-4d77-adf1-992284cb3314|7|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|ug/L FEU|[?]|1|BOWL|INTERPHALANGEAL JOINT 3|BILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-02-12|65
e|FA|f280a4a5-9826-4d77-adf1-992284cb3314|8|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mL/dL|[?]|1|uL/kg/day|ANAL VERGE|LATERAL|||CHILD|4|Visit_4|65|6|FOLLOW-UP|2021-02-12|65
e|FA|f280a4a5-9826-4d77-adf1-992284cb3314|9|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|g/L|PROXIMAL PHALANX 5 OF THE HAND|CONTRALATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|4|TREATMENT|2021-03-09|90
e|FA|f280a4a5-9826-4d77-adf1-992284cb3314|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|dpm/mL|[?]|1|mg/g/min|PUBIC BONE|BILATERAL|||GUARDIAN|5|Visit_5|90|7|FOLLOW-UP|2021-03-09|90
e|FA|82840929-7800-4254-b60a-8af4786664f6|1|DMEAT|Dietary Meat|[?]|GERD|[?]|Shock Wave|[?]|1|10^6 organisms/mL|CENTRAL NERVOUS SYSTEM|LEFT||Y|INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-06-04|10
e|FA|82840929-7800-4254-b60a-8af4786664f6|2|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|cs|[?]|1|EIA unit|TENTORIUM CEREBELLI|LEFT|Y||PARENT|1|Visit_1|10|2|TREATMENT|2020-06-04|10
e|FA|82840929-7800-4254-b60a-8af4786664f6|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|mg/g/min|OSTIOMEATAL COMPLEX|LEFT|||CAREGIVER|2|Visit_2|25|4|TREATMENT|2020-06-19|25
e|FA|82840929-7800-4254-b60a-8af4786664f6|4|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|RATIO|[?]|1|g/L|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|SCREENING|2020-06-19|25
e|FA|82840929-7800-4254-b60a-8af4786664f6|5|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|mEq/uL|[?]|1|mL/100g/min|FINGERNAIL|IPSILATERAL|||ADJUDICATOR|3|Visit_3|40|4|SCREENING|2020-07-04|40
e|FA|82840929-7800-4254-b60a-8af4786664f6|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|breaths/30s|[?]|1|CUP|COLON, ASCENDING|BILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|SCREENING|2020-07-04|40
e|FA|82840929-7800-4254-b60a-8af4786664f6|7|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|IMPLANT|[?]|1|HOURS|SKIN OF THE THIGH|RIGHT|||PARENT|4|Visit_4|65|3|TREATMENT|2020-07-29|65
e|FA|82840929-7800-4254-b60a-8af4786664f6|8|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|g/animal|[?]|1|L/h/m2|PAW|UNILATERAL||Y|FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-07-29|65
e|FA|82840929-7800-4254-b60a-8af4786664f6|9|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|Tesla|[?]|1|TRANSDUCING UNIT/mL|HIP|LEFT|Y||PROXY|5|Visit_5|90|3|TREATMENT|2020-08-23|90
e|FA|82840929-7800-4254-b60a-8af4786664f6|10|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mkat|[?]|1|U/10^12 RBC|PLEURA|RIGHT|||STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2020-08-23|90
e|FA|dae25bdb-38fd-4852-9a9a-7627368e9497|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|GBq/g|[?]|1|mg/g/min|RIB 6|LATERAL|||VENDOR|1|Visit_1|10|6|SCREENING|2020-09-02|10
e|FA|dae25bdb-38fd-4852-9a9a-7627368e9497|2|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|MPL U|[?]|1|fmol|EYE, VITREOUS CHAMBER|LEFT|Y||PARENT|1|Visit_1|10|5|TREATMENT|2020-09-02|10
e|FA|dae25bdb-38fd-4852-9a9a-7627368e9497|3|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|s/h|[?]|1|aMFI|LEFT CIRCUMFLEX CORONARY ARTERY|UNILATERAL|Y|Y|FRIEND|2|Visit_2|25|2|WASHOUT|2020-09-17|25
e|FA|dae25bdb-38fd-4852-9a9a-7627368e9497|4|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|Hz|[?]|1|mmHg/L/min|ESOPHAGUS, CERVICAL|BILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2020-09-17|25
e|FA|dae25bdb-38fd-4852-9a9a-7627368e9497|5|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|ng|[?]|1|fmol|ABDOMINAL CAVITY|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-10-02|40
e|FA|dae25bdb-38fd-4852-9a9a-7627368e9497|6|SEV|Severity/Intensity|[?]|GERD|[?]|Enzyme U/L|[?]|1|Pa|SOLEUS MUSCLE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-10-02|40
e|FA|dae25bdb-38fd-4852-9a9a-7627368e9497|7|OBJNUM|Number of Objects|[?]|GERD|[?]|AMPULE|[?]|1|mL/100g/min|ILIAC CREST|UNILATERAL|||FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2020-10-27|65
e|FA|dae25bdb-38fd-4852-9a9a-7627368e9497|8|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|gpELISA unit/mL|[?]|1|mEq|ANTERIOR HORN OF THE LATERAL VENTRICLE|UNILATERAL|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|7|SCREENING|2020-10-27|65
e|FA|dae25bdb-38fd-4852-9a9a-7627368e9497|9|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|mU|[?]|1|BAG|L5-S1 INTERVERTEBRAL SPACE|LEFT||Y|SIBLING|5|Visit_5|90|3|SCREENING|2020-11-21|90
e|FA|dae25bdb-38fd-4852-9a9a-7627368e9497|10|SEV|Severity/Intensity|[?]|GERD|[?]|10^3 CFU|[?]|1|Pa|MIDDLE PHALANX 2 OF THE HAND|LATERAL|Y||FAMILY MEMBER|5|Visit_5|90|1|FOLLOW-UP|2020-11-21|90
e|FA|9e009737-cd77-4b96-a4af-e9731ef7e9d0|1|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|cGy|[?]|1|g/cage/day|TRICUSPID VALVE, ANTERIOR CUSP|LEFT|Y||CAREGIVER|1|Visit_1|10|2|FOLLOW-UP|2020-10-05|10
e|FA|9e009737-cd77-4b96-a4af-e9731ef7e9d0|2|EVENTFRQ|Event Frequency|[?]|GERD|[?]|dram|[?]|1|ug/kg/h|T3 VERTEBRA|UNILATERAL||Y|FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-10-05|10
e|FA|9e009737-cd77-4b96-a4af-e9731ef7e9d0|3|SEV|Severity/Intensity|[?]|GERD|[?]|/kg|[?]|1|Pa|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|5|FOLLOW-UP|2020-10-20|25
e|FA|9e009737-cd77-4b96-a4af-e9731ef7e9d0|4|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|DIP|[?]|1|10^6 U|PARAMETRIUM|UNILATERAL|||PROXY|2|Visit_2|25|5|TREATMENT|2020-10-20|25
e|FA|9e009737-cd77-4b96-a4af-e9731ef7e9d0|5|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|EID 50/dose|[?]|1|BOWL|TRICUSPID VALVE, ANTERIOR CUSP|LATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|WASHOUT|2020-11-04|40
e|FA|9e009737-cd77-4b96-a4af-e9731ef7e9d0|6|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|psi|[?]|1|DROP|HIP|IPSILATERAL|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|6|TREATMENT|2020-11-04|40
e|FA|9e009737-cd77-4b96-a4af-e9731ef7e9d0|7|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|/2000 RBC|[?]|1|10^6/L|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|3|FOLLOW-UP|2020-11-29|65
e|FA|9e009737-cd77-4b96-a4af-e9731ef7e9d0|8|DFRUIT|Dietary Fruit|[?]|GERD|[?]|mOsm/kg|[?]|1|10^6 CFU/mL|INTERPHALANGEAL JOINT 2|LEFT|Y||CHILD|4|Visit_4|65|3|WASHOUT|2020-11-29|65
e|FA|9e009737-cd77-4b96-a4af-e9731ef7e9d0|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|pg/dL|[?]|1|Pa|COLON, LEFT|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|TREATMENT|2020-12-24|90
e|FA|9e009737-cd77-4b96-a4af-e9731ef7e9d0|10|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|DRUM|JAW|RIGHT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2020-12-24|90
e|FA|e7468d01-71b3-47c4-9715-62fe143364cb|1|DMEAT|Dietary Meat|[?]|GERD|[?]|fmol/L/sec|[?]|1|10^6 organisms/mL|ILIAC LYMPH NODE|CONTRALATERAL|||INVESTIGATOR|1|Visit_1|10|7|WASHOUT|2020-10-15|10
e|FA|e7468d01-71b3-47c4-9715-62fe143364cb|2|DMEAT|Dietary Meat|[?]|GERD|[?]|pmol/L/h|[?]|1|10^6 organisms/mL|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|IPSILATERAL|Y||INTERVIEWER|1|Visit_1|10|4|WASHOUT|2020-10-15|10
e|FA|e7468d01-71b3-47c4-9715-62fe143364cb|3|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|Sv|[?]|1|ng|CEREBRAL CORTEX|IPSILATERAL|||PARENT|2|Visit_2|25|6|TREATMENT|2020-10-30|25
e|FA|e7468d01-71b3-47c4-9715-62fe143364cb|4|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|/10^3|[?]|1|gtt|HILAR LYMPH NODE|UNILATERAL|||FRIEND|2|Visit_2|25|5|WASHOUT|2020-10-30|25
e|FA|e7468d01-71b3-47c4-9715-62fe143364cb|5|AGETRT1|Age At First Treatment|[?]|GERD|[?]|GBq|[?]|1|mL/mmHg/min/L|PALPEBRAL CONJUNCTIVA|UNILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|1|WASHOUT|2020-11-14|40
e|FA|e7468d01-71b3-47c4-9715-62fe143364cb|6|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|ft|[?]|1|NEEDLE GAUGE|SKIN OF THE KNEE|LEFT|||INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-11-14|40
e|FA|e7468d01-71b3-47c4-9715-62fe143364cb|7|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|g/m2/day|[?]|1|mEq|PANCREAS, BODY|LEFT|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2020-12-09|65
e|FA|e7468d01-71b3-47c4-9715-62fe143364cb|8|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|/10^3|[?]|1|10^9 CFU/g|HEART, LEFT VENTRICULAR WALL|RIGHT|Y|Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-12-09|65
e|FA|e7468d01-71b3-47c4-9715-62fe143364cb|9|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|10^6/g|[?]|1|g/cage/day|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|IPSILATERAL|||PARENT|5|Visit_5|90|5|SCREENING|2021-01-03|90
e|FA|e7468d01-71b3-47c4-9715-62fe143364cb|10|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|cmol|[?]|1|Hz/s|SACRAL VERTEBRA|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|FOLLOW-UP|2021-01-03|90
e|FA|6a021859-1b18-4eb5-9548-0e32c0c1edf7|1|STROKTYP|Stroke Type|[?]|GERD|[?]|CIGARETTE|[?]|1|g/L|MUCOSA|UNILATERAL|Y|Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-05-18|10
e|FA|6a021859-1b18-4eb5-9548-0e32c0c1edf7|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|CCID 50/dose|[?]|1|mg/g/min|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|IPSILATERAL|||INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-05-18|10
e|FA|6a021859-1b18-4eb5-9548-0e32c0c1edf7|3|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|ohm|LEFT MAIN CORONARY ARTERY BODY|UNILATERAL|||STUDY SUBJECT|2|Visit_2|25|5|WASHOUT|2020-06-02|25
e|FA|6a021859-1b18-4eb5-9548-0e32c0c1edf7|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|U/m2/min|[?]|1|%(v/v)|TIBIA|BILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-06-02|25
e|FA|6a021859-1b18-4eb5-9548-0e32c0c1edf7|5|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|PFU/dose|[?]|1|mEq|HEAD|LEFT||Y|PARENT|3|Visit_3|40|6|TREATMENT|2020-06-17|40
e|FA|6a021859-1b18-4eb5-9548-0e32c0c1edf7|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/m2/h|[?]|1|%(v/v)|MITRAL VALVE|UNILATERAL|||GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-06-17|40
e|FA|6a021859-1b18-4eb5-9548-0e32c0c1edf7|7|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mV/sec|[?]|1|mL|BLADDER, NECK|RIGHT||Y|INTERVIEWER|4|Visit_4|65|2|SCREENING|2020-07-12|65
e|FA|6a021859-1b18-4eb5-9548-0e32c0c1edf7|8|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|mg/m2/h|[?]|1|EIA unit|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-07-12|65
e|FA|6a021859-1b18-4eb5-9548-0e32c0c1edf7|9|DCAL|Dietary Calories|[?]|GERD|[?]|ppb|[?]|1|EIA unit|CAPITATE-HAMATE JOINT|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-08-06|90
e|FA|6a021859-1b18-4eb5-9548-0e32c0c1edf7|10|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|tuberculin unit/mL|[?]|1|IU/mmol|HAMATE BONE|UNILATERAL|Y||INTERVIEWER|5|Visit_5|90|6|FOLLOW-UP|2020-08-06|90
e|FA|eb409ec5-4c02-41c8-a11f-03d990818c2a|1|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|nmol/kg/day|[?]|1|Shock Wave|TONGUE|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|WASHOUT|2020-12-09|10
e|FA|eb409ec5-4c02-41c8-a11f-03d990818c2a|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|SFC/10^6 PBMC|[?]|1|mg/g/min|OPPONENS POLLICIS MUSCLE|LEFT|||STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2020-12-09|10
e|FA|eb409ec5-4c02-41c8-a11f-03d990818c2a|3|SEV|Severity/Intensity|[?]|GERD|[?]|uL|[?]|1|Pa|UTERUS|IPSILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-12-24|25
e|FA|eb409ec5-4c02-41c8-a11f-03d990818c2a|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|U/m2/h|[?]|1|%(v/v)|ATRIOVENTRICULAR VALVE|LEFT|||FRIEND|2|Visit_2|25|6|WASHOUT|2020-12-24|25
e|FA|eb409ec5-4c02-41c8-a11f-03d990818c2a|5|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|uIU/dL|[?]|1|SCOOPFUL|INTERPHALANGEAL JOINT 5 OF THE HAND|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|FOLLOW-UP|2021-01-08|40
e|FA|eb409ec5-4c02-41c8-a11f-03d990818c2a|6|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|10^6 IU/mL|CARPOMETACARPAL JOINT 5|IPSILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2021-01-08|40
e|FA|eb409ec5-4c02-41c8-a11f-03d990818c2a|7|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|/2500 WBC|[?]|1|mL/cm3/min|PERIANAL REGION|LATERAL|Y||SPOUSE|4|Visit_4|65|4|SCREENING|2021-02-02|65
e|FA|eb409ec5-4c02-41c8-a11f-03d990818c2a|8|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|%(w/w)|[?]|1|mL/dose|INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL|Y|Y|CHILD|4|Visit_4|65|7|WASHOUT|2021-02-02|65
e|FA|eb409ec5-4c02-41c8-a11f-03d990818c2a|9|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|umol/L/sec|[?]|1|umol|PARACAVAL LYMPH NODE|LATERAL||Y|INTERVIEWER|5|Visit_5|90|7|WASHOUT|2021-02-27|90
e|FA|eb409ec5-4c02-41c8-a11f-03d990818c2a|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|kPa|[?]|1|mg/g/min|QUADRICEPS MUSCLE|BILATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2021-02-27|90
e|FA|2178f542-809d-4306-84e4-26d3b3b370b0|1|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|nmol/kg/day|[?]|1|SACHET|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|RIGHT||Y|PROXY|1|Visit_1|10|7|TREATMENT|2020-11-06|10
e|FA|2178f542-809d-4306-84e4-26d3b3b370b0|2|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|g/dL|PREFRONTAL CORTEX|LATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|WASHOUT|2020-11-06|10
e|FA|2178f542-809d-4306-84e4-26d3b3b370b0|3|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|Tesla|[?]|1|g/cage/day|SKIN FOLD|IPSILATERAL|||FAMILY MEMBER|2|Visit_2|25|7|WASHOUT|2020-11-21|25
e|FA|2178f542-809d-4306-84e4-26d3b3b370b0|4|DVEG|Dietary Vegetable|[?]|GERD|[?]|ag|[?]|1|Ci/ug|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|IPSILATERAL|Y||CHILD|2|Visit_2|25|6|SCREENING|2020-11-21|25
e|FA|2178f542-809d-4306-84e4-26d3b3b370b0|5|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|BOWL|[?]|1|BOWL|SKIN OF THE ELBOW|RIGHT|||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-12-06|40
e|FA|2178f542-809d-4306-84e4-26d3b3b370b0|6|SEV|Severity/Intensity|[?]|GERD|[?]|10^4 CFU|[?]|1|Pa|AORTOCAVAL LYMPH NODE|LATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2020-12-06|40
e|FA|2178f542-809d-4306-84e4-26d3b3b370b0|7|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|cm|DELTOID MUSCLE|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|WASHOUT|2020-12-31|65
e|FA|2178f542-809d-4306-84e4-26d3b3b370b0|8|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|/wk|[?]|1|cmH2O/mL|ABDOMINAL WALL|IPSILATERAL|Y||PARENT|4|Visit_4|65|3|SCREENING|2020-12-31|65
e|FA|2178f542-809d-4306-84e4-26d3b3b370b0|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Siemens|[?]|1|Pa|AXILLARY LYMPH NODE LEVEL II|LATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|7|FOLLOW-UP|2021-01-25|90
e|FA|2178f542-809d-4306-84e4-26d3b3b370b0|10|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|SCOOPFUL|LATERAL THIRD DIAGONAL BRANCH ARTERY|BILATERAL|||ADJUDICATOR|5|Visit_5|90|7|WASHOUT|2021-01-25|90
e|FA|da7423fb-461e-43a6-bcb9-aa87051bda0a|1|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|umol|[?]|1|MBq|ESOPHAGEAL LYMPH NODE|LATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-10-04|10
e|FA|da7423fb-461e-43a6-bcb9-aa87051bda0a|2|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|/mm|[?]|1|MPS U|PERICARDIAL WALL|LATERAL|||CAREGIVER|1|Visit_1|10|7|FOLLOW-UP|2020-10-04|10
e|FA|da7423fb-461e-43a6-bcb9-aa87051bda0a|3|PPTFCT|Precipitating Factor|[?]|GERD|[?]|/10^5|[?]|1|EIA unit|T4 VERTEBRA|LEFT|||GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-10-19|25
e|FA|da7423fb-461e-43a6-bcb9-aa87051bda0a|4|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|AMPULE|[?]|1|mL/mmHg/min/L|TOOTH|LATERAL|Y||FRIEND|2|Visit_2|25|3|WASHOUT|2020-10-19|25
e|FA|da7423fb-461e-43a6-bcb9-aa87051bda0a|5|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|g/dL|[?]|1|mIU/L|RETINAL PIGMENTED EPITHELIAL LAYER|BILATERAL||Y|ADJUDICATOR|3|Visit_3|40|5|FOLLOW-UP|2020-11-03|40
e|FA|da7423fb-461e-43a6-bcb9-aa87051bda0a|6|DIAMETER|Diameter|[?]|GERD|[?]|Log10 ELISA unit|[?]|1|cm|PARASYMPATHETIC GANGLIA|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|1|FOLLOW-UP|2020-11-03|40
e|FA|da7423fb-461e-43a6-bcb9-aa87051bda0a|7|DMG|Dietary Magnesium|[?]|GERD|[?]|10^9/L|[?]|1|TRANSDUCING UNIT/mL|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|BILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|2|WASHOUT|2020-11-28|65
e|FA|da7423fb-461e-43a6-bcb9-aa87051bda0a|8|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mCi/kg|[?]|1|ug/kg/h|PORTA HEPATIS LYMPH NODE|BILATERAL|||VENDOR|4|Visit_4|65|6|SCREENING|2020-11-28|65
e|FA|da7423fb-461e-43a6-bcb9-aa87051bda0a|9|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|km/h|[?]|1|U/mmol|THIGH|UNILATERAL|||PARENT|5|Visit_5|90|3|TREATMENT|2020-12-23|90
e|FA|da7423fb-461e-43a6-bcb9-aa87051bda0a|10|SEV|Severity/Intensity|[?]|GERD|[?]|pg|[?]|1|Pa|MAMMARY GLAND|UNILATERAL|||FRIEND|5|Visit_5|90|5|SCREENING|2020-12-23|90
e|FA|40e4c69f-6115-4f0e-8555-45b12b222801|1|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|mL/min/mmHg|[?]|1|mEq/g|CALCANEUS|CONTRALATERAL|||DOMESTIC PARTNER|1|Visit_1|10|6|SCREENING|2021-01-30|10
e|FA|40e4c69f-6115-4f0e-8555-45b12b222801|2|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|ng|[?]|1|DRUM|SKIN OF THE INGUINAL REGION|BILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|SCREENING|2021-01-30|10
e|FA|40e4c69f-6115-4f0e-8555-45b12b222801|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|tuberculin unit|[?]|1|mg/g/min|PROXIMAL PHALANX 3 OF THE HAND|RIGHT|||FRIEND|2|Visit_2|25|4|SCREENING|2021-02-14|25
e|FA|40e4c69f-6115-4f0e-8555-45b12b222801|4|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|mL/kg/min|[?]|1|fmol|MEDIASTINUM, POSTERIOR|IPSILATERAL|Y||GUARDIAN|2|Visit_2|25|6|TREATMENT|2021-02-14|25
e|FA|40e4c69f-6115-4f0e-8555-45b12b222801|5|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|deg2|[?]|1|mm/h|TOOTH|BILATERAL|Y||INTERVIEWER|3|Visit_3|40|2|TREATMENT|2021-03-01|40
e|FA|40e4c69f-6115-4f0e-8555-45b12b222801|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|g/animal/wk|[?]|1|%(v/v)|BLOOD|RIGHT|||SPOUSE|3|Visit_3|40|7|WASHOUT|2021-03-01|40
e|FA|40e4c69f-6115-4f0e-8555-45b12b222801|7|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|v/v|[?]|1|mmHg/L/min|MIDBRAIN|UNILATERAL|||SPOUSE|4|Visit_4|65|4|SCREENING|2021-03-26|65
e|FA|40e4c69f-6115-4f0e-8555-45b12b222801|8|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|mg/dL|[?]|1|aMFI|ILIOPSOAS MUSCLE|CONTRALATERAL|||CAREGIVER|4|Visit_4|65|7|TREATMENT|2021-03-26|65
e|FA|40e4c69f-6115-4f0e-8555-45b12b222801|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|CCID 50/dose|[?]|1|mg/g/min|TIBIAL-CRURAL PERIPHERAL ARTERY|LEFT|||ADJUDICATOR|5|Visit_5|90|7|SCREENING|2021-04-20|90
e|FA|40e4c69f-6115-4f0e-8555-45b12b222801|10|DVEG|Dietary Vegetable|[?]|GERD|[?]|ug/animal|[?]|1|Ci/ug|ANTERIOR CINGULATE GYRUS|BILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2021-04-20|90
e|FA|1307d7f6-acb6-4096-a907-08345548a82b|1|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|PACK|FALLOPIAN TUBE|BILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-05-28|10
e|FA|1307d7f6-acb6-4096-a907-08345548a82b|2|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|/sec|[?]|1|mm|SKIN OF THE ELBOW|IPSILATERAL|||PROXY|1|Visit_1|10|5|TREATMENT|2020-05-28|10
e|FA|1307d7f6-acb6-4096-a907-08345548a82b|3|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|cL|[?]|1|IU/mg|KNEE JOINT|LATERAL|||SPOUSE|2|Visit_2|25|1|WASHOUT|2020-06-12|25
e|FA|1307d7f6-acb6-4096-a907-08345548a82b|4|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|JDF Unit|[?]|1|L|C5 VERTEBRA|CONTRALATERAL|Y|Y|CHILD|2|Visit_2|25|4|TREATMENT|2020-06-12|25
e|FA|1307d7f6-acb6-4096-a907-08345548a82b|5|STROKTYP|Stroke Type|[?]|GERD|[?]|mmHg/L/min|[?]|1|g/L|INTERPHALANGEAL JOINT 2|LEFT|Y||CHILD|3|Visit_3|40|1|TREATMENT|2020-06-27|40
e|FA|1307d7f6-acb6-4096-a907-08345548a82b|6|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|mol/mg|[?]|1|anti-Xa IU/mL|PERITONEAL CAVITY|CONTRALATERAL||Y|STUDY SUBJECT|3|Visit_3|40|1|WASHOUT|2020-06-27|40
e|FA|1307d7f6-acb6-4096-a907-08345548a82b|7|OBJNUM|Number of Objects|[?]|GERD|[?]|/month|[?]|1|mL/100g/min|COCCYX|LATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|2|FOLLOW-UP|2020-07-22|65
e|FA|1307d7f6-acb6-4096-a907-08345548a82b|8|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|mol/mol|[?]|1|IU/mmol|FINGER FLEXOR TENDONS|CONTRALATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-07-22|65
e|FA|1307d7f6-acb6-4096-a907-08345548a82b|9|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|gMFI|[?]|1|L|SKIN OF THE AXILLA|IPSILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|SCREENING|2020-08-16|90
e|FA|1307d7f6-acb6-4096-a907-08345548a82b|10|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|Weber|COCCYX|UNILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2020-08-16|90
e|FA|bac23835-1120-43b2-9d99-694bef97f44b|1|EXTRSCT|Extent of Resection|[?]|GERD|[?]|WEEKS|[?]|1|Weber|FINGERNAIL|LEFT|Y||VENDOR|1|Visit_1|10|6|WASHOUT|2020-05-21|10
e|FA|bac23835-1120-43b2-9d99-694bef97f44b|2|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|/h|[?]|1|cmH2O/mL|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|LEFT||Y|INDEPENDENT ASSESSOR|1|Visit_1|10|5|SCREENING|2020-05-21|10
e|FA|bac23835-1120-43b2-9d99-694bef97f44b|3|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|BOTTLE|[?]|1|mL/dose|TRICUSPID VALVE, POSTERIOR ANNULUS|IPSILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2020-06-05|25
e|FA|bac23835-1120-43b2-9d99-694bef97f44b|4|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|um|[?]|1|km|CAPITATE-HAMATE JOINT|LEFT||Y|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-06-05|25
e|FA|bac23835-1120-43b2-9d99-694bef97f44b|5|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|mm/2h|[?]|1|g/day|ABDOMINAL LYMPH NODE|CONTRALATERAL||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|WASHOUT|2020-06-20|40
e|FA|bac23835-1120-43b2-9d99-694bef97f44b|6|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|BOX|[?]|1|mL/m2|GASTROINTESTINAL TRACT, UPPER|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|FOLLOW-UP|2020-06-20|40
e|FA|bac23835-1120-43b2-9d99-694bef97f44b|7|ACNDEV|Action Taken With Device|[?]|GERD|[?]|ng/L|[?]|1|100 IU/mL|MITRAL VALVE ANNULUS|RIGHT||Y|VENDOR|4|Visit_4|65|5|FOLLOW-UP|2020-07-15|65
e|FA|bac23835-1120-43b2-9d99-694bef97f44b|8|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|ug/m2/h|[?]|1|m2|SUPRACLAVICULAR LYMPH NODE|LATERAL|Y||CHILD|4|Visit_4|65|2|TREATMENT|2020-07-15|65
e|FA|bac23835-1120-43b2-9d99-694bef97f44b|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|CCID 50/mL|[?]|1|mg/g/min|T8 VERTEBRA|UNILATERAL|||INVESTIGATOR|5|Visit_5|90|1|FOLLOW-UP|2020-08-09|90
e|FA|bac23835-1120-43b2-9d99-694bef97f44b|10|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/g|[?]|1|/200 HPFs|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|TREATMENT|2020-08-09|90
e|FA|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|1|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|L/s/kPa|[?]|1|DRUM|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|RIGHT|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|3|WASHOUT|2020-09-24|10
e|FA|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|2|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|MET|[?]|1|mL/h|JUGULAR VEIN|LATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|SCREENING|2020-09-24|10
e|FA|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|3|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|MHz|[?]|1|10^9 CFU/g|AORTIC ARCH|BILATERAL|Y||PROXY|2|Visit_2|25|3|FOLLOW-UP|2020-10-09|25
e|FA|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|4|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|cd|[?]|1|umol|PULMONARY VALVE|BILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-10-09|25
e|FA|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|5|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6 DNA copies/mL|[?]|1|PACK|INFRACLAVICULAR LYMPH NODE|LEFT|||SIBLING|3|Visit_3|40|6|SCREENING|2020-10-24|40
e|FA|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|6|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|g/L|[?]|1|/500 WBC|L2-L3 INTERVERTEBRAL SPACE|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-10-24|40
e|FA|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|7|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|cg|[?]|1|TRANSDUCING UNIT/mL|RIB 11|LATERAL|||GUARDIAN|4|Visit_4|65|1|TREATMENT|2020-11-18|65
e|FA|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|8|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|Coulomb|PRESACRAL SPACE|LATERAL|||GUARDIAN|4|Visit_4|65|3|FOLLOW-UP|2020-11-18|65
e|FA|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|9|DFRUIT|Dietary Fruit|[?]|GERD|[?]|g/kg/day|[?]|1|10^6 CFU/mL|CORPUS CALLOSUM, SPLENIUM|LEFT||Y|STUDY SUBJECT|5|Visit_5|90|7|FOLLOW-UP|2020-12-13|90
e|FA|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|Pack Year|[?]|1|%(v/v)|INTERNAL ILIAC LYMPH NODE|LEFT|||CHILD|5|Visit_5|90|1|TREATMENT|2020-12-13|90
e|FA|14cd64f5-f3c8-47a4-b40e-9c5090890870|1|EXTRSCT|Extent of Resection|[?]|GERD|[?]|in|[?]|1|Weber|BICEPS BRACHII MUSCLE|UNILATERAL||Y|INDEPENDENT ASSESSOR|1|Visit_1|10|4|WASHOUT|2020-09-24|10
e|FA|14cd64f5-f3c8-47a4-b40e-9c5090890870|2|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|/10^3|[?]|1|DRUM|COLON, ASCENDING|LEFT|Y||INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-09-24|10
e|FA|14cd64f5-f3c8-47a4-b40e-9c5090890870|3|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/day|[?]|1|mg/dose|EXTERNAL ILIAC ARTERY|UNILATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-10-09|25
e|FA|14cd64f5-f3c8-47a4-b40e-9c5090890870|4|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|kg/mol|[?]|1|mm|OPTIC DISC|CONTRALATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|6|FOLLOW-UP|2020-10-09|25
e|FA|14cd64f5-f3c8-47a4-b40e-9c5090890870|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|/day|[?]|1|%(v/v)|INGUINAL LYMPH NODE|LATERAL|||ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2020-10-24|40
e|FA|14cd64f5-f3c8-47a4-b40e-9c5090890870|6|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|ft3|[?]|1|mm/h|MITRAL VALVE, POSTERIOR CUSP|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|FOLLOW-UP|2020-10-24|40
e|FA|14cd64f5-f3c8-47a4-b40e-9c5090890870|7|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|hPa|[?]|1|BAG|CEREBRUM|LEFT|||INVESTIGATOR|4|Visit_4|65|4|FOLLOW-UP|2020-11-18|65
e|FA|14cd64f5-f3c8-47a4-b40e-9c5090890870|8|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|cP|[?]|1|QUANTITY SUFFICIENT|TALUS|LATERAL|Y||INTERVIEWER|4|Visit_4|65|2|FOLLOW-UP|2020-11-18|65
e|FA|14cd64f5-f3c8-47a4-b40e-9c5090890870|9|TRTSETT|Treatment Setting|[?]|GERD|[?]|umol/min|[?]|1|Coulomb|DUODENUM|BILATERAL|||VENDOR|5|Visit_5|90|6|TREATMENT|2020-12-13|90
e|FA|14cd64f5-f3c8-47a4-b40e-9c5090890870|10|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|/200 HPFs|FOREBRAIN|UNILATERAL|Y|Y|GUARDIAN|5|Visit_5|90|5|FOLLOW-UP|2020-12-13|90
e|FA|ca4a06be-5e6a-4220-9854-e5fe02b384af|1|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|mEq/uL|[?]|1|PACK|PERIHILAR LYMPH NODE|CONTRALATERAL|||INVESTIGATOR|1|Visit_1|10|7|SCREENING|2020-10-03|10
e|FA|ca4a06be-5e6a-4220-9854-e5fe02b384af|2|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|PELLET|[?]|1|mg/h|GINGIVAL MUCOSA|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-10-03|10
e|FA|ca4a06be-5e6a-4220-9854-e5fe02b384af|3|DMG|Dietary Magnesium|[?]|GERD|[?]|s/h|[?]|1|TRANSDUCING UNIT/mL|BLOOD VESSEL|RIGHT|||FRIEND|2|Visit_2|25|4|SCREENING|2020-10-18|25
e|FA|ca4a06be-5e6a-4220-9854-e5fe02b384af|4|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|10^6 CFU|[?]|1|cmH2O/mL|L3-L4 INTERVERTEBRAL SPACE|LEFT|||ADJUDICATOR|2|Visit_2|25|2|WASHOUT|2020-10-18|25
e|FA|ca4a06be-5e6a-4220-9854-e5fe02b384af|5|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|IU/mmol|[?]|1|h*%|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|UNILATERAL|Y||PARENT|3|Visit_3|40|6|WASHOUT|2020-11-02|40
e|FA|ca4a06be-5e6a-4220-9854-e5fe02b384af|6|OBJTYPE|Type of Object|[?]|GERD|[?]|U/g/day|[?]|1|ng|VERTEBRA|UNILATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-11-02|40
e|FA|ca4a06be-5e6a-4220-9854-e5fe02b384af|7|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|tsp|[?]|1|HOURS|ADDUCTOR MAGNUS MUSCLE|LEFT||Y|INTERVIEWER|4|Visit_4|65|2|WASHOUT|2020-11-27|65
e|FA|ca4a06be-5e6a-4220-9854-e5fe02b384af|8|CALBURN|Calories Burned|[?]|GERD|[?]|BU/mL|[?]|1|/kg|PARASPINAL REGION|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|2|TREATMENT|2020-11-27|65
e|FA|ca4a06be-5e6a-4220-9854-e5fe02b384af|9|DFRUIT|Dietary Fruit|[?]|GERD|[?]|DRINK|[?]|1|10^6 CFU/mL|APPENDIX|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|3|TREATMENT|2020-12-22|90
e|FA|ca4a06be-5e6a-4220-9854-e5fe02b384af|10|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|BOWL|SYMPATHETIC GANGLIA|LEFT|||SPOUSE|5|Visit_5|90|7|TREATMENT|2020-12-22|90
e|FA|55504c69-a659-402b-a0cb-95ab4e08c086|1|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|PIPE|[?]|1|mm/h|ANASTOMOSIS|LATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2021-01-14|10
e|FA|55504c69-a659-402b-a0cb-95ab4e08c086|2|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|U/mg|[?]|1|cm H2O|LEFT VENTRICULAR MID INFERIOR SEGMENT|UNILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|6|WASHOUT|2021-01-14|10
e|FA|55504c69-a659-402b-a0cb-95ab4e08c086|3|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|nCi|[?]|1|BAG|PARACAVAL LYMPH NODE|RIGHT|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|1|SCREENING|2021-01-29|25
e|FA|55504c69-a659-402b-a0cb-95ab4e08c086|4|DIAMETER|Diameter|[?]|GERD|[?]|MPS U|[?]|1|cm|PRECUNEUS|IPSILATERAL|||CHILD|2|Visit_2|25|6|FOLLOW-UP|2021-01-29|25
e|FA|55504c69-a659-402b-a0cb-95ab4e08c086|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|L/s/kPa|[?]|1|%(v/v)|PHARYNGEAL TONSIL|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|SCREENING|2021-02-13|40
e|FA|55504c69-a659-402b-a0cb-95ab4e08c086|6|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|grain|[?]|1|Bq/mg|BLADDER WALL|BILATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2021-02-13|40
e|FA|55504c69-a659-402b-a0cb-95ab4e08c086|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|mg/g/min|SKIN BETWEEN EYEBROWS|UNILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|WASHOUT|2021-03-10|65
e|FA|55504c69-a659-402b-a0cb-95ab4e08c086|8|DIAMETER|Diameter|[?]|GERD|[?]|PRESSOR UNITS|[?]|1|cm|PECTORALIS MAJOR MUSCLE|LEFT|||GUARDIAN|4|Visit_4|65|3|TREATMENT|2021-03-10|65
e|FA|55504c69-a659-402b-a0cb-95ab4e08c086|9|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|mIU/L|HAND DIGIT 4|CONTRALATERAL|Y||PROXY|5|Visit_5|90|4|WASHOUT|2021-04-04|90
e|FA|55504c69-a659-402b-a0cb-95ab4e08c086|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|kg/mol|[?]|1|mg/g/min|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL|Y|Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2021-04-04|90
e|FA|bffa468a-a27b-4e87-a60d-b5787a03c6f6|1|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|mIU/L|[?]|1|10^9 CFU/mL|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|||VENDOR|1|Visit_1|10|5|WASHOUT|2020-11-30|10
e|FA|bffa468a-a27b-4e87-a60d-b5787a03c6f6|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ug/kg|[?]|1|mg/g/min|METATARSOPHALANGEAL JOINT 5|LATERAL|||INVESTIGATOR|1|Visit_1|10|5|WASHOUT|2020-11-30|10
e|FA|bffa468a-a27b-4e87-a60d-b5787a03c6f6|3|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|BEAM BREAKS|[?]|1|mL/h|CEREBRAL CORTEX|IPSILATERAL||Y|SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2020-12-15|25
e|FA|bffa468a-a27b-4e87-a60d-b5787a03c6f6|4|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mol|[?]|1|CUP|PUPIL|IPSILATERAL|||PROXY|2|Visit_2|25|3|FOLLOW-UP|2020-12-15|25
e|FA|bffa468a-a27b-4e87-a60d-b5787a03c6f6|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|DAgU/mL|[?]|1|U/mg|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|CONTRALATERAL|||INTERVIEWER|3|Visit_3|40|7|TREATMENT|2020-12-30|40
e|FA|bffa468a-a27b-4e87-a60d-b5787a03c6f6|6|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|Weber|TOOTH CANAL|LEFT|||SIGNIFICANT OTHER|3|Visit_3|40|1|SCREENING|2020-12-30|40
e|FA|bffa468a-a27b-4e87-a60d-b5787a03c6f6|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|ELISA unit|[?]|1|U/mg|VASTUS LATERALIS MUSCLE|IPSILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|6|WASHOUT|2021-01-24|65
e|FA|bffa468a-a27b-4e87-a60d-b5787a03c6f6|8|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|mEq/g|[?]|1|g/dL|PARALARYNGEAL LYMPH NODE|BILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2021-01-24|65
e|FA|bffa468a-a27b-4e87-a60d-b5787a03c6f6|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|mEq/g|[?]|1|mL/dose|L3 VERTEBRA|BILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-02-18|90
e|FA|bffa468a-a27b-4e87-a60d-b5787a03c6f6|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|U/10^12 RBC|[?]|1|%(v/v)|PRIMARY VISUAL CORTEX|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-02-18|90
e|FA|2e25aa76-914f-41e3-82ce-7c56ba2f6271|1|DFIBER|Dietary Fiber|[?]|GERD|[?]|mL/cage/day|[?]|1|h*%|EXTRAOCULAR MUSCLE|RIGHT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|WASHOUT|2020-12-11|10
e|FA|2e25aa76-914f-41e3-82ce-7c56ba2f6271|2|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|fraction of 1|[?]|1|BP|SOLE|IPSILATERAL|Y|Y|CAREGIVER|1|Visit_1|10|2|WASHOUT|2020-12-11|10
e|FA|2e25aa76-914f-41e3-82ce-7c56ba2f6271|3|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|g/m2|[?]|1|umol|FOREHEAD|IPSILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-12-26|25
e|FA|2e25aa76-914f-41e3-82ce-7c56ba2f6271|4|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|Torr|[?]|1|BP|HEAD OF THE HUMERUS|IPSILATERAL|Y||INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-12-26|25
e|FA|2e25aa76-914f-41e3-82ce-7c56ba2f6271|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|U/kg/min|[?]|1|U/mmol|KNEE JOINT TENDONS|CONTRALATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|5|TREATMENT|2021-01-10|40
e|FA|2e25aa76-914f-41e3-82ce-7c56ba2f6271|6|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Anson U|[?]|1|oz eq|SEBACEOUS GLAND|IPSILATERAL||Y|INVESTIGATOR|3|Visit_3|40|5|SCREENING|2021-01-10|40
e|FA|2e25aa76-914f-41e3-82ce-7c56ba2f6271|7|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|AU/mL|FLEXOR HALLUCIS LONGUS MUSCLE|UNILATERAL|||STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2021-02-04|65
e|FA|2e25aa76-914f-41e3-82ce-7c56ba2f6271|8|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|cd*s/m2|[?]|1|Log10 ELISA unit|FOOT|UNILATERAL|||INVESTIGATOR|4|Visit_4|65|3|FOLLOW-UP|2021-02-04|65
e|FA|2e25aa76-914f-41e3-82ce-7c56ba2f6271|9|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|10^8 PFU|[?]|1|BOWL|CLITORIS|CONTRALATERAL|Y|Y|DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2021-03-01|90
e|FA|2e25aa76-914f-41e3-82ce-7c56ba2f6271|10|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|10^6 CFU/mL|THYMUS GLAND|LEFT||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2021-03-01|90
e|FA|12c24fff-080b-4889-a455-ff55d5c0536c|1|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|ug/m2/day|[?]|1|EIA unit|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|RIGHT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2021-01-27|10
e|FA|12c24fff-080b-4889-a455-ff55d5c0536c|2|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|ukat/L|[?]|1|Bq/mg|TEMPORAL ARTERY|RIGHT|||VENDOR|1|Visit_1|10|4|TREATMENT|2021-01-27|10
e|FA|12c24fff-080b-4889-a455-ff55d5c0536c|3|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/m2/min|[?]|1|10^9 CFU/mL|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|RIGHT||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2021-02-11|25
e|FA|12c24fff-080b-4889-a455-ff55d5c0536c|4|TOTNUM|Total Number|[?]|GERD|[?]|Shock Wave|[?]|1|/200 HPFs|METACARPAL BONE|RIGHT|||SIBLING|2|Visit_2|25|6|TREATMENT|2021-02-11|25
e|FA|12c24fff-080b-4889-a455-ff55d5c0536c|5|DFATT|Dietary Fat, Total|[?]|GERD|[?]|ngEq/L|[?]|1|Bq/mg|INTERTROCHANTERIC REGION|IPSILATERAL|Y||SPOUSE|3|Visit_3|40|7|FOLLOW-UP|2021-02-26|40
e|FA|12c24fff-080b-4889-a455-ff55d5c0536c|6|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|mL/cm H2O|[?]|1|DRUM|CLAW|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|6|FOLLOW-UP|2021-02-26|40
e|FA|12c24fff-080b-4889-a455-ff55d5c0536c|7|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|NFIU|[?]|1|10^6 CFU/mL|WAIST|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|SCREENING|2021-03-23|65
e|FA|12c24fff-080b-4889-a455-ff55d5c0536c|8|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|%/min|[?]|1|ng/day|HEEL OF THE FOOT|BILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2021-03-23|65
e|FA|12c24fff-080b-4889-a455-ff55d5c0536c|9|DGRAIN|Dietary Grain|[?]|GERD|[?]|U/mmol|[?]|1|10^9 CFU/g|JOINT|UNILATERAL||Y|INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2021-04-17|90
e|FA|12c24fff-080b-4889-a455-ff55d5c0536c|10|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|/10^5|[?]|1|BOWL|ILIAC CREST|BILATERAL|Y||PROXY|5|Visit_5|90|5|WASHOUT|2021-04-17|90
e|FA|aecfe062-4e0d-4c91-8b67-1f304c5765ae|1|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|U/kg/min|[?]|1|mmHg/L/min|ARTERY|RIGHT|||CHILD|1|Visit_1|10|2|TREATMENT|2021-01-21|10
e|FA|aecfe062-4e0d-4c91-8b67-1f304c5765ae|2|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|kat|[?]|1|mL/cm3/min|FOREBRAIN|BILATERAL|Y|Y|FRIEND|1|Visit_1|10|7|FOLLOW-UP|2021-01-21|10
e|FA|aecfe062-4e0d-4c91-8b67-1f304c5765ae|3|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|mmol/g|[?]|1|g/L|SCAPHOID BONE|RIGHT|||PROXY|2|Visit_2|25|3|TREATMENT|2021-02-05|25
e|FA|aecfe062-4e0d-4c91-8b67-1f304c5765ae|4|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|Tesla|[?]|1|km|BLOOD|LEFT|||CHILD|2|Visit_2|25|4|SCREENING|2021-02-05|25
e|FA|aecfe062-4e0d-4c91-8b67-1f304c5765ae|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|Ci/g|[?]|1|%(v/v)|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|CONTRALATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2021-02-20|40
e|FA|aecfe062-4e0d-4c91-8b67-1f304c5765ae|6|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|DISK|[?]|1|U/mg|OCULOMOTOR NERVE|RIGHT|||INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2021-02-20|40
e|FA|aecfe062-4e0d-4c91-8b67-1f304c5765ae|7|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|EIA unit|LEFT POSTEROLATERAL DESCENDING ARTERY|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|5|FOLLOW-UP|2021-03-17|65
e|FA|aecfe062-4e0d-4c91-8b67-1f304c5765ae|8|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|U/m2/min|[?]|1|AU/mL|PREPUTIAL GLAND|BILATERAL||Y|SIBLING|4|Visit_4|65|5|FOLLOW-UP|2021-03-17|65
e|FA|aecfe062-4e0d-4c91-8b67-1f304c5765ae|9|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|log10 IU/mL|[?]|1|mEq|SALIVARY GLAND, SUBLINGUAL|CONTRALATERAL||Y|VENDOR|5|Visit_5|90|5|TREATMENT|2021-04-11|90
e|FA|aecfe062-4e0d-4c91-8b67-1f304c5765ae|10|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|mL/dL|[?]|1|TRANSDUCING UNIT/mL|PERICARDIAL CAVITY|LEFT|||PROXY|5|Visit_5|90|7|WASHOUT|2021-04-11|90
e|FA|05a142dc-a779-44cb-ab2e-f961676a3940|1|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|ug/animal|[?]|1|m2|LEFT VENTRICULAR APICAL LATERAL SEGMENT|IPSILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-11-18|10
e|FA|05a142dc-a779-44cb-ab2e-f961676a3940|2|ESTWT|Estimated Weight|[?]|GERD|[?]|10^12 IU/L|[?]|1|g/day|PARASYMPATHETIC GANGLIA|IPSILATERAL|Y|Y|INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-11-18|10
e|FA|05a142dc-a779-44cb-ab2e-f961676a3940|3|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|MET*h|[?]|1|SCOOPFUL|VASTUS LATERALIS MUSCLE|LEFT|||FAMILY MEMBER|2|Visit_2|25|6|FOLLOW-UP|2020-12-03|25
e|FA|05a142dc-a779-44cb-ab2e-f961676a3940|4|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|mmHg|[?]|1|cmH2O/mL|SOFT TISSUE|RIGHT||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2020-12-03|25
e|FA|05a142dc-a779-44cb-ab2e-f961676a3940|5|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|pt_us|[?]|1|Shock Wave|WRIST JOINT|LEFT||Y|DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-12-18|40
e|FA|05a142dc-a779-44cb-ab2e-f961676a3940|6|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|ug/kg/h|HAIR SHAFT|RIGHT||Y|DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-12-18|40
e|FA|05a142dc-a779-44cb-ab2e-f961676a3940|7|DPROT|Dietary Protein|[?]|GERD|[?]|mV/sec|[?]|1|10^4 CFU/mL|ANTERIOR INFERIOR CEREBELLAR ARTERY|CONTRALATERAL|Y||STUDY SUBJECT|4|Visit_4|65|3|SCREENING|2021-01-12|65
e|FA|05a142dc-a779-44cb-ab2e-f961676a3940|8|STROKTYP|Stroke Type|[?]|GERD|[?]|mg/L|[?]|1|g/L|CHOROID|IPSILATERAL|||PROXY|4|Visit_4|65|1|TREATMENT|2021-01-12|65
e|FA|05a142dc-a779-44cb-ab2e-f961676a3940|9|SEV|Severity/Intensity|[?]|GERD|[?]|IU/g|[?]|1|Pa|ABDUCTOR HALLUCIS MUSCLE|LEFT|Y||SIGNIFICANT OTHER|5|Visit_5|90|2|SCREENING|2021-02-06|90
e|FA|05a142dc-a779-44cb-ab2e-f961676a3940|10|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|mN|[?]|1|mEq/g|PYRAMIDAL TRACTS, BRAINSTEM|LATERAL|Y||FAMILY MEMBER|5|Visit_5|90|4|WASHOUT|2021-02-06|90
e|FA|498524c5-08c4-41a4-af81-876ab2452f64|1|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|NEEDLE GAUGE|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|CONTRALATERAL||Y|GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-12-09|10
e|FA|498524c5-08c4-41a4-af81-876ab2452f64|2|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|mol/L|[?]|1|10^6/L|INTERPHALANGEAL JOINT 1 OF THE FOOT|LEFT|||SIGNIFICANT OTHER|1|Visit_1|10|2|SCREENING|2020-12-09|10
e|FA|498524c5-08c4-41a4-af81-876ab2452f64|3|DMG|Dietary Magnesium|[?]|GERD|[?]|ug/L/h|[?]|1|TRANSDUCING UNIT/mL|CAPITATE BONE|LATERAL||Y|VENDOR|2|Visit_2|25|1|FOLLOW-UP|2020-12-24|25
e|FA|498524c5-08c4-41a4-af81-876ab2452f64|4|DFATT|Dietary Fat, Total|[?]|GERD|[?]|g/g|[?]|1|Bq/mg|OVARIAN FOLLICLE|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-12-24|25
e|FA|498524c5-08c4-41a4-af81-876ab2452f64|5|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|BISCUIT|[?]|1|/200 HPFs|INTERNAL MAMMARY ARTERY|RIGHT|||PARENT|3|Visit_3|40|7|TREATMENT|2021-01-08|40
e|FA|498524c5-08c4-41a4-af81-876ab2452f64|6|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|10^3 copies/mL|[?]|1|mg/h|OPPONENS POLLICIS MUSCLE|RIGHT|Y||CAREGIVER|3|Visit_3|40|4|TREATMENT|2021-01-08|40
e|FA|498524c5-08c4-41a4-af81-876ab2452f64|7|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|P|[?]|1|g/day|SKIN OF THE SOLE|LEFT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|TREATMENT|2021-02-02|65
e|FA|498524c5-08c4-41a4-af81-876ab2452f64|8|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|mEq/g|ABDOMINAL WALL|IPSILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|5|SCREENING|2021-02-02|65
e|FA|498524c5-08c4-41a4-af81-876ab2452f64|9|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|U/kg|[?]|1|AU/mL|PYLORIC SPHINCTER|BILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|SCREENING|2021-02-27|90
e|FA|498524c5-08c4-41a4-af81-876ab2452f64|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|BLOCKS|[?]|1|mL|FLEXOR CARPI RADIALIS MUSCLE|LATERAL||Y|PARENT|5|Visit_5|90|7|SCREENING|2021-02-27|90
e|FA|93490930-01cd-470e-81a3-bcd7a140ccc1|1|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|PA|[?]|1|mL|HAND|BILATERAL|||SPOUSE|1|Visit_1|10|3|TREATMENT|2020-11-17|10
e|FA|93490930-01cd-470e-81a3-bcd7a140ccc1|2|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|gpELISA unit/mL|[?]|1|mAmp|LIP, UPPER|IPSILATERAL|Y||STUDY SUBJECT|1|Visit_1|10|3|SCREENING|2020-11-17|10
e|FA|93490930-01cd-470e-81a3-bcd7a140ccc1|3|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|mL/mmHg/min/L|RETROPERITONEAL LYMPH NODE|UNILATERAL|||FRIEND|2|Visit_2|25|6|TREATMENT|2020-12-02|25
e|FA|93490930-01cd-470e-81a3-bcd7a140ccc1|4|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|pmol/day|[?]|1|Gy/h|HEPATOBILIARY SYSTEM|RIGHT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|6|FOLLOW-UP|2020-12-02|25
e|FA|93490930-01cd-470e-81a3-bcd7a140ccc1|5|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|kV|[?]|1|SACHET|SIGMOID SINUS|LATERAL|Y|Y|PARENT|3|Visit_3|40|2|WASHOUT|2020-12-17|40
e|FA|93490930-01cd-470e-81a3-bcd7a140ccc1|6|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|mL|[?]|1|U/mg|MITRAL VALVE, POSTERIOR CUSP|LATERAL|Y|Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-12-17|40
e|FA|93490930-01cd-470e-81a3-bcd7a140ccc1|7|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|nL|[?]|1|mL/100g/min|PATELLA|BILATERAL|||INVESTIGATOR|4|Visit_4|65|1|SCREENING|2021-01-11|65
e|FA|93490930-01cd-470e-81a3-bcd7a140ccc1|8|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/g|[?]|1|EIA unit|PRONATOR TERES MUSCLE|LATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-01-11|65
e|FA|93490930-01cd-470e-81a3-bcd7a140ccc1|9|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mL/s/m2|[?]|1|uL/kg/day|METACARPOPHALANGEAL JOINT 3|CONTRALATERAL|||PROXY|5|Visit_5|90|3|FOLLOW-UP|2021-02-05|90
e|FA|93490930-01cd-470e-81a3-bcd7a140ccc1|10|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|ug/g/h|PINEAL GLAND|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|FOLLOW-UP|2021-02-05|90
e|FA|fd588c97-c57f-432f-81a0-a116a017c5dd|1|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|uL|[?]|1|10^6 CFU/mL|ESOPHAGUS, ABDOMINAL|CONTRALATERAL|||CHILD|1|Visit_1|10|4|FOLLOW-UP|2020-06-03|10
e|FA|fd588c97-c57f-432f-81a0-a116a017c5dd|2|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|kIU|[?]|1|/200 HPFs|POSTERIOR INFERIOR CEREBELLAR ARTERY|UNILATERAL|||GUARDIAN|1|Visit_1|10|6|WASHOUT|2020-06-03|10
e|FA|fd588c97-c57f-432f-81a0-a116a017c5dd|3|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|EIA unit|[?]|1|fmol|DISTAL RIGHT CORONARY ARTERY CONDUIT|CONTRALATERAL|||VENDOR|2|Visit_2|25|7|FOLLOW-UP|2020-06-18|25
e|FA|fd588c97-c57f-432f-81a0-a116a017c5dd|4|LESNUM|Number of Lesions|[?]|GERD|[?]|mmol2/L2|[?]|1|ng/day|LIMB|IPSILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|4|FOLLOW-UP|2020-06-18|25
e|FA|fd588c97-c57f-432f-81a0-a116a017c5dd|5|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|cycle/min|[?]|1|SCOOPFUL|FINGER FLEXOR TENDONS|IPSILATERAL|Y|Y|INVESTIGATOR|3|Visit_3|40|5|TREATMENT|2020-07-03|40
e|FA|fd588c97-c57f-432f-81a0-a116a017c5dd|6|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/kg/week|[?]|1|g/dL|WRIST JOINT FLEXOR TENDONS|IPSILATERAL|||FAMILY MEMBER|3|Visit_3|40|1|WASHOUT|2020-07-03|40
e|FA|fd588c97-c57f-432f-81a0-a116a017c5dd|7|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|mL/cage|[?]|1|Coulomb|GASTROCNEMIUS MUSCLE, LATERAL HEAD|BILATERAL|||VENDOR|4|Visit_4|65|1|WASHOUT|2020-07-28|65
e|FA|fd588c97-c57f-432f-81a0-a116a017c5dd|8|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|10^6 organisms/mg|[?]|1|IU/mmol|LARYNX|LATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2020-07-28|65
e|FA|fd588c97-c57f-432f-81a0-a116a017c5dd|9|TRTSETT|Treatment Setting|[?]|GERD|[?]|NEBULE|[?]|1|Coulomb|SKIN AROUND THE MOUTH|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|SCREENING|2020-08-22|90
e|FA|fd588c97-c57f-432f-81a0-a116a017c5dd|10|LESNUM|Number of Lesions|[?]|GERD|[?]|%(w/v)|[?]|1|ng/day|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|UNILATERAL||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|TREATMENT|2020-08-22|90
e|FA|18028efc-33b9-4741-a47a-8fdac0a90e6e|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|10^6 CFU/mL|[?]|1|L|METATARSOPHALANGEAL JOINT 1|LEFT||Y|SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-12-22|10
e|FA|18028efc-33b9-4741-a47a-8fdac0a90e6e|2|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|mg/dose|[?]|1|ug/g/h|SPLEEN, HILUM|IPSILATERAL|||PARENT|1|Visit_1|10|4|SCREENING|2020-12-22|10
e|FA|18028efc-33b9-4741-a47a-8fdac0a90e6e|3|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|10^3 organisms/g|[?]|1|QUANTITY SUFFICIENT|MESENTERIC VEIN|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2021-01-06|25
e|FA|18028efc-33b9-4741-a47a-8fdac0a90e6e|4|DFRUIT|Dietary Fruit|[?]|GERD|[?]|MET*min|[?]|1|10^6 CFU/mL|BUCCAL MUCOSA|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|TREATMENT|2021-01-06|25
e|FA|18028efc-33b9-4741-a47a-8fdac0a90e6e|5|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|kDa|[?]|1|mg/h|AXILLARY LYMPH NODE LEVEL II|LATERAL|||DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2021-01-21|40
e|FA|18028efc-33b9-4741-a47a-8fdac0a90e6e|6|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|gtt|[?]|1|km|CERVICAL VERTEBRA|LATERAL|||CHILD|3|Visit_3|40|2|FOLLOW-UP|2021-01-21|40
e|FA|18028efc-33b9-4741-a47a-8fdac0a90e6e|7|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|BP|CAROTID ARTERY|RIGHT|||GUARDIAN|4|Visit_4|65|6|TREATMENT|2021-02-15|65
e|FA|18028efc-33b9-4741-a47a-8fdac0a90e6e|8|LDIAM|Longest Diameter|[?]|GERD|[?]|min*mg/mL|[?]|1|Shock Wave|PRESACRAL LYMPH NODE|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|1|SCREENING|2021-02-15|65
e|FA|18028efc-33b9-4741-a47a-8fdac0a90e6e|9|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|GBq/mg|[?]|1|mL/cm3/min|RETROCRURAL LYMPH NODE|RIGHT|Y||ADJUDICATOR|5|Visit_5|90|3|SCREENING|2021-03-12|90
e|FA|18028efc-33b9-4741-a47a-8fdac0a90e6e|10|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|HOURS|DISTAL PHALANX 2 OF THE HAND|LATERAL|||SIBLING|5|Visit_5|90|1|FOLLOW-UP|2021-03-12|90
e|FA|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|1|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|mg/kg/day|[?]|1|g/L|BLADDER, FUNDUS|UNILATERAL||Y|INVESTIGATOR|1|Visit_1|10|6|SCREENING|2020-06-04|10
e|FA|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|2|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|VIRTUAL PIXEL|[?]|1|10^9 CFU/mL|MID-CIRCUMFLEX ARTERY|LEFT|Y||FRIEND|1|Visit_1|10|2|SCREENING|2020-06-04|10
e|FA|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|3|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|Gy|[?]|1|10^4 CFU/mL|T4 VERTEBRA|CONTRALATERAL||Y|PROXY|2|Visit_2|25|3|TREATMENT|2020-06-19|25
e|FA|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|m3|[?]|1|ug/g/h|SKIN OF THE AXILLA|LEFT||Y|CAREGIVER|2|Visit_2|25|1|TREATMENT|2020-06-19|25
e|FA|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|5|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mmol/g|[?]|1|gtt|INFERIOR PUBIC RAMUS|UNILATERAL||Y|INTERVIEWER|3|Visit_3|40|2|TREATMENT|2020-07-04|40
e|FA|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|6|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|BOWL|GLOMERULUS|IPSILATERAL|||SIBLING|3|Visit_3|40|2|TREATMENT|2020-07-04|40
e|FA|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|7|EXTRSCT|Extent of Resection|[?]|GERD|[?]|pmol/day|[?]|1|Weber|FLEXOR HALLUCIS BREVIS MUSCLE|CONTRALATERAL|||STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2020-07-29|65
e|FA|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|8|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|g/dL|PRESACRAL LYMPH NODE|IPSILATERAL|Y|Y|VENDOR|4|Visit_4|65|4|TREATMENT|2020-07-29|65
e|FA|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|9|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|cm|[?]|1|fmol|CEREBELLUM|IPSILATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|6|SCREENING|2020-08-23|90
e|FA|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|10|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|cm2|[?]|1|PACK|SENSORIMOTOR CORTEX|LATERAL||Y|CHILD|5|Visit_5|90|6|TREATMENT|2020-08-23|90
e|FA|08fccce4-64bf-431e-81b0-a96566e77df6|1|TOTNUM|Total Number|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|/200 HPFs|SUPRASPINATUS MUSCLE|CONTRALATERAL|Y|Y|DOMESTIC PARTNER|1|Visit_1|10|6|SCREENING|2021-01-20|10
e|FA|08fccce4-64bf-431e-81b0-a96566e77df6|2|ESTWT|Estimated Weight|[?]|GERD|[?]|uV*sec|[?]|1|g/day|BUCCAL MUCOSA|RIGHT|Y|Y|PROXY|1|Visit_1|10|7|TREATMENT|2021-01-20|10
e|FA|08fccce4-64bf-431e-81b0-a96566e77df6|3|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|TAMPON|[?]|1|mL/dose|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|||FAMILY MEMBER|2|Visit_2|25|5|TREATMENT|2021-02-04|25
e|FA|08fccce4-64bf-431e-81b0-a96566e77df6|4|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|uV2|[?]|1|SCOOPFUL|MITRAL VALVE, ANTERIOR CUSP|RIGHT|||PROXY|2|Visit_2|25|3|SCREENING|2021-02-04|25
e|FA|08fccce4-64bf-431e-81b0-a96566e77df6|5|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|Ejaculate U|[?]|1|Weber|FINGER EXTENSOR TENDONS|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2021-02-19|40
e|FA|08fccce4-64bf-431e-81b0-a96566e77df6|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Tesla|[?]|1|%(v/v)|CEREBRAL ARTERY|LEFT|Y||INTERVIEWER|3|Visit_3|40|2|FOLLOW-UP|2021-02-19|40
e|FA|08fccce4-64bf-431e-81b0-a96566e77df6|7|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|nmol|[?]|1|mL/cm3/min|ACROMIOCLAVICULAR JOINT|CONTRALATERAL||Y|STUDY SUBJECT|4|Visit_4|65|2|FOLLOW-UP|2021-03-16|65
e|FA|08fccce4-64bf-431e-81b0-a96566e77df6|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|copies/ug|[?]|1|mg/g/min|OLFACTORY NERVE|BILATERAL|||FAMILY MEMBER|4|Visit_4|65|7|TREATMENT|2021-03-16|65
e|FA|08fccce4-64bf-431e-81b0-a96566e77df6|9|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|IU/day|[?]|1|mAmp|BLADDER, DOME|CONTRALATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|2|FOLLOW-UP|2021-04-10|90
e|FA|08fccce4-64bf-431e-81b0-a96566e77df6|10|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|pptr|[?]|1|mmHg/L/min|TRICUSPID VALVE|LEFT||Y|INVESTIGATOR|5|Visit_5|90|2|WASHOUT|2021-04-10|90
e|FA|0354fab5-5636-4504-8345-af060ad4c90c|1|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|g/kg/day|[?]|1|mg/h|HEEL OF THE FOOT|RIGHT|||SIBLING|1|Visit_1|10|3|TREATMENT|2021-01-23|10
e|FA|0354fab5-5636-4504-8345-af060ad4c90c|2|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mg/g/h|[?]|1|cm H2O|NECK|UNILATERAL|Y||SIBLING|1|Visit_1|10|2|WASHOUT|2021-01-23|10
e|FA|0354fab5-5636-4504-8345-af060ad4c90c|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|SBE/mL|[?]|1|%(v/v)|SYNOVIAL FLUID|BILATERAL||Y|STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2021-02-07|25
e|FA|0354fab5-5636-4504-8345-af060ad4c90c|4|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|mL/h|FEMORAL NECK|LATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|3|WASHOUT|2021-02-07|25
e|FA|0354fab5-5636-4504-8345-af060ad4c90c|5|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|ukat/L|[?]|1|10^6 organisms/mL|FACET JOINT|LATERAL|Y|Y|SIGNIFICANT OTHER|3|Visit_3|40|1|WASHOUT|2021-02-22|40
e|FA|0354fab5-5636-4504-8345-af060ad4c90c|6|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|cd/m2|[?]|1|mmHg/L/min|ABDOMINAL AORTA|BILATERAL|||FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2021-02-22|40
e|FA|0354fab5-5636-4504-8345-af060ad4c90c|7|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|ug/dL|[?]|1|mmHg/L/min|PERITONEAL CAVITY|IPSILATERAL|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|1|SCREENING|2021-03-19|65
e|FA|0354fab5-5636-4504-8345-af060ad4c90c|8|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|mU|[?]|1|MBq|INTERNAL MAMMARY ARTERY|LATERAL|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2021-03-19|65
e|FA|0354fab5-5636-4504-8345-af060ad4c90c|9|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|SCOOPFUL|[?]|1|NEEDLE GAUGE|PULMONARY VALVE, LEFT CUSP|LEFT|||SPOUSE|5|Visit_5|90|1|WASHOUT|2021-04-13|90
e|FA|0354fab5-5636-4504-8345-af060ad4c90c|10|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|FIU|[?]|1|Bq/L|LEFT POSTERIOR DESCENDING ARTERY|LATERAL|||FRIEND|5|Visit_5|90|3|TREATMENT|2021-04-13|90
e|FA|f4f1a53a-d621-4f75-b44e-96b959aed03d|1|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|10^3 CFU/mL|[?]|1|mm/h|PREPUTIAL GLAND|LEFT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|3|TREATMENT|2021-01-09|10
e|FA|f4f1a53a-d621-4f75-b44e-96b959aed03d|2|SEV|Severity/Intensity|[?]|GERD|[?]|CAPSULE|[?]|1|Pa|PORTAL VEIN|BILATERAL|||STUDY SUBJECT|1|Visit_1|10|6|FOLLOW-UP|2021-01-09|10
e|FA|f4f1a53a-d621-4f75-b44e-96b959aed03d|3|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|DAgU/mL|[?]|1|g/dL|RECTOSIGMOID JUNCTION|RIGHT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2021-01-24|25
e|FA|f4f1a53a-d621-4f75-b44e-96b959aed03d|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Absorbance U|[?]|1|Pa|CUBOID BONE|LATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2021-01-24|25
e|FA|f4f1a53a-d621-4f75-b44e-96b959aed03d|5|AGETRT1|Age At First Treatment|[?]|GERD|[?]|ECL unit|[?]|1|mL/mmHg/min/L|PERIANAL REGION|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|2|TREATMENT|2021-02-08|40
e|FA|f4f1a53a-d621-4f75-b44e-96b959aed03d|6|SEV|Severity/Intensity|[?]|GERD|[?]|days/month|[?]|1|Pa|HEART, LEFT VENTRICLE|CONTRALATERAL|Y||GUARDIAN|3|Visit_3|40|3|SCREENING|2021-02-08|40
e|FA|f4f1a53a-d621-4f75-b44e-96b959aed03d|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/nmol|[?]|1|Pa|ANASTOMOSIS|RIGHT|||FRIEND|4|Visit_4|65|4|SCREENING|2021-03-05|65
e|FA|f4f1a53a-d621-4f75-b44e-96b959aed03d|8|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|U/g Hb|[?]|1|10^6/L|MAIN BRONCHUS, RIGHT|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2021-03-05|65
e|FA|f4f1a53a-d621-4f75-b44e-96b959aed03d|9|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|Ci/ug|[?]|1|ug/kg/h|HEART, RIGHT VENTRICULAR FREE WALL|LATERAL|Y||FAMILY MEMBER|5|Visit_5|90|4|FOLLOW-UP|2021-03-30|90
e|FA|f4f1a53a-d621-4f75-b44e-96b959aed03d|10|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|U/kg|[?]|1|DRUM|FLEXOR DIGITORUM BREVIS MUSCLE|IPSILATERAL||Y|SPOUSE|5|Visit_5|90|5|FOLLOW-UP|2021-03-30|90
e|FA|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|1|LDIAM|Longest Diameter|[?]|GERD|[?]|ug/g/h|[?]|1|Shock Wave|BLADDER, TRIGONE|CONTRALATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|2|WASHOUT|2020-10-01|10
e|FA|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|kat|[?]|1|mg/g/min|PROXIMAL PHALANX 1 OF THE HAND|BILATERAL|||INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-10-01|10
e|FA|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mIU/L|[?]|1|%(v/v)|SEMITENDINOSUS MUSCLE|UNILATERAL|||FAMILY MEMBER|2|Visit_2|25|2|FOLLOW-UP|2020-10-16|25
e|FA|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|4|EXCDUR|Exercise Duration|[?]|GERD|[?]|APPLICATION|[?]|1|mm|INGUINAL REGION|LATERAL|||ADJUDICATOR|2|Visit_2|25|5|SCREENING|2020-10-16|25
e|FA|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|5|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|ohm|[?]|1|100 IU/mL|OCCIPITAL LYMPH NODE|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|6|WASHOUT|2020-10-31|40
e|FA|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|6|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|kg|[?]|1|umol|ATRIOVENTRICULAR VALVE|IPSILATERAL|||SPOUSE|3|Visit_3|40|6|WASHOUT|2020-10-31|40
e|FA|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|7|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|mkat|[?]|1|anti-Xa IU/mL|OBTURATOR INTERNUS MUSCLE|LATERAL|||PROXY|4|Visit_4|65|6|FOLLOW-UP|2020-11-25|65
e|FA|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|8|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mg/mol|[?]|1|Weber|OROPHARYNX|RIGHT|Y||GUARDIAN|4|Visit_4|65|1|SCREENING|2020-11-25|65
e|FA|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|9|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|Coulomb|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|LATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2020-12-20|90
e|FA|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|10|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|damol/L|[?]|1|mmHg/L/min|TRANSVERSE TARSAL JOINT|LATERAL|||GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-12-20|90
e|FA|679423a4-92cf-4a93-8277-282f9b43f2ed|1|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|ppb|[?]|1|gtt|ANKLE MORTISE|LEFT|||INVESTIGATOR|1|Visit_1|10|6|SCREENING|2020-08-03|10
e|FA|679423a4-92cf-4a93-8277-282f9b43f2ed|2|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|PIXELS/cm|[?]|1|BAG|ARM|UNILATERAL|Y||FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-08-03|10
e|FA|679423a4-92cf-4a93-8277-282f9b43f2ed|3|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|mOsm|[?]|1|anti-Xa IU/mL|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-08-18|25
e|FA|679423a4-92cf-4a93-8277-282f9b43f2ed|4|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|g/L|CLITORIS|LEFT|Y|Y|CAREGIVER|2|Visit_2|25|5|TREATMENT|2020-08-18|25
e|FA|679423a4-92cf-4a93-8277-282f9b43f2ed|5|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|/10^4|[?]|1|mL/mmHg/min/L|GASTRIC CARDIA|LATERAL||Y|SIBLING|3|Visit_3|40|5|TREATMENT|2020-09-02|40
e|FA|679423a4-92cf-4a93-8277-282f9b43f2ed|6|QOLIMP|QOL Impact|[?]|GERD|[?]|g/kg|[?]|1|10^6/L|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-09-02|40
e|FA|679423a4-92cf-4a93-8277-282f9b43f2ed|7|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|100 IU/mL|COLON, HEPATIC FLEXURE|RIGHT|||PROXY|4|Visit_4|65|3|FOLLOW-UP|2020-09-27|65
e|FA|679423a4-92cf-4a93-8277-282f9b43f2ed|8|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|NFIU|[?]|1|MBq|OPHTHALMIC ARTERY|RIGHT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|SCREENING|2020-09-27|65
e|FA|679423a4-92cf-4a93-8277-282f9b43f2ed|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|cycle/min|[?]|1|%(v/v)|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|IPSILATERAL|Y||CHILD|5|Visit_5|90|4|SCREENING|2020-10-22|90
e|FA|679423a4-92cf-4a93-8277-282f9b43f2ed|10|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|MHz|[?]|1|mL/min/mmHg|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|LEFT||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|WASHOUT|2020-10-22|90
e|FA|fb686cda-337b-46aa-b67b-790414201d9a|1|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|nmol/mL/min|[?]|1|U/mg|SCAPHOID-TRAPEZOID JOINT|IPSILATERAL|||FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2020-05-26|10
e|FA|fb686cda-337b-46aa-b67b-790414201d9a|2|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|10^5/hpf|[?]|1|mmHg/L/min|BLOOD|LEFT|||FRIEND|1|Visit_1|10|6|WASHOUT|2020-05-26|10
e|FA|fb686cda-337b-46aa-b67b-790414201d9a|3|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|cpm|[?]|1|L|LUNG, RIGHT MIDDLE LOBE|LATERAL|Y||FAMILY MEMBER|2|Visit_2|25|5|FOLLOW-UP|2020-06-10|25
e|FA|fb686cda-337b-46aa-b67b-790414201d9a|4|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|pg/dL|[?]|1|Gy/h|GASTROCNEMIUS MUSCLE, LATERAL HEAD|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|FOLLOW-UP|2020-06-10|25
e|FA|fb686cda-337b-46aa-b67b-790414201d9a|5|SERVNUM|Number of Servings|[?]|GERD|[?]|CUP|[?]|1|Hz/s|FACIAL BONE|CONTRALATERAL||Y|SPOUSE|3|Visit_3|40|4|WASHOUT|2020-06-25|40
e|FA|fb686cda-337b-46aa-b67b-790414201d9a|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|MET*h|[?]|1|mg/g/min|HAND DIGIT 2|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-06-25|40
e|FA|fb686cda-337b-46aa-b67b-790414201d9a|7|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|uEq/L|[?]|1|cmH2O/mL|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-07-20|65
e|FA|fb686cda-337b-46aa-b67b-790414201d9a|8|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|mL/cage/wk|[?]|1|ug/kg/h|PALATE|LATERAL|Y|Y|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2020-07-20|65
e|FA|fb686cda-337b-46aa-b67b-790414201d9a|9|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|SFC/10^6 PBMC|[?]|1|PFU/dose|MIDDLE PHALANX 4 OF THE HAND|RIGHT||Y|CHILD|5|Visit_5|90|3|TREATMENT|2020-08-14|90
e|FA|fb686cda-337b-46aa-b67b-790414201d9a|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|ECL unit|[?]|1|km|L6 VERTEBRA|RIGHT|Y|Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-08-14|90
e|FA|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|1|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|IU|[?]|1|g/cage/day|HAND DIGIT 1|LEFT|Y||SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-10-05|10
e|FA|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|2|EXTRSCT|Extent of Resection|[?]|GERD|[?]|AgU/mL|[?]|1|Weber|GENITAL TUBERCLE|IPSILATERAL|||CAREGIVER|1|Visit_1|10|5|WASHOUT|2020-10-05|10
e|FA|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|3|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|copies/uL|[?]|1|cmH2O/mL|ILIAC CREST|BILATERAL|Y||CHILD|2|Visit_2|25|7|WASHOUT|2020-10-20|25
e|FA|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|4|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|umol/min|[?]|1|g/cage/day|LIGAMENT|CONTRALATERAL|Y|Y|INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-10-20|25
e|FA|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|5|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|mAmp|[?]|1|Shock Wave|TALUS|RIGHT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-11-04|40
e|FA|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|6|DMG|Dietary Magnesium|[?]|GERD|[?]|/cmH2O|[?]|1|TRANSDUCING UNIT/mL|RIB 2|BILATERAL|||SPOUSE|3|Visit_3|40|7|WASHOUT|2020-11-04|40
e|FA|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|7|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|ELISA unit/dose|[?]|1|oz eq|PAROTID GLAND|UNILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2020-11-29|65
e|FA|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|8|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|/cmH2O|[?]|1|mL/cm3/min|JOINT|RIGHT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-11-29|65
e|FA|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|9|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|Roentgen|[?]|1|10^6 organisms/mL|ESOPHAGUS, CERVICAL|LATERAL|||SPOUSE|5|Visit_5|90|3|SCREENING|2020-12-24|90
e|FA|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|MBq/uL|[?]|1|mL|ABDOMINAL LYMPH NODE|CONTRALATERAL|||CHILD|5|Visit_5|90|4|TREATMENT|2020-12-24|90
e|FA|92d7a180-9353-41f8-93e2-ebcee32a1c63|1|PPTFCT|Precipitating Factor|[?]|GERD|[?]|vp/dose|[?]|1|EIA unit|CALCANEUS|LEFT|||STUDY SUBJECT|1|Visit_1|10|7|FOLLOW-UP|2020-12-06|10
e|FA|92d7a180-9353-41f8-93e2-ebcee32a1c63|2|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/mL|[?]|1|mm/h|ANKLE JOINT|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-12-06|10
e|FA|92d7a180-9353-41f8-93e2-ebcee32a1c63|3|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|in|[?]|1|ohm|SCIATIC NERVE|CONTRALATERAL|||CAREGIVER|2|Visit_2|25|6|TREATMENT|2020-12-21|25
e|FA|92d7a180-9353-41f8-93e2-ebcee32a1c63|4|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|Bq/ug|[?]|1|DROP|RADIUS|LEFT|||VENDOR|2|Visit_2|25|1|WASHOUT|2020-12-21|25
e|FA|92d7a180-9353-41f8-93e2-ebcee32a1c63|5|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|Bq/L|[?]|1|NEEDLE GAUGE|TIBIA SHAFT|CONTRALATERAL|||GUARDIAN|3|Visit_3|40|5|TREATMENT|2021-01-05|40
e|FA|92d7a180-9353-41f8-93e2-ebcee32a1c63|6|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|cm|RADIAL ARTERY|UNILATERAL|||FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2021-01-05|40
e|FA|92d7a180-9353-41f8-93e2-ebcee32a1c63|7|DMEAT|Dietary Meat|[?]|GERD|[?]|mEq/L|[?]|1|10^6 organisms/mL|PARA-AORTIC LYMPH NODE|RIGHT|Y||GUARDIAN|4|Visit_4|65|2|TREATMENT|2021-01-30|65
e|FA|92d7a180-9353-41f8-93e2-ebcee32a1c63|8|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|MBq/uL|[?]|1|10^6 CFU/mL|AXILLARY LYMPH NODE LEVEL II|LEFT|Y||CHILD|4|Visit_4|65|6|WASHOUT|2021-01-30|65
e|FA|92d7a180-9353-41f8-93e2-ebcee32a1c63|9|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|uEq/L|[?]|1|CUP|ASCENDING AORTA, SINUS OF VALSALVA|LATERAL|||CHILD|5|Visit_5|90|4|TREATMENT|2021-02-24|90
e|FA|92d7a180-9353-41f8-93e2-ebcee32a1c63|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|km|AXILLARY LYMPH NODE LEVEL III|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|SCREENING|2021-02-24|90
e|FA|5da18fbc-1274-4cb3-bb6b-b57872b9815b|1|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|umol/kg/min|[?]|1|mm|ETHMOID SINUS|LEFT|Y|Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|SCREENING|2020-10-17|10
e|FA|5da18fbc-1274-4cb3-bb6b-b57872b9815b|2|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|grain|[?]|1|L/h/m2|SAPHENOUS VEIN|UNILATERAL||Y|ADJUDICATOR|1|Visit_1|10|7|WASHOUT|2020-10-17|10
e|FA|5da18fbc-1274-4cb3-bb6b-b57872b9815b|3|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|umol/mol|[?]|1|m2|GASTROCNEMIUS MUSCLE|RIGHT|||SIGNIFICANT OTHER|2|Visit_2|25|6|WASHOUT|2020-11-01|25
e|FA|5da18fbc-1274-4cb3-bb6b-b57872b9815b|4|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|U/L|[?]|1|umol|METACARPAL BONE 1|RIGHT|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|2|WASHOUT|2020-11-01|25
e|FA|5da18fbc-1274-4cb3-bb6b-b57872b9815b|5|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|cm H2O|[?]|1|mL/m2|T9 VERTEBRA|CONTRALATERAL|Y||STUDY SUBJECT|3|Visit_3|40|2|WASHOUT|2020-11-16|40
e|FA|5da18fbc-1274-4cb3-bb6b-b57872b9815b|6|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|IU/L|[?]|1|Hz/s|PRESACRAL LYMPH NODE|IPSILATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-11-16|40
e|FA|5da18fbc-1274-4cb3-bb6b-b57872b9815b|7|RLDEV|Relationship to Device|[?]|GERD|[?]|10^9 CFU/mL|[?]|1|mL/min/mmHg|BASAL GANGLIA|IPSILATERAL|||FRIEND|4|Visit_4|65|3|WASHOUT|2020-12-11|65
e|FA|5da18fbc-1274-4cb3-bb6b-b57872b9815b|8|QOLIMP|QOL Impact|[?]|GERD|[?]|mm/min|[?]|1|10^6/L|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|LATERAL|||ADJUDICATOR|4|Visit_4|65|1|WASHOUT|2020-12-11|65
e|FA|5da18fbc-1274-4cb3-bb6b-b57872b9815b|9|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|mmol2/L2|[?]|1|SACHET|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|CONTRALATERAL||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2021-01-05|90
e|FA|5da18fbc-1274-4cb3-bb6b-b57872b9815b|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|atm|[?]|1|10^6 U|PUTAMEN|LEFT|Y|Y|SIBLING|5|Visit_5|90|5|WASHOUT|2021-01-05|90
e|FA|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|1|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|pm|[?]|1|/500 WBC|C2 VERTEBRA|UNILATERAL||Y|SPOUSE|1|Visit_1|10|3|FOLLOW-UP|2020-11-21|10
e|FA|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|2|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|mph|[?]|1|IU/mg|UPPER RESPIRATORY SYSTEM|BILATERAL|||CAREGIVER|1|Visit_1|10|5|FOLLOW-UP|2020-11-21|10
e|FA|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|3|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mg|[?]|1|psi|SKIN BETWEEN EYEBROWS|BILATERAL|||CHILD|2|Visit_2|25|3|TREATMENT|2020-12-06|25
e|FA|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|4|LOCONSET|Localization of Onset|[?]|GERD|[?]|pmol/10^9 cells|[?]|1|g/L|PROXIMAL INTERPHALANGEAL JOINT 3|BILATERAL|||SIBLING|2|Visit_2|25|7|TREATMENT|2020-12-06|25
e|FA|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|INHALATION|[?]|1|mg/g/min|JOINT|LEFT|||ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2020-12-21|40
e|FA|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|6|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|kIU|[?]|1|MBq|RENAL FOSSA|LEFT|||PROXY|3|Visit_3|40|7|WASHOUT|2020-12-21|40
e|FA|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|7|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|L/h|[?]|1|in|EYE BULGE|LATERAL|Y||CHILD|4|Visit_4|65|4|TREATMENT|2021-01-15|65
e|FA|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|U/mg|[?]|1|10^6 U|LACRIMAL GLAND|IPSILATERAL|||FRIEND|4|Visit_4|65|6|SCREENING|2021-01-15|65
e|FA|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|9|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|kg/L|[?]|1|mL/mmHg/min/L|PERITONEAL CAVITY|UNILATERAL||Y|INTERVIEWER|5|Visit_5|90|6|WASHOUT|2021-02-09|90
e|FA|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|m3|[?]|1|U/mmol|HEART, RIGHT VENTRICLE|IPSILATERAL|Y||INTERVIEWER|5|Visit_5|90|4|TREATMENT|2021-02-09|90
e|FA|4a195822-d646-4b22-a3b9-f6642442474d|1|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|ft3|[?]|1|DROP|MITRAL VALVE ANNULUS|IPSILATERAL|Y||PROXY|1|Visit_1|10|6|FOLLOW-UP|2020-07-25|10
e|FA|4a195822-d646-4b22-a3b9-f6642442474d|2|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|10^6 organisms/g|[?]|1|10^6 CFU|GLUTEUS MAXIMUS|UNILATERAL||Y|CAREGIVER|1|Visit_1|10|4|SCREENING|2020-07-25|10
e|FA|4a195822-d646-4b22-a3b9-f6642442474d|3|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|nmol/L/h|[?]|1|BOWL|FACIAL BONE|IPSILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|1|FOLLOW-UP|2020-08-09|25
e|FA|4a195822-d646-4b22-a3b9-f6642442474d|4|VOL|Volume|[?]|GERD|[?]|KIT|[?]|1|vp/dose|FIBULA|BILATERAL|Y||STUDY SUBJECT|2|Visit_2|25|2|WASHOUT|2020-08-09|25
e|FA|4a195822-d646-4b22-a3b9-f6642442474d|5|TOXGR|Toxicity Grade|[?]|GERD|[?]|mg/kg|[?]|1|aMFI|BONE MARROW|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|FOLLOW-UP|2020-08-24|40
e|FA|4a195822-d646-4b22-a3b9-f6642442474d|6|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|uU/dL|[?]|1|umol|LYMPH NODE|CONTRALATERAL|||FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-08-24|40
e|FA|4a195822-d646-4b22-a3b9-f6642442474d|7|LESNUM|Number of Lesions|[?]|GERD|[?]|kN/cm2|[?]|1|ng/day|THIRD POSTEROLATERAL DESCENDING ARTERY|RIGHT|||GUARDIAN|4|Visit_4|65|2|WASHOUT|2020-09-18|65
e|FA|4a195822-d646-4b22-a3b9-f6642442474d|8|DISTANCE|Distance|[?]|GERD|[?]|kHz|[?]|1|BOWL|COLON, RIGHT|BILATERAL|||INVESTIGATOR|4|Visit_4|65|4|FOLLOW-UP|2020-09-18|65
e|FA|4a195822-d646-4b22-a3b9-f6642442474d|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|kat|[?]|1|ug/g/h|EXTERNAL ILIAC ARTERY|RIGHT||Y|VENDOR|5|Visit_5|90|4|TREATMENT|2020-10-13|90
e|FA|4a195822-d646-4b22-a3b9-f6642442474d|10|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|APS U|[?]|1|10^4 CFU/mL|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL||Y|SIBLING|5|Visit_5|90|3|WASHOUT|2020-10-13|90
e|FA|515808c1-fda7-43bb-91dc-28e2d4e308cd|1|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|yd|[?]|1|m2|LACRIMAL GLAND|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|FOLLOW-UP|2020-09-07|10
e|FA|515808c1-fda7-43bb-91dc-28e2d4e308cd|2|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|min|[?]|1|L|COMMON ILIAC LYMPH NODE|RIGHT||Y|CAREGIVER|1|Visit_1|10|1|TREATMENT|2020-09-07|10
e|FA|515808c1-fda7-43bb-91dc-28e2d4e308cd|3|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|10^6/Ejaculate U|[?]|1|HOURS|EYELASH|BILATERAL|||FAMILY MEMBER|2|Visit_2|25|3|TREATMENT|2020-09-22|25
e|FA|515808c1-fda7-43bb-91dc-28e2d4e308cd|4|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|umol/h/mmol|[?]|1|mL/m2|PISIFORM BONE|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2020-09-22|25
e|FA|515808c1-fda7-43bb-91dc-28e2d4e308cd|5|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|uV|[?]|1|EIA unit|CELIAC LYMPH NODE|LEFT|||PARENT|3|Visit_3|40|6|TREATMENT|2020-10-07|40
e|FA|515808c1-fda7-43bb-91dc-28e2d4e308cd|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|log10 TCID 50/mL|[?]|1|mg/g/min|SALIVARY GLAND, SUBLINGUAL|CONTRALATERAL||Y|FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-10-07|40
e|FA|515808c1-fda7-43bb-91dc-28e2d4e308cd|7|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|nU/cL|[?]|1|DROP|SPLENIC HILAR LYMPH NODE|CONTRALATERAL||Y|CHILD|4|Visit_4|65|6|WASHOUT|2020-11-01|65
e|FA|515808c1-fda7-43bb-91dc-28e2d4e308cd|8|RLDEV|Relationship to Device|[?]|GERD|[?]|cg|[?]|1|mL/min/mmHg|VENA CAVA|UNILATERAL|Y||GUARDIAN|4|Visit_4|65|1|SCREENING|2020-11-01|65
e|FA|515808c1-fda7-43bb-91dc-28e2d4e308cd|9|AGETRT1|Age At First Treatment|[?]|GERD|[?]|mg/L FEU|[?]|1|mL/mmHg/min/L|RECTUM|IPSILATERAL|||INTERVIEWER|5|Visit_5|90|6|SCREENING|2020-11-26|90
e|FA|515808c1-fda7-43bb-91dc-28e2d4e308cd|10|DCAL|Dietary Calories|[?]|GERD|[?]|vg/kg|[?]|1|EIA unit|PROXIMAL INTERPHALANGEAL JOINT 5|IPSILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|FOLLOW-UP|2020-11-26|90
e|FA|18461665-388d-403b-90e4-2b42fcb4a01a|1|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|fmol/L|[?]|1|umol|FLEXOR HALLUCIS LONGUS MUSCLE|CONTRALATERAL|||SPOUSE|1|Visit_1|10|6|WASHOUT|2020-10-03|10
e|FA|18461665-388d-403b-90e4-2b42fcb4a01a|2|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|U/g|[?]|1|BOWL|BLADDER WALL|IPSILATERAL|Y||INTERVIEWER|1|Visit_1|10|3|TREATMENT|2020-10-03|10
e|FA|18461665-388d-403b-90e4-2b42fcb4a01a|3|SEV|Severity/Intensity|[?]|GERD|[?]|/40 HPFs|[?]|1|Pa|PELVIS|BILATERAL|||ADJUDICATOR|2|Visit_2|25|3|WASHOUT|2020-10-18|25
e|FA|18461665-388d-403b-90e4-2b42fcb4a01a|4|SERVNUM|Number of Servings|[?]|GERD|[?]|mL/kg|[?]|1|Hz/s|CARPOMETACARPAL JOINT 1|IPSILATERAL|||PARENT|2|Visit_2|25|7|TREATMENT|2020-10-18|25
e|FA|18461665-388d-403b-90e4-2b42fcb4a01a|5|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|SYRINGE|[?]|1|km|LEFT MAIN CORONARY ARTERY BODY|CONTRALATERAL|||GUARDIAN|3|Visit_3|40|6|SCREENING|2020-11-02|40
e|FA|18461665-388d-403b-90e4-2b42fcb4a01a|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|L/s|[?]|1|%(v/v)|TYMPANIC MEMBRANE|LEFT|Y||PARENT|3|Visit_3|40|6|TREATMENT|2020-11-02|40
e|FA|18461665-388d-403b-90e4-2b42fcb4a01a|7|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|PRESSOR UNITS|[?]|1|/500 WBC|INTERPHALANGEAL JOINT 4 OF THE FOOT|BILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-11-27|65
e|FA|18461665-388d-403b-90e4-2b42fcb4a01a|8|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|mph|[?]|1|mAmp|T2 VERTEBRA|UNILATERAL||Y|PARENT|4|Visit_4|65|7|TREATMENT|2020-11-27|65
e|FA|18461665-388d-403b-90e4-2b42fcb4a01a|9|TOXGR|Toxicity Grade|[?]|GERD|[?]|mOsm/L|[?]|1|aMFI|TEMPLE|UNILATERAL||Y|STUDY SUBJECT|5|Visit_5|90|3|SCREENING|2020-12-22|90
e|FA|18461665-388d-403b-90e4-2b42fcb4a01a|10|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|10^3 DNA copies/mL|[?]|1|g/dL|LEFT POSTEROLATERAL DESCENDING ARTERY|RIGHT|||CAREGIVER|5|Visit_5|90|6|SCREENING|2020-12-22|90
e|FA|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|1|EXTRSCT|Extent of Resection|[?]|GERD|[?]|TCID 50/dose|[?]|1|Weber|EXTERNAL ILIAC ARTERY|CONTRALATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|7|WASHOUT|2020-08-14|10
e|FA|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|QUANTITY SUFFICIENT|[?]|1|Pa|PERIPHERAL NERVE|LATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|SCREENING|2020-08-14|10
e|FA|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|kg/cm|[?]|1|Pa|ASCENDING AORTA, AORTIC ROOT|IPSILATERAL||Y|SPOUSE|2|Visit_2|25|5|FOLLOW-UP|2020-08-29|25
e|FA|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|4|DMEAT|Dietary Meat|[?]|GERD|[?]|nsec|[?]|1|10^6 organisms/mL|ILIAC FOSSA|BILATERAL|||FRIEND|2|Visit_2|25|2|FOLLOW-UP|2020-08-29|25
e|FA|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|5|LOCONSET|Localization of Onset|[?]|GERD|[?]|umol/min|[?]|1|g/L|ADDUCTOR MAGNUS MUSCLE|CONTRALATERAL|Y||SIBLING|3|Visit_3|40|1|WASHOUT|2020-09-13|40
e|FA|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|6|TOTNUM|Total Number|[?]|GERD|[?]|foz_us|[?]|1|/200 HPFs|C6 VERTEBRA|IPSILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|SCREENING|2020-09-13|40
e|FA|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|7|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|genEq/mL|[?]|1|Gy/h|MESENTERIC ARTERY|IPSILATERAL|||FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2020-10-08|65
e|FA|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|8|SEV|Severity/Intensity|[?]|GERD|[?]|g/cage|[?]|1|Pa|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2020-10-08|65
e|FA|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|9|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|gtt|COMMON ILIAC LYMPH NODE|RIGHT|Y|Y|STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-11-02|90
e|FA|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|10|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mCi/L|[?]|1|100 IU/mL|PYRAMIDAL TRACTS, BRAINSTEM|LATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2020-11-02|90
e|FA|e3ce1661-1b72-4835-88d1-5a6d3655b674|1|DCAL|Dietary Calories|[?]|GERD|[?]|%(v/v)|[?]|1|EIA unit|ISCHIORECTAL FOSSA|RIGHT||Y|INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-08-12|10
e|FA|e3ce1661-1b72-4835-88d1-5a6d3655b674|2|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|PACKET|[?]|1|10^6 CFU|HIP ADDUCTORS|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-08-12|10
e|FA|e3ce1661-1b72-4835-88d1-5a6d3655b674|3|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/mL|[?]|1|mmHg/L/min|COSTOCHONDRAL JOINT 1|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-08-27|25
e|FA|e3ce1661-1b72-4835-88d1-5a6d3655b674|4|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|cmH2O/mL|[?]|1|IU/mmol|RAMUS INTERMEDIUS ARTERY|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|SCREENING|2020-08-27|25
e|FA|e3ce1661-1b72-4835-88d1-5a6d3655b674|5|DVEG|Dietary Vegetable|[?]|GERD|[?]|g/dL|[?]|1|Ci/ug|CERVICAL LYMPH NODE|CONTRALATERAL||Y|FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2020-09-11|40
e|FA|e3ce1661-1b72-4835-88d1-5a6d3655b674|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|mL|[?]|1|ug/g/h|THYMUS GLAND|LATERAL|||ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-09-11|40
e|FA|e3ce1661-1b72-4835-88d1-5a6d3655b674|7|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|VIRTUAL PIXEL|[?]|1|m2|RECTUM|IPSILATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-10-06|65
e|FA|e3ce1661-1b72-4835-88d1-5a6d3655b674|8|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit/dose|[?]|1|ng/day|LOWER RESPIRATORY SYSTEM|UNILATERAL|||VENDOR|4|Visit_4|65|5|TREATMENT|2020-10-06|65
e|FA|e3ce1661-1b72-4835-88d1-5a6d3655b674|9|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|TABLET|[?]|1|ug/kg/h|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|BILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|FOLLOW-UP|2020-10-31|90
e|FA|e3ce1661-1b72-4835-88d1-5a6d3655b674|10|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|/2000 RBC|[?]|1|umol|CAUDATE NUCLEUS|CONTRALATERAL|Y|Y|ADJUDICATION COMMITTEE|5|Visit_5|90|1|SCREENING|2020-10-31|90
e|FA|240844e9-3dda-438e-81b2-8f6aa4e0427e|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|keV|[?]|1|mg/g/min|ILIUM|IPSILATERAL|||VENDOR|1|Visit_1|10|6|TREATMENT|2020-12-09|10
e|FA|240844e9-3dda-438e-81b2-8f6aa4e0427e|2|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|GBq|[?]|1|BOWL|KIDNEY, LOWER LOBE|LATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|6|FOLLOW-UP|2020-12-09|10
e|FA|240844e9-3dda-438e-81b2-8f6aa4e0427e|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^9/g|[?]|1|%(v/v)|DISTAL PHALANX 4 OF THE HAND|CONTRALATERAL|||SPOUSE|2|Visit_2|25|3|TREATMENT|2020-12-24|25
e|FA|240844e9-3dda-438e-81b2-8f6aa4e0427e|4|SPEED|Speed|[?]|GERD|[?]|s/h|[?]|1|mEq/g|SARTORIUS MUSCLE|RIGHT||Y|PROXY|2|Visit_2|25|3|WASHOUT|2020-12-24|25
e|FA|240844e9-3dda-438e-81b2-8f6aa4e0427e|5|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|PHERESIS UNIT|[?]|1|10^9 CFU/mL|HYOID BONE|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|4|SCREENING|2021-01-08|40
e|FA|240844e9-3dda-438e-81b2-8f6aa4e0427e|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|GBq/mg|[?]|1|Shock Wave|ASCENDING AORTA, AORTIC ROOT|LATERAL|||STUDY SUBJECT|3|Visit_3|40|1|FOLLOW-UP|2021-01-08|40
e|FA|240844e9-3dda-438e-81b2-8f6aa4e0427e|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/nmol|[?]|1|%(v/v)|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|FOLLOW-UP|2021-02-02|65
e|FA|240844e9-3dda-438e-81b2-8f6aa4e0427e|8|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|mmHg*min/L|[?]|1|m2|PRIMARY VISUAL CORTEX|CONTRALATERAL||Y|GUARDIAN|4|Visit_4|65|3|FOLLOW-UP|2021-02-02|65
e|FA|240844e9-3dda-438e-81b2-8f6aa4e0427e|9|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|U/animal|[?]|1|mL/h|ANTERIOR CINGULATE GYRUS|LEFT|Y||ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2021-02-27|90
e|FA|240844e9-3dda-438e-81b2-8f6aa4e0427e|10|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|L/h|[?]|1|10^6 organisms/mL|NUCLEUS ACCUMBENS|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|SCREENING|2021-02-27|90
e|FA|fccf5c5d-deb6-4f13-a485-afcda3556578|1|DMG|Dietary Magnesium|[?]|GERD|[?]|EID 50/mL|[?]|1|TRANSDUCING UNIT/mL|MIDDLE EAR|LATERAL|Y|Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|WASHOUT|2020-08-04|10
e|FA|fccf5c5d-deb6-4f13-a485-afcda3556578|2|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|10^6 CFU/g|[?]|1|Gy/h|SUPERFICIAL FEMORAL ARTERY|BILATERAL||Y|FRIEND|1|Visit_1|10|4|TREATMENT|2020-08-04|10
e|FA|fccf5c5d-deb6-4f13-a485-afcda3556578|3|DFIBER|Dietary Fiber|[?]|GERD|[?]|Ci/mL|[?]|1|h*%|SMALL SAPHENOUS VEIN|IPSILATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|5|SCREENING|2020-08-19|25
e|FA|fccf5c5d-deb6-4f13-a485-afcda3556578|4|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|mm/min|[?]|1|g/cage/day|CORONARY ARTERY|IPSILATERAL|||GUARDIAN|2|Visit_2|25|4|TREATMENT|2020-08-19|25
e|FA|fccf5c5d-deb6-4f13-a485-afcda3556578|5|LESNUM|Number of Lesions|[?]|GERD|[?]|pkat/L|[?]|1|ng/day|DISTAL PHALANX 4 OF THE HAND|RIGHT|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|2|WASHOUT|2020-09-03|40
e|FA|fccf5c5d-deb6-4f13-a485-afcda3556578|6|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|genEq/mL|[?]|1|BAG|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-09-03|40
e|FA|fccf5c5d-deb6-4f13-a485-afcda3556578|7|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|Bq/L|[?]|1|mL/cm3/min|HAIR ROOT|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-09-28|65
e|FA|fccf5c5d-deb6-4f13-a485-afcda3556578|8|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|mIU/L|ARM|UNILATERAL|||INTERVIEWER|4|Visit_4|65|1|TREATMENT|2020-09-28|65
e|FA|fccf5c5d-deb6-4f13-a485-afcda3556578|9|EVENTFRQ|Event Frequency|[?]|GERD|[?]|g/g/day|[?]|1|ug/kg/h|PATELLA|BILATERAL|||VENDOR|5|Visit_5|90|5|FOLLOW-UP|2020-10-23|90
e|FA|fccf5c5d-deb6-4f13-a485-afcda3556578|10|EVENTNUM|Number of Events|[?]|GERD|[?]|mCi|[?]|1|U/10^12 RBC|GLOMERULUS|LATERAL|Y||INVESTIGATOR|5|Visit_5|90|2|FOLLOW-UP|2020-10-23|90
e|FA|94620ed0-1ae8-4fa5-a629-9210860b0be9|1|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|/min|[?]|1|uL/kg/day|CORONARY ARTERY, ANTERIOR DESCENDING|LEFT|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|TREATMENT|2020-08-04|10
e|FA|94620ed0-1ae8-4fa5-a629-9210860b0be9|2|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|mL/kg/h|[?]|1|Gy/h|FIRST DIAGONAL BRANCH ARTERY|CONTRALATERAL||Y|GUARDIAN|1|Visit_1|10|5|SCREENING|2020-08-04|10
e|FA|94620ed0-1ae8-4fa5-a629-9210860b0be9|3|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|10^8/L|[?]|1|m2|T10 VERTEBRA|LATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2020-08-19|25
e|FA|94620ed0-1ae8-4fa5-a629-9210860b0be9|4|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|OI50|[?]|1|mAmp|STERNOCLAVICULAR JOINT|LEFT|||STUDY SUBJECT|2|Visit_2|25|2|WASHOUT|2020-08-19|25
e|FA|94620ed0-1ae8-4fa5-a629-9210860b0be9|5|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|ohm|[?]|1|AU/mL|HYPOPHARYNX|LATERAL|Y||VENDOR|3|Visit_3|40|1|TREATMENT|2020-09-03|40
e|FA|94620ed0-1ae8-4fa5-a629-9210860b0be9|6|PPTFCT|Precipitating Factor|[?]|GERD|[?]|msec|[?]|1|EIA unit|ARTERY|RIGHT|||INVESTIGATOR|3|Visit_3|40|2|TREATMENT|2020-09-03|40
e|FA|94620ed0-1ae8-4fa5-a629-9210860b0be9|7|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|Ci/ug|MITRAL VALVE|LEFT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2020-09-28|65
e|FA|94620ed0-1ae8-4fa5-a629-9210860b0be9|8|LESNUM|Number of Lesions|[?]|GERD|[?]|ft3|[?]|1|ng/day|LIVER, RIGHT LOBE|UNILATERAL|||GUARDIAN|4|Visit_4|65|1|TREATMENT|2020-09-28|65
e|FA|94620ed0-1ae8-4fa5-a629-9210860b0be9|9|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|g/cage/wk|[?]|1|mEq|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|RIGHT||Y|GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-10-23|90
e|FA|94620ed0-1ae8-4fa5-a629-9210860b0be9|10|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|nkat/g Hb|[?]|1|mEq|ORBICULARIS OCULI MUSCLE|IPSILATERAL|Y||ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-10-23|90
e|FA|9c3b6912-19be-435c-87fc-781a08efb847|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|um2|[?]|1|CUP|SACRAL VERTEBRA|RIGHT|||FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2021-01-22|10
e|FA|9c3b6912-19be-435c-87fc-781a08efb847|2|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|BOX|[?]|1|km|METACARPAL BONE 5|LATERAL||Y|INVESTIGATOR|1|Visit_1|10|1|SCREENING|2021-01-22|10
e|FA|9c3b6912-19be-435c-87fc-781a08efb847|3|EXCDUR|Exercise Duration|[?]|GERD|[?]|h*%|[?]|1|mm|CORPUS STRIATUM|CONTRALATERAL||Y|PROXY|2|Visit_2|25|6|WASHOUT|2021-02-06|25
e|FA|9c3b6912-19be-435c-87fc-781a08efb847|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|EVENTS|[?]|1|%(v/v)|LUMBAR VERTEBRA|LEFT|||INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2021-02-06|25
e|FA|9c3b6912-19be-435c-87fc-781a08efb847|5|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|10^9 CFU|[?]|1|10^9 CFU/mL|T6 VERTEBRA|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2021-02-21|40
e|FA|9c3b6912-19be-435c-87fc-781a08efb847|6|ESTWT|Estimated Weight|[?]|GERD|[?]|nkat/g Hb|[?]|1|g/day|SKIN OF THE INGUINAL REGION|RIGHT|||FRIEND|3|Visit_3|40|6|TREATMENT|2021-02-21|40
e|FA|9c3b6912-19be-435c-87fc-781a08efb847|7|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|/40 HPFs|[?]|1|SCOOPFUL|SUPRACLAVICULAR LYMPH NODE|LEFT|||FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2021-03-18|65
e|FA|9c3b6912-19be-435c-87fc-781a08efb847|8|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|EU|[?]|1|AU/mL|C1 VERTEBRA|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|WASHOUT|2021-03-18|65
e|FA|9c3b6912-19be-435c-87fc-781a08efb847|9|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|Gauss|[?]|1|10^6 U|TEMPLE|LEFT|||DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2021-04-12|90
e|FA|9c3b6912-19be-435c-87fc-781a08efb847|10|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|uEq/L|[?]|1|g/day|FIRST RIGHT POSTEROLATERAL ARTERY|LEFT|||FAMILY MEMBER|5|Visit_5|90|4|WASHOUT|2021-04-12|90
e|FA|171a6d85-ba2e-45da-b31b-01651b26e890|1|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|/10^5|[?]|1|NEEDLE GAUGE|STERNEBRA|RIGHT|||PROXY|1|Visit_1|10|3|TREATMENT|2020-08-02|10
e|FA|171a6d85-ba2e-45da-b31b-01651b26e890|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|/200 HPFs|[?]|1|mg/g/min|PERIHILAR LYMPH NODE|LATERAL|Y|Y|INTERVIEWER|1|Visit_1|10|1|FOLLOW-UP|2020-08-02|10
e|FA|171a6d85-ba2e-45da-b31b-01651b26e890|3|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|Ci/ug|[?]|1|uCi/kg|CEREBRUM|LATERAL|||DOMESTIC PARTNER|2|Visit_2|25|7|WASHOUT|2020-08-17|25
e|FA|171a6d85-ba2e-45da-b31b-01651b26e890|4|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|dpm/mL|[?]|1|fmol|FEMUR|LATERAL|||SIBLING|2|Visit_2|25|5|FOLLOW-UP|2020-08-17|25
e|FA|171a6d85-ba2e-45da-b31b-01651b26e890|5|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|U/10^12 RBC|HEAD OF THE HUMERUS|CONTRALATERAL|||PROXY|3|Visit_3|40|5|SCREENING|2020-09-01|40
e|FA|171a6d85-ba2e-45da-b31b-01651b26e890|6|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|uV2|[?]|1|HOURS|LYMPH NODE|IPSILATERAL|||PROXY|3|Visit_3|40|1|SCREENING|2020-09-01|40
e|FA|171a6d85-ba2e-45da-b31b-01651b26e890|7|TRTSETT|Treatment Setting|[?]|GERD|[?]|FINGERTIP UNIT|[?]|1|Coulomb|WRIST JOINT FLEXOR MUSCLES|RIGHT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-09-26|65
e|FA|171a6d85-ba2e-45da-b31b-01651b26e890|8|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|CAPLET|[?]|1|g/cage/day|LUMBAR VERTEBRA|IPSILATERAL|||ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2020-09-26|65
e|FA|171a6d85-ba2e-45da-b31b-01651b26e890|9|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|IU/kg|[?]|1|DRUM|OBTURATOR INTERNUS MUSCLE|UNILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|3|FOLLOW-UP|2020-10-21|90
e|FA|171a6d85-ba2e-45da-b31b-01651b26e890|10|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|kg|[?]|1|PFU/dose|CARPOMETACARPAL JOINT 3|CONTRALATERAL|||DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2020-10-21|90
e|FA|a8338164-1bb5-4474-9432-4d5a81ab30d8|1|EVENTFRQ|Event Frequency|[?]|GERD|[?]|hr/day|[?]|1|ug/kg/h|URETHRAL SPHINCTER|UNILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|1|TREATMENT|2020-12-10|10
e|FA|a8338164-1bb5-4474-9432-4d5a81ab30d8|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|titer|[?]|1|%(v/v)|HEPATIC VEIN|BILATERAL||Y|PARENT|1|Visit_1|10|7|TREATMENT|2020-12-10|10
e|FA|a8338164-1bb5-4474-9432-4d5a81ab30d8|3|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|SPRAY|[?]|1|IU/mmol|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|IPSILATERAL|||SIBLING|2|Visit_2|25|3|TREATMENT|2020-12-25|25
e|FA|a8338164-1bb5-4474-9432-4d5a81ab30d8|4|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|km|[?]|1|PACK|SUPERIOR VENA CAVA|LEFT||Y|FRIEND|2|Visit_2|25|7|TREATMENT|2020-12-25|25
e|FA|a8338164-1bb5-4474-9432-4d5a81ab30d8|5|ESTWT|Estimated Weight|[?]|GERD|[?]|Tbsp|[?]|1|g/day|BONE MARROW|BILATERAL|||FAMILY MEMBER|3|Visit_3|40|4|FOLLOW-UP|2021-01-09|40
e|FA|a8338164-1bb5-4474-9432-4d5a81ab30d8|6|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|Ci/ug|CORPUS UTERI|UNILATERAL|Y|Y|SIBLING|3|Visit_3|40|5|SCREENING|2021-01-09|40
e|FA|a8338164-1bb5-4474-9432-4d5a81ab30d8|7|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|10^6/hpf|[?]|1|10^6 IU/mL|SKIN FOLD|UNILATERAL|Y||STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2021-02-03|65
e|FA|a8338164-1bb5-4474-9432-4d5a81ab30d8|8|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|L/s|[?]|1|cmH2O/mL|ANTECUBITAL FOSSA|LEFT|||ADJUDICATION COMMITTEE|4|Visit_4|65|1|SCREENING|2021-02-03|65
e|FA|a8338164-1bb5-4474-9432-4d5a81ab30d8|9|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|MnFI|[?]|1|in|CRANIAL NERVE|LEFT|||PARENT|5|Visit_5|90|6|WASHOUT|2021-02-28|90
e|FA|a8338164-1bb5-4474-9432-4d5a81ab30d8|10|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|TRACE|[?]|1|MPS U|TRACHEOBRONCHIAL TREE|LATERAL|Y|Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2021-02-28|90
e|FA|6d64077e-1f18-4bd6-ba86-53d90121f7a9|1|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|ukat/10^12 RBC|[?]|1|10^6 organisms/mL|FEMORO-POPLITEAL PERIPHERAL ARTERY|BILATERAL|||VENDOR|1|Visit_1|10|1|TREATMENT|2020-06-17|10
e|FA|6d64077e-1f18-4bd6-ba86-53d90121f7a9|2|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|mm/2h|[?]|1|mg/dose|PULMONARY VALVE, RIGHT CUSP|RIGHT|Y||SIBLING|1|Visit_1|10|1|TREATMENT|2020-06-17|10
e|FA|6d64077e-1f18-4bd6-ba86-53d90121f7a9|3|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/min|[?]|1|km|RETROAURICULAR LYMPH NODE|LEFT||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2020-07-02|25
e|FA|6d64077e-1f18-4bd6-ba86-53d90121f7a9|4|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|10^9/g|[?]|1|/500 WBC|ENDOCARDIUM|UNILATERAL|||CAREGIVER|2|Visit_2|25|2|WASHOUT|2020-07-02|25
e|FA|6d64077e-1f18-4bd6-ba86-53d90121f7a9|5|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|Hz|[?]|1|Shock Wave|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-07-17|40
e|FA|6d64077e-1f18-4bd6-ba86-53d90121f7a9|6|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|MBq|STERNEBRA|UNILATERAL||Y|CAREGIVER|3|Visit_3|40|7|SCREENING|2020-07-17|40
e|FA|6d64077e-1f18-4bd6-ba86-53d90121f7a9|7|LOCONSET|Localization of Onset|[?]|GERD|[?]|fmol/g|[?]|1|g/L|BRACHIOCEPHALIC ARTERY|BILATERAL|Y||STUDY SUBJECT|4|Visit_4|65|3|WASHOUT|2020-08-11|65
e|FA|6d64077e-1f18-4bd6-ba86-53d90121f7a9|8|DMEAT|Dietary Meat|[?]|GERD|[?]|ug/kg/min|[?]|1|10^6 organisms/mL|BULBAR CONJUNCTIVA|LATERAL|||VENDOR|4|Visit_4|65|2|FOLLOW-UP|2020-08-11|65
e|FA|6d64077e-1f18-4bd6-ba86-53d90121f7a9|9|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|g/mol|[?]|1|ug/m2/h|BLADDER, FUNDUS|CONTRALATERAL|Y|Y|INTERVIEWER|5|Visit_5|90|5|SCREENING|2020-09-05|90
e|FA|6d64077e-1f18-4bd6-ba86-53d90121f7a9|10|SERVNUM|Number of Servings|[?]|GERD|[?]|cal|[?]|1|Hz/s|PROFUNDA FEMORIS ARTERY|BILATERAL||Y|SIBLING|5|Visit_5|90|1|WASHOUT|2020-09-05|90
e|FA|91d08486-3db7-4c71-a63f-fd060f4ae1a4|1|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|km/h|[?]|1|10^9 CFU/mL|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|UNILATERAL|Y||PARENT|1|Visit_1|10|5|TREATMENT|2020-12-25|10
e|FA|91d08486-3db7-4c71-a63f-fd060f4ae1a4|2|STRCTNUM|Number of Strictures|[?]|GERD|[?]|mgEq|[?]|1|SACHET|CEREBELLUM|RIGHT|||FAMILY MEMBER|1|Visit_1|10|3|WASHOUT|2020-12-25|10
e|FA|91d08486-3db7-4c71-a63f-fd060f4ae1a4|3|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|mL/mmHg/min/L|[?]|1|g/day|CORNEAL EPITHELIUM|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|2|WASHOUT|2021-01-09|25
e|FA|91d08486-3db7-4c71-a63f-fd060f4ae1a4|4|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|IU/mmol|[?]|1|g/dL|HEAD|LEFT|||GUARDIAN|2|Visit_2|25|4|TREATMENT|2021-01-09|25
e|FA|91d08486-3db7-4c71-a63f-fd060f4ae1a4|5|TRTSETT|Treatment Setting|[?]|GERD|[?]|/10^3|[?]|1|Coulomb|AXIAL SKELETON|BILATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2021-01-24|40
e|FA|91d08486-3db7-4c71-a63f-fd060f4ae1a4|6|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|CAPSULE|[?]|1|g/cage/day|PANCREAS, BODY|IPSILATERAL|||FRIEND|3|Visit_3|40|3|WASHOUT|2021-01-24|40
e|FA|91d08486-3db7-4c71-a63f-fd060f4ae1a4|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|/cmH2O|[?]|1|mg/g/min|L5 VERTEBRA|RIGHT|||CAREGIVER|4|Visit_4|65|6|TREATMENT|2021-02-18|65
e|FA|91d08486-3db7-4c71-a63f-fd060f4ae1a4|8|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|DROP|[?]|1|Coulomb|LEFT VENTRICULAR MID ANTERIOR SEGMENT|RIGHT||Y|VENDOR|4|Visit_4|65|2|FOLLOW-UP|2021-02-18|65
e|FA|91d08486-3db7-4c71-a63f-fd060f4ae1a4|9|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mJoule/cm2|[?]|1|L/h/m2|INTERPHALANGEAL JOINT OF THE HAND|LEFT|||PARENT|5|Visit_5|90|3|TREATMENT|2021-03-15|90
e|FA|91d08486-3db7-4c71-a63f-fd060f4ae1a4|10|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|PA|[?]|1|ug/g/h|OLFACTORY NERVE|LEFT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|SCREENING|2021-03-15|90
e|FA|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|1|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|umol/day|[?]|1|oz eq|EXTRAHEPATIC BILE DUCT|RIGHT||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2020-08-14|10
e|FA|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/min/1.73m2|[?]|1|mg/g/min|FLEXOR DIGITORUM PROFUNDUS MUSCLE|UNILATERAL|||STUDY SUBJECT|1|Visit_1|10|4|FOLLOW-UP|2020-08-14|10
e|FA|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|3|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|PIXELS/in|[?]|1|ohm|UTERINE ARTERY|RIGHT|||ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2020-08-29|25
e|FA|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|ug/g/day|[?]|1|QUANTITY SUFFICIENT|T6 VERTEBRA|LEFT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2020-08-29|25
e|FA|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|5|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|uCi/kg|[?]|1|km|PARANASAL SINUS|LATERAL|||ADJUDICATOR|3|Visit_3|40|7|WASHOUT|2020-09-13|40
e|FA|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|6|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|EU|[?]|1|mIU/L|RIGHT ATRIAL ENDOCARDIUM|BILATERAL|||SIBLING|3|Visit_3|40|6|TREATMENT|2020-09-13|40
e|FA|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|7|CALBURN|Calories Burned|[?]|GERD|[?]|ug/day|[?]|1|/kg|PANCREAS, TAIL|UNILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|7|WASHOUT|2020-10-08|65
e|FA|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|8|DISTANCE|Distance|[?]|GERD|[?]|kPa|[?]|1|BOWL|SACRAL TUBEROSITY|RIGHT|||CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-10-08|65
e|FA|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|9|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|L/L|[?]|1|MPS U|GLUTEUS MAXIMUS|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-11-02|90
e|FA|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|EID 50/dose|[?]|1|U/mg|BASILIC VEIN|RIGHT|Y||PROXY|5|Visit_5|90|4|WASHOUT|2020-11-02|90
e|FA|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|1|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|/mm2|[?]|1|mg/h|TRAPEZIUS MUSCLE|CONTRALATERAL||Y|PROXY|1|Visit_1|10|3|FOLLOW-UP|2021-01-09|10
e|FA|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|usec|[?]|1|mg/g/min|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|RIGHT|Y||PARENT|1|Visit_1|10|1|WASHOUT|2021-01-09|10
e|FA|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|3|SEV|Severity/Intensity|[?]|GERD|[?]|cal|[?]|1|Pa|STERNEBRA|CONTRALATERAL|Y|Y|SIGNIFICANT OTHER|2|Visit_2|25|5|TREATMENT|2021-01-24|25
e|FA|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|4|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|Coulomb|PALPEBRAL CONJUNCTIVA|BILATERAL|Y||CHILD|2|Visit_2|25|6|TREATMENT|2021-01-24|25
e|FA|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|5|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|EIA unit|PREFRONTAL CORTEX|CONTRALATERAL|Y||CHILD|3|Visit_3|40|3|TREATMENT|2021-02-08|40
e|FA|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|6|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|L/kg|[?]|1|Gy/h|ESOPHAGUS, CERVICAL|BILATERAL|Y||STUDY SUBJECT|3|Visit_3|40|1|FOLLOW-UP|2021-02-08|40
e|FA|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|7|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|AMPULE|[?]|1|ug/g/h|MENINGES|LATERAL|||SIBLING|4|Visit_4|65|7|TREATMENT|2021-03-05|65
e|FA|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|8|OBJNUM|Number of Objects|[?]|GERD|[?]|%/min|[?]|1|mL/100g/min|DISTAL LAD ARTERY|LEFT|||PARENT|4|Visit_4|65|3|FOLLOW-UP|2021-03-05|65
e|FA|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|9|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|DAYS|[?]|1|mL/cm3/min|PERIPANCREATIC LYMPH NODE|BILATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|2|TREATMENT|2021-03-30|90
e|FA|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|PFU|[?]|1|mg/g/min|PRETRACHEAL LYMPH NODE|IPSILATERAL|Y||INVESTIGATOR|5|Visit_5|90|5|SCREENING|2021-03-30|90
e|FA|87998e13-813a-464d-935c-d5513cd0db5e|1|LDIAM|Longest Diameter|[?]|GERD|[?]|mg/g/h|[?]|1|Shock Wave|EXTENSOR HALLUCIS BREVIS MUSCLE|IPSILATERAL|||FAMILY MEMBER|1|Visit_1|10|4|FOLLOW-UP|2020-08-31|10
e|FA|87998e13-813a-464d-935c-d5513cd0db5e|2|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|BAR|[?]|1|BOWL|RIGHT POSTERIOR DESCENDING ARTERY|UNILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|4|FOLLOW-UP|2020-08-31|10
e|FA|87998e13-813a-464d-935c-d5513cd0db5e|3|TOTNUM|Total Number|[?]|GERD|[?]|Ci/kg|[?]|1|/200 HPFs|THIRD RIGHT POSTEROLATERAL ARTERY|IPSILATERAL|Y|Y|FRIEND|2|Visit_2|25|3|SCREENING|2020-09-15|25
e|FA|87998e13-813a-464d-935c-d5513cd0db5e|4|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|Ci/L|[?]|1|vp/dose|ENTORHINAL CORTEX|RIGHT|||SIBLING|2|Visit_2|25|5|TREATMENT|2020-09-15|25
e|FA|87998e13-813a-464d-935c-d5513cd0db5e|5|SEV|Severity/Intensity|[?]|GERD|[?]|10^9/L|[?]|1|Pa|PRESACRAL SPACE|LATERAL|||FRIEND|3|Visit_3|40|2|TREATMENT|2020-09-30|40
e|FA|87998e13-813a-464d-935c-d5513cd0db5e|6|SPEED|Speed|[?]|GERD|[?]|Weber|[?]|1|mEq/g|LEG|UNILATERAL|||STUDY SUBJECT|3|Visit_3|40|1|WASHOUT|2020-09-30|40
e|FA|87998e13-813a-464d-935c-d5513cd0db5e|7|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|pt_us|[?]|1|ohm|ETHMOID SINUS|LEFT||Y|CHILD|4|Visit_4|65|3|TREATMENT|2020-10-25|65
e|FA|87998e13-813a-464d-935c-d5513cd0db5e|8|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|uCi/kg|[?]|1|mL/100g/min|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|BILATERAL|||FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-10-25|65
e|FA|87998e13-813a-464d-935c-d5513cd0db5e|9|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mAmp|[?]|1|10^6 U|VERTEBRA|IPSILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2020-11-19|90
e|FA|87998e13-813a-464d-935c-d5513cd0db5e|10|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|ug/kg/min|[?]|1|PFU/dose|INCISOR|IPSILATERAL|||FAMILY MEMBER|5|Visit_5|90|6|FOLLOW-UP|2020-11-19|90
e|FA|7812e96e-ea53-4eb0-8160-d4118c567c9d|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|ng/mol|[?]|1|10^6 U|OLFACTORY NERVE|BILATERAL|||FRIEND|1|Visit_1|10|4|TREATMENT|2021-01-27|10
e|FA|7812e96e-ea53-4eb0-8160-d4118c567c9d|2|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|CFU/g|[?]|1|AU/mL|TRUNK|CONTRALATERAL|||VENDOR|1|Visit_1|10|5|SCREENING|2021-01-27|10
e|FA|7812e96e-ea53-4eb0-8160-d4118c567c9d|3|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|STRIP|[?]|1|h*%|ANTECUBITAL FOSSA|BILATERAL|Y||CAREGIVER|2|Visit_2|25|2|WASHOUT|2021-02-11|25
e|FA|7812e96e-ea53-4eb0-8160-d4118c567c9d|4|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|BLOCKS|[?]|1|EIA unit|HYMENAL RING|UNILATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|5|FOLLOW-UP|2021-02-11|25
e|FA|7812e96e-ea53-4eb0-8160-d4118c567c9d|5|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|Frames/s|[?]|1|g/cage/day|HILAR LYMPH NODE|UNILATERAL|||SIBLING|3|Visit_3|40|2|TREATMENT|2021-02-26|40
e|FA|7812e96e-ea53-4eb0-8160-d4118c567c9d|6|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|nCi|[?]|1|umol|MIDDLE PHALANX 4 OF THE HAND|UNILATERAL|||ADJUDICATOR|3|Visit_3|40|3|WASHOUT|2021-02-26|40
e|FA|7812e96e-ea53-4eb0-8160-d4118c567c9d|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|in|[?]|1|mg/g/min|POPLITEAL LYMPH NODE|RIGHT|Y||PROXY|4|Visit_4|65|7|SCREENING|2021-03-23|65
e|FA|7812e96e-ea53-4eb0-8160-d4118c567c9d|8|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|ng/L|[?]|1|Shock Wave|MIDDLE PHALANX 3 OF THE HAND|LATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2021-03-23|65
e|FA|7812e96e-ea53-4eb0-8160-d4118c567c9d|9|DIAMETER|Diameter|[?]|GERD|[?]|Osm|[?]|1|cm|RENAL PELVIS|IPSILATERAL|||FAMILY MEMBER|5|Visit_5|90|4|SCREENING|2021-04-17|90
e|FA|7812e96e-ea53-4eb0-8160-d4118c567c9d|10|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|cup eq|[?]|1|umol|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|LATERAL|Y||PARENT|5|Visit_5|90|3|TREATMENT|2021-04-17|90
e|FA|f9c6c448-0e3d-421f-a63f-be4aeb965256|1|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|nsec|[?]|1|mm/h|PERICARDIAL WALL|RIGHT|||FRIEND|1|Visit_1|10|2|SCREENING|2020-11-08|10
e|FA|f9c6c448-0e3d-421f-a63f-be4aeb965256|2|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|mL/m2/day|[?]|1|ug/g/h|INTERPHALANGEAL JOINT 1 OF THE FOOT|UNILATERAL||Y|INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-11-08|10
e|FA|f9c6c448-0e3d-421f-a63f-be4aeb965256|3|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|umol/L/sec|[?]|1|g/cage/day|ANKLE JOINT ANTERIOR FLEXOR TENDONS|IPSILATERAL|Y|Y|PARENT|2|Visit_2|25|6|TREATMENT|2020-11-23|25
e|FA|f9c6c448-0e3d-421f-a63f-be4aeb965256|4|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/kg/h|[?]|1|g/cage/day|SACRUM|CONTRALATERAL|Y||PARENT|2|Visit_2|25|2|FOLLOW-UP|2020-11-23|25
e|FA|f9c6c448-0e3d-421f-a63f-be4aeb965256|5|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|nU/cL|[?]|1|g/day|SUPERIOR PUBIC RAMUS|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|FOLLOW-UP|2020-12-08|40
e|FA|f9c6c448-0e3d-421f-a63f-be4aeb965256|6|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|Shock Wave|TRIANGULAR BONE|UNILATERAL|||PROXY|3|Visit_3|40|1|WASHOUT|2020-12-08|40
e|FA|f9c6c448-0e3d-421f-a63f-be4aeb965256|7|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|dram|[?]|1|10^6/L|ABDUCTOR POLLICIS BREVIS MUSCLE|RIGHT||Y|INTERVIEWER|4|Visit_4|65|6|TREATMENT|2021-01-02|65
e|FA|f9c6c448-0e3d-421f-a63f-be4aeb965256|8|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|dB|[?]|1|mL/animal/day|RETROPHARYNGEAL LYMPH NODE|LEFT|||SIBLING|4|Visit_4|65|4|WASHOUT|2021-01-02|65
e|FA|f9c6c448-0e3d-421f-a63f-be4aeb965256|9|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|/HPF|[?]|1|ug/kg/h|FRONTAL LOBE|CONTRALATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|1|WASHOUT|2021-01-27|90
e|FA|f9c6c448-0e3d-421f-a63f-be4aeb965256|10|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|IU/day|[?]|1|mIU/L|LOCUS CERULEUS|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2021-01-27|90
e|FA|e8da815a-b53c-46f4-a546-e8553152719f|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mEq/ug|[?]|1|mg/g/min|SUBCARINAL LYMPH NODE|UNILATERAL||Y|GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-12-27|10
e|FA|e8da815a-b53c-46f4-a546-e8553152719f|2|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|10^3 copies/mL|[?]|1|MBq|LUNG, RIGHT MIDDLE LOBE|UNILATERAL||Y|STUDY SUBJECT|1|Visit_1|10|1|TREATMENT|2020-12-27|10
e|FA|e8da815a-b53c-46f4-a546-e8553152719f|3|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|/cmH2O|[?]|1|cmH2O/mL|EPICONDYLE|RIGHT|||DOMESTIC PARTNER|2|Visit_2|25|5|FOLLOW-UP|2021-01-11|25
e|FA|e8da815a-b53c-46f4-a546-e8553152719f|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|um2|[?]|1|%(v/v)|CORPUS CALLOSUM, SPLENIUM|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|WASHOUT|2021-01-11|25
e|FA|e8da815a-b53c-46f4-a546-e8553152719f|5|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|10^6/g|[?]|1|km|LACRIMAL GLAND|LATERAL|||PARENT|3|Visit_3|40|5|TREATMENT|2021-01-26|40
e|FA|e8da815a-b53c-46f4-a546-e8553152719f|6|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|BP|[?]|1|g/day|HEART, VENTRICLE|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|SCREENING|2021-01-26|40
e|FA|e8da815a-b53c-46f4-a546-e8553152719f|7|STRCTNUM|Number of Strictures|[?]|GERD|[?]|BP|[?]|1|SACHET|INTERPHALANGEAL JOINT 4|UNILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-02-20|65
e|FA|e8da815a-b53c-46f4-a546-e8553152719f|8|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mg|[?]|1|SCOOPFUL|SPLEEN, HILUM|LEFT|||ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2021-02-20|65
e|FA|e8da815a-b53c-46f4-a546-e8553152719f|9|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|mAmp|[?]|1|CUP|OPHTHALMIC ARTERY|UNILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2021-03-17|90
e|FA|e8da815a-b53c-46f4-a546-e8553152719f|10|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|Anson U|[?]|1|DRUM|PENIS, RADIX|LEFT|||VENDOR|5|Visit_5|90|4|TREATMENT|2021-03-17|90
e|FA|701d794b-07b4-4394-a2a4-d31a9f5b743a|1|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|IU/mg|[?]|1|mL/h|ADDUCTOR MAGNUS MUSCLE|LATERAL||Y|INTERVIEWER|1|Visit_1|10|5|TREATMENT|2021-01-29|10
e|FA|701d794b-07b4-4394-a2a4-d31a9f5b743a|2|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|BEAM BREAKS|[?]|1|mL/animal/day|THYROID GLAND, RIGHT LOBE|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2021-01-29|10
e|FA|701d794b-07b4-4394-a2a4-d31a9f5b743a|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|SACHET|[?]|1|Pa|KNEE JOINT|UNILATERAL|Y||GUARDIAN|2|Visit_2|25|2|TREATMENT|2021-02-13|25
e|FA|701d794b-07b4-4394-a2a4-d31a9f5b743a|4|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|mL/dL|[?]|1|fmol|SECOND RIGHT POSTEROLATERAL ARTERY|RIGHT||Y|GUARDIAN|2|Visit_2|25|6|TREATMENT|2021-02-13|25
e|FA|701d794b-07b4-4394-a2a4-d31a9f5b743a|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|MHz|[?]|1|mg/g/min|PULMONARY TRUNK|UNILATERAL||Y|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2021-02-28|40
e|FA|701d794b-07b4-4394-a2a4-d31a9f5b743a|6|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|mg/g/h|[?]|1|uCi/kg|ADDUCTOR POLLICIS MUSCLE|CONTRALATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|2|TREATMENT|2021-02-28|40
e|FA|701d794b-07b4-4394-a2a4-d31a9f5b743a|7|DISTANCE|Distance|[?]|GERD|[?]|ug/g/min|[?]|1|BOWL|ANTERIOR CINGULATE CORTEX|LEFT|Y||SPOUSE|4|Visit_4|65|6|TREATMENT|2021-03-25|65
e|FA|701d794b-07b4-4394-a2a4-d31a9f5b743a|8|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|mL/(min*100mL)|[?]|1|mL/mmHg/min/L|NASOPHARYNX|RIGHT|||INDEPENDENT ASSESSOR|4|Visit_4|65|4|SCREENING|2021-03-25|65
e|FA|701d794b-07b4-4394-a2a4-d31a9f5b743a|9|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|uCi|[?]|1|mL/m2|HEART, RIGHT VENTRICULAR FREE WALL|UNILATERAL|||ADJUDICATOR|5|Visit_5|90|5|SCREENING|2021-04-19|90
e|FA|701d794b-07b4-4394-a2a4-d31a9f5b743a|10|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|vp/mL|[?]|1|Bq/mg|HAND DIGIT 3|CONTRALATERAL|Y|Y|SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2021-04-19|90
e|FA|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|1|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|Bq|[?]|1|IU/mg|TIBIALIS ANTERIOR MUSCLE|UNILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-12-25|10
e|FA|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|2|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|/2500 WBC|[?]|1|U/mg|T4 VERTEBRA|LEFT||Y|SIBLING|1|Visit_1|10|6|WASHOUT|2020-12-25|10
e|FA|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|3|ESTWT|Estimated Weight|[?]|GERD|[?]|U/m2|[?]|1|g/day|T10 VERTEBRA|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2021-01-09|25
e|FA|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|dpm/0.5 mL|[?]|1|PFU/dose|SCAPHOID-TRAPEZOID JOINT|CONTRALATERAL|Y||SIBLING|2|Visit_2|25|5|TREATMENT|2021-01-09|25
e|FA|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|5|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|IU/mmol|[?]|1|g/day|MEDIASTINAL LYMPH NODE|BILATERAL||Y|CAREGIVER|3|Visit_3|40|1|WASHOUT|2021-01-24|40
e|FA|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|6|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mL/g/min|[?]|1|Weber|RIB|BILATERAL||Y|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2021-01-24|40
e|FA|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|7|STRCTNUM|Number of Strictures|[?]|GERD|[?]|/mm2|[?]|1|SACHET|POSTERIOR POLE OF THE EYE|IPSILATERAL|Y|Y|PROXY|4|Visit_4|65|5|SCREENING|2021-02-18|65
e|FA|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|8|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mL/min/mmHg|[?]|1|10^6 U|STERNEBRA|BILATERAL|Y|Y|SIGNIFICANT OTHER|4|Visit_4|65|3|SCREENING|2021-02-18|65
e|FA|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Absorbance U|[?]|1|mg/g/min|PELVIC BONE|RIGHT|||CHILD|5|Visit_5|90|5|FOLLOW-UP|2021-03-15|90
e|FA|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mL/dL|[?]|1|%(v/v)|ISCHIORECTAL FOSSA|LEFT|Y|Y|SIGNIFICANT OTHER|5|Visit_5|90|5|WASHOUT|2021-03-15|90
e|FA|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|1|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|pt_us|[?]|1|Bq/L|ABDOMINAL WALL|RIGHT||Y|VENDOR|1|Visit_1|10|7|TREATMENT|2020-08-10|10
e|FA|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|2|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|pt_br|[?]|1|aMFI|OPTIC DISC|BILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|4|SCREENING|2020-08-10|10
e|FA|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|3|CALBURN|Calories Burned|[?]|GERD|[?]|CCID 50/mL|[?]|1|/kg|RAMUS INTERMEDIUS ARTERY|CONTRALATERAL|||SPOUSE|2|Visit_2|25|3|SCREENING|2020-08-25|25
e|FA|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|4|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|cm/s|[?]|1|Bq/L|T7 VERTEBRA|IPSILATERAL||Y|ADJUDICATOR|2|Visit_2|25|6|FOLLOW-UP|2020-08-25|25
e|FA|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|5|LESNUM|Number of Lesions|[?]|GERD|[?]|ug/L DDU|[?]|1|ng/day|SUPRACLAVICULAR FOSSA|UNILATERAL|||GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-09-09|40
e|FA|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|6|SEV|Severity/Intensity|[?]|GERD|[?]|10^3/hpf|[?]|1|Pa|ILIAC CREST|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|WASHOUT|2020-09-09|40
e|FA|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|HOMEOPATHIC DILUTION|[?]|1|mg/g/min|PRONATOR QUADRATUS MUSCLE|CONTRALATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-10-04|65
e|FA|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|kBq|[?]|1|PFU/dose|PENIS|RIGHT|Y|Y|VENDOR|4|Visit_4|65|2|SCREENING|2020-10-04|65
e|FA|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|9|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|/100 HPFs|[?]|1|AU/mL|RADIAL ARTERY|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|SCREENING|2020-10-29|90
e|FA|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|log EID 50/dose|[?]|1|QUANTITY SUFFICIENT|SKIN OF THE AXILLA|BILATERAL|||VENDOR|5|Visit_5|90|3|SCREENING|2020-10-29|90
e|FA|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|1|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|SCOOPFUL|[?]|1|AU/mL|TARSAL JOINT|RIGHT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2021-01-02|10
e|FA|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|2|EVENTFRQ|Event Frequency|[?]|GERD|[?]|vg/mL|[?]|1|ug/kg/h|XIPHOID PROCESS|RIGHT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|SCREENING|2021-01-02|10
e|FA|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Tesla|[?]|1|Pa|STOMACH|BILATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2021-01-17|25
e|FA|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|4|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|U/mg|[?]|1|HOURS|METACARPOPHALANGEAL JOINT 5|IPSILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|FOLLOW-UP|2021-01-17|25
e|FA|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|5|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|mL|MEDIAN BASILIC VEIN|LEFT|Y|Y|ADJUDICATION COMMITTEE|3|Visit_3|40|5|WASHOUT|2021-02-01|40
e|FA|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|6|TOXGR|Toxicity Grade|[?]|GERD|[?]|CAPFUL|[?]|1|aMFI|KNEE JOINT|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2021-02-01|40
e|FA|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Rad|[?]|1|mg/g/min|FASCIA|LEFT|||CHILD|4|Visit_4|65|4|WASHOUT|2021-02-26|65
e|FA|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|8|SEV|Severity/Intensity|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|Pa|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|BILATERAL|||FRIEND|4|Visit_4|65|6|SCREENING|2021-02-26|65
e|FA|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Pa|[?]|1|%(v/v)|LACRIMAL GLAND|IPSILATERAL|||INVESTIGATOR|5|Visit_5|90|4|WASHOUT|2021-03-23|90
e|FA|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|10|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|Ci/mL|[?]|1|anti-Xa IU/mL|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|UNILATERAL||Y|GUARDIAN|5|Visit_5|90|2|TREATMENT|2021-03-23|90
e|FA|bb2487c3-cc05-48f8-9031-0e433c07e3d6|1|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|mEq/ug|[?]|1|TRANSDUCING UNIT/mL|INTERPHALANGEAL JOINT OF THE HAND|BILATERAL|||PROXY|1|Visit_1|10|1|TREATMENT|2020-11-29|10
e|FA|bb2487c3-cc05-48f8-9031-0e433c07e3d6|2|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|cm|[?]|1|uCi/kg|RIGHT POSTERIOR DESCENDING ARTERY|LATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|5|WASHOUT|2020-11-29|10
e|FA|bb2487c3-cc05-48f8-9031-0e433c07e3d6|3|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|mN|[?]|1|uL/kg/day|FINGER FLEXOR TENDONS|LATERAL|||INVESTIGATOR|2|Visit_2|25|6|TREATMENT|2020-12-14|25
e|FA|bb2487c3-cc05-48f8-9031-0e433c07e3d6|4|TOTNUM|Total Number|[?]|GERD|[?]|U/mmol|[?]|1|/200 HPFs|THORACIC SPINE|LEFT|Y|Y|GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-12-14|25
e|FA|bb2487c3-cc05-48f8-9031-0e433c07e3d6|5|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|cmHg|[?]|1|QUANTITY SUFFICIENT|TOE|CONTRALATERAL|Y||FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-12-29|40
e|FA|bb2487c3-cc05-48f8-9031-0e433c07e3d6|6|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|umol/kg/min|[?]|1|mm/h|ESOPHAGUS, LOWER THIRD|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|6|FOLLOW-UP|2020-12-29|40
e|FA|bb2487c3-cc05-48f8-9031-0e433c07e3d6|7|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/mL|[?]|1|/200 HPFs|EYE, ANTERIOR SEGMENT|LATERAL|||INTERVIEWER|4|Visit_4|65|3|SCREENING|2021-01-23|65
e|FA|bb2487c3-cc05-48f8-9031-0e433c07e3d6|8|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol/kg/day|[?]|1|in|SCAPHOID-TRAPEZOID JOINT|UNILATERAL|Y|Y|ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2021-01-23|65
e|FA|bb2487c3-cc05-48f8-9031-0e433c07e3d6|9|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|SYRINGE|[?]|1|mmHg/L/min|BRACHIOCEPHALIC ARTERY|LATERAL|||STUDY SUBJECT|5|Visit_5|90|2|WASHOUT|2021-02-17|90
e|FA|bb2487c3-cc05-48f8-9031-0e433c07e3d6|10|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|cd|[?]|1|CUP|TOOTH CANAL|LATERAL|||SPOUSE|5|Visit_5|90|1|TREATMENT|2021-02-17|90
e|FA|2661da18-b539-49d8-ac80-9da03c127d21|1|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|uU/dL|[?]|1|MBq|DISTAL INTERPHALANGEAL JOINT 4|RIGHT|||DOMESTIC PARTNER|1|Visit_1|10|5|FOLLOW-UP|2020-07-26|10
e|FA|2661da18-b539-49d8-ac80-9da03c127d21|2|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|pg/dL|[?]|1|cmH2O/mL|TRICUSPID VALVE, POSTERIOR ANNULUS|LATERAL|Y|Y|ADJUDICATOR|1|Visit_1|10|3|SCREENING|2020-07-26|10
e|FA|2661da18-b539-49d8-ac80-9da03c127d21|3|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|anti-Xa IU|[?]|1|AU/mL|AXIAL SKELETON|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-08-10|25
e|FA|2661da18-b539-49d8-ac80-9da03c127d21|4|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|WEEKS|[?]|1|mL/h|COLON, DESCENDING|CONTRALATERAL|||SPOUSE|2|Visit_2|25|4|TREATMENT|2020-08-10|25
e|FA|2661da18-b539-49d8-ac80-9da03c127d21|5|DISTANCE|Distance|[?]|GERD|[?]|U|[?]|1|BOWL|CEREBRAL HEMISPHERE, LEFT|IPSILATERAL|Y||SPOUSE|3|Visit_3|40|1|TREATMENT|2020-08-25|40
e|FA|2661da18-b539-49d8-ac80-9da03c127d21|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|PRESSOR UNITS|[?]|1|mg/g/min|INTERPHALANGEAL JOINT 5 OF THE HAND|IPSILATERAL|||SPOUSE|3|Visit_3|40|5|FOLLOW-UP|2020-08-25|40
e|FA|2661da18-b539-49d8-ac80-9da03c127d21|7|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|VIRTUAL PIXEL|[?]|1|mg/h|LAD SEPTAL PERFORATOR ARTERY|CONTRALATERAL||Y|ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-09-19|65
e|FA|2661da18-b539-49d8-ac80-9da03c127d21|8|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|bel|[?]|1|NEEDLE GAUGE|AORTOCAVAL LYMPH NODE|LATERAL|Y||FRIEND|4|Visit_4|65|2|TREATMENT|2020-09-19|65
e|FA|2661da18-b539-49d8-ac80-9da03c127d21|9|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|umol/L|[?]|1|PACK|GREAT VESSELS|UNILATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-10-14|90
e|FA|2661da18-b539-49d8-ac80-9da03c127d21|10|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|mEq|PUPIL|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-10-14|90
e|FA|f1835786-c567-4235-9bd1-f7ffcec12741|1|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|AgU/mL|[?]|1|ug/g/h|JOINT|LEFT|||INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-08-06|10
e|FA|f1835786-c567-4235-9bd1-f7ffcec12741|2|DPROT|Dietary Protein|[?]|GERD|[?]|cmH2O*s/mL|[?]|1|10^4 CFU/mL|ILEUM WALL|LEFT||Y|PARENT|1|Visit_1|10|2|SCREENING|2020-08-06|10
e|FA|f1835786-c567-4235-9bd1-f7ffcec12741|3|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|mOsm/L|[?]|1|mL/h|ULNAR NERVE|LEFT|Y||FAMILY MEMBER|2|Visit_2|25|4|SCREENING|2020-08-21|25
e|FA|f1835786-c567-4235-9bd1-f7ffcec12741|4|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|/VF|[?]|1|/500 WBC|GASTRIC CURVATURE LYMPH NODE|UNILATERAL|Y||DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-08-21|25
e|FA|f1835786-c567-4235-9bd1-f7ffcec12741|5|DFIBER|Dietary Fiber|[?]|GERD|[?]|SACHET|[?]|1|h*%|MOTOR CORTEX|IPSILATERAL|Y||FAMILY MEMBER|3|Visit_3|40|4|SCREENING|2020-09-05|40
e|FA|f1835786-c567-4235-9bd1-f7ffcec12741|6|SPEED|Speed|[?]|GERD|[?]|hPa|[?]|1|mEq/g|BLOOD|IPSILATERAL|||PARENT|3|Visit_3|40|6|TREATMENT|2020-09-05|40
e|FA|f1835786-c567-4235-9bd1-f7ffcec12741|7|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|s/h|[?]|1|km|CORPUS CALLOSUM, BODY|RIGHT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|FOLLOW-UP|2020-09-30|65
e|FA|f1835786-c567-4235-9bd1-f7ffcec12741|8|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|g/kg/day|[?]|1|10^6 IU/mL|CORNEAL ENDOTHELIUM|CONTRALATERAL|Y||SIBLING|4|Visit_4|65|1|FOLLOW-UP|2020-09-30|65
e|FA|f1835786-c567-4235-9bd1-f7ffcec12741|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|RFU|[?]|1|mg/g/min|HEPATIC LYMPH NODE|BILATERAL|||CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-10-25|90
e|FA|f1835786-c567-4235-9bd1-f7ffcec12741|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|NFIU|[?]|1|Pa|CEREBRAL HEMISPHERE, LEFT|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2020-10-25|90
e|FA|019eb415-1da3-40fa-b4ba-b1f381ec3cac|1|SEV|Severity/Intensity|[?]|GERD|[?]|MONTHS|[?]|1|Pa|ACCESSORY RENAL ARTERY|LEFT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|TREATMENT|2020-07-10|10
e|FA|019eb415-1da3-40fa-b4ba-b1f381ec3cac|2|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|PFU|[?]|1|Shock Wave|ASCENDING AORTA, AORTIC ROOT|LATERAL|Y||FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-07-10|10
e|FA|019eb415-1da3-40fa-b4ba-b1f381ec3cac|3|SERVNUM|Number of Servings|[?]|GERD|[?]|breaths/min|[?]|1|Hz/s|STERNOCLAVICULAR JOINT|RIGHT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|5|SCREENING|2020-07-25|25
e|FA|019eb415-1da3-40fa-b4ba-b1f381ec3cac|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/day|[?]|1|mg/g/min|L4-L5 INTERVERTEBRAL SPACE|RIGHT|||SIGNIFICANT OTHER|2|Visit_2|25|7|TREATMENT|2020-07-25|25
e|FA|019eb415-1da3-40fa-b4ba-b1f381ec3cac|5|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|U/mmol|[?]|1|QUANTITY SUFFICIENT|CLAVICLE|UNILATERAL|||GUARDIAN|3|Visit_3|40|5|SCREENING|2020-08-09|40
e|FA|019eb415-1da3-40fa-b4ba-b1f381ec3cac|6|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|BLOCKS|[?]|1|cmH2O/mL|ASCENDING AORTA, SINOTUBULAR JUNCTION|LATERAL|||STUDY SUBJECT|3|Visit_3|40|1|TREATMENT|2020-08-09|40
e|FA|019eb415-1da3-40fa-b4ba-b1f381ec3cac|7|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|10^4/L|[?]|1|gtt|T9 VERTEBRA|IPSILATERAL|||CAREGIVER|4|Visit_4|65|2|TREATMENT|2020-09-03|65
e|FA|019eb415-1da3-40fa-b4ba-b1f381ec3cac|8|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|10^6 CFU/g|[?]|1|10^6 IU/mL|STERNUM|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|SCREENING|2020-09-03|65
e|FA|019eb415-1da3-40fa-b4ba-b1f381ec3cac|9|EXTRSCT|Extent of Resection|[?]|GERD|[?]|10^11/L|[?]|1|Weber|INTERNAL MAMMARY LYMPH NODE|UNILATERAL|Y|Y|FRIEND|5|Visit_5|90|7|TREATMENT|2020-09-28|90
e|FA|019eb415-1da3-40fa-b4ba-b1f381ec3cac|10|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|ug/L DDU|[?]|1|gtt|HILAR LYMPH NODE|CONTRALATERAL|||FRIEND|5|Visit_5|90|7|WASHOUT|2020-09-28|90
e|FA|2506c6e2-018f-4300-b3b5-44ff8d6e13df|1|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|copies/uL|[?]|1|umol|ILEUM LYMPH NODE|BILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-07-23|10
e|FA|2506c6e2-018f-4300-b3b5-44ff8d6e13df|2|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|Weber|T7 VERTEBRA|RIGHT|||STUDY SUBJECT|1|Visit_1|10|5|FOLLOW-UP|2020-07-23|10
e|FA|2506c6e2-018f-4300-b3b5-44ff8d6e13df|3|ESTWT|Estimated Weight|[?]|GERD|[?]|EID 50/dose|[?]|1|g/day|ENDOMETRIUM|CONTRALATERAL|Y|Y|STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-08-07|25
e|FA|2506c6e2-018f-4300-b3b5-44ff8d6e13df|4|SEV|Severity/Intensity|[?]|GERD|[?]|mEq/kg|[?]|1|Pa|EYE, ANTERIOR CHAMBER|UNILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|FOLLOW-UP|2020-08-07|25
e|FA|2506c6e2-018f-4300-b3b5-44ff8d6e13df|5|SEV|Severity/Intensity|[?]|GERD|[?]|/ms|[?]|1|Pa|INTERPHALANGEAL JOINT 5 OF THE FOOT|UNILATERAL|||CAREGIVER|3|Visit_3|40|7|TREATMENT|2020-08-22|40
e|FA|2506c6e2-018f-4300-b3b5-44ff8d6e13df|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|h/wk|[?]|1|Pa|MEDIASTINUM|CONTRALATERAL|Y|Y|PROXY|3|Visit_3|40|6|WASHOUT|2020-08-22|40
e|FA|2506c6e2-018f-4300-b3b5-44ff8d6e13df|7|RLDEV|Relationship to Device|[?]|GERD|[?]|Enzyme U/g Hb|[?]|1|mL/min/mmHg|RECTOSIGMOID JUNCTION|RIGHT|||PROXY|4|Visit_4|65|4|WASHOUT|2020-09-16|65
e|FA|2506c6e2-018f-4300-b3b5-44ff8d6e13df|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Enzyme U/g Hb|[?]|1|mg/g/min|RIB 4|BILATERAL|||PARENT|4|Visit_4|65|5|TREATMENT|2020-09-16|65
e|FA|2506c6e2-018f-4300-b3b5-44ff8d6e13df|9|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|/LPF|[?]|1|10^6 organisms/mL|T10 VERTEBRA|IPSILATERAL|Y||CAREGIVER|5|Visit_5|90|7|WASHOUT|2020-10-11|90
e|FA|2506c6e2-018f-4300-b3b5-44ff8d6e13df|10|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|Bq/L|LESSER TROCHANTER|BILATERAL||Y|FRIEND|5|Visit_5|90|4|TREATMENT|2020-10-11|90
e|FA|65c439f8-9658-4ac5-9eae-0837182a90fd|1|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|/2500 WBC|[?]|1|ug/m2/h|HAIR BULB|IPSILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-06-04|10
e|FA|65c439f8-9658-4ac5-9eae-0837182a90fd|2|SPEED|Speed|[?]|GERD|[?]|h/wk|[?]|1|mEq/g|PANCREAS, BODY|LATERAL|||GUARDIAN|1|Visit_1|10|4|WASHOUT|2020-06-04|10
e|FA|65c439f8-9658-4ac5-9eae-0837182a90fd|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|Pa|TAIL|LEFT|||SIBLING|2|Visit_2|25|7|FOLLOW-UP|2020-06-19|25
e|FA|65c439f8-9658-4ac5-9eae-0837182a90fd|4|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|L/s|[?]|1|g/cage/day|SCAPHOID BONE|IPSILATERAL|||ADJUDICATOR|2|Visit_2|25|3|SCREENING|2020-06-19|25
e|FA|65c439f8-9658-4ac5-9eae-0837182a90fd|5|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|damol/L|[?]|1|gtt|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|CONTRALATERAL|Y||STUDY SUBJECT|3|Visit_3|40|5|SCREENING|2020-07-04|40
e|FA|65c439f8-9658-4ac5-9eae-0837182a90fd|6|EVENTFRQ|Event Frequency|[?]|GERD|[?]|pL|[?]|1|ug/kg/h|NECK|UNILATERAL|||SPOUSE|3|Visit_3|40|6|TREATMENT|2020-07-04|40
e|FA|65c439f8-9658-4ac5-9eae-0837182a90fd|7|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|s*kPa|[?]|1|g/L|CEREBRAL VEIN|LATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-07-29|65
e|FA|65c439f8-9658-4ac5-9eae-0837182a90fd|8|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|U/m2/min|[?]|1|g/L|VASTUS MEDIALIS MUSCLE|LATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|6|FOLLOW-UP|2020-07-29|65
e|FA|65c439f8-9658-4ac5-9eae-0837182a90fd|9|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|uU/dL|[?]|1|IU/mmol|LUNG, LEFT UPPER LOBE|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|6|SCREENING|2020-08-23|90
e|FA|65c439f8-9658-4ac5-9eae-0837182a90fd|10|LDIAM|Longest Diameter|[?]|GERD|[?]|mol/mL|[?]|1|Shock Wave|HAND DIGIT 1|LATERAL|||ADJUDICATOR|5|Visit_5|90|3|FOLLOW-UP|2020-08-23|90
e|FA|5b73ad4c-bb28-47d1-a2f6-8508444059a5|1|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|AgU/mL|[?]|1|HOURS|SCIATIC NERVE|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-06-12|10
e|FA|5b73ad4c-bb28-47d1-a2f6-8508444059a5|2|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|10^8 PFU|[?]|1|mL/cm3/min|RIGHT CORONARY ARTERY OSTIUM|UNILATERAL|||SPOUSE|1|Visit_1|10|2|SCREENING|2020-06-12|10
e|FA|5b73ad4c-bb28-47d1-a2f6-8508444059a5|3|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|TUBE|[?]|1|Ci/ug|LEFT MAIN CORONARY ARTERY OSTIUM|IPSILATERAL|Y||FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2020-06-27|25
e|FA|5b73ad4c-bb28-47d1-a2f6-8508444059a5|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|uEq/L|[?]|1|10^6 IU/mL|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|LEFT|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|SCREENING|2020-06-27|25
e|FA|5b73ad4c-bb28-47d1-a2f6-8508444059a5|5|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|in|[?]|1|DROP|CONJUNCTIVA|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|WASHOUT|2020-07-12|40
e|FA|5b73ad4c-bb28-47d1-a2f6-8508444059a5|6|LDIAM|Longest Diameter|[?]|GERD|[?]|nkat/g Hb|[?]|1|Shock Wave|MESENTERY|IPSILATERAL||Y|CAREGIVER|3|Visit_3|40|1|TREATMENT|2020-07-12|40
e|FA|5b73ad4c-bb28-47d1-a2f6-8508444059a5|7|TOXGR|Toxicity Grade|[?]|GERD|[?]|Bq/L|[?]|1|aMFI|RIB|CONTRALATERAL||Y|INTERVIEWER|4|Visit_4|65|4|TREATMENT|2020-08-06|65
e|FA|5b73ad4c-bb28-47d1-a2f6-8508444059a5|8|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|mIU/L|[?]|1|QUANTITY SUFFICIENT|VOMER|CONTRALATERAL||Y|PROXY|4|Visit_4|65|5|WASHOUT|2020-08-06|65
e|FA|5b73ad4c-bb28-47d1-a2f6-8508444059a5|9|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/mL|[?]|1|AU/mL|EYE, VITREOUS CHAMBER|CONTRALATERAL|||GUARDIAN|5|Visit_5|90|1|SCREENING|2020-08-31|90
e|FA|5b73ad4c-bb28-47d1-a2f6-8508444059a5|10|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|nmol/mL/min|[?]|1|mmHg/L/min|HEART|RIGHT|||VENDOR|5|Visit_5|90|1|SCREENING|2020-08-31|90
e|FA|16dcaefa-701c-4863-b010-8ac640aeb55a|1|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|PIXEL|[?]|1|Coulomb|POPLITEAL VEIN|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-06-17|10
e|FA|16dcaefa-701c-4863-b010-8ac640aeb55a|2|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|ugEq/L|[?]|1|in|PROXIMAL LAD ARTERY|RIGHT|||INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-06-17|10
e|FA|16dcaefa-701c-4863-b010-8ac640aeb55a|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ms/mmHg|[?]|1|mg/g/min|SUPERFICIAL LYMPH NODE|LATERAL|Y||SPOUSE|2|Visit_2|25|2|FOLLOW-UP|2020-07-02|25
e|FA|16dcaefa-701c-4863-b010-8ac640aeb55a|4|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|days/wk|[?]|1|g/cage/day|RIB 1|IPSILATERAL|Y||INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-07-02|25
e|FA|16dcaefa-701c-4863-b010-8ac640aeb55a|5|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|10^4/L|[?]|1|vp/dose|PERICARDIUM|IPSILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2020-07-17|40
e|FA|16dcaefa-701c-4863-b010-8ac640aeb55a|6|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/g|[?]|1|mL/animal/day|VASTUS MEDIALIS MUSCLE|LEFT|Y||FAMILY MEMBER|3|Visit_3|40|4|SCREENING|2020-07-17|40
e|FA|16dcaefa-701c-4863-b010-8ac640aeb55a|7|ESTWT|Estimated Weight|[?]|GERD|[?]|Bq/L|[?]|1|g/day|PANCREATIC DUCT|IPSILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2020-08-11|65
e|FA|16dcaefa-701c-4863-b010-8ac640aeb55a|8|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|mIU/L|[?]|1|anti-Xa IU/mL|LARYNX|LEFT|Y||PARENT|4|Visit_4|65|3|TREATMENT|2020-08-11|65
e|FA|16dcaefa-701c-4863-b010-8ac640aeb55a|9|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mmol/day|[?]|1|cm H2O|METACARPAL BONE|BILATERAL|||FRIEND|5|Visit_5|90|1|FOLLOW-UP|2020-09-05|90
e|FA|16dcaefa-701c-4863-b010-8ac640aeb55a|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|/7.5 mL|[?]|1|QUANTITY SUFFICIENT|SCAPULA|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|SCREENING|2020-09-05|90
e|FA|4c19e870-9195-41d8-9c8a-8a54bb428732|1|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|mL/100g/min|[?]|1|mAmp|PROXIMAL INTERPHALANGEAL JOINT 2|CONTRALATERAL||Y|GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-08-03|10
e|FA|4c19e870-9195-41d8-9c8a-8a54bb428732|2|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/mol|[?]|1|ug/m2/h|TROCHLEAR NERVE|LEFT|Y|Y|GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-08-03|10
e|FA|4c19e870-9195-41d8-9c8a-8a54bb428732|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mm/2h|[?]|1|Pa|SUPRACLAVICULAR FOSSA|IPSILATERAL|Y||INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2020-08-18|25
e|FA|4c19e870-9195-41d8-9c8a-8a54bb428732|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|HEP|[?]|1|U/mmol|QUADRICEPS MUSCLE|LEFT|Y||CAREGIVER|2|Visit_2|25|4|TREATMENT|2020-08-18|25
e|FA|4c19e870-9195-41d8-9c8a-8a54bb428732|5|CALBURN|Calories Burned|[?]|GERD|[?]|POUCH|[?]|1|/kg|LOCUS CERULEUS|LEFT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-09-02|40
e|FA|4c19e870-9195-41d8-9c8a-8a54bb428732|6|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|PELLET|[?]|1|fmol|HEART, LEFT VENTRICULAR OUTFLOW TRACT|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2020-09-02|40
e|FA|4c19e870-9195-41d8-9c8a-8a54bb428732|7|SEV|Severity/Intensity|[?]|GERD|[?]|amu|[?]|1|Pa|MIDDLE PHALANX 5 OF THE HAND|BILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|FOLLOW-UP|2020-09-27|65
e|FA|4c19e870-9195-41d8-9c8a-8a54bb428732|8|SEV|Severity/Intensity|[?]|GERD|[?]|Log10 ELISA unit|[?]|1|Pa|SMALL INTESTINE|LATERAL|||STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-09-27|65
e|FA|4c19e870-9195-41d8-9c8a-8a54bb428732|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|PATCH|[?]|1|%(v/v)|COLON, LEFT|CONTRALATERAL|||INTERVIEWER|5|Visit_5|90|1|TREATMENT|2020-10-22|90
e|FA|4c19e870-9195-41d8-9c8a-8a54bb428732|10|LOCONSET|Localization of Onset|[?]|GERD|[?]|Enzyme U/g Hb|[?]|1|g/L|WRIST JOINT EXTENSOR MUSCLES|RIGHT|||STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2020-10-22|90
e|FA|7682184f-0801-4315-9c5f-116f7321a2b0|1|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/L|[?]|1|ug/m2/h|GASTROINTESTINAL TRACT, LOWER|RIGHT|||SPOUSE|1|Visit_1|10|1|TREATMENT|2020-12-22|10
e|FA|7682184f-0801-4315-9c5f-116f7321a2b0|2|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|P|[?]|1|/500 WBC|BRAIN STEM|LATERAL|||GUARDIAN|1|Visit_1|10|3|TREATMENT|2020-12-22|10
e|FA|7682184f-0801-4315-9c5f-116f7321a2b0|3|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|nmol/L|[?]|1|/500 WBC|RIB|LEFT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|2|WASHOUT|2021-01-06|25
e|FA|7682184f-0801-4315-9c5f-116f7321a2b0|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|deg|[?]|1|10^6 IU/mL|GASTROINTESTINAL TRACT, LOWER, WALL|LATERAL|Y||PROXY|2|Visit_2|25|2|SCREENING|2021-01-06|25
e|FA|7682184f-0801-4315-9c5f-116f7321a2b0|5|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|ohm|5TH LUMBAR SPINOUS PROCESS|RIGHT|Y||SIBLING|3|Visit_3|40|6|TREATMENT|2021-01-21|40
e|FA|7682184f-0801-4315-9c5f-116f7321a2b0|6|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|kDa|[?]|1|km|EPICONDYLE|LEFT|Y||CAREGIVER|3|Visit_3|40|1|WASHOUT|2021-01-21|40
e|FA|7682184f-0801-4315-9c5f-116f7321a2b0|7|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|L|[?]|1|QUANTITY SUFFICIENT|NAIL|LEFT|Y||PARENT|4|Visit_4|65|3|TREATMENT|2021-02-15|65
e|FA|7682184f-0801-4315-9c5f-116f7321a2b0|8|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|cg|[?]|1|10^6 CFU|SUPRAPUBIC REGION|RIGHT||Y|CHILD|4|Visit_4|65|6|FOLLOW-UP|2021-02-15|65
e|FA|7682184f-0801-4315-9c5f-116f7321a2b0|9|DVEG|Dietary Vegetable|[?]|GERD|[?]|anti-Xa IU/mL|[?]|1|Ci/ug|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|IPSILATERAL|Y|Y|INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2021-03-12|90
e|FA|7682184f-0801-4315-9c5f-116f7321a2b0|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|/mm|[?]|1|U/mg|POSTERIOR TIBIAL ARTERY|BILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|TREATMENT|2021-03-12|90
e|FA|c40f9cb3-b597-4614-8ba5-d40849030ff9|1|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|ug/m2/h|CARDIAC WALL|IPSILATERAL|||FRIEND|1|Visit_1|10|5|FOLLOW-UP|2020-12-12|10
e|FA|c40f9cb3-b597-4614-8ba5-d40849030ff9|2|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|cd*s/m2|[?]|1|10^6/L|SHOULDER|LATERAL|Y||VENDOR|1|Visit_1|10|4|SCREENING|2020-12-12|10
e|FA|c40f9cb3-b597-4614-8ba5-d40849030ff9|3|LDIAM|Longest Diameter|[?]|GERD|[?]|cm/min|[?]|1|Shock Wave|HIP JOINT|BILATERAL|Y||GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-12-27|25
e|FA|c40f9cb3-b597-4614-8ba5-d40849030ff9|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|/100 WBC|[?]|1|Pa|ANAL VERGE|UNILATERAL|Y|Y|FRIEND|2|Visit_2|25|5|FOLLOW-UP|2020-12-27|25
e|FA|c40f9cb3-b597-4614-8ba5-d40849030ff9|5|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|IU/mL|[?]|1|mL/h|EARLOBE|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|TREATMENT|2021-01-11|40
e|FA|c40f9cb3-b597-4614-8ba5-d40849030ff9|6|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|nsec|[?]|1|aMFI|EPICONDYLE|RIGHT|||PROXY|3|Visit_3|40|1|TREATMENT|2021-01-11|40
e|FA|c40f9cb3-b597-4614-8ba5-d40849030ff9|7|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|cycle/min|[?]|1|IU/mmol|GREAT TROCHANTER|CONTRALATERAL|||PARENT|4|Visit_4|65|6|TREATMENT|2021-02-05|65
e|FA|c40f9cb3-b597-4614-8ba5-d40849030ff9|8|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|10^12/L|[?]|1|Gy/h|ARTERY|BILATERAL|||SIBLING|4|Visit_4|65|2|TREATMENT|2021-02-05|65
e|FA|c40f9cb3-b597-4614-8ba5-d40849030ff9|9|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|g/mol|[?]|1|g/cage/day|TEMPORAL BONE|CONTRALATERAL|Y|Y|PROXY|5|Visit_5|90|2|TREATMENT|2021-03-02|90
e|FA|c40f9cb3-b597-4614-8ba5-d40849030ff9|10|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|mL/animal/wk|[?]|1|ug/m2/h|HEART, RIGHT ATRIUM|LATERAL||Y|CHILD|5|Visit_5|90|7|TREATMENT|2021-03-02|90
e|FA|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|1|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|mg/kg/min|[?]|1|fmol|PULMONARY TRUNK|IPSILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|2|FOLLOW-UP|2020-09-09|10
e|FA|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|2|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|EID 50/mL|[?]|1|NEEDLE GAUGE|THORAX|UNILATERAL|Y|Y|GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-09-09|10
e|FA|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|3|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|TCID 50/dose|[?]|1|Log10 ELISA unit|CARPOMETACARPAL JOINT 3|IPSILATERAL||Y|SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2020-09-24|25
e|FA|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|4|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|mEq/day|[?]|1|g/cage/day|COLON, LEFT|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|SCREENING|2020-09-24|25
e|FA|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|5|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|nU/cL|[?]|1|IU/mg|PULMONARY VALVE, ANTERIOR CUSP|LEFT|||CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2020-10-09|40
e|FA|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|6|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|ngEq/L|[?]|1|cm H2O|VASTUS LATERALIS MUSCLE|IPSILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|FOLLOW-UP|2020-10-09|40
e|FA|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|7|DPROT|Dietary Protein|[?]|GERD|[?]|mmAL|[?]|1|10^4 CFU/mL|HAND PHALANX|IPSILATERAL||Y|INVESTIGATOR|4|Visit_4|65|3|TREATMENT|2020-11-03|65
e|FA|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|8|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|U/mg|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|CONTRALATERAL|||CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-11-03|65
e|FA|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|9|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|umol/L|[?]|1|psi|ANAL CANAL|IPSILATERAL|||PARENT|5|Visit_5|90|3|TREATMENT|2020-11-28|90
e|FA|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|U/g Hb|[?]|1|%(v/v)|ABDUCTOR HALLUCIS MUSCLE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|SCREENING|2020-11-28|90
e|FA|c9308aa7-f38f-4b54-a919-d3f893b18cd1|1|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|Gy/h|[?]|1|U/10^12 RBC|BRAIN VENTRICLE|BILATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-11-07|10
e|FA|c9308aa7-f38f-4b54-a919-d3f893b18cd1|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|JAR|[?]|1|mg/g/min|DORSALIS PEDIS ARTERY|BILATERAL|||ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-11-07|10
e|FA|c9308aa7-f38f-4b54-a919-d3f893b18cd1|3|EVENTNUM|Number of Events|[?]|GERD|[?]|mg/kg|[?]|1|U/10^12 RBC|LATERAL SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|||VENDOR|2|Visit_2|25|1|SCREENING|2020-11-22|25
e|FA|c9308aa7-f38f-4b54-a919-d3f893b18cd1|4|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|10^8 PFU|[?]|1|mIU/L|NAIL BED|CONTRALATERAL|||STUDY SUBJECT|2|Visit_2|25|5|FOLLOW-UP|2020-11-22|25
e|FA|c9308aa7-f38f-4b54-a919-d3f893b18cd1|5|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|cy/cm|[?]|1|fmol|AORTIC VALVE ANNULUS|LEFT|Y||DOMESTIC PARTNER|3|Visit_3|40|1|WASHOUT|2020-12-07|40
e|FA|c9308aa7-f38f-4b54-a919-d3f893b18cd1|6|LDIAM|Longest Diameter|[?]|GERD|[?]|L/L|[?]|1|Shock Wave|PATELLA|UNILATERAL|Y|Y|GUARDIAN|3|Visit_3|40|1|TREATMENT|2020-12-07|40
e|FA|c9308aa7-f38f-4b54-a919-d3f893b18cd1|7|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|CIGAR|[?]|1|L/h/m2|PAW|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|3|FOLLOW-UP|2021-01-01|65
e|FA|c9308aa7-f38f-4b54-a919-d3f893b18cd1|8|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|DISK|[?]|1|TRANSDUCING UNIT/mL|ILIAC LYMPH NODE|UNILATERAL||Y|CAREGIVER|4|Visit_4|65|1|SCREENING|2021-01-01|65
e|FA|c9308aa7-f38f-4b54-a919-d3f893b18cd1|9|VOL|Volume|[?]|GERD|[?]|mmol|[?]|1|vp/dose|GASTROINTESTINAL TRACT|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|2|FOLLOW-UP|2021-01-26|90
e|FA|c9308aa7-f38f-4b54-a919-d3f893b18cd1|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|ECL unit|[?]|1|QUANTITY SUFFICIENT|LEFT CIRCUMFLEX ARTERY OSTIUM|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|4|TREATMENT|2021-01-26|90
e|FA|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|DIOPTER|[?]|1|SCOOPFUL|OLFACTORY MUCOSA|RIGHT||Y|ADJUDICATOR|1|Visit_1|10|5|TREATMENT|2020-08-22|10
e|FA|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|2|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/dose|[?]|1|aMFI|TRACHEA|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|SCREENING|2020-08-22|10
e|FA|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|10^6 U|[?]|1|Pa|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|BILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2020-09-06|25
e|FA|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|4|SEV|Severity/Intensity|[?]|GERD|[?]|ug/L/h|[?]|1|Pa|TOE|BILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|1|SCREENING|2020-09-06|25
e|FA|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|5|QOLIMP|QOL Impact|[?]|GERD|[?]|m/sec2|[?]|1|10^6/L|INTERPHALANGEAL JOINT 4|BILATERAL||Y|GUARDIAN|3|Visit_3|40|2|WASHOUT|2020-09-21|40
e|FA|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|6|AGETRT1|Age At First Treatment|[?]|GERD|[?]|10^6/g|[?]|1|mL/mmHg/min/L|METATARSOPHALANGEAL JOINT 3|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2020-09-21|40
e|FA|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|mg/kg/h|[?]|1|umol|COLON, DESCENDING|RIGHT|||INVESTIGATOR|4|Visit_4|65|3|WASHOUT|2020-10-16|65
e|FA|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|8|DPROT|Dietary Protein|[?]|GERD|[?]|mL/s/m2|[?]|1|10^4 CFU/mL|VULVOVAGINAL REGION|RIGHT||Y|PARENT|4|Visit_4|65|1|FOLLOW-UP|2020-10-16|65
e|FA|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|9|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|CCID 50/mL|[?]|1|ug/m2/h|PHARYNGEAL TONSIL|BILATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2020-11-10|90
e|FA|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol/L/min|[?]|1|mg/g/min|OMENTUM|RIGHT||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-11-10|90
e|FA|3da865e8-9680-4112-b6d3-1f5763cfdaae|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|U/g Hb|[?]|1|%(v/v)|EXTERNAL ILIAC ARTERY|BILATERAL||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|WASHOUT|2021-01-20|10
e|FA|3da865e8-9680-4112-b6d3-1f5763cfdaae|2|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|ug/kg|[?]|1|mg/dose|LEPTOMENINGES|UNILATERAL|||CHILD|1|Visit_1|10|7|TREATMENT|2021-01-20|10
e|FA|3da865e8-9680-4112-b6d3-1f5763cfdaae|3|DGRAIN|Dietary Grain|[?]|GERD|[?]|mL/g/day|[?]|1|10^9 CFU/g|COLON, RECTOSIGMOID|RIGHT|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2021-02-04|25
e|FA|3da865e8-9680-4112-b6d3-1f5763cfdaae|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|Pa|FEMORAL VEIN|CONTRALATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2021-02-04|25
e|FA|3da865e8-9680-4112-b6d3-1f5763cfdaae|5|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|nkat/g Hb|[?]|1|PACK|SACRAL VERTEBRA|RIGHT||Y|CAREGIVER|3|Visit_3|40|1|TREATMENT|2021-02-19|40
e|FA|3da865e8-9680-4112-b6d3-1f5763cfdaae|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|DROP|[?]|1|Shock Wave|LIVER, LEFT LOBE|CONTRALATERAL|Y||PARENT|3|Visit_3|40|1|TREATMENT|2021-02-19|40
e|FA|3da865e8-9680-4112-b6d3-1f5763cfdaae|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|10^7 TCID 50/dose|[?]|1|U/mmol|DUODENUM|LEFT||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-03-16|65
e|FA|3da865e8-9680-4112-b6d3-1f5763cfdaae|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/mL|[?]|1|Pa|BRONCHUS|CONTRALATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|2|WASHOUT|2021-03-16|65
e|FA|3da865e8-9680-4112-b6d3-1f5763cfdaae|9|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|ft3|[?]|1|QUANTITY SUFFICIENT|RIB|UNILATERAL||Y|INTERVIEWER|5|Visit_5|90|5|TREATMENT|2021-04-10|90
e|FA|3da865e8-9680-4112-b6d3-1f5763cfdaae|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|APL U/mL|[?]|1|mg/g/min|LATERAL FIRST DIAGONAL BRANCH ARTERY|CONTRALATERAL||Y|INTERVIEWER|5|Visit_5|90|3|TREATMENT|2021-04-10|90
e|FA|60afc3a3-56b7-4988-9006-e12f3bc1097c|1|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/mL/h|[?]|1|oz eq|BRACHIAL VEIN|IPSILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|6|WASHOUT|2020-08-16|10
e|FA|60afc3a3-56b7-4988-9006-e12f3bc1097c|2|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|BAG|CALCANEAL TUBEROSITY|LEFT||Y|GUARDIAN|1|Visit_1|10|6|WASHOUT|2020-08-16|10
e|FA|60afc3a3-56b7-4988-9006-e12f3bc1097c|3|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/g Hb|[?]|1|SACHET|LUMBAR REGION|LATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-08-31|25
e|FA|60afc3a3-56b7-4988-9006-e12f3bc1097c|4|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|/min|[?]|1|IU/mmol|MEDIASTINAL LYMPH NODE|CONTRALATERAL||Y|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-08-31|25
e|FA|60afc3a3-56b7-4988-9006-e12f3bc1097c|5|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|BOX|[?]|1|m2|METACARPAL BONE 1|RIGHT|||ADJUDICATOR|3|Visit_3|40|6|WASHOUT|2020-09-15|40
e|FA|60afc3a3-56b7-4988-9006-e12f3bc1097c|6|LENRSCT|Length of Resection|[?]|GERD|[?]|Gauss|[?]|1|psi|ANTRUM PYLORI|CONTRALATERAL|||VENDOR|3|Visit_3|40|5|SCREENING|2020-09-15|40
e|FA|60afc3a3-56b7-4988-9006-e12f3bc1097c|7|STRCTNUM|Number of Strictures|[?]|GERD|[?]|Absorbance U/mL|[?]|1|SACHET|FEMORAL ARTERY|IPSILATERAL|||PARENT|4|Visit_4|65|7|SCREENING|2020-10-10|65
e|FA|60afc3a3-56b7-4988-9006-e12f3bc1097c|8|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU/mL|[?]|1|Gy/h|CONJUNCTIVA|LATERAL|Y||PROXY|4|Visit_4|65|6|FOLLOW-UP|2020-10-10|65
e|FA|60afc3a3-56b7-4988-9006-e12f3bc1097c|9|DFATT|Dietary Fat, Total|[?]|GERD|[?]|min|[?]|1|Bq/mg|MIDBRAIN|LEFT||Y|PARENT|5|Visit_5|90|4|WASHOUT|2020-11-04|90
e|FA|60afc3a3-56b7-4988-9006-e12f3bc1097c|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/m2/h|[?]|1|mg/g/min|CORONARY ARTERY, RIGHT|UNILATERAL|Y||FAMILY MEMBER|5|Visit_5|90|1|FOLLOW-UP|2020-11-04|90
e|FA|440119fb-ad46-4348-b236-8e2979c7bf2e|1|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|Bq|[?]|1|mL/min/mmHg|ATRIOVENTRICULAR VALVE|LATERAL||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-12-16|10
e|FA|440119fb-ad46-4348-b236-8e2979c7bf2e|2|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|DIOPTER|[?]|1|mL/cm3/min|TRICUSPID VALVE, ANTERIOR CUSP|LEFT|||ADJUDICATOR|1|Visit_1|10|5|SCREENING|2020-12-16|10
e|FA|440119fb-ad46-4348-b236-8e2979c7bf2e|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|tsp|[?]|1|mg/h|INTERPHALANGEAL JOINT 3|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-12-31|25
e|FA|440119fb-ad46-4348-b236-8e2979c7bf2e|4|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|mmHg/L/min|[?]|1|cmH2O/mL|LATERAL FIRST DIAGONAL BRANCH ARTERY|CONTRALATERAL|||VENDOR|2|Visit_2|25|7|WASHOUT|2020-12-31|25
e|FA|440119fb-ad46-4348-b236-8e2979c7bf2e|5|DFIBER|Dietary Fiber|[?]|GERD|[?]|cmH2O*s2/mL|[?]|1|h*%|AZYGOS VEIN|IPSILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2021-01-15|40
e|FA|440119fb-ad46-4348-b236-8e2979c7bf2e|6|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|KIT|[?]|1|TRANSDUCING UNIT/mL|INTERNAL ILIAC LYMPH NODE|IPSILATERAL|Y||CHILD|3|Visit_3|40|4|FOLLOW-UP|2021-01-15|40
e|FA|440119fb-ad46-4348-b236-8e2979c7bf2e|7|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|kg/cm|[?]|1|Bq/mg|SKIN OF THE ELBOW|LEFT|Y|Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|FOLLOW-UP|2021-02-09|65
e|FA|440119fb-ad46-4348-b236-8e2979c7bf2e|8|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|lx|[?]|1|g/day|LOWER RESPIRATORY SYSTEM|LEFT||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|3|WASHOUT|2021-02-09|65
e|FA|440119fb-ad46-4348-b236-8e2979c7bf2e|9|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|mg/mL/day|[?]|1|SACHET|VERTEBRAL COLUMN|CONTRALATERAL||Y|INVESTIGATOR|5|Visit_5|90|6|FOLLOW-UP|2021-03-06|90
e|FA|440119fb-ad46-4348-b236-8e2979c7bf2e|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|mg/g/min|C5 VERTEBRA|BILATERAL|||GUARDIAN|5|Visit_5|90|5|TREATMENT|2021-03-06|90
e|FA|af45a9de-c8aa-4602-8e3b-d16998740ebd|1|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|Ci/uL|[?]|1|Log10 ELISA unit|CARPOMETACARPAL JOINT 3|LEFT|||SPOUSE|1|Visit_1|10|5|SCREENING|2020-06-15|10
e|FA|af45a9de-c8aa-4602-8e3b-d16998740ebd|2|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|cs|[?]|1|mmHg/L/min|ETHMOID SINUS|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-06-15|10
e|FA|af45a9de-c8aa-4602-8e3b-d16998740ebd|3|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|ohm|SPLEEN|LEFT||Y|FAMILY MEMBER|2|Visit_2|25|4|WASHOUT|2020-06-30|25
e|FA|af45a9de-c8aa-4602-8e3b-d16998740ebd|4|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|h*%|[?]|1|IU/mmol|AXILLA|IPSILATERAL|||STUDY SUBJECT|2|Visit_2|25|3|SCREENING|2020-06-30|25
e|FA|af45a9de-c8aa-4602-8e3b-d16998740ebd|5|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|ECL unit|[?]|1|fmol|PERIURETERAL REGION|RIGHT||Y|ADJUDICATOR|3|Visit_3|40|6|WASHOUT|2020-07-15|40
e|FA|af45a9de-c8aa-4602-8e3b-d16998740ebd|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|fmol/L|[?]|1|%(v/v)|ILIUM|BILATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|SCREENING|2020-07-15|40
e|FA|af45a9de-c8aa-4602-8e3b-d16998740ebd|7|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|ppth|[?]|1|mL/100g/min|MESENTERIC ARTERY|CONTRALATERAL|||DOMESTIC PARTNER|4|Visit_4|65|1|WASHOUT|2020-08-09|65
e|FA|af45a9de-c8aa-4602-8e3b-d16998740ebd|8|OBJNUM|Number of Objects|[?]|GERD|[?]|WEEKS|[?]|1|mL/100g/min|PARALARYNGEAL LYMPH NODE|IPSILATERAL|||FRIEND|4|Visit_4|65|6|TREATMENT|2020-08-09|65
e|FA|af45a9de-c8aa-4602-8e3b-d16998740ebd|9|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|U|[?]|1|Ci/ug|DIAPHRAGMATIC LYMPH NODE|IPSILATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|6|SCREENING|2020-09-03|90
e|FA|af45a9de-c8aa-4602-8e3b-d16998740ebd|10|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|10^6/Ejaculate U|[?]|1|cmH2O/mL|ABDOMINAL SKIN|CONTRALATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2020-09-03|90
e|FA|23306866-3fcb-418d-861b-de3bd779260d|1|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|U/cL|[?]|1|L/h/m2|ISCHIORECTAL FOSSA|LEFT||Y|PROXY|1|Visit_1|10|2|TREATMENT|2020-07-25|10
e|FA|23306866-3fcb-418d-861b-de3bd779260d|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|fmol|[?]|1|mg/g/min|CARPOMETACARPAL JOINT 1|IPSILATERAL|Y||SPOUSE|1|Visit_1|10|3|WASHOUT|2020-07-25|10
e|FA|23306866-3fcb-418d-861b-de3bd779260d|3|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|Hz/s|[?]|1|m2|PORTAL LYMPH NODE|LATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|WASHOUT|2020-08-09|25
e|FA|23306866-3fcb-418d-861b-de3bd779260d|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|Bq/mL|[?]|1|PFU/dose|L4 VERTEBRA|UNILATERAL|Y||CHILD|2|Visit_2|25|4|TREATMENT|2020-08-09|25
e|FA|23306866-3fcb-418d-861b-de3bd779260d|5|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|U/kg/day|[?]|1|/500 WBC|MALE GENITALIA|BILATERAL|||SIBLING|3|Visit_3|40|2|TREATMENT|2020-08-24|40
e|FA|23306866-3fcb-418d-861b-de3bd779260d|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|g/cm2|[?]|1|%(v/v)|BLADDER, FUNDUS|LATERAL|||INTERVIEWER|3|Visit_3|40|4|WASHOUT|2020-08-24|40
e|FA|23306866-3fcb-418d-861b-de3bd779260d|7|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|TRACE|[?]|1|BOWL|INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL||Y|DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2020-09-18|65
e|FA|23306866-3fcb-418d-861b-de3bd779260d|8|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mL/animal/wk|[?]|1|cm H2O|POSTERIOR TIBIAL ARTERY|RIGHT|||FRIEND|4|Visit_4|65|1|SCREENING|2020-09-18|65
e|FA|23306866-3fcb-418d-861b-de3bd779260d|9|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|pmol|[?]|1|L/h/m2|FEMORAL HEAD|LEFT|||SIBLING|5|Visit_5|90|2|TREATMENT|2020-10-13|90
e|FA|23306866-3fcb-418d-861b-de3bd779260d|10|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|nCi|[?]|1|MBq|WARDS TRIANGLE|IPSILATERAL|||PROXY|5|Visit_5|90|6|WASHOUT|2020-10-13|90
e|FA|144d2eb9-d79a-4a61-91f5-6a807832d8ca|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|10^6 copies/mL|[?]|1|km|APPENDICEAL TIP|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|SCREENING|2020-08-04|10
e|FA|144d2eb9-d79a-4a61-91f5-6a807832d8ca|2|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|g/g/day|[?]|1|BAG|PYRAMIDAL TRACTS, INTERNAL CAPSULE|LEFT|||FRIEND|1|Visit_1|10|4|TREATMENT|2020-08-04|10
e|FA|144d2eb9-d79a-4a61-91f5-6a807832d8ca|3|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|nmol|[?]|1|mm|CILIARY BODY|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2020-08-19|25
e|FA|144d2eb9-d79a-4a61-91f5-6a807832d8ca|4|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|MnFI|[?]|1|gtt|EPIGASTRIC LYMPH NODE|RIGHT|||PARENT|2|Visit_2|25|7|FOLLOW-UP|2020-08-19|25
e|FA|144d2eb9-d79a-4a61-91f5-6a807832d8ca|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|JAR|[?]|1|U/mg|ILIUM|RIGHT|||PROXY|3|Visit_3|40|3|WASHOUT|2020-09-03|40
e|FA|144d2eb9-d79a-4a61-91f5-6a807832d8ca|6|DISTANCE|Distance|[?]|GERD|[?]|nmol/day|[?]|1|BOWL|MITRAL VALVE|LEFT|||PARENT|3|Visit_3|40|2|FOLLOW-UP|2020-09-03|40
e|FA|144d2eb9-d79a-4a61-91f5-6a807832d8ca|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|Pa|COLON, DESCENDING|LEFT|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-09-28|65
e|FA|144d2eb9-d79a-4a61-91f5-6a807832d8ca|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|L/s/kPa|[?]|1|10^6 U|INTERPHALANGEAL JOINT 2 OF THE HAND|LATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|3|SCREENING|2020-09-28|65
e|FA|144d2eb9-d79a-4a61-91f5-6a807832d8ca|9|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|ug/min|[?]|1|ohm|LIVER, CAUDATE LOBE|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|4|TREATMENT|2020-10-23|90
e|FA|144d2eb9-d79a-4a61-91f5-6a807832d8ca|10|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|10^6 CFU/mL|[?]|1|/500 WBC|VASTUS INTERMEDIUS MUSCLE|BILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2020-10-23|90
e|FA|92855d33-eee6-449f-a9e6-c06a1532571f|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Bq/mg|[?]|1|Pa|FOOT DIGIT 2|IPSILATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-11-29|10
e|FA|92855d33-eee6-449f-a9e6-c06a1532571f|2|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|uL/kg/day|[?]|1|NEEDLE GAUGE|OPTIC NERVE|CONTRALATERAL|Y||ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-11-29|10
e|FA|92855d33-eee6-449f-a9e6-c06a1532571f|3|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|JAR|[?]|1|km|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|BILATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-12-14|25
e|FA|92855d33-eee6-449f-a9e6-c06a1532571f|4|DPROT|Dietary Protein|[?]|GERD|[?]|mL/dL|[?]|1|10^4 CFU/mL|HARD PALATE|LEFT|||SPOUSE|2|Visit_2|25|6|TREATMENT|2020-12-14|25
e|FA|92855d33-eee6-449f-a9e6-c06a1532571f|5|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|TUBE|[?]|1|10^6 CFU|CHEEK|UNILATERAL|||INVESTIGATOR|3|Visit_3|40|3|FOLLOW-UP|2020-12-29|40
e|FA|92855d33-eee6-449f-a9e6-c06a1532571f|6|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|ukat/L|[?]|1|10^4 CFU/mL|WRIST JOINT EXTENSOR MUSCLES|LATERAL|Y||INTERVIEWER|3|Visit_3|40|7|FOLLOW-UP|2020-12-29|40
e|FA|92855d33-eee6-449f-a9e6-c06a1532571f|7|TRTSETT|Treatment Setting|[?]|GERD|[?]|Pack Year|[?]|1|Coulomb|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|IPSILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|1|WASHOUT|2021-01-23|65
e|FA|92855d33-eee6-449f-a9e6-c06a1532571f|8|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|mEq/mL|[?]|1|SCOOPFUL|RETINAL ARTERY|LATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2021-01-23|65
e|FA|92855d33-eee6-449f-a9e6-c06a1532571f|9|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|cd|[?]|1|uCi/kg|RECTOVAGINAL SPACE|RIGHT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|TREATMENT|2021-02-17|90
e|FA|92855d33-eee6-449f-a9e6-c06a1532571f|10|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|Joule|[?]|1|10^6 organisms/mL|HUMERUS SHAFT|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2021-02-17|90
e|FA|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|1|STRCTNUM|Number of Strictures|[?]|GERD|[?]|ft2|[?]|1|SACHET|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|LATERAL||Y|FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2021-01-29|10
e|FA|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|2|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|GBq/ug|[?]|1|ng/day|ENDOMETRIAL CAVITY|CONTRALATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2021-01-29|10
e|FA|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|Pa|SKIN OF THE AXILLA|UNILATERAL|||PARENT|2|Visit_2|25|7|TREATMENT|2021-02-13|25
e|FA|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|4|DFATT|Dietary Fat, Total|[?]|GERD|[?]|BOX|[?]|1|Bq/mg|PINEAL GLAND|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2021-02-13|25
e|FA|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|5|DFATT|Dietary Fat, Total|[?]|GERD|[?]|BOTTLE|[?]|1|Bq/mg|FALCIFORM LIGAMENT|RIGHT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2021-02-28|40
e|FA|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|6|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|psi|[?]|1|NEEDLE GAUGE|SKIN FOLD|CONTRALATERAL|||INTERVIEWER|3|Visit_3|40|5|WASHOUT|2021-02-28|40
e|FA|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|7|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|g|[?]|1|gtt|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|LATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|1|SCREENING|2021-03-25|65
e|FA|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|8|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|10^9/L|[?]|1|100 IU/mL|SPINAL ACCESSORY NERVE|CONTRALATERAL|||CAREGIVER|4|Visit_4|65|5|FOLLOW-UP|2021-03-25|65
e|FA|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|9|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|uL/kg/day|BICEPS BRACHII MUSCLE|UNILATERAL|||ADJUDICATOR|5|Visit_5|90|4|TREATMENT|2021-04-19|90
e|FA|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/kg/h|[?]|1|mg/g/min|GASTROCNEMIUS MUSCLE|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2021-04-19|90
e|FA|40cb9bc3-abec-4158-bdee-becdeceba727|1|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|mL/100g/min|SKIN OF THE FACE|BILATERAL|Y|Y|CHILD|1|Visit_1|10|6|TREATMENT|2020-10-19|10
e|FA|40cb9bc3-abec-4158-bdee-becdeceba727|2|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|mg/cm2|[?]|1|g/L|HUMERUS SHAFT|RIGHT|Y||STUDY SUBJECT|1|Visit_1|10|1|WASHOUT|2020-10-19|10
e|FA|40cb9bc3-abec-4158-bdee-becdeceba727|3|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|uEq|[?]|1|Bq/mg|TRICUSPID VALVE, SEPTAL CUSP|BILATERAL|||INVESTIGATOR|2|Visit_2|25|3|WASHOUT|2020-11-03|25
e|FA|40cb9bc3-abec-4158-bdee-becdeceba727|4|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit/dose|[?]|1|10^6 U|L4 VERTEBRA|BILATERAL|||STUDY SUBJECT|2|Visit_2|25|5|FOLLOW-UP|2020-11-03|25
e|FA|40cb9bc3-abec-4158-bdee-becdeceba727|5|AGETRT1|Age At First Treatment|[?]|GERD|[?]|mg/g/h|[?]|1|mL/mmHg/min/L|LACRIMAL GLAND|CONTRALATERAL|Y|Y|CHILD|3|Visit_3|40|7|TREATMENT|2020-11-18|40
e|FA|40cb9bc3-abec-4158-bdee-becdeceba727|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|YEARS|[?]|1|mg/g/min|INTERPHALANGEAL OF THE FOOT|LATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-11-18|40
e|FA|40cb9bc3-abec-4158-bdee-becdeceba727|7|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|dpm/mg|[?]|1|uCi/kg|SUPERIOR PUBIC RAMUS|LATERAL|||CAREGIVER|4|Visit_4|65|1|TREATMENT|2020-12-13|65
e|FA|40cb9bc3-abec-4158-bdee-becdeceba727|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|cmol/L|[?]|1|mg/g/min|EXTENSOR DIGITORUM BREVIS MUSCLE|LATERAL||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|FOLLOW-UP|2020-12-13|65
e|FA|40cb9bc3-abec-4158-bdee-becdeceba727|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/min|[?]|1|mg/g/min|THIRD OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2021-01-07|90
e|FA|40cb9bc3-abec-4158-bdee-becdeceba727|10|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|ng/mol|[?]|1|gtt|FIBULA|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2021-01-07|90
e|FA|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|1|DPROT|Dietary Protein|[?]|GERD|[?]|mmAL|[?]|1|10^4 CFU/mL|CORONARY ARTERY|LATERAL||Y|SIBLING|1|Visit_1|10|4|TREATMENT|2020-10-17|10
e|FA|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|2|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|Enzyme U|[?]|1|mm|BLADDER|LEFT||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|SCREENING|2020-10-17|10
e|FA|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|3|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|Gy/h|[?]|1|10^6 organisms/mL|NAVICULAR BONE|CONTRALATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2020-11-01|25
e|FA|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|4|QOLIMP|QOL Impact|[?]|GERD|[?]|mL/cm|[?]|1|10^6/L|CORNEA|RIGHT|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-11-01|25
e|FA|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|5|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|mEq/mmol|[?]|1|m2|CERVICAL SPINE|RIGHT|||INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-11-16|40
e|FA|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|6|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|mL/h|[?]|1|/200 HPFs|CEREBRUM|LATERAL|||FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2020-11-16|40
e|FA|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|U/mL|[?]|1|%(v/v)|EYE, ANTERIOR SEGMENT|BILATERAL|||CHILD|4|Visit_4|65|4|TREATMENT|2020-12-11|65
e|FA|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|8|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|keV|[?]|1|mm|POSTERIOR SUPERIOR ILIAC SPINE|BILATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2020-12-11|65
e|FA|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|9|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|IU/dL|[?]|1|cm|DISTANT LYMPH NODE|LATERAL|||ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2021-01-05|90
e|FA|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|10|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|ng/mol|[?]|1|AU/mL|METACARPOPHALANGEAL JOINT 4|IPSILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|1|WASHOUT|2021-01-05|90
e|FA|616b284a-3fed-4009-bafe-7da10acd537e|1|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|BAU/mL|[?]|1|U/mmol|COSTOCHONDRAL JOINT 7|RIGHT|||FAMILY MEMBER|1|Visit_1|10|3|WASHOUT|2020-09-03|10
e|FA|616b284a-3fed-4009-bafe-7da10acd537e|2|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|ngEq/L|[?]|1|mEq|POPLITEAL ARTERY ABOVE KNEE|LATERAL|||DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-09-03|10
e|FA|616b284a-3fed-4009-bafe-7da10acd537e|3|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|ug/dL|[?]|1|mAmp|PRIMARY VISUAL CORTEX|IPSILATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2020-09-18|25
e|FA|616b284a-3fed-4009-bafe-7da10acd537e|4|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|mL/cage|[?]|1|km|ADDUCTOR BREVIS MUSCLE|UNILATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-09-18|25
e|FA|616b284a-3fed-4009-bafe-7da10acd537e|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|genEq/mL|[?]|1|Pa|TONGUE|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-10-03|40
e|FA|616b284a-3fed-4009-bafe-7da10acd537e|6|DCAL|Dietary Calories|[?]|GERD|[?]|U/kg|[?]|1|EIA unit|NASAL CAVITY|BILATERAL|||INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-10-03|40
e|FA|616b284a-3fed-4009-bafe-7da10acd537e|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|gtt|[?]|1|mg/g/min|SUBGLOTTIS|UNILATERAL|||STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-10-28|65
e|FA|616b284a-3fed-4009-bafe-7da10acd537e|8|EVENTFRQ|Event Frequency|[?]|GERD|[?]|RING|[?]|1|ug/kg/h|INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|Y|Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2020-10-28|65
e|FA|616b284a-3fed-4009-bafe-7da10acd537e|9|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|mOsm|[?]|1|L|SCROTUM|LATERAL|Y||CHILD|5|Visit_5|90|5|WASHOUT|2020-11-22|90
e|FA|616b284a-3fed-4009-bafe-7da10acd537e|10|SEV|Severity/Intensity|[?]|GERD|[?]|IU/dL|[?]|1|Pa|COLON WALL|LEFT|||INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2020-11-22|90
e|FA|d39b53da-187f-4da6-9614-2bd301e9ad05|1|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|Osm|[?]|1|BAG|COMMON ILIAC LYMPH NODE|LEFT|Y|Y|GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-10-02|10
e|FA|d39b53da-187f-4da6-9614-2bd301e9ad05|2|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|10^6 CFU|SUPRAGLOTTIS|LATERAL|||INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-10-02|10
e|FA|d39b53da-187f-4da6-9614-2bd301e9ad05|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|10^7 PFU|[?]|1|%(v/v)|BRAIN, THIRD VENTRICLE|LATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|WASHOUT|2020-10-17|25
e|FA|d39b53da-187f-4da6-9614-2bd301e9ad05|4|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|umol/min|[?]|1|TRANSDUCING UNIT/mL|KIDNEY, HILUM|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-10-17|25
e|FA|d39b53da-187f-4da6-9614-2bd301e9ad05|5|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|km/h|[?]|1|anti-Xa IU/mL|SOLE|RIGHT||Y|SIBLING|3|Visit_3|40|3|TREATMENT|2020-11-01|40
e|FA|d39b53da-187f-4da6-9614-2bd301e9ad05|6|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|VOXEL|[?]|1|mm/h|INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|||ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-11-01|40
e|FA|d39b53da-187f-4da6-9614-2bd301e9ad05|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^9 organisms/mg|[?]|1|mg/g/min|ULNAR NERVE|LEFT||Y|ADJUDICATOR|4|Visit_4|65|2|SCREENING|2020-11-26|65
e|FA|d39b53da-187f-4da6-9614-2bd301e9ad05|8|TOTNUM|Total Number|[?]|GERD|[?]|mEq/dL|[?]|1|/200 HPFs|INTRAHEPATIC BILE DUCT|RIGHT||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|4|FOLLOW-UP|2020-11-26|65
e|FA|d39b53da-187f-4da6-9614-2bd301e9ad05|9|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|EP U|[?]|1|/500 WBC|GLOBUS PALLIDUS|LEFT||Y|CAREGIVER|5|Visit_5|90|1|TREATMENT|2020-12-21|90
e|FA|d39b53da-187f-4da6-9614-2bd301e9ad05|10|EXTRSCT|Extent of Resection|[?]|GERD|[?]|Torr|[?]|1|Weber|MITRAL VALVE ANNULUS|RIGHT|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2020-12-21|90
e|FA|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|%(v/v)|LOWER JUGULAR LYMPH NODE|BILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|3|TREATMENT|2020-12-04|10
e|FA|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|2|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|in|MESENTERIC VEIN|RIGHT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-12-04|10
e|FA|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|3|QOLIMP|QOL Impact|[?]|GERD|[?]|ng/mol|[?]|1|10^6/L|PORTAL VEIN BIFURCATION|BILATERAL||Y|GUARDIAN|2|Visit_2|25|3|FOLLOW-UP|2020-12-19|25
e|FA|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|4|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|DIOPTER|[?]|1|uL/kg/day|SUBLINGUAL REGION|IPSILATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-12-19|25
e|FA|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|5|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|Bq/uL|[?]|1|anti-Xa IU/mL|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|Y||STUDY SUBJECT|3|Visit_3|40|6|WASHOUT|2021-01-03|40
e|FA|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|mg/g/min|LEFT CIRCUMFLEX ARTERY OSTIUM|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|FOLLOW-UP|2021-01-03|40
e|FA|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|7|OBJNUM|Number of Objects|[?]|GERD|[?]|kN/cm2|[?]|1|mL/100g/min|LIP, LOWER|RIGHT|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|4|FOLLOW-UP|2021-01-28|65
e|FA|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|8|EXTRSCT|Extent of Resection|[?]|GERD|[?]|P|[?]|1|Weber|THALAMUS|UNILATERAL|||SIBLING|4|Visit_4|65|7|SCREENING|2021-01-28|65
e|FA|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|9|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Ci/ug|[?]|1|umol|OPPONENS POLLICIS MUSCLE|LATERAL|||CAREGIVER|5|Visit_5|90|7|TREATMENT|2021-02-22|90
e|FA|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|ms/mmHg|[?]|1|U/mmol|LEFT VENTRICULAR APICAL LATERAL SEGMENT|BILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|6|FOLLOW-UP|2021-02-22|90
e|FA|e51cf168-af89-44d9-9e56-14785071f6b0|1|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|EIA unit|T8 VERTEBRA|LEFT||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|WASHOUT|2020-11-27|10
e|FA|e51cf168-af89-44d9-9e56-14785071f6b0|2|SEV|Severity/Intensity|[?]|GERD|[?]|Tbsp|[?]|1|Pa|THIRD DIAGONAL BRANCH ARTERY|LATERAL|||STUDY SUBJECT|1|Visit_1|10|6|FOLLOW-UP|2020-11-27|10
e|FA|e51cf168-af89-44d9-9e56-14785071f6b0|3|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|IU/mmol|THYROID GLAND, LEFT LOBE|BILATERAL|Y|Y|SIBLING|2|Visit_2|25|3|TREATMENT|2020-12-12|25
e|FA|e51cf168-af89-44d9-9e56-14785071f6b0|4|TRTSETT|Treatment Setting|[?]|GERD|[?]|BOX|[?]|1|Coulomb|AORTIC ARCH|CONTRALATERAL|||CHILD|2|Visit_2|25|7|WASHOUT|2020-12-12|25
e|FA|e51cf168-af89-44d9-9e56-14785071f6b0|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/day|[?]|1|%(v/v)|PORTAL VEIN BIFURCATION|UNILATERAL||Y|FRIEND|3|Visit_3|40|1|SCREENING|2020-12-27|40
e|FA|e51cf168-af89-44d9-9e56-14785071f6b0|6|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|ng/day|[?]|1|mg/dose|PALPEBRAL CONJUNCTIVA|LEFT|||VENDOR|3|Visit_3|40|2|TREATMENT|2020-12-27|40
e|FA|e51cf168-af89-44d9-9e56-14785071f6b0|7|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|dpm/0.5 mL|[?]|1|fmol|AORTIC VALVE, RIGHT CORONARY CUSP|RIGHT|||INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2021-01-21|65
e|FA|e51cf168-af89-44d9-9e56-14785071f6b0|8|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|ug|[?]|1|Log10 ELISA unit|SCLERA|RIGHT||Y|GUARDIAN|4|Visit_4|65|3|WASHOUT|2021-01-21|65
e|FA|e51cf168-af89-44d9-9e56-14785071f6b0|9|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|FFU|[?]|1|g/day|HYOID BONE|IPSILATERAL|Y||STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2021-02-15|90
e|FA|e51cf168-af89-44d9-9e56-14785071f6b0|10|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|s/h|[?]|1|mL/cm3/min|PARA-AORTIC LYMPH NODE|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|TREATMENT|2021-02-15|90
e|FA|8416f8c6-d0e4-43fc-9a66-6a916e853e87|1|STRCTNUM|Number of Strictures|[?]|GERD|[?]|Gy/min|[?]|1|SACHET|THORACIC ARTERY|CONTRALATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-06-13|10
e|FA|8416f8c6-d0e4-43fc-9a66-6a916e853e87|2|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|CIGAR|[?]|1|mL/100g/min|DISTAL INTERPHALANGEAL JOINT 4|CONTRALATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|WASHOUT|2020-06-13|10
e|FA|8416f8c6-d0e4-43fc-9a66-6a916e853e87|3|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/g/h|[?]|1|AU/mL|TRICEPS BRACHII MUSCLE|BILATERAL|||PROXY|2|Visit_2|25|5|FOLLOW-UP|2020-06-28|25
e|FA|8416f8c6-d0e4-43fc-9a66-6a916e853e87|4|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|mU/g|[?]|1|BP|HEEL OF THE HAND|RIGHT|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2020-06-28|25
e|FA|8416f8c6-d0e4-43fc-9a66-6a916e853e87|5|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|g/animal/day|[?]|1|IU/mg|MEDIAN NERVE|IPSILATERAL|||GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-07-13|40
e|FA|8416f8c6-d0e4-43fc-9a66-6a916e853e87|6|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|g/L|FINGER EXTENSOR MUSCLES|RIGHT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-07-13|40
e|FA|8416f8c6-d0e4-43fc-9a66-6a916e853e87|7|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|SYRINGE|[?]|1|10^6 CFU|DISTAL RIGHT CORONARY ARTERY CONDUIT|BILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|1|SCREENING|2020-08-07|65
e|FA|8416f8c6-d0e4-43fc-9a66-6a916e853e87|8|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|Pa|[?]|1|gtt|STERNOCLAVICULAR JOINT|BILATERAL|Y||DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2020-08-07|65
e|FA|8416f8c6-d0e4-43fc-9a66-6a916e853e87|9|ESTWT|Estimated Weight|[?]|GERD|[?]|mmHg*min/L|[?]|1|g/day|METATARSOPHALANGEAL JOINT 4|LEFT||Y|SPOUSE|5|Visit_5|90|6|TREATMENT|2020-09-01|90
e|FA|8416f8c6-d0e4-43fc-9a66-6a916e853e87|10|RLDEV|Relationship to Device|[?]|GERD|[?]|mL/m2|[?]|1|mL/min/mmHg|PERICARDIAL LYMPH NODE|BILATERAL|Y||SIGNIFICANT OTHER|5|Visit_5|90|5|SCREENING|2020-09-01|90
e|FA|a110e924-90a1-4e84-b47a-410f800fa201|1|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|NEBULE|[?]|1|mEq/g|RETROPERITONEAL LYMPH NODE|UNILATERAL||Y|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-10-29|10
e|FA|a110e924-90a1-4e84-b47a-410f800fa201|2|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|NEEDLE GAUGE|[?]|1|Log10 ELISA unit|KIDNEY, UPPER LOBE|RIGHT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|SCREENING|2020-10-29|10
e|FA|a110e924-90a1-4e84-b47a-410f800fa201|3|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|%/min|[?]|1|Log10 ELISA unit|ILIAC CREST|LATERAL||Y|CAREGIVER|2|Visit_2|25|2|SCREENING|2020-11-13|25
e|FA|a110e924-90a1-4e84-b47a-410f800fa201|4|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|%/min|[?]|1|TRANSDUCING UNIT/mL|CORONARY ARTERY, LEFT|CONTRALATERAL|||SPOUSE|2|Visit_2|25|1|TREATMENT|2020-11-13|25
e|FA|a110e924-90a1-4e84-b47a-410f800fa201|5|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|IU/g|[?]|1|oz eq|DUODENUM|CONTRALATERAL|||PROXY|3|Visit_3|40|2|WASHOUT|2020-11-28|40
e|FA|a110e924-90a1-4e84-b47a-410f800fa201|6|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|/4.0 mL|[?]|1|Hz/s|VASTUS LATERALIS MUSCLE|LEFT|Y||INVESTIGATOR|3|Visit_3|40|4|FOLLOW-UP|2020-11-28|40
e|FA|a110e924-90a1-4e84-b47a-410f800fa201|7|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT/mL|[?]|1|10^9 CFU/g|FIRST DIAGONAL BRANCH ARTERY|IPSILATERAL|||GUARDIAN|4|Visit_4|65|1|TREATMENT|2020-12-23|65
e|FA|a110e924-90a1-4e84-b47a-410f800fa201|8|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|nmol/g|[?]|1|Gy/h|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|LATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|WASHOUT|2020-12-23|65
e|FA|a110e924-90a1-4e84-b47a-410f800fa201|9|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|1/(s*kPa)|[?]|1|AU/mL|MITRAL VALVE|LATERAL||Y|INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2021-01-17|90
e|FA|a110e924-90a1-4e84-b47a-410f800fa201|10|STROKTYP|Stroke Type|[?]|GERD|[?]|titer|[?]|1|g/L|MAXILLARY SINUS|UNILATERAL|Y||ADJUDICATOR|5|Visit_5|90|2|FOLLOW-UP|2021-01-17|90
e|FA|40681cb8-5d49-4e1d-b893-f5fad62a0885|1|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|m2|ESOPHAGUS, THORACIC|LATERAL|||FRIEND|1|Visit_1|10|5|WASHOUT|2020-08-08|10
e|FA|40681cb8-5d49-4e1d-b893-f5fad62a0885|2|LDIAM|Longest Diameter|[?]|GERD|[?]|mgEq|[?]|1|Shock Wave|INTERPHALANGEAL JOINT 1|LATERAL|Y|Y|SIBLING|1|Visit_1|10|1|TREATMENT|2020-08-08|10
e|FA|40681cb8-5d49-4e1d-b893-f5fad62a0885|3|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/dose|[?]|1|NEEDLE GAUGE|HEART, LEFT VENTRICULAR WALL|LEFT|||STUDY SUBJECT|2|Visit_2|25|3|WASHOUT|2020-08-23|25
e|FA|40681cb8-5d49-4e1d-b893-f5fad62a0885|4|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|mg/g/h|[?]|1|g/L|FACET JOINT|LATERAL|Y||FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-08-23|25
e|FA|40681cb8-5d49-4e1d-b893-f5fad62a0885|5|SEV|Severity/Intensity|[?]|GERD|[?]|min*mg/mL|[?]|1|Pa|CENTRAL NERVOUS SYSTEM|CONTRALATERAL|||SPOUSE|3|Visit_3|40|3|TREATMENT|2020-09-07|40
e|FA|40681cb8-5d49-4e1d-b893-f5fad62a0885|6|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa|[?]|1|EIA unit|PARATRACHEAL LYMPH NODE|LEFT|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2020-09-07|40
e|FA|40681cb8-5d49-4e1d-b893-f5fad62a0885|7|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|aMFI|[?]|1|mL/cm3/min|TIBIALIS ANTERIOR MUSCLE|CONTRALATERAL|||FAMILY MEMBER|4|Visit_4|65|3|SCREENING|2020-10-02|65
e|FA|40681cb8-5d49-4e1d-b893-f5fad62a0885|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|VIRTUAL PIXEL|[?]|1|mL|SKIN OF THE BENDING JOINT|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|SCREENING|2020-10-02|65
e|FA|40681cb8-5d49-4e1d-b893-f5fad62a0885|9|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|%(w/v)|[?]|1|10^9 CFU/g|PARATRACHEAL LYMPH NODE|BILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|1|FOLLOW-UP|2020-10-27|90
e|FA|40681cb8-5d49-4e1d-b893-f5fad62a0885|10|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|m3|[?]|1|ohm|METATARSOPHALANGEAL JOINT 5|CONTRALATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-10-27|90
e|FA|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mmHg|[?]|1|km|PREFRONTAL CORTEX|CONTRALATERAL|||CHILD|1|Visit_1|10|4|TREATMENT|2020-12-17|10
e|FA|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|2|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|gtt|[?]|1|QUANTITY SUFFICIENT|TYMPANIC MEMBRANE|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-12-17|10
e|FA|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|3|STRCTNUM|Number of Strictures|[?]|GERD|[?]|Enzyme U/L|[?]|1|SACHET|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|RIGHT||Y|FAMILY MEMBER|2|Visit_2|25|2|WASHOUT|2021-01-01|25
e|FA|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|4|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms|[?]|1|BAG|ANTERIOR TIBIAL VEIN|RIGHT|||VENDOR|2|Visit_2|25|6|TREATMENT|2021-01-01|25
e|FA|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|5|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|mg/mol|[?]|1|mL/100g/min|MEDIASTINUM, MIDDLE|CONTRALATERAL|||INVESTIGATOR|3|Visit_3|40|6|SCREENING|2021-01-16|40
e|FA|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|6|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|mL/dL|[?]|1|Shock Wave|COLON, HEPATIC FLEXURE|IPSILATERAL|||STUDY SUBJECT|3|Visit_3|40|4|TREATMENT|2021-01-16|40
e|FA|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|7|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|U/mg|[?]|1|SCOOPFUL|LOCUS CERULEUS|LATERAL|||STUDY SUBJECT|4|Visit_4|65|5|FOLLOW-UP|2021-02-10|65
e|FA|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|8|AGETRT1|Age At First Treatment|[?]|GERD|[?]|ug/kg/h|[?]|1|mL/mmHg/min/L|SPINOUS PROCESS|BILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|5|FOLLOW-UP|2021-02-10|65
e|FA|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|9|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|mmHg/sec|[?]|1|HOURS|HEART, APEX|BILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|6|WASHOUT|2021-03-07|90
e|FA|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|10|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|VIRTUAL PIXEL|[?]|1|g/cage/day|AORTIC VALVE ANNULUS|LATERAL|Y||PROXY|5|Visit_5|90|4|TREATMENT|2021-03-07|90
e|FA|96e65c5c-723c-42d9-8e88-0bcb600e9f88|1|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|cmol|[?]|1|TRANSDUCING UNIT/mL|NAVICULAR BONE|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|FOLLOW-UP|2020-09-10|10
e|FA|96e65c5c-723c-42d9-8e88-0bcb600e9f88|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ug/L|[?]|1|mg/g/min|BLADDER, FUNDUS|IPSILATERAL|Y|Y|GUARDIAN|1|Visit_1|10|4|WASHOUT|2020-09-10|10
e|FA|96e65c5c-723c-42d9-8e88-0bcb600e9f88|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|vp/dose|[?]|1|mg/g/min|PISIFORM BONE|CONTRALATERAL|||SIBLING|2|Visit_2|25|5|FOLLOW-UP|2020-09-25|25
e|FA|96e65c5c-723c-42d9-8e88-0bcb600e9f88|4|TOTNUM|Total Number|[?]|GERD|[?]|BOTTLE|[?]|1|/200 HPFs|INTERPHALANGEAL JOINT 2|BILATERAL|||PROXY|2|Visit_2|25|6|FOLLOW-UP|2020-09-25|25
e|FA|96e65c5c-723c-42d9-8e88-0bcb600e9f88|5|DFATT|Dietary Fat, Total|[?]|GERD|[?]|mg/day|[?]|1|Bq/mg|HYPOPHARYNX|CONTRALATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-10-10|40
e|FA|96e65c5c-723c-42d9-8e88-0bcb600e9f88|6|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|Enzyme U|[?]|1|gtt|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|UNILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-10-10|40
e|FA|96e65c5c-723c-42d9-8e88-0bcb600e9f88|7|AGETRT1|Age At First Treatment|[?]|GERD|[?]|genEq|[?]|1|mL/mmHg/min/L|ALVEOLUS|IPSILATERAL|||CHILD|4|Visit_4|65|4|TREATMENT|2020-11-04|65
e|FA|96e65c5c-723c-42d9-8e88-0bcb600e9f88|8|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|mm2|[?]|1|mIU/L|EXTERNAL ILIAC ARTERY|LATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|6|FOLLOW-UP|2020-11-04|65
e|FA|96e65c5c-723c-42d9-8e88-0bcb600e9f88|9|LENRSCT|Length of Resection|[?]|GERD|[?]|ng/dL|[?]|1|psi|FIBULAR VEIN|LEFT|Y|Y|ADJUDICATOR|5|Visit_5|90|1|SCREENING|2020-11-29|90
e|FA|96e65c5c-723c-42d9-8e88-0bcb600e9f88|10|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|10^9/dose|[?]|1|Bq/L|OPTIC NERVE|IPSILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2020-11-29|90
e|FA|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|1|LENRSCT|Length of Resection|[?]|GERD|[?]|kg/mol|[?]|1|psi|WRIST JOINT EXTENSOR TENDONS|CONTRALATERAL|Y||SIBLING|1|Visit_1|10|3|TREATMENT|2020-07-12|10
e|FA|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|uU/dL|[?]|1|mg/g/min|STERNOCLAVICULAR JOINT|LEFT|||INVESTIGATOR|1|Visit_1|10|7|SCREENING|2020-07-12|10
e|FA|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|3|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|PHERESIS UNIT|[?]|1|PACK|VOMER|UNILATERAL|||CHILD|2|Visit_2|25|1|WASHOUT|2020-07-27|25
e|FA|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|4|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|mol/L|[?]|1|Bq/L|ULNA SHAFT|IPSILATERAL|||INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-07-27|25
e|FA|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|5|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|m|[?]|1|g/day|SKIN OF THE SOLE|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|FOLLOW-UP|2020-08-11|40
e|FA|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^3 organisms|[?]|1|%(v/v)|TROCHANTER|LATERAL|||VENDOR|3|Visit_3|40|4|TREATMENT|2020-08-11|40
e|FA|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|7|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|JDF Unit|[?]|1|anti-Xa IU/mL|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|LEFT|Y|Y|FAMILY MEMBER|4|Visit_4|65|5|TREATMENT|2020-09-05|65
e|FA|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|8|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|ug/animal|[?]|1|Log10 ELISA unit|HYPOPHARYNX|BILATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|7|TREATMENT|2020-09-05|65
e|FA|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|9|DFATT|Dietary Fat, Total|[?]|GERD|[?]|hPa|[?]|1|Bq/mg|OSTIOMEATAL COMPLEX|BILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-09-30|90
e|FA|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|10|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|uCi|[?]|1|mL/min/mmHg|ELBOW EXTENSOR MUSCLES|LATERAL|||SIBLING|5|Visit_5|90|4|SCREENING|2020-09-30|90
e|FA|f81742a2-5250-43d7-a6e2-8fcb1625a114|1|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mL/h|[?]|1|L/h/m2|SALIVARY GLAND, SUBLINGUAL|BILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-05-30|10
e|FA|f81742a2-5250-43d7-a6e2-8fcb1625a114|2|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT|[?]|1|h*%|SKIN OF THE CHIN|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|6|SCREENING|2020-05-30|10
e|FA|f81742a2-5250-43d7-a6e2-8fcb1625a114|3|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|mEq/ug|[?]|1|IU/mmol|INGUINAL LYMPH NODE|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-06-14|25
e|FA|f81742a2-5250-43d7-a6e2-8fcb1625a114|4|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|lx|[?]|1|/500 WBC|GREAT VESSELS|LEFT|Y||SIGNIFICANT OTHER|2|Visit_2|25|5|SCREENING|2020-06-14|25
e|FA|f81742a2-5250-43d7-a6e2-8fcb1625a114|5|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|10^6 CFU|[?]|1|mL/h|ASCENDING AORTA|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-06-29|40
e|FA|f81742a2-5250-43d7-a6e2-8fcb1625a114|6|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|DAgU|[?]|1|PFU/dose|NASAL BONE|BILATERAL|||SIBLING|3|Visit_3|40|5|TREATMENT|2020-06-29|40
e|FA|f81742a2-5250-43d7-a6e2-8fcb1625a114|7|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|damol/L|[?]|1|EIA unit|ACROMION|LATERAL||Y|PROXY|4|Visit_4|65|4|TREATMENT|2020-07-24|65
e|FA|f81742a2-5250-43d7-a6e2-8fcb1625a114|8|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|hPa|[?]|1|mL/m2|SOLEUS MUSCLE|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-07-24|65
e|FA|f81742a2-5250-43d7-a6e2-8fcb1625a114|9|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|Ejaculate U|[?]|1|ng|T8 VERTEBRA|BILATERAL|||FRIEND|5|Visit_5|90|6|FOLLOW-UP|2020-08-18|90
e|FA|f81742a2-5250-43d7-a6e2-8fcb1625a114|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|%(v/v)|CARPOMETACARPAL JOINT 2|LATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2020-08-18|90
e|FA|c6bad1d0-3514-4f98-b229-d093a94dfbc4|1|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mL|[?]|1|10^6 organisms/mL|LOWER GASTROINTESTINAL TRACT LYMPH NODE|RIGHT|||INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2020-06-24|10
e|FA|c6bad1d0-3514-4f98-b229-d093a94dfbc4|2|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|10^3/L|[?]|1|uL/kg/day|CARDIAC VALVE|IPSILATERAL||Y|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-06-24|10
e|FA|c6bad1d0-3514-4f98-b229-d093a94dfbc4|3|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|ug/L/h|[?]|1|Gy/h|C6 VERTEBRA|LEFT|Y||PROXY|2|Visit_2|25|4|TREATMENT|2020-07-09|25
e|FA|c6bad1d0-3514-4f98-b229-d093a94dfbc4|4|VOL|Volume|[?]|GERD|[?]|10^6 IU|[?]|1|vp/dose|LATERAL RAMUS INTERMEDIUS ARTERY|UNILATERAL|||STUDY SUBJECT|2|Visit_2|25|1|SCREENING|2020-07-09|25
e|FA|c6bad1d0-3514-4f98-b229-d093a94dfbc4|5|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|uSiemens|[?]|1|PFU/dose|SAPHENOUS VEIN|CONTRALATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|5|WASHOUT|2020-07-24|40
e|FA|c6bad1d0-3514-4f98-b229-d093a94dfbc4|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^3 organisms/g|[?]|1|mg/g/min|PITUITARY GLAND|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|FOLLOW-UP|2020-07-24|40
e|FA|c6bad1d0-3514-4f98-b229-d093a94dfbc4|7|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|ug/mL/h|[?]|1|ug/g/h|SKIN OF THE EAR|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|6|TREATMENT|2020-08-18|65
e|FA|c6bad1d0-3514-4f98-b229-d093a94dfbc4|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|P|[?]|1|mL|MEDIASTINUM, ANTERIOR|UNILATERAL||Y|VENDOR|4|Visit_4|65|2|WASHOUT|2020-08-18|65
e|FA|c6bad1d0-3514-4f98-b229-d093a94dfbc4|9|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|ug/L FEU|[?]|1|L/h/m2|FLEXOR HALLUCIS LONGUS MUSCLE|RIGHT|Y||FRIEND|5|Visit_5|90|4|FOLLOW-UP|2020-09-12|90
e|FA|c6bad1d0-3514-4f98-b229-d093a94dfbc4|10|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|%(w/v)|[?]|1|psi|CAPITATE-LUNATE JOINT|LEFT||Y|DOMESTIC PARTNER|5|Visit_5|90|5|SCREENING|2020-09-12|90
e|FA|84d68bcc-dc7a-4366-9630-40ce8885351d|1|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|Sv|[?]|1|mL/mmHg/min/L|GINGIVAL MUCOSA|RIGHT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-06-16|10
e|FA|84d68bcc-dc7a-4366-9630-40ce8885351d|2|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|BOLUS|[?]|1|Shock Wave|ANTRUM PYLORI|LEFT|||STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-06-16|10
e|FA|84d68bcc-dc7a-4366-9630-40ce8885351d|3|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|ug|[?]|1|BOWL|FALCIFORM LIGAMENT|RIGHT|||SIGNIFICANT OTHER|2|Visit_2|25|6|SCREENING|2020-07-01|25
e|FA|84d68bcc-dc7a-4366-9630-40ce8885351d|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|F|[?]|1|Pa|PALPEBRAL CONJUNCTIVA|LEFT|||PROXY|2|Visit_2|25|3|TREATMENT|2020-07-01|25
e|FA|84d68bcc-dc7a-4366-9630-40ce8885351d|5|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|Antibody Unit|[?]|1|cm|C3 VERTEBRA|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-07-16|40
e|FA|84d68bcc-dc7a-4366-9630-40ce8885351d|6|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|NEEDLE GAUGE|ESOPHAGUS, CERVICAL|UNILATERAL|||FRIEND|3|Visit_3|40|4|WASHOUT|2020-07-16|40
e|FA|84d68bcc-dc7a-4366-9630-40ce8885351d|7|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|APL U/mL|[?]|1|Bq/L|PECTORALIS MINOR MUSCLE|BILATERAL|Y||INVESTIGATOR|4|Visit_4|65|5|WASHOUT|2020-08-10|65
e|FA|84d68bcc-dc7a-4366-9630-40ce8885351d|8|VOL|Volume|[?]|GERD|[?]|cg|[?]|1|vp/dose|POPLITEAL ARTERY BELOW KNEE|UNILATERAL|||SIBLING|4|Visit_4|65|7|FOLLOW-UP|2020-08-10|65
e|FA|84d68bcc-dc7a-4366-9630-40ce8885351d|9|STROKTYP|Stroke Type|[?]|GERD|[?]|mg/cm2|[?]|1|g/L|COCCYGEAL VERTEBRA|IPSILATERAL|||PROXY|5|Visit_5|90|1|FOLLOW-UP|2020-09-04|90
e|FA|84d68bcc-dc7a-4366-9630-40ce8885351d|10|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|mEq/uL|[?]|1|psi|SUPRACLAVICULAR FOSSA|LEFT||Y|PARENT|5|Visit_5|90|1|WASHOUT|2020-09-04|90
e|FA|517f3930-5202-4e0a-b3e1-85ed4bd7e117|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|DNA copies/ug|[?]|1|Pa|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|RIGHT||Y|FRIEND|1|Visit_1|10|1|TREATMENT|2021-01-08|10
e|FA|517f3930-5202-4e0a-b3e1-85ed4bd7e117|2|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|mgEq|[?]|1|ug/m2/h|LUMBAR SPINE|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|SCREENING|2021-01-08|10
e|FA|517f3930-5202-4e0a-b3e1-85ed4bd7e117|3|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|mCi/kg|[?]|1|AU/mL|HYOID BONE|BILATERAL|||CHILD|2|Visit_2|25|1|WASHOUT|2021-01-23|25
e|FA|517f3930-5202-4e0a-b3e1-85ed4bd7e117|4|CALBURN|Calories Burned|[?]|GERD|[?]|mU/L|[?]|1|/kg|C2 VERTEBRA|BILATERAL|||SPOUSE|2|Visit_2|25|4|TREATMENT|2021-01-23|25
e|FA|517f3930-5202-4e0a-b3e1-85ed4bd7e117|5|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|BOTTLE|[?]|1|10^9 CFU/mL|HEPATIC LYMPH NODE|LATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2021-02-07|40
e|FA|517f3930-5202-4e0a-b3e1-85ed4bd7e117|6|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|VOXEL|[?]|1|mL/cm3/min|KIDNEY, MEDULLA|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|5|TREATMENT|2021-02-07|40
e|FA|517f3930-5202-4e0a-b3e1-85ed4bd7e117|7|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|%(w/w)|[?]|1|DROP|ARM SKIN|IPSILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|3|WASHOUT|2021-03-04|65
e|FA|517f3930-5202-4e0a-b3e1-85ed4bd7e117|8|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|Enzyme U/m2|[?]|1|mL/animal/day|HEART, RIGHT ATRIAL APPENDAGE|LATERAL|||GUARDIAN|4|Visit_4|65|1|TREATMENT|2021-03-04|65
e|FA|517f3930-5202-4e0a-b3e1-85ed4bd7e117|9|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|CUP|[?]|1|Weber|INTERNAL MAMMARY ARTERY|UNILATERAL|||ADJUDICATOR|5|Visit_5|90|4|WASHOUT|2021-03-29|90
e|FA|517f3930-5202-4e0a-b3e1-85ed4bd7e117|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|umol/L/h|[?]|1|QUANTITY SUFFICIENT|POSTERIOR TIBIAL VEIN|LATERAL|||INVESTIGATOR|5|Visit_5|90|5|FOLLOW-UP|2021-03-29|90
e|FA|edd73650-27bb-474f-bab7-d2c3d57b2dc4|1|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|L/L|[?]|1|10^9 CFU/mL|DISTAL PHALANX 2 OF THE HAND|RIGHT||Y|ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-12-21|10
e|FA|edd73650-27bb-474f-bab7-d2c3d57b2dc4|2|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|L/s/kPa|[?]|1|10^6 IU/mL|ESOPHAGEAL LYMPH NODE|LATERAL|||SIBLING|1|Visit_1|10|5|FOLLOW-UP|2020-12-21|10
e|FA|edd73650-27bb-474f-bab7-d2c3d57b2dc4|3|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|10^9/dose|[?]|1|Bq/L|METACARPAL 1 BASE|RIGHT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|WASHOUT|2021-01-05|25
e|FA|edd73650-27bb-474f-bab7-d2c3d57b2dc4|4|OBJTYPE|Type of Object|[?]|GERD|[?]|ng/L|[?]|1|ng|KIDNEY, LOWER LOBE|CONTRALATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2021-01-05|25
e|FA|edd73650-27bb-474f-bab7-d2c3d57b2dc4|5|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|mEq/day|[?]|1|DRUM|CERVICAL LYMPH NODE|BILATERAL|||CAREGIVER|3|Visit_3|40|6|FOLLOW-UP|2021-01-20|40
e|FA|edd73650-27bb-474f-bab7-d2c3d57b2dc4|6|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|g/animal/wk|[?]|1|uCi/kg|L5-S1 INTERVERTEBRAL SPACE|LEFT|||FRIEND|3|Visit_3|40|7|TREATMENT|2021-01-20|40
e|FA|edd73650-27bb-474f-bab7-d2c3d57b2dc4|7|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|CAPSULE|[?]|1|IU/mg|AORTIC VALVE, LEFT CORONARY CUSP|BILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2021-02-14|65
e|FA|edd73650-27bb-474f-bab7-d2c3d57b2dc4|8|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|gMFI|[?]|1|g/L|ESOPHAGEAL LYMPH NODE|UNILATERAL||Y|PROXY|4|Visit_4|65|3|FOLLOW-UP|2021-02-14|65
e|FA|edd73650-27bb-474f-bab7-d2c3d57b2dc4|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mgEq|[?]|1|mg/g/min|LATERAL RAMUS INTERMEDIUS ARTERY|IPSILATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|1|SCREENING|2021-03-11|90
e|FA|edd73650-27bb-474f-bab7-d2c3d57b2dc4|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mg/g/min|[?]|1|10^6 U|MUCOSA OF THE LIP|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|2|WASHOUT|2021-03-11|90
e|FA|98737dfa-0058-4420-a515-38526f01f90d|1|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|ug/mol|[?]|1|U/mg|LENS|LATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-09-09|10
e|FA|98737dfa-0058-4420-a515-38526f01f90d|2|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/dose|[?]|1|10^6 U|MEDIASTINUM, SUPERIOR|LATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-09-09|10
e|FA|98737dfa-0058-4420-a515-38526f01f90d|3|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/animal|[?]|1|ug/m2/h|PRONATOR TERES MUSCLE|LEFT|||ADJUDICATOR|2|Visit_2|25|3|WASHOUT|2020-09-24|25
e|FA|98737dfa-0058-4420-a515-38526f01f90d|4|AGETRT1|Age At First Treatment|[?]|GERD|[?]|mmol/kg|[?]|1|mL/mmHg/min/L|BONE MARROW|LEFT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-09-24|25
e|FA|98737dfa-0058-4420-a515-38526f01f90d|5|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|ug/m2/day|[?]|1|mL|MIDDLE EAR|IPSILATERAL|||CHILD|3|Visit_3|40|2|TREATMENT|2020-10-09|40
e|FA|98737dfa-0058-4420-a515-38526f01f90d|6|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|ug|[?]|1|Coulomb|LUNG, RIGHT LOWER LOBE|UNILATERAL||Y|INVESTIGATOR|3|Visit_3|40|5|SCREENING|2020-10-09|40
e|FA|98737dfa-0058-4420-a515-38526f01f90d|7|DMEAT|Dietary Meat|[?]|GERD|[?]|h/wk|[?]|1|10^6 organisms/mL|COMMON ILIAC LYMPH NODE|UNILATERAL|||INVESTIGATOR|4|Visit_4|65|1|WASHOUT|2020-11-03|65
e|FA|98737dfa-0058-4420-a515-38526f01f90d|8|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|IU/mg|PHARYNGEAL TONSIL|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-11-03|65
e|FA|98737dfa-0058-4420-a515-38526f01f90d|9|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|U/mmol|[?]|1|CUP|LOWER GASTROINTESTINAL TRACT LYMPH NODE|UNILATERAL|||INVESTIGATOR|5|Visit_5|90|6|FOLLOW-UP|2020-11-28|90
e|FA|98737dfa-0058-4420-a515-38526f01f90d|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|%(v/v)|CALF|CONTRALATERAL|||FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2020-11-28|90
e|FA|e713c631-cdd8-428f-a3a6-0195f6fb80b4|1|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|10^6 CFU/g|[?]|1|BOWL|SKIN OF THE UPPER LIMB|IPSILATERAL||Y|INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-10-03|10
e|FA|e713c631-cdd8-428f-a3a6-0195f6fb80b4|2|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|umol/L|[?]|1|g/L|LEFT VENTRICULAR MID ANTERIOR SEGMENT|UNILATERAL||Y|VENDOR|1|Visit_1|10|4|TREATMENT|2020-10-03|10
e|FA|e713c631-cdd8-428f-a3a6-0195f6fb80b4|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|genEq|[?]|1|10^6 U|CECUM|LATERAL|Y||ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-10-18|25
e|FA|e713c631-cdd8-428f-a3a6-0195f6fb80b4|4|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|titer|[?]|1|Log10 ELISA unit|PROXIMAL LAD ARTERY|LEFT|Y||SIGNIFICANT OTHER|2|Visit_2|25|1|FOLLOW-UP|2020-10-18|25
e|FA|e713c631-cdd8-428f-a3a6-0195f6fb80b4|5|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|Bq/mL|[?]|1|NEEDLE GAUGE|BLADDER, NECK|RIGHT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-11-02|40
e|FA|e713c631-cdd8-428f-a3a6-0195f6fb80b4|6|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|INHALATION|[?]|1|Log10 ELISA unit|ASCENDING AORTA, SINUS OF VALSALVA|CONTRALATERAL|||FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-11-02|40
e|FA|e713c631-cdd8-428f-a3a6-0195f6fb80b4|7|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|nU/cL|[?]|1|mm/h|SKIN OF THE INFRASCAPULAR REGION|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|6|TREATMENT|2020-11-27|65
e|FA|e713c631-cdd8-428f-a3a6-0195f6fb80b4|8|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|CAPLET|[?]|1|mL/cm3/min|PINEAL GLAND|UNILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|1|FOLLOW-UP|2020-11-27|65
e|FA|e713c631-cdd8-428f-a3a6-0195f6fb80b4|9|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|TRACE|[?]|1|U/mg|JUGULAR VEIN|IPSILATERAL|Y|Y|PARENT|5|Visit_5|90|5|WASHOUT|2020-12-22|90
e|FA|e713c631-cdd8-428f-a3a6-0195f6fb80b4|10|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|FFU|[?]|1|mL/min/mmHg|INGUINAL REGION|LEFT|Y||CAREGIVER|5|Visit_5|90|7|WASHOUT|2020-12-22|90
e|FA|a3964bed-1273-4bce-bbb4-b8d768b30aa3|1|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|%|[?]|1|cm H2O|ANUS|LEFT|||INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-09-20|10
e|FA|a3964bed-1273-4bce-bbb4-b8d768b30aa3|2|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|CARTRIDGE|[?]|1|L/h/m2|OCCIPITAL LOBE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|SCREENING|2020-09-20|10
e|FA|a3964bed-1273-4bce-bbb4-b8d768b30aa3|3|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|mL/min/mmHg|[?]|1|cmH2O/mL|RIB 3|RIGHT|||PARENT|2|Visit_2|25|2|TREATMENT|2020-10-05|25
e|FA|a3964bed-1273-4bce-bbb4-b8d768b30aa3|4|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|JAR|[?]|1|gtt|PROXIMAL CIRCUMFLEX ARTERY|RIGHT|||SPOUSE|2|Visit_2|25|6|SCREENING|2020-10-05|25
e|FA|a3964bed-1273-4bce-bbb4-b8d768b30aa3|5|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|mmHg/L/min|ILIUM|LATERAL|Y||INVESTIGATOR|3|Visit_3|40|5|WASHOUT|2020-10-20|40
e|FA|a3964bed-1273-4bce-bbb4-b8d768b30aa3|6|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|keV|[?]|1|mL/m2|PRONATOR TERES MUSCLE|UNILATERAL|Y||PARENT|3|Visit_3|40|2|TREATMENT|2020-10-20|40
e|FA|a3964bed-1273-4bce-bbb4-b8d768b30aa3|7|LOCONSET|Localization of Onset|[?]|GERD|[?]|SQU/mL|[?]|1|g/L|CORPUS CALLOSUM, SPLENIUM|IPSILATERAL|||INTERVIEWER|4|Visit_4|65|6|FOLLOW-UP|2020-11-14|65
e|FA|a3964bed-1273-4bce-bbb4-b8d768b30aa3|8|OBJTYPE|Type of Object|[?]|GERD|[?]|10^7 TCID 50/dose|[?]|1|ng|FOREHEAD|RIGHT||Y|FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2020-11-14|65
e|FA|a3964bed-1273-4bce-bbb4-b8d768b30aa3|9|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|g/day|SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|||CAREGIVER|5|Visit_5|90|1|FOLLOW-UP|2020-12-09|90
e|FA|a3964bed-1273-4bce-bbb4-b8d768b30aa3|10|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|100 IU/mL|SALIVARY GLAND|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-12-09|90
e|FA|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|hr/day|[?]|1|mL/animal/day|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|LATERAL|||INTERVIEWER|1|Visit_1|10|3|TREATMENT|2020-12-21|10
e|FA|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|2|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|SCOOPFUL|[?]|1|SCOOPFUL|METATARSOPHALANGEAL JOINT 1|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|SCREENING|2020-12-21|10
e|FA|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|3|SEV|Severity/Intensity|[?]|GERD|[?]|cup eq|[?]|1|Pa|LATERAL HUMERAL EPICONDYLE|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|WASHOUT|2021-01-05|25
e|FA|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|4|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|ng/day|LOWER JUGULAR LYMPH NODE|BILATERAL||Y|FAMILY MEMBER|2|Visit_2|25|3|SCREENING|2021-01-05|25
e|FA|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|5|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|POUCH|[?]|1|BAG|NAIL|IPSILATERAL|||FRIEND|3|Visit_3|40|1|TREATMENT|2021-01-20|40
e|FA|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|6|STRCTNUM|Number of Strictures|[?]|GERD|[?]|mCi/kg|[?]|1|SACHET|LUNG, RIGHT MIDDLE LOBE|CONTRALATERAL|Y|Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|FOLLOW-UP|2021-01-20|40
e|FA|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mm/sec|[?]|1|U/mg|GREATER CURVATURE OF THE STOMACH|LATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-02-14|65
e|FA|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|cd/m2|[?]|1|Pa|PELVIS|BILATERAL|Y||VENDOR|4|Visit_4|65|7|FOLLOW-UP|2021-02-14|65
e|FA|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|9|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|Torr|[?]|1|SCOOPFUL|TEMPORAL BONE|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2021-03-11|90
e|FA|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|10|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU|[?]|1|EIA unit|METATARSAL BONE|LEFT|||VENDOR|5|Visit_5|90|1|SCREENING|2021-03-11|90
e|FA|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|EID 50/dose|[?]|1|Pa|ABDOMINAL LYMPH NODE|LATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-06-09|10
e|FA|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ug/day|[?]|1|mg/g/min|RECTUS FEMORIS MUSCLE|UNILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2020-06-09|10
e|FA|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|DROP|[?]|1|mg/g/min|METACARPAL BONE|LATERAL||Y|CHILD|2|Visit_2|25|5|TREATMENT|2020-06-24|25
e|FA|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|pmol/10^10 cells|[?]|1|mg/g/min|EXTRAOCULAR MUSCLE|BILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-06-24|25
e|FA|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|5|TOTNUM|Total Number|[?]|GERD|[?]|BOWL|[?]|1|/200 HPFs|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|UNILATERAL||Y|FRIEND|3|Visit_3|40|1|TREATMENT|2020-07-09|40
e|FA|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|6|STRCTNUM|Number of Strictures|[?]|GERD|[?]|umol/h/mmol|[?]|1|SACHET|GALLBLADDER|RIGHT|||DOMESTIC PARTNER|3|Visit_3|40|1|WASHOUT|2020-07-09|40
e|FA|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|7|DFRUIT|Dietary Fruit|[?]|GERD|[?]|mL/animal|[?]|1|10^6 CFU/mL|OVARY|LATERAL|Y||FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2020-08-03|65
e|FA|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|8|EVENTFRQ|Event Frequency|[?]|GERD|[?]|uOsm|[?]|1|ug/kg/h|AORTIC VALVE, LEFT CORONARY CUSP|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2020-08-03|65
e|FA|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|9|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|10^6/g|[?]|1|BP|THYROID GLAND, RIGHT LOBE|IPSILATERAL|||FRIEND|5|Visit_5|90|1|FOLLOW-UP|2020-08-28|90
e|FA|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|10|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|mL/(min*100mL)|[?]|1|10^4 CFU/mL|GINGIVAL MUCOSA|IPSILATERAL|||FRIEND|5|Visit_5|90|2|WASHOUT|2020-08-28|90
e|FA|597ff319-c16e-4aae-a7d9-ed2bc25684dc|1|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|g/g|[?]|1|/500 WBC|LEFT POSTERIOR DESCENDING ARTERY|RIGHT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|WASHOUT|2020-05-28|10
e|FA|597ff319-c16e-4aae-a7d9-ed2bc25684dc|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|100 IU/mL|[?]|1|%(v/v)|MEDIASTINUM|IPSILATERAL||Y|STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2020-05-28|10
e|FA|597ff319-c16e-4aae-a7d9-ed2bc25684dc|3|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|HOMEOPATHIC DILUTION|[?]|1|MPS U|ESOPHAGEAL LYMPH NODE|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2020-06-12|25
e|FA|597ff319-c16e-4aae-a7d9-ed2bc25684dc|4|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|NEEDLE GAUGE|[?]|1|Log10 ELISA unit|DISTAL RADIOULNAR JOINT|UNILATERAL|||VENDOR|2|Visit_2|25|7|SCREENING|2020-06-12|25
e|FA|597ff319-c16e-4aae-a7d9-ed2bc25684dc|5|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|nmol/day|[?]|1|BAG|RADIUS SHAFT|LEFT|||INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-06-27|40
e|FA|597ff319-c16e-4aae-a7d9-ed2bc25684dc|6|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|g/m2|[?]|1|SCOOPFUL|ILIAC CREST|LATERAL||Y|INVESTIGATOR|3|Visit_3|40|2|FOLLOW-UP|2020-06-27|40
e|FA|597ff319-c16e-4aae-a7d9-ed2bc25684dc|7|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|ELISA unit|[?]|1|10^9 CFU/mL|CORRUGATOR SUPERCILII MUSCLE|LATERAL|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|7|WASHOUT|2020-07-22|65
e|FA|597ff319-c16e-4aae-a7d9-ed2bc25684dc|8|SEV|Severity/Intensity|[?]|GERD|[?]|NFIU|[?]|1|Pa|AORTA|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|SCREENING|2020-07-22|65
e|FA|597ff319-c16e-4aae-a7d9-ed2bc25684dc|9|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|10^3 DNA copies/mL|[?]|1|cm H2O|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|RIGHT|Y||CHILD|5|Visit_5|90|3|WASHOUT|2020-08-16|90
e|FA|597ff319-c16e-4aae-a7d9-ed2bc25684dc|10|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|mL/dose|MESENTERY|UNILATERAL||Y|ADJUDICATOR|5|Visit_5|90|3|SCREENING|2020-08-16|90
e|FA|7d845e3e-8bd1-4647-a3e8-352a52b585cb|1|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|g/m2|[?]|1|10^6 CFU|SARTORIUS MUSCLE|BILATERAL|||STUDY SUBJECT|1|Visit_1|10|6|TREATMENT|2020-11-08|10
e|FA|7d845e3e-8bd1-4647-a3e8-352a52b585cb|2|SEV|Severity/Intensity|[?]|GERD|[?]|CFU/mL|[?]|1|Pa|OMENTUM|LEFT|||SIBLING|1|Visit_1|10|3|TREATMENT|2020-11-08|10
e|FA|7d845e3e-8bd1-4647-a3e8-352a52b585cb|3|EVENTFRQ|Event Frequency|[?]|GERD|[?]|CUP|[?]|1|ug/kg/h|LUNG, RIGHT|LEFT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-11-23|25
e|FA|7d845e3e-8bd1-4647-a3e8-352a52b585cb|4|LOCONSET|Localization of Onset|[?]|GERD|[?]|mL/cm H2O|[?]|1|g/L|MITRAL VALVE, ANTERIOR CUSP|CONTRALATERAL|Y||INTERVIEWER|2|Visit_2|25|7|FOLLOW-UP|2020-11-23|25
e|FA|7d845e3e-8bd1-4647-a3e8-352a52b585cb|5|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|mCi/kg|[?]|1|mL/cm3/min|DISTAL INTERPHALANGEAL JOINT 2|BILATERAL|Y||SIBLING|3|Visit_3|40|5|TREATMENT|2020-12-08|40
e|FA|7d845e3e-8bd1-4647-a3e8-352a52b585cb|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|fL|[?]|1|Pa|EPIDIDYMIS|LATERAL|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-12-08|40
e|FA|7d845e3e-8bd1-4647-a3e8-352a52b585cb|7|SEV|Severity/Intensity|[?]|GERD|[?]|10^9/L|[?]|1|Pa|DISTAL RIGHT CORONARY ARTERY CONDUIT|RIGHT|||FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2021-01-02|65
e|FA|7d845e3e-8bd1-4647-a3e8-352a52b585cb|8|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|mL/(min*100mL)|[?]|1|mL/min/mmHg|SKIN OF THE PALM|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2021-01-02|65
e|FA|7d845e3e-8bd1-4647-a3e8-352a52b585cb|9|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/mL|[?]|1|gtt|CAPITATE BONE|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2021-01-27|90
e|FA|7d845e3e-8bd1-4647-a3e8-352a52b585cb|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/dose|[?]|1|mg/g/min|KIDNEY, HILUM|CONTRALATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|SCREENING|2021-01-27|90
e|FA|7e9f4283-f90b-4f74-939c-b42648e8373c|1|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|Bq/uL|[?]|1|BOWL|EAR, INNER|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|5|TREATMENT|2020-12-15|10
e|FA|7e9f4283-f90b-4f74-939c-b42648e8373c|2|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|Bq/kg|[?]|1|MPS U|PRESACRAL LYMPH NODE|IPSILATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|1|TREATMENT|2020-12-15|10
e|FA|7e9f4283-f90b-4f74-939c-b42648e8373c|3|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|foz_br|[?]|1|DRUM|REGIONAL LYMPH NODE|BILATERAL|||STUDY SUBJECT|2|Visit_2|25|1|WASHOUT|2020-12-30|25
e|FA|7e9f4283-f90b-4f74-939c-b42648e8373c|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/mmol|[?]|1|mg/g/min|GLUTEUS MAXIMUS|UNILATERAL|Y||INTERVIEWER|2|Visit_2|25|6|TREATMENT|2020-12-30|25
e|FA|7e9f4283-f90b-4f74-939c-b42648e8373c|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|mg/g/min|GLOSSOPHARYNGEAL NERVE|LATERAL|Y||VENDOR|3|Visit_3|40|5|SCREENING|2021-01-14|40
e|FA|7e9f4283-f90b-4f74-939c-b42648e8373c|6|DPROT|Dietary Protein|[?]|GERD|[?]|Ejaculate U|[?]|1|10^4 CFU/mL|LUNG|LATERAL|Y|Y|FRIEND|3|Visit_3|40|6|TREATMENT|2021-01-14|40
e|FA|7e9f4283-f90b-4f74-939c-b42648e8373c|7|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|10^4/hpf|[?]|1|g/L|ABDOMINAL CAVITY|UNILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|2|FOLLOW-UP|2021-02-08|65
e|FA|7e9f4283-f90b-4f74-939c-b42648e8373c|8|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|mAmp|SUBCUTIS|LATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2021-02-08|65
e|FA|7e9f4283-f90b-4f74-939c-b42648e8373c|9|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|HEP|[?]|1|oz eq|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|UNILATERAL|||INVESTIGATOR|5|Visit_5|90|2|SCREENING|2021-03-05|90
e|FA|7e9f4283-f90b-4f74-939c-b42648e8373c|10|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|mN|[?]|1|BP|GLENOID FOSSA|UNILATERAL|||STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2021-03-05|90
e|FA|20a637e6-83d2-4a86-9ecc-8ddb0523997f|1|LDIAM|Longest Diameter|[?]|GERD|[?]|mgEq|[?]|1|Shock Wave|NERVE|LEFT|||FRIEND|1|Visit_1|10|5|TREATMENT|2020-10-31|10
e|FA|20a637e6-83d2-4a86-9ecc-8ddb0523997f|2|TOTNUM|Total Number|[?]|GERD|[?]|USP U|[?]|1|/200 HPFs|URETHRA, PENILE|LEFT|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-10-31|10
e|FA|20a637e6-83d2-4a86-9ecc-8ddb0523997f|3|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|VIRTUAL PIXEL|[?]|1|DRUM|TARSUS BONE|RIGHT|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|3|SCREENING|2020-11-15|25
e|FA|20a637e6-83d2-4a86-9ecc-8ddb0523997f|4|OBJTYPE|Type of Object|[?]|GERD|[?]|gMFI|[?]|1|ng|LARGE INTESTINE|IPSILATERAL||Y|INTERVIEWER|2|Visit_2|25|6|WASHOUT|2020-11-15|25
e|FA|20a637e6-83d2-4a86-9ecc-8ddb0523997f|5|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|uCi/kg|PUPIL|LEFT|||PROXY|3|Visit_3|40|2|TREATMENT|2020-11-30|40
e|FA|20a637e6-83d2-4a86-9ecc-8ddb0523997f|6|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|uEq|[?]|1|uCi/kg|APPENDICEAL TIP|CONTRALATERAL|||FRIEND|3|Visit_3|40|5|SCREENING|2020-11-30|40
e|FA|20a637e6-83d2-4a86-9ecc-8ddb0523997f|7|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|ug|[?]|1|10^6/L|LUNG, LEFT LOWER LOBE|LATERAL|Y|Y|SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-12-25|65
e|FA|20a637e6-83d2-4a86-9ecc-8ddb0523997f|8|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|kHz|[?]|1|10^6 CFU|THIRD RIGHT POSTEROLATERAL ARTERY|RIGHT|||INTERVIEWER|4|Visit_4|65|1|TREATMENT|2020-12-25|65
e|FA|20a637e6-83d2-4a86-9ecc-8ddb0523997f|9|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|V|[?]|1|g/day|PARASPINAL REGION|RIGHT|||GUARDIAN|5|Visit_5|90|5|FOLLOW-UP|2021-01-19|90
e|FA|20a637e6-83d2-4a86-9ecc-8ddb0523997f|10|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|days/month|[?]|1|L/h/m2|PARAPHARYNGEAL LYMPH NODE|RIGHT|Y||CHILD|5|Visit_5|90|3|TREATMENT|2021-01-19|90
e|FA|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|1|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|msec|[?]|1|h*%|INTERPHALANGEAL JOINT 3 OF THE HAND|CONTRALATERAL|Y|Y|GUARDIAN|1|Visit_1|10|7|SCREENING|2020-05-16|10
e|FA|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/day|[?]|1|mg/g/min|FEMALE REPRODUCTIVE SYSTEM|LATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-05-16|10
e|FA|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|3|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|psi|[?]|1|m2|URINARY SYSTEM|LEFT||Y|FAMILY MEMBER|2|Visit_2|25|1|FOLLOW-UP|2020-05-31|25
e|FA|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|4|TRTSETT|Treatment Setting|[?]|GERD|[?]|mol/day|[?]|1|Coulomb|FOREHEAD|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|3|SCREENING|2020-05-31|25
e|FA|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|PLUG|[?]|1|mg/g/min|HAMATE BONE|UNILATERAL||Y|CHILD|3|Visit_3|40|4|TREATMENT|2020-06-15|40
e|FA|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|6|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|kPa|[?]|1|Shock Wave|LYMPH NODE HILUM|UNILATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-06-15|40
e|FA|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|ms2|[?]|1|umol|LOCUS CERULEUS|LEFT||Y|FAMILY MEMBER|4|Visit_4|65|7|WASHOUT|2020-07-10|65
e|FA|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|%(v/v)|PROXIMAL URETHRA|LATERAL|||ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-07-10|65
e|FA|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|9|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|log10 CFU/mL|[?]|1|AU/mL|LOCUS CERULEUS|RIGHT||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|7|WASHOUT|2020-08-04|90
e|FA|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|10|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|ug/animal|[?]|1|cm|COLON, SPLENIC FLEXURE|BILATERAL|||INTERVIEWER|5|Visit_5|90|3|TREATMENT|2020-08-04|90
e|FA|595aa95c-4378-47c1-96e9-5512d08fb653|1|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|PIPE|[?]|1|mL/cm3/min|L3-L4 INTERVERTEBRAL SPACE|UNILATERAL|Y||FRIEND|1|Visit_1|10|5|TREATMENT|2020-08-23|10
e|FA|595aa95c-4378-47c1-96e9-5512d08fb653|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ft|[?]|1|Pa|TROCHLEAR NERVE|RIGHT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|6|FOLLOW-UP|2020-08-23|10
e|FA|595aa95c-4378-47c1-96e9-5512d08fb653|3|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|TCID 50/dose|[?]|1|MBq|RETINAL PIGMENTED EPITHELIAL LAYER|LEFT|Y||VENDOR|2|Visit_2|25|3|FOLLOW-UP|2020-09-07|25
e|FA|595aa95c-4378-47c1-96e9-5512d08fb653|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|CFU/mL|[?]|1|NEEDLE GAUGE|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|RIGHT|||INVESTIGATOR|2|Visit_2|25|6|SCREENING|2020-09-07|25
e|FA|595aa95c-4378-47c1-96e9-5512d08fb653|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|ukat/L|[?]|1|mL/animal/day|HAND PHALANX|IPSILATERAL|||PROXY|3|Visit_3|40|4|SCREENING|2020-09-22|40
e|FA|595aa95c-4378-47c1-96e9-5512d08fb653|6|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|h/wk|[?]|1|Gy/h|EPIGASTRIC REGION|UNILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|6|TREATMENT|2020-09-22|40
e|FA|595aa95c-4378-47c1-96e9-5512d08fb653|7|SEV|Severity/Intensity|[?]|GERD|[?]|U/g|[?]|1|Pa|PALPEBRAL CONJUNCTIVA|BILATERAL|||ADJUDICATOR|4|Visit_4|65|2|SCREENING|2020-10-17|65
e|FA|595aa95c-4378-47c1-96e9-5512d08fb653|8|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|uCi/L|[?]|1|10^6 CFU|L2-L3 INTERVERTEBRAL SPACE|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-10-17|65
e|FA|595aa95c-4378-47c1-96e9-5512d08fb653|9|DCAL|Dietary Calories|[?]|GERD|[?]|um2|[?]|1|EIA unit|PATELLA|CONTRALATERAL|Y||PROXY|5|Visit_5|90|4|WASHOUT|2020-11-11|90
e|FA|595aa95c-4378-47c1-96e9-5512d08fb653|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|EVENTS|[?]|1|QUANTITY SUFFICIENT|KIDNEY, HILUM|UNILATERAL|||INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2020-11-11|90
e|FA|b528dc24-e791-41b1-95b3-fc0be18da47f|1|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|Hz/s|[?]|1|vp/dose|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|IPSILATERAL||Y|FRIEND|1|Visit_1|10|3|TREATMENT|2020-12-27|10
e|FA|b528dc24-e791-41b1-95b3-fc0be18da47f|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/m2/h|[?]|1|Pa|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|RIGHT|||ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-12-27|10
e|FA|b528dc24-e791-41b1-95b3-fc0be18da47f|3|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|mm/h|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|RIGHT|Y||CHILD|2|Visit_2|25|7|SCREENING|2021-01-11|25
e|FA|b528dc24-e791-41b1-95b3-fc0be18da47f|4|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|mEq/mL|[?]|1|g/day|POSTERIOR TIBIAL VEIN|UNILATERAL|||INTERVIEWER|2|Visit_2|25|5|TREATMENT|2021-01-11|25
e|FA|b528dc24-e791-41b1-95b3-fc0be18da47f|5|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|10^3 organisms/g|[?]|1|DROP|FIRST RIGHT POSTEROLATERAL ARTERY|LATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2021-01-26|40
e|FA|b528dc24-e791-41b1-95b3-fc0be18da47f|6|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|MBq/uL|[?]|1|EIA unit|VULVOVAGINAL REGION|CONTRALATERAL|||FRIEND|3|Visit_3|40|4|TREATMENT|2021-01-26|40
e|FA|b528dc24-e791-41b1-95b3-fc0be18da47f|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ms2|[?]|1|Pa|PERICARDIAL LYMPH NODE|LATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|2|SCREENING|2021-02-20|65
e|FA|b528dc24-e791-41b1-95b3-fc0be18da47f|8|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|10^12 IU/L|[?]|1|h*%|RIB 12|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2021-02-20|65
e|FA|b528dc24-e791-41b1-95b3-fc0be18da47f|9|DGRAIN|Dietary Grain|[?]|GERD|[?]|ELISA unit|[?]|1|10^9 CFU/g|RADIUS SHAFT|RIGHT|||PROXY|5|Visit_5|90|6|TREATMENT|2021-03-17|90
e|FA|b528dc24-e791-41b1-95b3-fc0be18da47f|10|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|EVENTS|[?]|1|cm H2O|SKIN AROUND THE EYE|UNILATERAL|||VENDOR|5|Visit_5|90|7|TREATMENT|2021-03-17|90
e|FA|7a43c892-0e7f-4f33-9130-e175e475531f|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|oz|[?]|1|mg/g/min|FOOT DIGIT 2|CONTRALATERAL|||VENDOR|1|Visit_1|10|7|TREATMENT|2020-05-17|10
e|FA|7a43c892-0e7f-4f33-9130-e175e475531f|2|PPTFCT|Precipitating Factor|[?]|GERD|[?]|CAN|[?]|1|EIA unit|CORONARY SINUS|IPSILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-05-17|10
e|FA|7a43c892-0e7f-4f33-9130-e175e475531f|3|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|BOTTLE|[?]|1|m2|METACARPAL 1 BASE|UNILATERAL|||SIBLING|2|Visit_2|25|2|TREATMENT|2020-06-01|25
e|FA|7a43c892-0e7f-4f33-9130-e175e475531f|4|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|nmol/mL/min|[?]|1|cm H2O|FLEXOR CARPI ULNARIS MUSCLE|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-06-01|25
e|FA|7a43c892-0e7f-4f33-9130-e175e475531f|5|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|kat|[?]|1|NEEDLE GAUGE|COLON LYMPH NODE|IPSILATERAL|Y||VENDOR|3|Visit_3|40|1|WASHOUT|2020-06-16|40
e|FA|7a43c892-0e7f-4f33-9130-e175e475531f|6|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|ugEq/L|[?]|1|ug/m2/h|BRACHIAL VEIN|LEFT|||GUARDIAN|3|Visit_3|40|4|FOLLOW-UP|2020-06-16|40
e|FA|7a43c892-0e7f-4f33-9130-e175e475531f|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/m2/h|[?]|1|mg/g/min|COSTAL CARTILAGE|IPSILATERAL|||SPOUSE|4|Visit_4|65|7|TREATMENT|2020-07-11|65
e|FA|7a43c892-0e7f-4f33-9130-e175e475531f|8|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|cmol/L|[?]|1|SCOOPFUL|T7 VERTEBRA|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|SCREENING|2020-07-11|65
e|FA|7a43c892-0e7f-4f33-9130-e175e475531f|9|OBJTYPE|Type of Object|[?]|GERD|[?]|APL U/mL|[?]|1|ng|PROSTATE GLAND, LATERAL LOBE|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|1|SCREENING|2020-08-05|90
e|FA|7a43c892-0e7f-4f33-9130-e175e475531f|10|DIAMETER|Diameter|[?]|GERD|[?]|keV|[?]|1|cm|POPLITEAL ARTERY BELOW KNEE|CONTRALATERAL||Y|VENDOR|5|Visit_5|90|5|FOLLOW-UP|2020-08-05|90
e|FA|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|1|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|MBq|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|CONTRALATERAL|Y||FRIEND|1|Visit_1|10|2|SCREENING|2020-12-10|10
e|FA|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|2|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|vp/dose|[?]|1|DRUM|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LATERAL||Y|FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-12-10|10
e|FA|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|3|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|kcal|[?]|1|gtt|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|RIGHT||Y|STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2020-12-25|25
e|FA|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mg/kg/dose|[?]|1|%(v/v)|PERIRECTAL LYMPH NODE|BILATERAL|||INVESTIGATOR|2|Visit_2|25|6|SCREENING|2020-12-25|25
e|FA|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|5|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|SYRINGE|[?]|1|CUP|PLACENTA|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|FOLLOW-UP|2021-01-09|40
e|FA|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|6|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|BOWL|5TH LUMBAR SPINOUS PROCESS|LEFT|||VENDOR|3|Visit_3|40|6|TREATMENT|2021-01-09|40
e|FA|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|7|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|DAYS|[?]|1|m2|INSULAR CORTEX|CONTRALATERAL|||DOMESTIC PARTNER|4|Visit_4|65|4|SCREENING|2021-02-03|65
e|FA|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|8|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|Newton|[?]|1|IU/mmol|LEFT VENTRICULAR APEX SEGMENT|LEFT|||SIGNIFICANT OTHER|4|Visit_4|65|5|FOLLOW-UP|2021-02-03|65
e|FA|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|9|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|GPL U|[?]|1|mg/dose|C3 VERTEBRA|RIGHT|||STUDY SUBJECT|5|Visit_5|90|1|FOLLOW-UP|2021-02-28|90
e|FA|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|10|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mg/m2|[?]|1|PFU/dose|TRICUSPID VALVE ANNULUS|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|7|TREATMENT|2021-02-28|90
e|FA|bde9096e-9ab9-45fe-8e96-1ec9762824a0|1|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|ug/kg/h|EARLOBE|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-08-27|10
e|FA|bde9096e-9ab9-45fe-8e96-1ec9762824a0|2|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa|[?]|1|mL/mmHg/min/L|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|LEFT||Y|SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-08-27|10
e|FA|bde9096e-9ab9-45fe-8e96-1ec9762824a0|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/m2/min|[?]|1|mg/g/min|BILIARY TRACT|IPSILATERAL|||PROXY|2|Visit_2|25|2|FOLLOW-UP|2020-09-11|25
e|FA|bde9096e-9ab9-45fe-8e96-1ec9762824a0|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|g/day|[?]|1|mg/g/min|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|UNILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|SCREENING|2020-09-11|25
e|FA|bde9096e-9ab9-45fe-8e96-1ec9762824a0|5|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|TCID 50/dose|[?]|1|cm H2O|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|IPSILATERAL||Y|CHILD|3|Visit_3|40|7|WASHOUT|2020-09-26|40
e|FA|bde9096e-9ab9-45fe-8e96-1ec9762824a0|6|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|10^3 copies/mL|[?]|1|L/h/m2|MAIN BRONCHUS, LEFT|BILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|WASHOUT|2020-09-26|40
e|FA|bde9096e-9ab9-45fe-8e96-1ec9762824a0|7|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|BAG|[?]|1|mm/h|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|BILATERAL|||GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-10-21|65
e|FA|bde9096e-9ab9-45fe-8e96-1ec9762824a0|8|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|10^5/L|[?]|1|oz eq|RETROPERITONEAL LYMPH NODE|RIGHT||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|5|FOLLOW-UP|2020-10-21|65
e|FA|bde9096e-9ab9-45fe-8e96-1ec9762824a0|9|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|m2|POSTEROLATERAL SEGMENTAL ARTERY|LEFT|Y|Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|SCREENING|2020-11-15|90
e|FA|bde9096e-9ab9-45fe-8e96-1ec9762824a0|10|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|/kg|[?]|1|/200 HPFs|FEMALE GENITALIA|BILATERAL|Y||PROXY|5|Visit_5|90|1|TREATMENT|2020-11-15|90
e|FA|ea7907aa-811e-48ec-9fc6-ab8affde8913|1|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|/h|[?]|1|NEEDLE GAUGE|ADDUCTOR POLLICIS MUSCLE|BILATERAL|||VENDOR|1|Visit_1|10|2|TREATMENT|2020-06-28|10
e|FA|ea7907aa-811e-48ec-9fc6-ab8affde8913|2|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|uV*sec|[?]|1|mL/dose|VAGINA|UNILATERAL|||SIBLING|1|Visit_1|10|7|SCREENING|2020-06-28|10
e|FA|ea7907aa-811e-48ec-9fc6-ab8affde8913|3|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|mU/g|[?]|1|mIU/L|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL|||STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-07-13|25
e|FA|ea7907aa-811e-48ec-9fc6-ab8affde8913|4|LENRSCT|Length of Resection|[?]|GERD|[?]|10^9/g|[?]|1|psi|PROSTATE GLAND, LATERAL LOBE|IPSILATERAL|||VENDOR|2|Visit_2|25|6|TREATMENT|2020-07-13|25
e|FA|ea7907aa-811e-48ec-9fc6-ab8affde8913|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|genEq|[?]|1|mL/animal/day|BRAIN STEM|UNILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|FOLLOW-UP|2020-07-28|40
e|FA|ea7907aa-811e-48ec-9fc6-ab8affde8913|6|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|PACKET|[?]|1|L/h/m2|NECK|LEFT|||STUDY SUBJECT|3|Visit_3|40|3|FOLLOW-UP|2020-07-28|40
e|FA|ea7907aa-811e-48ec-9fc6-ab8affde8913|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/dose|[?]|1|mg/g/min|MEDIASTINUM, ANTERIOR|CONTRALATERAL|Y|Y|CAREGIVER|4|Visit_4|65|3|TREATMENT|2020-08-22|65
e|FA|ea7907aa-811e-48ec-9fc6-ab8affde8913|8|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|RING|[?]|1|BOWL|ENDOMETRIUM|CONTRALATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|1|FOLLOW-UP|2020-08-22|65
e|FA|ea7907aa-811e-48ec-9fc6-ab8affde8913|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|10^6 IU/mL|CEREBRAL HEMISPHERE, LEFT|CONTRALATERAL|||SPOUSE|5|Visit_5|90|7|TREATMENT|2020-09-16|90
e|FA|ea7907aa-811e-48ec-9fc6-ab8affde8913|10|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|mg/h|[?]|1|cm H2O|ABDOMINAL LYMPH NODE|BILATERAL|||ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-09-16|90
e|FA|3aa9935c-943d-406a-bb6e-fc067fa8a487|1|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/mL|[?]|1|Hz/s|HEAD OF THE HUMERUS|LEFT|||PROXY|1|Visit_1|10|3|TREATMENT|2020-08-27|10
e|FA|3aa9935c-943d-406a-bb6e-fc067fa8a487|2|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|CYLINDER|[?]|1|uCi/kg|LUNG|CONTRALATERAL|Y|Y|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-08-27|10
e|FA|3aa9935c-943d-406a-bb6e-fc067fa8a487|3|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|%|[?]|1|fmol|SKIN OF THE KNEE|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|7|WASHOUT|2020-09-11|25
e|FA|3aa9935c-943d-406a-bb6e-fc067fa8a487|4|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/mg/min|[?]|1|g/dL|AORTIC VALVE ANNULUS|LEFT|Y||PARENT|2|Visit_2|25|1|TREATMENT|2020-09-11|25
e|FA|3aa9935c-943d-406a-bb6e-fc067fa8a487|5|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|min/day|[?]|1|/500 WBC|CORNEA|RIGHT|||FRIEND|3|Visit_3|40|6|SCREENING|2020-09-26|40
e|FA|3aa9935c-943d-406a-bb6e-fc067fa8a487|6|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|beats/min|[?]|1|oz eq|ULNAR ARTERY|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|WASHOUT|2020-09-26|40
e|FA|3aa9935c-943d-406a-bb6e-fc067fa8a487|7|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|BISCUIT|[?]|1|mEq|POSTERIOR SUPERIOR ILIAC SPINE|CONTRALATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|5|WASHOUT|2020-10-21|65
e|FA|3aa9935c-943d-406a-bb6e-fc067fa8a487|8|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|ug/L/h|[?]|1|mg/dose|HYPOGLOSSAL NERVE|BILATERAL|||FRIEND|4|Visit_4|65|5|FOLLOW-UP|2020-10-21|65
e|FA|3aa9935c-943d-406a-bb6e-fc067fa8a487|9|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|foz_br|[?]|1|IU/mmol|L5-S1 INTERVERTEBRAL SPACE|RIGHT|Y||STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-11-15|90
e|FA|3aa9935c-943d-406a-bb6e-fc067fa8a487|10|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mL/s|[?]|1|100 IU/mL|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|LEFT|||SPOUSE|5|Visit_5|90|4|TREATMENT|2020-11-15|90
e|FA|0cac2007-ca12-45ba-9b1c-70f753232f05|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mol/L|[?]|1|%(v/v)|FACET JOINT|UNILATERAL||Y|ADJUDICATOR|1|Visit_1|10|3|WASHOUT|2020-12-01|10
e|FA|0cac2007-ca12-45ba-9b1c-70f753232f05|2|OBJNUM|Number of Objects|[?]|GERD|[?]|kPa/L/sec|[?]|1|mL/100g/min|LEPTOMENINGES|LATERAL|||GUARDIAN|1|Visit_1|10|1|TREATMENT|2020-12-01|10
e|FA|0cac2007-ca12-45ba-9b1c-70f753232f05|3|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|Ci/ug|[?]|1|mAmp|VERTEBRAL ARTERY|RIGHT|||PARENT|2|Visit_2|25|1|TREATMENT|2020-12-16|25
e|FA|0cac2007-ca12-45ba-9b1c-70f753232f05|4|TOTNUM|Total Number|[?]|GERD|[?]|MPL U|[?]|1|/200 HPFs|EPIDURAL SPACE|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|3|WASHOUT|2020-12-16|25
e|FA|0cac2007-ca12-45ba-9b1c-70f753232f05|5|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|DAgU|[?]|1|vp/dose|CEPHALIC VEIN|UNILATERAL|Y||CAREGIVER|3|Visit_3|40|7|TREATMENT|2020-12-31|40
e|FA|0cac2007-ca12-45ba-9b1c-70f753232f05|6|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|mL/animal/day|SPHENOID SINUS|BILATERAL|Y||FRIEND|3|Visit_3|40|3|FOLLOW-UP|2020-12-31|40
e|FA|0cac2007-ca12-45ba-9b1c-70f753232f05|7|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|nmol/L/min|[?]|1|fmol|SKIN BETWEEN EYEBROWS|RIGHT|||CAREGIVER|4|Visit_4|65|6|SCREENING|2021-01-25|65
e|FA|0cac2007-ca12-45ba-9b1c-70f753232f05|8|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|100 IU/mL|[?]|1|cm|FEMORAL CONDYLE|UNILATERAL||Y|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2021-01-25|65
e|FA|0cac2007-ca12-45ba-9b1c-70f753232f05|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^9 organisms/g|[?]|1|%(v/v)|HEPATOBILIARY SYSTEM|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2021-02-19|90
e|FA|0cac2007-ca12-45ba-9b1c-70f753232f05|10|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|mL/m2/day|[?]|1|DRUM|FOOT DIGIT 3|IPSILATERAL|||PARENT|5|Visit_5|90|7|TREATMENT|2021-02-19|90
e|FA|2339e91a-b93e-426f-9b60-3d3b6969268d|1|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|U/kg/day|[?]|1|10^6 IU/mL|SPLENIC HILAR LYMPH NODE|BILATERAL|||PARENT|1|Visit_1|10|5|SCREENING|2020-07-07|10
e|FA|2339e91a-b93e-426f-9b60-3d3b6969268d|2|DFATT|Dietary Fat, Total|[?]|GERD|[?]|U/kg/day|[?]|1|Bq/mg|BRAIN VENTRICLE|UNILATERAL|Y|Y|PROXY|1|Visit_1|10|6|SCREENING|2020-07-07|10
e|FA|2339e91a-b93e-426f-9b60-3d3b6969268d|3|DVEG|Dietary Vegetable|[?]|GERD|[?]|kg/m2|[?]|1|Ci/ug|TEMPORAL BONE|IPSILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2020-07-22|25
e|FA|2339e91a-b93e-426f-9b60-3d3b6969268d|4|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|lm|[?]|1|in|ANASTOMOSIS|LATERAL|||FAMILY MEMBER|2|Visit_2|25|3|SCREENING|2020-07-22|25
e|FA|2339e91a-b93e-426f-9b60-3d3b6969268d|5|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/mL|[?]|1|ohm|INTERPHALANGEAL JOINT 5 OF THE HAND|UNILATERAL||Y|CHILD|3|Visit_3|40|6|WASHOUT|2020-08-06|40
e|FA|2339e91a-b93e-426f-9b60-3d3b6969268d|6|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|Tbsp|[?]|1|mL/m2|HYPOGLOSSAL NERVE|IPSILATERAL|Y||STUDY SUBJECT|3|Visit_3|40|1|FOLLOW-UP|2020-08-06|40
e|FA|2339e91a-b93e-426f-9b60-3d3b6969268d|7|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mL/breath|[?]|1|fmol|INTERPHALANGEAL JOINT 2 OF THE FOOT|CONTRALATERAL|||STUDY SUBJECT|4|Visit_4|65|4|FOLLOW-UP|2020-08-31|65
e|FA|2339e91a-b93e-426f-9b60-3d3b6969268d|8|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|mmHg/sec|[?]|1|/500 WBC|ANKLE MORTISE|RIGHT|||DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2020-08-31|65
e|FA|2339e91a-b93e-426f-9b60-3d3b6969268d|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|mAnson U/mL|[?]|1|ug/g/h|FLEXOR DIGITORUM LONGUS MUSCLE|BILATERAL|||PROXY|5|Visit_5|90|5|TREATMENT|2020-09-25|90
e|FA|2339e91a-b93e-426f-9b60-3d3b6969268d|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mOsm|[?]|1|U/mg|PHARYNX|UNILATERAL|||PROXY|5|Visit_5|90|5|WASHOUT|2020-09-25|90
e|FA|0d09e35b-e864-4492-a341-21c71d92b551|1|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|mol/mol|[?]|1|uL/kg/day|RIGHT ATRIAL ENDOCARDIUM|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|SCREENING|2020-10-30|10
e|FA|0d09e35b-e864-4492-a341-21c71d92b551|2|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|ohm|[?]|1|EIA unit|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|BILATERAL|Y|Y|DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-10-30|10
e|FA|0d09e35b-e864-4492-a341-21c71d92b551|3|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|Ci/kg|[?]|1|PFU/dose|COSTOCHONDRAL JOINT 7|RIGHT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2020-11-14|25
e|FA|0d09e35b-e864-4492-a341-21c71d92b551|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|/10^3|[?]|1|Pa|POSTERIOR CINGULATE CORTEX|LEFT|Y||STUDY SUBJECT|2|Visit_2|25|7|SCREENING|2020-11-14|25
e|FA|0d09e35b-e864-4492-a341-21c71d92b551|5|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|Ejaculate U|[?]|1|QUANTITY SUFFICIENT|RADIAL ARTERY|LATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-11-29|40
e|FA|0d09e35b-e864-4492-a341-21c71d92b551|6|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|mOsm/kg|[?]|1|g/cage/day|FEMORAL LYMPH NODE|RIGHT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|SCREENING|2020-11-29|40
e|FA|0d09e35b-e864-4492-a341-21c71d92b551|7|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|ELISA unit|[?]|1|h*%|INSULAR CORTEX|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|6|TREATMENT|2020-12-24|65
e|FA|0d09e35b-e864-4492-a341-21c71d92b551|8|SEV|Severity/Intensity|[?]|GERD|[?]|10^8/L|[?]|1|Pa|RENAL PELVIS|CONTRALATERAL|Y||CAREGIVER|4|Visit_4|65|4|WASHOUT|2020-12-24|65
e|FA|0d09e35b-e864-4492-a341-21c71d92b551|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/uL|[?]|1|Pa|BRAIN, THIRD VENTRICLE|BILATERAL|Y||FAMILY MEMBER|5|Visit_5|90|5|TREATMENT|2021-01-18|90
e|FA|0d09e35b-e864-4492-a341-21c71d92b551|10|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|days/wk|[?]|1|DRUM|ORAL MUCOSA|CONTRALATERAL|||GUARDIAN|5|Visit_5|90|3|TREATMENT|2021-01-18|90
e|FA|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|1|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|pt_us|[?]|1|umol|KIDNEY, MEDULLA|BILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|FOLLOW-UP|2020-06-05|10
e|FA|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|2|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|uV|[?]|1|ng|OBTURATOR EXTERNUS MUSCLE|IPSILATERAL|Y|Y|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-06-05|10
e|FA|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|3|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|mEq|[?]|1|in|MID-RIGHT CORONARY ARTERY CONDUIT|RIGHT|||PARENT|2|Visit_2|25|2|TREATMENT|2020-06-20|25
e|FA|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|PIXELS/cm|[?]|1|mg/g/min|BILIARY TRACT|UNILATERAL|Y|Y|FAMILY MEMBER|2|Visit_2|25|7|FOLLOW-UP|2020-06-20|25
e|FA|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|5|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|mAnson U/mL|[?]|1|10^6/L|NASAL BONE|BILATERAL|||FAMILY MEMBER|3|Visit_3|40|4|FOLLOW-UP|2020-07-05|40
e|FA|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|6|DMEAT|Dietary Meat|[?]|GERD|[?]|mIU/L|[?]|1|10^6 organisms/mL|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-07-05|40
e|FA|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|7|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|days/month|[?]|1|uL/kg/day|SKIN OF THE FACE|UNILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|3|TREATMENT|2020-07-30|65
e|FA|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|8|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|pm|[?]|1|mL/h|PERIRECTAL LYMPH NODE|RIGHT|||SIBLING|4|Visit_4|65|5|WASHOUT|2020-07-30|65
e|FA|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|9|LDIAM|Longest Diameter|[?]|GERD|[?]|GBq|[?]|1|Shock Wave|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|LEFT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-08-24|90
e|FA|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|10|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|IU/mmol|[?]|1|fmol|AORTIC VALVE, RIGHT CORONARY CUSP|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|WASHOUT|2020-08-24|90
e|FA|0a5b1036-cd00-4221-b218-ee2664e5a43e|1|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|10^9 CFU/g|COSTOCHONDRAL JOINT 7|LEFT|Y||CAREGIVER|1|Visit_1|10|1|FOLLOW-UP|2021-01-02|10
e|FA|0a5b1036-cd00-4221-b218-ee2664e5a43e|2|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|10^3/L|[?]|1|L|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|CONTRALATERAL|||INTERVIEWER|1|Visit_1|10|5|TREATMENT|2021-01-02|10
e|FA|0a5b1036-cd00-4221-b218-ee2664e5a43e|3|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|C|[?]|1|EIA unit|MID-CIRCUMFLEX ARTERY|LEFT|||INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2021-01-17|25
e|FA|0a5b1036-cd00-4221-b218-ee2664e5a43e|4|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|cal|[?]|1|mEq/g|COLON WALL|RIGHT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2021-01-17|25
e|FA|0a5b1036-cd00-4221-b218-ee2664e5a43e|5|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|BLOCKS|[?]|1|g/L|HEART, RIGHT VENTRICLE|RIGHT|||GUARDIAN|3|Visit_3|40|1|TREATMENT|2021-02-01|40
e|FA|0a5b1036-cd00-4221-b218-ee2664e5a43e|6|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|uCi/kg|[?]|1|10^6 IU/mL|FLEXOR DIGITORUM PROFUNDUS MUSCLE|LEFT|||FAMILY MEMBER|3|Visit_3|40|4|SCREENING|2021-02-01|40
e|FA|0a5b1036-cd00-4221-b218-ee2664e5a43e|7|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/mL|[?]|1|Hz/s|BLADDER|LATERAL||Y|FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2021-02-26|65
e|FA|0a5b1036-cd00-4221-b218-ee2664e5a43e|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|APS U|[?]|1|PFU/dose|DISTAL INTERPHALANGEAL JOINT 5|LATERAL|Y||SPOUSE|4|Visit_4|65|5|WASHOUT|2021-02-26|65
e|FA|0a5b1036-cd00-4221-b218-ee2664e5a43e|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|BISCUIT|[?]|1|Pa|PLEURA|RIGHT|Y||PARENT|5|Visit_5|90|6|SCREENING|2021-03-23|90
e|FA|0a5b1036-cd00-4221-b218-ee2664e5a43e|10|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU/mL|[?]|1|anti-Xa IU/mL|SKIN AROUND THE MOUTH|UNILATERAL|Y||SPOUSE|5|Visit_5|90|6|WASHOUT|2021-03-23|90
e|FA|a4f74465-7abc-4cc2-a0be-25d1c802af8c|1|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|PLUG|[?]|1|HOURS|TRANSVERSE TARSAL JOINT|CONTRALATERAL||Y|INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-09-30|10
e|FA|a4f74465-7abc-4cc2-a0be-25d1c802af8c|2|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|ug/min|[?]|1|g/cage/day|ENTORHINAL CORTEX|LEFT|||SIBLING|1|Visit_1|10|6|TREATMENT|2020-09-30|10
e|FA|a4f74465-7abc-4cc2-a0be-25d1c802af8c|3|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|Ci/L|[?]|1|gtt|MID-JUGULAR LYMPH NODE|LATERAL|Y||VENDOR|2|Visit_2|25|2|FOLLOW-UP|2020-10-15|25
e|FA|a4f74465-7abc-4cc2-a0be-25d1c802af8c|4|SERVNUM|Number of Servings|[?]|GERD|[?]|10^9 organisms/g|[?]|1|Hz/s|POSTERIOR SUPERIOR ILIAC SPINE|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2020-10-15|25
e|FA|a4f74465-7abc-4cc2-a0be-25d1c802af8c|5|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|m|[?]|1|ug/m2/h|ACROMION|BILATERAL|||INVESTIGATOR|3|Visit_3|40|5|TREATMENT|2020-10-30|40
e|FA|a4f74465-7abc-4cc2-a0be-25d1c802af8c|6|RLDEV|Relationship to Device|[?]|GERD|[?]|mmol/s|[?]|1|mL/min/mmHg|RESPIRATORY SYSTEM|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|6|SCREENING|2020-10-30|40
e|FA|a4f74465-7abc-4cc2-a0be-25d1c802af8c|7|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|mL/cm3/min|[?]|1|DROP|EPICARDIUM|UNILATERAL|Y|Y|PROXY|4|Visit_4|65|2|FOLLOW-UP|2020-11-24|65
e|FA|a4f74465-7abc-4cc2-a0be-25d1c802af8c|8|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|mL/s/m2|[?]|1|oz eq|LIVER, CAUDATE LOBE|RIGHT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|7|SCREENING|2020-11-24|65
e|FA|a4f74465-7abc-4cc2-a0be-25d1c802af8c|9|SPEED|Speed|[?]|GERD|[?]|GPL U/mL|[?]|1|mEq/g|INTERPHALANGEAL JOINT 2|LEFT|Y|Y|INTERVIEWER|5|Visit_5|90|2|SCREENING|2020-12-19|90
e|FA|a4f74465-7abc-4cc2-a0be-25d1c802af8c|10|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|copies/mL|[?]|1|MPS U|METACARPAL BONE 4|LEFT|Y|Y|INTERVIEWER|5|Visit_5|90|5|WASHOUT|2020-12-19|90
e|FA|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|1|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|V|[?]|1|uCi/kg|METATARSAL BONE|LATERAL||Y|SIBLING|1|Visit_1|10|1|TREATMENT|2020-11-12|10
e|FA|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|2|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|DNA copies/ug|[?]|1|g/day|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|BILATERAL|||INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-11-12|10
e|FA|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|3|LOCONSET|Localization of Onset|[?]|GERD|[?]|PACKET|[?]|1|g/L|LUNG LOBE|UNILATERAL|||INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-11-27|25
e|FA|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|4|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|nkat|[?]|1|cm H2O|DISTAL INTERPHALANGEAL JOINT 5|BILATERAL||Y|SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2020-11-27|25
e|FA|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|steps/min|[?]|1|mg/g/min|KIDNEY, CORTEX|LATERAL||Y|FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-12-12|40
e|FA|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|6|DVEG|Dietary Vegetable|[?]|GERD|[?]|L/min/m2|[?]|1|Ci/ug|TRAPEZIUM-TRAPEZOID JOINT|IPSILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|2|WASHOUT|2020-12-12|40
e|FA|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|7|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|BP|ESOPHAGEAL LYMPH NODE|RIGHT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|SCREENING|2021-01-06|65
e|FA|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|8|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|anti-Xa IU|[?]|1|mL/animal/day|HAIR SHAFT|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2021-01-06|65
e|FA|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|9|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|Bq/ug|[?]|1|Shock Wave|RIGHT POSTERIOR DESCENDING ARTERY|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|SCREENING|2021-01-31|90
e|FA|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|10|EXCDUR|Exercise Duration|[?]|GERD|[?]|MET*h|[?]|1|mm|ISCHIUM|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|3|WASHOUT|2021-01-31|90
e|FA|e7262592-01e8-4cb3-b967-ec1037505e81|1|PPTFCT|Precipitating Factor|[?]|GERD|[?]|eq|[?]|1|EIA unit|HEART, ATRIUM|LATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|1|SCREENING|2020-09-12|10
e|FA|e7262592-01e8-4cb3-b967-ec1037505e81|2|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|deg2|[?]|1|in|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|BILATERAL|||GUARDIAN|1|Visit_1|10|6|SCREENING|2020-09-12|10
e|FA|e7262592-01e8-4cb3-b967-ec1037505e81|3|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|mmAL|[?]|1|10^9 CFU/mL|COLON LYMPH NODE|LEFT|||GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-09-27|25
e|FA|e7262592-01e8-4cb3-b967-ec1037505e81|4|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|ng|[?]|1|g/cage/day|INTERATRIAL SEPTUM|CONTRALATERAL|||INTERVIEWER|2|Visit_2|25|2|FOLLOW-UP|2020-09-27|25
e|FA|e7262592-01e8-4cb3-b967-ec1037505e81|5|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/g Hb|[?]|1|BOWL|NASAL SEPTUM|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|WASHOUT|2020-10-12|40
e|FA|e7262592-01e8-4cb3-b967-ec1037505e81|6|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|mg/h|SKIN OF THE KNEE|BILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|FOLLOW-UP|2020-10-12|40
e|FA|e7262592-01e8-4cb3-b967-ec1037505e81|7|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|pmol/L|[?]|1|ohm|METACARPAL BONE|BILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-11-06|65
e|FA|e7262592-01e8-4cb3-b967-ec1037505e81|8|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|EID 50/dose|[?]|1|TRANSDUCING UNIT/mL|URETHRA, PROSTATIC|LEFT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-11-06|65
e|FA|e7262592-01e8-4cb3-b967-ec1037505e81|9|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|fmol|PARATHYROID GLAND|LEFT|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-12-01|90
e|FA|e7262592-01e8-4cb3-b967-ec1037505e81|10|LOCONSET|Localization of Onset|[?]|GERD|[?]|pg/cell|[?]|1|g/L|UPPER RESPIRATORY SYSTEM|CONTRALATERAL||Y|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2020-12-01|90
e|FA|bf150829-1b25-418a-9bc6-61716984387c|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|kIU|[?]|1|10^6 U|KNEE JOINT TENDONS|UNILATERAL||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|FOLLOW-UP|2020-06-15|10
e|FA|bf150829-1b25-418a-9bc6-61716984387c|2|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|g/cage/day|[?]|1|10^9 CFU/g|XIPHOID PROCESS|LEFT||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|2|FOLLOW-UP|2020-06-15|10
e|FA|bf150829-1b25-418a-9bc6-61716984387c|3|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|pkat/L|[?]|1|NEEDLE GAUGE|SPLENIC VEIN|BILATERAL|||STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2020-06-30|25
e|FA|bf150829-1b25-418a-9bc6-61716984387c|4|EVENTFRQ|Event Frequency|[?]|GERD|[?]|/2500 WBC|[?]|1|ug/kg/h|MEDIAN OR LOWER CERVICAL LYMPH NODE|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-06-30|25
e|FA|bf150829-1b25-418a-9bc6-61716984387c|5|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|U/g/h|[?]|1|mL/dose|SUBARACHNOID SPACE|UNILATERAL|||PROXY|3|Visit_3|40|4|TREATMENT|2020-07-15|40
e|FA|bf150829-1b25-418a-9bc6-61716984387c|6|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|mg/kg/min|[?]|1|MBq|ULNA SHAFT|LATERAL||Y|GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-07-15|40
e|FA|bf150829-1b25-418a-9bc6-61716984387c|7|STROKTYP|Stroke Type|[?]|GERD|[?]|%/s|[?]|1|g/L|C3 VERTEBRA|LATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2020-08-09|65
e|FA|bf150829-1b25-418a-9bc6-61716984387c|8|TOTNUM|Total Number|[?]|GERD|[?]|LENS|[?]|1|/200 HPFs|CLAVICLE|RIGHT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2020-08-09|65
e|FA|bf150829-1b25-418a-9bc6-61716984387c|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|uV*sec|[?]|1|mg/g/min|GLOTTIS|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2020-09-03|90
e|FA|bf150829-1b25-418a-9bc6-61716984387c|10|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/m2/min|[?]|1|AU/mL|URETHRA, POSTERIOR|IPSILATERAL|Y|Y|FAMILY MEMBER|5|Visit_5|90|2|FOLLOW-UP|2020-09-03|90
e|FA|5c1cc260-97a0-493c-bc11-57f31ffd7455|1|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|SBE/mL|[?]|1|10^9 CFU/g|PRESACRAL LYMPH NODE|RIGHT|||PROXY|1|Visit_1|10|1|FOLLOW-UP|2020-09-06|10
e|FA|5c1cc260-97a0-493c-bc11-57f31ffd7455|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|Hounsfield Unit|[?]|1|mEq/g|PUTAMEN|RIGHT|||INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-09-06|10
e|FA|5c1cc260-97a0-493c-bc11-57f31ffd7455|3|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|uCi/kg|[?]|1|mEq/g|ABDOMINAL WALL|CONTRALATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|SCREENING|2020-09-21|25
e|FA|5c1cc260-97a0-493c-bc11-57f31ffd7455|4|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|U/L|[?]|1|uL/kg/day|PORTAL LYMPH NODE|CONTRALATERAL|Y||INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-09-21|25
e|FA|5c1cc260-97a0-493c-bc11-57f31ffd7455|5|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|RING|[?]|1|SCOOPFUL|UPPER RESPIRATORY SYSTEM|LATERAL|||SPOUSE|3|Visit_3|40|1|SCREENING|2020-10-06|40
e|FA|5c1cc260-97a0-493c-bc11-57f31ffd7455|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|% INHIBITION|[?]|1|QUANTITY SUFFICIENT|SCAPHOID BONE|CONTRALATERAL|||FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2020-10-06|40
e|FA|5c1cc260-97a0-493c-bc11-57f31ffd7455|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/animal|[?]|1|mg/g/min|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-10-31|65
e|FA|5c1cc260-97a0-493c-bc11-57f31ffd7455|8|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|PIXEL|[?]|1|100 IU/mL|L6 VERTEBRA|BILATERAL|||PROXY|4|Visit_4|65|3|WASHOUT|2020-10-31|65
e|FA|5c1cc260-97a0-493c-bc11-57f31ffd7455|9|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|uL/kg/day|THORACIC SPINE|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|FOLLOW-UP|2020-11-25|90
e|FA|5c1cc260-97a0-493c-bc11-57f31ffd7455|10|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|ECL unit|[?]|1|h*%|THIRD OBTUSE MARGINAL BRANCH ARTERY|LATERAL||Y|STUDY SUBJECT|5|Visit_5|90|4|SCREENING|2020-11-25|90
e|FA|cca2835b-ca8d-4db6-89b4-9f2855968a8a|1|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|ug/animal|[?]|1|ng/day|LARGE INTESTINE|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-07-19|10
e|FA|cca2835b-ca8d-4db6-89b4-9f2855968a8a|2|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|BE/mL|[?]|1|BOWL|GLOSSOPHARYNGEAL NERVE|IPSILATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|2|FOLLOW-UP|2020-07-19|10
e|FA|cca2835b-ca8d-4db6-89b4-9f2855968a8a|3|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|ug/kg/h|CARPOMETACARPAL JOINT 1|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-08-03|25
e|FA|cca2835b-ca8d-4db6-89b4-9f2855968a8a|4|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|pg/L|[?]|1|g/day|MALE REPRODUCTIVE SYSTEM|RIGHT|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-08-03|25
e|FA|cca2835b-ca8d-4db6-89b4-9f2855968a8a|5|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|GPS U|[?]|1|g/day|NAIL BED|IPSILATERAL||Y|SPOUSE|3|Visit_3|40|3|TREATMENT|2020-08-18|40
e|FA|cca2835b-ca8d-4db6-89b4-9f2855968a8a|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|APS U|[?]|1|mg/g/min|SIGMOID SINUS|UNILATERAL|||ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-08-18|40
e|FA|cca2835b-ca8d-4db6-89b4-9f2855968a8a|7|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|POINT|[?]|1|IU/mg|THIRD RIGHT POSTEROLATERAL ARTERY|LEFT|||SIGNIFICANT OTHER|4|Visit_4|65|3|WASHOUT|2020-09-12|65
e|FA|cca2835b-ca8d-4db6-89b4-9f2855968a8a|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|U/mmol|RIB 1|BILATERAL|||GUARDIAN|4|Visit_4|65|5|TREATMENT|2020-09-12|65
e|FA|cca2835b-ca8d-4db6-89b4-9f2855968a8a|9|DISTANCE|Distance|[?]|GERD|[?]|dL|[?]|1|BOWL|ANTERIOR HORN OF THE LATERAL VENTRICLE|LATERAL||Y|STUDY SUBJECT|5|Visit_5|90|4|TREATMENT|2020-10-07|90
e|FA|cca2835b-ca8d-4db6-89b4-9f2855968a8a|10|RLDEV|Relationship to Device|[?]|GERD|[?]|IU|[?]|1|mL/min/mmHg|METACARPAL BONE|LATERAL|||INVESTIGATOR|5|Visit_5|90|4|WASHOUT|2020-10-07|90
e|FA|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|1|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|PATCH|[?]|1|g/day|HAND DIGIT 3|CONTRALATERAL|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-10-07|10
e|FA|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|2|DMG|Dietary Magnesium|[?]|GERD|[?]|10^6 RNA copies/mL|[?]|1|TRANSDUCING UNIT/mL|SECOND DIAGONAL BRANCH ARTERY|LEFT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-10-07|10
e|FA|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|copies/uL|[?]|1|mg/g/min|POSTERIOR TIBIAL ARTERY|RIGHT||Y|FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-10-22|25
e|FA|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|4|DMEAT|Dietary Meat|[?]|GERD|[?]|Coulomb|[?]|1|10^6 organisms/mL|LEFT CIRCUMFLEX ARTERY OSTIUM|LEFT|Y||VENDOR|2|Visit_2|25|5|SCREENING|2020-10-22|25
e|FA|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|5|SEV|Severity/Intensity|[?]|GERD|[?]|ag|[?]|1|Pa|QUADRICEPS MUSCLE|RIGHT|Y|Y|FRIEND|3|Visit_3|40|6|TREATMENT|2020-11-06|40
e|FA|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|6|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|nmol BCE/nmol|[?]|1|L|ARM SKIN|IPSILATERAL|Y||PROXY|3|Visit_3|40|2|WASHOUT|2020-11-06|40
e|FA|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|7|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT|[?]|1|MPS U|POSTERIOR TIBIAL VEIN|LEFT|||PROXY|4|Visit_4|65|6|WASHOUT|2020-12-01|65
e|FA|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|8|SEV|Severity/Intensity|[?]|GERD|[?]|PFU/dose|[?]|1|Pa|PROXIMAL PHALANX 2 OF THE HAND|LEFT|||SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2020-12-01|65
e|FA|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|9|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|P|[?]|1|mm/h|TIBIOTARSAL JOINT|IPSILATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|7|FOLLOW-UP|2020-12-26|90
e|FA|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|IMPLANT|[?]|1|Pa|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|IPSILATERAL|||INTERVIEWER|5|Visit_5|90|3|FOLLOW-UP|2020-12-26|90
e|FA|74cd0a4f-f9fe-4df9-93b8-7832512d0828|1|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|Antibody Unit|[?]|1|U/mg|MITRAL VALVE, ANTERIOR CUSP|LEFT|||CHILD|1|Visit_1|10|5|SCREENING|2020-05-15|10
e|FA|74cd0a4f-f9fe-4df9-93b8-7832512d0828|2|LDIAM|Longest Diameter|[?]|GERD|[?]|mL/kg|[?]|1|Shock Wave|FLANK|UNILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|3|TREATMENT|2020-05-15|10
e|FA|74cd0a4f-f9fe-4df9-93b8-7832512d0828|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|umol/dL|[?]|1|Shock Wave|BLADDER, TRIGONE|BILATERAL|||CHILD|2|Visit_2|25|3|TREATMENT|2020-05-30|25
e|FA|74cd0a4f-f9fe-4df9-93b8-7832512d0828|4|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|RNA copies/mL|[?]|1|SCOOPFUL|DISTAL INTERPHALANGEAL JOINT 3|CONTRALATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|6|SCREENING|2020-05-30|25
e|FA|74cd0a4f-f9fe-4df9-93b8-7832512d0828|5|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|mL/dose|[?]|1|MBq|PUPIL|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|FOLLOW-UP|2020-06-14|40
e|FA|74cd0a4f-f9fe-4df9-93b8-7832512d0828|6|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|foz_br|[?]|1|Log10 ELISA unit|STERNOCLAVICULAR JOINT|RIGHT|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-06-14|40
e|FA|74cd0a4f-f9fe-4df9-93b8-7832512d0828|7|DFRUIT|Dietary Fruit|[?]|GERD|[?]|MET*h|[?]|1|10^6 CFU/mL|T2 VERTEBRA|LEFT|||FRIEND|4|Visit_4|65|7|TREATMENT|2020-07-09|65
e|FA|74cd0a4f-f9fe-4df9-93b8-7832512d0828|8|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|/cmH2O|[?]|1|Shock Wave|INTERPHALANGEAL JOINT 1 OF THE FOOT|IPSILATERAL|Y||PROXY|4|Visit_4|65|5|TREATMENT|2020-07-09|65
e|FA|74cd0a4f-f9fe-4df9-93b8-7832512d0828|9|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|pm|[?]|1|anti-Xa IU/mL|PONS VAROLII|RIGHT|||FRIEND|5|Visit_5|90|1|TREATMENT|2020-08-03|90
e|FA|74cd0a4f-f9fe-4df9-93b8-7832512d0828|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|mg/g/min|SKIN OF THE HAND|BILATERAL|||SIBLING|5|Visit_5|90|3|SCREENING|2020-08-03|90
e|FA|09238251-feaf-45a9-b295-dfed9a75fbb2|1|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|ng|NASAL CAVITY|LEFT|||SIGNIFICANT OTHER|1|Visit_1|10|2|WASHOUT|2020-06-26|10
e|FA|09238251-feaf-45a9-b295-dfed9a75fbb2|2|TOXGR|Toxicity Grade|[?]|GERD|[?]|U/m2/day|[?]|1|aMFI|CALCANEAL TUBEROSITY|RIGHT|||STUDY SUBJECT|1|Visit_1|10|6|TREATMENT|2020-06-26|10
e|FA|09238251-feaf-45a9-b295-dfed9a75fbb2|3|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|mL/s|[?]|1|BP|METATARSOPHALANGEAL JOINT 5|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-07-11|25
e|FA|09238251-feaf-45a9-b295-dfed9a75fbb2|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|kat|[?]|1|U/mmol|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|BILATERAL||Y|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-07-11|25
e|FA|09238251-feaf-45a9-b295-dfed9a75fbb2|5|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|dpm/100mg|[?]|1|10^6 U|MEDIASTINUM, POSTERIOR|IPSILATERAL|||INTERVIEWER|3|Visit_3|40|5|TREATMENT|2020-07-26|40
e|FA|09238251-feaf-45a9-b295-dfed9a75fbb2|6|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|umol/L|[?]|1|aMFI|ANTERIOR TIBIAL VEIN|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-07-26|40
e|FA|09238251-feaf-45a9-b295-dfed9a75fbb2|7|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|mg/kg|[?]|1|BOWL|RETINAL ARTERY|RIGHT|||ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2020-08-20|65
e|FA|09238251-feaf-45a9-b295-dfed9a75fbb2|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|GBq/ug|[?]|1|mg/g/min|PROSTATE GLAND, POSTERIOR LOBE|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|FOLLOW-UP|2020-08-20|65
e|FA|09238251-feaf-45a9-b295-dfed9a75fbb2|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Ci/L|[?]|1|mg/g/min|SUPRAPUBIC REGION|RIGHT|||STUDY SUBJECT|5|Visit_5|90|4|SCREENING|2020-09-14|90
e|FA|09238251-feaf-45a9-b295-dfed9a75fbb2|10|SEV|Severity/Intensity|[?]|GERD|[?]|/wk|[?]|1|Pa|PANCREAS|LATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|SCREENING|2020-09-14|90
e|FA|3e896568-85dc-4a14-ba41-eb3575940a9d|1|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|fmol|[?]|1|ohm|IRIS|BILATERAL|||CAREGIVER|1|Visit_1|10|1|TREATMENT|2021-01-26|10
e|FA|3e896568-85dc-4a14-ba41-eb3575940a9d|2|PPTFCT|Precipitating Factor|[?]|GERD|[?]|days/wk|[?]|1|EIA unit|ADDUCTOR MAGNUS MUSCLE|IPSILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2021-01-26|10
e|FA|3e896568-85dc-4a14-ba41-eb3575940a9d|3|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|g/L|ANTECUBITAL FOSSA|LEFT||Y|SPOUSE|2|Visit_2|25|2|WASHOUT|2021-02-10|25
e|FA|3e896568-85dc-4a14-ba41-eb3575940a9d|4|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|BOX|[?]|1|ohm|GASTRIC CARDIA|BILATERAL||Y|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2021-02-10|25
e|FA|3e896568-85dc-4a14-ba41-eb3575940a9d|5|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|m3|[?]|1|10^6 CFU|HYPOTHALAMUS|CONTRALATERAL|Y||GUARDIAN|3|Visit_3|40|2|TREATMENT|2021-02-25|40
e|FA|3e896568-85dc-4a14-ba41-eb3575940a9d|6|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|ppth|[?]|1|AU/mL|URETHRA|LATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|6|FOLLOW-UP|2021-02-25|40
e|FA|3e896568-85dc-4a14-ba41-eb3575940a9d|7|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|L/h/m2|[?]|1|mL/h|AORTIC VALVE|LATERAL|Y||DOMESTIC PARTNER|4|Visit_4|65|1|FOLLOW-UP|2021-03-22|65
e|FA|3e896568-85dc-4a14-ba41-eb3575940a9d|8|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|mol/mL|[?]|1|mL/cm3/min|RENAL FOSSA|BILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-03-22|65
e|FA|3e896568-85dc-4a14-ba41-eb3575940a9d|9|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|umol/mg/min|[?]|1|mg/h|VENOUS SINUS|IPSILATERAL|Y||CHILD|5|Visit_5|90|6|WASHOUT|2021-04-16|90
e|FA|3e896568-85dc-4a14-ba41-eb3575940a9d|10|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|IU/mL|[?]|1|L|LEPTOMENINGES|RIGHT|||SIBLING|5|Visit_5|90|4|TREATMENT|2021-04-16|90
e|FA|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|1|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|nmol/L/h|[?]|1|QUANTITY SUFFICIENT|BRAIN VENTRICLE, LATERAL|UNILATERAL|Y||CHILD|1|Visit_1|10|4|TREATMENT|2020-10-22|10
e|FA|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|2|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|MAC50|[?]|1|Coulomb|FINGER FLEXOR MUSCLES|IPSILATERAL|||CAREGIVER|1|Visit_1|10|5|FOLLOW-UP|2020-10-22|10
e|FA|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|3|DISTANCE|Distance|[?]|GERD|[?]|mg/mol|[?]|1|BOWL|THYROID GLAND ISTHMUS|LEFT|||FAMILY MEMBER|2|Visit_2|25|1|SCREENING|2020-11-06|25
e|FA|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|fL|[?]|1|Pa|PUTAMEN|LEFT|||FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-11-06|25
e|FA|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|5|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|Coulomb|[?]|1|fmol|OPTIC DISC|RIGHT||Y|INTERVIEWER|3|Visit_3|40|2|TREATMENT|2020-11-21|40
e|FA|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|6|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|10^9/L|[?]|1|Ci/ug|SKIN OF THE HEAD|RIGHT|Y||SIBLING|3|Visit_3|40|7|TREATMENT|2020-11-21|40
e|FA|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|MBq/uL|[?]|1|%(v/v)|PUTAMEN|LATERAL|||PROXY|4|Visit_4|65|6|TREATMENT|2020-12-16|65
e|FA|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|8|LOCONSET|Localization of Onset|[?]|GERD|[?]|ppth|[?]|1|g/L|POSTERIOR INFERIOR CEREBELLAR ARTERY|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-12-16|65
e|FA|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|9|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|U/g|[?]|1|IU/mg|PARAMETRIUM|LEFT||Y|PROXY|5|Visit_5|90|1|FOLLOW-UP|2021-01-10|90
e|FA|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|10|LOCONSET|Localization of Onset|[?]|GERD|[?]|P|[?]|1|g/L|CLAVICLE|CONTRALATERAL||Y|INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2021-01-10|90
e|FA|725c5a91-72b0-4b2c-a51a-d1006303373e|1|LDIAM|Longest Diameter|[?]|GERD|[?]|CARTRIDGE|[?]|1|Shock Wave|RIB 1|LEFT|||SPOUSE|1|Visit_1|10|1|WASHOUT|2020-11-23|10
e|FA|725c5a91-72b0-4b2c-a51a-d1006303373e|2|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|mEq/uL|[?]|1|CUP|SCAPHOID BONE|UNILATERAL|||CHILD|1|Visit_1|10|4|WASHOUT|2020-11-23|10
e|FA|725c5a91-72b0-4b2c-a51a-d1006303373e|3|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|/kg|[?]|1|DROP|ANAL VERGE|UNILATERAL|||GUARDIAN|2|Visit_2|25|1|FOLLOW-UP|2020-12-08|25
e|FA|725c5a91-72b0-4b2c-a51a-d1006303373e|4|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|fmol|INFERIOR VENA CAVA|UNILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2020-12-08|25
e|FA|725c5a91-72b0-4b2c-a51a-d1006303373e|5|AGETRT1|Age At First Treatment|[?]|GERD|[?]|min*mg/mL|[?]|1|mL/mmHg/min/L|LIVER, CAUDATE LOBE|IPSILATERAL||Y|STUDY SUBJECT|3|Visit_3|40|6|WASHOUT|2020-12-23|40
e|FA|725c5a91-72b0-4b2c-a51a-d1006303373e|6|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|Pa|[?]|1|BAG|CLAW|BILATERAL|||INTERVIEWER|3|Visit_3|40|5|TREATMENT|2020-12-23|40
e|FA|725c5a91-72b0-4b2c-a51a-d1006303373e|7|LDIAM|Longest Diameter|[?]|GERD|[?]|Bq/mg|[?]|1|Shock Wave|VERTEBRAL COLUMN|IPSILATERAL||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|3|WASHOUT|2021-01-17|65
e|FA|725c5a91-72b0-4b2c-a51a-d1006303373e|8|TOXGR|Toxicity Grade|[?]|GERD|[?]|IU/mg|[?]|1|aMFI|FACET JOINT|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|WASHOUT|2021-01-17|65
e|FA|725c5a91-72b0-4b2c-a51a-d1006303373e|9|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|mL/dose|[?]|1|QUANTITY SUFFICIENT|MITRAL VALVE, ANTERIOR ANNULUS|BILATERAL|Y||CAREGIVER|5|Visit_5|90|5|FOLLOW-UP|2021-02-11|90
e|FA|725c5a91-72b0-4b2c-a51a-d1006303373e|10|TOTNUM|Total Number|[?]|GERD|[?]|Henry|[?]|1|/200 HPFs|INTERPHALANGEAL JOINT 3|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|WASHOUT|2021-02-11|90
e|FA|5bf5b31d-a59d-46b7-8f8f-97919d449565|1|DMEAT|Dietary Meat|[?]|GERD|[?]|10^6 organisms|[?]|1|10^6 organisms/mL|TOE|LEFT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|WASHOUT|2021-01-01|10
e|FA|5bf5b31d-a59d-46b7-8f8f-97919d449565|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|hPa|[?]|1|Pa|RETINAL PIGMENTED EPITHELIAL LAYER|LATERAL|||STUDY SUBJECT|1|Visit_1|10|5|SCREENING|2021-01-01|10
e|FA|5bf5b31d-a59d-46b7-8f8f-97919d449565|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|DAYS|[?]|1|mg/g/min|METACARPOPHALANGEAL JOINT 4|LEFT||Y|INTERVIEWER|2|Visit_2|25|6|WASHOUT|2021-01-16|25
e|FA|5bf5b31d-a59d-46b7-8f8f-97919d449565|4|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|mg/h|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|UNILATERAL|||GUARDIAN|2|Visit_2|25|4|WASHOUT|2021-01-16|25
e|FA|5bf5b31d-a59d-46b7-8f8f-97919d449565|5|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|nmol/kg/day|[?]|1|/500 WBC|NOSTRIL|BILATERAL|||CAREGIVER|3|Visit_3|40|6|WASHOUT|2021-01-31|40
e|FA|5bf5b31d-a59d-46b7-8f8f-97919d449565|6|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|10^3 organisms|[?]|1|/500 WBC|CEREBRAL SUBCORTEX|UNILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|FOLLOW-UP|2021-01-31|40
e|FA|5bf5b31d-a59d-46b7-8f8f-97919d449565|7|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|vg/kg|[?]|1|mEq/g|LEFT POSTERIOR DESCENDING ARTERY|RIGHT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|SCREENING|2021-02-25|65
e|FA|5bf5b31d-a59d-46b7-8f8f-97919d449565|8|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|10^6/L|[?]|1|10^6 CFU|LUNG, RIGHT|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2021-02-25|65
e|FA|5bf5b31d-a59d-46b7-8f8f-97919d449565|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|/min|[?]|1|mL/dose|LIVER LOBE|UNILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2021-03-22|90
e|FA|5bf5b31d-a59d-46b7-8f8f-97919d449565|10|AGETRT1|Age At First Treatment|[?]|GERD|[?]|g/animal/day|[?]|1|mL/mmHg/min/L|BLADDER WALL|RIGHT||Y|INTERVIEWER|5|Visit_5|90|4|TREATMENT|2021-03-22|90
e|FA|7fc35880-1672-4e64-ba3b-aa3f1e42764b|1|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|/kg|T8 VERTEBRA|LEFT|||INVESTIGATOR|1|Visit_1|10|3|WASHOUT|2020-05-26|10
e|FA|7fc35880-1672-4e64-ba3b-aa3f1e42764b|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|COAT|[?]|1|Pa|FOOT DIGIT 1|RIGHT|Y|Y|CHILD|1|Visit_1|10|6|WASHOUT|2020-05-26|10
e|FA|7fc35880-1672-4e64-ba3b-aa3f1e42764b|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|V/sec|[?]|1|mg/g/min|FLEXOR DIGITORUM BREVIS MUSCLE|LEFT|Y||INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2020-06-10|25
e|FA|7fc35880-1672-4e64-ba3b-aa3f1e42764b|4|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|umol/h/mmol|[?]|1|mL/mmHg/min/L|CAUDAL VERTEBRA|BILATERAL|Y|Y|SIBLING|2|Visit_2|25|1|TREATMENT|2020-06-10|25
e|FA|7fc35880-1672-4e64-ba3b-aa3f1e42764b|5|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|Ci/uL|[?]|1|mmHg/L/min|VOMER|CONTRALATERAL|Y||VENDOR|3|Visit_3|40|4|TREATMENT|2020-06-25|40
e|FA|7fc35880-1672-4e64-ba3b-aa3f1e42764b|6|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|STRIP|[?]|1|g/cage/day|DISTAL PHALANX 2 OF THE HAND|LATERAL|||FRIEND|3|Visit_3|40|5|TREATMENT|2020-06-25|40
e|FA|7fc35880-1672-4e64-ba3b-aa3f1e42764b|7|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|ohm|INTERPHALANGEAL JOINT 3|UNILATERAL|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|7|SCREENING|2020-07-20|65
e|FA|7fc35880-1672-4e64-ba3b-aa3f1e42764b|8|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|10^3/L|[?]|1|IU/mg|LUNG, LEFT UPPER LOBE|LATERAL|Y||SIBLING|4|Visit_4|65|2|WASHOUT|2020-07-20|65
e|FA|7fc35880-1672-4e64-ba3b-aa3f1e42764b|9|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|ng/day|PALPEBRAL CONJUNCTIVA|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|FOLLOW-UP|2020-08-14|90
e|FA|7fc35880-1672-4e64-ba3b-aa3f1e42764b|10|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|cpm|[?]|1|BOWL|TIBIOTARSAL JOINT|IPSILATERAL|||FRIEND|5|Visit_5|90|4|WASHOUT|2020-08-14|90
e|FA|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|g/g/day|[?]|1|CUP|T9 VERTEBRA|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-10-14|10
e|FA|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|2|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mol/day|[?]|1|ohm|POSTERIOR TIBIAL VEIN|CONTRALATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-10-14|10
e|FA|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|3|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|tuberculin unit|[?]|1|CUP|L5 VERTEBRA|BILATERAL||Y|FRIEND|2|Visit_2|25|3|TREATMENT|2020-10-29|25
e|FA|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|CCID 50/dose|[?]|1|MBq|PAROTID GLAND LYMPH NODE|IPSILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|4|WASHOUT|2020-10-29|25
e|FA|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|5|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|uV2|[?]|1|TRANSDUCING UNIT/mL|TRIANGULAR-HAMATE JOINT|IPSILATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-11-13|40
e|FA|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|6|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|dmol|[?]|1|m2|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2020-11-13|40
e|FA|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|m2|[?]|1|mg/g/min|PERIUMBILICAL REGION|LEFT|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2020-12-08|65
e|FA|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mm/min|[?]|1|%(v/v)|GENITAL TUBERCLE|BILATERAL|||PARENT|4|Visit_4|65|1|TREATMENT|2020-12-08|65
e|FA|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|9|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|anti-Xa IU/mL|CHOROID|RIGHT||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|3|SCREENING|2021-01-02|90
e|FA|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|10|TRTSETT|Treatment Setting|[?]|GERD|[?]|nkat/L|[?]|1|Coulomb|MESENTERIC ARTERY|RIGHT|||FRIEND|5|Visit_5|90|6|WASHOUT|2021-01-02|90
e|FA|f8878ffd-67af-414c-b346-596dbec640cf|1|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/h/mmol|[?]|1|in|SUPERFICIAL LYMPH NODE|RIGHT|||PROXY|1|Visit_1|10|1|WASHOUT|2021-01-04|10
e|FA|f8878ffd-67af-414c-b346-596dbec640cf|2|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|ug/m2/min|[?]|1|mIU/L|EPIGASTRIC LYMPH NODE|RIGHT|Y||DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2021-01-04|10
e|FA|f8878ffd-67af-414c-b346-596dbec640cf|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|sec|[?]|1|U/mg|UMBILICUS|RIGHT|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2021-01-19|25
e|FA|f8878ffd-67af-414c-b346-596dbec640cf|4|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|SCOOPFUL|TIBIALIS ANTERIOR MUSCLE|LEFT|||STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2021-01-19|25
e|FA|f8878ffd-67af-414c-b346-596dbec640cf|5|SEV|Severity/Intensity|[?]|GERD|[?]|BAU|[?]|1|Pa|INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT||Y|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2021-02-03|40
e|FA|f8878ffd-67af-414c-b346-596dbec640cf|6|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|umol/kg/min|[?]|1|TRANSDUCING UNIT/mL|EPIDIDYMIS|CONTRALATERAL|Y||VENDOR|3|Visit_3|40|6|SCREENING|2021-02-03|40
e|FA|f8878ffd-67af-414c-b346-596dbec640cf|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/m2/h|[?]|1|U/mmol|CEREBRAL VEIN|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2021-02-28|65
e|FA|f8878ffd-67af-414c-b346-596dbec640cf|8|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|/LSQN|[?]|1|mg/dose|ACUTE MARGINAL ARTERY|RIGHT|Y||INTERVIEWER|4|Visit_4|65|7|TREATMENT|2021-02-28|65
e|FA|f8878ffd-67af-414c-b346-596dbec640cf|9|SEV|Severity/Intensity|[?]|GERD|[?]|kBq|[?]|1|Pa|NASAL SEPTUM|LATERAL||Y|SPOUSE|5|Visit_5|90|5|TREATMENT|2021-03-25|90
e|FA|f8878ffd-67af-414c-b346-596dbec640cf|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mmol/kg|[?]|1|U/mg|L3-L4 INTERVERTEBRAL SPACE|LATERAL|||SPOUSE|5|Visit_5|90|6|TREATMENT|2021-03-25|90
e|FA|d8212248-cd8c-4404-8ad8-2c89c05bee9e|1|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|ug/m2/h|SKIN OF THE AXILLA|CONTRALATERAL|||FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2020-05-11|10
e|FA|d8212248-cd8c-4404-8ad8-2c89c05bee9e|2|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|Ci/uL|[?]|1|PFU/dose|LUNG, LEFT LOWER LOBE|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|WASHOUT|2020-05-11|10
e|FA|d8212248-cd8c-4404-8ad8-2c89c05bee9e|3|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|Ci/g|[?]|1|DRUM|HEART, LEFT ATRIUM|CONTRALATERAL||Y|SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2020-05-26|25
e|FA|d8212248-cd8c-4404-8ad8-2c89c05bee9e|4|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|pkat/L|[?]|1|h*%|BONE|CONTRALATERAL|Y||INVESTIGATOR|2|Visit_2|25|7|WASHOUT|2020-05-26|25
e|FA|d8212248-cd8c-4404-8ad8-2c89c05bee9e|5|DFIBER|Dietary Fiber|[?]|GERD|[?]|mg/h|[?]|1|h*%|LATERAL FIRST DIAGONAL BRANCH ARTERY|RIGHT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2020-06-10|40
e|FA|d8212248-cd8c-4404-8ad8-2c89c05bee9e|6|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|10^6/g|[?]|1|10^9 CFU/mL|HYPOPHARYNX|IPSILATERAL||Y|INVESTIGATOR|3|Visit_3|40|6|SCREENING|2020-06-10|40
e|FA|d8212248-cd8c-4404-8ad8-2c89c05bee9e|7|LOCONSET|Localization of Onset|[?]|GERD|[?]|IU/dL|[?]|1|g/L|TEMPLE|IPSILATERAL|||FAMILY MEMBER|4|Visit_4|65|3|FOLLOW-UP|2020-07-05|65
e|FA|d8212248-cd8c-4404-8ad8-2c89c05bee9e|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|MASK|[?]|1|mg/g/min|TAIL|LATERAL|||SPOUSE|4|Visit_4|65|4|SCREENING|2020-07-05|65
e|FA|d8212248-cd8c-4404-8ad8-2c89c05bee9e|9|SPEED|Speed|[?]|GERD|[?]|umol/L/h|[?]|1|mEq/g|MESENTERY|LATERAL|Y||VENDOR|5|Visit_5|90|1|TREATMENT|2020-07-30|90
e|FA|d8212248-cd8c-4404-8ad8-2c89c05bee9e|10|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|BE/mL|[?]|1|10^6 IU/mL|MITRAL VALVE, POSTERIOR ANNULUS|LATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2020-07-30|90
e|FA|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|1|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|U/L|[?]|1|g/dL|POSTERIOR POLE OF THE EYE|CONTRALATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|6|FOLLOW-UP|2020-07-02|10
e|FA|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|2|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|U/kg|[?]|1|CUP|APPENDICEAL TIP|LATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|FOLLOW-UP|2020-07-02|10
e|FA|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|3|QOLIMP|QOL Impact|[?]|GERD|[?]|mmHg|[?]|1|10^6/L|VAGINAL WALL|LEFT|||SIBLING|2|Visit_2|25|6|TREATMENT|2020-07-17|25
e|FA|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|4|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|CARTRIDGE|[?]|1|SCOOPFUL|LIVER LOBE|LATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|SCREENING|2020-07-17|25
e|FA|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mEq/kg|[?]|1|mg/g/min|HEART, LEFT VENTRICLE|UNILATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|3|SCREENING|2020-08-01|40
e|FA|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|6|QOLIMP|QOL Impact|[?]|GERD|[?]|PACKET|[?]|1|10^6/L|C7 VERTEBRA|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|WASHOUT|2020-08-01|40
e|FA|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|7|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|mm3/mm2/year|[?]|1|SCOOPFUL|CALF MUSCULAR VEIN|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|3|FOLLOW-UP|2020-08-26|65
e|FA|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|8|STRCTNUM|Number of Strictures|[?]|GERD|[?]|/4.0 mL|[?]|1|SACHET|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|RIGHT|||INTERVIEWER|4|Visit_4|65|2|TREATMENT|2020-08-26|65
e|FA|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|9|SEV|Severity/Intensity|[?]|GERD|[?]|cL|[?]|1|Pa|NAIL|IPSILATERAL||Y|ADJUDICATOR|5|Visit_5|90|6|WASHOUT|2020-09-20|90
e|FA|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|10|OBJTYPE|Type of Object|[?]|GERD|[?]|mg/kg/min|[?]|1|ng|SHIN|IPSILATERAL|Y||VENDOR|5|Visit_5|90|1|TREATMENT|2020-09-20|90
e|FA|b832144e-88c4-4ad6-b173-abac7802a36c|1|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|nL|[?]|1|AU/mL|PARACOLIC GUTTER|UNILATERAL|||SIBLING|1|Visit_1|10|2|TREATMENT|2021-01-14|10
e|FA|b832144e-88c4-4ad6-b173-abac7802a36c|2|AGETRT1|Age At First Treatment|[?]|GERD|[?]|copies/mL|[?]|1|mL/mmHg/min/L|DENTAL ARCH|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2021-01-14|10
e|FA|b832144e-88c4-4ad6-b173-abac7802a36c|3|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|mg/day|[?]|1|psi|METACARPAL BONE 2|IPSILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|WASHOUT|2021-01-29|25
e|FA|b832144e-88c4-4ad6-b173-abac7802a36c|4|EVENTFRQ|Event Frequency|[?]|GERD|[?]|ug/kg/h|[?]|1|ug/kg/h|CERVICAL VERTEBRA|BILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2021-01-29|25
e|FA|b832144e-88c4-4ad6-b173-abac7802a36c|5|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|USP U|[?]|1|Coulomb|OLFACTORY NERVE|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|SCREENING|2021-02-13|40
e|FA|b832144e-88c4-4ad6-b173-abac7802a36c|6|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|deg/mm|[?]|1|MPS U|INTRAHEPATIC LARGE BILE DUCT|CONTRALATERAL|Y|Y|PROXY|3|Visit_3|40|4|TREATMENT|2021-02-13|40
e|FA|b832144e-88c4-4ad6-b173-abac7802a36c|7|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|VOXEL|[?]|1|Gy/h|SALIVARY GLAND|BILATERAL|||ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2021-03-10|65
e|FA|b832144e-88c4-4ad6-b173-abac7802a36c|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mm/min|[?]|1|%(v/v)|HEEL OF THE FOOT|LEFT|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2021-03-10|65
e|FA|b832144e-88c4-4ad6-b173-abac7802a36c|9|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|pm|[?]|1|mL/mmHg/min/L|FEMORAL LYMPH NODE|RIGHT||Y|DOMESTIC PARTNER|5|Visit_5|90|1|WASHOUT|2021-04-04|90
e|FA|b832144e-88c4-4ad6-b173-abac7802a36c|10|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|mL/animal/wk|[?]|1|mmHg/L/min|ADDUCTOR MAGNUS MUSCLE|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2021-04-04|90
e|FA|6acacd87-c487-401c-8888-76ccf97b640d|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/kg|[?]|1|mg/g/min|TOE|IPSILATERAL||Y|VENDOR|1|Visit_1|10|6|TREATMENT|2020-05-25|10
e|FA|6acacd87-c487-401c-8888-76ccf97b640d|2|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|U/L|[?]|1|uCi/kg|METATARSOPHALANGEAL JOINT 5|BILATERAL|Y||GUARDIAN|1|Visit_1|10|7|WASHOUT|2020-05-25|10
e|FA|6acacd87-c487-401c-8888-76ccf97b640d|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|umol/L|[?]|1|mg/h|COLON LYMPH NODE|LEFT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-06-09|25
e|FA|6acacd87-c487-401c-8888-76ccf97b640d|4|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|10^4 CFU/mL|PROXIMAL PHALANX 3 OF THE HAND|BILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-06-09|25
e|FA|6acacd87-c487-401c-8888-76ccf97b640d|5|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|ug/m2/h|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|LEFT||Y|FRIEND|3|Visit_3|40|7|FOLLOW-UP|2020-06-24|40
e|FA|6acacd87-c487-401c-8888-76ccf97b640d|6|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|pm|[?]|1|U/mg|SARTORIUS MUSCLE|IPSILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2020-06-24|40
e|FA|6acacd87-c487-401c-8888-76ccf97b640d|7|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|g/kg|[?]|1|mg/dose|PAROTID GLAND|LEFT||Y|DOMESTIC PARTNER|4|Visit_4|65|2|TREATMENT|2020-07-19|65
e|FA|6acacd87-c487-401c-8888-76ccf97b640d|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|LB|[?]|1|Pa|PARASYMPATHETIC GANGLIA|BILATERAL|Y||PROXY|4|Visit_4|65|4|WASHOUT|2020-07-19|65
e|FA|6acacd87-c487-401c-8888-76ccf97b640d|9|LDIAM|Longest Diameter|[?]|GERD|[?]|EVENTS|[?]|1|Shock Wave|ILEUM LYMPH NODE|LATERAL|Y||INTERVIEWER|5|Visit_5|90|4|TREATMENT|2020-08-13|90
e|FA|6acacd87-c487-401c-8888-76ccf97b640d|10|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|nmol/mol|[?]|1|10^6 CFU|COLON, SIGMOID|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-08-13|90
e|FA|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Enzyme U/L|[?]|1|mg/g/min|LIVER, CAUDATE LOBE|BILATERAL||Y|CHILD|1|Visit_1|10|6|FOLLOW-UP|2020-07-16|10
e|FA|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|2|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|CUP|[?]|1|ohm|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LEFT|||CAREGIVER|1|Visit_1|10|7|SCREENING|2020-07-16|10
e|FA|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|3|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|ka_u/dL|[?]|1|EIA unit|THORACIC ARTERY|LATERAL|||FRIEND|2|Visit_2|25|5|WASHOUT|2020-07-31|25
e|FA|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|4|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mL|[?]|1|10^9 CFU/g|DISTAL RADIOULNAR JOINT|IPSILATERAL|||ADJUDICATOR|2|Visit_2|25|3|SCREENING|2020-07-31|25
e|FA|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|5|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|um/day|[?]|1|in|GASTROESOPHAGEAL JUNCTION|CONTRALATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|7|FOLLOW-UP|2020-08-15|40
e|FA|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|6|TOXGR|Toxicity Grade|[?]|GERD|[?]|10^7 TCID 50/dose|[?]|1|aMFI|DISTAL RADIOULNAR JOINT|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-08-15|40
e|FA|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|7|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/g|[?]|1|Hz/s|GINGIVAL MUCOSA|UNILATERAL|||FAMILY MEMBER|4|Visit_4|65|7|TREATMENT|2020-09-09|65
e|FA|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mEq/day|[?]|1|Pa|ACUTE MARGINAL ARTERY|IPSILATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|2|SCREENING|2020-09-09|65
e|FA|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|9|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|cal|[?]|1|ug/m2/h|ILEUM WALL|LEFT||Y|GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-10-04|90
e|FA|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|10|PPTFCT|Precipitating Factor|[?]|GERD|[?]|vp/mL|[?]|1|EIA unit|CEREBELLUM|UNILATERAL|||FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2020-10-04|90
e|FA|73988e01-56c0-4b31-84e2-c23ce0bac5ac|1|DFATT|Dietary Fat, Total|[?]|GERD|[?]|FIU|[?]|1|Bq/mg|ILIAC VEIN|LATERAL|||ADJUDICATOR|1|Visit_1|10|3|WASHOUT|2021-01-03|10
e|FA|73988e01-56c0-4b31-84e2-c23ce0bac5ac|2|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|10^9 organisms|[?]|1|ohm|PROSTATE GLAND|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2021-01-03|10
e|FA|73988e01-56c0-4b31-84e2-c23ce0bac5ac|3|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|U/g/min|[?]|1|TRANSDUCING UNIT/mL|CARPOMETACARPAL JOINT|CONTRALATERAL|||PROXY|2|Visit_2|25|5|SCREENING|2021-01-18|25
e|FA|73988e01-56c0-4b31-84e2-c23ce0bac5ac|4|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|cm H2O|[?]|1|uL/kg/day|COLON, DESCENDING|IPSILATERAL|Y||VENDOR|2|Visit_2|25|2|TREATMENT|2021-01-18|25
e|FA|73988e01-56c0-4b31-84e2-c23ce0bac5ac|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|BAU/mL|[?]|1|mg/g/min|ADDUCTOR POLLICIS MUSCLE|LEFT|||FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2021-02-02|40
e|FA|73988e01-56c0-4b31-84e2-c23ce0bac5ac|6|DMEAT|Dietary Meat|[?]|GERD|[?]|NEEDLE GAUGE|[?]|1|10^6 organisms/mL|HEPATOBILIARY SYSTEM|LATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2021-02-02|40
e|FA|73988e01-56c0-4b31-84e2-c23ce0bac5ac|7|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|pm|[?]|1|Gy/h|COLON|LATERAL|||SIBLING|4|Visit_4|65|7|SCREENING|2021-02-27|65
e|FA|73988e01-56c0-4b31-84e2-c23ce0bac5ac|8|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|umol/mol|[?]|1|PACK|BLOOD|BILATERAL|Y|Y|VENDOR|4|Visit_4|65|6|TREATMENT|2021-02-27|65
e|FA|73988e01-56c0-4b31-84e2-c23ce0bac5ac|9|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|Ci/mL|[?]|1|in|CORPUS STRIATUM|UNILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|2|SCREENING|2021-03-24|90
e|FA|73988e01-56c0-4b31-84e2-c23ce0bac5ac|10|SEV|Severity/Intensity|[?]|GERD|[?]|APPLICATION|[?]|1|Pa|LEFT CIRCUMFLEX ARTERY OSTIUM|UNILATERAL|||VENDOR|5|Visit_5|90|3|FOLLOW-UP|2021-03-24|90
e|FA|0670f6a3-18c9-4027-91c1-56f5555589a8|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|DROP|[?]|1|Pa|PORTAL LYMPH NODE|LEFT|||SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-05-13|10
e|FA|0670f6a3-18c9-4027-91c1-56f5555589a8|2|DPROT|Dietary Protein|[?]|GERD|[?]|g/cm2|[?]|1|10^4 CFU/mL|RETINAL NERVE FIBER LAYER|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|5|TREATMENT|2020-05-13|10
e|FA|0670f6a3-18c9-4027-91c1-56f5555589a8|3|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|uCi/kg|RETROCRURAL LYMPH NODE|BILATERAL||Y|INTERVIEWER|2|Visit_2|25|7|SCREENING|2020-05-28|25
e|FA|0670f6a3-18c9-4027-91c1-56f5555589a8|4|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|genEq|[?]|1|SACHET|FIRST DIAGONAL BRANCH ARTERY|IPSILATERAL|Y||ADJUDICATOR|2|Visit_2|25|6|FOLLOW-UP|2020-05-28|25
e|FA|0670f6a3-18c9-4027-91c1-56f5555589a8|5|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|CCID 50/mL|[?]|1|PACK|SKIN OF THE FOOT|IPSILATERAL|Y||ADJUDICATOR|3|Visit_3|40|2|FOLLOW-UP|2020-06-12|40
e|FA|0670f6a3-18c9-4027-91c1-56f5555589a8|6|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|mg/day|[?]|1|mm/h|SYNOVIAL FLUID|LATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-06-12|40
e|FA|0670f6a3-18c9-4027-91c1-56f5555589a8|7|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|Gy|[?]|1|mL/animal/day|ANKLE MORTISE|LATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|6|FOLLOW-UP|2020-07-07|65
e|FA|0670f6a3-18c9-4027-91c1-56f5555589a8|8|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|MBq/uL|[?]|1|anti-Xa IU/mL|FOREARM|LATERAL|||FRIEND|4|Visit_4|65|3|TREATMENT|2020-07-07|65
e|FA|0670f6a3-18c9-4027-91c1-56f5555589a8|9|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|10^5/L|[?]|1|DROP|TIBIA SHAFT|LEFT||Y|CHILD|5|Visit_5|90|2|TREATMENT|2020-08-01|90
e|FA|0670f6a3-18c9-4027-91c1-56f5555589a8|10|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|U.CARR|[?]|1|HOURS|HEPATOBILIARY SYSTEM|IPSILATERAL||Y|GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-08-01|90
e|FA|59179734-8784-4a88-aa6b-51b6082ffc1b|1|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|ks|[?]|1|PACK|SUPRARENAL AORTA|RIGHT|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|SCREENING|2020-08-11|10
e|FA|59179734-8784-4a88-aa6b-51b6082ffc1b|2|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|/MBP|[?]|1|mL/cm3/min|WRIST JOINT FLEXOR TENDONS|IPSILATERAL|||ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-08-11|10
e|FA|59179734-8784-4a88-aa6b-51b6082ffc1b|3|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/mL|[?]|1|oz eq|PERICARDIUM|CONTRALATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|2|FOLLOW-UP|2020-08-26|25
e|FA|59179734-8784-4a88-aa6b-51b6082ffc1b|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|10^9 CFU/g|[?]|1|U/mmol|METACARPOPHALANGEAL JOINT 3|IPSILATERAL||Y|INVESTIGATOR|2|Visit_2|25|2|FOLLOW-UP|2020-08-26|25
e|FA|59179734-8784-4a88-aa6b-51b6082ffc1b|5|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|10^6 organisms/mL|[?]|1|g/cage/day|BILE DUCT|RIGHT|Y||SIBLING|3|Visit_3|40|4|FOLLOW-UP|2020-09-10|40
e|FA|59179734-8784-4a88-aa6b-51b6082ffc1b|6|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|mL/cage/wk|[?]|1|mL/mmHg/min/L|RETROPERITONEAL LYMPH NODE|RIGHT|||FRIEND|3|Visit_3|40|1|FOLLOW-UP|2020-09-10|40
e|FA|59179734-8784-4a88-aa6b-51b6082ffc1b|7|DIAMETER|Diameter|[?]|GERD|[?]|mL/kg|[?]|1|cm|TEMPOROMANDIBULAR JOINT|IPSILATERAL|||STUDY SUBJECT|4|Visit_4|65|5|SCREENING|2020-10-05|65
e|FA|59179734-8784-4a88-aa6b-51b6082ffc1b|8|TRTSETT|Treatment Setting|[?]|GERD|[?]|ELISA unit|[?]|1|Coulomb|DISTAL PHALANX 4 OF THE HAND|RIGHT|||ADJUDICATOR|4|Visit_4|65|2|FOLLOW-UP|2020-10-05|65
e|FA|59179734-8784-4a88-aa6b-51b6082ffc1b|9|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|BOTTLE|[?]|1|CUP|UPPER URINARY SYSTEM|IPSILATERAL|||PROXY|5|Visit_5|90|4|TREATMENT|2020-10-30|90
e|FA|59179734-8784-4a88-aa6b-51b6082ffc1b|10|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|mEq/g|[?]|1|mm|GREAT VESSELS|UNILATERAL||Y|CAREGIVER|5|Visit_5|90|3|WASHOUT|2020-10-30|90
e|FA|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|1|DFIBER|Dietary Fiber|[?]|GERD|[?]|um/s|[?]|1|h*%|GALLBLADDER|UNILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|5|TREATMENT|2020-08-22|10
e|FA|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|2|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|Osm|[?]|1|mmHg/L/min|LUNG, RIGHT|RIGHT|||CHILD|1|Visit_1|10|1|FOLLOW-UP|2020-08-22|10
e|FA|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|3|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|FEU|[?]|1|mAmp|UVEA|CONTRALATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|5|WASHOUT|2020-09-06|25
e|FA|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|4|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mmHg|[?]|1|100 IU/mL|DISTAL INTERPHALANGEAL JOINT 4|CONTRALATERAL||Y|CHILD|2|Visit_2|25|7|WASHOUT|2020-09-06|25
e|FA|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|5|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|Gy|[?]|1|ohm|T6 VERTEBRA|RIGHT||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|WASHOUT|2020-09-21|40
e|FA|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|6|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|g/kg/day|[?]|1|10^9 CFU/mL|SEMITENDINOSUS MUSCLE|LEFT||Y|STUDY SUBJECT|3|Visit_3|40|5|WASHOUT|2020-09-21|40
e|FA|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|/4.0 mL|[?]|1|U/mg|BRAIN STEM|IPSILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|3|FOLLOW-UP|2020-10-16|65
e|FA|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|8|DGRAIN|Dietary Grain|[?]|GERD|[?]|STEPS|[?]|1|10^9 CFU/g|PROSTATE GLAND|LATERAL||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|TREATMENT|2020-10-16|65
e|FA|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|dmol|[?]|1|10^6 IU/mL|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|6|FOLLOW-UP|2020-11-10|90
e|FA|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|10|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|10^3 DNA copies/mL|[?]|1|mmHg/L/min|LOWER RESPIRATORY SYSTEM|LATERAL|||VENDOR|5|Visit_5|90|1|TREATMENT|2020-11-10|90
e|FA|01c642f8-48ef-4375-aa2b-d0940b74e580|1|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mmol/kg|[?]|1|fmol|ACHILLES TENDON|CONTRALATERAL|Y||SIBLING|1|Visit_1|10|3|TREATMENT|2020-09-19|10
e|FA|01c642f8-48ef-4375-aa2b-d0940b74e580|2|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|umol/L/min|[?]|1|mmHg/L/min|ABDUCTOR POLLICIS BREVIS MUSCLE|IPSILATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|5|WASHOUT|2020-09-19|10
e|FA|01c642f8-48ef-4375-aa2b-d0940b74e580|3|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|mL/cm|[?]|1|/200 HPFs|TESTIS|CONTRALATERAL|Y||INTERVIEWER|2|Visit_2|25|1|SCREENING|2020-10-04|25
e|FA|01c642f8-48ef-4375-aa2b-d0940b74e580|4|LESNUM|Number of Lesions|[?]|GERD|[?]|IU/g Hb|[?]|1|ng/day|LACRIMAL GLAND|IPSILATERAL||Y|PARENT|2|Visit_2|25|1|FOLLOW-UP|2020-10-04|25
e|FA|01c642f8-48ef-4375-aa2b-d0940b74e580|5|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|uL/kg/day|[?]|1|mg/dose|SKIN BETWEEN EYEBROWS|UNILATERAL|Y||ADJUDICATOR|3|Visit_3|40|6|FOLLOW-UP|2020-10-19|40
e|FA|01c642f8-48ef-4375-aa2b-d0940b74e580|6|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|U/10^12 RBC|[?]|1|BP|SKIN OF THE LOWER LIMB|RIGHT|||PROXY|3|Visit_3|40|3|WASHOUT|2020-10-19|40
e|FA|01c642f8-48ef-4375-aa2b-d0940b74e580|7|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|GPS U|[?]|1|mAmp|PECTORALIS MINOR MUSCLE|BILATERAL|||FRIEND|4|Visit_4|65|6|TREATMENT|2020-11-13|65
e|FA|01c642f8-48ef-4375-aa2b-d0940b74e580|8|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|BAR|[?]|1|10^6 CFU|ASCENDING AORTA, SINUS OF VALSALVA|UNILATERAL|Y||FAMILY MEMBER|4|Visit_4|65|4|FOLLOW-UP|2020-11-13|65
e|FA|01c642f8-48ef-4375-aa2b-d0940b74e580|9|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|mm|BILIARY TRACT|LEFT|||STUDY SUBJECT|5|Visit_5|90|1|SCREENING|2020-12-08|90
e|FA|01c642f8-48ef-4375-aa2b-d0940b74e580|10|SEV|Severity/Intensity|[?]|GERD|[?]|TRACE|[?]|1|Pa|PULMONARY ARTERY BRANCH|LATERAL|Y||CAREGIVER|5|Visit_5|90|4|FOLLOW-UP|2020-12-08|90
e|FA|c0e7028c-6f5c-410a-afde-e56af2177983|1|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|GLOBULE|[?]|1|uL/kg/day|MIDDLE PHALANX 3 OF THE HAND|RIGHT|||INTERVIEWER|1|Visit_1|10|4|TREATMENT|2020-07-06|10
e|FA|c0e7028c-6f5c-410a-afde-e56af2177983|2|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|mEq|[?]|1|cmH2O/mL|DISTAL LAD ARTERY|IPSILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-07-06|10
e|FA|c0e7028c-6f5c-410a-afde-e56af2177983|3|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|FFU|[?]|1|uL/kg/day|MEDIAN OR LOWER CERVICAL LYMPH NODE|RIGHT|||ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-07-21|25
e|FA|c0e7028c-6f5c-410a-afde-e56af2177983|4|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|cy/cm|[?]|1|Bq/L|EARLOBE|RIGHT||Y|INVESTIGATOR|2|Visit_2|25|5|SCREENING|2020-07-21|25
e|FA|c0e7028c-6f5c-410a-afde-e56af2177983|5|AGETRT1|Age At First Treatment|[?]|GERD|[?]|log10 IU/mL|[?]|1|mL/mmHg/min/L|TIBIOTARSAL JOINT|LEFT||Y|STUDY SUBJECT|3|Visit_3|40|3|SCREENING|2020-08-05|40
e|FA|c0e7028c-6f5c-410a-afde-e56af2177983|6|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|GBq|[?]|1|fmol|AORTIC VALVE, LEFT CORONARY CUSP|UNILATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-08-05|40
e|FA|c0e7028c-6f5c-410a-afde-e56af2177983|7|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|g/day|SCAPHOID BONE|LEFT|Y|Y|SPOUSE|4|Visit_4|65|1|TREATMENT|2020-08-30|65
e|FA|c0e7028c-6f5c-410a-afde-e56af2177983|8|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|mL/cage|[?]|1|aMFI|SKIN OF THE UPPER LIMB|RIGHT|||FRIEND|4|Visit_4|65|5|TREATMENT|2020-08-30|65
e|FA|c0e7028c-6f5c-410a-afde-e56af2177983|9|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|10^6 U|[?]|1|MBq|ADDUCTOR BREVIS MUSCLE|RIGHT||Y|GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-09-24|90
e|FA|c0e7028c-6f5c-410a-afde-e56af2177983|10|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|MESF|[?]|1|L|BLADDER, FUNDUS|CONTRALATERAL|||FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2020-09-24|90
e|FA|eba928ed-9434-4e75-b49d-169298f966e1|1|SEV|Severity/Intensity|[?]|GERD|[?]|pL|[?]|1|Pa|VESTIBULOCOCHLEAR NERVE|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2020-08-12|10
e|FA|eba928ed-9434-4e75-b49d-169298f966e1|2|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|U/g|[?]|1|10^6 organisms/mL|TYMPANIC MEMBRANE|UNILATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|5|FOLLOW-UP|2020-08-12|10
e|FA|eba928ed-9434-4e75-b49d-169298f966e1|3|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/s|[?]|1|AU/mL|HEAD OF THE HUMERUS|UNILATERAL||Y|FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-08-27|25
e|FA|eba928ed-9434-4e75-b49d-169298f966e1|4|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|10^7 TCID 50/dose|[?]|1|SACHET|KNEE JOINT TENDONS|LEFT||Y|GUARDIAN|2|Visit_2|25|3|WASHOUT|2020-08-27|25
e|FA|eba928ed-9434-4e75-b49d-169298f966e1|5|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mAmp|[?]|1|10^6 U|OPHTHALMIC ARTERY|UNILATERAL||Y|FRIEND|3|Visit_3|40|6|WASHOUT|2020-09-11|40
e|FA|eba928ed-9434-4e75-b49d-169298f966e1|6|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|AU/mL|[?]|1|BOWL|CORONARY VEIN|LATERAL||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|FOLLOW-UP|2020-09-11|40
e|FA|eba928ed-9434-4e75-b49d-169298f966e1|7|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|TUBE|[?]|1|cm H2O|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|RIGHT|Y|Y|PARENT|4|Visit_4|65|4|TREATMENT|2020-10-06|65
e|FA|eba928ed-9434-4e75-b49d-169298f966e1|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|LENS|[?]|1|%(v/v)|OVARIAN FOLLICLE|LATERAL|||STUDY SUBJECT|4|Visit_4|65|3|SCREENING|2020-10-06|65
e|FA|eba928ed-9434-4e75-b49d-169298f966e1|9|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|min*mg/mL|[?]|1|10^9 CFU/mL|THORACIC ARTERY|BILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|SCREENING|2020-10-31|90
e|FA|eba928ed-9434-4e75-b49d-169298f966e1|10|ESTWT|Estimated Weight|[?]|GERD|[?]|SYRINGE|[?]|1|g/day|TRICUSPID VALVE, POSTERIOR ANNULUS|CONTRALATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-10-31|90
e|FA|4772aa80-2097-4867-a549-b6f9b140f141|1|DISTANCE|Distance|[?]|GERD|[?]|min|[?]|1|BOWL|GLENOID FOSSA|RIGHT|||INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-07-12|10
e|FA|4772aa80-2097-4867-a549-b6f9b140f141|2|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|10^6 DNA copies/mL|[?]|1|L/h/m2|FEMORAL ARTERY|IPSILATERAL|||PROXY|1|Visit_1|10|1|TREATMENT|2020-07-12|10
e|FA|4772aa80-2097-4867-a549-b6f9b140f141|3|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|ug/day|[?]|1|km|BLADDER, TRIGONE|LEFT|||INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2020-07-27|25
e|FA|4772aa80-2097-4867-a549-b6f9b140f141|4|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|um/s|[?]|1|ug/m2/h|MASTOID PROCESS|UNILATERAL|||FRIEND|2|Visit_2|25|1|TREATMENT|2020-07-27|25
e|FA|4772aa80-2097-4867-a549-b6f9b140f141|5|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|h*%|[?]|1|mAmp|THORACIC ARTERY|CONTRALATERAL|||STUDY SUBJECT|3|Visit_3|40|3|FOLLOW-UP|2020-08-11|40
e|FA|4772aa80-2097-4867-a549-b6f9b140f141|6|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|umol|[?]|1|mm/h|POSTERIOR SUPERIOR ILIAC SPINE|IPSILATERAL|||SIBLING|3|Visit_3|40|2|SCREENING|2020-08-11|40
e|FA|4772aa80-2097-4867-a549-b6f9b140f141|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|pt_br|[?]|1|mg/g/min|PORTAL VEIN|UNILATERAL|Y||CHILD|4|Visit_4|65|4|TREATMENT|2020-09-05|65
e|FA|4772aa80-2097-4867-a549-b6f9b140f141|8|SEV|Severity/Intensity|[?]|GERD|[?]|dpm/mg|[?]|1|Pa|KNEE JOINT TENDONS|LEFT|||INTERVIEWER|4|Visit_4|65|4|TREATMENT|2020-09-05|65
e|FA|4772aa80-2097-4867-a549-b6f9b140f141|9|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|PACKET|[?]|1|ng/day|SUBMENTAL LYMPH NODE|UNILATERAL|||PARENT|5|Visit_5|90|1|SCREENING|2020-09-30|90
e|FA|4772aa80-2097-4867-a549-b6f9b140f141|10|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|PIPE|[?]|1|umol|LARGE INTESTINE|UNILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|TREATMENT|2020-09-30|90
e|FA|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|U/kg/h|[?]|1|L|GONAD|BILATERAL|||FRIEND|1|Visit_1|10|3|WASHOUT|2020-06-07|10
e|FA|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|2|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|log10 IU/mL|[?]|1|SCOOPFUL|PAROTID GLAND LYMPH NODE|RIGHT|||DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-06-07|10
e|FA|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ug/mol|[?]|1|mg/g/min|SPINAL ACCESSORY NERVE|LATERAL||Y|PROXY|2|Visit_2|25|5|FOLLOW-UP|2020-06-22|25
e|FA|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|4|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|mOsm/kg|[?]|1|mEq|SPLENIC LYMPH NODE|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|2|SCREENING|2020-06-22|25
e|FA|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|5|DCAL|Dietary Calories|[?]|GERD|[?]|mmol/day|[?]|1|EIA unit|HEART, LEFT VENTRICULAR WALL|BILATERAL|Y||GUARDIAN|3|Visit_3|40|7|TREATMENT|2020-07-07|40
e|FA|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|6|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|mIU/L|RECTOSIGMOID JUNCTION|LATERAL|||ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-07-07|40
e|FA|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|7|QOLIMP|QOL Impact|[?]|GERD|[?]|uCi/L|[?]|1|10^6/L|CERVIX UTERI|CONTRALATERAL|Y|Y|FRIEND|4|Visit_4|65|3|TREATMENT|2020-08-01|65
e|FA|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|cmol/L|[?]|1|U/mmol|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|SCREENING|2020-08-01|65
e|FA|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|9|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|g/g/day|[?]|1|uCi/kg|PYRAMIDAL TRACTS, INTERNAL CAPSULE|UNILATERAL|Y|Y|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-08-26|90
e|FA|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|10|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|Henry|[?]|1|mL/mmHg/min/L|SCAPHOID-TRAPEZOID JOINT|LATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|6|SCREENING|2020-08-26|90
e|FA|4d8dd0d0-407d-4374-8345-c11f30603273|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|uCi/kg|[?]|1|L|SKIN OF THE INGUINAL REGION|RIGHT|||FAMILY MEMBER|1|Visit_1|10|2|SCREENING|2021-01-01|10
e|FA|4d8dd0d0-407d-4374-8345-c11f30603273|2|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|g/animal/day|[?]|1|mL/animal/day|INTERNAL MAMMARY ARTERY|LEFT|Y|Y|FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2021-01-01|10
e|FA|4d8dd0d0-407d-4374-8345-c11f30603273|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|Shock Wave|ILEUM LYMPH NODE|LATERAL|Y||GUARDIAN|2|Visit_2|25|3|WASHOUT|2021-01-16|25
e|FA|4d8dd0d0-407d-4374-8345-c11f30603273|4|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|mmol/s|[?]|1|g/dL|PULMONARY TRUNK|LATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2021-01-16|25
e|FA|4d8dd0d0-407d-4374-8345-c11f30603273|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/min/1.73m2|[?]|1|mg/g/min|SUBARACHNOID SPACE|IPSILATERAL|||PARENT|3|Visit_3|40|1|FOLLOW-UP|2021-01-31|40
e|FA|4d8dd0d0-407d-4374-8345-c11f30603273|6|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|Sv|[?]|1|/200 HPFs|CEREBELLUM|LATERAL|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|7|SCREENING|2021-01-31|40
e|FA|4d8dd0d0-407d-4374-8345-c11f30603273|7|EVENTNUM|Number of Events|[?]|GERD|[?]|/cmH2O|[?]|1|U/10^12 RBC|PELVIS|LATERAL||Y|SIBLING|4|Visit_4|65|5|TREATMENT|2021-02-25|65
e|FA|4d8dd0d0-407d-4374-8345-c11f30603273|8|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|kIU|[?]|1|PACK|PROXIMAL INTERPHALANGEAL JOINT 5|LATERAL|Y|Y|SIBLING|4|Visit_4|65|5|TREATMENT|2021-02-25|65
e|FA|4d8dd0d0-407d-4374-8345-c11f30603273|9|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU|[?]|1|m2|URETHRA, PENILE|LEFT|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|WASHOUT|2021-03-22|90
e|FA|4d8dd0d0-407d-4374-8345-c11f30603273|10|LESNUM|Number of Lesions|[?]|GERD|[?]|nU/cL|[?]|1|ng/day|LEFT VENTRICULAR MID ANTERIOR SEGMENT|RIGHT|||SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2021-03-22|90
e|FA|6996077b-556a-47b9-bbff-20c1b4df35ea|1|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|cd/m2|[?]|1|AU/mL|RECTO-UTERINE POUCH|LATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|TREATMENT|2020-06-08|10
e|FA|6996077b-556a-47b9-bbff-20c1b4df35ea|2|DGRAIN|Dietary Grain|[?]|GERD|[?]|Tbsp|[?]|1|10^9 CFU/g|FEMORAL VEIN|IPSILATERAL||Y|CHILD|1|Visit_1|10|4|TREATMENT|2020-06-08|10
e|FA|6996077b-556a-47b9-bbff-20c1b4df35ea|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|anti-Xa IU|[?]|1|%(v/v)|PARALARYNGEAL LYMPH NODE|LEFT|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|5|WASHOUT|2020-06-23|25
e|FA|6996077b-556a-47b9-bbff-20c1b4df35ea|4|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|amu|[?]|1|oz eq|LARGE INTESTINE|CONTRALATERAL|Y||CHILD|2|Visit_2|25|4|TREATMENT|2020-06-23|25
e|FA|6996077b-556a-47b9-bbff-20c1b4df35ea|5|EXTRSCT|Extent of Resection|[?]|GERD|[?]|ECL unit|[?]|1|Weber|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|CONTRALATERAL|||SPOUSE|3|Visit_3|40|2|TREATMENT|2020-07-08|40
e|FA|6996077b-556a-47b9-bbff-20c1b4df35ea|6|SERVNUM|Number of Servings|[?]|GERD|[?]|MdFI|[?]|1|Hz/s|NUCLEUS OF DIAGONAL BAND|IPSILATERAL|||CAREGIVER|3|Visit_3|40|6|SCREENING|2020-07-08|40
e|FA|6996077b-556a-47b9-bbff-20c1b4df35ea|7|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|um2|[?]|1|mm|FEMORAL VEIN|UNILATERAL|Y||VENDOR|4|Visit_4|65|1|FOLLOW-UP|2020-08-02|65
e|FA|6996077b-556a-47b9-bbff-20c1b4df35ea|8|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|/40 HPFs|[?]|1|mg/h|TOOTH|IPSILATERAL|Y||VENDOR|4|Visit_4|65|4|TREATMENT|2020-08-02|65
e|FA|6996077b-556a-47b9-bbff-20c1b4df35ea|9|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|DROP|KIDNEY|BILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|5|WASHOUT|2020-08-27|90
e|FA|6996077b-556a-47b9-bbff-20c1b4df35ea|10|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|GPS U|[?]|1|mm/h|PROXIMAL INTERPHALANGEAL JOINT 4|CONTRALATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|FOLLOW-UP|2020-08-27|90
e|FA|d79d31c5-d51a-46a7-b22c-20d6d483f46e|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|mJoule/cm2|[?]|1|L|METACARPAL BONE|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-10-23|10
e|FA|d79d31c5-d51a-46a7-b22c-20d6d483f46e|2|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|BP|LEFT VENTRICULAR APEX SEGMENT|LEFT|||FRIEND|1|Visit_1|10|4|WASHOUT|2020-10-23|10
e|FA|d79d31c5-d51a-46a7-b22c-20d6d483f46e|3|AGETRT1|Age At First Treatment|[?]|GERD|[?]|umol/mol|[?]|1|mL/mmHg/min/L|POSTERIOR CINGULATE CORTEX|BILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-11-07|25
e|FA|d79d31c5-d51a-46a7-b22c-20d6d483f46e|4|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|mmol/min/kPa/L|[?]|1|mL|THORACIC ARTERY|UNILATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-11-07|25
e|FA|d79d31c5-d51a-46a7-b22c-20d6d483f46e|5|DIAMETER|Diameter|[?]|GERD|[?]|dpm/mg|[?]|1|cm|THYROID GLAND ISTHMUS|IPSILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2020-11-22|40
e|FA|d79d31c5-d51a-46a7-b22c-20d6d483f46e|6|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|DROP|BRACHIAL PLEXUS|LATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-11-22|40
e|FA|d79d31c5-d51a-46a7-b22c-20d6d483f46e|7|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|U/dL|[?]|1|10^6 CFU|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LATERAL||Y|CAREGIVER|4|Visit_4|65|5|SCREENING|2020-12-17|65
e|FA|d79d31c5-d51a-46a7-b22c-20d6d483f46e|8|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|RATIO|[?]|1|DRUM|MITRAL VALVE, POSTERIOR CUSP|IPSILATERAL|||SPOUSE|4|Visit_4|65|2|TREATMENT|2020-12-17|65
e|FA|d79d31c5-d51a-46a7-b22c-20d6d483f46e|9|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|Ejaculate U|[?]|1|/kg|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|Y|Y|INTERVIEWER|5|Visit_5|90|5|TREATMENT|2021-01-11|90
e|FA|d79d31c5-d51a-46a7-b22c-20d6d483f46e|10|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|LENS|[?]|1|m2|ATRIOVENTRICULAR VALVE|BILATERAL||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|WASHOUT|2021-01-11|90
e|FA|738d539e-a810-4207-8904-fc6a5d055424|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|nkat/L|[?]|1|CUP|SKIN OF THE FOREARM|UNILATERAL|||PARENT|1|Visit_1|10|5|TREATMENT|2021-01-08|10
e|FA|738d539e-a810-4207-8904-fc6a5d055424|2|SEV|Severity/Intensity|[?]|GERD|[?]|cpm|[?]|1|Pa|MUCOSA|BILATERAL||Y|GUARDIAN|1|Visit_1|10|5|WASHOUT|2021-01-08|10
e|FA|738d539e-a810-4207-8904-fc6a5d055424|3|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|10^5/L|[?]|1|g/cage/day|HILAR|LEFT||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|TREATMENT|2021-01-23|25
e|FA|738d539e-a810-4207-8904-fc6a5d055424|4|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|%|[?]|1|umol|C4 VERTEBRA|LEFT|||VENDOR|2|Visit_2|25|3|TREATMENT|2021-01-23|25
e|FA|738d539e-a810-4207-8904-fc6a5d055424|5|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|Ci/g|[?]|1|fmol|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|LEFT|||GUARDIAN|3|Visit_3|40|1|FOLLOW-UP|2021-02-07|40
e|FA|738d539e-a810-4207-8904-fc6a5d055424|6|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|Frames/s|[?]|1|gtt|SKIN OF THE UPPER LIMB|LEFT|Y||GUARDIAN|3|Visit_3|40|1|TREATMENT|2021-02-07|40
e|FA|738d539e-a810-4207-8904-fc6a5d055424|7|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|uU/dL|[?]|1|10^6 IU/mL|CORPUS STRIATUM|CONTRALATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|4|SCREENING|2021-03-04|65
e|FA|738d539e-a810-4207-8904-fc6a5d055424|8|TOTNUM|Total Number|[?]|GERD|[?]|kg/cm|[?]|1|/200 HPFs|CHEEK|IPSILATERAL||Y|PROXY|4|Visit_4|65|4|FOLLOW-UP|2021-03-04|65
e|FA|738d539e-a810-4207-8904-fc6a5d055424|9|TRTSETT|Treatment Setting|[?]|GERD|[?]|ug/kg/day|[?]|1|Coulomb|HEAD AND NECK|LEFT|||FAMILY MEMBER|5|Visit_5|90|7|FOLLOW-UP|2021-03-29|90
e|FA|738d539e-a810-4207-8904-fc6a5d055424|10|PPTFCT|Precipitating Factor|[?]|GERD|[?]|10^10/L|[?]|1|EIA unit|GLOSSOPHARYNGEAL NERVE|BILATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2021-03-29|90
e|FA|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|1|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|Gauss|[?]|1|ng/day|SECOND DIAGONAL BRANCH ARTERY|BILATERAL|||INTERVIEWER|1|Visit_1|10|6|FOLLOW-UP|2020-08-11|10
e|FA|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|Pa|ARM SKIN|BILATERAL||Y|INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-08-11|10
e|FA|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|/100 WBC|[?]|1|%(v/v)|T5 VERTEBRA|UNILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-08-26|25
e|FA|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|4|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|ug/animal|[?]|1|U/10^12 RBC|CORRUGATOR SUPERCILII MUSCLE|RIGHT|||PARENT|2|Visit_2|25|2|TREATMENT|2020-08-26|25
e|FA|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|5|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|mmol2/L2|[?]|1|cm H2O|HAND DIGIT 3|UNILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|7|FOLLOW-UP|2020-09-10|40
e|FA|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|6|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|nmol/L/min|[?]|1|SCOOPFUL|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|RIGHT|||SPOUSE|3|Visit_3|40|2|TREATMENT|2020-09-10|40
e|FA|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|7|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|L|[?]|1|10^6 IU/mL|FEMORO-POPLITEAL PERIPHERAL ARTERY|BILATERAL||Y|CHILD|4|Visit_4|65|7|TREATMENT|2020-10-05|65
e|FA|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|8|SEV|Severity/Intensity|[?]|GERD|[?]|ppb|[?]|1|Pa|CERVICAL SPINE|LATERAL||Y|ADJUDICATOR|4|Visit_4|65|1|FOLLOW-UP|2020-10-05|65
e|FA|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|9|DCAL|Dietary Calories|[?]|GERD|[?]|AMPULE|[?]|1|EIA unit|EPIGLOTTIS|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|TREATMENT|2020-10-30|90
e|FA|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|10|LDIAM|Longest Diameter|[?]|GERD|[?]|psi|[?]|1|Shock Wave|TROCHANTER|UNILATERAL|Y|Y|INTERVIEWER|5|Visit_5|90|5|FOLLOW-UP|2020-10-30|90
e|FA|20841d37-0444-4d1d-b934-1e805cdacdaf|1|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|GPL U|[?]|1|Shock Wave|EYE BULGE|BILATERAL|||ADJUDICATOR|1|Visit_1|10|1|WASHOUT|2020-11-22|10
e|FA|20841d37-0444-4d1d-b934-1e805cdacdaf|2|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|nsec|[?]|1|Coulomb|MEDIASTINUM, SUPERIOR|LATERAL|||GUARDIAN|1|Visit_1|10|4|SCREENING|2020-11-22|10
e|FA|20841d37-0444-4d1d-b934-1e805cdacdaf|3|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|Ejaculate U|[?]|1|ohm|SUPRACLAVICULAR FOSSA|CONTRALATERAL|||SPOUSE|2|Visit_2|25|2|TREATMENT|2020-12-07|25
e|FA|20841d37-0444-4d1d-b934-1e805cdacdaf|4|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|DNA copies/ug|[?]|1|BOWL|CEREBRAL VEIN|UNILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|FOLLOW-UP|2020-12-07|25
e|FA|20841d37-0444-4d1d-b934-1e805cdacdaf|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|JDF Unit|[?]|1|U/mmol|ADRENAL GLAND|UNILATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|6|FOLLOW-UP|2020-12-22|40
e|FA|20841d37-0444-4d1d-b934-1e805cdacdaf|6|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|SQU/mL|[?]|1|cm|C6 VERTEBRA|BILATERAL|Y||SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2020-12-22|40
e|FA|20841d37-0444-4d1d-b934-1e805cdacdaf|7|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|L/kg|[?]|1|10^6 IU/mL|LATERAL HUMERAL EPICONDYLE|CONTRALATERAL||Y|DOMESTIC PARTNER|4|Visit_4|65|6|TREATMENT|2021-01-16|65
e|FA|20841d37-0444-4d1d-b934-1e805cdacdaf|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|amu|[?]|1|mg/g/min|ULNA SHAFT|IPSILATERAL|Y||PROXY|4|Visit_4|65|7|TREATMENT|2021-01-16|65
e|FA|20841d37-0444-4d1d-b934-1e805cdacdaf|9|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|uL/mL|[?]|1|h*%|PROXIMAL PHALANX 5 OF THE HAND|RIGHT|||SPOUSE|5|Visit_5|90|1|TREATMENT|2021-02-10|90
e|FA|20841d37-0444-4d1d-b934-1e805cdacdaf|10|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|PFU/dose|[?]|1|in|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|RIGHT|||FAMILY MEMBER|5|Visit_5|90|5|SCREENING|2021-02-10|90
e|FA|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|cmH2O*s/mL|[?]|1|mL/animal/day|ILIAC VEIN|BILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2020-11-01|10
e|FA|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|2|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|umol|[?]|1|in|FINGERNAIL|RIGHT||Y|ADJUDICATOR|1|Visit_1|10|5|WASHOUT|2020-11-01|10
e|FA|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|g|[?]|1|mg/g/min|BODY|LATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2020-11-16|25
e|FA|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|4|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|ug/cm2|[?]|1|mg/dose|FOREARM|LATERAL|||VENDOR|2|Visit_2|25|5|FOLLOW-UP|2020-11-16|25
e|FA|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|5|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|Ejaculate U|[?]|1|vp/dose|GASTRIC CURVATURE LYMPH NODE|IPSILATERAL|Y|Y|INDEPENDENT ASSESSOR|3|Visit_3|40|5|SCREENING|2020-12-01|40
e|FA|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|6|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|AgU/mL|[?]|1|mL/dose|BLADDER WALL|UNILATERAL|Y||PARENT|3|Visit_3|40|1|TREATMENT|2020-12-01|40
e|FA|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|7|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|pmol/L|[?]|1|mg/dose|SUBCLAVIAN ARTERY|BILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2020-12-26|65
e|FA|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|JAR|[?]|1|10^6 U|METACARPAL BONE 2|RIGHT|Y||SIBLING|4|Visit_4|65|6|TREATMENT|2020-12-26|65
e|FA|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|9|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|mg/m2|[?]|1|L|GUT-ASSOCIATED LYMPHOID TISSUE|LATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|4|SCREENING|2021-01-20|90
e|FA|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|10|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|SYRINGE|[?]|1|ug/g/h|INGUINAL REGION|LATERAL|||VENDOR|5|Visit_5|90|1|TREATMENT|2021-01-20|90
e|FA|d74682f1-824e-449d-bdf1-db517d8fdf2e|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|MAC50|[?]|1|mg/g/min|THORAX|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|SCREENING|2020-08-08|10
e|FA|d74682f1-824e-449d-bdf1-db517d8fdf2e|2|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mg/mol|[?]|1|uL/kg/day|WAIST|UNILATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|3|SCREENING|2020-08-08|10
e|FA|d74682f1-824e-449d-bdf1-db517d8fdf2e|3|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|10^7 PFU|[?]|1|10^6 U|CARPOMETACARPAL JOINT 4|IPSILATERAL||Y|FRIEND|2|Visit_2|25|3|TREATMENT|2020-08-23|25
e|FA|d74682f1-824e-449d-bdf1-db517d8fdf2e|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|TRANSDUCING UNIT/mL|[?]|1|QUANTITY SUFFICIENT|UPPER RESPIRATORY SYSTEM|BILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2020-08-23|25
e|FA|d74682f1-824e-449d-bdf1-db517d8fdf2e|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|nmol/g|[?]|1|Pa|ILIAC FOSSA|UNILATERAL|||FAMILY MEMBER|3|Visit_3|40|2|WASHOUT|2020-09-07|40
e|FA|d74682f1-824e-449d-bdf1-db517d8fdf2e|6|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|g/L|[?]|1|/200 HPFs|BRACHIAL LYMPH NODE|LATERAL|||GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-09-07|40
e|FA|d74682f1-824e-449d-bdf1-db517d8fdf2e|7|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|C|[?]|1|BAG|VOMER|RIGHT|Y||PROXY|4|Visit_4|65|2|SCREENING|2020-10-02|65
e|FA|d74682f1-824e-449d-bdf1-db517d8fdf2e|8|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|U/kg/h|[?]|1|AU/mL|INTERPHALANGEAL JOINT 2|RIGHT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|4|FOLLOW-UP|2020-10-02|65
e|FA|d74682f1-824e-449d-bdf1-db517d8fdf2e|9|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|kUSP|[?]|1|g/cage/day|PHARYNX|BILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|4|WASHOUT|2020-10-27|90
e|FA|d74682f1-824e-449d-bdf1-db517d8fdf2e|10|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|dram|[?]|1|Bq/L|LUNG|RIGHT|||INTERVIEWER|5|Visit_5|90|3|TREATMENT|2020-10-27|90
e|FA|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|1|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/kg/h|[?]|1|in|HIP|UNILATERAL|Y||CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-12-07|10
e|FA|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|pmol/L|[?]|1|Pa|EAR, INNER|LATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|FOLLOW-UP|2020-12-07|10
e|FA|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|3|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|10^9 CFU/mL|CAPITATE BONE|LATERAL|||SPOUSE|2|Visit_2|25|1|SCREENING|2020-12-22|25
e|FA|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|4|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|kBq|[?]|1|10^6/L|PANCREAS, EXOCRINE|IPSILATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|1|FOLLOW-UP|2020-12-22|25
e|FA|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|5|RLDEV|Relationship to Device|[?]|GERD|[?]|Enzyme U/m2|[?]|1|mL/min/mmHg|MID-LAD ARTERY|RIGHT|||FRIEND|3|Visit_3|40|1|TREATMENT|2021-01-06|40
e|FA|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|6|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|uCi/kg|[?]|1|SACHET|HINDLIMB|IPSILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|1|SCREENING|2021-01-06|40
e|FA|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|MET*min|[?]|1|%(v/v)|POSTERIOR TIBIAL VEIN|BILATERAL|||VENDOR|4|Visit_4|65|6|WASHOUT|2021-01-31|65
e|FA|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|8|OBJNUM|Number of Objects|[?]|GERD|[?]|mmol/day|[?]|1|mL/100g/min|INFRATENTORIAL BRAIN|CONTRALATERAL|Y|Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|SCREENING|2021-01-31|65
e|FA|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|9|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|umol/L/h|[?]|1|L|LEG|CONTRALATERAL|||DOMESTIC PARTNER|5|Visit_5|90|5|SCREENING|2021-02-25|90
e|FA|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|10|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|TRACE|[?]|1|mmHg/L/min|RETINAL NERVE FIBER LAYER|RIGHT|||CHILD|5|Visit_5|90|5|TREATMENT|2021-02-25|90
e|FA|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|1|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|10^6/Ejaculate U|[?]|1|AU/mL|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|TREATMENT|2020-07-02|10
e|FA|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|2|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|U/kg/h|[?]|1|BOWL|HEART, RIGHT VENTRICULAR FREE WALL|BILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-07-02|10
e|FA|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|3|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|g/m2/day|[?]|1|mL/mmHg/min/L|AORTOCAVAL LYMPH NODE|LATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2020-07-17|25
e|FA|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|mCi/L|[?]|1|MBq|HEART, VENTRICULAR WALL|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|4|WASHOUT|2020-07-17|25
e|FA|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|5|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|mL/kg|[?]|1|g/day|HAND DIGIT 5|LEFT|||SIGNIFICANT OTHER|3|Visit_3|40|7|FOLLOW-UP|2020-08-01|40
e|FA|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|6|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|cycle/min|[?]|1|Gy/h|RADIUS SHAFT|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|SCREENING|2020-08-01|40
e|FA|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|7|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU|[?]|1|BP|METACARPAL BONE 4|CONTRALATERAL|||SIBLING|4|Visit_4|65|7|WASHOUT|2020-08-26|65
e|FA|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|MET*min|[?]|1|CUP|URETHRA, PROSTATIC|LATERAL|Y||GUARDIAN|4|Visit_4|65|6|TREATMENT|2020-08-26|65
e|FA|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|9|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|mEq/kg|[?]|1|km|MALE REPRODUCTIVE SYSTEM|UNILATERAL|||GUARDIAN|5|Visit_5|90|3|WASHOUT|2020-09-20|90
e|FA|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|10|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mL/g/day|[?]|1|umol|GRACILIS MUSCLE|UNILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2020-09-20|90
e|FA|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|1|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|damol/L|[?]|1|h*%|TIBIA|RIGHT|Y||PROXY|1|Visit_1|10|4|WASHOUT|2020-11-17|10
e|FA|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|2|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|NFIU|[?]|1|mmHg/L/min|KNEE JOINT|UNILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-11-17|10
e|FA|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|3|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mU|[?]|1|L/h/m2|FIBULA SHAFT|RIGHT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-12-02|25
e|FA|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|GBq|[?]|1|ug/g/h|GLOSSOPHARYNGEAL NERVE|LEFT|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-12-02|25
e|FA|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|5|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|BOLUS|[?]|1|in|PERIPANCREATIC LYMPH NODE|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-12-17|40
e|FA|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|6|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|nkat/L|[?]|1|mm|EAR, OUTER|IPSILATERAL|||CHILD|3|Visit_3|40|5|TREATMENT|2020-12-17|40
e|FA|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|7|SEV|Severity/Intensity|[?]|GERD|[?]|BISCUIT|[?]|1|Pa|SUPRACLAVICULAR FOSSA|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-01-11|65
e|FA|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|8|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|dL|[?]|1|umol|ABDUCTOR DIGITI QUINTI MUSCLE|BILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|7|TREATMENT|2021-01-11|65
e|FA|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|9|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|mm/min|[?]|1|ng/day|BRACHIAL VEIN|UNILATERAL|||SPOUSE|5|Visit_5|90|1|TREATMENT|2021-02-05|90
e|FA|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|10|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|uV*sec|[?]|1|cmH2O/mL|POSTERIOR TIBIAL VEIN|LEFT|||SPOUSE|5|Visit_5|90|6|TREATMENT|2021-02-05|90
e|FA|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|1|EVENTNUM|Number of Events|[?]|GERD|[?]|mJoule/cm2|[?]|1|U/10^12 RBC|FALLOPIAN TUBE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-10-27|10
e|FA|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|2|OBJNUM|Number of Objects|[?]|GERD|[?]|umol/L/sec|[?]|1|mL/100g/min|UPPER RESPIRATORY SYSTEM|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|SCREENING|2020-10-27|10
e|FA|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|3|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|BAU/mL|[?]|1|DROP|MIDDLE EAR|RIGHT|Y|Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-11-11|25
e|FA|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|ug/L FEU|[?]|1|PFU/dose|HEPATIC ARTERY|RIGHT|||GUARDIAN|2|Visit_2|25|2|TREATMENT|2020-11-11|25
e|FA|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|5|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|Hz/s|[?]|1|QUANTITY SUFFICIENT|PROXIMAL PHALANX 2 OF THE HAND|BILATERAL|||PROXY|3|Visit_3|40|4|FOLLOW-UP|2020-11-26|40
e|FA|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|6|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|PNU/mL|[?]|1|uCi/kg|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|RIGHT||Y|SIGNIFICANT OTHER|3|Visit_3|40|4|SCREENING|2020-11-26|40
e|FA|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|7|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|10^6/Ejaculate U|[?]|1|L/h/m2|THORACIC AORTA|IPSILATERAL||Y|SPOUSE|4|Visit_4|65|1|SCREENING|2020-12-21|65
e|FA|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|8|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|mL/h|[?]|1|10^6 organisms/mL|DISTAL PHALANX 5 OF THE HAND|RIGHT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-12-21|65
e|FA|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|9|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|mL/m2/day|[?]|1|Hz/s|SACRAL VERTEBRA|UNILATERAL||Y|SIBLING|5|Visit_5|90|3|TREATMENT|2021-01-15|90
e|FA|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|10|DISTANCE|Distance|[?]|GERD|[?]|BP|[?]|1|BOWL|HEAD OF THE HUMERUS|BILATERAL|||FAMILY MEMBER|5|Visit_5|90|4|SCREENING|2021-01-15|90
e|FA|b5644705-65e9-4d9b-9f5c-f8f62d26e257|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|EID 50/dose|[?]|1|km|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-12-24|10
e|FA|b5644705-65e9-4d9b-9f5c-f8f62d26e257|2|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|EID 50/dose|[?]|1|mL|URETHRA, POSTERIOR|LATERAL||Y|STUDY SUBJECT|1|Visit_1|10|4|TREATMENT|2020-12-24|10
e|FA|b5644705-65e9-4d9b-9f5c-f8f62d26e257|3|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|umol|[?]|1|g/day|INTERPHALANGEAL JOINT 4 OF THE FOOT|UNILATERAL|||VENDOR|2|Visit_2|25|2|TREATMENT|2021-01-08|25
e|FA|b5644705-65e9-4d9b-9f5c-f8f62d26e257|4|DPROT|Dietary Protein|[?]|GERD|[?]|IU/g|[?]|1|10^4 CFU/mL|PARATRACHEAL LYMPH NODE|BILATERAL|||VENDOR|2|Visit_2|25|2|TREATMENT|2021-01-08|25
e|FA|b5644705-65e9-4d9b-9f5c-f8f62d26e257|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|CAPSULE|[?]|1|mg/g/min|FINGER|RIGHT|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|6|FOLLOW-UP|2021-01-23|40
e|FA|b5644705-65e9-4d9b-9f5c-f8f62d26e257|6|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|mEq/dL|[?]|1|mg/h|PUBIC BONE|UNILATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|2|WASHOUT|2021-01-23|40
e|FA|b5644705-65e9-4d9b-9f5c-f8f62d26e257|7|DMEAT|Dietary Meat|[?]|GERD|[?]|PNU/mL|[?]|1|10^6 organisms/mL|PENIS, GLANS|UNILATERAL|Y|Y|SIGNIFICANT OTHER|4|Visit_4|65|5|WASHOUT|2021-02-17|65
e|FA|b5644705-65e9-4d9b-9f5c-f8f62d26e257|8|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|HOURS|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|3|FOLLOW-UP|2021-02-17|65
e|FA|b5644705-65e9-4d9b-9f5c-f8f62d26e257|9|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit|[?]|1|10^6 U|LUMBAR SPINE|CONTRALATERAL|Y||PROXY|5|Visit_5|90|2|TREATMENT|2021-03-14|90
e|FA|b5644705-65e9-4d9b-9f5c-f8f62d26e257|10|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|/500 WBC|[?]|1|mAmp|HEEL OF THE HAND|LATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2021-03-14|90
e|FA|ec82f59b-197a-4ccc-b5e5-d91627a86a27|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|CAPLET|[?]|1|10^6 U|DISTAL RADIOULNAR JOINT|IPSILATERAL|||CHILD|1|Visit_1|10|4|FOLLOW-UP|2020-05-16|10
e|FA|ec82f59b-197a-4ccc-b5e5-d91627a86a27|2|SEV|Severity/Intensity|[?]|GERD|[?]|uL/kg/day|[?]|1|Pa|PROXIMAL INTERPHALANGEAL JOINT 3|LEFT|||PROXY|1|Visit_1|10|6|TREATMENT|2020-05-16|10
e|FA|ec82f59b-197a-4ccc-b5e5-d91627a86a27|3|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|g/U|[?]|1|mL/100g/min|APPENDICEAL TIP|RIGHT|||PARENT|2|Visit_2|25|1|FOLLOW-UP|2020-05-31|25
e|FA|ec82f59b-197a-4ccc-b5e5-d91627a86a27|4|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|ug/kg|[?]|1|Log10 ELISA unit|ABDUCTOR DIGITI QUINTI MUSCLE|CONTRALATERAL|||SPOUSE|2|Visit_2|25|7|SCREENING|2020-05-31|25
e|FA|ec82f59b-197a-4ccc-b5e5-d91627a86a27|5|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|%/s|[?]|1|L/h/m2|TRIANGULAR-HAMATE JOINT|RIGHT||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-06-15|40
e|FA|ec82f59b-197a-4ccc-b5e5-d91627a86a27|6|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|mL/animal/day|ISCHIORECTAL FOSSA|IPSILATERAL|||FAMILY MEMBER|3|Visit_3|40|3|FOLLOW-UP|2020-06-15|40
e|FA|ec82f59b-197a-4ccc-b5e5-d91627a86a27|7|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|Shock Wave|FLOOR OF MOUTH|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-07-10|65
e|FA|ec82f59b-197a-4ccc-b5e5-d91627a86a27|8|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|ng|T6 VERTEBRA|LATERAL|Y||VENDOR|4|Visit_4|65|3|FOLLOW-UP|2020-07-10|65
e|FA|ec82f59b-197a-4ccc-b5e5-d91627a86a27|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|GBq|[?]|1|%(v/v)|BRAIN, PERIVENTRICULAR REGION|UNILATERAL|Y||SIBLING|5|Visit_5|90|3|FOLLOW-UP|2020-08-04|90
e|FA|ec82f59b-197a-4ccc-b5e5-d91627a86a27|10|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|amu|[?]|1|MBq|UPPER CERVICAL LYMPH NODE|BILATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|3|FOLLOW-UP|2020-08-04|90
e|FA|527fd604-110f-47b1-bd8b-b1de2f5b0d29|1|DISTANCE|Distance|[?]|GERD|[?]|/month|[?]|1|BOWL|INTERPHALANGEAL JOINT 3|LEFT||Y|INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-11-29|10
e|FA|527fd604-110f-47b1-bd8b-b1de2f5b0d29|2|LDIAM|Longest Diameter|[?]|GERD|[?]|PACKET|[?]|1|Shock Wave|LOCUS CERULEUS|IPSILATERAL||Y|SIBLING|1|Visit_1|10|1|TREATMENT|2020-11-29|10
e|FA|527fd604-110f-47b1-bd8b-b1de2f5b0d29|3|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|pmol/L/h|[?]|1|ng/day|LIMB, UPPER|RIGHT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|FOLLOW-UP|2020-12-14|25
e|FA|527fd604-110f-47b1-bd8b-b1de2f5b0d29|4|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|PELLET|[?]|1|U/mg|TRAPEZOID-CAPITATE JOINT|LEFT||Y|FRIEND|2|Visit_2|25|3|SCREENING|2020-12-14|25
e|FA|527fd604-110f-47b1-bd8b-b1de2f5b0d29|5|SEV|Severity/Intensity|[?]|GERD|[?]|uV*sec|[?]|1|Pa|PALATE|IPSILATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|2|WASHOUT|2020-12-29|40
e|FA|527fd604-110f-47b1-bd8b-b1de2f5b0d29|6|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|PFU/animal|[?]|1|10^6 U|EXTENSOR HALLUCIS BREVIS MUSCLE|CONTRALATERAL|Y||PROXY|3|Visit_3|40|4|TREATMENT|2020-12-29|40
e|FA|527fd604-110f-47b1-bd8b-b1de2f5b0d29|7|SEV|Severity/Intensity|[?]|GERD|[?]|10^6 copies/mL|[?]|1|Pa|RAPHE|IPSILATERAL||Y|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-01-23|65
e|FA|527fd604-110f-47b1-bd8b-b1de2f5b0d29|8|ACNDEV|Action Taken With Device|[?]|GERD|[?]|fmol/L|[?]|1|100 IU/mL|THORAX|RIGHT|||CAREGIVER|4|Visit_4|65|3|FOLLOW-UP|2021-01-23|65
e|FA|527fd604-110f-47b1-bd8b-b1de2f5b0d29|9|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|CUP|RADIUS|LEFT|||GUARDIAN|5|Visit_5|90|3|SCREENING|2021-02-17|90
e|FA|527fd604-110f-47b1-bd8b-b1de2f5b0d29|10|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|uV|[?]|1|Weber|VAGUS NERVE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2021-02-17|90
e|FA|1e1de453-920a-4132-b2f7-6335ee81ec83|1|DFATT|Dietary Fat, Total|[?]|GERD|[?]|10^7 TCID 50/dose|[?]|1|Bq/mg|CEREBELLUM|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|TREATMENT|2020-10-22|10
e|FA|1e1de453-920a-4132-b2f7-6335ee81ec83|2|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|nU/cL|[?]|1|Log10 ELISA unit|AORTOPULMONARY WINDOW LYMPH NODE|UNILATERAL||Y|GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-10-22|10
e|FA|1e1de453-920a-4132-b2f7-6335ee81ec83|3|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|tsp|[?]|1|IU/mmol|CEPHALIC VEIN|BILATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-11-06|25
e|FA|1e1de453-920a-4132-b2f7-6335ee81ec83|4|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|h/wk|[?]|1|IU/mmol|INTRAHEPATIC LARGE BILE DUCT|IPSILATERAL|||PARENT|2|Visit_2|25|4|TREATMENT|2020-11-06|25
e|FA|1e1de453-920a-4132-b2f7-6335ee81ec83|5|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|/day|[?]|1|gtt|PROFUNDA FEMORIS ARTERY|LATERAL|||SIBLING|3|Visit_3|40|3|TREATMENT|2020-11-21|40
e|FA|1e1de453-920a-4132-b2f7-6335ee81ec83|6|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|QUANTITY SUFFICIENT|[?]|1|Shock Wave|DENTAL ARCH|LEFT|||INDEPENDENT ASSESSOR|3|Visit_3|40|5|SCREENING|2020-11-21|40
e|FA|1e1de453-920a-4132-b2f7-6335ee81ec83|7|DFRUIT|Dietary Fruit|[?]|GERD|[?]|BU|[?]|1|10^6 CFU/mL|BRAIN, PERIVENTRICULAR REGION|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2020-12-16|65
e|FA|1e1de453-920a-4132-b2f7-6335ee81ec83|8|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|m2|JEJUNUM|UNILATERAL|Y||CHILD|4|Visit_4|65|4|TREATMENT|2020-12-16|65
e|FA|1e1de453-920a-4132-b2f7-6335ee81ec83|9|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|mol/mol|[?]|1|vp/dose|FINGER FLEXOR MUSCLES|LATERAL|||INVESTIGATOR|5|Visit_5|90|3|WASHOUT|2021-01-10|90
e|FA|1e1de453-920a-4132-b2f7-6335ee81ec83|10|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|umol/min|[?]|1|mL/h|LATERAL HUMERAL EPICONDYLE|LEFT|||GUARDIAN|5|Visit_5|90|4|WASHOUT|2021-01-10|90
e|FA|e553ad8e-96f4-4cb0-a005-51e9b64513b7|1|DMG|Dietary Magnesium|[?]|GERD|[?]|m|[?]|1|TRANSDUCING UNIT/mL|OSTIOMEATAL COMPLEX|IPSILATERAL|Y|Y|INVESTIGATOR|1|Visit_1|10|7|SCREENING|2020-06-29|10
e|FA|e553ad8e-96f4-4cb0-a005-51e9b64513b7|2|SEV|Severity/Intensity|[?]|GERD|[?]|g/U|[?]|1|Pa|AXILLARY LYMPH NODE LEVEL I|BILATERAL|||ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-06-29|10
e|FA|e553ad8e-96f4-4cb0-a005-51e9b64513b7|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Ci/mg|[?]|1|mg/g/min|EAR, OUTER|RIGHT||Y|FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-07-14|25
e|FA|e553ad8e-96f4-4cb0-a005-51e9b64513b7|4|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|BU|[?]|1|PACK|HEPATIC ARTERY|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|SCREENING|2020-07-14|25
e|FA|e553ad8e-96f4-4cb0-a005-51e9b64513b7|5|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|CYLINDER|[?]|1|10^6 U|MID-LAD ARTERY|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|FOLLOW-UP|2020-07-29|40
e|FA|e553ad8e-96f4-4cb0-a005-51e9b64513b7|6|AGETRT1|Age At First Treatment|[?]|GERD|[?]|10^10/L|[?]|1|mL/mmHg/min/L|C7 VERTEBRA|IPSILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|WASHOUT|2020-07-29|40
e|FA|e553ad8e-96f4-4cb0-a005-51e9b64513b7|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^3 organisms/g|[?]|1|%(v/v)|RECTUM|LEFT||Y|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-08-23|65
e|FA|e553ad8e-96f4-4cb0-a005-51e9b64513b7|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|kPa/L/sec|[?]|1|mL|FEMORAL CONDYLE|LEFT|Y||INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-08-23|65
e|FA|e553ad8e-96f4-4cb0-a005-51e9b64513b7|9|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|Shock Wave|HAIR BULB|IPSILATERAL|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|6|SCREENING|2020-09-17|90
e|FA|e553ad8e-96f4-4cb0-a005-51e9b64513b7|10|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|ug/m2/h|LEFT VENTRICULAR MID INFERIOR SEGMENT|CONTRALATERAL||Y|INVESTIGATOR|5|Visit_5|90|7|FOLLOW-UP|2020-09-17|90
e|FA|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|1|LDIAM|Longest Diameter|[?]|GERD|[?]|INHALATION|[?]|1|Shock Wave|LIVER, QUADRATE LOBE|IPSILATERAL|||GUARDIAN|1|Visit_1|10|4|WASHOUT|2020-12-16|10
e|FA|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|U/g/min|[?]|1|Pa|RIB|UNILATERAL|||ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-12-16|10
e|FA|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|3|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|steps/min|[?]|1|NEEDLE GAUGE|SOLE|LEFT|Y|Y|INDEPENDENT ASSESSOR|2|Visit_2|25|7|FOLLOW-UP|2020-12-31|25
e|FA|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|4|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|Torr|[?]|1|Log10 ELISA unit|CAUDAL VERTEBRA|RIGHT||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-12-31|25
e|FA|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|5|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|ELISA unit/mL|[?]|1|BP|AORTOCAVAL LYMPH NODE|BILATERAL|||ADJUDICATOR|3|Visit_3|40|1|WASHOUT|2021-01-15|40
e|FA|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|6|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|pptr|[?]|1|U/10^12 RBC|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|UNILATERAL|||PARENT|3|Visit_3|40|4|FOLLOW-UP|2021-01-15|40
e|FA|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|7|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|OD Unit|[?]|1|Weber|HEART, VENTRICLE|IPSILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|4|WASHOUT|2021-02-09|65
e|FA|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|8|DFIBER|Dietary Fiber|[?]|GERD|[?]|Frames/s|[?]|1|h*%|LEFT MAIN CORONARY ARTERY BIFURCATION|LEFT|||CHILD|4|Visit_4|65|3|WASHOUT|2021-02-09|65
e|FA|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|9|ACNDEV|Action Taken With Device|[?]|GERD|[?]|Absorbance U|[?]|1|100 IU/mL|STERNEBRA|UNILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|3|TREATMENT|2021-03-06|90
e|FA|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|U/g/h|[?]|1|10^6 U|MIDDLE PHALANX 5 OF THE HAND|RIGHT|Y||SIBLING|5|Visit_5|90|1|TREATMENT|2021-03-06|90
e|FA|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|1|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mV/sec|[?]|1|U/10^12 RBC|EAR, OUTER|UNILATERAL|||PARENT|1|Visit_1|10|5|TREATMENT|2020-06-09|10
e|FA|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|2|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/mL|[?]|1|MPS U|L2 VERTEBRA|LATERAL|||STUDY SUBJECT|1|Visit_1|10|6|WASHOUT|2020-06-09|10
e|FA|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|nmol/L|[?]|1|U/mg|LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT|LATERAL||Y|INTERVIEWER|2|Visit_2|25|6|FOLLOW-UP|2020-06-24|25
e|FA|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mEq/g|[?]|1|%(v/v)|COLON|RIGHT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|TREATMENT|2020-06-24|25
e|FA|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|5|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|PUFF|[?]|1|NEEDLE GAUGE|LIP, UPPER|LEFT|||CHILD|3|Visit_3|40|3|FOLLOW-UP|2020-07-09|40
e|FA|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|6|DFRUIT|Dietary Fruit|[?]|GERD|[?]|ug/m2/min|[?]|1|10^6 CFU/mL|PARAVERTEBRAL GANGLIA|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|TREATMENT|2020-07-09|40
e|FA|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|7|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|uCi/kg|[?]|1|cm H2O|GREAT TROCHANTER|LATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-08-03|65
e|FA|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|8|EVENTNUM|Number of Events|[?]|GERD|[?]|U/m2|[?]|1|U/10^12 RBC|DUCTUS ARTERIOSUS|UNILATERAL|Y||DOMESTIC PARTNER|4|Visit_4|65|6|WASHOUT|2020-08-03|65
e|FA|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|9|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|g/L|HEART, SEPTUM|RIGHT|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|2|FOLLOW-UP|2020-08-28|90
e|FA|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|10|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|cm/s|[?]|1|Coulomb|THROAT|UNILATERAL|||INTERVIEWER|5|Visit_5|90|1|TREATMENT|2020-08-28|90
e|FA|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|1|DISTANCE|Distance|[?]|GERD|[?]|lm|[?]|1|BOWL|METACARPOPHALANGEAL JOINT 5|RIGHT|||CAREGIVER|1|Visit_1|10|6|FOLLOW-UP|2020-10-29|10
e|FA|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|2|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|breaths/30s|[?]|1|U/10^12 RBC|GLENOID FOSSA|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|SCREENING|2020-10-29|10
e|FA|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|3|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|anti-Xa IU/mL|ASCENDING AORTA, AORTIC ROOT|LEFT||Y|STUDY SUBJECT|2|Visit_2|25|3|SCREENING|2020-11-13|25
e|FA|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|4|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|Ci/mL|[?]|1|mm/h|C3 VERTEBRA|RIGHT|||ADJUDICATION COMMITTEE|2|Visit_2|25|1|SCREENING|2020-11-13|25
e|FA|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|5|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mL/dose|[?]|1|ug/kg/h|SUPRATENTORIAL BRAIN|RIGHT|Y||VENDOR|3|Visit_3|40|4|TREATMENT|2020-11-28|40
e|FA|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|HOURS|[?]|1|Shock Wave|C2 VERTEBRA|RIGHT|||FRIEND|3|Visit_3|40|7|FOLLOW-UP|2020-11-28|40
e|FA|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|7|SEV|Severity/Intensity|[?]|GERD|[?]|U/kg|[?]|1|Pa|TOE|BILATERAL|||INTERVIEWER|4|Visit_4|65|4|TREATMENT|2020-12-23|65
e|FA|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|mL|FIBULA SHAFT|RIGHT|||FAMILY MEMBER|4|Visit_4|65|5|WASHOUT|2020-12-23|65
e|FA|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|9|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|nkat|[?]|1|km|LARGE INTESTINE|CONTRALATERAL|||FRIEND|5|Visit_5|90|7|SCREENING|2021-01-17|90
e|FA|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|%/min|[?]|1|mg/g/min|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|IPSILATERAL||Y|PARENT|5|Visit_5|90|4|TREATMENT|2021-01-17|90
e|FA|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|1|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|Newton|[?]|1|mg/dose|METATARSOPHALANGEAL JOINT 5|LATERAL|||INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-12-24|10
e|FA|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|2|LOCONSET|Localization of Onset|[?]|GERD|[?]|yd|[?]|1|g/L|RECTUS FEMORIS MUSCLE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|SCREENING|2020-12-24|10
e|FA|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|3|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|dpm/100mg|[?]|1|U/mmol|HEART, LEFT ATRIAL APPENDAGE|LEFT|||CHILD|2|Visit_2|25|1|FOLLOW-UP|2021-01-08|25
e|FA|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|4|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|IU/g|[?]|1|mL|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL||Y|INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2021-01-08|25
e|FA|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|5|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|mEq|[?]|1|Ci/ug|URETHRA|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|2|TREATMENT|2021-01-23|40
e|FA|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|6|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|MET*min|[?]|1|mAmp|GENITAL TUBERCLE|RIGHT|||GUARDIAN|3|Visit_3|40|7|TREATMENT|2021-01-23|40
e|FA|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|7|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|Roentgen|[?]|1|Log10 ELISA unit|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|UNILATERAL|Y||CAREGIVER|4|Visit_4|65|3|WASHOUT|2021-02-17|65
e|FA|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|8|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mL/sec/1.73m2|[?]|1|cm H2O|INTERATRIAL SEPTUM|RIGHT|||PROXY|4|Visit_4|65|3|TREATMENT|2021-02-17|65
e|FA|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|9|OBJTYPE|Type of Object|[?]|GERD|[?]|g/cage|[?]|1|ng|ANTERIOR TIBIAL VEIN|IPSILATERAL|||CAREGIVER|5|Visit_5|90|4|WASHOUT|2021-03-14|90
e|FA|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|10|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|cm/min|[?]|1|mm/h|CALCARINE SULCUS|CONTRALATERAL|||SIBLING|5|Visit_5|90|5|TREATMENT|2021-03-14|90
e|FA|ad04ec90-9fd5-49f2-ae23-264273eb0a24|1|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|uL/kg/day|INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|Y||CAREGIVER|1|Visit_1|10|4|TREATMENT|2020-10-17|10
e|FA|ad04ec90-9fd5-49f2-ae23-264273eb0a24|2|DVEG|Dietary Vegetable|[?]|GERD|[?]|umol/min|[?]|1|Ci/ug|SUBMANDIBULAR LYMPH NODE|UNILATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-10-17|10
e|FA|ad04ec90-9fd5-49f2-ae23-264273eb0a24|3|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mL/cage/wk|[?]|1|mL|EXTENSOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|||SIBLING|2|Visit_2|25|1|TREATMENT|2020-11-01|25
e|FA|ad04ec90-9fd5-49f2-ae23-264273eb0a24|4|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|log10 TCID 50/uL|[?]|1|10^6 U|COLON, RIGHT|IPSILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-11-01|25
e|FA|ad04ec90-9fd5-49f2-ae23-264273eb0a24|5|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|nsec|[?]|1|g/L|BRAIN VENTRICLE|LEFT|||SPOUSE|3|Visit_3|40|3|TREATMENT|2020-11-16|40
e|FA|ad04ec90-9fd5-49f2-ae23-264273eb0a24|6|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|mL/cm3/min|[?]|1|TRANSDUCING UNIT/mL|MIDDLE PHALANX 2 OF THE HAND|RIGHT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-11-16|40
e|FA|ad04ec90-9fd5-49f2-ae23-264273eb0a24|7|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|GBq/g|[?]|1|SACHET|INTRAHEPATIC LARGE BILE DUCT|LEFT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|WASHOUT|2020-12-11|65
e|FA|ad04ec90-9fd5-49f2-ae23-264273eb0a24|8|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|Shock Wave|FORELIMB|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2020-12-11|65
e|FA|ad04ec90-9fd5-49f2-ae23-264273eb0a24|9|ESTWT|Estimated Weight|[?]|GERD|[?]|ug/day|[?]|1|g/day|TRICUSPID VALVE ANNULUS|BILATERAL|||GUARDIAN|5|Visit_5|90|3|WASHOUT|2021-01-05|90
e|FA|ad04ec90-9fd5-49f2-ae23-264273eb0a24|10|EXCDUR|Exercise Duration|[?]|GERD|[?]|10^6 CFU/mL|[?]|1|mm|DISTAL PHALANX 3 OF THE HAND|BILATERAL|Y||CAREGIVER|5|Visit_5|90|4|SCREENING|2021-01-05|90
e|FA|a1d203ef-7ee1-4373-988a-370532bae2b1|1|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|anti-Xa IU|[?]|1|Hz/s|GALLBLADDER|RIGHT|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|6|FOLLOW-UP|2021-01-28|10
e|FA|a1d203ef-7ee1-4373-988a-370532bae2b1|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|nkat/g Hb|[?]|1|%(v/v)|RIB 7|RIGHT|||SPOUSE|1|Visit_1|10|5|TREATMENT|2021-01-28|10
e|FA|a1d203ef-7ee1-4373-988a-370532bae2b1|3|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|INHALATION|[?]|1|10^4 CFU/mL|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|CONTRALATERAL|Y||PARENT|2|Visit_2|25|3|TREATMENT|2021-02-12|25
e|FA|a1d203ef-7ee1-4373-988a-370532bae2b1|4|TOXGR|Toxicity Grade|[?]|GERD|[?]|mOsm/kg|[?]|1|aMFI|SUBMENTAL LYMPH NODE|RIGHT||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|7|WASHOUT|2021-02-12|25
e|FA|a1d203ef-7ee1-4373-988a-370532bae2b1|5|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|L/s|[?]|1|mL/cm3/min|COMMON FEMORAL ARTERY|LATERAL|||ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2021-02-27|40
e|FA|a1d203ef-7ee1-4373-988a-370532bae2b1|6|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|pmol/day|[?]|1|g/day|ETHMOID SINUS|BILATERAL|||FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2021-02-27|40
e|FA|a1d203ef-7ee1-4373-988a-370532bae2b1|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|bel|[?]|1|umol|T11 VERTEBRA|BILATERAL|||GUARDIAN|4|Visit_4|65|2|TREATMENT|2021-03-24|65
e|FA|a1d203ef-7ee1-4373-988a-370532bae2b1|8|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|HOMEOPATHIC DILUTION|[?]|1|km|PROCERUS MUSCLE|LATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|1|TREATMENT|2021-03-24|65
e|FA|a1d203ef-7ee1-4373-988a-370532bae2b1|9|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT/mL|[?]|1|cmH2O/mL|SYMPATHETIC GANGLIA|IPSILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|SCREENING|2021-04-18|90
e|FA|a1d203ef-7ee1-4373-988a-370532bae2b1|10|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|Bq/L|[?]|1|mL/h|BRAIN VENTRICLE, LATERAL|RIGHT|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|2|FOLLOW-UP|2021-04-18|90
e|FA|4389d158-cb51-4779-b19a-f38dbef0806a|1|OBJNUM|Number of Objects|[?]|GERD|[?]|10^9 organisms/mL|[?]|1|mL/100g/min|DUODENUM|UNILATERAL|||FAMILY MEMBER|1|Visit_1|10|7|WASHOUT|2020-06-22|10
e|FA|4389d158-cb51-4779-b19a-f38dbef0806a|2|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|mm2|[?]|1|mL|GASTROINTESTINAL TRACT|IPSILATERAL||Y|FRIEND|1|Visit_1|10|4|FOLLOW-UP|2020-06-22|10
e|FA|4389d158-cb51-4779-b19a-f38dbef0806a|3|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/g/day|[?]|1|10^9 CFU/mL|EXTENSOR HALLUCIS BREVIS MUSCLE|IPSILATERAL||Y|VENDOR|2|Visit_2|25|1|SCREENING|2020-07-07|25
e|FA|4389d158-cb51-4779-b19a-f38dbef0806a|4|DFIBER|Dietary Fiber|[?]|GERD|[?]|IU/dL|[?]|1|h*%|THYMUS GLAND|UNILATERAL|Y||INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-07-07|25
e|FA|4389d158-cb51-4779-b19a-f38dbef0806a|5|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|umol|[?]|1|ug/m2/h|CEREBRAL VEIN|CONTRALATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|5|SCREENING|2020-07-22|40
e|FA|4389d158-cb51-4779-b19a-f38dbef0806a|6|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|10^6 CFU|VENOUS SINUS|UNILATERAL|||PROXY|3|Visit_3|40|3|TREATMENT|2020-07-22|40
e|FA|4389d158-cb51-4779-b19a-f38dbef0806a|7|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|ug/L DDU|[?]|1|cm H2O|MITRAL VALVE, ANTERIOR ANNULUS|UNILATERAL||Y|PROXY|4|Visit_4|65|4|TREATMENT|2020-08-16|65
e|FA|4389d158-cb51-4779-b19a-f38dbef0806a|8|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|U/g/day|[?]|1|NEEDLE GAUGE|MIDBRAIN|CONTRALATERAL|||VENDOR|4|Visit_4|65|2|FOLLOW-UP|2020-08-16|65
e|FA|4389d158-cb51-4779-b19a-f38dbef0806a|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|cal|[?]|1|Pa|MALE REPRODUCTIVE SYSTEM|BILATERAL|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|3|FOLLOW-UP|2020-09-10|90
e|FA|4389d158-cb51-4779-b19a-f38dbef0806a|10|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|/MBP|[?]|1|/500 WBC|ISCHIUM|IPSILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|7|WASHOUT|2020-09-10|90
e|FA|3a973b7a-3583-4383-b59e-3dab51b511bd|1|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|amol|[?]|1|mL/dose|FEMORAL VEIN|LATERAL|||INTERVIEWER|1|Visit_1|10|4|WASHOUT|2021-01-19|10
e|FA|3a973b7a-3583-4383-b59e-3dab51b511bd|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT|[?]|1|mg/g/min|PRONATOR TERES MUSCLE|BILATERAL||Y|CAREGIVER|1|Visit_1|10|3|TREATMENT|2021-01-19|10
e|FA|3a973b7a-3583-4383-b59e-3dab51b511bd|3|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|uSiemens|[?]|1|uL/kg/day|EYELID|CONTRALATERAL||Y|CAREGIVER|2|Visit_2|25|6|TREATMENT|2021-02-03|25
e|FA|3a973b7a-3583-4383-b59e-3dab51b511bd|4|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|kg/m2|[?]|1|gtt|SALIVARY GLAND|UNILATERAL|Y||SPOUSE|2|Visit_2|25|7|SCREENING|2021-02-03|25
e|FA|3a973b7a-3583-4383-b59e-3dab51b511bd|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/dose|[?]|1|mg/g/min|RIB 10|UNILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|FOLLOW-UP|2021-02-18|40
e|FA|3a973b7a-3583-4383-b59e-3dab51b511bd|6|ACNDEV|Action Taken With Device|[?]|GERD|[?]|rpm|[?]|1|100 IU/mL|TONSIL|IPSILATERAL|||INTERVIEWER|3|Visit_3|40|5|WASHOUT|2021-02-18|40
e|FA|3a973b7a-3583-4383-b59e-3dab51b511bd|7|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/g Hb|[?]|1|TRANSDUCING UNIT/mL|ILIOTIBIAL BAND|RIGHT|||ADJUDICATION COMMITTEE|4|Visit_4|65|6|SCREENING|2021-03-15|65
e|FA|3a973b7a-3583-4383-b59e-3dab51b511bd|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU|[?]|1|PFU/dose|CANINE TOOTH|LATERAL||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2021-03-15|65
e|FA|3a973b7a-3583-4383-b59e-3dab51b511bd|9|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|Hz|[?]|1|U/10^12 RBC|EPIGLOTTIS|IPSILATERAL|Y||INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2021-04-09|90
e|FA|3a973b7a-3583-4383-b59e-3dab51b511bd|10|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|dL|[?]|1|DROP|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|IPSILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|TREATMENT|2021-04-09|90
e|FA|d283591c-2085-459e-94f2-d3eb6b81aea7|1|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|ug/kg/h|ATRIOVENTRICULAR VALVE|LEFT|Y|Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|WASHOUT|2020-09-28|10
e|FA|d283591c-2085-459e-94f2-d3eb6b81aea7|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|GPS U|[?]|1|%(v/v)|MEDIASTINUM, POSTERIOR|CONTRALATERAL|Y||FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-09-28|10
e|FA|d283591c-2085-459e-94f2-d3eb6b81aea7|3|AGETRT1|Age At First Treatment|[?]|GERD|[?]|Hz|[?]|1|mL/mmHg/min/L|PENIS, RADIX|LATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|FOLLOW-UP|2020-10-13|25
e|FA|d283591c-2085-459e-94f2-d3eb6b81aea7|4|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|RATIO|[?]|1|DROP|SPLENIC VEIN|LATERAL||Y|SPOUSE|2|Visit_2|25|3|TREATMENT|2020-10-13|25
e|FA|d283591c-2085-459e-94f2-d3eb6b81aea7|5|SEV|Severity/Intensity|[?]|GERD|[?]|tuberculin unit|[?]|1|Pa|FACET JOINT|LATERAL|Y||ADJUDICATOR|3|Visit_3|40|6|WASHOUT|2020-10-28|40
e|FA|d283591c-2085-459e-94f2-d3eb6b81aea7|6|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|vp/dose|[?]|1|/200 HPFs|T12 VERTEBRA|IPSILATERAL|Y||CAREGIVER|3|Visit_3|40|7|SCREENING|2020-10-28|40
e|FA|d283591c-2085-459e-94f2-d3eb6b81aea7|7|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|PATCH|[?]|1|IU/mg|CARDIOVASCULAR SYSTEM|CONTRALATERAL||Y|CAREGIVER|4|Visit_4|65|1|TREATMENT|2020-11-22|65
e|FA|d283591c-2085-459e-94f2-d3eb6b81aea7|8|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|deg|[?]|1|10^6 CFU/mL|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|BILATERAL|||VENDOR|4|Visit_4|65|1|SCREENING|2020-11-22|65
e|FA|d283591c-2085-459e-94f2-d3eb6b81aea7|9|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|ks|[?]|1|Bq/mg|ORAL MUCOSA|BILATERAL|||CHILD|5|Visit_5|90|4|TREATMENT|2020-12-17|90
e|FA|d283591c-2085-459e-94f2-d3eb6b81aea7|10|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/nmol|[?]|1|ng/day|FIBULA|IPSILATERAL|Y||INTERVIEWER|5|Visit_5|90|1|TREATMENT|2020-12-17|90
e|FA|da31f695-9f6a-46b2-8002-5c1c21b55cf3|1|EXTRSCT|Extent of Resection|[?]|GERD|[?]|U/g/day|[?]|1|Weber|KNEE JOINT TENDONS|LATERAL|||INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-10-01|10
e|FA|da31f695-9f6a-46b2-8002-5c1c21b55cf3|2|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|nmol/L/h|[?]|1|mmHg/L/min|MAIN BRONCHUS, LEFT|RIGHT|Y|Y|VENDOR|1|Visit_1|10|3|FOLLOW-UP|2020-10-01|10
e|FA|da31f695-9f6a-46b2-8002-5c1c21b55cf3|3|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|Bq/uL|[?]|1|PACK|GLUTEUS MAXIMUS|BILATERAL|||FRIEND|2|Visit_2|25|7|TREATMENT|2020-10-16|25
e|FA|da31f695-9f6a-46b2-8002-5c1c21b55cf3|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ft2|[?]|1|mg/g/min|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|UNILATERAL|Y|Y|INDEPENDENT ASSESSOR|2|Visit_2|25|1|TREATMENT|2020-10-16|25
e|FA|da31f695-9f6a-46b2-8002-5c1c21b55cf3|5|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mL/s/m2|[?]|1|ohm|GASTROINTESTINAL TRACT, UPPER|LATERAL||Y|FRIEND|3|Visit_3|40|4|TREATMENT|2020-10-31|40
e|FA|da31f695-9f6a-46b2-8002-5c1c21b55cf3|6|DCAL|Dietary Calories|[?]|GERD|[?]|nm|[?]|1|EIA unit|NUCLEUS OF DIAGONAL BAND|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|7|SCREENING|2020-10-31|40
e|FA|da31f695-9f6a-46b2-8002-5c1c21b55cf3|7|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|PFU|[?]|1|Ci/ug|PITUITARY GLAND|LATERAL|||INVESTIGATOR|4|Visit_4|65|7|WASHOUT|2020-11-25|65
e|FA|da31f695-9f6a-46b2-8002-5c1c21b55cf3|8|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mg/mL/min|[?]|1|100 IU/mL|INTERNAL MAMMARY LYMPH NODE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|SCREENING|2020-11-25|65
e|FA|da31f695-9f6a-46b2-8002-5c1c21b55cf3|9|ESTWT|Estimated Weight|[?]|GERD|[?]|Ci/L|[?]|1|g/day|T3 VERTEBRA|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|FOLLOW-UP|2020-12-20|90
e|FA|da31f695-9f6a-46b2-8002-5c1c21b55cf3|10|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|dpm/100mg|[?]|1|ohm|T10 VERTEBRA|BILATERAL|||PARENT|5|Visit_5|90|1|FOLLOW-UP|2020-12-20|90
e|FA|4cd63e56-3d93-403a-8011-3b4fcf26e445|1|SERVNUM|Number of Servings|[?]|GERD|[?]|foz_us|[?]|1|Hz/s|INTERPHALANGEAL JOINT 2 OF THE FOOT|LEFT|||STUDY SUBJECT|1|Visit_1|10|5|SCREENING|2020-12-27|10
e|FA|4cd63e56-3d93-403a-8011-3b4fcf26e445|2|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|pkat|[?]|1|g/cage/day|SKIN OF THE EAR|LATERAL|||INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-12-27|10
e|FA|4cd63e56-3d93-403a-8011-3b4fcf26e445|3|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|cmHg|[?]|1|g/dL|ANAL CANAL|IPSILATERAL|Y|Y|FRIEND|2|Visit_2|25|4|FOLLOW-UP|2021-01-11|25
e|FA|4cd63e56-3d93-403a-8011-3b4fcf26e445|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|MBP|[?]|1|Pa|BONE MARROW|UNILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2021-01-11|25
e|FA|4cd63e56-3d93-403a-8011-3b4fcf26e445|5|EVENTFRQ|Event Frequency|[?]|GERD|[?]|PFU/mL|[?]|1|ug/kg/h|SKIN OF THE PALM|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2021-01-26|40
e|FA|4cd63e56-3d93-403a-8011-3b4fcf26e445|6|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mol/mL|[?]|1|Weber|UTERUS|IPSILATERAL|||CAREGIVER|3|Visit_3|40|5|FOLLOW-UP|2021-01-26|40
e|FA|4cd63e56-3d93-403a-8011-3b4fcf26e445|7|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|gMFI|[?]|1|uCi/kg|PLEURA|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|SCREENING|2021-02-20|65
e|FA|4cd63e56-3d93-403a-8011-3b4fcf26e445|8|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|CIGAR|[?]|1|Bq/L|ISCHIAL TUBEROSITY|IPSILATERAL||Y|FRIEND|4|Visit_4|65|6|TREATMENT|2021-02-20|65
e|FA|4cd63e56-3d93-403a-8011-3b4fcf26e445|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|COAT|[?]|1|10^6 IU/mL|SACRAL TUBEROSITY|LATERAL|Y||VENDOR|5|Visit_5|90|2|TREATMENT|2021-03-17|90
e|FA|4cd63e56-3d93-403a-8011-3b4fcf26e445|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|POUCH|[?]|1|mg/g/min|SCAPHOID-TRAPEZIUM JOINT|RIGHT|||SPOUSE|5|Visit_5|90|6|WASHOUT|2021-03-17|90
e|FA|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|1|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|kPa|[?]|1|Ci/ug|LOWER GASTROINTESTINAL TRACT LYMPH NODE|LEFT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|5|WASHOUT|2020-05-23|10
e|FA|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|2|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|10^9/L|[?]|1|ug/g/h|PROXIMAL CIRCUMFLEX ARTERY|BILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2020-05-23|10
e|FA|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|3|LESNUM|Number of Lesions|[?]|GERD|[?]|s/h|[?]|1|ng/day|BRONCHUS|UNILATERAL|||SPOUSE|2|Visit_2|25|7|SCREENING|2020-06-07|25
e|FA|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|4|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|dmol|[?]|1|mL/h|EAR, INNER|RIGHT|||CHILD|2|Visit_2|25|4|WASHOUT|2020-06-07|25
e|FA|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|5|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|mph|[?]|1|mg/h|VOCAL CORD|LATERAL|||PROXY|3|Visit_3|40|2|TREATMENT|2020-06-22|40
e|FA|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|6|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/g|[?]|1|IU/mg|TRICUSPID VALVE|CONTRALATERAL|||STUDY SUBJECT|3|Visit_3|40|2|WASHOUT|2020-06-22|40
e|FA|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|7|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|U/cL|[?]|1|fmol|T9 VERTEBRA|LEFT|Y|Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|SCREENING|2020-07-17|65
e|FA|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|8|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|POINT|[?]|1|oz eq|PROXIMAL INTERPHALANGEAL JOINT 4|UNILATERAL|||CHILD|4|Visit_4|65|3|TREATMENT|2020-07-17|65
e|FA|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|9|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|pt_br|[?]|1|/kg|BUCCAL MUCOSA|UNILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2020-08-11|90
e|FA|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|10|SEV|Severity/Intensity|[?]|GERD|[?]|ug/animal|[?]|1|Pa|JOINT|LEFT|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2020-08-11|90
e|FA|f31bab3b-3624-44a5-a62f-f8cf9055eec4|1|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|% INHIBITION|[?]|1|SACHET|KIDNEY, HILUM|RIGHT|Y||GUARDIAN|1|Visit_1|10|4|WASHOUT|2020-08-09|10
e|FA|f31bab3b-3624-44a5-a62f-f8cf9055eec4|2|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|mEq|[?]|1|/200 HPFs|TEMPLE|UNILATERAL|||INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-08-09|10
e|FA|f31bab3b-3624-44a5-a62f-f8cf9055eec4|3|VOL|Volume|[?]|GERD|[?]|RFU|[?]|1|vp/dose|LEFT VENTRICULAR APEX SEGMENT|RIGHT||Y|SIBLING|2|Visit_2|25|3|FOLLOW-UP|2020-08-24|25
e|FA|f31bab3b-3624-44a5-a62f-f8cf9055eec4|4|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|s/h|[?]|1|10^6 U|HEART, ATRIUM|UNILATERAL|||SPOUSE|2|Visit_2|25|1|TREATMENT|2020-08-24|25
e|FA|f31bab3b-3624-44a5-a62f-f8cf9055eec4|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|IU/kg|[?]|1|%(v/v)|PROXIMAL INTERPHALANGEAL JOINT 5|LEFT|||FRIEND|3|Visit_3|40|1|TREATMENT|2020-09-08|40
e|FA|f31bab3b-3624-44a5-a62f-f8cf9055eec4|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ngEq/L|[?]|1|%(v/v)|GRACILIS MUSCLE|CONTRALATERAL|||FAMILY MEMBER|3|Visit_3|40|2|FOLLOW-UP|2020-09-08|40
e|FA|f31bab3b-3624-44a5-a62f-f8cf9055eec4|7|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|Antibody Unit|[?]|1|g/dL|HYPOGLOSSAL NERVE|LATERAL|||FRIEND|4|Visit_4|65|1|TREATMENT|2020-10-03|65
e|FA|f31bab3b-3624-44a5-a62f-f8cf9055eec4|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|LB|[?]|1|mg/g/min|PRELARYNGEAL LYMPH NODE|IPSILATERAL|||CAREGIVER|4|Visit_4|65|7|SCREENING|2020-10-03|65
e|FA|f31bab3b-3624-44a5-a62f-f8cf9055eec4|9|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|mCi/kg|[?]|1|10^6 CFU/mL|ETHMOID SINUS|IPSILATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2020-10-28|90
e|FA|f31bab3b-3624-44a5-a62f-f8cf9055eec4|10|OBJTYPE|Type of Object|[?]|GERD|[?]|10^6 RNA copies/mL|[?]|1|ng|PARASPINAL REGION|RIGHT|||INVESTIGATOR|5|Visit_5|90|4|FOLLOW-UP|2020-10-28|90
e|FA|0b5675aa-4ec0-4548-9a0b-a13f8de89883|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|SFC/10^6 PBMC|[?]|1|%(v/v)|MID-CIRCUMFLEX ARTERY|UNILATERAL|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|3|TREATMENT|2020-06-28|10
e|FA|0b5675aa-4ec0-4548-9a0b-a13f8de89883|2|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|pg|[?]|1|mg/dose|HILAR|LATERAL||Y|SIBLING|1|Visit_1|10|5|FOLLOW-UP|2020-06-28|10
e|FA|0b5675aa-4ec0-4548-9a0b-a13f8de89883|3|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|ug/g/min|[?]|1|psi|ABDUCTOR POLLICIS BREVIS MUSCLE|UNILATERAL|||GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-07-13|25
e|FA|0b5675aa-4ec0-4548-9a0b-a13f8de89883|4|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|EP U|[?]|1|L|PARASPINAL REGION|RIGHT|Y|Y|SIBLING|2|Visit_2|25|6|FOLLOW-UP|2020-07-13|25
e|FA|0b5675aa-4ec0-4548-9a0b-a13f8de89883|5|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|oz|[?]|1|PACK|T6 VERTEBRA|IPSILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-07-28|40
e|FA|0b5675aa-4ec0-4548-9a0b-a13f8de89883|6|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|10^3 DNA copies/mL|[?]|1|DROP|BLADDER|BILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-07-28|40
e|FA|0b5675aa-4ec0-4548-9a0b-a13f8de89883|7|DMEAT|Dietary Meat|[?]|GERD|[?]|mg/dose|[?]|1|10^6 organisms/mL|LIVER, CAUDATE LOBE|IPSILATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|5|TREATMENT|2020-08-22|65
e|FA|0b5675aa-4ec0-4548-9a0b-a13f8de89883|8|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|uV*sec|[?]|1|mL/mmHg/min/L|URINARY SYSTEM|IPSILATERAL|||FRIEND|4|Visit_4|65|7|TREATMENT|2020-08-22|65
e|FA|0b5675aa-4ec0-4548-9a0b-a13f8de89883|9|DMG|Dietary Magnesium|[?]|GERD|[?]|km|[?]|1|TRANSDUCING UNIT/mL|SENSORIMOTOR CORTEX|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|5|SCREENING|2020-09-16|90
e|FA|0b5675aa-4ec0-4548-9a0b-a13f8de89883|10|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|log10 PFU/mL|[?]|1|CUP|SPLENIC LYMPH NODE|RIGHT||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|WASHOUT|2020-09-16|90
e|FA|9bdf9856-3b2a-43db-b369-3e13868ef413|1|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|dL|[?]|1|mEq|MEDULLA OBLONGATA|IPSILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2021-01-23|10
e|FA|9bdf9856-3b2a-43db-b369-3e13868ef413|2|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|PELLET|[?]|1|gtt|SIGMOID SINUS|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2021-01-23|10
e|FA|9bdf9856-3b2a-43db-b369-3e13868ef413|3|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|amp|[?]|1|AU/mL|C7 VERTEBRA|UNILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2021-02-07|25
e|FA|9bdf9856-3b2a-43db-b369-3e13868ef413|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|g/animal|[?]|1|Pa|LIVER, RIGHT LOBE|UNILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|2|SCREENING|2021-02-07|25
e|FA|9bdf9856-3b2a-43db-b369-3e13868ef413|5|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|CCID 50/mL|[?]|1|mL/100g/min|LEFT VENTRICULAR MID ANTERIOR SEGMENT|LEFT||Y|SIBLING|3|Visit_3|40|7|FOLLOW-UP|2021-02-22|40
e|FA|9bdf9856-3b2a-43db-b369-3e13868ef413|6|CALBURN|Calories Burned|[?]|GERD|[?]|TRACE|[?]|1|/kg|MIDDLE PHALANX 3 OF THE HAND|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|WASHOUT|2021-02-22|40
e|FA|9bdf9856-3b2a-43db-b369-3e13868ef413|7|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|rpm|[?]|1|m2|CARPAL BONE|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2021-03-19|65
e|FA|9bdf9856-3b2a-43db-b369-3e13868ef413|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|CUP|DISTAL LAD ARTERY|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2021-03-19|65
e|FA|9bdf9856-3b2a-43db-b369-3e13868ef413|9|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|10^6 CFU/mL|FOREBRAIN|UNILATERAL|||VENDOR|5|Visit_5|90|1|TREATMENT|2021-04-13|90
e|FA|9bdf9856-3b2a-43db-b369-3e13868ef413|10|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|breaths/min|[?]|1|psi|MALE REPRODUCTIVE SYSTEM|LATERAL||Y|INTERVIEWER|5|Visit_5|90|7|WASHOUT|2021-04-13|90
e|FA|5cc53922-60c0-4bce-8d4a-bc59e9203d63|1|STROKTYP|Stroke Type|[?]|GERD|[?]|g/U|[?]|1|g/L|UPPER URINARY SYSTEM|LATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-12-28|10
e|FA|5cc53922-60c0-4bce-8d4a-bc59e9203d63|2|OBJTYPE|Type of Object|[?]|GERD|[?]|EID 50/mL|[?]|1|ng|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|6|WASHOUT|2020-12-28|10
e|FA|5cc53922-60c0-4bce-8d4a-bc59e9203d63|3|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|L/day|[?]|1|uCi/kg|AORTIC VALVE ANNULUS|BILATERAL||Y|GUARDIAN|2|Visit_2|25|3|TREATMENT|2021-01-12|25
e|FA|5cc53922-60c0-4bce-8d4a-bc59e9203d63|4|PPTFCT|Precipitating Factor|[?]|GERD|[?]|cup eq|[?]|1|EIA unit|COMMON ILIAC LYMPH NODE|CONTRALATERAL|Y||INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2021-01-12|25
e|FA|5cc53922-60c0-4bce-8d4a-bc59e9203d63|5|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|Bq/ug|[?]|1|L/h/m2|FIBULA SHAFT|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|WASHOUT|2021-01-27|40
e|FA|5cc53922-60c0-4bce-8d4a-bc59e9203d63|6|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|K|[?]|1|Bq/mg|FEMUR SHAFT|RIGHT|Y|Y|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2021-01-27|40
e|FA|5cc53922-60c0-4bce-8d4a-bc59e9203d63|7|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|ft3|[?]|1|MPS U|OPPONENS POLLICIS MUSCLE|RIGHT|||INVESTIGATOR|4|Visit_4|65|3|SCREENING|2021-02-21|65
e|FA|5cc53922-60c0-4bce-8d4a-bc59e9203d63|8|SEV|Severity/Intensity|[?]|GERD|[?]|breaths/min|[?]|1|Pa|GLUTEUS MAXIMUS|LEFT|Y|Y|SIBLING|4|Visit_4|65|6|TREATMENT|2021-02-21|65
e|FA|5cc53922-60c0-4bce-8d4a-bc59e9203d63|9|TOXGR|Toxicity Grade|[?]|GERD|[?]|mmol/g|[?]|1|aMFI|METACARPAL BONE 1|IPSILATERAL|||FRIEND|5|Visit_5|90|2|SCREENING|2021-03-18|90
e|FA|5cc53922-60c0-4bce-8d4a-bc59e9203d63|10|TOXGR|Toxicity Grade|[?]|GERD|[?]|mmol/g|[?]|1|aMFI|RECTOSIGMOID JUNCTION|IPSILATERAL|||PARENT|5|Visit_5|90|6|SCREENING|2021-03-18|90
e|FA|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|CUP|DIAPHRAGM|LEFT|||CHILD|1|Visit_1|10|6|SCREENING|2020-12-29|10
e|FA|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|2|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|10^4/L|[?]|1|psi|SKIN|CONTRALATERAL|||DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-12-29|10
e|FA|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|3|SEV|Severity/Intensity|[?]|GERD|[?]|10^8/L|[?]|1|Pa|CALCARINE SULCUS|LEFT|||SPOUSE|2|Visit_2|25|3|TREATMENT|2021-01-13|25
e|FA|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|4|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|GBq/ug|[?]|1|DRUM|GALLBLADDER|LATERAL|Y||FAMILY MEMBER|2|Visit_2|25|3|SCREENING|2021-01-13|25
e|FA|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|5|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|U/m2/min|[?]|1|Hz/s|T3 VERTEBRA|CONTRALATERAL||Y|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2021-01-28|40
e|FA|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|6|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|ug/dose|[?]|1|IU/mmol|CALF|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|1|TREATMENT|2021-01-28|40
e|FA|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|7|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|BAG|LYMPH NODE HILUM|RIGHT|||INDEPENDENT ASSESSOR|4|Visit_4|65|1|WASHOUT|2021-02-22|65
e|FA|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|8|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|/mm2|[?]|1|MBq|PERIRECTAL LYMPH NODE|BILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|2|FOLLOW-UP|2021-02-22|65
e|FA|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|9|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|PRESSOR UNITS|[?]|1|MPS U|T5 VERTEBRA|RIGHT||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|SCREENING|2021-03-19|90
e|FA|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|10|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|Roentgen|[?]|1|cm H2O|ORAL MUCOSA|BILATERAL|||ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2021-03-19|90
e|FA|066281d3-27b8-439f-8340-f59115f646ef|1|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|MESF|[?]|1|HOURS|PERICARDIAL WALL|CONTRALATERAL|||SIBLING|1|Visit_1|10|4|TREATMENT|2020-10-21|10
e|FA|066281d3-27b8-439f-8340-f59115f646ef|2|DFATT|Dietary Fat, Total|[?]|GERD|[?]|10^9 organisms/mL|[?]|1|Bq/mg|INFRACLAVICULAR LYMPH NODE|LEFT|||PROXY|1|Visit_1|10|4|WASHOUT|2020-10-21|10
e|FA|066281d3-27b8-439f-8340-f59115f646ef|3|TOTNUM|Total Number|[?]|GERD|[?]|min|[?]|1|/200 HPFs|PARS COMPACTA|CONTRALATERAL|||INVESTIGATOR|2|Visit_2|25|5|FOLLOW-UP|2020-11-05|25
e|FA|066281d3-27b8-439f-8340-f59115f646ef|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|mm/2h|[?]|1|10^6 IU/mL|BRAIN STEM|CONTRALATERAL|Y||VENDOR|2|Visit_2|25|4|TREATMENT|2020-11-05|25
e|FA|066281d3-27b8-439f-8340-f59115f646ef|5|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|MBP|[?]|1|m2|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|IPSILATERAL|||FRIEND|3|Visit_3|40|3|TREATMENT|2020-11-20|40
e|FA|066281d3-27b8-439f-8340-f59115f646ef|6|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|ms/mmHg|[?]|1|BP|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|RIGHT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-11-20|40
e|FA|066281d3-27b8-439f-8340-f59115f646ef|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|BE/mL|[?]|1|mg/g/min|ELBOW EXTENSOR MUSCLES|BILATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-12-15|65
e|FA|066281d3-27b8-439f-8340-f59115f646ef|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|kg/L|[?]|1|Pa|LIVER, CAUDATE LOBE|BILATERAL|||CAREGIVER|4|Visit_4|65|6|WASHOUT|2020-12-15|65
e|FA|066281d3-27b8-439f-8340-f59115f646ef|9|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|U/mg|CORONARY VEIN|LATERAL|||CHILD|5|Visit_5|90|2|WASHOUT|2021-01-09|90
e|FA|066281d3-27b8-439f-8340-f59115f646ef|10|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|mU|[?]|1|MPS U|TOOTH CANAL|UNILATERAL|||SPOUSE|5|Visit_5|90|5|TREATMENT|2021-01-09|90
e|FA|d23cc47e-da96-4042-a69f-60097beaef0e|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|%(v/v)|EAR, INNER|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2021-01-21|10
e|FA|d23cc47e-da96-4042-a69f-60097beaef0e|2|DFATT|Dietary Fat, Total|[?]|GERD|[?]|mg/animal|[?]|1|Bq/mg|TRUNK|LEFT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|FOLLOW-UP|2021-01-21|10
e|FA|d23cc47e-da96-4042-a69f-60097beaef0e|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|umol|[?]|1|Shock Wave|TRICUSPID VALVE, POSTERIOR ANNULUS|LATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2021-02-05|25
e|FA|d23cc47e-da96-4042-a69f-60097beaef0e|4|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|VIRTUAL PIXEL|[?]|1|SCOOPFUL|PERICARDIAL CAVITY|RIGHT||Y|DOMESTIC PARTNER|2|Visit_2|25|2|SCREENING|2021-02-05|25
e|FA|d23cc47e-da96-4042-a69f-60097beaef0e|5|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|Ci/uL|[?]|1|mL/m2|LUNG, LEFT|BILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2021-02-20|40
e|FA|d23cc47e-da96-4042-a69f-60097beaef0e|6|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|Hz|[?]|1|mEq|COLON, HEPATIC FLEXURE|UNILATERAL|Y|Y|SPOUSE|3|Visit_3|40|4|TREATMENT|2021-02-20|40
e|FA|d23cc47e-da96-4042-a69f-60097beaef0e|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mL|[?]|1|%(v/v)|OPHTHALMIC ARTERY|BILATERAL|Y||INTERVIEWER|4|Visit_4|65|4|SCREENING|2021-03-17|65
e|FA|d23cc47e-da96-4042-a69f-60097beaef0e|8|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|cg|[?]|1|DRUM|THIGH|IPSILATERAL|Y||SPOUSE|4|Visit_4|65|2|TREATMENT|2021-03-17|65
e|FA|d23cc47e-da96-4042-a69f-60097beaef0e|9|SERVNUM|Number of Servings|[?]|GERD|[?]|PFU|[?]|1|Hz/s|OPTIC DISC|UNILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2021-04-11|90
e|FA|d23cc47e-da96-4042-a69f-60097beaef0e|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mol/mL|[?]|1|mg/g/min|RIB 6|BILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2021-04-11|90
e|FA|b896c679-87d0-4e29-ad27-3944cf09b3ec|1|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|ug/g/h|[?]|1|10^6 IU/mL|PHARYNGEAL TONSIL|IPSILATERAL|Y|Y|STUDY SUBJECT|1|Visit_1|10|3|WASHOUT|2021-01-02|10
e|FA|b896c679-87d0-4e29-ad27-3944cf09b3ec|2|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|LENS|[?]|1|Bq/L|THYROID GLAND ISTHMUS|LEFT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|WASHOUT|2021-01-02|10
e|FA|b896c679-87d0-4e29-ad27-3944cf09b3ec|3|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|EIA unit|HAND DIGIT 2|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|SCREENING|2021-01-17|25
e|FA|b896c679-87d0-4e29-ad27-3944cf09b3ec|4|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mg/kg/week|[?]|1|L/h/m2|SCAPHOID-RADIUS JOINT|BILATERAL|||VENDOR|2|Visit_2|25|2|SCREENING|2021-01-17|25
e|FA|b896c679-87d0-4e29-ad27-3944cf09b3ec|5|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|mEq/g|PARANASAL SINUS|RIGHT|Y||INTERVIEWER|3|Visit_3|40|1|TREATMENT|2021-02-01|40
e|FA|b896c679-87d0-4e29-ad27-3944cf09b3ec|6|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|umol/mol|[?]|1|mL/animal/day|PANCREATIC DUCT|LEFT|Y||ADJUDICATOR|3|Visit_3|40|1|FOLLOW-UP|2021-02-01|40
e|FA|b896c679-87d0-4e29-ad27-3944cf09b3ec|7|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|MPS U|[?]|1|uCi/kg|PERIPHERAL NERVE|CONTRALATERAL|||SPOUSE|4|Visit_4|65|2|TREATMENT|2021-02-26|65
e|FA|b896c679-87d0-4e29-ad27-3944cf09b3ec|8|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|mmol/day|[?]|1|Hz/s|SUPRACLAVICULAR LYMPH NODE|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|6|SCREENING|2021-02-26|65
e|FA|b896c679-87d0-4e29-ad27-3944cf09b3ec|9|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|PIPE|[?]|1|MBq|ILEUM LYMPH NODE|IPSILATERAL|||CHILD|5|Visit_5|90|5|SCREENING|2021-03-23|90
e|FA|b896c679-87d0-4e29-ad27-3944cf09b3ec|10|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|cd|[?]|1|mL/cm3/min|SKIN OF THE SOLE|RIGHT|||FAMILY MEMBER|5|Visit_5|90|7|SCREENING|2021-03-23|90
e|FA|6d0ec221-6eb6-4fed-806e-2bc700968333|1|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|Gy/h|KNEE JOINT TENDONS|UNILATERAL|||CHILD|1|Visit_1|10|6|FOLLOW-UP|2020-07-27|10
e|FA|6d0ec221-6eb6-4fed-806e-2bc700968333|2|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|AgU/mL|[?]|1|mL/dose|MUSCLE|LEFT|||FAMILY MEMBER|1|Visit_1|10|5|SCREENING|2020-07-27|10
e|FA|6d0ec221-6eb6-4fed-806e-2bc700968333|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|SQU/mL|[?]|1|mg/g/min|MESENTERY|UNILATERAL|||INTERVIEWER|2|Visit_2|25|2|FOLLOW-UP|2020-08-11|25
e|FA|6d0ec221-6eb6-4fed-806e-2bc700968333|4|SEV|Severity/Intensity|[?]|GERD|[?]|10^6 IU|[?]|1|Pa|THYMUS GLAND|RIGHT||Y|SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2020-08-11|25
e|FA|6d0ec221-6eb6-4fed-806e-2bc700968333|5|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|ohm|RIB 12|RIGHT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-08-26|40
e|FA|6d0ec221-6eb6-4fed-806e-2bc700968333|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Arbitrary U|[?]|1|mg/g/min|ACCESSORY RENAL ARTERY|LATERAL|||INTERVIEWER|3|Visit_3|40|1|TREATMENT|2020-08-26|40
e|FA|6d0ec221-6eb6-4fed-806e-2bc700968333|7|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|U/animal|[?]|1|BAG|RIB 6|IPSILATERAL|||GUARDIAN|4|Visit_4|65|6|TREATMENT|2020-09-20|65
e|FA|6d0ec221-6eb6-4fed-806e-2bc700968333|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|% INHIBITION|[?]|1|mg/g/min|PERIPANCREATIC LYMPH NODE|UNILATERAL|||INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2020-09-20|65
e|FA|6d0ec221-6eb6-4fed-806e-2bc700968333|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Osm|[?]|1|mg/g/min|SKULL|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|SCREENING|2020-10-15|90
e|FA|6d0ec221-6eb6-4fed-806e-2bc700968333|10|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|Gy/h|TRACHEOBRONCHIAL TREE|BILATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|WASHOUT|2020-10-15|90
e|FA|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|1|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|uEq/L|[?]|1|mg/dose|PRIMARY VISUAL CORTEX|CONTRALATERAL|Y|Y|SIBLING|1|Visit_1|10|2|SCREENING|2020-10-03|10
e|FA|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|2|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|TRANSDUCING UNIT/mL|[?]|1|QUANTITY SUFFICIENT|AORTOCAVAL LYMPH NODE|RIGHT|||SPOUSE|1|Visit_1|10|7|SCREENING|2020-10-03|10
e|FA|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|3|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/dose|[?]|1|mL/100g/min|WARDS TRIANGLE|UNILATERAL|||PROXY|2|Visit_2|25|7|FOLLOW-UP|2020-10-18|25
e|FA|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|4|DPROT|Dietary Protein|[?]|GERD|[?]|min/day|[?]|1|10^4 CFU/mL|COLON, LEFT|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|SCREENING|2020-10-18|25
e|FA|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|5|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|ohm|[?]|1|ug/m2/h|PREFRONTAL CORTEX|LATERAL|||SIBLING|3|Visit_3|40|2|TREATMENT|2020-11-02|40
e|FA|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|6|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|Enzyme U/m2|[?]|1|/500 WBC|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|RIGHT|||INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-11-02|40
e|FA|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|7|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|QUANTITY SUFFICIENT|MEDIAN BASILIC VEIN|LATERAL|||PROXY|4|Visit_4|65|7|SCREENING|2020-11-27|65
e|FA|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|8|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|BAU|[?]|1|BP|HEART, LEFT ATRIUM|RIGHT|||CAREGIVER|4|Visit_4|65|3|TREATMENT|2020-11-27|65
e|FA|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|9|PPTFCT|Precipitating Factor|[?]|GERD|[?]|umol/L/min|[?]|1|EIA unit|LOWER GASTROINTESTINAL TRACT LYMPH NODE|IPSILATERAL|||SIBLING|5|Visit_5|90|5|TREATMENT|2020-12-22|90
e|FA|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|1/(s*kPa)|[?]|1|mg/g/min|COCCYGEAL VERTEBRA|LEFT|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2020-12-22|90
e|FA|15e5e7ca-b832-450c-a20c-b21585086328|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|Pa|TARSUS BONE|RIGHT|Y||CAREGIVER|1|Visit_1|10|2|TREATMENT|2021-01-05|10
e|FA|15e5e7ca-b832-450c-a20c-b21585086328|2|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|BAU/mL|[?]|1|Ci/ug|LEFT CIRCUMFLEX ARTERY OSTIUM|IPSILATERAL||Y|SPOUSE|1|Visit_1|10|5|TREATMENT|2021-01-05|10
e|FA|15e5e7ca-b832-450c-a20c-b21585086328|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|SYRINGE|[?]|1|%(v/v)|HAIR SHAFT|CONTRALATERAL|Y||SPOUSE|2|Visit_2|25|3|TREATMENT|2021-01-20|25
e|FA|15e5e7ca-b832-450c-a20c-b21585086328|4|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|mg/h|[?]|1|uCi/kg|SIGMOID SINUS|CONTRALATERAL|||INTERVIEWER|2|Visit_2|25|5|SCREENING|2021-01-20|25
e|FA|15e5e7ca-b832-450c-a20c-b21585086328|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|10^6 organisms/mg|[?]|1|mL/animal/day|PANCREAS|RIGHT|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|6|WASHOUT|2021-02-04|40
e|FA|15e5e7ca-b832-450c-a20c-b21585086328|6|SEV|Severity/Intensity|[?]|GERD|[?]|log10 TCID 50/dose|[?]|1|Pa|EYE|CONTRALATERAL|||VENDOR|3|Visit_3|40|3|SCREENING|2021-02-04|40
e|FA|15e5e7ca-b832-450c-a20c-b21585086328|7|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|DDU|[?]|1|mL/m2|INTERPHALANGEAL JOINT 4|RIGHT|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2021-03-01|65
e|FA|15e5e7ca-b832-450c-a20c-b21585086328|8|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|nU/cL|[?]|1|NEEDLE GAUGE|CHOROID|LEFT|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|6|FOLLOW-UP|2021-03-01|65
e|FA|15e5e7ca-b832-450c-a20c-b21585086328|9|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|mL/s/m2|[?]|1|SCOOPFUL|HEAD AND NECK|LEFT|Y||DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2021-03-26|90
e|FA|15e5e7ca-b832-450c-a20c-b21585086328|10|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|mV2/Hz|[?]|1|mg/dose|PUBIC BONE|UNILATERAL||Y|PROXY|5|Visit_5|90|4|WASHOUT|2021-03-26|90
e|FA|b46ff3a2-f257-4803-8064-e29bd1114bfc|1|EXTRSCT|Extent of Resection|[?]|GERD|[?]|fmol/L/sec|[?]|1|Weber|THYMUS GLAND|RIGHT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|SCREENING|2020-10-13|10
e|FA|b46ff3a2-f257-4803-8064-e29bd1114bfc|2|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mL/kg/h|[?]|1|Weber|C3 VERTEBRA|CONTRALATERAL|||CHILD|1|Visit_1|10|3|FOLLOW-UP|2020-10-13|10
e|FA|b46ff3a2-f257-4803-8064-e29bd1114bfc|3|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mAmp|[?]|1|L/h/m2|MEDIAN BASILIC VEIN|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|1|SCREENING|2020-10-28|25
e|FA|b46ff3a2-f257-4803-8064-e29bd1114bfc|4|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|CARTRIDGE|[?]|1|g/cage/day|SKIN OF THE CHEST|RIGHT|||PARENT|2|Visit_2|25|3|TREATMENT|2020-10-28|25
e|FA|b46ff3a2-f257-4803-8064-e29bd1114bfc|5|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|GBq/mg|[?]|1|in|SMALL INTESTINE|RIGHT||Y|SIBLING|3|Visit_3|40|5|TREATMENT|2020-11-12|40
e|FA|b46ff3a2-f257-4803-8064-e29bd1114bfc|6|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|mg/dose|UVEA|BILATERAL|||CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-11-12|40
e|FA|b46ff3a2-f257-4803-8064-e29bd1114bfc|7|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|h*%|[?]|1|gtt|TIBIA SHAFT|LEFT|||CHILD|4|Visit_4|65|5|FOLLOW-UP|2020-12-07|65
e|FA|b46ff3a2-f257-4803-8064-e29bd1114bfc|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mmol|[?]|1|%(v/v)|DISTAL LAD ARTERY|CONTRALATERAL|||INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-12-07|65
e|FA|b46ff3a2-f257-4803-8064-e29bd1114bfc|9|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|ms/mmHg|[?]|1|mL/mmHg/min/L|MUSCULOSKELETAL SYSTEM|LEFT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2021-01-01|90
e|FA|b46ff3a2-f257-4803-8064-e29bd1114bfc|10|EXTRSCT|Extent of Resection|[?]|GERD|[?]|STRIP|[?]|1|Weber|CLITORIS|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|WASHOUT|2021-01-01|90
e|FA|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/mg|[?]|1|mg/g/min|BASAL GANGLIA|LEFT|||ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-12-06|10
e|FA|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|2|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|Enzyme U/g Hb|[?]|1|MBq|LUNG, RIGHT LOWER LOBE|RIGHT||Y|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-12-06|10
e|FA|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|3|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|IU/mmol|[?]|1|Log10 ELISA unit|CEPHALIC VEIN|IPSILATERAL|||FAMILY MEMBER|2|Visit_2|25|6|WASHOUT|2020-12-21|25
e|FA|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|4|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|mV*min|[?]|1|Gy/h|METACARPAL BONE 4|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|4|FOLLOW-UP|2020-12-21|25
e|FA|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|5|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|ukat/10^12 RBC|[?]|1|PFU/dose|MID-CIRCUMFLEX ARTERY|BILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|7|SCREENING|2021-01-05|40
e|FA|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|6|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|SBE/mL|[?]|1|psi|SUBSCAPULARIS MUSCLE|RIGHT|||GUARDIAN|3|Visit_3|40|5|WASHOUT|2021-01-05|40
e|FA|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|7|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|g|[?]|1|mL/dose|ANTERIOR INFERIOR CEREBELLAR ARTERY|IPSILATERAL|||FRIEND|4|Visit_4|65|4|TREATMENT|2021-01-30|65
e|FA|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|8|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|STRIP|[?]|1|mmHg/L/min|LEFT CIRCUMFLEX CORONARY ARTERY|UNILATERAL||Y|GUARDIAN|4|Visit_4|65|4|TREATMENT|2021-01-30|65
e|FA|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|U/g/h|[?]|1|mL/dose|JAW|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2021-02-24|90
e|FA|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|10|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|Tbsp|[?]|1|mL/cm3/min|BRACHIALIS MUSCLE|UNILATERAL|||PARENT|5|Visit_5|90|7|TREATMENT|2021-02-24|90
e|FA|a5c667d1-d2ac-49f7-ad44-bf9a44762025|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|km|NASAL SEPTUM|LEFT||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-10-06|10
e|FA|a5c667d1-d2ac-49f7-ad44-bf9a44762025|2|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|/wk|[?]|1|EIA unit|PRESACRAL SPACE|LEFT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-10-06|10
e|FA|a5c667d1-d2ac-49f7-ad44-bf9a44762025|3|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|Watt|[?]|1|mIU/L|SHOULDER JOINT|RIGHT|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-10-21|25
e|FA|a5c667d1-d2ac-49f7-ad44-bf9a44762025|4|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol/L|[?]|1|mL/animal/day|RIGHT VENTRICULAR BRANCH|IPSILATERAL||Y|PARENT|2|Visit_2|25|2|TREATMENT|2020-10-21|25
e|FA|a5c667d1-d2ac-49f7-ad44-bf9a44762025|5|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|%(w/w)|[?]|1|BOWL|LOWER JUGULAR LYMPH NODE|LATERAL|||SPOUSE|3|Visit_3|40|2|TREATMENT|2020-11-05|40
e|FA|a5c667d1-d2ac-49f7-ad44-bf9a44762025|6|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|GLOBULE|[?]|1|mIU/L|SUBMANDIBULAR GLAND|UNILATERAL|||SPOUSE|3|Visit_3|40|1|TREATMENT|2020-11-05|40
e|FA|a5c667d1-d2ac-49f7-ad44-bf9a44762025|7|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|IU/mmol|[?]|1|Bq/L|METACARPAL BONE 1|IPSILATERAL||Y|INTERVIEWER|4|Visit_4|65|7|WASHOUT|2020-11-30|65
e|FA|a5c667d1-d2ac-49f7-ad44-bf9a44762025|8|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|Watt|[?]|1|mL/animal/day|FOOT|LEFT||Y|STUDY SUBJECT|4|Visit_4|65|2|WASHOUT|2020-11-30|65
e|FA|a5c667d1-d2ac-49f7-ad44-bf9a44762025|9|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|mL/sec/1.73m2|[?]|1|cm|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|UNILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|2|FOLLOW-UP|2020-12-25|90
e|FA|a5c667d1-d2ac-49f7-ad44-bf9a44762025|10|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|EP U|[?]|1|PACK|SKIN OF THE CHIN|LEFT|Y||INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-12-25|90
e|FA|944a2627-13f1-4ecf-9545-8819a1327138|1|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|VIRTUAL PIXEL|[?]|1|mg/dose|PARA-AORTIC LYMPH NODE|RIGHT|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|SCREENING|2021-01-17|10
e|FA|944a2627-13f1-4ecf-9545-8819a1327138|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|/5x10^4 WBC|[?]|1|mg/g/min|MESENTERIC LYMPH NODE|CONTRALATERAL|||DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2021-01-17|10
e|FA|944a2627-13f1-4ecf-9545-8819a1327138|3|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|bel|[?]|1|EIA unit|PROXIMAL INTERPHALANGEAL JOINT 2|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2021-02-01|25
e|FA|944a2627-13f1-4ecf-9545-8819a1327138|4|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|U/kg|[?]|1|in|EPIDIDYMIS|LATERAL||Y|INVESTIGATOR|2|Visit_2|25|6|SCREENING|2021-02-01|25
e|FA|944a2627-13f1-4ecf-9545-8819a1327138|5|ESTWT|Estimated Weight|[?]|GERD|[?]|pt_br|[?]|1|g/day|VASTUS MEDIALIS MUSCLE|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|7|FOLLOW-UP|2021-02-16|40
e|FA|944a2627-13f1-4ecf-9545-8819a1327138|6|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|kg/cm2|[?]|1|NEEDLE GAUGE|OVARIAN FOLLICLE|UNILATERAL||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2021-02-16|40
e|FA|944a2627-13f1-4ecf-9545-8819a1327138|7|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|L/kg|[?]|1|ohm|OCCIPITAL SCALP|CONTRALATERAL||Y|VENDOR|4|Visit_4|65|2|TREATMENT|2021-03-13|65
e|FA|944a2627-13f1-4ecf-9545-8819a1327138|8|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|APS U|[?]|1|oz eq|SUPRAGLOTTIS|LATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|4|FOLLOW-UP|2021-03-13|65
e|FA|944a2627-13f1-4ecf-9545-8819a1327138|9|DMG|Dietary Magnesium|[?]|GERD|[?]|oz|[?]|1|TRANSDUCING UNIT/mL|RIB|BILATERAL|||GUARDIAN|5|Visit_5|90|1|TREATMENT|2021-04-07|90
e|FA|944a2627-13f1-4ecf-9545-8819a1327138|10|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|EP U|[?]|1|h*%|LEPTOMENINGES|RIGHT|||FRIEND|5|Visit_5|90|4|WASHOUT|2021-04-07|90
e|FA|7902955a-6336-45e5-a15d-7c368a28ac4f|1|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|COAT|[?]|1|BP|CHOROID PLEXUS|BILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-06-01|10
e|FA|7902955a-6336-45e5-a15d-7c368a28ac4f|2|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|pmol/dL|[?]|1|Bq/L|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|UNILATERAL|||ADJUDICATOR|1|Visit_1|10|5|SCREENING|2020-06-01|10
e|FA|7902955a-6336-45e5-a15d-7c368a28ac4f|3|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|%/s|[?]|1|mL|BICEPS BRACHII MUSCLE|IPSILATERAL|Y|Y|INVESTIGATOR|2|Visit_2|25|6|SCREENING|2020-06-16|25
e|FA|7902955a-6336-45e5-a15d-7c368a28ac4f|4|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Linear ft*LB|[?]|1|mm/h|SALIVARY GLAND, SUBLINGUAL|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|7|WASHOUT|2020-06-16|25
e|FA|7902955a-6336-45e5-a15d-7c368a28ac4f|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mN|[?]|1|Pa|URETHRA|LEFT|||FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2020-07-01|40
e|FA|7902955a-6336-45e5-a15d-7c368a28ac4f|6|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|log10 CCID 50/dose|[?]|1|mL/animal/day|HYPOTHALAMUS|IPSILATERAL|||STUDY SUBJECT|3|Visit_3|40|4|SCREENING|2020-07-01|40
e|FA|7902955a-6336-45e5-a15d-7c368a28ac4f|7|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|amp|[?]|1|mL/animal/day|EYE, ANTERIOR SEGMENT|IPSILATERAL|||ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2020-07-26|65
e|FA|7902955a-6336-45e5-a15d-7c368a28ac4f|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mg/dL|[?]|1|%(v/v)|WRIST JOINT FLEXOR TENDONS|LATERAL|||CHILD|4|Visit_4|65|3|TREATMENT|2020-07-26|65
e|FA|7902955a-6336-45e5-a15d-7c368a28ac4f|9|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|mL/cm H2O|[?]|1|BP|SKIN OF THE EAR|RIGHT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|7|WASHOUT|2020-08-20|90
e|FA|7902955a-6336-45e5-a15d-7c368a28ac4f|10|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|um/day|[?]|1|DRUM|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|LEFT|||INVESTIGATOR|5|Visit_5|90|2|SCREENING|2020-08-20|90
e|FA|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|1|DCAL|Dietary Calories|[?]|GERD|[?]|Tesla|[?]|1|EIA unit|VAS DEFERENS|LATERAL|Y|Y|CHILD|1|Visit_1|10|3|FOLLOW-UP|2020-12-20|10
e|FA|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|2|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|mEq/day|[?]|1|Hz/s|EXTENSOR DIGITORUM BREVIS MUSCLE|RIGHT|||GUARDIAN|1|Visit_1|10|2|SCREENING|2020-12-20|10
e|FA|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|3|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|Bq/mg|[?]|1|mm/h|PARASPINAL REGION|LATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|7|SCREENING|2021-01-04|25
e|FA|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|4|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|EIA unit|[?]|1|EIA unit|BRAIN VENTRICLE|CONTRALATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|4|SCREENING|2021-01-04|25
e|FA|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|5|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/g/min|[?]|1|mIU/L|RETROAURICULAR LYMPH NODE|BILATERAL|||SPOUSE|3|Visit_3|40|7|SCREENING|2021-01-19|40
e|FA|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|6|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|mg/L|[?]|1|AU/mL|PORTAL VEIN BIFURCATION|CONTRALATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|1|FOLLOW-UP|2021-01-19|40
e|FA|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|7|SEV|Severity/Intensity|[?]|GERD|[?]|ug/dose|[?]|1|Pa|RIB 6|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-02-13|65
e|FA|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|8|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|pmol/dL|[?]|1|in|FIRST DIAGONAL BRANCH ARTERY|LATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2021-02-13|65
e|FA|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|9|LESNUM|Number of Lesions|[?]|GERD|[?]|mmHg/L/min|[?]|1|ng/day|CECUM|RIGHT|Y||VENDOR|5|Visit_5|90|1|TREATMENT|2021-03-10|90
e|FA|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|10|PPTFCT|Precipitating Factor|[?]|GERD|[?]|L/kg|[?]|1|EIA unit|INFERIOR VENA CAVA|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-03-10|90
e|FA|6071d81f-2f38-414f-90ca-4ad80c971054|1|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|ug/kg|[?]|1|10^6 CFU/mL|GLENOID FOSSA|BILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|FOLLOW-UP|2020-09-07|10
e|FA|6071d81f-2f38-414f-90ca-4ad80c971054|2|SEV|Severity/Intensity|[?]|GERD|[?]|Bq/L|[?]|1|Pa|MITRAL VALVE, ANTERIOR CUSP|LEFT|Y||INVESTIGATOR|1|Visit_1|10|6|WASHOUT|2020-09-07|10
e|FA|6071d81f-2f38-414f-90ca-4ad80c971054|3|TOXGR|Toxicity Grade|[?]|GERD|[?]|DISK|[?]|1|aMFI|DURAL VENOUS SINUS|RIGHT|Y||STUDY SUBJECT|2|Visit_2|25|5|WASHOUT|2020-09-22|25
e|FA|6071d81f-2f38-414f-90ca-4ad80c971054|4|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|mU|[?]|1|mmHg/L/min|PERINEUM|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|SCREENING|2020-09-22|25
e|FA|6071d81f-2f38-414f-90ca-4ad80c971054|5|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|vg/mL|[?]|1|fmol|APPENDICULAR SKELETON|LATERAL|||INVESTIGATOR|3|Visit_3|40|5|TREATMENT|2020-10-07|40
e|FA|6071d81f-2f38-414f-90ca-4ad80c971054|6|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|nmol|[?]|1|IU/mmol|LEFT MAIN CORONARY ARTERY BIFURCATION|UNILATERAL|||PARENT|3|Visit_3|40|6|WASHOUT|2020-10-07|40
e|FA|6071d81f-2f38-414f-90ca-4ad80c971054|7|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|foz_br|[?]|1|DRUM|INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT|||FRIEND|4|Visit_4|65|6|TREATMENT|2020-11-01|65
e|FA|6071d81f-2f38-414f-90ca-4ad80c971054|8|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|Gauss|[?]|1|mg/h|C3 VERTEBRA|BILATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|4|TREATMENT|2020-11-01|65
e|FA|6071d81f-2f38-414f-90ca-4ad80c971054|9|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|PFU|[?]|1|h*%|LUNG LOBE|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|TREATMENT|2020-11-26|90
e|FA|6071d81f-2f38-414f-90ca-4ad80c971054|10|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit|[?]|1|mL/h|RIB 11|RIGHT|||FAMILY MEMBER|5|Visit_5|90|7|WASHOUT|2020-11-26|90
e|FA|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|1|LENRSCT|Length of Resection|[?]|GERD|[?]|ugEq/L|[?]|1|psi|LEFT CIRCUMFLEX ARTERY OSTIUM|BILATERAL|||FRIEND|1|Visit_1|10|5|TREATMENT|2020-09-28|10
e|FA|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|2|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|mOsm/L|[?]|1|anti-Xa IU/mL|MANDIBLE|RIGHT||Y|CHILD|1|Visit_1|10|6|SCREENING|2020-09-28|10
e|FA|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|mg/g/min|ARM|UNILATERAL||Y|CHILD|2|Visit_2|25|5|TREATMENT|2020-10-13|25
e|FA|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|4|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|BU|[?]|1|uCi/kg|VAGUS NERVE|BILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2020-10-13|25
e|FA|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|5|RLDEV|Relationship to Device|[?]|GERD|[?]|mEq/uL|[?]|1|mL/min/mmHg|ENDOCARDIUM|IPSILATERAL|||PARENT|3|Visit_3|40|2|SCREENING|2020-10-28|40
e|FA|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|6|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|mg/m2|[?]|1|10^6 IU/mL|SECOND OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-10-28|40
e|FA|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|7|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|ppb|[?]|1|Shock Wave|LUNG, RIGHT MIDDLE LOBE|IPSILATERAL||Y|SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2020-11-22|65
e|FA|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|BOTTLE|[?]|1|mg/g/min|ILEUM WALL|UNILATERAL|||CHILD|4|Visit_4|65|4|TREATMENT|2020-11-22|65
e|FA|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|9|TOTNUM|Total Number|[?]|GERD|[?]|g/mol|[?]|1|/200 HPFs|LOWER JUGULAR LYMPH NODE|CONTRALATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|4|FOLLOW-UP|2020-12-17|90
e|FA|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|10|EXTRSCT|Extent of Resection|[?]|GERD|[?]|MnFI|[?]|1|Weber|MALLEUS|UNILATERAL|||SPOUSE|5|Visit_5|90|1|TREATMENT|2020-12-17|90
e|FA|a046d48d-b1fa-4d46-902e-3984aed00ec7|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|HEP|[?]|1|10^6 U|PROFUNDA FEMORIS VEIN|CONTRALATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|5|WASHOUT|2020-08-01|10
e|FA|a046d48d-b1fa-4d46-902e-3984aed00ec7|2|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|10^6/Ejaculate U|[?]|1|U/10^12 RBC|HIP ADDUCTORS|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|4|FOLLOW-UP|2020-08-01|10
e|FA|a046d48d-b1fa-4d46-902e-3984aed00ec7|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Bq/uL|[?]|1|Pa|PAROTID GLAND|RIGHT|Y|Y|SPOUSE|2|Visit_2|25|7|WASHOUT|2020-08-16|25
e|FA|a046d48d-b1fa-4d46-902e-3984aed00ec7|4|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|10^4 CFU/mL|[?]|1|mIU/L|SUBMANDIBULAR LYMPH NODE|LATERAL||Y|FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-08-16|25
e|FA|a046d48d-b1fa-4d46-902e-3984aed00ec7|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^10/L|[?]|1|%(v/v)|FRONTAL SINUS|CONTRALATERAL|||FRIEND|3|Visit_3|40|7|FOLLOW-UP|2020-08-31|40
e|FA|a046d48d-b1fa-4d46-902e-3984aed00ec7|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|kg|[?]|1|%(v/v)|CORPUS STRIATUM|UNILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2020-08-31|40
e|FA|a046d48d-b1fa-4d46-902e-3984aed00ec7|7|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mL/day|[?]|1|mAmp|OCCIPITAL LYMPH NODE|LEFT|||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-09-25|65
e|FA|a046d48d-b1fa-4d46-902e-3984aed00ec7|8|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|kBq|[?]|1|Ci/ug|STERNAL MANUBRIUM|UNILATERAL|Y||SIBLING|4|Visit_4|65|3|SCREENING|2020-09-25|65
e|FA|a046d48d-b1fa-4d46-902e-3984aed00ec7|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mol/mg|[?]|1|mg/g/min|HAIR SHAFT|LATERAL|||ADJUDICATOR|5|Visit_5|90|1|TREATMENT|2020-10-20|90
e|FA|a046d48d-b1fa-4d46-902e-3984aed00ec7|10|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|CFU/g|[?]|1|cm H2O|PORTAL VEIN|LEFT||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|SCREENING|2020-10-20|90
e|FA|8b60e1b0-2cd9-419d-b345-9006af042932|1|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mL/min/mmHg|[?]|1|NEEDLE GAUGE|OROPHARYNX|RIGHT|||ADJUDICATOR|1|Visit_1|10|6|FOLLOW-UP|2020-12-16|10
e|FA|8b60e1b0-2cd9-419d-b345-9006af042932|2|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|10^3 RNA copies/mL|[?]|1|Weber|FOOT DIGIT 4|BILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-12-16|10
e|FA|8b60e1b0-2cd9-419d-b345-9006af042932|3|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|ka_u/dL|[?]|1|mAmp|OMENTUM|LATERAL|Y||CHILD|2|Visit_2|25|6|TREATMENT|2020-12-31|25
e|FA|8b60e1b0-2cd9-419d-b345-9006af042932|4|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|umol/kg/min|[?]|1|DRUM|ENDOCERVIX|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-12-31|25
e|FA|8b60e1b0-2cd9-419d-b345-9006af042932|5|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|Rad|[?]|1|Bq/L|BRONCHUS|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|6|WASHOUT|2021-01-15|40
e|FA|8b60e1b0-2cd9-419d-b345-9006af042932|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|10^7 CFU/mL|[?]|1|PACK|WAIST|BILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|FOLLOW-UP|2021-01-15|40
e|FA|8b60e1b0-2cd9-419d-b345-9006af042932|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|Pa|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LATERAL|||INVESTIGATOR|4|Visit_4|65|4|FOLLOW-UP|2021-02-09|65
e|FA|8b60e1b0-2cd9-419d-b345-9006af042932|8|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|PIPE|[?]|1|Coulomb|PULMONARY VALVE, ANTERIOR CUSP|IPSILATERAL|||VENDOR|4|Visit_4|65|7|TREATMENT|2021-02-09|65
e|FA|8b60e1b0-2cd9-419d-b345-9006af042932|9|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|DROP|[?]|1|SCOOPFUL|COMMON ILIAC LYMPH NODE|CONTRALATERAL|Y||SIGNIFICANT OTHER|5|Visit_5|90|5|WASHOUT|2021-03-06|90
e|FA|8b60e1b0-2cd9-419d-b345-9006af042932|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|uEq/L|[?]|1|mL|SUBCARINAL LYMPH NODE|BILATERAL|Y||FAMILY MEMBER|5|Visit_5|90|3|SCREENING|2021-03-06|90
e|FA|712029bc-471a-4e3d-9123-e38b3c38bc6c|1|DGRAIN|Dietary Grain|[?]|GERD|[?]|nmol BCE/mmol|[?]|1|10^9 CFU/g|SCIATIC NERVE|RIGHT|||FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2021-01-24|10
e|FA|712029bc-471a-4e3d-9123-e38b3c38bc6c|2|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|/200 HPFs|ULNA|LEFT|||INDEPENDENT ASSESSOR|1|Visit_1|10|3|WASHOUT|2021-01-24|10
e|FA|712029bc-471a-4e3d-9123-e38b3c38bc6c|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|bel|[?]|1|U/mg|VENOUS SINUS|CONTRALATERAL||Y|ADJUDICATOR|2|Visit_2|25|2|FOLLOW-UP|2021-02-08|25
e|FA|712029bc-471a-4e3d-9123-e38b3c38bc6c|4|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|ukat|[?]|1|L/h/m2|FLEXOR CARPI ULNARIS MUSCLE|LEFT||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2021-02-08|25
e|FA|712029bc-471a-4e3d-9123-e38b3c38bc6c|5|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|uV|[?]|1|10^6 U|GLENOID FOSSA|LEFT|Y||DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2021-02-23|40
e|FA|712029bc-471a-4e3d-9123-e38b3c38bc6c|6|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|USP U|[?]|1|mL/min/mmHg|ATRIOVENTRICULAR VALVE|LEFT|||CAREGIVER|3|Visit_3|40|7|SCREENING|2021-02-23|40
e|FA|712029bc-471a-4e3d-9123-e38b3c38bc6c|7|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mmHg/sec|[?]|1|mL|PROXIMAL CIRCUMFLEX ARTERY|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|6|TREATMENT|2021-03-20|65
e|FA|712029bc-471a-4e3d-9123-e38b3c38bc6c|8|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|mN|[?]|1|Log10 ELISA unit|INTERPHALANGEAL JOINT 1 OF THE FOOT|UNILATERAL||Y|PROXY|4|Visit_4|65|2|TREATMENT|2021-03-20|65
e|FA|712029bc-471a-4e3d-9123-e38b3c38bc6c|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|pmol/L|[?]|1|mg/g/min|ORAL CAVITY|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2021-04-14|90
e|FA|712029bc-471a-4e3d-9123-e38b3c38bc6c|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|U/mg|DORSALIS PEDIS ARTERY|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|SCREENING|2021-04-14|90
e|FA|92c0183d-5704-45ad-9aec-e24bc5777b80|1|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|10^9/g|[?]|1|mg/h|PERIFACIAL LYMPH NODE|LATERAL||Y|SPOUSE|1|Visit_1|10|3|FOLLOW-UP|2021-01-20|10
e|FA|92c0183d-5704-45ad-9aec-e24bc5777b80|2|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|g/m2|[?]|1|uCi/kg|RETROCRURAL LYMPH NODE|RIGHT|||ADJUDICATOR|1|Visit_1|10|5|FOLLOW-UP|2021-01-20|10
e|FA|92c0183d-5704-45ad-9aec-e24bc5777b80|3|DFATT|Dietary Fat, Total|[?]|GERD|[?]|min/day|[?]|1|Bq/mg|HAND DIGIT 1|IPSILATERAL|Y||INTERVIEWER|2|Visit_2|25|1|TREATMENT|2021-02-04|25
e|FA|92c0183d-5704-45ad-9aec-e24bc5777b80|4|LESNUM|Number of Lesions|[?]|GERD|[?]|/500 WBC|[?]|1|ng/day|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|IPSILATERAL|||STUDY SUBJECT|2|Visit_2|25|5|FOLLOW-UP|2021-02-04|25
e|FA|92c0183d-5704-45ad-9aec-e24bc5777b80|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mL/min/1.73m2|[?]|1|%(v/v)|CORONARY SINUS|BILATERAL|Y|Y|PROXY|3|Visit_3|40|5|WASHOUT|2021-02-19|40
e|FA|92c0183d-5704-45ad-9aec-e24bc5777b80|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|kHz|[?]|1|mg/g/min|ARM|CONTRALATERAL|||DOMESTIC PARTNER|3|Visit_3|40|1|FOLLOW-UP|2021-02-19|40
e|FA|92c0183d-5704-45ad-9aec-e24bc5777b80|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|/h|[?]|1|%(v/v)|HAND DIGIT 3|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2021-03-16|65
e|FA|92c0183d-5704-45ad-9aec-e24bc5777b80|8|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa|[?]|1|g/L|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|UNILATERAL|Y||INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2021-03-16|65
e|FA|92c0183d-5704-45ad-9aec-e24bc5777b80|9|LENRSCT|Length of Resection|[?]|GERD|[?]|MPL U/mL|[?]|1|psi|INTERNAL MAMMARY LYMPH NODE|BILATERAL||Y|FRIEND|5|Visit_5|90|6|WASHOUT|2021-04-10|90
e|FA|92c0183d-5704-45ad-9aec-e24bc5777b80|10|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|uV*sec|[?]|1|10^6 organisms/mL|INTESTINE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2021-04-10|90
e|FA|52ce3b1f-9500-4323-861d-73c8b96f59de|1|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|KIT|[?]|1|10^9 CFU/g|LIMB, UPPER|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|WASHOUT|2020-10-26|10
e|FA|52ce3b1f-9500-4323-861d-73c8b96f59de|2|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|umol/mg/min|[?]|1|mg/h|FEMALE REPRODUCTIVE SYSTEM|IPSILATERAL||Y|GUARDIAN|1|Visit_1|10|3|TREATMENT|2020-10-26|10
e|FA|52ce3b1f-9500-4323-861d-73c8b96f59de|3|PPTFCT|Precipitating Factor|[?]|GERD|[?]|BU|[?]|1|EIA unit|INTERPHALANGEAL JOINT 1 OF THE FOOT|CONTRALATERAL|Y|Y|SPOUSE|2|Visit_2|25|1|FOLLOW-UP|2020-11-10|25
e|FA|52ce3b1f-9500-4323-861d-73c8b96f59de|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|SQU/mL|[?]|1|mg/g/min|PARS COMPACTA|IPSILATERAL|||SPOUSE|2|Visit_2|25|4|TREATMENT|2020-11-10|25
e|FA|52ce3b1f-9500-4323-861d-73c8b96f59de|5|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|cg|[?]|1|MBq|PROXIMAL PHALANX 5 OF THE HAND|LATERAL||Y|FAMILY MEMBER|3|Visit_3|40|4|WASHOUT|2020-11-25|40
e|FA|52ce3b1f-9500-4323-861d-73c8b96f59de|6|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|h/wk|[?]|1|10^6/L|EYE, ANTERIOR SEGMENT|LATERAL|||SPOUSE|3|Visit_3|40|1|WASHOUT|2020-11-25|40
e|FA|52ce3b1f-9500-4323-861d-73c8b96f59de|7|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|deg/mm|[?]|1|IU/mg|SHOULDER|LATERAL|||SPOUSE|4|Visit_4|65|5|TREATMENT|2020-12-20|65
e|FA|52ce3b1f-9500-4323-861d-73c8b96f59de|8|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|lm|[?]|1|BOWL|PELVIC BONE|IPSILATERAL|Y||INVESTIGATOR|4|Visit_4|65|3|WASHOUT|2020-12-20|65
e|FA|52ce3b1f-9500-4323-861d-73c8b96f59de|9|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|mg/kg/day|[?]|1|mL/h|ILEUM LYMPH NODE|LATERAL|||VENDOR|5|Visit_5|90|5|TREATMENT|2021-01-14|90
e|FA|52ce3b1f-9500-4323-861d-73c8b96f59de|10|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mg/dL|[?]|1|CUP|HAIR|RIGHT|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|TREATMENT|2021-01-14|90
e|FA|3655d198-2e7e-419e-8337-d7eea7d795ca|1|DVEG|Dietary Vegetable|[?]|GERD|[?]|10^12/L|[?]|1|Ci/ug|SCAPHOID BONE|LATERAL||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|SCREENING|2020-11-23|10
e|FA|3655d198-2e7e-419e-8337-d7eea7d795ca|2|LDIAM|Longest Diameter|[?]|GERD|[?]|F|[?]|1|Shock Wave|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|7|SCREENING|2020-11-23|10
e|FA|3655d198-2e7e-419e-8337-d7eea7d795ca|3|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|CYLINDER|[?]|1|g/day|AORTIC VALVE ANNULUS|RIGHT|||VENDOR|2|Visit_2|25|1|TREATMENT|2020-12-08|25
e|FA|3655d198-2e7e-419e-8337-d7eea7d795ca|4|LESNUM|Number of Lesions|[?]|GERD|[?]|mm/h|[?]|1|ng/day|PRESACRAL SPACE|LEFT||Y|PARENT|2|Visit_2|25|3|FOLLOW-UP|2020-12-08|25
e|FA|3655d198-2e7e-419e-8337-d7eea7d795ca|5|PPTFCT|Precipitating Factor|[?]|GERD|[?]|kg|[?]|1|EIA unit|DORSALIS PEDIS ARTERY|CONTRALATERAL|||FRIEND|3|Visit_3|40|1|TREATMENT|2020-12-23|40
e|FA|3655d198-2e7e-419e-8337-d7eea7d795ca|6|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|CAPLET|[?]|1|Shock Wave|SHOULDER JOINT TENDONS|CONTRALATERAL|||SPOUSE|3|Visit_3|40|5|FOLLOW-UP|2020-12-23|40
e|FA|3655d198-2e7e-419e-8337-d7eea7d795ca|7|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|10^8 PFU|[?]|1|mL/h|HAIR FOLLICLE|RIGHT|||INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2021-01-17|65
e|FA|3655d198-2e7e-419e-8337-d7eea7d795ca|8|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|Bq/ug|[?]|1|10^9 CFU/g|FINGER FLEXOR TENDONS|IPSILATERAL|||PROXY|4|Visit_4|65|2|SCREENING|2021-01-17|65
e|FA|3655d198-2e7e-419e-8337-d7eea7d795ca|9|ACNDEV|Action Taken With Device|[?]|GERD|[?]|ug/mol|[?]|1|100 IU/mL|CARPOMETACARPAL JOINT 4|IPSILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2021-02-11|90
e|FA|3655d198-2e7e-419e-8337-d7eea7d795ca|10|AGETRT1|Age At First Treatment|[?]|GERD|[?]|uEq/L|[?]|1|mL/mmHg/min/L|PHARYNX|IPSILATERAL|||CAREGIVER|5|Visit_5|90|6|TREATMENT|2021-02-11|90
e|FA|d47da6bf-8abf-4b62-8bb8-797155981158|1|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|mIU/L|[?]|1|h*%|GLOMERULUS|RIGHT||Y|GUARDIAN|1|Visit_1|10|5|TREATMENT|2020-09-10|10
e|FA|d47da6bf-8abf-4b62-8bb8-797155981158|2|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|DNA copies/ug|[?]|1|DROP|ABDUCTOR DIGITI QUINTI MUSCLE|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|7|TREATMENT|2020-09-10|10
e|FA|d47da6bf-8abf-4b62-8bb8-797155981158|3|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|m2|[?]|1|10^6 CFU/mL|TESTIS|RIGHT|||VENDOR|2|Visit_2|25|1|WASHOUT|2020-09-25|25
e|FA|d47da6bf-8abf-4b62-8bb8-797155981158|4|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|/h|[?]|1|anti-Xa IU/mL|SKIN BETWEEN EYEBROWS|UNILATERAL|||CHILD|2|Visit_2|25|7|TREATMENT|2020-09-25|25
e|FA|d47da6bf-8abf-4b62-8bb8-797155981158|5|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|ks|[?]|1|mL/h|LESSER TROCHANTER|LATERAL|Y||STUDY SUBJECT|3|Visit_3|40|1|FOLLOW-UP|2020-10-10|40
e|FA|d47da6bf-8abf-4b62-8bb8-797155981158|6|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|g/mol|[?]|1|MBq|LIVER, LEFT LOBE|UNILATERAL||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2020-10-10|40
e|FA|d47da6bf-8abf-4b62-8bb8-797155981158|7|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|mAmp|COLON, SPLENIC FLEXURE|UNILATERAL|||STUDY SUBJECT|4|Visit_4|65|1|FOLLOW-UP|2020-11-04|65
e|FA|d47da6bf-8abf-4b62-8bb8-797155981158|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mEq/uL|[?]|1|U/mmol|NECK|LATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2020-11-04|65
e|FA|d47da6bf-8abf-4b62-8bb8-797155981158|9|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|/h|[?]|1|mmHg/L/min|OVARY|UNILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|2|FOLLOW-UP|2020-11-29|90
e|FA|d47da6bf-8abf-4b62-8bb8-797155981158|10|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|JAR|[?]|1|/500 WBC|PATELLA|RIGHT|||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2020-11-29|90
e|FA|25e81c81-8c23-4c9e-be79-35247384dd1f|1|SEV|Severity/Intensity|[?]|GERD|[?]|MESF|[?]|1|Pa|RAPHE|CONTRALATERAL|Y||CHILD|1|Visit_1|10|1|TREATMENT|2020-08-08|10
e|FA|25e81c81-8c23-4c9e-be79-35247384dd1f|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PFU/dose|[?]|1|mg/g/min|LATERAL RAMUS INTERMEDIUS ARTERY|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-08-08|10
e|FA|25e81c81-8c23-4c9e-be79-35247384dd1f|3|DFRUIT|Dietary Fruit|[?]|GERD|[?]|mOsm|[?]|1|10^6 CFU/mL|THORACIC VERTEBRA|IPSILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-08-23|25
e|FA|25e81c81-8c23-4c9e-be79-35247384dd1f|4|TOXGR|Toxicity Grade|[?]|GERD|[?]|EVENTS|[?]|1|aMFI|EPIDURAL SPACE|RIGHT||Y|INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2020-08-23|25
e|FA|25e81c81-8c23-4c9e-be79-35247384dd1f|5|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|tuberculin unit|[?]|1|cmH2O/mL|C5 VERTEBRA|LEFT|Y||SIBLING|3|Visit_3|40|4|WASHOUT|2020-09-07|40
e|FA|25e81c81-8c23-4c9e-be79-35247384dd1f|6|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|cm/min|[?]|1|AU/mL|PROSTATE GLAND, LATERAL LOBE|CONTRALATERAL|Y||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-09-07|40
e|FA|25e81c81-8c23-4c9e-be79-35247384dd1f|7|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|tuberculin unit/mL|[?]|1|Gy/h|NAIL BED|BILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|1|FOLLOW-UP|2020-10-02|65
e|FA|25e81c81-8c23-4c9e-be79-35247384dd1f|8|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|10^7/L|[?]|1|Log10 ELISA unit|CARPAL BONE|RIGHT|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|WASHOUT|2020-10-02|65
e|FA|25e81c81-8c23-4c9e-be79-35247384dd1f|9|SEV|Severity/Intensity|[?]|GERD|[?]|g|[?]|1|Pa|OBTURATOR MUSCLE|LEFT|||VENDOR|5|Visit_5|90|2|TREATMENT|2020-10-27|90
e|FA|25e81c81-8c23-4c9e-be79-35247384dd1f|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|kHz|[?]|1|km|PORTAL VEIN|LEFT||Y|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-10-27|90
e|FA|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|1|LDIAM|Longest Diameter|[?]|GERD|[?]|cy/cm|[?]|1|Shock Wave|GREAT VESSELS|LEFT|||INTERVIEWER|1|Visit_1|10|7|FOLLOW-UP|2020-07-27|10
e|FA|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|2|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|dpm/0.5 mL|[?]|1|U/mg|INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|WASHOUT|2020-07-27|10
e|FA|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|3|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|Ci/kg|[?]|1|mL/m2|RADIUS|BILATERAL||Y|INTERVIEWER|2|Visit_2|25|2|TREATMENT|2020-08-11|25
e|FA|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|GBq|[?]|1|QUANTITY SUFFICIENT|CERVICAL VERTEBRA|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|2|SCREENING|2020-08-11|25
e|FA|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|5|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|Ci/uL|[?]|1|10^4 CFU/mL|NAVICULAR BONE|CONTRALATERAL|||SPOUSE|3|Visit_3|40|5|TREATMENT|2020-08-26|40
e|FA|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|6|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|/10^3|[?]|1|anti-Xa IU/mL|RADIAL ARTERY|IPSILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-08-26|40
e|FA|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|7|QOLIMP|QOL Impact|[?]|GERD|[?]|/10^4|[?]|1|10^6/L|GENITOURINARY SYSTEM|RIGHT|||GUARDIAN|4|Visit_4|65|3|WASHOUT|2020-09-20|65
e|FA|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|8|DMEAT|Dietary Meat|[?]|GERD|[?]|h*%|[?]|1|10^6 organisms/mL|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2020-09-20|65
e|FA|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|9|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|vp/mL|[?]|1|Shock Wave|COMMON ILIAC ARTERY|IPSILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|4|FOLLOW-UP|2020-10-15|90
e|FA|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|10|SERVNUM|Number of Servings|[?]|GERD|[?]|TCID 50/dose|[?]|1|Hz/s|HEART, APEX|UNILATERAL|Y|Y|PARENT|5|Visit_5|90|5|TREATMENT|2020-10-15|90
e|FA|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|1|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|GPS U|[?]|1|/500 WBC|MID-JUGULAR LYMPH NODE|IPSILATERAL|||STUDY SUBJECT|1|Visit_1|10|6|TREATMENT|2020-11-12|10
e|FA|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/h|[?]|1|mg/g/min|BRACHIAL LYMPH NODE|LEFT|||PARENT|1|Visit_1|10|5|SCREENING|2020-11-12|10
e|FA|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|3|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|mg/kg/week|[?]|1|Gy/h|ACROMION|LEFT|||GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-11-27|25
e|FA|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|4|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mmol|[?]|1|10^6 U|HEAD|UNILATERAL|||INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-11-27|25
e|FA|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|5|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|atm|[?]|1|mL/m2|BLADDER, DOME|RIGHT|Y||SIBLING|3|Visit_3|40|2|TREATMENT|2020-12-12|40
e|FA|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|LENS|[?]|1|%(v/v)|PORTAL VEIN BIFURCATION|IPSILATERAL|||STUDY SUBJECT|3|Visit_3|40|3|FOLLOW-UP|2020-12-12|40
e|FA|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|7|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|F|[?]|1|mL/h|COMMON ILIAC ARTERY|UNILATERAL|Y||FRIEND|4|Visit_4|65|4|SCREENING|2021-01-06|65
e|FA|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|8|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|log10 IU/mL|[?]|1|DROP|NASAL BONE|RIGHT|||STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2021-01-06|65
e|FA|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|9|DMEAT|Dietary Meat|[?]|GERD|[?]|nmol BCE/L|[?]|1|10^6 organisms/mL|PERITONEAL CAVITY|LEFT|Y||CAREGIVER|5|Visit_5|90|5|FOLLOW-UP|2021-01-31|90
e|FA|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|TRANSDUCING UNIT/mL|[?]|1|QUANTITY SUFFICIENT|TONGUE|UNILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-01-31|90
e|FA|5ba70148-c29b-47af-9280-10d1a942380a|1|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|AMPULE|[?]|1|mmHg/L/min|MESENTERIC VEIN|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|WASHOUT|2020-11-28|10
e|FA|5ba70148-c29b-47af-9280-10d1a942380a|2|DFRUIT|Dietary Fruit|[?]|GERD|[?]|vg/kg|[?]|1|10^6 CFU/mL|PULMONARY VALVE, ANTERIOR CUSP|UNILATERAL|Y||VENDOR|1|Visit_1|10|1|SCREENING|2020-11-28|10
e|FA|5ba70148-c29b-47af-9280-10d1a942380a|3|ESTWT|Estimated Weight|[?]|GERD|[?]|10^9/dose|[?]|1|g/day|ABDOMINAL AORTA|RIGHT||Y|SPOUSE|2|Visit_2|25|2|SCREENING|2020-12-13|25
e|FA|5ba70148-c29b-47af-9280-10d1a942380a|4|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|10^6/hpf|[?]|1|MPS U|MEDIASTINUM|RIGHT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-12-13|25
e|FA|5ba70148-c29b-47af-9280-10d1a942380a|5|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|BEAM BREAKS|[?]|1|mL/h|INTERPHALANGEAL JOINT 5|LEFT||Y|FRIEND|3|Visit_3|40|3|WASHOUT|2020-12-28|40
e|FA|5ba70148-c29b-47af-9280-10d1a942380a|6|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|pptr|[?]|1|vp/dose|DISTAL PHALANX 3 OF THE HAND|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|WASHOUT|2020-12-28|40
e|FA|5ba70148-c29b-47af-9280-10d1a942380a|7|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|L/day|[?]|1|MBq|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|RIGHT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-01-22|65
e|FA|5ba70148-c29b-47af-9280-10d1a942380a|8|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|cm|[?]|1|mL/m2|WARDS TRIANGLE|CONTRALATERAL|Y|Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|FOLLOW-UP|2021-01-22|65
e|FA|5ba70148-c29b-47af-9280-10d1a942380a|9|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|mL/cm3/min|THORACIC ARTERY|RIGHT|Y||STUDY SUBJECT|5|Visit_5|90|3|WASHOUT|2021-02-16|90
e|FA|5ba70148-c29b-47af-9280-10d1a942380a|10|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|/2000 RBC|[?]|1|umol|LEFT CIRCUMFLEX CORONARY ARTERY|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|WASHOUT|2021-02-16|90
e|FA|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|1|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|WEEKS|[?]|1|L|THYMUS GLAND|BILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2020-05-27|10
e|FA|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|2|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|PIXELS/cm|[?]|1|uL/kg/day|BUCCAL MUCOSA|CONTRALATERAL|||STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2020-05-27|10
e|FA|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|U/mg|ILIAC FOSSA|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-06-11|25
e|FA|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|4|DFIBER|Dietary Fiber|[?]|GERD|[?]|/cmH2O|[?]|1|h*%|INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|Y|Y|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-06-11|25
e|FA|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|5|SEV|Severity/Intensity|[?]|GERD|[?]|min|[?]|1|Pa|LUNG, RIGHT LOWER LOBE|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2020-06-26|40
e|FA|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|6|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|MPL U/mL|[?]|1|g/dL|HAND DIGIT 3|RIGHT|Y|Y|INVESTIGATOR|3|Visit_3|40|3|WASHOUT|2020-06-26|40
e|FA|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|7|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|mL/h|[?]|1|BP|SKIN OF THE HAND|BILATERAL|Y||VENDOR|4|Visit_4|65|1|TREATMENT|2020-07-21|65
e|FA|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|8|ACNDEV|Action Taken With Device|[?]|GERD|[?]|ug/g/min|[?]|1|100 IU/mL|MEDIAL FEMORAL CONDYLE|UNILATERAL|||INTERVIEWER|4|Visit_4|65|3|FOLLOW-UP|2020-07-21|65
e|FA|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|9|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|ug/m2/day|[?]|1|U/mmol|BLOOD|LEFT|||PROXY|5|Visit_5|90|3|SCREENING|2020-08-15|90
e|FA|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|Pa|[?]|1|10^6 U|THYROID GLAND|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|WASHOUT|2020-08-15|90
e|FA|2d8f8b1e-7914-400b-afc5-8dc23a626d76|1|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Gauss|[?]|1|mL|TEMPORAL LOBE|CONTRALATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|FOLLOW-UP|2020-06-19|10
e|FA|2d8f8b1e-7914-400b-afc5-8dc23a626d76|2|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|MnFI|[?]|1|MBq|HEART, LEFT VENTRICLE|CONTRALATERAL||Y|CAREGIVER|1|Visit_1|10|4|SCREENING|2020-06-19|10
e|FA|2d8f8b1e-7914-400b-afc5-8dc23a626d76|3|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mmAL|[?]|1|100 IU/mL|AORTIC VALVE|LATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-07-04|25
e|FA|2d8f8b1e-7914-400b-afc5-8dc23a626d76|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/s|[?]|1|NEEDLE GAUGE|LIP|RIGHT|||PROXY|2|Visit_2|25|2|TREATMENT|2020-07-04|25
e|FA|2d8f8b1e-7914-400b-afc5-8dc23a626d76|5|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|Bq|[?]|1|g/cage/day|INTERPHALANGEAL JOINT 3 OF THE HAND|UNILATERAL||Y|SIGNIFICANT OTHER|3|Visit_3|40|6|FOLLOW-UP|2020-07-19|40
e|FA|2d8f8b1e-7914-400b-afc5-8dc23a626d76|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/dose|[?]|1|mg/g/min|OCCIPITAL LOBE|RIGHT|||INTERVIEWER|3|Visit_3|40|1|FOLLOW-UP|2020-07-19|40
e|FA|2d8f8b1e-7914-400b-afc5-8dc23a626d76|7|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|Henry|[?]|1|mEq|METATARSOPHALANGEAL JOINT 3|UNILATERAL|Y||FAMILY MEMBER|4|Visit_4|65|1|WASHOUT|2020-08-13|65
e|FA|2d8f8b1e-7914-400b-afc5-8dc23a626d76|8|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|Gy|[?]|1|10^9 CFU/mL|PROXIMAL INTERPHALANGEAL JOINT 3|CONTRALATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|3|WASHOUT|2020-08-13|65
e|FA|2d8f8b1e-7914-400b-afc5-8dc23a626d76|9|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|mm/h|[?]|1|mg/dose|SALIVARY GLAND|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2020-09-07|90
e|FA|2d8f8b1e-7914-400b-afc5-8dc23a626d76|10|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|Linear ft*LB|[?]|1|mL/min/mmHg|RIB 3|CONTRALATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|SCREENING|2020-09-07|90
e|FA|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|1|DVEG|Dietary Vegetable|[?]|GERD|[?]|pg|[?]|1|Ci/ug|METATARSOPHALANGEAL JOINT 4|UNILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|6|FOLLOW-UP|2020-08-20|10
e|FA|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|2|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|nmol BCE/mmol|[?]|1|ohm|SACRAL TUBEROSITY|CONTRALATERAL|||INTERVIEWER|1|Visit_1|10|5|SCREENING|2020-08-20|10
e|FA|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|uEq/L|[?]|1|10^6 U|EXTERNAL ILIAC ARTERY|CONTRALATERAL|||SIBLING|2|Visit_2|25|1|SCREENING|2020-09-04|25
e|FA|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|NEEDLE GAUGE|ABDUCTOR POLLICIS BREVIS MUSCLE|UNILATERAL|Y||PROXY|2|Visit_2|25|4|SCREENING|2020-09-04|25
e|FA|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|5|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|aMFI|CARPOMETACARPAL JOINT 4|LEFT|||FRIEND|3|Visit_3|40|1|TREATMENT|2020-09-19|40
e|FA|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|6|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|mg/kg/min|[?]|1|cmH2O/mL|ETHMOID BONE|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-09-19|40
e|FA|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|7|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|kcal|[?]|1|uL/kg/day|SHOULDER|LATERAL|Y|Y|SIGNIFICANT OTHER|4|Visit_4|65|7|WASHOUT|2020-10-14|65
e|FA|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|8|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|Gauss|[?]|1|mL/min/mmHg|BRACHIORADIALIS MUSCLE|LEFT||Y|GUARDIAN|4|Visit_4|65|4|WASHOUT|2020-10-14|65
e|FA|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|ug/g/h|RETROAURICULAR LYMPH NODE|RIGHT|||GUARDIAN|5|Visit_5|90|7|FOLLOW-UP|2020-11-08|90
e|FA|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|10|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|CARTRIDGE|[?]|1|BAG|SUBMANDIBULAR GLAND|LEFT|||PARENT|5|Visit_5|90|2|TREATMENT|2020-11-08|90
e|FA|a73142e4-e34b-4144-b95f-7a5562574c1b|1|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|10^5/L|[?]|1|IU/mmol|PRIMARY VISUAL CORTEX|CONTRALATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|6|SCREENING|2020-08-08|10
e|FA|a73142e4-e34b-4144-b95f-7a5562574c1b|2|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|mm|VEIN|IPSILATERAL||Y|SPOUSE|1|Visit_1|10|7|TREATMENT|2020-08-08|10
e|FA|a73142e4-e34b-4144-b95f-7a5562574c1b|3|OBJNUM|Number of Objects|[?]|GERD|[?]|nmol BCE/mmol|[?]|1|mL/100g/min|EYELID|CONTRALATERAL|Y||VENDOR|2|Visit_2|25|7|TREATMENT|2020-08-23|25
e|FA|a73142e4-e34b-4144-b95f-7a5562574c1b|4|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|nmol/mol|[?]|1|/500 WBC|CERVIX UTERI|IPSILATERAL|Y|Y|SPOUSE|2|Visit_2|25|5|TREATMENT|2020-08-23|25
e|FA|a73142e4-e34b-4144-b95f-7a5562574c1b|5|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/100g/min|[?]|1|NEEDLE GAUGE|RAPHE|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-09-07|40
e|FA|a73142e4-e34b-4144-b95f-7a5562574c1b|6|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|umol|[?]|1|g/cage/day|VENOUS SINUS|BILATERAL|Y||STUDY SUBJECT|3|Visit_3|40|7|FOLLOW-UP|2020-09-07|40
e|FA|a73142e4-e34b-4144-b95f-7a5562574c1b|7|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|L/s|[?]|1|EIA unit|LACRIMAL BONE|CONTRALATERAL|||CAREGIVER|4|Visit_4|65|7|WASHOUT|2020-10-02|65
e|FA|a73142e4-e34b-4144-b95f-7a5562574c1b|8|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|MPL U|[?]|1|MBq|SUBMANDIBULAR LYMPH NODE|IPSILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-10-02|65
e|FA|a73142e4-e34b-4144-b95f-7a5562574c1b|9|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|dyn|[?]|1|in|WALDEYER'S TONSILLAR RING|LEFT|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|2|SCREENING|2020-10-27|90
e|FA|a73142e4-e34b-4144-b95f-7a5562574c1b|10|DVEG|Dietary Vegetable|[?]|GERD|[?]|P|[?]|1|Ci/ug|SOFT TISSUE|IPSILATERAL|||SPOUSE|5|Visit_5|90|1|TREATMENT|2020-10-27|90
e|FA|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|1|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|ug/L|[?]|1|mEq|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|LATERAL|||CAREGIVER|1|Visit_1|10|5|FOLLOW-UP|2020-06-03|10
e|FA|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|2|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|mg2/dL2|[?]|1|ug/m2/h|SUPRACLAVICULAR FOSSA|LEFT|||ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-06-03|10
e|FA|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|3|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|cmH2O*s/mL|[?]|1|mEq/g|SAPHENOUS VEIN|BILATERAL|||STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2020-06-18|25
e|FA|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|4|DVEG|Dietary Vegetable|[?]|GERD|[?]|ukat/10^12 RBC|[?]|1|Ci/ug|INTERVENTRICULAR SEPTUM|CONTRALATERAL||Y|INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-06-18|25
e|FA|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|EID 50/dose|[?]|1|mL/animal/day|THYROID GLAND ISTHMUS|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2020-07-03|40
e|FA|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|gtt|[?]|1|mg/g/min|LEFT VENTRICULAR MID INFERIOR SEGMENT|LATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2020-07-03|40
e|FA|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|7|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|DNA copies/ug|[?]|1|uL/kg/day|FLEXOR HALLUCIS LONGUS MUSCLE|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-07-28|65
e|FA|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|8|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|fL|[?]|1|Coulomb|FLOOR OF MOUTH|CONTRALATERAL||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-07-28|65
e|FA|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|9|ESTWT|Estimated Weight|[?]|GERD|[?]|MONTHS|[?]|1|g/day|XIPHOID PROCESS|UNILATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|5|WASHOUT|2020-08-22|90
e|FA|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|10|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|BAR|[?]|1|AU/mL|UPPER RESPIRATORY SYSTEM|LATERAL||Y|FRIEND|5|Visit_5|90|2|TREATMENT|2020-08-22|90
e|FA|0f682806-b63c-4c3f-9fda-1e59befbd3a3|1|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|cd/m2|[?]|1|h*%|SPLEEN, HILUM|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-05-29|10
e|FA|0f682806-b63c-4c3f-9fda-1e59befbd3a3|2|VOL|Volume|[?]|GERD|[?]|amu|[?]|1|vp/dose|PULMONARY VALVE|RIGHT|Y||CAREGIVER|1|Visit_1|10|3|TREATMENT|2020-05-29|10
e|FA|0f682806-b63c-4c3f-9fda-1e59befbd3a3|3|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|cd/m2|[?]|1|Shock Wave|RECTO-UTERINE POUCH|BILATERAL|||FRIEND|2|Visit_2|25|7|TREATMENT|2020-06-13|25
e|FA|0f682806-b63c-4c3f-9fda-1e59befbd3a3|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|/10^5|[?]|1|mg/g/min|POSTERIOR CERVICAL LYMPH NODE|LATERAL|Y|Y|PROXY|2|Visit_2|25|1|WASHOUT|2020-06-13|25
e|FA|0f682806-b63c-4c3f-9fda-1e59befbd3a3|5|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|mmol2/L2|[?]|1|EIA unit|CAUDATE NUCLEUS|UNILATERAL|Y||FRIEND|3|Visit_3|40|4|TREATMENT|2020-06-28|40
e|FA|0f682806-b63c-4c3f-9fda-1e59befbd3a3|6|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|mL*cmH2O|[?]|1|U/mmol|LEPTOMENINGES|BILATERAL|Y|Y|PARENT|3|Visit_3|40|1|SCREENING|2020-06-28|40
e|FA|0f682806-b63c-4c3f-9fda-1e59befbd3a3|7|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|vg/mL|[?]|1|DRUM|TRUNK|LEFT||Y|PARENT|4|Visit_4|65|2|WASHOUT|2020-07-23|65
e|FA|0f682806-b63c-4c3f-9fda-1e59befbd3a3|8|EVENTFRQ|Event Frequency|[?]|GERD|[?]|MBq/uL|[?]|1|ug/kg/h|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|RIGHT|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|3|WASHOUT|2020-07-23|65
e|FA|0f682806-b63c-4c3f-9fda-1e59befbd3a3|9|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|cmH2O/mL|[?]|1|cmH2O/mL|SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL|||DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-08-17|90
e|FA|0f682806-b63c-4c3f-9fda-1e59befbd3a3|10|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|mEq/kg|[?]|1|L|SKIN OF THE FINGER|CONTRALATERAL|||CHILD|5|Visit_5|90|2|FOLLOW-UP|2020-08-17|90
e|FA|1d8aba56-f62e-4116-b447-899dedd3d4df|1|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|MASK|[?]|1|mL/h|ILIAC VEIN|LATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|5|TREATMENT|2020-09-29|10
e|FA|1d8aba56-f62e-4116-b447-899dedd3d4df|2|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|m|[?]|1|fmol|METATARSOPHALANGEAL JOINT 4|LATERAL|Y||CAREGIVER|1|Visit_1|10|3|TREATMENT|2020-09-29|10
e|FA|1d8aba56-f62e-4116-b447-899dedd3d4df|3|ACNDEV|Action Taken With Device|[?]|GERD|[?]|SQU/mL|[?]|1|100 IU/mL|GASTROINTESTINAL TRACT, UPPER, WALL|LATERAL|||INTERVIEWER|2|Visit_2|25|5|WASHOUT|2020-10-14|25
e|FA|1d8aba56-f62e-4116-b447-899dedd3d4df|4|DISTANCE|Distance|[?]|GERD|[?]|mL/kg/min|[?]|1|BOWL|FOOT DIGIT 3|UNILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|6|SCREENING|2020-10-14|25
e|FA|1d8aba56-f62e-4116-b447-899dedd3d4df|5|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mL/breath|[?]|1|mAmp|METATARSOPHALANGEAL JOINT 1|LEFT|||SPOUSE|3|Visit_3|40|4|WASHOUT|2020-10-29|40
e|FA|1d8aba56-f62e-4116-b447-899dedd3d4df|6|SERVNUM|Number of Servings|[?]|GERD|[?]|mL/animal/day|[?]|1|Hz/s|LIMB, LOWER|IPSILATERAL|Y||FRIEND|3|Visit_3|40|3|TREATMENT|2020-10-29|40
e|FA|1d8aba56-f62e-4116-b447-899dedd3d4df|7|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|PA|[?]|1|mL/mmHg/min/L|ESOPHAGUS, ABDOMINAL|UNILATERAL|Y||SPOUSE|4|Visit_4|65|6|WASHOUT|2020-11-23|65
e|FA|1d8aba56-f62e-4116-b447-899dedd3d4df|8|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|/kg|SUBGLOTTIS|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|WASHOUT|2020-11-23|65
e|FA|1d8aba56-f62e-4116-b447-899dedd3d4df|9|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|mm/h|SKIN OF THE ELBOW|LEFT|||DOMESTIC PARTNER|5|Visit_5|90|7|FOLLOW-UP|2020-12-18|90
e|FA|1d8aba56-f62e-4116-b447-899dedd3d4df|10|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|IU/g|[?]|1|AU/mL|TARSAL JOINT|IPSILATERAL|||SPOUSE|5|Visit_5|90|4|TREATMENT|2020-12-18|90
e|FA|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|1|CALBURN|Calories Burned|[?]|GERD|[?]|Enzyme U/m2|[?]|1|/kg|EYE, ANTERIOR CHAMBER|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-08-14|10
e|FA|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|2|TOTNUM|Total Number|[?]|GERD|[?]|10^6/g|[?]|1|/200 HPFs|INTERPHALANGEAL JOINT 4 OF THE FOOT|CONTRALATERAL|||PARENT|1|Visit_1|10|5|TREATMENT|2020-08-14|10
e|FA|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|3|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|CAPLET|[?]|1|umol|FINGER EXTENSOR TENDONS|LATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-08-29|25
e|FA|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|U/mmol|FLEXOR DIGITORUM BREVIS MUSCLE|UNILATERAL|||STUDY SUBJECT|2|Visit_2|25|5|WASHOUT|2020-08-29|25
e|FA|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|umol/mg/min|[?]|1|%(v/v)|POSTERIOR INFERIOR CEREBELLAR ARTERY|CONTRALATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2020-09-13|40
e|FA|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|6|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|copies/uL|[?]|1|mL/h|LIVER, QUADRATE LOBE|LEFT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-09-13|40
e|FA|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|7|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|U/dL|[?]|1|NEEDLE GAUGE|RECTUM|CONTRALATERAL||Y|CAREGIVER|4|Visit_4|65|4|TREATMENT|2020-10-08|65
e|FA|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|8|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|U/g/day|[?]|1|MPS U|FINGER FLEXOR MUSCLES|RIGHT|||INVESTIGATOR|4|Visit_4|65|5|FOLLOW-UP|2020-10-08|65
e|FA|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|9|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|mm3/mm2/year|[?]|1|L/h/m2|RIGHT ATRIAL ENDOCARDIUM|RIGHT|||PROXY|5|Visit_5|90|1|TREATMENT|2020-11-02|90
e|FA|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mol/g|[?]|1|mg/g/min|MEDIASTINUM, ANTERIOR|BILATERAL|||STUDY SUBJECT|5|Visit_5|90|2|WASHOUT|2020-11-02|90
e|FA|383d3f30-14b7-48c3-b1a8-0f481ef37a50|1|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|g/animal|[?]|1|MPS U|SKIN OF THE BENDING JOINT|BILATERAL|||FRIEND|1|Visit_1|10|3|SCREENING|2020-06-07|10
e|FA|383d3f30-14b7-48c3-b1a8-0f481ef37a50|2|DGRAIN|Dietary Grain|[?]|GERD|[?]|10^8 PFU|[?]|1|10^9 CFU/g|POPLITEAL ARTERY BELOW KNEE|LEFT||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|SCREENING|2020-06-07|10
e|FA|383d3f30-14b7-48c3-b1a8-0f481ef37a50|3|LESNUM|Number of Lesions|[?]|GERD|[?]|mkat|[?]|1|ng/day|RIB 1|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2020-06-22|25
e|FA|383d3f30-14b7-48c3-b1a8-0f481ef37a50|4|DFIBER|Dietary Fiber|[?]|GERD|[?]|IU/kg/h|[?]|1|h*%|TRICUSPID VALVE, ANTERIOR CUSP|BILATERAL|||FAMILY MEMBER|2|Visit_2|25|5|FOLLOW-UP|2020-06-22|25
e|FA|383d3f30-14b7-48c3-b1a8-0f481ef37a50|5|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|10^6 IU/mL|[?]|1|mL|LEFT ATRIOVENTRICULAR ARTERY|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-07-07|40
e|FA|383d3f30-14b7-48c3-b1a8-0f481ef37a50|6|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|/200 HPFs|RADIUS SHAFT|LATERAL|Y||PARENT|3|Visit_3|40|3|TREATMENT|2020-07-07|40
e|FA|383d3f30-14b7-48c3-b1a8-0f481ef37a50|7|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|breaths/min|[?]|1|g/day|NAIL|UNILATERAL|||CHILD|4|Visit_4|65|4|WASHOUT|2020-08-01|65
e|FA|383d3f30-14b7-48c3-b1a8-0f481ef37a50|8|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|/LSQN|[?]|1|g/dL|L4-L5 INTERVERTEBRAL SPACE|BILATERAL|||INTERVIEWER|4|Visit_4|65|6|TREATMENT|2020-08-01|65
e|FA|383d3f30-14b7-48c3-b1a8-0f481ef37a50|9|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|mV2/Hz|[?]|1|PACK|FLEXOR DIGITORUM BREVIS MUSCLE|RIGHT|||FRIEND|5|Visit_5|90|5|TREATMENT|2020-08-26|90
e|FA|383d3f30-14b7-48c3-b1a8-0f481ef37a50|10|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|IMPLANT|[?]|1|PACK|RIB 12|IPSILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-08-26|90
e|FA|b4f81b74-fee9-4544-9404-206d931ed8e5|1|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|Anson U|[?]|1|mEq|PANCREAS, TAIL|BILATERAL||Y|INTERVIEWER|1|Visit_1|10|6|TREATMENT|2020-10-18|10
e|FA|b4f81b74-fee9-4544-9404-206d931ed8e5|2|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|cpm|[?]|1|10^6 organisms/mL|ABDUCTOR HALLUCIS MUSCLE|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-10-18|10
e|FA|b4f81b74-fee9-4544-9404-206d931ed8e5|3|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|10^8 PFU|[?]|1|mL/100g/min|COMMON FEMORAL ARTERY|UNILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-11-02|25
e|FA|b4f81b74-fee9-4544-9404-206d931ed8e5|4|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|BEAM BREAKS|[?]|1|km|METACARPAL BONE 5|RIGHT|||INTERVIEWER|2|Visit_2|25|1|FOLLOW-UP|2020-11-02|25
e|FA|b4f81b74-fee9-4544-9404-206d931ed8e5|5|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|atm|[?]|1|mL/100g/min|MUCOSA OF THE LIP|CONTRALATERAL|||STUDY SUBJECT|3|Visit_3|40|7|TREATMENT|2020-11-17|40
e|FA|b4f81b74-fee9-4544-9404-206d931ed8e5|6|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|ug/mL/h|[?]|1|h*%|RENAL FOSSA|LATERAL|||FRIEND|3|Visit_3|40|1|TREATMENT|2020-11-17|40
e|FA|b4f81b74-fee9-4544-9404-206d931ed8e5|7|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|breaths/30s|[?]|1|Gy/h|GENITAL TUBERCLE|UNILATERAL||Y|CHILD|4|Visit_4|65|6|TREATMENT|2020-12-12|65
e|FA|b4f81b74-fee9-4544-9404-206d931ed8e5|8|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|/VF|[?]|1|10^9 CFU/mL|STERNUM|LEFT|||SIBLING|4|Visit_4|65|7|FOLLOW-UP|2020-12-12|65
e|FA|b4f81b74-fee9-4544-9404-206d931ed8e5|9|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|mEq|[?]|1|mEq|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|||INTERVIEWER|5|Visit_5|90|6|SCREENING|2021-01-06|90
e|FA|b4f81b74-fee9-4544-9404-206d931ed8e5|10|TOTNUM|Total Number|[?]|GERD|[?]|Gravitational Unit|[?]|1|/200 HPFs|NOSTRIL|CONTRALATERAL|Y||STUDY SUBJECT|5|Visit_5|90|4|WASHOUT|2021-01-06|90
e|FA|9e69b457-20db-45e5-a535-0cd8ac102fea|1|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|cm/min|[?]|1|Bq/mg|DISTAL COMMON BILE DUCT|LEFT|||CAREGIVER|1|Visit_1|10|2|WASHOUT|2020-06-07|10
e|FA|9e69b457-20db-45e5-a535-0cd8ac102fea|2|EXCDUR|Exercise Duration|[?]|GERD|[?]|Gy|[?]|1|mm|ESOPHAGUS, ABDOMINAL|UNILATERAL||Y|PROXY|1|Visit_1|10|2|TREATMENT|2020-06-07|10
e|FA|9e69b457-20db-45e5-a535-0cd8ac102fea|3|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|10^10/L|[?]|1|AU/mL|PREFRONTAL CORTEX|IPSILATERAL|Y||CAREGIVER|2|Visit_2|25|1|FOLLOW-UP|2020-06-22|25
e|FA|9e69b457-20db-45e5-a535-0cd8ac102fea|4|LDIAM|Longest Diameter|[?]|GERD|[?]|RFU|[?]|1|Shock Wave|HEAD|IPSILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|5|TREATMENT|2020-06-22|25
e|FA|9e69b457-20db-45e5-a535-0cd8ac102fea|5|PPTFCT|Precipitating Factor|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|EIA unit|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|BILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|FOLLOW-UP|2020-07-07|40
e|FA|9e69b457-20db-45e5-a535-0cd8ac102fea|6|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|uCi/kg|SKIN OF THE CHIN|IPSILATERAL||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2020-07-07|40
e|FA|9e69b457-20db-45e5-a535-0cd8ac102fea|7|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|10^6 RNA copies/mL|[?]|1|Shock Wave|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LATERAL|||GUARDIAN|4|Visit_4|65|1|TREATMENT|2020-08-01|65
e|FA|9e69b457-20db-45e5-a535-0cd8ac102fea|8|VOL|Volume|[?]|GERD|[?]|dmol|[?]|1|vp/dose|NUCLEUS OF DIAGONAL BAND|BILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2020-08-01|65
e|FA|9e69b457-20db-45e5-a535-0cd8ac102fea|9|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|PLUG|[?]|1|psi|TEMPORAL LOBE|LATERAL|||GUARDIAN|5|Visit_5|90|6|FOLLOW-UP|2020-08-26|90
e|FA|9e69b457-20db-45e5-a535-0cd8ac102fea|10|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|mmol/g|[?]|1|/500 WBC|PERIUMBILICAL REGION|LEFT|||CAREGIVER|5|Visit_5|90|2|FOLLOW-UP|2020-08-26|90
e|FA|14211798-ddf6-47c8-bd9d-056d95bad8ff|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|%(v/v)|[?]|1|%(v/v)|AZYGOS VEIN|UNILATERAL|||STUDY SUBJECT|1|Visit_1|10|1|SCREENING|2020-09-26|10
e|FA|14211798-ddf6-47c8-bd9d-056d95bad8ff|2|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|10^3 RNA copies/mL|[?]|1|ug/kg/h|ANTERIOR CINGULATE CORTEX|IPSILATERAL||Y|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-09-26|10
e|FA|14211798-ddf6-47c8-bd9d-056d95bad8ff|3|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/mmol|[?]|1|mIU/L|SOLEUS MUSCLE|UNILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2020-10-11|25
e|FA|14211798-ddf6-47c8-bd9d-056d95bad8ff|4|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|U/kg/h|[?]|1|10^6/L|LUNG, RIGHT MIDDLE LOBE|LATERAL|Y|Y|STUDY SUBJECT|2|Visit_2|25|6|SCREENING|2020-10-11|25
e|FA|14211798-ddf6-47c8-bd9d-056d95bad8ff|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|dmol|[?]|1|mg/g/min|FRONTAL SINUS|LEFT|||INDEPENDENT ASSESSOR|3|Visit_3|40|3|WASHOUT|2020-10-26|40
e|FA|14211798-ddf6-47c8-bd9d-056d95bad8ff|6|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|JAR|[?]|1|g/cage/day|ASCENDING AORTA, AORTIC ROOT|LATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|1|WASHOUT|2020-10-26|40
e|FA|14211798-ddf6-47c8-bd9d-056d95bad8ff|7|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|10^7 CFU|[?]|1|fmol|CRANIAL CAVITY|LATERAL|||PROXY|4|Visit_4|65|3|FOLLOW-UP|2020-11-20|65
e|FA|14211798-ddf6-47c8-bd9d-056d95bad8ff|8|STRCTNUM|Number of Strictures|[?]|GERD|[?]|yd|[?]|1|SACHET|DENTAL ARCH|CONTRALATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|5|FOLLOW-UP|2020-11-20|65
e|FA|14211798-ddf6-47c8-bd9d-056d95bad8ff|9|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|%/s|[?]|1|EIA unit|PANCREATIC DUCT|IPSILATERAL|||FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2020-12-15|90
e|FA|14211798-ddf6-47c8-bd9d-056d95bad8ff|10|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|mU/g|[?]|1|g/day|LACRIMAL GLAND|UNILATERAL||Y|SPOUSE|5|Visit_5|90|1|WASHOUT|2020-12-15|90
e|FA|63f3194e-9b88-491a-9a68-19109ed86e2b|1|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|MONTHS|[?]|1|anti-Xa IU/mL|L6 VERTEBRA|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-06-10|10
e|FA|63f3194e-9b88-491a-9a68-19109ed86e2b|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/kg|[?]|1|mg/g/min|LIVER LOBE|LATERAL|||FRIEND|1|Visit_1|10|7|TREATMENT|2020-06-10|10
e|FA|63f3194e-9b88-491a-9a68-19109ed86e2b|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mOsm|[?]|1|mg/g/min|EAR, INNER|IPSILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|WASHOUT|2020-06-25|25
e|FA|63f3194e-9b88-491a-9a68-19109ed86e2b|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|mg/g/min|PROXIMAL PHALANX 4 OF THE HAND|UNILATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-06-25|25
e|FA|63f3194e-9b88-491a-9a68-19109ed86e2b|5|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mg/dose|[?]|1|ug/kg/h|LIP, UPPER|UNILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2020-07-10|40
e|FA|63f3194e-9b88-491a-9a68-19109ed86e2b|6|DFIBER|Dietary Fiber|[?]|GERD|[?]|10^12 IU/L|[?]|1|h*%|PROXIMAL CIRCUMFLEX ARTERY|LATERAL|||GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-07-10|40
e|FA|63f3194e-9b88-491a-9a68-19109ed86e2b|7|VOL|Volume|[?]|GERD|[?]|cm H2O|[?]|1|vp/dose|ANKLE JOINT ANTERIOR FLEXOR TENDONS|BILATERAL|||CAREGIVER|4|Visit_4|65|1|SCREENING|2020-08-04|65
e|FA|63f3194e-9b88-491a-9a68-19109ed86e2b|8|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|vg/mL|[?]|1|fmol|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|UNILATERAL||Y|FRIEND|4|Visit_4|65|2|WASHOUT|2020-08-04|65
e|FA|63f3194e-9b88-491a-9a68-19109ed86e2b|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|nkat|[?]|1|mg/g/min|FUNDUS UTERI|CONTRALATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|3|WASHOUT|2020-08-29|90
e|FA|63f3194e-9b88-491a-9a68-19109ed86e2b|10|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|ug/kg/h|[?]|1|mL/100g/min|MEDIASTINUM|IPSILATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-08-29|90
e|FA|b6208258-d7c2-4dde-addf-4677946ab165|1|DIAMETER|Diameter|[?]|GERD|[?]|mg/kg/day|[?]|1|cm|HEPATIC ARTERY|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|6|TREATMENT|2020-09-20|10
e|FA|b6208258-d7c2-4dde-addf-4677946ab165|2|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|/HPF|[?]|1|g/dL|FOOT DIGIT 5|LEFT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|FOLLOW-UP|2020-09-20|10
e|FA|b6208258-d7c2-4dde-addf-4677946ab165|3|DMEAT|Dietary Meat|[?]|GERD|[?]|10^6 IU/mL|[?]|1|10^6 organisms/mL|SYMPATHETIC GANGLIA|CONTRALATERAL||Y|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-10-05|25
e|FA|b6208258-d7c2-4dde-addf-4677946ab165|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|EP U|[?]|1|%(v/v)|TRAPEZIUS MUSCLE|CONTRALATERAL|Y|Y|GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-10-05|25
e|FA|b6208258-d7c2-4dde-addf-4677946ab165|5|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|ft2|[?]|1|10^6 IU/mL|FUNDUS OF THE EYE|LATERAL|||DOMESTIC PARTNER|3|Visit_3|40|2|TREATMENT|2020-10-20|40
e|FA|b6208258-d7c2-4dde-addf-4677946ab165|6|DISTANCE|Distance|[?]|GERD|[?]|10^6/g|[?]|1|BOWL|CAUDATE NUCLEUS|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|5|WASHOUT|2020-10-20|40
e|FA|b6208258-d7c2-4dde-addf-4677946ab165|7|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|dB|[?]|1|IU/mmol|RESPIRATORY SYSTEM|BILATERAL|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-11-14|65
e|FA|b6208258-d7c2-4dde-addf-4677946ab165|8|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|BP|[?]|1|TRANSDUCING UNIT/mL|PARATHYROID GLAND|BILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|FOLLOW-UP|2020-11-14|65
e|FA|b6208258-d7c2-4dde-addf-4677946ab165|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|10^7/L|[?]|1|ug/g/h|DISTAL EXTRAHEPATIC BILE DUCT REGION|CONTRALATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2020-12-09|90
e|FA|b6208258-d7c2-4dde-addf-4677946ab165|10|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|NEEDLE GAUGE|LUNG, LEFT UPPER LOBE|LEFT|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-12-09|90
e|FA|a669a7b9-2034-4bca-aa80-0371c5fb46d3|1|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|Weber|[?]|1|IU/mmol|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL||Y|FAMILY MEMBER|1|Visit_1|10|2|FOLLOW-UP|2021-01-26|10
e|FA|a669a7b9-2034-4bca-aa80-0371c5fb46d3|2|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|WEEKS|[?]|1|g/cage/day|BRAIN VENTRICLE, LATERAL|LATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|FOLLOW-UP|2021-01-26|10
e|FA|a669a7b9-2034-4bca-aa80-0371c5fb46d3|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mol/g|[?]|1|%(v/v)|TRICUSPID VALVE, ANTERIOR CUSP|LATERAL|Y||PARENT|2|Visit_2|25|2|FOLLOW-UP|2021-02-10|25
e|FA|a669a7b9-2034-4bca-aa80-0371c5fb46d3|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|m/sec2|[?]|1|mg/g/min|NASAL CAVITY|UNILATERAL|Y||CAREGIVER|2|Visit_2|25|4|FOLLOW-UP|2021-02-10|25
e|FA|a669a7b9-2034-4bca-aa80-0371c5fb46d3|5|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|kg/m2|[?]|1|mL/dose|GASTROINTESTINAL TRACT|RIGHT|Y||PROXY|3|Visit_3|40|7|SCREENING|2021-02-25|40
e|FA|a669a7b9-2034-4bca-aa80-0371c5fb46d3|6|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|ms/mmHg|[?]|1|mL/h|EPIGASTRIC LYMPH NODE|RIGHT|||INVESTIGATOR|3|Visit_3|40|4|SCREENING|2021-02-25|40
e|FA|a669a7b9-2034-4bca-aa80-0371c5fb46d3|7|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|mm2|[?]|1|mEq|CECUM|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|5|TREATMENT|2021-03-22|65
e|FA|a669a7b9-2034-4bca-aa80-0371c5fb46d3|8|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|IU/mg|SUPERIOR PUBIC RAMUS|CONTRALATERAL|||FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2021-03-22|65
e|FA|a669a7b9-2034-4bca-aa80-0371c5fb46d3|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|PELLET|[?]|1|ug/g/h|FOREARM|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|5|SCREENING|2021-04-16|90
e|FA|a669a7b9-2034-4bca-aa80-0371c5fb46d3|10|SEV|Severity/Intensity|[?]|GERD|[?]|mmol/day|[?]|1|Pa|COLON, HEPATIC FLEXURE|LATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|WASHOUT|2021-04-16|90
e|FA|e148c13d-ee41-4503-a7e5-397dd6155f04|1|AGETRT1|Age At First Treatment|[?]|GERD|[?]|/day|[?]|1|mL/mmHg/min/L|METACARPAL BONE 2|IPSILATERAL||Y|FAMILY MEMBER|1|Visit_1|10|6|TREATMENT|2020-07-18|10
e|FA|e148c13d-ee41-4503-a7e5-397dd6155f04|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|nkat|[?]|1|mg/g/min|SKIN OF THE FOREARM|LATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|7|TREATMENT|2020-07-18|10
e|FA|e148c13d-ee41-4503-a7e5-397dd6155f04|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|Shock Wave|PREAURICULAR LYMPH NODE|LATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-08-02|25
e|FA|e148c13d-ee41-4503-a7e5-397dd6155f04|4|VOL|Volume|[?]|GERD|[?]|AU/mL|[?]|1|vp/dose|ESOPHAGUS, LOWER THIRD|BILATERAL|Y||SPOUSE|2|Visit_2|25|7|FOLLOW-UP|2020-08-02|25
e|FA|e148c13d-ee41-4503-a7e5-397dd6155f04|5|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|amp|[?]|1|CUP|DIGIT|RIGHT|||SIGNIFICANT OTHER|3|Visit_3|40|3|FOLLOW-UP|2020-08-17|40
e|FA|e148c13d-ee41-4503-a7e5-397dd6155f04|6|SEV|Severity/Intensity|[?]|GERD|[?]|/mm|[?]|1|Pa|THYROID GLAND, LEFT LOBE|LATERAL||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|WASHOUT|2020-08-17|40
e|FA|e148c13d-ee41-4503-a7e5-397dd6155f04|7|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|pmol/L/h|[?]|1|mL/dose|METACARPAL BONE 1|RIGHT|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|1|WASHOUT|2020-09-11|65
e|FA|e148c13d-ee41-4503-a7e5-397dd6155f04|8|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/g|[?]|1|cm H2O|ELBOW JOINT|RIGHT|||INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2020-09-11|65
e|FA|e148c13d-ee41-4503-a7e5-397dd6155f04|9|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|g/kg/day|[?]|1|IU/mg|PROSTATE GLAND, POSTERIOR LOBE|BILATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2020-10-06|90
e|FA|e148c13d-ee41-4503-a7e5-397dd6155f04|10|SEV|Severity/Intensity|[?]|GERD|[?]|in|[?]|1|Pa|ARM|BILATERAL|||VENDOR|5|Visit_5|90|2|TREATMENT|2020-10-06|90
e|FA|815de94a-f259-41ee-8951-8df150184a25|1|SEV|Severity/Intensity|[?]|GERD|[?]|MESF|[?]|1|Pa|DISTAL INTERPHALANGEAL JOINT 2|RIGHT|||GUARDIAN|1|Visit_1|10|4|SCREENING|2020-07-07|10
e|FA|815de94a-f259-41ee-8951-8df150184a25|2|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|Gy/min|[?]|1|IU/mg|COLON, DESCENDING|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|FOLLOW-UP|2020-07-07|10
e|FA|815de94a-f259-41ee-8951-8df150184a25|3|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|Bq/mL|[?]|1|ohm|ANTERIOR TIBIAL ARTERY|LEFT|||SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2020-07-22|25
e|FA|815de94a-f259-41ee-8951-8df150184a25|4|OBJNUM|Number of Objects|[?]|GERD|[?]|TABLET|[?]|1|mL/100g/min|AORTIC VALVE, RIGHT CORONARY CUSP|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-07-22|25
e|FA|815de94a-f259-41ee-8951-8df150184a25|5|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|log EID 50/dose|[?]|1|mL/h|MITRAL VALVE, ANTERIOR ANNULUS|LEFT||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|SCREENING|2020-08-06|40
e|FA|815de94a-f259-41ee-8951-8df150184a25|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ngEq/L|[?]|1|Pa|CERVICAL LYMPH NODE|CONTRALATERAL|||PROXY|3|Visit_3|40|5|TREATMENT|2020-08-06|40
e|FA|815de94a-f259-41ee-8951-8df150184a25|7|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg/min/L|[?]|1|mL/h|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|IPSILATERAL|||PROXY|4|Visit_4|65|7|TREATMENT|2020-08-31|65
e|FA|815de94a-f259-41ee-8951-8df150184a25|8|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|uIU/L|[?]|1|QUANTITY SUFFICIENT|RIGHT ATRIAL ENDOCARDIUM|RIGHT|Y||GUARDIAN|4|Visit_4|65|2|TREATMENT|2020-08-31|65
e|FA|815de94a-f259-41ee-8951-8df150184a25|9|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|LB|[?]|1|PFU/dose|PANCREAS|CONTRALATERAL|Y||FRIEND|5|Visit_5|90|4|WASHOUT|2020-09-25|90
e|FA|815de94a-f259-41ee-8951-8df150184a25|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|vp/dose|[?]|1|mg/g/min|LUMBAR REGION|BILATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-09-25|90
e|FA|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|1|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|BP|METACARPAL BONE 3|BILATERAL|||ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-05-16|10
e|FA|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|m/sec|[?]|1|Pa|METACARPAL BONE 5|BILATERAL|||INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-05-16|10
e|FA|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|3|STRCTNUM|Number of Strictures|[?]|GERD|[?]|grain|[?]|1|SACHET|GLUTEAL MUSCLE|LEFT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-05-31|25
e|FA|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|oz|[?]|1|mg/g/min|FEMORAL LYMPH NODE|IPSILATERAL|||STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-05-31|25
e|FA|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|5|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|uOsm|[?]|1|m2|C3 VERTEBRA|LATERAL|||VENDOR|3|Visit_3|40|5|SCREENING|2020-06-15|40
e|FA|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|6|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|10^6 CFU|PROSTATE GLAND, POSTERIOR LOBE|RIGHT||Y|PROXY|3|Visit_3|40|4|TREATMENT|2020-06-15|40
e|FA|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|7|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|mg/h|[?]|1|DRUM|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LATERAL|||GUARDIAN|4|Visit_4|65|5|TREATMENT|2020-07-10|65
e|FA|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|8|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|ks|[?]|1|mL/h|POSTERIOR TIBIAL ARTERY|UNILATERAL||Y|SIBLING|4|Visit_4|65|1|FOLLOW-UP|2020-07-10|65
e|FA|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|9|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mL/m2/h|[?]|1|Weber|ESOPHAGUS|UNILATERAL|Y||CAREGIVER|5|Visit_5|90|6|TREATMENT|2020-08-04|90
e|FA|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|10|OBJTYPE|Type of Object|[?]|GERD|[?]|copies/ug|[?]|1|ng|WRIST JOINT|LEFT||Y|INTERVIEWER|5|Visit_5|90|7|WASHOUT|2020-08-04|90
e|FA|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/breath|[?]|1|km|LEFT ATRIOVENTRICULAR ARTERY|LATERAL|Y||SIBLING|1|Visit_1|10|7|TREATMENT|2021-01-25|10
e|FA|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|2|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|FIU|[?]|1|cm|ORBIT|LEFT||Y|FRIEND|1|Visit_1|10|3|SCREENING|2021-01-25|10
e|FA|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|3|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|AgU/mL|[?]|1|mL/mmHg/min/L|SOFT TISSUE|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2021-02-09|25
e|FA|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|4|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|min|[?]|1|10^6 CFU|TIBIALIS POSTERIOR MUSCLE|RIGHT|||PARENT|2|Visit_2|25|4|FOLLOW-UP|2021-02-09|25
e|FA|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|dB|[?]|1|ug/g/h|MYOMETRIUM|UNILATERAL|||CAREGIVER|3|Visit_3|40|3|TREATMENT|2021-02-24|40
e|FA|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|6|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|mOsm|[?]|1|/500 WBC|ORAL CAVITY|LATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2021-02-24|40
e|FA|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PIXELS/cm|[?]|1|mg/g/min|UPPER RESPIRATORY SYSTEM|UNILATERAL||Y|FAMILY MEMBER|4|Visit_4|65|7|WASHOUT|2021-03-21|65
e|FA|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|8|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|ug/mol|[?]|1|MBq|EPICONDYLE|LEFT||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2021-03-21|65
e|FA|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^6 organisms/mg|[?]|1|mg/g/min|ANKLE JOINT|LEFT||Y|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2021-04-15|90
e|FA|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|10|SEV|Severity/Intensity|[?]|GERD|[?]|10^3 RNA copies/mL|[?]|1|Pa|TYMPANIC MEMBRANE|LATERAL||Y|PROXY|5|Visit_5|90|4|FOLLOW-UP|2021-04-15|90
e|FA|a616ef00-05d6-459a-8474-06ab3eb493b1|1|EXTRSCT|Extent of Resection|[?]|GERD|[?]|kPa|[?]|1|Weber|METACARPOPHALANGEAL JOINT 4|UNILATERAL|||INVESTIGATOR|1|Visit_1|10|4|WASHOUT|2020-09-25|10
e|FA|a616ef00-05d6-459a-8474-06ab3eb493b1|2|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|nsec|[?]|1|anti-Xa IU/mL|PROXIMAL INTERPHALANGEAL JOINT 2|UNILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-09-25|10
e|FA|a616ef00-05d6-459a-8474-06ab3eb493b1|3|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6/L|[?]|1|mg/dose|AXILLARY LYMPH NODE|IPSILATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2020-10-10|25
e|FA|a616ef00-05d6-459a-8474-06ab3eb493b1|4|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|BE/mL|[?]|1|Log10 ELISA unit|GASTROINTESTINAL TRACT|LEFT|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-10-10|25
e|FA|a616ef00-05d6-459a-8474-06ab3eb493b1|5|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|/200 HPFs|SPLENIC VEIN|RIGHT|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|FOLLOW-UP|2020-10-25|40
e|FA|a616ef00-05d6-459a-8474-06ab3eb493b1|6|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|umol|INTESTINE|LATERAL|||INVESTIGATOR|3|Visit_3|40|1|WASHOUT|2020-10-25|40
e|FA|a616ef00-05d6-459a-8474-06ab3eb493b1|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|PELLET|[?]|1|U/mmol|KIDNEY, CORTEX|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|WASHOUT|2020-11-19|65
e|FA|a616ef00-05d6-459a-8474-06ab3eb493b1|8|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|min|[?]|1|gtt|ANTERIOR CINGULATE GYRUS|LATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2020-11-19|65
e|FA|a616ef00-05d6-459a-8474-06ab3eb493b1|9|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|RFU|[?]|1|Log10 ELISA unit|PERIURETERAL REGION|BILATERAL||Y|INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2020-12-14|90
e|FA|a616ef00-05d6-459a-8474-06ab3eb493b1|10|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|kg|[?]|1|IU/mmol|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|Y||FRIEND|5|Visit_5|90|7|WASHOUT|2020-12-14|90
e|FA|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|1|TOXGR|Toxicity Grade|[?]|GERD|[?]|mmHg/L/min|[?]|1|aMFI|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|LATERAL|||DOMESTIC PARTNER|1|Visit_1|10|3|WASHOUT|2020-08-20|10
e|FA|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|2|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|ka_u/dL|[?]|1|SCOOPFUL|COSTAL CARTILAGE|BILATERAL|||SIBLING|1|Visit_1|10|2|SCREENING|2020-08-20|10
e|FA|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|3|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|m/sec|[?]|1|AU/mL|POSTERIOR INFERIOR CEREBELLAR ARTERY|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-09-04|25
e|FA|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|4|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|mCi/L|[?]|1|PACK|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|LEFT|Y||SIGNIFICANT OTHER|2|Visit_2|25|2|SCREENING|2020-09-04|25
e|FA|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|U/mg|ASCENDING AORTA, SINOTUBULAR JUNCTION|LEFT||Y|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-09-19|40
e|FA|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|mL/min/mmHg|[?]|1|QUANTITY SUFFICIENT|ANTRUM PYLORI|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|FOLLOW-UP|2020-09-19|40
e|FA|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|7|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|CUP|PARAMETRIUM|LEFT|||CHILD|4|Visit_4|65|7|WASHOUT|2020-10-14|65
e|FA|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|8|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|DNA copies/mL|[?]|1|psi|MUCOSA|IPSILATERAL|||SIBLING|4|Visit_4|65|4|TREATMENT|2020-10-14|65
e|FA|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|9|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|IU/mg|FOOT PHALANX|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|5|TREATMENT|2020-11-08|90
e|FA|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|10|DGRAIN|Dietary Grain|[?]|GERD|[?]|mMU/mL|[?]|1|10^9 CFU/g|FEMORAL ARTERY|CONTRALATERAL|||VENDOR|5|Visit_5|90|1|TREATMENT|2020-11-08|90
e|FA|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|1|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|uL/kg/day|EAR, INNER|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|SCREENING|2020-10-21|10
e|FA|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|2|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|nL|[?]|1|U/mmol|ESOPHAGUS, THORACIC|LEFT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|WASHOUT|2020-10-21|10
e|FA|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/L|[?]|1|Pa|HAIR BULB|BILATERAL|||INVESTIGATOR|2|Visit_2|25|7|SCREENING|2020-11-05|25
e|FA|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|4|DMEAT|Dietary Meat|[?]|GERD|[?]|/LSQN|[?]|1|10^6 organisms/mL|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|CONTRALATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|7|FOLLOW-UP|2020-11-05|25
e|FA|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|5|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|BP|[?]|1|g/day|DISTAL RIGHT CORONARY ARTERY CONDUIT|LATERAL|||SPOUSE|3|Visit_3|40|7|TREATMENT|2020-11-20|40
e|FA|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|6|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|Hz|[?]|1|L/h/m2|LUNG, LEFT UPPER LOBE|BILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|SCREENING|2020-11-20|40
e|FA|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|7|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|m2|[?]|1|SCOOPFUL|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|LEFT||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-12-15|65
e|FA|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^3 CFU/g|[?]|1|%(v/v)|CORPUS CALLOSUM|LEFT|Y|Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-12-15|65
e|FA|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|9|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|OI50|[?]|1|mm/h|INTERPHALANGEAL JOINT 4 OF THE FOOT|LEFT|||VENDOR|5|Visit_5|90|4|SCREENING|2021-01-09|90
e|FA|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|10|DCAL|Dietary Calories|[?]|GERD|[?]|Gy|[?]|1|EIA unit|TALUS|IPSILATERAL|||PARENT|5|Visit_5|90|5|TREATMENT|2021-01-09|90
e|FA|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|1|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|kg|[?]|1|TRANSDUCING UNIT/mL|LYMPH NODE|BILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|3|TREATMENT|2020-07-04|10
e|FA|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|2|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|ECL unit|[?]|1|mL/h|HAIR ROOT|LEFT|Y||STUDY SUBJECT|1|Visit_1|10|2|WASHOUT|2020-07-04|10
e|FA|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|3|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|/min|[?]|1|L/h/m2|BICEPS FEMORIS MUSCLE|BILATERAL|Y||DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-07-19|25
e|FA|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|mg/g/h|[?]|1|MBq|LIP|UNILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|2|WASHOUT|2020-07-19|25
e|FA|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|uV|[?]|1|%(v/v)|PORTAL VEIN BIFURCATION|RIGHT||Y|VENDOR|3|Visit_3|40|5|WASHOUT|2020-08-03|40
e|FA|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|6|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|mIU/L|[?]|1|Hz/s|CORPUS CALLOSUM, BODY|BILATERAL|||INVESTIGATOR|3|Visit_3|40|4|WASHOUT|2020-08-03|40
e|FA|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|7|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|uEq|[?]|1|IU/mg|KNEE JOINT|RIGHT|||FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-08-28|65
e|FA|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|8|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|mm/h|[?]|1|mg/dose|C4 VERTEBRA|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2020-08-28|65
e|FA|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|9|EVENTFRQ|Event Frequency|[?]|GERD|[?]|KIT|[?]|1|ug/kg/h|OLFACTORY BULB|RIGHT|Y||DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2020-09-22|90
e|FA|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|10|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|g/mol|[?]|1|cm H2O|OCCIPITAL LYMPH NODE|IPSILATERAL|||ADJUDICATOR|5|Visit_5|90|3|SCREENING|2020-09-22|90
e|FA|2014bcd0-1430-4096-87f5-650a01dae626|1|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|mL/m2/min|[?]|1|mg/h|BRAIN, THIRD VENTRICLE|LATERAL|Y||VENDOR|1|Visit_1|10|7|FOLLOW-UP|2020-05-31|10
e|FA|2014bcd0-1430-4096-87f5-650a01dae626|2|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|MET*min|[?]|1|BOWL|LUNG, LEFT UPPER LOBE|LATERAL|||SIBLING|1|Visit_1|10|6|SCREENING|2020-05-31|10
e|FA|2014bcd0-1430-4096-87f5-650a01dae626|3|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|ug/kg/h|T5 VERTEBRA|LEFT|Y||FRIEND|2|Visit_2|25|2|TREATMENT|2020-06-15|25
e|FA|2014bcd0-1430-4096-87f5-650a01dae626|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|mg/L|[?]|1|ug/g/h|GASTRIC CURVATURE LYMPH NODE|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-06-15|25
e|FA|2014bcd0-1430-4096-87f5-650a01dae626|5|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|g/dL|[?]|1|10^6 organisms/mL|PANCREAS, BODY|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-06-30|40
e|FA|2014bcd0-1430-4096-87f5-650a01dae626|6|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|mgEq|[?]|1|mL/h|RADIAL NERVE|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2020-06-30|40
e|FA|2014bcd0-1430-4096-87f5-650a01dae626|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Frames/s|[?]|1|Pa|DISTAL PHALANX 5 OF THE HAND|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|4|WASHOUT|2020-07-25|65
e|FA|2014bcd0-1430-4096-87f5-650a01dae626|8|LESNUM|Number of Lesions|[?]|GERD|[?]|foz_br|[?]|1|ng/day|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|UNILATERAL|||PARENT|4|Visit_4|65|5|SCREENING|2020-07-25|65
e|FA|2014bcd0-1430-4096-87f5-650a01dae626|9|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|ms2|[?]|1|mIU/L|ULNAR ARTERY|IPSILATERAL|Y|Y|STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2020-08-19|90
e|FA|2014bcd0-1430-4096-87f5-650a01dae626|10|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|BOTTLE|[?]|1|uCi/kg|LIVER, RIGHT LOBE|RIGHT|||CHILD|5|Visit_5|90|1|TREATMENT|2020-08-19|90
e|FA|e043f1b3-6b65-45c0-bdae-eb783406c263|1|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|mL/m2/min|[?]|1|TRANSDUCING UNIT/mL|MAXILLA|UNILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|7|WASHOUT|2020-11-11|10
e|FA|e043f1b3-6b65-45c0-bdae-eb783406c263|2|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|U/mmol|[?]|1|10^4 CFU/mL|RENAL ARTERY|RIGHT|||INTERVIEWER|1|Visit_1|10|6|TREATMENT|2020-11-11|10
e|FA|e043f1b3-6b65-45c0-bdae-eb783406c263|3|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|10^7 CFU|[?]|1|g/cage/day|MEDIASTINUM, MIDDLE|RIGHT|Y|Y|INVESTIGATOR|2|Visit_2|25|7|FOLLOW-UP|2020-11-26|25
e|FA|e043f1b3-6b65-45c0-bdae-eb783406c263|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|%(w/v)|[?]|1|Pa|GASTROINTESTINAL TRACT, UPPER, WALL|LEFT|||VENDOR|2|Visit_2|25|4|WASHOUT|2020-11-26|25
e|FA|e043f1b3-6b65-45c0-bdae-eb783406c263|5|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mL/g/min|[?]|1|Weber|TRACHEA|LEFT|||VENDOR|3|Visit_3|40|5|WASHOUT|2020-12-11|40
e|FA|e043f1b3-6b65-45c0-bdae-eb783406c263|6|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|grain|[?]|1|Log10 ELISA unit|PENIS, BODY|LEFT|||CAREGIVER|3|Visit_3|40|2|FOLLOW-UP|2020-12-11|40
e|FA|e043f1b3-6b65-45c0-bdae-eb783406c263|7|EXCDUR|Exercise Duration|[?]|GERD|[?]|ug/kg/min|[?]|1|mm|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-01-05|65
e|FA|e043f1b3-6b65-45c0-bdae-eb783406c263|8|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|IU/mg|NASAL SEPTUM|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2021-01-05|65
e|FA|e043f1b3-6b65-45c0-bdae-eb783406c263|9|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|Ejaculate U|[?]|1|/500 WBC|DISTAL INTERPHALANGEAL JOINT 4|BILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|6|SCREENING|2021-01-30|90
e|FA|e043f1b3-6b65-45c0-bdae-eb783406c263|10|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|cup eq|[?]|1|CUP|PUTAMEN|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2021-01-30|90
e|FA|45623c39-86de-4b2f-bf2d-998d0e941e92|1|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|10^7 PFU|[?]|1|DRUM|MAIN BRONCHUS, RIGHT|RIGHT|||DOMESTIC PARTNER|1|Visit_1|10|2|WASHOUT|2020-07-22|10
e|FA|45623c39-86de-4b2f-bf2d-998d0e941e92|2|ACNDEV|Action Taken With Device|[?]|GERD|[?]|cmH2O*s/mL|[?]|1|100 IU/mL|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|IPSILATERAL|||CHILD|1|Visit_1|10|5|FOLLOW-UP|2020-07-22|10
e|FA|45623c39-86de-4b2f-bf2d-998d0e941e92|3|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|LB|[?]|1|U/10^12 RBC|INTESTINE|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2020-08-06|25
e|FA|45623c39-86de-4b2f-bf2d-998d0e941e92|4|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|dyn|[?]|1|cm H2O|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|||SIBLING|2|Visit_2|25|4|TREATMENT|2020-08-06|25
e|FA|45623c39-86de-4b2f-bf2d-998d0e941e92|5|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|U/kg/h|[?]|1|L|INCISOR|BILATERAL|||PROXY|3|Visit_3|40|4|SCREENING|2020-08-21|40
e|FA|45623c39-86de-4b2f-bf2d-998d0e941e92|6|STROKTYP|Stroke Type|[?]|GERD|[?]|10^12/L|[?]|1|g/L|RENAL ARTERY|LATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-08-21|40
e|FA|45623c39-86de-4b2f-bf2d-998d0e941e92|7|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|MBP|[?]|1|CUP|L1 VERTEBRA|LATERAL|||FRIEND|4|Visit_4|65|1|TREATMENT|2020-09-15|65
e|FA|45623c39-86de-4b2f-bf2d-998d0e941e92|8|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ft3|[?]|1|uL/kg/day|AXILLARY LYMPH NODE LEVEL III|IPSILATERAL||Y|GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-09-15|65
e|FA|45623c39-86de-4b2f-bf2d-998d0e941e92|9|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|deg2|[?]|1|cm|METACARPOPHALANGEAL JOINT 5|UNILATERAL|||INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2020-10-10|90
e|FA|45623c39-86de-4b2f-bf2d-998d0e941e92|10|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|MAC50|[?]|1|BOWL|LUNG, LEFT UPPER LOBE|BILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|6|FOLLOW-UP|2020-10-10|90
e|FA|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|um/s|[?]|1|mg/g/min|ANTERIOR CINGULATE CORTEX|CONTRALATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-10-18|10
e|FA|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|2|RLDEV|Relationship to Device|[?]|GERD|[?]|IU/day|[?]|1|mL/min/mmHg|SECOND RIGHT POSTEROLATERAL ARTERY|LATERAL|||INTERVIEWER|1|Visit_1|10|4|TREATMENT|2020-10-18|10
e|FA|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|3|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|AU/mL|[?]|1|cmH2O/mL|URETHRA|RIGHT|||ADJUDICATOR|2|Visit_2|25|7|WASHOUT|2020-11-02|25
e|FA|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|4|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|CIGARETTE|[?]|1|mg/h|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|BILATERAL|||FAMILY MEMBER|2|Visit_2|25|3|FOLLOW-UP|2020-11-02|25
e|FA|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|5|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|ms/mmHg|[?]|1|10^9 CFU/mL|KIDNEY, LOWER LOBE|RIGHT|||PARENT|3|Visit_3|40|1|TREATMENT|2020-11-17|40
e|FA|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|6|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|uCi/L|[?]|1|cm H2O|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|IPSILATERAL||Y|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2020-11-17|40
e|FA|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|7|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|mm/h|LACRIMAL GLAND|BILATERAL|Y||FAMILY MEMBER|4|Visit_4|65|5|SCREENING|2020-12-12|65
e|FA|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|PIXELS/in|[?]|1|10^6 U|METATARSAL BONE|BILATERAL|||CHILD|4|Visit_4|65|6|FOLLOW-UP|2020-12-12|65
e|FA|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|9|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|BISCUIT|[?]|1|km|CHEST|IPSILATERAL||Y|FRIEND|5|Visit_5|90|7|SCREENING|2021-01-06|90
e|FA|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|10|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|uCi/L|[?]|1|aMFI|CALCANEUS|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2021-01-06|90
e|FA|e5a105f7-38ac-4f19-aace-4149ed9b1100|1|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|/MBP|[?]|1|aMFI|CRANIAL CAVITY|BILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-09-03|10
e|FA|e5a105f7-38ac-4f19-aace-4149ed9b1100|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|mL*cmH2O|[?]|1|mEq/g|PARASYMPATHETIC GANGLIA|RIGHT|Y||STUDY SUBJECT|1|Visit_1|10|2|WASHOUT|2020-09-03|10
e|FA|e5a105f7-38ac-4f19-aace-4149ed9b1100|3|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|uV2|[?]|1|ug/g/h|TRIANGULAR-LUNATE JOINT|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|2|WASHOUT|2020-09-18|25
e|FA|e5a105f7-38ac-4f19-aace-4149ed9b1100|4|DMEAT|Dietary Meat|[?]|GERD|[?]|mL/beat|[?]|1|10^6 organisms/mL|PROCERUS MUSCLE|CONTRALATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|6|WASHOUT|2020-09-18|25
e|FA|e5a105f7-38ac-4f19-aace-4149ed9b1100|5|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|DDU|[?]|1|anti-Xa IU/mL|INTERPHALANGEAL JOINT 2|UNILATERAL|||INVESTIGATOR|3|Visit_3|40|6|WASHOUT|2020-10-03|40
e|FA|e5a105f7-38ac-4f19-aace-4149ed9b1100|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/cage/wk|[?]|1|Pa|THORAX|IPSILATERAL|||PARENT|3|Visit_3|40|3|FOLLOW-UP|2020-10-03|40
e|FA|e5a105f7-38ac-4f19-aace-4149ed9b1100|7|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|MPS U|[?]|1|gtt|GASTROINTESTINAL TRACT, LOWER, WALL|LATERAL|Y|Y|CAREGIVER|4|Visit_4|65|6|SCREENING|2020-10-28|65
e|FA|e5a105f7-38ac-4f19-aace-4149ed9b1100|8|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mg|[?]|1|Shock Wave|PANCREAS, BODY|CONTRALATERAL|||GUARDIAN|4|Visit_4|65|1|SCREENING|2020-10-28|65
e|FA|e5a105f7-38ac-4f19-aace-4149ed9b1100|9|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|Ci/uL|[?]|1|DROP|PROSTATE GLAND, MIDDLE LOBE|IPSILATERAL|Y|Y|ADJUDICATION COMMITTEE|5|Visit_5|90|7|SCREENING|2020-11-22|90
e|FA|e5a105f7-38ac-4f19-aace-4149ed9b1100|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ng/mol|[?]|1|U/mmol|CERVICAL SPINE|LEFT|||CAREGIVER|5|Visit_5|90|4|WASHOUT|2020-11-22|90
e|FA|c568ab93-8e7f-4e4e-9685-f0c13f293606|1|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|L/min|[?]|1|g/cage/day|COMMON FEMORAL VEIN|BILATERAL|Y||CHILD|1|Visit_1|10|3|TREATMENT|2021-01-14|10
e|FA|c568ab93-8e7f-4e4e-9685-f0c13f293606|2|SERVNUM|Number of Servings|[?]|GERD|[?]|s*kPa|[?]|1|Hz/s|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|LATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2021-01-14|10
e|FA|c568ab93-8e7f-4e4e-9685-f0c13f293606|3|PPTFCT|Precipitating Factor|[?]|GERD|[?]|PACK|[?]|1|EIA unit|FINGER|CONTRALATERAL||Y|STUDY SUBJECT|2|Visit_2|25|6|SCREENING|2021-01-29|25
e|FA|c568ab93-8e7f-4e4e-9685-f0c13f293606|4|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|10^6/hpf|[?]|1|Shock Wave|ANTRUM PYLORI|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2021-01-29|25
e|FA|c568ab93-8e7f-4e4e-9685-f0c13f293606|5|DMEAT|Dietary Meat|[?]|GERD|[?]|LOZENGE|[?]|1|10^6 organisms/mL|PROFUNDA FEMORIS VEIN|LEFT|||FRIEND|3|Visit_3|40|1|TREATMENT|2021-02-13|40
e|FA|c568ab93-8e7f-4e4e-9685-f0c13f293606|6|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|IU/mg|[?]|1|/500 WBC|HYMENAL RING|RIGHT|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|WASHOUT|2021-02-13|40
e|FA|c568ab93-8e7f-4e4e-9685-f0c13f293606|7|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|Bq/mg|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|BILATERAL|||PROXY|4|Visit_4|65|7|FOLLOW-UP|2021-03-10|65
e|FA|c568ab93-8e7f-4e4e-9685-f0c13f293606|8|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|Bq/L|FIBULA SHAFT|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|FOLLOW-UP|2021-03-10|65
e|FA|c568ab93-8e7f-4e4e-9685-f0c13f293606|9|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|mEq/day|[?]|1|TRANSDUCING UNIT/mL|PAROTID GLAND|RIGHT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2021-04-04|90
e|FA|c568ab93-8e7f-4e4e-9685-f0c13f293606|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|WAFER|[?]|1|mL|CORPUS LUTEUM|RIGHT||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|WASHOUT|2021-04-04|90
e|FA|bccd8af0-2ecf-4091-92e4-681597b57ca4|1|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|U/L|[?]|1|HOURS|LIMB|CONTRALATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-09-30|10
e|FA|bccd8af0-2ecf-4091-92e4-681597b57ca4|2|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mL/cm|[?]|1|PFU/dose|TENTORIUM CEREBELLI|LEFT|||SIBLING|1|Visit_1|10|2|TREATMENT|2020-09-30|10
e|FA|bccd8af0-2ecf-4091-92e4-681597b57ca4|3|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|atm|[?]|1|mm/h|TRIANGULAR BONE|LEFT|||VENDOR|2|Visit_2|25|5|SCREENING|2020-10-15|25
e|FA|bccd8af0-2ecf-4091-92e4-681597b57ca4|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|TRACE|[?]|1|mg/g/min|RECTUM|LATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|FOLLOW-UP|2020-10-15|25
e|FA|bccd8af0-2ecf-4091-92e4-681597b57ca4|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/cm3/min|[?]|1|mg/g/min|POSTERIOR CERVICAL LYMPH NODE|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2020-10-30|40
e|FA|bccd8af0-2ecf-4091-92e4-681597b57ca4|6|EXTRSCT|Extent of Resection|[?]|GERD|[?]|km|[?]|1|Weber|FEMORAL ARTERY|RIGHT|Y||INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-10-30|40
e|FA|bccd8af0-2ecf-4091-92e4-681597b57ca4|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mm2|[?]|1|mg/g/min|THORACIC VERTEBRA|LATERAL|||STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2020-11-24|65
e|FA|bccd8af0-2ecf-4091-92e4-681597b57ca4|8|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|Coulomb|[?]|1|mEq|SUBCARINAL LYMPH NODE|LATERAL|||FRIEND|4|Visit_4|65|2|WASHOUT|2020-11-24|65
e|FA|bccd8af0-2ecf-4091-92e4-681597b57ca4|9|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|nkat/L|[?]|1|U/mmol|INTRAHEPATIC BILE DUCT|LATERAL||Y|STUDY SUBJECT|5|Visit_5|90|7|WASHOUT|2020-12-19|90
e|FA|bccd8af0-2ecf-4091-92e4-681597b57ca4|10|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|BOWL|CORNEAL STROMA|IPSILATERAL||Y|PARENT|5|Visit_5|90|7|TREATMENT|2020-12-19|90
e|FA|bf069a02-03a6-4013-b16d-d7c954a6cc3d|1|QOLIMP|QOL Impact|[?]|GERD|[?]|BLOCKS|[?]|1|10^6/L|VERTEBRAL ARTERY|UNILATERAL|Y||CAREGIVER|1|Visit_1|10|6|FOLLOW-UP|2020-08-06|10
e|FA|bf069a02-03a6-4013-b16d-d7c954a6cc3d|2|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|fmol/L/sec|[?]|1|EIA unit|LACRIMAL GLAND|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-08-06|10
e|FA|bf069a02-03a6-4013-b16d-d7c954a6cc3d|3|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|mL/m2/min|[?]|1|mAmp|ANKLE MORTISE|BILATERAL|||FRIEND|2|Visit_2|25|4|TREATMENT|2020-08-21|25
e|FA|bf069a02-03a6-4013-b16d-d7c954a6cc3d|4|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|10^12/L|[?]|1|fmol|FINGERNAIL|LEFT|||SIBLING|2|Visit_2|25|3|SCREENING|2020-08-21|25
e|FA|bf069a02-03a6-4013-b16d-d7c954a6cc3d|5|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|dram|[?]|1|mL/dose|MENINGES|RIGHT|||SIBLING|3|Visit_3|40|6|TREATMENT|2020-09-05|40
e|FA|bf069a02-03a6-4013-b16d-d7c954a6cc3d|6|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|g/mol|[?]|1|Bq/L|COSTOCHONDRAL JOINT 1|UNILATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-09-05|40
e|FA|bf069a02-03a6-4013-b16d-d7c954a6cc3d|7|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|ug/kg/min|[?]|1|uL/kg/day|DISTAL LAD ARTERY|UNILATERAL|||INTERVIEWER|4|Visit_4|65|7|SCREENING|2020-09-30|65
e|FA|bf069a02-03a6-4013-b16d-d7c954a6cc3d|8|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|um/s|[?]|1|10^6 CFU/mL|BUCCAL LYMPH NODE|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|FOLLOW-UP|2020-09-30|65
e|FA|bf069a02-03a6-4013-b16d-d7c954a6cc3d|9|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|mmol|[?]|1|h*%|EYE BULGE|LATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-10-25|90
e|FA|bf069a02-03a6-4013-b16d-d7c954a6cc3d|10|DFIBER|Dietary Fiber|[?]|GERD|[?]|%/min|[?]|1|h*%|CALCANEAL TUBEROSITY|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-10-25|90
e|FA|c40fc52b-2668-4fab-b051-5b258da72f2c|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|HOMEOPATHIC DILUTION|[?]|1|mL/animal/day|PERICARDIUM|LEFT||Y|PARENT|1|Visit_1|10|6|TREATMENT|2020-10-11|10
e|FA|c40fc52b-2668-4fab-b051-5b258da72f2c|2|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|CAPLET|[?]|1|g/day|OLFACTORY BULB|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|SCREENING|2020-10-11|10
e|FA|c40fc52b-2668-4fab-b051-5b258da72f2c|3|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|PUFF|[?]|1|ug/kg/h|BODY OF STOMACH|RIGHT|||FRIEND|2|Visit_2|25|3|WASHOUT|2020-10-26|25
e|FA|c40fc52b-2668-4fab-b051-5b258da72f2c|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|10^5/L|[?]|1|ug/g/h|PARALARYNGEAL LYMPH NODE|IPSILATERAL|||INVESTIGATOR|2|Visit_2|25|6|TREATMENT|2020-10-26|25
e|FA|c40fc52b-2668-4fab-b051-5b258da72f2c|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|WEEKS|[?]|1|mg/g/min|AXILLA|LATERAL|||PARENT|3|Visit_3|40|7|TREATMENT|2020-11-10|40
e|FA|c40fc52b-2668-4fab-b051-5b258da72f2c|6|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|10^3 CFU|[?]|1|DROP|C1 VERTEBRA|BILATERAL||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|SCREENING|2020-11-10|40
e|FA|c40fc52b-2668-4fab-b051-5b258da72f2c|7|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Arbitrary U|[?]|1|oz eq|LIP|UNILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2020-12-05|65
e|FA|c40fc52b-2668-4fab-b051-5b258da72f2c|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|/2000 RBC|[?]|1|Pa|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|CONTRALATERAL||Y|FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2020-12-05|65
e|FA|c40fc52b-2668-4fab-b051-5b258da72f2c|9|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|vp/dose|[?]|1|cm H2O|OLFACTORY BULB|LATERAL|||FRIEND|5|Visit_5|90|2|SCREENING|2020-12-30|90
e|FA|c40fc52b-2668-4fab-b051-5b258da72f2c|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|rpm|[?]|1|mg/g/min|DISTANT LYMPH NODE|CONTRALATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|4|TREATMENT|2020-12-30|90
e|FA|d7c792d8-fc98-41ab-8a9e-59de1e186a06|1|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|/kg|[?]|1|Log10 ELISA unit|SKIN OF THE CHIN|RIGHT|||SPOUSE|1|Visit_1|10|2|FOLLOW-UP|2020-07-28|10
e|FA|d7c792d8-fc98-41ab-8a9e-59de1e186a06|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^6/hpf|[?]|1|mg/g/min|NUCHAL LYMPH NODE|UNILATERAL|||GUARDIAN|1|Visit_1|10|1|FOLLOW-UP|2020-07-28|10
e|FA|d7c792d8-fc98-41ab-8a9e-59de1e186a06|3|ACNDEV|Action Taken With Device|[?]|GERD|[?]|GBq/mg|[?]|1|100 IU/mL|BONE|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|4|FOLLOW-UP|2020-08-12|25
e|FA|d7c792d8-fc98-41ab-8a9e-59de1e186a06|4|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|GBq/ug|[?]|1|BOWL|NASOPHARYNX|BILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2020-08-12|25
e|FA|d7c792d8-fc98-41ab-8a9e-59de1e186a06|5|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|PIXEL|[?]|1|mIU/L|DISTAL RIGHT CORONARY ARTERY CONDUIT|CONTRALATERAL|Y|Y|PROXY|3|Visit_3|40|1|TREATMENT|2020-08-27|40
e|FA|d7c792d8-fc98-41ab-8a9e-59de1e186a06|6|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|kat|[?]|1|gtt|BACK|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|SCREENING|2020-08-27|40
e|FA|d7c792d8-fc98-41ab-8a9e-59de1e186a06|7|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|pg/cell|[?]|1|Hz/s|AORTOPULMONARY WINDOW LYMPH NODE|RIGHT|Y|Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2020-09-21|65
e|FA|d7c792d8-fc98-41ab-8a9e-59de1e186a06|8|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|umol|[?]|1|Hz/s|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LATERAL|Y||STUDY SUBJECT|4|Visit_4|65|1|SCREENING|2020-09-21|65
e|FA|d7c792d8-fc98-41ab-8a9e-59de1e186a06|9|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|DRUM|[?]|1|U/mmol|CEREBRAL VEIN|LATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|FOLLOW-UP|2020-10-16|90
e|FA|d7c792d8-fc98-41ab-8a9e-59de1e186a06|10|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|DRINK|[?]|1|DROP|SKIN OF THE INFRASCAPULAR REGION|IPSILATERAL|||FAMILY MEMBER|5|Visit_5|90|2|FOLLOW-UP|2020-10-16|90
e|FA|f7773659-f207-4b29-8389-3aa766a6337a|1|STRCTNUM|Number of Strictures|[?]|GERD|[?]|MESF|[?]|1|SACHET|CORONARY ARTERY, ANTERIOR DESCENDING|UNILATERAL|||ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-10-19|10
e|FA|f7773659-f207-4b29-8389-3aa766a6337a|2|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|cmH2O/mL|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LEFT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|WASHOUT|2020-10-19|10
e|FA|f7773659-f207-4b29-8389-3aa766a6337a|3|DFRUIT|Dietary Fruit|[?]|GERD|[?]|mmol/kg|[?]|1|10^6 CFU/mL|PONS VAROLII|RIGHT|||PARENT|2|Visit_2|25|4|TREATMENT|2020-11-03|25
e|FA|f7773659-f207-4b29-8389-3aa766a6337a|4|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|Hounsfield Unit|[?]|1|10^4 CFU/mL|INTERPHALANGEAL JOINT 3 OF THE HAND|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2020-11-03|25
e|FA|f7773659-f207-4b29-8389-3aa766a6337a|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/L|[?]|1|U/mmol|EPIGLOTTIS|LEFT|||DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-11-18|40
e|FA|f7773659-f207-4b29-8389-3aa766a6337a|6|SEV|Severity/Intensity|[?]|GERD|[?]|TAMPON|[?]|1|Pa|HEART, LEFT ATRIAL APPENDAGE|LEFT||Y|CHILD|3|Visit_3|40|6|TREATMENT|2020-11-18|40
e|FA|f7773659-f207-4b29-8389-3aa766a6337a|7|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|pg/cell|[?]|1|TRANSDUCING UNIT/mL|URACHAL TRACT|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2020-12-13|65
e|FA|f7773659-f207-4b29-8389-3aa766a6337a|8|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|U/g Hb|[?]|1|Bq/mg|SOFT PALATE|RIGHT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2020-12-13|65
e|FA|f7773659-f207-4b29-8389-3aa766a6337a|9|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|grain|[?]|1|vp/dose|VULVA|RIGHT|||VENDOR|5|Visit_5|90|1|TREATMENT|2021-01-07|90
e|FA|f7773659-f207-4b29-8389-3aa766a6337a|10|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|Hz/s|[?]|1|anti-Xa IU/mL|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|IPSILATERAL|||VENDOR|5|Visit_5|90|1|FOLLOW-UP|2021-01-07|90
e|FA|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|keV|[?]|1|10^6 U|PREFRONTAL CORTEX|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|1|SCREENING|2021-01-07|10
e|FA|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|2|OBJTYPE|Type of Object|[?]|GERD|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|ng|NUCHAL LYMPH NODE|LEFT|||INVESTIGATOR|1|Visit_1|10|3|TREATMENT|2021-01-07|10
e|FA|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|3|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|Gy|[?]|1|CUP|MID-RIGHT CORONARY ARTERY CONDUIT|LATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2021-01-22|25
e|FA|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|4|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|mL/mmHg/min/L|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LEFT|||PARENT|2|Visit_2|25|2|TREATMENT|2021-01-22|25
e|FA|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|5|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|SUPPOSITORY|[?]|1|HOURS|GONAD|BILATERAL|||PROXY|3|Visit_3|40|2|TREATMENT|2021-02-06|40
e|FA|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|IU/kg/h|[?]|1|mg/g/min|FLEXOR DIGITORUM LONGUS MUSCLE|UNILATERAL|||FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2021-02-06|40
e|FA|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|7|OBJTYPE|Type of Object|[?]|GERD|[?]|AFU|[?]|1|ng|INTRAHEPATIC LARGE BILE DUCT|LATERAL||Y|CAREGIVER|4|Visit_4|65|4|TREATMENT|2021-03-03|65
e|FA|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/mL|[?]|1|mg/g/min|PROSTATE GLAND, LATERAL LOBE|CONTRALATERAL|||INTERVIEWER|4|Visit_4|65|5|TREATMENT|2021-03-03|65
e|FA|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|9|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|mg/g/min|[?]|1|Log10 ELISA unit|INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|||CHILD|5|Visit_5|90|7|TREATMENT|2021-03-28|90
e|FA|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|10^6 U|PRELARYNGEAL LYMPH NODE|RIGHT|||FRIEND|5|Visit_5|90|1|TREATMENT|2021-03-28|90
e|FA|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|1|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|/10^4|[?]|1|PACK|BRAIN VENTRICLE, LATERAL|CONTRALATERAL||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|WASHOUT|2021-01-26|10
e|FA|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|2|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|NFIU|[?]|1|Bq/L|UMBILICUS|LATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|6|SCREENING|2021-01-26|10
e|FA|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|nmol BCE/mmol|[?]|1|mg/g/min|SKIN AROUND THE MOUTH|IPSILATERAL||Y|CHILD|2|Visit_2|25|1|SCREENING|2021-02-10|25
e|FA|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|4|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/mL|[?]|1|100 IU/mL|INTERTROCHANTERIC REGION|UNILATERAL|||PROXY|2|Visit_2|25|4|TREATMENT|2021-02-10|25
e|FA|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|5|DMEAT|Dietary Meat|[?]|GERD|[?]|APPLICATION|[?]|1|10^6 organisms/mL|BICEPS FEMORIS MUSCLE|UNILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|4|SCREENING|2021-02-25|40
e|FA|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|6|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|usec|[?]|1|ng|FLEXOR DIGITORUM PROFUNDUS MUSCLE|RIGHT|||INVESTIGATOR|3|Visit_3|40|7|SCREENING|2021-02-25|40
e|FA|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|7|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|pm|[?]|1|L/h/m2|UVEA|RIGHT||Y|VENDOR|4|Visit_4|65|5|SCREENING|2021-03-22|65
e|FA|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|nmol|[?]|1|Pa|LAD SEPTAL PERFORATOR ARTERY|LATERAL||Y|CAREGIVER|4|Visit_4|65|7|TREATMENT|2021-03-22|65
e|FA|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mV*min|[?]|1|mg/g/min|HEPATIC LYMPH NODE|CONTRALATERAL|||PARENT|5|Visit_5|90|6|TREATMENT|2021-04-16|90
e|FA|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|10|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|10^4 CFU/mL|BASILIC VEIN|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|WASHOUT|2021-04-16|90
e|FA|700049a2-ef66-466b-b1d8-f0800bcfde43|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/m2/day|[?]|1|%(v/v)|COLON, HEPATIC FLEXURE|IPSILATERAL|||SIBLING|1|Visit_1|10|1|TREATMENT|2020-06-27|10
e|FA|700049a2-ef66-466b-b1d8-f0800bcfde43|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|mgEq|[?]|1|TRANSDUCING UNIT/mL|HEART, LEFT VENTRICLE|LATERAL|||PARENT|1|Visit_1|10|2|WASHOUT|2020-06-27|10
e|FA|700049a2-ef66-466b-b1d8-f0800bcfde43|3|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|DROP|[?]|1|mL/animal/day|PUPIL|LEFT|Y||DOMESTIC PARTNER|2|Visit_2|25|1|FOLLOW-UP|2020-07-12|25
e|FA|700049a2-ef66-466b-b1d8-f0800bcfde43|4|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|mg/cm2|[?]|1|oz eq|RIB|CONTRALATERAL|||FRIEND|2|Visit_2|25|6|TREATMENT|2020-07-12|25
e|FA|700049a2-ef66-466b-b1d8-f0800bcfde43|5|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|Ci|[?]|1|mL/m2|INFERIOR PUBIC RAMUS|IPSILATERAL|||PROXY|3|Visit_3|40|3|SCREENING|2020-07-27|40
e|FA|700049a2-ef66-466b-b1d8-f0800bcfde43|6|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|mL/kg|[?]|1|Log10 ELISA unit|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|FOLLOW-UP|2020-07-27|40
e|FA|700049a2-ef66-466b-b1d8-f0800bcfde43|7|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|/500 WBC|AXIAL SKELETON|IPSILATERAL|||CAREGIVER|4|Visit_4|65|3|TREATMENT|2020-08-21|65
e|FA|700049a2-ef66-466b-b1d8-f0800bcfde43|8|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|gtt|[?]|1|mmHg/L/min|RETINAL ARTERY|IPSILATERAL|Y|Y|CAREGIVER|4|Visit_4|65|7|SCREENING|2020-08-21|65
e|FA|700049a2-ef66-466b-b1d8-f0800bcfde43|9|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|SQU/mL|[?]|1|g/day|MIDBRAIN|UNILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|6|SCREENING|2020-09-15|90
e|FA|700049a2-ef66-466b-b1d8-f0800bcfde43|10|SEV|Severity/Intensity|[?]|GERD|[?]|U/m2/h|[?]|1|Pa|CECUM|LEFT|||CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-09-15|90
e|FA|00d906a6-2d14-4199-aff9-524388c5117f|1|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|V/sec|[?]|1|ng/day|CORONARY ARTERY, LEFT|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2020-11-24|10
e|FA|00d906a6-2d14-4199-aff9-524388c5117f|2|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|kcal/day|[?]|1|10^6/L|RETROAURICULAR LYMPH NODE|LATERAL|||PARENT|1|Visit_1|10|2|TREATMENT|2020-11-24|10
e|FA|00d906a6-2d14-4199-aff9-524388c5117f|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|MET|[?]|1|mg/g/min|DISTAL CIRCUMFLEX ARTERY|LEFT|Y||FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-12-09|25
e|FA|00d906a6-2d14-4199-aff9-524388c5117f|4|DISTANCE|Distance|[?]|GERD|[?]|m|[?]|1|BOWL|HEART, VENTRICULAR WALL|RIGHT|Y|Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-12-09|25
e|FA|00d906a6-2d14-4199-aff9-524388c5117f|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cP|[?]|1|mg/g/min|TRIANGULAR-HAMATE JOINT|CONTRALATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2020-12-24|40
e|FA|00d906a6-2d14-4199-aff9-524388c5117f|6|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|Hounsfield Unit|[?]|1|DRUM|ADDUCTOR MAGNUS MUSCLE|BILATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2020-12-24|40
e|FA|00d906a6-2d14-4199-aff9-524388c5117f|7|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|Rad|[?]|1|MPS U|LACRIMAL GLAND|LEFT|||CHILD|4|Visit_4|65|5|FOLLOW-UP|2021-01-18|65
e|FA|00d906a6-2d14-4199-aff9-524388c5117f|8|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|GBq/ug|[?]|1|Shock Wave|PARASPINAL REGION|RIGHT|||STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2021-01-18|65
e|FA|00d906a6-2d14-4199-aff9-524388c5117f|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mol/day|[?]|1|mg/g/min|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|UNILATERAL|Y|Y|SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2021-02-12|90
e|FA|00d906a6-2d14-4199-aff9-524388c5117f|10|STRCTNUM|Number of Strictures|[?]|GERD|[?]|Sv|[?]|1|SACHET|OLFACTORY BULB|CONTRALATERAL|||INTERVIEWER|5|Visit_5|90|4|WASHOUT|2021-02-12|90
e|FA|2fcc5910-bce0-4510-b17e-3925850d6d32|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ukat|[?]|1|Pa|PERIPANCREATIC LYMPH NODE|UNILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|3|WASHOUT|2020-12-16|10
e|FA|2fcc5910-bce0-4510-b17e-3925850d6d32|2|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|ugEq|[?]|1|Bq/L|DORSALIS PEDIS ARTERY|LATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|2|WASHOUT|2020-12-16|10
e|FA|2fcc5910-bce0-4510-b17e-3925850d6d32|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|km/h|[?]|1|mg/g/min|PLEURAL CAVITY|IPSILATERAL|||CAREGIVER|2|Visit_2|25|1|WASHOUT|2020-12-31|25
e|FA|2fcc5910-bce0-4510-b17e-3925850d6d32|4|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|L/h/m2|[?]|1|BAG|SUBSCAPULARIS MUSCLE|BILATERAL||Y|GUARDIAN|2|Visit_2|25|2|TREATMENT|2020-12-31|25
e|FA|2fcc5910-bce0-4510-b17e-3925850d6d32|5|DPROT|Dietary Protein|[?]|GERD|[?]|log10 CFU/g|[?]|1|10^4 CFU/mL|ABDOMINAL REGION|IPSILATERAL|||CHILD|3|Visit_3|40|6|TREATMENT|2021-01-15|40
e|FA|2fcc5910-bce0-4510-b17e-3925850d6d32|6|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|cup eq|[?]|1|g/cage/day|ADRENAL GLAND|BILATERAL|Y||FAMILY MEMBER|3|Visit_3|40|3|SCREENING|2021-01-15|40
e|FA|2fcc5910-bce0-4510-b17e-3925850d6d32|7|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|DIP|[?]|1|10^6 U|COMMON ILIAC ARTERY|LATERAL||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|SCREENING|2021-02-09|65
e|FA|2fcc5910-bce0-4510-b17e-3925850d6d32|8|SERVNUM|Number of Servings|[?]|GERD|[?]|ukat/10^12 RBC|[?]|1|Hz/s|LEFT POSTEROLATERAL DESCENDING ARTERY|CONTRALATERAL|Y|Y|DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2021-02-09|65
e|FA|2fcc5910-bce0-4510-b17e-3925850d6d32|9|EXCDUR|Exercise Duration|[?]|GERD|[?]|g/dL|[?]|1|mm|SKIN OF THE AXILLA|LEFT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|WASHOUT|2021-03-06|90
e|FA|2fcc5910-bce0-4510-b17e-3925850d6d32|10|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|ug/g/h|CARDIAC WALL|LATERAL|||SIBLING|5|Visit_5|90|6|TREATMENT|2021-03-06|90
e|FA|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|1|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|pm|[?]|1|DRUM|OBTURATOR INTERNUS MUSCLE|BILATERAL|||STUDY SUBJECT|1|Visit_1|10|6|TREATMENT|2020-08-31|10
e|FA|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|2|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|PACKAGE|[?]|1|Gy/h|HILAR LYMPH NODE|RIGHT||Y|ADJUDICATOR|1|Visit_1|10|5|TREATMENT|2020-08-31|10
e|FA|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|3|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|mg/dose|ACCESSORY RENAL ARTERY|CONTRALATERAL||Y|SIBLING|2|Visit_2|25|7|TREATMENT|2020-09-15|25
e|FA|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|4|SERVNUM|Number of Servings|[?]|GERD|[?]|BU|[?]|1|Hz/s|INCUS|LATERAL|||ADJUDICATOR|2|Visit_2|25|6|FOLLOW-UP|2020-09-15|25
e|FA|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|5|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|NEEDLE GAUGE|KNEE JOINT|LEFT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2020-09-30|40
e|FA|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|6|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|cm|[?]|1|in|SPINOUS PROCESS|LATERAL||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|6|SCREENING|2020-09-30|40
e|FA|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|7|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|DRUM|[?]|1|ug/kg/h|ADDUCTOR MAGNUS MUSCLE|IPSILATERAL|||CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-10-25|65
e|FA|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|usec|[?]|1|10^6 U|GASTROINTESTINAL TRACT, UPPER, WALL|UNILATERAL||Y|CHILD|4|Visit_4|65|2|SCREENING|2020-10-25|65
e|FA|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|9|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|10^4/hpf|[?]|1|mL/cm3/min|PROXIMAL INTERPHALANGEAL JOINT 3|RIGHT||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|3|SCREENING|2020-11-19|90
e|FA|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/min|[?]|1|U/mmol|LUNG, HILUM|LEFT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2020-11-19|90
e|FA|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|1|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|dL|[?]|1|10^4 CFU/mL|INTERPHALANGEAL JOINT 4 OF THE HAND|LATERAL|||FAMILY MEMBER|1|Visit_1|10|7|WASHOUT|2020-07-26|10
e|FA|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|L/kg|[?]|1|g/day|T5 VERTEBRA|LEFT|||SPOUSE|1|Visit_1|10|2|FOLLOW-UP|2020-07-26|10
e|FA|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|3|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|DRINK|[?]|1|mm/h|LEPTOMENINGES|LATERAL|Y|Y|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-08-10|25
e|FA|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|4|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|WAFER|[?]|1|mL|EYE, ANTERIOR SEGMENT|RIGHT|||VENDOR|2|Visit_2|25|5|TREATMENT|2020-08-10|25
e|FA|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|5|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|kHz|[?]|1|CUP|RADIAL ARTERY|IPSILATERAL|Y||PARENT|3|Visit_3|40|4|WASHOUT|2020-08-25|40
e|FA|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 2|LATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|SCREENING|2020-08-25|40
e|FA|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/h|[?]|1|mg/g/min|SCAPHOID BONE|CONTRALATERAL|||FRIEND|4|Visit_4|65|5|FOLLOW-UP|2020-09-19|65
e|FA|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|8|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|BE/mL|[?]|1|mL/min/mmHg|THROAT|UNILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2020-09-19|65
e|FA|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|9|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|mmol/min/kPa|[?]|1|uL/kg/day|GASTROCNEMIUS MUSCLE|UNILATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|6|WASHOUT|2020-10-14|90
e|FA|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|Pa|ANTECUBITAL FOSSA|IPSILATERAL||Y|SIBLING|5|Visit_5|90|6|FOLLOW-UP|2020-10-14|90
e|FA|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|1|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|Shock Wave|RENAL PELVIS|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|WASHOUT|2020-10-28|10
e|FA|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|2|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|Siemens|[?]|1|m2|MESENTERIC VEIN|LATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|3|TREATMENT|2020-10-28|10
e|FA|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|3|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|IU|[?]|1|mL/h|SKIN AROUND THE MOUTH|CONTRALATERAL|Y|Y|SIBLING|2|Visit_2|25|2|FOLLOW-UP|2020-11-12|25
e|FA|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|4|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|uOsm|[?]|1|m2|MEDIASTINUM, MIDDLE|LATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|FOLLOW-UP|2020-11-12|25
e|FA|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|5|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|ukat/L|[?]|1|10^6/L|ANTERIOR CINGULATE GYRUS|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-11-27|40
e|FA|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|6|DMG|Dietary Magnesium|[?]|GERD|[?]|/kg|[?]|1|TRANSDUCING UNIT/mL|DISTAL INTERPHALANGEAL JOINT 3|IPSILATERAL|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2020-11-27|40
e|FA|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|7|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|10^3/hpf|[?]|1|PACK|LINGULA OF THE LUNG|IPSILATERAL|||VENDOR|4|Visit_4|65|1|FOLLOW-UP|2020-12-22|65
e|FA|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|DNA copies/mL|[?]|1|mg/g/min|SPLENIC LYMPH NODE|RIGHT||Y|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2020-12-22|65
e|FA|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|9|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|APL U|[?]|1|km|FOOT DIGIT 1|LATERAL|||INTERVIEWER|5|Visit_5|90|3|WASHOUT|2021-01-16|90
e|FA|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|10|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|min/day|[?]|1|g/L|HEART, LEFT VENTRICULAR WALL|LEFT|Y|Y|STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2021-01-16|90
e|FA|ff163542-abec-4260-b257-f15a11e580ee|1|DFATT|Dietary Fat, Total|[?]|GERD|[?]|uL/dose|[?]|1|Bq/mg|WRIST JOINT FLEXOR TENDONS|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|SCREENING|2020-08-16|10
e|FA|ff163542-abec-4260-b257-f15a11e580ee|2|SEV|Severity/Intensity|[?]|GERD|[?]|cy/cm|[?]|1|Pa|ULNA|LEFT||Y|VENDOR|1|Visit_1|10|3|TREATMENT|2020-08-16|10
e|FA|ff163542-abec-4260-b257-f15a11e580ee|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|LOZENGE|[?]|1|Shock Wave|METATARSOPHALANGEAL JOINT 5|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|4|WASHOUT|2020-08-31|25
e|FA|ff163542-abec-4260-b257-f15a11e580ee|4|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|ug/day|[?]|1|SACHET|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|IPSILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-08-31|25
e|FA|ff163542-abec-4260-b257-f15a11e580ee|5|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|10^6 CFU|[?]|1|L|CARPOMETACARPAL JOINT 5|LEFT|||CLINICAL STUDY SPONSOR|3|Visit_3|40|6|SCREENING|2020-09-15|40
e|FA|ff163542-abec-4260-b257-f15a11e580ee|6|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|IU|[?]|1|BOWL|SCAPHOID-LUNATE-CAPITATE JOINT|RIGHT||Y|PARENT|3|Visit_3|40|3|TREATMENT|2020-09-15|40
e|FA|ff163542-abec-4260-b257-f15a11e580ee|7|LENRSCT|Length of Resection|[?]|GERD|[?]|in2|[?]|1|psi|DISTAL EXTRAHEPATIC BILE DUCT REGION|LATERAL|Y|Y|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-10-10|65
e|FA|ff163542-abec-4260-b257-f15a11e580ee|8|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|mL/min/mmHg|[?]|1|mL/m2|SKIN OF THE HEAD|RIGHT|Y||DOMESTIC PARTNER|4|Visit_4|65|5|FOLLOW-UP|2020-10-10|65
e|FA|ff163542-abec-4260-b257-f15a11e580ee|9|LOCONSET|Localization of Onset|[?]|GERD|[?]|/500 WBC|[?]|1|g/L|AORTIC ARCH|CONTRALATERAL|||VENDOR|5|Visit_5|90|5|WASHOUT|2020-11-04|90
e|FA|ff163542-abec-4260-b257-f15a11e580ee|10|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|BAR|[?]|1|Log10 ELISA unit|PARACAVAL LYMPH NODE|IPSILATERAL|||FRIEND|5|Visit_5|90|4|TREATMENT|2020-11-04|90
e|FA|bb73f732-a52f-4013-9ae6-60ff23b9c224|1|DMG|Dietary Magnesium|[?]|GERD|[?]|nmol/g|[?]|1|TRANSDUCING UNIT/mL|COLON, DESCENDING|BILATERAL|||CAREGIVER|1|Visit_1|10|7|WASHOUT|2020-08-05|10
e|FA|bb73f732-a52f-4013-9ae6-60ff23b9c224|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|uU/L|[?]|1|mg/g/min|SINUS|BILATERAL|||INTERVIEWER|1|Visit_1|10|6|TREATMENT|2020-08-05|10
e|FA|bb73f732-a52f-4013-9ae6-60ff23b9c224|3|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|mm/h|[?]|1|EIA unit|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|BILATERAL|||PROXY|2|Visit_2|25|4|TREATMENT|2020-08-20|25
e|FA|bb73f732-a52f-4013-9ae6-60ff23b9c224|4|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|mL/animal/wk|[?]|1|ng|FLOOR OF MOUTH|CONTRALATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2020-08-20|25
e|FA|bb73f732-a52f-4013-9ae6-60ff23b9c224|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mEq/dL|[?]|1|mg/g/min|LATERAL SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL|||INTERVIEWER|3|Visit_3|40|1|TREATMENT|2020-09-04|40
e|FA|bb73f732-a52f-4013-9ae6-60ff23b9c224|6|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|Sv|[?]|1|L|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|CONTRALATERAL|Y||SIBLING|3|Visit_3|40|1|WASHOUT|2020-09-04|40
e|FA|bb73f732-a52f-4013-9ae6-60ff23b9c224|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|cmol|[?]|1|U/mmol|BRACHIAL PLEXUS|RIGHT||Y|SIBLING|4|Visit_4|65|6|TREATMENT|2020-09-29|65
e|FA|bb73f732-a52f-4013-9ae6-60ff23b9c224|8|SPEED|Speed|[?]|GERD|[?]|mgEq|[?]|1|mEq/g|PULMONARY VALVE, RIGHT CUSP|RIGHT|||INTERVIEWER|4|Visit_4|65|2|TREATMENT|2020-09-29|65
e|FA|bb73f732-a52f-4013-9ae6-60ff23b9c224|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mm/min|[?]|1|mg/g/min|APPENDICEAL TIP|RIGHT|||FRIEND|5|Visit_5|90|6|TREATMENT|2020-10-24|90
e|FA|bb73f732-a52f-4013-9ae6-60ff23b9c224|10|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|ag|[?]|1|U/10^12 RBC|HAND PHALANX|IPSILATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|3|TREATMENT|2020-10-24|90
e|FA|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|1|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|/kg|MID-LAD ARTERY|BILATERAL|||CHILD|1|Visit_1|10|1|TREATMENT|2020-07-21|10
e|FA|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|2|QOLIMP|QOL Impact|[?]|GERD|[?]|BOTTLE|[?]|1|10^6/L|PALATINE BONE|RIGHT|||FRIEND|1|Visit_1|10|3|FOLLOW-UP|2020-07-21|10
e|FA|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|COAT|[?]|1|Pa|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|LATERAL|||INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-08-05|25
e|FA|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|4|QOLIMP|QOL Impact|[?]|GERD|[?]|gtt|[?]|1|10^6/L|EXTENSOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|||SPOUSE|2|Visit_2|25|3|TREATMENT|2020-08-05|25
e|FA|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|5|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|cd/m2|[?]|1|DRUM|CEREBELLUM|LATERAL||Y|ADJUDICATOR|3|Visit_3|40|6|SCREENING|2020-08-20|40
e|FA|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|6|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|PFU/dose|PANCREAS, ENDOCRINE|LATERAL|||GUARDIAN|3|Visit_3|40|1|FOLLOW-UP|2020-08-20|40
e|FA|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|7|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|10^9 organisms/mg|[?]|1|Bq/L|LEFT MAIN CORONARY ARTERY BIFURCATION|CONTRALATERAL|||PARENT|4|Visit_4|65|7|TREATMENT|2020-09-14|65
e|FA|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|8|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|VIAL|[?]|1|mL/min/mmHg|SUBSTANTIA NIGRA|RIGHT||Y|FRIEND|4|Visit_4|65|2|TREATMENT|2020-09-14|65
e|FA|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|9|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/g/day|[?]|1|g/cage/day|SKIN OF THE HEAD|LEFT|||VENDOR|5|Visit_5|90|1|TREATMENT|2020-10-09|90
e|FA|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|10|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|fmol/L/sec|[?]|1|g/day|DISTAL LAD ARTERY|CONTRALATERAL|||FRIEND|5|Visit_5|90|5|SCREENING|2020-10-09|90
e|FA|8e056558-ffd2-4c43-bbfa-40914b38af34|1|AGETRT1|Age At First Treatment|[?]|GERD|[?]|Tbsp|[?]|1|mL/mmHg/min/L|LIP|CONTRALATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|2|WASHOUT|2021-01-29|10
e|FA|8e056558-ffd2-4c43-bbfa-40914b38af34|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|Pa|UTERINE ARTERY|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|3|WASHOUT|2021-01-29|10
e|FA|8e056558-ffd2-4c43-bbfa-40914b38af34|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|m|[?]|1|U/mg|NASAL SEPTUM|UNILATERAL||Y|FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2021-02-13|25
e|FA|8e056558-ffd2-4c43-bbfa-40914b38af34|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|%(v/v)|HEPATIC ARTERY|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|6|TREATMENT|2021-02-13|25
e|FA|8e056558-ffd2-4c43-bbfa-40914b38af34|5|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|SACHET|[?]|1|in|LEFT CIRCUMFLEX CORONARY ARTERY|UNILATERAL|||GUARDIAN|3|Visit_3|40|1|SCREENING|2021-02-28|40
e|FA|8e056558-ffd2-4c43-bbfa-40914b38af34|6|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|KIT|[?]|1|ng|INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL||Y|INTERVIEWER|3|Visit_3|40|2|FOLLOW-UP|2021-02-28|40
e|FA|8e056558-ffd2-4c43-bbfa-40914b38af34|7|LENRSCT|Length of Resection|[?]|GERD|[?]|10^3 CFU/g|[?]|1|psi|LUNG, RIGHT UPPER LOBE|LATERAL|||SIBLING|4|Visit_4|65|5|SCREENING|2021-03-25|65
e|FA|8e056558-ffd2-4c43-bbfa-40914b38af34|8|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|nmol/L|[?]|1|uL/kg/day|GREATER CURVATURE OF THE STOMACH|BILATERAL|||INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2021-03-25|65
e|FA|8e056558-ffd2-4c43-bbfa-40914b38af34|9|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|cm|LEFT VENTRICULAR APICAL LATERAL SEGMENT|IPSILATERAL||Y|ADJUDICATOR|5|Visit_5|90|4|TREATMENT|2021-04-19|90
e|FA|8e056558-ffd2-4c43-bbfa-40914b38af34|10|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|mEq|[?]|1|TRANSDUCING UNIT/mL|HUMERUS|IPSILATERAL|||PROXY|5|Visit_5|90|7|TREATMENT|2021-04-19|90
e|FA|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|1|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|YEARS|[?]|1|/500 WBC|PERIRECTAL LYMPH NODE|CONTRALATERAL||Y|INVESTIGATOR|1|Visit_1|10|1|WASHOUT|2020-05-29|10
e|FA|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|2|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|Hz|[?]|1|DRUM|HAIR|CONTRALATERAL|||INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-05-29|10
e|FA|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|3|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|mg/day|[?]|1|SCOOPFUL|ENDOCERVIX|CONTRALATERAL|Y|Y|CAREGIVER|2|Visit_2|25|1|SCREENING|2020-06-13|25
e|FA|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|4|OBJTYPE|Type of Object|[?]|GERD|[?]|CAN|[?]|1|ng|PRECUNEUS|LEFT||Y|FRIEND|2|Visit_2|25|3|TREATMENT|2020-06-13|25
e|FA|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|5|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|LB|[?]|1|10^6 U|PENIS, RADIX|LEFT|||STUDY SUBJECT|3|Visit_3|40|6|WASHOUT|2020-06-28|40
e|FA|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|6|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|PFU/mL|[?]|1|/500 WBC|CEPHALIC VEIN|RIGHT|||INVESTIGATOR|3|Visit_3|40|6|WASHOUT|2020-06-28|40
e|FA|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|CONTAINER|[?]|1|mg/g/min|MAIN BRONCHUS, LEFT|BILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-07-23|65
e|FA|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|8|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|uV2|[?]|1|10^4 CFU/mL|BULBAR CONJUNCTIVA|BILATERAL|||GUARDIAN|4|Visit_4|65|7|TREATMENT|2020-07-23|65
e|FA|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|9|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|cs|[?]|1|DRUM|FALLOPIAN TUBE|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-08-17|90
e|FA|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|10|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|/HPF|[?]|1|ng/day|CORONARY SINUS|LEFT|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|2|FOLLOW-UP|2020-08-17|90
e|FA|624c1353-347a-417d-9aab-7f1e7077ba7f|1|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|10^6 IU/mL|SCIATIC NERVE|CONTRALATERAL|Y||SIBLING|1|Visit_1|10|5|SCREENING|2020-08-28|10
e|FA|624c1353-347a-417d-9aab-7f1e7077ba7f|2|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|ks|[?]|1|TRANSDUCING UNIT/mL|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|RIGHT|||GUARDIAN|1|Visit_1|10|5|FOLLOW-UP|2020-08-28|10
e|FA|624c1353-347a-417d-9aab-7f1e7077ba7f|3|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|SPRAY|[?]|1|mg/dose|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2020-09-12|25
e|FA|624c1353-347a-417d-9aab-7f1e7077ba7f|4|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|mg/dL|[?]|1|/500 WBC|GREAT VESSELS|LATERAL|||GUARDIAN|2|Visit_2|25|6|WASHOUT|2020-09-12|25
e|FA|624c1353-347a-417d-9aab-7f1e7077ba7f|5|SEV|Severity/Intensity|[?]|GERD|[?]|Shock Wave|[?]|1|Pa|PALPEBRAL FISSURE|RIGHT|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|FOLLOW-UP|2020-09-27|40
e|FA|624c1353-347a-417d-9aab-7f1e7077ba7f|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|uL/mL|[?]|1|QUANTITY SUFFICIENT|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|IPSILATERAL|Y||STUDY SUBJECT|3|Visit_3|40|1|WASHOUT|2020-09-27|40
e|FA|624c1353-347a-417d-9aab-7f1e7077ba7f|7|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ECL unit|[?]|1|mL|HILAR LYMPH NODE|BILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2020-10-22|65
e|FA|624c1353-347a-417d-9aab-7f1e7077ba7f|8|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg/min/L|[?]|1|TRANSDUCING UNIT/mL|URETHRA, PENILE|BILATERAL|||VENDOR|4|Visit_4|65|7|WASHOUT|2020-10-22|65
e|FA|624c1353-347a-417d-9aab-7f1e7077ba7f|9|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|mL/min|[?]|1|/200 HPFs|FLEXOR DIGITORUM LONGUS MUSCLE|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-11-16|90
e|FA|624c1353-347a-417d-9aab-7f1e7077ba7f|10|TOTNUM|Total Number|[?]|GERD|[?]|mmol/L|[?]|1|/200 HPFs|URETHRA, PENILE|LEFT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|SCREENING|2020-11-16|90
e|FA|ef1cddb8-f4ce-45c4-8671-32fe95f00993|1|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|mmol/min/kPa/L|[?]|1|mEq|URETERIC ORIFICE|BILATERAL|||INVESTIGATOR|1|Visit_1|10|7|SCREENING|2020-08-02|10
e|FA|ef1cddb8-f4ce-45c4-8671-32fe95f00993|2|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|cd|[?]|1|AU/mL|BODY OF STOMACH|LATERAL|||FAMILY MEMBER|1|Visit_1|10|3|WASHOUT|2020-08-02|10
e|FA|ef1cddb8-f4ce-45c4-8671-32fe95f00993|3|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|U/mmol|[?]|1|gtt|CARPOMETACARPAL JOINT 1|LATERAL||Y|VENDOR|2|Visit_2|25|1|TREATMENT|2020-08-17|25
e|FA|ef1cddb8-f4ce-45c4-8671-32fe95f00993|4|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|in|ANTERIOR CINGULATE GYRUS|RIGHT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-08-17|25
e|FA|ef1cddb8-f4ce-45c4-8671-32fe95f00993|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|Pa|SKIN OF THE BENDING JOINT|IPSILATERAL|Y||CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-09-01|40
e|FA|ef1cddb8-f4ce-45c4-8671-32fe95f00993|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|fmol/L|[?]|1|CUP|SUDORIFEROUS GLAND|BILATERAL||Y|PARENT|3|Visit_3|40|3|TREATMENT|2020-09-01|40
e|FA|ef1cddb8-f4ce-45c4-8671-32fe95f00993|7|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|Enzyme U/m2|[?]|1|mL/h|PREPUTIAL GLAND|BILATERAL|||CAREGIVER|4|Visit_4|65|3|FOLLOW-UP|2020-09-26|65
e|FA|ef1cddb8-f4ce-45c4-8671-32fe95f00993|8|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|LB|[?]|1|DROP|HEART, RIGHT VENTRICULAR FREE WALL|CONTRALATERAL|||INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-09-26|65
e|FA|ef1cddb8-f4ce-45c4-8671-32fe95f00993|9|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|10^6 U|[?]|1|AU/mL|ILIAC VEIN|UNILATERAL|||SPOUSE|5|Visit_5|90|4|FOLLOW-UP|2020-10-21|90
e|FA|ef1cddb8-f4ce-45c4-8671-32fe95f00993|10|LDIAM|Longest Diameter|[?]|GERD|[?]|AFU|[?]|1|Shock Wave|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT|||SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2020-10-21|90
e|FA|da6294b5-de91-4bf7-b160-55d22fefcb07|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ug|[?]|1|%(v/v)|RADIUS-LUNATE JOINT|UNILATERAL|||VENDOR|1|Visit_1|10|1|FOLLOW-UP|2020-06-28|10
e|FA|da6294b5-de91-4bf7-b160-55d22fefcb07|2|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|WAFER|[?]|1|g/dL|INTERNAL MAMMARY ARTERY|BILATERAL|Y|Y|INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2020-06-28|10
e|FA|da6294b5-de91-4bf7-b160-55d22fefcb07|3|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|U/g/min|[?]|1|anti-Xa IU/mL|ANTERIOR SUPERIOR ILIAC SPINE|LEFT|||INTERVIEWER|2|Visit_2|25|7|WASHOUT|2020-07-13|25
e|FA|da6294b5-de91-4bf7-b160-55d22fefcb07|4|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|pt_br|[?]|1|BP|LATERAL THIRD DIAGONAL BRANCH ARTERY|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2020-07-13|25
e|FA|da6294b5-de91-4bf7-b160-55d22fefcb07|5|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|mmol/L|[?]|1|uCi/kg|CELIAC ARTERY|LEFT|||CHILD|3|Visit_3|40|3|SCREENING|2020-07-28|40
e|FA|da6294b5-de91-4bf7-b160-55d22fefcb07|6|OBJTYPE|Type of Object|[?]|GERD|[?]|mL/sec/1.73m2|[?]|1|ng|TRICUSPID VALVE, POSTERIOR CUSP|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-07-28|40
e|FA|da6294b5-de91-4bf7-b160-55d22fefcb07|7|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|DROP|PYRAMIDAL TRACTS, INTERNAL CAPSULE|LEFT||Y|CAREGIVER|4|Visit_4|65|6|TREATMENT|2020-08-22|65
e|FA|da6294b5-de91-4bf7-b160-55d22fefcb07|8|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|IU/mg|[?]|1|100 IU/mL|L4 VERTEBRA|BILATERAL|||INVESTIGATOR|4|Visit_4|65|1|FOLLOW-UP|2020-08-22|65
e|FA|da6294b5-de91-4bf7-b160-55d22fefcb07|9|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|Bq/mg|PERINEUM|IPSILATERAL|||ADJUDICATOR|5|Visit_5|90|2|TREATMENT|2020-09-16|90
e|FA|da6294b5-de91-4bf7-b160-55d22fefcb07|10|EVENTFRQ|Event Frequency|[?]|GERD|[?]|U/m2/min|[?]|1|ug/kg/h|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|CONTRALATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-09-16|90
e|FA|c01c16d4-7a37-421d-9191-1874eba6a1e3|1|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|damol/L|[?]|1|umol|KIDNEY, CORTEX|LATERAL|||CAREGIVER|1|Visit_1|10|6|FOLLOW-UP|2020-10-09|10
e|FA|c01c16d4-7a37-421d-9191-1874eba6a1e3|2|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|kg/L|[?]|1|10^6/L|SUPERIOR VENA CAVA|BILATERAL|||PARENT|1|Visit_1|10|4|TREATMENT|2020-10-09|10
e|FA|c01c16d4-7a37-421d-9191-1874eba6a1e3|3|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|cmH2O/mL|INTESTINE|LATERAL|Y||PROXY|2|Visit_2|25|2|TREATMENT|2020-10-24|25
e|FA|c01c16d4-7a37-421d-9191-1874eba6a1e3|4|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/dose|[?]|1|/500 WBC|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|UNILATERAL|Y||GUARDIAN|2|Visit_2|25|2|TREATMENT|2020-10-24|25
e|FA|c01c16d4-7a37-421d-9191-1874eba6a1e3|5|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|GPS U|[?]|1|cm H2O|AXILLARY ARTERY|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|5|TREATMENT|2020-11-08|40
e|FA|c01c16d4-7a37-421d-9191-1874eba6a1e3|6|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|IU/mg|[?]|1|EIA unit|ETHMOID SINUS|LEFT|||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|FOLLOW-UP|2020-11-08|40
e|FA|c01c16d4-7a37-421d-9191-1874eba6a1e3|7|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|U/mmol|[?]|1|mL/dose|POSTERIOR INFERIOR CEREBELLAR ARTERY|UNILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2020-12-03|65
e|FA|c01c16d4-7a37-421d-9191-1874eba6a1e3|8|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|ngEq/L|[?]|1|anti-Xa IU/mL|FINGER FLEXOR MUSCLES|IPSILATERAL|Y||FRIEND|4|Visit_4|65|2|TREATMENT|2020-12-03|65
e|FA|c01c16d4-7a37-421d-9191-1874eba6a1e3|9|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|km|SYMPATHETIC GANGLIA|RIGHT|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|SCREENING|2020-12-28|90
e|FA|c01c16d4-7a37-421d-9191-1874eba6a1e3|10|CALBURN|Calories Burned|[?]|GERD|[?]|ugEq/L|[?]|1|/kg|URETHRA, ANTERIOR|BILATERAL|||ADJUDICATOR|5|Visit_5|90|4|TREATMENT|2020-12-28|90
e|FA|6036407d-5ac8-400d-91f7-afd63f3cab88|1|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|SCOOPFUL|[?]|1|10^6 U|HEART, VENTRICULAR WALL|LATERAL|||INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-06-22|10
e|FA|6036407d-5ac8-400d-91f7-afd63f3cab88|2|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|Sv|[?]|1|ug/m2/h|ADDUCTOR MAGNUS MUSCLE|RIGHT||Y|VENDOR|1|Visit_1|10|3|FOLLOW-UP|2020-06-22|10
e|FA|6036407d-5ac8-400d-91f7-afd63f3cab88|3|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|U/m2/min|[?]|1|ug/kg/h|CORONARY SINUS|CONTRALATERAL||Y|CHILD|2|Visit_2|25|5|TREATMENT|2020-07-07|25
e|FA|6036407d-5ac8-400d-91f7-afd63f3cab88|4|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|mL/cm|[?]|1|m2|MEDIAN OR LOWER CERVICAL LYMPH NODE|LEFT||Y|GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-07-07|25
e|FA|6036407d-5ac8-400d-91f7-afd63f3cab88|5|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|mg/dL|[?]|1|ug/kg/h|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|BILATERAL|||GUARDIAN|3|Visit_3|40|4|FOLLOW-UP|2020-07-22|40
e|FA|6036407d-5ac8-400d-91f7-afd63f3cab88|6|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|umol/mg/min|[?]|1|aMFI|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|LATERAL|Y||VENDOR|3|Visit_3|40|5|SCREENING|2020-07-22|40
e|FA|6036407d-5ac8-400d-91f7-afd63f3cab88|7|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|TUBE|[?]|1|MBq|ILIAC LYMPH NODE|LATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2020-08-16|65
e|FA|6036407d-5ac8-400d-91f7-afd63f3cab88|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa/L|[?]|1|mg/g/min|DIGIT|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2020-08-16|65
e|FA|6036407d-5ac8-400d-91f7-afd63f3cab88|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|DNA copies/ug|[?]|1|mL|PERONEAL ARTERY|RIGHT|||INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2020-09-10|90
e|FA|6036407d-5ac8-400d-91f7-afd63f3cab88|10|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|uL/kg/day|LEFT VENTRICULAR MID INFERIOR SEGMENT|LATERAL|||STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2020-09-10|90
e|FA|69cf0c4b-13f6-4955-8046-72a333059d6e|1|STROKTYP|Stroke Type|[?]|GERD|[?]|km/h|[?]|1|g/L|NUCLEUS OF DIAGONAL BAND|UNILATERAL|||GUARDIAN|1|Visit_1|10|4|SCREENING|2020-12-16|10
e|FA|69cf0c4b-13f6-4955-8046-72a333059d6e|2|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|10^6 CFU|LEFT VENTRICULAR EPICARDIUM|RIGHT|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|FOLLOW-UP|2020-12-16|10
e|FA|69cf0c4b-13f6-4955-8046-72a333059d6e|3|LENRSCT|Length of Resection|[?]|GERD|[?]|/wk|[?]|1|psi|OCCIPITAL LYMPH NODE|BILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-12-31|25
e|FA|69cf0c4b-13f6-4955-8046-72a333059d6e|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ppm|[?]|1|mg/g/min|TONGUE|LEFT||Y|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-12-31|25
e|FA|69cf0c4b-13f6-4955-8046-72a333059d6e|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol/g|[?]|1|mg/g/min|PARATHYROID GLAND|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|SCREENING|2021-01-15|40
e|FA|69cf0c4b-13f6-4955-8046-72a333059d6e|6|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|IU|[?]|1|mL/cm3/min|ABDOMINAL AORTA|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2021-01-15|40
e|FA|69cf0c4b-13f6-4955-8046-72a333059d6e|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|PHERESIS UNIT|[?]|1|%(v/v)|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-02-09|65
e|FA|69cf0c4b-13f6-4955-8046-72a333059d6e|8|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|mL/m2|[?]|1|mm/h|DELTOID MUSCLE|RIGHT||Y|CAREGIVER|4|Visit_4|65|1|FOLLOW-UP|2021-02-09|65
e|FA|69cf0c4b-13f6-4955-8046-72a333059d6e|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|AgU/mL|[?]|1|mg/g/min|MOTOR CORTEX|BILATERAL|||SPOUSE|5|Visit_5|90|2|WASHOUT|2021-03-06|90
e|FA|69cf0c4b-13f6-4955-8046-72a333059d6e|10|DFIBER|Dietary Fiber|[?]|GERD|[?]|mg/mL/day|[?]|1|h*%|TIBIA|UNILATERAL|||VENDOR|5|Visit_5|90|6|WASHOUT|2021-03-06|90
e|FA|19829028-595c-4811-90e3-0ca696a04ba3|1|SEV|Severity/Intensity|[?]|GERD|[?]|U/dL|[?]|1|Pa|MEDIAN OR LOWER CERVICAL LYMPH NODE|RIGHT|Y|Y|GUARDIAN|1|Visit_1|10|3|TREATMENT|2020-07-15|10
e|FA|19829028-595c-4811-90e3-0ca696a04ba3|2|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|lx|[?]|1|mm/h|SOLE|UNILATERAL|Y|Y|INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2020-07-15|10
e|FA|19829028-595c-4811-90e3-0ca696a04ba3|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|MET*min|[?]|1|%(v/v)|VOMER|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|2|TREATMENT|2020-07-30|25
e|FA|19829028-595c-4811-90e3-0ca696a04ba3|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|ft|[?]|1|QUANTITY SUFFICIENT|CARDIAC VALVE|LEFT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-07-30|25
e|FA|19829028-595c-4811-90e3-0ca696a04ba3|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|CIGARETTE|[?]|1|ug/g/h|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|LATERAL|||SIBLING|3|Visit_3|40|2|SCREENING|2020-08-14|40
e|FA|19829028-595c-4811-90e3-0ca696a04ba3|6|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|mL/cm|[?]|1|mL/dose|LATERAL FIRST DIAGONAL BRANCH ARTERY|LEFT|Y||GUARDIAN|3|Visit_3|40|4|FOLLOW-UP|2020-08-14|40
e|FA|19829028-595c-4811-90e3-0ca696a04ba3|7|SEV|Severity/Intensity|[?]|GERD|[?]|breaths/30s|[?]|1|Pa|T12 VERTEBRA|IPSILATERAL||Y|CAREGIVER|4|Visit_4|65|4|SCREENING|2020-09-08|65
e|FA|19829028-595c-4811-90e3-0ca696a04ba3|8|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|Roentgen|[?]|1|L/h/m2|SPLEEN, HILUM|LEFT|Y||PARENT|4|Visit_4|65|2|TREATMENT|2020-09-08|65
e|FA|19829028-595c-4811-90e3-0ca696a04ba3|9|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|APL U|[?]|1|DROP|THYMUS GLAND|CONTRALATERAL|||STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2020-10-03|90
e|FA|19829028-595c-4811-90e3-0ca696a04ba3|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/s/m2|[?]|1|km|TROCHLEAR NERVE|LEFT|||SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-10-03|90
e|FA|562a8182-8e9b-4a68-9b95-bc52df58ed46|1|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|mg|[?]|1|mL/100g/min|APPENDICULAR SKELETON|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2020-09-05|10
e|FA|562a8182-8e9b-4a68-9b95-bc52df58ed46|2|LDIAM|Longest Diameter|[?]|GERD|[?]|m/sec2|[?]|1|Shock Wave|GASTROINTESTINAL TRACT, UPPER, WALL|BILATERAL|||CAREGIVER|1|Visit_1|10|3|TREATMENT|2020-09-05|10
e|FA|562a8182-8e9b-4a68-9b95-bc52df58ed46|3|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|GBq/g|[?]|1|Gy/h|LUNG, RIGHT LOWER LOBE|RIGHT|Y||VENDOR|2|Visit_2|25|7|FOLLOW-UP|2020-09-20|25
e|FA|562a8182-8e9b-4a68-9b95-bc52df58ed46|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|gMFI|[?]|1|%(v/v)|BREAST|LATERAL|Y|Y|GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-09-20|25
e|FA|562a8182-8e9b-4a68-9b95-bc52df58ed46|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|%(v/v)|MALE GENITALIA|UNILATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|3|SCREENING|2020-10-05|40
e|FA|562a8182-8e9b-4a68-9b95-bc52df58ed46|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|um|[?]|1|mg/g/min|LOWER GASTROINTESTINAL TRACT LYMPH NODE|BILATERAL|||ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-10-05|40
e|FA|562a8182-8e9b-4a68-9b95-bc52df58ed46|7|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|NFIU|[?]|1|cmH2O/mL|RETROAURICULAR LYMPH NODE|CONTRALATERAL|Y||SPOUSE|4|Visit_4|65|7|TREATMENT|2020-10-30|65
e|FA|562a8182-8e9b-4a68-9b95-bc52df58ed46|8|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|10^9 CFU/mL|T11 VERTEBRA|BILATERAL|||SPOUSE|4|Visit_4|65|4|SCREENING|2020-10-30|65
e|FA|562a8182-8e9b-4a68-9b95-bc52df58ed46|9|EVENTNUM|Number of Events|[?]|GERD|[?]|10^3 CFU/g|[?]|1|U/10^12 RBC|TIBIO-PERONEAL TRUNK|BILATERAL|||ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2020-11-24|90
e|FA|562a8182-8e9b-4a68-9b95-bc52df58ed46|10|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU/mL|[?]|1|mg/dose|RIGHT VENTRICULAR BRANCH|UNILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|6|FOLLOW-UP|2020-11-24|90
e|FA|b29e6912-42f4-471b-ad90-1ec446f89ac0|1|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|mL|[?]|1|10^6 IU/mL|AXILLARY LYMPH NODE|LATERAL|||ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2021-01-19|10
e|FA|b29e6912-42f4-471b-ad90-1ec446f89ac0|2|DGRAIN|Dietary Grain|[?]|GERD|[?]|Bq/g|[?]|1|10^9 CFU/g|DUCTUS ARTERIOSUS|IPSILATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2021-01-19|10
e|FA|b29e6912-42f4-471b-ad90-1ec446f89ac0|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|kat|[?]|1|mg/g/min|FAT PAD|UNILATERAL||Y|VENDOR|2|Visit_2|25|3|FOLLOW-UP|2021-02-03|25
e|FA|b29e6912-42f4-471b-ad90-1ec446f89ac0|4|LENRSCT|Length of Resection|[?]|GERD|[?]|/h|[?]|1|psi|ANTERIOR SUPERIOR ILIAC SPINE|LEFT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2021-02-03|25
e|FA|b29e6912-42f4-471b-ad90-1ec446f89ac0|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|CIGAR|[?]|1|ug/g/h|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|IPSILATERAL|||PROXY|3|Visit_3|40|7|TREATMENT|2021-02-18|40
e|FA|b29e6912-42f4-471b-ad90-1ec446f89ac0|6|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|U/dL|[?]|1|ng/day|ISCHIAL TUBEROSITY|RIGHT|||PROXY|3|Visit_3|40|5|SCREENING|2021-02-18|40
e|FA|b29e6912-42f4-471b-ad90-1ec446f89ac0|7|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|SFC/10^6 PBMC|[?]|1|anti-Xa IU/mL|GENITALIA|BILATERAL|||SPOUSE|4|Visit_4|65|3|FOLLOW-UP|2021-03-15|65
e|FA|b29e6912-42f4-471b-ad90-1ec446f89ac0|8|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|mL/m2|[?]|1|mIU/L|CHOROID PLEXUS|LATERAL|||SIBLING|4|Visit_4|65|2|FOLLOW-UP|2021-03-15|65
e|FA|b29e6912-42f4-471b-ad90-1ec446f89ac0|9|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|g/animal/wk|[?]|1|IU/mg|SUPRACLAVICULAR LYMPH NODE|LEFT|||CHILD|5|Visit_5|90|1|SCREENING|2021-04-09|90
e|FA|b29e6912-42f4-471b-ad90-1ec446f89ac0|10|DVEG|Dietary Vegetable|[?]|GERD|[?]|lx|[?]|1|Ci/ug|PLACENTA|LEFT|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2021-04-09|90
e|FA|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|1|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|ugEq/L|[?]|1|DROP|EYE, ANTERIOR CHAMBER|LATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-06-09|10
e|FA|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|2|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|NEBULE|[?]|1|ohm|FEMORAL CONDYLE|CONTRALATERAL||Y|SPOUSE|1|Visit_1|10|7|FOLLOW-UP|2020-06-09|10
e|FA|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mAnson U/mL|[?]|1|%(v/v)|ILEUM WALL|LEFT|Y||CHILD|2|Visit_2|25|6|TREATMENT|2020-06-24|25
e|FA|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mV|[?]|1|mg/g/min|RIB|LATERAL|||INVESTIGATOR|2|Visit_2|25|3|WASHOUT|2020-06-24|25
e|FA|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|5|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|BE/mL|[?]|1|mL|NAVICULAR BONE|RIGHT||Y|STUDY SUBJECT|3|Visit_3|40|6|SCREENING|2020-07-09|40
e|FA|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mL/m2|[?]|1|CUP|PROXIMAL LAD ARTERY|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|WASHOUT|2020-07-09|40
e|FA|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|umol/L/sec|[?]|1|U/mmol|DUCTUS ARTERIOSUS|BILATERAL|||CHILD|4|Visit_4|65|5|TREATMENT|2020-08-03|65
e|FA|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|8|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|kcal/day|[?]|1|10^6 IU/mL|CLAW|LEFT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|6|FOLLOW-UP|2020-08-03|65
e|FA|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mCi|[?]|1|Pa|VENOUS SINUS|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-08-28|90
e|FA|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|10|DGRAIN|Dietary Grain|[?]|GERD|[?]|mg/g/min|[?]|1|10^9 CFU/g|SKIN OF THE BENDING JOINT|CONTRALATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-08-28|90
e|FA|396295ba-9f4c-4689-88c2-f80cb28b567a|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|fg|[?]|1|km|ATRIOVENTRICULAR VALVE|IPSILATERAL|||FRIEND|1|Visit_1|10|5|SCREENING|2020-12-31|10
e|FA|396295ba-9f4c-4689-88c2-f80cb28b567a|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|scm|[?]|1|mEq/g|LIVER, CAUDATE LOBE|UNILATERAL|||FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-12-31|10
e|FA|396295ba-9f4c-4689-88c2-f80cb28b567a|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|L/s|[?]|1|%(v/v)|ILEUM, TERMINAL|UNILATERAL|||SPOUSE|2|Visit_2|25|4|TREATMENT|2021-01-15|25
e|FA|396295ba-9f4c-4689-88c2-f80cb28b567a|4|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|Gy/h|[?]|1|mg/dose|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2021-01-15|25
e|FA|396295ba-9f4c-4689-88c2-f80cb28b567a|5|SPEED|Speed|[?]|GERD|[?]|Pa|[?]|1|mEq/g|TEMPORAL BONE|RIGHT|||SIBLING|3|Visit_3|40|5|TREATMENT|2021-01-30|40
e|FA|396295ba-9f4c-4689-88c2-f80cb28b567a|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|mCi/kg|[?]|1|QUANTITY SUFFICIENT|L1 VERTEBRA|LATERAL|||FRIEND|3|Visit_3|40|7|SCREENING|2021-01-30|40
e|FA|396295ba-9f4c-4689-88c2-f80cb28b567a|7|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|pkat/L|[?]|1|BAG|SUPRASPINATUS MUSCLE|LATERAL|||INTERVIEWER|4|Visit_4|65|1|SCREENING|2021-02-24|65
e|FA|396295ba-9f4c-4689-88c2-f80cb28b567a|8|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|/100 HPFs|[?]|1|anti-Xa IU/mL|SAPHENOUS VEIN|LATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|FOLLOW-UP|2021-02-24|65
e|FA|396295ba-9f4c-4689-88c2-f80cb28b567a|9|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|LB|[?]|1|Gy/h|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|CONTRALATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2021-03-21|90
e|FA|396295ba-9f4c-4689-88c2-f80cb28b567a|10|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|ug/mL/h|[?]|1|umol|AXILLARY LYMPH NODE LEVEL I|LEFT|Y||SIBLING|5|Visit_5|90|6|TREATMENT|2021-03-21|90
e|FA|56072c44-67c3-4c93-8db7-2d1570b2bbbc|1|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|RNA copies/mL|[?]|1|BOWL|ANKLE MORTISE|LEFT|||CHILD|1|Visit_1|10|3|TREATMENT|2020-08-26|10
e|FA|56072c44-67c3-4c93-8db7-2d1570b2bbbc|2|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|U/kg/h|[?]|1|mL|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|2|SCREENING|2020-08-26|10
e|FA|56072c44-67c3-4c93-8db7-2d1570b2bbbc|3|VOL|Volume|[?]|GERD|[?]|cs|[?]|1|vp/dose|INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|WASHOUT|2020-09-10|25
e|FA|56072c44-67c3-4c93-8db7-2d1570b2bbbc|4|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|foz_us|[?]|1|oz eq|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|LEFT|||INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-09-10|25
e|FA|56072c44-67c3-4c93-8db7-2d1570b2bbbc|5|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|10^9 CFU/mL|[?]|1|g/dL|INFRATENTORIAL BRAIN|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|WASHOUT|2020-09-25|40
e|FA|56072c44-67c3-4c93-8db7-2d1570b2bbbc|6|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|km|CAPITATE-HAMATE JOINT|RIGHT|Y|Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|FOLLOW-UP|2020-09-25|40
e|FA|56072c44-67c3-4c93-8db7-2d1570b2bbbc|7|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|in|[?]|1|km|BILIARY TRACT|CONTRALATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2020-10-20|65
e|FA|56072c44-67c3-4c93-8db7-2d1570b2bbbc|8|VOL|Volume|[?]|GERD|[?]|kPa/L/sec|[?]|1|vp/dose|PARALARYNGEAL LYMPH NODE|LEFT||Y|CAREGIVER|4|Visit_4|65|2|WASHOUT|2020-10-20|65
e|FA|56072c44-67c3-4c93-8db7-2d1570b2bbbc|9|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|damol/L|[?]|1|mEq/g|STERNUM|IPSILATERAL|||ADJUDICATOR|5|Visit_5|90|1|FOLLOW-UP|2020-11-14|90
e|FA|56072c44-67c3-4c93-8db7-2d1570b2bbbc|10|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|mL/s|[?]|1|cm H2O|HEPATIC LYMPH NODE|UNILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2020-11-14|90
e|FA|55b23180-01f2-498e-a0af-cb9cd7d81750|1|DISTANCE|Distance|[?]|GERD|[?]|umol/min|[?]|1|BOWL|BASAL GANGLIA|IPSILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|4|SCREENING|2020-07-01|10
e|FA|55b23180-01f2-498e-a0af-cb9cd7d81750|2|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|QUANTITY SUFFICIENT|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|BILATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|5|SCREENING|2020-07-01|10
e|FA|55b23180-01f2-498e-a0af-cb9cd7d81750|3|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|mm/sec|[?]|1|10^6 IU/mL|GUT-ASSOCIATED LYMPHOID TISSUE|IPSILATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-07-16|25
e|FA|55b23180-01f2-498e-a0af-cb9cd7d81750|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|NEBULE|[?]|1|PFU/dose|SKIN OF THE NECK|IPSILATERAL|||FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-07-16|25
e|FA|55b23180-01f2-498e-a0af-cb9cd7d81750|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|ug/m2/min|[?]|1|ug/g/h|FIBULA SHAFT|UNILATERAL|Y||FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2020-07-31|40
e|FA|55b23180-01f2-498e-a0af-cb9cd7d81750|6|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|vp/dose|[?]|1|umol|SPLEEN, HILUM|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|WASHOUT|2020-07-31|40
e|FA|55b23180-01f2-498e-a0af-cb9cd7d81750|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|uCi|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 2|LEFT|Y||SIBLING|4|Visit_4|65|7|WASHOUT|2020-08-25|65
e|FA|55b23180-01f2-498e-a0af-cb9cd7d81750|8|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|MONTHS|[?]|1|BAG|CORPUS UTERI|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|WASHOUT|2020-08-25|65
e|FA|55b23180-01f2-498e-a0af-cb9cd7d81750|9|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|BOWL|ENDOCERVIX|CONTRALATERAL|||GUARDIAN|5|Visit_5|90|1|SCREENING|2020-09-19|90
e|FA|55b23180-01f2-498e-a0af-cb9cd7d81750|10|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|mEq/uL|[?]|1|MBq|MUCOSA OF THE LIP|IPSILATERAL||Y|INTERVIEWER|5|Visit_5|90|2|SCREENING|2020-09-19|90
e|FA|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|1|DFATT|Dietary Fat, Total|[?]|GERD|[?]|pg/dL|[?]|1|Bq/mg|SKIN OF THE LIP|BILATERAL|||SPOUSE|1|Visit_1|10|4|TREATMENT|2020-11-09|10
e|FA|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|2|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|mmHg*min/L|[?]|1|10^6 CFU|PULMONARY VALVE, RIGHT CUSP|RIGHT|Y||FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2020-11-09|10
e|FA|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|3|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|mm/sec|[?]|1|10^6 CFU|ORAL CAVITY|BILATERAL|||CAREGIVER|2|Visit_2|25|2|TREATMENT|2020-11-24|25
e|FA|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|4|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|NEEDLE GAUGE|[?]|1|Hz/s|CANINE TOOTH|UNILATERAL||Y|INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-11-24|25
e|FA|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|5|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|U/kg/h|[?]|1|Shock Wave|FOREBRAIN|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|4|FOLLOW-UP|2020-12-09|40
e|FA|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|6|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|%(w/w)|[?]|1|mL/m2|UPPER CERVICAL LYMPH NODE|RIGHT||Y|PROXY|3|Visit_3|40|5|WASHOUT|2020-12-09|40
e|FA|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|7|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|bel|[?]|1|ug/m2/h|FEMORO-POPLITEAL PERIPHERAL ARTERY|RIGHT|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|6|SCREENING|2021-01-03|65
e|FA|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|8|DGRAIN|Dietary Grain|[?]|GERD|[?]|EID 50/mL|[?]|1|10^9 CFU/g|FEMORAL VEIN|CONTRALATERAL|Y|Y|DOMESTIC PARTNER|4|Visit_4|65|4|SCREENING|2021-01-03|65
e|FA|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|9|EVENTNUM|Number of Events|[?]|GERD|[?]|g/cm2|[?]|1|U/10^12 RBC|CERVICAL VERTEBRA|LEFT||Y|GUARDIAN|5|Visit_5|90|6|WASHOUT|2021-01-28|90
e|FA|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|10|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|psi|LINGULA OF THE LUNG|CONTRALATERAL|Y|Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|SCREENING|2021-01-28|90
e|FA|940e4aef-5648-46b3-9c3e-7c40f7930030|1|DCAL|Dietary Calories|[?]|GERD|[?]|mEq/ug|[?]|1|EIA unit|RIB|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|1|SCREENING|2020-11-15|10
e|FA|940e4aef-5648-46b3-9c3e-7c40f7930030|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|g/L|[?]|1|mEq/g|LUNG, LEFT|RIGHT|||DOMESTIC PARTNER|1|Visit_1|10|1|TREATMENT|2020-11-15|10
e|FA|940e4aef-5648-46b3-9c3e-7c40f7930030|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/dose|[?]|1|Pa|HEPATIC LYMPH NODE|RIGHT|||INVESTIGATOR|2|Visit_2|25|4|WASHOUT|2020-11-30|25
e|FA|940e4aef-5648-46b3-9c3e-7c40f7930030|4|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|L/kg|[?]|1|TRANSDUCING UNIT/mL|PYLORIC SPHINCTER|IPSILATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|1|FOLLOW-UP|2020-11-30|25
e|FA|940e4aef-5648-46b3-9c3e-7c40f7930030|5|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|g/cm2|[?]|1|MPS U|PARASPINAL REGION|BILATERAL|||CAREGIVER|3|Visit_3|40|2|TREATMENT|2020-12-15|40
e|FA|940e4aef-5648-46b3-9c3e-7c40f7930030|6|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU/mL|[?]|1|EIA unit|HEART, APEX|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-12-15|40
e|FA|940e4aef-5648-46b3-9c3e-7c40f7930030|7|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|psi|[?]|1|BAG|LACRIMAL BONE|IPSILATERAL|||SIBLING|4|Visit_4|65|2|SCREENING|2021-01-09|65
e|FA|940e4aef-5648-46b3-9c3e-7c40f7930030|8|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|uEq/L|[?]|1|Weber|METATARSAL BONE|BILATERAL|||SIBLING|4|Visit_4|65|1|TREATMENT|2021-01-09|65
e|FA|940e4aef-5648-46b3-9c3e-7c40f7930030|9|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|g/animal/day|[?]|1|mm/h|HEART, ATRIUM|BILATERAL||Y|PROXY|5|Visit_5|90|6|FOLLOW-UP|2021-02-03|90
e|FA|940e4aef-5648-46b3-9c3e-7c40f7930030|10|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|PACKET|[?]|1|g/day|BRAIN, PERIVENTRICULAR REGION|LATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|SCREENING|2021-02-03|90
e|FA|e4bece1e-6672-4b55-824f-56aa923e60f9|1|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|Bq|[?]|1|BOWL|COLON, DESCENDING|CONTRALATERAL|Y||ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-06-22|10
e|FA|e4bece1e-6672-4b55-824f-56aa923e60f9|2|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|nkat/L|[?]|1|PFU/dose|FLEXOR POLLICIS LONGUS MUSCLE|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-06-22|10
e|FA|e4bece1e-6672-4b55-824f-56aa923e60f9|3|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|aMFI|TRICUSPID VALVE, ANTERIOR CUSP|RIGHT|||INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-07-07|25
e|FA|e4bece1e-6672-4b55-824f-56aa923e60f9|4|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/m2|[?]|1|mg/dose|BRAIN VENTRICLE, LATERAL|LEFT|Y|Y|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-07-07|25
e|FA|e4bece1e-6672-4b55-824f-56aa923e60f9|5|EXCDUR|Exercise Duration|[?]|GERD|[?]|mU/g|[?]|1|mm|TRANSVERSE TARSAL JOINT|RIGHT|Y||VENDOR|3|Visit_3|40|4|SCREENING|2020-07-22|40
e|FA|e4bece1e-6672-4b55-824f-56aa923e60f9|6|DCAL|Dietary Calories|[?]|GERD|[?]|min|[?]|1|EIA unit|PROXIMAL PHALANX 3 OF THE HAND|IPSILATERAL|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|7|TREATMENT|2020-07-22|40
e|FA|e4bece1e-6672-4b55-824f-56aa923e60f9|7|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|DIOPTER|[?]|1|DRUM|URETHRA|IPSILATERAL|||CHILD|4|Visit_4|65|3|TREATMENT|2020-08-16|65
e|FA|e4bece1e-6672-4b55-824f-56aa923e60f9|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|10^6 U|FEMORAL LYMPH NODE|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|SCREENING|2020-08-16|65
e|FA|e4bece1e-6672-4b55-824f-56aa923e60f9|9|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|dB|[?]|1|mAmp|APPENDICEAL TIP|RIGHT|||PARENT|5|Visit_5|90|6|TREATMENT|2020-09-10|90
e|FA|e4bece1e-6672-4b55-824f-56aa923e60f9|10|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|beats/min|[?]|1|mmHg/L/min|AXILLARY ARTERY|RIGHT|||INTERVIEWER|5|Visit_5|90|1|TREATMENT|2020-09-10|90
e|FA|12e607da-f53c-4078-9742-23a111db6f54|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|mL/kg|[?]|1|L|HEART, APEX|BILATERAL|Y|Y|VENDOR|1|Visit_1|10|2|FOLLOW-UP|2020-10-03|10
e|FA|12e607da-f53c-4078-9742-23a111db6f54|2|LENRSCT|Length of Resection|[?]|GERD|[?]|fmol/L|[?]|1|psi|GENITALIA|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|TREATMENT|2020-10-03|10
e|FA|12e607da-f53c-4078-9742-23a111db6f54|3|LDIAM|Longest Diameter|[?]|GERD|[?]|mL/mmHg|[?]|1|Shock Wave|NASAL SEPTUM|RIGHT|Y||SPOUSE|2|Visit_2|25|1|TREATMENT|2020-10-18|25
e|FA|12e607da-f53c-4078-9742-23a111db6f54|4|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|STEPS|[?]|1|uL/kg/day|CINGULATE CORTEX|LEFT|Y||PROXY|2|Visit_2|25|4|WASHOUT|2020-10-18|25
e|FA|12e607da-f53c-4078-9742-23a111db6f54|5|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|kPa|[?]|1|Log10 ELISA unit|LUNG, HILUM|RIGHT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-11-02|40
e|FA|12e607da-f53c-4078-9742-23a111db6f54|6|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|ka_u/dL|[?]|1|mm/h|ILIAC CREST|UNILATERAL||Y|SIGNIFICANT OTHER|3|Visit_3|40|5|TREATMENT|2020-11-02|40
e|FA|12e607da-f53c-4078-9742-23a111db6f54|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/animal/day|[?]|1|mg/g/min|RAPHE|LATERAL|||STUDY SUBJECT|4|Visit_4|65|7|SCREENING|2020-11-27|65
e|FA|12e607da-f53c-4078-9742-23a111db6f54|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|MET|[?]|1|mL|CORPUS CALLOSUM|LATERAL|||INVESTIGATOR|4|Visit_4|65|3|SCREENING|2020-11-27|65
e|FA|12e607da-f53c-4078-9742-23a111db6f54|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Bq/g|[?]|1|Pa|TRAPEZOID BONE|LEFT|||ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-12-22|90
e|FA|12e607da-f53c-4078-9742-23a111db6f54|10|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|U/m2/day|[?]|1|g/dL|LUNG LOBE|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-12-22|90
e|FA|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|mg/g/min|URETHRA, PROSTATIC|RIGHT|||PARENT|1|Visit_1|10|2|TREATMENT|2021-01-26|10
e|FA|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mEq/mL|[?]|1|%(v/v)|PECTORALIS MAJOR MUSCLE|CONTRALATERAL||Y|PARENT|1|Visit_1|10|3|FOLLOW-UP|2021-01-26|10
e|FA|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|3|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|RING|[?]|1|mL/m2|LATISSIMUS DORSI MUSCLE|CONTRALATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|2|FOLLOW-UP|2021-02-10|25
e|FA|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|4|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|/2500 WBC|[?]|1|Weber|HILAR|IPSILATERAL|||SIBLING|2|Visit_2|25|6|TREATMENT|2021-02-10|25
e|FA|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mm3/mm2/year|[?]|1|Pa|LUMBAR SPINE|LATERAL|||ADJUDICATOR|3|Visit_3|40|1|SCREENING|2021-02-25|40
e|FA|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|6|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|10^5/L|[?]|1|10^9 CFU/g|BRAIN|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2021-02-25|40
e|FA|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|7|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|log EID 50/dose|[?]|1|ug/kg/h|PERIURETERAL REGION|BILATERAL|||FAMILY MEMBER|4|Visit_4|65|6|WASHOUT|2021-03-22|65
e|FA|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|8|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|ppm|[?]|1|AU/mL|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|LATERAL|||FRIEND|4|Visit_4|65|2|TREATMENT|2021-03-22|65
e|FA|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|9|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|mol/mol|[?]|1|g/cage/day|FLEXOR POLLICIS LONGUS MUSCLE|CONTRALATERAL|||FAMILY MEMBER|5|Visit_5|90|6|WASHOUT|2021-04-16|90
e|FA|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ms2|[?]|1|mg/g/min|LIP, UPPER|BILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2021-04-16|90
e|FA|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|1|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|10^7 TCID 50/dose|[?]|1|Shock Wave|FUNDUS UTERI|LATERAL|||CHILD|1|Visit_1|10|3|TREATMENT|2020-07-16|10
e|FA|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|2|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|10^6 IU/mL|[?]|1|BAG|PALATE|LEFT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|FOLLOW-UP|2020-07-16|10
e|FA|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|3|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|mU/L|[?]|1|fmol|LUNG, LEFT LOWER LOBE|LEFT|||CAREGIVER|2|Visit_2|25|4|FOLLOW-UP|2020-07-31|25
e|FA|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|4|DVEG|Dietary Vegetable|[?]|GERD|[?]|10^3/hpf|[?]|1|Ci/ug|CENTRAL NERVOUS SYSTEM|LEFT||Y|ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-07-31|25
e|FA|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|5|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|uL/kg/day|RENAL ARTERY|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|FOLLOW-UP|2020-08-15|40
e|FA|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|6|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|/10^5|[?]|1|L/h/m2|HAMATE BONE|LEFT|||SIBLING|3|Visit_3|40|7|TREATMENT|2020-08-15|40
e|FA|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|7|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mg/cm2|[?]|1|Weber|AORTOPULMONARY WINDOW LYMPH NODE|RIGHT|||SIBLING|4|Visit_4|65|3|WASHOUT|2020-09-09|65
e|FA|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|cP|[?]|1|U/mmol|WRIST JOINT EXTENSOR MUSCLES|LATERAL||Y|INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-09-09|65
e|FA|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|9|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|10^6 organisms/g|[?]|1|gtt|FLEXOR CARPI RADIALIS MUSCLE|BILATERAL|||SPOUSE|5|Visit_5|90|6|SCREENING|2020-10-04|90
e|FA|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|10|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|g/day|PAROTID GLAND LYMPH NODE|LEFT|||DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-10-04|90
e|FA|3260122d-3bf4-45ff-a026-2379158721d0|1|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|cmol|[?]|1|TRANSDUCING UNIT/mL|AORTOCAVAL LYMPH NODE|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-06-04|10
e|FA|3260122d-3bf4-45ff-a026-2379158721d0|2|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|10^6 CFU/mL|POSTERIOR CINGULATE CORTEX|LEFT||Y|SPOUSE|1|Visit_1|10|7|TREATMENT|2020-06-04|10
e|FA|3260122d-3bf4-45ff-a026-2379158721d0|3|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|g/animal/wk|[?]|1|mEq|TRICUSPID VALVE|IPSILATERAL|||INVESTIGATOR|2|Visit_2|25|7|FOLLOW-UP|2020-06-19|25
e|FA|3260122d-3bf4-45ff-a026-2379158721d0|4|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|10^7 TCID 50/dose|[?]|1|mL/cm3/min|SKIN OF THE FOOT|RIGHT|Y|Y|SPOUSE|2|Visit_2|25|4|SCREENING|2020-06-19|25
e|FA|3260122d-3bf4-45ff-a026-2379158721d0|5|SEV|Severity/Intensity|[?]|GERD|[?]|genEq|[?]|1|Pa|INCISOR|LEFT|||GUARDIAN|3|Visit_3|40|1|TREATMENT|2020-07-04|40
e|FA|3260122d-3bf4-45ff-a026-2379158721d0|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/L|[?]|1|mg/g/min|INTERPHALANGEAL THUMB JOINT|IPSILATERAL|||FRIEND|3|Visit_3|40|3|TREATMENT|2020-07-04|40
e|FA|3260122d-3bf4-45ff-a026-2379158721d0|7|DFRUIT|Dietary Fruit|[?]|GERD|[?]|Gy|[?]|1|10^6 CFU/mL|GASTROCNEMIUS MUSCLE|LEFT|Y||INTERVIEWER|4|Visit_4|65|5|FOLLOW-UP|2020-07-29|65
e|FA|3260122d-3bf4-45ff-a026-2379158721d0|8|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|L/min/m2|[?]|1|ug/kg/h|PULMONARY VALVE, ANTERIOR CUSP|RIGHT|||PROXY|4|Visit_4|65|7|TREATMENT|2020-07-29|65
e|FA|3260122d-3bf4-45ff-a026-2379158721d0|9|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|uL/dose|[?]|1|mIU/L|BRACHIAL ARTERY|LATERAL|||INVESTIGATOR|5|Visit_5|90|7|FOLLOW-UP|2020-08-23|90
e|FA|3260122d-3bf4-45ff-a026-2379158721d0|10|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|TCID 50/dose|[?]|1|ng/day|CORONARY SINUS|UNILATERAL||Y|FRIEND|5|Visit_5|90|6|FOLLOW-UP|2020-08-23|90
e|FA|05eb4e29-887e-4cdb-8854-49939a8a13d1|1|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|mL/h|SCAPHOID-LUNATE JOINT|IPSILATERAL|||CHILD|1|Visit_1|10|7|WASHOUT|2020-11-05|10
e|FA|05eb4e29-887e-4cdb-8854-49939a8a13d1|2|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|mmol/L|[?]|1|mEq|PROXIMAL CIRCUMFLEX ARTERY|LATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|SCREENING|2020-11-05|10
e|FA|05eb4e29-887e-4cdb-8854-49939a8a13d1|3|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|pptr|[?]|1|cmH2O/mL|LUMBAR VERTEBRA|LEFT|||INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-11-20|25
e|FA|05eb4e29-887e-4cdb-8854-49939a8a13d1|4|DIAMETER|Diameter|[?]|GERD|[?]|cmH2O*s/mL|[?]|1|cm|CARDIAC VALVE|LATERAL|||PARENT|2|Visit_2|25|2|TREATMENT|2020-11-20|25
e|FA|05eb4e29-887e-4cdb-8854-49939a8a13d1|5|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|/10^5|[?]|1|aMFI|SUPERIOR VENA CAVA|RIGHT|||PROXY|3|Visit_3|40|2|SCREENING|2020-12-05|40
e|FA|05eb4e29-887e-4cdb-8854-49939a8a13d1|6|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|cm|WRIST JOINT EXTENSOR TENDONS|LATERAL||Y|SIBLING|3|Visit_3|40|4|WASHOUT|2020-12-05|40
e|FA|05eb4e29-887e-4cdb-8854-49939a8a13d1|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Mile|[?]|1|mg/g/min|OSTIOMEATAL COMPLEX|UNILATERAL|||FRIEND|4|Visit_4|65|4|TREATMENT|2020-12-30|65
e|FA|05eb4e29-887e-4cdb-8854-49939a8a13d1|8|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|mg/L|[?]|1|mL/h|STOMACH|RIGHT|||CHILD|4|Visit_4|65|1|TREATMENT|2020-12-30|65
e|FA|05eb4e29-887e-4cdb-8854-49939a8a13d1|9|SEV|Severity/Intensity|[?]|GERD|[?]|10^6 copies/mL|[?]|1|Pa|POSTERIOR CINGULATE CORTEX|LATERAL|||INTERVIEWER|5|Visit_5|90|2|FOLLOW-UP|2021-01-24|90
e|FA|05eb4e29-887e-4cdb-8854-49939a8a13d1|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^3 organisms|[?]|1|%(v/v)|HAMSTRING MUSCLE|UNILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2021-01-24|90
e|FA|c8390c70-766d-4252-9356-39591651bcdf|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|km|DISTAL INTERPHALANGEAL JOINT 2|BILATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|3|WASHOUT|2020-08-11|10
e|FA|c8390c70-766d-4252-9356-39591651bcdf|2|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|GPL U|[?]|1|aMFI|TIBIALIS POSTERIOR MUSCLE|CONTRALATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-08-11|10
e|FA|c8390c70-766d-4252-9356-39591651bcdf|3|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|Bq/kg|[?]|1|CUP|DISTAL INTERPHALANGEAL JOINT 2|LEFT|Y||GUARDIAN|2|Visit_2|25|7|SCREENING|2020-08-26|25
e|FA|c8390c70-766d-4252-9356-39591651bcdf|4|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|mg/mol|[?]|1|km|CERVICAL LYMPH NODE|CONTRALATERAL||Y|GUARDIAN|2|Visit_2|25|7|SCREENING|2020-08-26|25
e|FA|c8390c70-766d-4252-9356-39591651bcdf|5|SPEED|Speed|[?]|GERD|[?]|mL/breath|[?]|1|mEq/g|BLADDER, NECK|IPSILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|5|SCREENING|2020-09-10|40
e|FA|c8390c70-766d-4252-9356-39591651bcdf|6|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|Bq/mg|[?]|1|mL|KNEE JOINT TENDONS|RIGHT||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2020-09-10|40
e|FA|c8390c70-766d-4252-9356-39591651bcdf|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|CAPLET|[?]|1|PFU/dose|L2 VERTEBRA|BILATERAL|||GUARDIAN|4|Visit_4|65|7|WASHOUT|2020-10-05|65
e|FA|c8390c70-766d-4252-9356-39591651bcdf|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|kg/mol|[?]|1|U/mmol|COLON|LEFT|||PARENT|4|Visit_4|65|2|WASHOUT|2020-10-05|65
e|FA|c8390c70-766d-4252-9356-39591651bcdf|9|DPROT|Dietary Protein|[?]|GERD|[?]|mL/cm3/min|[?]|1|10^4 CFU/mL|SUBCARINAL LYMPH NODE|IPSILATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|7|TREATMENT|2020-10-30|90
e|FA|c8390c70-766d-4252-9356-39591651bcdf|10|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|log EID 50/dose|[?]|1|TRANSDUCING UNIT/mL|CALF|UNILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|FOLLOW-UP|2020-10-30|90
e|FA|a40bf877-c070-40b3-89df-d566b942246e|1|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|10^7 PFU|[?]|1|Shock Wave|SKIN OF THE PALM|LEFT|Y|Y|CHILD|1|Visit_1|10|4|TREATMENT|2020-06-16|10
e|FA|a40bf877-c070-40b3-89df-d566b942246e|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|mV*min|[?]|1|g/day|FOREARM|LATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|4|FOLLOW-UP|2020-06-16|10
e|FA|a40bf877-c070-40b3-89df-d566b942246e|3|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mL|[?]|1|cm H2O|ORBICULARIS OCULI MUSCLE|LEFT|||INDEPENDENT ASSESSOR|2|Visit_2|25|4|SCREENING|2020-07-01|25
e|FA|a40bf877-c070-40b3-89df-d566b942246e|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|mg/g/min|BLADDER, FUNDUS|UNILATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-07-01|25
e|FA|a40bf877-c070-40b3-89df-d566b942246e|5|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|mmol/L|[?]|1|g/dL|BODY|UNILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|5|TREATMENT|2020-07-16|40
e|FA|a40bf877-c070-40b3-89df-d566b942246e|6|DGRAIN|Dietary Grain|[?]|GERD|[?]|umol/h/mmol|[?]|1|10^9 CFU/g|SUPRACLAVICULAR FOSSA|UNILATERAL||Y|PARENT|3|Visit_3|40|4|TREATMENT|2020-07-16|40
e|FA|a40bf877-c070-40b3-89df-d566b942246e|7|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|g/m2/day|[?]|1|g/dL|PROXIMAL PHALANX 5 OF THE HAND|UNILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|4|WASHOUT|2020-08-10|65
e|FA|a40bf877-c070-40b3-89df-d566b942246e|8|PPTFCT|Precipitating Factor|[?]|GERD|[?]|CAPSULE|[?]|1|EIA unit|CALCANEAL TUBEROSITY|CONTRALATERAL|Y||ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2020-08-10|65
e|FA|a40bf877-c070-40b3-89df-d566b942246e|9|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|foz_us|[?]|1|AU/mL|LARYNX|IPSILATERAL|||PARENT|5|Visit_5|90|5|TREATMENT|2020-09-04|90
e|FA|a40bf877-c070-40b3-89df-d566b942246e|10|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|mg/dose|[?]|1|10^9 CFU/mL|ASCENDING AORTA, SINOTUBULAR JUNCTION|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|7|WASHOUT|2020-09-04|90
e|FA|e9633621-3d08-4b47-b394-5bd3fa47c07f|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|dL|[?]|1|mg/g/min|GREAT TROCHANTER|UNILATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|4|FOLLOW-UP|2021-01-16|10
e|FA|e9633621-3d08-4b47-b394-5bd3fa47c07f|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|mEq/g|SEBACEOUS GLAND|RIGHT|Y||FRIEND|1|Visit_1|10|3|TREATMENT|2021-01-16|10
e|FA|e9633621-3d08-4b47-b394-5bd3fa47c07f|3|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|TRANSDUCING UNIT/mL|[?]|1|10^6 IU/mL|TARSAL JOINT|LATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|5|FOLLOW-UP|2021-01-31|25
e|FA|e9633621-3d08-4b47-b394-5bd3fa47c07f|4|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|v/v|[?]|1|gtt|TOOTH|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2021-01-31|25
e|FA|e9633621-3d08-4b47-b394-5bd3fa47c07f|5|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|CIGAR|[?]|1|mg/dose|TALUS|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|3|WASHOUT|2021-02-15|40
e|FA|e9633621-3d08-4b47-b394-5bd3fa47c07f|6|SEV|Severity/Intensity|[?]|GERD|[?]|10^3 DNA copies/mL|[?]|1|Pa|INFERIOR VENA CAVA|LATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|4|SCREENING|2021-02-15|40
e|FA|e9633621-3d08-4b47-b394-5bd3fa47c07f|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mL/h|[?]|1|PFU/dose|HEEL OF THE FOOT|LEFT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2021-03-12|65
e|FA|e9633621-3d08-4b47-b394-5bd3fa47c07f|8|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|CCID 50/mL|[?]|1|km|INTERPHALANGEAL JOINT 5|LEFT|||STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2021-03-12|65
e|FA|e9633621-3d08-4b47-b394-5bd3fa47c07f|9|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mL/cage|[?]|1|CUP|LATERAL RAMUS INTERMEDIUS ARTERY|LATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-04-06|90
e|FA|e9633621-3d08-4b47-b394-5bd3fa47c07f|10|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|mm/h|[?]|1|DRUM|RETINAL ARTERY|UNILATERAL|Y||ADJUDICATOR|5|Visit_5|90|2|TREATMENT|2021-04-06|90
e|FA|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|1|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|Bq/kg|[?]|1|mL/dose|ULNA|CONTRALATERAL|Y|Y|INDEPENDENT ASSESSOR|1|Visit_1|10|2|SCREENING|2020-06-08|10
e|FA|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|2|ESTWT|Estimated Weight|[?]|GERD|[?]|/sec|[?]|1|g/day|AXILLARY LYMPH NODE LEVEL III|UNILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-06-08|10
e|FA|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|Pa|INFERIOR VENA CAVA|RIGHT|||INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-06-23|25
e|FA|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|4|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|Weber|CINGULATE CORTEX|CONTRALATERAL||Y|SIBLING|2|Visit_2|25|6|WASHOUT|2020-06-23|25
e|FA|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|5|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|g/m2/day|[?]|1|g/day|VESTIBULOCOCHLEAR NERVE|IPSILATERAL|||PROXY|3|Visit_3|40|2|SCREENING|2020-07-08|40
e|FA|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|6|EXTRSCT|Extent of Resection|[?]|GERD|[?]|ug/mL/h|[?]|1|Weber|SEMITENDINOSUS MUSCLE|IPSILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|7|TREATMENT|2020-07-08|40
e|FA|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|7|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|g/m2|[?]|1|Hz/s|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|LEFT|||GUARDIAN|4|Visit_4|65|3|SCREENING|2020-08-02|65
e|FA|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|8|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|s/h|[?]|1|Bq/mg|ANKLE JOINT|UNILATERAL||Y|SIBLING|4|Visit_4|65|4|FOLLOW-UP|2020-08-02|65
e|FA|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|9|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|sec|[?]|1|DROP|POPLITEAL FOSSA|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|3|FOLLOW-UP|2020-08-27|90
e|FA|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|10|EXCDUR|Exercise Duration|[?]|GERD|[?]|INHALATION|[?]|1|mm|RECTOSIGMOID JUNCTION|IPSILATERAL|Y||INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2020-08-27|90
e|FA|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|1|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|cy/cm|[?]|1|BOWL|TAIL|UNILATERAL|||STUDY SUBJECT|1|Visit_1|10|2|SCREENING|2020-07-16|10
e|FA|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|2|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|log10 TCID 50/mL|[?]|1|mmHg/L/min|COCCYGEAL VERTEBRA|LATERAL|||INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-07-16|10
e|FA|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|3|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|DPM|[?]|1|Bq/L|LOWER GASTROINTESTINAL TRACT LYMPH NODE|RIGHT|||FRIEND|2|Visit_2|25|4|SCREENING|2020-07-31|25
e|FA|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|4|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|umol/h/mmol|[?]|1|mL/min/mmHg|PROXIMAL LAD ARTERY|UNILATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2020-07-31|25
e|FA|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|5|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|gtt|[?]|1|AU/mL|SUBMANDIBULAR LYMPH NODE|IPSILATERAL|||STUDY SUBJECT|3|Visit_3|40|5|TREATMENT|2020-08-15|40
e|FA|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|6|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|DRINK|[?]|1|/200 HPFs|HINDLIMB|RIGHT|||FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-08-15|40
e|FA|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|7|CALBURN|Calories Burned|[?]|GERD|[?]|deg/mm|[?]|1|/kg|PHARYNX|IPSILATERAL|Y||PROXY|4|Visit_4|65|3|TREATMENT|2020-09-09|65
e|FA|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|%(v/v)|[?]|1|U/mmol|FEMORAL VEIN|LEFT|Y||CAREGIVER|4|Visit_4|65|6|TREATMENT|2020-09-09|65
e|FA|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|9|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|Bq/mg|EPICONDYLE|LEFT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-10-04|90
e|FA|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|10|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|umol/mol|[?]|1|mL/animal/day|LUNG, LEFT|LEFT|||SPOUSE|5|Visit_5|90|5|TREATMENT|2020-10-04|90
e|FA|63f43990-e56e-440c-a445-76e7d114cf26|1|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|BP|[?]|1|ug/kg/h|PHARYNGEAL TONSIL|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|FOLLOW-UP|2020-10-02|10
e|FA|63f43990-e56e-440c-a445-76e7d114cf26|2|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|mV/sec|[?]|1|IU/mg|DUODENUM|RIGHT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|5|SCREENING|2020-10-02|10
e|FA|63f43990-e56e-440c-a445-76e7d114cf26|3|CALBURN|Calories Burned|[?]|GERD|[?]|tuberculin unit/mL|[?]|1|/kg|POSTERIOR INFERIOR CEREBELLAR ARTERY|LEFT|||SIGNIFICANT OTHER|2|Visit_2|25|6|SCREENING|2020-10-17|25
e|FA|63f43990-e56e-440c-a445-76e7d114cf26|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|uL|[?]|1|Pa|ARM SKIN|LEFT|Y||SIGNIFICANT OTHER|2|Visit_2|25|5|FOLLOW-UP|2020-10-17|25
e|FA|63f43990-e56e-440c-a445-76e7d114cf26|5|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|100 IU/mL|[?]|1|L/h/m2|MASTOID PROCESS|IPSILATERAL|||PROXY|3|Visit_3|40|3|TREATMENT|2020-11-01|40
e|FA|63f43990-e56e-440c-a445-76e7d114cf26|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mOsm|[?]|1|mg/g/min|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LATERAL|||FAMILY MEMBER|3|Visit_3|40|4|SCREENING|2020-11-01|40
e|FA|63f43990-e56e-440c-a445-76e7d114cf26|7|LDIAM|Longest Diameter|[?]|GERD|[?]|tsp|[?]|1|Shock Wave|KIDNEY, HILUM|IPSILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2020-11-26|65
e|FA|63f43990-e56e-440c-a445-76e7d114cf26|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|APL U/mL|[?]|1|Pa|HEART, LEFT ATRIUM|CONTRALATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|3|WASHOUT|2020-11-26|65
e|FA|63f43990-e56e-440c-a445-76e7d114cf26|9|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|Shock Wave|COCCYGEAL VERTEBRA|UNILATERAL|||INTERVIEWER|5|Visit_5|90|3|SCREENING|2020-12-21|90
e|FA|63f43990-e56e-440c-a445-76e7d114cf26|10|DIAMETER|Diameter|[?]|GERD|[?]|aMFI|[?]|1|cm|TRICUSPID VALVE|LEFT|||INVESTIGATOR|5|Visit_5|90|1|FOLLOW-UP|2020-12-21|90
e|FA|380c89f4-2650-4a54-92f5-5e1278b9a91e|1|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|pm|[?]|1|10^6/L|BRACHIOCEPHALIC ARTERY|BILATERAL|||STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-10-22|10
e|FA|380c89f4-2650-4a54-92f5-5e1278b9a91e|2|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|10^4 CFU/mL|VERTEBRAL ARTERY|UNILATERAL|||SIBLING|1|Visit_1|10|7|TREATMENT|2020-10-22|10
e|FA|380c89f4-2650-4a54-92f5-5e1278b9a91e|3|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|MPS U|[?]|1|BP|MUCOSA|BILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|SCREENING|2020-11-06|25
e|FA|380c89f4-2650-4a54-92f5-5e1278b9a91e|4|DGRAIN|Dietary Grain|[?]|GERD|[?]|mL/beat|[?]|1|10^9 CFU/g|RIB 9|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|WASHOUT|2020-11-06|25
e|FA|380c89f4-2650-4a54-92f5-5e1278b9a91e|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|mL/breath|[?]|1|mL/animal/day|AORTO-ILIAC PERIPHERAL ARTERY|BILATERAL||Y|ADJUDICATOR|3|Visit_3|40|2|SCREENING|2020-11-21|40
e|FA|380c89f4-2650-4a54-92f5-5e1278b9a91e|6|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|ng/day|BLADDER WALL|LEFT||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|1|FOLLOW-UP|2020-11-21|40
e|FA|380c89f4-2650-4a54-92f5-5e1278b9a91e|7|DPROT|Dietary Protein|[?]|GERD|[?]|ukat|[?]|1|10^4 CFU/mL|COMMON ILIAC LYMPH NODE|UNILATERAL|Y||DOMESTIC PARTNER|4|Visit_4|65|6|SCREENING|2020-12-16|65
e|FA|380c89f4-2650-4a54-92f5-5e1278b9a91e|8|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|min|[?]|1|IU/mg|MEDIASTINAL LYMPH NODE|LATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|4|TREATMENT|2020-12-16|65
e|FA|380c89f4-2650-4a54-92f5-5e1278b9a91e|9|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|10^6 copies/mL|[?]|1|m2|LEG|LATERAL||Y|STUDY SUBJECT|5|Visit_5|90|4|TREATMENT|2021-01-10|90
e|FA|380c89f4-2650-4a54-92f5-5e1278b9a91e|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|BE/mL|[?]|1|10^6 U|L1 VERTEBRA|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|FOLLOW-UP|2021-01-10|90
e|FA|84c1f5f4-6415-49d8-b854-22e7529d65b6|1|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|log10 copies/mL|[?]|1|ug/g/h|PANCREAS|IPSILATERAL|||ADJUDICATOR|1|Visit_1|10|2|SCREENING|2020-12-05|10
e|FA|84c1f5f4-6415-49d8-b854-22e7529d65b6|2|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|CAPLET|[?]|1|U/mg|PARASYMPATHETIC GANGLIA|CONTRALATERAL|Y||SPOUSE|1|Visit_1|10|1|SCREENING|2020-12-05|10
e|FA|84c1f5f4-6415-49d8-b854-22e7529d65b6|3|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|amol|[?]|1|HOURS|LOCUS CERULEUS|UNILATERAL|||VENDOR|2|Visit_2|25|4|SCREENING|2020-12-20|25
e|FA|84c1f5f4-6415-49d8-b854-22e7529d65b6|4|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|pmol|[?]|1|10^9 CFU/mL|SARTORIUS MUSCLE|RIGHT|Y|Y|ADJUDICATOR|2|Visit_2|25|7|FOLLOW-UP|2020-12-20|25
e|FA|84c1f5f4-6415-49d8-b854-22e7529d65b6|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|dyn|[?]|1|%(v/v)|RIB 3|BILATERAL|||PARENT|3|Visit_3|40|7|TREATMENT|2021-01-04|40
e|FA|84c1f5f4-6415-49d8-b854-22e7529d65b6|6|LENRSCT|Length of Resection|[?]|GERD|[?]|ug/L DDU|[?]|1|psi|FASCIA|LATERAL||Y|CHILD|3|Visit_3|40|7|TREATMENT|2021-01-04|40
e|FA|84c1f5f4-6415-49d8-b854-22e7529d65b6|7|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|uCi|[?]|1|m2|CORNEAL STROMA|RIGHT|||SIBLING|4|Visit_4|65|5|WASHOUT|2021-01-29|65
e|FA|84c1f5f4-6415-49d8-b854-22e7529d65b6|8|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|mL/animal/day|SKULL, BASE|LATERAL|||PARENT|4|Visit_4|65|3|TREATMENT|2021-01-29|65
e|FA|84c1f5f4-6415-49d8-b854-22e7529d65b6|9|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|10^6/L|DORSAL MOTOR NUCLEUS|RIGHT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|SCREENING|2021-02-23|90
e|FA|84c1f5f4-6415-49d8-b854-22e7529d65b6|10|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|Absorbance U|[?]|1|umol|MENINGES|IPSILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|2|TREATMENT|2021-02-23|90
e|FA|77c26a0c-0c84-44d7-8351-a50f3236e59a|1|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|cd*s/m2|[?]|1|IU/mmol|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|LATERAL|Y||INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-05-14|10
e|FA|77c26a0c-0c84-44d7-8351-a50f3236e59a|2|STRCTNUM|Number of Strictures|[?]|GERD|[?]|umol/h/mmol|[?]|1|SACHET|URETHRA, ANTERIOR|RIGHT|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|5|TREATMENT|2020-05-14|10
e|FA|77c26a0c-0c84-44d7-8351-a50f3236e59a|3|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|mg/h|[?]|1|mL/mmHg/min/L|LUNG, LEFT|IPSILATERAL|||PROXY|2|Visit_2|25|5|SCREENING|2020-05-29|25
e|FA|77c26a0c-0c84-44d7-8351-a50f3236e59a|4|DISTANCE|Distance|[?]|GERD|[?]|10^9/g|[?]|1|BOWL|ABDOMINAL AORTA|UNILATERAL|||CAREGIVER|2|Visit_2|25|4|TREATMENT|2020-05-29|25
e|FA|77c26a0c-0c84-44d7-8351-a50f3236e59a|5|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|U/mmol|[?]|1|10^9 CFU/mL|LEFT MAIN CORONARY ARTERY BIFURCATION|LATERAL||Y|GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-06-13|40
e|FA|77c26a0c-0c84-44d7-8351-a50f3236e59a|6|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|log EID 50/dose|[?]|1|U/mmol|GENITAL TUBERCLE|LATERAL||Y|FRIEND|3|Visit_3|40|3|TREATMENT|2020-06-13|40
e|FA|77c26a0c-0c84-44d7-8351-a50f3236e59a|7|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|mV/sec|[?]|1|SACHET|CORPUS CALLOSUM|LATERAL|||GUARDIAN|4|Visit_4|65|1|TREATMENT|2020-07-08|65
e|FA|77c26a0c-0c84-44d7-8351-a50f3236e59a|8|DISTANCE|Distance|[?]|GERD|[?]|kcal/day|[?]|1|BOWL|PRETRACHEAL LYMPH NODE|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|2|FOLLOW-UP|2020-07-08|65
e|FA|77c26a0c-0c84-44d7-8351-a50f3236e59a|9|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|STRIP|[?]|1|cm H2O|T1 VERTEBRA|RIGHT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|TREATMENT|2020-08-02|90
e|FA|77c26a0c-0c84-44d7-8351-a50f3236e59a|10|TOXGR|Toxicity Grade|[?]|GERD|[?]|Roentgen|[?]|1|aMFI|GREAT VESSELS|IPSILATERAL|Y||INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-08-02|90
e|FA|a201c78a-e826-4f42-a997-7c6a019e2c91|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ug/g/day|[?]|1|%(v/v)|AXIAL SKELETON|IPSILATERAL||Y|PROXY|1|Visit_1|10|5|TREATMENT|2020-08-03|10
e|FA|a201c78a-e826-4f42-a997-7c6a019e2c91|2|AGETRT1|Age At First Treatment|[?]|GERD|[?]|Enzyme U|[?]|1|mL/mmHg/min/L|SKIN OF THE HAND|BILATERAL|||CAREGIVER|1|Visit_1|10|5|TREATMENT|2020-08-03|10
e|FA|a201c78a-e826-4f42-a997-7c6a019e2c91|3|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|ug/L|[?]|1|mL/h|METACARPAL BONE 1|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-08-18|25
e|FA|a201c78a-e826-4f42-a997-7c6a019e2c91|4|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|IMPLANT|[?]|1|mIU/L|PANCREAS|LEFT|||GUARDIAN|2|Visit_2|25|1|SCREENING|2020-08-18|25
e|FA|a201c78a-e826-4f42-a997-7c6a019e2c91|5|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|DPM|[?]|1|km|RIGHT VENTRICULAR BRANCH|LEFT|||CHILD|3|Visit_3|40|7|FOLLOW-UP|2020-09-02|40
e|FA|a201c78a-e826-4f42-a997-7c6a019e2c91|6|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|pmol|[?]|1|mmHg/L/min|SUBMANDIBULAR LYMPH NODE|BILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|FOLLOW-UP|2020-09-02|40
e|FA|a201c78a-e826-4f42-a997-7c6a019e2c91|7|DGRAIN|Dietary Grain|[?]|GERD|[?]|gMFI|[?]|1|10^9 CFU/g|AORTOPULMONARY WINDOW LYMPH NODE|LEFT|||INDEPENDENT ASSESSOR|4|Visit_4|65|5|TREATMENT|2020-09-27|65
e|FA|a201c78a-e826-4f42-a997-7c6a019e2c91|8|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|BAU/mL|[?]|1|AU/mL|TIBIALIS POSTERIOR MUSCLE|LEFT|||GUARDIAN|4|Visit_4|65|1|SCREENING|2020-09-27|65
e|FA|a201c78a-e826-4f42-a997-7c6a019e2c91|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|pg/dL|[?]|1|10^6 IU/mL|POSTERIOR CINGULATE CORTEX|BILATERAL||Y|CAREGIVER|5|Visit_5|90|2|TREATMENT|2020-10-22|90
e|FA|a201c78a-e826-4f42-a997-7c6a019e2c91|10|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|MPL U/mL|[?]|1|ohm|PAROTID GLAND LYMPH NODE|RIGHT|||INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2020-10-22|90
e|FA|c41880bd-1e29-4961-b74d-bb0d979ab00f|1|SEV|Severity/Intensity|[?]|GERD|[?]|Sv|[?]|1|Pa|KIDNEY|BILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|2|SCREENING|2020-09-11|10
e|FA|c41880bd-1e29-4961-b74d-bb0d979ab00f|2|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|ug/m2/h|[?]|1|fmol|FLEXOR HALLUCIS LONGUS MUSCLE|LEFT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|FOLLOW-UP|2020-09-11|10
e|FA|c41880bd-1e29-4961-b74d-bb0d979ab00f|3|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|EU|[?]|1|mL/h|LUMBAR SPINE|IPSILATERAL||Y|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-09-26|25
e|FA|c41880bd-1e29-4961-b74d-bb0d979ab00f|4|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|Weber|PROXIMAL INTERPHALANGEAL JOINT 2|LATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|3|WASHOUT|2020-09-26|25
e|FA|c41880bd-1e29-4961-b74d-bb0d979ab00f|5|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|ug/g/h|[?]|1|IU/mg|THYROID GLAND, LEFT LOBE|IPSILATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|7|TREATMENT|2020-10-11|40
e|FA|c41880bd-1e29-4961-b74d-bb0d979ab00f|6|SEV|Severity/Intensity|[?]|GERD|[?]|ft|[?]|1|Pa|EXTRAOCULAR MUSCLE|BILATERAL|Y||SIBLING|3|Visit_3|40|6|FOLLOW-UP|2020-10-11|40
e|FA|c41880bd-1e29-4961-b74d-bb0d979ab00f|7|OBJTYPE|Type of Object|[?]|GERD|[?]|K|[?]|1|ng|OVARY|IPSILATERAL|||FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2020-11-05|65
e|FA|c41880bd-1e29-4961-b74d-bb0d979ab00f|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|mg/g/min|FEMORAL LYMPH NODE|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-11-05|65
e|FA|c41880bd-1e29-4961-b74d-bb0d979ab00f|9|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|atm|[?]|1|Bq/L|CALF|LATERAL|||GUARDIAN|5|Visit_5|90|6|FOLLOW-UP|2020-11-30|90
e|FA|c41880bd-1e29-4961-b74d-bb0d979ab00f|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|EP U|[?]|1|mg/g/min|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|LEFT|||PROXY|5|Visit_5|90|5|SCREENING|2020-11-30|90
e|FA|7de60015-fa9d-4a39-bd19-51c718a624e6|1|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|GBq/ug|[?]|1|g/day|PROXIMAL PHALANX 3 OF THE HAND|RIGHT|||VENDOR|1|Visit_1|10|3|SCREENING|2020-10-24|10
e|FA|7de60015-fa9d-4a39-bd19-51c718a624e6|2|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|mg/animal|[?]|1|m2|UPPER CERVICAL LYMPH NODE|CONTRALATERAL|||FAMILY MEMBER|1|Visit_1|10|1|FOLLOW-UP|2020-10-24|10
e|FA|7de60015-fa9d-4a39-bd19-51c718a624e6|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|%(v/v)|ENTORHINAL CORTEX|LEFT|||STUDY SUBJECT|2|Visit_2|25|4|WASHOUT|2020-11-08|25
e|FA|7de60015-fa9d-4a39-bd19-51c718a624e6|4|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|Frames/s|[?]|1|cmH2O/mL|GASTROCNEMIUS MUSCLE|RIGHT|||FRIEND|2|Visit_2|25|6|FOLLOW-UP|2020-11-08|25
e|FA|7de60015-fa9d-4a39-bd19-51c718a624e6|5|LDIAM|Longest Diameter|[?]|GERD|[?]|U/g|[?]|1|Shock Wave|CLITORIS|LATERAL|||CAREGIVER|3|Visit_3|40|1|FOLLOW-UP|2020-11-23|40
e|FA|7de60015-fa9d-4a39-bd19-51c718a624e6|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|cL|[?]|1|mg/g/min|LEFT VENTRICULAR APEX SEGMENT|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|SCREENING|2020-11-23|40
e|FA|7de60015-fa9d-4a39-bd19-51c718a624e6|7|SPEED|Speed|[?]|GERD|[?]|pkat/L|[?]|1|mEq/g|WRIST JOINT EXTENSOR MUSCLES|LATERAL|||PARENT|4|Visit_4|65|1|FOLLOW-UP|2020-12-18|65
e|FA|7de60015-fa9d-4a39-bd19-51c718a624e6|8|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|nmol/day|[?]|1|cmH2O/mL|SEBACEOUS GLAND|IPSILATERAL||Y|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2020-12-18|65
e|FA|7de60015-fa9d-4a39-bd19-51c718a624e6|9|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|nmol/L/h|[?]|1|umol|SOLE|RIGHT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|WASHOUT|2021-01-12|90
e|FA|7de60015-fa9d-4a39-bd19-51c718a624e6|10|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mol/L|[?]|1|uL/kg/day|BRACHIAL LYMPH NODE|LEFT||Y|INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2021-01-12|90
e|FA|34d03f58-155a-4908-bba3-aa979be84610|1|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|STRIP|[?]|1|mg/dose|HAIR SHAFT|LATERAL|||PROXY|1|Visit_1|10|4|WASHOUT|2020-06-29|10
e|FA|34d03f58-155a-4908-bba3-aa979be84610|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|10^8 PFU|[?]|1|%(v/v)|NECK|LEFT|Y||GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-06-29|10
e|FA|34d03f58-155a-4908-bba3-aa979be84610|3|PPTFCT|Precipitating Factor|[?]|GERD|[?]|kg/m2|[?]|1|EIA unit|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|UNILATERAL||Y|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-07-14|25
e|FA|34d03f58-155a-4908-bba3-aa979be84610|4|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|g/L|CORPUS CALLOSUM, SPLENIUM|RIGHT|||ADJUDICATION COMMITTEE|2|Visit_2|25|3|FOLLOW-UP|2020-07-14|25
e|FA|34d03f58-155a-4908-bba3-aa979be84610|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|10^9/dose|[?]|1|U/mg|PITUITARY GLAND|LATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-07-29|40
e|FA|34d03f58-155a-4908-bba3-aa979be84610|6|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|Ci/mg|[?]|1|g/cage/day|ENDOCERVIX|UNILATERAL|||STUDY SUBJECT|3|Visit_3|40|2|FOLLOW-UP|2020-07-29|40
e|FA|34d03f58-155a-4908-bba3-aa979be84610|7|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|Pa|[?]|1|ug/kg/h|LUNG, LEFT LOWER LOBE|BILATERAL|||ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-08-23|65
e|FA|34d03f58-155a-4908-bba3-aa979be84610|8|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|10^4/L|[?]|1|cm H2O|PALATE|CONTRALATERAL|||STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2020-08-23|65
e|FA|34d03f58-155a-4908-bba3-aa979be84610|9|DFIBER|Dietary Fiber|[?]|GERD|[?]|10^3 copies/mL|[?]|1|h*%|VASTUS INTERMEDIUS MUSCLE|LEFT|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|WASHOUT|2020-09-17|90
e|FA|34d03f58-155a-4908-bba3-aa979be84610|10|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|cycle/min|[?]|1|gtt|OLECRANON|LEFT||Y|STUDY SUBJECT|5|Visit_5|90|2|WASHOUT|2020-09-17|90
e|FA|3818424f-cbc9-4e79-94b8-7edbc706bdbc|1|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|/2000 RBC|[?]|1|NEEDLE GAUGE|THIRD OBTUSE MARGINAL BRANCH ARTERY|LEFT|||DOMESTIC PARTNER|1|Visit_1|10|4|WASHOUT|2020-08-23|10
e|FA|3818424f-cbc9-4e79-94b8-7edbc706bdbc|2|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|ELISA unit|[?]|1|BOWL|FEMALE GENITALIA|RIGHT|||CHILD|1|Visit_1|10|1|TREATMENT|2020-08-23|10
e|FA|3818424f-cbc9-4e79-94b8-7edbc706bdbc|3|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|IU|[?]|1|10^6 organisms/mL|GINGIVA|CONTRALATERAL|||ADJUDICATOR|2|Visit_2|25|7|WASHOUT|2020-09-07|25
e|FA|3818424f-cbc9-4e79-94b8-7edbc706bdbc|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|pmol/L|[?]|1|%(v/v)|ORAL CAVITY|LEFT|Y||CAREGIVER|2|Visit_2|25|7|WASHOUT|2020-09-07|25
e|FA|3818424f-cbc9-4e79-94b8-7edbc706bdbc|5|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|Osm|[?]|1|10^6 CFU|ABDUCTOR POLLICIS BREVIS MUSCLE|RIGHT|||SIBLING|3|Visit_3|40|4|TREATMENT|2020-09-22|40
e|FA|3818424f-cbc9-4e79-94b8-7edbc706bdbc|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|cmH2O*s2/mL|[?]|1|ug/g/h|CORPUS CALLOSUM, SPLENIUM|UNILATERAL|||FAMILY MEMBER|3|Visit_3|40|2|FOLLOW-UP|2020-09-22|40
e|FA|3818424f-cbc9-4e79-94b8-7edbc706bdbc|7|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|nmol/day|[?]|1|DROP|OBTURATOR EXTERNUS MUSCLE|LATERAL|||GUARDIAN|4|Visit_4|65|7|TREATMENT|2020-10-17|65
e|FA|3818424f-cbc9-4e79-94b8-7edbc706bdbc|8|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|msec|[?]|1|ug/m2/h|INTERNAL ILIAC ARTERY|RIGHT|Y||FAMILY MEMBER|4|Visit_4|65|1|SCREENING|2020-10-17|65
e|FA|3818424f-cbc9-4e79-94b8-7edbc706bdbc|9|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/mL|[?]|1|ug/m2/h|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|LATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-11-11|90
e|FA|3818424f-cbc9-4e79-94b8-7edbc706bdbc|10|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|Bq/kg|[?]|1|HOURS|SUPRATENTORIAL BRAIN|BILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-11-11|90
e|FA|4191788e-b2dc-4885-87d8-da9feb6deea5|1|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|PFU/dose|[?]|1|10^6 CFU|COLON, HEPATIC FLEXURE|CONTRALATERAL|Y||PROXY|1|Visit_1|10|7|WASHOUT|2020-09-11|10
e|FA|4191788e-b2dc-4885-87d8-da9feb6deea5|2|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|mmol/s|[?]|1|g/day|LINGULA OF THE LUNG|LATERAL|||GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-09-11|10
e|FA|4191788e-b2dc-4885-87d8-da9feb6deea5|3|EVENTFRQ|Event Frequency|[?]|GERD|[?]|APL U/mL|[?]|1|ug/kg/h|CORPUS STRIATUM|UNILATERAL|Y||SIBLING|2|Visit_2|25|7|SCREENING|2020-09-26|25
e|FA|4191788e-b2dc-4885-87d8-da9feb6deea5|4|DPROT|Dietary Protein|[?]|GERD|[?]|g/animal/day|[?]|1|10^4 CFU/mL|METACARPAL 1 BASE|CONTRALATERAL|||CAREGIVER|2|Visit_2|25|3|TREATMENT|2020-09-26|25
e|FA|4191788e-b2dc-4885-87d8-da9feb6deea5|5|SERVNUM|Number of Servings|[?]|GERD|[?]|g/U|[?]|1|Hz/s|PARALARYNGEAL LYMPH NODE|UNILATERAL|Y||FRIEND|3|Visit_3|40|6|FOLLOW-UP|2020-10-11|40
e|FA|4191788e-b2dc-4885-87d8-da9feb6deea5|6|STRCTNUM|Number of Strictures|[?]|GERD|[?]|pt_br|[?]|1|SACHET|SKIN OF THE NECK|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2020-10-11|40
e|FA|4191788e-b2dc-4885-87d8-da9feb6deea5|7|STRCTNUM|Number of Strictures|[?]|GERD|[?]|10^3 CFU/mL|[?]|1|SACHET|BLADDER WALL|RIGHT|||VENDOR|4|Visit_4|65|4|TREATMENT|2020-11-05|65
e|FA|4191788e-b2dc-4885-87d8-da9feb6deea5|8|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|mV|[?]|1|mm/h|TARSUS BONE|LEFT|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-11-05|65
e|FA|4191788e-b2dc-4885-87d8-da9feb6deea5|9|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|pt_us|[?]|1|TRANSDUCING UNIT/mL|LIVER, CAUDATE LOBE|CONTRALATERAL|||VENDOR|5|Visit_5|90|5|TREATMENT|2020-11-30|90
e|FA|4191788e-b2dc-4885-87d8-da9feb6deea5|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|TAMPON|[?]|1|U/mg|FIRST DIAGONAL BRANCH ARTERY|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-11-30|90
e|FA|8572a9c4-eb87-4745-81b9-8316bc8de69e|1|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|pmol/day|[?]|1|SACHET|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|IPSILATERAL||Y|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-12-24|10
e|FA|8572a9c4-eb87-4745-81b9-8316bc8de69e|2|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg|[?]|1|aMFI|OSTIOMEATAL COMPLEX|BILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-12-24|10
e|FA|8572a9c4-eb87-4745-81b9-8316bc8de69e|3|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|10^8/L|[?]|1|TRANSDUCING UNIT/mL|DISTAL INTERPHALANGEAL JOINT 5|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2021-01-08|25
e|FA|8572a9c4-eb87-4745-81b9-8316bc8de69e|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|HOURS|[?]|1|Pa|CARDIAC VALVE|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|1|WASHOUT|2021-01-08|25
e|FA|8572a9c4-eb87-4745-81b9-8316bc8de69e|5|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|DRUM|[?]|1|10^6 U|DISTANT LYMPH NODE|LATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|WASHOUT|2021-01-23|40
e|FA|8572a9c4-eb87-4745-81b9-8316bc8de69e|6|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|usec|[?]|1|10^6 U|SACRUM|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2021-01-23|40
e|FA|8572a9c4-eb87-4745-81b9-8316bc8de69e|7|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|U/m2/h|[?]|1|mg/h|SECOND DIAGONAL BRANCH ARTERY|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|SCREENING|2021-02-17|65
e|FA|8572a9c4-eb87-4745-81b9-8316bc8de69e|8|DVEG|Dietary Vegetable|[?]|GERD|[?]|PFU/dose|[?]|1|Ci/ug|LIVER, LEFT LOBE|LEFT|||INVESTIGATOR|4|Visit_4|65|4|SCREENING|2021-02-17|65
e|FA|8572a9c4-eb87-4745-81b9-8316bc8de69e|9|DIAMETER|Diameter|[?]|GERD|[?]|Watt|[?]|1|cm|EPIDIDYMIS|CONTRALATERAL||Y|GUARDIAN|5|Visit_5|90|1|TREATMENT|2021-03-14|90
e|FA|8572a9c4-eb87-4745-81b9-8316bc8de69e|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|tsp eq|[?]|1|mg/g/min|ACUTE MARGINAL ARTERY|LATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|FOLLOW-UP|2021-03-14|90
e|FA|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|1|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|YEARS|[?]|1|10^9 CFU/g|PHARYNGEAL TONSIL|CONTRALATERAL|||STUDY SUBJECT|1|Visit_1|10|4|FOLLOW-UP|2020-11-26|10
e|FA|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|2|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|kBq|[?]|1|/500 WBC|FASCIA|LEFT|||STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2020-11-26|10
e|FA|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|3|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|Ci/ug|[?]|1|g/dL|ILIOPSOAS MUSCLE|BILATERAL|Y||SIBLING|2|Visit_2|25|1|TREATMENT|2020-12-11|25
e|FA|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|4|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|Shock Wave|URETERIC ORIFICE|CONTRALATERAL|Y|Y|INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-12-11|25
e|FA|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|5|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|10^6 RNA copies/mL|[?]|1|mIU/L|HEART, VENTRICULAR WALL|LEFT|||FRIEND|3|Visit_3|40|3|FOLLOW-UP|2020-12-26|40
e|FA|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|6|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|SCOOPFUL|LEFT MAIN CORONARY ARTERY BODY|BILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2020-12-26|40
e|FA|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|7|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|mEq/L|[?]|1|cmH2O/mL|SEMINAL VESICLE|LEFT|Y||INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2021-01-20|65
e|FA|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Enzyme U|[?]|1|Pa|VESTIBULOCOCHLEAR NERVE|LATERAL|Y||FAMILY MEMBER|4|Visit_4|65|1|WASHOUT|2021-01-20|65
e|FA|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|9|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|amp|[?]|1|PFU/dose|PROXIMAL PHALANX 2 OF THE HAND|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|1|FOLLOW-UP|2021-02-14|90
e|FA|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|10|SPEED|Speed|[?]|GERD|[?]|PIXELS/cm|[?]|1|mEq/g|BLADDER, NECK|LATERAL|Y||PARENT|5|Visit_5|90|7|TREATMENT|2021-02-14|90
e|FA|3eceae61-a4a0-49fd-964b-9f142e0da067|1|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|DAgU/mL|[?]|1|Coulomb|L4 VERTEBRA|LATERAL|||SPOUSE|1|Visit_1|10|2|TREATMENT|2020-08-28|10
e|FA|3eceae61-a4a0-49fd-964b-9f142e0da067|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|v/v|[?]|1|%(v/v)|ETHMOID BONE|CONTRALATERAL|Y||GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-08-28|10
e|FA|3eceae61-a4a0-49fd-964b-9f142e0da067|3|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|uCi|[?]|1|/200 HPFs|PROFUNDA FEMORIS ARTERY|UNILATERAL|||VENDOR|2|Visit_2|25|2|FOLLOW-UP|2020-09-12|25
e|FA|3eceae61-a4a0-49fd-964b-9f142e0da067|4|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|WAFER|[?]|1|MPS U|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LATERAL|||INVESTIGATOR|2|Visit_2|25|5|FOLLOW-UP|2020-09-12|25
e|FA|3eceae61-a4a0-49fd-964b-9f142e0da067|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|amu|[?]|1|%(v/v)|ARM SKIN|IPSILATERAL|Y||INTERVIEWER|3|Visit_3|40|4|TREATMENT|2020-09-27|40
e|FA|3eceae61-a4a0-49fd-964b-9f142e0da067|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/m2|[?]|1|mg/g/min|SKIN FOLD|UNILATERAL||Y|FRIEND|3|Visit_3|40|1|TREATMENT|2020-09-27|40
e|FA|3eceae61-a4a0-49fd-964b-9f142e0da067|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|BISCUIT|[?]|1|%(v/v)|PENIS|CONTRALATERAL|||VENDOR|4|Visit_4|65|6|TREATMENT|2020-10-22|65
e|FA|3eceae61-a4a0-49fd-964b-9f142e0da067|8|DVEG|Dietary Vegetable|[?]|GERD|[?]|mL*cmH2O|[?]|1|Ci/ug|CEREBRUM|IPSILATERAL||Y|PROXY|4|Visit_4|65|4|TREATMENT|2020-10-22|65
e|FA|3eceae61-a4a0-49fd-964b-9f142e0da067|9|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|g/g|[?]|1|ug/m2/h|HEAD OF THE HUMERUS|RIGHT||Y|FAMILY MEMBER|5|Visit_5|90|5|TREATMENT|2020-11-16|90
e|FA|3eceae61-a4a0-49fd-964b-9f142e0da067|10|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|deg/s|[?]|1|in|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|RIGHT|Y||STUDY SUBJECT|5|Visit_5|90|7|FOLLOW-UP|2020-11-16|90
e|FA|fe7ad71c-601d-4909-b56a-401c9a10f00c|1|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|mEq/g|[?]|1|BAG|LUNG LOBE|LEFT|||CAREGIVER|1|Visit_1|10|7|SCREENING|2020-05-21|10
e|FA|fe7ad71c-601d-4909-b56a-401c9a10f00c|2|STROKTYP|Stroke Type|[?]|GERD|[?]|lx|[?]|1|g/L|SCAPULA|LATERAL|||CHILD|1|Visit_1|10|6|WASHOUT|2020-05-21|10
e|FA|fe7ad71c-601d-4909-b56a-401c9a10f00c|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg/min/L|[?]|1|mg/g/min|PROSTATE GLAND, LATERAL LOBE|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2020-06-05|25
e|FA|fe7ad71c-601d-4909-b56a-401c9a10f00c|4|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/mL|[?]|1|psi|MYOMETRIUM|UNILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2020-06-05|25
e|FA|fe7ad71c-601d-4909-b56a-401c9a10f00c|5|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|mL/dL|[?]|1|BOWL|T12 VERTEBRA|CONTRALATERAL||Y|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2020-06-20|40
e|FA|fe7ad71c-601d-4909-b56a-401c9a10f00c|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|tuberculin unit|[?]|1|PACK|CENTRAL NERVOUS SYSTEM|UNILATERAL||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|6|SCREENING|2020-06-20|40
e|FA|fe7ad71c-601d-4909-b56a-401c9a10f00c|7|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|g/m2|[?]|1|g/L|TRUNK|LEFT|Y||PARENT|4|Visit_4|65|2|TREATMENT|2020-07-15|65
e|FA|fe7ad71c-601d-4909-b56a-401c9a10f00c|8|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|mmol/g|[?]|1|10^9 CFU/mL|ESOPHAGUS, THORACIC|RIGHT|Y||INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-07-15|65
e|FA|fe7ad71c-601d-4909-b56a-401c9a10f00c|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|uV2|[?]|1|mL|MEDIASTINUM, POSTERIOR|BILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2020-08-09|90
e|FA|fe7ad71c-601d-4909-b56a-401c9a10f00c|10|ESTWT|Estimated Weight|[?]|GERD|[?]|Arbitrary U|[?]|1|g/day|URETHRA, POSTERIOR|IPSILATERAL|||ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2020-08-09|90
e|FA|cc52d895-5819-46c0-b8e6-b948f1cd2408|1|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|mL/g/h|[?]|1|TRANSDUCING UNIT/mL|HEPATIC LYMPH NODE|UNILATERAL||Y|INVESTIGATOR|1|Visit_1|10|5|FOLLOW-UP|2020-07-06|10
e|FA|cc52d895-5819-46c0-b8e6-b948f1cd2408|2|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|mL*cmH2O|[?]|1|10^4 CFU/mL|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|IPSILATERAL|Y|Y|PARENT|1|Visit_1|10|6|WASHOUT|2020-07-06|10
e|FA|cc52d895-5819-46c0-b8e6-b948f1cd2408|3|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|/HPF|[?]|1|mL/dose|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|RIGHT|||SIGNIFICANT OTHER|2|Visit_2|25|5|WASHOUT|2020-07-21|25
e|FA|cc52d895-5819-46c0-b8e6-b948f1cd2408|4|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mL/cm H2O|[?]|1|ug/kg/h|TRICEPS BRACHII MUSCLE|IPSILATERAL|||INTERVIEWER|2|Visit_2|25|5|TREATMENT|2020-07-21|25
e|FA|cc52d895-5819-46c0-b8e6-b948f1cd2408|5|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|mm|[?]|1|IU/mg|POPLITEAL ARTERY BELOW KNEE|UNILATERAL|||CHILD|3|Visit_3|40|3|TREATMENT|2020-08-05|40
e|FA|cc52d895-5819-46c0-b8e6-b948f1cd2408|6|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mEq/L|[?]|1|mL|MEDIASTINUM, POSTERIOR|UNILATERAL|||VENDOR|3|Visit_3|40|1|TREATMENT|2020-08-05|40
e|FA|cc52d895-5819-46c0-b8e6-b948f1cd2408|7|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/dL|[?]|1|mg/dose|DURAL VENOUS SINUS|RIGHT|||SPOUSE|4|Visit_4|65|6|FOLLOW-UP|2020-08-30|65
e|FA|cc52d895-5819-46c0-b8e6-b948f1cd2408|8|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|DRINK|[?]|1|Shock Wave|HEART, RIGHT VENTRICULAR FREE WALL|UNILATERAL|||GUARDIAN|4|Visit_4|65|2|TREATMENT|2020-08-30|65
e|FA|cc52d895-5819-46c0-b8e6-b948f1cd2408|9|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|mL/cage/wk|[?]|1|g/cage/day|PERICARDIAL CAVITY|RIGHT|||GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-09-24|90
e|FA|cc52d895-5819-46c0-b8e6-b948f1cd2408|10|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|mL/animal/day|EYE, ANTERIOR SEGMENT|LEFT||Y|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2020-09-24|90
e|FA|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|1|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|Ci/ug|[?]|1|in|TRAPEZOID-CAPITATE JOINT|BILATERAL|||PROXY|1|Visit_1|10|7|FOLLOW-UP|2021-01-29|10
e|FA|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|2|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|U/g/day|[?]|1|10^9 CFU/g|CARPOMETACARPAL JOINT 5|BILATERAL|||GUARDIAN|1|Visit_1|10|5|TREATMENT|2021-01-29|10
e|FA|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|3|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|uU/dL|[?]|1|mL/cm3/min|FRONTAL SINUS|RIGHT|||VENDOR|2|Visit_2|25|3|TREATMENT|2021-02-13|25
e|FA|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|4|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|U/mg|[?]|1|10^6 organisms/mL|CUBOID BONE|LEFT|||VENDOR|2|Visit_2|25|2|TREATMENT|2021-02-13|25
e|FA|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|5|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|cP|[?]|1|SACHET|INTERNAL MAMMARY LYMPH NODE|IPSILATERAL|Y|Y|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2021-02-28|40
e|FA|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|6|EVENTFRQ|Event Frequency|[?]|GERD|[?]|Arbitrary U|[?]|1|ug/kg/h|CORONARY ARTERY, ANTERIOR DESCENDING|BILATERAL|||CAREGIVER|3|Visit_3|40|7|FOLLOW-UP|2021-02-28|40
e|FA|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|7|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|mOsm|[?]|1|ug/g/h|TRACHEA|RIGHT|||VENDOR|4|Visit_4|65|6|TREATMENT|2021-03-25|65
e|FA|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|8|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|mOsm/kg|[?]|1|Coulomb|PORTAL VEIN BIFURCATION|LATERAL|||FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2021-03-25|65
e|FA|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|9|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|ug/g/min|[?]|1|TRANSDUCING UNIT/mL|SKIN OF THE HEAD|RIGHT|Y||GUARDIAN|5|Visit_5|90|2|FOLLOW-UP|2021-04-19|90
e|FA|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|10|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|cL|[?]|1|/kg|STRIATUM|IPSILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-04-19|90
e|FA|1409edea-a372-4938-889b-df6ee93b8543|1|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|/200 HPFs|MESENTERIC LYMPH NODE|RIGHT|||SIBLING|1|Visit_1|10|6|TREATMENT|2020-08-27|10
e|FA|1409edea-a372-4938-889b-df6ee93b8543|2|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|copies/mL|[?]|1|mL/animal/day|PALM|BILATERAL|||PROXY|1|Visit_1|10|5|WASHOUT|2020-08-27|10
e|FA|1409edea-a372-4938-889b-df6ee93b8543|3|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|g/m2/day|[?]|1|IU/mg|FOREBRAIN|BILATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|7|SCREENING|2020-09-11|25
e|FA|1409edea-a372-4938-889b-df6ee93b8543|4|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|L/day|[?]|1|Log10 ELISA unit|BLOOD VESSEL|BILATERAL|Y|Y|CAREGIVER|2|Visit_2|25|1|FOLLOW-UP|2020-09-11|25
e|FA|1409edea-a372-4938-889b-df6ee93b8543|5|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|NEEDLE GAUGE|[?]|1|ohm|RETINAL PIGMENTED EPITHELIAL LAYER|UNILATERAL|||INTERVIEWER|3|Visit_3|40|2|SCREENING|2020-09-26|40
e|FA|1409edea-a372-4938-889b-df6ee93b8543|6|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|CONTAINER|[?]|1|BOWL|TENTORIUM CEREBELLI|RIGHT||Y|FRIEND|3|Visit_3|40|4|TREATMENT|2020-09-26|40
e|FA|1409edea-a372-4938-889b-df6ee93b8543|7|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|usec|[?]|1|gtt|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|UNILATERAL|||SPOUSE|4|Visit_4|65|4|TREATMENT|2020-10-21|65
e|FA|1409edea-a372-4938-889b-df6ee93b8543|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|vp/dose|[?]|1|Pa|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|IPSILATERAL|Y||FRIEND|4|Visit_4|65|7|TREATMENT|2020-10-21|65
e|FA|1409edea-a372-4938-889b-df6ee93b8543|9|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/mL|[?]|1|mm|SOLEUS MUSCLE|LATERAL|Y||SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-11-15|90
e|FA|1409edea-a372-4938-889b-df6ee93b8543|10|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|dpm/100mg|[?]|1|SCOOPFUL|LIP, LOWER|LATERAL|Y|Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2020-11-15|90
e|FA|3dc16ad2-d49d-4fad-9823-d0197fb57a42|1|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mL/kg/min|[?]|1|ug/kg/h|TRAPEZIAL BONE|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|WASHOUT|2020-09-04|10
e|FA|3dc16ad2-d49d-4fad-9823-d0197fb57a42|2|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|cm H2O|[?]|1|EIA unit|SKIN OF THE CHIN|BILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-09-04|10
e|FA|3dc16ad2-d49d-4fad-9823-d0197fb57a42|3|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|g/cage/day|[?]|1|IU/mmol|SALIVARY GLAND, SUBLINGUAL|BILATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2020-09-19|25
e|FA|3dc16ad2-d49d-4fad-9823-d0197fb57a42|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|BEAM BREAKS|[?]|1|QUANTITY SUFFICIENT|ABDOMINAL CAVITY|BILATERAL|Y||PROXY|2|Visit_2|25|7|TREATMENT|2020-09-19|25
e|FA|3dc16ad2-d49d-4fad-9823-d0197fb57a42|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^6 organisms/g|[?]|1|mg/g/min|CARPOMETACARPAL JOINT 4|RIGHT|Y||STUDY SUBJECT|3|Visit_3|40|1|WASHOUT|2020-10-04|40
e|FA|3dc16ad2-d49d-4fad-9823-d0197fb57a42|6|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|umol/min|[?]|1|mm|VOMER|LATERAL|||CAREGIVER|3|Visit_3|40|2|TREATMENT|2020-10-04|40
e|FA|3dc16ad2-d49d-4fad-9823-d0197fb57a42|7|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|10^12 IU/L|[?]|1|Weber|CORPUS CALLOSUM, SPLENIUM|LATERAL|||FRIEND|4|Visit_4|65|3|TREATMENT|2020-10-29|65
e|FA|3dc16ad2-d49d-4fad-9823-d0197fb57a42|8|OBJNUM|Number of Objects|[?]|GERD|[?]|U/cL|[?]|1|mL/100g/min|TRAPEZOID-CAPITATE JOINT|RIGHT||Y|GUARDIAN|4|Visit_4|65|3|SCREENING|2020-10-29|65
e|FA|3dc16ad2-d49d-4fad-9823-d0197fb57a42|9|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|psi|[?]|1|mL/m2|PULMONARY ARTERY BRANCH|UNILATERAL|||INTERVIEWER|5|Visit_5|90|4|TREATMENT|2020-11-23|90
e|FA|3dc16ad2-d49d-4fad-9823-d0197fb57a42|10|EXTRSCT|Extent of Resection|[?]|GERD|[?]|Siemens|[?]|1|Weber|POPLITEAL LYMPH NODE|LATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|WASHOUT|2020-11-23|90
e|FA|7c244128-0508-422f-88ba-ecce68cec054|1|STROKTYP|Stroke Type|[?]|GERD|[?]|MESF|[?]|1|g/L|HUMERUS SHAFT|CONTRALATERAL||Y|INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-08-05|10
e|FA|7c244128-0508-422f-88ba-ecce68cec054|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/animal|[?]|1|mg/g/min|LUNG, LEFT|CONTRALATERAL|||STUDY SUBJECT|1|Visit_1|10|6|FOLLOW-UP|2020-08-05|10
e|FA|7c244128-0508-422f-88ba-ecce68cec054|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|pkat|[?]|1|U/mg|THYROID GLAND, RIGHT LOBE|IPSILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2020-08-20|25
e|FA|7c244128-0508-422f-88ba-ecce68cec054|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|dB|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|1|SCREENING|2020-08-20|25
e|FA|7c244128-0508-422f-88ba-ecce68cec054|5|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|%/s|[?]|1|IU/mg|AXILLARY LYMPH NODE LEVEL III|LATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|5|TREATMENT|2020-09-04|40
e|FA|7c244128-0508-422f-88ba-ecce68cec054|6|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mV2/Hz|[?]|1|NEEDLE GAUGE|BRAIN, PERIVENTRICULAR REGION|LATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|5|TREATMENT|2020-09-04|40
e|FA|7c244128-0508-422f-88ba-ecce68cec054|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|v/v|[?]|1|%(v/v)|CRANIAL CAVITY|LEFT|Y||PARENT|4|Visit_4|65|2|FOLLOW-UP|2020-09-29|65
e|FA|7c244128-0508-422f-88ba-ecce68cec054|8|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|CFU/mL|[?]|1|cm|CEPHALIC VEIN|LATERAL|||INTERVIEWER|4|Visit_4|65|2|SCREENING|2020-09-29|65
e|FA|7c244128-0508-422f-88ba-ecce68cec054|9|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|mmol/mol|[?]|1|mL/m2|GENITAL TUBERCLE|UNILATERAL|||VENDOR|5|Visit_5|90|5|SCREENING|2020-10-24|90
e|FA|7c244128-0508-422f-88ba-ecce68cec054|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/day|[?]|1|mg/g/min|OCCIPITAL LOBE|RIGHT||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|5|SCREENING|2020-10-24|90
e|FA|247814c7-9fb3-43f2-9e0a-db70b27b3d95|1|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|pt_us|[?]|1|Shock Wave|HAND DIGIT 5|LEFT|||STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-12-16|10
e|FA|247814c7-9fb3-43f2-9e0a-db70b27b3d95|2|LOCONSET|Localization of Onset|[?]|GERD|[?]|days/month|[?]|1|g/L|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|SCREENING|2020-12-16|10
e|FA|247814c7-9fb3-43f2-9e0a-db70b27b3d95|3|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|mg/day|[?]|1|L|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|IPSILATERAL|||STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2020-12-31|25
e|FA|247814c7-9fb3-43f2-9e0a-db70b27b3d95|4|ACNDEV|Action Taken With Device|[?]|GERD|[?]|km/h|[?]|1|100 IU/mL|FIBULAR VEIN|BILATERAL|||VENDOR|2|Visit_2|25|2|SCREENING|2020-12-31|25
e|FA|247814c7-9fb3-43f2-9e0a-db70b27b3d95|5|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|Bq/uL|[?]|1|PFU/dose|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|UNILATERAL|Y|Y|INVESTIGATOR|3|Visit_3|40|3|FOLLOW-UP|2021-01-15|40
e|FA|247814c7-9fb3-43f2-9e0a-db70b27b3d95|6|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|BP|[?]|1|IU/mg|SUBLINGUAL REGION|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|WASHOUT|2021-01-15|40
e|FA|247814c7-9fb3-43f2-9e0a-db70b27b3d95|7|EVENTFRQ|Event Frequency|[?]|GERD|[?]|vg/mL|[?]|1|ug/kg/h|VOCAL CORD|RIGHT|||INVESTIGATOR|4|Visit_4|65|6|WASHOUT|2021-02-09|65
e|FA|247814c7-9fb3-43f2-9e0a-db70b27b3d95|8|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|mg/mol|[?]|1|g/day|UTERUS|BILATERAL|||STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2021-02-09|65
e|FA|247814c7-9fb3-43f2-9e0a-db70b27b3d95|9|SPEED|Speed|[?]|GERD|[?]|U/m2/day|[?]|1|mEq/g|FLOOR OF MOUTH|BILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2021-03-06|90
e|FA|247814c7-9fb3-43f2-9e0a-db70b27b3d95|10|SEV|Severity/Intensity|[?]|GERD|[?]|kHz|[?]|1|Pa|ILEUM LYMPH NODE|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|SCREENING|2021-03-06|90
e|FA|e870fe2f-b08c-41d9-a672-07da09fe2b99|1|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|pg/cell|[?]|1|MBq|JOINT|IPSILATERAL|||FRIEND|1|Visit_1|10|5|SCREENING|2020-08-12|10
e|FA|e870fe2f-b08c-41d9-a672-07da09fe2b99|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|v/v|[?]|1|mg/g/min|POPLITEAL FOSSA|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|2|WASHOUT|2020-08-12|10
e|FA|e870fe2f-b08c-41d9-a672-07da09fe2b99|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|uSiemens|[?]|1|mg/h|OPTIC DISC|BILATERAL||Y|SIBLING|2|Visit_2|25|5|TREATMENT|2020-08-27|25
e|FA|e870fe2f-b08c-41d9-a672-07da09fe2b99|4|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|EU|[?]|1|DROP|PLACENTA|RIGHT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-08-27|25
e|FA|e870fe2f-b08c-41d9-a672-07da09fe2b99|5|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|Hz/s|INTRAHEPATIC LARGE BILE DUCT|RIGHT||Y|DOMESTIC PARTNER|3|Visit_3|40|6|FOLLOW-UP|2020-09-11|40
e|FA|e870fe2f-b08c-41d9-a672-07da09fe2b99|6|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|mg/mL/day|[?]|1|Bq/L|MANDIBLE|CONTRALATERAL||Y|FRIEND|3|Visit_3|40|6|WASHOUT|2020-09-11|40
e|FA|e870fe2f-b08c-41d9-a672-07da09fe2b99|7|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|g/L|[?]|1|Ci/ug|SKIN OF THE TRUNK|RIGHT||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-10-06|65
e|FA|e870fe2f-b08c-41d9-a672-07da09fe2b99|8|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|MAC50|[?]|1|Bq/L|LIGAMENT|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-10-06|65
e|FA|e870fe2f-b08c-41d9-a672-07da09fe2b99|9|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|km|ANKLE JOINT ANTERIOR FLEXOR TENDONS|BILATERAL|||ADJUDICATOR|5|Visit_5|90|6|WASHOUT|2020-10-31|90
e|FA|e870fe2f-b08c-41d9-a672-07da09fe2b99|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|nm|[?]|1|10^6 U|AMYGDALA|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|6|WASHOUT|2020-10-31|90
e|FA|32979638-fb88-4cbb-a110-a4d2016e9bc5|1|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|Joule|[?]|1|10^6 CFU|APPENDICULAR SKELETON|IPSILATERAL||Y|PROXY|1|Visit_1|10|2|WASHOUT|2020-07-15|10
e|FA|32979638-fb88-4cbb-a110-a4d2016e9bc5|2|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|log10 PFU/mL|[?]|1|psi|SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-07-15|10
e|FA|32979638-fb88-4cbb-a110-a4d2016e9bc5|3|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|10^6 U|[?]|1|BAG|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-07-30|25
e|FA|32979638-fb88-4cbb-a110-a4d2016e9bc5|4|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|deg2|[?]|1|anti-Xa IU/mL|SKIN OF THE FOREARM|UNILATERAL|||VENDOR|2|Visit_2|25|5|TREATMENT|2020-07-30|25
e|FA|32979638-fb88-4cbb-a110-a4d2016e9bc5|5|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|/10^3|[?]|1|Gy/h|FACET JOINT|RIGHT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|FOLLOW-UP|2020-08-14|40
e|FA|32979638-fb88-4cbb-a110-a4d2016e9bc5|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|min/day|[?]|1|%(v/v)|T12 VERTEBRA|LATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|2|FOLLOW-UP|2020-08-14|40
e|FA|32979638-fb88-4cbb-a110-a4d2016e9bc5|7|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/mL|[?]|1|g/cage/day|SCAPHOID-LUNATE JOINT|IPSILATERAL|||ADJUDICATOR|4|Visit_4|65|4|TREATMENT|2020-09-08|65
e|FA|32979638-fb88-4cbb-a110-a4d2016e9bc5|8|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|10^7 TCID 50/dose|[?]|1|anti-Xa IU/mL|HEART, RIGHT VENTRICULAR FREE WALL|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|7|FOLLOW-UP|2020-09-08|65
e|FA|32979638-fb88-4cbb-a110-a4d2016e9bc5|9|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|Enzyme U|[?]|1|IU/mmol|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|LEFT|Y||CHILD|5|Visit_5|90|6|TREATMENT|2020-10-03|90
e|FA|32979638-fb88-4cbb-a110-a4d2016e9bc5|10|CALBURN|Calories Burned|[?]|GERD|[?]|nmol/g|[?]|1|/kg|EPIGLOTTIS|RIGHT|||STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-10-03|90
e|FA|39b8db88-810b-4402-9ca3-c2bab1939c1c|1|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|BOWL|BICEPS BRACHII MUSCLE|IPSILATERAL|||PROXY|1|Visit_1|10|1|TREATMENT|2020-11-15|10
e|FA|39b8db88-810b-4402-9ca3-c2bab1939c1c|2|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|umol/min|[?]|1|Hz/s|INCISOR|CONTRALATERAL|||CHILD|1|Visit_1|10|2|FOLLOW-UP|2020-11-15|10
e|FA|39b8db88-810b-4402-9ca3-c2bab1939c1c|3|STRCTNUM|Number of Strictures|[?]|GERD|[?]|FEU|[?]|1|SACHET|TRIANGULAR-LUNATE JOINT|CONTRALATERAL||Y|INVESTIGATOR|2|Visit_2|25|7|SCREENING|2020-11-30|25
e|FA|39b8db88-810b-4402-9ca3-c2bab1939c1c|4|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|Hz|[?]|1|mIU/L|TRAPEZIUM-TRAPEZOID JOINT|UNILATERAL|Y||SIBLING|2|Visit_2|25|6|FOLLOW-UP|2020-11-30|25
e|FA|39b8db88-810b-4402-9ca3-c2bab1939c1c|5|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|10^6 RNA copies/mL|[?]|1|fmol|SKIN OF THE CHEST|BILATERAL||Y|PROXY|3|Visit_3|40|7|WASHOUT|2020-12-15|40
e|FA|39b8db88-810b-4402-9ca3-c2bab1939c1c|6|LENRSCT|Length of Resection|[?]|GERD|[?]|U.CARR|[?]|1|psi|LEG|CONTRALATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2020-12-15|40
e|FA|39b8db88-810b-4402-9ca3-c2bab1939c1c|7|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|cm/s|[?]|1|ug/g/h|ATRIOVENTRICULAR VALVE|BILATERAL|||SPOUSE|4|Visit_4|65|2|TREATMENT|2021-01-09|65
e|FA|39b8db88-810b-4402-9ca3-c2bab1939c1c|8|EXTRSCT|Extent of Resection|[?]|GERD|[?]|PACKET|[?]|1|Weber|EXTRAOCULAR MUSCLE|UNILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|WASHOUT|2021-01-09|65
e|FA|39b8db88-810b-4402-9ca3-c2bab1939c1c|9|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|ukat/10^12 RBC|[?]|1|BOWL|FIBULA SHAFT|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|SCREENING|2021-02-03|90
e|FA|39b8db88-810b-4402-9ca3-c2bab1939c1c|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ft2|[?]|1|mg/g/min|PRETRACHEAL LYMPH NODE|LATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2021-02-03|90
e|FA|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|1|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|ppth|[?]|1|AU/mL|AORTIC VALVE, LEFT CORONARY CUSP|LEFT|||CAREGIVER|1|Visit_1|10|3|WASHOUT|2020-07-27|10
e|FA|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|2|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|ugEq|[?]|1|10^6 IU/mL|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|LATERAL|||INVESTIGATOR|1|Visit_1|10|4|SCREENING|2020-07-27|10
e|FA|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|3|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|mL/m2|OCCIPITAL LOBE|UNILATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|5|WASHOUT|2020-08-11|25
e|FA|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Antibody Unit|[?]|1|mg/g/min|CANINE TOOTH|CONTRALATERAL|Y|Y|VENDOR|2|Visit_2|25|2|TREATMENT|2020-08-11|25
e|FA|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|5|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|ug/m2/day|[?]|1|ohm|FUNDUS UTERI|CONTRALATERAL|Y||INVESTIGATOR|3|Visit_3|40|2|FOLLOW-UP|2020-08-26|40
e|FA|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|6|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|RING|[?]|1|mEq/g|HEART, LEFT VENTRICULAR WALL|RIGHT|||STUDY SUBJECT|3|Visit_3|40|5|TREATMENT|2020-08-26|40
e|FA|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|7|CALBURN|Calories Burned|[?]|GERD|[?]|JDF Unit|[?]|1|/kg|CHOROID PLEXUS|CONTRALATERAL||Y|VENDOR|4|Visit_4|65|3|TREATMENT|2020-09-20|65
e|FA|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|8|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|Bq/ug|[?]|1|10^4 CFU/mL|TOE|LATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|FOLLOW-UP|2020-09-20|65
e|FA|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|g/kg|[?]|1|mg/g/min|BICEPS FEMORIS MUSCLE|BILATERAL|Y|Y|INTERVIEWER|5|Visit_5|90|1|FOLLOW-UP|2020-10-15|90
e|FA|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|10|DFIBER|Dietary Fiber|[?]|GERD|[?]|Sv|[?]|1|h*%|STERNAL MANUBRIUM|LATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-10-15|90
e|FA|bca1f50d-04e6-46f5-afb3-e48aaea1069d|1|SEV|Severity/Intensity|[?]|GERD|[?]|PNU/mL|[?]|1|Pa|KNEE JOINT|UNILATERAL|||FRIEND|1|Visit_1|10|3|SCREENING|2020-11-03|10
e|FA|bca1f50d-04e6-46f5-afb3-e48aaea1069d|2|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|mg/m2/day|[?]|1|mmHg/L/min|GENITALIA|LEFT|||STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2020-11-03|10
e|FA|bca1f50d-04e6-46f5-afb3-e48aaea1069d|3|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|m3|[?]|1|mL/h|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LEFT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|SCREENING|2020-11-18|25
e|FA|bca1f50d-04e6-46f5-afb3-e48aaea1069d|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|WAFER|[?]|1|ug/g/h|BRAIN, PERIVENTRICULAR REGION|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-11-18|25
e|FA|bca1f50d-04e6-46f5-afb3-e48aaea1069d|5|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/dL|[?]|1|km|THROAT|LATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-12-03|40
e|FA|bca1f50d-04e6-46f5-afb3-e48aaea1069d|6|PPTFCT|Precipitating Factor|[?]|GERD|[?]|dpm/100mg|[?]|1|EIA unit|SPLENIC HILAR LYMPH NODE|LEFT|||CAREGIVER|3|Visit_3|40|7|SCREENING|2020-12-03|40
e|FA|bca1f50d-04e6-46f5-afb3-e48aaea1069d|7|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|C|[?]|1|BP|NASAL SEPTUM|LEFT|||PARENT|4|Visit_4|65|2|TREATMENT|2020-12-28|65
e|FA|bca1f50d-04e6-46f5-afb3-e48aaea1069d|8|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|FFU|[?]|1|Weber|STERNAL MANUBRIUM|LEFT|||CAREGIVER|4|Visit_4|65|2|WASHOUT|2020-12-28|65
e|FA|bca1f50d-04e6-46f5-afb3-e48aaea1069d|9|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|EIA unit|[?]|1|10^9 CFU/mL|HEART, ATRIUM|BILATERAL||Y|FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2021-01-22|90
e|FA|bca1f50d-04e6-46f5-afb3-e48aaea1069d|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|U.CARR|[?]|1|QUANTITY SUFFICIENT|PENIS, RADIX|LEFT||Y|VENDOR|5|Visit_5|90|3|SCREENING|2021-01-22|90
e|FA|6bddadef-13fb-4fab-b281-aa33aa97aa8f|1|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|umol/mg/min|[?]|1|10^6 CFU|CHEST|LEFT|Y|Y|SIGNIFICANT OTHER|1|Visit_1|10|7|SCREENING|2020-05-24|10
e|FA|6bddadef-13fb-4fab-b281-aa33aa97aa8f|2|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|m/sec|[?]|1|Bq/L|PRONATOR QUADRATUS MUSCLE|CONTRALATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-05-24|10
e|FA|6bddadef-13fb-4fab-b281-aa33aa97aa8f|3|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|g/animal|[?]|1|SACHET|LEFT VENTRICULAR EPICARDIUM|LEFT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|2|TREATMENT|2020-06-08|25
e|FA|6bddadef-13fb-4fab-b281-aa33aa97aa8f|4|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|uCi/kg|[?]|1|g/day|FIBULAR VEIN|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|SCREENING|2020-06-08|25
e|FA|6bddadef-13fb-4fab-b281-aa33aa97aa8f|5|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mL/mmHg/min/L|[?]|1|NEEDLE GAUGE|STERNUM|LATERAL||Y|SPOUSE|3|Visit_3|40|1|TREATMENT|2020-06-23|40
e|FA|6bddadef-13fb-4fab-b281-aa33aa97aa8f|6|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|m|[?]|1|cm H2O|CALF|RIGHT||Y|PARENT|3|Visit_3|40|6|WASHOUT|2020-06-23|40
e|FA|6bddadef-13fb-4fab-b281-aa33aa97aa8f|7|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|10^6 CFU/mL|PLEURAL CAVITY|LEFT|Y|Y|ADJUDICATOR|4|Visit_4|65|2|FOLLOW-UP|2020-07-18|65
e|FA|6bddadef-13fb-4fab-b281-aa33aa97aa8f|8|DPROT|Dietary Protein|[?]|GERD|[?]|mL/dL|[?]|1|10^4 CFU/mL|EYE BULGE|BILATERAL|||VENDOR|4|Visit_4|65|6|TREATMENT|2020-07-18|65
e|FA|6bddadef-13fb-4fab-b281-aa33aa97aa8f|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mIU/L|[?]|1|mg/g/min|ARM|UNILATERAL||Y|PROXY|5|Visit_5|90|6|WASHOUT|2020-08-12|90
e|FA|6bddadef-13fb-4fab-b281-aa33aa97aa8f|10|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|pmol/L/h|[?]|1|MBq|SUBMANDIBULAR GLAND|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2020-08-12|90
e|FA|6edb7414-d8f4-44da-8483-504b93a7e705|1|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mmol2/L2|[?]|1|umol|GREAT SAPHENOUS VEIN|LEFT|Y||CHILD|1|Visit_1|10|3|TREATMENT|2020-06-07|10
e|FA|6edb7414-d8f4-44da-8483-504b93a7e705|2|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|fraction of 1|[?]|1|10^6 U|FEMUR|RIGHT|||CAREGIVER|1|Visit_1|10|7|FOLLOW-UP|2020-06-07|10
e|FA|6edb7414-d8f4-44da-8483-504b93a7e705|3|RLDEV|Relationship to Device|[?]|GERD|[?]|CIGARETTE|[?]|1|mL/min/mmHg|ENDOMETRIAL CAVITY|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2020-06-22|25
e|FA|6edb7414-d8f4-44da-8483-504b93a7e705|4|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|log10 CFU/mL|[?]|1|BAG|SCAPHOID-CAPITATE JOINT|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2020-06-22|25
e|FA|6edb7414-d8f4-44da-8483-504b93a7e705|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|U/mmol|EYE BULGE|UNILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-07-07|40
e|FA|6edb7414-d8f4-44da-8483-504b93a7e705|6|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|cs|[?]|1|uL/kg/day|C1 VERTEBRA|LATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|1|WASHOUT|2020-07-07|40
e|FA|6edb7414-d8f4-44da-8483-504b93a7e705|7|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|/2000 RBC|[?]|1|fmol|GREAT TROCHANTER|RIGHT|||ADJUDICATOR|4|Visit_4|65|2|SCREENING|2020-08-01|65
e|FA|6edb7414-d8f4-44da-8483-504b93a7e705|8|LENRSCT|Length of Resection|[?]|GERD|[?]|mOsm/L|[?]|1|psi|SCAPHOID-CAPITATE JOINT|BILATERAL||Y|SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2020-08-01|65
e|FA|6edb7414-d8f4-44da-8483-504b93a7e705|9|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|BOWL|[?]|1|L/h/m2|ANTRUM PYLORI|LATERAL|Y||PARENT|5|Visit_5|90|6|TREATMENT|2020-08-26|90
e|FA|6edb7414-d8f4-44da-8483-504b93a7e705|10|LENRSCT|Length of Resection|[?]|GERD|[?]|psec|[?]|1|psi|RECTOSIGMOID JUNCTION|LEFT|||SIGNIFICANT OTHER|5|Visit_5|90|5|SCREENING|2020-08-26|90
e|FA|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|1|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|Bq|[?]|1|IU/mmol|HAIR SHAFT|RIGHT|||VENDOR|1|Visit_1|10|2|TREATMENT|2020-05-16|10
e|FA|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|V/sec|[?]|1|mg/g/min|CEREBELLUM|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|3|FOLLOW-UP|2020-05-16|10
e|FA|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|3|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|mg/dL|[?]|1|g/day|LIP|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|6|FOLLOW-UP|2020-05-31|25
e|FA|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|4|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|mm/h|PENIS, BODY|BILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-05-31|25
e|FA|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|5|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|L/h|[?]|1|Shock Wave|PERITONEUM|CONTRALATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-06-15|40
e|FA|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|6|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|cs|[?]|1|mEq|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-06-15|40
e|FA|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|7|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|SACHET|MUSCLE|IPSILATERAL|||CAREGIVER|4|Visit_4|65|6|TREATMENT|2020-07-10|65
e|FA|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|8|DIAMETER|Diameter|[?]|GERD|[?]|IU/dL|[?]|1|cm|PANCREATIC DUCT|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|FOLLOW-UP|2020-07-10|65
e|FA|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|9|EXCDUR|Exercise Duration|[?]|GERD|[?]|ug/min|[?]|1|mm|DISTAL LAD ARTERY|LEFT|||INTERVIEWER|5|Visit_5|90|3|WASHOUT|2020-08-04|90
e|FA|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|10|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|ELISA unit/dose|[?]|1|DRUM|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|BILATERAL|Y|Y|FAMILY MEMBER|5|Visit_5|90|5|FOLLOW-UP|2020-08-04|90
e|FA|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|1|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|mmAL|[?]|1|anti-Xa IU/mL|ANAL VERGE|BILATERAL||Y|ADJUDICATOR|1|Visit_1|10|1|WASHOUT|2020-05-18|10
e|FA|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|uV*sec|[?]|1|mg/g/min|CAUDATE NUCLEUS|RIGHT|||PROXY|1|Visit_1|10|7|TREATMENT|2020-05-18|10
e|FA|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mL/100g/min|[?]|1|10^6 U|COLON, DESCENDING|CONTRALATERAL|||ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-06-02|25
e|FA|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|umol/kg/min|[?]|1|U/mmol|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|IPSILATERAL|Y||INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-06-02|25
e|FA|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|5|DIAMETER|Diameter|[?]|GERD|[?]|Ci/mL|[?]|1|cm|METATARSOPHALANGEAL JOINT 3|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|5|TREATMENT|2020-06-17|40
e|FA|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|6|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|uV2|[?]|1|L/h/m2|WRIST JOINT EXTENSOR MUSCLES|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-06-17|40
e|FA|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|7|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|EIA unit|CORNEA|CONTRALATERAL|Y||VENDOR|4|Visit_4|65|2|TREATMENT|2020-07-12|65
e|FA|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|tsp eq|[?]|1|mg/g/min|SKIN OF THE FACE|LATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|3|SCREENING|2020-07-12|65
e|FA|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|9|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|Ci/ug|[?]|1|IU/mg|METACARPAL BONE 3|BILATERAL||Y|CHILD|5|Visit_5|90|4|WASHOUT|2020-08-06|90
e|FA|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|10|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/g|[?]|1|ug/kg/h|HAND DIGIT 4|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|SCREENING|2020-08-06|90
e|FA|47d55e87-e559-424d-a6ad-d533a0d77f39|1|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|Ci/mg|[?]|1|mL/mmHg/min/L|GREAT SAPHENOUS VEIN|IPSILATERAL|Y||CHILD|1|Visit_1|10|5|WASHOUT|2021-01-12|10
e|FA|47d55e87-e559-424d-a6ad-d533a0d77f39|2|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|dpm/100mg|[?]|1|mm/h|FOOT DIGIT 3|CONTRALATERAL|Y|Y|GUARDIAN|1|Visit_1|10|5|TREATMENT|2021-01-12|10
e|FA|47d55e87-e559-424d-a6ad-d533a0d77f39|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|uV2|[?]|1|%(v/v)|SKIN OF THE INGUINAL REGION|LATERAL|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|WASHOUT|2021-01-27|25
e|FA|47d55e87-e559-424d-a6ad-d533a0d77f39|4|VOL|Volume|[?]|GERD|[?]|mg/mol|[?]|1|vp/dose|ORBICULARIS OCULI MUSCLE|LATERAL|||DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2021-01-27|25
e|FA|47d55e87-e559-424d-a6ad-d533a0d77f39|5|DFRUIT|Dietary Fruit|[?]|GERD|[?]|pmol/10^9 cells|[?]|1|10^6 CFU/mL|INTERNAL ILIAC LYMPH NODE|UNILATERAL|||CAREGIVER|3|Visit_3|40|4|FOLLOW-UP|2021-02-11|40
e|FA|47d55e87-e559-424d-a6ad-d533a0d77f39|6|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|nm|[?]|1|ug/kg/h|TIBIA|CONTRALATERAL|||SPOUSE|3|Visit_3|40|5|WASHOUT|2021-02-11|40
e|FA|47d55e87-e559-424d-a6ad-d533a0d77f39|7|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|fg|[?]|1|ug/kg/h|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|LATERAL|Y||ADJUDICATOR|4|Visit_4|65|6|SCREENING|2021-03-08|65
e|FA|47d55e87-e559-424d-a6ad-d533a0d77f39|8|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|ms2|[?]|1|L/h/m2|FORELIMB|CONTRALATERAL||Y|VENDOR|4|Visit_4|65|3|SCREENING|2021-03-08|65
e|FA|47d55e87-e559-424d-a6ad-d533a0d77f39|9|TOXGR|Toxicity Grade|[?]|GERD|[?]|10^4/hpf|[?]|1|aMFI|SUPRATENTORIAL BRAIN|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-04-02|90
e|FA|47d55e87-e559-424d-a6ad-d533a0d77f39|10|AGETRT1|Age At First Treatment|[?]|GERD|[?]|Enzyme U/L|[?]|1|mL/mmHg/min/L|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|BILATERAL||Y|SIBLING|5|Visit_5|90|3|FOLLOW-UP|2021-04-02|90
e|FA|f89c08df-2e24-4c97-a451-1980cecebf14|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|uL/kg/day|[?]|1|mL/animal/day|FOREBRAIN|LEFT|Y||INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-12-18|10
e|FA|f89c08df-2e24-4c97-a451-1980cecebf14|2|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|ug/h|[?]|1|ug/kg/h|PERIURETHRAL REGION|LATERAL||Y|INDEPENDENT ASSESSOR|1|Visit_1|10|6|FOLLOW-UP|2020-12-18|10
e|FA|f89c08df-2e24-4c97-a451-1980cecebf14|3|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|SCOOPFUL|T6 VERTEBRA|LATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2021-01-02|25
e|FA|f89c08df-2e24-4c97-a451-1980cecebf14|4|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|uU/L|[?]|1|10^6/L|FLANK|LATERAL|||SIBLING|2|Visit_2|25|7|SCREENING|2021-01-02|25
e|FA|f89c08df-2e24-4c97-a451-1980cecebf14|5|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|GPL U|[?]|1|Hz/s|FOOT PHALANX|CONTRALATERAL||Y|INTERVIEWER|3|Visit_3|40|7|TREATMENT|2021-01-17|40
e|FA|f89c08df-2e24-4c97-a451-1980cecebf14|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|EU|[?]|1|Pa|PREFRONTAL CORTEX|LATERAL||Y|CHILD|3|Visit_3|40|4|TREATMENT|2021-01-17|40
e|FA|f89c08df-2e24-4c97-a451-1980cecebf14|7|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|MnFI|[?]|1|SCOOPFUL|HEART, RIGHT VENTRICULAR FREE WALL|LEFT|||INDEPENDENT ASSESSOR|4|Visit_4|65|7|FOLLOW-UP|2021-02-11|65
e|FA|f89c08df-2e24-4c97-a451-1980cecebf14|8|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|ng/day|MENINGES|UNILATERAL||Y|SIBLING|4|Visit_4|65|3|TREATMENT|2021-02-11|65
e|FA|f89c08df-2e24-4c97-a451-1980cecebf14|9|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|cP|[?]|1|mAmp|EXTERNAL ILIAC ARTERY|CONTRALATERAL|Y||PROXY|5|Visit_5|90|3|FOLLOW-UP|2021-03-08|90
e|FA|f89c08df-2e24-4c97-a451-1980cecebf14|10|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|foz_us|[?]|1|TRANSDUCING UNIT/mL|LOCUS CERULEUS|LATERAL|||DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2021-03-08|90
e|FA|dbb225ed-e322-4946-a60a-0fafd7e22953|1|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|h*%|HEPATIC VEIN|RIGHT|Y||PARENT|1|Visit_1|10|5|TREATMENT|2021-01-24|10
e|FA|dbb225ed-e322-4946-a60a-0fafd7e22953|2|ESTWT|Estimated Weight|[?]|GERD|[?]|cP|[?]|1|g/day|FEMORAL ARTERY|LEFT|Y||PARENT|1|Visit_1|10|2|SCREENING|2021-01-24|10
e|FA|dbb225ed-e322-4946-a60a-0fafd7e22953|3|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|GBq/g|[?]|1|ug/m2/h|TEMPLE|UNILATERAL|||SIBLING|2|Visit_2|25|2|TREATMENT|2021-02-08|25
e|FA|dbb225ed-e322-4946-a60a-0fafd7e22953|4|DISTANCE|Distance|[?]|GERD|[?]|U/g/day|[?]|1|BOWL|FINGER FLEXOR TENDONS|LEFT|Y||PROXY|2|Visit_2|25|6|SCREENING|2021-02-08|25
e|FA|dbb225ed-e322-4946-a60a-0fafd7e22953|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|copies/ug|[?]|1|mg/g/min|TRACHEOBRONCHIAL TREE|LATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|1|FOLLOW-UP|2021-02-23|40
e|FA|dbb225ed-e322-4946-a60a-0fafd7e22953|6|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|pptr|[?]|1|m2|CORNEAL STROMA|CONTRALATERAL|Y|Y|CHILD|3|Visit_3|40|4|SCREENING|2021-02-23|40
e|FA|dbb225ed-e322-4946-a60a-0fafd7e22953|7|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|umol/h/mmol|[?]|1|10^6 U|SKIN OF THE BENDING JOINT|IPSILATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|2|FOLLOW-UP|2021-03-20|65
e|FA|dbb225ed-e322-4946-a60a-0fafd7e22953|8|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mL/kg/min|[?]|1|Weber|THIRD DIAGONAL BRANCH ARTERY|LEFT|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2021-03-20|65
e|FA|dbb225ed-e322-4946-a60a-0fafd7e22953|9|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|SCOOPFUL|CARPAL BONE|LEFT|Y||GUARDIAN|5|Visit_5|90|7|WASHOUT|2021-04-14|90
e|FA|dbb225ed-e322-4946-a60a-0fafd7e22953|10|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|PIPE|[?]|1|U/10^12 RBC|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|BILATERAL|||PROXY|5|Visit_5|90|6|TREATMENT|2021-04-14|90
e|FA|95e61698-43f7-4cc5-aafa-06dac7870743|1|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|oz eq|[?]|1|L/h/m2|BASILIC VEIN|UNILATERAL|||VENDOR|1|Visit_1|10|7|SCREENING|2020-12-25|10
e|FA|95e61698-43f7-4cc5-aafa-06dac7870743|2|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|10^6 IU/mL|[?]|1|g/L|VENOUS SINUS|CONTRALATERAL|Y||INTERVIEWER|1|Visit_1|10|4|WASHOUT|2020-12-25|10
e|FA|95e61698-43f7-4cc5-aafa-06dac7870743|3|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|pkat/L|[?]|1|MBq|THYROID GLAND|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|6|SCREENING|2021-01-09|25
e|FA|95e61698-43f7-4cc5-aafa-06dac7870743|4|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|10^6 copies/mL|[?]|1|IU/mg|CHEST|RIGHT|||PARENT|2|Visit_2|25|5|SCREENING|2021-01-09|25
e|FA|95e61698-43f7-4cc5-aafa-06dac7870743|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^9/dose|[?]|1|%(v/v)|SUPRAPUBIC REGION|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2021-01-24|40
e|FA|95e61698-43f7-4cc5-aafa-06dac7870743|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|U/mg|[?]|1|CUP|KIDNEY, LOWER LOBE|LEFT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2021-01-24|40
e|FA|95e61698-43f7-4cc5-aafa-06dac7870743|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|BU|[?]|1|mg/g/min|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LATERAL|Y||STUDY SUBJECT|4|Visit_4|65|6|WASHOUT|2021-02-18|65
e|FA|95e61698-43f7-4cc5-aafa-06dac7870743|8|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|CFU/mL|[?]|1|g/dL|PULMONARY ARTERY BRANCH|IPSILATERAL|||FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2021-02-18|65
e|FA|95e61698-43f7-4cc5-aafa-06dac7870743|9|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|PACKET|[?]|1|ng|HAIR FOLLICLE|UNILATERAL||Y|FAMILY MEMBER|5|Visit_5|90|7|SCREENING|2021-03-15|90
e|FA|95e61698-43f7-4cc5-aafa-06dac7870743|10|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|m3|[?]|1|L/h/m2|SYMPATHETIC GANGLIA|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|3|WASHOUT|2021-03-15|90
e|FA|151308c7-03aa-4a0b-b13f-9838edb218ef|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|DPM|[?]|1|%(v/v)|WARDS TRIANGLE|RIGHT|||INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-09-13|10
e|FA|151308c7-03aa-4a0b-b13f-9838edb218ef|2|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|P|[?]|1|DRUM|FEMUR|RIGHT|||FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-09-13|10
e|FA|151308c7-03aa-4a0b-b13f-9838edb218ef|3|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|SACHET|[?]|1|g/cage/day|INTERNAL MAMMARY ARTERY|RIGHT|Y||GUARDIAN|2|Visit_2|25|7|FOLLOW-UP|2020-09-28|25
e|FA|151308c7-03aa-4a0b-b13f-9838edb218ef|4|LOCONSET|Localization of Onset|[?]|GERD|[?]|sec|[?]|1|g/L|SCAPHOID-LUNATE JOINT|LEFT|||INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-09-28|25
e|FA|151308c7-03aa-4a0b-b13f-9838edb218ef|5|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|PFU/animal|[?]|1|DROP|LUNG|CONTRALATERAL||Y|GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-10-13|40
e|FA|151308c7-03aa-4a0b-b13f-9838edb218ef|6|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/g Hb|[?]|1|mmHg/L/min|ANAL CANAL|IPSILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2020-10-13|40
e|FA|151308c7-03aa-4a0b-b13f-9838edb218ef|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/kg/dose|[?]|1|%(v/v)|AZYGOS VEIN|BILATERAL|Y||GUARDIAN|4|Visit_4|65|5|TREATMENT|2020-11-07|65
e|FA|151308c7-03aa-4a0b-b13f-9838edb218ef|8|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|mg2/dL2|[?]|1|10^6 IU/mL|CEREBRAL VEIN|LEFT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-11-07|65
e|FA|151308c7-03aa-4a0b-b13f-9838edb218ef|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|Pa|PATELLA|LATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|7|TREATMENT|2020-12-02|90
e|FA|151308c7-03aa-4a0b-b13f-9838edb218ef|10|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|mL*cmH2O|[?]|1|mEq|DISTAL PHALANX 3 OF THE HAND|IPSILATERAL|||CHILD|5|Visit_5|90|3|TREATMENT|2020-12-02|90
e|FA|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|1|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|pmol/dL|[?]|1|ohm|PROXIMAL INTERPHALANGEAL JOINT 2|UNILATERAL|Y||SPOUSE|1|Visit_1|10|5|WASHOUT|2020-06-15|10
e|FA|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|g/cage/day|[?]|1|mEq/g|CORPUS CALLOSUM|CONTRALATERAL||Y|ADJUDICATOR|1|Visit_1|10|4|FOLLOW-UP|2020-06-15|10
e|FA|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|%(v/v)|ILIOPSOAS MUSCLE|IPSILATERAL|||PARENT|2|Visit_2|25|7|FOLLOW-UP|2020-06-30|25
e|FA|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|4|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|ELISA unit|[?]|1|ng/day|HAND DIGIT 5|CONTRALATERAL||Y|PROXY|2|Visit_2|25|2|WASHOUT|2020-06-30|25
e|FA|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|5|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|U/g|[?]|1|10^6 CFU|INTERPHALANGEAL JOINT 3|BILATERAL||Y|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2020-07-15|40
e|FA|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|6|SEV|Severity/Intensity|[?]|GERD|[?]|/2500 WBC|[?]|1|Pa|TARSUS BONE|CONTRALATERAL|||SIBLING|3|Visit_3|40|6|TREATMENT|2020-07-15|40
e|FA|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|7|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|cd|[?]|1|10^6 U|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|IPSILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2020-08-09|65
e|FA|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|8|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|anti-Xa IU/mL|ABDUCTOR DIGITI QUINTI MUSCLE|IPSILATERAL||Y|INVESTIGATOR|4|Visit_4|65|2|FOLLOW-UP|2020-08-09|65
e|FA|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|9|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|fg|[?]|1|Shock Wave|BRAIN VENTRICLE|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|6|WASHOUT|2020-09-03|90
e|FA|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|10|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|100 IU/mL|SKIN OF THE BUTTOCK|BILATERAL|||PROXY|5|Visit_5|90|6|TREATMENT|2020-09-03|90
e|FA|23605586-1b30-4f05-bb15-417dd3a79994|1|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|SQU/mL|[?]|1|mIU/L|TRICUSPID VALVE ANNULUS|LEFT||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|WASHOUT|2020-10-31|10
e|FA|23605586-1b30-4f05-bb15-417dd3a79994|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit/dose|[?]|1|Pa|ISCHIUM|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|SCREENING|2020-10-31|10
e|FA|23605586-1b30-4f05-bb15-417dd3a79994|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|BU/mL|[?]|1|mg/h|PUPIL|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|WASHOUT|2020-11-15|25
e|FA|23605586-1b30-4f05-bb15-417dd3a79994|4|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|g/L|GASTROINTESTINAL TRACT, UPPER, WALL|LEFT|||INVESTIGATOR|2|Visit_2|25|2|WASHOUT|2020-11-15|25
e|FA|23605586-1b30-4f05-bb15-417dd3a79994|5|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|pmol/L/h|[?]|1|10^6 organisms/mL|LOWER RESPIRATORY SYSTEM|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-11-30|40
e|FA|23605586-1b30-4f05-bb15-417dd3a79994|6|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|mCi|[?]|1|mL/animal/day|SKIN OF THE PALM|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|3|WASHOUT|2020-11-30|40
e|FA|23605586-1b30-4f05-bb15-417dd3a79994|7|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|IU/mg|[?]|1|10^4 CFU/mL|INTERPHALANGEAL JOINT 5 OF THE HAND|CONTRALATERAL|||CAREGIVER|4|Visit_4|65|4|WASHOUT|2020-12-25|65
e|FA|23605586-1b30-4f05-bb15-417dd3a79994|8|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|uV*sec|[?]|1|aMFI|EPICONDYLE|IPSILATERAL|||VENDOR|4|Visit_4|65|3|TREATMENT|2020-12-25|65
e|FA|23605586-1b30-4f05-bb15-417dd3a79994|9|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|mL/m2/day|[?]|1|Gy/h|PENIS, BODY|UNILATERAL|||SPOUSE|5|Visit_5|90|3|TREATMENT|2021-01-19|90
e|FA|23605586-1b30-4f05-bb15-417dd3a79994|10|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|PIPE|[?]|1|10^6 CFU/mL|DISTAL RADIOULNAR JOINT|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2021-01-19|90
e|FA|57d15ac0-06a6-40e0-9201-4d947651c9b0|1|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|OI50|[?]|1|gtt|INTERPHALANGEAL JOINT 2 OF THE HAND|CONTRALATERAL|||FRIEND|1|Visit_1|10|4|TREATMENT|2020-08-28|10
e|FA|57d15ac0-06a6-40e0-9201-4d947651c9b0|2|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|cL|[?]|1|mIU/L|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|IPSILATERAL|||VENDOR|1|Visit_1|10|1|TREATMENT|2020-08-28|10
e|FA|57d15ac0-06a6-40e0-9201-4d947651c9b0|3|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|mL/g/min|[?]|1|h*%|TRANSVERSE TARSAL JOINT|RIGHT||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-09-12|25
e|FA|57d15ac0-06a6-40e0-9201-4d947651c9b0|4|EXCDUR|Exercise Duration|[?]|GERD|[?]|fraction of 1|[?]|1|mm|SKIN OF THE LIP|RIGHT||Y|CAREGIVER|2|Visit_2|25|1|TREATMENT|2020-09-12|25
e|FA|57d15ac0-06a6-40e0-9201-4d947651c9b0|5|LESNUM|Number of Lesions|[?]|GERD|[?]|mEq/day|[?]|1|ng/day|MITRAL VALVE, ANTERIOR ANNULUS|CONTRALATERAL||Y|SPOUSE|3|Visit_3|40|4|FOLLOW-UP|2020-09-27|40
e|FA|57d15ac0-06a6-40e0-9201-4d947651c9b0|6|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|psi|[?]|1|mL/min/mmHg|BLADDER, NECK|LEFT||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|FOLLOW-UP|2020-09-27|40
e|FA|57d15ac0-06a6-40e0-9201-4d947651c9b0|7|EVENTFRQ|Event Frequency|[?]|GERD|[?]|ug|[?]|1|ug/kg/h|PISIFORM BONE|LATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|5|FOLLOW-UP|2020-10-22|65
e|FA|57d15ac0-06a6-40e0-9201-4d947651c9b0|8|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|SACHET|[?]|1|mL/cm3/min|TEMPOROMANDIBULAR JOINT|BILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-10-22|65
e|FA|57d15ac0-06a6-40e0-9201-4d947651c9b0|9|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|NEEDLE GAUGE|PYRAMIDAL TRACTS, BRAINSTEM|IPSILATERAL||Y|GUARDIAN|5|Visit_5|90|6|FOLLOW-UP|2020-11-16|90
e|FA|57d15ac0-06a6-40e0-9201-4d947651c9b0|10|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|Torr|[?]|1|PACK|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|LEFT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|TREATMENT|2020-11-16|90
e|FA|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|/cmH2O|[?]|1|Pa|ANTERIOR CINGULATE GYRUS|RIGHT|Y|Y|VENDOR|1|Visit_1|10|1|FOLLOW-UP|2020-08-12|10
e|FA|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|2|LESNUM|Number of Lesions|[?]|GERD|[?]|APS U|[?]|1|ng/day|FEMORAL CONDYLE|UNILATERAL|||STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2020-08-12|10
e|FA|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|3|STRCTNUM|Number of Strictures|[?]|GERD|[?]|kBq|[?]|1|SACHET|SPINAL CORD|UNILATERAL||Y|ADJUDICATOR|2|Visit_2|25|7|WASHOUT|2020-08-27|25
e|FA|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|4|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|TRANSDUCING UNIT/mL|PLEURAL CAVITY|RIGHT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-08-27|25
e|FA|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|5|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/cage/wk|[?]|1|/500 WBC|SKIN OF THE UPPER LIMB|RIGHT|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|6|TREATMENT|2020-09-11|40
e|FA|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|amol|[?]|1|Shock Wave|HEPATIC VEIN|CONTRALATERAL|||ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2020-09-11|40
e|FA|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|7|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|%|[?]|1|cm|BONE MARROW|CONTRALATERAL|Y|Y|INDEPENDENT ASSESSOR|4|Visit_4|65|2|TREATMENT|2020-10-06|65
e|FA|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|8|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|TUBE|[?]|1|vp/dose|DORSALIS PEDIS ARTERY|BILATERAL|||SPOUSE|4|Visit_4|65|1|WASHOUT|2020-10-06|65
e|FA|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|9|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|10^8 PFU|[?]|1|umol|BLADDER, DOME|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-10-31|90
e|FA|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|10|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|kat|[?]|1|PACK|COLON, HEPATIC FLEXURE|LEFT|||INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2020-10-31|90
e|FA|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|1|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|mCi/kg|[?]|1|g/dL|L5-S1 INTERVERTEBRAL SPACE|RIGHT|Y|Y|INDEPENDENT ASSESSOR|1|Visit_1|10|5|TREATMENT|2020-08-31|10
e|FA|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|2|EVENTNUM|Number of Events|[?]|GERD|[?]|mg/g/min|[?]|1|U/10^12 RBC|ANKLE JOINT ANTERIOR FLEXOR TENDONS|LATERAL|Y|Y|ADJUDICATOR|1|Visit_1|10|1|SCREENING|2020-08-31|10
e|FA|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|3|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|ng/dL|[?]|1|g/dL|HEPATIC ARTERY|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-09-15|25
e|FA|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|4|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|mgEq|[?]|1|Bq/mg|INTERPHALANGEAL JOINT 4 OF THE HAND|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-09-15|25
e|FA|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|5|EVENTNUM|Number of Events|[?]|GERD|[?]|log10 PFU/mL|[?]|1|U/10^12 RBC|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|UNILATERAL|||SIBLING|3|Visit_3|40|7|FOLLOW-UP|2020-09-30|40
e|FA|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|6|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|mm3/mm2/year|[?]|1|10^6 organisms/mL|VAS DEFERENS|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-09-30|40
e|FA|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|7|SEV|Severity/Intensity|[?]|GERD|[?]|U|[?]|1|Pa|URETHRA|CONTRALATERAL|||PARENT|4|Visit_4|65|7|TREATMENT|2020-10-25|65
e|FA|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|8|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|kBq/uL|[?]|1|mL/m2|PHARYNGEAL TONSIL|LEFT||Y|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-10-25|65
e|FA|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|9|TOTNUM|Total Number|[?]|GERD|[?]|dL|[?]|1|/200 HPFs|JAW|LEFT|||VENDOR|5|Visit_5|90|2|TREATMENT|2020-11-19|90
e|FA|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|10|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|Bq/L|[?]|1|AU/mL|OCCIPITAL SCALP|LATERAL|||FRIEND|5|Visit_5|90|4|WASHOUT|2020-11-19|90
e|FA|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|Antibody Unit|[?]|1|%(v/v)|RETROCRURAL LYMPH NODE|RIGHT|||ADJUDICATOR|1|Visit_1|10|6|SCREENING|2020-12-24|10
e|FA|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|2|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|10^5/L|[?]|1|Gy/h|TRACHEOBRONCHIAL TREE|BILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-12-24|10
e|FA|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|3|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|COAT|[?]|1|cm H2O|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|IPSILATERAL|Y||STUDY SUBJECT|2|Visit_2|25|7|SCREENING|2021-01-08|25
e|FA|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|4|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|MAC50|[?]|1|TRANSDUCING UNIT/mL|OCULOMOTOR NERVE|BILATERAL|||GUARDIAN|2|Visit_2|25|7|FOLLOW-UP|2021-01-08|25
e|FA|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|C|[?]|1|mg/g/min|HUMERUS|LATERAL|||SIBLING|3|Visit_3|40|7|TREATMENT|2021-01-23|40
e|FA|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|6|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|U/mg|T3 VERTEBRA|LATERAL|||ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2021-01-23|40
e|FA|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|7|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|BOWL|[?]|1|DRUM|CAROTID ARTERY|IPSILATERAL||Y|FRIEND|4|Visit_4|65|4|TREATMENT|2021-02-17|65
e|FA|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|8|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|fmol|CARDIOVASCULAR SYSTEM|CONTRALATERAL|||CHILD|4|Visit_4|65|7|TREATMENT|2021-02-17|65
e|FA|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|9|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|MHz|[?]|1|10^6 CFU|PREAURICULAR LYMPH NODE|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2021-03-14|90
e|FA|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|ngEq/L|[?]|1|U/mg|SKULL|BILATERAL||Y|CAREGIVER|5|Visit_5|90|7|SCREENING|2021-03-14|90
e|FA|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|1|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|uU/dL|[?]|1|U/mmol|TRICUSPID VALVE, POSTERIOR ANNULUS|CONTRALATERAL||Y|INTERVIEWER|1|Visit_1|10|4|TREATMENT|2020-07-02|10
e|FA|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|2|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|pg/dL|[?]|1|Gy/h|PLACENTA|UNILATERAL|||FRIEND|1|Visit_1|10|6|FOLLOW-UP|2020-07-02|10
e|FA|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|3|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|/LPF|[?]|1|gtt|SEMINAL VESICLE|CONTRALATERAL|Y||CAREGIVER|2|Visit_2|25|2|TREATMENT|2020-07-17|25
e|FA|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|4|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|10^7 CFU|[?]|1|DRUM|BLOOD|IPSILATERAL||Y|CHILD|2|Visit_2|25|3|TREATMENT|2020-07-17|25
e|FA|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|Pa|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT|||INDEPENDENT ASSESSOR|3|Visit_3|40|7|TREATMENT|2020-08-01|40
e|FA|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|/4.0 mL|[?]|1|mg/g/min|DISTAL INTERPHALANGEAL JOINT 5|UNILATERAL|||SIBLING|3|Visit_3|40|1|WASHOUT|2020-08-01|40
e|FA|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|7|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|mL/g/day|[?]|1|Shock Wave|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|UNILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|4|TREATMENT|2020-08-26|65
e|FA|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|8|LDIAM|Longest Diameter|[?]|GERD|[?]|ug/L|[?]|1|Shock Wave|L5-S1 INTERVERTEBRAL SPACE|BILATERAL|Y||ADJUDICATOR|4|Visit_4|65|2|WASHOUT|2020-08-26|65
e|FA|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|9|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|s/h|[?]|1|/500 WBC|GRACILIS MUSCLE|IPSILATERAL|||INTERVIEWER|5|Visit_5|90|7|SCREENING|2020-09-20|90
e|FA|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mm3/mm2/year|[?]|1|10^6 U|LATERAL HUMERAL EPICONDYLE|BILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|6|FOLLOW-UP|2020-09-20|90
e|FA|81f62132-123e-4888-abbe-8e289599e965|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|mg/g/min|ABDUCTOR POLLICIS BREVIS MUSCLE|CONTRALATERAL|||SIBLING|1|Visit_1|10|7|WASHOUT|2020-12-04|10
e|FA|81f62132-123e-4888-abbe-8e289599e965|2|DMG|Dietary Magnesium|[?]|GERD|[?]|deg2|[?]|1|TRANSDUCING UNIT/mL|ANTERIOR CINGULATE CORTEX|LEFT|Y|Y|DOMESTIC PARTNER|1|Visit_1|10|7|SCREENING|2020-12-04|10
e|FA|81f62132-123e-4888-abbe-8e289599e965|3|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|Bq/uL|[?]|1|g/L|HAIR FOLLICLE|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-12-19|25
e|FA|81f62132-123e-4888-abbe-8e289599e965|4|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|BOWL|[?]|1|mL/cm3/min|LIP|CONTRALATERAL|||INVESTIGATOR|2|Visit_2|25|6|WASHOUT|2020-12-19|25
e|FA|81f62132-123e-4888-abbe-8e289599e965|5|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mL/cage|[?]|1|Weber|BLOOD|LATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|FOLLOW-UP|2021-01-03|40
e|FA|81f62132-123e-4888-abbe-8e289599e965|6|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|mEq|PARASPINAL REGION|LATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|SCREENING|2021-01-03|40
e|FA|81f62132-123e-4888-abbe-8e289599e965|7|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|umol/L/h|[?]|1|ug/m2/h|AXILLARY LYMPH NODE LEVEL II|LEFT|||FAMILY MEMBER|4|Visit_4|65|7|TREATMENT|2021-01-28|65
e|FA|81f62132-123e-4888-abbe-8e289599e965|8|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|pL|[?]|1|TRANSDUCING UNIT/mL|LIMB, UPPER|LATERAL|||CHILD|4|Visit_4|65|3|SCREENING|2021-01-28|65
e|FA|81f62132-123e-4888-abbe-8e289599e965|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|umol/min|[?]|1|mg/g/min|POPLITEAL VEIN|LEFT|||INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2021-02-22|90
e|FA|81f62132-123e-4888-abbe-8e289599e965|10|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|s*kPa|[?]|1|mL/mmHg/min/L|CORONARY SINUS|LATERAL|Y||INVESTIGATOR|5|Visit_5|90|6|SCREENING|2021-02-22|90
e|FA|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|1|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|%(w/v)|[?]|1|mg/dose|CERVIX UTERI|RIGHT||Y|PARENT|1|Visit_1|10|3|TREATMENT|2020-05-16|10
e|FA|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|2|DFIBER|Dietary Fiber|[?]|GERD|[?]|ug/mL/h|[?]|1|h*%|DELTOID MUSCLE|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-05-16|10
e|FA|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mOsm/kg|[?]|1|%(v/v)|PITUITARY GLAND|RIGHT|||SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2020-05-31|25
e|FA|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|DISK|[?]|1|Pa|COLON, RECTOSIGMOID|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-05-31|25
e|FA|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|5|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|nmol|[?]|1|oz eq|ATRIOVENTRICULAR VALVE|LEFT|||SIBLING|3|Visit_3|40|7|WASHOUT|2020-06-15|40
e|FA|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|6|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|/MBP|[?]|1|mIU/L|DENTAL ARCH|LATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|5|WASHOUT|2020-06-15|40
e|FA|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|7|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|Ci/g|[?]|1|mm|COMMON ILIAC ARTERY|BILATERAL|||CAREGIVER|4|Visit_4|65|6|WASHOUT|2020-07-10|65
e|FA|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|8|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|GPL U/mL|[?]|1|AU/mL|RETINAL NERVE FIBER LAYER|IPSILATERAL|||ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-07-10|65
e|FA|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|9|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|tsp|[?]|1|g/L|SPLENIC ARTERY|LATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2020-08-04|90
e|FA|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|deg|[?]|1|%(v/v)|CLITORIS|CONTRALATERAL|Y||PROXY|5|Visit_5|90|1|FOLLOW-UP|2020-08-04|90
e|FA|49282406-97ec-4108-adf9-e01c18ce59c6|1|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms|[?]|1|umol|THORAX|RIGHT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-05-17|10
e|FA|49282406-97ec-4108-adf9-e01c18ce59c6|2|VOL|Volume|[?]|GERD|[?]|mEq|[?]|1|vp/dose|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|UNILATERAL||Y|FRIEND|1|Visit_1|10|6|FOLLOW-UP|2020-05-17|10
e|FA|49282406-97ec-4108-adf9-e01c18ce59c6|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|cd|[?]|1|Pa|FLEXOR DIGITORUM BREVIS MUSCLE|BILATERAL||Y|PARENT|2|Visit_2|25|5|WASHOUT|2020-06-01|25
e|FA|49282406-97ec-4108-adf9-e01c18ce59c6|4|DIAMETER|Diameter|[?]|GERD|[?]|FIU|[?]|1|cm|HAIR|LEFT|||VENDOR|2|Visit_2|25|4|FOLLOW-UP|2020-06-01|25
e|FA|49282406-97ec-4108-adf9-e01c18ce59c6|5|SEV|Severity/Intensity|[?]|GERD|[?]|mg2/dL2|[?]|1|Pa|THORACIC LYMPH NODE|CONTRALATERAL|||SPOUSE|3|Visit_3|40|7|TREATMENT|2020-06-16|40
e|FA|49282406-97ec-4108-adf9-e01c18ce59c6|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|log10 TCID 50/uL|[?]|1|mg/g/min|SUPERIOR VENA CAVA|UNILATERAL||Y|INTERVIEWER|3|Visit_3|40|5|TREATMENT|2020-06-16|40
e|FA|49282406-97ec-4108-adf9-e01c18ce59c6|7|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|mmol/day|[?]|1|U/10^12 RBC|TRIGEMINAL NERVE|LEFT|||FAMILY MEMBER|4|Visit_4|65|3|FOLLOW-UP|2020-07-11|65
e|FA|49282406-97ec-4108-adf9-e01c18ce59c6|8|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|10^3 copies/mL|[?]|1|Coulomb|PROSTATE GLAND|RIGHT|||PARENT|4|Visit_4|65|6|TREATMENT|2020-07-11|65
e|FA|49282406-97ec-4108-adf9-e01c18ce59c6|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|amu|[?]|1|%(v/v)|FLEXOR DIGITORUM PROFUNDUS MUSCLE|UNILATERAL|||ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-08-05|90
e|FA|49282406-97ec-4108-adf9-e01c18ce59c6|10|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|U/cL|[?]|1|Bq/L|FINGER EXTENSOR MUSCLES|RIGHT|Y|Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2020-08-05|90
e|FA|310936c8-7d24-4eea-9892-1cd8bb675421|1|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|ms/mmHg|[?]|1|Shock Wave|MIDBRAIN|CONTRALATERAL|||STUDY SUBJECT|1|Visit_1|10|4|FOLLOW-UP|2020-07-06|10
e|FA|310936c8-7d24-4eea-9892-1cd8bb675421|2|SEV|Severity/Intensity|[?]|GERD|[?]|JAR|[?]|1|Pa|NASOPHARYNX|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|FOLLOW-UP|2020-07-06|10
e|FA|310936c8-7d24-4eea-9892-1cd8bb675421|3|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|BAR|[?]|1|Weber|ANTECUBITAL FOSSA|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-07-21|25
e|FA|310936c8-7d24-4eea-9892-1cd8bb675421|4|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|MESF|[?]|1|mIU/L|T4 VERTEBRA|RIGHT|||PARENT|2|Visit_2|25|6|TREATMENT|2020-07-21|25
e|FA|310936c8-7d24-4eea-9892-1cd8bb675421|5|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|umol/mg/min|[?]|1|mL/cm3/min|LUNG|BILATERAL||Y|SIBLING|3|Visit_3|40|2|TREATMENT|2020-08-05|40
e|FA|310936c8-7d24-4eea-9892-1cd8bb675421|6|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|ug/animal|[?]|1|psi|RADIUS SHAFT|BILATERAL||Y|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-08-05|40
e|FA|310936c8-7d24-4eea-9892-1cd8bb675421|7|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|/kg|[?]|1|g/day|PROCERUS MUSCLE|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-08-30|65
e|FA|310936c8-7d24-4eea-9892-1cd8bb675421|8|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|m3|[?]|1|mIU/L|PERIUMBILICAL REGION|UNILATERAL|||VENDOR|4|Visit_4|65|2|FOLLOW-UP|2020-08-30|65
e|FA|310936c8-7d24-4eea-9892-1cd8bb675421|9|QOLIMP|QOL Impact|[?]|GERD|[?]|Joule|[?]|1|10^6/L|XIPHOID PROCESS|UNILATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2020-09-24|90
e|FA|310936c8-7d24-4eea-9892-1cd8bb675421|10|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|Tesla|[?]|1|cmH2O/mL|PERICARDIAL LYMPH NODE|CONTRALATERAL|||PROXY|5|Visit_5|90|4|TREATMENT|2020-09-24|90
e|FA|034e303b-5675-4188-bcea-fc2e53b155d6|1|RLDEV|Relationship to Device|[?]|GERD|[?]|dyn|[?]|1|mL/min/mmHg|INTERPHALANGEAL JOINT 4 OF THE FOOT|BILATERAL|||FRIEND|1|Visit_1|10|7|TREATMENT|2020-06-01|10
e|FA|034e303b-5675-4188-bcea-fc2e53b155d6|2|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|/500 WBC|[?]|1|cm H2O|CERVIX UTERI|CONTRALATERAL||Y|SPOUSE|1|Visit_1|10|2|TREATMENT|2020-06-01|10
e|FA|034e303b-5675-4188-bcea-fc2e53b155d6|3|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|Bq/kg|[?]|1|10^9 CFU/mL|SUBLINGUAL REGION|UNILATERAL|Y|Y|INTERVIEWER|2|Visit_2|25|3|TREATMENT|2020-06-16|25
e|FA|034e303b-5675-4188-bcea-fc2e53b155d6|4|SEV|Severity/Intensity|[?]|GERD|[?]|TRACE|[?]|1|Pa|LACRIMAL GLAND|CONTRALATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-06-16|25
e|FA|034e303b-5675-4188-bcea-fc2e53b155d6|5|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|m2|ANKLE JOINT ANTERIOR FLEXOR TENDONS|LATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-07-01|40
e|FA|034e303b-5675-4188-bcea-fc2e53b155d6|6|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|cmol|[?]|1|oz eq|PALPEBRAL FISSURE|CONTRALATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|WASHOUT|2020-07-01|40
e|FA|034e303b-5675-4188-bcea-fc2e53b155d6|7|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mg/kg/min|[?]|1|10^6 U|ANASTOMOSIS|UNILATERAL|||CAREGIVER|4|Visit_4|65|1|TREATMENT|2020-07-26|65
e|FA|034e303b-5675-4188-bcea-fc2e53b155d6|8|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|in|BODY OF STOMACH|IPSILATERAL||Y|INTERVIEWER|4|Visit_4|65|1|WASHOUT|2020-07-26|65
e|FA|034e303b-5675-4188-bcea-fc2e53b155d6|9|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|mEq/g|[?]|1|mL/h|MAXILLA|RIGHT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-08-20|90
e|FA|034e303b-5675-4188-bcea-fc2e53b155d6|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|pg/L|[?]|1|oz eq|HARD PALATE|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|SCREENING|2020-08-20|90
e|FA|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|1|LENRSCT|Length of Resection|[?]|GERD|[?]|log10 TCID 50/dose|[?]|1|psi|LUNG, RIGHT|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|SCREENING|2020-07-07|10
e|FA|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|MASK|[?]|1|mg/g/min|TRICUSPID VALVE, ANTERIOR CUSP|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|WASHOUT|2020-07-07|10
e|FA|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|3|DCAL|Dietary Calories|[?]|GERD|[?]|EU|[?]|1|EIA unit|ACHILLES TENDON|RIGHT|||CAREGIVER|2|Visit_2|25|3|TREATMENT|2020-07-22|25
e|FA|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/cm2|[?]|1|Pa|STRIATUM|LATERAL|||FAMILY MEMBER|2|Visit_2|25|7|WASHOUT|2020-07-22|25
e|FA|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|5|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|MPL U|[?]|1|mL/cm3/min|GALLBLADDER|IPSILATERAL||Y|VENDOR|3|Visit_3|40|4|TREATMENT|2020-08-06|40
e|FA|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|6|DFIBER|Dietary Fiber|[?]|GERD|[?]|pmol/day|[?]|1|h*%|CAPITATE-LUNATE JOINT|BILATERAL|||PARENT|3|Visit_3|40|6|TREATMENT|2020-08-06|40
e|FA|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|7|ACNDEV|Action Taken With Device|[?]|GERD|[?]|nmol/kg/day|[?]|1|100 IU/mL|HEAD|LEFT||Y|CHILD|4|Visit_4|65|4|TREATMENT|2020-08-31|65
e|FA|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|8|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|TUBE|[?]|1|BOWL|DISTAL EXTRAHEPATIC BILE DUCT REGION|UNILATERAL|||FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2020-08-31|65
e|FA|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|9|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|EIA unit|[?]|1|U/mmol|FEMUR SHAFT|CONTRALATERAL|||GUARDIAN|5|Visit_5|90|7|SCREENING|2020-09-25|90
e|FA|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|10|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU|[?]|1|CUP|CALCARINE SULCUS|BILATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|5|SCREENING|2020-09-25|90
e|FA|c912affb-cbc2-4919-81b4-ecaa03908261|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|%(v/v)|FINGER EXTENSOR MUSCLES|LATERAL||Y|SPOUSE|1|Visit_1|10|1|WASHOUT|2020-07-12|10
e|FA|c912affb-cbc2-4919-81b4-ecaa03908261|2|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|mMU/mL|[?]|1|Gy/h|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|LEFT|||SIBLING|1|Visit_1|10|3|TREATMENT|2020-07-12|10
e|FA|c912affb-cbc2-4919-81b4-ecaa03908261|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|log10 PFU/mL|[?]|1|mg/g/min|KIDNEY, LOWER LOBE|IPSILATERAL||Y|FRIEND|2|Visit_2|25|2|TREATMENT|2020-07-27|25
e|FA|c912affb-cbc2-4919-81b4-ecaa03908261|4|OBJNUM|Number of Objects|[?]|GERD|[?]|nmol BCE/nmol|[?]|1|mL/100g/min|COLON, ASCENDING|LATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2020-07-27|25
e|FA|c912affb-cbc2-4919-81b4-ecaa03908261|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/g/min|[?]|1|Pa|SUBCARINAL LYMPH NODE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|TREATMENT|2020-08-11|40
e|FA|c912affb-cbc2-4919-81b4-ecaa03908261|6|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|10^3/L|[?]|1|mIU/L|PALPEBRAL CONJUNCTIVA|UNILATERAL|||SPOUSE|3|Visit_3|40|6|TREATMENT|2020-08-11|40
e|FA|c912affb-cbc2-4919-81b4-ecaa03908261|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|/wk|[?]|1|mg/g/min|GREAT SAPHENOUS VEIN|RIGHT|||GUARDIAN|4|Visit_4|65|2|WASHOUT|2020-09-05|65
e|FA|c912affb-cbc2-4919-81b4-ecaa03908261|8|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|cGy|[?]|1|TRANSDUCING UNIT/mL|LIVER FISSURE|LEFT|||ADJUDICATOR|4|Visit_4|65|4|TREATMENT|2020-09-05|65
e|FA|c912affb-cbc2-4919-81b4-ecaa03908261|9|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|mL/h|[?]|1|Bq/mg|ANUS|BILATERAL||Y|CHILD|5|Visit_5|90|3|WASHOUT|2020-09-30|90
e|FA|c912affb-cbc2-4919-81b4-ecaa03908261|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|steps/min|[?]|1|mg/g/min|COMMON FEMORAL VEIN|RIGHT|Y|Y|SPOUSE|5|Visit_5|90|2|WASHOUT|2020-09-30|90
e|FA|5af817f0-5dfb-4046-ac7c-4bae16a90036|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|10^3 DNA copies/mL|[?]|1|SCOOPFUL|HEART|BILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-07-06|10
e|FA|5af817f0-5dfb-4046-ac7c-4bae16a90036|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|copies/mL|[?]|1|mg/g/min|METACARPAL BONE 2|IPSILATERAL|Y||ADJUDICATOR|1|Visit_1|10|5|TREATMENT|2020-07-06|10
e|FA|5af817f0-5dfb-4046-ac7c-4bae16a90036|3|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|cg|[?]|1|mm|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|BILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-07-21|25
e|FA|5af817f0-5dfb-4046-ac7c-4bae16a90036|4|DFIBER|Dietary Fiber|[?]|GERD|[?]|Gy/h|[?]|1|h*%|SENSORIMOTOR CORTEX|UNILATERAL|||INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-07-21|25
e|FA|5af817f0-5dfb-4046-ac7c-4bae16a90036|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|CAPSULE|[?]|1|mg/g/min|HEPATIC LYMPH NODE|RIGHT|||PARENT|3|Visit_3|40|4|TREATMENT|2020-08-05|40
e|FA|5af817f0-5dfb-4046-ac7c-4bae16a90036|6|DISTANCE|Distance|[?]|GERD|[?]|pt_us|[?]|1|BOWL|POSTERIOR POLE OF THE EYE|RIGHT|||STUDY SUBJECT|3|Visit_3|40|2|FOLLOW-UP|2020-08-05|40
e|FA|5af817f0-5dfb-4046-ac7c-4bae16a90036|7|SERVNUM|Number of Servings|[?]|GERD|[?]|mmol/mol|[?]|1|Hz/s|BRACHIAL PLEXUS|UNILATERAL|||STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2020-08-30|65
e|FA|5af817f0-5dfb-4046-ac7c-4bae16a90036|8|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|APS U|[?]|1|ohm|GENITAL TUBERCLE|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|WASHOUT|2020-08-30|65
e|FA|5af817f0-5dfb-4046-ac7c-4bae16a90036|9|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|pt_br|[?]|1|10^9 CFU/g|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|IPSILATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|7|FOLLOW-UP|2020-09-24|90
e|FA|5af817f0-5dfb-4046-ac7c-4bae16a90036|10|SEV|Severity/Intensity|[?]|GERD|[?]|U/kg|[?]|1|Pa|WARDS TRIANGLE|UNILATERAL||Y|PARENT|5|Visit_5|90|4|TREATMENT|2020-09-24|90
e|FA|dcefd656-a59a-4b71-9260-efcbcecd2132|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/g/day|[?]|1|Pa|FLEXOR DIGITORUM LONGUS MUSCLE|CONTRALATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|7|SCREENING|2020-06-04|10
e|FA|dcefd656-a59a-4b71-9260-efcbcecd2132|2|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|fmol/g|[?]|1|U/mmol|TEMPORAL ARTERY|RIGHT|Y|Y|ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-06-04|10
e|FA|dcefd656-a59a-4b71-9260-efcbcecd2132|3|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|mL/cm H2O|[?]|1|cmH2O/mL|MIDBRAIN|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|SCREENING|2020-06-19|25
e|FA|dcefd656-a59a-4b71-9260-efcbcecd2132|4|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|titer|[?]|1|SACHET|POPLITEAL ARTERY ABOVE KNEE|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-06-19|25
e|FA|dcefd656-a59a-4b71-9260-efcbcecd2132|5|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|mL|SCAPHOID-LUNATE-CAPITATE JOINT|IPSILATERAL|Y|Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|TREATMENT|2020-07-04|40
e|FA|dcefd656-a59a-4b71-9260-efcbcecd2132|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|Shock Wave|BODY|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2020-07-04|40
e|FA|dcefd656-a59a-4b71-9260-efcbcecd2132|7|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/mL|[?]|1|SACHET|CEREBRAL SUBCORTEX|BILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|6|SCREENING|2020-07-29|65
e|FA|dcefd656-a59a-4b71-9260-efcbcecd2132|8|DFRUIT|Dietary Fruit|[?]|GERD|[?]|pmol/L/h|[?]|1|10^6 CFU/mL|GLOTTIS|CONTRALATERAL||Y|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-07-29|65
e|FA|dcefd656-a59a-4b71-9260-efcbcecd2132|9|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|PACKAGE|[?]|1|uL/kg/day|MESENTERIC ARTERY|CONTRALATERAL|Y||PROXY|5|Visit_5|90|4|TREATMENT|2020-08-23|90
e|FA|dcefd656-a59a-4b71-9260-efcbcecd2132|10|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/m2|[?]|1|g/cage/day|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|RIGHT|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|WASHOUT|2020-08-23|90
e|FA|641c8067-941a-4f1a-a7b1-4eea0242f1d7|1|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/g|[?]|1|uCi/kg|L5-S1 INTERVERTEBRAL SPACE|LATERAL|||STUDY SUBJECT|1|Visit_1|10|5|FOLLOW-UP|2020-12-22|10
e|FA|641c8067-941a-4f1a-a7b1-4eea0242f1d7|2|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|DRUM|[?]|1|cmH2O/mL|EXTERNAL ILIAC LYMPH NODE|LEFT|||FRIEND|1|Visit_1|10|6|TREATMENT|2020-12-22|10
e|FA|641c8067-941a-4f1a-a7b1-4eea0242f1d7|3|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|BAG|[?]|1|CUP|FLEXOR DIGITORUM BREVIS MUSCLE|RIGHT|||GUARDIAN|2|Visit_2|25|3|TREATMENT|2021-01-06|25
e|FA|641c8067-941a-4f1a-a7b1-4eea0242f1d7|4|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|kHz|[?]|1|mmHg/L/min|GASTROINTESTINAL TRACT, UPPER, WALL|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2021-01-06|25
e|FA|641c8067-941a-4f1a-a7b1-4eea0242f1d7|5|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|cmHg|[?]|1|mg/dose|RAMUS INTERMEDIUS ARTERY|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|7|FOLLOW-UP|2021-01-21|40
e|FA|641c8067-941a-4f1a-a7b1-4eea0242f1d7|6|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|10^11/L|[?]|1|in|LEFT POSTERIOR DESCENDING ARTERY|CONTRALATERAL||Y|FRIEND|3|Visit_3|40|3|TREATMENT|2021-01-21|40
e|FA|641c8067-941a-4f1a-a7b1-4eea0242f1d7|7|LENRSCT|Length of Resection|[?]|GERD|[?]|Henry|[?]|1|psi|NAVICULAR BONE|RIGHT|Y||INTERVIEWER|4|Visit_4|65|4|FOLLOW-UP|2021-02-15|65
e|FA|641c8067-941a-4f1a-a7b1-4eea0242f1d7|8|LESNUM|Number of Lesions|[?]|GERD|[?]|U/dL|[?]|1|ng/day|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|||INTERVIEWER|4|Visit_4|65|1|FOLLOW-UP|2021-02-15|65
e|FA|641c8067-941a-4f1a-a7b1-4eea0242f1d7|9|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|Watt|[?]|1|IU/mmol|UPPER RESPIRATORY SYSTEM|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2021-03-12|90
e|FA|641c8067-941a-4f1a-a7b1-4eea0242f1d7|10|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|10^8/L|[?]|1|L/h/m2|HEPATOBILIARY SYSTEM|BILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|3|FOLLOW-UP|2021-03-12|90
e|FA|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|1|TOTNUM|Total Number|[?]|GERD|[?]|fg|[?]|1|/200 HPFs|HEART, ATRIUM|RIGHT|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|5|WASHOUT|2020-09-24|10
e|FA|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|2|EXTRSCT|Extent of Resection|[?]|GERD|[?]|DDU|[?]|1|Weber|EPIGASTRIC REGION|RIGHT||Y|PROXY|1|Visit_1|10|6|TREATMENT|2020-09-24|10
e|FA|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|3|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|vp/dose|CUBOID BONE|IPSILATERAL|Y|Y|CAREGIVER|2|Visit_2|25|7|TREATMENT|2020-10-09|25
e|FA|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|4|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|min*mg/mL|[?]|1|mL|ENDOMETRIUM|CONTRALATERAL||Y|FAMILY MEMBER|2|Visit_2|25|1|SCREENING|2020-10-09|25
e|FA|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU|[?]|1|mg/g/min|INFRACLAVICULAR LYMPH NODE|UNILATERAL|Y|Y|PROXY|3|Visit_3|40|1|TREATMENT|2020-10-24|40
e|FA|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|6|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|Torr|[?]|1|mL/cm3/min|HILAR|BILATERAL|||PROXY|3|Visit_3|40|2|WASHOUT|2020-10-24|40
e|FA|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|7|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|L/s|[?]|1|10^6 U|PERONEAL ARTERY|BILATERAL|||VENDOR|4|Visit_4|65|6|TREATMENT|2020-11-18|65
e|FA|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|8|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|cd/m2|[?]|1|in|ABDUCTOR POLLICIS BREVIS MUSCLE|LATERAL||Y|SIBLING|4|Visit_4|65|3|TREATMENT|2020-11-18|65
e|FA|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|9|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|DROP|[?]|1|BOWL|AORTIC VALVE, LEFT CORONARY CUSP|UNILATERAL||Y|SPOUSE|5|Visit_5|90|4|TREATMENT|2020-12-13|90
e|FA|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|10|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|IU/mL|[?]|1|m2|MIDDLE PHALANX 5 OF THE HAND|LATERAL||Y|CHILD|5|Visit_5|90|4|TREATMENT|2020-12-13|90
e|FA|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|1|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|QUANTITY SUFFICIENT|RIGHT VENTRICULAR BRANCH|UNILATERAL|Y||SPOUSE|1|Visit_1|10|2|TREATMENT|2020-10-31|10
e|FA|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|2|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|dram|[?]|1|U/mg|RIGHT CORONARY ARTERY OSTIUM|IPSILATERAL|||FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2020-10-31|10
e|FA|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|3|VOL|Volume|[?]|GERD|[?]|titer|[?]|1|vp/dose|HAND PHALANX|IPSILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|3|SCREENING|2020-11-15|25
e|FA|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|4|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|Ci/L|[?]|1|ohm|CLITORIS|RIGHT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2020-11-15|25
e|FA|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|5|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|mL/m2/day|[?]|1|mIU/L|MESENTERIC ARTERY|RIGHT|||GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-11-30|40
e|FA|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|6|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|kPa/L/sec|[?]|1|10^6 U|HAND DIGIT 5|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-11-30|40
e|FA|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|7|SEV|Severity/Intensity|[?]|GERD|[?]|ft2|[?]|1|Pa|FINGER EXTENSOR MUSCLES|BILATERAL||Y|PARENT|4|Visit_4|65|5|WASHOUT|2020-12-25|65
e|FA|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|8|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|mg/mL/min|[?]|1|DRUM|PITUITARY GLAND|UNILATERAL||Y|CAREGIVER|4|Visit_4|65|4|WASHOUT|2020-12-25|65
e|FA|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|9|SERVNUM|Number of Servings|[?]|GERD|[?]|mmol/kg|[?]|1|Hz/s|PROCERUS MUSCLE|IPSILATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2021-01-19|90
e|FA|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/kg/day|[?]|1|mg/g/min|THROAT|IPSILATERAL|||ADJUDICATOR|5|Visit_5|90|4|WASHOUT|2021-01-19|90
e|FA|46304edd-0b05-4819-8fcb-35cf9c02764d|1|LOCONSET|Localization of Onset|[?]|GERD|[?]|log10 copies/mL|[?]|1|g/L|PAROTID GLAND LYMPH NODE|LATERAL|||STUDY SUBJECT|1|Visit_1|10|5|SCREENING|2020-12-03|10
e|FA|46304edd-0b05-4819-8fcb-35cf9c02764d|2|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|L/day|[?]|1|10^6 U|SKIN OF THE LIP|BILATERAL||Y|SIBLING|1|Visit_1|10|4|FOLLOW-UP|2020-12-03|10
e|FA|46304edd-0b05-4819-8fcb-35cf9c02764d|3|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|cpm|[?]|1|TRANSDUCING UNIT/mL|BLADDER, NECK|RIGHT|||ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-12-18|25
e|FA|46304edd-0b05-4819-8fcb-35cf9c02764d|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PRESSOR UNITS|[?]|1|mg/g/min|LOWER GASTROINTESTINAL TRACT LYMPH NODE|IPSILATERAL||Y|CAREGIVER|2|Visit_2|25|6|TREATMENT|2020-12-18|25
e|FA|46304edd-0b05-4819-8fcb-35cf9c02764d|5|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|/2500 WBC|[?]|1|psi|INTERPHALANGEAL JOINT OF THE HAND|BILATERAL|||INVESTIGATOR|3|Visit_3|40|4|WASHOUT|2021-01-02|40
e|FA|46304edd-0b05-4819-8fcb-35cf9c02764d|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|KIT|[?]|1|ug/g/h|BODY|LATERAL|||GUARDIAN|3|Visit_3|40|1|SCREENING|2021-01-02|40
e|FA|46304edd-0b05-4819-8fcb-35cf9c02764d|7|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|Absorbance U|[?]|1|oz eq|PRELARYNGEAL LYMPH NODE|RIGHT||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|SCREENING|2021-01-27|65
e|FA|46304edd-0b05-4819-8fcb-35cf9c02764d|8|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|Ci/uL|[?]|1|g/L|URETHRAL SPHINCTER|CONTRALATERAL|||VENDOR|4|Visit_4|65|3|SCREENING|2021-01-27|65
e|FA|46304edd-0b05-4819-8fcb-35cf9c02764d|9|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|10^9 organisms/mg|[?]|1|L|INTERPHALANGEAL OF THE FOOT|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|SCREENING|2021-02-21|90
e|FA|46304edd-0b05-4819-8fcb-35cf9c02764d|10|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|cm|[?]|1|10^6/L|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|BILATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|4|WASHOUT|2021-02-21|90
e|FA|3fd6dab2-b35f-4cc5-88dd-b507583d9539|1|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|10^4 CFU/mL|[?]|1|mm/h|RENAL PELVIS|CONTRALATERAL|Y||SPOUSE|1|Visit_1|10|2|FOLLOW-UP|2020-05-26|10
e|FA|3fd6dab2-b35f-4cc5-88dd-b507583d9539|2|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|10^6 CFU/g|[?]|1|fmol|METACARPAL BONE 3|BILATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|SCREENING|2020-05-26|10
e|FA|3fd6dab2-b35f-4cc5-88dd-b507583d9539|3|LENRSCT|Length of Resection|[?]|GERD|[?]|pmol/dL|[?]|1|psi|PERIUMBILICAL REGION|CONTRALATERAL|||VENDOR|2|Visit_2|25|3|FOLLOW-UP|2020-06-10|25
e|FA|3fd6dab2-b35f-4cc5-88dd-b507583d9539|4|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|mL/cage|[?]|1|gtt|BREAST|IPSILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-06-10|25
e|FA|3fd6dab2-b35f-4cc5-88dd-b507583d9539|5|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|vp/mL|[?]|1|/500 WBC|SUPERIOR VENA CAVA|BILATERAL||Y|INTERVIEWER|3|Visit_3|40|5|TREATMENT|2020-06-25|40
e|FA|3fd6dab2-b35f-4cc5-88dd-b507583d9539|6|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|APPLICATION|[?]|1|Shock Wave|SAPHENOUS VEIN|LEFT||Y|SIGNIFICANT OTHER|3|Visit_3|40|1|FOLLOW-UP|2020-06-25|40
e|FA|3fd6dab2-b35f-4cc5-88dd-b507583d9539|7|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|pkat/L|[?]|1|km|POSTERIOR CINGULATE CORTEX|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|WASHOUT|2020-07-20|65
e|FA|3fd6dab2-b35f-4cc5-88dd-b507583d9539|8|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|log10 CFU/g|[?]|1|cm|ARTERY|CONTRALATERAL|||FRIEND|4|Visit_4|65|1|TREATMENT|2020-07-20|65
e|FA|3fd6dab2-b35f-4cc5-88dd-b507583d9539|9|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|cm|[?]|1|DRUM|COCCYX|LEFT|||STUDY SUBJECT|5|Visit_5|90|7|FOLLOW-UP|2020-08-14|90
e|FA|3fd6dab2-b35f-4cc5-88dd-b507583d9539|10|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|DISK|[?]|1|DRUM|PANCREAS, BODY|LEFT|||DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-08-14|90
e|FA|daa3b89e-637a-43de-86c1-d0db93f00430|1|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|GLOBULE|[?]|1|SACHET|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|CONTRALATERAL|||PROXY|1|Visit_1|10|5|WASHOUT|2020-10-11|10
e|FA|daa3b89e-637a-43de-86c1-d0db93f00430|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT|[?]|1|Pa|HAND DIGIT 4|UNILATERAL|||INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-10-11|10
e|FA|daa3b89e-637a-43de-86c1-d0db93f00430|3|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|pkat/L|[?]|1|/500 WBC|BULBAR CONJUNCTIVA|LATERAL|||INTERVIEWER|2|Visit_2|25|3|TREATMENT|2020-10-26|25
e|FA|daa3b89e-637a-43de-86c1-d0db93f00430|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|NEBULE|[?]|1|Pa|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|6|FOLLOW-UP|2020-10-26|25
e|FA|daa3b89e-637a-43de-86c1-d0db93f00430|5|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|min/day|[?]|1|BOWL|NOSE|CONTRALATERAL|||PROXY|3|Visit_3|40|4|WASHOUT|2020-11-10|40
e|FA|daa3b89e-637a-43de-86c1-d0db93f00430|6|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|ug/L FEU|[?]|1|mAmp|VASTUS INTERMEDIUS MUSCLE|LATERAL|Y||PROXY|3|Visit_3|40|3|FOLLOW-UP|2020-11-10|40
e|FA|daa3b89e-637a-43de-86c1-d0db93f00430|7|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|10^3 copies/mL|[?]|1|mg/dose|LUNG, LEFT UPPER LOBE|LEFT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-12-05|65
e|FA|daa3b89e-637a-43de-86c1-d0db93f00430|8|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|mL/100g/min|[?]|1|psi|CORNEAL EPITHELIUM|CONTRALATERAL|Y||FRIEND|4|Visit_4|65|4|TREATMENT|2020-12-05|65
e|FA|daa3b89e-637a-43de-86c1-d0db93f00430|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^6 CFU/mL|[?]|1|mg/g/min|VASTUS LATERALIS MUSCLE|IPSILATERAL|||FRIEND|5|Visit_5|90|5|TREATMENT|2020-12-30|90
e|FA|daa3b89e-637a-43de-86c1-d0db93f00430|10|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|kBq|[?]|1|IU/mg|INCUS|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2020-12-30|90
e|FA|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|1|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|10^6 U|SUBGLOTTIS|CONTRALATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|5|TREATMENT|2020-07-04|10
e|FA|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|2|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|/ms|[?]|1|m2|CORPUS CALLOSUM, GENU|UNILATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-07-04|10
e|FA|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^6 organisms|[?]|1|%(v/v)|MITRAL VALVE, ANTERIOR CUSP|UNILATERAL||Y|SIBLING|2|Visit_2|25|7|FOLLOW-UP|2020-07-19|25
e|FA|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|4|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|CIGAR|[?]|1|L/h/m2|TYMPANIC MEMBRANE|BILATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|7|FOLLOW-UP|2020-07-19|25
e|FA|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|5|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|foz_us|[?]|1|/200 HPFs|PECTORALIS MINOR MUSCLE|BILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-08-03|40
e|FA|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|6|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|10^5/hpf|[?]|1|ohm|LOWER JUGULAR LYMPH NODE|LATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-08-03|40
e|FA|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|7|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|pmol/L|[?]|1|mAmp|PERIHILAR LYMPH NODE|IPSILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|5|SCREENING|2020-08-28|65
e|FA|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|8|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/L|[?]|1|/kg|GLOTTIS|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|FOLLOW-UP|2020-08-28|65
e|FA|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^7 PFU|[?]|1|%(v/v)|FEMALE GENITALIA|RIGHT||Y|STUDY SUBJECT|5|Visit_5|90|4|TREATMENT|2020-09-22|90
e|FA|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|10|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|mg/mL/min|[?]|1|BP|RECTOSIGMOID JUNCTION|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2020-09-22|90
e|FA|c22014f2-2d7b-4897-8ad5-e46785e51837|1|OBJTYPE|Type of Object|[?]|GERD|[?]|mL/cage|[?]|1|ng|EYELASH|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-08-13|10
e|FA|c22014f2-2d7b-4897-8ad5-e46785e51837|2|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|OD Unit|[?]|1|BOWL|SEMINAL VESICLE|CONTRALATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2020-08-13|10
e|FA|c22014f2-2d7b-4897-8ad5-e46785e51837|3|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|mg/kg/week|[?]|1|mmHg/L/min|AXILLARY LYMPH NODE LEVEL I|RIGHT|||FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-08-28|25
e|FA|c22014f2-2d7b-4897-8ad5-e46785e51837|4|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|EID 50/dose|[?]|1|fmol|POPLITEAL VEIN|RIGHT|||SIBLING|2|Visit_2|25|5|TREATMENT|2020-08-28|25
e|FA|c22014f2-2d7b-4897-8ad5-e46785e51837|5|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|kIU|[?]|1|PACK|RADIUS-LUNATE JOINT|CONTRALATERAL|||FRIEND|3|Visit_3|40|6|TREATMENT|2020-09-12|40
e|FA|c22014f2-2d7b-4897-8ad5-e46785e51837|6|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|BOWL|[?]|1|Ci/ug|MUCOSA OF THE LIP|RIGHT||Y|VENDOR|3|Visit_3|40|3|TREATMENT|2020-09-12|40
e|FA|c22014f2-2d7b-4897-8ad5-e46785e51837|7|DFIBER|Dietary Fiber|[?]|GERD|[?]|mmol/s|[?]|1|h*%|SUDORIFEROUS GLAND|CONTRALATERAL|||INTERVIEWER|4|Visit_4|65|3|TREATMENT|2020-10-07|65
e|FA|c22014f2-2d7b-4897-8ad5-e46785e51837|8|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|scm|[?]|1|HOURS|EPIGASTRIC REGION|IPSILATERAL|Y|Y|ADJUDICATION COMMITTEE|4|Visit_4|65|1|FOLLOW-UP|2020-10-07|65
e|FA|c22014f2-2d7b-4897-8ad5-e46785e51837|9|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|ng|GALLBLADDER|BILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|WASHOUT|2020-11-01|90
e|FA|c22014f2-2d7b-4897-8ad5-e46785e51837|10|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|dpm/mL|[?]|1|mm/h|ENDOMETRIAL CAVITY|BILATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2020-11-01|90
e|FA|987102b2-fe2f-4d72-b8dc-14a71bf034b5|1|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|U/mL|[?]|1|BP|PENIS|IPSILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-10-11|10
e|FA|987102b2-fe2f-4d72-b8dc-14a71bf034b5|2|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|TABLET|[?]|1|uCi/kg|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-10-11|10
e|FA|987102b2-fe2f-4d72-b8dc-14a71bf034b5|3|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU|[?]|1|mL/animal/day|EXTRAHEPATIC BILE DUCT|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|4|WASHOUT|2020-10-26|25
e|FA|987102b2-fe2f-4d72-b8dc-14a71bf034b5|4|DMG|Dietary Magnesium|[?]|GERD|[?]|ngEq/L|[?]|1|TRANSDUCING UNIT/mL|INFERIOR VENA CAVA|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-10-26|25
e|FA|987102b2-fe2f-4d72-b8dc-14a71bf034b5|5|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|Coulomb|TRICEPS BRACHII MUSCLE|LATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2020-11-10|40
e|FA|987102b2-fe2f-4d72-b8dc-14a71bf034b5|6|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|nmol|[?]|1|BAG|LEFT MAIN CORONARY ARTERY BODY|LEFT||Y|ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-11-10|40
e|FA|987102b2-fe2f-4d72-b8dc-14a71bf034b5|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|INHALATION|[?]|1|mg/g/min|URETHRA, PROSTATIC|LATERAL||Y|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-12-05|65
e|FA|987102b2-fe2f-4d72-b8dc-14a71bf034b5|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/kg/week|[?]|1|mg/g/min|TALUS|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-12-05|65
e|FA|987102b2-fe2f-4d72-b8dc-14a71bf034b5|9|LDIAM|Longest Diameter|[?]|GERD|[?]|pmol/L/h|[?]|1|Shock Wave|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2020-12-30|90
e|FA|987102b2-fe2f-4d72-b8dc-14a71bf034b5|10|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|CCID 50/mL|[?]|1|EIA unit|FINGER EXTENSOR TENDONS|UNILATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|7|FOLLOW-UP|2020-12-30|90
e|FA|24ce0c77-1921-4b87-91da-3627e2afd399|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|CARTRIDGE|[?]|1|%(v/v)|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|RIGHT|||CHILD|1|Visit_1|10|4|TREATMENT|2021-01-29|10
e|FA|24ce0c77-1921-4b87-91da-3627e2afd399|2|DVEG|Dietary Vegetable|[?]|GERD|[?]|/day|[?]|1|Ci/ug|MALE GENITALIA|RIGHT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2021-01-29|10
e|FA|24ce0c77-1921-4b87-91da-3627e2afd399|3|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|cal|[?]|1|Bq/mg|GASTROINTESTINAL TRACT, UPPER|LATERAL|||SPOUSE|2|Visit_2|25|7|FOLLOW-UP|2021-02-13|25
e|FA|24ce0c77-1921-4b87-91da-3627e2afd399|4|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|cup eq|[?]|1|U/mg|PINEAL GLAND|LEFT|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2021-02-13|25
e|FA|24ce0c77-1921-4b87-91da-3627e2afd399|5|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|nkat/L|[?]|1|MBq|MEDIASTINUM, MIDDLE|RIGHT|||STUDY SUBJECT|3|Visit_3|40|5|WASHOUT|2021-02-28|40
e|FA|24ce0c77-1921-4b87-91da-3627e2afd399|6|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|10^9 organisms/mg|[?]|1|BOWL|TRAPEZIAL BONE|BILATERAL|||FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2021-02-28|40
e|FA|24ce0c77-1921-4b87-91da-3627e2afd399|7|DGRAIN|Dietary Grain|[?]|GERD|[?]|NEBULE|[?]|1|10^9 CFU/g|TRUNK|BILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-03-25|65
e|FA|24ce0c77-1921-4b87-91da-3627e2afd399|8|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|TUBE|[?]|1|oz eq|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|||INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2021-03-25|65
e|FA|24ce0c77-1921-4b87-91da-3627e2afd399|9|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|100 IU/mL|[?]|1|mm/h|INTERPHALANGEAL JOINT 5|LEFT|Y||ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2021-04-19|90
e|FA|24ce0c77-1921-4b87-91da-3627e2afd399|10|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|BAU/mL|[?]|1|gtt|ANTERIOR CINGULATE CORTEX|LEFT|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2021-04-19|90
e|FA|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|1|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|gpELISA unit/mL|[?]|1|g/day|COLON, SIGMOID|RIGHT|||CAREGIVER|1|Visit_1|10|3|WASHOUT|2020-08-20|10
e|FA|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|2|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|/min|[?]|1|10^6 IU/mL|RIB 2|UNILATERAL|Y||INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-08-20|10
e|FA|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|3|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|CAPFUL|[?]|1|g/L|OLECRANON|LATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|TREATMENT|2020-09-04|25
e|FA|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|4|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|Ejaculate U|[?]|1|mIU/L|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2020-09-04|25
e|FA|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|5|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/g/day|[?]|1|mIU/L|TRIANGULAR-HAMATE JOINT|RIGHT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-09-19|40
e|FA|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|6|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|100 IU/mL|PRESACRAL LYMPH NODE|RIGHT|||CHILD|3|Visit_3|40|6|WASHOUT|2020-09-19|40
e|FA|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|7|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|mAmp|HEART, RIGHT VENTRICULAR WALL|BILATERAL||Y|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-10-14|65
e|FA|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|8|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/dose|[?]|1|mg/h|LACRIMAL GLAND|BILATERAL|||ADJUDICATOR|4|Visit_4|65|1|SCREENING|2020-10-14|65
e|FA|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|9|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|cycle/min|[?]|1|AU/mL|EXTERNAL ILIAC LYMPH NODE|LATERAL|||PARENT|5|Visit_5|90|6|WASHOUT|2020-11-08|90
e|FA|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|10|DVEG|Dietary Vegetable|[?]|GERD|[?]|foz_br|[?]|1|Ci/ug|SKIN OF THE ELBOW|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-11-08|90
e|FA|f4b83a72-7cde-4e02-8883-05e789c617a8|1|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|umol/L|[?]|1|ng|ABDOMINAL CAVITY|IPSILATERAL||Y|CAREGIVER|1|Visit_1|10|3|WASHOUT|2020-12-25|10
e|FA|f4b83a72-7cde-4e02-8883-05e789c617a8|2|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|10^6 copies/mL|[?]|1|mmHg/L/min|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|LEFT|||DOMESTIC PARTNER|1|Visit_1|10|2|SCREENING|2020-12-25|10
e|FA|f4b83a72-7cde-4e02-8883-05e789c617a8|3|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|AgU/mL|[?]|1|ohm|PROXIMAL URETHRA|RIGHT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|FOLLOW-UP|2021-01-09|25
e|FA|f4b83a72-7cde-4e02-8883-05e789c617a8|4|CALBURN|Calories Burned|[?]|GERD|[?]|mEq/uL|[?]|1|/kg|SCAPULA|CONTRALATERAL|||PARENT|2|Visit_2|25|3|SCREENING|2021-01-09|25
e|FA|f4b83a72-7cde-4e02-8883-05e789c617a8|5|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|cd/m2|[?]|1|m2|SUBSTANTIA NIGRA|CONTRALATERAL|Y|Y|GUARDIAN|3|Visit_3|40|3|WASHOUT|2021-01-24|40
e|FA|f4b83a72-7cde-4e02-8883-05e789c617a8|6|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|Sv|[?]|1|MPS U|THIRD DIAGONAL BRANCH ARTERY|IPSILATERAL|||FAMILY MEMBER|3|Visit_3|40|6|FOLLOW-UP|2021-01-24|40
e|FA|f4b83a72-7cde-4e02-8883-05e789c617a8|7|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|SUPPOSITORY|[?]|1|MPS U|RETROCRURAL LYMPH NODE|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2021-02-18|65
e|FA|f4b83a72-7cde-4e02-8883-05e789c617a8|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|g|[?]|1|Pa|PROSTATE GLAND, POSTERIOR LOBE|BILATERAL|||STUDY SUBJECT|4|Visit_4|65|1|WASHOUT|2021-02-18|65
e|FA|f4b83a72-7cde-4e02-8883-05e789c617a8|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ka_u/dL|[?]|1|Pa|CORNEAL STROMA|LEFT|||GUARDIAN|5|Visit_5|90|6|TREATMENT|2021-03-15|90
e|FA|f4b83a72-7cde-4e02-8883-05e789c617a8|10|SERVNUM|Number of Servings|[?]|GERD|[?]|/MBP|[?]|1|Hz/s|SUPERFICIAL LYMPH NODE|RIGHT|||PARENT|5|Visit_5|90|3|WASHOUT|2021-03-15|90
e|FA|c4087538-422a-4bcf-af25-ed4aab36ed4b|1|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|kN/cm2|[?]|1|Ci/ug|PRELARYNGEAL LYMPH NODE|CONTRALATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2021-01-09|10
e|FA|c4087538-422a-4bcf-af25-ed4aab36ed4b|2|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|cd/m2|[?]|1|EIA unit|PREAURICULAR LYMPH NODE|IPSILATERAL||Y|CAREGIVER|1|Visit_1|10|6|TREATMENT|2021-01-09|10
e|FA|c4087538-422a-4bcf-af25-ed4aab36ed4b|3|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|g/dL|FIBULAR VEIN|BILATERAL||Y|STUDY SUBJECT|2|Visit_2|25|2|WASHOUT|2021-01-24|25
e|FA|c4087538-422a-4bcf-af25-ed4aab36ed4b|4|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|ug/dL|[?]|1|10^6 CFU|PANCREAS|LATERAL|Y|Y|PROXY|2|Visit_2|25|3|TREATMENT|2021-01-24|25
e|FA|c4087538-422a-4bcf-af25-ed4aab36ed4b|5|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|pkat/L|[?]|1|10^6 U|RETINAL NERVE FIBER LAYER|UNILATERAL|Y||FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2021-02-08|40
e|FA|c4087538-422a-4bcf-af25-ed4aab36ed4b|6|DFATT|Dietary Fat, Total|[?]|GERD|[?]|vp/dose|[?]|1|Bq/mg|THIRD OBTUSE MARGINAL BRANCH ARTERY|LATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|SCREENING|2021-02-08|40
e|FA|c4087538-422a-4bcf-af25-ed4aab36ed4b|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/day|[?]|1|Pa|LIVER FISSURE|LEFT|||ADJUDICATION COMMITTEE|4|Visit_4|65|1|FOLLOW-UP|2021-03-05|65
e|FA|c4087538-422a-4bcf-af25-ed4aab36ed4b|8|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|Hz/s|BRAIN STEM|LATERAL|||PROXY|4|Visit_4|65|3|TREATMENT|2021-03-05|65
e|FA|c4087538-422a-4bcf-af25-ed4aab36ed4b|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|10^6 IU/mL|COLON|RIGHT|||CHILD|5|Visit_5|90|4|FOLLOW-UP|2021-03-30|90
e|FA|c4087538-422a-4bcf-af25-ed4aab36ed4b|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|cmol/L|[?]|1|mg/g/min|MAXILLARY SINUS|IPSILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|2|FOLLOW-UP|2021-03-30|90
e|FA|947aefaf-20c7-47fc-ac56-140f9b6f38f3|1|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|uV|[?]|1|oz eq|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|LATERAL|||VENDOR|1|Visit_1|10|7|FOLLOW-UP|2020-11-06|10
e|FA|947aefaf-20c7-47fc-ac56-140f9b6f38f3|2|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|AU/mL|[?]|1|10^6 IU/mL|THIGH|CONTRALATERAL|||FRIEND|1|Visit_1|10|1|TREATMENT|2020-11-06|10
e|FA|947aefaf-20c7-47fc-ac56-140f9b6f38f3|3|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|log EID 50/dose|[?]|1|10^6 IU/mL|STOMACH|LEFT||Y|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-11-21|25
e|FA|947aefaf-20c7-47fc-ac56-140f9b6f38f3|4|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|10^9 CFU/g|PARAVERTEBRAL GANGLIA|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-11-21|25
e|FA|947aefaf-20c7-47fc-ac56-140f9b6f38f3|5|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|bel|[?]|1|mg/dose|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|LEFT|||STUDY SUBJECT|3|Visit_3|40|1|TREATMENT|2020-12-06|40
e|FA|947aefaf-20c7-47fc-ac56-140f9b6f38f3|6|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|CCID 50/mL|[?]|1|/500 WBC|PELVIC LYMPH NODE|LEFT|Y||INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-12-06|40
e|FA|947aefaf-20c7-47fc-ac56-140f9b6f38f3|7|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|mL/m2/min|[?]|1|ug/kg/h|ISCHIORECTAL FOSSA|LEFT|||INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-12-31|65
e|FA|947aefaf-20c7-47fc-ac56-140f9b6f38f3|8|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|10^6 CFU|GASTROINTESTINAL TRACT, UPPER|BILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|7|SCREENING|2020-12-31|65
e|FA|947aefaf-20c7-47fc-ac56-140f9b6f38f3|9|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|APS U|[?]|1|IU/mg|FEMORAL CONDYLE|RIGHT||Y|VENDOR|5|Visit_5|90|2|WASHOUT|2021-01-25|90
e|FA|947aefaf-20c7-47fc-ac56-140f9b6f38f3|10|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|U/cL|[?]|1|mg/h|HEART, LEFT ATRIUM|LATERAL||Y|INTERVIEWER|5|Visit_5|90|6|TREATMENT|2021-01-25|90
e|FA|3a0c00eb-5614-4053-844d-6bdb71efb1cd|1|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|mmol/s|[?]|1|L/h/m2|PARATRACHEAL LYMPH NODE|RIGHT||Y|DOMESTIC PARTNER|1|Visit_1|10|1|SCREENING|2020-08-11|10
e|FA|3a0c00eb-5614-4053-844d-6bdb71efb1cd|2|DFIBER|Dietary Fiber|[?]|GERD|[?]|ft2|[?]|1|h*%|ABDOMINAL LYMPH NODE|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|WASHOUT|2020-08-11|10
e|FA|3a0c00eb-5614-4053-844d-6bdb71efb1cd|3|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|IU/mg|[?]|1|g/L|PROXIMAL PHALANX 2 OF THE HAND|LATERAL||Y|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2020-08-26|25
e|FA|3a0c00eb-5614-4053-844d-6bdb71efb1cd|4|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|SACHET|COLON, HEPATIC FLEXURE|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|WASHOUT|2020-08-26|25
e|FA|3a0c00eb-5614-4053-844d-6bdb71efb1cd|5|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|h*%|TIBIOTARSAL JOINT|UNILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2020-09-10|40
e|FA|3a0c00eb-5614-4053-844d-6bdb71efb1cd|6|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|kg|[?]|1|SCOOPFUL|KIDNEY|CONTRALATERAL|||PARENT|3|Visit_3|40|5|TREATMENT|2020-09-10|40
e|FA|3a0c00eb-5614-4053-844d-6bdb71efb1cd|7|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|IU|[?]|1|NEEDLE GAUGE|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|RIGHT||Y|ADJUDICATOR|4|Visit_4|65|6|WASHOUT|2020-10-05|65
e|FA|3a0c00eb-5614-4053-844d-6bdb71efb1cd|8|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|mmol/L|[?]|1|IU/mg|APPENDIX|IPSILATERAL|Y||PROXY|4|Visit_4|65|2|WASHOUT|2020-10-05|65
e|FA|3a0c00eb-5614-4053-844d-6bdb71efb1cd|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|Gauss|[?]|1|ug/g/h|GASTROCNEMIUS MUSCLE, LATERAL HEAD|RIGHT|Y||SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2020-10-30|90
e|FA|3a0c00eb-5614-4053-844d-6bdb71efb1cd|10|EXCDUR|Exercise Duration|[?]|GERD|[?]|/wk|[?]|1|mm|VASTUS LATERALIS MUSCLE|UNILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|6|TREATMENT|2020-10-30|90
e|FA|dc3ce247-24dd-4255-85a8-ec7a58d30c86|1|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|U/g/min|[?]|1|L|AZYGOS VEIN|IPSILATERAL|||STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2020-10-11|10
e|FA|dc3ce247-24dd-4255-85a8-ec7a58d30c86|2|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|ug/g/h|PANCREAS, ENDOCRINE|LEFT|||FAMILY MEMBER|1|Visit_1|10|6|WASHOUT|2020-10-11|10
e|FA|dc3ce247-24dd-4255-85a8-ec7a58d30c86|3|PPTFCT|Precipitating Factor|[?]|GERD|[?]|FFU|[?]|1|EIA unit|ASCENDING AORTA|LEFT|Y||CAREGIVER|2|Visit_2|25|5|FOLLOW-UP|2020-10-26|25
e|FA|dc3ce247-24dd-4255-85a8-ec7a58d30c86|4|DVEG|Dietary Vegetable|[?]|GERD|[?]|um/s|[?]|1|Ci/ug|FUNDUS OF THE STOMACH|IPSILATERAL|||VENDOR|2|Visit_2|25|1|TREATMENT|2020-10-26|25
e|FA|dc3ce247-24dd-4255-85a8-ec7a58d30c86|5|SEV|Severity/Intensity|[?]|GERD|[?]|ng/L|[?]|1|Pa|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|LATERAL|||FRIEND|3|Visit_3|40|2|TREATMENT|2020-11-10|40
e|FA|dc3ce247-24dd-4255-85a8-ec7a58d30c86|6|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|Osm|[?]|1|Shock Wave|C2 VERTEBRA|RIGHT||Y|ADJUDICATOR|3|Visit_3|40|2|FOLLOW-UP|2020-11-10|40
e|FA|dc3ce247-24dd-4255-85a8-ec7a58d30c86|7|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|/100 HPFs|[?]|1|/kg|HAND|LATERAL||Y|FAMILY MEMBER|4|Visit_4|65|4|SCREENING|2020-12-05|65
e|FA|dc3ce247-24dd-4255-85a8-ec7a58d30c86|8|ACNDEV|Action Taken With Device|[?]|GERD|[?]|mm/2h|[?]|1|100 IU/mL|NUCLEUS ACCUMBENS|IPSILATERAL|||INTERVIEWER|4|Visit_4|65|7|TREATMENT|2020-12-05|65
e|FA|dc3ce247-24dd-4255-85a8-ec7a58d30c86|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|CAPFUL|[?]|1|mL|SARTORIUS MUSCLE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-12-30|90
e|FA|dc3ce247-24dd-4255-85a8-ec7a58d30c86|10|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|U/g Hb|[?]|1|mmHg/L/min|TONSIL|BILATERAL||Y|PARENT|5|Visit_5|90|6|WASHOUT|2020-12-30|90
e|FA|61c19f94-bdfc-456d-ba7a-c9097ca1c645|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cycle/min|[?]|1|mg/g/min|PERICARDIAL CAVITY|BILATERAL|Y|Y|PROXY|1|Visit_1|10|1|TREATMENT|2020-07-04|10
e|FA|61c19f94-bdfc-456d-ba7a-c9097ca1c645|2|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|10^6 IU|[?]|1|/500 WBC|SPLENIC LYMPH NODE|IPSILATERAL||Y|FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2020-07-04|10
e|FA|61c19f94-bdfc-456d-ba7a-c9097ca1c645|3|TOXGR|Toxicity Grade|[?]|GERD|[?]|nmol BCE/L|[?]|1|aMFI|THIRD DIAGONAL BRANCH ARTERY|LEFT|Y||FRIEND|2|Visit_2|25|4|TREATMENT|2020-07-19|25
e|FA|61c19f94-bdfc-456d-ba7a-c9097ca1c645|4|DIAMETER|Diameter|[?]|GERD|[?]|/wk|[?]|1|cm|DISTAL PHALANX 4 OF THE HAND|BILATERAL||Y|ADJUDICATOR|2|Visit_2|25|7|SCREENING|2020-07-19|25
e|FA|61c19f94-bdfc-456d-ba7a-c9097ca1c645|5|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|ug/h|[?]|1|mL/mmHg/min/L|FLEXOR DIGITORUM LONGUS MUSCLE|BILATERAL|||CAREGIVER|3|Visit_3|40|3|FOLLOW-UP|2020-08-03|40
e|FA|61c19f94-bdfc-456d-ba7a-c9097ca1c645|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|DNA copies/mL|[?]|1|%(v/v)|PERIUMBILICAL REGION|UNILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|2|TREATMENT|2020-08-03|40
e|FA|61c19f94-bdfc-456d-ba7a-c9097ca1c645|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|umol/min|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|BILATERAL|||STUDY SUBJECT|4|Visit_4|65|1|FOLLOW-UP|2020-08-28|65
e|FA|61c19f94-bdfc-456d-ba7a-c9097ca1c645|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|kPa/L/sec|[?]|1|%(v/v)|AZYGOS VEIN|LEFT||Y|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2020-08-28|65
e|FA|61c19f94-bdfc-456d-ba7a-c9097ca1c645|9|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|um/day|[?]|1|QUANTITY SUFFICIENT|HEART, RIGHT ATRIAL APPENDAGE|LEFT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-09-22|90
e|FA|61c19f94-bdfc-456d-ba7a-c9097ca1c645|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|CCID 50/dose|[?]|1|mL|LEFT MAIN CORONARY ARTERY BIFURCATION|LATERAL|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2020-09-22|90
e|FA|1e577f2d-2c45-477d-b74f-af24b81d6d20|1|DGRAIN|Dietary Grain|[?]|GERD|[?]|Enzyme U/m2|[?]|1|10^9 CFU/g|T6 VERTEBRA|IPSILATERAL|Y||SIBLING|1|Visit_1|10|6|TREATMENT|2020-09-23|10
e|FA|1e577f2d-2c45-477d-b74f-af24b81d6d20|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol/kg/day|[?]|1|mg/g/min|CANINE TOOTH|CONTRALATERAL|||CAREGIVER|1|Visit_1|10|1|SCREENING|2020-09-23|10
e|FA|1e577f2d-2c45-477d-b74f-af24b81d6d20|3|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|/500 WBC|[?]|1|uCi/kg|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|CONTRALATERAL|Y||STUDY SUBJECT|2|Visit_2|25|1|WASHOUT|2020-10-08|25
e|FA|1e577f2d-2c45-477d-b74f-af24b81d6d20|4|SEV|Severity/Intensity|[?]|GERD|[?]|kBq|[?]|1|Pa|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|LEFT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-10-08|25
e|FA|1e577f2d-2c45-477d-b74f-af24b81d6d20|5|SPEED|Speed|[?]|GERD|[?]|mmol/s|[?]|1|mEq/g|XIPHOID PROCESS|BILATERAL|||PARENT|3|Visit_3|40|5|TREATMENT|2020-10-23|40
e|FA|1e577f2d-2c45-477d-b74f-af24b81d6d20|6|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|CARTRIDGE|[?]|1|HOURS|BONE MARROW|LATERAL||Y|INVESTIGATOR|3|Visit_3|40|7|TREATMENT|2020-10-23|40
e|FA|1e577f2d-2c45-477d-b74f-af24b81d6d20|7|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|MET*h|[?]|1|/kg|THORACIC VERTEBRA|UNILATERAL|||SIBLING|4|Visit_4|65|5|FOLLOW-UP|2020-11-17|65
e|FA|1e577f2d-2c45-477d-b74f-af24b81d6d20|8|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|mL/100g/min|TIBIALIS POSTERIOR MUSCLE|RIGHT|||STUDY SUBJECT|4|Visit_4|65|2|FOLLOW-UP|2020-11-17|65
e|FA|1e577f2d-2c45-477d-b74f-af24b81d6d20|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|MPL U/mL|[?]|1|ug/g/h|GENITOURINARY SYSTEM|LEFT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2020-12-12|90
e|FA|1e577f2d-2c45-477d-b74f-af24b81d6d20|10|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|mL/m2/min|[?]|1|anti-Xa IU/mL|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|LATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-12-12|90
e|FA|f845101e-c057-4f84-94b3-6043afb42ac7|1|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|ug/kg/min|[?]|1|BAG|PREAURICULAR LYMPH NODE|LEFT|||INVESTIGATOR|1|Visit_1|10|2|SCREENING|2020-10-27|10
e|FA|f845101e-c057-4f84-94b3-6043afb42ac7|2|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|ug/dose|[?]|1|MBq|BUCCAL LYMPH NODE|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|SCREENING|2020-10-27|10
e|FA|f845101e-c057-4f84-94b3-6043afb42ac7|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|keV|[?]|1|mg/g/min|TRAPEZIUM-TRAPEZOID JOINT|UNILATERAL|||PROXY|2|Visit_2|25|4|TREATMENT|2020-11-11|25
e|FA|f845101e-c057-4f84-94b3-6043afb42ac7|4|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|mmol/mol|[?]|1|L|PECTORALIS MINOR MUSCLE|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2020-11-11|25
e|FA|f845101e-c057-4f84-94b3-6043afb42ac7|5|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|BOX|[?]|1|h*%|INTERPHALANGEAL JOINT 1|CONTRALATERAL|||CAREGIVER|3|Visit_3|40|4|FOLLOW-UP|2020-11-26|40
e|FA|f845101e-c057-4f84-94b3-6043afb42ac7|6|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|CAPFUL|[?]|1|cmH2O/mL|THORACIC VERTEBRA|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2020-11-26|40
e|FA|f845101e-c057-4f84-94b3-6043afb42ac7|7|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|Antibody Unit|[?]|1|Bq/mg|ABDUCTOR POLLICIS BREVIS MUSCLE|BILATERAL|||FRIEND|4|Visit_4|65|1|TREATMENT|2020-12-21|65
e|FA|f845101e-c057-4f84-94b3-6043afb42ac7|8|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|kBq|[?]|1|g/cage/day|PARAPHARYNGEAL LYMPH NODE|RIGHT|||PROXY|4|Visit_4|65|6|WASHOUT|2020-12-21|65
e|FA|f845101e-c057-4f84-94b3-6043afb42ac7|9|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|Gy/h|[?]|1|mL/cm3/min|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|IPSILATERAL|Y||CHILD|5|Visit_5|90|3|SCREENING|2021-01-15|90
e|FA|f845101e-c057-4f84-94b3-6043afb42ac7|10|ESTWT|Estimated Weight|[?]|GERD|[?]|ug/g/day|[?]|1|g/day|RADIUS|LEFT||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|SCREENING|2021-01-15|90
e|FA|4ddb2076-6837-4028-81bc-3e8057475977|1|DCAL|Dietary Calories|[?]|GERD|[?]|IU/mg|[?]|1|EIA unit|HAND DIGIT 1|IPSILATERAL|Y||GUARDIAN|1|Visit_1|10|5|SCREENING|2020-12-27|10
e|FA|4ddb2076-6837-4028-81bc-3e8057475977|2|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|uCi/kg|[?]|1|ug/g/h|FEMORAL HEAD|LEFT|Y||INVESTIGATOR|1|Visit_1|10|1|WASHOUT|2020-12-27|10
e|FA|4ddb2076-6837-4028-81bc-3e8057475977|3|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|vp/dose|[?]|1|Shock Wave|BUCCAL MUCOSA|RIGHT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2021-01-11|25
e|FA|4ddb2076-6837-4028-81bc-3e8057475977|4|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|fmol/L/sec|[?]|1|mL/cm3/min|RETROPERITONEAL LYMPH NODE|BILATERAL|Y||CHILD|2|Visit_2|25|5|TREATMENT|2021-01-11|25
e|FA|4ddb2076-6837-4028-81bc-3e8057475977|5|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|BP|[?]|1|SCOOPFUL|PERIPANCREATIC LYMPH NODE|LATERAL||Y|FRIEND|3|Visit_3|40|2|TREATMENT|2021-01-26|40
e|FA|4ddb2076-6837-4028-81bc-3e8057475977|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|mg/g/min|RIB 1|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2021-01-26|40
e|FA|4ddb2076-6837-4028-81bc-3e8057475977|7|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|QUANTITY SUFFICIENT|FEMUR SHAFT|RIGHT|||SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2021-02-20|65
e|FA|4ddb2076-6837-4028-81bc-3e8057475977|8|SEV|Severity/Intensity|[?]|GERD|[?]|cmol/L|[?]|1|Pa|LIMB|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|WASHOUT|2021-02-20|65
e|FA|4ddb2076-6837-4028-81bc-3e8057475977|9|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|/wk|[?]|1|ng/day|LIMB|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-03-17|90
e|FA|4ddb2076-6837-4028-81bc-3e8057475977|10|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|mL*cmH2O|[?]|1|MBq|RIB 10|LEFT|Y|Y|SPOUSE|5|Visit_5|90|4|FOLLOW-UP|2021-03-17|90
e|FA|c165c69c-2ab2-495c-a190-e32d1204bc4e|1|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|ft|[?]|1|IU/mmol|GLOBUS PALLIDUS|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2021-01-01|10
e|FA|c165c69c-2ab2-495c-a190-e32d1204bc4e|2|STRCTNUM|Number of Strictures|[?]|GERD|[?]|amu|[?]|1|SACHET|AORTIC VALVE, NON-CORONARY CUSP|IPSILATERAL|||FAMILY MEMBER|1|Visit_1|10|4|WASHOUT|2021-01-01|10
e|FA|c165c69c-2ab2-495c-a190-e32d1204bc4e|3|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|PLUG|[?]|1|gtt|HEPATOBILIARY SYSTEM|IPSILATERAL|||STUDY SUBJECT|2|Visit_2|25|4|WASHOUT|2021-01-16|25
e|FA|c165c69c-2ab2-495c-a190-e32d1204bc4e|4|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|cycle/min|[?]|1|PACK|LUNG LOBE|IPSILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|WASHOUT|2021-01-16|25
e|FA|c165c69c-2ab2-495c-a190-e32d1204bc4e|5|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|APPLICATION|[?]|1|m2|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|UNILATERAL||Y|VENDOR|3|Visit_3|40|4|TREATMENT|2021-01-31|40
e|FA|c165c69c-2ab2-495c-a190-e32d1204bc4e|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|PFU/mL|[?]|1|mg/g/min|BASAL GANGLIA|LATERAL|||ADJUDICATOR|3|Visit_3|40|2|FOLLOW-UP|2021-01-31|40
e|FA|c165c69c-2ab2-495c-a190-e32d1204bc4e|7|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|cg|[?]|1|uCi/kg|RETROPERITONEUM|CONTRALATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|SCREENING|2021-02-25|65
e|FA|c165c69c-2ab2-495c-a190-e32d1204bc4e|8|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|MBP|[?]|1|ug/g/h|GENITOURINARY SYSTEM|BILATERAL||Y|FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2021-02-25|65
e|FA|c165c69c-2ab2-495c-a190-e32d1204bc4e|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|DAYS|[?]|1|Pa|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|CONTRALATERAL|Y||INTERVIEWER|5|Visit_5|90|6|TREATMENT|2021-03-22|90
e|FA|c165c69c-2ab2-495c-a190-e32d1204bc4e|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|U/mmol|[?]|1|km|SCAPHOID-CAPITATE JOINT|UNILATERAL|||FRIEND|5|Visit_5|90|7|TREATMENT|2021-03-22|90
e|FA|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|1|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|uU/dL|[?]|1|DROP|PENIS|LEFT|Y|Y|ADJUDICATOR|1|Visit_1|10|7|SCREENING|2020-12-29|10
e|FA|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|2|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|m/sec|[?]|1|/200 HPFs|OBTURATOR MUSCLE|LATERAL|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|WASHOUT|2020-12-29|10
e|FA|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|3|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|ag|[?]|1|SCOOPFUL|ACETABULUM|BILATERAL|||SIBLING|2|Visit_2|25|7|WASHOUT|2021-01-13|25
e|FA|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|4|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|Roentgen|[?]|1|Hz/s|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|LATERAL|||FRIEND|2|Visit_2|25|2|TREATMENT|2021-01-13|25
e|FA|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|5|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|/LSQN|[?]|1|m2|ACROMIOCLAVICULAR JOINT|UNILATERAL||Y|SPOUSE|3|Visit_3|40|4|TREATMENT|2021-01-28|40
e|FA|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|6|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|km|URETHRAL SPHINCTER|UNILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2021-01-28|40
e|FA|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|um/day|[?]|1|mg/g/min|CAROTID ARTERY|BILATERAL|||PARENT|4|Visit_4|65|1|SCREENING|2021-02-22|65
e|FA|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|8|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|mol/g|[?]|1|mm/h|AORTIC VALVE ANNULUS|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2021-02-22|65
e|FA|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|9|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|ug/kg/min|[?]|1|DROP|TAIL|LEFT||Y|SPOUSE|5|Visit_5|90|1|TREATMENT|2021-03-19|90
e|FA|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Hz|[?]|1|mg/g/min|COLON, SIGMOID|CONTRALATERAL|||CHILD|5|Visit_5|90|3|TREATMENT|2021-03-19|90
e|FA|024a9f6d-4ff1-4673-8617-3790f831fce7|1|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|um/s|[?]|1|mL/cm3/min|SUPRACLAVICULAR FOSSA|LATERAL|||DOMESTIC PARTNER|1|Visit_1|10|6|FOLLOW-UP|2020-06-13|10
e|FA|024a9f6d-4ff1-4673-8617-3790f831fce7|2|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|steps/min|[?]|1|QUANTITY SUFFICIENT|RETROAURICULAR LYMPH NODE|IPSILATERAL|Y|Y|ADJUDICATION COMMITTEE|1|Visit_1|10|6|SCREENING|2020-06-13|10
e|FA|024a9f6d-4ff1-4673-8617-3790f831fce7|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|g/m2/day|[?]|1|Shock Wave|EAR, INNER|UNILATERAL|||INVESTIGATOR|2|Visit_2|25|7|WASHOUT|2020-06-28|25
e|FA|024a9f6d-4ff1-4673-8617-3790f831fce7|4|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|mm2|[?]|1|mmHg/L/min|HEAD OF THE HUMERUS|CONTRALATERAL|Y|Y|STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2020-06-28|25
e|FA|024a9f6d-4ff1-4673-8617-3790f831fce7|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|kcal|[?]|1|mg/g/min|INTERNAL MAMMARY ARTERY|RIGHT||Y|SIGNIFICANT OTHER|3|Visit_3|40|4|WASHOUT|2020-07-13|40
e|FA|024a9f6d-4ff1-4673-8617-3790f831fce7|6|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|tuberculin unit/mL|[?]|1|gtt|THIRD OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|Y||STUDY SUBJECT|3|Visit_3|40|5|FOLLOW-UP|2020-07-13|40
e|FA|024a9f6d-4ff1-4673-8617-3790f831fce7|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|IU/dL|[?]|1|mg/g/min|RETROPHARYNGEAL LYMPH NODE|LATERAL|Y||CAREGIVER|4|Visit_4|65|6|SCREENING|2020-08-07|65
e|FA|024a9f6d-4ff1-4673-8617-3790f831fce7|8|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|mEq/g|PANCREAS, EXOCRINE|UNILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|SCREENING|2020-08-07|65
e|FA|024a9f6d-4ff1-4673-8617-3790f831fce7|9|OBJTYPE|Type of Object|[?]|GERD|[?]|%/min|[?]|1|ng|RIB 12|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|FOLLOW-UP|2020-09-01|90
e|FA|024a9f6d-4ff1-4673-8617-3790f831fce7|10|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|STRIP|[?]|1|10^9 CFU/mL|METATARSOPHALANGEAL JOINT 4|LATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-09-01|90
e|FA|40936fc6-251d-4a17-ae9d-3bd1150f8d20|1|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|mg/min|[?]|1|10^6 organisms/mL|URETHRA, PROSTATIC|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-11-18|10
e|FA|40936fc6-251d-4a17-ae9d-3bd1150f8d20|2|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|INHALATION|[?]|1|SCOOPFUL|ABDOMINAL AORTA|BILATERAL|||GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-11-18|10
e|FA|40936fc6-251d-4a17-ae9d-3bd1150f8d20|3|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|LB|[?]|1|oz eq|CAUDATE NUCLEUS|CONTRALATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|SCREENING|2020-12-03|25
e|FA|40936fc6-251d-4a17-ae9d-3bd1150f8d20|4|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|mol/mol|[?]|1|h*%|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|LATERAL|||CAREGIVER|2|Visit_2|25|4|WASHOUT|2020-12-03|25
e|FA|40936fc6-251d-4a17-ae9d-3bd1150f8d20|5|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|IU|[?]|1|ug/m2/h|MANDIBLE|CONTRALATERAL|Y||SIBLING|3|Visit_3|40|3|SCREENING|2020-12-18|40
e|FA|40936fc6-251d-4a17-ae9d-3bd1150f8d20|6|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|ng|[?]|1|PFU/dose|HEAD OF THE HUMERUS|LATERAL|||PROXY|3|Visit_3|40|4|SCREENING|2020-12-18|40
e|FA|40936fc6-251d-4a17-ae9d-3bd1150f8d20|7|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|DIP|[?]|1|IU/mg|ANTERIOR INFERIOR CEREBELLAR ARTERY|RIGHT||Y|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-01-12|65
e|FA|40936fc6-251d-4a17-ae9d-3bd1150f8d20|8|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|min/day|[?]|1|cmH2O/mL|MAXILLA|BILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|WASHOUT|2021-01-12|65
e|FA|40936fc6-251d-4a17-ae9d-3bd1150f8d20|9|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|tuberculin unit/mL|[?]|1|mmHg/L/min|FEMORAL VEIN|LATERAL|Y|Y|PARENT|5|Visit_5|90|2|TREATMENT|2021-02-06|90
e|FA|40936fc6-251d-4a17-ae9d-3bd1150f8d20|10|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|VOXEL|[?]|1|mL/m2|MIDDLE PHALANX 3 OF THE HAND|RIGHT|Y|Y|CHILD|5|Visit_5|90|4|FOLLOW-UP|2021-02-06|90
e|FA|17b9fa7a-f15d-423a-9671-99cd0cbbd362|1|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|TRANSDUCING UNIT/mL|PATELLA|UNILATERAL|||PARENT|1|Visit_1|10|2|TREATMENT|2020-11-11|10
e|FA|17b9fa7a-f15d-423a-9671-99cd0cbbd362|2|OBJTYPE|Type of Object|[?]|GERD|[?]|dpm/0.5 mL|[?]|1|ng|CEREBRAL HEMISPHERE, RIGHT|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|FOLLOW-UP|2020-11-11|10
e|FA|17b9fa7a-f15d-423a-9671-99cd0cbbd362|3|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mmol/g|[?]|1|uL/kg/day|OSTIOMEATAL COMPLEX|RIGHT|||CAREGIVER|2|Visit_2|25|5|WASHOUT|2020-11-26|25
e|FA|17b9fa7a-f15d-423a-9671-99cd0cbbd362|4|LDIAM|Longest Diameter|[?]|GERD|[?]|mm2|[?]|1|Shock Wave|URETHRAL SPHINCTER|RIGHT|||INTERVIEWER|2|Visit_2|25|7|TREATMENT|2020-11-26|25
e|FA|17b9fa7a-f15d-423a-9671-99cd0cbbd362|5|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg|[?]|1|Gy/h|LUNG, RIGHT|IPSILATERAL|||FRIEND|3|Visit_3|40|3|SCREENING|2020-12-11|40
e|FA|17b9fa7a-f15d-423a-9671-99cd0cbbd362|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|dpm/mL|[?]|1|PACK|TEMPORAL BONE|LATERAL||Y|FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-12-11|40
e|FA|17b9fa7a-f15d-423a-9671-99cd0cbbd362|7|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|IU|[?]|1|mL/m2|LEFT VENTRICULAR EPICARDIUM|RIGHT|||INVESTIGATOR|4|Visit_4|65|2|FOLLOW-UP|2021-01-05|65
e|FA|17b9fa7a-f15d-423a-9671-99cd0cbbd362|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|PACKET|[?]|1|10^6 U|PANCREATIC DUCT|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2021-01-05|65
e|FA|17b9fa7a-f15d-423a-9671-99cd0cbbd362|9|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|IU/mg|[?]|1|cm|VENOUS SINUS|BILATERAL|Y|Y|SIGNIFICANT OTHER|5|Visit_5|90|4|FOLLOW-UP|2021-01-30|90
e|FA|17b9fa7a-f15d-423a-9671-99cd0cbbd362|10|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|mV2/Hz|[?]|1|fmol|GREAT TROCHANTER|BILATERAL|Y||INTERVIEWER|5|Visit_5|90|5|WASHOUT|2021-01-30|90
e|FA|95c4465b-162a-433d-83c9-6d67dd729c9e|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/mL/day|[?]|1|Pa|FOOT DIGIT 3|LEFT|||PARENT|1|Visit_1|10|2|FOLLOW-UP|2020-10-22|10
e|FA|95c4465b-162a-433d-83c9-6d67dd729c9e|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|g/cage/day|[?]|1|mg/g/min|LUNG, RIGHT MIDDLE LOBE|CONTRALATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-10-22|10
e|FA|95c4465b-162a-433d-83c9-6d67dd729c9e|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|cm|[?]|1|Shock Wave|TRAPEZIUM-TRAPEZOID JOINT|RIGHT|Y||CHILD|2|Visit_2|25|4|WASHOUT|2020-11-06|25
e|FA|95c4465b-162a-433d-83c9-6d67dd729c9e|4|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|IU/mmol|UPPER CERVICAL LYMPH NODE|LATERAL|Y||INTERVIEWER|2|Visit_2|25|6|SCREENING|2020-11-06|25
e|FA|95c4465b-162a-433d-83c9-6d67dd729c9e|5|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|cm2|[?]|1|MBq|MITRAL VALVE ANNULUS|IPSILATERAL|||FRIEND|3|Visit_3|40|1|TREATMENT|2020-11-21|40
e|FA|95c4465b-162a-433d-83c9-6d67dd729c9e|6|DISTANCE|Distance|[?]|GERD|[?]|days/month|[?]|1|BOWL|HAMATE BONE|UNILATERAL||Y|FAMILY MEMBER|3|Visit_3|40|2|SCREENING|2020-11-21|40
e|FA|95c4465b-162a-433d-83c9-6d67dd729c9e|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|uU/dL|[?]|1|%(v/v)|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|IPSILATERAL||Y|CHILD|4|Visit_4|65|1|FOLLOW-UP|2020-12-16|65
e|FA|95c4465b-162a-433d-83c9-6d67dd729c9e|8|DFATT|Dietary Fat, Total|[?]|GERD|[?]|ag|[?]|1|Bq/mg|SUPERIOR VENA CAVA|LATERAL|||INTERVIEWER|4|Visit_4|65|1|WASHOUT|2020-12-16|65
e|FA|95c4465b-162a-433d-83c9-6d67dd729c9e|9|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|dpm/mL|[?]|1|mL/m2|CORPUS CALLOSUM|CONTRALATERAL||Y|PROXY|5|Visit_5|90|4|TREATMENT|2021-01-10|90
e|FA|95c4465b-162a-433d-83c9-6d67dd729c9e|10|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|Ci/L|[?]|1|mL/m2|TRACHEOBRONCHIAL TREE|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2021-01-10|90
e|FA|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|1|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|100 IU/mL|[?]|1|ohm|METACARPAL BONE 5|CONTRALATERAL|||VENDOR|1|Visit_1|10|3|TREATMENT|2020-06-27|10
e|FA|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|2|LDIAM|Longest Diameter|[?]|GERD|[?]|IU/mg|[?]|1|Shock Wave|URACHAL TRACT|LEFT|||CAREGIVER|1|Visit_1|10|1|TREATMENT|2020-06-27|10
e|FA|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|3|SEV|Severity/Intensity|[?]|GERD|[?]|PIXELS/cm|[?]|1|Pa|NERVE|RIGHT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2020-07-12|25
e|FA|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|4|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|ELISA unit/dose|[?]|1|BP|CENTRAL NERVOUS SYSTEM|RIGHT|Y||ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-07-12|25
e|FA|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|5|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|C|[?]|1|MPS U|TIBIALIS POSTERIOR MUSCLE|LATERAL|||INVESTIGATOR|3|Visit_3|40|1|WASHOUT|2020-07-27|40
e|FA|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|TABLET|[?]|1|mg/g/min|SACRAL VERTEBRA|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-07-27|40
e|FA|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|7|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|mph|[?]|1|Log10 ELISA unit|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|RIGHT||Y|FAMILY MEMBER|4|Visit_4|65|7|WASHOUT|2020-08-21|65
e|FA|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|8|SEV|Severity/Intensity|[?]|GERD|[?]|cmH2O*s2/mL|[?]|1|Pa|T9 VERTEBRA|IPSILATERAL||Y|INVESTIGATOR|4|Visit_4|65|6|WASHOUT|2020-08-21|65
e|FA|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|9|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|/10^5|[?]|1|mEq|PARAPHARYNGEAL LYMPH NODE|CONTRALATERAL|||STUDY SUBJECT|5|Visit_5|90|1|SCREENING|2020-09-15|90
e|FA|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|10|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|hr/day|[?]|1|g/day|PALATE|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|4|TREATMENT|2020-09-15|90
e|FA|beb6b1ab-1264-456a-bf2b-81e28493301d|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|/7.5 mL|[?]|1|mL/animal/day|CERVIX UTERI|CONTRALATERAL|||FAMILY MEMBER|1|Visit_1|10|7|FOLLOW-UP|2020-06-10|10
e|FA|beb6b1ab-1264-456a-bf2b-81e28493301d|2|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mL/cage/day|[?]|1|gtt|LEFT VENTRICULAR MID ANTERIOR SEGMENT|LEFT|||SIBLING|1|Visit_1|10|2|TREATMENT|2020-06-10|10
e|FA|beb6b1ab-1264-456a-bf2b-81e28493301d|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|/10^3|[?]|1|%(v/v)|PELVIC LYMPH NODE|LATERAL|||FAMILY MEMBER|2|Visit_2|25|1|SCREENING|2020-06-25|25
e|FA|beb6b1ab-1264-456a-bf2b-81e28493301d|4|RLDEV|Relationship to Device|[?]|GERD|[?]|DRUM|[?]|1|mL/min/mmHg|SPLENIC LYMPH NODE|IPSILATERAL|||FAMILY MEMBER|2|Visit_2|25|3|SCREENING|2020-06-25|25
e|FA|beb6b1ab-1264-456a-bf2b-81e28493301d|5|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|mm2|[?]|1|mEq/g|CEPHALIC VEIN|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|WASHOUT|2020-07-10|40
e|FA|beb6b1ab-1264-456a-bf2b-81e28493301d|6|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|10^9 organisms/mL|[?]|1|in|BILIARY TRACT|CONTRALATERAL|||ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2020-07-10|40
e|FA|beb6b1ab-1264-456a-bf2b-81e28493301d|7|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|psec|[?]|1|mL/animal/day|SUPERIOR SAGITTAL SINUS|RIGHT|||VENDOR|4|Visit_4|65|1|TREATMENT|2020-08-04|65
e|FA|beb6b1ab-1264-456a-bf2b-81e28493301d|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|umol/L/sec|[?]|1|%(v/v)|SUBMANDIBULAR GLAND|LEFT|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|FOLLOW-UP|2020-08-04|65
e|FA|beb6b1ab-1264-456a-bf2b-81e28493301d|9|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|s*kPa|[?]|1|vp/dose|FRONTAL LOBE|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-08-29|90
e|FA|beb6b1ab-1264-456a-bf2b-81e28493301d|10|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|cm|TOENAIL|RIGHT|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|FOLLOW-UP|2020-08-29|90
e|FA|4292c06d-044e-4dff-aea0-830178a6e220|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|DIP|[?]|1|mg/g/min|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|LEFT|||VENDOR|1|Visit_1|10|1|WASHOUT|2020-12-02|10
e|FA|4292c06d-044e-4dff-aea0-830178a6e220|2|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|IU|[?]|1|mm/h|RIGHT POSTERIOR DESCENDING ARTERY|LATERAL|Y||PROXY|1|Visit_1|10|3|TREATMENT|2020-12-02|10
e|FA|4292c06d-044e-4dff-aea0-830178a6e220|3|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|umol/L/h|[?]|1|10^6 U|SPLEEN, HILUM|LEFT||Y|INTERVIEWER|2|Visit_2|25|5|FOLLOW-UP|2020-12-17|25
e|FA|4292c06d-044e-4dff-aea0-830178a6e220|4|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|ng/mol|[?]|1|in|DISTAL LAD ARTERY|CONTRALATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|1|FOLLOW-UP|2020-12-17|25
e|FA|4292c06d-044e-4dff-aea0-830178a6e220|5|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|breaths/min|[?]|1|mL/h|COMMON ILIAC ARTERY|RIGHT|||PROXY|3|Visit_3|40|2|SCREENING|2021-01-01|40
e|FA|4292c06d-044e-4dff-aea0-830178a6e220|6|LDIAM|Longest Diameter|[?]|GERD|[?]|mmHg/sec|[?]|1|Shock Wave|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|UNILATERAL|||FRIEND|3|Visit_3|40|3|TREATMENT|2021-01-01|40
e|FA|4292c06d-044e-4dff-aea0-830178a6e220|7|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|cmHg|[?]|1|fmol|FEMORAL CONDYLE|LEFT|||SIGNIFICANT OTHER|4|Visit_4|65|1|WASHOUT|2021-01-26|65
e|FA|4292c06d-044e-4dff-aea0-830178a6e220|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|nL|[?]|1|Pa|HEART, LEFT VENTRICULAR OUTFLOW TRACT|CONTRALATERAL||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|WASHOUT|2021-01-26|65
e|FA|4292c06d-044e-4dff-aea0-830178a6e220|9|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|m2|SUBMENTAL LYMPH NODE|CONTRALATERAL|||PROXY|5|Visit_5|90|6|TREATMENT|2021-02-20|90
e|FA|4292c06d-044e-4dff-aea0-830178a6e220|10|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU/mL|[?]|1|ug/g/h|MEDIASTINUM, MIDDLE|CONTRALATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|2|TREATMENT|2021-02-20|90
e|FA|050c12d2-cf9f-402b-9332-d6a9771ed115|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|GBq/g|[?]|1|%(v/v)|TEMPORAL BONE|BILATERAL||Y|VENDOR|1|Visit_1|10|4|TREATMENT|2020-08-18|10
e|FA|050c12d2-cf9f-402b-9332-d6a9771ed115|2|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|CYLINDER|[?]|1|h*%|CEREBRAL CORTEX|LATERAL|||SIBLING|1|Visit_1|10|7|TREATMENT|2020-08-18|10
e|FA|050c12d2-cf9f-402b-9332-d6a9771ed115|3|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|MPS U|[?]|1|mL/min/mmHg|ESOPHAGUS, UPPER THIRD|RIGHT|||GUARDIAN|2|Visit_2|25|2|WASHOUT|2020-09-02|25
e|FA|050c12d2-cf9f-402b-9332-d6a9771ed115|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|mg/g/min|TROCHLEAR NERVE|LATERAL|Y|Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|WASHOUT|2020-09-02|25
e|FA|050c12d2-cf9f-402b-9332-d6a9771ed115|5|DIAMETER|Diameter|[?]|GERD|[?]|pmol/L|[?]|1|cm|URETHRA|LATERAL|Y||SPOUSE|3|Visit_3|40|3|WASHOUT|2020-09-17|40
e|FA|050c12d2-cf9f-402b-9332-d6a9771ed115|6|VOL|Volume|[?]|GERD|[?]|mL/animal/day|[?]|1|vp/dose|HEPATIC VEIN|RIGHT||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|1|WASHOUT|2020-09-17|40
e|FA|050c12d2-cf9f-402b-9332-d6a9771ed115|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|%(v/v)|ADDUCTOR BREVIS MUSCLE|LEFT|||SIBLING|4|Visit_4|65|4|FOLLOW-UP|2020-10-12|65
e|FA|050c12d2-cf9f-402b-9332-d6a9771ed115|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|BLOCKS|[?]|1|%(v/v)|DISTAL RIGHT CORONARY ARTERY CONDUIT|RIGHT|Y|Y|DOMESTIC PARTNER|4|Visit_4|65|1|WASHOUT|2020-10-12|65
e|FA|050c12d2-cf9f-402b-9332-d6a9771ed115|9|PPTFCT|Precipitating Factor|[?]|GERD|[?]|IU|[?]|1|EIA unit|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LEFT|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|4|SCREENING|2020-11-06|90
e|FA|050c12d2-cf9f-402b-9332-d6a9771ed115|10|EVENTNUM|Number of Events|[?]|GERD|[?]|/10^4|[?]|1|U/10^12 RBC|PARATRACHEAL LYMPH NODE|CONTRALATERAL|||VENDOR|5|Visit_5|90|7|TREATMENT|2020-11-06|90
e|FA|2f1073e4-607f-423f-a5de-f531b828e2d3|1|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|min/day|[?]|1|NEEDLE GAUGE|GUT-ASSOCIATED LYMPHOID TISSUE|LATERAL|||PARENT|1|Visit_1|10|2|FOLLOW-UP|2020-10-15|10
e|FA|2f1073e4-607f-423f-a5de-f531b828e2d3|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|OD Unit|[?]|1|TRANSDUCING UNIT/mL|LUNG, HILUM|BILATERAL|Y|Y|CHILD|1|Visit_1|10|3|TREATMENT|2020-10-15|10
e|FA|2f1073e4-607f-423f-a5de-f531b828e2d3|3|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|PA|[?]|1|10^6 CFU|EYE, ANTERIOR SEGMENT|CONTRALATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|SCREENING|2020-10-30|25
e|FA|2f1073e4-607f-423f-a5de-f531b828e2d3|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|pptr|[?]|1|mg/g/min|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|||SPOUSE|2|Visit_2|25|7|TREATMENT|2020-10-30|25
e|FA|2f1073e4-607f-423f-a5de-f531b828e2d3|5|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|kIU|[?]|1|10^6 IU/mL|COLON WALL|RIGHT|||PROXY|3|Visit_3|40|1|TREATMENT|2020-11-14|40
e|FA|2f1073e4-607f-423f-a5de-f531b828e2d3|6|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|U|[?]|1|gtt|FIRST OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|Y||INVESTIGATOR|3|Visit_3|40|7|TREATMENT|2020-11-14|40
e|FA|2f1073e4-607f-423f-a5de-f531b828e2d3|7|SPEED|Speed|[?]|GERD|[?]|cP|[?]|1|mEq/g|INTERPHALANGEAL OF THE FOOT|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2020-12-09|65
e|FA|2f1073e4-607f-423f-a5de-f531b828e2d3|8|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|cm/s|[?]|1|umol|FEMUR|LATERAL||Y|PROXY|4|Visit_4|65|4|TREATMENT|2020-12-09|65
e|FA|2f1073e4-607f-423f-a5de-f531b828e2d3|9|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|kcal|[?]|1|10^6 U|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|LATERAL|Y|Y|INTERVIEWER|5|Visit_5|90|6|TREATMENT|2021-01-03|90
e|FA|2f1073e4-607f-423f-a5de-f531b828e2d3|10|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|m3|[?]|1|PFU/dose|UPPER CERVICAL LYMPH NODE|RIGHT|||CAREGIVER|5|Visit_5|90|2|SCREENING|2021-01-03|90
e|FA|df466903-3212-4e73-bff0-a183447c7408|1|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|U/mmol|THYROID GLAND|LEFT|Y|Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-11-01|10
e|FA|df466903-3212-4e73-bff0-a183447c7408|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/mol|[?]|1|Pa|VERTEBRAL ARTERY|UNILATERAL|||SPOUSE|1|Visit_1|10|6|SCREENING|2020-11-01|10
e|FA|df466903-3212-4e73-bff0-a183447c7408|3|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|ug/dose|[?]|1|Gy/h|OCCIPITAL LOBE|LATERAL|Y|Y|CAREGIVER|2|Visit_2|25|5|TREATMENT|2020-11-16|25
e|FA|df466903-3212-4e73-bff0-a183447c7408|4|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|MBq/uL|[?]|1|uL/kg/day|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|LATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|5|FOLLOW-UP|2020-11-16|25
e|FA|df466903-3212-4e73-bff0-a183447c7408|5|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|IU/kg/h|[?]|1|mL/dose|LUNG, RIGHT MIDDLE LOBE|IPSILATERAL|||INTERVIEWER|3|Visit_3|40|1|FOLLOW-UP|2020-12-01|40
e|FA|df466903-3212-4e73-bff0-a183447c7408|6|SERVNUM|Number of Servings|[?]|GERD|[?]|PIPE|[?]|1|Hz/s|CANINE TOOTH|CONTRALATERAL||Y|PROXY|3|Visit_3|40|1|TREATMENT|2020-12-01|40
e|FA|df466903-3212-4e73-bff0-a183447c7408|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|POINT|[?]|1|PFU/dose|INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL||Y|VENDOR|4|Visit_4|65|7|TREATMENT|2020-12-26|65
e|FA|df466903-3212-4e73-bff0-a183447c7408|8|DIAMETER|Diameter|[?]|GERD|[?]|MdFI|[?]|1|cm|URETHRAL SPHINCTER|LEFT|||ADJUDICATOR|4|Visit_4|65|4|SCREENING|2020-12-26|65
e|FA|df466903-3212-4e73-bff0-a183447c7408|9|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|g/kg|[?]|1|U/mmol|BLADDER|BILATERAL|||FAMILY MEMBER|5|Visit_5|90|4|FOLLOW-UP|2021-01-20|90
e|FA|df466903-3212-4e73-bff0-a183447c7408|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|%(v/v)|STERNEBRA|LATERAL|||ADJUDICATOR|5|Visit_5|90|2|FOLLOW-UP|2021-01-20|90
e|FA|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|1|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|ugEq/L|[?]|1|U/mmol|PROCERUS MUSCLE|BILATERAL|||CHILD|1|Visit_1|10|7|SCREENING|2020-07-13|10
e|FA|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|2|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|PACKAGE|[?]|1|10^6 U|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|6|TREATMENT|2020-07-13|10
e|FA|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|3|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|tuberculin unit/mL|[?]|1|m2|CORPUS CALLOSUM, BODY|RIGHT|||SIBLING|2|Visit_2|25|5|TREATMENT|2020-07-28|25
e|FA|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|4|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|TRACE|[?]|1|ug/m2/h|INTESTINE|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2020-07-28|25
e|FA|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|5|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|pt_us|[?]|1|g/L|ABDOMINAL AORTA|BILATERAL|||ADJUDICATOR|3|Visit_3|40|5|FOLLOW-UP|2020-08-12|40
e|FA|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|6|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|foz_us|[?]|1|PFU/dose|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|||CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-08-12|40
e|FA|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|7|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/mL/h|[?]|1|10^9 CFU/mL|HAND DIGIT 2|UNILATERAL||Y|CAREGIVER|4|Visit_4|65|2|SCREENING|2020-09-06|65
e|FA|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|8|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|10^3/L|[?]|1|mL/h|HEART, ATRIUM|CONTRALATERAL|Y||STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-09-06|65
e|FA|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|9|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|NEBULE|[?]|1|MBq|SALIVARY GLAND, SUBLINGUAL|IPSILATERAL||Y|GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-10-01|90
e|FA|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|10|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|IU/mg|TRIANGULAR-HAMATE JOINT|LATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|FOLLOW-UP|2020-10-01|90
e|FA|c37df2f6-be8a-4709-b97d-061ab9754e0d|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|copies/ug|[?]|1|km|SHOULDER JOINT|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-08-01|10
e|FA|c37df2f6-be8a-4709-b97d-061ab9754e0d|2|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mL/s|[?]|1|L/h/m2|DUCTUS ARTERIOSUS|RIGHT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|4|FOLLOW-UP|2020-08-01|10
e|FA|c37df2f6-be8a-4709-b97d-061ab9754e0d|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mV|[?]|1|mg/g/min|ANTERIOR TIBIAL VEIN|IPSILATERAL|||SIBLING|2|Visit_2|25|3|SCREENING|2020-08-16|25
e|FA|c37df2f6-be8a-4709-b97d-061ab9754e0d|4|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|U/dL|[?]|1|100 IU/mL|ARM|UNILATERAL||Y|CAREGIVER|2|Visit_2|25|6|SCREENING|2020-08-16|25
e|FA|c37df2f6-be8a-4709-b97d-061ab9754e0d|5|TOTNUM|Total Number|[?]|GERD|[?]|mL/cage/day|[?]|1|/200 HPFs|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|RIGHT|||INTERVIEWER|3|Visit_3|40|2|TREATMENT|2020-08-31|40
e|FA|c37df2f6-be8a-4709-b97d-061ab9754e0d|6|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|anti-Xa IU|[?]|1|L/h/m2|DURAL VENOUS SINUS|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|WASHOUT|2020-08-31|40
e|FA|c37df2f6-be8a-4709-b97d-061ab9754e0d|7|PPTFCT|Precipitating Factor|[?]|GERD|[?]|nCi|[?]|1|EIA unit|LATERAL THIRD DIAGONAL BRANCH ARTERY|UNILATERAL|||VENDOR|4|Visit_4|65|5|TREATMENT|2020-09-25|65
e|FA|c37df2f6-be8a-4709-b97d-061ab9754e0d|8|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|/200 HPFs|URETHRAL SPHINCTER|CONTRALATERAL|||GUARDIAN|4|Visit_4|65|7|FOLLOW-UP|2020-09-25|65
e|FA|c37df2f6-be8a-4709-b97d-061ab9754e0d|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|yd|[?]|1|%(v/v)|GLUTEAL MUSCLE|CONTRALATERAL||Y|INTERVIEWER|5|Visit_5|90|1|TREATMENT|2020-10-20|90
e|FA|c37df2f6-be8a-4709-b97d-061ab9754e0d|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|mg/m2/min|[?]|1|km|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|UNILATERAL|||PROXY|5|Visit_5|90|4|WASHOUT|2020-10-20|90
e|FA|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|1|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|mEq/g|PONS VAROLII|LATERAL|||PROXY|1|Visit_1|10|2|FOLLOW-UP|2020-05-13|10
e|FA|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|2|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|amp|[?]|1|mL/dose|SPLENIC LYMPH NODE|RIGHT|Y||FRIEND|1|Visit_1|10|6|TREATMENT|2020-05-13|10
e|FA|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|mL/s/m2|[?]|1|mg/h|MID-RIGHT CORONARY ARTERY CONDUIT|IPSILATERAL|Y|Y|STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-05-28|25
e|FA|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|4|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|L/s|[?]|1|mL/h|SKIN OF THE AXILLA|IPSILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2020-05-28|25
e|FA|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|log10 CCID 50/dose|[?]|1|mg/g/min|MIDDLE PHALANX 2 OF THE HAND|CONTRALATERAL|Y||GUARDIAN|3|Visit_3|40|3|FOLLOW-UP|2020-06-12|40
e|FA|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|6|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|10^5/L|[?]|1|10^6 U|UMBILICAL CORD|CONTRALATERAL|||PARENT|3|Visit_3|40|3|WASHOUT|2020-06-12|40
e|FA|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mL|[?]|1|U/mmol|OLFACTORY MUCOSA|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|FOLLOW-UP|2020-07-07|65
e|FA|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|8|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|ug/kg/h|HAIR SHAFT|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|1|TREATMENT|2020-07-07|65
e|FA|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|9|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|cg|[?]|1|m2|METACARPAL BONE 5|BILATERAL|||PROXY|5|Visit_5|90|1|TREATMENT|2020-08-01|90
e|FA|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|10|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|cm/s|[?]|1|/500 WBC|FASCIA|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-08-01|90
e|FA|cec9e0ce-4d09-470c-9c26-df661d316a69|1|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|pkat/L|[?]|1|MPS U|HEART, VENTRICULAR WALL|LATERAL|||INTERVIEWER|1|Visit_1|10|4|TREATMENT|2021-01-05|10
e|FA|cec9e0ce-4d09-470c-9c26-df661d316a69|2|AGETRT1|Age At First Treatment|[?]|GERD|[?]|cmHg|[?]|1|mL/mmHg/min/L|CORPUS UTERI|IPSILATERAL|||INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2021-01-05|10
e|FA|cec9e0ce-4d09-470c-9c26-df661d316a69|3|SPEED|Speed|[?]|GERD|[?]|nmol/L/min|[?]|1|mEq/g|SPINAL CORD|CONTRALATERAL|||CHILD|2|Visit_2|25|7|TREATMENT|2021-01-20|25
e|FA|cec9e0ce-4d09-470c-9c26-df661d316a69|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^6 CFU/mL|[?]|1|mg/g/min|SOLEUS MUSCLE|UNILATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|FOLLOW-UP|2021-01-20|25
e|FA|cec9e0ce-4d09-470c-9c26-df661d316a69|5|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|Bq/mL|[?]|1|anti-Xa IU/mL|PANCREAS|RIGHT|Y|Y|INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2021-02-04|40
e|FA|cec9e0ce-4d09-470c-9c26-df661d316a69|6|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|ug/kg/h|[?]|1|10^6 organisms/mL|MID-RIGHT CORONARY ARTERY CONDUIT|LATERAL|Y||FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2021-02-04|40
e|FA|cec9e0ce-4d09-470c-9c26-df661d316a69|7|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|g/cage/wk|[?]|1|vp/dose|SPINAL ACCESSORY NERVE|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|TREATMENT|2021-03-01|65
e|FA|cec9e0ce-4d09-470c-9c26-df661d316a69|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/cage|[?]|1|mg/g/min|OPTIC NERVE|UNILATERAL||Y|PARENT|4|Visit_4|65|3|TREATMENT|2021-03-01|65
e|FA|cec9e0ce-4d09-470c-9c26-df661d316a69|9|EVENTFRQ|Event Frequency|[?]|GERD|[?]|10^6 copies/mL|[?]|1|ug/kg/h|FEMALE GENITALIA|UNILATERAL|||INVESTIGATOR|5|Visit_5|90|7|SCREENING|2021-03-26|90
e|FA|cec9e0ce-4d09-470c-9c26-df661d316a69|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|pmol/L|[?]|1|mg/g/min|SUPERIOR SAGITTAL SINUS|LEFT|||FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2021-03-26|90
e|FA|b98b4e19-51ac-40cc-80d5-cb6d8000c112|1|SEV|Severity/Intensity|[?]|GERD|[?]|MBP|[?]|1|Pa|KIDNEY|LEFT|Y||CAREGIVER|1|Visit_1|10|4|WASHOUT|2021-01-17|10
e|FA|b98b4e19-51ac-40cc-80d5-cb6d8000c112|2|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|TRACE|[?]|1|uCi/kg|NOSTRIL|CONTRALATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|WASHOUT|2021-01-17|10
e|FA|b98b4e19-51ac-40cc-80d5-cb6d8000c112|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU|[?]|1|mg/g/min|LOWER GASTROINTESTINAL TRACT LYMPH NODE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2021-02-01|25
e|FA|b98b4e19-51ac-40cc-80d5-cb6d8000c112|4|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|mg/dose|[?]|1|mL/min/mmHg|ILEUM LYMPH NODE|RIGHT|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|6|FOLLOW-UP|2021-02-01|25
e|FA|b98b4e19-51ac-40cc-80d5-cb6d8000c112|5|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|kat|[?]|1|10^6 CFU|KIDNEY, LOWER LOBE|LATERAL|||STUDY SUBJECT|3|Visit_3|40|6|WASHOUT|2021-02-16|40
e|FA|b98b4e19-51ac-40cc-80d5-cb6d8000c112|6|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|mg/mL/day|[?]|1|DROP|PRONATOR QUADRATUS MUSCLE|RIGHT||Y|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2021-02-16|40
e|FA|b98b4e19-51ac-40cc-80d5-cb6d8000c112|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/mol|[?]|1|mg/g/min|ANTERIOR HORN OF THE LATERAL VENTRICLE|IPSILATERAL|||GUARDIAN|4|Visit_4|65|7|TREATMENT|2021-03-13|65
e|FA|b98b4e19-51ac-40cc-80d5-cb6d8000c112|8|AGETRT1|Age At First Treatment|[?]|GERD|[?]|TAMPON|[?]|1|mL/mmHg/min/L|GASTROESOPHAGEAL JUNCTION|BILATERAL|||STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2021-03-13|65
e|FA|b98b4e19-51ac-40cc-80d5-cb6d8000c112|9|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|TROCHE|[?]|1|/500 WBC|TIBIALIS POSTERIOR MUSCLE|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2021-04-07|90
e|FA|b98b4e19-51ac-40cc-80d5-cb6d8000c112|10|DGRAIN|Dietary Grain|[?]|GERD|[?]|DAgU/mL|[?]|1|10^9 CFU/g|ABDOMINAL CAVITY|BILATERAL|||STUDY SUBJECT|5|Visit_5|90|5|FOLLOW-UP|2021-04-07|90
e|FA|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|1|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|FEU|[?]|1|mmHg/L/min|EYE|IPSILATERAL|||INVESTIGATOR|1|Visit_1|10|7|SCREENING|2020-07-07|10
e|FA|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|2|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|vg/kg|[?]|1|BOWL|OROPHARYNX|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-07-07|10
e|FA|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|3|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|mL/s|[?]|1|mm/h|EAR|LATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|5|SCREENING|2020-07-22|25
e|FA|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|4|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|ug/day|[?]|1|L/h/m2|SKIN OF THE LIP|IPSILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|5|FOLLOW-UP|2020-07-22|25
e|FA|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|5|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|pg/cell|[?]|1|uCi/kg|CORNEAL ENDOTHELIUM|BILATERAL||Y|VENDOR|3|Visit_3|40|7|WASHOUT|2020-08-06|40
e|FA|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|6|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU/mL|[?]|1|MPS U|UVEA|LEFT|||SIGNIFICANT OTHER|3|Visit_3|40|3|WASHOUT|2020-08-06|40
e|FA|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|7|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mg/animal|[?]|1|ug/kg/h|SKIN OF THE NECK|CONTRALATERAL|Y||STUDY SUBJECT|4|Visit_4|65|6|WASHOUT|2020-08-31|65
e|FA|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|umol/mg/min|[?]|1|%(v/v)|HAIR BULB|LATERAL||Y|SIGNIFICANT OTHER|4|Visit_4|65|2|FOLLOW-UP|2020-08-31|65
e|FA|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|9|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|EVENTS|[?]|1|cm H2O|NASAL BONE|RIGHT|||SIBLING|5|Visit_5|90|4|WASHOUT|2020-09-25|90
e|FA|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|10|SEV|Severity/Intensity|[?]|GERD|[?]|/kg|[?]|1|Pa|CORONARY ARTERY, RIGHT|CONTRALATERAL|Y||STUDY SUBJECT|5|Visit_5|90|2|WASHOUT|2020-09-25|90
e|FA|4bc30b18-c8d8-41a3-91d5-33b8b064087b|1|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|USP U|[?]|1|Bq/mg|PRETRACHEAL LYMPH NODE|UNILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|3|TREATMENT|2020-07-12|10
e|FA|4bc30b18-c8d8-41a3-91d5-33b8b064087b|2|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|pmol|[?]|1|cm H2O|SKIN OF THE NECK|LEFT|||ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-07-12|10
e|FA|4bc30b18-c8d8-41a3-91d5-33b8b064087b|3|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|%(w/w)|[?]|1|Ci/ug|HEART, SEPTUM|IPSILATERAL|||GUARDIAN|2|Visit_2|25|7|SCREENING|2020-07-27|25
e|FA|4bc30b18-c8d8-41a3-91d5-33b8b064087b|4|AGETRT1|Age At First Treatment|[?]|GERD|[?]|10^6 CFU|[?]|1|mL/mmHg/min/L|ANTERIOR INFERIOR CEREBELLAR ARTERY|RIGHT||Y|INTERVIEWER|2|Visit_2|25|6|TREATMENT|2020-07-27|25
e|FA|4bc30b18-c8d8-41a3-91d5-33b8b064087b|5|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|IU/mmol|AXILLA|BILATERAL|Y|Y|CAREGIVER|3|Visit_3|40|7|FOLLOW-UP|2020-08-11|40
e|FA|4bc30b18-c8d8-41a3-91d5-33b8b064087b|6|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|/kg|RIB 1|RIGHT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-08-11|40
e|FA|4bc30b18-c8d8-41a3-91d5-33b8b064087b|7|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|pmol/day|[?]|1|mL/cm3/min|EXTENSOR HALLUCIS BREVIS MUSCLE|IPSILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2020-09-05|65
e|FA|4bc30b18-c8d8-41a3-91d5-33b8b064087b|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|fmol/L|[?]|1|%(v/v)|LIVER, RIGHT LOBE|IPSILATERAL||Y|ADJUDICATOR|4|Visit_4|65|4|TREATMENT|2020-09-05|65
e|FA|4bc30b18-c8d8-41a3-91d5-33b8b064087b|9|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|U/mg|LUNG, HILUM|BILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|SCREENING|2020-09-30|90
e|FA|4bc30b18-c8d8-41a3-91d5-33b8b064087b|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|beats/min|[?]|1|mg/g/min|ANTERIOR SUPERIOR ILIAC SPINE|LEFT|||CAREGIVER|5|Visit_5|90|3|TREATMENT|2020-09-30|90
e|FA|7ff27a70-0472-4cc1-b057-6b161ab29568|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa|[?]|1|SCOOPFUL|AXILLARY LYMPH NODE LEVEL II|UNILATERAL|||STUDY SUBJECT|1|Visit_1|10|6|TREATMENT|2020-11-19|10
e|FA|7ff27a70-0472-4cc1-b057-6b161ab29568|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|g/m2|[?]|1|%(v/v)|NASAL CAVITY|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|WASHOUT|2020-11-19|10
e|FA|7ff27a70-0472-4cc1-b057-6b161ab29568|3|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|breaths/min|[?]|1|IU/mmol|PONS VAROLII|CONTRALATERAL||Y|SIBLING|2|Visit_2|25|3|TREATMENT|2020-12-04|25
e|FA|7ff27a70-0472-4cc1-b057-6b161ab29568|4|DGRAIN|Dietary Grain|[?]|GERD|[?]|mol/day|[?]|1|10^9 CFU/g|RECTO-UTERINE POUCH|BILATERAL|Y||FAMILY MEMBER|2|Visit_2|25|4|TREATMENT|2020-12-04|25
e|FA|7ff27a70-0472-4cc1-b057-6b161ab29568|5|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|Bq/kg|[?]|1|BP|T6 VERTEBRA|RIGHT|||FRIEND|3|Visit_3|40|6|TREATMENT|2020-12-19|40
e|FA|7ff27a70-0472-4cc1-b057-6b161ab29568|6|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|ug/m2/h|[?]|1|Log10 ELISA unit|FEMALE GENITALIA|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|WASHOUT|2020-12-19|40
e|FA|7ff27a70-0472-4cc1-b057-6b161ab29568|7|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|pg/cell|[?]|1|m2|NUCHAL LYMPH NODE|RIGHT||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|SCREENING|2021-01-13|65
e|FA|7ff27a70-0472-4cc1-b057-6b161ab29568|8|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|DROP|[?]|1|mIU/L|SENSORIMOTOR CORTEX|CONTRALATERAL|Y||STUDY SUBJECT|4|Visit_4|65|1|SCREENING|2021-01-13|65
e|FA|7ff27a70-0472-4cc1-b057-6b161ab29568|9|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|10^6/g|[?]|1|mIU/L|INTERVENTRICULAR SEPTUM|IPSILATERAL|||FRIEND|5|Visit_5|90|3|WASHOUT|2021-02-07|90
e|FA|7ff27a70-0472-4cc1-b057-6b161ab29568|10|EVENTNUM|Number of Events|[?]|GERD|[?]|U/kg/h|[?]|1|U/10^12 RBC|SKIN OF THE ELBOW|LEFT|||ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2021-02-07|90
e|FA|40529b01-9a80-4ada-a8df-96eec0e65043|1|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|HOURS|[?]|1|AU/mL|EYE, ANTERIOR CHAMBER|BILATERAL|||SPOUSE|1|Visit_1|10|1|TREATMENT|2020-06-17|10
e|FA|40529b01-9a80-4ada-a8df-96eec0e65043|2|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|U/L|[?]|1|mL|THORACIC VERTEBRA|CONTRALATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-06-17|10
e|FA|40529b01-9a80-4ada-a8df-96eec0e65043|3|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|POINT|[?]|1|km|EARLOBE|IPSILATERAL|Y||PARENT|2|Visit_2|25|7|TREATMENT|2020-07-02|25
e|FA|40529b01-9a80-4ada-a8df-96eec0e65043|4|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|mEq/day|[?]|1|10^6/L|ADDUCTOR POLLICIS MUSCLE|IPSILATERAL|||SPOUSE|2|Visit_2|25|7|TREATMENT|2020-07-02|25
e|FA|40529b01-9a80-4ada-a8df-96eec0e65043|5|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|MBq|[?]|1|10^6 U|RETROCRURAL LYMPH NODE|CONTRALATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|2|FOLLOW-UP|2020-07-17|40
e|FA|40529b01-9a80-4ada-a8df-96eec0e65043|6|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|GBq|[?]|1|cm H2O|JOINT|RIGHT|Y||STUDY SUBJECT|3|Visit_3|40|2|FOLLOW-UP|2020-07-17|40
e|FA|40529b01-9a80-4ada-a8df-96eec0e65043|7|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|10^9 CFU/mL|RECTUS FEMORIS MUSCLE|LATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|7|FOLLOW-UP|2020-08-11|65
e|FA|40529b01-9a80-4ada-a8df-96eec0e65043|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/animal|[?]|1|mg/g/min|SKIN OF THE LOWER LIMB|CONTRALATERAL|Y|Y|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-08-11|65
e|FA|40529b01-9a80-4ada-a8df-96eec0e65043|9|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|deg/mm|[?]|1|cmH2O/mL|LUMBAR VERTEBRA|LATERAL|Y||GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-09-05|90
e|FA|40529b01-9a80-4ada-a8df-96eec0e65043|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit/dose|[?]|1|mg/g/min|DISTAL COMMON BILE DUCT|RIGHT||Y|FRIEND|5|Visit_5|90|7|SCREENING|2020-09-05|90
e|FA|f3e22efc-0948-4c6e-9173-8e284d342d33|1|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|anti-Xa IU|[?]|1|BOWL|FOOT DIGIT 5|BILATERAL||Y|VENDOR|1|Visit_1|10|4|SCREENING|2020-12-06|10
e|FA|f3e22efc-0948-4c6e-9173-8e284d342d33|2|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|SACHET|[?]|1|Shock Wave|FOOT DIGIT 3|LATERAL|||INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-12-06|10
e|FA|f3e22efc-0948-4c6e-9173-8e284d342d33|3|OBJNUM|Number of Objects|[?]|GERD|[?]|BOLUS|[?]|1|mL/100g/min|LUNG, RIGHT LOWER LOBE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-12-21|25
e|FA|f3e22efc-0948-4c6e-9173-8e284d342d33|4|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|DIP|[?]|1|h*%|SARTORIUS MUSCLE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|SCREENING|2020-12-21|25
e|FA|f3e22efc-0948-4c6e-9173-8e284d342d33|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|uEq/L|[?]|1|%(v/v)|SKIN OF THE AXILLA|LEFT||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|1|FOLLOW-UP|2021-01-05|40
e|FA|f3e22efc-0948-4c6e-9173-8e284d342d33|6|DPROT|Dietary Protein|[?]|GERD|[?]|hPa|[?]|1|10^4 CFU/mL|TOOTH CANAL|LEFT|||CAREGIVER|3|Visit_3|40|7|TREATMENT|2021-01-05|40
e|FA|f3e22efc-0948-4c6e-9173-8e284d342d33|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|BU|[?]|1|U/mmol|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|BILATERAL||Y|DOMESTIC PARTNER|4|Visit_4|65|5|SCREENING|2021-01-30|65
e|FA|f3e22efc-0948-4c6e-9173-8e284d342d33|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|h*%|[?]|1|%(v/v)|5TH LUMBAR SPINOUS PROCESS|LEFT||Y|SIBLING|4|Visit_4|65|4|TREATMENT|2021-01-30|65
e|FA|f3e22efc-0948-4c6e-9173-8e284d342d33|9|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|g/cage/wk|[?]|1|mL/animal/day|OLFACTORY MUCOSA|UNILATERAL|||VENDOR|5|Visit_5|90|1|SCREENING|2021-02-24|90
e|FA|f3e22efc-0948-4c6e-9173-8e284d342d33|10|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|psec|[?]|1|TRANSDUCING UNIT/mL|METATARSAL BONE|RIGHT||Y|GUARDIAN|5|Visit_5|90|1|TREATMENT|2021-02-24|90
e|FA|919eb5b4-a3df-41c6-86f7-c78501bb4335|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|cy/cm|[?]|1|%(v/v)|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|RIGHT|||ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-10-01|10
e|FA|919eb5b4-a3df-41c6-86f7-c78501bb4335|2|DCAL|Dietary Calories|[?]|GERD|[?]|PUFF|[?]|1|EIA unit|THYROID GLAND, RIGHT LOBE|LEFT|Y||INTERVIEWER|1|Visit_1|10|6|TREATMENT|2020-10-01|10
e|FA|919eb5b4-a3df-41c6-86f7-c78501bb4335|3|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/dose|[?]|1|ng|COMMON ILIAC ARTERY|IPSILATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|SCREENING|2020-10-16|25
e|FA|919eb5b4-a3df-41c6-86f7-c78501bb4335|4|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|/month|[?]|1|ohm|CORONARY ARTERY, LEFT|CONTRALATERAL||Y|FRIEND|2|Visit_2|25|7|WASHOUT|2020-10-16|25
e|FA|919eb5b4-a3df-41c6-86f7-c78501bb4335|5|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|/2000 RBC|[?]|1|MPS U|ABDOMINAL CAVITY|LEFT|||PROXY|3|Visit_3|40|1|TREATMENT|2020-10-31|40
e|FA|919eb5b4-a3df-41c6-86f7-c78501bb4335|6|SPEED|Speed|[?]|GERD|[?]|Antibody Unit|[?]|1|mEq/g|FEMUR|CONTRALATERAL|Y|Y|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-10-31|40
e|FA|919eb5b4-a3df-41c6-86f7-c78501bb4335|7|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|IU/kg|[?]|1|/kg|MID-RIGHT CORONARY ARTERY CONDUIT|LATERAL|||CHILD|4|Visit_4|65|2|FOLLOW-UP|2020-11-25|65
e|FA|919eb5b4-a3df-41c6-86f7-c78501bb4335|8|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|kg/L|[?]|1|g/day|PITUITARY GLAND|UNILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2020-11-25|65
e|FA|919eb5b4-a3df-41c6-86f7-c78501bb4335|9|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|Ci|[?]|1|mL/cm3/min|KIDNEY, LOWER LOBE|IPSILATERAL|||PROXY|5|Visit_5|90|6|FOLLOW-UP|2020-12-20|90
e|FA|919eb5b4-a3df-41c6-86f7-c78501bb4335|10|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|fg|[?]|1|mL/m2|METACARPOPHALANGEAL JOINT 1|RIGHT||Y|INVESTIGATOR|5|Visit_5|90|7|SCREENING|2020-12-20|90
e|FA|f918d6e0-6fc2-4303-b323-521c5d531773|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/mol|[?]|1|mg/g/min|ASCENDING AORTA, SINOTUBULAR JUNCTION|CONTRALATERAL|||FAMILY MEMBER|1|Visit_1|10|5|WASHOUT|2020-07-31|10
e|FA|f918d6e0-6fc2-4303-b323-521c5d531773|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|ELISA unit|[?]|1|TRANSDUCING UNIT/mL|LIVER, LEFT LOBE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|WASHOUT|2020-07-31|10
e|FA|f918d6e0-6fc2-4303-b323-521c5d531773|3|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|/HPF|[?]|1|ug/g/h|FLOOR OF MOUTH|RIGHT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2020-08-15|25
e|FA|f918d6e0-6fc2-4303-b323-521c5d531773|4|DMG|Dietary Magnesium|[?]|GERD|[?]|uV*sec|[?]|1|TRANSDUCING UNIT/mL|URETHRA, PENILE|RIGHT|||FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-08-15|25
e|FA|f918d6e0-6fc2-4303-b323-521c5d531773|5|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|dmol|[?]|1|mL/h|HILAR LYMPH NODE|UNILATERAL||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-08-30|40
e|FA|f918d6e0-6fc2-4303-b323-521c5d531773|6|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|mV*min|[?]|1|ug/kg/h|CARDIAC VALVE|UNILATERAL|Y||ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-08-30|40
e|FA|f918d6e0-6fc2-4303-b323-521c5d531773|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|FIU|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|Y|Y|INTERVIEWER|4|Visit_4|65|4|FOLLOW-UP|2020-09-24|65
e|FA|f918d6e0-6fc2-4303-b323-521c5d531773|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|log10 IU/mL|[?]|1|%(v/v)|SPINOUS PROCESS|LEFT|||FRIEND|4|Visit_4|65|6|WASHOUT|2020-09-24|65
e|FA|f918d6e0-6fc2-4303-b323-521c5d531773|9|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|APPLICATION|[?]|1|in|CEREBRAL VEIN|CONTRALATERAL|||PROXY|5|Visit_5|90|4|SCREENING|2020-10-19|90
e|FA|f918d6e0-6fc2-4303-b323-521c5d531773|10|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|gtt|SKIN OF THE CHEST|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2020-10-19|90
e|FA|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|1|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|ug/m2|[?]|1|TRANSDUCING UNIT/mL|RETROCRURAL LYMPH NODE|LATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-11-24|10
e|FA|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|2|DFIBER|Dietary Fiber|[?]|GERD|[?]|kat|[?]|1|h*%|VULVA|LATERAL|||PARENT|1|Visit_1|10|4|WASHOUT|2020-11-24|10
e|FA|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|3|SEV|Severity/Intensity|[?]|GERD|[?]|mV*min|[?]|1|Pa|LUNG, RIGHT UPPER LOBE|IPSILATERAL|||INTERVIEWER|2|Visit_2|25|2|TREATMENT|2020-12-09|25
e|FA|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|steps/min|[?]|1|10^6 IU/mL|ESOPHAGUS, ABDOMINAL|RIGHT|Y||CHILD|2|Visit_2|25|1|SCREENING|2020-12-09|25
e|FA|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|5|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|umol/h/mmol|[?]|1|umol|ALVEOLUS|RIGHT|||CHILD|3|Visit_3|40|2|SCREENING|2020-12-24|40
e|FA|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ft3|[?]|1|mg/g/min|OSTIOMEATAL COMPLEX|LEFT|||VENDOR|3|Visit_3|40|5|FOLLOW-UP|2020-12-24|40
e|FA|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|7|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|Ci/g|[?]|1|100 IU/mL|ILIOPSOAS MUSCLE|UNILATERAL|||SPOUSE|4|Visit_4|65|4|FOLLOW-UP|2021-01-18|65
e|FA|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|8|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|/40 HPFs|[?]|1|mL/h|RESPIRATORY SYSTEM|RIGHT|||STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2021-01-18|65
e|FA|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|9|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|EID 50/dose|[?]|1|10^6 CFU/mL|CENTRAL NERVOUS SYSTEM|CONTRALATERAL|Y||GUARDIAN|5|Visit_5|90|5|TREATMENT|2021-02-12|90
e|FA|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|10|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|ug/dose|[?]|1|IU/mg|LEFT CIRCUMFLEX ARTERY OSTIUM|LATERAL|||DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2021-02-12|90
e|FA|4b1e011f-a16d-4ff6-902d-451d5d13ee97|1|EXTRSCT|Extent of Resection|[?]|GERD|[?]|ug/L|[?]|1|Weber|PINEAL GLAND|LEFT|||SPOUSE|1|Visit_1|10|1|FOLLOW-UP|2020-06-21|10
e|FA|4b1e011f-a16d-4ff6-902d-451d5d13ee97|2|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|MBP|[?]|1|anti-Xa IU/mL|BLOOD VESSEL|CONTRALATERAL|||INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-06-21|10
e|FA|4b1e011f-a16d-4ff6-902d-451d5d13ee97|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Sv|[?]|1|%(v/v)|CHOROID PLEXUS|UNILATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-07-06|25
e|FA|4b1e011f-a16d-4ff6-902d-451d5d13ee97|4|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|mkat|[?]|1|/500 WBC|STERNOCLAVICULAR JOINT|BILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|FOLLOW-UP|2020-07-06|25
e|FA|4b1e011f-a16d-4ff6-902d-451d5d13ee97|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|nsec|[?]|1|mg/g/min|NOSTRIL|UNILATERAL|||SIBLING|3|Visit_3|40|3|TREATMENT|2020-07-21|40
e|FA|4b1e011f-a16d-4ff6-902d-451d5d13ee97|6|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|ug/g/day|[?]|1|g/day|PROXIMAL CIRCUMFLEX ARTERY|IPSILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|5|FOLLOW-UP|2020-07-21|40
e|FA|4b1e011f-a16d-4ff6-902d-451d5d13ee97|7|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|YEARS|[?]|1|mEq|SACROILIAC JOINT|UNILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2020-08-15|65
e|FA|4b1e011f-a16d-4ff6-902d-451d5d13ee97|8|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|mmol/day|[?]|1|g/dL|LIVER, RIGHT LOBE|RIGHT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2020-08-15|65
e|FA|4b1e011f-a16d-4ff6-902d-451d5d13ee97|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mEq/uL|[?]|1|mg/g/min|METACARPAL BONE 1|RIGHT|Y||SPOUSE|5|Visit_5|90|2|FOLLOW-UP|2020-09-09|90
e|FA|4b1e011f-a16d-4ff6-902d-451d5d13ee97|10|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|pkat|[?]|1|mmHg/L/min|BRACHIAL VEIN|LEFT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|SCREENING|2020-09-09|90
e|FA|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|1|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|BOTTLE|[?]|1|fmol|TALUS|RIGHT||Y|SPOUSE|1|Visit_1|10|1|TREATMENT|2020-07-19|10
e|FA|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|mg/g/min|FEMORO-POPLITEAL PERIPHERAL ARTERY|LEFT|Y||SIGNIFICANT OTHER|1|Visit_1|10|5|FOLLOW-UP|2020-07-19|10
e|FA|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|3|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/g|[?]|1|Log10 ELISA unit|TALUS|RIGHT|||INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-08-03|25
e|FA|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|uV*sec|[?]|1|10^6 IU/mL|LEFT VENTRICULAR MID ANTERIOR SEGMENT|BILATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-08-03|25
e|FA|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|5|QOLIMP|QOL Impact|[?]|GERD|[?]|mL/kg/day|[?]|1|10^6/L|ESOPHAGUS, UPPER THIRD|BILATERAL|Y||VENDOR|3|Visit_3|40|4|TREATMENT|2020-08-18|40
e|FA|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|6|EXCDUR|Exercise Duration|[?]|GERD|[?]|CIGAR|[?]|1|mm|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|CONTRALATERAL|||GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-08-18|40
e|FA|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|7|TOTNUM|Total Number|[?]|GERD|[?]|pg/cell|[?]|1|/200 HPFs|T12 VERTEBRA|BILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2020-09-12|65
e|FA|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|mg/animal|[?]|1|mL|PECTORALIS MAJOR MUSCLE|UNILATERAL|Y|Y|SIBLING|4|Visit_4|65|2|TREATMENT|2020-09-12|65
e|FA|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|9|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|mL/mmHg/min/L|EXTRAOCULAR MUSCLE|LATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-10-07|90
e|FA|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|10|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|BLOCKS|[?]|1|ohm|INTERPHALANGEAL JOINT 5 OF THE HAND|BILATERAL|||INVESTIGATOR|5|Visit_5|90|2|WASHOUT|2020-10-07|90
e|FA|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^3 organisms/mL|[?]|1|mg/g/min|LATERAL FIRST DIAGONAL BRANCH ARTERY|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|SCREENING|2020-11-27|10
e|FA|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|2|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|MnFI|[?]|1|Gy/h|BRAIN VENTRICLE, LATERAL|IPSILATERAL|Y||PARENT|1|Visit_1|10|6|WASHOUT|2020-11-27|10
e|FA|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|3|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|km/h|[?]|1|Bq/mg|ABDOMINAL LYMPH NODE|BILATERAL|Y|Y|SPOUSE|2|Visit_2|25|6|FOLLOW-UP|2020-12-12|25
e|FA|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|HEP|[?]|1|QUANTITY SUFFICIENT|PRESACRAL SPACE|BILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-12-12|25
e|FA|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|EU|[?]|1|mg/g/min|SUBGLOTTIS|UNILATERAL|||SPOUSE|3|Visit_3|40|7|SCREENING|2020-12-27|40
e|FA|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|6|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|MPL U|[?]|1|MBq|RIB 6|UNILATERAL|||FAMILY MEMBER|3|Visit_3|40|4|FOLLOW-UP|2020-12-27|40
e|FA|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|CUP|[?]|1|umol|CECUM|UNILATERAL|Y||FRIEND|4|Visit_4|65|2|SCREENING|2021-01-21|65
e|FA|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|8|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|g/animal|[?]|1|Gy/h|SUBSCAPULARIS MUSCLE|RIGHT|||ADJUDICATION COMMITTEE|4|Visit_4|65|4|WASHOUT|2021-01-21|65
e|FA|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|umol/dL|[?]|1|Pa|PELVIC LYMPH NODE|BILATERAL||Y|INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2021-02-15|90
e|FA|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|10|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|pg/cell|[?]|1|U/10^12 RBC|RIGHT ATRIAL ENDOCARDIUM|BILATERAL|Y||SIBLING|5|Visit_5|90|1|TREATMENT|2021-02-15|90
e|FA|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|1|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|mg/m2/h|[?]|1|TRANSDUCING UNIT/mL|CAPITATE BONE|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-12-09|10
e|FA|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|2|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/g|[?]|1|mg/dose|HAND DIGIT 1|LEFT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|WASHOUT|2020-12-09|10
e|FA|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|Shock Wave|APPENDIX|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|2|FOLLOW-UP|2020-12-24|25
e|FA|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|4|LDIAM|Longest Diameter|[?]|GERD|[?]|cm|[?]|1|Shock Wave|CEREBRAL HEMISPHERE, RIGHT|CONTRALATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|WASHOUT|2020-12-24|25
e|FA|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|5|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|DROP|CORONARY ARTERY|IPSILATERAL|Y||GUARDIAN|3|Visit_3|40|6|TREATMENT|2021-01-08|40
e|FA|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|6|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|mEq/day|[?]|1|10^6 organisms/mL|PARATHYROID GLAND|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|FOLLOW-UP|2021-01-08|40
e|FA|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|7|SERVNUM|Number of Servings|[?]|GERD|[?]|mm/min|[?]|1|Hz/s|PARATRACHEAL LYMPH NODE|LEFT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-02-02|65
e|FA|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|8|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|U/kg|[?]|1|uCi/kg|ETHMOID SINUS|UNILATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|WASHOUT|2021-02-02|65
e|FA|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|Bq/uL|[?]|1|mL/dose|DISTAL FEMUR R1|RIGHT|||SIGNIFICANT OTHER|5|Visit_5|90|1|SCREENING|2021-02-27|90
e|FA|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|10|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|mL/kg/h|[?]|1|mm/h|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|||FRIEND|5|Visit_5|90|5|FOLLOW-UP|2021-02-27|90
e|FA|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|1|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|10^9 organisms/mg|[?]|1|NEEDLE GAUGE|ELBOW FLEXOR MUSCLES|LATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-07-06|10
e|FA|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|2|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|mmol/day|[?]|1|mg/dose|MALE GENITALIA|LATERAL|||CAREGIVER|1|Visit_1|10|7|WASHOUT|2020-07-06|10
e|FA|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|3|EVENTFRQ|Event Frequency|[?]|GERD|[?]|Log10 ELISA unit|[?]|1|ug/kg/h|INSULAR CORTEX|LEFT|Y||FRIEND|2|Visit_2|25|2|FOLLOW-UP|2020-07-21|25
e|FA|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|4|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/mL|[?]|1|mL/h|LESSER TROCHANTER|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2020-07-21|25
e|FA|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|5|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|uEq|[?]|1|cm|HEART|UNILATERAL|||SIBLING|3|Visit_3|40|5|SCREENING|2020-08-05|40
e|FA|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|6|DFRUIT|Dietary Fruit|[?]|GERD|[?]|10^7 CFU|[?]|1|10^6 CFU/mL|FEMORAL VEIN|LEFT|||SPOUSE|3|Visit_3|40|4|TREATMENT|2020-08-05|40
e|FA|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|7|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|h*%|[?]|1|BOWL|PROXIMAL PHALANX 5 OF THE HAND|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|FOLLOW-UP|2020-08-30|65
e|FA|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|8|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|VIAL|[?]|1|10^6 CFU|T6 VERTEBRA|LEFT|||FRIEND|4|Visit_4|65|1|SCREENING|2020-08-30|65
e|FA|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|9|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|VIAL|[?]|1|ng/day|MESENTERIC VEIN|IPSILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-09-24|90
e|FA|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|10|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|s*kPa|[?]|1|PACK|PRIMARY VISUAL CORTEX|RIGHT|||VENDOR|5|Visit_5|90|3|TREATMENT|2020-09-24|90
e|FA|7f1e0661-ebbd-4abd-9031-cb6b424977e2|1|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|mL/100g/min|CORPUS CALLOSUM|UNILATERAL|||SIBLING|1|Visit_1|10|3|FOLLOW-UP|2020-12-13|10
e|FA|7f1e0661-ebbd-4abd-9031-cb6b424977e2|2|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/uL|[?]|1|SACHET|COLON, LEFT|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|5|SCREENING|2020-12-13|10
e|FA|7f1e0661-ebbd-4abd-9031-cb6b424977e2|3|EXTRSCT|Extent of Resection|[?]|GERD|[?]|PA|[?]|1|Weber|LAD SEPTAL PERFORATOR ARTERY|RIGHT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|5|FOLLOW-UP|2020-12-28|25
e|FA|7f1e0661-ebbd-4abd-9031-cb6b424977e2|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ELISA unit|[?]|1|%(v/v)|SKIN OF THE FOREARM|RIGHT|||PARENT|2|Visit_2|25|6|TREATMENT|2020-12-28|25
e|FA|7f1e0661-ebbd-4abd-9031-cb6b424977e2|5|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|LOZENGE|[?]|1|10^6 CFU|SOLE|LATERAL|||FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2021-01-12|40
e|FA|7f1e0661-ebbd-4abd-9031-cb6b424977e2|6|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|LENS|[?]|1|uL/kg/day|INTERPHALANGEAL JOINT 3|LEFT|||CHILD|3|Visit_3|40|2|TREATMENT|2021-01-12|40
e|FA|7f1e0661-ebbd-4abd-9031-cb6b424977e2|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|MAC50|[?]|1|PFU/dose|NERVE|CONTRALATERAL|||GUARDIAN|4|Visit_4|65|2|WASHOUT|2021-02-06|65
e|FA|7f1e0661-ebbd-4abd-9031-cb6b424977e2|8|RLDEV|Relationship to Device|[?]|GERD|[?]|10^6 organisms/mL|[?]|1|mL/min/mmHg|HEPATIC LYMPH NODE|IPSILATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|4|TREATMENT|2021-02-06|65
e|FA|7f1e0661-ebbd-4abd-9031-cb6b424977e2|9|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|U/g/min|[?]|1|AU/mL|PARASYMPATHETIC GANGLIA|LATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2021-03-03|90
e|FA|7f1e0661-ebbd-4abd-9031-cb6b424977e2|10|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mm/sec|[?]|1|Weber|SUPERIOR VENA CAVA|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2021-03-03|90
e|FA|324a2c67-4802-4806-aff2-04fb9c7394d4|1|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|/kg|[?]|1|10^6 CFU|TAIL|UNILATERAL|||FAMILY MEMBER|1|Visit_1|10|1|SCREENING|2020-05-27|10
e|FA|324a2c67-4802-4806-aff2-04fb9c7394d4|2|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|DNA copies/mL|[?]|1|L/h/m2|AORTOPULMONARY WINDOW LYMPH NODE|BILATERAL|||PARENT|1|Visit_1|10|1|TREATMENT|2020-05-27|10
e|FA|324a2c67-4802-4806-aff2-04fb9c7394d4|3|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|Gauss|[?]|1|IU/mg|HEPATOBILIARY SYSTEM|CONTRALATERAL|Y||PROXY|2|Visit_2|25|5|TREATMENT|2020-06-11|25
e|FA|324a2c67-4802-4806-aff2-04fb9c7394d4|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|QUANTITY SUFFICIENT|CORPUS CALLOSUM, BODY|CONTRALATERAL||Y|PROXY|2|Visit_2|25|3|TREATMENT|2020-06-11|25
e|FA|324a2c67-4802-4806-aff2-04fb9c7394d4|5|EXCDUR|Exercise Duration|[?]|GERD|[?]|MET*min|[?]|1|mm|CUBOID BONE|RIGHT||Y|SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2020-06-26|40
e|FA|324a2c67-4802-4806-aff2-04fb9c7394d4|6|SEV|Severity/Intensity|[?]|GERD|[?]|nmol/g|[?]|1|Pa|AXILLARY LYMPH NODE LEVEL I|CONTRALATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|2|TREATMENT|2020-06-26|40
e|FA|324a2c67-4802-4806-aff2-04fb9c7394d4|7|DIAMETER|Diameter|[?]|GERD|[?]|genEq/mL|[?]|1|cm|HAIR FOLLICLE|BILATERAL|||CHILD|4|Visit_4|65|1|TREATMENT|2020-07-21|65
e|FA|324a2c67-4802-4806-aff2-04fb9c7394d4|8|LOCONSET|Localization of Onset|[?]|GERD|[?]|cd*s/m2|[?]|1|g/L|TEMPORAL ARTERY|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2020-07-21|65
e|FA|324a2c67-4802-4806-aff2-04fb9c7394d4|9|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|mEq/uL|[?]|1|NEEDLE GAUGE|HAND DIGIT 5|CONTRALATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-08-15|90
e|FA|324a2c67-4802-4806-aff2-04fb9c7394d4|10|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|kg/L|[?]|1|ug/m2/h|CORNEA|IPSILATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|5|TREATMENT|2020-08-15|90
e|FA|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mg/kg/week|[?]|1|10^6 U|PULMONARY TRUNK|RIGHT|||PROXY|1|Visit_1|10|1|TREATMENT|2020-12-19|10
e|FA|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|2|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|mOsm|[?]|1|PACK|INTERNAL MAMMARY ARTERY|UNILATERAL|Y||PARENT|1|Visit_1|10|7|TREATMENT|2020-12-19|10
e|FA|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|3|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|10^4/hpf|[?]|1|AU/mL|APPENDICULAR SKELETON|LATERAL|Y|Y|STUDY SUBJECT|2|Visit_2|25|1|FOLLOW-UP|2021-01-03|25
e|FA|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|4|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Pa|[?]|1|oz eq|BICEPS FEMORIS MUSCLE|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2021-01-03|25
e|FA|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|5|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|uL/kg/day|C5 VERTEBRA|LEFT|||PROXY|3|Visit_3|40|6|SCREENING|2021-01-18|40
e|FA|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|6|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|titer|[?]|1|10^9 CFU/g|NUCLEUS ACCUMBENS|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|3|WASHOUT|2021-01-18|40
e|FA|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|7|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|10^5/hpf|[?]|1|IU/mg|HEART, APEX|CONTRALATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2021-02-12|65
e|FA|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mol|[?]|1|mg/g/min|LIMB, LOWER|BILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|2|WASHOUT|2021-02-12|65
e|FA|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|9|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|V|[?]|1|IU/mg|EYE, ANTERIOR CHAMBER|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2021-03-09|90
e|FA|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|10|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/m2|[?]|1|ug/kg/h|MEDIASTINAL LYMPH NODE|RIGHT||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|FOLLOW-UP|2021-03-09|90
e|FA|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|1|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|STEPS|[?]|1|mL/dose|BRACHIORADIALIS MUSCLE|IPSILATERAL||Y|PARENT|1|Visit_1|10|7|WASHOUT|2020-08-24|10
e|FA|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|2|QOLIMP|QOL Impact|[?]|GERD|[?]|mol/mol|[?]|1|10^6/L|BODY OF STOMACH|RIGHT|||PROXY|1|Visit_1|10|5|FOLLOW-UP|2020-08-24|10
e|FA|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|3|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|ng|[?]|1|10^6/L|HYMENAL RING|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-09-08|25
e|FA|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|4|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|cm2|[?]|1|PACK|GASTROINTESTINAL TRACT, LOWER, WALL|LEFT|||SIGNIFICANT OTHER|2|Visit_2|25|7|TREATMENT|2020-09-08|25
e|FA|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|5|DMEAT|Dietary Meat|[?]|GERD|[?]|g/kg|[?]|1|10^6 organisms/mL|CECUM|LEFT|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2020-09-23|40
e|FA|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Hz|[?]|1|%(v/v)|HUMERUS SHAFT|BILATERAL|||GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-09-23|40
e|FA|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|7|DFIBER|Dietary Fiber|[?]|GERD|[?]|CIGARETTE|[?]|1|h*%|LEFT VENTRICULAR APICAL LATERAL SEGMENT|UNILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|2|FOLLOW-UP|2020-10-18|65
e|FA|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mCi/kg|[?]|1|mg/g/min|ELBOW FLEXOR MUSCLES|LATERAL|||GUARDIAN|4|Visit_4|65|2|FOLLOW-UP|2020-10-18|65
e|FA|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|9|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|m/sec|[?]|1|psi|KIDNEY, LOWER LOBE|LATERAL|||FRIEND|5|Visit_5|90|4|SCREENING|2020-11-12|90
e|FA|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|10|DFIBER|Dietary Fiber|[?]|GERD|[?]|pmol|[?]|1|h*%|SUBLINGUAL REGION|LEFT||Y|INTERVIEWER|5|Visit_5|90|4|SCREENING|2020-11-12|90
e|FA|911dc297-91cb-42b1-8a26-18f6c83c32a6|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|g/cage|[?]|1|CUP|SACRAL TUBEROSITY|CONTRALATERAL|||CHILD|1|Visit_1|10|4|TREATMENT|2020-12-01|10
e|FA|911dc297-91cb-42b1-8a26-18f6c83c32a6|2|DFRUIT|Dietary Fruit|[?]|GERD|[?]|mmol/min/kPa|[?]|1|10^6 CFU/mL|RESPIRATORY SYSTEM|BILATERAL|||INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-12-01|10
e|FA|911dc297-91cb-42b1-8a26-18f6c83c32a6|3|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|SCOOPFUL|[?]|1|Ci/ug|TRACHEA|UNILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|2|SCREENING|2020-12-16|25
e|FA|911dc297-91cb-42b1-8a26-18f6c83c32a6|4|SERVNUM|Number of Servings|[?]|GERD|[?]|mL/cm3/min|[?]|1|Hz/s|OLFACTORY BULB|LEFT|||STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-12-16|25
e|FA|911dc297-91cb-42b1-8a26-18f6c83c32a6|5|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|BOWL|ABDUCTOR POLLICIS BREVIS MUSCLE|RIGHT|||FRIEND|3|Visit_3|40|6|FOLLOW-UP|2020-12-31|40
e|FA|911dc297-91cb-42b1-8a26-18f6c83c32a6|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6 RNA copies/mL|[?]|1|PACK|GINGIVA|LATERAL|||DOMESTIC PARTNER|3|Visit_3|40|1|SCREENING|2020-12-31|40
e|FA|911dc297-91cb-42b1-8a26-18f6c83c32a6|7|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|uCi/kg|ORBICULARIS OCULI MUSCLE|LEFT|||SPOUSE|4|Visit_4|65|5|TREATMENT|2021-01-25|65
e|FA|911dc297-91cb-42b1-8a26-18f6c83c32a6|8|SPEED|Speed|[?]|GERD|[?]|ug/m2|[?]|1|mEq/g|ACROMIOCLAVICULAR JOINT|CONTRALATERAL|||FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2021-01-25|65
e|FA|911dc297-91cb-42b1-8a26-18f6c83c32a6|9|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|um2|[?]|1|DRUM|COLON LYMPH NODE|IPSILATERAL|||CHILD|5|Visit_5|90|5|TREATMENT|2021-02-19|90
e|FA|911dc297-91cb-42b1-8a26-18f6c83c32a6|10|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|Absorbance U|[?]|1|mIU/L|FOREBRAIN|LATERAL|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|1|SCREENING|2021-02-19|90
e|FA|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|1|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|U/kg/day|[?]|1|cmH2O/mL|HEPATOBILIARY SYSTEM|IPSILATERAL|||STUDY SUBJECT|1|Visit_1|10|6|TREATMENT|2020-11-25|10
e|FA|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|2|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|BISCUIT|[?]|1|psi|MENINGES|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|SCREENING|2020-11-25|10
e|FA|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|3|LDIAM|Longest Diameter|[?]|GERD|[?]|mL/dL|[?]|1|Shock Wave|SECOND RIGHT POSTEROLATERAL ARTERY|IPSILATERAL|||ADJUDICATOR|2|Visit_2|25|4|SCREENING|2020-12-10|25
e|FA|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|4|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|/100 HPFs|[?]|1|gtt|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|BILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2020-12-10|25
e|FA|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|5|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|kN/cm2|[?]|1|NEEDLE GAUGE|PHARYNX|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-12-25|40
e|FA|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|6|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/mmol|[?]|1|in|ISCHIORECTAL FOSSA|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|FOLLOW-UP|2020-12-25|40
e|FA|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|7|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|MET*min|[?]|1|g/cage/day|QUADRICEPS MUSCLE|UNILATERAL|||VENDOR|4|Visit_4|65|7|WASHOUT|2021-01-19|65
e|FA|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|8|SEV|Severity/Intensity|[?]|GERD|[?]|kPa|[?]|1|Pa|HIP JOINT|IPSILATERAL|Y||PARENT|4|Visit_4|65|5|SCREENING|2021-01-19|65
e|FA|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cm2|[?]|1|mg/g/min|CHIN|IPSILATERAL|Y||CAREGIVER|5|Visit_5|90|6|TREATMENT|2021-02-13|90
e|FA|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|10|DFIBER|Dietary Fiber|[?]|GERD|[?]|fmol/L/sec|[?]|1|h*%|LEFT ATRIOVENTRICULAR ARTERY|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2021-02-13|90
e|FA|9bfcd733-2233-4e54-a6cd-641a59fc8a01|1|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|ug/L DDU|[?]|1|gtt|OLFACTORY BULB|RIGHT|||FRIEND|1|Visit_1|10|3|TREATMENT|2020-08-15|10
e|FA|9bfcd733-2233-4e54-a6cd-641a59fc8a01|2|SEV|Severity/Intensity|[?]|GERD|[?]|mL/min/mmHg|[?]|1|Pa|POSTEROLATERAL SEGMENTAL ARTERY|BILATERAL|Y||FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-08-15|10
e|FA|9bfcd733-2233-4e54-a6cd-641a59fc8a01|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mL/s/m2|[?]|1|U/mg|RAPHE|IPSILATERAL|||ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-08-30|25
e|FA|9bfcd733-2233-4e54-a6cd-641a59fc8a01|4|DFATT|Dietary Fat, Total|[?]|GERD|[?]|mg/day|[?]|1|Bq/mg|SKIN AROUND THE MOUTH|IPSILATERAL|||GUARDIAN|2|Visit_2|25|2|SCREENING|2020-08-30|25
e|FA|9bfcd733-2233-4e54-a6cd-641a59fc8a01|5|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|pmol/10^9 cells|[?]|1|SACHET|T2 VERTEBRA|LEFT|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-09-14|40
e|FA|9bfcd733-2233-4e54-a6cd-641a59fc8a01|6|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|L/kg|[?]|1|mL/mmHg/min/L|AORTIC VALVE ANNULUS|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|WASHOUT|2020-09-14|40
e|FA|9bfcd733-2233-4e54-a6cd-641a59fc8a01|7|PPTFCT|Precipitating Factor|[?]|GERD|[?]|ks|[?]|1|EIA unit|VEIN|LATERAL|||STUDY SUBJECT|4|Visit_4|65|1|SCREENING|2020-10-09|65
e|FA|9bfcd733-2233-4e54-a6cd-641a59fc8a01|8|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|mg|[?]|1|MPS U|TONGUE|IPSILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|6|FOLLOW-UP|2020-10-09|65
e|FA|9bfcd733-2233-4e54-a6cd-641a59fc8a01|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|AU/mL|[?]|1|mg/g/min|PARAMETRIUM|UNILATERAL|||ADJUDICATOR|5|Visit_5|90|2|TREATMENT|2020-11-03|90
e|FA|9bfcd733-2233-4e54-a6cd-641a59fc8a01|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|mg/g/min|GASTRIC CURVATURE LYMPH NODE|LEFT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|SCREENING|2020-11-03|90
e|FA|7eb97152-173c-4923-8604-5dad3140cc25|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mL|[?]|1|Pa|INTERNAL MAMMARY ARTERY|CONTRALATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|4|SCREENING|2020-09-05|10
e|FA|7eb97152-173c-4923-8604-5dad3140cc25|2|SEV|Severity/Intensity|[?]|GERD|[?]|nmol|[?]|1|Pa|RETINAL PIGMENTED EPITHELIAL LAYER|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|SCREENING|2020-09-05|10
e|FA|7eb97152-173c-4923-8604-5dad3140cc25|3|DMG|Dietary Magnesium|[?]|GERD|[?]|umol/L/min|[?]|1|TRANSDUCING UNIT/mL|COLON, RECTOSIGMOID|LEFT|Y||SIGNIFICANT OTHER|2|Visit_2|25|5|WASHOUT|2020-09-20|25
e|FA|7eb97152-173c-4923-8604-5dad3140cc25|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|min/day|[?]|1|%(v/v)|ORBIT|BILATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-09-20|25
e|FA|7eb97152-173c-4923-8604-5dad3140cc25|5|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|mEq/uL|[?]|1|PACK|POPLITEAL ARTERY BELOW KNEE|LATERAL|||VENDOR|3|Visit_3|40|1|SCREENING|2020-10-05|40
e|FA|7eb97152-173c-4923-8604-5dad3140cc25|6|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|nmol/mL/min|[?]|1|10^9 CFU/g|BRAIN|RIGHT|Y||CHILD|3|Visit_3|40|5|TREATMENT|2020-10-05|40
e|FA|7eb97152-173c-4923-8604-5dad3140cc25|7|SEV|Severity/Intensity|[?]|GERD|[?]|U/m2/day|[?]|1|Pa|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|||INVESTIGATOR|4|Visit_4|65|3|TREATMENT|2020-10-30|65
e|FA|7eb97152-173c-4923-8604-5dad3140cc25|8|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|mL/kg/day|[?]|1|Shock Wave|LAD SEPTAL PERFORATOR ARTERY|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-10-30|65
e|FA|7eb97152-173c-4923-8604-5dad3140cc25|9|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|mL/cm H2O|[?]|1|ohm|PELVIC BONE|CONTRALATERAL|||ADJUDICATOR|5|Visit_5|90|2|TREATMENT|2020-11-24|90
e|FA|7eb97152-173c-4923-8604-5dad3140cc25|10|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|APL U|[?]|1|BOWL|HAND DIGIT 5|IPSILATERAL|||CAREGIVER|5|Visit_5|90|7|TREATMENT|2020-11-24|90
e|FA|0b2104d0-e1e3-4516-8c4b-de5d42f82784|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|hr/day|[?]|1|%(v/v)|PERIFACIAL LYMPH NODE|RIGHT|Y|Y|INTERVIEWER|1|Visit_1|10|6|FOLLOW-UP|2020-08-08|10
e|FA|0b2104d0-e1e3-4516-8c4b-de5d42f82784|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|mOsm/L|[?]|1|mEq/g|SECOND RIGHT POSTEROLATERAL ARTERY|UNILATERAL|Y||VENDOR|1|Visit_1|10|7|TREATMENT|2020-08-08|10
e|FA|0b2104d0-e1e3-4516-8c4b-de5d42f82784|3|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|DRUM|[?]|1|/500 WBC|SUBCUTIS|LEFT|Y|Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|SCREENING|2020-08-23|25
e|FA|0b2104d0-e1e3-4516-8c4b-de5d42f82784|4|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|U/g/day|[?]|1|mAmp|PUTAMEN|BILATERAL|||VENDOR|2|Visit_2|25|6|TREATMENT|2020-08-23|25
e|FA|0b2104d0-e1e3-4516-8c4b-de5d42f82784|5|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|ug/h|[?]|1|aMFI|PUPIL|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|1|WASHOUT|2020-09-07|40
e|FA|0b2104d0-e1e3-4516-8c4b-de5d42f82784|6|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|cd/m2|[?]|1|g/day|TRICUSPID VALVE, POSTERIOR ANNULUS|BILATERAL||Y|STUDY SUBJECT|3|Visit_3|40|6|TREATMENT|2020-09-07|40
e|FA|0b2104d0-e1e3-4516-8c4b-de5d42f82784|7|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|g/L|[?]|1|fmol|ANKLE MORTISE|BILATERAL||Y|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-10-02|65
e|FA|0b2104d0-e1e3-4516-8c4b-de5d42f82784|8|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|mL/s|[?]|1|10^6 IU/mL|MOTOR CORTEX|CONTRALATERAL||Y|INVESTIGATOR|4|Visit_4|65|6|TREATMENT|2020-10-02|65
e|FA|0b2104d0-e1e3-4516-8c4b-de5d42f82784|9|STRCTNUM|Number of Strictures|[?]|GERD|[?]|ng/L|[?]|1|SACHET|BICEPS BRACHII MUSCLE|IPSILATERAL|||CHILD|5|Visit_5|90|6|SCREENING|2020-10-27|90
e|FA|0b2104d0-e1e3-4516-8c4b-de5d42f82784|10|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|atm|[?]|1|BP|LATERAL HUMERAL EPICONDYLE|RIGHT|||STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-10-27|90
e|FA|96f68979-6869-403b-a8bd-78c8f965f98a|1|EVENTNUM|Number of Events|[?]|GERD|[?]|cL|[?]|1|U/10^12 RBC|ESOPHAGUS, MIDDLE THIRD|IPSILATERAL|||STUDY SUBJECT|1|Visit_1|10|7|WASHOUT|2020-05-26|10
e|FA|96f68979-6869-403b-a8bd-78c8f965f98a|2|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|10^6 U|PANCREAS, HEAD|RIGHT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|2|TREATMENT|2020-05-26|10
e|FA|96f68979-6869-403b-a8bd-78c8f965f98a|3|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|BAU/mL|[?]|1|PACK|OPPONENS POLLICIS MUSCLE|RIGHT||Y|VENDOR|2|Visit_2|25|2|SCREENING|2020-06-10|25
e|FA|96f68979-6869-403b-a8bd-78c8f965f98a|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|10^3 organisms/g|[?]|1|U/mmol|GENITALIA|RIGHT|||GUARDIAN|2|Visit_2|25|6|WASHOUT|2020-06-10|25
e|FA|96f68979-6869-403b-a8bd-78c8f965f98a|5|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|mEq|INFRATENTORIAL BRAIN|LEFT|Y||CHILD|3|Visit_3|40|7|FOLLOW-UP|2020-06-25|40
e|FA|96f68979-6869-403b-a8bd-78c8f965f98a|6|EXCDUR|Exercise Duration|[?]|GERD|[?]|mV|[?]|1|mm|KIDNEY, MEDULLA|CONTRALATERAL|||INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-06-25|40
e|FA|96f68979-6869-403b-a8bd-78c8f965f98a|7|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|nkat|[?]|1|Coulomb|SECOND OBTUSE MARGINAL BRANCH ARTERY|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-07-20|65
e|FA|96f68979-6869-403b-a8bd-78c8f965f98a|8|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|10^6 CFU|ANTERIOR TIBIAL VEIN|UNILATERAL|||SPOUSE|4|Visit_4|65|6|TREATMENT|2020-07-20|65
e|FA|96f68979-6869-403b-a8bd-78c8f965f98a|9|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|/kg|CARPOMETACARPAL JOINT 2|RIGHT|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2020-08-14|90
e|FA|96f68979-6869-403b-a8bd-78c8f965f98a|10|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|mmHg/sec|[?]|1|mL/dose|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|LEFT|||FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2020-08-14|90
e|FA|e0f67610-b86a-4f5a-88eb-905b1e0aa609|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|/wk|[?]|1|km|DORSALIS PEDIS ARTERY|LATERAL|Y|Y|CHILD|1|Visit_1|10|1|WASHOUT|2020-10-16|10
e|FA|e0f67610-b86a-4f5a-88eb-905b1e0aa609|2|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|EIA unit|FEMORO-POPLITEAL PERIPHERAL ARTERY|BILATERAL|||VENDOR|1|Visit_1|10|2|SCREENING|2020-10-16|10
e|FA|e0f67610-b86a-4f5a-88eb-905b1e0aa609|3|STROKTYP|Stroke Type|[?]|GERD|[?]|mg/mol|[?]|1|g/L|INTRAHEPATIC LARGE BILE DUCT|IPSILATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|1|FOLLOW-UP|2020-10-31|25
e|FA|e0f67610-b86a-4f5a-88eb-905b1e0aa609|4|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|/100 WBC|[?]|1|g/day|XIPHOID PROCESS|IPSILATERAL|||INVESTIGATOR|2|Visit_2|25|5|WASHOUT|2020-10-31|25
e|FA|e0f67610-b86a-4f5a-88eb-905b1e0aa609|5|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|ug/day|[?]|1|10^6 CFU|SPLENIC VEIN|BILATERAL||Y|FRIEND|3|Visit_3|40|4|FOLLOW-UP|2020-11-15|40
e|FA|e0f67610-b86a-4f5a-88eb-905b1e0aa609|6|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|APL U/mL|[?]|1|BOWL|DISTAL PHALANX 2 OF THE HAND|LEFT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|SCREENING|2020-11-15|40
e|FA|e0f67610-b86a-4f5a-88eb-905b1e0aa609|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|genEq/mL|[?]|1|PFU/dose|COMMON FEMORAL ARTERY|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2020-12-10|65
e|FA|e0f67610-b86a-4f5a-88eb-905b1e0aa609|8|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|Anson U|[?]|1|g/day|SMALL INTESTINE|LATERAL|Y||FRIEND|4|Visit_4|65|4|WASHOUT|2020-12-10|65
e|FA|e0f67610-b86a-4f5a-88eb-905b1e0aa609|9|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|V/sec|[?]|1|NEEDLE GAUGE|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|UNILATERAL|||CHILD|5|Visit_5|90|3|WASHOUT|2021-01-04|90
e|FA|e0f67610-b86a-4f5a-88eb-905b1e0aa609|10|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|/7.5 mL|[?]|1|/500 WBC|SPLENIC LYMPH NODE|BILATERAL|||CAREGIVER|5|Visit_5|90|4|TREATMENT|2021-01-04|90
e|FA|d62dc655-8865-4592-af0b-744524d9a24c|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|APS U|[?]|1|mL/animal/day|BRAIN VENTRICLE|RIGHT|||FAMILY MEMBER|1|Visit_1|10|6|TREATMENT|2020-09-29|10
e|FA|d62dc655-8865-4592-af0b-744524d9a24c|2|SEV|Severity/Intensity|[?]|GERD|[?]|U/mg|[?]|1|Pa|PROXIMAL PHALANX 3 OF THE HAND|CONTRALATERAL|Y||VENDOR|1|Visit_1|10|3|SCREENING|2020-09-29|10
e|FA|d62dc655-8865-4592-af0b-744524d9a24c|3|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/L/h|[?]|1|uL/kg/day|FINGER FLEXOR MUSCLES|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-10-14|25
e|FA|d62dc655-8865-4592-af0b-744524d9a24c|4|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|PA|[?]|1|DRUM|GREAT SAPHENOUS VEIN|LEFT|||INDEPENDENT ASSESSOR|2|Visit_2|25|6|WASHOUT|2020-10-14|25
e|FA|d62dc655-8865-4592-af0b-744524d9a24c|5|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|mL/cage/day|[?]|1|Shock Wave|METACARPOPHALANGEAL JOINT 2|UNILATERAL|Y||PROXY|3|Visit_3|40|3|TREATMENT|2020-10-29|40
e|FA|d62dc655-8865-4592-af0b-744524d9a24c|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/L DDU|[?]|1|%(v/v)|GASTROCNEMIUS MUSCLE, LATERAL HEAD|IPSILATERAL|Y||ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2020-10-29|40
e|FA|d62dc655-8865-4592-af0b-744524d9a24c|7|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|Siemens|[?]|1|mAmp|ANTRUM PYLORI|RIGHT|Y|Y|VENDOR|4|Visit_4|65|4|TREATMENT|2020-11-23|65
e|FA|d62dc655-8865-4592-af0b-744524d9a24c|8|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|U/kg/min|[?]|1|uL/kg/day|BRAIN|CONTRALATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-11-23|65
e|FA|d62dc655-8865-4592-af0b-744524d9a24c|9|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|uL/kg/day|SKIN OF THE PALM|UNILATERAL|||CHILD|5|Visit_5|90|5|TREATMENT|2020-12-18|90
e|FA|d62dc655-8865-4592-af0b-744524d9a24c|10|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|Osm|[?]|1|IU/mmol|CENTRAL NERVOUS SYSTEM|LEFT|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2020-12-18|90
e|FA|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|1|ACNDEV|Action Taken With Device|[?]|GERD|[?]|mg|[?]|1|100 IU/mL|LUNG, RIGHT|LEFT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|SCREENING|2021-01-08|10
e|FA|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|2|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|mm/h|[?]|1|PACK|VASTUS MEDIALIS MUSCLE|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|WASHOUT|2021-01-08|10
e|FA|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|3|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|ng|[?]|1|10^6 U|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|TREATMENT|2021-01-23|25
e|FA|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|ug/mol|[?]|1|MBq|QUADRICEPS MUSCLE|LEFT|||CHILD|2|Visit_2|25|2|SCREENING|2021-01-23|25
e|FA|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|5|DVEG|Dietary Vegetable|[?]|GERD|[?]|ECL unit|[?]|1|Ci/ug|SIGMOID SINUS|CONTRALATERAL||Y|SPOUSE|3|Visit_3|40|1|WASHOUT|2021-02-07|40
e|FA|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|%(v/v)|OCCIPITAL LYMPH NODE|LATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2021-02-07|40
e|FA|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|7|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|g/g|[?]|1|cm H2O|MEDIASTINUM, SUPERIOR|BILATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|FOLLOW-UP|2021-03-04|65
e|FA|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|8|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|/7.5 mL|[?]|1|10^6 organisms/mL|RETINAL ARTERY|IPSILATERAL|||INVESTIGATOR|4|Visit_4|65|1|WASHOUT|2021-03-04|65
e|FA|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|9|ESTWT|Estimated Weight|[?]|GERD|[?]|ug/min|[?]|1|g/day|FINGER EXTENSOR TENDONS|IPSILATERAL|||GUARDIAN|5|Visit_5|90|4|TREATMENT|2021-03-29|90
e|FA|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mCi/kg|[?]|1|10^6 U|SUPRAGLOTTIS|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2021-03-29|90
e|FA|8005bd56-3bd6-477a-a466-b9a3bd189770|1|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/L/sec|[?]|1|mg/dose|STERNEBRA|LEFT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-12-23|10
e|FA|8005bd56-3bd6-477a-a466-b9a3bd189770|2|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|mL/day|[?]|1|mL/h|THORACIC ARTERY|BILATERAL|||ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-12-23|10
e|FA|8005bd56-3bd6-477a-a466-b9a3bd189770|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/g|[?]|1|mg/g/min|TIBIO-PERONEAL TRUNK|RIGHT|||INDEPENDENT ASSESSOR|2|Visit_2|25|3|FOLLOW-UP|2021-01-07|25
e|FA|8005bd56-3bd6-477a-a466-b9a3bd189770|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|ka_u/dL|[?]|1|PFU/dose|ABDOMINAL AORTA|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2021-01-07|25
e|FA|8005bd56-3bd6-477a-a466-b9a3bd189770|5|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|10^7/L|[?]|1|ng/day|TROCHLEAR NERVE|BILATERAL||Y|CAREGIVER|3|Visit_3|40|5|TREATMENT|2021-01-22|40
e|FA|8005bd56-3bd6-477a-a466-b9a3bd189770|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mCi/L|[?]|1|%(v/v)|PROXIMAL PHALANX 1 OF THE HAND|LEFT|Y|Y|SIBLING|3|Visit_3|40|7|WASHOUT|2021-01-22|40
e|FA|8005bd56-3bd6-477a-a466-b9a3bd189770|7|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|RNA copies/mL|[?]|1|mL/dose|PERIUMBILICAL REGION|BILATERAL|||STUDY SUBJECT|4|Visit_4|65|6|FOLLOW-UP|2021-02-16|65
e|FA|8005bd56-3bd6-477a-a466-b9a3bd189770|8|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|mkat|[?]|1|10^6 IU/mL|DISTAL COMMON BILE DUCT|LEFT|||INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-02-16|65
e|FA|8005bd56-3bd6-477a-a466-b9a3bd189770|9|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|mL/animal/day|[?]|1|MPS U|VEIN|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|TREATMENT|2021-03-13|90
e|FA|8005bd56-3bd6-477a-a466-b9a3bd189770|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|DROP|[?]|1|mg/g/min|ULNA|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|5|SCREENING|2021-03-13|90
e|FA|078ea33d-4114-4320-9116-740b8385a94e|1|LENRSCT|Length of Resection|[?]|GERD|[?]|mAmp|[?]|1|psi|HYPOPHARYNX|BILATERAL|||CHILD|1|Visit_1|10|6|WASHOUT|2020-07-26|10
e|FA|078ea33d-4114-4320-9116-740b8385a94e|2|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|mEq/g|[?]|1|MPS U|COSTOCHONDRAL JOINT 7|UNILATERAL|||INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-07-26|10
e|FA|078ea33d-4114-4320-9116-740b8385a94e|3|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|L/day|[?]|1|mL/cm3/min|FIBULAR VEIN|IPSILATERAL||Y|CHILD|2|Visit_2|25|4|TREATMENT|2020-08-10|25
e|FA|078ea33d-4114-4320-9116-740b8385a94e|4|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|in|[?]|1|vp/dose|TUNICA INTIMA|LATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|1|FOLLOW-UP|2020-08-10|25
e|FA|078ea33d-4114-4320-9116-740b8385a94e|5|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|ELISA unit|[?]|1|10^6 U|LUNG, LEFT LOWER LOBE|CONTRALATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-08-25|40
e|FA|078ea33d-4114-4320-9116-740b8385a94e|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/m2/h|[?]|1|mg/g/min|ATRIOVENTRICULAR VALVE|UNILATERAL|Y|Y|CHILD|3|Visit_3|40|2|FOLLOW-UP|2020-08-25|40
e|FA|078ea33d-4114-4320-9116-740b8385a94e|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|DAgU|[?]|1|PFU/dose|TRIANGULAR BONE|LEFT||Y|CHILD|4|Visit_4|65|4|TREATMENT|2020-09-19|65
e|FA|078ea33d-4114-4320-9116-740b8385a94e|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|pm|[?]|1|%(v/v)|VOCAL CORD|LEFT|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2020-09-19|65
e|FA|078ea33d-4114-4320-9116-740b8385a94e|9|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|DRUM|[?]|1|gtt|TOE|LATERAL|||VENDOR|5|Visit_5|90|5|WASHOUT|2020-10-14|90
e|FA|078ea33d-4114-4320-9116-740b8385a94e|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|umol/L/sec|[?]|1|%(v/v)|LEFT VENTRICULAR MID INFERIOR SEGMENT|CONTRALATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2020-10-14|90
e|FA|1ca91975-9a42-4f4d-9c55-53f7561d82fa|1|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|MET*min|[?]|1|cmH2O/mL|INTERPHALANGEAL JOINT OF THE HAND|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-06-03|10
e|FA|1ca91975-9a42-4f4d-9c55-53f7561d82fa|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mm2|[?]|1|Pa|AXILLA|LATERAL|||STUDY SUBJECT|1|Visit_1|10|7|FOLLOW-UP|2020-06-03|10
e|FA|1ca91975-9a42-4f4d-9c55-53f7561d82fa|3|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|Arbitrary U|[?]|1|10^6/L|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2020-06-18|25
e|FA|1ca91975-9a42-4f4d-9c55-53f7561d82fa|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|mV|[?]|1|QUANTITY SUFFICIENT|POPLITEAL ARTERY ABOVE KNEE|UNILATERAL|||VENDOR|2|Visit_2|25|2|WASHOUT|2020-06-18|25
e|FA|1ca91975-9a42-4f4d-9c55-53f7561d82fa|5|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|/wk|[?]|1|10^6 U|TEMPOROMANDIBULAR JOINT|LATERAL|||CHILD|3|Visit_3|40|6|WASHOUT|2020-07-03|40
e|FA|1ca91975-9a42-4f4d-9c55-53f7561d82fa|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|MBP|[?]|1|%(v/v)|THYROID GLAND, LEFT LOBE|UNILATERAL|Y||GUARDIAN|3|Visit_3|40|4|FOLLOW-UP|2020-07-03|40
e|FA|1ca91975-9a42-4f4d-9c55-53f7561d82fa|7|CALBURN|Calories Burned|[?]|GERD|[?]|U/animal|[?]|1|/kg|INFRARENAL AORTA|RIGHT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|3|WASHOUT|2020-07-28|65
e|FA|1ca91975-9a42-4f4d-9c55-53f7561d82fa|8|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|V/sec|[?]|1|g/day|SKIN OF THE INFRASCAPULAR REGION|UNILATERAL|||INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2020-07-28|65
e|FA|1ca91975-9a42-4f4d-9c55-53f7561d82fa|9|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|mg/mL/day|[?]|1|CUP|LEFT ATRIOVENTRICULAR ARTERY|BILATERAL|Y||INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-08-22|90
e|FA|1ca91975-9a42-4f4d-9c55-53f7561d82fa|10|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|BLOCKS|[?]|1|mAmp|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|UNILATERAL||Y|FRIEND|5|Visit_5|90|3|TREATMENT|2020-08-22|90
e|FA|c5f292ad-1729-402b-820f-83ecd29ba00d|1|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|mV*min|[?]|1|cm|PROFUNDA FEMORIS VEIN|LEFT|||SIBLING|1|Visit_1|10|2|FOLLOW-UP|2020-06-08|10
e|FA|c5f292ad-1729-402b-820f-83ecd29ba00d|2|SEV|Severity/Intensity|[?]|GERD|[?]|PIPE|[?]|1|Pa|BRACHIAL PLEXUS|LEFT|||INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2020-06-08|10
e|FA|c5f292ad-1729-402b-820f-83ecd29ba00d|3|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|Ci/mL|[?]|1|/500 WBC|HEART|RIGHT|||SIBLING|2|Visit_2|25|2|WASHOUT|2020-06-23|25
e|FA|c5f292ad-1729-402b-820f-83ecd29ba00d|4|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|IU/g Hb|[?]|1|ng/day|CHOROID|LATERAL|||CHILD|2|Visit_2|25|7|TREATMENT|2020-06-23|25
e|FA|c5f292ad-1729-402b-820f-83ecd29ba00d|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/100g/min|[?]|1|%(v/v)|EXTRAHEPATIC BILE DUCT|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|FOLLOW-UP|2020-07-08|40
e|FA|c5f292ad-1729-402b-820f-83ecd29ba00d|6|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|s/h|[?]|1|mL/100g/min|UPPER URINARY SYSTEM|UNILATERAL|||PARENT|3|Visit_3|40|6|TREATMENT|2020-07-08|40
e|FA|c5f292ad-1729-402b-820f-83ecd29ba00d|7|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|damol/L|[?]|1|MPS U|FOOT|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-08-02|65
e|FA|c5f292ad-1729-402b-820f-83ecd29ba00d|8|DGRAIN|Dietary Grain|[?]|GERD|[?]|fg|[?]|1|10^9 CFU/g|UTERINE ARTERY|UNILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|5|TREATMENT|2020-08-02|65
e|FA|c5f292ad-1729-402b-820f-83ecd29ba00d|9|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|deg/mm|[?]|1|MBq|ULNA SHAFT|LEFT|||ADJUDICATOR|5|Visit_5|90|2|TREATMENT|2020-08-27|90
e|FA|c5f292ad-1729-402b-820f-83ecd29ba00d|10|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|/2500 WBC|[?]|1|/kg|MEDIAN BASILIC VEIN|LEFT|Y||INTERVIEWER|5|Visit_5|90|2|TREATMENT|2020-08-27|90
e|FA|a746aefb-16c8-43db-a0c4-8e9a4efdb244|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|days/month|[?]|1|10^6 U|PRECUNEUS|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|WASHOUT|2020-06-27|10
e|FA|a746aefb-16c8-43db-a0c4-8e9a4efdb244|2|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|10^9 CFU/mL|HEPATIC ARTERY|LEFT|Y||SIBLING|1|Visit_1|10|2|WASHOUT|2020-06-27|10
e|FA|a746aefb-16c8-43db-a0c4-8e9a4efdb244|3|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|min/day|[?]|1|MBq|COLON, SIGMOID|LATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-07-12|25
e|FA|a746aefb-16c8-43db-a0c4-8e9a4efdb244|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|/100 WBC|[?]|1|mg/g/min|GALLBLADDER|BILATERAL|Y||PROXY|2|Visit_2|25|6|TREATMENT|2020-07-12|25
e|FA|a746aefb-16c8-43db-a0c4-8e9a4efdb244|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|TRANSDUCING UNIT/mL|[?]|1|%(v/v)|MESENTERY|BILATERAL|||FRIEND|3|Visit_3|40|2|TREATMENT|2020-07-27|40
e|FA|a746aefb-16c8-43db-a0c4-8e9a4efdb244|6|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|mL/animal|[?]|1|uL/kg/day|FACIAL BONE|LEFT||Y|STUDY SUBJECT|3|Visit_3|40|4|WASHOUT|2020-07-27|40
e|FA|a746aefb-16c8-43db-a0c4-8e9a4efdb244|7|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|pmol/day|[?]|1|km|NUCLEUS OF DIAGONAL BAND|IPSILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|4|WASHOUT|2020-08-21|65
e|FA|a746aefb-16c8-43db-a0c4-8e9a4efdb244|8|DFATT|Dietary Fat, Total|[?]|GERD|[?]|ug/min|[?]|1|Bq/mg|FUNDUS OF THE EYE|LEFT|||VENDOR|4|Visit_4|65|7|TREATMENT|2020-08-21|65
e|FA|a746aefb-16c8-43db-a0c4-8e9a4efdb244|9|SEV|Severity/Intensity|[?]|GERD|[?]|TRANSDUCING UNIT|[?]|1|Pa|STERNOCLAVICULAR JOINT|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2020-09-15|90
e|FA|a746aefb-16c8-43db-a0c4-8e9a4efdb244|10|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|Tbsp|[?]|1|mEq/g|RIB 3|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2020-09-15|90
e|FA|7f95b9c0-3b77-4c60-8890-ecc955f97122|1|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|nL|[?]|1|mmHg/L/min|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|BILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|4|FOLLOW-UP|2020-09-25|10
e|FA|7f95b9c0-3b77-4c60-8890-ecc955f97122|2|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|IU/day|[?]|1|U/mg|T11 VERTEBRA|UNILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-09-25|10
e|FA|7f95b9c0-3b77-4c60-8890-ecc955f97122|3|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|cmH2O*s/mL|[?]|1|g/dL|BUTTOCK|LEFT|Y|Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|FOLLOW-UP|2020-10-10|25
e|FA|7f95b9c0-3b77-4c60-8890-ecc955f97122|4|DMG|Dietary Magnesium|[?]|GERD|[?]|DIP|[?]|1|TRANSDUCING UNIT/mL|L6 VERTEBRA|IPSILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|7|TREATMENT|2020-10-10|25
e|FA|7f95b9c0-3b77-4c60-8890-ecc955f97122|5|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|L/h|[?]|1|PACK|ASCENDING AORTA|LATERAL||Y|FRIEND|3|Visit_3|40|3|SCREENING|2020-10-25|40
e|FA|7f95b9c0-3b77-4c60-8890-ecc955f97122|6|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|cmH2O*s2/mL|[?]|1|cm H2O|LATERAL RAMUS INTERMEDIUS ARTERY|LATERAL|||VENDOR|3|Visit_3|40|2|TREATMENT|2020-10-25|40
e|FA|7f95b9c0-3b77-4c60-8890-ecc955f97122|7|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|ug/dose|[?]|1|BP|FLEXOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|Y|Y|PROXY|4|Visit_4|65|7|SCREENING|2020-11-19|65
e|FA|7f95b9c0-3b77-4c60-8890-ecc955f97122|8|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|mm/min|[?]|1|10^6 organisms/mL|ANUS|RIGHT|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2020-11-19|65
e|FA|7f95b9c0-3b77-4c60-8890-ecc955f97122|9|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mEq|[?]|1|U/mmol|COLON, SIGMOID|LEFT||Y|FRIEND|5|Visit_5|90|6|WASHOUT|2020-12-14|90
e|FA|7f95b9c0-3b77-4c60-8890-ecc955f97122|10|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|LENS|[?]|1|Shock Wave|INTERPHALANGEAL JOINT 4 OF THE FOOT|IPSILATERAL|Y||SIBLING|5|Visit_5|90|1|SCREENING|2020-12-14|90
e|FA|2be43c56-83f3-4148-9cb1-97c6d191d20e|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|mg/g/min|METACARPOPHALANGEAL JOINT 4|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-10-03|10
e|FA|2be43c56-83f3-4148-9cb1-97c6d191d20e|2|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|GBq|[?]|1|Ci/ug|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2020-10-03|10
e|FA|2be43c56-83f3-4148-9cb1-97c6d191d20e|3|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|HOURS|[?]|1|10^6 CFU|SECOND OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|||FAMILY MEMBER|2|Visit_2|25|2|SCREENING|2020-10-18|25
e|FA|2be43c56-83f3-4148-9cb1-97c6d191d20e|4|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|DDU|[?]|1|10^4 CFU/mL|JUGULAR VEIN|CONTRALATERAL|||FRIEND|2|Visit_2|25|4|TREATMENT|2020-10-18|25
e|FA|2be43c56-83f3-4148-9cb1-97c6d191d20e|5|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|beats/min|[?]|1|DRUM|T5 VERTEBRA|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-11-02|40
e|FA|2be43c56-83f3-4148-9cb1-97c6d191d20e|6|DVEG|Dietary Vegetable|[?]|GERD|[?]|10^3 organisms/mL|[?]|1|Ci/ug|MID-LAD ARTERY|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|4|SCREENING|2020-11-02|40
e|FA|2be43c56-83f3-4148-9cb1-97c6d191d20e|7|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|IU/mg|GASTRIC CURVATURE LYMPH NODE|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2020-11-27|65
e|FA|2be43c56-83f3-4148-9cb1-97c6d191d20e|8|AGETRT1|Age At First Treatment|[?]|GERD|[?]|um/day|[?]|1|mL/mmHg/min/L|HAIR SHAFT|LATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-11-27|65
e|FA|2be43c56-83f3-4148-9cb1-97c6d191d20e|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|Rad|[?]|1|10^6 IU/mL|GASTROINTESTINAL SYSTEM|CONTRALATERAL|||SIBLING|5|Visit_5|90|2|TREATMENT|2020-12-22|90
e|FA|2be43c56-83f3-4148-9cb1-97c6d191d20e|10|LDIAM|Longest Diameter|[?]|GERD|[?]|BOX|[?]|1|Shock Wave|INTERPHALANGEAL THUMB JOINT|CONTRALATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2020-12-22|90
e|FA|e27e0325-5fbe-46c0-8264-982d83124203|1|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|mg/h|[?]|1|IU/mmol|ACETABULUM|IPSILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|SCREENING|2020-07-07|10
e|FA|e27e0325-5fbe-46c0-8264-982d83124203|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|FFU|[?]|1|mg/g/min|POPLITEAL ARTERY ABOVE KNEE|RIGHT|Y||DOMESTIC PARTNER|1|Visit_1|10|2|TREATMENT|2020-07-07|10
e|FA|e27e0325-5fbe-46c0-8264-982d83124203|3|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|%/min|[?]|1|Ci/ug|PRECUNEUS|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|2|WASHOUT|2020-07-22|25
e|FA|e27e0325-5fbe-46c0-8264-982d83124203|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ug/m2|[?]|1|%(v/v)|UPPER RESPIRATORY SYSTEM|RIGHT|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|FOLLOW-UP|2020-07-22|25
e|FA|e27e0325-5fbe-46c0-8264-982d83124203|5|EVENTFRQ|Event Frequency|[?]|GERD|[?]|/min|[?]|1|ug/kg/h|WARDS TRIANGLE|CONTRALATERAL||Y|VENDOR|3|Visit_3|40|3|FOLLOW-UP|2020-08-06|40
e|FA|e27e0325-5fbe-46c0-8264-982d83124203|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/cage/wk|[?]|1|mg/g/min|PATELLA|BILATERAL|||FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2020-08-06|40
e|FA|e27e0325-5fbe-46c0-8264-982d83124203|7|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|uU/L|[?]|1|10^6 CFU|PERIANAL REGION|UNILATERAL||Y|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2020-08-31|65
e|FA|e27e0325-5fbe-46c0-8264-982d83124203|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|Pa|DIAPHRAGMATIC LYMPH NODE|UNILATERAL|||VENDOR|4|Visit_4|65|1|TREATMENT|2020-08-31|65
e|FA|e27e0325-5fbe-46c0-8264-982d83124203|9|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|Weber|HEART, LEFT VENTRICLE|UNILATERAL|||CHILD|5|Visit_5|90|6|SCREENING|2020-09-25|90
e|FA|e27e0325-5fbe-46c0-8264-982d83124203|10|EVENTFRQ|Event Frequency|[?]|GERD|[?]|STRIP|[?]|1|ug/kg/h|SYNOVIAL FLUID|RIGHT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|FOLLOW-UP|2020-09-25|90
e|FA|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|1|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|Hz/s|[?]|1|10^6 IU/mL|RETINAL PIGMENTED EPITHELIAL LAYER|LEFT|Y||CAREGIVER|1|Visit_1|10|6|WASHOUT|2020-12-19|10
e|FA|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|2|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|kg/mol|[?]|1|aMFI|NASOPHARYNX|BILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-12-19|10
e|FA|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|fmol|[?]|1|%(v/v)|RESPIRATORY SYSTEM|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|5|FOLLOW-UP|2021-01-03|25
e|FA|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|4|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|/500 WBC|[?]|1|Shock Wave|SUPERFICIAL LYMPH NODE|LATERAL|Y||SIBLING|2|Visit_2|25|2|WASHOUT|2021-01-03|25
e|FA|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|5|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|10^7 CFU/mL|[?]|1|10^4 CFU/mL|ORAL MUCOSA|RIGHT|Y||GUARDIAN|3|Visit_3|40|2|TREATMENT|2021-01-18|40
e|FA|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|6|DFIBER|Dietary Fiber|[?]|GERD|[?]|Enzyme U/L|[?]|1|h*%|SACRUM|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2021-01-18|40
e|FA|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|7|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|SCOOPFUL|[?]|1|10^6 U|SKIN OF THE FOOT|LATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2021-02-12|65
e|FA|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mL/breath|[?]|1|PFU/dose|BILE DUCT|UNILATERAL|||PROXY|4|Visit_4|65|3|TREATMENT|2021-02-12|65
e|FA|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|9|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|10^10/L|[?]|1|cm H2O|LOWER RESPIRATORY SYSTEM|RIGHT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|3|SCREENING|2021-03-09|90
e|FA|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|10|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|g/kg|[?]|1|mL/m2|ARTERY|LATERAL||Y|SPOUSE|5|Visit_5|90|1|FOLLOW-UP|2021-03-09|90
e|FA|29e08650-9eae-461f-981e-f2a20d8d4492|1|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|uV|[?]|1|MPS U|SUPERIOR SAGITTAL SINUS|UNILATERAL|||FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-11-17|10
e|FA|29e08650-9eae-461f-981e-f2a20d8d4492|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IMPLANT|[?]|1|mg/g/min|RETINAL ARTERY|IPSILATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-11-17|10
e|FA|29e08650-9eae-461f-981e-f2a20d8d4492|3|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|mEq/kg|[?]|1|Shock Wave|LATERAL RAMUS INTERMEDIUS ARTERY|UNILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2020-12-02|25
e|FA|29e08650-9eae-461f-981e-f2a20d8d4492|4|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|um|[?]|1|g/L|LUNG|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2020-12-02|25
e|FA|29e08650-9eae-461f-981e-f2a20d8d4492|5|DMEAT|Dietary Meat|[?]|GERD|[?]|PNU/mL|[?]|1|10^6 organisms/mL|MEDIASTINUM, ANTERIOR|CONTRALATERAL|Y||VENDOR|3|Visit_3|40|5|TREATMENT|2020-12-17|40
e|FA|29e08650-9eae-461f-981e-f2a20d8d4492|6|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|/100 HPFs|[?]|1|mL/m2|INSULAR CORTEX|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2020-12-17|40
e|FA|29e08650-9eae-461f-981e-f2a20d8d4492|7|LOCONSET|Localization of Onset|[?]|GERD|[?]|pt_br|[?]|1|g/L|HUMERUS SHAFT|IPSILATERAL||Y|CAREGIVER|4|Visit_4|65|7|FOLLOW-UP|2021-01-11|65
e|FA|29e08650-9eae-461f-981e-f2a20d8d4492|8|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol/L|[?]|1|km|INTERPHALANGEAL JOINT 1|IPSILATERAL|Y||FRIEND|4|Visit_4|65|1|TREATMENT|2021-01-11|65
e|FA|29e08650-9eae-461f-981e-f2a20d8d4492|9|EXCDUR|Exercise Duration|[?]|GERD|[?]|mg/min|[?]|1|mm|ABDOMINAL CAVITY|IPSILATERAL|||GUARDIAN|5|Visit_5|90|6|FOLLOW-UP|2021-02-05|90
e|FA|29e08650-9eae-461f-981e-f2a20d8d4492|10|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|mL/kg/min|[?]|1|BP|FORELIMB|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2021-02-05|90
e|FA|2b944a62-10bc-475e-a90d-da3f07a2c4df|1|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|DISK|[?]|1|/500 WBC|CEREBRAL SUBCORTEX|LEFT|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|WASHOUT|2020-09-01|10
e|FA|2b944a62-10bc-475e-a90d-da3f07a2c4df|2|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|BOWL|[?]|1|anti-Xa IU/mL|BRACHIAL ARTERY|IPSILATERAL|||PARENT|1|Visit_1|10|4|TREATMENT|2020-09-01|10
e|FA|2b944a62-10bc-475e-a90d-da3f07a2c4df|3|DISTANCE|Distance|[?]|GERD|[?]|log10 TCID 50/dose|[?]|1|BOWL|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|UNILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-09-16|25
e|FA|2b944a62-10bc-475e-a90d-da3f07a2c4df|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|mAmp|[?]|1|PFU/dose|LEFT VENTRICULAR MID ANTERIOR SEGMENT|LEFT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-09-16|25
e|FA|2b944a62-10bc-475e-a90d-da3f07a2c4df|5|TOXGR|Toxicity Grade|[?]|GERD|[?]|Frames/s|[?]|1|aMFI|SPHENOID SINUS|RIGHT||Y|STUDY SUBJECT|3|Visit_3|40|4|TREATMENT|2020-10-01|40
e|FA|2b944a62-10bc-475e-a90d-da3f07a2c4df|6|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|mg/kg/day|[?]|1|mAmp|ESOPHAGUS, ABDOMINAL|CONTRALATERAL|Y|Y|ADJUDICATION COMMITTEE|3|Visit_3|40|5|TREATMENT|2020-10-01|40
e|FA|2b944a62-10bc-475e-a90d-da3f07a2c4df|7|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|pmol/day|[?]|1|ug/g/h|MITRAL VALVE, ANTERIOR ANNULUS|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|SCREENING|2020-10-26|65
e|FA|2b944a62-10bc-475e-a90d-da3f07a2c4df|8|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|um/day|[?]|1|/500 WBC|ABDOMINAL LYMPH NODE|CONTRALATERAL|||ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2020-10-26|65
e|FA|2b944a62-10bc-475e-a90d-da3f07a2c4df|9|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|cg|[?]|1|mm/h|LEFT VENTRICULAR APICAL LATERAL SEGMENT|BILATERAL||Y|INTERVIEWER|5|Visit_5|90|1|TREATMENT|2020-11-20|90
e|FA|2b944a62-10bc-475e-a90d-da3f07a2c4df|10|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|MAC50|[?]|1|Bq/L|PULMONARY VALVE|CONTRALATERAL|||FRIEND|5|Visit_5|90|1|TREATMENT|2020-11-20|90
e|FA|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|L/h|[?]|1|mg/g/min|THORACIC LYMPH NODE|BILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-09-09|10
e|FA|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|2|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|BAU|[?]|1|mL/m2|LIVER, QUADRATE LOBE|UNILATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-09-09|10
e|FA|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|3|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mL/cage/day|[?]|1|fmol|INFRARENAL AORTA|LEFT|||INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-09-24|25
e|FA|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|4|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|BOX|[?]|1|DRUM|NERVE|LEFT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|FOLLOW-UP|2020-09-24|25
e|FA|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|5|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|PIPE|[?]|1|EIA unit|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT|||CHILD|3|Visit_3|40|5|TREATMENT|2020-10-09|40
e|FA|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|6|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|/500 WBC|[?]|1|m2|ANTERIOR TIBIAL ARTERY|RIGHT|||CAREGIVER|3|Visit_3|40|5|TREATMENT|2020-10-09|40
e|FA|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|7|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|TAMPON|[?]|1|/200 HPFs|EYE, ANTERIOR CHAMBER|CONTRALATERAL|Y||INVESTIGATOR|4|Visit_4|65|6|SCREENING|2020-11-03|65
e|FA|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|8|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|IU/L|[?]|1|uCi/kg|BONE|RIGHT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-11-03|65
e|FA|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|9|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|msec|[?]|1|mEq|TOOTH CANAL|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|7|SCREENING|2020-11-28|90
e|FA|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|10|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mg/kg|[?]|1|cm H2O|LACRIMAL GLAND|CONTRALATERAL||Y|STUDY SUBJECT|5|Visit_5|90|1|TREATMENT|2020-11-28|90
e|FA|8aa77db3-b078-4073-a7f3-9b9a7fb14570|1|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|10^6 U|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|BILATERAL|Y||INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-11-12|10
e|FA|8aa77db3-b078-4073-a7f3-9b9a7fb14570|2|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|SQU/mL|[?]|1|PFU/dose|SKIN OF THE HEAD|LATERAL|||SPOUSE|1|Visit_1|10|1|WASHOUT|2020-11-12|10
e|FA|8aa77db3-b078-4073-a7f3-9b9a7fb14570|3|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|ukat/10^12 RBC|[?]|1|anti-Xa IU/mL|MAMMARY GLAND|IPSILATERAL|||CHILD|2|Visit_2|25|3|TREATMENT|2020-11-27|25
e|FA|8aa77db3-b078-4073-a7f3-9b9a7fb14570|4|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit|[?]|1|10^6 organisms/mL|SPLENIC HILAR LYMPH NODE|LATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|7|WASHOUT|2020-11-27|25
e|FA|8aa77db3-b078-4073-a7f3-9b9a7fb14570|5|ESTWT|Estimated Weight|[?]|GERD|[?]|FIU|[?]|1|g/day|SMALL SAPHENOUS VEIN|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|SCREENING|2020-12-12|40
e|FA|8aa77db3-b078-4073-a7f3-9b9a7fb14570|6|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|Log10 ELISA unit|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-12-12|40
e|FA|8aa77db3-b078-4073-a7f3-9b9a7fb14570|7|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|cmHg|[?]|1|10^4 CFU/mL|CORRUGATOR SUPERCILII MUSCLE|RIGHT|||PROXY|4|Visit_4|65|3|SCREENING|2021-01-06|65
e|FA|8aa77db3-b078-4073-a7f3-9b9a7fb14570|8|STROKTYP|Stroke Type|[?]|GERD|[?]|/10^4|[?]|1|g/L|WRIST JOINT FLEXOR TENDONS|CONTRALATERAL|||SIBLING|4|Visit_4|65|1|TREATMENT|2021-01-06|65
e|FA|8aa77db3-b078-4073-a7f3-9b9a7fb14570|9|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|g/animal/wk|[?]|1|mg/h|INTERPHALANGEAL JOINT 3|CONTRALATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|2|WASHOUT|2021-01-31|90
e|FA|8aa77db3-b078-4073-a7f3-9b9a7fb14570|10|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|mV|[?]|1|DROP|HILAR|BILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|1|WASHOUT|2021-01-31|90
e|FA|1fce031b-680b-414f-9b74-d6383e10091d|1|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|nmol/mL/min|[?]|1|mAmp|CERVICAL LYMPH NODE|IPSILATERAL|||FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-05-31|10
e|FA|1fce031b-680b-414f-9b74-d6383e10091d|2|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|ukat/10^12 RBC|[?]|1|MPS U|ESOPHAGUS, MIDDLE THIRD|CONTRALATERAL||Y|GUARDIAN|1|Visit_1|10|1|TREATMENT|2020-05-31|10
e|FA|1fce031b-680b-414f-9b74-d6383e10091d|3|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|mU/L|[?]|1|mEq|PROXIMAL PHALANX 1 OF THE HAND|CONTRALATERAL|||INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-06-15|25
e|FA|1fce031b-680b-414f-9b74-d6383e10091d|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|pmol/dL|[?]|1|Pa|GANGLION|IPSILATERAL|||INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2020-06-15|25
e|FA|1fce031b-680b-414f-9b74-d6383e10091d|5|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|umol/L/min|[?]|1|10^6 IU/mL|PARA-AORTIC LYMPH NODE|CONTRALATERAL||Y|PARENT|3|Visit_3|40|5|FOLLOW-UP|2020-06-30|40
e|FA|1fce031b-680b-414f-9b74-d6383e10091d|6|LENRSCT|Length of Resection|[?]|GERD|[?]|CCID 50/mL|[?]|1|psi|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|IPSILATERAL|||SIBLING|3|Visit_3|40|1|TREATMENT|2020-06-30|40
e|FA|1fce031b-680b-414f-9b74-d6383e10091d|7|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|Enzyme U/L|[?]|1|IU/mg|TEMPORAL LOBE|LEFT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-07-25|65
e|FA|1fce031b-680b-414f-9b74-d6383e10091d|8|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|umol/dL|[?]|1|IU/mmol|INTERTROCHANTERIC REGION|RIGHT|Y|Y|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-07-25|65
e|FA|1fce031b-680b-414f-9b74-d6383e10091d|9|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|BE/mL|[?]|1|10^6/L|SKIN OF THE TRUNK|CONTRALATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|2|TREATMENT|2020-08-19|90
e|FA|1fce031b-680b-414f-9b74-d6383e10091d|10|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|mkat|[?]|1|ng|L2-L3 INTERVERTEBRAL SPACE|CONTRALATERAL|||SPOUSE|5|Visit_5|90|5|TREATMENT|2020-08-19|90
e|FA|dcc67696-e91a-4cef-81dd-f2d2711363ae|1|DISTANCE|Distance|[?]|GERD|[?]|USP U|[?]|1|BOWL|FOREARM|LATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-12-28|10
e|FA|dcc67696-e91a-4cef-81dd-f2d2711363ae|2|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|Joule|[?]|1|IU/mmol|PLACENTA|BILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|WASHOUT|2020-12-28|10
e|FA|dcc67696-e91a-4cef-81dd-f2d2711363ae|3|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|Bq/ug|[?]|1|Shock Wave|MEDIASTINUM, POSTERIOR|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2021-01-12|25
e|FA|dcc67696-e91a-4cef-81dd-f2d2711363ae|4|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|FINGERTIP UNIT|[?]|1|Bq/L|PROSTATE GLAND|CONTRALATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|2|WASHOUT|2021-01-12|25
e|FA|dcc67696-e91a-4cef-81dd-f2d2711363ae|5|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|g/U|[?]|1|10^6/L|FORELIMB|LATERAL||Y|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2021-01-27|40
e|FA|dcc67696-e91a-4cef-81dd-f2d2711363ae|6|DFIBER|Dietary Fiber|[?]|GERD|[?]|g|[?]|1|h*%|SACRAL TUBEROSITY|CONTRALATERAL||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2021-01-27|40
e|FA|dcc67696-e91a-4cef-81dd-f2d2711363ae|7|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|10^6 IU/mL|INTERPHALANGEAL JOINT 3|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|TREATMENT|2021-02-21|65
e|FA|dcc67696-e91a-4cef-81dd-f2d2711363ae|8|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|PFU/animal|[?]|1|anti-Xa IU/mL|TIBIA|LEFT|||GUARDIAN|4|Visit_4|65|3|FOLLOW-UP|2021-02-21|65
e|FA|dcc67696-e91a-4cef-81dd-f2d2711363ae|9|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|aMFI|[?]|1|Bq/L|STERNAL MANUBRIUM|BILATERAL||Y|SPOUSE|5|Visit_5|90|4|FOLLOW-UP|2021-03-18|90
e|FA|dcc67696-e91a-4cef-81dd-f2d2711363ae|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|h*%|[?]|1|%(v/v)|JUGULAR VEIN|UNILATERAL|||ADJUDICATOR|5|Visit_5|90|2|SCREENING|2021-03-18|90
e|FA|91e83d7a-186a-4fed-8750-af796d77d356|1|AGETRT1|Age At First Treatment|[?]|GERD|[?]|uL/mL|[?]|1|mL/mmHg/min/L|PAW|IPSILATERAL|Y|Y|SIBLING|1|Visit_1|10|7|TREATMENT|2020-06-02|10
e|FA|91e83d7a-186a-4fed-8750-af796d77d356|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Bq/ug|[?]|1|Pa|TROCHLEAR NERVE|LEFT|Y||PARENT|1|Visit_1|10|7|TREATMENT|2020-06-02|10
e|FA|91e83d7a-186a-4fed-8750-af796d77d356|3|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|tsp|[?]|1|Weber|TONGUE|LEFT|||ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-06-17|25
e|FA|91e83d7a-186a-4fed-8750-af796d77d356|4|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|g/m2|[?]|1|/500 WBC|FALCIFORM LIGAMENT|CONTRALATERAL|Y||ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-06-17|25
e|FA|91e83d7a-186a-4fed-8750-af796d77d356|5|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|L/min|[?]|1|10^6 CFU/mL|METATARSOPHALANGEAL JOINT 4|CONTRALATERAL|||INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-07-02|40
e|FA|91e83d7a-186a-4fed-8750-af796d77d356|6|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|10^6 U|PARASYMPATHETIC GANGLIA|UNILATERAL|||CHILD|3|Visit_3|40|7|FOLLOW-UP|2020-07-02|40
e|FA|91e83d7a-186a-4fed-8750-af796d77d356|7|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mol/mL|[?]|1|uL/kg/day|SIGMOID SINUS|UNILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2020-07-27|65
e|FA|91e83d7a-186a-4fed-8750-af796d77d356|8|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|QUANTITY SUFFICIENT|RIB|UNILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|3|WASHOUT|2020-07-27|65
e|FA|91e83d7a-186a-4fed-8750-af796d77d356|9|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|mL/mmHg/min/L|[?]|1|g/day|JUGULAR VEIN|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|FOLLOW-UP|2020-08-21|90
e|FA|91e83d7a-186a-4fed-8750-af796d77d356|10|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|Coulomb|C6 VERTEBRA|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|SCREENING|2020-08-21|90
e|FA|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|1|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|BOWL|LEG SKIN|RIGHT||Y|VENDOR|1|Visit_1|10|5|SCREENING|2020-05-13|10
e|FA|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|2|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|EU|[?]|1|ohm|NECK|CONTRALATERAL|||SPOUSE|1|Visit_1|10|1|SCREENING|2020-05-13|10
e|FA|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|3|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|Osm|[?]|1|Gy/h|L1 VERTEBRA|IPSILATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|3|SCREENING|2020-05-28|25
e|FA|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|4|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|BEAM BREAKS|[?]|1|ug/m2/h|HEART, RIGHT ATRIAL APPENDAGE|UNILATERAL|||GUARDIAN|2|Visit_2|25|2|FOLLOW-UP|2020-05-28|25
e|FA|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|5|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|mL/min|[?]|1|MPS U|METATARSOPHALANGEAL JOINT 1|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-06-12|40
e|FA|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|6|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|BOLUS|[?]|1|Log10 ELISA unit|SKIN OF THE AXILLA|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|2|TREATMENT|2020-06-12|40
e|FA|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|7|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|SCOOPFUL|[?]|1|10^9 CFU/mL|HINDLIMB|LATERAL||Y|SPOUSE|4|Visit_4|65|6|FOLLOW-UP|2020-07-07|65
e|FA|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|8|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/g|[?]|1|mL/100g/min|HAMSTRING MUSCLE|CONTRALATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|1|FOLLOW-UP|2020-07-07|65
e|FA|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|9|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|mL/min/mmHg|[?]|1|SACHET|INTERPHALANGEAL JOINT 5 OF THE HAND|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|FOLLOW-UP|2020-08-01|90
e|FA|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|10|VOL|Volume|[?]|GERD|[?]|BAR|[?]|1|vp/dose|HEART, RIGHT ATRIAL APPENDAGE|RIGHT|||CAREGIVER|5|Visit_5|90|3|WASHOUT|2020-08-01|90
e|FA|0145dfac-a107-4368-b358-bcd136e1ecb3|1|DPROT|Dietary Protein|[?]|GERD|[?]|10^6 U|[?]|1|10^4 CFU/mL|COLON, RIGHT|UNILATERAL|Y||PARENT|1|Visit_1|10|6|SCREENING|2021-01-08|10
e|FA|0145dfac-a107-4368-b358-bcd136e1ecb3|2|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|10^5/hpf|[?]|1|mL/h|INTESTINE|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|WASHOUT|2021-01-08|10
e|FA|0145dfac-a107-4368-b358-bcd136e1ecb3|3|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|kg/L|[?]|1|g/L|MITRAL VALVE, ANTERIOR ANNULUS|LEFT||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|SCREENING|2021-01-23|25
e|FA|0145dfac-a107-4368-b358-bcd136e1ecb3|4|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|PFU/dose|[?]|1|10^6 U|PANCREAS, TAIL|LEFT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|7|FOLLOW-UP|2021-01-23|25
e|FA|0145dfac-a107-4368-b358-bcd136e1ecb3|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|mEq/kg|[?]|1|U/mg|RETINAL PIGMENTED EPITHELIAL LAYER|RIGHT|||ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2021-02-07|40
e|FA|0145dfac-a107-4368-b358-bcd136e1ecb3|6|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|nkat|[?]|1|mmHg/L/min|FACIAL BONE|UNILATERAL|||SIBLING|3|Visit_3|40|2|TREATMENT|2021-02-07|40
e|FA|0145dfac-a107-4368-b358-bcd136e1ecb3|7|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|%/s|[?]|1|anti-Xa IU/mL|ILEUM|LEFT|||GUARDIAN|4|Visit_4|65|5|WASHOUT|2021-03-04|65
e|FA|0145dfac-a107-4368-b358-bcd136e1ecb3|8|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|mOsm/kg|[?]|1|mL/h|MITRAL VALVE|LATERAL||Y|VENDOR|4|Visit_4|65|7|TREATMENT|2021-03-04|65
e|FA|0145dfac-a107-4368-b358-bcd136e1ecb3|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Osm|[?]|1|Pa|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|RIGHT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-03-29|90
e|FA|0145dfac-a107-4368-b358-bcd136e1ecb3|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms|[?]|1|oz eq|CARDIOVASCULAR SYSTEM|UNILATERAL|||GUARDIAN|5|Visit_5|90|5|TREATMENT|2021-03-29|90
e|FA|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|1|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|ng|[?]|1|DROP|ANAL CANAL|BILATERAL|Y|Y|FRIEND|1|Visit_1|10|6|TREATMENT|2020-12-29|10
e|FA|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|2|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|umol/mol|[?]|1|L|SKIN BETWEEN EYEBROWS|UNILATERAL|||SPOUSE|1|Visit_1|10|7|TREATMENT|2020-12-29|10
e|FA|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|3|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^8/L|[?]|1|mL|PROXIMAL PHALANX 4 OF THE HAND|UNILATERAL|Y|Y|PARENT|2|Visit_2|25|4|WASHOUT|2021-01-13|25
e|FA|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|cmol|[?]|1|U/mmol|ADRENAL GLAND|UNILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2021-01-13|25
e|FA|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|5|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|tuberculin unit|[?]|1|DROP|WRIST JOINT|RIGHT|Y|Y|SPOUSE|3|Visit_3|40|6|TREATMENT|2021-01-28|40
e|FA|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|6|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|ukat/L|[?]|1|/500 WBC|KIDNEY|IPSILATERAL||Y|CHILD|3|Visit_3|40|4|TREATMENT|2021-01-28|40
e|FA|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|7|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|cP|[?]|1|/200 HPFs|SCAPHOID-LUNATE-CAPITATE JOINT|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2021-02-22|65
e|FA|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Hz|[?]|1|Pa|LINGULA OF THE LUNG|IPSILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|FOLLOW-UP|2021-02-22|65
e|FA|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|9|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|genEq|[?]|1|gtt|EPIGLOTTIS|BILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|SCREENING|2021-03-19|90
e|FA|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|10|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|mg/L FEU|[?]|1|cmH2O/mL|COMMON FEMORAL ARTERY|CONTRALATERAL||Y|VENDOR|5|Visit_5|90|5|FOLLOW-UP|2021-03-19|90
e|FA|d4d79f6a-ba90-4503-934b-8a86286d83d3|1|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|umol/L/h|[?]|1|m2|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|IPSILATERAL|Y|Y|PROXY|1|Visit_1|10|5|WASHOUT|2020-11-17|10
e|FA|d4d79f6a-ba90-4503-934b-8a86286d83d3|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6/Ejaculate U|[?]|1|mg/g/min|MAXILLA|IPSILATERAL|Y||CHILD|1|Visit_1|10|1|WASHOUT|2020-11-17|10
e|FA|d4d79f6a-ba90-4503-934b-8a86286d83d3|3|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|mL/g/day|[?]|1|10^9 CFU/g|TRIANGULAR-HAMATE JOINT|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|FOLLOW-UP|2020-12-02|25
e|FA|d4d79f6a-ba90-4503-934b-8a86286d83d3|4|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|g/dL|SUPRATENTORIAL BRAIN|CONTRALATERAL|||FRIEND|2|Visit_2|25|2|FOLLOW-UP|2020-12-02|25
e|FA|d4d79f6a-ba90-4503-934b-8a86286d83d3|5|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|fmol/g|[?]|1|L/h/m2|ISCHIUM|LATERAL|||INTERVIEWER|3|Visit_3|40|4|WASHOUT|2020-12-17|40
e|FA|d4d79f6a-ba90-4503-934b-8a86286d83d3|6|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|DAgU/mL|[?]|1|10^6 IU/mL|CORPUS CALLOSUM, GENU|IPSILATERAL|||CHILD|3|Visit_3|40|6|TREATMENT|2020-12-17|40
e|FA|d4d79f6a-ba90-4503-934b-8a86286d83d3|7|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mL/animal/day|[?]|1|oz eq|ANTERIOR TIBIAL VEIN|LATERAL|Y||PROXY|4|Visit_4|65|6|TREATMENT|2021-01-11|65
e|FA|d4d79f6a-ba90-4503-934b-8a86286d83d3|8|OBJNUM|Number of Objects|[?]|GERD|[?]|cmHg|[?]|1|mL/100g/min|BRAIN, THIRD VENTRICLE|BILATERAL|||CAREGIVER|4|Visit_4|65|7|TREATMENT|2021-01-11|65
e|FA|d4d79f6a-ba90-4503-934b-8a86286d83d3|9|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mL|[?]|1|oz eq|TENTORIUM CEREBELLI|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|3|WASHOUT|2021-02-05|90
e|FA|d4d79f6a-ba90-4503-934b-8a86286d83d3|10|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|U/kg/min|[?]|1|100 IU/mL|CARDIAC WALL|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|5|TREATMENT|2021-02-05|90
e|FA|a329c350-49e2-415d-ba3c-e1ee929aec86|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|GBq|[?]|1|SCOOPFUL|TROCHANTER|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|WASHOUT|2020-08-15|10
e|FA|a329c350-49e2-415d-ba3c-e1ee929aec86|2|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|HEP|[?]|1|km|LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT|UNILATERAL|Y|Y|ADJUDICATOR|1|Visit_1|10|2|SCREENING|2020-08-15|10
e|FA|a329c350-49e2-415d-ba3c-e1ee929aec86|3|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|SCOOPFUL|[?]|1|fmol|PERITONEAL CAVITY|LEFT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-08-30|25
e|FA|a329c350-49e2-415d-ba3c-e1ee929aec86|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|uCi/kg|[?]|1|NEEDLE GAUGE|SKIN OF THE AXILLA|LEFT|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-08-30|25
e|FA|a329c350-49e2-415d-ba3c-e1ee929aec86|5|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|U/kg/day|[?]|1|anti-Xa IU/mL|TRAPEZIAL BONE|CONTRALATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2020-09-14|40
e|FA|a329c350-49e2-415d-ba3c-e1ee929aec86|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|mU/g|[?]|1|ug/g/h|LATERAL SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL||Y|PARENT|3|Visit_3|40|4|TREATMENT|2020-09-14|40
e|FA|a329c350-49e2-415d-ba3c-e1ee929aec86|7|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|g|[?]|1|10^6 U|AORTIC VALVE, NON-CORONARY CUSP|CONTRALATERAL|Y||FAMILY MEMBER|4|Visit_4|65|7|TREATMENT|2020-10-09|65
e|FA|a329c350-49e2-415d-ba3c-e1ee929aec86|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mg|[?]|1|CUP|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|CONTRALATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|5|SCREENING|2020-10-09|65
e|FA|a329c350-49e2-415d-ba3c-e1ee929aec86|9|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|RING|[?]|1|10^9 CFU/mL|CORONARY SINUS|LEFT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-11-03|90
e|FA|a329c350-49e2-415d-ba3c-e1ee929aec86|10|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|uL/mL|[?]|1|mmHg/L/min|HAMATE BONE|IPSILATERAL|||VENDOR|5|Visit_5|90|4|TREATMENT|2020-11-03|90
e|FA|ff0e3543-c1f3-47f8-987f-7b00a4a33704|1|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|fmol/L|[?]|1|m2|EXTERNAL ILIAC LYMPH NODE|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-10-01|10
e|FA|ff0e3543-c1f3-47f8-987f-7b00a4a33704|2|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|10^6 IU|[?]|1|IU/mg|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|CONTRALATERAL|||SPOUSE|1|Visit_1|10|3|TREATMENT|2020-10-01|10
e|FA|ff0e3543-c1f3-47f8-987f-7b00a4a33704|3|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|cpm|[?]|1|NEEDLE GAUGE|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|RIGHT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-10-16|25
e|FA|ff0e3543-c1f3-47f8-987f-7b00a4a33704|4|ACNDEV|Action Taken With Device|[?]|GERD|[?]|BAU/mL|[?]|1|100 IU/mL|TENTORIUM CEREBELLI|BILATERAL||Y|CHILD|2|Visit_2|25|7|TREATMENT|2020-10-16|25
e|FA|ff0e3543-c1f3-47f8-987f-7b00a4a33704|5|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|cmol|[?]|1|TRANSDUCING UNIT/mL|EPICONDYLE|CONTRALATERAL|Y||INVESTIGATOR|3|Visit_3|40|4|FOLLOW-UP|2020-10-31|40
e|FA|ff0e3543-c1f3-47f8-987f-7b00a4a33704|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mmol/mol|[?]|1|Pa|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|UNILATERAL|Y||PROXY|3|Visit_3|40|1|WASHOUT|2020-10-31|40
e|FA|ff0e3543-c1f3-47f8-987f-7b00a4a33704|7|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|Antibody Unit|[?]|1|NEEDLE GAUGE|POSTERIOR POLE OF THE EYE|LATERAL|Y||INVESTIGATOR|4|Visit_4|65|7|SCREENING|2020-11-25|65
e|FA|ff0e3543-c1f3-47f8-987f-7b00a4a33704|8|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|ECL unit|[?]|1|DRUM|HEART, LEFT ATRIUM|LEFT||Y|FRIEND|4|Visit_4|65|4|TREATMENT|2020-11-25|65
e|FA|ff0e3543-c1f3-47f8-987f-7b00a4a33704|9|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|CYLINDER|[?]|1|mL/min/mmHg|SCAPHOID-LUNATE-CAPITATE JOINT|UNILATERAL|||GUARDIAN|5|Visit_5|90|4|WASHOUT|2020-12-20|90
e|FA|ff0e3543-c1f3-47f8-987f-7b00a4a33704|10|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|10^3/L|[?]|1|mg/h|ENDOMETRIUM|CONTRALATERAL|||FRIEND|5|Visit_5|90|3|WASHOUT|2020-12-20|90
e|FA|128153ce-7bee-4f8d-bb60-fb1776370b6d|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|Ci/mg|[?]|1|10^6 U|CAROTID ARTERY|IPSILATERAL|||ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2021-01-11|10
e|FA|128153ce-7bee-4f8d-bb60-fb1776370b6d|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|uL/dose|[?]|1|%(v/v)|GLOSSOPHARYNGEAL NERVE|LEFT|||SPOUSE|1|Visit_1|10|1|FOLLOW-UP|2021-01-11|10
e|FA|128153ce-7bee-4f8d-bb60-fb1776370b6d|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|rpm|[?]|1|mg/g/min|CARPOMETACARPAL JOINT 1|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2021-01-26|25
e|FA|128153ce-7bee-4f8d-bb60-fb1776370b6d|4|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|Linear ft*LB|[?]|1|NEEDLE GAUGE|AXILLARY ARTERY|LATERAL|Y||FRIEND|2|Visit_2|25|6|FOLLOW-UP|2021-01-26|25
e|FA|128153ce-7bee-4f8d-bb60-fb1776370b6d|5|TRTSETT|Treatment Setting|[?]|GERD|[?]|vp/mL|[?]|1|Coulomb|RIGHT VENTRICULAR ENDOCARDIUM|RIGHT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|SCREENING|2021-02-10|40
e|FA|128153ce-7bee-4f8d-bb60-fb1776370b6d|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|BEAM BREAKS|[?]|1|ug/g/h|INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL||Y|GUARDIAN|3|Visit_3|40|1|SCREENING|2021-02-10|40
e|FA|128153ce-7bee-4f8d-bb60-fb1776370b6d|7|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|10^3/L|[?]|1|uL/kg/day|PUBIC BONE|BILATERAL|||INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2021-03-07|65
e|FA|128153ce-7bee-4f8d-bb60-fb1776370b6d|8|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|uL/kg/day|STERNOCLAVICULAR JOINT|RIGHT|||CHILD|4|Visit_4|65|7|TREATMENT|2021-03-07|65
e|FA|128153ce-7bee-4f8d-bb60-fb1776370b6d|9|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|log10 copies/mL|[?]|1|mmHg/L/min|OLFACTORY NERVE|RIGHT|||DOMESTIC PARTNER|5|Visit_5|90|7|WASHOUT|2021-04-01|90
e|FA|128153ce-7bee-4f8d-bb60-fb1776370b6d|10|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|ng/day|SKIN BETWEEN EYEBROWS|BILATERAL|||ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2021-04-01|90
e|FA|22ee2f20-4a66-458f-a153-9d7e871e1db2|1|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|10^4/L|[?]|1|ug/m2/h|HIP|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|WASHOUT|2020-06-17|10
e|FA|22ee2f20-4a66-458f-a153-9d7e871e1db2|2|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|VIRTUAL PIXEL|[?]|1|mL/h|MASTOID PROCESS|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|7|FOLLOW-UP|2020-06-17|10
e|FA|22ee2f20-4a66-458f-a153-9d7e871e1db2|3|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|in|[?]|1|umol|MITRAL VALVE, ANTERIOR ANNULUS|BILATERAL|||CHILD|2|Visit_2|25|3|TREATMENT|2020-07-02|25
e|FA|22ee2f20-4a66-458f-a153-9d7e871e1db2|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|MBq|POSTERIOR INFERIOR CEREBELLAR ARTERY|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-07-02|25
e|FA|22ee2f20-4a66-458f-a153-9d7e871e1db2|5|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|ug/kg/h|[?]|1|anti-Xa IU/mL|FEMUR SHAFT|LATERAL|||PROXY|3|Visit_3|40|4|SCREENING|2020-07-17|40
e|FA|22ee2f20-4a66-458f-a153-9d7e871e1db2|6|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|DROP|SKIN OF THE FACE|LATERAL|Y||GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-07-17|40
e|FA|22ee2f20-4a66-458f-a153-9d7e871e1db2|7|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|fmol|[?]|1|BAG|COCCYX|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|7|SCREENING|2020-08-11|65
e|FA|22ee2f20-4a66-458f-a153-9d7e871e1db2|8|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|ug/L|[?]|1|SACHET|AORTOCAVAL LYMPH NODE|LEFT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|3|FOLLOW-UP|2020-08-11|65
e|FA|22ee2f20-4a66-458f-a153-9d7e871e1db2|9|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|IU/L|[?]|1|SACHET|SUPRAGLOTTIS|CONTRALATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|7|WASHOUT|2020-09-05|90
e|FA|22ee2f20-4a66-458f-a153-9d7e871e1db2|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/uL|[?]|1|10^6 U|GREAT TROCHANTER|IPSILATERAL|Y||PARENT|5|Visit_5|90|6|TREATMENT|2020-09-05|90
e|FA|b7caaa04-bcc7-4350-ad98-85670a19778f|1|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/mL|[?]|1|umol|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|BILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|FOLLOW-UP|2020-07-06|10
e|FA|b7caaa04-bcc7-4350-ad98-85670a19778f|2|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|IU/mL|[?]|1|10^6 U|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|BILATERAL||Y|VENDOR|1|Visit_1|10|4|FOLLOW-UP|2020-07-06|10
e|FA|b7caaa04-bcc7-4350-ad98-85670a19778f|3|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|mL/cm|[?]|1|L|INTRAHEPATIC BILE DUCT|IPSILATERAL|Y|Y|PROXY|2|Visit_2|25|6|FOLLOW-UP|2020-07-21|25
e|FA|b7caaa04-bcc7-4350-ad98-85670a19778f|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|mg/mL/day|[?]|1|MBq|RIB 6|LEFT|||ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-07-21|25
e|FA|b7caaa04-bcc7-4350-ad98-85670a19778f|5|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg/min/L|[?]|1|mL/h|AXILLARY VEIN|BILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|SCREENING|2020-08-05|40
e|FA|b7caaa04-bcc7-4350-ad98-85670a19778f|6|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|mm/h|LUNG, LEFT UPPER LOBE|IPSILATERAL|||INVESTIGATOR|3|Visit_3|40|3|FOLLOW-UP|2020-08-05|40
e|FA|b7caaa04-bcc7-4350-ad98-85670a19778f|7|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|pkat/L|[?]|1|/500 WBC|HEART, LEFT VENTRICULAR OUTFLOW TRACT|LEFT|||FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2020-08-30|65
e|FA|b7caaa04-bcc7-4350-ad98-85670a19778f|8|ACNDEV|Action Taken With Device|[?]|GERD|[?]|FFU|[?]|1|100 IU/mL|TIBIA SHAFT|LEFT|||VENDOR|4|Visit_4|65|4|TREATMENT|2020-08-30|65
e|FA|b7caaa04-bcc7-4350-ad98-85670a19778f|9|OBJTYPE|Type of Object|[?]|GERD|[?]|ug/h|[?]|1|ng|BASILIC VEIN|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2020-09-24|90
e|FA|b7caaa04-bcc7-4350-ad98-85670a19778f|10|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|MPL U|[?]|1|mL/dose|EAR, INNER|LATERAL|Y|Y|PARENT|5|Visit_5|90|2|SCREENING|2020-09-24|90
e|FA|2b58d5fd-3ec8-415b-bb53-a252049f228a|1|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|U/10^12 RBC|[?]|1|/kg|PANCREAS, ENDOCRINE|UNILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|SCREENING|2020-12-17|10
e|FA|2b58d5fd-3ec8-415b-bb53-a252049f228a|2|EVENTNUM|Number of Events|[?]|GERD|[?]|BOTTLE|[?]|1|U/10^12 RBC|THORACIC CAVITY|BILATERAL|Y||INVESTIGATOR|1|Visit_1|10|1|WASHOUT|2020-12-17|10
e|FA|2b58d5fd-3ec8-415b-bb53-a252049f228a|3|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|uL/dose|[?]|1|ug/kg/h|GASTROINTESTINAL TRACT, LOWER|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2021-01-01|25
e|FA|2b58d5fd-3ec8-415b-bb53-a252049f228a|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|fg|[?]|1|QUANTITY SUFFICIENT|PELVIS|BILATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2021-01-01|25
e|FA|2b58d5fd-3ec8-415b-bb53-a252049f228a|5|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|DPM|[?]|1|mEq/g|LEFT POSTERIOR DESCENDING ARTERY|BILATERAL|||FRIEND|3|Visit_3|40|6|TREATMENT|2021-01-16|40
e|FA|2b58d5fd-3ec8-415b-bb53-a252049f228a|6|OBJNUM|Number of Objects|[?]|GERD|[?]|/10^3|[?]|1|mL/100g/min|RETINA|BILATERAL|Y|Y|FAMILY MEMBER|3|Visit_3|40|6|FOLLOW-UP|2021-01-16|40
e|FA|2b58d5fd-3ec8-415b-bb53-a252049f228a|7|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|pmol/10^9 cells|[?]|1|mmHg/L/min|RIGHT CORONARY ARTERY OSTIUM|UNILATERAL|||GUARDIAN|4|Visit_4|65|6|FOLLOW-UP|2021-02-10|65
e|FA|2b58d5fd-3ec8-415b-bb53-a252049f228a|8|DFATT|Dietary Fat, Total|[?]|GERD|[?]|STRIP|[?]|1|Bq/mg|STERNOCLAVICULAR JOINT|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-02-10|65
e|FA|2b58d5fd-3ec8-415b-bb53-a252049f228a|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ug/dose|[?]|1|mg/g/min|ACHILLES TENDON|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|WASHOUT|2021-03-07|90
e|FA|2b58d5fd-3ec8-415b-bb53-a252049f228a|10|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|EP U|[?]|1|vp/dose|URETHRA, ANTERIOR|RIGHT|||ADJUDICATOR|5|Visit_5|90|1|WASHOUT|2021-03-07|90
e|FA|60b23345-43f6-42eb-9225-5a674456c9b9|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Ci|[?]|1|mg/g/min|POPLITEAL FOSSA|LEFT||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|2|FOLLOW-UP|2021-01-15|10
e|FA|60b23345-43f6-42eb-9225-5a674456c9b9|2|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|in2|[?]|1|ohm|GLOMERULUS|CONTRALATERAL|Y||STUDY SUBJECT|1|Visit_1|10|4|FOLLOW-UP|2021-01-15|10
e|FA|60b23345-43f6-42eb-9225-5a674456c9b9|3|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|g/dL|[?]|1|psi|ILIOPSOAS MUSCLE|UNILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|6|SCREENING|2021-01-30|25
e|FA|60b23345-43f6-42eb-9225-5a674456c9b9|4|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|mL/breath|[?]|1|h*%|CRANIAL NERVE|UNILATERAL|||PROXY|2|Visit_2|25|1|SCREENING|2021-01-30|25
e|FA|60b23345-43f6-42eb-9225-5a674456c9b9|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|dmol|[?]|1|mg/g/min|PARAPHARYNGEAL LYMPH NODE|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2021-02-14|40
e|FA|60b23345-43f6-42eb-9225-5a674456c9b9|6|OBJNUM|Number of Objects|[?]|GERD|[?]|mL/kg/h|[?]|1|mL/100g/min|TRACHEA|LATERAL|Y|Y|SIBLING|3|Visit_3|40|5|TREATMENT|2021-02-14|40
e|FA|60b23345-43f6-42eb-9225-5a674456c9b9|7|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|pmol/10^10 cells|[?]|1|km|GREAT SAPHENOUS VEIN|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-03-11|65
e|FA|60b23345-43f6-42eb-9225-5a674456c9b9|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|nkat|[?]|1|U/mmol|HINDLIMB|CONTRALATERAL||Y|INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2021-03-11|65
e|FA|60b23345-43f6-42eb-9225-5a674456c9b9|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|STRIP|[?]|1|mL|PELVIS|LEFT||Y|FRIEND|5|Visit_5|90|7|TREATMENT|2021-04-05|90
e|FA|60b23345-43f6-42eb-9225-5a674456c9b9|10|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|ppm|[?]|1|/500 WBC|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|Y||VENDOR|5|Visit_5|90|4|TREATMENT|2021-04-05|90
e|FA|7979239e-2a6b-48e3-9d11-41c97b33d229|1|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|L/L|[?]|1|mg/dose|SKIN OF THE BACK|UNILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|3|FOLLOW-UP|2021-01-15|10
e|FA|7979239e-2a6b-48e3-9d11-41c97b33d229|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|CONTAINER|[?]|1|Pa|PATELLA|BILATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|6|FOLLOW-UP|2021-01-15|10
e|FA|7979239e-2a6b-48e3-9d11-41c97b33d229|3|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|nmol/mol|[?]|1|/500 WBC|ANKLE MORTISE|BILATERAL||Y|FAMILY MEMBER|2|Visit_2|25|5|FOLLOW-UP|2021-01-30|25
e|FA|7979239e-2a6b-48e3-9d11-41c97b33d229|4|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|tsp eq|[?]|1|Bq/L|AORTIC VALVE|LEFT|||ADJUDICATOR|2|Visit_2|25|3|SCREENING|2021-01-30|25
e|FA|7979239e-2a6b-48e3-9d11-41c97b33d229|5|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|nmol/kg/day|[?]|1|gtt|PROFUNDA FEMORIS ARTERY|UNILATERAL|||ADJUDICATOR|3|Visit_3|40|2|FOLLOW-UP|2021-02-14|40
e|FA|7979239e-2a6b-48e3-9d11-41c97b33d229|6|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|msec|[?]|1|BOWL|SUBCLAVIAN VEIN|LATERAL|||GUARDIAN|3|Visit_3|40|1|TREATMENT|2021-02-14|40
e|FA|7979239e-2a6b-48e3-9d11-41c97b33d229|7|DMG|Dietary Magnesium|[?]|GERD|[?]|nmol/kg/day|[?]|1|TRANSDUCING UNIT/mL|INTERPHALANGEAL JOINT 3 OF THE FOOT|BILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|FOLLOW-UP|2021-03-11|65
e|FA|7979239e-2a6b-48e3-9d11-41c97b33d229|8|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|fmol|CORONARY ARTERY, ANTERIOR DESCENDING|LEFT|||SIGNIFICANT OTHER|4|Visit_4|65|2|SCREENING|2021-03-11|65
e|FA|7979239e-2a6b-48e3-9d11-41c97b33d229|9|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|pptr|[?]|1|uL/kg/day|GLOMERULUS|RIGHT|Y||VENDOR|5|Visit_5|90|6|TREATMENT|2021-04-05|90
e|FA|7979239e-2a6b-48e3-9d11-41c97b33d229|10|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|foz_us|[?]|1|cm H2O|LUNG, LEFT LOWER LOBE|LATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2021-04-05|90
e|FA|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|1|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|Rad|[?]|1|MBq|LUMBRICAL MUSCLES OF THE HAND|LEFT|||INTERVIEWER|1|Visit_1|10|4|TREATMENT|2020-08-06|10
e|FA|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|2|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|U/kg/min|[?]|1|mL/dose|CEREBRAL CORTEX|UNILATERAL|||SIBLING|1|Visit_1|10|5|SCREENING|2020-08-06|10
e|FA|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^5/hpf|[?]|1|mg/g/min|MAXILLA|LEFT|Y|Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|WASHOUT|2020-08-21|25
e|FA|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|4|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|g/kg/day|[?]|1|CUP|COSTOCHONDRAL JOINT 1|UNILATERAL|||CAREGIVER|2|Visit_2|25|4|SCREENING|2020-08-21|25
e|FA|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|5|AGETRT1|Age At First Treatment|[?]|GERD|[?]|pmol/g|[?]|1|mL/mmHg/min/L|CEREBRAL VEIN|CONTRALATERAL|||DOMESTIC PARTNER|3|Visit_3|40|7|WASHOUT|2020-09-05|40
e|FA|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|6|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|ug/g/h|[?]|1|MPS U|BLOOD|BILATERAL|||INTERVIEWER|3|Visit_3|40|1|TREATMENT|2020-09-05|40
e|FA|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|7|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|/2000 RBC|[?]|1|g/dL|SPLENIC VEIN|LATERAL|||VENDOR|4|Visit_4|65|5|TREATMENT|2020-09-30|65
e|FA|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|8|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|/10^3|[?]|1|mL/cm3/min|TRICUSPID VALVE|BILATERAL|||SIBLING|4|Visit_4|65|1|FOLLOW-UP|2020-09-30|65
e|FA|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|9|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|10^4 CFU/mL|HEART, BASE|BILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|SCREENING|2020-10-25|90
e|FA|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|10|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|RNA copies/mL|[?]|1|anti-Xa IU/mL|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|CONTRALATERAL|||STUDY SUBJECT|5|Visit_5|90|3|WASHOUT|2020-10-25|90
e|FA|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|1|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|ug/m2|[?]|1|Log10 ELISA unit|TALUS|BILATERAL|||FRIEND|1|Visit_1|10|2|WASHOUT|2021-01-05|10
e|FA|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|2|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|10^4/L|[?]|1|AU/mL|TEMPORAL ARTERY|RIGHT||Y|CHILD|1|Visit_1|10|3|FOLLOW-UP|2021-01-05|10
e|FA|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|3|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|umol|MEDIASTINUM, ANTERIOR|IPSILATERAL|||CAREGIVER|2|Visit_2|25|5|TREATMENT|2021-01-20|25
e|FA|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|CAN|[?]|1|U/mmol|C3 VERTEBRA|LATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2021-01-20|25
e|FA|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|5|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|mol/mg|[?]|1|BAG|EXTENSOR HALLUCIS BREVIS MUSCLE|BILATERAL||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|WASHOUT|2021-02-04|40
e|FA|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|6|DFIBER|Dietary Fiber|[?]|GERD|[?]|BLOCKS|[?]|1|h*%|NUCLEUS OF DIAGONAL BAND|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|7|SCREENING|2021-02-04|40
e|FA|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|7|ESTWT|Estimated Weight|[?]|GERD|[?]|SCOOPFUL|[?]|1|g/day|ENDOMETRIAL CAVITY|LEFT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|WASHOUT|2021-03-01|65
e|FA|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^6 CFU|[?]|1|%(v/v)|SYMPATHETIC GANGLIA|CONTRALATERAL|||VENDOR|4|Visit_4|65|5|SCREENING|2021-03-01|65
e|FA|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|9|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mol/day|[?]|1|mAmp|INTRATHORACIC LYMPH NODE|LEFT|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|FOLLOW-UP|2021-03-26|90
e|FA|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|10|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|TROCHE|[?]|1|BP|COLON, RECTOSIGMOID|RIGHT|||SIGNIFICANT OTHER|5|Visit_5|90|4|WASHOUT|2021-03-26|90
e|FA|da35fc01-4258-4e4d-99d9-4172e84c46e8|1|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|U/g|[?]|1|PFU/dose|COMMON FEMORAL VEIN|BILATERAL|||CHILD|1|Visit_1|10|1|TREATMENT|2020-07-22|10
e|FA|da35fc01-4258-4e4d-99d9-4172e84c46e8|2|SEV|Severity/Intensity|[?]|GERD|[?]|kN/cm2|[?]|1|Pa|5TH LUMBAR SPINOUS PROCESS|LEFT|||SPOUSE|1|Visit_1|10|2|TREATMENT|2020-07-22|10
e|FA|da35fc01-4258-4e4d-99d9-4172e84c46e8|3|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|BP|MITRAL VALVE ANNULUS|UNILATERAL|||CHILD|2|Visit_2|25|6|WASHOUT|2020-08-06|25
e|FA|da35fc01-4258-4e4d-99d9-4172e84c46e8|4|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|g/animal|[?]|1|DROP|T12 VERTEBRA|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-08-06|25
e|FA|da35fc01-4258-4e4d-99d9-4172e84c46e8|5|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|genEq|[?]|1|10^6 CFU|RADIUS SHAFT|IPSILATERAL|||SIBLING|3|Visit_3|40|4|TREATMENT|2020-08-21|40
e|FA|da35fc01-4258-4e4d-99d9-4172e84c46e8|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|keV|[?]|1|mg/g/min|NAIL|UNILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|SCREENING|2020-08-21|40
e|FA|da35fc01-4258-4e4d-99d9-4172e84c46e8|7|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|in2|[?]|1|cm H2O|PROXIMAL PHALANX 3 OF THE HAND|RIGHT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|FOLLOW-UP|2020-09-15|65
e|FA|da35fc01-4258-4e4d-99d9-4172e84c46e8|8|DGRAIN|Dietary Grain|[?]|GERD|[?]|umol/L/min|[?]|1|10^9 CFU/g|ESOPHAGUS, UPPER THIRD|LEFT|Y||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-09-15|65
e|FA|da35fc01-4258-4e4d-99d9-4172e84c46e8|9|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|/7.5 mL|[?]|1|10^9 CFU/g|GLOTTIS|LEFT|||SIGNIFICANT OTHER|5|Visit_5|90|5|WASHOUT|2020-10-10|90
e|FA|da35fc01-4258-4e4d-99d9-4172e84c46e8|10|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|vg/mL|[?]|1|in|TRANSVERSE TARSAL JOINT|BILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|5|TREATMENT|2020-10-10|90
e|FA|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|km|SACRAL VERTEBRA|UNILATERAL|||INVESTIGATOR|1|Visit_1|10|6|FOLLOW-UP|2020-08-04|10
e|FA|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|2|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|PFU/animal|[?]|1|mL/m2|CALF MUSCULAR VEIN|RIGHT|||SIBLING|1|Visit_1|10|7|FOLLOW-UP|2020-08-04|10
e|FA|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|3|OBJTYPE|Type of Object|[?]|GERD|[?]|CAN|[?]|1|ng|VULVOVAGINAL REGION|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-08-19|25
e|FA|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|4|DPROT|Dietary Protein|[?]|GERD|[?]|TUBE|[?]|1|10^4 CFU/mL|POPLITEAL LYMPH NODE|LEFT||Y|CAREGIVER|2|Visit_2|25|7|TREATMENT|2020-08-19|25
e|FA|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|5|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|ppth|[?]|1|MBq|SIGMOID SINUS|RIGHT|Y|Y|INTERVIEWER|3|Visit_3|40|6|WASHOUT|2020-09-03|40
e|FA|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit|[?]|1|CUP|APPENDICULAR SKELETON|IPSILATERAL|Y|Y|INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-09-03|40
e|FA|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|g/cage/wk|[?]|1|Pa|HAMATE BONE|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|FOLLOW-UP|2020-09-28|65
e|FA|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|8|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|ug/m2/day|[?]|1|mmHg/L/min|PERITONEAL CAVITY|LATERAL|||INVESTIGATOR|4|Visit_4|65|2|SCREENING|2020-09-28|65
e|FA|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|9|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/g|[?]|1|ohm|MAXILLA|BILATERAL|||CAREGIVER|5|Visit_5|90|2|SCREENING|2020-10-23|90
e|FA|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|10|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|dram|[?]|1|IU/mg|VAGUS NERVE|LATERAL|||INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2020-10-23|90
e|FA|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|1|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|Pa|[?]|1|NEEDLE GAUGE|ESOPHAGUS, THORACIC|LEFT|Y|Y|GUARDIAN|1|Visit_1|10|7|WASHOUT|2020-12-14|10
e|FA|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|2|RLDEV|Relationship to Device|[?]|GERD|[?]|RNA copies/mL|[?]|1|mL/min/mmHg|CEREBRAL ARTERY|LEFT|||INDEPENDENT ASSESSOR|1|Visit_1|10|5|TREATMENT|2020-12-14|10
e|FA|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|DDU|[?]|1|mg/g/min|THIRD POSTEROLATERAL DESCENDING ARTERY|BILATERAL|Y||PARENT|2|Visit_2|25|7|SCREENING|2020-12-29|25
e|FA|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|4|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|/500 WBC|[?]|1|mL/h|GASTROINTESTINAL TRACT, WALL|IPSILATERAL||Y|SIBLING|2|Visit_2|25|6|TREATMENT|2020-12-29|25
e|FA|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|5|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|DRUM|[?]|1|PFU/dose|SUBGLOTTIS|CONTRALATERAL||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|WASHOUT|2021-01-13|40
e|FA|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|6|DPROT|Dietary Protein|[?]|GERD|[?]|DAgU/mL|[?]|1|10^4 CFU/mL|COLON, SIGMOID|RIGHT|||STUDY SUBJECT|3|Visit_3|40|1|SCREENING|2021-01-13|40
e|FA|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|7|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|g/L|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|RIGHT|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|3|SCREENING|2021-02-07|65
e|FA|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|8|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/mL|[?]|1|ng|PARATRACHEAL LYMPH NODE|BILATERAL|||INTERVIEWER|4|Visit_4|65|2|FOLLOW-UP|2021-02-07|65
e|FA|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|9|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|EID 50/dose|[?]|1|SACHET|RECTO-UTERINE POUCH|LEFT|||PROXY|5|Visit_5|90|2|FOLLOW-UP|2021-03-04|90
e|FA|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|10|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|/mm2|[?]|1|mmHg/L/min|INTERPHALANGEAL JOINT 3|IPSILATERAL|||PARENT|5|Visit_5|90|2|WASHOUT|2021-03-04|90
e|FA|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|1|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|1/(s*kPa)|[?]|1|TRANSDUCING UNIT/mL|PENIS, GLANS|UNILATERAL||Y|VENDOR|1|Visit_1|10|7|TREATMENT|2020-06-09|10
e|FA|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|2|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|umol|URETHRAL SPHINCTER|UNILATERAL|Y||SIBLING|1|Visit_1|10|6|TREATMENT|2020-06-09|10
e|FA|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|3|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mL/(min*100mL)|[?]|1|100 IU/mL|PERICARDIAL WALL|UNILATERAL|||CHILD|2|Visit_2|25|4|FOLLOW-UP|2020-06-24|25
e|FA|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|4|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|Enzyme U/L|[?]|1|g/day|SCAPULA|LATERAL|||VENDOR|2|Visit_2|25|5|SCREENING|2020-06-24|25
e|FA|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|5|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|g/day|[?]|1|g/L|SKIN AROUND THE MOUTH|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-07-09|40
e|FA|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|6|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|L/s|[?]|1|10^6 IU/mL|COLON WALL|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2020-07-09|40
e|FA|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|7|ACNDEV|Action Taken With Device|[?]|GERD|[?]|ugEq/L|[?]|1|100 IU/mL|HEPATIC LYMPH NODE|LEFT||Y|SIBLING|4|Visit_4|65|7|WASHOUT|2020-08-03|65
e|FA|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|8|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|ng|COLON, SPLENIC FLEXURE|CONTRALATERAL|||PROXY|4|Visit_4|65|4|TREATMENT|2020-08-03|65
e|FA|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|9|DGRAIN|Dietary Grain|[?]|GERD|[?]|damol/L|[?]|1|10^9 CFU/g|HAMATE BONE|UNILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-08-28|90
e|FA|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|uV|[?]|1|%(v/v)|HEART, VENTRICULAR WALL|UNILATERAL|Y|Y|CHILD|5|Visit_5|90|2|WASHOUT|2020-08-28|90
e|FA|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|1|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|mL/m2/day|[?]|1|m2|SUBCARINAL LYMPH NODE|LATERAL||Y|INVESTIGATOR|1|Visit_1|10|3|TREATMENT|2020-05-24|10
e|FA|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|2|SEV|Severity/Intensity|[?]|GERD|[?]|m2|[?]|1|Pa|SUPRARENAL AORTA|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|TREATMENT|2020-05-24|10
e|FA|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|3|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|Ci/ug|[?]|1|ohm|SKIN OF THE INGUINAL REGION|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-06-08|25
e|FA|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|4|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|10^4 CFU|[?]|1|ng|LEG SKIN|RIGHT|||ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-06-08|25
e|FA|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|5|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|copies/uL|[?]|1|m2|METACARPAL BONE 3|LEFT|||DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2020-06-23|40
e|FA|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|6|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|cmol|[?]|1|mL/m2|OVARY|UNILATERAL||Y|INTERVIEWER|3|Visit_3|40|5|SCREENING|2020-06-23|40
e|FA|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|7|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|tsp|[?]|1|cmH2O/mL|GASTROINTESTINAL TRACT|RIGHT|||SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2020-07-18|65
e|FA|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|8|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|PACK|[?]|1|10^6 IU/mL|LEFT VENTRICULAR MID ANTERIOR SEGMENT|CONTRALATERAL||Y|SPOUSE|4|Visit_4|65|7|SCREENING|2020-07-18|65
e|FA|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|9|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Bq/mg|[?]|1|oz eq|FAT PAD|UNILATERAL||Y|GUARDIAN|5|Visit_5|90|6|TREATMENT|2020-08-12|90
e|FA|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|10|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|kPa|[?]|1|Bq/L|MEDIAN NERVE|RIGHT|||INVESTIGATOR|5|Visit_5|90|7|FOLLOW-UP|2020-08-12|90
e|FA|136d59c6-9645-447a-a047-68d33dbb708e|1|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|cd|[?]|1|mL/mmHg/min/L|HEART, RIGHT ATRIUM|BILATERAL||Y|GUARDIAN|1|Visit_1|10|3|WASHOUT|2020-09-24|10
e|FA|136d59c6-9645-447a-a047-68d33dbb708e|2|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|10^3 RNA copies/mL|[?]|1|cmH2O/mL|TRAPEZOID-CAPITATE JOINT|LATERAL|||SIBLING|1|Visit_1|10|6|TREATMENT|2020-09-24|10
e|FA|136d59c6-9645-447a-a047-68d33dbb708e|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|uCi|[?]|1|10^6 U|VASTUS MEDIALIS MUSCLE|RIGHT|Y||INVESTIGATOR|2|Visit_2|25|1|SCREENING|2020-10-09|25
e|FA|136d59c6-9645-447a-a047-68d33dbb708e|4|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|10^9 organisms/g|[?]|1|L/h/m2|POPLITEAL ARTERY ABOVE KNEE|CONTRALATERAL|||FAMILY MEMBER|2|Visit_2|25|2|SCREENING|2020-10-09|25
e|FA|136d59c6-9645-447a-a047-68d33dbb708e|5|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|mCi/L|[?]|1|TRANSDUCING UNIT/mL|CALF|IPSILATERAL|||CHILD|3|Visit_3|40|2|WASHOUT|2020-10-24|40
e|FA|136d59c6-9645-447a-a047-68d33dbb708e|6|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|mEq/mL|[?]|1|mL/cm3/min|PARAPHARYNGEAL LYMPH NODE|UNILATERAL|Y||PARENT|3|Visit_3|40|3|FOLLOW-UP|2020-10-24|40
e|FA|136d59c6-9645-447a-a047-68d33dbb708e|7|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|mL/dose|FOOT DIGIT 2|IPSILATERAL|||VENDOR|4|Visit_4|65|2|TREATMENT|2020-11-18|65
e|FA|136d59c6-9645-447a-a047-68d33dbb708e|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ug/L/h|[?]|1|%(v/v)|FEMORAL HEAD|UNILATERAL|||SPOUSE|4|Visit_4|65|5|WASHOUT|2020-11-18|65
e|FA|136d59c6-9645-447a-a047-68d33dbb708e|9|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|ug/kg/h|SKIN OF THE NECK|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2020-12-13|90
e|FA|136d59c6-9645-447a-a047-68d33dbb708e|10|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|mOsm/L|[?]|1|Ci/ug|THIGH|LEFT||Y|SIGNIFICANT OTHER|5|Visit_5|90|1|SCREENING|2020-12-13|90
e|FA|2e393b90-213c-4661-ad55-cabb2008bf14|1|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|umol/kg/min|[?]|1|HOURS|CORONARY ARTERY, RIGHT|RIGHT|Y||SIBLING|1|Visit_1|10|3|TREATMENT|2020-06-26|10
e|FA|2e393b90-213c-4661-ad55-cabb2008bf14|2|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|/sec|[?]|1|psi|TROCHANTER|BILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-06-26|10
e|FA|2e393b90-213c-4661-ad55-cabb2008bf14|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|g/day|[?]|1|mg/g/min|HAND DIGIT 3|LATERAL|||FRIEND|2|Visit_2|25|3|TREATMENT|2020-07-11|25
e|FA|2e393b90-213c-4661-ad55-cabb2008bf14|4|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|amu|[?]|1|in|ESOPHAGUS, CERVICAL|CONTRALATERAL|Y||DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2020-07-11|25
e|FA|2e393b90-213c-4661-ad55-cabb2008bf14|5|SEV|Severity/Intensity|[?]|GERD|[?]|PFU|[?]|1|Pa|EAR|UNILATERAL|||ADJUDICATOR|3|Visit_3|40|2|SCREENING|2020-07-26|40
e|FA|2e393b90-213c-4661-ad55-cabb2008bf14|6|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|log10 PFU|[?]|1|mg/dose|PANCREAS, BODY|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|WASHOUT|2020-07-26|40
e|FA|2e393b90-213c-4661-ad55-cabb2008bf14|7|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|/500 WBC|[?]|1|Hz/s|ULNA SHAFT|CONTRALATERAL|Y||FRIEND|4|Visit_4|65|6|FOLLOW-UP|2020-08-20|65
e|FA|2e393b90-213c-4661-ad55-cabb2008bf14|8|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|mL/min/mmHg|[?]|1|ug/m2/h|RETINA|CONTRALATERAL|||FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2020-08-20|65
e|FA|2e393b90-213c-4661-ad55-cabb2008bf14|9|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|in|PAROTID GLAND|BILATERAL|Y|Y|STUDY SUBJECT|5|Visit_5|90|6|FOLLOW-UP|2020-09-14|90
e|FA|2e393b90-213c-4661-ad55-cabb2008bf14|10|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|SACHET|[?]|1|ohm|PLEURAL CAVITY|LEFT|||FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2020-09-14|90
e|FA|f72002d8-262b-49da-84a4-42e6011286f0|1|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|USP U|[?]|1|/500 WBC|PANCREAS, BODY|BILATERAL|Y|Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|2|TREATMENT|2020-10-14|10
e|FA|f72002d8-262b-49da-84a4-42e6011286f0|2|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Gauss|[?]|1|mm/h|L4 VERTEBRA|BILATERAL|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|3|TREATMENT|2020-10-14|10
e|FA|f72002d8-262b-49da-84a4-42e6011286f0|3|LESNUM|Number of Lesions|[?]|GERD|[?]|fmol/g|[?]|1|ng/day|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|IPSILATERAL|||CHILD|2|Visit_2|25|4|SCREENING|2020-10-29|25
e|FA|f72002d8-262b-49da-84a4-42e6011286f0|4|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|10^6 organisms/g|[?]|1|mL/animal/day|WRIST JOINT EXTENSOR MUSCLES|CONTRALATERAL||Y|INTERVIEWER|2|Visit_2|25|1|SCREENING|2020-10-29|25
e|FA|f72002d8-262b-49da-84a4-42e6011286f0|5|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|AU/mL|[?]|1|QUANTITY SUFFICIENT|TEMPOROMANDIBULAR JOINT|CONTRALATERAL|Y||CHILD|3|Visit_3|40|2|TREATMENT|2020-11-13|40
e|FA|f72002d8-262b-49da-84a4-42e6011286f0|6|SEV|Severity/Intensity|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|Pa|METACARPOPHALANGEAL JOINT 4|LEFT|Y||PROXY|3|Visit_3|40|4|FOLLOW-UP|2020-11-13|40
e|FA|f72002d8-262b-49da-84a4-42e6011286f0|7|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|nmol/kg/day|[?]|1|ohm|PENIS|LATERAL|Y||GUARDIAN|4|Visit_4|65|7|TREATMENT|2020-12-08|65
e|FA|f72002d8-262b-49da-84a4-42e6011286f0|8|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|titer|[?]|1|Log10 ELISA unit|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|RIGHT|||VENDOR|4|Visit_4|65|1|TREATMENT|2020-12-08|65
e|FA|f72002d8-262b-49da-84a4-42e6011286f0|9|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|mV*min|[?]|1|MBq|SKIN OF THE BENDING JOINT|RIGHT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|SCREENING|2021-01-02|90
e|FA|f72002d8-262b-49da-84a4-42e6011286f0|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|pt_us|[?]|1|QUANTITY SUFFICIENT|METACARPOPHALANGEAL JOINT 4|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-01-02|90
e|FA|68869dda-531d-4218-b2b0-4f5f46825569|1|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|FFU|[?]|1|g/day|TIBIALIS POSTERIOR MUSCLE|LEFT|||SPOUSE|1|Visit_1|10|3|TREATMENT|2020-12-08|10
e|FA|68869dda-531d-4218-b2b0-4f5f46825569|2|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mg/m2|[?]|1|oz eq|ILIAC VEIN|RIGHT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|2|TREATMENT|2020-12-08|10
e|FA|68869dda-531d-4218-b2b0-4f5f46825569|3|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|s/h|[?]|1|/200 HPFs|CARPOMETACARPAL JOINT 5|UNILATERAL|||CAREGIVER|2|Visit_2|25|4|SCREENING|2020-12-23|25
e|FA|68869dda-531d-4218-b2b0-4f5f46825569|4|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/min|[?]|1|in|MIDDLE PHALANX 2 OF THE HAND|LATERAL|||CHILD|2|Visit_2|25|5|WASHOUT|2020-12-23|25
e|FA|68869dda-531d-4218-b2b0-4f5f46825569|5|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|YEARS|[?]|1|Hz/s|EAR, INNER|IPSILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|1|TREATMENT|2021-01-07|40
e|FA|68869dda-531d-4218-b2b0-4f5f46825569|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|L/s/kPa|[?]|1|Pa|EAR|LEFT||Y|STUDY SUBJECT|3|Visit_3|40|1|TREATMENT|2021-01-07|40
e|FA|68869dda-531d-4218-b2b0-4f5f46825569|7|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|fmol|[?]|1|mL/dose|POPLITEAL VEIN|LATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2021-02-01|65
e|FA|68869dda-531d-4218-b2b0-4f5f46825569|8|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|Shock Wave|HIP|IPSILATERAL|||PROXY|4|Visit_4|65|2|TREATMENT|2021-02-01|65
e|FA|68869dda-531d-4218-b2b0-4f5f46825569|9|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|SYRINGE|[?]|1|10^9 CFU/mL|RETINAL NERVE FIBER LAYER|BILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2021-02-26|90
e|FA|68869dda-531d-4218-b2b0-4f5f46825569|10|LENRSCT|Length of Resection|[?]|GERD|[?]|TAMPON|[?]|1|psi|THYROID GLAND, RIGHT LOBE|IPSILATERAL||Y|PROXY|5|Visit_5|90|2|WASHOUT|2021-02-26|90
e|FA|68888445-1819-4f4c-bd0c-a445906476fb|1|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|MASK|[?]|1|mL/h|SKIN BETWEEN EYEBROWS|RIGHT|||CHILD|1|Visit_1|10|2|FOLLOW-UP|2021-01-14|10
e|FA|68888445-1819-4f4c-bd0c-a445906476fb|2|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|mL/cm|[?]|1|gtt|DISTAL PHALANX 5 OF THE HAND|RIGHT||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|FOLLOW-UP|2021-01-14|10
e|FA|68888445-1819-4f4c-bd0c-a445906476fb|3|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|dyn|[?]|1|gtt|RETROAURICULAR LYMPH NODE|RIGHT|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2021-01-29|25
e|FA|68888445-1819-4f4c-bd0c-a445906476fb|4|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|ng|[?]|1|mL/m2|VERTEBRA|IPSILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2021-01-29|25
e|FA|68888445-1819-4f4c-bd0c-a445906476fb|5|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|g/L|[?]|1|cm H2O|KNEE JOINT TENDONS|CONTRALATERAL||Y|STUDY SUBJECT|3|Visit_3|40|5|SCREENING|2021-02-13|40
e|FA|68888445-1819-4f4c-bd0c-a445906476fb|6|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|%/min|[?]|1|IU/mg|SALIVARY GLAND, SUBLINGUAL|IPSILATERAL|||ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2021-02-13|40
e|FA|68888445-1819-4f4c-bd0c-a445906476fb|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|Tbsp|[?]|1|U/mmol|C1 VERTEBRA|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-03-10|65
e|FA|68888445-1819-4f4c-bd0c-a445906476fb|8|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|mEq|ANTECUBITAL FOSSA|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|WASHOUT|2021-03-10|65
e|FA|68888445-1819-4f4c-bd0c-a445906476fb|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ECL unit|[?]|1|%(v/v)|TRAPEZOID-CAPITATE JOINT|BILATERAL||Y|PARENT|5|Visit_5|90|7|SCREENING|2021-04-04|90
e|FA|68888445-1819-4f4c-bd0c-a445906476fb|10|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|U/L|[?]|1|vp/dose|VOCAL CORD|LATERAL|Y||STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2021-04-04|90
e|FA|b2ce31a0-513a-449a-aa2c-7c9668fde275|1|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|g/kg|[?]|1|MBq|SMALL SAPHENOUS VEIN|LATERAL|Y|Y|INVESTIGATOR|1|Visit_1|10|2|SCREENING|2020-06-24|10
e|FA|b2ce31a0-513a-449a-aa2c-7c9668fde275|2|LESNUM|Number of Lesions|[?]|GERD|[?]|psi|[?]|1|ng/day|CORRUGATOR SUPERCILII MUSCLE|LEFT|Y||DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-06-24|10
e|FA|b2ce31a0-513a-449a-aa2c-7c9668fde275|3|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|MPS U|SKIN OF THE FOOT|LATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-07-09|25
e|FA|b2ce31a0-513a-449a-aa2c-7c9668fde275|4|OBJTYPE|Type of Object|[?]|GERD|[?]|lm|[?]|1|ng|ENDOCERVIX|BILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-07-09|25
e|FA|b2ce31a0-513a-449a-aa2c-7c9668fde275|5|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|ng/day|RIB 6|LEFT|||CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2020-07-24|40
e|FA|b2ce31a0-513a-449a-aa2c-7c9668fde275|6|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mL|[?]|1|umol|URACHAL TRACT|IPSILATERAL|||FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-07-24|40
e|FA|b2ce31a0-513a-449a-aa2c-7c9668fde275|7|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|/200 HPFs|MESENTERIC VEIN|LATERAL||Y|CAREGIVER|4|Visit_4|65|4|FOLLOW-UP|2020-08-18|65
e|FA|b2ce31a0-513a-449a-aa2c-7c9668fde275|8|SPEED|Speed|[?]|GERD|[?]|mL/cm3/min|[?]|1|mEq/g|MEDIASTINUM, MIDDLE|RIGHT|||INVESTIGATOR|4|Visit_4|65|4|WASHOUT|2020-08-18|65
e|FA|b2ce31a0-513a-449a-aa2c-7c9668fde275|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|/h|[?]|1|%(v/v)|LIGAMENT|UNILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|6|TREATMENT|2020-09-12|90
e|FA|b2ce31a0-513a-449a-aa2c-7c9668fde275|10|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|GPS U|[?]|1|ng/day|PRETRACHEAL LYMPH NODE|LATERAL|||INTERVIEWER|5|Visit_5|90|5|SCREENING|2020-09-12|90
e|FA|6c1d481b-985a-4be0-97ca-ecd06a81b456|1|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|um/s|[?]|1|10^9 CFU/mL|TRACHEOBRONCHIAL TREE|IPSILATERAL|||FRIEND|1|Visit_1|10|2|TREATMENT|2020-10-05|10
e|FA|6c1d481b-985a-4be0-97ca-ecd06a81b456|2|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/cm3/min|[?]|1|mIU/L|LYMPH NODE|CONTRALATERAL|Y||CHILD|1|Visit_1|10|2|TREATMENT|2020-10-05|10
e|FA|6c1d481b-985a-4be0-97ca-ecd06a81b456|3|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|pmol/10^9 cells|[?]|1|Shock Wave|FLEXOR HALLUCIS BREVIS MUSCLE|BILATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|WASHOUT|2020-10-20|25
e|FA|6c1d481b-985a-4be0-97ca-ecd06a81b456|4|CALBURN|Calories Burned|[?]|GERD|[?]|cL|[?]|1|/kg|CILIARY BODY|CONTRALATERAL|Y||VENDOR|2|Visit_2|25|7|TREATMENT|2020-10-20|25
e|FA|6c1d481b-985a-4be0-97ca-ecd06a81b456|5|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|/500 WBC|PERIURETHRAL REGION|IPSILATERAL|||SIBLING|3|Visit_3|40|7|SCREENING|2020-11-04|40
e|FA|6c1d481b-985a-4be0-97ca-ecd06a81b456|6|DFRUIT|Dietary Fruit|[?]|GERD|[?]|kg/m2|[?]|1|10^6 CFU/mL|RETROCRURAL LYMPH NODE|BILATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2020-11-04|40
e|FA|6c1d481b-985a-4be0-97ca-ecd06a81b456|7|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|FEU|[?]|1|AU/mL|HEART, VENTRICULAR WALL|BILATERAL|||FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2020-11-29|65
e|FA|6c1d481b-985a-4be0-97ca-ecd06a81b456|8|DMEAT|Dietary Meat|[?]|GERD|[?]|mEq/mL|[?]|1|10^6 organisms/mL|EYELID|UNILATERAL||Y|PARENT|4|Visit_4|65|2|WASHOUT|2020-11-29|65
e|FA|6c1d481b-985a-4be0-97ca-ecd06a81b456|9|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|SYRINGE|[?]|1|vp/dose|SCAPULA|CONTRALATERAL|||SIBLING|5|Visit_5|90|2|TREATMENT|2020-12-24|90
e|FA|6c1d481b-985a-4be0-97ca-ecd06a81b456|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|kDa|[?]|1|mg/g/min|MAMMARY GLAND|IPSILATERAL|Y||PARENT|5|Visit_5|90|1|TREATMENT|2020-12-24|90
e|FA|645a9247-efcb-4641-9514-58d6e28560e0|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|nmol/mL/min|[?]|1|%(v/v)|COLON, RIGHT|BILATERAL|||INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-12-21|10
e|FA|645a9247-efcb-4641-9514-58d6e28560e0|2|SEV|Severity/Intensity|[?]|GERD|[?]|pmol/dL|[?]|1|Pa|BILE DUCT|IPSILATERAL||Y|SIBLING|1|Visit_1|10|2|TREATMENT|2020-12-21|10
e|FA|645a9247-efcb-4641-9514-58d6e28560e0|3|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|umol/day|[?]|1|/500 WBC|THORACIC AORTA|IPSILATERAL|||PROXY|2|Visit_2|25|5|TREATMENT|2021-01-05|25
e|FA|645a9247-efcb-4641-9514-58d6e28560e0|4|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|fraction of 1|[?]|1|mL/min/mmHg|PANCREAS|RIGHT|||STUDY SUBJECT|2|Visit_2|25|7|WASHOUT|2021-01-05|25
e|FA|645a9247-efcb-4641-9514-58d6e28560e0|5|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|aMFI|LIVER, CAUDATE LOBE|BILATERAL|||ADJUDICATOR|3|Visit_3|40|4|WASHOUT|2021-01-20|40
e|FA|645a9247-efcb-4641-9514-58d6e28560e0|6|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|in|PARASPINAL REGION|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2021-01-20|40
e|FA|645a9247-efcb-4641-9514-58d6e28560e0|7|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa/L|[?]|1|cm|POSTERIOR INFERIOR CEREBELLAR ARTERY|CONTRALATERAL|||VENDOR|4|Visit_4|65|1|TREATMENT|2021-02-14|65
e|FA|645a9247-efcb-4641-9514-58d6e28560e0|8|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|MPS U|[?]|1|mm|INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2021-02-14|65
e|FA|645a9247-efcb-4641-9514-58d6e28560e0|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|10^6 organisms/mL|[?]|1|ug/g/h|RADIUS SHAFT|LEFT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|3|TREATMENT|2021-03-11|90
e|FA|645a9247-efcb-4641-9514-58d6e28560e0|10|DFIBER|Dietary Fiber|[?]|GERD|[?]|cg|[?]|1|h*%|FIBULA SHAFT|UNILATERAL||Y|PARENT|5|Visit_5|90|6|TREATMENT|2021-03-11|90
e|FA|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|1|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|aMFI|[?]|1|U/mg|PARASPINAL REGION|UNILATERAL|Y||STUDY SUBJECT|1|Visit_1|10|2|FOLLOW-UP|2020-09-15|10
e|FA|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|2|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|uV*sec|[?]|1|CUP|FLEXOR HALLUCIS LONGUS MUSCLE|CONTRALATERAL|||SIBLING|1|Visit_1|10|2|FOLLOW-UP|2020-09-15|10
e|FA|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|3|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|genEq|[?]|1|HOURS|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|CONTRALATERAL|Y||STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-09-30|25
e|FA|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|4|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|RFU|[?]|1|fmol|LOWER GASTROINTESTINAL TRACT LYMPH NODE|CONTRALATERAL|||INTERVIEWER|2|Visit_2|25|3|TREATMENT|2020-09-30|25
e|FA|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|HOURS|[?]|1|mg/g/min|VASTUS MEDIALIS MUSCLE|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|7|SCREENING|2020-10-15|40
e|FA|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|anti-Xa IU/mL|[?]|1|mg/g/min|INTERPHALANGEAL JOINT OF THE HAND|UNILATERAL||Y|SPOUSE|3|Visit_3|40|7|WASHOUT|2020-10-15|40
e|FA|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|7|SEV|Severity/Intensity|[?]|GERD|[?]|/100 HPFs|[?]|1|Pa|ISCHIUM|UNILATERAL|Y||INVESTIGATOR|4|Visit_4|65|6|FOLLOW-UP|2020-11-09|65
e|FA|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Ci/ug|[?]|1|mg/g/min|SKIN OF THE THIGH|UNILATERAL|||GUARDIAN|4|Visit_4|65|7|TREATMENT|2020-11-09|65
e|FA|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|pkat/L|[?]|1|mg/g/min|PERIURETERAL REGION|LATERAL|Y|Y|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2020-12-04|90
e|FA|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|10|SEV|Severity/Intensity|[?]|GERD|[?]|ng|[?]|1|Pa|CAROTID ARTERY|UNILATERAL||Y|FRIEND|5|Visit_5|90|4|TREATMENT|2020-12-04|90
e|FA|05b05951-b1ba-4c51-b50f-9c842532bc4e|1|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|IU/kg/h|[?]|1|uL/kg/day|LATERAL RAMUS INTERMEDIUS ARTERY|IPSILATERAL|||SPOUSE|1|Visit_1|10|5|FOLLOW-UP|2020-07-28|10
e|FA|05b05951-b1ba-4c51-b50f-9c842532bc4e|2|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|L/min/m2|[?]|1|IU/mmol|GENITAL TUBERCLE|CONTRALATERAL|Y||PARENT|1|Visit_1|10|5|SCREENING|2020-07-28|10
e|FA|05b05951-b1ba-4c51-b50f-9c842532bc4e|3|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mol/mol|[?]|1|Weber|LUNG, RIGHT UPPER LOBE|UNILATERAL|||FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-08-12|25
e|FA|05b05951-b1ba-4c51-b50f-9c842532bc4e|4|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|DISK|[?]|1|g/cage/day|POPLITEAL LYMPH NODE|UNILATERAL|Y||SIBLING|2|Visit_2|25|7|TREATMENT|2020-08-12|25
e|FA|05b05951-b1ba-4c51-b50f-9c842532bc4e|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|mg/g/min|WRIST JOINT|BILATERAL||Y|SPOUSE|3|Visit_3|40|3|SCREENING|2020-08-27|40
e|FA|05b05951-b1ba-4c51-b50f-9c842532bc4e|6|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|h*%|[?]|1|h*%|SKIN AROUND THE MOUTH|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2020-08-27|40
e|FA|05b05951-b1ba-4c51-b50f-9c842532bc4e|7|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|/500 WBC|EYE BULGE|RIGHT|||SIBLING|4|Visit_4|65|6|SCREENING|2020-09-21|65
e|FA|05b05951-b1ba-4c51-b50f-9c842532bc4e|8|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|oz|[?]|1|ug/g/h|RAPHE|BILATERAL|||FAMILY MEMBER|4|Visit_4|65|7|SCREENING|2020-09-21|65
e|FA|05b05951-b1ba-4c51-b50f-9c842532bc4e|9|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mol/mL|[?]|1|mAmp|SPLENIC VEIN|UNILATERAL|Y||GUARDIAN|5|Visit_5|90|2|FOLLOW-UP|2020-10-16|90
e|FA|05b05951-b1ba-4c51-b50f-9c842532bc4e|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Farad|[?]|1|Pa|URETHRA|UNILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2020-10-16|90
e|FA|ab38e976-8c2b-48ff-bdba-5a056637ecdd|1|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/mL|[?]|1|Gy/h|HAMSTRING MUSCLE|BILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-10-23|10
e|FA|ab38e976-8c2b-48ff-bdba-5a056637ecdd|2|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|tsp eq|[?]|1|ug/m2/h|LATERAL THIRD DIAGONAL BRANCH ARTERY|LEFT|||CAREGIVER|1|Visit_1|10|1|WASHOUT|2020-10-23|10
e|FA|ab38e976-8c2b-48ff-bdba-5a056637ecdd|3|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|umol/dL|[?]|1|L/h/m2|PERIHILAR LYMPH NODE|LEFT|||VENDOR|2|Visit_2|25|7|TREATMENT|2020-11-07|25
e|FA|ab38e976-8c2b-48ff-bdba-5a056637ecdd|4|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|fmol|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2020-11-07|25
e|FA|ab38e976-8c2b-48ff-bdba-5a056637ecdd|5|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|BE/mL|[?]|1|L/h/m2|MUCOSA|RIGHT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|TREATMENT|2020-11-22|40
e|FA|ab38e976-8c2b-48ff-bdba-5a056637ecdd|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|LOZENGE|[?]|1|mg/g/min|NIPPLE|IPSILATERAL|Y||FRIEND|3|Visit_3|40|2|FOLLOW-UP|2020-11-22|40
e|FA|ab38e976-8c2b-48ff-bdba-5a056637ecdd|7|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|MAC50|[?]|1|DROP|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|UNILATERAL|||GUARDIAN|4|Visit_4|65|1|WASHOUT|2020-12-17|65
e|FA|ab38e976-8c2b-48ff-bdba-5a056637ecdd|8|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|Hz|[?]|1|NEEDLE GAUGE|SUPRACLAVICULAR LYMPH NODE|RIGHT||Y|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-12-17|65
e|FA|ab38e976-8c2b-48ff-bdba-5a056637ecdd|9|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|EIA unit|THIRD RIGHT POSTEROLATERAL ARTERY|RIGHT|Y||CAREGIVER|5|Visit_5|90|3|FOLLOW-UP|2021-01-11|90
e|FA|ab38e976-8c2b-48ff-bdba-5a056637ecdd|10|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|fg|[?]|1|psi|TIBIOTARSAL JOINT|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|SCREENING|2021-01-11|90
e|FA|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|1|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mmol/min/kPa/L|[?]|1|Weber|EPIGASTRIC REGION|BILATERAL|Y||INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-08-31|10
e|FA|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|2|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|mEq/dL|[?]|1|mmHg/L/min|INTERPHALANGEAL JOINT 2 OF THE FOOT|RIGHT|||SIBLING|1|Visit_1|10|7|WASHOUT|2020-08-31|10
e|FA|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|3|CALBURN|Calories Burned|[?]|GERD|[?]|cy/cm|[?]|1|/kg|ABDOMINAL LYMPH NODE|LATERAL||Y|PROXY|2|Visit_2|25|3|SCREENING|2020-09-15|25
e|FA|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|m/sec|[?]|1|Pa|URACHAL TRACT|CONTRALATERAL|||STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-09-15|25
e|FA|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|5|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|ft|[?]|1|100 IU/mL|SKIN OF THE THIGH|RIGHT|||INTERVIEWER|3|Visit_3|40|1|WASHOUT|2020-09-30|40
e|FA|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|6|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|GPS U|[?]|1|IU/mg|RADIUS SHAFT|LEFT|||STUDY SUBJECT|3|Visit_3|40|5|WASHOUT|2020-09-30|40
e|FA|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|7|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa/L|[?]|1|Shock Wave|TRAPEZIUM-TRAPEZOID JOINT|UNILATERAL||Y|GUARDIAN|4|Visit_4|65|7|TREATMENT|2020-10-25|65
e|FA|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|8|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|mL/kg/day|[?]|1|uL/kg/day|SUPRARENAL AORTA|IPSILATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|7|WASHOUT|2020-10-25|65
e|FA|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|9|DFRUIT|Dietary Fruit|[?]|GERD|[?]|mEq/g|[?]|1|10^6 CFU/mL|L5-S1 INTERVERTEBRAL SPACE|IPSILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2020-11-19|90
e|FA|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|10|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|SQU/mL|[?]|1|Shock Wave|HEART, RIGHT VENTRICULAR FREE WALL|LATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2020-11-19|90
e|FA|51a49847-6405-4842-b549-0e2ab99f61b2|1|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|BU|[?]|1|cmH2O/mL|SUPERIOR SAGITTAL SINUS|RIGHT|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2021-01-16|10
e|FA|51a49847-6405-4842-b549-0e2ab99f61b2|2|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|cmH2O/mL|[?]|1|BOWL|SUPRAGLOTTIS|LEFT|||PARENT|1|Visit_1|10|1|TREATMENT|2021-01-16|10
e|FA|51a49847-6405-4842-b549-0e2ab99f61b2|3|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|fL|[?]|1|mEq/g|RADIUS|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|2|TREATMENT|2021-01-31|25
e|FA|51a49847-6405-4842-b549-0e2ab99f61b2|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|%/s|[?]|1|mL/dose|CALF MUSCULAR VEIN|UNILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2021-01-31|25
e|FA|51a49847-6405-4842-b549-0e2ab99f61b2|5|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|pmol/dL|[?]|1|cmH2O/mL|TRIANGULAR BONE|LEFT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|FOLLOW-UP|2021-02-15|40
e|FA|51a49847-6405-4842-b549-0e2ab99f61b2|6|AGETRT1|Age At First Treatment|[?]|GERD|[?]|msec|[?]|1|mL/mmHg/min/L|CEREBRAL VEIN|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2021-02-15|40
e|FA|51a49847-6405-4842-b549-0e2ab99f61b2|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|CCID 50/mL|[?]|1|U/mg|SUPRACLAVICULAR LYMPH NODE|LEFT|||SIBLING|4|Visit_4|65|6|TREATMENT|2021-03-12|65
e|FA|51a49847-6405-4842-b549-0e2ab99f61b2|8|DGRAIN|Dietary Grain|[?]|GERD|[?]|sec|[?]|1|10^9 CFU/g|EYE, ANTERIOR CHAMBER|CONTRALATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2021-03-12|65
e|FA|51a49847-6405-4842-b549-0e2ab99f61b2|9|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|PFU|[?]|1|mIU/L|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|6|FOLLOW-UP|2021-04-06|90
e|FA|51a49847-6405-4842-b549-0e2ab99f61b2|10|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|mEq/uL|[?]|1|cm H2O|OCULOMOTOR NERVE|RIGHT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2021-04-06|90
e|FA|44dcfb9a-c590-4826-a28c-b5e9f83129d5|1|OBJNUM|Number of Objects|[?]|GERD|[?]|CAN|[?]|1|mL/100g/min|ABDOMINAL REGION|LATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2020-05-21|10
e|FA|44dcfb9a-c590-4826-a28c-b5e9f83129d5|2|DMEAT|Dietary Meat|[?]|GERD|[?]|mol/L|[?]|1|10^6 organisms/mL|HILAR LYMPH NODE|UNILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-05-21|10
e|FA|44dcfb9a-c590-4826-a28c-b5e9f83129d5|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|/h|[?]|1|Pa|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|WASHOUT|2020-06-05|25
e|FA|44dcfb9a-c590-4826-a28c-b5e9f83129d5|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|breaths/30s|[?]|1|%(v/v)|MEDIAN BASILIC VEIN|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-06-05|25
e|FA|44dcfb9a-c590-4826-a28c-b5e9f83129d5|5|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|ug/dL|[?]|1|mg/dose|TUNICA INTIMA|LEFT|||INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-06-20|40
e|FA|44dcfb9a-c590-4826-a28c-b5e9f83129d5|6|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|psi|[?]|1|10^4 CFU/mL|LUNG, LEFT|LATERAL|||SPOUSE|3|Visit_3|40|2|SCREENING|2020-06-20|40
e|FA|44dcfb9a-c590-4826-a28c-b5e9f83129d5|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|gMFI|[?]|1|umol|TONSIL|IPSILATERAL|||STUDY SUBJECT|4|Visit_4|65|7|SCREENING|2020-07-15|65
e|FA|44dcfb9a-c590-4826-a28c-b5e9f83129d5|8|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|OI50|[?]|1|Coulomb|FIBULAR VEIN|RIGHT||Y|INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-07-15|65
e|FA|44dcfb9a-c590-4826-a28c-b5e9f83129d5|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|eq|[?]|1|%(v/v)|CERVICAL LYMPH NODE|LATERAL|Y||INVESTIGATOR|5|Visit_5|90|1|FOLLOW-UP|2020-08-09|90
e|FA|44dcfb9a-c590-4826-a28c-b5e9f83129d5|10|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|cs|[?]|1|umol|PELVIC LYMPH NODE|IPSILATERAL||Y|SPOUSE|5|Visit_5|90|3|FOLLOW-UP|2020-08-09|90
e|FA|98166d74-caa7-4693-a817-b2cbae947ff8|1|LESNUM|Number of Lesions|[?]|GERD|[?]|ka_u/dL|[?]|1|ng/day|NOSE|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|5|WASHOUT|2021-01-11|10
e|FA|98166d74-caa7-4693-a817-b2cbae947ff8|2|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|days/wk|[?]|1|10^9 CFU/g|SOFT PALATE|LATERAL||Y|FAMILY MEMBER|1|Visit_1|10|6|SCREENING|2021-01-11|10
e|FA|98166d74-caa7-4693-a817-b2cbae947ff8|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mol/L|[?]|1|mg/g/min|BODY OF STOMACH|LEFT||Y|SPOUSE|2|Visit_2|25|3|SCREENING|2021-01-26|25
e|FA|98166d74-caa7-4693-a817-b2cbae947ff8|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|MBq/uL|[?]|1|ug/g/h|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2021-01-26|25
e|FA|98166d74-caa7-4693-a817-b2cbae947ff8|5|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|Arbitrary U|[?]|1|DROP|RADIUS-LUNATE JOINT|IPSILATERAL|Y||ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2021-02-10|40
e|FA|98166d74-caa7-4693-a817-b2cbae947ff8|6|OBJNUM|Number of Objects|[?]|GERD|[?]|ms2|[?]|1|mL/100g/min|LEFT CIRCUMFLEX ARTERY OSTIUM|LEFT||Y|CHILD|3|Visit_3|40|5|FOLLOW-UP|2021-02-10|40
e|FA|98166d74-caa7-4693-a817-b2cbae947ff8|7|SPEED|Speed|[?]|GERD|[?]|pt_br|[?]|1|mEq/g|CLITORIS|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|WASHOUT|2021-03-07|65
e|FA|98166d74-caa7-4693-a817-b2cbae947ff8|8|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|U/m2/day|[?]|1|cm H2O|INTERPHALANGEAL JOINT 4 OF THE FOOT|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2021-03-07|65
e|FA|98166d74-caa7-4693-a817-b2cbae947ff8|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|mg/g/min|INTERNAL MAMMARY ARTERY|BILATERAL||Y|SIBLING|5|Visit_5|90|5|TREATMENT|2021-04-01|90
e|FA|98166d74-caa7-4693-a817-b2cbae947ff8|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|%/min|[?]|1|U/mmol|AXILLARY ARTERY|UNILATERAL|||PROXY|5|Visit_5|90|5|SCREENING|2021-04-01|90
e|FA|cb07675a-2042-44da-a1f9-8b7783347e88|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Osm|[?]|1|Pa|ULNAR NERVE|RIGHT|||CHILD|1|Visit_1|10|2|TREATMENT|2020-12-05|10
e|FA|cb07675a-2042-44da-a1f9-8b7783347e88|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/sec/1.73m2|[?]|1|%(v/v)|PALM|RIGHT|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|6|WASHOUT|2020-12-05|10
e|FA|cb07675a-2042-44da-a1f9-8b7783347e88|3|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|yd|[?]|1|TRANSDUCING UNIT/mL|DISTAL PHALANX 5 OF THE HAND|UNILATERAL|||INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-12-20|25
e|FA|cb07675a-2042-44da-a1f9-8b7783347e88|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|pmol/10^9 cells|[?]|1|10^6 IU/mL|WRIST JOINT EXTENSOR MUSCLES|LEFT|Y|Y|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-12-20|25
e|FA|cb07675a-2042-44da-a1f9-8b7783347e88|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mEq/dL|[?]|1|Pa|GASTROCNEMIUS MUSCLE, LATERAL HEAD|UNILATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|2|FOLLOW-UP|2021-01-04|40
e|FA|cb07675a-2042-44da-a1f9-8b7783347e88|6|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|Antibody Unit|[?]|1|mL/min/mmHg|PERITONEUM|CONTRALATERAL|Y|Y|INVESTIGATOR|3|Visit_3|40|4|WASHOUT|2021-01-04|40
e|FA|cb07675a-2042-44da-a1f9-8b7783347e88|7|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|IMPLANT|[?]|1|mL/h|SEBACEOUS GLAND|IPSILATERAL|Y|Y|INDEPENDENT ASSESSOR|4|Visit_4|65|4|WASHOUT|2021-01-29|65
e|FA|cb07675a-2042-44da-a1f9-8b7783347e88|8|ACNDEV|Action Taken With Device|[?]|GERD|[?]|cd|[?]|1|100 IU/mL|FOOT DIGIT 2|IPSILATERAL|||FAMILY MEMBER|4|Visit_4|65|1|FOLLOW-UP|2021-01-29|65
e|FA|cb07675a-2042-44da-a1f9-8b7783347e88|9|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|s/h|[?]|1|uL/kg/day|HEART, RIGHT ATRIAL APPENDAGE|RIGHT|||INTERVIEWER|5|Visit_5|90|7|WASHOUT|2021-02-23|90
e|FA|cb07675a-2042-44da-a1f9-8b7783347e88|10|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|g/day|[?]|1|ng|POSTERIOR TIBIAL ARTERY|CONTRALATERAL|||INTERVIEWER|5|Visit_5|90|7|SCREENING|2021-02-23|90
e|FA|a8a14aa1-4484-4bbc-86bf-c44257146a26|1|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|mU/g|[?]|1|mg/dose|GASTROESOPHAGEAL JUNCTION|LATERAL|Y|Y|ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-07-01|10
e|FA|a8a14aa1-4484-4bbc-86bf-c44257146a26|2|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|IU/mmol|CLAVICLE|UNILATERAL||Y|FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2020-07-01|10
e|FA|a8a14aa1-4484-4bbc-86bf-c44257146a26|3|PPTFCT|Precipitating Factor|[?]|GERD|[?]|vp/mL|[?]|1|EIA unit|FLEXOR DIGITORUM PROFUNDUS MUSCLE|LATERAL|Y|Y|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-07-16|25
e|FA|a8a14aa1-4484-4bbc-86bf-c44257146a26|4|LESNUM|Number of Lesions|[?]|GERD|[?]|GBq|[?]|1|ng/day|MALLEUS|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|5|SCREENING|2020-07-16|25
e|FA|a8a14aa1-4484-4bbc-86bf-c44257146a26|5|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|Joule|[?]|1|EIA unit|EAR, INNER|UNILATERAL|||CAREGIVER|3|Visit_3|40|7|FOLLOW-UP|2020-07-31|40
e|FA|a8a14aa1-4484-4bbc-86bf-c44257146a26|6|LDIAM|Longest Diameter|[?]|GERD|[?]|uIU/dL|[?]|1|Shock Wave|BRAIN|LATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-07-31|40
e|FA|a8a14aa1-4484-4bbc-86bf-c44257146a26|7|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|VIAL|[?]|1|Shock Wave|MITRAL VALVE, ANTERIOR ANNULUS|RIGHT||Y|PARENT|4|Visit_4|65|6|WASHOUT|2020-08-25|65
e|FA|a8a14aa1-4484-4bbc-86bf-c44257146a26|8|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|fmol/g|[?]|1|m2|EYE, ANTERIOR CHAMBER|LATERAL|||ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2020-08-25|65
e|FA|a8a14aa1-4484-4bbc-86bf-c44257146a26|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|%(v/v)|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|||PARENT|5|Visit_5|90|6|FOLLOW-UP|2020-09-19|90
e|FA|a8a14aa1-4484-4bbc-86bf-c44257146a26|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|PHERESIS UNIT|[?]|1|10^6 U|INTERPHALANGEAL JOINT 3|UNILATERAL|||FRIEND|5|Visit_5|90|4|SCREENING|2020-09-19|90
e|FA|dfa4c661-9317-4bec-b307-a31eeadcaba6|1|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|BP|[?]|1|ug/g/h|KIDNEY, MEDULLA|RIGHT|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|1|TREATMENT|2020-06-04|10
e|FA|dfa4c661-9317-4bec-b307-a31eeadcaba6|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|genEq|[?]|1|mg/g/min|SEBACEOUS GLAND|CONTRALATERAL||Y|SPOUSE|1|Visit_1|10|3|TREATMENT|2020-06-04|10
e|FA|dfa4c661-9317-4bec-b307-a31eeadcaba6|3|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|POUCH|[?]|1|PFU/dose|METACARPAL BONE 5|RIGHT|Y||CHILD|2|Visit_2|25|1|SCREENING|2020-06-19|25
e|FA|dfa4c661-9317-4bec-b307-a31eeadcaba6|4|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|IU/mmol|[?]|1|m2|VERTEBRAL ARTERY|CONTRALATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|SCREENING|2020-06-19|25
e|FA|dfa4c661-9317-4bec-b307-a31eeadcaba6|5|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|PACKAGE|[?]|1|Log10 ELISA unit|SUBARACHNOID SPACE|BILATERAL||Y|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2020-07-04|40
e|FA|dfa4c661-9317-4bec-b307-a31eeadcaba6|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|100 IU/mL|[?]|1|ug/g/h|LIVER|LATERAL|Y|Y|STUDY SUBJECT|3|Visit_3|40|1|WASHOUT|2020-07-04|40
e|FA|dfa4c661-9317-4bec-b307-a31eeadcaba6|7|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|10^7 CFU/mL|[?]|1|mm/h|ABDOMINAL WALL|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|WASHOUT|2020-07-29|65
e|FA|dfa4c661-9317-4bec-b307-a31eeadcaba6|8|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|/500 WBC|ABDOMINAL SKIN|LEFT|||SIBLING|4|Visit_4|65|5|TREATMENT|2020-07-29|65
e|FA|dfa4c661-9317-4bec-b307-a31eeadcaba6|9|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|mL/mmHg/min/L|MOTOR CORTEX|LATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2020-08-23|90
e|FA|dfa4c661-9317-4bec-b307-a31eeadcaba6|10|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|Enzyme U|[?]|1|EIA unit|CERVICAL SPINE|UNILATERAL|Y|Y|GUARDIAN|5|Visit_5|90|2|SCREENING|2020-08-23|90
e|FA|9ed984a9-c153-4729-9dc9-3bb3d9059919|1|PPTFCT|Precipitating Factor|[?]|GERD|[?]|mL/cm|[?]|1|EIA unit|INGUINAL REGION|RIGHT|||CHILD|1|Visit_1|10|3|FOLLOW-UP|2020-09-01|10
e|FA|9ed984a9-c153-4729-9dc9-3bb3d9059919|2|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|umol/L/min|[?]|1|fmol|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|CONTRALATERAL|||DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-09-01|10
e|FA|9ed984a9-c153-4729-9dc9-3bb3d9059919|3|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|U/g Hb|[?]|1|anti-Xa IU/mL|ILIUM|BILATERAL|Y||STUDY SUBJECT|2|Visit_2|25|5|WASHOUT|2020-09-16|25
e|FA|9ed984a9-c153-4729-9dc9-3bb3d9059919|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|PIXELS/in|[?]|1|10^6 IU/mL|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|BILATERAL|||VENDOR|2|Visit_2|25|2|TREATMENT|2020-09-16|25
e|FA|9ed984a9-c153-4729-9dc9-3bb3d9059919|5|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|FEU|[?]|1|U/10^12 RBC|BASILIC VEIN|RIGHT||Y|GUARDIAN|3|Visit_3|40|2|WASHOUT|2020-10-01|40
e|FA|9ed984a9-c153-4729-9dc9-3bb3d9059919|6|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|APS U|[?]|1|mL/mmHg/min/L|5TH LUMBAR SPINOUS PROCESS|UNILATERAL||Y|SIGNIFICANT OTHER|3|Visit_3|40|5|TREATMENT|2020-10-01|40
e|FA|9ed984a9-c153-4729-9dc9-3bb3d9059919|7|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|kHz|[?]|1|Shock Wave|MUSCULOSKELETAL SYSTEM|CONTRALATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-10-26|65
e|FA|9ed984a9-c153-4729-9dc9-3bb3d9059919|8|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|mL/kg/h|[?]|1|mL/dose|PROXIMAL INTERPHALANGEAL JOINT 5|LEFT||Y|PROXY|4|Visit_4|65|7|SCREENING|2020-10-26|65
e|FA|9ed984a9-c153-4729-9dc9-3bb3d9059919|9|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|mL/m2|SKIN OF THE HAND|LATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2020-11-20|90
e|FA|9ed984a9-c153-4729-9dc9-3bb3d9059919|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|scm|[?]|1|10^6 U|POSTERIOR CERVICAL LYMPH NODE|UNILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-11-20|90
e|FA|fb234b67-3c81-4d55-bc63-2389a23d67b2|1|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|/sec|[?]|1|/500 WBC|PREFRONTAL CORTEX|LEFT|||INTERVIEWER|1|Visit_1|10|6|TREATMENT|2021-01-11|10
e|FA|fb234b67-3c81-4d55-bc63-2389a23d67b2|2|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|nmol/L/h|[?]|1|BP|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|RIGHT|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|WASHOUT|2021-01-11|10
e|FA|fb234b67-3c81-4d55-bc63-2389a23d67b2|3|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|10^7 TCID 50/dose|[?]|1|anti-Xa IU/mL|SCIATIC NERVE|BILATERAL||Y|PARENT|2|Visit_2|25|5|FOLLOW-UP|2021-01-26|25
e|FA|fb234b67-3c81-4d55-bc63-2389a23d67b2|4|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|POINT|[?]|1|DROP|SKIN OF THE UPPER LIMB|RIGHT|||SPOUSE|2|Visit_2|25|7|TREATMENT|2021-01-26|25
e|FA|fb234b67-3c81-4d55-bc63-2389a23d67b2|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|mL/(min*100mL)|[?]|1|ug/g/h|BLADDER, NECK|LATERAL|Y||PARENT|3|Visit_3|40|7|TREATMENT|2021-02-10|40
e|FA|fb234b67-3c81-4d55-bc63-2389a23d67b2|6|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|km|[?]|1|Bq/mg|RETINAL NERVE FIBER LAYER|IPSILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|4|WASHOUT|2021-02-10|40
e|FA|fb234b67-3c81-4d55-bc63-2389a23d67b2|7|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|mEq/g|SPLEEN|IPSILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|WASHOUT|2021-03-07|65
e|FA|fb234b67-3c81-4d55-bc63-2389a23d67b2|8|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mmHg*min/L|[?]|1|Weber|FEMORAL VEIN|BILATERAL||Y|PARENT|4|Visit_4|65|4|FOLLOW-UP|2021-03-07|65
e|FA|fb234b67-3c81-4d55-bc63-2389a23d67b2|9|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|USP U|[?]|1|g/cage/day|EPITROCHLEAR LYMPH NODE|LATERAL|||STUDY SUBJECT|5|Visit_5|90|7|WASHOUT|2021-04-01|90
e|FA|fb234b67-3c81-4d55-bc63-2389a23d67b2|10|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|L|[?]|1|Gy/h|T9 VERTEBRA|RIGHT|||STUDY SUBJECT|5|Visit_5|90|6|SCREENING|2021-04-01|90
e|FA|84d7ff44-cbe2-446f-b667-5bc539de519b|1|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|g/m2/day|[?]|1|BP|THORAX|RIGHT|||INDEPENDENT ASSESSOR|1|Visit_1|10|5|FOLLOW-UP|2020-07-06|10
e|FA|84d7ff44-cbe2-446f-b667-5bc539de519b|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ks|[?]|1|Pa|VAGINA|LEFT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|WASHOUT|2020-07-06|10
e|FA|84d7ff44-cbe2-446f-b667-5bc539de519b|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|g/g/day|[?]|1|%(v/v)|HYPOTHALAMUS|UNILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-07-21|25
e|FA|84d7ff44-cbe2-446f-b667-5bc539de519b|4|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|ELISA unit/dose|[?]|1|mL/h|SOLEUS MUSCLE|RIGHT|Y||SPOUSE|2|Visit_2|25|4|TREATMENT|2020-07-21|25
e|FA|84d7ff44-cbe2-446f-b667-5bc539de519b|5|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|uL/kg/day|SKIN OF THE FINGER|CONTRALATERAL||Y|VENDOR|3|Visit_3|40|6|TREATMENT|2020-08-05|40
e|FA|84d7ff44-cbe2-446f-b667-5bc539de519b|6|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/mL|[?]|1|/200 HPFs|HYPOTHALAMUS|LEFT|||DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-08-05|40
e|FA|84d7ff44-cbe2-446f-b667-5bc539de519b|7|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|v/v|[?]|1|mg/dose|BICEPS BRACHII MUSCLE|BILATERAL|Y||CAREGIVER|4|Visit_4|65|6|TREATMENT|2020-08-30|65
e|FA|84d7ff44-cbe2-446f-b667-5bc539de519b|8|SEV|Severity/Intensity|[?]|GERD|[?]|mL/cage/day|[?]|1|Pa|FEMORAL NECK|RIGHT||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|SCREENING|2020-08-30|65
e|FA|84d7ff44-cbe2-446f-b667-5bc539de519b|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|CIGAR|[?]|1|mg/g/min|MAMMARY GLAND|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-09-24|90
e|FA|84d7ff44-cbe2-446f-b667-5bc539de519b|10|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|mg/m2|[?]|1|psi|GALLBLADDER|LEFT|Y|Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2020-09-24|90
e|FA|c96e4485-4aff-4c18-9c65-5f1a800cc6db|1|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|s^-1(%O2)^-1|[?]|1|mL/m2|OCCIPITAL LYMPH NODE|IPSILATERAL|||SPOUSE|1|Visit_1|10|4|WASHOUT|2020-09-24|10
e|FA|c96e4485-4aff-4c18-9c65-5f1a800cc6db|2|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|ppm|[?]|1|mIU/L|FIBULAR VEIN|RIGHT|||SIBLING|1|Visit_1|10|3|FOLLOW-UP|2020-09-24|10
e|FA|c96e4485-4aff-4c18-9c65-5f1a800cc6db|3|STRCTNUM|Number of Strictures|[?]|GERD|[?]|fmol/L|[?]|1|SACHET|LIP, UPPER|IPSILATERAL|Y|Y|ADJUDICATION COMMITTEE|2|Visit_2|25|2|FOLLOW-UP|2020-10-09|25
e|FA|c96e4485-4aff-4c18-9c65-5f1a800cc6db|4|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|Farad|[?]|1|cmH2O/mL|THYMUS GLAND|LEFT|Y|Y|INDEPENDENT ASSESSOR|2|Visit_2|25|1|TREATMENT|2020-10-09|25
e|FA|c96e4485-4aff-4c18-9c65-5f1a800cc6db|5|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|tsp|[?]|1|fmol|SEMITENDINOSUS MUSCLE|BILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|4|SCREENING|2020-10-24|40
e|FA|c96e4485-4aff-4c18-9c65-5f1a800cc6db|6|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|cm2|[?]|1|Shock Wave|MUCOSA|RIGHT|||PARENT|3|Visit_3|40|3|WASHOUT|2020-10-24|40
e|FA|c96e4485-4aff-4c18-9c65-5f1a800cc6db|7|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|mU/L|[?]|1|m2|ISCHIAL TUBEROSITY|UNILATERAL|Y||CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-11-18|65
e|FA|c96e4485-4aff-4c18-9c65-5f1a800cc6db|8|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|umol/min|[?]|1|DROP|APPENDICULAR SKELETON|CONTRALATERAL|||VENDOR|4|Visit_4|65|1|TREATMENT|2020-11-18|65
e|FA|c96e4485-4aff-4c18-9c65-5f1a800cc6db|9|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|g/animal|[?]|1|L/h/m2|SINUS|LEFT|Y||INTERVIEWER|5|Visit_5|90|6|WASHOUT|2020-12-13|90
e|FA|c96e4485-4aff-4c18-9c65-5f1a800cc6db|10|DISTANCE|Distance|[?]|GERD|[?]|Coulomb|[?]|1|BOWL|INTERPHALANGEAL JOINT OF THE HAND|CONTRALATERAL|||INTERVIEWER|5|Visit_5|90|7|TREATMENT|2020-12-13|90
e|FA|955188f1-b434-40ab-94c8-0c0fb7f23e84|1|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mL/kg/day|[?]|1|PFU/dose|MEDIASTINUM|CONTRALATERAL|Y|Y|FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-12-14|10
e|FA|955188f1-b434-40ab-94c8-0c0fb7f23e84|2|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|days/wk|[?]|1|mm/h|DURAL VENOUS SINUS|RIGHT|Y||INTERVIEWER|1|Visit_1|10|2|WASHOUT|2020-12-14|10
e|FA|955188f1-b434-40ab-94c8-0c0fb7f23e84|3|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|CCID 50/mL|[?]|1|mL/animal/day|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|CONTRALATERAL|||FRIEND|2|Visit_2|25|4|FOLLOW-UP|2020-12-29|25
e|FA|955188f1-b434-40ab-94c8-0c0fb7f23e84|4|DVEG|Dietary Vegetable|[?]|GERD|[?]|amu|[?]|1|Ci/ug|SKIN BETWEEN EYEBROWS|BILATERAL|||SPOUSE|2|Visit_2|25|2|TREATMENT|2020-12-29|25
e|FA|955188f1-b434-40ab-94c8-0c0fb7f23e84|5|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|kg/cm|[?]|1|g/L|RADIAL NERVE|LEFT||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|5|SCREENING|2021-01-13|40
e|FA|955188f1-b434-40ab-94c8-0c0fb7f23e84|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|nkat/L|[?]|1|Pa|CINGULATE CORTEX|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2021-01-13|40
e|FA|955188f1-b434-40ab-94c8-0c0fb7f23e84|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ft3|[?]|1|Pa|RIB 12|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|SCREENING|2021-02-07|65
e|FA|955188f1-b434-40ab-94c8-0c0fb7f23e84|8|EVENTNUM|Number of Events|[?]|GERD|[?]|Ci/kg|[?]|1|U/10^12 RBC|IRIS|BILATERAL|||CHILD|4|Visit_4|65|7|TREATMENT|2021-02-07|65
e|FA|955188f1-b434-40ab-94c8-0c0fb7f23e84|9|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|nmol/g|[?]|1|Coulomb|PALATINE BONE|IPSILATERAL|||SIBLING|5|Visit_5|90|2|TREATMENT|2021-03-04|90
e|FA|955188f1-b434-40ab-94c8-0c0fb7f23e84|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|KIT|[?]|1|mg/g/min|FACIAL BONE|UNILATERAL|Y||STUDY SUBJECT|5|Visit_5|90|6|SCREENING|2021-03-04|90
e|FA|5a384b5e-954c-4af9-bd60-96aadc72ca44|1|SPEED|Speed|[?]|GERD|[?]|in2|[?]|1|mEq/g|WRIST JOINT EXTENSOR TENDONS|BILATERAL|||INVESTIGATOR|1|Visit_1|10|6|SCREENING|2020-10-09|10
e|FA|5a384b5e-954c-4af9-bd60-96aadc72ca44|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|JAR|[?]|1|g/day|POPLITEAL ARTERY BELOW KNEE|RIGHT|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-10-09|10
e|FA|5a384b5e-954c-4af9-bd60-96aadc72ca44|3|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|Sv|[?]|1|PACK|FOOT DIGIT 1|UNILATERAL|||FRIEND|2|Visit_2|25|3|WASHOUT|2020-10-24|25
e|FA|5a384b5e-954c-4af9-bd60-96aadc72ca44|4|EXCDUR|Exercise Duration|[?]|GERD|[?]|U/g/h|[?]|1|mm|RETROPERITONEAL LYMPH NODE|UNILATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-10-24|25
e|FA|5a384b5e-954c-4af9-bd60-96aadc72ca44|5|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|mU/L|[?]|1|/200 HPFs|SUBARACHNOID SPACE|LATERAL|||CAREGIVER|3|Visit_3|40|4|FOLLOW-UP|2020-11-08|40
e|FA|5a384b5e-954c-4af9-bd60-96aadc72ca44|6|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|ohm|SEMINAL VESICLE|LATERAL|Y|Y|DOMESTIC PARTNER|3|Visit_3|40|1|FOLLOW-UP|2020-11-08|40
e|FA|5a384b5e-954c-4af9-bd60-96aadc72ca44|7|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|m/sec|[?]|1|umol|LEPTOMENINGES|RIGHT|||INTERVIEWER|4|Visit_4|65|2|WASHOUT|2020-12-03|65
e|FA|5a384b5e-954c-4af9-bd60-96aadc72ca44|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|C|[?]|1|%(v/v)|LOWER RESPIRATORY SYSTEM|RIGHT||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-12-03|65
e|FA|5a384b5e-954c-4af9-bd60-96aadc72ca44|9|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|kg/m2|[?]|1|cmH2O/mL|PORTAL VEIN|CONTRALATERAL|||PROXY|5|Visit_5|90|1|TREATMENT|2020-12-28|90
e|FA|5a384b5e-954c-4af9-bd60-96aadc72ca44|10|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|U/kg|[?]|1|BP|INFERIOR VENA CAVA|UNILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|2|TREATMENT|2020-12-28|90
e|FA|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|1|LESNUM|Number of Lesions|[?]|GERD|[?]|tsp|[?]|1|ng/day|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|BILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-07-02|10
e|FA|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|2|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|DRINK|[?]|1|MPS U|TRUNK|RIGHT|||DOMESTIC PARTNER|1|Visit_1|10|1|TREATMENT|2020-07-02|10
e|FA|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|3|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|h*%|[?]|1|BOWL|RIB 5|RIGHT|Y||SPOUSE|2|Visit_2|25|7|SCREENING|2020-07-17|25
e|FA|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|4|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|EIA unit|MEDIASTINUM, MIDDLE|LEFT|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-07-17|25
e|FA|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|usec|[?]|1|mg/g/min|GLENOID FOSSA|LEFT|||GUARDIAN|3|Visit_3|40|2|SCREENING|2020-08-01|40
e|FA|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|6|SEV|Severity/Intensity|[?]|GERD|[?]|ug/h|[?]|1|Pa|SKIN OF THE FOOT|RIGHT|Y|Y|VENDOR|3|Visit_3|40|7|TREATMENT|2020-08-01|40
e|FA|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|7|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|mL/min/mmHg|[?]|1|10^6 IU/mL|ESOPHAGUS, UPPER THIRD|UNILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|1|FOLLOW-UP|2020-08-26|65
e|FA|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|Henry|[?]|1|CUP|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|UNILATERAL|||CHILD|4|Visit_4|65|3|TREATMENT|2020-08-26|65
e|FA|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|9|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|U/kg/day|[?]|1|10^4 CFU/mL|SKIN OF THE INFRASCAPULAR REGION|LATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-09-20|90
e|FA|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|10|EVENTFRQ|Event Frequency|[?]|GERD|[?]|Log10 ELISA unit|[?]|1|ug/kg/h|LEFT MAIN CORONARY ARTERY BIFURCATION|UNILATERAL|||CHILD|5|Visit_5|90|4|FOLLOW-UP|2020-09-20|90
e|FA|f9432d72-f7d7-4cdf-a173-2e2029258474|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|mL/sec/1.73m2|[?]|1|mL/animal/day|URETER|LATERAL|||CHILD|1|Visit_1|10|4|FOLLOW-UP|2020-11-20|10
e|FA|f9432d72-f7d7-4cdf-a173-2e2029258474|2|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|Hz/s|[?]|1|EIA unit|SPINAL ACCESSORY NERVE|LEFT|||SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-11-20|10
e|FA|f9432d72-f7d7-4cdf-a173-2e2029258474|3|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|PIXELS/cm|[?]|1|mL/dose|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LATERAL|||PROXY|2|Visit_2|25|1|TREATMENT|2020-12-05|25
e|FA|f9432d72-f7d7-4cdf-a173-2e2029258474|4|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa/L|[?]|1|in|SKULL|LEFT|Y||STUDY SUBJECT|2|Visit_2|25|3|FOLLOW-UP|2020-12-05|25
e|FA|f9432d72-f7d7-4cdf-a173-2e2029258474|5|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|/500 WBC|[?]|1|mL/cm3/min|EYE, ANTERIOR CHAMBER|LATERAL|||FAMILY MEMBER|3|Visit_3|40|4|WASHOUT|2020-12-20|40
e|FA|f9432d72-f7d7-4cdf-a173-2e2029258474|6|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|PLUG|[?]|1|10^6 U|SCIATIC NERVE|BILATERAL|Y||PARENT|3|Visit_3|40|3|SCREENING|2020-12-20|40
e|FA|f9432d72-f7d7-4cdf-a173-2e2029258474|7|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|Hounsfield Unit|[?]|1|DRUM|CHOROID PLEXUS|BILATERAL|Y|Y|ADJUDICATOR|4|Visit_4|65|1|FOLLOW-UP|2021-01-14|65
e|FA|f9432d72-f7d7-4cdf-a173-2e2029258474|8|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|ug/cm2|[?]|1|BAG|ULNAR NERVE|LATERAL|||ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2021-01-14|65
e|FA|f9432d72-f7d7-4cdf-a173-2e2029258474|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|HOMEOPATHIC DILUTION|[?]|1|mg/g/min|TRACHEOBRONCHIAL TREE|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-02-08|90
e|FA|f9432d72-f7d7-4cdf-a173-2e2029258474|10|SERVNUM|Number of Servings|[?]|GERD|[?]|uU/L|[?]|1|Hz/s|FOREARM|BILATERAL|||INTERVIEWER|5|Visit_5|90|5|TREATMENT|2021-02-08|90
e|FA|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|1|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|pmol/10^9 cells|[?]|1|oz eq|ANTRUM PYLORI|LEFT||Y|ADJUDICATOR|1|Visit_1|10|7|WASHOUT|2020-12-19|10
e|FA|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|2|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|days/month|[?]|1|Shock Wave|MAXILLA|BILATERAL||Y|SPOUSE|1|Visit_1|10|3|WASHOUT|2020-12-19|10
e|FA|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|3|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|genEq/mL|[?]|1|10^6 CFU/mL|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|RIGHT|||CHILD|2|Visit_2|25|5|TREATMENT|2021-01-03|25
e|FA|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|4|SEV|Severity/Intensity|[?]|GERD|[?]|Bq/mL|[?]|1|Pa|GENITAL TUBERCLE|LATERAL|||INTERVIEWER|2|Visit_2|25|6|TREATMENT|2021-01-03|25
e|FA|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|5|EXTRSCT|Extent of Resection|[?]|GERD|[?]|Rad|[?]|1|Weber|HEART, RIGHT VENTRICULAR WALL|RIGHT||Y|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2021-01-18|40
e|FA|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|6|DCAL|Dietary Calories|[?]|GERD|[?]|mL/mmHg|[?]|1|EIA unit|PATELLA|BILATERAL|||FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2021-01-18|40
e|FA|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|7|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|kIU|[?]|1|mL/m2|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LATERAL||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|TREATMENT|2021-02-12|65
e|FA|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|8|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|GPS U|[?]|1|mL/h|SHOULDER JOINT|UNILATERAL||Y|SIBLING|4|Visit_4|65|6|TREATMENT|2021-02-12|65
e|FA|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|9|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|IU/dL|[?]|1|mL/cm3/min|COLON, TRANSVERSE|LEFT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2021-03-09|90
e|FA|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|10|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|uU/L|[?]|1|mL/cm3/min|ISCHIAL TUBEROSITY|LEFT|Y||SPOUSE|5|Visit_5|90|3|SCREENING|2021-03-09|90
e|FA|0fc0650f-ed95-422d-b407-dcee93178780|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|titer|[?]|1|mg/g/min|ORAL CAVITY|LEFT|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-08-23|10
e|FA|0fc0650f-ed95-422d-b407-dcee93178780|2|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|Tbsp|[?]|1|Shock Wave|BRACHIAL ARTERY|IPSILATERAL|||FRIEND|1|Visit_1|10|7|SCREENING|2020-08-23|10
e|FA|0fc0650f-ed95-422d-b407-dcee93178780|3|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|aMFI|[?]|1|gtt|OMENTUM|LEFT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|SCREENING|2020-09-07|25
e|FA|0fc0650f-ed95-422d-b407-dcee93178780|4|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|YEARS|[?]|1|10^6 U|PROXIMAL INTERPHALANGEAL JOINT 5|IPSILATERAL||Y|ADJUDICATOR|2|Visit_2|25|3|SCREENING|2020-09-07|25
e|FA|0fc0650f-ed95-422d-b407-dcee93178780|5|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|10^9 organisms/mg|[?]|1|Log10 ELISA unit|EPITROCHLEAR LYMPH NODE|LATERAL|||CAREGIVER|3|Visit_3|40|7|SCREENING|2020-09-22|40
e|FA|0fc0650f-ed95-422d-b407-dcee93178780|6|SEV|Severity/Intensity|[?]|GERD|[?]|BP|[?]|1|Pa|COLON, DESCENDING|LEFT|||GUARDIAN|3|Visit_3|40|1|SCREENING|2020-09-22|40
e|FA|0fc0650f-ed95-422d-b407-dcee93178780|7|DVEG|Dietary Vegetable|[?]|GERD|[?]|mg/dL|[?]|1|Ci/ug|FRONTAL LOBE|LEFT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|WASHOUT|2020-10-17|65
e|FA|0fc0650f-ed95-422d-b407-dcee93178780|8|DIAMETER|Diameter|[?]|GERD|[?]|kPa/L/sec|[?]|1|cm|METACARPAL BONE 5|LATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-10-17|65
e|FA|0fc0650f-ed95-422d-b407-dcee93178780|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|1/(s*kPa)|[?]|1|Pa|FRONTAL SINUS|CONTRALATERAL||Y|VENDOR|5|Visit_5|90|2|FOLLOW-UP|2020-11-11|90
e|FA|0fc0650f-ed95-422d-b407-dcee93178780|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|tuberculin unit|[?]|1|QUANTITY SUFFICIENT|DELTOID MUSCLE|IPSILATERAL|||VENDOR|5|Visit_5|90|4|FOLLOW-UP|2020-11-11|90
e|FA|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|1|ACNDEV|Action Taken With Device|[?]|GERD|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|100 IU/mL|C5 VERTEBRA|RIGHT|||PARENT|1|Visit_1|10|3|TREATMENT|2020-06-03|10
e|FA|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|2|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|L/L|[?]|1|mL/cm3/min|THIGH|BILATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|5|TREATMENT|2020-06-03|10
e|FA|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|3|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|/kg|[?]|1|mL/animal/day|HEART|CONTRALATERAL|Y||PARENT|2|Visit_2|25|3|WASHOUT|2020-06-18|25
e|FA|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|4|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|Ci/kg|[?]|1|CUP|INTERNAL ILIAC LYMPH NODE|IPSILATERAL|||FRIEND|2|Visit_2|25|7|TREATMENT|2020-06-18|25
e|FA|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|5|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|nmol/day|[?]|1|IU/mmol|CAROTID ARTERY|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|WASHOUT|2020-07-03|40
e|FA|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|6|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|fmol/L/sec|[?]|1|fmol|CENTRAL NERVOUS SYSTEM|BILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-07-03|40
e|FA|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|7|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|g/cage|[?]|1|uCi/kg|LEFT POSTEROLATERAL DESCENDING ARTERY|UNILATERAL||Y|ADJUDICATOR|4|Visit_4|65|4|TREATMENT|2020-07-28|65
e|FA|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|pL|[?]|1|10^6 U|T11 VERTEBRA|UNILATERAL|||INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2020-07-28|65
e|FA|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|9|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|mmol/mol|[?]|1|BOWL|SCLERA|BILATERAL|Y|Y|CHILD|5|Visit_5|90|2|TREATMENT|2020-08-22|90
e|FA|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|10|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|ppth|[?]|1|mm/h|VASTUS LATERALIS MUSCLE|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2020-08-22|90
e|FA|a6f48290-787a-46ad-bee1-ae263ad3c121|1|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|um/day|[?]|1|cm H2O|FEMALE REPRODUCTIVE SYSTEM|UNILATERAL||Y|CAREGIVER|1|Visit_1|10|3|FOLLOW-UP|2021-01-19|10
e|FA|a6f48290-787a-46ad-bee1-ae263ad3c121|2|OBJNUM|Number of Objects|[?]|GERD|[?]|Log10 ELISA unit/dose|[?]|1|mL/100g/min|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|LEFT|||VENDOR|1|Visit_1|10|5|TREATMENT|2021-01-19|10
e|FA|a6f48290-787a-46ad-bee1-ae263ad3c121|3|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|g/day|[?]|1|uCi/kg|NUCLEUS OF DIAGONAL BAND|LATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|3|FOLLOW-UP|2021-02-03|25
e|FA|a6f48290-787a-46ad-bee1-ae263ad3c121|4|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|mIU/L|[?]|1|BOWL|SUBTALAR JOINT|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|FOLLOW-UP|2021-02-03|25
e|FA|a6f48290-787a-46ad-bee1-ae263ad3c121|5|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|Enzyme U|[?]|1|h*%|CORNEAL STROMA|LATERAL|||INVESTIGATOR|3|Visit_3|40|1|SCREENING|2021-02-18|40
e|FA|a6f48290-787a-46ad-bee1-ae263ad3c121|6|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|mmol/s|[?]|1|cmH2O/mL|PONS VAROLII|BILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|2|FOLLOW-UP|2021-02-18|40
e|FA|a6f48290-787a-46ad-bee1-ae263ad3c121|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|LENS|[?]|1|mg/g/min|SKULL, BASE|LATERAL|||FRIEND|4|Visit_4|65|7|TREATMENT|2021-03-15|65
e|FA|a6f48290-787a-46ad-bee1-ae263ad3c121|8|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|mL/g/h|[?]|1|ohm|SPINOUS PROCESS|BILATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2021-03-15|65
e|FA|a6f48290-787a-46ad-bee1-ae263ad3c121|9|STROKTYP|Stroke Type|[?]|GERD|[?]|nmol/mL/min|[?]|1|g/L|EYE|IPSILATERAL|Y||VENDOR|5|Visit_5|90|7|FOLLOW-UP|2021-04-09|90
e|FA|a6f48290-787a-46ad-bee1-ae263ad3c121|10|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|mL/kg|[?]|1|mL/m2|CORPUS UTERI|IPSILATERAL|||VENDOR|5|Visit_5|90|5|TREATMENT|2021-04-09|90
e|FA|565e5c83-9c67-4718-bd54-af34be936427|1|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|AU/mL|SKIN OF THE THIGH|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-06-09|10
e|FA|565e5c83-9c67-4718-bd54-af34be936427|2|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|uOsm|[?]|1|mg/h|PANCREATIC DUCT|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|FOLLOW-UP|2020-06-09|10
e|FA|565e5c83-9c67-4718-bd54-af34be936427|3|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|mmAL|[?]|1|BP|PANCREAS, ENDOCRINE|IPSILATERAL||Y|VENDOR|2|Visit_2|25|6|FOLLOW-UP|2020-06-24|25
e|FA|565e5c83-9c67-4718-bd54-af34be936427|4|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|10^9 organisms/mL|[?]|1|IU/mmol|VULVOVAGINAL REGION|BILATERAL|||GUARDIAN|2|Visit_2|25|4|TREATMENT|2020-06-24|25
e|FA|565e5c83-9c67-4718-bd54-af34be936427|5|DCAL|Dietary Calories|[?]|GERD|[?]|nmol BCE/L|[?]|1|EIA unit|COCCYX|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2020-07-09|40
e|FA|565e5c83-9c67-4718-bd54-af34be936427|6|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|PFU/dose|[?]|1|DRUM|PALATE|IPSILATERAL|Y|Y|CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-07-09|40
e|FA|565e5c83-9c67-4718-bd54-af34be936427|7|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|cmol/L|[?]|1|mL/animal/day|GLOBUS PALLIDUS|IPSILATERAL|Y|Y|PROXY|4|Visit_4|65|7|WASHOUT|2020-08-03|65
e|FA|565e5c83-9c67-4718-bd54-af34be936427|8|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|SFC/10^6 PBMC|[?]|1|umol|METACARPOPHALANGEAL JOINT 4|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-08-03|65
e|FA|565e5c83-9c67-4718-bd54-af34be936427|9|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|10^4 CFU/mL|GREAT SAPHENOUS VEIN|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2020-08-28|90
e|FA|565e5c83-9c67-4718-bd54-af34be936427|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/kg/min|[?]|1|mL|LARGE INTESTINE|RIGHT|||INDEPENDENT ASSESSOR|5|Visit_5|90|1|FOLLOW-UP|2020-08-28|90
e|FA|b238304c-15ef-4c6e-a32c-9cd583a233a9|1|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|ug/L/h|[?]|1|in|FEMORO-POPLITEAL PERIPHERAL ARTERY|UNILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2021-01-07|10
e|FA|b238304c-15ef-4c6e-a32c-9cd583a233a9|2|SEV|Severity/Intensity|[?]|GERD|[?]|mmAL|[?]|1|Pa|HAIR FOLLICLE|BILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|FOLLOW-UP|2021-01-07|10
e|FA|b238304c-15ef-4c6e-a32c-9cd583a233a9|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|TRANSDUCING UNIT/mL|[?]|1|10^6 U|FUNDUS OF THE EYE|CONTRALATERAL|||INVESTIGATOR|2|Visit_2|25|4|SCREENING|2021-01-22|25
e|FA|b238304c-15ef-4c6e-a32c-9cd583a233a9|4|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|L/day|[?]|1|Gy/h|BLADDER, NECK|CONTRALATERAL||Y|GUARDIAN|2|Visit_2|25|7|TREATMENT|2021-01-22|25
e|FA|b238304c-15ef-4c6e-a32c-9cd583a233a9|5|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|/10^5|[?]|1|10^6 IU/mL|T1 VERTEBRA|IPSILATERAL|||STUDY SUBJECT|3|Visit_3|40|4|SCREENING|2021-02-06|40
e|FA|b238304c-15ef-4c6e-a32c-9cd583a233a9|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|mEq/mmol|[?]|1|QUANTITY SUFFICIENT|ILIAC LYMPH NODE|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2021-02-06|40
e|FA|b238304c-15ef-4c6e-a32c-9cd583a233a9|7|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|TAMPON|[?]|1|mL/cm3/min|TIBIA SHAFT|CONTRALATERAL||Y|DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2021-03-03|65
e|FA|b238304c-15ef-4c6e-a32c-9cd583a233a9|8|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|nL|[?]|1|Log10 ELISA unit|TRAPEZOID-CAPITATE JOINT|LEFT|||PARENT|4|Visit_4|65|2|SCREENING|2021-03-03|65
e|FA|b238304c-15ef-4c6e-a32c-9cd583a233a9|9|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|pmol/L|[?]|1|10^6 CFU|BILIARY TRACT|LATERAL|||CHILD|5|Visit_5|90|7|TREATMENT|2021-03-28|90
e|FA|b238304c-15ef-4c6e-a32c-9cd583a233a9|10|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|MPL U/mL|[?]|1|Hz/s|C6 VERTEBRA|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2021-03-28|90
e|FA|c273f039-bca9-4d55-8620-5c5db32a6c4b|1|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|Absorbance U|[?]|1|mmHg/L/min|LUMBRICAL MUSCLES OF THE HAND|IPSILATERAL||Y|INVESTIGATOR|1|Visit_1|10|2|WASHOUT|2020-09-23|10
e|FA|c273f039-bca9-4d55-8620-5c5db32a6c4b|2|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|U/dL|[?]|1|mL/dose|UTERINE ARTERY|CONTRALATERAL|||SPOUSE|1|Visit_1|10|1|SCREENING|2020-09-23|10
e|FA|c273f039-bca9-4d55-8620-5c5db32a6c4b|3|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|nL|[?]|1|umol|MIDDLE PHALANX 4 OF THE HAND|LEFT|||VENDOR|2|Visit_2|25|1|TREATMENT|2020-10-08|25
e|FA|c273f039-bca9-4d55-8620-5c5db32a6c4b|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|Log10 ELISA unit/dose|[?]|1|QUANTITY SUFFICIENT|ATRIOVENTRICULAR VALVE|CONTRALATERAL|Y||PROXY|2|Visit_2|25|2|FOLLOW-UP|2020-10-08|25
e|FA|c273f039-bca9-4d55-8620-5c5db32a6c4b|5|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|Ci/mg|[?]|1|ng/day|SCAPHOID-CAPITATE JOINT|RIGHT|Y|Y|INVESTIGATOR|3|Visit_3|40|4|WASHOUT|2020-10-23|40
e|FA|c273f039-bca9-4d55-8620-5c5db32a6c4b|6|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|10^6 CFU/g|[?]|1|TRANSDUCING UNIT/mL|METACARPOPHALANGEAL JOINT 4|BILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2020-10-23|40
e|FA|c273f039-bca9-4d55-8620-5c5db32a6c4b|7|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|/ms|[?]|1|QUANTITY SUFFICIENT|RENAL PELVIS|BILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|5|WASHOUT|2020-11-17|65
e|FA|c273f039-bca9-4d55-8620-5c5db32a6c4b|8|ESTWT|Estimated Weight|[?]|GERD|[?]|/500 WBC|[?]|1|g/day|LINGULA OF THE LUNG|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|WASHOUT|2020-11-17|65
e|FA|c273f039-bca9-4d55-8620-5c5db32a6c4b|9|SEV|Severity/Intensity|[?]|GERD|[?]|ugEq|[?]|1|Pa|QUADRICEPS MUSCLE|IPSILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|4|FOLLOW-UP|2020-12-12|90
e|FA|c273f039-bca9-4d55-8620-5c5db32a6c4b|10|SEV|Severity/Intensity|[?]|GERD|[?]|U/g|[?]|1|Pa|PERITONEUM|LATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-12-12|90
e|FA|2cdb5053-2108-4f50-8906-8afabc855a36|1|DMEAT|Dietary Meat|[?]|GERD|[?]|mCi|[?]|1|10^6 organisms/mL|INTERPHALANGEAL JOINT 2|RIGHT||Y|DOMESTIC PARTNER|1|Visit_1|10|2|TREATMENT|2020-08-28|10
e|FA|2cdb5053-2108-4f50-8906-8afabc855a36|2|TOXGR|Toxicity Grade|[?]|GERD|[?]|BOWL|[?]|1|aMFI|SEMITENDINOSUS MUSCLE|CONTRALATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|3|SCREENING|2020-08-28|10
e|FA|2cdb5053-2108-4f50-8906-8afabc855a36|3|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|um|[?]|1|psi|BACK|IPSILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-09-12|25
e|FA|2cdb5053-2108-4f50-8906-8afabc855a36|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|mg/g/min|VERTEBRAL ARTERY|CONTRALATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2020-09-12|25
e|FA|2cdb5053-2108-4f50-8906-8afabc855a36|5|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|mg/animal|[?]|1|BOWL|SACROILIAC JOINT|RIGHT|||SIBLING|3|Visit_3|40|2|TREATMENT|2020-09-27|40
e|FA|2cdb5053-2108-4f50-8906-8afabc855a36|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/dL|[?]|1|mg/g/min|INTERPHALANGEAL JOINT 3 OF THE HAND|LEFT|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2020-09-27|40
e|FA|2cdb5053-2108-4f50-8906-8afabc855a36|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms|[?]|1|Pa|KIDNEY, HILUM|CONTRALATERAL||Y|FRIEND|4|Visit_4|65|7|SCREENING|2020-10-22|65
e|FA|2cdb5053-2108-4f50-8906-8afabc855a36|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|/500 WBC|[?]|1|mg/g/min|PALPEBRAL CONJUNCTIVA|LEFT|||SPOUSE|4|Visit_4|65|5|TREATMENT|2020-10-22|65
e|FA|2cdb5053-2108-4f50-8906-8afabc855a36|9|DGRAIN|Dietary Grain|[?]|GERD|[?]|Enzyme U/L|[?]|1|10^9 CFU/g|HUMERUS|LATERAL||Y|VENDOR|5|Visit_5|90|5|TREATMENT|2020-11-16|90
e|FA|2cdb5053-2108-4f50-8906-8afabc855a36|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|IU/day|[?]|1|QUANTITY SUFFICIENT|COMMON ILIAC LYMPH NODE|UNILATERAL|||CAREGIVER|5|Visit_5|90|3|WASHOUT|2020-11-16|90
e|FA|fce7149a-503e-4209-8c62-8044a2ad1c1c|1|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|BAG|HILAR|LEFT||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|3|FOLLOW-UP|2020-08-06|10
e|FA|fce7149a-503e-4209-8c62-8044a2ad1c1c|2|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|ug/kg/h|[?]|1|Gy/h|TRAPEZOID BONE|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|SCREENING|2020-08-06|10
e|FA|fce7149a-503e-4209-8c62-8044a2ad1c1c|3|SEV|Severity/Intensity|[?]|GERD|[?]|cm2|[?]|1|Pa|HUMERAL EPICONDYLE|RIGHT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|FOLLOW-UP|2020-08-21|25
e|FA|fce7149a-503e-4209-8c62-8044a2ad1c1c|4|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|SPRAY|[?]|1|g/day|COMMON ILIAC LYMPH NODE|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-08-21|25
e|FA|fce7149a-503e-4209-8c62-8044a2ad1c1c|5|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|kN/cm2|[?]|1|g/day|HEART, LEFT VENTRICLE|LEFT|Y||INDEPENDENT ASSESSOR|3|Visit_3|40|6|SCREENING|2020-09-05|40
e|FA|fce7149a-503e-4209-8c62-8044a2ad1c1c|6|DVEG|Dietary Vegetable|[?]|GERD|[?]|umol/L|[?]|1|Ci/ug|ENDOMETRIUM|RIGHT|||PROXY|3|Visit_3|40|4|TREATMENT|2020-09-05|40
e|FA|fce7149a-503e-4209-8c62-8044a2ad1c1c|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/h|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|IPSILATERAL|||CAREGIVER|4|Visit_4|65|1|FOLLOW-UP|2020-09-30|65
e|FA|fce7149a-503e-4209-8c62-8044a2ad1c1c|8|AGETRT1|Age At First Treatment|[?]|GERD|[?]|mV|[?]|1|mL/mmHg/min/L|ILEUM, TERMINAL|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|FOLLOW-UP|2020-09-30|65
e|FA|fce7149a-503e-4209-8c62-8044a2ad1c1c|9|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|ukat/L|[?]|1|ug/m2/h|PERONEAL ARTERY|RIGHT|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|WASHOUT|2020-10-25|90
e|FA|fce7149a-503e-4209-8c62-8044a2ad1c1c|10|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|ug/L FEU|[?]|1|gtt|RADIUS|LATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2020-10-25|90
e|FA|c8aad550-11a1-4473-8b35-79b7dfb08122|1|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|U/cL|[?]|1|m2|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|IPSILATERAL|||FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2020-06-09|10
e|FA|c8aad550-11a1-4473-8b35-79b7dfb08122|2|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg/min/L|[?]|1|umol|ISCHIAL TUBEROSITY|CONTRALATERAL||Y|STUDY SUBJECT|1|Visit_1|10|6|FOLLOW-UP|2020-06-09|10
e|FA|c8aad550-11a1-4473-8b35-79b7dfb08122|3|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/m2|[?]|1|100 IU/mL|COMMON FEMORAL VEIN|LATERAL|||STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-06-24|25
e|FA|c8aad550-11a1-4473-8b35-79b7dfb08122|4|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|Arbitrary U|[?]|1|mL/cm3/min|PROXIMAL INTERPHALANGEAL JOINT 5|LATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|6|SCREENING|2020-06-24|25
e|FA|c8aad550-11a1-4473-8b35-79b7dfb08122|5|DPROT|Dietary Protein|[?]|GERD|[?]|cmol/L|[?]|1|10^4 CFU/mL|SKIN OF THE KNEE|RIGHT|Y||FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2020-07-09|40
e|FA|c8aad550-11a1-4473-8b35-79b7dfb08122|6|DISTANCE|Distance|[?]|GERD|[?]|Enzyme U|[?]|1|BOWL|CARPOMETACARPAL JOINT 5|RIGHT|||DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-07-09|40
e|FA|c8aad550-11a1-4473-8b35-79b7dfb08122|7|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|DAgU/mL|[?]|1|10^6 U|ORBICULARIS OCULI MUSCLE|BILATERAL|Y||SIBLING|4|Visit_4|65|2|SCREENING|2020-08-03|65
e|FA|c8aad550-11a1-4473-8b35-79b7dfb08122|8|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|cycle/min|[?]|1|anti-Xa IU/mL|RIB 3|IPSILATERAL|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2020-08-03|65
e|FA|c8aad550-11a1-4473-8b35-79b7dfb08122|9|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|amu|[?]|1|km|T1 VERTEBRA|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|2|FOLLOW-UP|2020-08-28|90
e|FA|c8aad550-11a1-4473-8b35-79b7dfb08122|10|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|F|[?]|1|g/cage/day|ABDUCTOR POLLICIS BREVIS MUSCLE|RIGHT|||PARENT|5|Visit_5|90|3|TREATMENT|2020-08-28|90
e|FA|f1967c6e-c520-4482-be7e-01ada4380d87|1|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|10^6/g|[?]|1|10^6 IU/mL|BRAIN, PERIVENTRICULAR REGION|CONTRALATERAL|Y||CAREGIVER|1|Visit_1|10|7|TREATMENT|2021-01-05|10
e|FA|f1967c6e-c520-4482-be7e-01ada4380d87|2|PPTFCT|Precipitating Factor|[?]|GERD|[?]|% INHIBITION|[?]|1|EIA unit|CERVIX UTERI|LEFT|||PROXY|1|Visit_1|10|6|SCREENING|2021-01-05|10
e|FA|f1967c6e-c520-4482-be7e-01ada4380d87|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ug/day|[?]|1|%(v/v)|INTERPHALANGEAL JOINT 5|IPSILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|6|WASHOUT|2021-01-20|25
e|FA|f1967c6e-c520-4482-be7e-01ada4380d87|4|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mCi|[?]|1|NEEDLE GAUGE|ILIOPSOAS MUSCLE|IPSILATERAL|Y|Y|SIBLING|2|Visit_2|25|1|FOLLOW-UP|2021-01-20|25
e|FA|f1967c6e-c520-4482-be7e-01ada4380d87|5|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|pmol/g|[?]|1|Coulomb|HAND DIGIT 2|IPSILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2021-02-04|40
e|FA|f1967c6e-c520-4482-be7e-01ada4380d87|6|TRTSETT|Treatment Setting|[?]|GERD|[?]|L/s/kPa|[?]|1|Coulomb|PAROTID GLAND LYMPH NODE|BILATERAL|Y|Y|PROXY|3|Visit_3|40|7|TREATMENT|2021-02-04|40
e|FA|f1967c6e-c520-4482-be7e-01ada4380d87|7|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|kcal/day|[?]|1|BAG|C4 VERTEBRA|IPSILATERAL||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2021-03-01|65
e|FA|f1967c6e-c520-4482-be7e-01ada4380d87|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/mL|[?]|1|%(v/v)|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|||PARENT|4|Visit_4|65|6|FOLLOW-UP|2021-03-01|65
e|FA|f1967c6e-c520-4482-be7e-01ada4380d87|9|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|mol/mL|[?]|1|U/mg|ANTERIOR INFERIOR CEREBELLAR ARTERY|CONTRALATERAL|||FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2021-03-26|90
e|FA|f1967c6e-c520-4482-be7e-01ada4380d87|10|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|g/day|TRICUSPID VALVE, POSTERIOR CUSP|BILATERAL|||CAREGIVER|5|Visit_5|90|1|WASHOUT|2021-03-26|90
e|FA|2a5a1c03-f54e-47da-8dda-2104c9423e94|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|gMFI|[?]|1|mg/g/min|HIPPOCAMPUS|UNILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2021-01-01|10
e|FA|2a5a1c03-f54e-47da-8dda-2104c9423e94|2|RLDEV|Relationship to Device|[?]|GERD|[?]|pmol/L|[?]|1|mL/min/mmHg|HUMERUS|UNILATERAL||Y|CHILD|1|Visit_1|10|4|TREATMENT|2021-01-01|10
e|FA|2a5a1c03-f54e-47da-8dda-2104c9423e94|3|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|mmol/min/kPa|[?]|1|g/day|SKIN OF THE CHEST|RIGHT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|FOLLOW-UP|2021-01-16|25
e|FA|2a5a1c03-f54e-47da-8dda-2104c9423e94|4|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|ugEq|[?]|1|mEq|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|LEFT|Y||GUARDIAN|2|Visit_2|25|2|TREATMENT|2021-01-16|25
e|FA|2a5a1c03-f54e-47da-8dda-2104c9423e94|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|CCID 50/dose|[?]|1|%(v/v)|DISTAL COMMON BILE DUCT|RIGHT|||STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2021-01-31|40
e|FA|2a5a1c03-f54e-47da-8dda-2104c9423e94|6|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|RNA copies/mL|[?]|1|100 IU/mL|COLON, TRANSVERSE|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2021-01-31|40
e|FA|2a5a1c03-f54e-47da-8dda-2104c9423e94|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|kg|[?]|1|Pa|VAGUS NERVE|CONTRALATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|5|FOLLOW-UP|2021-02-25|65
e|FA|2a5a1c03-f54e-47da-8dda-2104c9423e94|8|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|foz_br|[?]|1|cm H2O|LOWER GASTROINTESTINAL TRACT LYMPH NODE|CONTRALATERAL|Y||VENDOR|4|Visit_4|65|5|TREATMENT|2021-02-25|65
e|FA|2a5a1c03-f54e-47da-8dda-2104c9423e94|9|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|rpm|[?]|1|U/mmol|LEG SKIN|IPSILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2021-03-22|90
e|FA|2a5a1c03-f54e-47da-8dda-2104c9423e94|10|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|BOLUS|[?]|1|mEq/g|SCAPHOID-TRAPEZOID JOINT|BILATERAL|||CAREGIVER|5|Visit_5|90|3|TREATMENT|2021-03-22|90
e|FA|8f98bac3-8010-4902-8ae1-783dc5fea72d|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Anson U|[?]|1|Pa|CECUM|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|1|Visit_1|10|6|SCREENING|2020-06-29|10
e|FA|8f98bac3-8010-4902-8ae1-783dc5fea72d|2|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|cs|[?]|1|10^9 CFU/mL|LYMPH NODE|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-06-29|10
e|FA|8f98bac3-8010-4902-8ae1-783dc5fea72d|3|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|ug/g/day|[?]|1|fmol|OVARY|RIGHT|||PARENT|2|Visit_2|25|2|TREATMENT|2020-07-14|25
e|FA|8f98bac3-8010-4902-8ae1-783dc5fea72d|4|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|Ci/ug|UMBILICUS|RIGHT||Y|CHILD|2|Visit_2|25|1|SCREENING|2020-07-14|25
e|FA|8f98bac3-8010-4902-8ae1-783dc5fea72d|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mg/m2/min|[?]|1|%(v/v)|WRIST JOINT FLEXOR TENDONS|LATERAL|||INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-07-29|40
e|FA|8f98bac3-8010-4902-8ae1-783dc5fea72d|6|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|SFC/10^6 PBMC|[?]|1|g/day|AXILLA|IPSILATERAL|||PROXY|3|Visit_3|40|1|SCREENING|2020-07-29|40
e|FA|8f98bac3-8010-4902-8ae1-783dc5fea72d|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/kg/dose|[?]|1|mg/g/min|RADIAL NERVE|RIGHT|Y|Y|FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2020-08-23|65
e|FA|8f98bac3-8010-4902-8ae1-783dc5fea72d|8|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|SUPPOSITORY|[?]|1|gtt|WALDEYER'S TONSILLAR RING|UNILATERAL|||SPOUSE|4|Visit_4|65|6|TREATMENT|2020-08-23|65
e|FA|8f98bac3-8010-4902-8ae1-783dc5fea72d|9|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|m2|[?]|1|/kg|LATERAL SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL||Y|SIBLING|5|Visit_5|90|6|TREATMENT|2020-09-17|90
e|FA|8f98bac3-8010-4902-8ae1-783dc5fea72d|10|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|mg/cm2|[?]|1|10^9 CFU/g|GASTROINTESTINAL TRACT, LOWER|LEFT|||VENDOR|5|Visit_5|90|1|TREATMENT|2020-09-17|90
e|FA|0fd7cece-4d9d-4d8c-82e0-df0c75613888|1|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/g|[?]|1|EIA unit|EPICARDIUM|RIGHT||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|SCREENING|2020-12-11|10
e|FA|0fd7cece-4d9d-4d8c-82e0-df0c75613888|2|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|ukat|[?]|1|HOURS|SPLEEN, HILUM|RIGHT|||STUDY SUBJECT|1|Visit_1|10|3|WASHOUT|2020-12-11|10
e|FA|0fd7cece-4d9d-4d8c-82e0-df0c75613888|3|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|mL/dL|[?]|1|BOWL|CEREBRAL CORTEX|IPSILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-12-26|25
e|FA|0fd7cece-4d9d-4d8c-82e0-df0c75613888|4|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|Ci/uL|[?]|1|cm H2O|SKIN OF THE KNEE|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-12-26|25
e|FA|0fd7cece-4d9d-4d8c-82e0-df0c75613888|5|LDIAM|Longest Diameter|[?]|GERD|[?]|CFU/mL|[?]|1|Shock Wave|SCAPHOID-LUNATE-CAPITATE JOINT|IPSILATERAL||Y|SIBLING|3|Visit_3|40|5|SCREENING|2021-01-10|40
e|FA|0fd7cece-4d9d-4d8c-82e0-df0c75613888|6|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|IU/kg/h|[?]|1|10^6 CFU/mL|NASAL BONE|LEFT|Y||PROXY|3|Visit_3|40|6|FOLLOW-UP|2021-01-10|40
e|FA|0fd7cece-4d9d-4d8c-82e0-df0c75613888|7|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Bq/g|[?]|1|oz eq|UPPER CERVICAL LYMPH NODE|UNILATERAL||Y|VENDOR|4|Visit_4|65|2|TREATMENT|2021-02-04|65
e|FA|0fd7cece-4d9d-4d8c-82e0-df0c75613888|8|STROKTYP|Stroke Type|[?]|GERD|[?]|mL/s/m2|[?]|1|g/L|PYRAMIDAL TRACTS, INTERNAL CAPSULE|CONTRALATERAL|||FRIEND|4|Visit_4|65|3|FOLLOW-UP|2021-02-04|65
e|FA|0fd7cece-4d9d-4d8c-82e0-df0c75613888|9|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|SQU/mL|[?]|1|SCOOPFUL|COLON, HEPATIC FLEXURE|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|SCREENING|2021-03-01|90
e|FA|0fd7cece-4d9d-4d8c-82e0-df0c75613888|10|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|mg/kg/min|[?]|1|mL/mmHg/min/L|PORTAL LYMPH NODE|LEFT|||GUARDIAN|5|Visit_5|90|2|SCREENING|2021-03-01|90
e|FA|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|ug|[?]|1|SCOOPFUL|BILE DUCT|RIGHT||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|FOLLOW-UP|2020-06-13|10
e|FA|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|2|DFATT|Dietary Fat, Total|[?]|GERD|[?]|10^7 CFU|[?]|1|Bq/mg|ILIUM|LATERAL|||CHILD|1|Visit_1|10|1|FOLLOW-UP|2020-06-13|10
e|FA|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|3|EVENTFRQ|Event Frequency|[?]|GERD|[?]|BOLUS|[?]|1|ug/kg/h|VESTIBULOCOCHLEAR NERVE|RIGHT||Y|SIGNIFICANT OTHER|2|Visit_2|25|7|FOLLOW-UP|2020-06-28|25
e|FA|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|4|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|cm H2O|[?]|1|mg/h|ACCESSORY RENAL ARTERY|LEFT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|6|FOLLOW-UP|2020-06-28|25
e|FA|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|5|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|msec|[?]|1|mL/h|LYMPH NODE HILUM|BILATERAL|||VENDOR|3|Visit_3|40|3|SCREENING|2020-07-13|40
e|FA|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|6|STROKTYP|Stroke Type|[?]|GERD|[?]|nmol BCE/mmol|[?]|1|g/L|LENS|LATERAL|||GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-07-13|40
e|FA|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|7|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|nCi|[?]|1|HOURS|LEFT VENTRICULAR MID ANTERIOR SEGMENT|CONTRALATERAL|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2020-08-07|65
e|FA|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|8|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|10^6/L|[?]|1|uCi/kg|RIGHT VENTRICULAR ENDOCARDIUM|LEFT||Y|SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-08-07|65
e|FA|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|9|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|mg/cm2|[?]|1|g/cage/day|URETHRA, POSTERIOR|BILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2020-09-01|90
e|FA|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|U/mmol|FACIAL NERVE|UNILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|7|FOLLOW-UP|2020-09-01|90
e|FA|4be1ea69-9baf-45b4-873b-13a879544d9c|1|TOXGR|Toxicity Grade|[?]|GERD|[?]|/200 HPFs|[?]|1|aMFI|MID-RIGHT CORONARY ARTERY CONDUIT|BILATERAL|Y||GUARDIAN|1|Visit_1|10|2|SCREENING|2021-01-26|10
e|FA|4be1ea69-9baf-45b4-873b-13a879544d9c|2|TRTSETT|Treatment Setting|[?]|GERD|[?]|10^12/L|[?]|1|Coulomb|HAND DIGIT 4|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2021-01-26|10
e|FA|4be1ea69-9baf-45b4-873b-13a879544d9c|3|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|mEq/ug|[?]|1|ug/kg/h|PELVIC LYMPH NODE|RIGHT|||SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2021-02-10|25
e|FA|4be1ea69-9baf-45b4-873b-13a879544d9c|4|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|DDU|[?]|1|L|ANTERIOR HORN OF THE LATERAL VENTRICLE|CONTRALATERAL|Y||CHILD|2|Visit_2|25|5|WASHOUT|2021-02-10|25
e|FA|4be1ea69-9baf-45b4-873b-13a879544d9c|5|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mL/beat|[?]|1|gtt|RIGHT CORONARY ARTERY OSTIUM|LATERAL|Y||PROXY|3|Visit_3|40|5|TREATMENT|2021-02-25|40
e|FA|4be1ea69-9baf-45b4-873b-13a879544d9c|6|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|MET*h|[?]|1|Shock Wave|INTERNAL MAMMARY ARTERY|UNILATERAL|Y||PROXY|3|Visit_3|40|4|TREATMENT|2021-02-25|40
e|FA|4be1ea69-9baf-45b4-873b-13a879544d9c|7|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|ng/L|[?]|1|AU/mL|RETROPHARYNGEAL LYMPH NODE|LEFT|Y||CHILD|4|Visit_4|65|2|WASHOUT|2021-03-22|65
e|FA|4be1ea69-9baf-45b4-873b-13a879544d9c|8|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|nmol/L/min|[?]|1|10^9 CFU/g|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|LEFT||Y|PROXY|4|Visit_4|65|3|WASHOUT|2021-03-22|65
e|FA|4be1ea69-9baf-45b4-873b-13a879544d9c|9|SEV|Severity/Intensity|[?]|GERD|[?]|dL|[?]|1|Pa|INTERPHALANGEAL OF THE FOOT|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-04-16|90
e|FA|4be1ea69-9baf-45b4-873b-13a879544d9c|10|SEV|Severity/Intensity|[?]|GERD|[?]|g/animal/day|[?]|1|Pa|CELIAC ARTERY|UNILATERAL|||SPOUSE|5|Visit_5|90|3|TREATMENT|2021-04-16|90
e|FA|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|1|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|mg/kg/day|[?]|1|g/day|GRACILIS MUSCLE|LATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-10-29|10
e|FA|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|2|DFIBER|Dietary Fiber|[?]|GERD|[?]|uEq|[?]|1|h*%|EXTRAOCULAR MUSCLE|RIGHT|||ADJUDICATOR|1|Visit_1|10|5|WASHOUT|2020-10-29|10
e|FA|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|in|[?]|1|10^6 U|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|UNILATERAL|Y||FRIEND|2|Visit_2|25|2|SCREENING|2020-11-13|25
e|FA|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|/month|[?]|1|QUANTITY SUFFICIENT|METACARPOPHALANGEAL JOINT 1|LATERAL||Y|STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2020-11-13|25
e|FA|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|5|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|APS U|[?]|1|mEq|LYMPH NODE HILUM|BILATERAL|||SPOUSE|3|Visit_3|40|5|TREATMENT|2020-11-28|40
e|FA|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/g|[?]|1|mg/g/min|BLADDER WALL|CONTRALATERAL|||INTERVIEWER|3|Visit_3|40|7|TREATMENT|2020-11-28|40
e|FA|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|APS U|[?]|1|mg/g/min|TARSUS BONE|CONTRALATERAL|||VENDOR|4|Visit_4|65|7|SCREENING|2020-12-23|65
e|FA|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|8|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|km|[?]|1|mg/dose|AXILLARY LYMPH NODE|LATERAL||Y|GUARDIAN|4|Visit_4|65|6|SCREENING|2020-12-23|65
e|FA|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|log10 IU/mL|[?]|1|mL|ILIAC VEIN|BILATERAL|||CHILD|5|Visit_5|90|1|TREATMENT|2021-01-17|90
e|FA|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|10|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|%/s|[?]|1|10^6 CFU|FEMORAL HEAD|CONTRALATERAL|Y||GUARDIAN|5|Visit_5|90|1|TREATMENT|2021-01-17|90
e|FA|16720f71-55b5-478f-b041-00b61ae19ac9|1|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|kBq/uL|[?]|1|oz eq|HIP JOINT|BILATERAL|||ADJUDICATOR|1|Visit_1|10|6|SCREENING|2021-01-10|10
e|FA|16720f71-55b5-478f-b041-00b61ae19ac9|2|VOL|Volume|[?]|GERD|[?]|10^6 organisms|[?]|1|vp/dose|SUBCUTIS|CONTRALATERAL|Y||FAMILY MEMBER|1|Visit_1|10|7|SCREENING|2021-01-10|10
e|FA|16720f71-55b5-478f-b041-00b61ae19ac9|3|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|/ms|[?]|1|cm|OLECRANON|LEFT|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2021-01-25|25
e|FA|16720f71-55b5-478f-b041-00b61ae19ac9|4|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|uL/mL|[?]|1|g/L|RADIUS|UNILATERAL|||INVESTIGATOR|2|Visit_2|25|4|FOLLOW-UP|2021-01-25|25
e|FA|16720f71-55b5-478f-b041-00b61ae19ac9|5|EVENTFRQ|Event Frequency|[?]|GERD|[?]|uU/dL|[?]|1|ug/kg/h|FLEXOR DIGITORUM BREVIS MUSCLE|LATERAL||Y|GUARDIAN|3|Visit_3|40|3|WASHOUT|2021-02-09|40
e|FA|16720f71-55b5-478f-b041-00b61ae19ac9|6|OBJNUM|Number of Objects|[?]|GERD|[?]|km/h|[?]|1|mL/100g/min|HYOID BONE|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|SCREENING|2021-02-09|40
e|FA|16720f71-55b5-478f-b041-00b61ae19ac9|7|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|U/10^12 RBC|[?]|1|Ci/ug|TRACHEA|LEFT||Y|SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2021-03-06|65
e|FA|16720f71-55b5-478f-b041-00b61ae19ac9|8|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|ug/m2/h|[?]|1|IU/mmol|OBTURATOR EXTERNUS MUSCLE|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2021-03-06|65
e|FA|16720f71-55b5-478f-b041-00b61ae19ac9|9|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|vg/mL|[?]|1|g/cage/day|VENA CAVA|LEFT||Y|SIGNIFICANT OTHER|5|Visit_5|90|3|WASHOUT|2021-03-31|90
e|FA|16720f71-55b5-478f-b041-00b61ae19ac9|10|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|EID 50/mL|[?]|1|AU/mL|LEFT VENTRICULAR MID ANTERIOR SEGMENT|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2021-03-31|90
e|FA|4349f45e-f18b-4606-9a72-fd45e64e17dc|1|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|copies/mL|[?]|1|Bq/L|THYMUS GLAND|CONTRALATERAL|Y||INTERVIEWER|1|Visit_1|10|7|TREATMENT|2021-01-11|10
e|FA|4349f45e-f18b-4606-9a72-fd45e64e17dc|2|PPTFCT|Precipitating Factor|[?]|GERD|[?]|g/cage/wk|[?]|1|EIA unit|EXTENSOR HALLUCIS BREVIS MUSCLE|UNILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2021-01-11|10
e|FA|4349f45e-f18b-4606-9a72-fd45e64e17dc|3|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU|[?]|1|Log10 ELISA unit|SPINAL CORD|BILATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|5|SCREENING|2021-01-26|25
e|FA|4349f45e-f18b-4606-9a72-fd45e64e17dc|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|Pa|WRIST JOINT EXTENSOR TENDONS|LEFT|Y|Y|PARENT|2|Visit_2|25|1|SCREENING|2021-01-26|25
e|FA|4349f45e-f18b-4606-9a72-fd45e64e17dc|5|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|kat|[?]|1|g/cage/day|SOFT TISSUE|CONTRALATERAL|||PROXY|3|Visit_3|40|6|FOLLOW-UP|2021-02-10|40
e|FA|4349f45e-f18b-4606-9a72-fd45e64e17dc|6|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|RING|[?]|1|uL/kg/day|ILIUM|CONTRALATERAL|||DOMESTIC PARTNER|3|Visit_3|40|5|WASHOUT|2021-02-10|40
e|FA|4349f45e-f18b-4606-9a72-fd45e64e17dc|7|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|MPL U|[?]|1|h*%|NOSE|IPSILATERAL|||FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2021-03-07|65
e|FA|4349f45e-f18b-4606-9a72-fd45e64e17dc|8|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|m3|[?]|1|DROP|LUMBRICAL MUSCLES OF THE HAND|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2021-03-07|65
e|FA|4349f45e-f18b-4606-9a72-fd45e64e17dc|9|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|pm|[?]|1|uL/kg/day|LACRIMAL BONE|LEFT|Y||STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2021-04-01|90
e|FA|4349f45e-f18b-4606-9a72-fd45e64e17dc|10|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|TROCHE|[?]|1|mAmp|RADIUS SHAFT|RIGHT|||ADJUDICATOR|5|Visit_5|90|2|SCREENING|2021-04-01|90
e|FA|32e36ec1-6895-42ff-bf33-52977e72b338|1|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|K|[?]|1|mg/h|TARSAL JOINT|BILATERAL|Y||ADJUDICATOR|1|Visit_1|10|7|FOLLOW-UP|2020-09-05|10
e|FA|32e36ec1-6895-42ff-bf33-52977e72b338|2|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|mL/s|[?]|1|MBq|SCAPHOID-LUNATE-CAPITATE JOINT|LATERAL|||PARENT|1|Visit_1|10|6|SCREENING|2020-09-05|10
e|FA|32e36ec1-6895-42ff-bf33-52977e72b338|3|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|U/mmol|[?]|1|HOURS|LATERAL RAMUS INTERMEDIUS ARTERY|LEFT|Y||DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-09-20|25
e|FA|32e36ec1-6895-42ff-bf33-52977e72b338|4|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|/100 WBC|[?]|1|Gy/h|ESOPHAGUS, LOWER THIRD|IPSILATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|4|WASHOUT|2020-09-20|25
e|FA|32e36ec1-6895-42ff-bf33-52977e72b338|5|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|KIT|[?]|1|vp/dose|EYE|BILATERAL|Y||PARENT|3|Visit_3|40|4|FOLLOW-UP|2020-10-05|40
e|FA|32e36ec1-6895-42ff-bf33-52977e72b338|6|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT/mL|[?]|1|cmH2O/mL|MEDIAN OR LOWER CERVICAL LYMPH NODE|LATERAL|Y||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-10-05|40
e|FA|32e36ec1-6895-42ff-bf33-52977e72b338|7|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|g/cage/wk|[?]|1|Shock Wave|PUTAMEN|LEFT|||FRIEND|4|Visit_4|65|4|TREATMENT|2020-10-30|65
e|FA|32e36ec1-6895-42ff-bf33-52977e72b338|8|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|mph|[?]|1|g/cage/day|POPLITEAL VEIN|LATERAL|||VENDOR|4|Visit_4|65|5|TREATMENT|2020-10-30|65
e|FA|32e36ec1-6895-42ff-bf33-52977e72b338|9|SPEED|Speed|[?]|GERD|[?]|cd|[?]|1|mEq/g|GONAD|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|FOLLOW-UP|2020-11-24|90
e|FA|32e36ec1-6895-42ff-bf33-52977e72b338|10|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU|[?]|1|AU/mL|GLOSSOPHARYNGEAL NERVE|LEFT|||CAREGIVER|5|Visit_5|90|4|SCREENING|2020-11-24|90
e|FA|e546f2d8-baea-4a6e-93cb-c7ec7292b423|1|DVEG|Dietary Vegetable|[?]|GERD|[?]|mmol2/L2|[?]|1|Ci/ug|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|IPSILATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|5|WASHOUT|2020-10-25|10
e|FA|e546f2d8-baea-4a6e-93cb-c7ec7292b423|2|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|g/dL|[?]|1|mm|LUNG, RIGHT MIDDLE LOBE|LATERAL||Y|CHILD|1|Visit_1|10|6|WASHOUT|2020-10-25|10
e|FA|e546f2d8-baea-4a6e-93cb-c7ec7292b423|3|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|MBq|PULMONARY VALVE, LEFT CUSP|LATERAL|Y||VENDOR|2|Visit_2|25|2|FOLLOW-UP|2020-11-09|25
e|FA|e546f2d8-baea-4a6e-93cb-c7ec7292b423|4|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|%|[?]|1|g/cage/day|ARTERY|RIGHT|Y||SIBLING|2|Visit_2|25|3|FOLLOW-UP|2020-11-09|25
e|FA|e546f2d8-baea-4a6e-93cb-c7ec7292b423|5|DISTANCE|Distance|[?]|GERD|[?]|eq|[?]|1|BOWL|EARLOBE|LATERAL||Y|PARENT|3|Visit_3|40|3|TREATMENT|2020-11-24|40
e|FA|e546f2d8-baea-4a6e-93cb-c7ec7292b423|6|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|PACK|BLADDER, FUNDUS|LEFT|||DOMESTIC PARTNER|3|Visit_3|40|3|FOLLOW-UP|2020-11-24|40
e|FA|e546f2d8-baea-4a6e-93cb-c7ec7292b423|7|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|anti-Xa IU/mL|[?]|1|g/cage/day|INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2020-12-19|65
e|FA|e546f2d8-baea-4a6e-93cb-c7ec7292b423|8|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|nmol/mol|[?]|1|Gy/h|ILIUM|LEFT|||ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-12-19|65
e|FA|e546f2d8-baea-4a6e-93cb-c7ec7292b423|9|DMG|Dietary Magnesium|[?]|GERD|[?]|mg2/dL2|[?]|1|TRANSDUCING UNIT/mL|PREAURICULAR LYMPH NODE|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2021-01-13|90
e|FA|e546f2d8-baea-4a6e-93cb-c7ec7292b423|10|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|nsec|[?]|1|AU/mL|PAROTID GLAND LYMPH NODE|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2021-01-13|90
e|FA|0329de16-fc7a-4941-900c-b390dac637aa|1|LENRSCT|Length of Resection|[?]|GERD|[?]|/ms|[?]|1|psi|C2 VERTEBRA|IPSILATERAL|||SPOUSE|1|Visit_1|10|1|SCREENING|2020-09-27|10
e|FA|0329de16-fc7a-4941-900c-b390dac637aa|2|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|pg/cell|[?]|1|ug/kg/h|THYMUS GLAND|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|SCREENING|2020-09-27|10
e|FA|0329de16-fc7a-4941-900c-b390dac637aa|3|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|mAnson U/mL|[?]|1|ohm|METATARSOPHALANGEAL JOINT 4|UNILATERAL|Y|Y|CAREGIVER|2|Visit_2|25|6|TREATMENT|2020-10-12|25
e|FA|0329de16-fc7a-4941-900c-b390dac637aa|4|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|AU/mL|[?]|1|Hz/s|L3 VERTEBRA|RIGHT|||ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-10-12|25
e|FA|0329de16-fc7a-4941-900c-b390dac637aa|5|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|AU/mL|INGUINAL REGION|LEFT||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|4|WASHOUT|2020-10-27|40
e|FA|0329de16-fc7a-4941-900c-b390dac637aa|6|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|ft|[?]|1|ng/day|TYMPANIC MEMBRANE|UNILATERAL|||CAREGIVER|3|Visit_3|40|7|TREATMENT|2020-10-27|40
e|FA|0329de16-fc7a-4941-900c-b390dac637aa|7|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|OD Unit|[?]|1|Log10 ELISA unit|WAIST|RIGHT|||PARENT|4|Visit_4|65|6|TREATMENT|2020-11-21|65
e|FA|0329de16-fc7a-4941-900c-b390dac637aa|8|SEV|Severity/Intensity|[?]|GERD|[?]|L/s/kPa|[?]|1|Pa|FLEXOR DIGITORUM PROFUNDUS MUSCLE|RIGHT|Y|Y|SIGNIFICANT OTHER|4|Visit_4|65|5|FOLLOW-UP|2020-11-21|65
e|FA|0329de16-fc7a-4941-900c-b390dac637aa|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|CAPLET|[?]|1|mL|LOWER JUGULAR LYMPH NODE|RIGHT|||INTERVIEWER|5|Visit_5|90|2|SCREENING|2020-12-16|90
e|FA|0329de16-fc7a-4941-900c-b390dac637aa|10|DFIBER|Dietary Fiber|[?]|GERD|[?]|mL/animal/wk|[?]|1|h*%|TEMPORAL LOBE|CONTRALATERAL|||STUDY SUBJECT|5|Visit_5|90|1|FOLLOW-UP|2020-12-16|90
e|FA|89d364c9-1338-472b-af0b-19280e45508b|1|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|mg2/dL2|[?]|1|mL/m2|SUBGLOTTIS|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-10-15|10
e|FA|89d364c9-1338-472b-af0b-19280e45508b|2|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|ng/L|[?]|1|mL/m2|UMBILICUS|UNILATERAL|||ADJUDICATOR|1|Visit_1|10|7|SCREENING|2020-10-15|10
e|FA|89d364c9-1338-472b-af0b-19280e45508b|3|DCAL|Dietary Calories|[?]|GERD|[?]|mCi/L|[?]|1|EIA unit|LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT|RIGHT|||PARENT|2|Visit_2|25|1|WASHOUT|2020-10-30|25
e|FA|89d364c9-1338-472b-af0b-19280e45508b|4|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|PFU/dose|[?]|1|TRANSDUCING UNIT/mL|HEART, APEX|CONTRALATERAL|||FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-10-30|25
e|FA|89d364c9-1338-472b-af0b-19280e45508b|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Bq/mg|[?]|1|%(v/v)|PANCREAS|LEFT|||CHILD|3|Visit_3|40|2|TREATMENT|2020-11-14|40
e|FA|89d364c9-1338-472b-af0b-19280e45508b|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|APPLICATION|[?]|1|QUANTITY SUFFICIENT|SUBLINGUAL REGION|CONTRALATERAL||Y|INTERVIEWER|3|Visit_3|40|1|TREATMENT|2020-11-14|40
e|FA|89d364c9-1338-472b-af0b-19280e45508b|7|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|min*mg/mL|[?]|1|10^9 CFU/g|CERVICAL LYMPH NODE|LATERAL|Y||PARENT|4|Visit_4|65|7|WASHOUT|2020-12-09|65
e|FA|89d364c9-1338-472b-af0b-19280e45508b|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/cm2|[?]|1|mg/g/min|URACHAL TRACT|BILATERAL|Y|Y|INTERVIEWER|4|Visit_4|65|4|FOLLOW-UP|2020-12-09|65
e|FA|89d364c9-1338-472b-af0b-19280e45508b|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|mg/g/min|TRIGEMINAL NERVE|BILATERAL|||INVESTIGATOR|5|Visit_5|90|6|FOLLOW-UP|2021-01-03|90
e|FA|89d364c9-1338-472b-af0b-19280e45508b|10|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|umol/dL|[?]|1|ohm|AXILLARY LYMPH NODE LEVEL III|LEFT|Y|Y|CHILD|5|Visit_5|90|7|SCREENING|2021-01-03|90
e|FA|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|1|RLDEV|Relationship to Device|[?]|GERD|[?]|um/day|[?]|1|mL/min/mmHg|GLUTEUS MAXIMUS|CONTRALATERAL|||INVESTIGATOR|1|Visit_1|10|5|SCREENING|2020-05-27|10
e|FA|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|2|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/h|[?]|1|km|FIBULAR VEIN|LEFT|||INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-05-27|10
e|FA|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|3|DFRUIT|Dietary Fruit|[?]|GERD|[?]|EID 50/mL|[?]|1|10^6 CFU/mL|T10 VERTEBRA|CONTRALATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2020-06-11|25
e|FA|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|BAG|[?]|1|MBq|HAND DIGIT 1|UNILATERAL|Y|Y|PARENT|2|Visit_2|25|1|TREATMENT|2020-06-11|25
e|FA|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|5|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|POINT|[?]|1|gtt|TEMPLE|RIGHT|Y|Y|CHILD|3|Visit_3|40|3|TREATMENT|2020-06-26|40
e|FA|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|6|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|DIOPTER|[?]|1|fmol|PERIFACIAL LYMPH NODE|LEFT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|SCREENING|2020-06-26|40
e|FA|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|7|DVEG|Dietary Vegetable|[?]|GERD|[?]|mL/(min*100mL)|[?]|1|Ci/ug|PROXIMAL PHALANX 2 OF THE HAND|UNILATERAL|||SPOUSE|4|Visit_4|65|7|SCREENING|2020-07-21|65
e|FA|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|8|SEV|Severity/Intensity|[?]|GERD|[?]|mL/dL|[?]|1|Pa|ULNA|UNILATERAL|Y||ADJUDICATOR|4|Visit_4|65|1|FOLLOW-UP|2020-07-21|65
e|FA|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|9|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|ug/g/min|[?]|1|100 IU/mL|SUBARACHNOID SPACE|CONTRALATERAL||Y|VENDOR|5|Visit_5|90|3|FOLLOW-UP|2020-08-15|90
e|FA|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|10|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|BOWL|GREAT VESSELS|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-08-15|90
e|FA|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|1|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|g/cage/day|PROSTATE GLAND|CONTRALATERAL|||FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2020-10-12|10
e|FA|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|2|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|aMFI|[?]|1|psi|PANCREAS, TAIL|LATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|3|SCREENING|2020-10-12|10
e|FA|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|3|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|mEq/mL|[?]|1|vp/dose|CORONARY ARTERY, LEFT|UNILATERAL||Y|PARENT|2|Visit_2|25|2|TREATMENT|2020-10-27|25
e|FA|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|4|STRCTNUM|Number of Strictures|[?]|GERD|[?]|AgU/mL|[?]|1|SACHET|PALATINE BONE|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|FOLLOW-UP|2020-10-27|25
e|FA|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|5|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|Absorbance U/mL|[?]|1|Gy/h|T8 VERTEBRA|CONTRALATERAL|Y|Y|CHILD|3|Visit_3|40|5|SCREENING|2020-11-11|40
e|FA|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|6|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|POUCH|[?]|1|TRANSDUCING UNIT/mL|POPLITEAL ARTERY BELOW KNEE|IPSILATERAL|||SIBLING|3|Visit_3|40|5|SCREENING|2020-11-11|40
e|FA|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|7|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|cmH2O*s/mL|[?]|1|mL/mmHg/min/L|SOLE|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2020-12-06|65
e|FA|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|8|DVEG|Dietary Vegetable|[?]|GERD|[?]|msec|[?]|1|Ci/ug|PANCREAS, HEAD|IPSILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|4|SCREENING|2020-12-06|65
e|FA|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|9|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|/2000 RBC|[?]|1|/kg|CORPUS UTERI|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|4|WASHOUT|2020-12-31|90
e|FA|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|10|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|umol/dL|[?]|1|aMFI|POSTERIOR SUPERIOR ILIAC SPINE|UNILATERAL|Y||SIBLING|5|Visit_5|90|3|TREATMENT|2020-12-31|90
e|FA|0c103005-efae-48ed-91e3-35d38fa1d359|1|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/cage/day|[?]|1|/500 WBC|PERIHILAR LYMPH NODE|BILATERAL|||PROXY|1|Visit_1|10|5|TREATMENT|2020-05-28|10
e|FA|0c103005-efae-48ed-91e3-35d38fa1d359|2|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|DRINK|[?]|1|fmol|TRICUSPID VALVE, POSTERIOR ANNULUS|CONTRALATERAL|||FAMILY MEMBER|1|Visit_1|10|5|SCREENING|2020-05-28|10
e|FA|0c103005-efae-48ed-91e3-35d38fa1d359|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|Pa|ETHMOID BONE|LATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|2|FOLLOW-UP|2020-06-12|25
e|FA|0c103005-efae-48ed-91e3-35d38fa1d359|4|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|GBq/ug|[?]|1|BP|SALIVARY GLAND|UNILATERAL|||STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-06-12|25
e|FA|0c103005-efae-48ed-91e3-35d38fa1d359|5|PPTFCT|Precipitating Factor|[?]|GERD|[?]|in|[?]|1|EIA unit|METACARPAL BONE 1|CONTRALATERAL|||PROXY|3|Visit_3|40|4|SCREENING|2020-06-27|40
e|FA|0c103005-efae-48ed-91e3-35d38fa1d359|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|/ms|[?]|1|QUANTITY SUFFICIENT|PROXIMAL INTERPHALANGEAL JOINT 2|LEFT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|SCREENING|2020-06-27|40
e|FA|0c103005-efae-48ed-91e3-35d38fa1d359|7|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|L|[?]|1|IU/mg|SUPRAGLOTTIS|UNILATERAL||Y|CHILD|4|Visit_4|65|2|SCREENING|2020-07-22|65
e|FA|0c103005-efae-48ed-91e3-35d38fa1d359|8|LESNUM|Number of Lesions|[?]|GERD|[?]|Gravitational Unit|[?]|1|ng/day|PALATINE BONE|IPSILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2020-07-22|65
e|FA|0c103005-efae-48ed-91e3-35d38fa1d359|9|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|pmol/L/h|[?]|1|mL/100g/min|CLAW|BILATERAL|||PROXY|5|Visit_5|90|6|TREATMENT|2020-08-16|90
e|FA|0c103005-efae-48ed-91e3-35d38fa1d359|10|DFIBER|Dietary Fiber|[?]|GERD|[?]|ug/kg/min|[?]|1|h*%|PARASPINAL REGION|IPSILATERAL|||PROXY|5|Visit_5|90|5|TREATMENT|2020-08-16|90
e|FA|c9808184-3432-448c-a5e5-50176715effa|1|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|/4.0 mL|[?]|1|Log10 ELISA unit|TRIGEMINAL NERVE|IPSILATERAL|||GUARDIAN|1|Visit_1|10|3|TREATMENT|2020-12-29|10
e|FA|c9808184-3432-448c-a5e5-50176715effa|2|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|ug/g/day|[?]|1|BAG|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|RIGHT|||ADJUDICATOR|1|Visit_1|10|1|FOLLOW-UP|2020-12-29|10
e|FA|c9808184-3432-448c-a5e5-50176715effa|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/kg/h|[?]|1|mg/g/min|PANCREAS, ENDOCRINE|CONTRALATERAL||Y|SIBLING|2|Visit_2|25|6|WASHOUT|2021-01-13|25
e|FA|c9808184-3432-448c-a5e5-50176715effa|4|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|mEq|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|LATERAL|||INTERVIEWER|2|Visit_2|25|4|TREATMENT|2021-01-13|25
e|FA|c9808184-3432-448c-a5e5-50176715effa|5|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|uL|[?]|1|g/day|PRIMARY VISUAL CORTEX|IPSILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|1|FOLLOW-UP|2021-01-28|40
e|FA|c9808184-3432-448c-a5e5-50176715effa|6|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|10^6 CFU|HYOID BONE|LEFT|Y||ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2021-01-28|40
e|FA|c9808184-3432-448c-a5e5-50176715effa|7|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|pmol|[?]|1|cmH2O/mL|THORACIC CAVITY|LEFT|||PARENT|4|Visit_4|65|1|SCREENING|2021-02-22|65
e|FA|c9808184-3432-448c-a5e5-50176715effa|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|um2|[?]|1|U/mmol|RADIAL NERVE|BILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|7|FOLLOW-UP|2021-02-22|65
e|FA|c9808184-3432-448c-a5e5-50176715effa|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|FEU|[?]|1|mL|COMMON ILIAC ARTERY|LATERAL||Y|VENDOR|5|Visit_5|90|5|TREATMENT|2021-03-19|90
e|FA|c9808184-3432-448c-a5e5-50176715effa|10|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|umol/L/h|[?]|1|mmHg/L/min|HAIR BULB|RIGHT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|FOLLOW-UP|2021-03-19|90
e|FA|c3d7d293-975f-44de-bd35-0168eec40ac9|1|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|kBq/uL|[?]|1|PACK|FACE|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2021-01-04|10
e|FA|c3d7d293-975f-44de-bd35-0168eec40ac9|2|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|PFU/dose|[?]|1|Bq/L|CORNEA|UNILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|1|WASHOUT|2021-01-04|10
e|FA|c3d7d293-975f-44de-bd35-0168eec40ac9|3|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|PFU/dose|EAR, OUTER|UNILATERAL|Y||FRIEND|2|Visit_2|25|5|TREATMENT|2021-01-19|25
e|FA|c3d7d293-975f-44de-bd35-0168eec40ac9|4|AGETRT1|Age At First Treatment|[?]|GERD|[?]|fg|[?]|1|mL/mmHg/min/L|RIGHT VENTRICULAR BRANCH|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2021-01-19|25
e|FA|c3d7d293-975f-44de-bd35-0168eec40ac9|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mm/h|[?]|1|mg/g/min|EARLOBE|BILATERAL||Y|GUARDIAN|3|Visit_3|40|1|FOLLOW-UP|2021-02-03|40
e|FA|c3d7d293-975f-44de-bd35-0168eec40ac9|6|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|VIAL|[?]|1|anti-Xa IU/mL|HYMENAL RING|IPSILATERAL|||VENDOR|3|Visit_3|40|5|FOLLOW-UP|2021-02-03|40
e|FA|c3d7d293-975f-44de-bd35-0168eec40ac9|7|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|vp/mL|[?]|1|Ci/ug|LUMBAR REGION|CONTRALATERAL|||INTERVIEWER|4|Visit_4|65|4|WASHOUT|2021-02-28|65
e|FA|c3d7d293-975f-44de-bd35-0168eec40ac9|8|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|/200 HPFs|[?]|1|Gy/h|MITRAL VALVE, ANTERIOR ANNULUS|LATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|5|TREATMENT|2021-02-28|65
e|FA|c3d7d293-975f-44de-bd35-0168eec40ac9|9|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|uEq/L|[?]|1|Shock Wave|FALCIFORM LIGAMENT|CONTRALATERAL|Y|Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|4|TREATMENT|2021-03-25|90
e|FA|c3d7d293-975f-44de-bd35-0168eec40ac9|10|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|g/g/day|[?]|1|mIU/L|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|BILATERAL|||PARENT|5|Visit_5|90|2|TREATMENT|2021-03-25|90
e|FA|2db1f07d-a7db-4cc3-8943-536e24378f08|1|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|ng/dL|[?]|1|10^4 CFU/mL|INTERPHALANGEAL THUMB JOINT|LEFT|||INTERVIEWER|1|Visit_1|10|5|WASHOUT|2020-06-12|10
e|FA|2db1f07d-a7db-4cc3-8943-536e24378f08|2|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|gMFI|[?]|1|ng|BASILIC VEIN|LEFT|||SPOUSE|1|Visit_1|10|5|TREATMENT|2020-06-12|10
e|FA|2db1f07d-a7db-4cc3-8943-536e24378f08|3|SPEED|Speed|[?]|GERD|[?]|mL/s|[?]|1|mEq/g|OBTURATOR INTERNUS MUSCLE|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|4|WASHOUT|2020-06-27|25
e|FA|2db1f07d-a7db-4cc3-8943-536e24378f08|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|nmol|[?]|1|10^6 IU/mL|ENDOCERVIX|LATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|TREATMENT|2020-06-27|25
e|FA|2db1f07d-a7db-4cc3-8943-536e24378f08|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|cm/min|[?]|1|U/mg|BLADDER WALL|LATERAL||Y|VENDOR|3|Visit_3|40|6|TREATMENT|2020-07-12|40
e|FA|2db1f07d-a7db-4cc3-8943-536e24378f08|6|TOTNUM|Total Number|[?]|GERD|[?]|nmol/mol|[?]|1|/200 HPFs|FINGER EXTENSOR MUSCLES|CONTRALATERAL|||ADJUDICATOR|3|Visit_3|40|1|SCREENING|2020-07-12|40
e|FA|2db1f07d-a7db-4cc3-8943-536e24378f08|7|LDIAM|Longest Diameter|[?]|GERD|[?]|/2000 RBC|[?]|1|Shock Wave|PANCREAS, ENDOCRINE|LEFT|||VENDOR|4|Visit_4|65|2|TREATMENT|2020-08-06|65
e|FA|2db1f07d-a7db-4cc3-8943-536e24378f08|8|DPROT|Dietary Protein|[?]|GERD|[?]|Frames/s|[?]|1|10^4 CFU/mL|DISTANT LYMPH NODE|LATERAL|||GUARDIAN|4|Visit_4|65|5|TREATMENT|2020-08-06|65
e|FA|2db1f07d-a7db-4cc3-8943-536e24378f08|9|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/g Hb|[?]|1|PACK|HEART, LEFT VENTRICLE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-08-31|90
e|FA|2db1f07d-a7db-4cc3-8943-536e24378f08|10|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|/100 WBC|[?]|1|g/L|SCALP|LATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-08-31|90
e|FA|c343ba98-87d7-40bc-b0e8-b866e42d3a21|1|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|mm/sec|[?]|1|g/day|CAUDAL VERTEBRA|IPSILATERAL|||PARENT|1|Visit_1|10|4|TREATMENT|2020-12-15|10
e|FA|c343ba98-87d7-40bc-b0e8-b866e42d3a21|2|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|ks|[?]|1|cmH2O/mL|LIP, UPPER|BILATERAL|||CHILD|1|Visit_1|10|1|SCREENING|2020-12-15|10
e|FA|c343ba98-87d7-40bc-b0e8-b866e42d3a21|3|SEV|Severity/Intensity|[?]|GERD|[?]|RATIO|[?]|1|Pa|PELVIC LYMPH NODE|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-12-30|25
e|FA|c343ba98-87d7-40bc-b0e8-b866e42d3a21|4|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|mEq/dL|[?]|1|DRUM|AXILLARY LYMPH NODE LEVEL I|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-12-30|25
e|FA|c343ba98-87d7-40bc-b0e8-b866e42d3a21|5|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|mL/min/mmHg|[?]|1|g/day|DISTAL LAD ARTERY|LATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|5|SCREENING|2021-01-14|40
e|FA|c343ba98-87d7-40bc-b0e8-b866e42d3a21|6|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|h/wk|[?]|1|gtt|HEART, APEX|LATERAL||Y|ADJUDICATOR|3|Visit_3|40|6|SCREENING|2021-01-14|40
e|FA|c343ba98-87d7-40bc-b0e8-b866e42d3a21|7|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|mL/mmHg/min/L|HAND PHALANX|IPSILATERAL|Y||FAMILY MEMBER|4|Visit_4|65|7|FOLLOW-UP|2021-02-08|65
e|FA|c343ba98-87d7-40bc-b0e8-b866e42d3a21|8|STROKTYP|Stroke Type|[?]|GERD|[?]|Joule|[?]|1|g/L|TRAPEZOID BONE|BILATERAL|||SIBLING|4|Visit_4|65|7|SCREENING|2021-02-08|65
e|FA|c343ba98-87d7-40bc-b0e8-b866e42d3a21|9|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|IU/kg/h|[?]|1|/200 HPFs|SOLE|CONTRALATERAL|||VENDOR|5|Visit_5|90|1|TREATMENT|2021-03-05|90
e|FA|c343ba98-87d7-40bc-b0e8-b866e42d3a21|10|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|U.CARR|[?]|1|g/day|C2 VERTEBRA|UNILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|2|FOLLOW-UP|2021-03-05|90
e|FA|d2b31ba9-9718-43ce-82ca-3276c28ac42a|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mmol/s|[?]|1|mg/g/min|ENDOMETRIAL CAVITY|LATERAL|||ADJUDICATOR|1|Visit_1|10|2|WASHOUT|2020-12-04|10
e|FA|d2b31ba9-9718-43ce-82ca-3276c28ac42a|2|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|dpm/mg|[?]|1|10^6 IU/mL|GASTROINTESTINAL TRACT, LOWER, WALL|IPSILATERAL||Y|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-12-04|10
e|FA|d2b31ba9-9718-43ce-82ca-3276c28ac42a|3|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|U|[?]|1|TRANSDUCING UNIT/mL|APPENDICEAL TIP|CONTRALATERAL|||FAMILY MEMBER|2|Visit_2|25|7|TREATMENT|2020-12-19|25
e|FA|d2b31ba9-9718-43ce-82ca-3276c28ac42a|4|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|mCi/L|[?]|1|m2|SKIN OF THE HEAD|LATERAL||Y|SIGNIFICANT OTHER|2|Visit_2|25|2|WASHOUT|2020-12-19|25
e|FA|d2b31ba9-9718-43ce-82ca-3276c28ac42a|5|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|STRIP|[?]|1|DROP|FRONTAL LOBE|IPSILATERAL|||CAREGIVER|3|Visit_3|40|1|TREATMENT|2021-01-03|40
e|FA|d2b31ba9-9718-43ce-82ca-3276c28ac42a|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|AgU/mL|[?]|1|mg/g/min|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|IPSILATERAL|Y||SIBLING|3|Visit_3|40|5|TREATMENT|2021-01-03|40
e|FA|d2b31ba9-9718-43ce-82ca-3276c28ac42a|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|cP|[?]|1|umol|RENAL ARTERY|UNILATERAL|||SPOUSE|4|Visit_4|65|1|SCREENING|2021-01-28|65
e|FA|d2b31ba9-9718-43ce-82ca-3276c28ac42a|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|/4.0 mL|[?]|1|CUP|MEDIASTINAL LYMPH NODE|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-01-28|65
e|FA|d2b31ba9-9718-43ce-82ca-3276c28ac42a|9|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|AMPULE|[?]|1|gtt|ILEUM LYMPH NODE|LATERAL|Y|Y|VENDOR|5|Visit_5|90|7|TREATMENT|2021-02-22|90
e|FA|d2b31ba9-9718-43ce-82ca-3276c28ac42a|10|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|umol/L/min|[?]|1|DRUM|COMMON FEMORAL ARTERY|LATERAL|||CAREGIVER|5|Visit_5|90|4|WASHOUT|2021-02-22|90
e|FA|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|1|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|nmol|[?]|1|DRUM|GENITALIA|UNILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|FOLLOW-UP|2020-07-23|10
e|FA|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|2|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|cmH2O/mL|[?]|1|ng|INTERPHALANGEAL JOINT 4|UNILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-07-23|10
e|FA|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|3|TOTNUM|Total Number|[?]|GERD|[?]|h*%|[?]|1|/200 HPFs|ADRENAL GLAND|LATERAL||Y|INTERVIEWER|2|Visit_2|25|4|WASHOUT|2020-08-07|25
e|FA|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|4|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|10^3/hpf|[?]|1|Log10 ELISA unit|CEREBRAL SUBCORTEX|RIGHT|||DOMESTIC PARTNER|2|Visit_2|25|6|WASHOUT|2020-08-07|25
e|FA|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|5|DFRUIT|Dietary Fruit|[?]|GERD|[?]|IU/g Hb|[?]|1|10^6 CFU/mL|PARACOLIC GUTTER|IPSILATERAL|||PROXY|3|Visit_3|40|5|TREATMENT|2020-08-22|40
e|FA|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|tsp|[?]|1|Shock Wave|INTERPHALANGEAL JOINT 5|BILATERAL|||ADJUDICATOR|3|Visit_3|40|6|FOLLOW-UP|2020-08-22|40
e|FA|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/L|[?]|1|Pa|RENAL PELVIS|RIGHT|Y|Y|SIBLING|4|Visit_4|65|5|TREATMENT|2020-09-16|65
e|FA|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|8|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|g/day|HILAR|UNILATERAL|||STUDY SUBJECT|4|Visit_4|65|5|SCREENING|2020-09-16|65
e|FA|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|9|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|mL/h|[?]|1|Shock Wave|ILIAC VEIN|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2020-10-11|90
e|FA|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|10|DGRAIN|Dietary Grain|[?]|GERD|[?]|L/s/kPa|[?]|1|10^9 CFU/g|WRIST JOINT|BILATERAL|Y|Y|ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2020-10-11|90
e|FA|0a42f96a-49c3-492f-a272-bf9989e53e9d|1|SPEED|Speed|[?]|GERD|[?]|IU|[?]|1|mEq/g|BRAIN VENTRICLE|IPSILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2021-01-26|10
e|FA|0a42f96a-49c3-492f-a272-bf9989e53e9d|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|um|[?]|1|mg/g/min|PERIPANCREATIC LYMPH NODE|BILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|SCREENING|2021-01-26|10
e|FA|0a42f96a-49c3-492f-a272-bf9989e53e9d|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|10^3 RNA copies/mL|[?]|1|U/mg|ELBOW EXTENSOR MUSCLES|LATERAL|Y||CHILD|2|Visit_2|25|1|TREATMENT|2021-02-10|25
e|FA|0a42f96a-49c3-492f-a272-bf9989e53e9d|4|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|GPL U|[?]|1|gtt|OBTURATOR INTERNUS MUSCLE|IPSILATERAL||Y|SIBLING|2|Visit_2|25|1|WASHOUT|2021-02-10|25
e|FA|0a42f96a-49c3-492f-a272-bf9989e53e9d|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|mg/g/min|TIBIA SHAFT|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2021-02-25|40
e|FA|0a42f96a-49c3-492f-a272-bf9989e53e9d|6|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|ug/m2/min|[?]|1|L|PROXIMAL URETHRA|BILATERAL|||SPOUSE|3|Visit_3|40|2|TREATMENT|2021-02-25|40
e|FA|0a42f96a-49c3-492f-a272-bf9989e53e9d|7|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|NEBULE|[?]|1|km|HYMENAL RING|LEFT||Y|CAREGIVER|4|Visit_4|65|5|SCREENING|2021-03-22|65
e|FA|0a42f96a-49c3-492f-a272-bf9989e53e9d|8|QOLIMP|QOL Impact|[?]|GERD|[?]|mEq/g|[?]|1|10^6/L|SEMITENDINOSUS MUSCLE|RIGHT|||STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2021-03-22|65
e|FA|0a42f96a-49c3-492f-a272-bf9989e53e9d|9|VOL|Volume|[?]|GERD|[?]|DRINK|[?]|1|vp/dose|RADIAL NERVE|IPSILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2021-04-16|90
e|FA|0a42f96a-49c3-492f-a272-bf9989e53e9d|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|HOMEOPATHIC DILUTION|[?]|1|U/mmol|GENITALIA|UNILATERAL|||FAMILY MEMBER|5|Visit_5|90|4|FOLLOW-UP|2021-04-16|90
e|FA|a78e7287-581c-4bf2-b3ca-ad2476c010cd|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/animal/wk|[?]|1|mg/g/min|METACARPOPHALANGEAL JOINT 5|LATERAL|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|FOLLOW-UP|2021-01-08|10
e|FA|a78e7287-581c-4bf2-b3ca-ad2476c010cd|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|ELISA unit/mL|[?]|1|g/day|UTERUS|LATERAL|||VENDOR|1|Visit_1|10|2|WASHOUT|2021-01-08|10
e|FA|a78e7287-581c-4bf2-b3ca-ad2476c010cd|3|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|Joule|[?]|1|PACK|GLOTTIS|IPSILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2021-01-23|25
e|FA|a78e7287-581c-4bf2-b3ca-ad2476c010cd|4|DGRAIN|Dietary Grain|[?]|GERD|[?]|Gy/h|[?]|1|10^9 CFU/g|HEART, SEPTUM|CONTRALATERAL|Y|Y|CAREGIVER|2|Visit_2|25|4|WASHOUT|2021-01-23|25
e|FA|a78e7287-581c-4bf2-b3ca-ad2476c010cd|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|BAG|[?]|1|mg/g/min|PROXIMAL PHALANX 2 OF THE HAND|LATERAL|||CHILD|3|Visit_3|40|4|SCREENING|2021-02-07|40
e|FA|a78e7287-581c-4bf2-b3ca-ad2476c010cd|6|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|ppb|[?]|1|mL/animal/day|FEMORAL LYMPH NODE|UNILATERAL|||SPOUSE|3|Visit_3|40|7|TREATMENT|2021-02-07|40
e|FA|a78e7287-581c-4bf2-b3ca-ad2476c010cd|7|TRTSETT|Treatment Setting|[?]|GERD|[?]|mol/mL|[?]|1|Coulomb|TUNICA INTIMA|UNILATERAL|||FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2021-03-04|65
e|FA|a78e7287-581c-4bf2-b3ca-ad2476c010cd|8|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|mL/m2|BLADDER, NECK|UNILATERAL||Y|ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2021-03-04|65
e|FA|a78e7287-581c-4bf2-b3ca-ad2476c010cd|9|DPROT|Dietary Protein|[?]|GERD|[?]|10^6 DNA copies/mL|[?]|1|10^4 CFU/mL|SCALP|IPSILATERAL|||ADJUDICATOR|5|Visit_5|90|2|SCREENING|2021-03-29|90
e|FA|a78e7287-581c-4bf2-b3ca-ad2476c010cd|10|ACNDEV|Action Taken With Device|[?]|GERD|[?]|mg2/dL2|[?]|1|100 IU/mL|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|LEFT|||STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2021-03-29|90
e|FA|d3651e5f-bc38-4c96-afbf-5a65873ff306|1|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|BAU/mL|[?]|1|mm/h|HIP|BILATERAL||Y|STUDY SUBJECT|1|Visit_1|10|3|TREATMENT|2020-07-28|10
e|FA|d3651e5f-bc38-4c96-afbf-5a65873ff306|2|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|mg/dose|[?]|1|10^9 CFU/g|CORONARY SINUS|IPSILATERAL||Y|FRIEND|1|Visit_1|10|6|SCREENING|2020-07-28|10
e|FA|d3651e5f-bc38-4c96-afbf-5a65873ff306|3|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|DRUM|HUMERUS|LATERAL|Y|Y|INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-08-12|25
e|FA|d3651e5f-bc38-4c96-afbf-5a65873ff306|4|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|mL/min|[?]|1|mL/m2|DISTAL CIRCUMFLEX ARTERY|RIGHT|||SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2020-08-12|25
e|FA|d3651e5f-bc38-4c96-afbf-5a65873ff306|5|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|Gy/min|[?]|1|mIU/L|PROSTATE GLAND, POSTERIOR LOBE|LATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-08-27|40
e|FA|d3651e5f-bc38-4c96-afbf-5a65873ff306|6|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|CAPFUL|[?]|1|Gy/h|ORAL CAVITY|LEFT|||INDEPENDENT ASSESSOR|3|Visit_3|40|7|SCREENING|2020-08-27|40
e|FA|d3651e5f-bc38-4c96-afbf-5a65873ff306|7|OBJNUM|Number of Objects|[?]|GERD|[?]|L/h|[?]|1|mL/100g/min|PRONATOR QUADRATUS MUSCLE|RIGHT||Y|FAMILY MEMBER|4|Visit_4|65|5|SCREENING|2020-09-21|65
e|FA|d3651e5f-bc38-4c96-afbf-5a65873ff306|8|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|s*kPa|[?]|1|mmHg/L/min|HEART, APEX|BILATERAL||Y|INTERVIEWER|4|Visit_4|65|6|FOLLOW-UP|2020-09-21|65
e|FA|d3651e5f-bc38-4c96-afbf-5a65873ff306|9|DPROT|Dietary Protein|[?]|GERD|[?]|kN/cm2|[?]|1|10^4 CFU/mL|TAIL|RIGHT|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|FOLLOW-UP|2020-10-16|90
e|FA|d3651e5f-bc38-4c96-afbf-5a65873ff306|10|VOL|Volume|[?]|GERD|[?]|cmol|[?]|1|vp/dose|PERICARDIUM|IPSILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|2|FOLLOW-UP|2020-10-16|90
e|FA|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|1|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|RFU|[?]|1|BOWL|SCIATIC NERVE|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2020-06-11|10
e|FA|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|2|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|dB|[?]|1|mm|BRAIN, PERIVENTRICULAR REGION|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-06-11|10
e|FA|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|3|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|dmol|[?]|1|U/mg|TEMPORAL BONE|RIGHT||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-06-26|25
e|FA|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|4|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mL/animal/wk|[?]|1|fmol|COLON, DESCENDING|RIGHT|||CAREGIVER|2|Visit_2|25|5|SCREENING|2020-06-26|25
e|FA|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|5|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|umol/mg/min|[?]|1|DRUM|PALPEBRAL FISSURE|BILATERAL||Y|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-07-11|40
e|FA|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|6|SEV|Severity/Intensity|[?]|GERD|[?]|mEq/ug|[?]|1|Pa|PENIS, GLANS|LATERAL||Y|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-07-11|40
e|FA|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|7|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|cL|[?]|1|mg/dose|GASTROINTESTINAL TRACT, WALL|BILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-08-05|65
e|FA|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|8|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|10^3/hpf|[?]|1|DROP|BRAIN|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-08-05|65
e|FA|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|9|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|TRACE|[?]|1|DRUM|POPLITEAL ARTERY BELOW KNEE|UNILATERAL|||SPOUSE|5|Visit_5|90|6|WASHOUT|2020-08-30|90
e|FA|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|10|DGRAIN|Dietary Grain|[?]|GERD|[?]|HEP|[?]|1|10^9 CFU/g|ILIAC FOSSA|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|WASHOUT|2020-08-30|90
e|FA|f50537d2-e098-4dae-8f91-16f2357d709c|1|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|nmol/kg/day|[?]|1|umol|RADIAL ARTERY|BILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-12-07|10
e|FA|f50537d2-e098-4dae-8f91-16f2357d709c|2|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|cup eq|[?]|1|IU/mg|PRIMARY VISUAL CORTEX|UNILATERAL|Y||VENDOR|1|Visit_1|10|6|TREATMENT|2020-12-07|10
e|FA|f50537d2-e098-4dae-8f91-16f2357d709c|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mg/mL/day|[?]|1|10^6 U|FLEXOR DIGITORUM LONGUS MUSCLE|BILATERAL||Y|FRIEND|2|Visit_2|25|7|SCREENING|2020-12-22|25
e|FA|f50537d2-e098-4dae-8f91-16f2357d709c|4|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|10^7 TCID 50/dose|[?]|1|Shock Wave|GREATER CURVATURE OF THE STOMACH|RIGHT|Y||PROXY|2|Visit_2|25|3|TREATMENT|2020-12-22|25
e|FA|f50537d2-e098-4dae-8f91-16f2357d709c|5|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|dL|[?]|1|L|FINGER FLEXOR TENDONS|LATERAL|Y||FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2021-01-06|40
e|FA|f50537d2-e098-4dae-8f91-16f2357d709c|6|SEV|Severity/Intensity|[?]|GERD|[?]|mg/L FEU|[?]|1|Pa|PORTAL LYMPH NODE|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2021-01-06|40
e|FA|f50537d2-e098-4dae-8f91-16f2357d709c|7|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|pmol/day|[?]|1|Shock Wave|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|UNILATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|5|TREATMENT|2021-01-31|65
e|FA|f50537d2-e098-4dae-8f91-16f2357d709c|8|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|DRINK|[?]|1|PACK|DISTAL PHALANX 2 OF THE HAND|UNILATERAL||Y|INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2021-01-31|65
e|FA|f50537d2-e098-4dae-8f91-16f2357d709c|9|SERVNUM|Number of Servings|[?]|GERD|[?]|cL|[?]|1|Hz/s|PENIS|CONTRALATERAL|||SPOUSE|5|Visit_5|90|3|FOLLOW-UP|2021-02-25|90
e|FA|f50537d2-e098-4dae-8f91-16f2357d709c|10|EVENTNUM|Number of Events|[?]|GERD|[?]|umol|[?]|1|U/10^12 RBC|ILIAC LYMPH NODE|LEFT|||CAREGIVER|5|Visit_5|90|7|WASHOUT|2021-02-25|90
e|FA|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|1|CALBURN|Calories Burned|[?]|GERD|[?]|mL/dL|[?]|1|/kg|INTERPHALANGEAL JOINT 3 OF THE HAND|CONTRALATERAL||Y|INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-07-19|10
e|FA|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|2|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/min|[?]|1|mIU/L|L1 VERTEBRA|IPSILATERAL|||INTERVIEWER|1|Visit_1|10|6|WASHOUT|2020-07-19|10
e|FA|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|nm|[?]|1|Pa|MITRAL VALVE, POSTERIOR CUSP|LATERAL||Y|SPOUSE|2|Visit_2|25|2|FOLLOW-UP|2020-08-03|25
e|FA|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|4|STROKTYP|Stroke Type|[?]|GERD|[?]|breaths/30s|[?]|1|g/L|PHARYNGEAL TONSIL|RIGHT|||FAMILY MEMBER|2|Visit_2|25|5|SCREENING|2020-08-03|25
e|FA|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|5|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|kN/cm2|[?]|1|DROP|HEPATIC ARTERY|BILATERAL|||GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-08-18|40
e|FA|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|6|AGETRT1|Age At First Treatment|[?]|GERD|[?]|nmol/mol|[?]|1|mL/mmHg/min/L|SKIN OF THE SOLE|RIGHT|||STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2020-08-18|40
e|FA|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|7|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|mV|[?]|1|Coulomb|RADIUS-LUNATE JOINT|RIGHT|||STUDY SUBJECT|4|Visit_4|65|2|SCREENING|2020-09-12|65
e|FA|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|8|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|dL|[?]|1|SCOOPFUL|SCAPHOID BONE|RIGHT|Y|Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2020-09-12|65
e|FA|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|9|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|tuberculin unit/mL|[?]|1|anti-Xa IU/mL|AXILLARY LYMPH NODE LEVEL I|UNILATERAL|Y||ADJUDICATOR|5|Visit_5|90|6|WASHOUT|2020-10-07|90
e|FA|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mL/g/h|[?]|1|%(v/v)|METACARPAL BONE 5|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|WASHOUT|2020-10-07|90
e|FA|489870ed-9da5-4df6-a5ef-17821c449c84|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|BOLUS|[?]|1|mL/animal/day|VULVA|BILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|SCREENING|2020-07-30|10
e|FA|489870ed-9da5-4df6-a5ef-17821c449c84|2|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|ug/kg|[?]|1|DROP|THORACIC ARTERY|RIGHT|||CAREGIVER|1|Visit_1|10|1|TREATMENT|2020-07-30|10
e|FA|489870ed-9da5-4df6-a5ef-17821c449c84|3|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|Bq/L|MENINGES|RIGHT||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-08-14|25
e|FA|489870ed-9da5-4df6-a5ef-17821c449c84|4|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|mg/day|[?]|1|Gy/h|CEREBELLUM|CONTRALATERAL||Y|PROXY|2|Visit_2|25|5|FOLLOW-UP|2020-08-14|25
e|FA|489870ed-9da5-4df6-a5ef-17821c449c84|5|LDIAM|Longest Diameter|[?]|GERD|[?]|/h|[?]|1|Shock Wave|FUNDUS OF THE EYE|BILATERAL|Y||ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2020-08-29|40
e|FA|489870ed-9da5-4df6-a5ef-17821c449c84|6|DVEG|Dietary Vegetable|[?]|GERD|[?]|BU/mL|[?]|1|Ci/ug|C6 VERTEBRA|CONTRALATERAL|||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-08-29|40
e|FA|489870ed-9da5-4df6-a5ef-17821c449c84|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/m2/day|[?]|1|mg/g/min|VOMER|RIGHT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2020-09-23|65
e|FA|489870ed-9da5-4df6-a5ef-17821c449c84|8|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|PA|[?]|1|DRUM|HEART, APEX|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-09-23|65
e|FA|489870ed-9da5-4df6-a5ef-17821c449c84|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|um/day|[?]|1|mg/g/min|VASTUS LATERALIS MUSCLE|CONTRALATERAL|Y|Y|CHILD|5|Visit_5|90|1|FOLLOW-UP|2020-10-18|90
e|FA|489870ed-9da5-4df6-a5ef-17821c449c84|10|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|umol/h/mmol|[?]|1|Ci/ug|INTERPHALANGEAL JOINT 4|BILATERAL|Y||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|SCREENING|2020-10-18|90
e|FA|90fe992f-5a11-4829-b3b0-1c8314f53012|1|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|cmHg|[?]|1|DROP|ISCHIORECTAL FOSSA|LEFT|Y|Y|SPOUSE|1|Visit_1|10|7|FOLLOW-UP|2020-09-23|10
e|FA|90fe992f-5a11-4829-b3b0-1c8314f53012|2|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|msec|[?]|1|g/cage/day|L2-L3 INTERVERTEBRAL SPACE|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|1|FOLLOW-UP|2020-09-23|10
e|FA|90fe992f-5a11-4829-b3b0-1c8314f53012|3|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|Bq/ug|[?]|1|g/day|BRACHIAL ARTERY|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|SCREENING|2020-10-08|25
e|FA|90fe992f-5a11-4829-b3b0-1c8314f53012|4|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|/10^4|[?]|1|mL/m2|EARLOBE|LEFT|Y||FRIEND|2|Visit_2|25|2|SCREENING|2020-10-08|25
e|FA|90fe992f-5a11-4829-b3b0-1c8314f53012|5|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|vg/kg|[?]|1|mmHg/L/min|FLEXOR CARPI ULNARIS MUSCLE|UNILATERAL|||FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-10-23|40
e|FA|90fe992f-5a11-4829-b3b0-1c8314f53012|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/g/day|[?]|1|mg/g/min|TRACHEA|UNILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|TREATMENT|2020-10-23|40
e|FA|90fe992f-5a11-4829-b3b0-1c8314f53012|7|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|U/dL|[?]|1|uL/kg/day|RETROPERITONEUM|BILATERAL||Y|GUARDIAN|4|Visit_4|65|1|FOLLOW-UP|2020-11-17|65
e|FA|90fe992f-5a11-4829-b3b0-1c8314f53012|8|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|/10^4|[?]|1|h*%|METATARSOPHALANGEAL JOINT 1|LATERAL||Y|SIGNIFICANT OTHER|4|Visit_4|65|4|WASHOUT|2020-11-17|65
e|FA|90fe992f-5a11-4829-b3b0-1c8314f53012|9|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|cd/m2|[?]|1|m2|DORSAL MOTOR NUCLEUS|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2020-12-12|90
e|FA|90fe992f-5a11-4829-b3b0-1c8314f53012|10|DIAMETER|Diameter|[?]|GERD|[?]|ng/dL|[?]|1|cm|LYMPH NODE|LEFT|||GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-12-12|90
e|FA|74be8de0-3307-4cc3-9044-05068b60f7e0|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ug/cm2|[?]|1|mg/g/min|CHEST|UNILATERAL|||STUDY SUBJECT|1|Visit_1|10|4|SCREENING|2020-10-20|10
e|FA|74be8de0-3307-4cc3-9044-05068b60f7e0|2|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|IU/kg/h|[?]|1|10^6 IU/mL|PERIRECTAL LYMPH NODE|IPSILATERAL|Y||PROXY|1|Visit_1|10|5|TREATMENT|2020-10-20|10
e|FA|74be8de0-3307-4cc3-9044-05068b60f7e0|3|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|cmol/L|[?]|1|ug/g/h|SACRAL TUBEROSITY|LATERAL|Y|Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2020-11-04|25
e|FA|74be8de0-3307-4cc3-9044-05068b60f7e0|4|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|U/kg|[?]|1|BOWL|FLOOR OF MOUTH|LATERAL|||CAREGIVER|2|Visit_2|25|7|WASHOUT|2020-11-04|25
e|FA|74be8de0-3307-4cc3-9044-05068b60f7e0|5|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|Antibody Unit|[?]|1|ug/m2/h|JUGULAR VEIN|LEFT|||SIGNIFICANT OTHER|3|Visit_3|40|1|WASHOUT|2020-11-19|40
e|FA|74be8de0-3307-4cc3-9044-05068b60f7e0|6|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|cmH2O*s2/mL|[?]|1|Gy/h|SHOULDER|CONTRALATERAL|Y||PARENT|3|Visit_3|40|4|SCREENING|2020-11-19|40
e|FA|74be8de0-3307-4cc3-9044-05068b60f7e0|7|DFATT|Dietary Fat, Total|[?]|GERD|[?]|fmol/g|[?]|1|Bq/mg|MALE GENITALIA|LEFT|||FAMILY MEMBER|4|Visit_4|65|5|WASHOUT|2020-12-14|65
e|FA|74be8de0-3307-4cc3-9044-05068b60f7e0|8|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|umol/L/sec|[?]|1|cmH2O/mL|PHARYNX|BILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|7|WASHOUT|2020-12-14|65
e|FA|74be8de0-3307-4cc3-9044-05068b60f7e0|9|SEV|Severity/Intensity|[?]|GERD|[?]|g/mol|[?]|1|Pa|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|LEFT|||CAREGIVER|5|Visit_5|90|6|TREATMENT|2021-01-08|90
e|FA|74be8de0-3307-4cc3-9044-05068b60f7e0|10|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/g|[?]|1|L/h/m2|COMMON ILIAC ARTERY|LATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|SCREENING|2021-01-08|90
e|FA|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|1|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|FIU|[?]|1|Hz/s|SENSORIMOTOR CORTEX|UNILATERAL||Y|CAREGIVER|1|Visit_1|10|5|SCREENING|2020-06-11|10
e|FA|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|2|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|ppm|[?]|1|DROP|TRICUSPID VALVE, POSTERIOR CUSP|UNILATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-06-11|10
e|FA|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|3|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|cy/cm|[?]|1|uL/kg/day|ANTRUM PYLORI|BILATERAL|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-06-26|25
e|FA|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|4|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|in|[?]|1|mEq/g|RIB 1|LEFT|Y||INVESTIGATOR|2|Visit_2|25|1|SCREENING|2020-06-26|25
e|FA|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|5|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|SACHET|[?]|1|h*%|METACARPAL BONE 1|LEFT|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|WASHOUT|2020-07-11|40
e|FA|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|6|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|g|[?]|1|BP|FACIAL BONE|CONTRALATERAL|||PARENT|3|Visit_3|40|2|TREATMENT|2020-07-11|40
e|FA|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|SPRAY|[?]|1|mg/g/min|INFRATENTORIAL BRAIN|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-08-05|65
e|FA|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|8|DPROT|Dietary Protein|[?]|GERD|[?]|U/g Hb|[?]|1|10^4 CFU/mL|GUT-ASSOCIATED LYMPHOID TISSUE|BILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-08-05|65
e|FA|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|9|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|Osm|[?]|1|cmH2O/mL|NUCLEUS ACCUMBENS|IPSILATERAL|Y|Y|ADJUDICATOR|5|Visit_5|90|4|WASHOUT|2020-08-30|90
e|FA|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|10|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|CAPFUL|[?]|1|mAmp|SUPRACLAVICULAR FOSSA|UNILATERAL||Y|VENDOR|5|Visit_5|90|6|TREATMENT|2020-08-30|90
e|FA|8825b806-fa76-49d7-b281-d36fc42fee1e|1|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|titer|[?]|1|psi|LYMPH NODE HILUM|LEFT||Y|SIBLING|1|Visit_1|10|1|TREATMENT|2020-08-29|10
e|FA|8825b806-fa76-49d7-b281-d36fc42fee1e|2|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|Anson U|[?]|1|g/day|NAVICULAR BONE|UNILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|4|FOLLOW-UP|2020-08-29|10
e|FA|8825b806-fa76-49d7-b281-d36fc42fee1e|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|MONTHS|[?]|1|mg/g/min|THIRD RIGHT POSTEROLATERAL ARTERY|CONTRALATERAL|Y||PROXY|2|Visit_2|25|2|SCREENING|2020-09-13|25
e|FA|8825b806-fa76-49d7-b281-d36fc42fee1e|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|umol/day|[?]|1|mg/g/min|GLUTEAL MUSCLE|UNILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|7|SCREENING|2020-09-13|25
e|FA|8825b806-fa76-49d7-b281-d36fc42fee1e|5|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|cmol/L|[?]|1|BAG|PROXIMAL INTERPHALANGEAL JOINT 3|LEFT|Y||FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-09-28|40
e|FA|8825b806-fa76-49d7-b281-d36fc42fee1e|6|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|10^7/L|[?]|1|mEq|VOMER|LATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|TREATMENT|2020-09-28|40
e|FA|8825b806-fa76-49d7-b281-d36fc42fee1e|7|EXTRSCT|Extent of Resection|[?]|GERD|[?]|ug/cm2|[?]|1|Weber|CHOROID|RIGHT|Y||INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-10-23|65
e|FA|8825b806-fa76-49d7-b281-d36fc42fee1e|8|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|uEq/L|[?]|1|10^6 CFU/mL|SEBACEOUS GLAND|RIGHT||Y|DOMESTIC PARTNER|4|Visit_4|65|5|TREATMENT|2020-10-23|65
e|FA|8825b806-fa76-49d7-b281-d36fc42fee1e|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|BLOCKS|[?]|1|mg/g/min|PREPUTIAL GLAND|LEFT|||STUDY SUBJECT|5|Visit_5|90|6|FOLLOW-UP|2020-11-17|90
e|FA|8825b806-fa76-49d7-b281-d36fc42fee1e|10|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|MESF|[?]|1|fmol|PERITONEAL CAVITY|UNILATERAL|||ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-11-17|90
e|FA|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|1|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|g/g|[?]|1|mL/m2|GONAD|RIGHT|Y||SPOUSE|1|Visit_1|10|1|WASHOUT|2020-05-19|10
e|FA|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|2|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|mL/cage/wk|[?]|1|oz eq|CLITORIS|CONTRALATERAL|Y||VENDOR|1|Visit_1|10|1|TREATMENT|2020-05-19|10
e|FA|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|3|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|umol|[?]|1|TRANSDUCING UNIT/mL|ANTECUBITAL FOSSA|CONTRALATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-06-03|25
e|FA|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|4|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|DIP|[?]|1|10^9 CFU/mL|CAPITATE BONE|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-06-03|25
e|FA|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|5|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|OD Unit|[?]|1|cmH2O/mL|LIVER, RIGHT LOBE|BILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2020-06-18|40
e|FA|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|6|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|GBq/mg|[?]|1|10^6 U|EPIGASTRIC LYMPH NODE|BILATERAL|||VENDOR|3|Visit_3|40|1|WASHOUT|2020-06-18|40
e|FA|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|7|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|mol/mol|[?]|1|in|RIB 4|RIGHT||Y|VENDOR|4|Visit_4|65|7|FOLLOW-UP|2020-07-13|65
e|FA|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|8|RLDEV|Relationship to Device|[?]|GERD|[?]|PHERESIS UNIT|[?]|1|mL/min/mmHg|BRAIN VENTRICLE, LATERAL|UNILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-07-13|65
e|FA|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|9|QOLIMP|QOL Impact|[?]|GERD|[?]|cd|[?]|1|10^6/L|PROFUNDA FEMORIS ARTERY|LATERAL|||INVESTIGATOR|5|Visit_5|90|5|FOLLOW-UP|2020-08-07|90
e|FA|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|10|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|cP|[?]|1|IU/mmol|STERNOCLAVICULAR JOINT|LEFT|||INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2020-08-07|90
e|FA|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|1|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|Shock Wave|RETINAL ARTERY|RIGHT|Y||VENDOR|1|Visit_1|10|1|FOLLOW-UP|2021-01-14|10
e|FA|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|2|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|mg/dose|[?]|1|BOWL|PROCERUS MUSCLE|IPSILATERAL|||STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2021-01-14|10
e|FA|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|3|TOTNUM|Total Number|[?]|GERD|[?]|ug/mol|[?]|1|/200 HPFs|CORNEAL ENDOTHELIUM|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2021-01-29|25
e|FA|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|4|ESTWT|Estimated Weight|[?]|GERD|[?]|mg/mL/day|[?]|1|g/day|JEJUNUM|IPSILATERAL|||PARENT|2|Visit_2|25|3|TREATMENT|2021-01-29|25
e|FA|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|5|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|kUSP|[?]|1|mmHg/L/min|PUBIC BONE|IPSILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2021-02-13|40
e|FA|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|6|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|mm2|[?]|1|mL/m2|PALATINE BONE|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2021-02-13|40
e|FA|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|dpm/mg|[?]|1|Pa|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|IPSILATERAL|||SPOUSE|4|Visit_4|65|3|SCREENING|2021-03-10|65
e|FA|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|8|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|mL/dose|CHOROID|RIGHT|||FRIEND|4|Visit_4|65|2|WASHOUT|2021-03-10|65
e|FA|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|9|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|cmol|[?]|1|mL/h|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|RIGHT|Y||FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-04-04|90
e|FA|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|10|LESNUM|Number of Lesions|[?]|GERD|[?]|nkat/g Hb|[?]|1|ng/day|CAUDATE NUCLEUS|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2021-04-04|90
e|FA|b36220d8-c129-48bf-8c41-542a954b819a|1|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/g|[?]|1|10^6 organisms/mL|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|UNILATERAL||Y|ADJUDICATOR|1|Visit_1|10|5|TREATMENT|2020-05-24|10
e|FA|b36220d8-c129-48bf-8c41-542a954b819a|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|ft3|[?]|1|mg/g/min|RECTO-UTERINE POUCH|BILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|FOLLOW-UP|2020-05-24|10
e|FA|b36220d8-c129-48bf-8c41-542a954b819a|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|kDa|[?]|1|10^6 U|C1 VERTEBRA|LEFT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|WASHOUT|2020-06-08|25
e|FA|b36220d8-c129-48bf-8c41-542a954b819a|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|dpm/mL|[?]|1|NEEDLE GAUGE|CARDIOVASCULAR SYSTEM|IPSILATERAL|||FRIEND|2|Visit_2|25|4|TREATMENT|2020-06-08|25
e|FA|b36220d8-c129-48bf-8c41-542a954b819a|5|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|10^6 organisms/mL|[?]|1|IU/mg|FOREBRAIN|LEFT|||DOMESTIC PARTNER|3|Visit_3|40|1|SCREENING|2020-06-23|40
e|FA|b36220d8-c129-48bf-8c41-542a954b819a|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|MET|[?]|1|Pa|INTERPHALANGEAL JOINT 4|LATERAL||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-06-23|40
e|FA|b36220d8-c129-48bf-8c41-542a954b819a|7|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|/mm2|[?]|1|PACK|C4 VERTEBRA|RIGHT|||GUARDIAN|4|Visit_4|65|6|TREATMENT|2020-07-18|65
e|FA|b36220d8-c129-48bf-8c41-542a954b819a|8|RLDEV|Relationship to Device|[?]|GERD|[?]|MET*min|[?]|1|mL/min/mmHg|EYE|LEFT||Y|PARENT|4|Visit_4|65|2|WASHOUT|2020-07-18|65
e|FA|b36220d8-c129-48bf-8c41-542a954b819a|9|EXCDUR|Exercise Duration|[?]|GERD|[?]|mN|[?]|1|mm|CEREBRUM|BILATERAL|||FRIEND|5|Visit_5|90|6|TREATMENT|2020-08-12|90
e|FA|b36220d8-c129-48bf-8c41-542a954b819a|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|U/m2|[?]|1|%(v/v)|SOFT TISSUE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|TREATMENT|2020-08-12|90
e|FA|92d3477b-7460-4ce8-b237-38ca4c55fc91|1|OBJTYPE|Type of Object|[?]|GERD|[?]|BLOCKS|[?]|1|ng|LESSER TROCHANTER|BILATERAL|Y|Y|ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2020-08-14|10
e|FA|92d3477b-7460-4ce8-b237-38ca4c55fc91|2|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/uL|[?]|1|mL/m2|RIB 3|CONTRALATERAL|||FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-08-14|10
e|FA|92d3477b-7460-4ce8-b237-38ca4c55fc91|3|LENRSCT|Length of Resection|[?]|GERD|[?]|g/L|[?]|1|psi|CEREBRAL HEMISPHERE, RIGHT|BILATERAL|||SPOUSE|2|Visit_2|25|2|FOLLOW-UP|2020-08-29|25
e|FA|92d3477b-7460-4ce8-b237-38ca4c55fc91|4|EXCDUR|Exercise Duration|[?]|GERD|[?]|gtt|[?]|1|mm|SKIN OF THE FOOT|BILATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|4|FOLLOW-UP|2020-08-29|25
e|FA|92d3477b-7460-4ce8-b237-38ca4c55fc91|5|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|mmHg/sec|[?]|1|cmH2O/mL|PRELARYNGEAL LYMPH NODE|LATERAL|||VENDOR|3|Visit_3|40|5|TREATMENT|2020-09-13|40
e|FA|92d3477b-7460-4ce8-b237-38ca4c55fc91|6|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|km/h|[?]|1|m2|SKIN|RIGHT|||SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2020-09-13|40
e|FA|92d3477b-7460-4ce8-b237-38ca4c55fc91|7|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|BOWL|[?]|1|HOURS|TRICUSPID VALVE|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-10-08|65
e|FA|92d3477b-7460-4ce8-b237-38ca4c55fc91|8|PPTFCT|Precipitating Factor|[?]|GERD|[?]|mm|[?]|1|EIA unit|EPIGLOTTIS|UNILATERAL|||PARENT|4|Visit_4|65|3|TREATMENT|2020-10-08|65
e|FA|92d3477b-7460-4ce8-b237-38ca4c55fc91|9|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|SACHET|HEART, VENTRICULAR WALL|RIGHT|||FAMILY MEMBER|5|Visit_5|90|5|FOLLOW-UP|2020-11-02|90
e|FA|92d3477b-7460-4ce8-b237-38ca4c55fc91|10|ACNDEV|Action Taken With Device|[?]|GERD|[?]|mOsm|[?]|1|100 IU/mL|LUNG, RIGHT LOWER LOBE|LATERAL|||VENDOR|5|Visit_5|90|7|TREATMENT|2020-11-02|90
e|FA|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|1|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|/h|[?]|1|ohm|TRICEPS BRACHII MUSCLE|LEFT||Y|SPOUSE|1|Visit_1|10|7|TREATMENT|2020-12-16|10
e|FA|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|2|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|U/g/min|[?]|1|L/h/m2|FUNDUS OF THE EYE|BILATERAL|Y|Y|INDEPENDENT ASSESSOR|1|Visit_1|10|4|WASHOUT|2020-12-16|10
e|FA|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|3|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|yd|[?]|1|mEq|FEMORO-POPLITEAL PERIPHERAL ARTERY|LEFT|Y||VENDOR|2|Visit_2|25|5|TREATMENT|2020-12-31|25
e|FA|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|4|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|ag|[?]|1|mL|CHEST WALL|RIGHT|||FRIEND|2|Visit_2|25|1|SCREENING|2020-12-31|25
e|FA|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|5|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|mCi|[?]|1|m2|GANGLION|LEFT|Y||PROXY|3|Visit_3|40|3|TREATMENT|2021-01-15|40
e|FA|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|6|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mg/cm2|[?]|1|L/h/m2|PROXIMAL CIRCUMFLEX ARTERY|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|1|TREATMENT|2021-01-15|40
e|FA|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|7|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|ug/animal|[?]|1|L/h/m2|POSTERIOR SUPERIOR ILIAC SPINE|CONTRALATERAL||Y|CAREGIVER|4|Visit_4|65|5|TREATMENT|2021-02-09|65
e|FA|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|8|RLDEV|Relationship to Device|[?]|GERD|[?]|U/g/day|[?]|1|mL/min/mmHg|VOMER|BILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2021-02-09|65
e|FA|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|9|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|IU|[?]|1|mL/cm3/min|MENINGES|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2021-03-06|90
e|FA|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|10|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|Weber|RIGHT VENTRICULAR ENDOCARDIUM|UNILATERAL|||PROXY|5|Visit_5|90|5|WASHOUT|2021-03-06|90
e|FA|db13afe0-14f6-445b-869a-b0d9fe87e5b9|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|mm2|[?]|1|L|FOOT DIGIT 5|IPSILATERAL|Y||VENDOR|1|Visit_1|10|6|TREATMENT|2020-08-22|10
e|FA|db13afe0-14f6-445b-869a-b0d9fe87e5b9|2|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|ug/m2/min|[?]|1|mm/h|PARACOLIC GUTTER|UNILATERAL|||CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-08-22|10
e|FA|db13afe0-14f6-445b-869a-b0d9fe87e5b9|3|ESTWT|Estimated Weight|[?]|GERD|[?]|mmol/day|[?]|1|g/day|COLON, DESCENDING|UNILATERAL|||INVESTIGATOR|2|Visit_2|25|4|SCREENING|2020-09-06|25
e|FA|db13afe0-14f6-445b-869a-b0d9fe87e5b9|4|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|mL/animal/wk|[?]|1|mL/min/mmHg|KIDNEY, LOWER LOBE|LATERAL|||PROXY|2|Visit_2|25|4|TREATMENT|2020-09-06|25
e|FA|db13afe0-14f6-445b-869a-b0d9fe87e5b9|5|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|SCOOPFUL|C5 VERTEBRA|BILATERAL|||ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-09-21|40
e|FA|db13afe0-14f6-445b-869a-b0d9fe87e5b9|6|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|g/g|[?]|1|ug/g/h|T3 VERTEBRA|UNILATERAL|||PARENT|3|Visit_3|40|4|TREATMENT|2020-09-21|40
e|FA|db13afe0-14f6-445b-869a-b0d9fe87e5b9|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/animal/wk|[?]|1|U/mmol|SUPERIOR PUBIC RAMUS|UNILATERAL||Y|GUARDIAN|4|Visit_4|65|4|FOLLOW-UP|2020-10-16|65
e|FA|db13afe0-14f6-445b-869a-b0d9fe87e5b9|8|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|Rad|[?]|1|mg/h|MALLEUS|RIGHT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2020-10-16|65
e|FA|db13afe0-14f6-445b-869a-b0d9fe87e5b9|9|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|oz eq|LATERAL THIRD DIAGONAL BRANCH ARTERY|IPSILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|SCREENING|2020-11-10|90
e|FA|db13afe0-14f6-445b-869a-b0d9fe87e5b9|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|U/L|[?]|1|10^6 U|PARIETAL LOBE|BILATERAL|||INVESTIGATOR|5|Visit_5|90|7|FOLLOW-UP|2020-11-10|90
e|FA|3f75a463-1348-4c7f-8b29-7472d29628c8|1|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|10^6/L|[?]|1|ohm|OLECRANON|UNILATERAL|Y||FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-07-12|10
e|FA|3f75a463-1348-4c7f-8b29-7472d29628c8|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mOsm/L|[?]|1|%(v/v)|SKIN AROUND THE MOUTH|CONTRALATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-07-12|10
e|FA|3f75a463-1348-4c7f-8b29-7472d29628c8|3|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|ug/m2/h|[?]|1|100 IU/mL|SKULL, BASE|LATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2020-07-27|25
e|FA|3f75a463-1348-4c7f-8b29-7472d29628c8|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|Pa|HEART, APEX|LATERAL||Y|VENDOR|2|Visit_2|25|7|TREATMENT|2020-07-27|25
e|FA|3f75a463-1348-4c7f-8b29-7472d29628c8|5|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|U/kg/day|[?]|1|Log10 ELISA unit|METACARPOPHALANGEAL JOINT 1|CONTRALATERAL|||ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2020-08-11|40
e|FA|3f75a463-1348-4c7f-8b29-7472d29628c8|6|SEV|Severity/Intensity|[?]|GERD|[?]|mmol/s|[?]|1|Pa|PARASPINAL REGION|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-08-11|40
e|FA|3f75a463-1348-4c7f-8b29-7472d29628c8|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|10^6 IU|[?]|1|%(v/v)|T2 VERTEBRA|UNILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|4|FOLLOW-UP|2020-09-05|65
e|FA|3f75a463-1348-4c7f-8b29-7472d29628c8|8|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|ng|[?]|1|mL/dose|LIVER, RIGHT LOBE|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|WASHOUT|2020-09-05|65
e|FA|3f75a463-1348-4c7f-8b29-7472d29628c8|9|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|kUSP|[?]|1|g/day|BRAIN, THIRD VENTRICLE|UNILATERAL||Y|FAMILY MEMBER|5|Visit_5|90|2|SCREENING|2020-09-30|90
e|FA|3f75a463-1348-4c7f-8b29-7472d29628c8|10|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|kIU|[?]|1|cm H2O|HEAD|BILATERAL|||FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2020-09-30|90
e|FA|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|EIA unit|[?]|1|mL/animal/day|FINGER FLEXOR MUSCLES|RIGHT|Y||GUARDIAN|1|Visit_1|10|7|WASHOUT|2021-01-30|10
e|FA|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|2|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|dB|[?]|1|umol|SKIN FOLD|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|FOLLOW-UP|2021-01-30|10
e|FA|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|3|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|g/L|ELBOW JOINT|LEFT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|SCREENING|2021-02-14|25
e|FA|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|4|DMG|Dietary Magnesium|[?]|GERD|[?]|ng/L|[?]|1|TRANSDUCING UNIT/mL|DISTAL FEMUR R1|CONTRALATERAL|||STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2021-02-14|25
e|FA|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|5|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|ugEq|[?]|1|/500 WBC|ILIUM|UNILATERAL|||ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2021-03-01|40
e|FA|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Gy/h|[?]|1|%(v/v)|SEBACEOUS GLAND|LATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|4|WASHOUT|2021-03-01|40
e|FA|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/min|[?]|1|Pa|PORTAL VEIN|IPSILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|6|TREATMENT|2021-03-26|65
e|FA|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mEq/g|[?]|1|Pa|L4 VERTEBRA|BILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-03-26|65
e|FA|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|9|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|APPLICATION|[?]|1|oz eq|DIAPHRAGMATIC LYMPH NODE|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|TREATMENT|2021-04-20|90
e|FA|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|Pa|[?]|1|km|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|FOLLOW-UP|2021-04-20|90
e|FA|4b00b9ef-ddc3-4669-8a73-f69c73743bce|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|deg/s|[?]|1|mL/animal/day|PAROTID GLAND LYMPH NODE|BILATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|FOLLOW-UP|2020-07-23|10
e|FA|4b00b9ef-ddc3-4669-8a73-f69c73743bce|2|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|gtt|GRACILIS MUSCLE|LATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|SCREENING|2020-07-23|10
e|FA|4b00b9ef-ddc3-4669-8a73-f69c73743bce|3|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|MHz|[?]|1|PACK|UMBILICAL CORD|RIGHT|Y||PROXY|2|Visit_2|25|6|WASHOUT|2020-08-07|25
e|FA|4b00b9ef-ddc3-4669-8a73-f69c73743bce|4|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|IU/L|[?]|1|ng/day|RIB 1|UNILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2020-08-07|25
e|FA|4b00b9ef-ddc3-4669-8a73-f69c73743bce|5|SEV|Severity/Intensity|[?]|GERD|[?]|damol/L|[?]|1|Pa|INTERATRIAL SEPTUM|BILATERAL|||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-08-22|40
e|FA|4b00b9ef-ddc3-4669-8a73-f69c73743bce|6|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/L|[?]|1|IU/mg|HEAD OF THE HUMERUS|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-08-22|40
e|FA|4b00b9ef-ddc3-4669-8a73-f69c73743bce|7|LDIAM|Longest Diameter|[?]|GERD|[?]|RNA copies/mL|[?]|1|Shock Wave|EYE|BILATERAL|Y||SPOUSE|4|Visit_4|65|5|TREATMENT|2020-09-16|65
e|FA|4b00b9ef-ddc3-4669-8a73-f69c73743bce|8|DISTANCE|Distance|[?]|GERD|[?]|U.CARR|[?]|1|BOWL|LUNG, LEFT LOWER LOBE|RIGHT|Y||CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-09-16|65
e|FA|4b00b9ef-ddc3-4669-8a73-f69c73743bce|9|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|SQU/mL|[?]|1|Bq/mg|KIDNEY, HILUM|BILATERAL|||GUARDIAN|5|Visit_5|90|2|SCREENING|2020-10-11|90
e|FA|4b00b9ef-ddc3-4669-8a73-f69c73743bce|10|STROKTYP|Stroke Type|[?]|GERD|[?]|cy/cm|[?]|1|g/L|SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL||Y|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-10-11|90
e|FA|a125efdf-aec8-47a1-b492-cdaf8b619a78|1|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|EIA unit|[?]|1|QUANTITY SUFFICIENT|THYROID GLAND, RIGHT LOBE|LEFT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-09-30|10
e|FA|a125efdf-aec8-47a1-b492-cdaf8b619a78|2|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|pt_br|[?]|1|IU/mmol|L2 VERTEBRA|BILATERAL||Y|CHILD|1|Visit_1|10|4|WASHOUT|2020-09-30|10
e|FA|a125efdf-aec8-47a1-b492-cdaf8b619a78|3|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|lx|[?]|1|cmH2O/mL|FIBULA SHAFT|LEFT|||SIBLING|2|Visit_2|25|2|TREATMENT|2020-10-15|25
e|FA|a125efdf-aec8-47a1-b492-cdaf8b619a78|4|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|pptr|[?]|1|HOURS|ABDUCTOR DIGITI QUINTI MUSCLE|IPSILATERAL|Y||DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-10-15|25
e|FA|a125efdf-aec8-47a1-b492-cdaf8b619a78|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/kg/min|[?]|1|mg/g/min|ILIUM|CONTRALATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-10-30|40
e|FA|a125efdf-aec8-47a1-b492-cdaf8b619a78|6|ACNDEV|Action Taken With Device|[?]|GERD|[?]|Antibody Unit|[?]|1|100 IU/mL|RIB 2|LATERAL||Y|SIBLING|3|Visit_3|40|2|TREATMENT|2020-10-30|40
e|FA|a125efdf-aec8-47a1-b492-cdaf8b619a78|7|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|fg|[?]|1|10^6 U|SHOULDER JOINT TENDONS|IPSILATERAL|Y||SPOUSE|4|Visit_4|65|6|WASHOUT|2020-11-24|65
e|FA|a125efdf-aec8-47a1-b492-cdaf8b619a78|8|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa/L|[?]|1|mg/dose|UPPER CERVICAL LYMPH NODE|IPSILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-11-24|65
e|FA|a125efdf-aec8-47a1-b492-cdaf8b619a78|9|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|ug/m2/h|COLON, SPLENIC FLEXURE|LATERAL||Y|PARENT|5|Visit_5|90|3|TREATMENT|2020-12-19|90
e|FA|a125efdf-aec8-47a1-b492-cdaf8b619a78|10|DMG|Dietary Magnesium|[?]|GERD|[?]|100 IU/mL|[?]|1|TRANSDUCING UNIT/mL|SCAPHOID BONE|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-12-19|90
e|FA|9171362e-0166-46f2-ab2d-2748d8c291d5|1|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|umol/L|[?]|1|km|CECUM|LATERAL||Y|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2021-01-12|10
e|FA|9171362e-0166-46f2-ab2d-2748d8c291d5|2|EXCDUR|Exercise Duration|[?]|GERD|[?]|aMFI|[?]|1|mm|CORONARY ARTERY, RIGHT|BILATERAL|||GUARDIAN|1|Visit_1|10|4|TREATMENT|2021-01-12|10
e|FA|9171362e-0166-46f2-ab2d-2748d8c291d5|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|AgU/mL|[?]|1|mg/g/min|METACARPAL BONE 1|LATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|6|SCREENING|2021-01-27|25
e|FA|9171362e-0166-46f2-ab2d-2748d8c291d5|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|Pa|PANCREAS, ENDOCRINE|CONTRALATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|7|WASHOUT|2021-01-27|25
e|FA|9171362e-0166-46f2-ab2d-2748d8c291d5|5|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Arbitrary U|[?]|1|mL|DIAPHRAGMATIC LYMPH NODE|LATERAL|||INTERVIEWER|3|Visit_3|40|6|SCREENING|2021-02-11|40
e|FA|9171362e-0166-46f2-ab2d-2748d8c291d5|6|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|deg2|[?]|1|Gy/h|5TH LUMBAR SPINOUS PROCESS|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2021-02-11|40
e|FA|9171362e-0166-46f2-ab2d-2748d8c291d5|7|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|umol/L/h|[?]|1|SACHET|URETHRAL SPHINCTER|RIGHT||Y|FRIEND|4|Visit_4|65|4|TREATMENT|2021-03-08|65
e|FA|9171362e-0166-46f2-ab2d-2748d8c291d5|8|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|SBE/mL|[?]|1|Shock Wave|PORTACAVAL LYMPH NODE|LATERAL|Y|Y|INVESTIGATOR|4|Visit_4|65|7|FOLLOW-UP|2021-03-08|65
e|FA|9171362e-0166-46f2-ab2d-2748d8c291d5|9|DPROT|Dietary Protein|[?]|GERD|[?]|10^9 organisms|[?]|1|10^4 CFU/mL|CHEEK|CONTRALATERAL|||INTERVIEWER|5|Visit_5|90|6|SCREENING|2021-04-02|90
e|FA|9171362e-0166-46f2-ab2d-2748d8c291d5|10|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|sec|[?]|1|fmol|T9 VERTEBRA|LEFT|Y|Y|CHILD|5|Visit_5|90|1|TREATMENT|2021-04-02|90
e|FA|9b150e38-dc85-4a28-aad3-43f7620be460|1|TOXGR|Toxicity Grade|[?]|GERD|[?]|mL/cage|[?]|1|aMFI|COMMON ILIAC ARTERY|LATERAL|||VENDOR|1|Visit_1|10|7|FOLLOW-UP|2020-07-22|10
e|FA|9b150e38-dc85-4a28-aad3-43f7620be460|2|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|cmH2O/mL|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|BILATERAL|||SPOUSE|1|Visit_1|10|3|SCREENING|2020-07-22|10
e|FA|9b150e38-dc85-4a28-aad3-43f7620be460|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|10^3 RNA copies/mL|[?]|1|Pa|EXTENSOR DIGITORUM BREVIS MUSCLE|UNILATERAL|||CAREGIVER|2|Visit_2|25|7|TREATMENT|2020-08-06|25
e|FA|9b150e38-dc85-4a28-aad3-43f7620be460|4|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|SPRAY|[?]|1|10^9 CFU/g|FACIAL BONE|CONTRALATERAL|||SPOUSE|2|Visit_2|25|1|TREATMENT|2020-08-06|25
e|FA|9b150e38-dc85-4a28-aad3-43f7620be460|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cd|[?]|1|mg/g/min|VEIN|RIGHT||Y|INTERVIEWER|3|Visit_3|40|2|TREATMENT|2020-08-21|40
e|FA|9b150e38-dc85-4a28-aad3-43f7620be460|6|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|AgU/mL|[?]|1|SCOOPFUL|T7 VERTEBRA|BILATERAL|||ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2020-08-21|40
e|FA|9b150e38-dc85-4a28-aad3-43f7620be460|7|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|uL/dose|[?]|1|DRUM|UPPER URINARY SYSTEM|RIGHT|||INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-09-15|65
e|FA|9b150e38-dc85-4a28-aad3-43f7620be460|8|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit|[?]|1|mL/animal/day|PELVIC LYMPH NODE|LATERAL||Y|INTERVIEWER|4|Visit_4|65|6|WASHOUT|2020-09-15|65
e|FA|9b150e38-dc85-4a28-aad3-43f7620be460|9|TRTSETT|Treatment Setting|[?]|GERD|[?]|mmol|[?]|1|Coulomb|SARTORIUS MUSCLE|UNILATERAL|||SIBLING|5|Visit_5|90|1|FOLLOW-UP|2020-10-10|90
e|FA|9b150e38-dc85-4a28-aad3-43f7620be460|10|OBJNUM|Number of Objects|[?]|GERD|[?]|L/L|[?]|1|mL/100g/min|MEDIASTINAL LYMPH NODE|LEFT|||SPOUSE|5|Visit_5|90|7|TREATMENT|2020-10-10|90
e|FA|2a595fc0-7621-4ec9-bd77-74444886052e|1|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|CAPSULE|[?]|1|NEEDLE GAUGE|LEFT MAIN CORONARY ARTERY OSTIUM|RIGHT|Y||DOMESTIC PARTNER|1|Visit_1|10|5|SCREENING|2020-10-25|10
e|FA|2a595fc0-7621-4ec9-bd77-74444886052e|2|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|SCOOPFUL|THORACIC AORTA|LEFT|||SPOUSE|1|Visit_1|10|2|TREATMENT|2020-10-25|10
e|FA|2a595fc0-7621-4ec9-bd77-74444886052e|3|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|VIAL|[?]|1|SACHET|PENIS|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2020-11-09|25
e|FA|2a595fc0-7621-4ec9-bd77-74444886052e|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/cm3/min|[?]|1|mg/g/min|FINGER EXTENSOR MUSCLES|BILATERAL|||FRIEND|2|Visit_2|25|6|SCREENING|2020-11-09|25
e|FA|2a595fc0-7621-4ec9-bd77-74444886052e|5|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|grain|[?]|1|BAG|AXILLARY ARTERY|UNILATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-11-24|40
e|FA|2a595fc0-7621-4ec9-bd77-74444886052e|6|SPEED|Speed|[?]|GERD|[?]|CAPLET|[?]|1|mEq/g|RIB 3|IPSILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|FOLLOW-UP|2020-11-24|40
e|FA|2a595fc0-7621-4ec9-bd77-74444886052e|7|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|MET*min|[?]|1|PACK|BUCCAL LYMPH NODE|IPSILATERAL|Y||SPOUSE|4|Visit_4|65|4|FOLLOW-UP|2020-12-19|65
e|FA|2a595fc0-7621-4ec9-bd77-74444886052e|8|QOLIMP|QOL Impact|[?]|GERD|[?]|mmol|[?]|1|10^6/L|COLON, LEFT|UNILATERAL|||SPOUSE|4|Visit_4|65|6|TREATMENT|2020-12-19|65
e|FA|2a595fc0-7621-4ec9-bd77-74444886052e|9|SEV|Severity/Intensity|[?]|GERD|[?]|log10 copies/mL|[?]|1|Pa|CALF MUSCULAR VEIN|LATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2021-01-13|90
e|FA|2a595fc0-7621-4ec9-bd77-74444886052e|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|COAT|[?]|1|%(v/v)|CORPUS LUTEUM|RIGHT|||INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2021-01-13|90
e|FA|0bab89c8-cf57-4d19-9b95-884a2e9da523|1|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|AgU/mL|[?]|1|BP|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|RIGHT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|WASHOUT|2020-12-20|10
e|FA|0bab89c8-cf57-4d19-9b95-884a2e9da523|2|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|10^4/L|[?]|1|mg/dose|ABDOMINAL CAVITY|LATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-12-20|10
e|FA|0bab89c8-cf57-4d19-9b95-884a2e9da523|3|SEV|Severity/Intensity|[?]|GERD|[?]|10^10/L|[?]|1|Pa|SECOND RIGHT POSTEROLATERAL ARTERY|LATERAL||Y|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2021-01-04|25
e|FA|0bab89c8-cf57-4d19-9b95-884a2e9da523|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|ug/mol|[?]|1|mL/dose|CILIARY BODY|UNILATERAL||Y|VENDOR|2|Visit_2|25|2|TREATMENT|2021-01-04|25
e|FA|0bab89c8-cf57-4d19-9b95-884a2e9da523|5|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|/MBP|[?]|1|PFU/dose|RIB 3|CONTRALATERAL|||INVESTIGATOR|3|Visit_3|40|2|WASHOUT|2021-01-19|40
e|FA|0bab89c8-cf57-4d19-9b95-884a2e9da523|6|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol|[?]|1|ug/m2/h|NUCLEUS ACCUMBENS|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2021-01-19|40
e|FA|0bab89c8-cf57-4d19-9b95-884a2e9da523|7|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|DRUM|HAIR FOLLICLE|CONTRALATERAL|||FRIEND|4|Visit_4|65|2|TREATMENT|2021-02-13|65
e|FA|0bab89c8-cf57-4d19-9b95-884a2e9da523|8|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|cL|[?]|1|QUANTITY SUFFICIENT|BLADDER, NECK|LATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2021-02-13|65
e|FA|0bab89c8-cf57-4d19-9b95-884a2e9da523|9|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|Roentgen|[?]|1|10^6 U|T5 VERTEBRA|LEFT|||PROXY|5|Visit_5|90|6|TREATMENT|2021-03-10|90
e|FA|0bab89c8-cf57-4d19-9b95-884a2e9da523|10|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|BISCUIT|[?]|1|10^6 organisms/mL|ACHILLES TENDON|CONTRALATERAL|||SPOUSE|5|Visit_5|90|3|SCREENING|2021-03-10|90
e|FA|84edaa9d-ce48-4866-ab43-af91bee126ae|1|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|HOURS|[?]|1|mL/mmHg/min/L|HEPATIC ARTERY|LATERAL||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-05-11|10
e|FA|84edaa9d-ce48-4866-ab43-af91bee126ae|2|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|g/cage/day|C4 VERTEBRA|LEFT|Y||INVESTIGATOR|1|Visit_1|10|3|TREATMENT|2020-05-11|10
e|FA|84edaa9d-ce48-4866-ab43-af91bee126ae|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|GBq/ug|[?]|1|Pa|MUSCLE|LATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-05-26|25
e|FA|84edaa9d-ce48-4866-ab43-af91bee126ae|4|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|Ci/mg|[?]|1|h*%|SPLENIC VEIN|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2020-05-26|25
e|FA|84edaa9d-ce48-4866-ab43-af91bee126ae|5|SEV|Severity/Intensity|[?]|GERD|[?]|ug/mL/h|[?]|1|Pa|TESTIS|LATERAL||Y|FAMILY MEMBER|3|Visit_3|40|7|WASHOUT|2020-06-10|40
e|FA|84edaa9d-ce48-4866-ab43-af91bee126ae|6|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|mU/g|[?]|1|in|OLFACTORY BULB|CONTRALATERAL|Y|Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2020-06-10|40
e|FA|84edaa9d-ce48-4866-ab43-af91bee126ae|7|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|ohm|[?]|1|Gy/h|PERIANAL REGION|LATERAL|Y|Y|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-07-05|65
e|FA|84edaa9d-ce48-4866-ab43-af91bee126ae|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|cy/cm|[?]|1|U/mmol|IRIS|LEFT|||FRIEND|4|Visit_4|65|2|TREATMENT|2020-07-05|65
e|FA|84edaa9d-ce48-4866-ab43-af91bee126ae|9|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|umol/L/h|[?]|1|uL/kg/day|FEMUR|LEFT|Y|Y|DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2020-07-30|90
e|FA|84edaa9d-ce48-4866-ab43-af91bee126ae|10|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|v/v|[?]|1|TRANSDUCING UNIT/mL|TRICUSPID VALVE|IPSILATERAL|Y||PARENT|5|Visit_5|90|1|TREATMENT|2020-07-30|90
e|FA|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|1|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|/200 HPFs|[?]|1|NEEDLE GAUGE|LOWER RESPIRATORY SYSTEM|IPSILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|7|SCREENING|2020-08-03|10
e|FA|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|2|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|fmol|AXILLARY VEIN|RIGHT|||SPOUSE|1|Visit_1|10|3|FOLLOW-UP|2020-08-03|10
e|FA|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|3|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|Joule|[?]|1|L|VENOUS SINUS|CONTRALATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|6|FOLLOW-UP|2020-08-18|25
e|FA|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|4|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|Farad|[?]|1|mm/h|MITRAL VALVE ANNULUS|UNILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|3|WASHOUT|2020-08-18|25
e|FA|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|5|EXTRSCT|Extent of Resection|[?]|GERD|[?]|kcal|[?]|1|Weber|MEDULLA OBLONGATA|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2020-09-02|40
e|FA|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|6|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|ft|[?]|1|10^6 U|PARATRACHEAL LYMPH NODE|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|FOLLOW-UP|2020-09-02|40
e|FA|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|7|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|BE/mL|[?]|1|ug/m2/h|MEDIASTINUM, MIDDLE|LATERAL||Y|VENDOR|4|Visit_4|65|1|TREATMENT|2020-09-27|65
e|FA|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|8|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|U/m2/min|[?]|1|ohm|AXILLARY LYMPH NODE LEVEL III|LATERAL|||INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-09-27|65
e|FA|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|cmol|[?]|1|%(v/v)|POSTEROLATERAL SEGMENTAL ARTERY|RIGHT||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2020-10-22|90
e|FA|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|10|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|in|[?]|1|IU/mg|LUNG, LEFT|IPSILATERAL|||CHILD|5|Visit_5|90|7|FOLLOW-UP|2020-10-22|90
e|FA|9734ec2a-d06b-43e1-82a5-37764af17890|1|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|Tesla|[?]|1|DRUM|ULNAR ARTERY|RIGHT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|3|WASHOUT|2020-09-29|10
e|FA|9734ec2a-d06b-43e1-82a5-37764af17890|2|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|uCi|[?]|1|cm H2O|POPLITEAL ARTERY BELOW KNEE|RIGHT|Y||CAREGIVER|1|Visit_1|10|7|FOLLOW-UP|2020-09-29|10
e|FA|9734ec2a-d06b-43e1-82a5-37764af17890|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|MESF|[?]|1|mg/g/min|STERNAL MANUBRIUM|RIGHT|||SPOUSE|2|Visit_2|25|1|WASHOUT|2020-10-14|25
e|FA|9734ec2a-d06b-43e1-82a5-37764af17890|4|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|HOURS|COLON, TRANSVERSE|BILATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|7|TREATMENT|2020-10-14|25
e|FA|9734ec2a-d06b-43e1-82a5-37764af17890|5|TOTNUM|Total Number|[?]|GERD|[?]|cd|[?]|1|/200 HPFs|FOOT|UNILATERAL|||GUARDIAN|3|Visit_3|40|6|WASHOUT|2020-10-29|40
e|FA|9734ec2a-d06b-43e1-82a5-37764af17890|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/day|[?]|1|%(v/v)|THYROID GLAND, LEFT LOBE|RIGHT|||PARENT|3|Visit_3|40|1|TREATMENT|2020-10-29|40
e|FA|9734ec2a-d06b-43e1-82a5-37764af17890|7|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|mL/100g/min|[?]|1|anti-Xa IU/mL|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|IPSILATERAL|||CAREGIVER|4|Visit_4|65|5|SCREENING|2020-11-23|65
e|FA|9734ec2a-d06b-43e1-82a5-37764af17890|8|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mL/animal|[?]|1|ohm|LATERAL FIRST DIAGONAL BRANCH ARTERY|RIGHT|Y|Y|SIBLING|4|Visit_4|65|5|TREATMENT|2020-11-23|65
e|FA|9734ec2a-d06b-43e1-82a5-37764af17890|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|log10 copies/mL|[?]|1|mg/g/min|HEAD AND NECK|UNILATERAL||Y|SIBLING|5|Visit_5|90|5|WASHOUT|2020-12-18|90
e|FA|9734ec2a-d06b-43e1-82a5-37764af17890|10|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|10^3/L|[?]|1|aMFI|ELBOW EXTENSOR MUSCLES|LATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|6|TREATMENT|2020-12-18|90
e|FA|9a0ce525-7f10-4651-885a-f64bd9c8925e|1|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|m|[?]|1|10^6 CFU|HEART|IPSILATERAL|||CHILD|1|Visit_1|10|3|FOLLOW-UP|2020-11-28|10
e|FA|9a0ce525-7f10-4651-885a-f64bd9c8925e|2|STRCTNUM|Number of Strictures|[?]|GERD|[?]|U/kg/h|[?]|1|SACHET|ORAL CAVITY|BILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|2|SCREENING|2020-11-28|10
e|FA|9a0ce525-7f10-4651-885a-f64bd9c8925e|3|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|kV|[?]|1|g/L|ILIAC LYMPH NODE|CONTRALATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-12-13|25
e|FA|9a0ce525-7f10-4651-885a-f64bd9c8925e|4|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|ELISA unit|[?]|1|mg/dose|LUNG LOBE|IPSILATERAL|||PROXY|2|Visit_2|25|4|SCREENING|2020-12-13|25
e|FA|9a0ce525-7f10-4651-885a-f64bd9c8925e|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/kg|[?]|1|%(v/v)|PERIUMBILICAL REGION|RIGHT|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-12-28|40
e|FA|9a0ce525-7f10-4651-885a-f64bd9c8925e|6|VOL|Volume|[?]|GERD|[?]|/min|[?]|1|vp/dose|EPICONDYLE|RIGHT||Y|ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2020-12-28|40
e|FA|9a0ce525-7f10-4651-885a-f64bd9c8925e|7|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|ug/cm2|[?]|1|QUANTITY SUFFICIENT|MID-RIGHT CORONARY ARTERY CONDUIT|RIGHT|Y|Y|PROXY|4|Visit_4|65|5|TREATMENT|2021-01-22|65
e|FA|9a0ce525-7f10-4651-885a-f64bd9c8925e|8|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|U/kg/h|[?]|1|mL/h|C5 VERTEBRA|RIGHT|Y||INTERVIEWER|4|Visit_4|65|7|TREATMENT|2021-01-22|65
e|FA|9a0ce525-7f10-4651-885a-f64bd9c8925e|9|DVEG|Dietary Vegetable|[?]|GERD|[?]|ft3|[?]|1|Ci/ug|DISTAL INTERPHALANGEAL JOINT 4|RIGHT|Y||VENDOR|5|Visit_5|90|5|TREATMENT|2021-02-16|90
e|FA|9a0ce525-7f10-4651-885a-f64bd9c8925e|10|PPTFCT|Precipitating Factor|[?]|GERD|[?]|g/m2|[?]|1|EIA unit|COLON LYMPH NODE|LATERAL|||VENDOR|5|Visit_5|90|2|FOLLOW-UP|2021-02-16|90
e|FA|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|1|DFIBER|Dietary Fiber|[?]|GERD|[?]|BISCUIT|[?]|1|h*%|ANTERIOR CINGULATE CORTEX|LATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|5|FOLLOW-UP|2020-07-15|10
e|FA|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|2|EVENTFRQ|Event Frequency|[?]|GERD|[?]|cd*s/m2|[?]|1|ug/kg/h|PENIS|LEFT|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|FOLLOW-UP|2020-07-15|10
e|FA|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|3|SEV|Severity/Intensity|[?]|GERD|[?]|ug/min|[?]|1|Pa|SKIN OF THE CHIN|BILATERAL|Y|Y|SIGNIFICANT OTHER|2|Visit_2|25|5|SCREENING|2020-07-30|25
e|FA|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|4|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|mg/g/min|[?]|1|CUP|HAIR SHAFT|CONTRALATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-07-30|25
e|FA|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/kg/day|[?]|1|mg/g/min|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|LATERAL||Y|ADJUDICATOR|3|Visit_3|40|3|FOLLOW-UP|2020-08-14|40
e|FA|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|6|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|10^6 IU|[?]|1|QUANTITY SUFFICIENT|PRONATOR QUADRATUS MUSCLE|UNILATERAL||Y|SIGNIFICANT OTHER|3|Visit_3|40|7|FOLLOW-UP|2020-08-14|40
e|FA|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|7|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|10^6 organisms/mL|[?]|1|Shock Wave|CORPUS CALLOSUM, GENU|UNILATERAL|||PROXY|4|Visit_4|65|6|TREATMENT|2020-09-08|65
e|FA|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|8|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|kIU|[?]|1|mL/dose|THORACIC CAVITY|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2020-09-08|65
e|FA|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|9|SEV|Severity/Intensity|[?]|GERD|[?]|Shock Wave|[?]|1|Pa|UPPER RESPIRATORY SYSTEM|RIGHT|Y|Y|FAMILY MEMBER|5|Visit_5|90|7|WASHOUT|2020-10-03|90
e|FA|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|10|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mL/cage/day|[?]|1|umol|HAND DIGIT 5|RIGHT||Y|FRIEND|5|Visit_5|90|3|TREATMENT|2020-10-03|90
e|FA|4ba88073-0003-461a-a950-4504ef7680e7|1|STROKTYP|Stroke Type|[?]|GERD|[?]|DIP|[?]|1|g/L|L3-L4 INTERVERTEBRAL SPACE|LATERAL||Y|PARENT|1|Visit_1|10|6|TREATMENT|2020-09-02|10
e|FA|4ba88073-0003-461a-a950-4504ef7680e7|2|LENRSCT|Length of Resection|[?]|GERD|[?]|Enzyme U|[?]|1|psi|PROSTATE GLAND, POSTERIOR LOBE|LATERAL|Y||FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-09-02|10
e|FA|4ba88073-0003-461a-a950-4504ef7680e7|3|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|umol/day|[?]|1|L/h/m2|T3 VERTEBRA|RIGHT||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|SCREENING|2020-09-17|25
e|FA|4ba88073-0003-461a-a950-4504ef7680e7|4|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|BOX|[?]|1|g/dL|PERINEUM|LEFT|Y||FRIEND|2|Visit_2|25|5|WASHOUT|2020-09-17|25
e|FA|4ba88073-0003-461a-a950-4504ef7680e7|5|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|mmHg/L/min|SYNOVIAL FLUID|RIGHT|Y||ADJUDICATOR|3|Visit_3|40|6|SCREENING|2020-10-02|40
e|FA|4ba88073-0003-461a-a950-4504ef7680e7|6|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mmol/s|[?]|1|cm H2O|NOSE|RIGHT|Y||INVESTIGATOR|3|Visit_3|40|2|SCREENING|2020-10-02|40
e|FA|4ba88073-0003-461a-a950-4504ef7680e7|7|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|oz eq|[?]|1|L/h/m2|INFRARENAL AORTA|CONTRALATERAL||Y|FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2020-10-27|65
e|FA|4ba88073-0003-461a-a950-4504ef7680e7|8|CALBURN|Calories Burned|[?]|GERD|[?]|ug/kg|[?]|1|/kg|DISTAL PHALANX 4 OF THE HAND|CONTRALATERAL|||CHILD|4|Visit_4|65|2|WASHOUT|2020-10-27|65
e|FA|4ba88073-0003-461a-a950-4504ef7680e7|9|SEV|Severity/Intensity|[?]|GERD|[?]|kg/mol|[?]|1|Pa|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|LEFT|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|5|TREATMENT|2020-11-21|90
e|FA|4ba88073-0003-461a-a950-4504ef7680e7|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|PFU/animal|[?]|1|mg/g/min|FEMALE REPRODUCTIVE SYSTEM|LEFT|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-11-21|90
e|FA|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|1|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|ppth|[?]|1|BOWL|HUMERUS|LEFT||Y|VENDOR|1|Visit_1|10|2|TREATMENT|2020-09-01|10
e|FA|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|U/m2/min|[?]|1|%(v/v)|FLEXOR HALLUCIS BREVIS MUSCLE|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2020-09-01|10
e|FA|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|3|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|/4.0 mL|[?]|1|QUANTITY SUFFICIENT|DENTAL ARCH|CONTRALATERAL|||INTERVIEWER|2|Visit_2|25|5|TREATMENT|2020-09-16|25
e|FA|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|4|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|10^4/L|[?]|1|L|COCCYGEAL VERTEBRA|IPSILATERAL|Y|Y|SPOUSE|2|Visit_2|25|7|SCREENING|2020-09-16|25
e|FA|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|5|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|anti-Xa IU/mL|LUNG, LEFT UPPER LOBE|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|WASHOUT|2020-10-01|40
e|FA|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|aMFI|[?]|1|%(v/v)|HEEL OF THE FOOT|RIGHT||Y|FRIEND|3|Visit_3|40|3|TREATMENT|2020-10-01|40
e|FA|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|7|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|GPL U|[?]|1|IU/mg|THROAT|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|TREATMENT|2020-10-26|65
e|FA|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|AU/mL|[?]|1|mg/g/min|INTERTROCHANTERIC REGION|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|2|SCREENING|2020-10-26|65
e|FA|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|9|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|L/h|[?]|1|NEEDLE GAUGE|SOLEUS MUSCLE|CONTRALATERAL|Y||SIBLING|5|Visit_5|90|5|TREATMENT|2020-11-20|90
e|FA|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|10|STROKTYP|Stroke Type|[?]|GERD|[?]|mL/m2|[?]|1|g/L|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|3|WASHOUT|2020-11-20|90
e|FA|f552fa78-d78f-44c5-9590-30a737e6652d|1|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|nm|[?]|1|cm|PENIS|LEFT|||VENDOR|1|Visit_1|10|7|FOLLOW-UP|2020-10-05|10
e|FA|f552fa78-d78f-44c5-9590-30a737e6652d|2|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|mg/kg/dose|[?]|1|MBq|FOOT DIGIT 2|CONTRALATERAL||Y|VENDOR|1|Visit_1|10|5|TREATMENT|2020-10-05|10
e|FA|f552fa78-d78f-44c5-9590-30a737e6652d|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^3 CFU/g|[?]|1|%(v/v)|HEART, RIGHT ATRIUM|IPSILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-10-20|25
e|FA|f552fa78-d78f-44c5-9590-30a737e6652d|4|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|/sec|[?]|1|ug/m2/h|LIP|BILATERAL|||CAREGIVER|2|Visit_2|25|4|TREATMENT|2020-10-20|25
e|FA|f552fa78-d78f-44c5-9590-30a737e6652d|5|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|um/day|[?]|1|IU/mmol|GLOTTIS|CONTRALATERAL||Y|FAMILY MEMBER|3|Visit_3|40|5|FOLLOW-UP|2020-11-04|40
e|FA|f552fa78-d78f-44c5-9590-30a737e6652d|6|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/animal|[?]|1|10^9 CFU/mL|DISTAL PHALANX 3 OF THE HAND|UNILATERAL|Y|Y|FRIEND|3|Visit_3|40|4|SCREENING|2020-11-04|40
e|FA|f552fa78-d78f-44c5-9590-30a737e6652d|7|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|ug/m2|[?]|1|g/L|CAPITATE BONE|LEFT||Y|VENDOR|4|Visit_4|65|2|TREATMENT|2020-11-29|65
e|FA|f552fa78-d78f-44c5-9590-30a737e6652d|8|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|km|[?]|1|SCOOPFUL|GENITAL TUBERCLE|LEFT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|WASHOUT|2020-11-29|65
e|FA|f552fa78-d78f-44c5-9590-30a737e6652d|9|DCAL|Dietary Calories|[?]|GERD|[?]|mm/2h|[?]|1|EIA unit|ATRIOVENTRICULAR VALVE|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2020-12-24|90
e|FA|f552fa78-d78f-44c5-9590-30a737e6652d|10|EXTRSCT|Extent of Resection|[?]|GERD|[?]|Frames/s|[?]|1|Weber|OLFACTORY BULB|LATERAL|Y||INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2020-12-24|90
e|FA|38d83f86-d8ce-461a-a288-95aebe498d22|1|SEV|Severity/Intensity|[?]|GERD|[?]|U/m2/h|[?]|1|Pa|RETROPERITONEUM|LEFT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-08-25|10
e|FA|38d83f86-d8ce-461a-a288-95aebe498d22|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|L/min/m2|[?]|1|Pa|SKIN OF THE TRUNK|LEFT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|FOLLOW-UP|2020-08-25|10
e|FA|38d83f86-d8ce-461a-a288-95aebe498d22|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|uOsm|[?]|1|%(v/v)|ADDUCTOR MAGNUS MUSCLE|BILATERAL||Y|VENDOR|2|Visit_2|25|6|SCREENING|2020-09-09|25
e|FA|38d83f86-d8ce-461a-a288-95aebe498d22|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|Pa|POSTERIOR TIBIAL ARTERY|RIGHT||Y|INTERVIEWER|2|Visit_2|25|6|TREATMENT|2020-09-09|25
e|FA|38d83f86-d8ce-461a-a288-95aebe498d22|5|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|Coulomb|[?]|1|Log10 ELISA unit|LUNG, RIGHT|LATERAL|Y||FAMILY MEMBER|3|Visit_3|40|7|SCREENING|2020-09-24|40
e|FA|38d83f86-d8ce-461a-a288-95aebe498d22|6|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|DDU|[?]|1|mL/m2|SCALP|CONTRALATERAL|Y|Y|DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2020-09-24|40
e|FA|38d83f86-d8ce-461a-a288-95aebe498d22|7|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|mL/breath|[?]|1|BOWL|AZYGOS VEIN|UNILATERAL|Y|Y|CHILD|4|Visit_4|65|1|TREATMENT|2020-10-19|65
e|FA|38d83f86-d8ce-461a-a288-95aebe498d22|8|DGRAIN|Dietary Grain|[?]|GERD|[?]|mg/m2/day|[?]|1|10^9 CFU/g|MITRAL VALVE, ANTERIOR CUSP|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-10-19|65
e|FA|38d83f86-d8ce-461a-a288-95aebe498d22|9|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|IU|[?]|1|IU/mmol|SHOULDER JOINT|RIGHT|Y|Y|INTERVIEWER|5|Visit_5|90|3|WASHOUT|2020-11-13|90
e|FA|38d83f86-d8ce-461a-a288-95aebe498d22|10|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|nL|[?]|1|HOURS|AXILLARY LYMPH NODE LEVEL II|LEFT|||CAREGIVER|5|Visit_5|90|7|WASHOUT|2020-11-13|90
e|FA|b31e8820-cc17-4ce5-af30-358dbeb12ba2|1|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mm/min|[?]|1|ohm|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|BILATERAL|||PROXY|1|Visit_1|10|1|WASHOUT|2020-08-13|10
e|FA|b31e8820-cc17-4ce5-af30-358dbeb12ba2|2|DFATT|Dietary Fat, Total|[?]|GERD|[?]|g/cage|[?]|1|Bq/mg|PISIFORM BONE|LATERAL|||GUARDIAN|1|Visit_1|10|5|WASHOUT|2020-08-13|10
e|FA|b31e8820-cc17-4ce5-af30-358dbeb12ba2|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|nU/cL|[?]|1|mg/h|OPTIC DISC|IPSILATERAL|||GUARDIAN|2|Visit_2|25|5|WASHOUT|2020-08-28|25
e|FA|b31e8820-cc17-4ce5-af30-358dbeb12ba2|4|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|Linear ft*LB|[?]|1|g/day|CEREBRAL HEMISPHERE, RIGHT|LATERAL|||STUDY SUBJECT|2|Visit_2|25|5|WASHOUT|2020-08-28|25
e|FA|b31e8820-cc17-4ce5-af30-358dbeb12ba2|5|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|mg/cm2|[?]|1|QUANTITY SUFFICIENT|ILEUM|IPSILATERAL|||SIBLING|3|Visit_3|40|3|TREATMENT|2020-09-12|40
e|FA|b31e8820-cc17-4ce5-af30-358dbeb12ba2|6|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|CCID 50/mL|[?]|1|mm|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|UNILATERAL||Y|SIGNIFICANT OTHER|3|Visit_3|40|4|TREATMENT|2020-09-12|40
e|FA|b31e8820-cc17-4ce5-af30-358dbeb12ba2|7|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|RNA copies/mL|[?]|1|mL/cm3/min|ULNA|LEFT|||INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2020-10-07|65
e|FA|b31e8820-cc17-4ce5-af30-358dbeb12ba2|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6 IU|[?]|1|mg/g/min|COMMON ILIAC ARTERY|LEFT|Y||VENDOR|4|Visit_4|65|3|TREATMENT|2020-10-07|65
e|FA|b31e8820-cc17-4ce5-af30-358dbeb12ba2|9|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|GLOBULE|[?]|1|uL/kg/day|AORTIC VALVE|RIGHT|||FAMILY MEMBER|5|Visit_5|90|5|TREATMENT|2020-11-01|90
e|FA|b31e8820-cc17-4ce5-af30-358dbeb12ba2|10|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|10^6 IU|[?]|1|L/h/m2|COLON, RECTOSIGMOID|UNILATERAL|||GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-11-01|90
e|FA|cf39d5bd-7682-4546-8495-5bcf48600a69|1|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|cs|[?]|1|Shock Wave|HEART, ATRIUM|RIGHT||Y|CHILD|1|Visit_1|10|6|WASHOUT|2021-01-20|10
e|FA|cf39d5bd-7682-4546-8495-5bcf48600a69|2|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|gpELISA unit/mL|[?]|1|km|PERIANAL REGION|RIGHT|||ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2021-01-20|10
e|FA|cf39d5bd-7682-4546-8495-5bcf48600a69|3|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|EID 50/mL|[?]|1|g/cage/day|MESENTERIC ARTERY|LATERAL|Y||VENDOR|2|Visit_2|25|1|FOLLOW-UP|2021-02-04|25
e|FA|cf39d5bd-7682-4546-8495-5bcf48600a69|4|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/kg|[?]|1|PACK|GLUTEUS MAXIMUS|UNILATERAL|||CHILD|2|Visit_2|25|1|TREATMENT|2021-02-04|25
e|FA|cf39d5bd-7682-4546-8495-5bcf48600a69|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/cage|[?]|1|mg/g/min|PERIANAL REGION|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|SCREENING|2021-02-19|40
e|FA|cf39d5bd-7682-4546-8495-5bcf48600a69|6|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|nmol BCE/nmol|[?]|1|10^6 U|BASAL GANGLIA|RIGHT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2021-02-19|40
e|FA|cf39d5bd-7682-4546-8495-5bcf48600a69|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|m3|[?]|1|U/mmol|TRICUSPID VALVE, ANTERIOR CUSP|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2021-03-16|65
e|FA|cf39d5bd-7682-4546-8495-5bcf48600a69|8|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|mL/cage|[?]|1|mEq/g|SEMITENDINOSUS MUSCLE|CONTRALATERAL|||VENDOR|4|Visit_4|65|2|TREATMENT|2021-03-16|65
e|FA|cf39d5bd-7682-4546-8495-5bcf48600a69|9|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|g/dL|[?]|1|fmol|RETROCRURAL LYMPH NODE|LATERAL||Y|FRIEND|5|Visit_5|90|5|SCREENING|2021-04-10|90
e|FA|cf39d5bd-7682-4546-8495-5bcf48600a69|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|usec|[?]|1|%(v/v)|CALF|CONTRALATERAL||Y|SIBLING|5|Visit_5|90|1|SCREENING|2021-04-10|90
e|FA|84c17e7b-8d56-4726-96a5-9ca41fb9d894|1|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|mm/h|SENSORIMOTOR CORTEX|LATERAL||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-11-24|10
e|FA|84c17e7b-8d56-4726-96a5-9ca41fb9d894|2|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|vp/mL|[?]|1|mL/100g/min|PELVIS|CONTRALATERAL|Y||SIBLING|1|Visit_1|10|7|TREATMENT|2020-11-24|10
e|FA|84c17e7b-8d56-4726-96a5-9ca41fb9d894|3|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|nkat|[?]|1|m2|AXILLARY ARTERY|LATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-12-09|25
e|FA|84c17e7b-8d56-4726-96a5-9ca41fb9d894|4|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|deg/s|[?]|1|L/h/m2|SEMITENDINOSUS MUSCLE|LATERAL|Y||GUARDIAN|2|Visit_2|25|7|FOLLOW-UP|2020-12-09|25
e|FA|84c17e7b-8d56-4726-96a5-9ca41fb9d894|5|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|PATCH|[?]|1|Ci/ug|COCCYX|BILATERAL|||GUARDIAN|3|Visit_3|40|3|FOLLOW-UP|2020-12-24|40
e|FA|84c17e7b-8d56-4726-96a5-9ca41fb9d894|6|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|10^11/L|[?]|1|BOWL|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|SCREENING|2020-12-24|40
e|FA|84c17e7b-8d56-4726-96a5-9ca41fb9d894|7|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|mL/min/mmHg|EXTRAOCULAR MUSCLE|IPSILATERAL|||CHILD|4|Visit_4|65|4|SCREENING|2021-01-18|65
e|FA|84c17e7b-8d56-4726-96a5-9ca41fb9d894|8|LENRSCT|Length of Resection|[?]|GERD|[?]|CUP|[?]|1|psi|MIDBRAIN|LATERAL|Y||INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2021-01-18|65
e|FA|84c17e7b-8d56-4726-96a5-9ca41fb9d894|9|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|OI50|[?]|1|MBq|DISTANT LYMPH NODE|RIGHT|||DOMESTIC PARTNER|5|Visit_5|90|1|FOLLOW-UP|2021-02-12|90
e|FA|84c17e7b-8d56-4726-96a5-9ca41fb9d894|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|g/mol|[?]|1|mL|LUNG, RIGHT MIDDLE LOBE|LATERAL|||CAREGIVER|5|Visit_5|90|2|FOLLOW-UP|2021-02-12|90
e|FA|6e557fd7-efaf-4c86-806d-9bd66c7de7da|1|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|ug/L|[?]|1|cm H2O|ETHMOID BONE|CONTRALATERAL|||GUARDIAN|1|Visit_1|10|5|TREATMENT|2021-01-27|10
e|FA|6e557fd7-efaf-4c86-806d-9bd66c7de7da|2|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|ukat/10^12 RBC|[?]|1|mg/dose|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|UNILATERAL|Y|Y|PARENT|1|Visit_1|10|3|WASHOUT|2021-01-27|10
e|FA|6e557fd7-efaf-4c86-806d-9bd66c7de7da|3|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|10^3 DNA copies/mL|[?]|1|IU/mmol|COLON, RECTOSIGMOID|RIGHT|||FAMILY MEMBER|2|Visit_2|25|4|SCREENING|2021-02-11|25
e|FA|6e557fd7-efaf-4c86-806d-9bd66c7de7da|4|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|10^6/L|ARM|IPSILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2021-02-11|25
e|FA|6e557fd7-efaf-4c86-806d-9bd66c7de7da|5|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|U/g|[?]|1|PFU/dose|SKIN OF THE KNEE|CONTRALATERAL|||DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2021-02-26|40
e|FA|6e557fd7-efaf-4c86-806d-9bd66c7de7da|6|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|tsp eq|[?]|1|mEq|GASTROINTESTINAL TRACT, UPPER, WALL|LEFT||Y|SIBLING|3|Visit_3|40|3|TREATMENT|2021-02-26|40
e|FA|6e557fd7-efaf-4c86-806d-9bd66c7de7da|7|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU|[?]|1|MPS U|C5 VERTEBRA|IPSILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2021-03-23|65
e|FA|6e557fd7-efaf-4c86-806d-9bd66c7de7da|8|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|copies/uL|[?]|1|uCi/kg|COCCYX|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|WASHOUT|2021-03-23|65
e|FA|6e557fd7-efaf-4c86-806d-9bd66c7de7da|9|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|10^6/hpf|[?]|1|10^6 CFU|FLEXOR POLLICIS LONGUS MUSCLE|IPSILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2021-04-17|90
e|FA|6e557fd7-efaf-4c86-806d-9bd66c7de7da|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|CARTRIDGE|[?]|1|mg/g/min|METACARPAL BONE 3|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2021-04-17|90
e|FA|2b25e1f9-929c-4bdc-8758-79f33b832026|1|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|TROCHE|[?]|1|PACK|ENTORHINAL CORTEX|RIGHT|||INVESTIGATOR|1|Visit_1|10|6|WASHOUT|2020-10-19|10
e|FA|2b25e1f9-929c-4bdc-8758-79f33b832026|2|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|mL/m2|[?]|1|mmHg/L/min|FORELIMB|IPSILATERAL||Y|CHILD|1|Visit_1|10|4|WASHOUT|2020-10-19|10
e|FA|2b25e1f9-929c-4bdc-8758-79f33b832026|3|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|cm H2O|[?]|1|L|BACK|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-11-03|25
e|FA|2b25e1f9-929c-4bdc-8758-79f33b832026|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|psi|[?]|1|mL/dose|BRAIN, THIRD VENTRICLE|RIGHT|||STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-11-03|25
e|FA|2b25e1f9-929c-4bdc-8758-79f33b832026|5|DCAL|Dietary Calories|[?]|GERD|[?]|TCID 50/dose|[?]|1|EIA unit|TONGUE|RIGHT|||INTERVIEWER|3|Visit_3|40|2|FOLLOW-UP|2020-11-18|40
e|FA|2b25e1f9-929c-4bdc-8758-79f33b832026|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mEq/kg|[?]|1|mg/g/min|SUBCLAVIAN VEIN|IPSILATERAL|||GUARDIAN|3|Visit_3|40|7|WASHOUT|2020-11-18|40
e|FA|2b25e1f9-929c-4bdc-8758-79f33b832026|7|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|ug/dose|[?]|1|ug/g/h|CRANIAL NERVE|CONTRALATERAL||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-12-13|65
e|FA|2b25e1f9-929c-4bdc-8758-79f33b832026|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|%/s|[?]|1|mg/g/min|TESTIS|IPSILATERAL|||PROXY|4|Visit_4|65|4|TREATMENT|2020-12-13|65
e|FA|2b25e1f9-929c-4bdc-8758-79f33b832026|9|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|mOsm|[?]|1|g/cage/day|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|CONTRALATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|3|FOLLOW-UP|2021-01-07|90
e|FA|2b25e1f9-929c-4bdc-8758-79f33b832026|10|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|deg2|[?]|1|IU/mmol|COSTOCHONDRAL JOINT 7|BILATERAL|||INVESTIGATOR|5|Visit_5|90|5|WASHOUT|2021-01-07|90
e|FA|d02c7553-17f5-44ec-8c24-469234d080e8|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|nU/cL|[?]|1|mg/g/min|COMMON ILIAC LYMPH NODE|RIGHT|Y||SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2021-01-26|10
e|FA|d02c7553-17f5-44ec-8c24-469234d080e8|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU|[?]|1|Pa|EAR, OUTER|LATERAL||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2021-01-26|10
e|FA|d02c7553-17f5-44ec-8c24-469234d080e8|3|DGRAIN|Dietary Grain|[?]|GERD|[?]|cup eq|[?]|1|10^9 CFU/g|EYE|IPSILATERAL|Y|Y|SPOUSE|2|Visit_2|25|4|TREATMENT|2021-02-10|25
e|FA|d02c7553-17f5-44ec-8c24-469234d080e8|4|SEV|Severity/Intensity|[?]|GERD|[?]|Ejaculate U|[?]|1|Pa|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|RIGHT||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2021-02-10|25
e|FA|d02c7553-17f5-44ec-8c24-469234d080e8|5|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|PIXELS/in|[?]|1|10^6/L|MEDIASTINUM|CONTRALATERAL||Y|INVESTIGATOR|3|Visit_3|40|2|FOLLOW-UP|2021-02-25|40
e|FA|d02c7553-17f5-44ec-8c24-469234d080e8|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|SYRINGE|[?]|1|%(v/v)|ANASTOMOSIS|LATERAL|||DOMESTIC PARTNER|3|Visit_3|40|2|WASHOUT|2021-02-25|40
e|FA|d02c7553-17f5-44ec-8c24-469234d080e8|7|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|Ci/ug|TRACHEA|IPSILATERAL||Y|FAMILY MEMBER|4|Visit_4|65|7|FOLLOW-UP|2021-03-22|65
e|FA|d02c7553-17f5-44ec-8c24-469234d080e8|8|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|mL/cage|[?]|1|Shock Wave|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|UNILATERAL|||INTERVIEWER|4|Visit_4|65|7|WASHOUT|2021-03-22|65
e|FA|d02c7553-17f5-44ec-8c24-469234d080e8|9|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mmHg*min/L|[?]|1|10^6 U|SUBARACHNOID SPACE|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|SCREENING|2021-04-16|90
e|FA|d02c7553-17f5-44ec-8c24-469234d080e8|10|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|MONTHS|[?]|1|EIA unit|COLON, SPLENIC FLEXURE|BILATERAL||Y|SIBLING|5|Visit_5|90|5|WASHOUT|2021-04-16|90
e|FA|e819939e-548d-4e05-83e3-7976790de7e1|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mL|[?]|1|CUP|POPLITEAL LYMPH NODE|BILATERAL|||ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-09-07|10
e|FA|e819939e-548d-4e05-83e3-7976790de7e1|2|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|mL/m2/min|[?]|1|ug/g/h|CORPUS CALLOSUM, BODY|LATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-09-07|10
e|FA|e819939e-548d-4e05-83e3-7976790de7e1|3|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mEq|[?]|1|NEEDLE GAUGE|SUDORIFEROUS GLAND|RIGHT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-09-22|25
e|FA|e819939e-548d-4e05-83e3-7976790de7e1|4|SEV|Severity/Intensity|[?]|GERD|[?]|mL/m2|[?]|1|Pa|COLON, ASCENDING|BILATERAL|||FRIEND|2|Visit_2|25|7|SCREENING|2020-09-22|25
e|FA|e819939e-548d-4e05-83e3-7976790de7e1|5|DPROT|Dietary Protein|[?]|GERD|[?]|g/g/day|[?]|1|10^4 CFU/mL|VERTEBRAL COLUMN|CONTRALATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|4|FOLLOW-UP|2020-10-07|40
e|FA|e819939e-548d-4e05-83e3-7976790de7e1|6|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|amp|[?]|1|DRUM|HEART, LEFT ATRIAL APPENDAGE|CONTRALATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|SCREENING|2020-10-07|40
e|FA|e819939e-548d-4e05-83e3-7976790de7e1|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|log EID 50/dose|[?]|1|mg/g/min|DUODENUM|UNILATERAL|||FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2020-11-01|65
e|FA|e819939e-548d-4e05-83e3-7976790de7e1|8|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|mL/s/m2|[?]|1|L|COLON, RIGHT|RIGHT||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|5|SCREENING|2020-11-01|65
e|FA|e819939e-548d-4e05-83e3-7976790de7e1|9|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|pg|[?]|1|cm|CARPOMETACARPAL JOINT 4|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|WASHOUT|2020-11-26|90
e|FA|e819939e-548d-4e05-83e3-7976790de7e1|10|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|atm|[?]|1|100 IU/mL|BUTTOCK|CONTRALATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|2|WASHOUT|2020-11-26|90
e|FA|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|1|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/m2|[?]|1|uL/kg/day|PREPUTIAL GLAND|UNILATERAL||Y|SPOUSE|1|Visit_1|10|3|WASHOUT|2020-08-18|10
e|FA|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|2|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|APS U|[?]|1|cm H2O|ACROMIOCLAVICULAR JOINT|LEFT|Y|Y|CHILD|1|Visit_1|10|7|WASHOUT|2020-08-18|10
e|FA|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|3|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|10^3/L|[?]|1|/500 WBC|PARIETAL LOBE|LEFT||Y|INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-09-02|25
e|FA|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|4|SEV|Severity/Intensity|[?]|GERD|[?]|mL/kg|[?]|1|Pa|HEAD AND NECK|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|WASHOUT|2020-09-02|25
e|FA|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|5|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|10^9 CFU/mL|SKIN OF THE ELBOW|LEFT|||INDEPENDENT ASSESSOR|3|Visit_3|40|5|TREATMENT|2020-09-17|40
e|FA|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|6|SERVNUM|Number of Servings|[?]|GERD|[?]|L/min/m2|[?]|1|Hz/s|TIBIO-PERONEAL TRUNK|BILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-09-17|40
e|FA|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|7|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|10^9/g|[?]|1|mEq/g|BLADDER|LATERAL||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2020-10-12|65
e|FA|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|8|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/mL|[?]|1|mL/m2|LATERAL HUMERAL EPICONDYLE|CONTRALATERAL|Y||INVESTIGATOR|4|Visit_4|65|7|FOLLOW-UP|2020-10-12|65
e|FA|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|9|PPTFCT|Precipitating Factor|[?]|GERD|[?]|mg|[?]|1|EIA unit|MITRAL VALVE|CONTRALATERAL||Y|INVESTIGATOR|5|Visit_5|90|7|SCREENING|2020-11-06|90
e|FA|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|10|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|RATIO|[?]|1|BOWL|LEFT VENTRICULAR MID INFERIOR SEGMENT|LEFT||Y|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2020-11-06|90
e|FA|ea5229ad-6469-4147-be40-546d27c04c4c|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|uU/L|[?]|1|mL/animal/day|ILIOPSOAS MUSCLE|CONTRALATERAL||Y|PROXY|1|Visit_1|10|7|SCREENING|2020-06-09|10
e|FA|ea5229ad-6469-4147-be40-546d27c04c4c|2|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mol/mol|[?]|1|U/mmol|HUMERUS SHAFT|IPSILATERAL||Y|PROXY|1|Visit_1|10|6|WASHOUT|2020-06-09|10
e|FA|ea5229ad-6469-4147-be40-546d27c04c4c|3|DFRUIT|Dietary Fruit|[?]|GERD|[?]|ng/L|[?]|1|10^6 CFU/mL|LEFT POSTERIOR DESCENDING ARTERY|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2020-06-24|25
e|FA|ea5229ad-6469-4147-be40-546d27c04c4c|4|EVENTNUM|Number of Events|[?]|GERD|[?]|kcal|[?]|1|U/10^12 RBC|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|RIGHT||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|TREATMENT|2020-06-24|25
e|FA|ea5229ad-6469-4147-be40-546d27c04c4c|5|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|mL/cage|[?]|1|psi|STERNAL MANUBRIUM|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|TREATMENT|2020-07-09|40
e|FA|ea5229ad-6469-4147-be40-546d27c04c4c|6|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|PIXELS/in|[?]|1|10^6 U|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|LATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-07-09|40
e|FA|ea5229ad-6469-4147-be40-546d27c04c4c|7|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|gpELISA unit/mL|[?]|1|mAmp|RIB 11|CONTRALATERAL|||STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2020-08-03|65
e|FA|ea5229ad-6469-4147-be40-546d27c04c4c|8|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|Gy|[?]|1|mg/h|PHARYNX|LATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-08-03|65
e|FA|ea5229ad-6469-4147-be40-546d27c04c4c|9|DIAMETER|Diameter|[?]|GERD|[?]|/5x10^4 WBC|[?]|1|cm|PANCREATIC DUCT|LEFT|||INVESTIGATOR|5|Visit_5|90|2|SCREENING|2020-08-28|90
e|FA|ea5229ad-6469-4147-be40-546d27c04c4c|10|STRCTNUM|Number of Strictures|[?]|GERD|[?]|ug/g/h|[?]|1|SACHET|GASTROINTESTINAL TRACT, UPPER, WALL|IPSILATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2020-08-28|90
e|FA|0a566742-0f71-4603-85f0-875e2c3395e7|1|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|mm/2h|[?]|1|fmol|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|UNILATERAL|Y||FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2021-01-08|10
e|FA|0a566742-0f71-4603-85f0-875e2c3395e7|2|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|CFU/g|[?]|1|Shock Wave|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|BILATERAL|||ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2021-01-08|10
e|FA|0a566742-0f71-4603-85f0-875e2c3395e7|3|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|DNA copies/mL|[?]|1|mL/mmHg/min/L|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|LATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|WASHOUT|2021-01-23|25
e|FA|0a566742-0f71-4603-85f0-875e2c3395e7|4|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|/cmH2O|[?]|1|mmHg/L/min|HIP|BILATERAL||Y|PROXY|2|Visit_2|25|6|SCREENING|2021-01-23|25
e|FA|0a566742-0f71-4603-85f0-875e2c3395e7|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|10^6 CFU|[?]|1|ug/g/h|MESENTERIC VEIN|BILATERAL|Y||ADJUDICATOR|3|Visit_3|40|2|FOLLOW-UP|2021-02-07|40
e|FA|0a566742-0f71-4603-85f0-875e2c3395e7|6|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|nmol/L|[?]|1|mg/dose|INSULAR CORTEX|UNILATERAL||Y|CHILD|3|Visit_3|40|5|TREATMENT|2021-02-07|40
e|FA|0a566742-0f71-4603-85f0-875e2c3395e7|7|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|uOsm|[?]|1|mm|ANASTOMOSIS|RIGHT|||DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2021-03-04|65
e|FA|0a566742-0f71-4603-85f0-875e2c3395e7|8|SEV|Severity/Intensity|[?]|GERD|[?]|g/m2|[?]|1|Pa|INTERPHALANGEAL JOINT 3|LATERAL||Y|FRIEND|4|Visit_4|65|7|WASHOUT|2021-03-04|65
e|FA|0a566742-0f71-4603-85f0-875e2c3395e7|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cal|[?]|1|mg/g/min|LEFT POSTEROLATERAL DESCENDING ARTERY|BILATERAL|||ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2021-03-29|90
e|FA|0a566742-0f71-4603-85f0-875e2c3395e7|10|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|min*mg/mL|[?]|1|mL/dose|DISTAL RADIOULNAR JOINT|LATERAL||Y|SIBLING|5|Visit_5|90|4|TREATMENT|2021-03-29|90
e|FA|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|1|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|10^9 CFU|[?]|1|U/mmol|VENA CAVA|BILATERAL||Y|SIBLING|1|Visit_1|10|1|TREATMENT|2020-05-14|10
e|FA|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|10^6 RNA copies/mL|[?]|1|mg/g/min|T12 VERTEBRA|IPSILATERAL|||PROXY|1|Visit_1|10|4|TREATMENT|2020-05-14|10
e|FA|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|3|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|mmAL|[?]|1|g/L|SPLENIC ARTERY|RIGHT|||CHILD|2|Visit_2|25|1|TREATMENT|2020-05-29|25
e|FA|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|4|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|min*mg/mL|[?]|1|BOWL|HYPOGLOSSAL NERVE|UNILATERAL|||INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-05-29|25
e|FA|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|5|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|U/g/min|[?]|1|Bq/L|OPTIC DISC|LEFT|||CHILD|3|Visit_3|40|2|TREATMENT|2020-06-13|40
e|FA|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|6|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|deg/mm|[?]|1|10^9 CFU/mL|FUNDUS OF THE EYE|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-06-13|40
e|FA|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|fL|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 2|UNILATERAL|||CHILD|4|Visit_4|65|1|TREATMENT|2020-07-08|65
e|FA|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|8|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mL/kg/h|[?]|1|NEEDLE GAUGE|T9 VERTEBRA|RIGHT|||PARENT|4|Visit_4|65|5|TREATMENT|2020-07-08|65
e|FA|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/L|[?]|1|mg/g/min|HAIR FOLLICLE|LEFT|||ADJUDICATOR|5|Visit_5|90|1|TREATMENT|2020-08-02|90
e|FA|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|10|DMG|Dietary Magnesium|[?]|GERD|[?]|mg/cm2|[?]|1|TRANSDUCING UNIT/mL|LATERAL THIRD DIAGONAL BRANCH ARTERY|IPSILATERAL|||CHILD|5|Visit_5|90|2|WASHOUT|2020-08-02|90
e|FA|48103500-0f3d-4108-9167-6afee1098773|1|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|KIT|[?]|1|AU/mL|MEDIASTINUM|RIGHT|||CAREGIVER|1|Visit_1|10|7|FOLLOW-UP|2020-05-15|10
e|FA|48103500-0f3d-4108-9167-6afee1098773|2|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|IU/day|[?]|1|mL/m2|LIMB, LOWER|LATERAL|||FRIEND|1|Visit_1|10|4|TREATMENT|2020-05-15|10
e|FA|48103500-0f3d-4108-9167-6afee1098773|3|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|CAN|[?]|1|ug/g/h|HIP|UNILATERAL|||FAMILY MEMBER|2|Visit_2|25|2|SCREENING|2020-05-30|25
e|FA|48103500-0f3d-4108-9167-6afee1098773|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|nmol/mL/min|[?]|1|%(v/v)|MALE GENITALIA|RIGHT|Y|Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2020-05-30|25
e|FA|48103500-0f3d-4108-9167-6afee1098773|5|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|g/day|[?]|1|10^6 U|LIP, UPPER|LEFT|Y||PARENT|3|Visit_3|40|4|TREATMENT|2020-06-14|40
e|FA|48103500-0f3d-4108-9167-6afee1098773|6|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|ks|[?]|1|BAG|LOCUS CERULEUS|UNILATERAL|Y|Y|PARENT|3|Visit_3|40|3|WASHOUT|2020-06-14|40
e|FA|48103500-0f3d-4108-9167-6afee1098773|7|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|10^6 U|HAIR BULB|LEFT|||CAREGIVER|4|Visit_4|65|1|WASHOUT|2020-07-09|65
e|FA|48103500-0f3d-4108-9167-6afee1098773|8|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|mg/kg/day|[?]|1|mIU/L|TRANSVERSE TARSAL JOINT|LEFT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-07-09|65
e|FA|48103500-0f3d-4108-9167-6afee1098773|9|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|log10 CCID 50/dose|[?]|1|mmHg/L/min|ATRIOVENTRICULAR VALVE|CONTRALATERAL|||CAREGIVER|5|Visit_5|90|7|TREATMENT|2020-08-03|90
e|FA|48103500-0f3d-4108-9167-6afee1098773|10|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|uL/kg/day|[?]|1|BOWL|SUPERIOR SAGITTAL SINUS|LEFT|||SIBLING|5|Visit_5|90|3|TREATMENT|2020-08-03|90
e|FA|9855fc59-f162-48ba-8c51-e8c6c54b72f3|1|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mg/kg/day|[?]|1|gtt|ANKLE JOINT ANTERIOR FLEXOR TENDONS|RIGHT|Y|Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|WASHOUT|2020-07-25|10
e|FA|9855fc59-f162-48ba-8c51-e8c6c54b72f3|2|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|10^6 CFU|PANCREAS|LATERAL||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2020-07-25|10
e|FA|9855fc59-f162-48ba-8c51-e8c6c54b72f3|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mol/mL|[?]|1|%(v/v)|DELTOID MUSCLE|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2020-08-09|25
e|FA|9855fc59-f162-48ba-8c51-e8c6c54b72f3|4|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/dL|[?]|1|10^9 CFU/mL|SPLEEN, HILUM|BILATERAL|||CHILD|2|Visit_2|25|7|SCREENING|2020-08-09|25
e|FA|9855fc59-f162-48ba-8c51-e8c6c54b72f3|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|copies/mL|[?]|1|mg/g/min|LUNG LOBE|RIGHT|Y||VENDOR|3|Visit_3|40|7|TREATMENT|2020-08-24|40
e|FA|9855fc59-f162-48ba-8c51-e8c6c54b72f3|6|ACNDEV|Action Taken With Device|[?]|GERD|[?]|cg|[?]|1|100 IU/mL|SPINAL ACCESSORY NERVE|LEFT|Y|Y|SPOUSE|3|Visit_3|40|4|SCREENING|2020-08-24|40
e|FA|9855fc59-f162-48ba-8c51-e8c6c54b72f3|7|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|MBq|TIBIO-PERONEAL TRUNK|LEFT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2020-09-18|65
e|FA|9855fc59-f162-48ba-8c51-e8c6c54b72f3|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|g/m2/day|[?]|1|10^6 U|WRIST JOINT EXTENSOR TENDONS|CONTRALATERAL|Y||CHILD|4|Visit_4|65|4|TREATMENT|2020-09-18|65
e|FA|9855fc59-f162-48ba-8c51-e8c6c54b72f3|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|RNA copies/mL|[?]|1|mg/g/min|GANGLION|UNILATERAL|||FRIEND|5|Visit_5|90|3|TREATMENT|2020-10-13|90
e|FA|9855fc59-f162-48ba-8c51-e8c6c54b72f3|10|SERVNUM|Number of Servings|[?]|GERD|[?]|Mile|[?]|1|Hz/s|TENTORIUM CEREBELLI|IPSILATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|3|SCREENING|2020-10-13|90
e|FA|ceab42b0-3a7e-4aad-b599-5da311398148|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/dL|[?]|1|mg/g/min|ACUTE MARGINAL ARTERY|BILATERAL|||GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-06-21|10
e|FA|ceab42b0-3a7e-4aad-b599-5da311398148|2|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|ECL unit|[?]|1|IU/mmol|VAGUS NERVE|RIGHT||Y|GUARDIAN|1|Visit_1|10|1|FOLLOW-UP|2020-06-21|10
e|FA|ceab42b0-3a7e-4aad-b599-5da311398148|3|DFRUIT|Dietary Fruit|[?]|GERD|[?]|pmol/L/h|[?]|1|10^6 CFU/mL|ESOPHAGUS, THORACIC|LEFT|Y||INVESTIGATOR|2|Visit_2|25|5|FOLLOW-UP|2020-07-06|25
e|FA|ceab42b0-3a7e-4aad-b599-5da311398148|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|in|[?]|1|%(v/v)|TRANSVERSE TARSAL JOINT|UNILATERAL|Y||GUARDIAN|2|Visit_2|25|3|TREATMENT|2020-07-06|25
e|FA|ceab42b0-3a7e-4aad-b599-5da311398148|5|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/dose|[?]|1|10^9 CFU/mL|POSTERIOR SUPERIOR ILIAC SPINE|LEFT|||PARENT|3|Visit_3|40|2|TREATMENT|2020-07-21|40
e|FA|ceab42b0-3a7e-4aad-b599-5da311398148|6|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mL/m2/day|[?]|1|mAmp|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|LATERAL|||CAREGIVER|3|Visit_3|40|4|WASHOUT|2020-07-21|40
e|FA|ceab42b0-3a7e-4aad-b599-5da311398148|7|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|POUCH|[?]|1|TRANSDUCING UNIT/mL|ABDUCTOR DIGITI QUINTI MUSCLE|UNILATERAL|||CAREGIVER|4|Visit_4|65|6|SCREENING|2020-08-15|65
e|FA|ceab42b0-3a7e-4aad-b599-5da311398148|8|AGETRT1|Age At First Treatment|[?]|GERD|[?]|BAG|[?]|1|mL/mmHg/min/L|HEART, LEFT VENTRICLE|CONTRALATERAL|||CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-08-15|65
e|FA|ceab42b0-3a7e-4aad-b599-5da311398148|9|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|umol/kg/min|[?]|1|10^9 CFU/mL|PULMONARY VALVE|LEFT|Y||FRIEND|5|Visit_5|90|3|SCREENING|2020-09-09|90
e|FA|ceab42b0-3a7e-4aad-b599-5da311398148|10|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|/10^5|[?]|1|umol|VENOUS SINUS|RIGHT|Y||VENDOR|5|Visit_5|90|4|TREATMENT|2020-09-09|90
e|FA|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|V/sec|[?]|1|mg/g/min|EXTENSOR HALLUCIS BREVIS MUSCLE|UNILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|3|TREATMENT|2020-07-09|10
e|FA|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|2|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|scm|[?]|1|NEEDLE GAUGE|SACRAL TUBEROSITY|IPSILATERAL|||SPOUSE|1|Visit_1|10|4|TREATMENT|2020-07-09|10
e|FA|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|3|ACNDEV|Action Taken With Device|[?]|GERD|[?]|cup eq|[?]|1|100 IU/mL|PULMONARY ARTERY BRANCH|RIGHT||Y|VENDOR|2|Visit_2|25|2|TREATMENT|2020-07-24|25
e|FA|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|4|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mCi|[?]|1|in|SOLE|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|7|FOLLOW-UP|2020-07-24|25
e|FA|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|5|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|10^3/hpf|[?]|1|ohm|PREAURICULAR LYMPH NODE|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-08-08|40
e|FA|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|6|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|MdFI|[?]|1|AU/mL|INTRAHEPATIC BILE DUCT|RIGHT|||CLINICAL STUDY SPONSOR|3|Visit_3|40|7|TREATMENT|2020-08-08|40
e|FA|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|7|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|10^4 CFU/mL|[?]|1|BP|GLOBUS PALLIDUS|UNILATERAL|||INTERVIEWER|4|Visit_4|65|7|SCREENING|2020-09-02|65
e|FA|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|8|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|pmol/dL|[?]|1|Coulomb|AORTOCAVAL LYMPH NODE|RIGHT|||ADJUDICATOR|4|Visit_4|65|2|SCREENING|2020-09-02|65
e|FA|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|9|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|vp/dose|ABDUCTOR HALLUCIS MUSCLE|LEFT|||FRIEND|5|Visit_5|90|1|TREATMENT|2020-09-27|90
e|FA|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|10|DIAMETER|Diameter|[?]|GERD|[?]|g|[?]|1|cm|LATERAL THIRD DIAGONAL BRANCH ARTERY|UNILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2020-09-27|90
e|FA|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|1|LESNUM|Number of Lesions|[?]|GERD|[?]|g/m2/day|[?]|1|ng/day|EYE, VITREOUS CHAMBER|LEFT|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-07-10|10
e|FA|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|2|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|genEq/mL|[?]|1|fmol|SUPERFICIAL FEMORAL ARTERY|BILATERAL|||INVESTIGATOR|1|Visit_1|10|6|SCREENING|2020-07-10|10
e|FA|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|3|ACNDEV|Action Taken With Device|[?]|GERD|[?]|genEq/mL|[?]|1|100 IU/mL|CAUDATE NUCLEUS|UNILATERAL|||VENDOR|2|Visit_2|25|3|TREATMENT|2020-07-25|25
e|FA|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|4|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|copies/ug|[?]|1|/kg|SKIN OF THE HEAD|UNILATERAL||Y|INTERVIEWER|2|Visit_2|25|6|TREATMENT|2020-07-25|25
e|FA|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|5|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|vg/kg|[?]|1|10^9 CFU/mL|UMBILICAL CORD|BILATERAL||Y|INTERVIEWER|3|Visit_3|40|7|TREATMENT|2020-08-09|40
e|FA|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|6|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|ng/day|[?]|1|DROP|PLEURA|RIGHT|Y|Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|SCREENING|2020-08-09|40
e|FA|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|7|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|PATCH|[?]|1|Log10 ELISA unit|THORAX|RIGHT|Y||INTERVIEWER|4|Visit_4|65|6|FOLLOW-UP|2020-09-03|65
e|FA|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|8|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|mL/kg/h|[?]|1|g/day|FINGER EXTENSOR MUSCLES|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|SCREENING|2020-09-03|65
e|FA|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|9|STRCTNUM|Number of Strictures|[?]|GERD|[?]|kDa|[?]|1|SACHET|BODY|CONTRALATERAL|Y||ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-09-28|90
e|FA|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|10|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|mL/day|[?]|1|psi|STERNUM|LATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|7|WASHOUT|2020-09-28|90
e|FA|36a54b72-6368-460e-ab4c-952923e0fd14|1|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|kBq|[?]|1|MPS U|FRONTAL SINUS|IPSILATERAL||Y|INVESTIGATOR|1|Visit_1|10|5|TREATMENT|2020-05-15|10
e|FA|36a54b72-6368-460e-ab4c-952923e0fd14|2|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|U/mmol|[?]|1|HOURS|HYPOTHALAMUS|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|TREATMENT|2020-05-15|10
e|FA|36a54b72-6368-460e-ab4c-952923e0fd14|3|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|STEPS|[?]|1|h*%|SPINAL CORD|LATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|FOLLOW-UP|2020-05-30|25
e|FA|36a54b72-6368-460e-ab4c-952923e0fd14|4|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|breaths/30s|[?]|1|10^9 CFU/mL|PERIURETERAL REGION|LEFT||Y|VENDOR|2|Visit_2|25|1|FOLLOW-UP|2020-05-30|25
e|FA|36a54b72-6368-460e-ab4c-952923e0fd14|5|LOCONSET|Localization of Onset|[?]|GERD|[?]|g/g/day|[?]|1|g/L|FACET JOINT|IPSILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|6|TREATMENT|2020-06-14|40
e|FA|36a54b72-6368-460e-ab4c-952923e0fd14|6|OBJNUM|Number of Objects|[?]|GERD|[?]|C|[?]|1|mL/100g/min|LUNG, RIGHT UPPER LOBE|LATERAL|||DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2020-06-14|40
e|FA|36a54b72-6368-460e-ab4c-952923e0fd14|7|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|ft2|[?]|1|/kg|EYE BULGE|LATERAL||Y|PROXY|4|Visit_4|65|6|WASHOUT|2020-07-09|65
e|FA|36a54b72-6368-460e-ab4c-952923e0fd14|8|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|pg/L|[?]|1|m2|C3 VERTEBRA|LEFT|Y||FAMILY MEMBER|4|Visit_4|65|5|SCREENING|2020-07-09|65
e|FA|36a54b72-6368-460e-ab4c-952923e0fd14|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|mL/(min*100mL)|[?]|1|ug/g/h|CAUDATE NUCLEUS|RIGHT|||INDEPENDENT ASSESSOR|5|Visit_5|90|1|WASHOUT|2020-08-03|90
e|FA|36a54b72-6368-460e-ab4c-952923e0fd14|10|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|BOX|[?]|1|g/dL|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|6|SCREENING|2020-08-03|90
e|FA|84e56692-9a33-472a-9ddc-545d3342da34|1|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|U/kg/min|[?]|1|NEEDLE GAUGE|HEART, APEX|LATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-12-19|10
e|FA|84e56692-9a33-472a-9ddc-545d3342da34|2|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|PACK|[?]|1|uL/kg/day|LEFT MAIN CORONARY ARTERY BODY|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2020-12-19|10
e|FA|84e56692-9a33-472a-9ddc-545d3342da34|3|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|Enzyme U/L|[?]|1|ug/g/h|POPLITEAL ARTERY BELOW KNEE|LATERAL|||STUDY SUBJECT|2|Visit_2|25|4|WASHOUT|2021-01-03|25
e|FA|84e56692-9a33-472a-9ddc-545d3342da34|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|fraction of 1|[?]|1|Pa|MAMMARY GLAND|CONTRALATERAL|||PROXY|2|Visit_2|25|6|TREATMENT|2021-01-03|25
e|FA|84e56692-9a33-472a-9ddc-545d3342da34|5|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|10^6 copies/mL|[?]|1|mg/h|L4-L5 INTERVERTEBRAL SPACE|UNILATERAL|||GUARDIAN|3|Visit_3|40|2|TREATMENT|2021-01-18|40
e|FA|84e56692-9a33-472a-9ddc-545d3342da34|6|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|mg/min|[?]|1|uCi/kg|HEART, APEX|RIGHT|||CLINICAL STUDY SPONSOR|3|Visit_3|40|7|TREATMENT|2021-01-18|40
e|FA|84e56692-9a33-472a-9ddc-545d3342da34|7|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|EVENTS|[?]|1|mL/mmHg/min/L|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|CONTRALATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|WASHOUT|2021-02-12|65
e|FA|84e56692-9a33-472a-9ddc-545d3342da34|8|TOXGR|Toxicity Grade|[?]|GERD|[?]|APL U/mL|[?]|1|aMFI|HUMERUS|BILATERAL|||INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2021-02-12|65
e|FA|84e56692-9a33-472a-9ddc-545d3342da34|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/kg|[?]|1|mg/g/min|HEART, LEFT VENTRICULAR OUTFLOW TRACT|LEFT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|WASHOUT|2021-03-09|90
e|FA|84e56692-9a33-472a-9ddc-545d3342da34|10|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|LENS|[?]|1|Hz/s|RETINAL NERVE FIBER LAYER|IPSILATERAL|Y||GUARDIAN|5|Visit_5|90|3|WASHOUT|2021-03-09|90
e|FA|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|1|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|APL U|[?]|1|uCi/kg|TAIL|UNILATERAL|Y||INVESTIGATOR|1|Visit_1|10|1|SCREENING|2020-05-31|10
e|FA|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|2|TRTSETT|Treatment Setting|[?]|GERD|[?]|10^7 CFU/mL|[?]|1|Coulomb|HEPATIC LYMPH NODE|IPSILATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|7|TREATMENT|2020-05-31|10
e|FA|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|3|VOL|Volume|[?]|GERD|[?]|uV|[?]|1|vp/dose|LINGULA OF THE LUNG|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|2|SCREENING|2020-06-15|25
e|FA|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|4|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ng/day|[?]|1|km|DISTAL RIGHT CORONARY ARTERY CONDUIT|LEFT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|WASHOUT|2020-06-15|25
e|FA|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|5|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|BOWL|PROXIMAL INTERPHALANGEAL JOINT 4|IPSILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|7|WASHOUT|2020-06-30|40
e|FA|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|6|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|cy/cm|[?]|1|BOWL|GENITAL TUBERCLE|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-06-30|40
e|FA|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|7|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|mEq/g|PROSTATE GLAND, MIDDLE LOBE|BILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|FOLLOW-UP|2020-07-25|65
e|FA|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|8|EXCDUR|Exercise Duration|[?]|GERD|[?]|CFU/mL|[?]|1|mm|MEDIASTINUM, ANTERIOR|IPSILATERAL|||CHILD|4|Visit_4|65|3|SCREENING|2020-07-25|65
e|FA|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|/HPF|[?]|1|%(v/v)|BRAIN VENTRICLE|UNILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2020-08-19|90
e|FA|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|10|DFATT|Dietary Fat, Total|[?]|GERD|[?]|ft2|[?]|1|Bq/mg|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|LEFT|||INVESTIGATOR|5|Visit_5|90|6|WASHOUT|2020-08-19|90
e|FA|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|m/sec2|[?]|1|10^6 U|SCAPHOID-LUNATE-CAPITATE JOINT|RIGHT|||INTERVIEWER|1|Visit_1|10|6|TREATMENT|2020-06-10|10
e|FA|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|damol/L|[?]|1|mg/g/min|CORPUS CALLOSUM|LEFT|||INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-06-10|10
e|FA|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ag|[?]|1|Pa|SKIN OF THE FOOT|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|WASHOUT|2020-06-25|25
e|FA|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|4|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|MHz|[?]|1|vp/dose|RADIAL NERVE|LEFT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-06-25|25
e|FA|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|5|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|ft2|[?]|1|cm|EPIGASTRIC REGION|LEFT||Y|INVESTIGATOR|3|Visit_3|40|3|WASHOUT|2020-07-10|40
e|FA|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|6|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|/100 WBC|[?]|1|Shock Wave|CELIAC LYMPH NODE|LEFT|||INVESTIGATOR|3|Visit_3|40|5|WASHOUT|2020-07-10|40
e|FA|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|7|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|BU|[?]|1|g/day|CAPITATE-HAMATE JOINT|LEFT|||ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-08-04|65
e|FA|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|8|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|dyn|[?]|1|mL/100g/min|SUPRARENAL AORTA|BILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2020-08-04|65
e|FA|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|9|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|ag|[?]|1|g/dL|5TH LUMBAR SPINOUS PROCESS|RIGHT||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2020-08-29|90
e|FA|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|10|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|pt_br|[?]|1|cm H2O|C2 VERTEBRA|LATERAL|||SPOUSE|5|Visit_5|90|1|WASHOUT|2020-08-29|90
e|FA|ae0e05c1-3953-4406-bfae-299295c1fa4c|1|LENRSCT|Length of Resection|[?]|GERD|[?]|10^3 CFU/mL|[?]|1|psi|INTERPHALANGEAL JOINT 4 OF THE FOOT|UNILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2021-01-12|10
e|FA|ae0e05c1-3953-4406-bfae-299295c1fa4c|2|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|Bq/kg|[?]|1|mAmp|BRAIN VENTRICLE, LATERAL|RIGHT|||PROXY|1|Visit_1|10|3|FOLLOW-UP|2021-01-12|10
e|FA|ae0e05c1-3953-4406-bfae-299295c1fa4c|3|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|NFIU|[?]|1|psi|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|IPSILATERAL|Y|Y|GUARDIAN|2|Visit_2|25|3|FOLLOW-UP|2021-01-27|25
e|FA|ae0e05c1-3953-4406-bfae-299295c1fa4c|4|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|CUP|[?]|1|g/day|CERVICAL SPINE|IPSILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|7|TREATMENT|2021-01-27|25
e|FA|ae0e05c1-3953-4406-bfae-299295c1fa4c|5|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|EIA unit|MIDDLE EAR|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2021-02-11|40
e|FA|ae0e05c1-3953-4406-bfae-299295c1fa4c|6|DCAL|Dietary Calories|[?]|GERD|[?]|/ms|[?]|1|EIA unit|ILIAC LYMPH NODE|RIGHT|Y||FRIEND|3|Visit_3|40|4|SCREENING|2021-02-11|40
e|FA|ae0e05c1-3953-4406-bfae-299295c1fa4c|7|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|mN|[?]|1|TRANSDUCING UNIT/mL|INTERPHALANGEAL JOINT OF THE HAND|RIGHT|||INDEPENDENT ASSESSOR|4|Visit_4|65|4|SCREENING|2021-03-08|65
e|FA|ae0e05c1-3953-4406-bfae-299295c1fa4c|8|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|Gy/h|[?]|1|Log10 ELISA unit|RECTUS FEMORIS MUSCLE|LATERAL||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2021-03-08|65
e|FA|ae0e05c1-3953-4406-bfae-299295c1fa4c|9|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|CIGARETTE|[?]|1|h*%|RETROPERITONEAL LYMPH NODE|BILATERAL|||FRIEND|5|Visit_5|90|6|SCREENING|2021-04-02|90
e|FA|ae0e05c1-3953-4406-bfae-299295c1fa4c|10|SEV|Severity/Intensity|[?]|GERD|[?]|ug/kg|[?]|1|Pa|THIRD RIGHT POSTEROLATERAL ARTERY|BILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2021-04-02|90
e|FA|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|1|TRTSETT|Treatment Setting|[?]|GERD|[?]|V/sec|[?]|1|Coulomb|OBTURATOR MUSCLE|BILATERAL|||VENDOR|1|Visit_1|10|3|TREATMENT|2021-01-16|10
e|FA|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|2|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|EIA unit|CORONARY ARTERY, LEFT|UNILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2021-01-16|10
e|FA|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|3|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|nmol/kg/day|[?]|1|ng|TYMPANIC MEMBRANE|UNILATERAL|||CAREGIVER|2|Visit_2|25|5|FOLLOW-UP|2021-01-31|25
e|FA|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|pt_br|[?]|1|%(v/v)|CORPUS CALLOSUM, BODY|LATERAL||Y|ADJUDICATOR|2|Visit_2|25|3|FOLLOW-UP|2021-01-31|25
e|FA|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|ug/g/h|[?]|1|ug/g/h|DISTAL PHALANX 4 OF THE HAND|BILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|WASHOUT|2021-02-15|40
e|FA|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|6|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|U|[?]|1|AU/mL|PYLORIC SPHINCTER|LEFT||Y|SIBLING|3|Visit_3|40|2|TREATMENT|2021-02-15|40
e|FA|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|7|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|mL/min/mmHg|THORACIC SPINE|CONTRALATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|7|TREATMENT|2021-03-12|65
e|FA|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|8|SEV|Severity/Intensity|[?]|GERD|[?]|10^4/hpf|[?]|1|Pa|DISTAL RIGHT CORONARY ARTERY CONDUIT|IPSILATERAL|Y||INTERVIEWER|4|Visit_4|65|1|TREATMENT|2021-03-12|65
e|FA|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|9|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|mg/mL/day|[?]|1|MPS U|HEART, LEFT ATRIAL APPENDAGE|RIGHT|Y||VENDOR|5|Visit_5|90|6|FOLLOW-UP|2021-04-06|90
e|FA|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|10|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|VOXEL|[?]|1|Gy/h|CARPOMETACARPAL JOINT 1|RIGHT|||INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2021-04-06|90
e|FA|ab09e76d-8bbf-4126-a60d-08d6b5292836|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|10^3 copies/mL|[?]|1|CUP|FOOT DIGIT 1|LEFT||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|6|FOLLOW-UP|2020-12-25|10
e|FA|ab09e76d-8bbf-4126-a60d-08d6b5292836|2|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|BAG|[?]|1|mm/h|SHOULDER JOINT TENDONS|CONTRALATERAL|Y||GUARDIAN|1|Visit_1|10|3|TREATMENT|2020-12-25|10
e|FA|ab09e76d-8bbf-4126-a60d-08d6b5292836|3|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT|[?]|1|mEq/g|5TH LUMBAR SPINOUS PROCESS|IPSILATERAL|||INTERVIEWER|2|Visit_2|25|3|TREATMENT|2021-01-09|25
e|FA|ab09e76d-8bbf-4126-a60d-08d6b5292836|4|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^7/L|[?]|1|mL|UMBILICAL CORD|CONTRALATERAL|||FRIEND|2|Visit_2|25|5|TREATMENT|2021-01-09|25
e|FA|ab09e76d-8bbf-4126-a60d-08d6b5292836|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|U/cL|[?]|1|%(v/v)|DISTAL EXTRAHEPATIC BILE DUCT REGION|CONTRALATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|SCREENING|2021-01-24|40
e|FA|ab09e76d-8bbf-4126-a60d-08d6b5292836|6|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|nmol/g|[?]|1|U/10^12 RBC|SALIVARY GLAND|LEFT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2021-01-24|40
e|FA|ab09e76d-8bbf-4126-a60d-08d6b5292836|7|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|amp|[?]|1|10^6 U|HEART, RIGHT VENTRICLE|RIGHT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2021-02-18|65
e|FA|ab09e76d-8bbf-4126-a60d-08d6b5292836|8|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/g|[?]|1|10^4 CFU/mL|KNEE JOINT|BILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|2|SCREENING|2021-02-18|65
e|FA|ab09e76d-8bbf-4126-a60d-08d6b5292836|9|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|um2|[?]|1|ng/day|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT|||INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2021-03-15|90
e|FA|ab09e76d-8bbf-4126-a60d-08d6b5292836|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|copies/uL|[?]|1|%(v/v)|BRONCHUS|UNILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|3|SCREENING|2021-03-15|90
e|FA|8b7e3909-4115-4736-b07a-e0b6c382aa7e|1|DVEG|Dietary Vegetable|[?]|GERD|[?]|CAN|[?]|1|Ci/ug|HEEL OF THE FOOT|LEFT||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|SCREENING|2020-07-11|10
e|FA|8b7e3909-4115-4736-b07a-e0b6c382aa7e|2|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|ms2|[?]|1|Gy/h|INTERPHALANGEAL JOINT 5 OF THE FOOT|LEFT||Y|CHILD|1|Visit_1|10|2|SCREENING|2020-07-11|10
e|FA|8b7e3909-4115-4736-b07a-e0b6c382aa7e|3|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|nm|[?]|1|Coulomb|COSTAL CARTILAGE|UNILATERAL|||ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-07-26|25
e|FA|8b7e3909-4115-4736-b07a-e0b6c382aa7e|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|FIU|[?]|1|U/mmol|INTRAHEPATIC LARGE BILE DUCT|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-07-26|25
e|FA|8b7e3909-4115-4736-b07a-e0b6c382aa7e|5|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/dL|[?]|1|mg/dose|NAIL|BILATERAL|||ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-08-10|40
e|FA|8b7e3909-4115-4736-b07a-e0b6c382aa7e|6|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|h*%|[?]|1|10^6 organisms/mL|SALIVARY GLAND|CONTRALATERAL||Y|GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-08-10|40
e|FA|8b7e3909-4115-4736-b07a-e0b6c382aa7e|7|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|10^7/L|[?]|1|psi|CORONARY ARTERY, LEFT|LEFT|||INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2020-09-04|65
e|FA|8b7e3909-4115-4736-b07a-e0b6c382aa7e|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|AU/mL|[?]|1|10^6 U|INTERPHALANGEAL OF THE FOOT|IPSILATERAL|||SPOUSE|4|Visit_4|65|2|TREATMENT|2020-09-04|65
e|FA|8b7e3909-4115-4736-b07a-e0b6c382aa7e|9|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|10^3 RNA copies/mL|[?]|1|TRANSDUCING UNIT/mL|INTERPHALANGEAL JOINT 5 OF THE FOOT|RIGHT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-09-29|90
e|FA|8b7e3909-4115-4736-b07a-e0b6c382aa7e|10|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|mg/day|[?]|1|10^6 CFU|PERIHILAR LYMPH NODE|CONTRALATERAL||Y|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2020-09-29|90
e|FA|187b2279-526f-4978-89d4-d2da56cc2257|1|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|DIP|[?]|1|QUANTITY SUFFICIENT|CECUM|LEFT|Y||INVESTIGATOR|1|Visit_1|10|5|TREATMENT|2020-06-21|10
e|FA|187b2279-526f-4978-89d4-d2da56cc2257|2|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|/2500 WBC|[?]|1|10^6 U|MESENTERIC VEIN|LATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-06-21|10
e|FA|187b2279-526f-4978-89d4-d2da56cc2257|3|DFRUIT|Dietary Fruit|[?]|GERD|[?]|PHERESIS UNIT|[?]|1|10^6 CFU/mL|CEREBRAL HEMISPHERE, LEFT|IPSILATERAL|||INTERVIEWER|2|Visit_2|25|5|TREATMENT|2020-07-06|25
e|FA|187b2279-526f-4978-89d4-d2da56cc2257|4|LENRSCT|Length of Resection|[?]|GERD|[?]|GBq/mg|[?]|1|psi|UTERUS|BILATERAL|||FRIEND|2|Visit_2|25|3|WASHOUT|2020-07-06|25
e|FA|187b2279-526f-4978-89d4-d2da56cc2257|5|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|cs|[?]|1|DRUM|POPLITEAL FOSSA|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-07-21|40
e|FA|187b2279-526f-4978-89d4-d2da56cc2257|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|L/h|[?]|1|Shock Wave|RIGHT VENTRICULAR BRANCH|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|WASHOUT|2020-07-21|40
e|FA|187b2279-526f-4978-89d4-d2da56cc2257|7|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|LB|[?]|1|uL/kg/day|LATERAL SECOND DIAGONAL BRANCH ARTERY|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-08-15|65
e|FA|187b2279-526f-4978-89d4-d2da56cc2257|8|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|MET|[?]|1|g/day|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|LEFT||Y|SPOUSE|4|Visit_4|65|4|FOLLOW-UP|2020-08-15|65
e|FA|187b2279-526f-4978-89d4-d2da56cc2257|9|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|mmHg*min/L|[?]|1|HOURS|ADRENAL GLAND|LATERAL||Y|CAREGIVER|5|Visit_5|90|2|TREATMENT|2020-09-09|90
e|FA|187b2279-526f-4978-89d4-d2da56cc2257|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|kat|[?]|1|mg/g/min|VERTEBRA|LEFT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|SCREENING|2020-09-09|90
e|FA|53506a04-dedb-495b-8e35-0576cdf1b323|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|CUP|HEART, RIGHT VENTRICULAR WALL|RIGHT|Y||VENDOR|1|Visit_1|10|7|SCREENING|2020-11-07|10
e|FA|53506a04-dedb-495b-8e35-0576cdf1b323|2|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|mL/animal|[?]|1|BAG|MEDIASTINUM|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2020-11-07|10
e|FA|53506a04-dedb-495b-8e35-0576cdf1b323|3|LDIAM|Longest Diameter|[?]|GERD|[?]|mg/L|[?]|1|Shock Wave|DISTAL INTERPHALANGEAL JOINT 3|UNILATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|2|SCREENING|2020-11-22|25
e|FA|53506a04-dedb-495b-8e35-0576cdf1b323|4|OBJNUM|Number of Objects|[?]|GERD|[?]|/h|[?]|1|mL/100g/min|THYROID GLAND, RIGHT LOBE|UNILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|SCREENING|2020-11-22|25
e|FA|53506a04-dedb-495b-8e35-0576cdf1b323|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|copies/ug|[?]|1|%(v/v)|EYE BULGE|CONTRALATERAL|||INTERVIEWER|3|Visit_3|40|5|TREATMENT|2020-12-07|40
e|FA|53506a04-dedb-495b-8e35-0576cdf1b323|6|DGRAIN|Dietary Grain|[?]|GERD|[?]|dpm/mg|[?]|1|10^9 CFU/g|CEREBELLUM|IPSILATERAL|||GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-12-07|40
e|FA|53506a04-dedb-495b-8e35-0576cdf1b323|7|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|BP|PERIPHERAL NERVE|IPSILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|6|WASHOUT|2021-01-01|65
e|FA|53506a04-dedb-495b-8e35-0576cdf1b323|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|s*kPa|[?]|1|Pa|DIGIT|CONTRALATERAL|||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2021-01-01|65
e|FA|53506a04-dedb-495b-8e35-0576cdf1b323|9|SEV|Severity/Intensity|[?]|GERD|[?]|nmol/L/min|[?]|1|Pa|INFRACLAVICULAR LYMPH NODE|UNILATERAL|Y||STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2021-01-26|90
e|FA|53506a04-dedb-495b-8e35-0576cdf1b323|10|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|mV|[?]|1|10^6 CFU/mL|CHOROID PLEXUS|LATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|TREATMENT|2021-01-26|90
e|FA|defa600c-4205-476e-a40c-690cb16769b3|1|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|10^10/L|[?]|1|uCi/kg|LEFT VENTRICULAR APEX SEGMENT|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|5|SCREENING|2021-01-24|10
e|FA|defa600c-4205-476e-a40c-690cb16769b3|2|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|tuberculin unit/mL|[?]|1|g/L|PORTAL LYMPH NODE|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2021-01-24|10
e|FA|defa600c-4205-476e-a40c-690cb16769b3|3|DMG|Dietary Magnesium|[?]|GERD|[?]|mEq/kg|[?]|1|TRANSDUCING UNIT/mL|SKIN OF THE INGUINAL REGION|LEFT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2021-02-08|25
e|FA|defa600c-4205-476e-a40c-690cb16769b3|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|g/cage/day|[?]|1|NEEDLE GAUGE|ORBICULARIS OCULI MUSCLE|RIGHT|||INTERVIEWER|2|Visit_2|25|3|WASHOUT|2021-02-08|25
e|FA|defa600c-4205-476e-a40c-690cb16769b3|5|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|ug/kg/h|[?]|1|mL/h|FOOT DIGIT 5|IPSILATERAL|Y||INTERVIEWER|3|Visit_3|40|4|TREATMENT|2021-02-23|40
e|FA|defa600c-4205-476e-a40c-690cb16769b3|6|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|kg|[?]|1|ohm|INCUS|RIGHT||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2021-02-23|40
e|FA|defa600c-4205-476e-a40c-690cb16769b3|7|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|min*mg/mL|[?]|1|SCOOPFUL|INCISOR|UNILATERAL|Y||SIBLING|4|Visit_4|65|3|SCREENING|2021-03-20|65
e|FA|defa600c-4205-476e-a40c-690cb16769b3|8|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|U/mg|SUBARACHNOID SPACE|CONTRALATERAL||Y|INVESTIGATOR|4|Visit_4|65|2|FOLLOW-UP|2021-03-20|65
e|FA|defa600c-4205-476e-a40c-690cb16769b3|9|QOLIMP|QOL Impact|[?]|GERD|[?]|ms/mmHg|[?]|1|10^6/L|CLAW|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2021-04-14|90
e|FA|defa600c-4205-476e-a40c-690cb16769b3|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/min|[?]|1|%(v/v)|ILIUM|LATERAL|||ADJUDICATOR|5|Visit_5|90|1|SCREENING|2021-04-14|90
e|FA|e5092583-4259-40ba-a6a2-eeef6607263b|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|gpELISA unit/mL|[?]|1|SCOOPFUL|FEMORAL HEAD|RIGHT|Y||SIBLING|1|Visit_1|10|7|FOLLOW-UP|2020-09-16|10
e|FA|e5092583-4259-40ba-a6a2-eeef6607263b|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|lx|[?]|1|%(v/v)|KIDNEY, HILUM|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|FOLLOW-UP|2020-09-16|10
e|FA|e5092583-4259-40ba-a6a2-eeef6607263b|3|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|U/g Hb|[?]|1|g/cage/day|PROFUNDA FEMORIS VEIN|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-10-01|25
e|FA|e5092583-4259-40ba-a6a2-eeef6607263b|4|SEV|Severity/Intensity|[?]|GERD|[?]|/kg|[?]|1|Pa|PARASYMPATHETIC GANGLIA|BILATERAL|Y||DOMESTIC PARTNER|2|Visit_2|25|4|FOLLOW-UP|2020-10-01|25
e|FA|e5092583-4259-40ba-a6a2-eeef6607263b|5|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|Hounsfield Unit|[?]|1|ohm|CELIAC LYMPH NODE|RIGHT||Y|INVESTIGATOR|3|Visit_3|40|1|SCREENING|2020-10-16|40
e|FA|e5092583-4259-40ba-a6a2-eeef6607263b|6|DMG|Dietary Magnesium|[?]|GERD|[?]|nmol/day|[?]|1|TRANSDUCING UNIT/mL|INFRACLAVICULAR LYMPH NODE|CONTRALATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-10-16|40
e|FA|e5092583-4259-40ba-a6a2-eeef6607263b|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|pg/dL|[?]|1|mg/g/min|MESENTERY|RIGHT|Y|Y|INTERVIEWER|4|Visit_4|65|2|TREATMENT|2020-11-10|65
e|FA|e5092583-4259-40ba-a6a2-eeef6607263b|8|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|PUFF|[?]|1|ohm|ESOPHAGUS, MIDDLE THIRD|BILATERAL|||ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2020-11-10|65
e|FA|e5092583-4259-40ba-a6a2-eeef6607263b|9|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ukat/L|[?]|1|oz eq|HEART, LEFT VENTRICULAR WALL|RIGHT||Y|VENDOR|5|Visit_5|90|4|TREATMENT|2020-12-05|90
e|FA|e5092583-4259-40ba-a6a2-eeef6607263b|10|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|10^3 RNA copies/mL|[?]|1|10^6 CFU|PANCREATIC DUCT|LEFT|||CAREGIVER|5|Visit_5|90|6|TREATMENT|2020-12-05|90
e|FA|461196d1-1213-4e5f-9bac-71f097b6cfdb|1|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|STRIP|[?]|1|ug/m2/h|PROXIMAL PHALANX 3 OF THE HAND|CONTRALATERAL|||PARENT|1|Visit_1|10|4|FOLLOW-UP|2020-11-13|10
e|FA|461196d1-1213-4e5f-9bac-71f097b6cfdb|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|Pa|LEFT POSTERIOR DESCENDING ARTERY|IPSILATERAL|Y||GUARDIAN|1|Visit_1|10|3|WASHOUT|2020-11-13|10
e|FA|461196d1-1213-4e5f-9bac-71f097b6cfdb|3|LENRSCT|Length of Resection|[?]|GERD|[?]|cd*s/m2|[?]|1|psi|MALE GENITALIA|CONTRALATERAL|||STUDY SUBJECT|2|Visit_2|25|7|FOLLOW-UP|2020-11-28|25
e|FA|461196d1-1213-4e5f-9bac-71f097b6cfdb|4|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mg/m2|[?]|1|CUP|DISTANT LYMPH NODE|BILATERAL|||CHILD|2|Visit_2|25|3|FOLLOW-UP|2020-11-28|25
e|FA|461196d1-1213-4e5f-9bac-71f097b6cfdb|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/day|[?]|1|mg/g/min|FUNDUS OF THE EYE|IPSILATERAL|||SPOUSE|3|Visit_3|40|5|SCREENING|2020-12-13|40
e|FA|461196d1-1213-4e5f-9bac-71f097b6cfdb|6|STRCTNUM|Number of Strictures|[?]|GERD|[?]|mEq/uL|[?]|1|SACHET|DISTAL INTERPHALANGEAL JOINT 5|LEFT|Y||DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-12-13|40
e|FA|461196d1-1213-4e5f-9bac-71f097b6cfdb|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|MBP|[?]|1|mg/g/min|EARLOBE|BILATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2021-01-07|65
e|FA|461196d1-1213-4e5f-9bac-71f097b6cfdb|8|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|10^6 CFU|SUBARACHNOID SPACE|UNILATERAL|||VENDOR|4|Visit_4|65|6|TREATMENT|2021-01-07|65
e|FA|461196d1-1213-4e5f-9bac-71f097b6cfdb|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|Pa|APPENDICULAR SKELETON|BILATERAL|||SPOUSE|5|Visit_5|90|6|TREATMENT|2021-02-01|90
e|FA|461196d1-1213-4e5f-9bac-71f097b6cfdb|10|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/mg|[?]|1|10^9 CFU/mL|BLADDER, FUNDUS|BILATERAL|||ADJUDICATOR|5|Visit_5|90|3|FOLLOW-UP|2021-02-01|90
e|FA|4c82922a-55d0-45b9-a7bb-4edac32b0f68|1|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|Pa|[?]|1|10^6/L|TARSUS BONE|LATERAL|||ADJUDICATOR|1|Visit_1|10|1|SCREENING|2020-12-09|10
e|FA|4c82922a-55d0-45b9-a7bb-4edac32b0f68|2|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|kg/cm|[?]|1|Ci/ug|LEPTOMENINGES|LATERAL|||FRIEND|1|Visit_1|10|3|TREATMENT|2020-12-09|10
e|FA|4c82922a-55d0-45b9-a7bb-4edac32b0f68|3|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|PIXELS/cm|[?]|1|L|CEREBRAL ARTERY|BILATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|1|WASHOUT|2020-12-24|25
e|FA|4c82922a-55d0-45b9-a7bb-4edac32b0f68|4|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|log10 IU/mL|[?]|1|mL/min/mmHg|SCIATIC NERVE|LATERAL|||INTERVIEWER|2|Visit_2|25|5|TREATMENT|2020-12-24|25
e|FA|4c82922a-55d0-45b9-a7bb-4edac32b0f68|5|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|L/min/m2|[?]|1|ug/g/h|NASAL SEPTUM|LATERAL|||SIBLING|3|Visit_3|40|4|TREATMENT|2021-01-08|40
e|FA|4c82922a-55d0-45b9-a7bb-4edac32b0f68|6|DGRAIN|Dietary Grain|[?]|GERD|[?]|PIXELS/in|[?]|1|10^9 CFU/g|CUBOID BONE|IPSILATERAL|||FAMILY MEMBER|3|Visit_3|40|7|WASHOUT|2021-01-08|40
e|FA|4c82922a-55d0-45b9-a7bb-4edac32b0f68|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/g/h|[?]|1|mg/g/min|SUDORIFEROUS GLAND|UNILATERAL|||SIBLING|4|Visit_4|65|2|TREATMENT|2021-02-02|65
e|FA|4c82922a-55d0-45b9-a7bb-4edac32b0f68|8|EVENTNUM|Number of Events|[?]|GERD|[?]|ft3|[?]|1|U/10^12 RBC|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|BILATERAL|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2021-02-02|65
e|FA|4c82922a-55d0-45b9-a7bb-4edac32b0f68|9|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|Pack Year|[?]|1|mmHg/L/min|MESENTERIC LYMPH NODE|RIGHT||Y|CHILD|5|Visit_5|90|3|TREATMENT|2021-02-27|90
e|FA|4c82922a-55d0-45b9-a7bb-4edac32b0f68|10|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|V/sec|[?]|1|/500 WBC|T8 VERTEBRA|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2021-02-27|90
e|FA|57971bdc-14df-4d9e-a59a-2665703c12ab|1|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/mL|[?]|1|Shock Wave|URETHRA, PENILE|BILATERAL|Y||ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-05-30|10
e|FA|57971bdc-14df-4d9e-a59a-2665703c12ab|2|LESNUM|Number of Lesions|[?]|GERD|[?]|log10 PFU/mL|[?]|1|ng/day|HYMENAL RING|IPSILATERAL|Y||GUARDIAN|1|Visit_1|10|1|TREATMENT|2020-05-30|10
e|FA|57971bdc-14df-4d9e-a59a-2665703c12ab|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/day|[?]|1|mg/g/min|ENDOMETRIUM|BILATERAL|Y||INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-06-14|25
e|FA|57971bdc-14df-4d9e-a59a-2665703c12ab|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|pt_br|[?]|1|PFU/dose|LATERAL FIRST DIAGONAL BRANCH ARTERY|RIGHT|Y||SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2020-06-14|25
e|FA|57971bdc-14df-4d9e-a59a-2665703c12ab|5|DIAMETER|Diameter|[?]|GERD|[?]|pmol/L|[?]|1|cm|SHIN|LATERAL||Y|SIBLING|3|Visit_3|40|6|TREATMENT|2020-06-29|40
e|FA|57971bdc-14df-4d9e-a59a-2665703c12ab|6|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|ug/kg|[?]|1|10^6 U|BLOOD VESSEL|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|WASHOUT|2020-06-29|40
e|FA|57971bdc-14df-4d9e-a59a-2665703c12ab|7|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|mEq/g|PRETRACHEAL LYMPH NODE|LEFT|||STUDY SUBJECT|4|Visit_4|65|2|FOLLOW-UP|2020-07-24|65
e|FA|57971bdc-14df-4d9e-a59a-2665703c12ab|8|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|amp|[?]|1|mEq|LEG|UNILATERAL|Y|Y|ADJUDICATOR|4|Visit_4|65|3|WASHOUT|2020-07-24|65
e|FA|57971bdc-14df-4d9e-a59a-2665703c12ab|9|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|ug/kg/h|[?]|1|ohm|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|RIGHT|Y|Y|ADJUDICATION COMMITTEE|5|Visit_5|90|4|SCREENING|2020-08-18|90
e|FA|57971bdc-14df-4d9e-a59a-2665703c12ab|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|U/mmol|THYMUS GLAND|UNILATERAL||Y|GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-08-18|90
e|FA|dacea2da-9101-41e9-97aa-1cb8445b1320|1|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|10^4/hpf|[?]|1|10^6 IU/mL|MITRAL VALVE, ANTERIOR ANNULUS|LATERAL|||CHILD|1|Visit_1|10|1|WASHOUT|2020-10-09|10
e|FA|dacea2da-9101-41e9-97aa-1cb8445b1320|2|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|CFU/g|[?]|1|10^4 CFU/mL|FOOT DIGIT 1|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|FOLLOW-UP|2020-10-09|10
e|FA|dacea2da-9101-41e9-97aa-1cb8445b1320|3|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|U/m2/min|[?]|1|10^6 U|TIBIAL-CRURAL PERIPHERAL ARTERY|BILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|1|WASHOUT|2020-10-24|25
e|FA|dacea2da-9101-41e9-97aa-1cb8445b1320|4|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|mph|[?]|1|DRUM|HEART, SEPTUM|BILATERAL|||SIBLING|2|Visit_2|25|6|TREATMENT|2020-10-24|25
e|FA|dacea2da-9101-41e9-97aa-1cb8445b1320|5|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|mL/kg/min|[?]|1|QUANTITY SUFFICIENT|PANCREAS, TAIL|RIGHT|||VENDOR|3|Visit_3|40|2|TREATMENT|2020-11-08|40
e|FA|dacea2da-9101-41e9-97aa-1cb8445b1320|6|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|uU/dL|[?]|1|10^9 CFU/mL|TRANSVERSE TARSAL JOINT|LATERAL|||PROXY|3|Visit_3|40|4|WASHOUT|2020-11-08|40
e|FA|dacea2da-9101-41e9-97aa-1cb8445b1320|7|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|deg2|[?]|1|mL/cm3/min|STERNUM|LATERAL|Y|Y|VENDOR|4|Visit_4|65|7|TREATMENT|2020-12-03|65
e|FA|dacea2da-9101-41e9-97aa-1cb8445b1320|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Ci|[?]|1|mg/g/min|CERVICAL LYMPH NODE|CONTRALATERAL|||VENDOR|4|Visit_4|65|5|TREATMENT|2020-12-03|65
e|FA|dacea2da-9101-41e9-97aa-1cb8445b1320|9|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|g/kg|[?]|1|MPS U|RESPIRATORY SYSTEM|BILATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|1|WASHOUT|2020-12-28|90
e|FA|dacea2da-9101-41e9-97aa-1cb8445b1320|10|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|mL/cm3/min|PREPUTIAL GLAND|LATERAL|||PARENT|5|Visit_5|90|6|TREATMENT|2020-12-28|90
e|FA|cbf5d05e-e934-4946-b991-5fef63a01888|1|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|U/m2/h|[?]|1|EIA unit|CINGULATE CORTEX|IPSILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2020-11-06|10
e|FA|cbf5d05e-e934-4946-b991-5fef63a01888|2|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|mEq/day|[?]|1|ng/day|SUBCLAVIAN VEIN|CONTRALATERAL||Y|INVESTIGATOR|1|Visit_1|10|5|FOLLOW-UP|2020-11-06|10
e|FA|cbf5d05e-e934-4946-b991-5fef63a01888|3|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|s/h|[?]|1|BP|SKIN OF THE EAR|RIGHT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|WASHOUT|2020-11-21|25
e|FA|cbf5d05e-e934-4946-b991-5fef63a01888|4|AGETRT1|Age At First Treatment|[?]|GERD|[?]|uCi/L|[?]|1|mL/mmHg/min/L|RADIUS-LUNATE JOINT|LATERAL|Y|Y|INVESTIGATOR|2|Visit_2|25|6|SCREENING|2020-11-21|25
e|FA|cbf5d05e-e934-4946-b991-5fef63a01888|5|TOTNUM|Total Number|[?]|GERD|[?]|U/m2/h|[?]|1|/200 HPFs|PAW|IPSILATERAL||Y|GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-12-06|40
e|FA|cbf5d05e-e934-4946-b991-5fef63a01888|6|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|PELLET|[?]|1|ug/kg/h|LATERAL FIRST DIAGONAL BRANCH ARTERY|LATERAL|Y||FRIEND|3|Visit_3|40|6|WASHOUT|2020-12-06|40
e|FA|cbf5d05e-e934-4946-b991-5fef63a01888|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|%(v/v)|SECOND OBTUSE MARGINAL BRANCH ARTERY|RIGHT|||ADJUDICATION COMMITTEE|4|Visit_4|65|1|SCREENING|2020-12-31|65
e|FA|cbf5d05e-e934-4946-b991-5fef63a01888|8|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|cL|[?]|1|m2|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|UNILATERAL|Y||FRIEND|4|Visit_4|65|6|TREATMENT|2020-12-31|65
e|FA|cbf5d05e-e934-4946-b991-5fef63a01888|9|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|DRUM|[?]|1|uL/kg/day|CELIAC ARTERY|CONTRALATERAL|||DOMESTIC PARTNER|5|Visit_5|90|1|WASHOUT|2021-01-25|90
e|FA|cbf5d05e-e934-4946-b991-5fef63a01888|10|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|g/day|[?]|1|cm H2O|EAR, OUTER|RIGHT|||INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2021-01-25|90
e|FA|be18633c-0ff9-4775-9737-dc8a9524fd2c|1|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|/min|[?]|1|PFU/dose|GASTROCNEMIUS MUSCLE|BILATERAL|||STUDY SUBJECT|1|Visit_1|10|7|FOLLOW-UP|2020-10-18|10
e|FA|be18633c-0ff9-4775-9737-dc8a9524fd2c|2|SEV|Severity/Intensity|[?]|GERD|[?]|uIU/dL|[?]|1|Pa|PARALARYNGEAL LYMPH NODE|LEFT||Y|PARENT|1|Visit_1|10|5|SCREENING|2020-10-18|10
e|FA|be18633c-0ff9-4775-9737-dc8a9524fd2c|3|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|Gauss|[?]|1|mL/100g/min|DUCTUS ARTERIOSUS|BILATERAL|||INTERVIEWER|2|Visit_2|25|5|TREATMENT|2020-11-02|25
e|FA|be18633c-0ff9-4775-9737-dc8a9524fd2c|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|kg/cm|[?]|1|ug/g/h|SUBLINGUAL REGION|RIGHT|||DOMESTIC PARTNER|2|Visit_2|25|3|SCREENING|2020-11-02|25
e|FA|be18633c-0ff9-4775-9737-dc8a9524fd2c|5|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|fmol|[?]|1|oz eq|THYROID GLAND|LEFT|||DOMESTIC PARTNER|3|Visit_3|40|3|SCREENING|2020-11-17|40
e|FA|be18633c-0ff9-4775-9737-dc8a9524fd2c|6|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|/2000 RBC|[?]|1|m2|ARTERY|CONTRALATERAL||Y|FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-11-17|40
e|FA|be18633c-0ff9-4775-9737-dc8a9524fd2c|7|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|kPa/L/sec|[?]|1|vp/dose|FACET JOINT|UNILATERAL||Y|VENDOR|4|Visit_4|65|2|TREATMENT|2020-12-12|65
e|FA|be18633c-0ff9-4775-9737-dc8a9524fd2c|8|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|mmol/mol|[?]|1|h*%|CARDIAC WALL|CONTRALATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|1|SCREENING|2020-12-12|65
e|FA|be18633c-0ff9-4775-9737-dc8a9524fd2c|9|EVENTNUM|Number of Events|[?]|GERD|[?]|mg/m2|[?]|1|U/10^12 RBC|SKIN OF THE THIGH|UNILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-01-06|90
e|FA|be18633c-0ff9-4775-9737-dc8a9524fd2c|10|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|/min|[?]|1|EIA unit|ARTERY|LATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|TREATMENT|2021-01-06|90
e|FA|f7eba9b8-94fb-46b8-842a-0322eb68a355|1|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|ug/m2/day|[?]|1|mL/m2|L4-L5 INTERVERTEBRAL SPACE|RIGHT|||INVESTIGATOR|1|Visit_1|10|3|FOLLOW-UP|2020-05-12|10
e|FA|f7eba9b8-94fb-46b8-842a-0322eb68a355|2|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|Arbitrary U|[?]|1|100 IU/mL|HAIR|BILATERAL|||PROXY|1|Visit_1|10|7|TREATMENT|2020-05-12|10
e|FA|f7eba9b8-94fb-46b8-842a-0322eb68a355|3|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|PFU/dose|KNEE JOINT|BILATERAL|Y|Y|GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-05-27|25
e|FA|f7eba9b8-94fb-46b8-842a-0322eb68a355|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|CUP|[?]|1|mg/g/min|SUBCUTIS|LATERAL|Y|Y|SPOUSE|2|Visit_2|25|6|FOLLOW-UP|2020-05-27|25
e|FA|f7eba9b8-94fb-46b8-842a-0322eb68a355|5|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|fmol|FEMORAL NECK|CONTRALATERAL|||SIBLING|3|Visit_3|40|4|SCREENING|2020-06-11|40
e|FA|f7eba9b8-94fb-46b8-842a-0322eb68a355|6|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|PRESSOR UNITS|[?]|1|Hz/s|PORTA HEPATIS LYMPH NODE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|SCREENING|2020-06-11|40
e|FA|f7eba9b8-94fb-46b8-842a-0322eb68a355|7|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|ug/L|[?]|1|ohm|DIAPHRAGMATIC LYMPH NODE|LEFT|Y||SIGNIFICANT OTHER|4|Visit_4|65|6|SCREENING|2020-07-06|65
e|FA|f7eba9b8-94fb-46b8-842a-0322eb68a355|8|STROKTYP|Stroke Type|[?]|GERD|[?]|mmol/L|[?]|1|g/L|ETHMOID SINUS|RIGHT|Y||STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2020-07-06|65
e|FA|f7eba9b8-94fb-46b8-842a-0322eb68a355|9|EVENTFRQ|Event Frequency|[?]|GERD|[?]|MdFI|[?]|1|ug/kg/h|POSTERIOR POLE OF THE EYE|BILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|WASHOUT|2020-07-31|90
e|FA|f7eba9b8-94fb-46b8-842a-0322eb68a355|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|in2|[?]|1|mg/g/min|BLADDER|UNILATERAL|||GUARDIAN|5|Visit_5|90|5|SCREENING|2020-07-31|90
e|FA|903199e2-56e1-41e4-8904-d33cc6846ee3|1|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|DIOPTER|[?]|1|mmHg/L/min|OCCIPITAL SCALP|BILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2021-01-18|10
e|FA|903199e2-56e1-41e4-8904-d33cc6846ee3|2|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|Enzyme U|[?]|1|AU/mL|METATARSOPHALANGEAL JOINT 3|BILATERAL|Y||VENDOR|1|Visit_1|10|3|TREATMENT|2021-01-18|10
e|FA|903199e2-56e1-41e4-8904-d33cc6846ee3|3|VOL|Volume|[?]|GERD|[?]|Ci/kg|[?]|1|vp/dose|STERNAL MANUBRIUM|CONTRALATERAL|||SPOUSE|2|Visit_2|25|4|TREATMENT|2021-02-02|25
e|FA|903199e2-56e1-41e4-8904-d33cc6846ee3|4|DCAL|Dietary Calories|[?]|GERD|[?]|mL/min/mmHg|[?]|1|EIA unit|BACK|LATERAL|Y||CHILD|2|Visit_2|25|6|SCREENING|2021-02-02|25
e|FA|903199e2-56e1-41e4-8904-d33cc6846ee3|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|BP|[?]|1|mg/g/min|PERIUMBILICAL REGION|CONTRALATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|5|SCREENING|2021-02-17|40
e|FA|903199e2-56e1-41e4-8904-d33cc6846ee3|6|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|g/day|FOOT|IPSILATERAL||Y|INVESTIGATOR|3|Visit_3|40|6|TREATMENT|2021-02-17|40
e|FA|903199e2-56e1-41e4-8904-d33cc6846ee3|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|uCi/L|[?]|1|mg/g/min|ESOPHAGUS, MIDDLE THIRD|IPSILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|4|WASHOUT|2021-03-14|65
e|FA|903199e2-56e1-41e4-8904-d33cc6846ee3|8|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|Ci/uL|[?]|1|ug/kg/h|T5 VERTEBRA|LEFT||Y|GUARDIAN|4|Visit_4|65|3|SCREENING|2021-03-14|65
e|FA|903199e2-56e1-41e4-8904-d33cc6846ee3|9|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|GLOBULE|[?]|1|uL/kg/day|RIB 7|LEFT|||DOMESTIC PARTNER|5|Visit_5|90|7|FOLLOW-UP|2021-04-08|90
e|FA|903199e2-56e1-41e4-8904-d33cc6846ee3|10|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|KIT|[?]|1|cmH2O/mL|INCUS|BILATERAL|Y||FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2021-04-08|90
e|FA|32567f8d-e746-44e1-a269-d95ba3bb0b11|1|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|kg/cm|[?]|1|/kg|EYELASH|BILATERAL|||SPOUSE|1|Visit_1|10|1|TREATMENT|2020-11-02|10
e|FA|32567f8d-e746-44e1-a269-d95ba3bb0b11|2|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|EVENTS|[?]|1|ug/m2/h|LIVER, QUADRATE LOBE|IPSILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|7|SCREENING|2020-11-02|10
e|FA|32567f8d-e746-44e1-a269-d95ba3bb0b11|3|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|pmol/L|[?]|1|gtt|PULMONARY VALVE, ANTERIOR CUSP|BILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|5|SCREENING|2020-11-17|25
e|FA|32567f8d-e746-44e1-a269-d95ba3bb0b11|4|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|mgEq|[?]|1|IU/mg|ABDOMINAL CAVITY|LATERAL||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|TREATMENT|2020-11-17|25
e|FA|32567f8d-e746-44e1-a269-d95ba3bb0b11|5|SEV|Severity/Intensity|[?]|GERD|[?]|g/g|[?]|1|Pa|SKIN OF THE BENDING JOINT|LATERAL|||FAMILY MEMBER|3|Visit_3|40|5|FOLLOW-UP|2020-12-02|40
e|FA|32567f8d-e746-44e1-a269-d95ba3bb0b11|6|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|km/h|[?]|1|Ci/ug|QUADRICEPS MUSCLE|UNILATERAL|||SPOUSE|3|Visit_3|40|7|WASHOUT|2020-12-02|40
e|FA|32567f8d-e746-44e1-a269-d95ba3bb0b11|7|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|nkat/L|[?]|1|g/L|FEMALE REPRODUCTIVE SYSTEM|IPSILATERAL|||INTERVIEWER|4|Visit_4|65|4|SCREENING|2020-12-27|65
e|FA|32567f8d-e746-44e1-a269-d95ba3bb0b11|8|SPEED|Speed|[?]|GERD|[?]|psec|[?]|1|mEq/g|MITRAL VALVE ANNULUS|CONTRALATERAL||Y|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-12-27|65
e|FA|32567f8d-e746-44e1-a269-d95ba3bb0b11|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|amu|[?]|1|Pa|HEART, RIGHT ATRIUM|IPSILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2021-01-21|90
e|FA|32567f8d-e746-44e1-a269-d95ba3bb0b11|10|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|EP U|[?]|1|Bq/L|SCAPHOID-TRAPEZIUM JOINT|IPSILATERAL|Y||CAREGIVER|5|Visit_5|90|6|TREATMENT|2021-01-21|90
e|FA|ecdc54eb-c02f-4112-8e85-8a3352470b3b|1|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|nmol/L/h|[?]|1|HOURS|CARPOMETACARPAL JOINT 4|RIGHT||Y|ADJUDICATOR|1|Visit_1|10|4|FOLLOW-UP|2020-11-11|10
e|FA|ecdc54eb-c02f-4112-8e85-8a3352470b3b|2|TOXGR|Toxicity Grade|[?]|GERD|[?]|mL/kg/min|[?]|1|aMFI|EAR|UNILATERAL||Y|FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-11-11|10
e|FA|ecdc54eb-c02f-4112-8e85-8a3352470b3b|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|fmol/L/sec|[?]|1|%(v/v)|HAND DIGIT 2|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-11-26|25
e|FA|ecdc54eb-c02f-4112-8e85-8a3352470b3b|4|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|uOsm|[?]|1|L/h/m2|CAPITATE-HAMATE JOINT|LEFT|||PROXY|2|Visit_2|25|1|TREATMENT|2020-11-26|25
e|FA|ecdc54eb-c02f-4112-8e85-8a3352470b3b|5|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|PFU/mL|[?]|1|in|PENIS, GLANS|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|2|FOLLOW-UP|2020-12-11|40
e|FA|ecdc54eb-c02f-4112-8e85-8a3352470b3b|6|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|IU/L|[?]|1|mg/h|AXIAL SKELETON|CONTRALATERAL||Y|INVESTIGATOR|3|Visit_3|40|7|TREATMENT|2020-12-11|40
e|FA|ecdc54eb-c02f-4112-8e85-8a3352470b3b|7|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|mg/kg/week|[?]|1|SCOOPFUL|CEREBELLUM|LATERAL|||CHILD|4|Visit_4|65|3|TREATMENT|2021-01-05|65
e|FA|ecdc54eb-c02f-4112-8e85-8a3352470b3b|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|Pa|BILIARY TRACT|IPSILATERAL|||SPOUSE|4|Visit_4|65|4|FOLLOW-UP|2021-01-05|65
e|FA|ecdc54eb-c02f-4112-8e85-8a3352470b3b|9|DGRAIN|Dietary Grain|[?]|GERD|[?]|kDa|[?]|1|10^9 CFU/g|FOOT DIGIT 2|UNILATERAL||Y|SPOUSE|5|Visit_5|90|1|WASHOUT|2021-01-30|90
e|FA|ecdc54eb-c02f-4112-8e85-8a3352470b3b|10|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|IU|[?]|1|in|BUCCAL MUCOSA|LATERAL|Y||SPOUSE|5|Visit_5|90|5|TREATMENT|2021-01-30|90
e|FA|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|1|DCAL|Dietary Calories|[?]|GERD|[?]|mOsm|[?]|1|EIA unit|PATELLA|LEFT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|SCREENING|2020-07-09|10
e|FA|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|2|DMEAT|Dietary Meat|[?]|GERD|[?]|MAC50|[?]|1|10^6 organisms/mL|WRIST JOINT EXTENSOR TENDONS|LATERAL|||SPOUSE|1|Visit_1|10|7|TREATMENT|2020-07-09|10
e|FA|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|3|SPEED|Speed|[?]|GERD|[?]|mg/L|[?]|1|mEq/g|URETHRA, PENILE|UNILATERAL|||INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2020-07-24|25
e|FA|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|4|OBJTYPE|Type of Object|[?]|GERD|[?]|10^9 organisms/mL|[?]|1|ng|ORAL CAVITY|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|WASHOUT|2020-07-24|25
e|FA|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|5|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|BAU/mL|[?]|1|U/10^12 RBC|COSTOCHONDRAL JOINT 1|UNILATERAL|||INVESTIGATOR|3|Visit_3|40|6|FOLLOW-UP|2020-08-08|40
e|FA|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|6|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|pm|[?]|1|mAmp|COSTOCHONDRAL JOINT 7|UNILATERAL|||STUDY SUBJECT|3|Visit_3|40|7|WASHOUT|2020-08-08|40
e|FA|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|7|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|cmHg|[?]|1|NEEDLE GAUGE|HEAD|LEFT|||ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-09-02|65
e|FA|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|8|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|mm/sec|[?]|1|g/day|ILEUM|UNILATERAL|||FRIEND|4|Visit_4|65|1|TREATMENT|2020-09-02|65
e|FA|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|9|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|mmHg/L/min|[?]|1|mL/100g/min|LOWER RESPIRATORY SYSTEM|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|SCREENING|2020-09-27|90
e|FA|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|10|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|/month|[?]|1|10^9 CFU/mL|TRANSVERSE TARSAL JOINT|CONTRALATERAL|||SIBLING|5|Visit_5|90|5|SCREENING|2020-09-27|90
e|FA|5d7241ec-120d-486d-ab39-b9e14ab4ce90|1|LOCONSET|Localization of Onset|[?]|GERD|[?]|10^3 DNA copies/mL|[?]|1|g/L|TIBIOTARSAL JOINT|BILATERAL|||INVESTIGATOR|1|Visit_1|10|5|TREATMENT|2020-08-01|10
e|FA|5d7241ec-120d-486d-ab39-b9e14ab4ce90|2|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|RFU|[?]|1|umol|BASAL GANGLIA|LATERAL|Y||CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-08-01|10
e|FA|5d7241ec-120d-486d-ab39-b9e14ab4ce90|3|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|ug/kg|[?]|1|anti-Xa IU/mL|SYNOVIAL FLUID|LEFT|Y||SIGNIFICANT OTHER|2|Visit_2|25|5|TREATMENT|2020-08-16|25
e|FA|5d7241ec-120d-486d-ab39-b9e14ab4ce90|4|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|days/wk|[?]|1|in|METACARPAL BONE|CONTRALATERAL|||CAREGIVER|2|Visit_2|25|4|SCREENING|2020-08-16|25
e|FA|5d7241ec-120d-486d-ab39-b9e14ab4ce90|5|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|10^6/hpf|[?]|1|g/day|RENAL PELVIS|LATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|SCREENING|2020-08-31|40
e|FA|5d7241ec-120d-486d-ab39-b9e14ab4ce90|6|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|ohm|PLEURAL CAVITY|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-08-31|40
e|FA|5d7241ec-120d-486d-ab39-b9e14ab4ce90|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|DAgU|[?]|1|umol|STOMACH|UNILATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|4|TREATMENT|2020-09-25|65
e|FA|5d7241ec-120d-486d-ab39-b9e14ab4ce90|8|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|10^7 TCID 50/dose|[?]|1|10^6 CFU|PARAVERTEBRAL GANGLIA|RIGHT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|SCREENING|2020-09-25|65
e|FA|5d7241ec-120d-486d-ab39-b9e14ab4ce90|9|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|kg/L|[?]|1|/500 WBC|MID-RIGHT CORONARY ARTERY CONDUIT|IPSILATERAL|||INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2020-10-20|90
e|FA|5d7241ec-120d-486d-ab39-b9e14ab4ce90|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|g/cage|[?]|1|mL|BRAIN, THIRD VENTRICLE|LEFT|||VENDOR|5|Visit_5|90|3|SCREENING|2020-10-20|90
e|FA|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|1|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|Gravitational Unit|[?]|1|HOURS|LEFT CIRCUMFLEX ARTERY OSTIUM|RIGHT|Y||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|WASHOUT|2020-06-01|10
e|FA|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|2|OBJNUM|Number of Objects|[?]|GERD|[?]|U/kg/h|[?]|1|mL/100g/min|TALUS|UNILATERAL|||CAREGIVER|1|Visit_1|10|3|SCREENING|2020-06-01|10
e|FA|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/day|[?]|1|mg/g/min|BLADDER|LEFT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-06-16|25
e|FA|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|4|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|log10 PFU/mL|[?]|1|g/L|LYMPH NODE HILUM|LEFT|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|7|WASHOUT|2020-06-16|25
e|FA|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|NFIU|[?]|1|%(v/v)|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|BILATERAL|||FRIEND|3|Visit_3|40|7|SCREENING|2020-07-01|40
e|FA|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|6|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|cGy|[?]|1|10^4 CFU/mL|INTERPHALANGEAL JOINT 3 OF THE HAND|LEFT|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-07-01|40
e|FA|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|7|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|mm|[?]|1|Bq/L|PRESACRAL SPACE|UNILATERAL||Y|STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-07-26|65
e|FA|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|8|DMG|Dietary Magnesium|[?]|GERD|[?]|Gravitational Unit|[?]|1|TRANSDUCING UNIT/mL|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|LEFT||Y|VENDOR|4|Visit_4|65|7|TREATMENT|2020-07-26|65
e|FA|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|9|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|/200 HPFs|[?]|1|psi|SALIVARY GLAND, SUBLINGUAL|CONTRALATERAL|Y|Y|GUARDIAN|5|Visit_5|90|7|WASHOUT|2020-08-20|90
e|FA|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|10|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|U/dL|[?]|1|mm/h|PHARYNX|RIGHT|||INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2020-08-20|90
e|FA|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|1|EXCDUR|Exercise Duration|[?]|GERD|[?]|Gy|[?]|1|mm|INTERPHALANGEAL JOINT 3|LEFT|||INVESTIGATOR|1|Visit_1|10|3|TREATMENT|2020-07-04|10
e|FA|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|2|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|mg/g/min|[?]|1|g/dL|PALATE|IPSILATERAL|||SPOUSE|1|Visit_1|10|6|SCREENING|2020-07-04|10
e|FA|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|3|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|/500 WBC|DIGIT|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|WASHOUT|2020-07-19|25
e|FA|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|4|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|10^6 CFU/g|[?]|1|m2|TYMPANIC MEMBRANE|UNILATERAL|||STUDY SUBJECT|2|Visit_2|25|6|WASHOUT|2020-07-19|25
e|FA|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|5|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|ug/min|[?]|1|L/h/m2|BILIARY TRACT|UNILATERAL|||PROXY|3|Visit_3|40|6|FOLLOW-UP|2020-08-03|40
e|FA|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|6|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|/MBP|[?]|1|IU/mg|TIBIALIS ANTERIOR MUSCLE|CONTRALATERAL|Y|Y|SIBLING|3|Visit_3|40|3|FOLLOW-UP|2020-08-03|40
e|FA|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|7|TOTNUM|Total Number|[?]|GERD|[?]|mmol/kg|[?]|1|/200 HPFs|FINGER|CONTRALATERAL|||CHILD|4|Visit_4|65|2|TREATMENT|2020-08-28|65
e|FA|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|8|LENRSCT|Length of Resection|[?]|GERD|[?]|ft3|[?]|1|psi|WAIST|RIGHT||Y|GUARDIAN|4|Visit_4|65|7|TREATMENT|2020-08-28|65
e|FA|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|9|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|%(w/w)|[?]|1|/500 WBC|INCISOR|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2020-09-22|90
e|FA|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|10|EVENTFRQ|Event Frequency|[?]|GERD|[?]|CONTAINER|[?]|1|ug/kg/h|ABDUCENS NERVE|IPSILATERAL|||CHILD|5|Visit_5|90|7|TREATMENT|2020-09-22|90
e|FA|a69c6182-9c35-4365-b732-b238e0584ba7|1|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|10^10/L|[?]|1|TRANSDUCING UNIT/mL|L4 VERTEBRA|BILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|1|WASHOUT|2020-08-07|10
e|FA|a69c6182-9c35-4365-b732-b238e0584ba7|2|SPEED|Speed|[?]|GERD|[?]|mV2/Hz|[?]|1|mEq/g|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|UNILATERAL|Y|Y|GUARDIAN|1|Visit_1|10|5|TREATMENT|2020-08-07|10
e|FA|a69c6182-9c35-4365-b732-b238e0584ba7|3|OBJNUM|Number of Objects|[?]|GERD|[?]|PFU/animal|[?]|1|mL/100g/min|CALCANEAL TUBEROSITY|LATERAL|||INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-08-22|25
e|FA|a69c6182-9c35-4365-b732-b238e0584ba7|4|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mL|[?]|1|Shock Wave|POSTERIOR POLE OF THE EYE|IPSILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-08-22|25
e|FA|a69c6182-9c35-4365-b732-b238e0584ba7|5|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|Osm|[?]|1|mAmp|GUT-ASSOCIATED LYMPHOID TISSUE|RIGHT||Y|DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-09-06|40
e|FA|a69c6182-9c35-4365-b732-b238e0584ba7|6|AGETRT1|Age At First Treatment|[?]|GERD|[?]|PIXELS/in|[?]|1|mL/mmHg/min/L|GLUTEAL MUSCLE|LEFT|Y||SPOUSE|3|Visit_3|40|7|TREATMENT|2020-09-06|40
e|FA|a69c6182-9c35-4365-b732-b238e0584ba7|7|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|MPL U|[?]|1|oz eq|LUNG LOBE|RIGHT||Y|ADJUDICATOR|4|Visit_4|65|1|WASHOUT|2020-10-01|65
e|FA|a69c6182-9c35-4365-b732-b238e0584ba7|8|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|Ci/mL|[?]|1|cm H2O|LATERAL SECOND DIAGONAL BRANCH ARTERY|LEFT||Y|FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2020-10-01|65
e|FA|a69c6182-9c35-4365-b732-b238e0584ba7|9|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|Enzyme U/g Hb|[?]|1|g/dL|CALF MUSCULAR VEIN|CONTRALATERAL|||DOMESTIC PARTNER|5|Visit_5|90|4|SCREENING|2020-10-26|90
e|FA|a69c6182-9c35-4365-b732-b238e0584ba7|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|IU/day|[?]|1|mg/g/min|ORBICULARIS OCULI MUSCLE|LATERAL|||SPOUSE|5|Visit_5|90|2|TREATMENT|2020-10-26|90
e|FA|1b9896cf-160e-4a56-8737-9759cd83e784|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|BOX|[?]|1|mL/animal/day|DORSALIS PEDIS ARTERY|CONTRALATERAL||Y|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-12-11|10
e|FA|1b9896cf-160e-4a56-8737-9759cd83e784|2|SEV|Severity/Intensity|[?]|GERD|[?]|10^3 DNA copies/mL|[?]|1|Pa|LUNG, RIGHT UPPER LOBE|UNILATERAL||Y|GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-12-11|10
e|FA|1b9896cf-160e-4a56-8737-9759cd83e784|3|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|U/kg/day|[?]|1|BOWL|AORTIC VALVE ANNULUS|CONTRALATERAL|||INVESTIGATOR|2|Visit_2|25|3|SCREENING|2020-12-26|25
e|FA|1b9896cf-160e-4a56-8737-9759cd83e784|4|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|MBP|[?]|1|mL/cm3/min|PROXIMAL INTERPHALANGEAL JOINT 5|UNILATERAL|Y||VENDOR|2|Visit_2|25|4|SCREENING|2020-12-26|25
e|FA|1b9896cf-160e-4a56-8737-9759cd83e784|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|%(v/v)|FOREHEAD|IPSILATERAL|||SPOUSE|3|Visit_3|40|6|TREATMENT|2021-01-10|40
e|FA|1b9896cf-160e-4a56-8737-9759cd83e784|6|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|SACHET|[?]|1|mL/dose|MEDIAL FEMORAL CONDYLE|LEFT|||FAMILY MEMBER|3|Visit_3|40|2|SCREENING|2021-01-10|40
e|FA|1b9896cf-160e-4a56-8737-9759cd83e784|7|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|ug/min|[?]|1|fmol|PANCREAS, ENDOCRINE|UNILATERAL|||SPOUSE|4|Visit_4|65|3|TREATMENT|2021-02-04|65
e|FA|1b9896cf-160e-4a56-8737-9759cd83e784|8|TOTNUM|Total Number|[?]|GERD|[?]|mOsm|[?]|1|/200 HPFs|PARANASAL SINUS|UNILATERAL||Y|CHILD|4|Visit_4|65|4|SCREENING|2021-02-04|65
e|FA|1b9896cf-160e-4a56-8737-9759cd83e784|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|ng/L|[?]|1|ug/g/h|CEREBRAL SUBCORTEX|UNILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-03-01|90
e|FA|1b9896cf-160e-4a56-8737-9759cd83e784|10|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|VIAL|[?]|1|mmHg/L/min|HYPOTHALAMUS|IPSILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-03-01|90
e|FA|ea87b553-e331-40cf-bd86-d2bd22694476|1|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|mol|[?]|1|MBq|NUCLEUS OF DIAGONAL BAND|LATERAL|||ADJUDICATOR|1|Visit_1|10|3|SCREENING|2020-08-05|10
e|FA|ea87b553-e331-40cf-bd86-d2bd22694476|2|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|U/L|[?]|1|10^6 U|NAIL|CONTRALATERAL|||FRIEND|1|Visit_1|10|2|TREATMENT|2020-08-05|10
e|FA|ea87b553-e331-40cf-bd86-d2bd22694476|3|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|10^8 PFU|[?]|1|MPS U|GASTROINTESTINAL SYSTEM|LEFT|||CHILD|2|Visit_2|25|7|FOLLOW-UP|2020-08-20|25
e|FA|ea87b553-e331-40cf-bd86-d2bd22694476|4|SEV|Severity/Intensity|[?]|GERD|[?]|SYRINGE|[?]|1|Pa|STRIATUM|CONTRALATERAL|||SPOUSE|2|Visit_2|25|1|FOLLOW-UP|2020-08-20|25
e|FA|ea87b553-e331-40cf-bd86-d2bd22694476|5|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|deg/mm|[?]|1|mm|SKIN OF THE AXILLA|BILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|5|TREATMENT|2020-09-04|40
e|FA|ea87b553-e331-40cf-bd86-d2bd22694476|6|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mU|[?]|1|PFU/dose|C1 VERTEBRA|LEFT|Y||ADJUDICATOR|3|Visit_3|40|1|WASHOUT|2020-09-04|40
e|FA|ea87b553-e331-40cf-bd86-d2bd22694476|7|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|PIXELS/cm|[?]|1|ug/g/h|NASAL BONE|IPSILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|6|FOLLOW-UP|2020-09-29|65
e|FA|ea87b553-e331-40cf-bd86-d2bd22694476|8|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|ug/kg|[?]|1|ug/m2/h|T5 VERTEBRA|RIGHT|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|6|FOLLOW-UP|2020-09-29|65
e|FA|ea87b553-e331-40cf-bd86-d2bd22694476|9|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|pg/cell|[?]|1|EIA unit|ILIOTIBIAL BAND|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-10-24|90
e|FA|ea87b553-e331-40cf-bd86-d2bd22694476|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|VOXEL|[?]|1|Pa|FALCIFORM LIGAMENT|IPSILATERAL|Y||GUARDIAN|5|Visit_5|90|3|TREATMENT|2020-10-24|90
e|FA|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|pmol/L|[?]|1|mg/g/min|FINGER FLEXOR TENDONS|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-07-30|10
e|FA|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|2|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|cmol/L|[?]|1|mm/h|BILE DUCT|CONTRALATERAL|Y|Y|INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2020-07-30|10
e|FA|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|kg/cm2|[?]|1|mg/g/min|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|LEFT|||CHILD|2|Visit_2|25|7|TREATMENT|2020-08-14|25
e|FA|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|4|DPROT|Dietary Protein|[?]|GERD|[?]|sec|[?]|1|10^4 CFU/mL|THORACIC AORTA|UNILATERAL|||STUDY SUBJECT|2|Visit_2|25|6|SCREENING|2020-08-14|25
e|FA|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|umol/min|[?]|1|%(v/v)|SUBMENTAL LYMPH NODE|BILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-08-29|40
e|FA|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|6|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|fmol/g|[?]|1|anti-Xa IU/mL|C6 VERTEBRA|RIGHT|Y|Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|TREATMENT|2020-08-29|40
e|FA|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|7|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|kBq/uL|[?]|1|Log10 ELISA unit|MAXILLARY SINUS|LATERAL|||SPOUSE|4|Visit_4|65|2|TREATMENT|2020-09-23|65
e|FA|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|8|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Mile|[?]|1|oz eq|GASTROINTESTINAL TRACT, LOWER, WALL|BILATERAL|Y||GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-09-23|65
e|FA|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|10^6 IU|[?]|1|ug/g/h|AZYGOS VEIN|LATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|6|WASHOUT|2020-10-18|90
e|FA|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|10|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|Shock Wave|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|LEFT|||FAMILY MEMBER|5|Visit_5|90|2|TREATMENT|2020-10-18|90
e|FA|051dc064-be6f-43eb-aa51-7ed8634d6e23|1|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|um/day|[?]|1|mEq|DIGIT|IPSILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-07-08|10
e|FA|051dc064-be6f-43eb-aa51-7ed8634d6e23|2|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|ug/kg/min|[?]|1|Bq/L|CRANIAL NERVE|BILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|FOLLOW-UP|2020-07-08|10
e|FA|051dc064-be6f-43eb-aa51-7ed8634d6e23|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|Pa|GALLBLADDER|BILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-07-23|25
e|FA|051dc064-be6f-43eb-aa51-7ed8634d6e23|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|PIXELS/in|[?]|1|%(v/v)|AORTIC ARCH|CONTRALATERAL|Y|Y|PROXY|2|Visit_2|25|4|TREATMENT|2020-07-23|25
e|FA|051dc064-be6f-43eb-aa51-7ed8634d6e23|5|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|10^8 PFU|[?]|1|ng/day|FOREARM|CONTRALATERAL|Y||ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-08-07|40
e|FA|051dc064-be6f-43eb-aa51-7ed8634d6e23|6|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|EIA unit|[?]|1|in|OVARY|BILATERAL|Y||CHILD|3|Visit_3|40|4|TREATMENT|2020-08-07|40
e|FA|051dc064-be6f-43eb-aa51-7ed8634d6e23|7|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|SQU/mL|[?]|1|uCi/kg|HEART, RIGHT VENTRICULAR FREE WALL|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-09-01|65
e|FA|051dc064-be6f-43eb-aa51-7ed8634d6e23|8|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|VIRTUAL PIXEL|[?]|1|cm H2O|TRICUSPID VALVE, POSTERIOR CUSP|IPSILATERAL|||INTERVIEWER|4|Visit_4|65|5|TREATMENT|2020-09-01|65
e|FA|051dc064-be6f-43eb-aa51-7ed8634d6e23|9|DMEAT|Dietary Meat|[?]|GERD|[?]|ug/m2|[?]|1|10^6 organisms/mL|RIB 9|LEFT|||FRIEND|5|Visit_5|90|4|TREATMENT|2020-09-26|90
e|FA|051dc064-be6f-43eb-aa51-7ed8634d6e23|10|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|Ci|[?]|1|/kg|LEFT VENTRICULAR APICAL LATERAL SEGMENT|RIGHT|Y||SIBLING|5|Visit_5|90|4|SCREENING|2020-09-26|90
e|FA|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|1|AGETRT1|Age At First Treatment|[?]|GERD|[?]|U/cL|[?]|1|mL/mmHg/min/L|L2-L3 INTERVERTEBRAL SPACE|CONTRALATERAL|Y||SIGNIFICANT OTHER|1|Visit_1|10|2|WASHOUT|2020-06-03|10
e|FA|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|2|OBJTYPE|Type of Object|[?]|GERD|[?]|PELLET|[?]|1|ng|METATARSAL BONE|RIGHT|Y|Y|CHILD|1|Visit_1|10|1|TREATMENT|2020-06-03|10
e|FA|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|3|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|IU/g Hb|[?]|1|gtt|DISTAL LAD ARTERY|LATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|3|FOLLOW-UP|2020-06-18|25
e|FA|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|4|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|ug/kg/min|[?]|1|BAG|INSULAR CORTEX|CONTRALATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|4|FOLLOW-UP|2020-06-18|25
e|FA|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|5|EVENTFRQ|Event Frequency|[?]|GERD|[?]|U/m2/min|[?]|1|ug/kg/h|AXILLARY VEIN|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|SCREENING|2020-07-03|40
e|FA|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|6|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|dB|[?]|1|mL/cm3/min|ESOPHAGUS, ABDOMINAL|LATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2020-07-03|40
e|FA|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|gtt|[?]|1|%(v/v)|COMMON FEMORAL VEIN|IPSILATERAL|||FRIEND|4|Visit_4|65|7|TREATMENT|2020-07-28|65
e|FA|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ug/mL/h|[?]|1|mg/g/min|ULNA SHAFT|LEFT|||SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-07-28|65
e|FA|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|9|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|10^6 CFU/g|[?]|1|in|ESOPHAGUS, CERVICAL|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2020-08-22|90
e|FA|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|10|TRTSETT|Treatment Setting|[?]|GERD|[?]|ug/m2/min|[?]|1|Coulomb|INFRATENTORIAL BRAIN|CONTRALATERAL|Y||SIGNIFICANT OTHER|5|Visit_5|90|1|FOLLOW-UP|2020-08-22|90
e|FA|7a17fe21-b640-4bc5-bf19-b1bceb393dab|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mm/min|[?]|1|mg/g/min|ULNAR NERVE|LATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|6|FOLLOW-UP|2020-09-02|10
e|FA|7a17fe21-b640-4bc5-bf19-b1bceb393dab|2|DMEAT|Dietary Meat|[?]|GERD|[?]|Roentgen|[?]|1|10^6 organisms/mL|PERICARDIAL CAVITY|UNILATERAL|||SIBLING|1|Visit_1|10|5|TREATMENT|2020-09-02|10
e|FA|7a17fe21-b640-4bc5-bf19-b1bceb393dab|3|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|CAPLET|[?]|1|Gy/h|RIB 6|BILATERAL|||CHILD|2|Visit_2|25|3|TREATMENT|2020-09-17|25
e|FA|7a17fe21-b640-4bc5-bf19-b1bceb393dab|4|LESNUM|Number of Lesions|[?]|GERD|[?]|cmH2O*s2/mL|[?]|1|ng/day|ABDOMINAL SKIN|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-09-17|25
e|FA|7a17fe21-b640-4bc5-bf19-b1bceb393dab|5|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|BAG|[?]|1|g/day|RECTO-UTERINE POUCH|IPSILATERAL|||ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-10-02|40
e|FA|7a17fe21-b640-4bc5-bf19-b1bceb393dab|6|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|GBq/mg|[?]|1|umol|NERVE|UNILATERAL|||SIBLING|3|Visit_3|40|5|FOLLOW-UP|2020-10-02|40
e|FA|7a17fe21-b640-4bc5-bf19-b1bceb393dab|7|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|log10 TCID 50/uL|[?]|1|TRANSDUCING UNIT/mL|SACRAL TUBEROSITY|RIGHT|Y||FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2020-10-27|65
e|FA|7a17fe21-b640-4bc5-bf19-b1bceb393dab|8|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|100 IU/mL|[?]|1|umol|FACE|LATERAL|Y||STUDY SUBJECT|4|Visit_4|65|1|WASHOUT|2020-10-27|65
e|FA|7a17fe21-b640-4bc5-bf19-b1bceb393dab|9|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|Pack Year|[?]|1|mL/cm3/min|CHOROID PLEXUS|BILATERAL|||PARENT|5|Visit_5|90|5|FOLLOW-UP|2020-11-21|90
e|FA|7a17fe21-b640-4bc5-bf19-b1bceb393dab|10|TOTNUM|Total Number|[?]|GERD|[?]|GLOBULE|[?]|1|/200 HPFs|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|BILATERAL|||FRIEND|5|Visit_5|90|3|WASHOUT|2020-11-21|90
e|FA|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|1|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|DAYS|[?]|1|oz eq|UPPER URINARY SYSTEM|LATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|2|WASHOUT|2021-01-20|10
e|FA|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|CYLINDER|[?]|1|%(v/v)|ANTRUM PYLORI|UNILATERAL|||SIBLING|1|Visit_1|10|4|FOLLOW-UP|2021-01-20|10
e|FA|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|3|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mOsm/L|[?]|1|ohm|TRICUSPID VALVE, POSTERIOR CUSP|LEFT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2021-02-04|25
e|FA|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|4|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|g/kg/day|[?]|1|Shock Wave|EPIGASTRIC LYMPH NODE|UNILATERAL||Y|FRIEND|2|Visit_2|25|6|TREATMENT|2021-02-04|25
e|FA|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|5|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|bel|[?]|1|mEq|DUCTUS ARTERIOSUS|UNILATERAL||Y|FRIEND|3|Visit_3|40|2|TREATMENT|2021-02-19|40
e|FA|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|6|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|NEEDLE GAUGE|[?]|1|NEEDLE GAUGE|CARPOMETACARPAL JOINT 1|BILATERAL||Y|SIBLING|3|Visit_3|40|4|WASHOUT|2021-02-19|40
e|FA|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|7|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|ECL unit|[?]|1|MPS U|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|LEFT|||INVESTIGATOR|4|Visit_4|65|5|FOLLOW-UP|2021-03-16|65
e|FA|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|NFIU|[?]|1|CUP|PERONEAL ARTERY|UNILATERAL|||INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2021-03-16|65
e|FA|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|9|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|EIA unit|[?]|1|/200 HPFs|FLEXOR DIGITORUM PROFUNDUS MUSCLE|RIGHT|Y||CHILD|5|Visit_5|90|1|FOLLOW-UP|2021-04-10|90
e|FA|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|10|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|ug/mol|[?]|1|mL/100g/min|VENOUS SINUS|LATERAL|||GUARDIAN|5|Visit_5|90|7|WASHOUT|2021-04-10|90
e|FA|f1d0daec-aa97-4838-9c53-e16dae3e17b2|1|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|FINGERTIP UNIT|[?]|1|L|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|UNILATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|5|TREATMENT|2020-06-23|10
e|FA|f1d0daec-aa97-4838-9c53-e16dae3e17b2|2|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|mAnson U/mL|[?]|1|10^9 CFU/mL|ANTERIOR INFERIOR CEREBELLAR ARTERY|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|SCREENING|2020-06-23|10
e|FA|f1d0daec-aa97-4838-9c53-e16dae3e17b2|3|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|U/g|[?]|1|SCOOPFUL|MUCOSA|LEFT|||INDEPENDENT ASSESSOR|2|Visit_2|25|1|TREATMENT|2020-07-08|25
e|FA|f1d0daec-aa97-4838-9c53-e16dae3e17b2|4|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|10^6 organisms|[?]|1|mL/cm3/min|SKIN OF THE CHIN|CONTRALATERAL|||VENDOR|2|Visit_2|25|5|TREATMENT|2020-07-08|25
e|FA|f1d0daec-aa97-4838-9c53-e16dae3e17b2|5|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|RNA copies/mL|[?]|1|mL/h|CECUM|RIGHT|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|FOLLOW-UP|2020-07-23|40
e|FA|f1d0daec-aa97-4838-9c53-e16dae3e17b2|6|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|deg/s|[?]|1|oz eq|CARPOMETACARPAL JOINT 5|LATERAL||Y|INVESTIGATOR|3|Visit_3|40|7|TREATMENT|2020-07-23|40
e|FA|f1d0daec-aa97-4838-9c53-e16dae3e17b2|7|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mL/h|[?]|1|uL/kg/day|RIB 9|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2020-08-17|65
e|FA|f1d0daec-aa97-4838-9c53-e16dae3e17b2|8|DVEG|Dietary Vegetable|[?]|GERD|[?]|APS U|[?]|1|Ci/ug|SKIN OF THE INGUINAL REGION|RIGHT|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|WASHOUT|2020-08-17|65
e|FA|f1d0daec-aa97-4838-9c53-e16dae3e17b2|9|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|g/g|[?]|1|km|HAND DIGIT 3|CONTRALATERAL|Y||SIBLING|5|Visit_5|90|5|SCREENING|2020-09-11|90
e|FA|f1d0daec-aa97-4838-9c53-e16dae3e17b2|10|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|dpm/mg|[?]|1|SACHET|MITRAL VALVE, POSTERIOR ANNULUS|LATERAL|Y|Y|ADJUDICATOR|5|Visit_5|90|6|WASHOUT|2020-09-11|90
e|FA|835594ab-e93c-402b-8129-6af659be5ae1|1|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|log10 TCID 50/dose|[?]|1|g/L|NUCLEUS OF DIAGONAL BAND|LATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|SCREENING|2020-11-01|10
e|FA|835594ab-e93c-402b-8129-6af659be5ae1|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|umol/kg/min|[?]|1|mg/g/min|NASAL BONE|CONTRALATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|2|WASHOUT|2020-11-01|10
e|FA|835594ab-e93c-402b-8129-6af659be5ae1|3|LESNUM|Number of Lesions|[?]|GERD|[?]|v/v|[?]|1|ng/day|AMYGDALA|BILATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-11-16|25
e|FA|835594ab-e93c-402b-8129-6af659be5ae1|4|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|PFU/mL|[?]|1|Shock Wave|OPPONENS POLLICIS MUSCLE|LEFT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|FOLLOW-UP|2020-11-16|25
e|FA|835594ab-e93c-402b-8129-6af659be5ae1|5|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|IU/mmol|[?]|1|AU/mL|PROXIMAL INTERPHALANGEAL JOINT 2|UNILATERAL|||STUDY SUBJECT|3|Visit_3|40|1|FOLLOW-UP|2020-12-01|40
e|FA|835594ab-e93c-402b-8129-6af659be5ae1|6|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|mL|[?]|1|10^6/L|INTERPHALANGEAL OF THE FOOT|LATERAL|Y||INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-12-01|40
e|FA|835594ab-e93c-402b-8129-6af659be5ae1|7|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|CAPFUL|[?]|1|10^6/L|XIPHOID PROCESS|RIGHT|||PROXY|4|Visit_4|65|6|SCREENING|2020-12-26|65
e|FA|835594ab-e93c-402b-8129-6af659be5ae1|8|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|Bq/L|POPLITEAL LYMPH NODE|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|FOLLOW-UP|2020-12-26|65
e|FA|835594ab-e93c-402b-8129-6af659be5ae1|9|DMEAT|Dietary Meat|[?]|GERD|[?]|CUP|[?]|1|10^6 organisms/mL|GASTROINTESTINAL TRACT, LOWER|UNILATERAL|||GUARDIAN|5|Visit_5|90|3|SCREENING|2021-01-20|90
e|FA|835594ab-e93c-402b-8129-6af659be5ae1|10|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|mm|VESTIBULOCOCHLEAR NERVE|LATERAL|Y||FRIEND|5|Visit_5|90|7|TREATMENT|2021-01-20|90
e|FA|c3c85786-d24b-4620-9ee0-c13b1cc4f951|1|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|INHALATION|[?]|1|mL|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|BILATERAL|Y||ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-10-07|10
e|FA|c3c85786-d24b-4620-9ee0-c13b1cc4f951|2|DPROT|Dietary Protein|[?]|GERD|[?]|GPL U|[?]|1|10^4 CFU/mL|TRAPEZIAL BONE|LATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|7|WASHOUT|2020-10-07|10
e|FA|c3c85786-d24b-4620-9ee0-c13b1cc4f951|3|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|V|[?]|1|MPS U|CLITORIS|BILATERAL|||CHILD|2|Visit_2|25|7|FOLLOW-UP|2020-10-22|25
e|FA|c3c85786-d24b-4620-9ee0-c13b1cc4f951|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|% INHIBITION|[?]|1|mL/dose|SENSORIMOTOR CORTEX|UNILATERAL|Y||SIBLING|2|Visit_2|25|4|FOLLOW-UP|2020-10-22|25
e|FA|c3c85786-d24b-4620-9ee0-c13b1cc4f951|5|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/mL|[?]|1|Shock Wave|FLEXOR CARPI ULNARIS MUSCLE|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|WASHOUT|2020-11-06|40
e|FA|c3c85786-d24b-4620-9ee0-c13b1cc4f951|6|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|MET*h|[?]|1|HOURS|ABDUCTOR HALLUCIS MUSCLE|LATERAL|||PROXY|3|Visit_3|40|4|SCREENING|2020-11-06|40
e|FA|c3c85786-d24b-4620-9ee0-c13b1cc4f951|7|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|fmol|[?]|1|PACK|THIGH|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|TREATMENT|2020-12-01|65
e|FA|c3c85786-d24b-4620-9ee0-c13b1cc4f951|8|LENRSCT|Length of Resection|[?]|GERD|[?]|CYLINDER|[?]|1|psi|HINDLIMB|LEFT|||CHILD|4|Visit_4|65|3|TREATMENT|2020-12-01|65
e|FA|c3c85786-d24b-4620-9ee0-c13b1cc4f951|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|cmH2O*s/mL|[?]|1|%(v/v)|PANCREAS, HEAD|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|WASHOUT|2020-12-26|90
e|FA|c3c85786-d24b-4620-9ee0-c13b1cc4f951|10|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/g Hb|[?]|1|Shock Wave|BLOOD|LATERAL|||SPOUSE|5|Visit_5|90|1|TREATMENT|2020-12-26|90
e|FA|5354e3c4-4106-4e4c-85c3-2dbbd001688c|1|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|g/animal/day|[?]|1|/kg|FALCIFORM LIGAMENT|IPSILATERAL|Y|Y|FRIEND|1|Visit_1|10|6|TREATMENT|2020-11-15|10
e|FA|5354e3c4-4106-4e4c-85c3-2dbbd001688c|2|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|TUBE|[?]|1|mEq/g|PERONEAL ARTERY|UNILATERAL|Y||SPOUSE|1|Visit_1|10|7|TREATMENT|2020-11-15|10
e|FA|5354e3c4-4106-4e4c-85c3-2dbbd001688c|3|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|Pa|[?]|1|aMFI|TENTORIUM CEREBELLI|LEFT||Y|FAMILY MEMBER|2|Visit_2|25|5|TREATMENT|2020-11-30|25
e|FA|5354e3c4-4106-4e4c-85c3-2dbbd001688c|4|DMG|Dietary Magnesium|[?]|GERD|[?]|dpm/100mg|[?]|1|TRANSDUCING UNIT/mL|SKIN OF THE LIP|UNILATERAL|||VENDOR|2|Visit_2|25|5|TREATMENT|2020-11-30|25
e|FA|5354e3c4-4106-4e4c-85c3-2dbbd001688c|5|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|Hz/s|[?]|1|mL/min/mmHg|PROXIMAL INTERPHALANGEAL JOINT 2|RIGHT|||CHILD|3|Visit_3|40|3|WASHOUT|2020-12-15|40
e|FA|5354e3c4-4106-4e4c-85c3-2dbbd001688c|6|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|QUANTITY SUFFICIENT|[?]|1|10^6 CFU|SPLENIC ARTERY|IPSILATERAL||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|FOLLOW-UP|2020-12-15|40
e|FA|5354e3c4-4106-4e4c-85c3-2dbbd001688c|7|SEV|Severity/Intensity|[?]|GERD|[?]|U/kg|[?]|1|Pa|DISTAL INTERPHALANGEAL JOINT 4|UNILATERAL|Y|Y|DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2021-01-09|65
e|FA|5354e3c4-4106-4e4c-85c3-2dbbd001688c|8|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|g/mol|[?]|1|m2|C2 VERTEBRA|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|SCREENING|2021-01-09|65
e|FA|5354e3c4-4106-4e4c-85c3-2dbbd001688c|9|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|log10 TCID 50/uL|[?]|1|uCi/kg|TRICUSPID VALVE, SEPTAL CUSP|UNILATERAL|||PARENT|5|Visit_5|90|3|WASHOUT|2021-02-03|90
e|FA|5354e3c4-4106-4e4c-85c3-2dbbd001688c|10|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|L/min/m2|[?]|1|Shock Wave|OROPHARYNX|IPSILATERAL||Y|INTERVIEWER|5|Visit_5|90|2|FOLLOW-UP|2021-02-03|90
e|FA|f10e9188-ef7b-46f9-a80a-0669436eb4dd|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|uCi/L|[?]|1|CUP|WRIST JOINT FLEXOR TENDONS|IPSILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-06-24|10
e|FA|f10e9188-ef7b-46f9-a80a-0669436eb4dd|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|cal|[?]|1|TRANSDUCING UNIT/mL|ULNAR NERVE|LATERAL|Y|Y|CAREGIVER|1|Visit_1|10|3|FOLLOW-UP|2020-06-24|10
e|FA|f10e9188-ef7b-46f9-a80a-0669436eb4dd|3|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|pmol|[?]|1|oz eq|DISTAL COMMON BILE DUCT|RIGHT|||SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2020-07-09|25
e|FA|f10e9188-ef7b-46f9-a80a-0669436eb4dd|4|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|JAR|[?]|1|Log10 ELISA unit|PAW|BILATERAL|Y||CAREGIVER|2|Visit_2|25|2|WASHOUT|2020-07-09|25
e|FA|f10e9188-ef7b-46f9-a80a-0669436eb4dd|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|kg/cm|[?]|1|mL/animal/day|WALDEYER'S TONSILLAR RING|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|7|TREATMENT|2020-07-24|40
e|FA|f10e9188-ef7b-46f9-a80a-0669436eb4dd|6|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|mL/min/mmHg|[?]|1|mL/dose|PENIS, RADIX|RIGHT||Y|FRIEND|3|Visit_3|40|6|TREATMENT|2020-07-24|40
e|FA|f10e9188-ef7b-46f9-a80a-0669436eb4dd|7|ACNDEV|Action Taken With Device|[?]|GERD|[?]|g/m2/day|[?]|1|100 IU/mL|ABDOMINAL REGION|BILATERAL||Y|FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2020-08-18|65
e|FA|f10e9188-ef7b-46f9-a80a-0669436eb4dd|8|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|ngEq/L|[?]|1|cm|BUCCAL LYMPH NODE|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|5|TREATMENT|2020-08-18|65
e|FA|f10e9188-ef7b-46f9-a80a-0669436eb4dd|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^6 CFU/mL|[?]|1|%(v/v)|MUCOSA OF THE LIP|RIGHT|||SPOUSE|5|Visit_5|90|5|SCREENING|2020-09-12|90
e|FA|f10e9188-ef7b-46f9-a80a-0669436eb4dd|10|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mCi/kg|[?]|1|Weber|TAIL|RIGHT|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2020-09-12|90
e|FA|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|/mm|[?]|1|mL/animal/day|FEMORAL LYMPH NODE|LATERAL|Y|Y|CAREGIVER|1|Visit_1|10|7|FOLLOW-UP|2020-08-13|10
e|FA|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|2|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms|[?]|1|ng/day|C5 VERTEBRA|LATERAL|||SIBLING|1|Visit_1|10|3|TREATMENT|2020-08-13|10
e|FA|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|3|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|pg/dL|[?]|1|mL|SKIN AROUND THE MOUTH|LATERAL|||DOMESTIC PARTNER|2|Visit_2|25|4|FOLLOW-UP|2020-08-28|25
e|FA|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|4|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|ng/day|HYPOPHARYNX|UNILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-08-28|25
e|FA|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/100g/min|[?]|1|mL/animal/day|PARACAVAL LYMPH NODE|LATERAL|Y||VENDOR|3|Visit_3|40|6|WASHOUT|2020-09-12|40
e|FA|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|6|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|10^3 organisms/mL|[?]|1|AU/mL|BULBAR CONJUNCTIVA|UNILATERAL|||SPOUSE|3|Visit_3|40|2|TREATMENT|2020-09-12|40
e|FA|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/s|[?]|1|Pa|FACE|LEFT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|SCREENING|2020-10-07|65
e|FA|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|8|LDIAM|Longest Diameter|[?]|GERD|[?]|Ejaculate U|[?]|1|Shock Wave|SPHENOID SINUS|LATERAL|||DOMESTIC PARTNER|4|Visit_4|65|3|SCREENING|2020-10-07|65
e|FA|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|9|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|kBq|[?]|1|umol|METACARPOPHALANGEAL JOINT 3|UNILATERAL|||ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-11-01|90
e|FA|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|10|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|POINT|[?]|1|g/day|PONS VAROLII|RIGHT|||INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2020-11-01|90
e|FA|000b5b99-a92d-4c84-9edc-ee08930d8a2e|1|LENRSCT|Length of Resection|[?]|GERD|[?]|Bq/kg|[?]|1|psi|TRIANGULAR-HAMATE JOINT|UNILATERAL|||INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-10-15|10
e|FA|000b5b99-a92d-4c84-9edc-ee08930d8a2e|2|VOL|Volume|[?]|GERD|[?]|mPa|[?]|1|vp/dose|SPLENIC HILAR LYMPH NODE|LEFT|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-10-15|10
e|FA|000b5b99-a92d-4c84-9edc-ee08930d8a2e|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|pt_br|[?]|1|mg/g/min|AORTIC ARCH|CONTRALATERAL|||SPOUSE|2|Visit_2|25|6|TREATMENT|2020-10-30|25
e|FA|000b5b99-a92d-4c84-9edc-ee08930d8a2e|4|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|PATCH|[?]|1|mIU/L|INTRAHEPATIC LARGE BILE DUCT|LEFT||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2020-10-30|25
e|FA|000b5b99-a92d-4c84-9edc-ee08930d8a2e|5|SERVNUM|Number of Servings|[?]|GERD|[?]|U/kg/h|[?]|1|Hz/s|LUMBAR VERTEBRA|IPSILATERAL|||ADJUDICATOR|3|Visit_3|40|4|SCREENING|2020-11-14|40
e|FA|000b5b99-a92d-4c84-9edc-ee08930d8a2e|6|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|ms/mmHg|[?]|1|Weber|THIGH|UNILATERAL|Y||ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-11-14|40
e|FA|000b5b99-a92d-4c84-9edc-ee08930d8a2e|7|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|OD Unit|[?]|1|mL/dose|SCAPHOID-RADIUS JOINT|UNILATERAL|Y|Y|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2020-12-09|65
e|FA|000b5b99-a92d-4c84-9edc-ee08930d8a2e|8|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|CCID 50/mL|[?]|1|MBq|VERTEBRAL ARTERY|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2020-12-09|65
e|FA|000b5b99-a92d-4c84-9edc-ee08930d8a2e|9|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|BU/mL|[?]|1|gtt|TRICUSPID VALVE, SEPTAL CUSP|LEFT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2021-01-03|90
e|FA|000b5b99-a92d-4c84-9edc-ee08930d8a2e|10|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|pt_br|[?]|1|ug/m2/h|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|RIGHT|||INVESTIGATOR|5|Visit_5|90|1|WASHOUT|2021-01-03|90
e|FA|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|CFU/mL|[?]|1|%(v/v)|HIP ADDUCTORS|IPSILATERAL|||PARENT|1|Visit_1|10|5|FOLLOW-UP|2020-06-01|10
e|FA|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|2|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|EVENTS|[?]|1|uL/kg/day|METACARPOPHALANGEAL JOINT 5|LEFT|Y||CAREGIVER|1|Visit_1|10|7|TREATMENT|2020-06-01|10
e|FA|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|3|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|gMFI|[?]|1|mL/h|UVEA|LEFT|||SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-06-16|25
e|FA|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|dpm/mg|[?]|1|PFU/dose|LUMBRICAL MUSCLES OF THE HAND|CONTRALATERAL|||CHILD|2|Visit_2|25|4|TREATMENT|2020-06-16|25
e|FA|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|mg/g/min|RIB 5|RIGHT||Y|INVESTIGATOR|3|Visit_3|40|5|WASHOUT|2020-07-01|40
e|FA|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|6|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|BAU|[?]|1|in|ANKLE JOINT|LEFT|||SIBLING|3|Visit_3|40|7|TREATMENT|2020-07-01|40
e|FA|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mV/sec|[?]|1|mg/g/min|BONE MARROW|IPSILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|6|WASHOUT|2020-07-26|65
e|FA|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|8|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|nkat/L|[?]|1|DRUM|COLON|CONTRALATERAL|Y||INTERVIEWER|4|Visit_4|65|2|SCREENING|2020-07-26|65
e|FA|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|9|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|cP|[?]|1|mEq|METACARPOPHALANGEAL JOINT 1|LEFT|Y||SPOUSE|5|Visit_5|90|7|TREATMENT|2020-08-20|90
e|FA|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|10|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|uV2|[?]|1|g/L|CLITORIS|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-08-20|90
e|FA|11b2b359-d4a1-411d-a676-075b26e1453c|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|mg/g/min|TRICUSPID VALVE, POSTERIOR ANNULUS|IPSILATERAL||Y|CAREGIVER|1|Visit_1|10|6|FOLLOW-UP|2020-09-20|10
e|FA|11b2b359-d4a1-411d-a676-075b26e1453c|2|DFIBER|Dietary Fiber|[?]|GERD|[?]|10^4/hpf|[?]|1|h*%|FEMORO-POPLITEAL PERIPHERAL ARTERY|LATERAL|||CHILD|1|Visit_1|10|2|SCREENING|2020-09-20|10
e|FA|11b2b359-d4a1-411d-a676-075b26e1453c|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|g/kg|[?]|1|mg/g/min|SUBGLOTTIS|CONTRALATERAL||Y|VENDOR|2|Visit_2|25|1|SCREENING|2020-10-05|25
e|FA|11b2b359-d4a1-411d-a676-075b26e1453c|4|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|GLOBULE|[?]|1|SCOOPFUL|VERTEBRAL ARTERY|LEFT|||SPOUSE|2|Visit_2|25|4|TREATMENT|2020-10-05|25
e|FA|11b2b359-d4a1-411d-a676-075b26e1453c|5|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|mL/min|[?]|1|DROP|FLEXOR DIGITORUM BREVIS MUSCLE|LEFT|||PROXY|3|Visit_3|40|1|TREATMENT|2020-10-20|40
e|FA|11b2b359-d4a1-411d-a676-075b26e1453c|6|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|U/m2/min|[?]|1|km|HAND|LATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-10-20|40
e|FA|11b2b359-d4a1-411d-a676-075b26e1453c|7|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|mL/cage|[?]|1|fmol|OPPONENS POLLICIS MUSCLE|UNILATERAL|||ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-11-14|65
e|FA|11b2b359-d4a1-411d-a676-075b26e1453c|8|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|IU/mmol|THYROID GLAND, RIGHT LOBE|UNILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|1|WASHOUT|2020-11-14|65
e|FA|11b2b359-d4a1-411d-a676-075b26e1453c|9|DMEAT|Dietary Meat|[?]|GERD|[?]|10^5/hpf|[?]|1|10^6 organisms/mL|PENIS, RADIX|IPSILATERAL||Y|SPOUSE|5|Visit_5|90|3|TREATMENT|2020-12-09|90
e|FA|11b2b359-d4a1-411d-a676-075b26e1453c|10|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|genEq/mL|[?]|1|Gy/h|COLON, SIGMOID|LEFT|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|TREATMENT|2020-12-09|90
e|FA|293f673d-af6a-473e-8bce-118bb85bbd9e|1|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|km|[?]|1|Coulomb|DURAL VENOUS SINUS|LEFT|||CAREGIVER|1|Visit_1|10|6|FOLLOW-UP|2020-10-19|10
e|FA|293f673d-af6a-473e-8bce-118bb85bbd9e|2|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|Sv|[?]|1|10^6 organisms/mL|BRONCHUS|LEFT|||FRIEND|1|Visit_1|10|5|TREATMENT|2020-10-19|10
e|FA|293f673d-af6a-473e-8bce-118bb85bbd9e|3|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|GBq/g|[?]|1|mm/h|PULMONARY VALVE, LEFT CUSP|BILATERAL|||INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-11-03|25
e|FA|293f673d-af6a-473e-8bce-118bb85bbd9e|4|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|DROP|[?]|1|mL/cm3/min|PORTAL VEIN|LATERAL|||DOMESTIC PARTNER|2|Visit_2|25|1|SCREENING|2020-11-03|25
e|FA|293f673d-af6a-473e-8bce-118bb85bbd9e|5|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|nmol|[?]|1|ng/day|URETHRA, PROSTATIC|UNILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-11-18|40
e|FA|293f673d-af6a-473e-8bce-118bb85bbd9e|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mEq/g|[?]|1|mg/g/min|THIRD POSTEROLATERAL DESCENDING ARTERY|RIGHT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|FOLLOW-UP|2020-11-18|40
e|FA|293f673d-af6a-473e-8bce-118bb85bbd9e|7|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|pmol/day|[?]|1|umol|FLEXOR CARPI RADIALIS MUSCLE|LATERAL|||SIBLING|4|Visit_4|65|6|TREATMENT|2020-12-13|65
e|FA|293f673d-af6a-473e-8bce-118bb85bbd9e|8|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|U/kg/h|[?]|1|/kg|GASTROCNEMIUS MUSCLE|CONTRALATERAL|||INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2020-12-13|65
e|FA|293f673d-af6a-473e-8bce-118bb85bbd9e|9|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/dL|[?]|1|km|FEMUR SHAFT|BILATERAL|||SIBLING|5|Visit_5|90|6|WASHOUT|2021-01-07|90
e|FA|293f673d-af6a-473e-8bce-118bb85bbd9e|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|CUP|[?]|1|Pa|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|LEFT||Y|GUARDIAN|5|Visit_5|90|5|TREATMENT|2021-01-07|90
e|FA|0f60ab31-ee13-4846-93d2-6bcac139006f|1|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|uV*sec|[?]|1|umol|ILEUM LYMPH NODE|UNILATERAL|||ADJUDICATOR|1|Visit_1|10|7|SCREENING|2020-07-02|10
e|FA|0f60ab31-ee13-4846-93d2-6bcac139006f|2|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|bel|[?]|1|BP|ABDUCTOR DIGITI QUINTI MUSCLE|RIGHT|||SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-07-02|10
e|FA|0f60ab31-ee13-4846-93d2-6bcac139006f|3|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|g/L|LEFT CIRCUMFLEX ARTERY OSTIUM|LEFT|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-07-17|25
e|FA|0f60ab31-ee13-4846-93d2-6bcac139006f|4|DCAL|Dietary Calories|[?]|GERD|[?]|min*mg/mL|[?]|1|EIA unit|GLUTEAL MUSCLE|IPSILATERAL||Y|CHILD|2|Visit_2|25|2|TREATMENT|2020-07-17|25
e|FA|0f60ab31-ee13-4846-93d2-6bcac139006f|5|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|PFU/dose|[?]|1|mIU/L|LYMPH NODE HILUM|BILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2020-08-01|40
e|FA|0f60ab31-ee13-4846-93d2-6bcac139006f|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|U/dL|[?]|1|Pa|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|WASHOUT|2020-08-01|40
e|FA|0f60ab31-ee13-4846-93d2-6bcac139006f|7|RLDEV|Relationship to Device|[?]|GERD|[?]|cpm|[?]|1|mL/min/mmHg|SUBCUTIS|IPSILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|2|SCREENING|2020-08-26|65
e|FA|0f60ab31-ee13-4846-93d2-6bcac139006f|8|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Ci/g|[?]|1|mm/h|METACARPAL 1 BASE|LATERAL|||CHILD|4|Visit_4|65|3|TREATMENT|2020-08-26|65
e|FA|0f60ab31-ee13-4846-93d2-6bcac139006f|9|LDIAM|Longest Diameter|[?]|GERD|[?]|OI50|[?]|1|Shock Wave|FOREARM|IPSILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|6|FOLLOW-UP|2020-09-20|90
e|FA|0f60ab31-ee13-4846-93d2-6bcac139006f|10|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|U/m2/day|[?]|1|vp/dose|DISTANT LYMPH NODE|IPSILATERAL|Y|Y|FRIEND|5|Visit_5|90|3|TREATMENT|2020-09-20|90
e|FA|d49f37ce-2d6e-4ebb-91af-7ed32322f824|1|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|TRACE|[?]|1|anti-Xa IU/mL|SKIN OF THE FOOT|UNILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|2|TREATMENT|2020-08-31|10
e|FA|d49f37ce-2d6e-4ebb-91af-7ed32322f824|2|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|uL/mL|[?]|1|PACK|SCLERA|LEFT|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|SCREENING|2020-08-31|10
e|FA|d49f37ce-2d6e-4ebb-91af-7ed32322f824|3|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|min/day|[?]|1|DROP|PORTA HEPATIS LYMPH NODE|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-09-15|25
e|FA|d49f37ce-2d6e-4ebb-91af-7ed32322f824|4|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|U/cL|[?]|1|U/mg|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|LEFT|||PARENT|2|Visit_2|25|4|TREATMENT|2020-09-15|25
e|FA|d49f37ce-2d6e-4ebb-91af-7ed32322f824|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|umol/L/sec|[?]|1|U/mg|PAROTID GLAND LYMPH NODE|BILATERAL|||GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-09-30|40
e|FA|d49f37ce-2d6e-4ebb-91af-7ed32322f824|6|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|vp/dose|[?]|1|10^6/L|GASTROINTESTINAL TRACT, LOWER, WALL|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|1|TREATMENT|2020-09-30|40
e|FA|d49f37ce-2d6e-4ebb-91af-7ed32322f824|7|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|pmol|[?]|1|TRANSDUCING UNIT/mL|EPIGASTRIC REGION|RIGHT|Y||INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-10-25|65
e|FA|d49f37ce-2d6e-4ebb-91af-7ed32322f824|8|TOTNUM|Total Number|[?]|GERD|[?]|QUANTITY SUFFICIENT|[?]|1|/200 HPFs|POPLITEAL LYMPH NODE|LEFT|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|7|FOLLOW-UP|2020-10-25|65
e|FA|d49f37ce-2d6e-4ebb-91af-7ed32322f824|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|NEEDLE GAUGE|[?]|1|%(v/v)|ENDOCERVIX|LATERAL||Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-11-19|90
e|FA|d49f37ce-2d6e-4ebb-91af-7ed32322f824|10|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|days/month|[?]|1|mEq/g|INTERNAL ILIAC ARTERY|BILATERAL|||VENDOR|5|Visit_5|90|3|TREATMENT|2020-11-19|90
e|FA|76dd2fe2-bc9e-48e4-870c-af7ece70009a|1|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|mL/mmHg/min/L|AORTA|BILATERAL|||ADJUDICATOR|1|Visit_1|10|1|SCREENING|2020-07-06|10
e|FA|76dd2fe2-bc9e-48e4-870c-af7ece70009a|2|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|pg/L|[?]|1|NEEDLE GAUGE|RECTO-UTERINE POUCH|CONTRALATERAL||Y|CAREGIVER|1|Visit_1|10|4|TREATMENT|2020-07-06|10
e|FA|76dd2fe2-bc9e-48e4-870c-af7ece70009a|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/cm3/min|[?]|1|%(v/v)|PORTA HEPATIS LYMPH NODE|RIGHT|||FRIEND|2|Visit_2|25|5|SCREENING|2020-07-21|25
e|FA|76dd2fe2-bc9e-48e4-870c-af7ece70009a|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|ug/dL|[?]|1|mL/dose|CEPHALIC VEIN|RIGHT|Y||CHILD|2|Visit_2|25|2|TREATMENT|2020-07-21|25
e|FA|76dd2fe2-bc9e-48e4-870c-af7ece70009a|5|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|beats/min|[?]|1|U/mg|T8 VERTEBRA|RIGHT|Y||SIBLING|3|Visit_3|40|1|SCREENING|2020-08-05|40
e|FA|76dd2fe2-bc9e-48e4-870c-af7ece70009a|6|LOCONSET|Localization of Onset|[?]|GERD|[?]|vg/mL|[?]|1|g/L|CHEEK|LEFT||Y|INTERVIEWER|3|Visit_3|40|4|TREATMENT|2020-08-05|40
e|FA|76dd2fe2-bc9e-48e4-870c-af7ece70009a|7|LOCONSET|Localization of Onset|[?]|GERD|[?]|DRUM|[?]|1|g/L|FEMORAL CONDYLE|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2020-08-30|65
e|FA|76dd2fe2-bc9e-48e4-870c-af7ece70009a|8|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|GLOBULE|[?]|1|uCi/kg|WRIST JOINT|IPSILATERAL|Y|Y|INTERVIEWER|4|Visit_4|65|4|WASHOUT|2020-08-30|65
e|FA|76dd2fe2-bc9e-48e4-870c-af7ece70009a|9|DPROT|Dietary Protein|[?]|GERD|[?]|DDU|[?]|1|10^4 CFU/mL|QUADRICEPS MUSCLE|BILATERAL|||SPOUSE|5|Visit_5|90|5|FOLLOW-UP|2020-09-24|90
e|FA|76dd2fe2-bc9e-48e4-870c-af7ece70009a|10|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|EIA unit|[?]|1|TRANSDUCING UNIT/mL|ENDOMETRIUM|CONTRALATERAL|Y||GUARDIAN|5|Visit_5|90|3|SCREENING|2020-09-24|90
e|FA|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|1|SERVNUM|Number of Servings|[?]|GERD|[?]|L/h|[?]|1|Hz/s|SECOND DIAGONAL BRANCH ARTERY|LEFT|||DOMESTIC PARTNER|1|Visit_1|10|1|WASHOUT|2020-11-24|10
e|FA|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|2|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|MET|[?]|1|anti-Xa IU/mL|HYPOTHALAMUS|LATERAL|Y||ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-11-24|10
e|FA|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|3|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|min|[?]|1|g/day|CORPUS UTERI|RIGHT|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-12-09|25
e|FA|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|4|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|ng/mol|[?]|1|ng|MEDIAN BASILIC VEIN|UNILATERAL|Y||FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-12-09|25
e|FA|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|5|DFIBER|Dietary Fiber|[?]|GERD|[?]|VIRTUAL PIXEL|[?]|1|h*%|ISCHIAL TUBEROSITY|LATERAL|||SIBLING|3|Visit_3|40|2|TREATMENT|2020-12-24|40
e|FA|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|6|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|ohm|[?]|1|mg/dose|ABDUCTOR POLLICIS BREVIS MUSCLE|RIGHT|||PROXY|3|Visit_3|40|1|WASHOUT|2020-12-24|40
e|FA|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|7|DIAMETER|Diameter|[?]|GERD|[?]|steps/min|[?]|1|cm|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|RIGHT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2021-01-18|65
e|FA|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|IU/mmol|[?]|1|mL|BRAIN VENTRICLE|UNILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|6|TREATMENT|2021-01-18|65
e|FA|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|9|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|psi|[?]|1|g/L|CORPUS CALLOSUM, GENU|BILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|4|WASHOUT|2021-02-12|90
e|FA|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|10|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|10^7 TCID 50/dose|[?]|1|IU/mmol|SHIN|LEFT|Y||SIBLING|5|Visit_5|90|5|SCREENING|2021-02-12|90
e|FA|78778706-6b5b-4ad8-90af-f56d602863ae|1|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|dmol|[?]|1|mL/cm3/min|ILIAC FOSSA|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-05-13|10
e|FA|78778706-6b5b-4ad8-90af-f56d602863ae|2|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|pmol/L|[?]|1|/500 WBC|OLFACTORY NERVE|LATERAL|||INVESTIGATOR|1|Visit_1|10|3|TREATMENT|2020-05-13|10
e|FA|78778706-6b5b-4ad8-90af-f56d602863ae|3|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|BAR|[?]|1|U/mmol|HEEL OF THE HAND|UNILATERAL|||INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-05-28|25
e|FA|78778706-6b5b-4ad8-90af-f56d602863ae|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|uV*sec|[?]|1|NEEDLE GAUGE|FOOT DIGIT 1|LEFT|Y||INTERVIEWER|2|Visit_2|25|4|SCREENING|2020-05-28|25
e|FA|78778706-6b5b-4ad8-90af-f56d602863ae|5|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|CIGARETTE|[?]|1|BOWL|SKULL|RIGHT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-06-12|40
e|FA|78778706-6b5b-4ad8-90af-f56d602863ae|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|CUP|WRIST JOINT EXTENSOR TENDONS|RIGHT|||FRIEND|3|Visit_3|40|2|TREATMENT|2020-06-12|40
e|FA|78778706-6b5b-4ad8-90af-f56d602863ae|7|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|cmHg|[?]|1|mL/min/mmHg|EPIDIDYMIS|IPSILATERAL|||FRIEND|4|Visit_4|65|4|TREATMENT|2020-07-07|65
e|FA|78778706-6b5b-4ad8-90af-f56d602863ae|8|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|MBq|HEART, SEPTUM|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2020-07-07|65
e|FA|78778706-6b5b-4ad8-90af-f56d602863ae|9|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|kg/mol|[?]|1|g/L|PULMONARY VALVE|LEFT|||FRIEND|5|Visit_5|90|1|FOLLOW-UP|2020-08-01|90
e|FA|78778706-6b5b-4ad8-90af-f56d602863ae|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mmol|[?]|1|10^6 U|FORELIMB|IPSILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|SCREENING|2020-08-01|90
e|FA|a6954aa1-4860-412a-b988-7f708aca2ab2|1|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|hPa|[?]|1|L/h/m2|DORSALIS PEDIS ARTERY|LEFT|Y|Y|INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-09-17|10
e|FA|a6954aa1-4860-412a-b988-7f708aca2ab2|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mEq/L|[?]|1|%(v/v)|MEDIAL FEMORAL CONDYLE|IPSILATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-09-17|10
e|FA|a6954aa1-4860-412a-b988-7f708aca2ab2|3|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|mL/breath|[?]|1|mEq|LEFT VENTRICULAR EPICARDIUM|LATERAL|||CHILD|2|Visit_2|25|3|FOLLOW-UP|2020-10-02|25
e|FA|a6954aa1-4860-412a-b988-7f708aca2ab2|4|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|mm/sec|[?]|1|Shock Wave|MID-JUGULAR LYMPH NODE|LATERAL|Y||SIBLING|2|Visit_2|25|7|SCREENING|2020-10-02|25
e|FA|a6954aa1-4860-412a-b988-7f708aca2ab2|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|mg/g/min|METATARSOPHALANGEAL JOINT 5|LATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-10-17|40
e|FA|a6954aa1-4860-412a-b988-7f708aca2ab2|6|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|anti-Xa IU|[?]|1|mAmp|KNEE JOINT TENDONS|CONTRALATERAL|Y||SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-10-17|40
e|FA|a6954aa1-4860-412a-b988-7f708aca2ab2|7|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mg/kg/min|[?]|1|NEEDLE GAUGE|RIGHT POSTERIOR DESCENDING ARTERY|IPSILATERAL|Y||CHILD|4|Visit_4|65|6|FOLLOW-UP|2020-11-11|65
e|FA|a6954aa1-4860-412a-b988-7f708aca2ab2|8|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|mg/day|[?]|1|TRANSDUCING UNIT/mL|MITRAL VALVE, ANTERIOR CUSP|IPSILATERAL|||GUARDIAN|4|Visit_4|65|2|TREATMENT|2020-11-11|65
e|FA|a6954aa1-4860-412a-b988-7f708aca2ab2|9|SERVNUM|Number of Servings|[?]|GERD|[?]|10^7 TCID 50/dose|[?]|1|Hz/s|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2020-12-06|90
e|FA|a6954aa1-4860-412a-b988-7f708aca2ab2|10|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|psi|[?]|1|Shock Wave|ILEUM LYMPH NODE|RIGHT|||PROXY|5|Visit_5|90|1|SCREENING|2020-12-06|90
e|FA|0a970eb4-f958-42ad-ad8b-60bb427c9cba|1|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mEq/dL|[?]|1|cm H2O|BICEPS BRACHII MUSCLE|UNILATERAL|||PROXY|1|Visit_1|10|3|SCREENING|2020-05-14|10
e|FA|0a970eb4-f958-42ad-ad8b-60bb427c9cba|2|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|IU/mmol|[?]|1|mm/h|EXTENSOR HALLUCIS BREVIS MUSCLE|CONTRALATERAL|||STUDY SUBJECT|1|Visit_1|10|2|SCREENING|2020-05-14|10
e|FA|0a970eb4-f958-42ad-ad8b-60bb427c9cba|3|LDIAM|Longest Diameter|[?]|GERD|[?]|kPa/L/sec|[?]|1|Shock Wave|MENINGES|UNILATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2020-05-29|25
e|FA|0a970eb4-f958-42ad-ad8b-60bb427c9cba|4|LESNUM|Number of Lesions|[?]|GERD|[?]|SYRINGE|[?]|1|ng/day|ASCENDING AORTA, AORTIC ROOT|LATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|2|WASHOUT|2020-05-29|25
e|FA|0a970eb4-f958-42ad-ad8b-60bb427c9cba|5|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|IU/g Hb|[?]|1|oz eq|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|CONTRALATERAL||Y|INVESTIGATOR|3|Visit_3|40|6|SCREENING|2020-06-13|40
e|FA|0a970eb4-f958-42ad-ad8b-60bb427c9cba|6|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|mol/day|[?]|1|BAG|GASTROINTESTINAL TRACT, UPPER, WALL|LEFT|||DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-06-13|40
e|FA|0a970eb4-f958-42ad-ad8b-60bb427c9cba|7|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|BOWL|INTERPHALANGEAL JOINT 5 OF THE HAND|CONTRALATERAL||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|SCREENING|2020-07-08|65
e|FA|0a970eb4-f958-42ad-ad8b-60bb427c9cba|8|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|mV/sec|[?]|1|BAG|HUMERUS SHAFT|LEFT|Y|Y|PARENT|4|Visit_4|65|2|WASHOUT|2020-07-08|65
e|FA|0a970eb4-f958-42ad-ad8b-60bb427c9cba|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|GPL U/mL|[?]|1|mg/g/min|CEREBRAL VEIN|IPSILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|5|WASHOUT|2020-08-02|90
e|FA|0a970eb4-f958-42ad-ad8b-60bb427c9cba|10|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|umol/L/min|[?]|1|mL/cm3/min|ABDOMINAL AORTA|LATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2020-08-02|90
e|FA|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|1|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|mg/dose|PANCREAS, EXOCRINE|UNILATERAL|Y||GUARDIAN|1|Visit_1|10|1|WASHOUT|2021-01-26|10
e|FA|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|2|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|PELLET|[?]|1|BAG|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|CONTRALATERAL||Y|PROXY|1|Visit_1|10|7|SCREENING|2021-01-26|10
e|FA|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|3|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|mL/s/m2|[?]|1|cm H2O|CEREBRUM|CONTRALATERAL|Y||PROXY|2|Visit_2|25|2|SCREENING|2021-02-10|25
e|FA|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|4|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|deg|[?]|1|uCi/kg|FINGER FLEXOR MUSCLES|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2021-02-10|25
e|FA|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|5|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|ka_u/dL|[?]|1|Bq/L|POSTERIOR CINGULATE CORTEX|IPSILATERAL|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2021-02-25|40
e|FA|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|6|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mg/min|[?]|1|gtt|THALAMUS|BILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2021-02-25|40
e|FA|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|7|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|/wk|[?]|1|CUP|THORACIC VERTEBRA|CONTRALATERAL||Y|INVESTIGATOR|4|Visit_4|65|3|WASHOUT|2021-03-22|65
e|FA|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|8|STRCTNUM|Number of Strictures|[?]|GERD|[?]|MPS U|[?]|1|SACHET|INTRAHEPATIC BILE DUCT|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2021-03-22|65
e|FA|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|9|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|MPL U/mL|[?]|1|10^6/L|MITRAL VALVE|LEFT||Y|STUDY SUBJECT|5|Visit_5|90|1|TREATMENT|2021-04-16|90
e|FA|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|10|DFRUIT|Dietary Fruit|[?]|GERD|[?]|CAPFUL|[?]|1|10^6 CFU/mL|TRACHEA|LATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|FOLLOW-UP|2021-04-16|90
e|FA|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|BOWL|[?]|1|mg/g/min|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|CONTRALATERAL||Y|DOMESTIC PARTNER|1|Visit_1|10|7|FOLLOW-UP|2020-08-24|10
e|FA|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|2|STROKTYP|Stroke Type|[?]|GERD|[?]|10^9 CFU/mL|[?]|1|g/L|PENIS|LATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|SCREENING|2020-08-24|10
e|FA|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|3|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|Pack Year|[?]|1|ug/m2/h|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|UNILATERAL||Y|GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-09-08|25
e|FA|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|4|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|10^12 IU/L|[?]|1|Shock Wave|NASAL CAVITY|IPSILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2020-09-08|25
e|FA|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|5|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|POINT|[?]|1|mL|CORONARY ARTERY, LEFT|IPSILATERAL|||FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2020-09-23|40
e|FA|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|6|LDIAM|Longest Diameter|[?]|GERD|[?]|MBq/uL|[?]|1|Shock Wave|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|Y||PROXY|3|Visit_3|40|2|WASHOUT|2020-09-23|40
e|FA|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|7|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|IU/mmol|[?]|1|ohm|PARALARYNGEAL LYMPH NODE|RIGHT||Y|CHILD|4|Visit_4|65|7|FOLLOW-UP|2020-10-18|65
e|FA|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|pg/dL|[?]|1|U/mmol|UPPER CERVICAL LYMPH NODE|IPSILATERAL|||FRIEND|4|Visit_4|65|4|TREATMENT|2020-10-18|65
e|FA|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|9|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|ukat|[?]|1|MBq|BRAIN VENTRICLE|IPSILATERAL||Y|SIGNIFICANT OTHER|5|Visit_5|90|1|SCREENING|2020-11-12|90
e|FA|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|10|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|cal|[?]|1|mL/animal/day|LIVER, CAUDATE LOBE|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2020-11-12|90
e|FA|9b268a13-dc40-4eb6-8729-c131ac302dd3|1|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|mm/h|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|LATERAL|Y||STUDY SUBJECT|1|Visit_1|10|7|WASHOUT|2020-05-15|10
e|FA|9b268a13-dc40-4eb6-8729-c131ac302dd3|2|LENRSCT|Length of Resection|[?]|GERD|[?]|CCID 50/mL|[?]|1|psi|L2 VERTEBRA|LATERAL|||CHILD|1|Visit_1|10|2|TREATMENT|2020-05-15|10
e|FA|9b268a13-dc40-4eb6-8729-c131ac302dd3|3|DISTANCE|Distance|[?]|GERD|[?]|ukat|[?]|1|BOWL|CORNEA|LATERAL|||PROXY|2|Visit_2|25|4|TREATMENT|2020-05-30|25
e|FA|9b268a13-dc40-4eb6-8729-c131ac302dd3|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|BOTTLE|[?]|1|NEEDLE GAUGE|GASTROINTESTINAL TRACT, LOWER|LATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-05-30|25
e|FA|9b268a13-dc40-4eb6-8729-c131ac302dd3|5|QOLIMP|QOL Impact|[?]|GERD|[?]|log10 CFU/g|[?]|1|10^6/L|DUCTUS ARTERIOSUS|RIGHT|||VENDOR|3|Visit_3|40|1|FOLLOW-UP|2020-06-14|40
e|FA|9b268a13-dc40-4eb6-8729-c131ac302dd3|6|SEV|Severity/Intensity|[?]|GERD|[?]|/h|[?]|1|Pa|CORNEAL EPITHELIUM|RIGHT||Y|STUDY SUBJECT|3|Visit_3|40|1|TREATMENT|2020-06-14|40
e|FA|9b268a13-dc40-4eb6-8729-c131ac302dd3|7|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|g/dL|MEDULLA OBLONGATA|LEFT||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-07-09|65
e|FA|9b268a13-dc40-4eb6-8729-c131ac302dd3|8|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mmol/g|[?]|1|fmol|SACROILIAC JOINT|IPSILATERAL|||ADJUDICATOR|4|Visit_4|65|6|FOLLOW-UP|2020-07-09|65
e|FA|9b268a13-dc40-4eb6-8729-c131ac302dd3|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|PACK|[?]|1|%(v/v)|RIB 9|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|WASHOUT|2020-08-03|90
e|FA|9b268a13-dc40-4eb6-8729-c131ac302dd3|10|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mol/g|[?]|1|NEEDLE GAUGE|URETHRAL SPHINCTER|LATERAL|Y||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2020-08-03|90
e|FA|fa11534a-92f9-4887-828b-25b7637b8f57|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|nmol/kg/day|[?]|1|%(v/v)|CORNEAL STROMA|BILATERAL|||PROXY|1|Visit_1|10|4|TREATMENT|2020-12-13|10
e|FA|fa11534a-92f9-4887-828b-25b7637b8f57|2|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mEq/L|[?]|1|cm H2O|RETINAL ARTERY|LEFT|||STUDY SUBJECT|1|Visit_1|10|3|TREATMENT|2020-12-13|10
e|FA|fa11534a-92f9-4887-828b-25b7637b8f57|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|Pa|HAND DIGIT 3|CONTRALATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|SCREENING|2020-12-28|25
e|FA|fa11534a-92f9-4887-828b-25b7637b8f57|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mU/g|[?]|1|mg/g/min|DISTAL INTERPHALANGEAL JOINT 3|BILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-12-28|25
e|FA|fa11534a-92f9-4887-828b-25b7637b8f57|5|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|keV|[?]|1|L/h/m2|LYMPH NODE HILUM|IPSILATERAL|||FAMILY MEMBER|3|Visit_3|40|7|WASHOUT|2021-01-12|40
e|FA|fa11534a-92f9-4887-828b-25b7637b8f57|6|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|/4.0 mL|[?]|1|mg/h|SYMPATHETIC GANGLIA|CONTRALATERAL|Y|Y|PARENT|3|Visit_3|40|6|TREATMENT|2021-01-12|40
e|FA|fa11534a-92f9-4887-828b-25b7637b8f57|7|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|U|[?]|1|QUANTITY SUFFICIENT|ESOPHAGUS|RIGHT|||GUARDIAN|4|Visit_4|65|3|SCREENING|2021-02-06|65
e|FA|fa11534a-92f9-4887-828b-25b7637b8f57|8|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|in|[?]|1|g/day|LIMB|LEFT|Y||VENDOR|4|Visit_4|65|6|TREATMENT|2021-02-06|65
e|FA|fa11534a-92f9-4887-828b-25b7637b8f57|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|min|[?]|1|mg/g/min|GASTROESOPHAGEAL JUNCTION|LEFT||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|SCREENING|2021-03-03|90
e|FA|fa11534a-92f9-4887-828b-25b7637b8f57|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mmol/kg|[?]|1|%(v/v)|HAND DIGIT 1|RIGHT|||ADJUDICATION COMMITTEE|5|Visit_5|90|7|SCREENING|2021-03-03|90
e|FA|f305f7a3-8c8b-4eca-afb2-4a376f811170|1|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|10^3 RNA copies/mL|[?]|1|oz eq|TRIANGULAR BONE|LATERAL||Y|SPOUSE|1|Visit_1|10|1|TREATMENT|2020-10-04|10
e|FA|f305f7a3-8c8b-4eca-afb2-4a376f811170|2|SEV|Severity/Intensity|[?]|GERD|[?]|USP U|[?]|1|Pa|PANCREAS, TAIL|CONTRALATERAL|||PROXY|1|Visit_1|10|1|TREATMENT|2020-10-04|10
e|FA|f305f7a3-8c8b-4eca-afb2-4a376f811170|3|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|10^3 DNA copies/mL|[?]|1|AU/mL|PERIPHERAL NERVE|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-10-19|25
e|FA|f305f7a3-8c8b-4eca-afb2-4a376f811170|4|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|mL/m2/day|[?]|1|g/cage/day|HEAD AND NECK|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|2|Visit_2|25|1|TREATMENT|2020-10-19|25
e|FA|f305f7a3-8c8b-4eca-afb2-4a376f811170|5|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|TAMPON|[?]|1|BP|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|BILATERAL|Y|Y|PARENT|3|Visit_3|40|5|WASHOUT|2020-11-03|40
e|FA|f305f7a3-8c8b-4eca-afb2-4a376f811170|6|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|mEq/g|[?]|1|mg/h|NUCHAL LYMPH NODE|IPSILATERAL||Y|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-11-03|40
e|FA|f305f7a3-8c8b-4eca-afb2-4a376f811170|7|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|DAYS|[?]|1|in|CORPUS UTERI|UNILATERAL|||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-11-28|65
e|FA|f305f7a3-8c8b-4eca-afb2-4a376f811170|8|EPSDNUM|Number of Episodes|[?]|GERD|[?]|L/min/m2|[?]|1|%(v/v)|UPPER URINARY SYSTEM|LATERAL|Y||DOMESTIC PARTNER|4|Visit_4|65|1|SCREENING|2020-11-28|65
e|FA|f305f7a3-8c8b-4eca-afb2-4a376f811170|9|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|10^9/g|[?]|1|10^6 IU/mL|FINGERNAIL|IPSILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-12-23|90
e|FA|f305f7a3-8c8b-4eca-afb2-4a376f811170|10|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|uEq/L|[?]|1|Coulomb|PANCREAS, ENDOCRINE|LATERAL|||PROXY|5|Visit_5|90|4|TREATMENT|2020-12-23|90
e|FA|6e4ed6b3-e419-464c-a40e-f100a6894baa|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|CAN|[?]|1|L|LEFT VENTRICULAR EPICARDIUM|CONTRALATERAL||Y|CAREGIVER|1|Visit_1|10|1|SCREENING|2020-06-07|10
e|FA|6e4ed6b3-e419-464c-a40e-f100a6894baa|2|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|BLOCKS|[?]|1|in|COMMON FEMORAL ARTERY|RIGHT||Y|DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-06-07|10
e|FA|6e4ed6b3-e419-464c-a40e-f100a6894baa|3|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|/40 HPFs|[?]|1|IU/mg|SKIN OF THE BUTTOCK|UNILATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|7|WASHOUT|2020-06-22|25
e|FA|6e4ed6b3-e419-464c-a40e-f100a6894baa|4|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|10^3/hpf|[?]|1|mEq|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|LEFT|||DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-06-22|25
e|FA|6e4ed6b3-e419-464c-a40e-f100a6894baa|5|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|uEq|[?]|1|EIA unit|PULMONARY VALVE|RIGHT|Y||SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2020-07-07|40
e|FA|6e4ed6b3-e419-464c-a40e-f100a6894baa|6|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|mmol|[?]|1|/500 WBC|CHEEK|LEFT|||SIBLING|3|Visit_3|40|2|WASHOUT|2020-07-07|40
e|FA|6e4ed6b3-e419-464c-a40e-f100a6894baa|7|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|POUCH|[?]|1|m2|PANCREAS, HEAD|UNILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|2|FOLLOW-UP|2020-08-01|65
e|FA|6e4ed6b3-e419-464c-a40e-f100a6894baa|8|AGETRT1|Age At First Treatment|[?]|GERD|[?]|fL|[?]|1|mL/mmHg/min/L|INFRATENTORIAL BRAIN|UNILATERAL||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2020-08-01|65
e|FA|6e4ed6b3-e419-464c-a40e-f100a6894baa|9|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|oz eq|PANCREAS, TAIL|IPSILATERAL||Y|GUARDIAN|5|Visit_5|90|6|TREATMENT|2020-08-26|90
e|FA|6e4ed6b3-e419-464c-a40e-f100a6894baa|10|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|s^-1(%O2)^-1|[?]|1|mIU/L|SKIN OF THE FINGER|LEFT|Y|Y|INDEPENDENT ASSESSOR|5|Visit_5|90|4|TREATMENT|2020-08-26|90
e|FA|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|1|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|Gauss|[?]|1|MPS U|TUNICA INTIMA|LEFT|||PROXY|1|Visit_1|10|1|TREATMENT|2020-08-08|10
e|FA|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|2|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|% INHIBITION|[?]|1|Gy/h|HEART, LEFT VENTRICULAR WALL|IPSILATERAL|||CHILD|1|Visit_1|10|5|FOLLOW-UP|2020-08-08|10
e|FA|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|3|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|mg/cm2|[?]|1|mm/h|PROXIMAL INTERPHALANGEAL JOINT 2|CONTRALATERAL|||STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-08-23|25
e|FA|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|4|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|titer|[?]|1|MBq|ULNAR ARTERY|CONTRALATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-08-23|25
e|FA|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|5|DISTANCE|Distance|[?]|GERD|[?]|10^6/Ejaculate U|[?]|1|BOWL|TRAPEZIUM-TRAPEZOID JOINT|RIGHT|Y|Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-09-07|40
e|FA|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|6|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mEq/kg|[?]|1|10^6 U|BLOOD|BILATERAL|Y||GUARDIAN|3|Visit_3|40|7|TREATMENT|2020-09-07|40
e|FA|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|7|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|ug/g/h|[?]|1|mL/dose|SUPRATENTORIAL BRAIN|RIGHT|Y||FRIEND|4|Visit_4|65|5|FOLLOW-UP|2020-10-02|65
e|FA|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|in2|[?]|1|%(v/v)|SCAPULA|RIGHT||Y|SPOUSE|4|Visit_4|65|1|TREATMENT|2020-10-02|65
e|FA|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|9|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|Pack Year|[?]|1|mL/h|SCAPHOID-TRAPEZIUM JOINT|RIGHT|||SPOUSE|5|Visit_5|90|4|FOLLOW-UP|2020-10-27|90
e|FA|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|10|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|10^6 organisms|[?]|1|IU/mg|GLENOID FOSSA|UNILATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2020-10-27|90
e|FA|5d25ac6d-428d-41eb-9549-c23df035a54e|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|g/kg/day|[?]|1|Pa|PINEAL GLAND|LATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|2|SCREENING|2020-05-13|10
e|FA|5d25ac6d-428d-41eb-9549-c23df035a54e|2|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|kDa|[?]|1|g/cage/day|TROCHLEAR NERVE|BILATERAL|||INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-05-13|10
e|FA|5d25ac6d-428d-41eb-9549-c23df035a54e|3|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|g/g/day|[?]|1|mm/h|LATERAL FIRST DIAGONAL BRANCH ARTERY|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|SCREENING|2020-05-28|25
e|FA|5d25ac6d-428d-41eb-9549-c23df035a54e|4|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|Hz|[?]|1|Log10 ELISA unit|T11 VERTEBRA|BILATERAL||Y|STUDY SUBJECT|2|Visit_2|25|6|SCREENING|2020-05-28|25
e|FA|5d25ac6d-428d-41eb-9549-c23df035a54e|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ngEq/L|[?]|1|Pa|PROFUNDA FEMORIS VEIN|UNILATERAL|Y|Y|INDEPENDENT ASSESSOR|3|Visit_3|40|7|TREATMENT|2020-06-12|40
e|FA|5d25ac6d-428d-41eb-9549-c23df035a54e|6|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|ug/g/day|[?]|1|DROP|VESTIBULOCOCHLEAR NERVE|LEFT|||CHILD|3|Visit_3|40|1|WASHOUT|2020-06-12|40
e|FA|5d25ac6d-428d-41eb-9549-c23df035a54e|7|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|10^6 organisms/mg|[?]|1|DRUM|EPIGLOTTIS|IPSILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-07-07|65
e|FA|5d25ac6d-428d-41eb-9549-c23df035a54e|8|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|mgEq|[?]|1|10^6/L|PERIURETERAL REGION|IPSILATERAL|Y|Y|ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-07-07|65
e|FA|5d25ac6d-428d-41eb-9549-c23df035a54e|9|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|SACHET|[?]|1|g/L|PALM|BILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|SCREENING|2020-08-01|90
e|FA|5d25ac6d-428d-41eb-9549-c23df035a54e|10|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|SBE/mL|[?]|1|U/10^12 RBC|INTERPHALANGEAL JOINT 2|CONTRALATERAL|||GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-08-01|90
e|FA|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|1|DMG|Dietary Magnesium|[?]|GERD|[?]|mL*cmH2O|[?]|1|TRANSDUCING UNIT/mL|RIB 1|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|SCREENING|2020-10-30|10
e|FA|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|2|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|PFU/mL|[?]|1|10^9 CFU/mL|MITRAL VALVE, ANTERIOR ANNULUS|RIGHT|||SIBLING|1|Visit_1|10|6|TREATMENT|2020-10-30|10
e|FA|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|3|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|mL/cm3/min|[?]|1|ug/g/h|RIB 7|LEFT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-11-14|25
e|FA|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|4|OBJNUM|Number of Objects|[?]|GERD|[?]|KIT|[?]|1|mL/100g/min|VULVOVAGINAL REGION|BILATERAL|Y||SIBLING|2|Visit_2|25|5|FOLLOW-UP|2020-11-14|25
e|FA|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|fmol|[?]|1|U/mmol|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|LATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|SCREENING|2020-11-29|40
e|FA|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|6|LDIAM|Longest Diameter|[?]|GERD|[?]|10^12/L|[?]|1|Shock Wave|TONSIL|CONTRALATERAL|Y||PARENT|3|Visit_3|40|2|TREATMENT|2020-11-29|40
e|FA|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|7|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|ug/kg/h|[?]|1|mmHg/L/min|MEDIASTINUM, SUPERIOR|RIGHT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|3|WASHOUT|2020-12-24|65
e|FA|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|8|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|10^6 DNA copies/mL|[?]|1|10^6/L|FLEXOR DIGITORUM LONGUS MUSCLE|RIGHT||Y|FRIEND|4|Visit_4|65|6|TREATMENT|2020-12-24|65
e|FA|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|9|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|Gy/min|[?]|1|ng|COLON WALL|LATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|4|TREATMENT|2021-01-18|90
e|FA|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|10|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|10^3 CFU/mL|[?]|1|IU/mg|MEDULLA OBLONGATA|UNILATERAL|||GUARDIAN|5|Visit_5|90|1|TREATMENT|2021-01-18|90
e|FA|173aea61-964d-4f4a-8d48-56a1a58de6d8|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|ng/day|[?]|1|mL/animal/day|RETINAL ARTERY|RIGHT||Y|CAREGIVER|1|Visit_1|10|1|TREATMENT|2020-10-13|10
e|FA|173aea61-964d-4f4a-8d48-56a1a58de6d8|2|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|g/animal/day|[?]|1|uCi/kg|HEART, LEFT VENTRICULAR OUTFLOW TRACT|LATERAL|||PARENT|1|Visit_1|10|5|TREATMENT|2020-10-13|10
e|FA|173aea61-964d-4f4a-8d48-56a1a58de6d8|3|AGETRT1|Age At First Treatment|[?]|GERD|[?]|umol/L/h|[?]|1|mL/mmHg/min/L|CINGULATE CORTEX|UNILATERAL|Y||STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-10-28|25
e|FA|173aea61-964d-4f4a-8d48-56a1a58de6d8|4|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|pg/cell|[?]|1|uL/kg/day|MID-JUGULAR LYMPH NODE|IPSILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2020-10-28|25
e|FA|173aea61-964d-4f4a-8d48-56a1a58de6d8|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Weber|[?]|1|mg/g/min|BONE MARROW|LEFT||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2020-11-12|40
e|FA|173aea61-964d-4f4a-8d48-56a1a58de6d8|6|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|SACHET|TROCHLEAR NERVE|RIGHT||Y|PARENT|3|Visit_3|40|1|SCREENING|2020-11-12|40
e|FA|173aea61-964d-4f4a-8d48-56a1a58de6d8|7|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|mg/m2|[?]|1|cmH2O/mL|LUNG, RIGHT LOWER LOBE|IPSILATERAL|||ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-12-07|65
e|FA|173aea61-964d-4f4a-8d48-56a1a58de6d8|8|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms/g|[?]|1|Weber|GLENOID FOSSA|LATERAL|||VENDOR|4|Visit_4|65|7|TREATMENT|2020-12-07|65
e|FA|173aea61-964d-4f4a-8d48-56a1a58de6d8|9|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|BOWL|[?]|1|Hz/s|PRIMARY VISUAL CORTEX|RIGHT|Y|Y|INTERVIEWER|5|Visit_5|90|3|TREATMENT|2021-01-01|90
e|FA|173aea61-964d-4f4a-8d48-56a1a58de6d8|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|PIXELS/cm|[?]|1|mg/g/min|AORTOPULMONARY WINDOW LYMPH NODE|BILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|4|SCREENING|2021-01-01|90
e|FA|45d1adb8-9b3b-4f06-87cb-740205448680|1|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|PFU/mL|[?]|1|mEq|AORTIC ARCH|LATERAL|Y||STUDY SUBJECT|1|Visit_1|10|7|WASHOUT|2020-07-17|10
e|FA|45d1adb8-9b3b-4f06-87cb-740205448680|2|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|deg2|[?]|1|PFU/dose|MIDDLE EAR|LEFT||Y|SPOUSE|1|Visit_1|10|1|FOLLOW-UP|2020-07-17|10
e|FA|45d1adb8-9b3b-4f06-87cb-740205448680|3|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|ng/L|[?]|1|L/h/m2|EXTRAOCULAR MUSCLE|BILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-08-01|25
e|FA|45d1adb8-9b3b-4f06-87cb-740205448680|4|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit|[?]|1|SACHET|RIB 8|UNILATERAL|Y||STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-08-01|25
e|FA|45d1adb8-9b3b-4f06-87cb-740205448680|5|DPROT|Dietary Protein|[?]|GERD|[?]|mg/kg/h|[?]|1|10^4 CFU/mL|DISTAL CIRCUMFLEX ARTERY|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-08-16|40
e|FA|45d1adb8-9b3b-4f06-87cb-740205448680|6|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|ngEq/L|[?]|1|IU/mg|SUPRAPUBIC REGION|LEFT|||SIGNIFICANT OTHER|3|Visit_3|40|7|WASHOUT|2020-08-16|40
e|FA|45d1adb8-9b3b-4f06-87cb-740205448680|7|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|uEq|[?]|1|Log10 ELISA unit|PERICARDIAL WALL|LATERAL|||CAREGIVER|4|Visit_4|65|6|TREATMENT|2020-09-10|65
e|FA|45d1adb8-9b3b-4f06-87cb-740205448680|8|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|10^11/L|[?]|1|MPS U|SUBCUTIS|LEFT|Y||STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2020-09-10|65
e|FA|45d1adb8-9b3b-4f06-87cb-740205448680|9|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|ug/mol|[?]|1|mL/mmHg/min/L|HEART, RIGHT ATRIUM|LATERAL|||DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2020-10-05|90
e|FA|45d1adb8-9b3b-4f06-87cb-740205448680|10|STRCTNUM|Number of Strictures|[?]|GERD|[?]|/200 HPFs|[?]|1|SACHET|SKULL|IPSILATERAL|Y||INVESTIGATOR|5|Visit_5|90|4|FOLLOW-UP|2020-10-05|90
e|FA|7403ad67-7ed5-4716-a874-c360429845bc|1|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|ug/h|[?]|1|mmHg/L/min|EPIGLOTTIS|BILATERAL||Y|FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2020-05-30|10
e|FA|7403ad67-7ed5-4716-a874-c360429845bc|2|DFIBER|Dietary Fiber|[?]|GERD|[?]|ug/dose|[?]|1|h*%|GINGIVA|IPSILATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|SCREENING|2020-05-30|10
e|FA|7403ad67-7ed5-4716-a874-c360429845bc|3|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|CARTRIDGE|[?]|1|mEq|POPLITEAL LYMPH NODE|LEFT|||CAREGIVER|2|Visit_2|25|3|SCREENING|2020-06-14|25
e|FA|7403ad67-7ed5-4716-a874-c360429845bc|4|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|NEBULE|[?]|1|IU/mmol|DISTAL RIGHT CORONARY ARTERY CONDUIT|IPSILATERAL|||STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-06-14|25
e|FA|7403ad67-7ed5-4716-a874-c360429845bc|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|GBq/ug|[?]|1|U/mmol|ACUTE MARGINAL ARTERY|LEFT|||INDEPENDENT ASSESSOR|3|Visit_3|40|3|WASHOUT|2020-06-29|40
e|FA|7403ad67-7ed5-4716-a874-c360429845bc|6|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|SCOOPFUL|NOSTRIL|LEFT||Y|PARENT|3|Visit_3|40|2|WASHOUT|2020-06-29|40
e|FA|7403ad67-7ed5-4716-a874-c360429845bc|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|U/mmol|[?]|1|Pa|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|IPSILATERAL|||PROXY|4|Visit_4|65|5|SCREENING|2020-07-24|65
e|FA|7403ad67-7ed5-4716-a874-c360429845bc|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|U/kg/h|[?]|1|PFU/dose|GINGIVA|CONTRALATERAL|||STUDY SUBJECT|4|Visit_4|65|1|SCREENING|2020-07-24|65
e|FA|7403ad67-7ed5-4716-a874-c360429845bc|9|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|keV|[?]|1|vp/dose|COLON, DESCENDING|RIGHT|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2020-08-18|90
e|FA|7403ad67-7ed5-4716-a874-c360429845bc|10|OBJTYPE|Type of Object|[?]|GERD|[?]|OI50|[?]|1|ng|SKIN OF THE INFRASCAPULAR REGION|BILATERAL||Y|CHILD|5|Visit_5|90|3|TREATMENT|2020-08-18|90
e|FA|8be919ce-34da-4e49-ac7a-3679c7af632d|1|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|nmol/L/h|[?]|1|PFU/dose|CAROTID ARTERY|RIGHT||Y|SPOUSE|1|Visit_1|10|5|TREATMENT|2021-01-13|10
e|FA|8be919ce-34da-4e49-ac7a-3679c7af632d|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|/min|[?]|1|mg/g/min|TUNICA INTIMA|UNILATERAL|||FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2021-01-13|10
e|FA|8be919ce-34da-4e49-ac7a-3679c7af632d|3|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|PFU/mL|[?]|1|g/day|FINGER|LEFT|||ADJUDICATOR|2|Visit_2|25|5|WASHOUT|2021-01-28|25
e|FA|8be919ce-34da-4e49-ac7a-3679c7af632d|4|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|GBq/g|[?]|1|uCi/kg|HEEL OF THE FOOT|BILATERAL||Y|FRIEND|2|Visit_2|25|6|FOLLOW-UP|2021-01-28|25
e|FA|8be919ce-34da-4e49-ac7a-3679c7af632d|5|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mL/(min*100mL)|[?]|1|100 IU/mL|DIGIT|UNILATERAL|Y|Y|ADJUDICATOR|3|Visit_3|40|5|SCREENING|2021-02-12|40
e|FA|8be919ce-34da-4e49-ac7a-3679c7af632d|6|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|10^9 CFU/mL|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|RIGHT||Y|CHILD|3|Visit_3|40|2|FOLLOW-UP|2021-02-12|40
e|FA|8be919ce-34da-4e49-ac7a-3679c7af632d|7|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|FEU|[?]|1|MBq|FUNDUS OF THE EYE|IPSILATERAL|Y||FAMILY MEMBER|4|Visit_4|65|5|TREATMENT|2021-03-09|65
e|FA|8be919ce-34da-4e49-ac7a-3679c7af632d|8|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU|[?]|1|BAG|COLON WALL|UNILATERAL|||SPOUSE|4|Visit_4|65|6|TREATMENT|2021-03-09|65
e|FA|8be919ce-34da-4e49-ac7a-3679c7af632d|9|EXTRSCT|Extent of Resection|[?]|GERD|[?]|CAPFUL|[?]|1|Weber|PARS COMPACTA|IPSILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|7|SCREENING|2021-04-03|90
e|FA|8be919ce-34da-4e49-ac7a-3679c7af632d|10|DVEG|Dietary Vegetable|[?]|GERD|[?]|Mile|[?]|1|Ci/ug|TRIANGULAR-LUNATE JOINT|LATERAL|||STUDY SUBJECT|5|Visit_5|90|7|FOLLOW-UP|2021-04-03|90
e|FA|9c44967b-914e-43d5-be1e-6829804e04ab|1|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|mL/cage|[?]|1|uL/kg/day|BLADDER, FUNDUS|BILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2021-01-24|10
e|FA|9c44967b-914e-43d5-be1e-6829804e04ab|2|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mL/g/min|[?]|1|PFU/dose|DIGIT|LEFT|||INTERVIEWER|1|Visit_1|10|5|TREATMENT|2021-01-24|10
e|FA|9c44967b-914e-43d5-be1e-6829804e04ab|3|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|genEq|[?]|1|10^9 CFU/g|LATERAL RAMUS INTERMEDIUS ARTERY|LEFT|Y||ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2021-02-08|25
e|FA|9c44967b-914e-43d5-be1e-6829804e04ab|4|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|mAmp|[?]|1|10^6/L|PANCREATIC DUCT|BILATERAL|Y||SPOUSE|2|Visit_2|25|6|WASHOUT|2021-02-08|25
e|FA|9c44967b-914e-43d5-be1e-6829804e04ab|5|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|MESF|[?]|1|cm H2O|LEFT MAIN CORONARY ARTERY BODY|IPSILATERAL|||VENDOR|3|Visit_3|40|4|TREATMENT|2021-02-23|40
e|FA|9c44967b-914e-43d5-be1e-6829804e04ab|6|SERVNUM|Number of Servings|[?]|GERD|[?]|mL/kg/day|[?]|1|Hz/s|ANTERIOR TIBIAL VEIN|LATERAL|||FRIEND|3|Visit_3|40|6|TREATMENT|2021-02-23|40
e|FA|9c44967b-914e-43d5-be1e-6829804e04ab|7|DGRAIN|Dietary Grain|[?]|GERD|[?]|mL/animal/day|[?]|1|10^9 CFU/g|RIB 1|BILATERAL|Y||FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2021-03-20|65
e|FA|9c44967b-914e-43d5-be1e-6829804e04ab|8|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|10^9 CFU/g|[?]|1|gtt|NERVE|LEFT||Y|FAMILY MEMBER|4|Visit_4|65|7|TREATMENT|2021-03-20|65
e|FA|9c44967b-914e-43d5-be1e-6829804e04ab|9|SERVNUM|Number of Servings|[?]|GERD|[?]|eq|[?]|1|Hz/s|ARM|RIGHT|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|WASHOUT|2021-04-14|90
e|FA|9c44967b-914e-43d5-be1e-6829804e04ab|10|SEV|Severity/Intensity|[?]|GERD|[?]|min/day|[?]|1|Pa|TRIANGULAR-HAMATE JOINT|CONTRALATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|WASHOUT|2021-04-14|90
e|FA|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|1|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|ng/dL|[?]|1|10^6 U|PARACAVAL LYMPH NODE|RIGHT|||STUDY SUBJECT|1|Visit_1|10|7|SCREENING|2020-07-31|10
e|FA|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|2|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|mL/h|[?]|1|cmH2O/mL|DIAPHRAGMATIC LYMPH NODE|BILATERAL|Y||SPOUSE|1|Visit_1|10|6|SCREENING|2020-07-31|10
e|FA|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|3|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|uL/mL|[?]|1|MPS U|T10 VERTEBRA|LATERAL|Y||CAREGIVER|2|Visit_2|25|6|FOLLOW-UP|2020-08-15|25
e|FA|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|4|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|mol|[?]|1|BP|HYPOGLOSSAL NERVE|UNILATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-08-15|25
e|FA|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|5|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|STEPS|[?]|1|mm/h|KIDNEY|CONTRALATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2020-08-30|40
e|FA|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|6|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|ngEq/L|[?]|1|mL/m2|L6 VERTEBRA|IPSILATERAL||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|5|FOLLOW-UP|2020-08-30|40
e|FA|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/m2/min|[?]|1|mg/g/min|THIRD OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL||Y|VENDOR|4|Visit_4|65|4|TREATMENT|2020-09-24|65
e|FA|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|8|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|mL/dose|[?]|1|mL/cm3/min|SKULL, BASE|UNILATERAL|Y||INTERVIEWER|4|Visit_4|65|4|TREATMENT|2020-09-24|65
e|FA|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|9|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|MBq|[?]|1|uL/kg/day|BRAIN|LATERAL|||GUARDIAN|5|Visit_5|90|6|TREATMENT|2020-10-19|90
e|FA|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|10|VOL|Volume|[?]|GERD|[?]|APL U|[?]|1|vp/dose|L5-S1 INTERVERTEBRAL SPACE|IPSILATERAL|||INVESTIGATOR|5|Visit_5|90|3|WASHOUT|2020-10-19|90
e|FA|cad8c553-739f-4046-a898-d939eb286dba|1|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|mg/m2/h|[?]|1|cm|SEMITENDINOSUS MUSCLE|LATERAL|||CHILD|1|Visit_1|10|2|TREATMENT|2020-05-17|10
e|FA|cad8c553-739f-4046-a898-d939eb286dba|2|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|V|[?]|1|mL/animal/day|VERTEBRAL COLUMN|IPSILATERAL|||CHILD|1|Visit_1|10|1|TREATMENT|2020-05-17|10
e|FA|cad8c553-739f-4046-a898-d939eb286dba|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|umol/L/sec|[?]|1|mg/g/min|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|LATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|WASHOUT|2020-06-01|25
e|FA|cad8c553-739f-4046-a898-d939eb286dba|4|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|mOsm/kg|[?]|1|HOURS|SCAPHOID-LUNATE-CAPITATE JOINT|LATERAL|||FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-06-01|25
e|FA|cad8c553-739f-4046-a898-d939eb286dba|5|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mg/mol|[?]|1|ug/kg/h|SUBLINGUAL REGION|LEFT|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-06-16|40
e|FA|cad8c553-739f-4046-a898-d939eb286dba|6|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|Newton|[?]|1|Shock Wave|INTERPHALANGEAL THUMB JOINT|LATERAL|||FRIEND|3|Visit_3|40|3|TREATMENT|2020-06-16|40
e|FA|cad8c553-739f-4046-a898-d939eb286dba|7|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|vg/kg|[?]|1|cm H2O|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|CONTRALATERAL|||FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2020-07-11|65
e|FA|cad8c553-739f-4046-a898-d939eb286dba|8|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/g|[?]|1|cm H2O|ORAL CAVITY|CONTRALATERAL|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|SCREENING|2020-07-11|65
e|FA|cad8c553-739f-4046-a898-d939eb286dba|9|SEV|Severity/Intensity|[?]|GERD|[?]|APPLICATION|[?]|1|Pa|PANCREAS|BILATERAL|Y||CAREGIVER|5|Visit_5|90|5|TREATMENT|2020-08-05|90
e|FA|cad8c553-739f-4046-a898-d939eb286dba|10|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|10^6/Ejaculate U|[?]|1|mEq|SECOND RIGHT POSTEROLATERAL ARTERY|LATERAL|||VENDOR|5|Visit_5|90|2|WASHOUT|2020-08-05|90
e|FA|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|1|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ug/L FEU|[?]|1|%(v/v)|GANGLION|LEFT|||FRIEND|1|Visit_1|10|3|SCREENING|2020-09-11|10
e|FA|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|2|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|mm3/mm2/year|[?]|1|MBq|PORTACAVAL LYMPH NODE|CONTRALATERAL|||PARENT|1|Visit_1|10|1|SCREENING|2020-09-11|10
e|FA|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|3|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|Tesla|[?]|1|EIA unit|KIDNEY, UPPER LOBE|LATERAL|||CAREGIVER|2|Visit_2|25|4|WASHOUT|2020-09-26|25
e|FA|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|4|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|%|[?]|1|Bq/mg|REGIONAL LYMPH NODE|LEFT|Y|Y|INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2020-09-26|25
e|FA|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|5|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|mL/cage/wk|[?]|1|10^9 CFU/g|URETHRA, ANTERIOR|RIGHT|||INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-10-11|40
e|FA|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|6|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|mmol/s|[?]|1|g/cage/day|C1 VERTEBRA|LEFT||Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2020-10-11|40
e|FA|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|h/wk|[?]|1|mg/g/min|BRAIN, THIRD VENTRICLE|LEFT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-11-05|65
e|FA|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|8|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|MAC50|[?]|1|ug/m2/h|FACIAL NERVE|LATERAL|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2020-11-05|65
e|FA|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/min|[?]|1|mg/g/min|PROXIMAL LAD ARTERY|BILATERAL|||CHILD|5|Visit_5|90|1|SCREENING|2020-11-30|90
e|FA|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|10|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|vg/dose|[?]|1|mIU/L|FACIAL NERVE|BILATERAL|||ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-11-30|90
e|FA|81e934f8-7bcc-48d2-8d15-5270e51f2870|1|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|ug/kg/day|[?]|1|ohm|AXILLARY LYMPH NODE LEVEL III|LATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|5|WASHOUT|2021-01-24|10
e|FA|81e934f8-7bcc-48d2-8d15-5270e51f2870|2|SEV|Severity/Intensity|[?]|GERD|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|Pa|ANAL VERGE|BILATERAL|Y||INVESTIGATOR|1|Visit_1|10|7|FOLLOW-UP|2021-01-24|10
e|FA|81e934f8-7bcc-48d2-8d15-5270e51f2870|3|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|CIGARETTE|[?]|1|IU/mmol|EXTRAOCULAR MUSCLE|LATERAL|||PROXY|2|Visit_2|25|3|SCREENING|2021-02-08|25
e|FA|81e934f8-7bcc-48d2-8d15-5270e51f2870|4|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|mAnson U/mL|[?]|1|h*%|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|BILATERAL||Y|DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2021-02-08|25
e|FA|81e934f8-7bcc-48d2-8d15-5270e51f2870|5|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|mEq/mmol|[?]|1|uL/kg/day|DISTAL INTERPHALANGEAL JOINT 2|LEFT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2021-02-23|40
e|FA|81e934f8-7bcc-48d2-8d15-5270e51f2870|6|DFRUIT|Dietary Fruit|[?]|GERD|[?]|nmol/L|[?]|1|10^6 CFU/mL|BODY OF STOMACH|LATERAL|||ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2021-02-23|40
e|FA|81e934f8-7bcc-48d2-8d15-5270e51f2870|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|IU|[?]|1|mg/g/min|PANCREAS, TAIL|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-03-20|65
e|FA|81e934f8-7bcc-48d2-8d15-5270e51f2870|8|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|% INHIBITION|[?]|1|h*%|FIRST DIAGONAL BRANCH ARTERY|IPSILATERAL|||FRIEND|4|Visit_4|65|6|SCREENING|2021-03-20|65
e|FA|81e934f8-7bcc-48d2-8d15-5270e51f2870|9|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/g|[?]|1|10^9 CFU/g|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LATERAL|||SPOUSE|5|Visit_5|90|4|WASHOUT|2021-04-14|90
e|FA|81e934f8-7bcc-48d2-8d15-5270e51f2870|10|DISTANCE|Distance|[?]|GERD|[?]|POUCH|[?]|1|BOWL|MESENTERY|LATERAL|Y|Y|FAMILY MEMBER|5|Visit_5|90|5|WASHOUT|2021-04-14|90
e|FA|5713cabe-4d79-4f77-8ddc-daad1242a837|1|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|LENS|[?]|1|ug/m2/h|DISTAL LAD ARTERY|UNILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|WASHOUT|2020-09-09|10
e|FA|5713cabe-4d79-4f77-8ddc-daad1242a837|2|LENRSCT|Length of Resection|[?]|GERD|[?]|ug/g/min|[?]|1|psi|PRESACRAL SPACE|LEFT|||FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-09-09|10
e|FA|5713cabe-4d79-4f77-8ddc-daad1242a837|3|ACNDEV|Action Taken With Device|[?]|GERD|[?]|ng/mol|[?]|1|100 IU/mL|POPLITEAL VEIN|LATERAL|Y|Y|INDEPENDENT ASSESSOR|2|Visit_2|25|1|SCREENING|2020-09-24|25
e|FA|5713cabe-4d79-4f77-8ddc-daad1242a837|4|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|PACKET|[?]|1|cm|ANTERIOR CINGULATE GYRUS|RIGHT|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2020-09-24|25
e|FA|5713cabe-4d79-4f77-8ddc-daad1242a837|5|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|g/animal|[?]|1|g/L|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|LEFT|||ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-10-09|40
e|FA|5713cabe-4d79-4f77-8ddc-daad1242a837|6|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|genEq/mL|[?]|1|TRANSDUCING UNIT/mL|CARPOMETACARPAL JOINT|LATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|5|FOLLOW-UP|2020-10-09|40
e|FA|5713cabe-4d79-4f77-8ddc-daad1242a837|7|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|10^6/hpf|[?]|1|Shock Wave|LUNG, RIGHT|LATERAL|||SIBLING|4|Visit_4|65|1|TREATMENT|2020-11-03|65
e|FA|5713cabe-4d79-4f77-8ddc-daad1242a837|8|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|uCi|[?]|1|mL/h|HEART, RIGHT VENTRICULAR WALL|LATERAL||Y|VENDOR|4|Visit_4|65|2|TREATMENT|2020-11-03|65
e|FA|5713cabe-4d79-4f77-8ddc-daad1242a837|9|SEV|Severity/Intensity|[?]|GERD|[?]|nU/cL|[?]|1|Pa|5TH LUMBAR SPINOUS PROCESS|LEFT|||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2020-11-28|90
e|FA|5713cabe-4d79-4f77-8ddc-daad1242a837|10|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|log10 copies/mL|[?]|1|mIU/L|HEART, RIGHT ATRIUM|RIGHT|||PARENT|5|Visit_5|90|1|SCREENING|2020-11-28|90
e|FA|414d20c7-8dc8-49ad-8ae9-f113b9610109|1|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|10^8 PFU|[?]|1|NEEDLE GAUGE|NIPPLE|IPSILATERAL||Y|STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2020-07-10|10
e|FA|414d20c7-8dc8-49ad-8ae9-f113b9610109|2|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|mol/day|[?]|1|mL/animal/day|RIB 3|LATERAL|||FRIEND|1|Visit_1|10|7|TREATMENT|2020-07-10|10
e|FA|414d20c7-8dc8-49ad-8ae9-f113b9610109|3|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|um|[?]|1|10^6 organisms/mL|SHOULDER JOINT TENDONS|UNILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-07-25|25
e|FA|414d20c7-8dc8-49ad-8ae9-f113b9610109|4|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|umol|[?]|1|DROP|FALCIFORM LIGAMENT|IPSILATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-07-25|25
e|FA|414d20c7-8dc8-49ad-8ae9-f113b9610109|5|DIAMETER|Diameter|[?]|GERD|[?]|uL/kg/day|[?]|1|cm|T5 VERTEBRA|LATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|WASHOUT|2020-08-09|40
e|FA|414d20c7-8dc8-49ad-8ae9-f113b9610109|6|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|cmol/L|[?]|1|10^6 IU/mL|ANTERIOR INFERIOR CEREBELLAR ARTERY|UNILATERAL|||CAREGIVER|3|Visit_3|40|1|TREATMENT|2020-08-09|40
e|FA|414d20c7-8dc8-49ad-8ae9-f113b9610109|7|DGRAIN|Dietary Grain|[?]|GERD|[?]|VIRTUAL PIXEL|[?]|1|10^9 CFU/g|C6 VERTEBRA|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-09-03|65
e|FA|414d20c7-8dc8-49ad-8ae9-f113b9610109|8|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|mL/m2/h|[?]|1|MBq|HEART, LEFT ATRIAL APPENDAGE|IPSILATERAL|Y|Y|PROXY|4|Visit_4|65|7|FOLLOW-UP|2020-09-03|65
e|FA|414d20c7-8dc8-49ad-8ae9-f113b9610109|9|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|/min|[?]|1|BOWL|OBTURATOR INTERNUS MUSCLE|LEFT|Y|Y|GUARDIAN|5|Visit_5|90|5|WASHOUT|2020-09-28|90
e|FA|414d20c7-8dc8-49ad-8ae9-f113b9610109|10|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|cL|[?]|1|mL/dose|T7 VERTEBRA|LEFT||Y|CAREGIVER|5|Visit_5|90|1|TREATMENT|2020-09-28|90
e|FA|21e16094-23bd-4d20-b5f8-10d45858160e|1|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|s/h|[?]|1|umol|NUCLEUS OF DIAGONAL BAND|UNILATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|SCREENING|2020-09-17|10
e|FA|21e16094-23bd-4d20-b5f8-10d45858160e|2|OCCUR|Occurrence Indicator|[?]|GERD|[?]|genEq/mL|[?]|1|mg/g/min|CEREBRAL HEMISPHERE, LEFT|LEFT||Y|SIGNIFICANT OTHER|1|Visit_1|10|2|FOLLOW-UP|2020-09-17|10
e|FA|21e16094-23bd-4d20-b5f8-10d45858160e|3|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|mm/2h|[?]|1|SCOOPFUL|SCALP|UNILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|6|WASHOUT|2020-10-02|25
e|FA|21e16094-23bd-4d20-b5f8-10d45858160e|4|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|STRIP|[?]|1|mIU/L|COMMON FEMORAL VEIN|BILATERAL|||PARENT|2|Visit_2|25|4|SCREENING|2020-10-02|25
e|FA|21e16094-23bd-4d20-b5f8-10d45858160e|5|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|IU/mmol|[?]|1|mAmp|HEART, ATRIUM|CONTRALATERAL|||SPOUSE|3|Visit_3|40|6|FOLLOW-UP|2020-10-17|40
e|FA|21e16094-23bd-4d20-b5f8-10d45858160e|6|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|mEq/kg|[?]|1|Gy/h|PENIS|CONTRALATERAL|Y|Y|CHILD|3|Visit_3|40|7|TREATMENT|2020-10-17|40
e|FA|21e16094-23bd-4d20-b5f8-10d45858160e|7|EPSDNUM|Number of Episodes|[?]|GERD|[?]|/LSQN|[?]|1|%(v/v)|FAT PAD|BILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|1|TREATMENT|2020-11-11|65
e|FA|21e16094-23bd-4d20-b5f8-10d45858160e|8|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|pmol/L/h|[?]|1|aMFI|UTERUS|RIGHT|Y||INTERVIEWER|4|Visit_4|65|5|FOLLOW-UP|2020-11-11|65
e|FA|21e16094-23bd-4d20-b5f8-10d45858160e|9|DMEAT|Dietary Meat|[?]|GERD|[?]|g/animal/wk|[?]|1|10^6 organisms/mL|BUCCAL MUCOSA|LEFT|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|WASHOUT|2020-12-06|90
e|FA|21e16094-23bd-4d20-b5f8-10d45858160e|10|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|GPS U|[?]|1|10^9 CFU/mL|VERTEBRAL COLUMN|RIGHT||Y|INTERVIEWER|5|Visit_5|90|4|WASHOUT|2020-12-06|90
e|FA|2346613e-6734-476a-a414-511606c2d753|1|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|100 IU/mL|MIDDLE PHALANX 4 OF THE HAND|IPSILATERAL|Y||INVESTIGATOR|1|Visit_1|10|1|FOLLOW-UP|2020-09-22|10
e|FA|2346613e-6734-476a-a414-511606c2d753|2|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|10^3 CFU/mL|[?]|1|mg/dose|RAPHE|BILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|SCREENING|2020-09-22|10
e|FA|2346613e-6734-476a-a414-511606c2d753|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|GBq/ug|[?]|1|mg/g/min|CORPUS CALLOSUM|CONTRALATERAL|||SIBLING|2|Visit_2|25|7|SCREENING|2020-10-07|25
e|FA|2346613e-6734-476a-a414-511606c2d753|4|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|/4.0 mL|[?]|1|U/mg|PREAURICULAR LYMPH NODE|LEFT|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2020-10-07|25
e|FA|2346613e-6734-476a-a414-511606c2d753|5|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|pmol/10^10 cells|[?]|1|TRANSDUCING UNIT/mL|AXIAL SKELETON|BILATERAL|Y||SIBLING|3|Visit_3|40|4|TREATMENT|2020-10-22|40
e|FA|2346613e-6734-476a-a414-511606c2d753|6|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|/2000 RBC|[?]|1|mL/cm3/min|RETROAURICULAR LYMPH NODE|UNILATERAL|Y|Y|PARENT|3|Visit_3|40|4|TREATMENT|2020-10-22|40
e|FA|2346613e-6734-476a-a414-511606c2d753|7|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|v/v|[?]|1|mg/h|RIGHT POSTERIOR DESCENDING ARTERY|CONTRALATERAL|Y|Y|INTERVIEWER|4|Visit_4|65|6|SCREENING|2020-11-16|65
e|FA|2346613e-6734-476a-a414-511606c2d753|8|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|umol/mg/min|[?]|1|Gy/h|FOREARM|LEFT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-11-16|65
e|FA|2346613e-6734-476a-a414-511606c2d753|9|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|mOsm|[?]|1|mL/cm3/min|ILIAC CREST|LATERAL|Y||STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-12-11|90
e|FA|2346613e-6734-476a-a414-511606c2d753|10|ESTWT|Estimated Weight|[?]|GERD|[?]|Osm|[?]|1|g/day|VASTUS INTERMEDIUS MUSCLE|LEFT|Y||INTERVIEWER|5|Visit_5|90|7|TREATMENT|2020-12-11|90
e|FA|6a8bda83-1b5a-481e-af4f-77fe74bc37be|1|OBJTYPE|Type of Object|[?]|GERD|[?]|EID 50/dose|[?]|1|ng|INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL|||SPOUSE|1|Visit_1|10|6|WASHOUT|2020-11-26|10
e|FA|6a8bda83-1b5a-481e-af4f-77fe74bc37be|2|STRCTNUM|Number of Strictures|[?]|GERD|[?]|VIAL|[?]|1|SACHET|HIPPOCAMPUS|IPSILATERAL||Y|PROXY|1|Visit_1|10|5|WASHOUT|2020-11-26|10
e|FA|6a8bda83-1b5a-481e-af4f-77fe74bc37be|3|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|EID 50/dose|[?]|1|PFU/dose|LEG SKIN|RIGHT|||PARENT|2|Visit_2|25|1|TREATMENT|2020-12-11|25
e|FA|6a8bda83-1b5a-481e-af4f-77fe74bc37be|4|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|%/min|[?]|1|mg/h|SPLEEN, HILUM|CONTRALATERAL|||CAREGIVER|2|Visit_2|25|4|WASHOUT|2020-12-11|25
e|FA|6a8bda83-1b5a-481e-af4f-77fe74bc37be|5|SEV|Severity/Intensity|[?]|GERD|[?]|g/animal/wk|[?]|1|Pa|CAROTID ARTERY|LATERAL|||FRIEND|3|Visit_3|40|4|FOLLOW-UP|2020-12-26|40
e|FA|6a8bda83-1b5a-481e-af4f-77fe74bc37be|6|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|/month|[?]|1|AU/mL|PROSTATE GLAND, LATERAL LOBE|LEFT|||PROXY|3|Visit_3|40|2|TREATMENT|2020-12-26|40
e|FA|6a8bda83-1b5a-481e-af4f-77fe74bc37be|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|CIGARETTE|[?]|1|U/mg|T4 VERTEBRA|IPSILATERAL|||SIBLING|4|Visit_4|65|6|FOLLOW-UP|2021-01-20|65
e|FA|6a8bda83-1b5a-481e-af4f-77fe74bc37be|8|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|10^7 CFU|[?]|1|g/cage/day|JEJUNUM|LEFT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2021-01-20|65
e|FA|6a8bda83-1b5a-481e-af4f-77fe74bc37be|9|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|%(w/v)|[?]|1|mg/g/min|EPIDIDYMIS|LEFT||Y|FRIEND|5|Visit_5|90|1|FOLLOW-UP|2021-02-14|90
e|FA|6a8bda83-1b5a-481e-af4f-77fe74bc37be|10|SEV|Severity/Intensity|[?]|GERD|[?]|mPa|[?]|1|Pa|DISTAL PHALANX 5 OF THE HAND|CONTRALATERAL|||FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2021-02-14|90
e|FA|748ef401-3def-4674-8d5e-4a198709d672|1|LESNUM|Number of Lesions|[?]|GERD|[?]|10^9/g|[?]|1|ng/day|L6 VERTEBRA|LATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|3|WASHOUT|2020-06-08|10
e|FA|748ef401-3def-4674-8d5e-4a198709d672|2|STROKTYP|Stroke Type|[?]|GERD|[?]|nmol/L/h|[?]|1|g/L|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|BILATERAL|Y||STUDY SUBJECT|1|Visit_1|10|3|TREATMENT|2020-06-08|10
e|FA|748ef401-3def-4674-8d5e-4a198709d672|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ms2|[?]|1|Pa|URETHRA, PROSTATIC|BILATERAL|||FRIEND|2|Visit_2|25|7|SCREENING|2020-06-23|25
e|FA|748ef401-3def-4674-8d5e-4a198709d672|4|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/m2|[?]|1|cmH2O/mL|EAR, OUTER|UNILATERAL|||INTERVIEWER|2|Visit_2|25|5|FOLLOW-UP|2020-06-23|25
e|FA|748ef401-3def-4674-8d5e-4a198709d672|5|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|/h|[?]|1|cm|GINGIVAL MUCOSA|LEFT||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|WASHOUT|2020-07-08|40
e|FA|748ef401-3def-4674-8d5e-4a198709d672|6|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|cmol|[?]|1|BAG|LIP, UPPER|IPSILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-07-08|40
e|FA|748ef401-3def-4674-8d5e-4a198709d672|7|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|C|[?]|1|IU/mmol|TRANSVERSE TARSAL JOINT|RIGHT|Y||INVESTIGATOR|4|Visit_4|65|4|FOLLOW-UP|2020-08-02|65
e|FA|748ef401-3def-4674-8d5e-4a198709d672|8|DISTANCE|Distance|[?]|GERD|[?]|mL/animal/wk|[?]|1|BOWL|TENTORIUM CEREBELLI|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|WASHOUT|2020-08-02|65
e|FA|748ef401-3def-4674-8d5e-4a198709d672|9|SEV|Severity/Intensity|[?]|GERD|[?]|ELISA unit|[?]|1|Pa|FOOT DIGIT 4|BILATERAL|Y||ADJUDICATOR|5|Visit_5|90|4|WASHOUT|2020-08-27|90
e|FA|748ef401-3def-4674-8d5e-4a198709d672|10|CALBURN|Calories Burned|[?]|GERD|[?]|U/m2/day|[?]|1|/kg|MEDIAN OR LOWER CERVICAL LYMPH NODE|IPSILATERAL|||FRIEND|5|Visit_5|90|6|WASHOUT|2020-08-27|90
e|FA|03c399c1-77b9-4879-a6e8-42ba58ca68d4|1|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|Pa|[?]|1|ug/m2/h|SUPRAGLOTTIS|BILATERAL|||INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-07-15|10
e|FA|03c399c1-77b9-4879-a6e8-42ba58ca68d4|2|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|ng/mol|[?]|1|EIA unit|DELTOID MUSCLE|UNILATERAL|||PARENT|1|Visit_1|10|1|TREATMENT|2020-07-15|10
e|FA|03c399c1-77b9-4879-a6e8-42ba58ca68d4|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|min/day|[?]|1|%(v/v)|ANASTOMOSIS|UNILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-07-30|25
e|FA|03c399c1-77b9-4879-a6e8-42ba58ca68d4|4|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/mL|[?]|1|oz eq|KNEE JOINT|UNILATERAL|Y||CAREGIVER|2|Visit_2|25|3|FOLLOW-UP|2020-07-30|25
e|FA|03c399c1-77b9-4879-a6e8-42ba58ca68d4|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|CAPFUL|[?]|1|%(v/v)|MAIN BRONCHUS, RIGHT|RIGHT|||CAREGIVER|3|Visit_3|40|4|FOLLOW-UP|2020-08-14|40
e|FA|03c399c1-77b9-4879-a6e8-42ba58ca68d4|6|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|log10 PFU|[?]|1|U/mg|OBTURATOR MUSCLE|RIGHT|Y||INVESTIGATOR|3|Visit_3|40|5|FOLLOW-UP|2020-08-14|40
e|FA|03c399c1-77b9-4879-a6e8-42ba58ca68d4|7|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|log10 IU/mL|[?]|1|DROP|CANINE TOOTH|IPSILATERAL|||SIBLING|4|Visit_4|65|6|TREATMENT|2020-09-08|65
e|FA|03c399c1-77b9-4879-a6e8-42ba58ca68d4|8|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|ng/mol|[?]|1|AU/mL|INTERPHALANGEAL JOINT 2 OF THE HAND|UNILATERAL|||GUARDIAN|4|Visit_4|65|3|WASHOUT|2020-09-08|65
e|FA|03c399c1-77b9-4879-a6e8-42ba58ca68d4|9|SEV|Severity/Intensity|[?]|GERD|[?]|mg/min|[?]|1|Pa|LATERAL FIRST DIAGONAL BRANCH ARTERY|IPSILATERAL|Y||INVESTIGATOR|5|Visit_5|90|7|FOLLOW-UP|2020-10-03|90
e|FA|03c399c1-77b9-4879-a6e8-42ba58ca68d4|10|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|10^4 CFU/mL|[?]|1|NEEDLE GAUGE|SUPERIOR VENA CAVA|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2020-10-03|90
e|FA|b8afdaf1-5c4d-408f-b8ba-381461f15bde|1|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|KIT|[?]|1|10^9 CFU/mL|ISCHIORECTAL FOSSA|LEFT|||ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-11-13|10
e|FA|b8afdaf1-5c4d-408f-b8ba-381461f15bde|2|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|mol/g|[?]|1|mg/dose|GASTROINTESTINAL SYSTEM|UNILATERAL|Y||FRIEND|1|Visit_1|10|5|TREATMENT|2020-11-13|10
e|FA|b8afdaf1-5c4d-408f-b8ba-381461f15bde|3|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|m|[?]|1|IU/mmol|SEBACEOUS GLAND|RIGHT||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-11-28|25
e|FA|b8afdaf1-5c4d-408f-b8ba-381461f15bde|4|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|mL/h|[?]|1|mL/cm3/min|GLOSSOPHARYNGEAL NERVE|LEFT||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-11-28|25
e|FA|b8afdaf1-5c4d-408f-b8ba-381461f15bde|5|SERVNUM|Number of Servings|[?]|GERD|[?]|/10^4|[?]|1|Hz/s|T1 VERTEBRA|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|FOLLOW-UP|2020-12-13|40
e|FA|b8afdaf1-5c4d-408f-b8ba-381461f15bde|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|umol/dL|[?]|1|mg/g/min|ABDOMINAL WALL|LATERAL|Y||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|SCREENING|2020-12-13|40
e|FA|b8afdaf1-5c4d-408f-b8ba-381461f15bde|7|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|mL/mmHg/min/L|VULVA|LATERAL|Y||GUARDIAN|4|Visit_4|65|1|WASHOUT|2021-01-07|65
e|FA|b8afdaf1-5c4d-408f-b8ba-381461f15bde|8|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|L/s/kPa|[?]|1|cmH2O/mL|ORBICULARIS OCULI MUSCLE|UNILATERAL|Y||PROXY|4|Visit_4|65|5|SCREENING|2021-01-07|65
e|FA|b8afdaf1-5c4d-408f-b8ba-381461f15bde|9|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|ugEq/L|[?]|1|10^6 U|HAND DIGIT 2|UNILATERAL||Y|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|SCREENING|2021-02-01|90
e|FA|b8afdaf1-5c4d-408f-b8ba-381461f15bde|10|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|DNA copies/mL|[?]|1|U/mmol|ENDOMETRIAL CAVITY|BILATERAL|||CHILD|5|Visit_5|90|4|SCREENING|2021-02-01|90
e|FA|8115d6e8-0908-4491-a82a-08f43ccf1f0d|1|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|usec|[?]|1|mm/h|SPLENIC HILAR LYMPH NODE|RIGHT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|SCREENING|2020-11-28|10
e|FA|8115d6e8-0908-4491-a82a-08f43ccf1f0d|2|SEV|Severity/Intensity|[?]|GERD|[?]|Ci/mg|[?]|1|Pa|URACHAL TRACT|IPSILATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-11-28|10
e|FA|8115d6e8-0908-4491-a82a-08f43ccf1f0d|3|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|nU/cL|[?]|1|mL/h|FEMORAL LYMPH NODE|LATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|WASHOUT|2020-12-13|25
e|FA|8115d6e8-0908-4491-a82a-08f43ccf1f0d|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|U/kg|[?]|1|PFU/dose|TEMPORAL ARTERY|RIGHT|Y|Y|FAMILY MEMBER|2|Visit_2|25|4|TREATMENT|2020-12-13|25
e|FA|8115d6e8-0908-4491-a82a-08f43ccf1f0d|5|LOCONSET|Localization of Onset|[?]|GERD|[?]|m|[?]|1|g/L|ABDUCENS NERVE|LEFT|||FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-12-28|40
e|FA|8115d6e8-0908-4491-a82a-08f43ccf1f0d|6|SEV|Severity/Intensity|[?]|GERD|[?]|mol|[?]|1|Pa|NASOPHARYNX|LATERAL|Y||FRIEND|3|Visit_3|40|4|TREATMENT|2020-12-28|40
e|FA|8115d6e8-0908-4491-a82a-08f43ccf1f0d|7|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|uSiemens|[?]|1|mL/cm3/min|INTERPHALANGEAL JOINT 2 OF THE FOOT|RIGHT|||INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2021-01-22|65
e|FA|8115d6e8-0908-4491-a82a-08f43ccf1f0d|8|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|mV2/Hz|[?]|1|g/dL|GASTRIC CURVATURE LYMPH NODE|UNILATERAL|Y||FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2021-01-22|65
e|FA|8115d6e8-0908-4491-a82a-08f43ccf1f0d|9|SEV|Severity/Intensity|[?]|GERD|[?]|/10^5|[?]|1|Pa|INTERPHALANGEAL JOINT 2 OF THE FOOT|LEFT|||SIBLING|5|Visit_5|90|1|TREATMENT|2021-02-16|90
e|FA|8115d6e8-0908-4491-a82a-08f43ccf1f0d|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Tesla|[?]|1|mg/g/min|CEREBRUM|LEFT|Y||FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-02-16|90
e|FA|fbd7ecb2-905f-40a9-babc-ebaf310cc372|1|EPSDNUM|Number of Episodes|[?]|GERD|[?]|Linear ft*LB|[?]|1|%(v/v)|TRACHEOBRONCHIAL TREE|LATERAL|||VENDOR|1|Visit_1|10|3|WASHOUT|2020-06-30|10
e|FA|fbd7ecb2-905f-40a9-babc-ebaf310cc372|2|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|gMFI|[?]|1|vp/dose|FACE|LATERAL||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-06-30|10
e|FA|fbd7ecb2-905f-40a9-babc-ebaf310cc372|3|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|EID 50/dose|[?]|1|IU/mmol|APPENDICEAL TIP|CONTRALATERAL|||ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-07-15|25
e|FA|fbd7ecb2-905f-40a9-babc-ebaf310cc372|4|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|Newton|[?]|1|g/cage/day|TOOTH CANAL|BILATERAL|Y|Y|GUARDIAN|2|Visit_2|25|4|WASHOUT|2020-07-15|25
e|FA|fbd7ecb2-905f-40a9-babc-ebaf310cc372|5|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|mL/mmHg|[?]|1|MPS U|OVARY|UNILATERAL|||SIBLING|3|Visit_3|40|7|WASHOUT|2020-07-30|40
e|FA|fbd7ecb2-905f-40a9-babc-ebaf310cc372|6|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|PFU|[?]|1|Bq/L|FAT PAD|RIGHT|Y||PARENT|3|Visit_3|40|2|WASHOUT|2020-07-30|40
e|FA|fbd7ecb2-905f-40a9-babc-ebaf310cc372|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mmol/g|[?]|1|mg/g/min|PELVIC LYMPH NODE|BILATERAL|Y|Y|STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2020-08-24|65
e|FA|fbd7ecb2-905f-40a9-babc-ebaf310cc372|8|LESNUM|Number of Lesions|[?]|GERD|[?]|mL/m2/day|[?]|1|ng/day|INTERNAL MAMMARY ARTERY|RIGHT|||FAMILY MEMBER|4|Visit_4|65|5|FOLLOW-UP|2020-08-24|65
e|FA|fbd7ecb2-905f-40a9-babc-ebaf310cc372|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|MPS U|[?]|1|mg/g/min|CEREBRAL VEIN|CONTRALATERAL||Y|ADJUDICATION COMMITTEE|5|Visit_5|90|7|FOLLOW-UP|2020-09-18|90
e|FA|fbd7ecb2-905f-40a9-babc-ebaf310cc372|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|10^6 CFU/mL|[?]|1|%(v/v)|PROXIMAL INTERPHALANGEAL JOINT 3|RIGHT|||DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2020-09-18|90
e|FA|1a0e1a66-82dd-4945-9c9f-179fba9d781e|1|LENRSCT|Length of Resection|[?]|GERD|[?]|nmol BCE/L|[?]|1|psi|ARM|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2020-12-09|10
e|FA|1a0e1a66-82dd-4945-9c9f-179fba9d781e|2|QOLIMP|QOL Impact|[?]|GERD|[?]|mL/beat|[?]|1|10^6/L|ILIAC FOSSA|CONTRALATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|SCREENING|2020-12-09|10
e|FA|1a0e1a66-82dd-4945-9c9f-179fba9d781e|3|SEV|Severity/Intensity|[?]|GERD|[?]|Pa|[?]|1|Pa|DISTAL PHALANX 5 OF THE HAND|LATERAL|||CAREGIVER|2|Visit_2|25|1|TREATMENT|2020-12-24|25
e|FA|1a0e1a66-82dd-4945-9c9f-179fba9d781e|4|DFRUIT|Dietary Fruit|[?]|GERD|[?]|g/dL|[?]|1|10^6 CFU/mL|APPENDICEAL TIP|UNILATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|1|TREATMENT|2020-12-24|25
e|FA|1a0e1a66-82dd-4945-9c9f-179fba9d781e|5|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|10^6 RNA copies/mL|[?]|1|L/h/m2|ESOPHAGUS, LOWER THIRD|LATERAL|Y||PARENT|3|Visit_3|40|6|FOLLOW-UP|2021-01-08|40
e|FA|1a0e1a66-82dd-4945-9c9f-179fba9d781e|6|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|PATCH|[?]|1|10^9 CFU/mL|PATELLA|RIGHT|Y||GUARDIAN|3|Visit_3|40|2|SCREENING|2021-01-08|40
e|FA|1a0e1a66-82dd-4945-9c9f-179fba9d781e|7|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|fmol/L/sec|[?]|1|oz eq|MESENTERIC LYMPH NODE|LEFT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2021-02-02|65
e|FA|1a0e1a66-82dd-4945-9c9f-179fba9d781e|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Bq/mL|[?]|1|%(v/v)|FAT PAD|RIGHT|Y||CHILD|4|Visit_4|65|6|FOLLOW-UP|2021-02-02|65
e|FA|1a0e1a66-82dd-4945-9c9f-179fba9d781e|9|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/L|[?]|1|SACHET|CARPOMETACARPAL JOINT 4|RIGHT|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|TREATMENT|2021-02-27|90
e|FA|1a0e1a66-82dd-4945-9c9f-179fba9d781e|10|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|ug/mL/h|[?]|1|10^4 CFU/mL|PANCREAS, TAIL|UNILATERAL||Y|CHILD|5|Visit_5|90|4|WASHOUT|2021-02-27|90
e|FA|b3ab1879-3dc7-41fa-be53-f4484af21fbd|1|DMEAT|Dietary Meat|[?]|GERD|[?]|IU/mL|[?]|1|10^6 organisms/mL|FEMORAL CONDYLE|RIGHT|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|SCREENING|2020-11-19|10
e|FA|b3ab1879-3dc7-41fa-be53-f4484af21fbd|2|SYMPINDC|Symptom Indicator|[?]|GERD|[?]|min*mg/mL|[?]|1|g/dL|RENAL PELVIS|LEFT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-11-19|10
e|FA|b3ab1879-3dc7-41fa-be53-f4484af21fbd|3|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|Farad|[?]|1|vp/dose|FLEXOR POLLICIS LONGUS MUSCLE|RIGHT|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-12-04|25
e|FA|b3ab1879-3dc7-41fa-be53-f4484af21fbd|4|EVENTFRQ|Event Frequency|[?]|GERD|[?]|Linear ft*LB|[?]|1|ug/kg/h|METATARSOPHALANGEAL JOINT 2|LEFT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|FOLLOW-UP|2020-12-04|25
e|FA|b3ab1879-3dc7-41fa-be53-f4484af21fbd|5|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|log10 PFU/mL|[?]|1|g/day|MAMMARY GLAND|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-12-19|40
e|FA|b3ab1879-3dc7-41fa-be53-f4484af21fbd|6|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|PATCH|[?]|1|EIA unit|PERIHILAR LYMPH NODE|BILATERAL|||GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-12-19|40
e|FA|b3ab1879-3dc7-41fa-be53-f4484af21fbd|7|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|km|[?]|1|mAmp|RIB 3|UNILATERAL|Y||INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2021-01-13|65
e|FA|b3ab1879-3dc7-41fa-be53-f4484af21fbd|8|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|Gy|[?]|1|fmol|HAMATE BONE|LEFT|||ADJUDICATOR|4|Visit_4|65|7|SCREENING|2021-01-13|65
e|FA|b3ab1879-3dc7-41fa-be53-f4484af21fbd|9|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|%(w/w)|[?]|1|Log10 ELISA unit|PUPIL|BILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2021-02-07|90
e|FA|b3ab1879-3dc7-41fa-be53-f4484af21fbd|10|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/mL|[?]|1|CUP|INTERPHALANGEAL JOINT 4 OF THE FOOT|BILATERAL|Y||VENDOR|5|Visit_5|90|6|TREATMENT|2021-02-07|90
e|FA|bc71ddfa-c71c-447b-9684-005e4c112172|1|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|CAPSULE|[?]|1|10^9 CFU/g|OBTURATOR MUSCLE|CONTRALATERAL|Y||CAREGIVER|1|Visit_1|10|2|TREATMENT|2020-07-11|10
e|FA|bc71ddfa-c71c-447b-9684-005e4c112172|2|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms|[?]|1|EIA unit|PORTACAVAL LYMPH NODE|LATERAL||Y|SPOUSE|1|Visit_1|10|3|WASHOUT|2020-07-11|10
e|FA|bc71ddfa-c71c-447b-9684-005e4c112172|3|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mV/sec|[?]|1|ug/kg/h|ILIAC VEIN|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|7|WASHOUT|2020-07-26|25
e|FA|bc71ddfa-c71c-447b-9684-005e4c112172|4|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|Weber|BRACHIAL PLEXUS|BILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-07-26|25
e|FA|bc71ddfa-c71c-447b-9684-005e4c112172|5|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|keV|[?]|1|fmol|RETROAURICULAR LYMPH NODE|IPSILATERAL|||FRIEND|3|Visit_3|40|3|TREATMENT|2020-08-10|40
e|FA|bc71ddfa-c71c-447b-9684-005e4c112172|6|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|dmol|[?]|1|Bq/L|METACARPAL BONE 2|UNILATERAL|||STUDY SUBJECT|3|Visit_3|40|2|FOLLOW-UP|2020-08-10|40
e|FA|bc71ddfa-c71c-447b-9684-005e4c112172|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|TUBE|[?]|1|umol|T11 VERTEBRA|IPSILATERAL|Y||GUARDIAN|4|Visit_4|65|1|WASHOUT|2020-09-04|65
e|FA|bc71ddfa-c71c-447b-9684-005e4c112172|8|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|Antibody Unit|[?]|1|BAG|HEAD|LATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-09-04|65
e|FA|bc71ddfa-c71c-447b-9684-005e4c112172|9|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|foz_us|[?]|1|AU/mL|FOREHEAD|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-09-29|90
e|FA|bc71ddfa-c71c-447b-9684-005e4c112172|10|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|mL/cm3/min|[?]|1|SACHET|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|RIGHT|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-09-29|90
e|FA|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|1|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|cmol/L|[?]|1|U/mg|SUBSTANTIA NIGRA|IPSILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|6|SCREENING|2020-12-09|10
e|FA|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|2|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|mmHg/L/min|[?]|1|DROP|RETROPERITONEAL LYMPH NODE|UNILATERAL|||GUARDIAN|1|Visit_1|10|5|SCREENING|2020-12-09|10
e|FA|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|3|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|kg/L|[?]|1|AU/mL|KIDNEY, UPPER LOBE|BILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-12-24|25
e|FA|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|fg|[?]|1|QUANTITY SUFFICIENT|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|CONTRALATERAL|||SIBLING|2|Visit_2|25|4|TREATMENT|2020-12-24|25
e|FA|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|5|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|mg/L|[?]|1|HOURS|LUNG, LEFT|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|2|WASHOUT|2021-01-08|40
e|FA|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|6|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|U/m2/h|[?]|1|h*%|BREAST|CONTRALATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2021-01-08|40
e|FA|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|7|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|CCID 50/dose|[?]|1|mL/m2|SENSORIMOTOR CORTEX|IPSILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|5|SCREENING|2021-02-02|65
e|FA|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|8|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|cpm|[?]|1|km|LOWER JUGULAR LYMPH NODE|CONTRALATERAL|||DOMESTIC PARTNER|4|Visit_4|65|7|SCREENING|2021-02-02|65
e|FA|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|nmol/L/min|[?]|1|%(v/v)|PYLORIC SPHINCTER|CONTRALATERAL||Y|GUARDIAN|5|Visit_5|90|7|SCREENING|2021-02-27|90
e|FA|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|10|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|g/animal|[?]|1|anti-Xa IU/mL|5TH LUMBAR SPINOUS PROCESS|RIGHT||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|SCREENING|2021-02-27|90
e|FA|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|1|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Osm|[?]|1|umol|ILIOPSOAS MUSCLE|IPSILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|WASHOUT|2020-09-06|10
e|FA|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|2|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|APS U|[?]|1|m2|RIB 3|UNILATERAL|Y||PROXY|1|Visit_1|10|4|TREATMENT|2020-09-06|10
e|FA|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|3|TPDEPIND|Unable to Taper Dependent Indicator|[?]|GERD|[?]|grain|[?]|1|in|MEDIASTINUM, MIDDLE|RIGHT|||CAREGIVER|2|Visit_2|25|6|TREATMENT|2020-09-21|25
e|FA|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|4|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|C|[?]|1|h*%|GLENOID FOSSA|CONTRALATERAL|||CHILD|2|Visit_2|25|3|WASHOUT|2020-09-21|25
e|FA|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|5|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|km/h|[?]|1|mL/cm3/min|CORONARY ARTERY|UNILATERAL|Y|Y|CHILD|3|Visit_3|40|2|WASHOUT|2020-10-06|40
e|FA|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|6|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|ukat/10^12 RBC|[?]|1|mL/animal/day|CHEST|UNILATERAL||Y|SIBLING|3|Visit_3|40|1|SCREENING|2020-10-06|40
e|FA|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|mg/g/min|NASAL CAVITY|LATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|3|WASHOUT|2020-10-31|65
e|FA|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|8|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|mJoule/cm2|[?]|1|NEEDLE GAUGE|VULVA|LATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2020-10-31|65
e|FA|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|9|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|BISCUIT|[?]|1|TRANSDUCING UNIT/mL|LEG|UNILATERAL|Y||PROXY|5|Visit_5|90|6|TREATMENT|2020-11-25|90
e|FA|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|10|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|Pa|[?]|1|mEq|PROXIMAL PHALANX 2 OF THE HAND|RIGHT||Y|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2020-11-25|90
e|FA|b1b3e113-8c73-4446-8095-3341f8912bd7|1|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|/100 WBC|[?]|1|Log10 ELISA unit|GASTROINTESTINAL TRACT, UPPER|UNILATERAL|||PROXY|1|Visit_1|10|3|WASHOUT|2021-01-27|10
e|FA|b1b3e113-8c73-4446-8095-3341f8912bd7|2|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|s^-1(%O2)^-1|[?]|1|QUANTITY SUFFICIENT|UPPER URINARY SYSTEM|LATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2021-01-27|10
e|FA|b1b3e113-8c73-4446-8095-3341f8912bd7|3|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|/kg|[?]|1|g/day|CHOROID PLEXUS|IPSILATERAL|Y||INVESTIGATOR|2|Visit_2|25|5|FOLLOW-UP|2021-02-11|25
e|FA|b1b3e113-8c73-4446-8095-3341f8912bd7|4|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|mL/g/day|[?]|1|TRANSDUCING UNIT/mL|LATISSIMUS DORSI MUSCLE|IPSILATERAL|Y|Y|CAREGIVER|2|Visit_2|25|6|SCREENING|2021-02-11|25
e|FA|b1b3e113-8c73-4446-8095-3341f8912bd7|5|EXTRSCT|Extent of Resection|[?]|GERD|[?]|HOURS|[?]|1|Weber|SHOULDER JOINT|LATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|FOLLOW-UP|2021-02-26|40
e|FA|b1b3e113-8c73-4446-8095-3341f8912bd7|6|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|ukat|[?]|1|Coulomb|PHARYNX|LATERAL|||FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2021-02-26|40
e|FA|b1b3e113-8c73-4446-8095-3341f8912bd7|7|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa|[?]|1|HOURS|T11 VERTEBRA|LATERAL|||FAMILY MEMBER|4|Visit_4|65|5|TREATMENT|2021-03-23|65
e|FA|b1b3e113-8c73-4446-8095-3341f8912bd7|8|LESNUM|Number of Lesions|[?]|GERD|[?]|mL/100g/min|[?]|1|ng/day|HEART, RIGHT ATRIUM|UNILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|3|TREATMENT|2021-03-23|65
e|FA|b1b3e113-8c73-4446-8095-3341f8912bd7|9|DCAL|Dietary Calories|[?]|GERD|[?]|BAU|[?]|1|EIA unit|THORACIC LYMPH NODE|RIGHT|||FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2021-04-17|90
e|FA|b1b3e113-8c73-4446-8095-3341f8912bd7|10|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|Coulomb|[?]|1|ohm|ATRIOVENTRICULAR VALVE|IPSILATERAL|Y||SIBLING|5|Visit_5|90|6|SCREENING|2021-04-17|90
e|FA|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|1|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|g/U|[?]|1|ug/g/h|SUBCLAVIAN ARTERY|LEFT|Y||FRIEND|1|Visit_1|10|7|WASHOUT|2020-11-22|10
e|FA|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|2|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|mL|[?]|1|uL/kg/day|ULNAR ARTERY|LATERAL||Y|VENDOR|1|Visit_1|10|1|WASHOUT|2020-11-22|10
e|FA|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|3|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|MBq|[?]|1|/500 WBC|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|BILATERAL|||SPOUSE|2|Visit_2|25|2|TREATMENT|2020-12-07|25
e|FA|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|4|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|PRE-SPECIFIED AE|[?]|PACKET|[?]|1|ug/g/h|SKIN OF THE BENDING JOINT|CONTRALATERAL|||PARENT|2|Visit_2|25|7|WASHOUT|2020-12-07|25
e|FA|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Ci/g|[?]|1|Pa|HAMSTRING MUSCLE|RIGHT||Y|STUDY SUBJECT|3|Visit_3|40|1|TREATMENT|2020-12-22|40
e|FA|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|6|DFIBER|Dietary Fiber|[?]|GERD|[?]|Tesla|[?]|1|h*%|ESOPHAGUS, MIDDLE THIRD|LATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-12-22|40
e|FA|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|7|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|Henry|[?]|1|fmol|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|IPSILATERAL|Y|Y|INVESTIGATOR|4|Visit_4|65|7|WASHOUT|2021-01-16|65
e|FA|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|8|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|uV|[?]|1|Weber|PITUITARY GLAND|RIGHT|||PROXY|4|Visit_4|65|6|TREATMENT|2021-01-16|65
e|FA|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Enzyme U|[?]|1|Pa|FALLOPIAN TUBE|LATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|6|FOLLOW-UP|2021-02-10|90
e|FA|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|10|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|nmol/L/h|[?]|1|ug/kg/h|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|IPSILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|FOLLOW-UP|2021-02-10|90
e|FA|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|um2|[?]|1|Pa|WRIST JOINT EXTENSOR TENDONS|CONTRALATERAL|||PROXY|1|Visit_1|10|4|WASHOUT|2020-08-06|10
e|FA|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|2|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|um|[?]|1|mL/animal/day|PISIFORM BONE|CONTRALATERAL|||CHILD|1|Visit_1|10|3|SCREENING|2020-08-06|10
e|FA|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Roentgen|[?]|1|Pa|ILIOTIBIAL BAND|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2020-08-21|25
e|FA|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|4|EXCDUR|Exercise Duration|[?]|GERD|[?]|hPa|[?]|1|mm|HEART, BASE|BILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-08-21|25
e|FA|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|5|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms|[?]|1|mL/cm3/min|SKIN OF THE BUTTOCK|RIGHT||Y|VENDOR|3|Visit_3|40|4|FOLLOW-UP|2020-09-05|40
e|FA|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|6|SEV|Severity/Intensity|[?]|GERD|[?]|SFC/10^6 PBMC|[?]|1|Pa|CEREBELLUM|BILATERAL|||PARENT|3|Visit_3|40|2|SCREENING|2020-09-05|40
e|FA|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|7|LDIAM|Longest Diameter|[?]|GERD|[?]|Hz|[?]|1|Shock Wave|FINGER EXTENSOR MUSCLES|RIGHT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|7|WASHOUT|2020-09-30|65
e|FA|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|DISK|[?]|1|mg/g/min|LOWER GASTROINTESTINAL TRACT LYMPH NODE|UNILATERAL|Y||FRIEND|4|Visit_4|65|6|WASHOUT|2020-09-30|65
e|FA|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mg/L|[?]|1|mg/g/min|T2 VERTEBRA|RIGHT|||PARENT|5|Visit_5|90|4|SCREENING|2020-10-25|90
e|FA|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|10|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|mg/dL|[?]|1|IU/mg|DISTAL RADIOULNAR JOINT|RIGHT|||SIBLING|5|Visit_5|90|4|SCREENING|2020-10-25|90
e|FA|3b83c7a0-e22b-45b1-b065-71971f014039|1|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|/mm2|[?]|1|mAmp|PLEURAL CAVITY|CONTRALATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|WASHOUT|2020-09-01|10
e|FA|3b83c7a0-e22b-45b1-b065-71971f014039|2|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|mmol/kg|[?]|1|umol|AXILLARY LYMPH NODE LEVEL II|LATERAL||Y|SIBLING|1|Visit_1|10|3|WASHOUT|2020-09-01|10
e|FA|3b83c7a0-e22b-45b1-b065-71971f014039|3|TOTNUM|Total Number|[?]|GERD|[?]|g/g/day|[?]|1|/200 HPFs|EPIDURAL SPACE|BILATERAL|||CHILD|2|Visit_2|25|1|SCREENING|2020-09-16|25
e|FA|3b83c7a0-e22b-45b1-b065-71971f014039|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|JDF Unit|[?]|1|mg/g/min|PELVIS|UNILATERAL|Y||VENDOR|2|Visit_2|25|6|WASHOUT|2020-09-16|25
e|FA|3b83c7a0-e22b-45b1-b065-71971f014039|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|psec|[?]|1|mg/g/min|SACRUM|LEFT|Y||DOMESTIC PARTNER|3|Visit_3|40|4|WASHOUT|2020-10-01|40
e|FA|3b83c7a0-e22b-45b1-b065-71971f014039|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|kg/m2|[?]|1|mg/g/min|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-10-01|40
e|FA|3b83c7a0-e22b-45b1-b065-71971f014039|7|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|hr/day|[?]|1|mL/cm3/min|OLFACTORY BULB|IPSILATERAL|||CAREGIVER|4|Visit_4|65|4|TREATMENT|2020-10-26|65
e|FA|3b83c7a0-e22b-45b1-b065-71971f014039|8|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mU/L|[?]|1|cm H2O|CLAW|BILATERAL|Y|Y|FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2020-10-26|65
e|FA|3b83c7a0-e22b-45b1-b065-71971f014039|9|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|kg|[?]|1|NEEDLE GAUGE|UPPER CERVICAL LYMPH NODE|LATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2020-11-20|90
e|FA|3b83c7a0-e22b-45b1-b065-71971f014039|10|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|mL/beat|[?]|1|mL/cm3/min|INTERPHALANGEAL JOINT 3|UNILATERAL|||GUARDIAN|5|Visit_5|90|3|TREATMENT|2020-11-20|90
e|FA|92c849ce-12b8-4c38-baab-f91c44a007b9|1|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|ELISA unit/mL|[?]|1|U/mg|TRICUSPID VALVE|IPSILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|SCREENING|2020-11-12|10
e|FA|92c849ce-12b8-4c38-baab-f91c44a007b9|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|10^8/L|[?]|1|g/day|CERVIX UTERI|IPSILATERAL|Y||PARENT|1|Visit_1|10|7|WASHOUT|2020-11-12|10
e|FA|92c849ce-12b8-4c38-baab-f91c44a007b9|3|OBJNUM|Number of Objects|[?]|GERD|[?]|SCOOPFUL|[?]|1|mL/100g/min|TONGUE|LATERAL|Y||SPOUSE|2|Visit_2|25|4|WASHOUT|2020-11-27|25
e|FA|92c849ce-12b8-4c38-baab-f91c44a007b9|4|DMEAT|Dietary Meat|[?]|GERD|[?]|atm|[?]|1|10^6 organisms/mL|UTERUS|LATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2020-11-27|25
e|FA|92c849ce-12b8-4c38-baab-f91c44a007b9|5|TOXGR|Toxicity Grade|[?]|GERD|[?]|Gy/min|[?]|1|aMFI|PANCREAS, ENDOCRINE|UNILATERAL||Y|INVESTIGATOR|3|Visit_3|40|2|TREATMENT|2020-12-12|40
e|FA|92c849ce-12b8-4c38-baab-f91c44a007b9|6|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|IU/mmol|[?]|1|BOWL|WALDEYER'S TONSILLAR RING|BILATERAL|||PARENT|3|Visit_3|40|4|TREATMENT|2020-12-12|40
e|FA|92c849ce-12b8-4c38-baab-f91c44a007b9|7|LDIAM|Longest Diameter|[?]|GERD|[?]|nmol/mol|[?]|1|Shock Wave|PROXIMAL INTERPHALANGEAL JOINT 5|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|WASHOUT|2021-01-06|65
e|FA|92c849ce-12b8-4c38-baab-f91c44a007b9|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|vg/kg|[?]|1|PFU/dose|ILIAC LYMPH NODE|UNILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|7|TREATMENT|2021-01-06|65
e|FA|92c849ce-12b8-4c38-baab-f91c44a007b9|9|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|mJoule/cm2|[?]|1|Ci/ug|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|BILATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-01-31|90
e|FA|92c849ce-12b8-4c38-baab-f91c44a007b9|10|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|mV2/Hz|[?]|1|ng/day|SEMINAL VESICLE|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-01-31|90
e|FA|f2101018-c983-435e-a453-148f182388f7|1|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|IU/mL|[?]|1|MPS U|UTERUS|LEFT|||SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-09-01|10
e|FA|f2101018-c983-435e-a453-148f182388f7|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|mg/g/min|T9 VERTEBRA|UNILATERAL|Y||PARENT|1|Visit_1|10|6|WASHOUT|2020-09-01|10
e|FA|f2101018-c983-435e-a453-148f182388f7|3|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|Osm|[?]|1|10^6/L|PECTORALIS MAJOR MUSCLE|UNILATERAL||Y|CHILD|2|Visit_2|25|4|TREATMENT|2020-09-16|25
e|FA|f2101018-c983-435e-a453-148f182388f7|4|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|uIU/L|[?]|1|QUANTITY SUFFICIENT|DISTAL EXTRAHEPATIC BILE DUCT REGION|UNILATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|WASHOUT|2020-09-16|25
e|FA|f2101018-c983-435e-a453-148f182388f7|5|DFATT|Dietary Fat, Total|[?]|GERD|[?]|10^6 DNA copies/mL|[?]|1|Bq/mg|NERVE|IPSILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|SCREENING|2020-10-01|40
e|FA|f2101018-c983-435e-a453-148f182388f7|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|Pa|CEREBRAL HEMISPHERE, RIGHT|CONTRALATERAL|Y||INTERVIEWER|3|Visit_3|40|4|TREATMENT|2020-10-01|40
e|FA|f2101018-c983-435e-a453-148f182388f7|7|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|Osm|[?]|1|h*%|EYE, ANTERIOR SEGMENT|UNILATERAL|Y||ADJUDICATOR|4|Visit_4|65|5|SCREENING|2020-10-26|65
e|FA|f2101018-c983-435e-a453-148f182388f7|8|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|lx|[?]|1|NEEDLE GAUGE|GLOTTIS|UNILATERAL|Y|Y|DOMESTIC PARTNER|4|Visit_4|65|6|SCREENING|2020-10-26|65
e|FA|f2101018-c983-435e-a453-148f182388f7|9|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|ppth|[?]|1|mL/h|PENIS|UNILATERAL|Y||STUDY SUBJECT|5|Visit_5|90|4|TREATMENT|2020-11-20|90
e|FA|f2101018-c983-435e-a453-148f182388f7|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|mV2/Hz|[?]|1|QUANTITY SUFFICIENT|HYPOPHARYNX|UNILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2020-11-20|90
e|FA|613284eb-edbe-446b-b4fe-f96f1510e626|1|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|ug/L DDU|[?]|1|DROP|QUADRICEPS MUSCLE|RIGHT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|WASHOUT|2020-11-07|10
e|FA|613284eb-edbe-446b-b4fe-f96f1510e626|2|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|IU/dL|[?]|1|m2|PULMONARY TRUNK|LEFT|||ADJUDICATOR|1|Visit_1|10|3|WASHOUT|2020-11-07|10
e|FA|613284eb-edbe-446b-b4fe-f96f1510e626|3|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|umol/mol|[?]|1|Shock Wave|LACRIMAL GLAND|LEFT|||VENDOR|2|Visit_2|25|4|TREATMENT|2020-11-22|25
e|FA|613284eb-edbe-446b-b4fe-f96f1510e626|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|VOXEL|[?]|1|mg/g/min|PROXIMAL PHALANX 3 OF THE HAND|BILATERAL|||STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-11-22|25
e|FA|613284eb-edbe-446b-b4fe-f96f1510e626|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|L/h|[?]|1|Pa|GLENOID FOSSA|RIGHT||Y|SIGNIFICANT OTHER|3|Visit_3|40|6|SCREENING|2020-12-07|40
e|FA|613284eb-edbe-446b-b4fe-f96f1510e626|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|PFU/animal|[?]|1|Pa|GLOSSOPHARYNGEAL NERVE|BILATERAL|||CHILD|3|Visit_3|40|6|TREATMENT|2020-12-07|40
e|FA|613284eb-edbe-446b-b4fe-f96f1510e626|7|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|ng|[?]|1|fmol|FEMALE REPRODUCTIVE SYSTEM|UNILATERAL|||PARENT|4|Visit_4|65|1|SCREENING|2021-01-01|65
e|FA|613284eb-edbe-446b-b4fe-f96f1510e626|8|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|g/dL|[?]|1|mL/dose|PERICARDIAL LYMPH NODE|LATERAL|||VENDOR|4|Visit_4|65|4|FOLLOW-UP|2021-01-01|65
e|FA|613284eb-edbe-446b-b4fe-f96f1510e626|9|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|mCi/L|[?]|1|mAmp|WAIST|LATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2021-01-26|90
e|FA|613284eb-edbe-446b-b4fe-f96f1510e626|10|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|AgU/mL|[?]|1|/kg|THIGH|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2021-01-26|90
e|FA|65e8391b-0c34-4687-a0ab-cb291a4cdf36|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/cm H2O|[?]|1|mg/g/min|DELTOID MUSCLE|LEFT|||ADJUDICATION COMMITTEE|1|Visit_1|10|3|WASHOUT|2020-07-15|10
e|FA|65e8391b-0c34-4687-a0ab-cb291a4cdf36|2|AGETRT1|Age At First Treatment|[?]|GERD|[?]|COAT|[?]|1|mL/mmHg/min/L|LACRIMAL BONE|LATERAL|Y||CAREGIVER|1|Visit_1|10|6|WASHOUT|2020-07-15|10
e|FA|65e8391b-0c34-4687-a0ab-cb291a4cdf36|3|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|ft|[?]|1|g/dL|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|RIGHT|Y||SIGNIFICANT OTHER|2|Visit_2|25|7|SCREENING|2020-07-30|25
e|FA|65e8391b-0c34-4687-a0ab-cb291a4cdf36|4|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|U/kg/h|[?]|1|MPS U|HEART, LEFT VENTRICLE|UNILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|SCREENING|2020-07-30|25
e|FA|65e8391b-0c34-4687-a0ab-cb291a4cdf36|5|TOTNUM|Total Number|[?]|GERD|[?]|usec|[?]|1|/200 HPFs|NOSTRIL|RIGHT|||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-08-14|40
e|FA|65e8391b-0c34-4687-a0ab-cb291a4cdf36|6|SEV|Severity/Intensity|[?]|GERD|[?]|Pa|[?]|1|Pa|BRACHIAL ARTERY|RIGHT|||VENDOR|3|Visit_3|40|2|WASHOUT|2020-08-14|40
e|FA|65e8391b-0c34-4687-a0ab-cb291a4cdf36|7|SEV|Severity/Intensity|[?]|GERD|[?]|TCID 50/dose|[?]|1|Pa|PANCREAS, BODY|RIGHT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2020-09-08|65
e|FA|65e8391b-0c34-4687-a0ab-cb291a4cdf36|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|mg/h|[?]|1|mL|CARPAL BONE|CONTRALATERAL|||INTERVIEWER|4|Visit_4|65|1|FOLLOW-UP|2020-09-08|65
e|FA|65e8391b-0c34-4687-a0ab-cb291a4cdf36|9|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|CCID 50/dose|[?]|1|10^9 CFU/mL|ORAL CAVITY|RIGHT|||FRIEND|5|Visit_5|90|3|SCREENING|2020-10-03|90
e|FA|65e8391b-0c34-4687-a0ab-cb291a4cdf36|10|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|mg/cm2|[?]|1|MBq|SUPRARENAL AORTA|UNILATERAL|||SPOUSE|5|Visit_5|90|3|SCREENING|2020-10-03|90
e|FA|2350438a-0bc8-4da5-b6c9-99a6c012b454|1|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|CARTRIDGE|[?]|1|U/mmol|T7 VERTEBRA|BILATERAL||Y|CAREGIVER|1|Visit_1|10|4|FOLLOW-UP|2020-08-21|10
e|FA|2350438a-0bc8-4da5-b6c9-99a6c012b454|2|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|VIAL|[?]|1|/kg|GREAT VESSELS|UNILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|7|FOLLOW-UP|2020-08-21|10
e|FA|2350438a-0bc8-4da5-b6c9-99a6c012b454|3|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|SCOOPFUL|[?]|1|QUANTITY SUFFICIENT|BLADDER, NECK|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2020-09-05|25
e|FA|2350438a-0bc8-4da5-b6c9-99a6c012b454|4|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|10^4 CFU|[?]|1|mm/h|ANTERIOR TIBIAL VEIN|LATERAL|Y||STUDY SUBJECT|2|Visit_2|25|3|SCREENING|2020-09-05|25
e|FA|2350438a-0bc8-4da5-b6c9-99a6c012b454|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^6 organisms/mL|[?]|1|mg/g/min|BLOOD|UNILATERAL|||FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-09-20|40
e|FA|2350438a-0bc8-4da5-b6c9-99a6c012b454|6|DMG|Dietary Magnesium|[?]|GERD|[?]|10^9 CFU/mL|[?]|1|TRANSDUCING UNIT/mL|TRICEPS BRACHII MUSCLE|LEFT|||INVESTIGATOR|3|Visit_3|40|6|TREATMENT|2020-09-20|40
e|FA|2350438a-0bc8-4da5-b6c9-99a6c012b454|7|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|g/kg|[?]|1|PACK|SYMPATHETIC GANGLIA|LATERAL|Y||FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2020-10-15|65
e|FA|2350438a-0bc8-4da5-b6c9-99a6c012b454|8|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|mL/cm|[?]|1|Coulomb|HEART, BASE|LEFT|Y||PARENT|4|Visit_4|65|2|WASHOUT|2020-10-15|65
e|FA|2350438a-0bc8-4da5-b6c9-99a6c012b454|9|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|PFU|[?]|1|BOWL|PECTORALIS MAJOR MUSCLE|LEFT|||CHILD|5|Visit_5|90|6|FOLLOW-UP|2020-11-09|90
e|FA|2350438a-0bc8-4da5-b6c9-99a6c012b454|10|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|CIGARETTE|[?]|1|HOURS|LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT|IPSILATERAL|||FRIEND|5|Visit_5|90|4|WASHOUT|2020-11-09|90
e|FA|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|EVENTS|[?]|1|Pa|MIDDLE PHALANX 4 OF THE HAND|CONTRALATERAL|Y||FAMILY MEMBER|1|Visit_1|10|4|FOLLOW-UP|2020-11-16|10
e|FA|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|2|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|mL/m2|[?]|1|10^6/L|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|IPSILATERAL|||SIGNIFICANT OTHER|1|Visit_1|10|3|SCREENING|2020-11-16|10
e|FA|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|NEBULE|[?]|1|mg/g/min|VERTEBRAL ARTERY|LATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|2|WASHOUT|2020-12-01|25
e|FA|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|Bq/L|[?]|1|Pa|CORPUS STRIATUM|BILATERAL|||FRIEND|2|Visit_2|25|7|FOLLOW-UP|2020-12-01|25
e|FA|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|pmol/10^10 cells|[?]|1|mg/g/min|RIB|BILATERAL||Y|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-12-16|40
e|FA|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|6|TOTNUM|Total Number|[?]|GERD|[?]|CCID 50/dose|[?]|1|/200 HPFs|ANAL CANAL|UNILATERAL|||SPOUSE|3|Visit_3|40|4|WASHOUT|2020-12-16|40
e|FA|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|7|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|pL|[?]|1|mL/dose|INTERPHALANGEAL JOINT 1 OF THE FOOT|BILATERAL|||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2021-01-10|65
e|FA|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|8|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|cup eq|[?]|1|100 IU/mL|CHIN|IPSILATERAL|Y||CHILD|4|Visit_4|65|2|SCREENING|2021-01-10|65
e|FA|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|kg/cm2|[?]|1|%(v/v)|INSULAR CORTEX|LEFT|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2021-02-04|90
e|FA|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/animal/wk|[?]|1|mg/g/min|HEART, LEFT ATRIAL APPENDAGE|CONTRALATERAL|Y||SIBLING|5|Visit_5|90|1|TREATMENT|2021-02-04|90
e|FA|416fe99b-1258-4e72-b1df-48b989f8f8ed|1|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg/min/L|[?]|1|mg/g/min|SYNOVIAL FLUID|RIGHT||Y|SIBLING|1|Visit_1|10|6|WASHOUT|2020-08-28|10
e|FA|416fe99b-1258-4e72-b1df-48b989f8f8ed|2|DIAMETER|Diameter|[?]|GERD|[?]|g/kg/day|[?]|1|cm|CORONARY VEIN|BILATERAL|||INVESTIGATOR|1|Visit_1|10|3|TREATMENT|2020-08-28|10
e|FA|416fe99b-1258-4e72-b1df-48b989f8f8ed|3|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|g/g|[?]|1|MPS U|PREAURICULAR LYMPH NODE|UNILATERAL|Y|Y|DOMESTIC PARTNER|2|Visit_2|25|4|FOLLOW-UP|2020-09-12|25
e|FA|416fe99b-1258-4e72-b1df-48b989f8f8ed|4|QOLIMP|QOL Impact|[?]|GERD|[?]|10^3 organisms/mL|[?]|1|10^6/L|LATERAL RAMUS INTERMEDIUS ARTERY|BILATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|WASHOUT|2020-09-12|25
e|FA|416fe99b-1258-4e72-b1df-48b989f8f8ed|5|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|L/min/m2|[?]|1|Gy/h|MEDIASTINAL LYMPH NODE|LATERAL|||DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2020-09-27|40
e|FA|416fe99b-1258-4e72-b1df-48b989f8f8ed|6|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|mEq/L|[?]|1|100 IU/mL|GREATER CURVATURE OF THE STOMACH|LATERAL||Y|PROXY|3|Visit_3|40|7|FOLLOW-UP|2020-09-27|40
e|FA|416fe99b-1258-4e72-b1df-48b989f8f8ed|7|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|ng/L|[?]|1|mIU/L|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|UNILATERAL||Y|SIGNIFICANT OTHER|4|Visit_4|65|5|FOLLOW-UP|2020-10-22|65
e|FA|416fe99b-1258-4e72-b1df-48b989f8f8ed|8|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|Ci/g|[?]|1|ug/kg/h|PANCREAS, ENDOCRINE|RIGHT|||INVESTIGATOR|4|Visit_4|65|5|SCREENING|2020-10-22|65
e|FA|416fe99b-1258-4e72-b1df-48b989f8f8ed|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|kg/L|[?]|1|mL|SCAPHOID-RADIUS JOINT|LEFT|||STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2020-11-16|90
e|FA|416fe99b-1258-4e72-b1df-48b989f8f8ed|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|Pa|T10 VERTEBRA|IPSILATERAL|||STUDY SUBJECT|5|Visit_5|90|7|FOLLOW-UP|2020-11-16|90
e|FA|16a9e070-3e5d-444c-9ac1-6a1abfac0370|1|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|Bq/uL|[?]|1|m2|GLUTEUS MAXIMUS|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|FOLLOW-UP|2020-05-26|10
e|FA|16a9e070-3e5d-444c-9ac1-6a1abfac0370|2|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|FINGERTIP UNIT|[?]|1|g/day|PORTAL LYMPH NODE|BILATERAL||Y|PROXY|1|Visit_1|10|3|TREATMENT|2020-05-26|10
e|FA|16a9e070-3e5d-444c-9ac1-6a1abfac0370|3|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|beats/min|[?]|1|BP|SKIN AROUND THE MOUTH|LEFT|||SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2020-06-10|25
e|FA|16a9e070-3e5d-444c-9ac1-6a1abfac0370|4|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU|[?]|1|DRUM|FIRST RIGHT POSTEROLATERAL ARTERY|LATERAL||Y|STUDY SUBJECT|2|Visit_2|25|5|WASHOUT|2020-06-10|25
e|FA|16a9e070-3e5d-444c-9ac1-6a1abfac0370|5|TOXGR|Toxicity Grade|[?]|GERD|[?]|mCi/L|[?]|1|aMFI|LUNG, RIGHT MIDDLE LOBE|RIGHT|Y||CAREGIVER|3|Visit_3|40|4|SCREENING|2020-06-25|40
e|FA|16a9e070-3e5d-444c-9ac1-6a1abfac0370|6|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|foz_br|[?]|1|h*%|COLON, RIGHT|IPSILATERAL|||CHILD|3|Visit_3|40|4|TREATMENT|2020-06-25|40
e|FA|16a9e070-3e5d-444c-9ac1-6a1abfac0370|7|PPTFCT|Precipitating Factor|[?]|GERD|[?]|tsp|[?]|1|EIA unit|BRAIN, PERIVENTRICULAR REGION|RIGHT|||GUARDIAN|4|Visit_4|65|7|SCREENING|2020-07-20|65
e|FA|16a9e070-3e5d-444c-9ac1-6a1abfac0370|8|TPDEPIND|Unable to Taper Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|in|INTERNAL MAMMARY ARTERY|BILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-07-20|65
e|FA|16a9e070-3e5d-444c-9ac1-6a1abfac0370|9|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|Ci/uL|[?]|1|mL/mmHg/min/L|INFERIOR PUBIC RAMUS|CONTRALATERAL|||INVESTIGATOR|5|Visit_5|90|7|WASHOUT|2020-08-14|90
e|FA|16a9e070-3e5d-444c-9ac1-6a1abfac0370|10|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|mN|[?]|1|mL/h|UTERINE ARTERY|IPSILATERAL|Y|Y|INVESTIGATOR|5|Visit_5|90|7|SCREENING|2020-08-14|90
e|FA|1497a00d-55b1-4e02-a957-cf15e3d15512|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|g/m2|[?]|1|mg/g/min|AXILLARY LYMPH NODE LEVEL I|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2021-01-25|10
e|FA|1497a00d-55b1-4e02-a957-cf15e3d15512|2|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|uL/kg/day|[?]|1|HOURS|SUPERIOR SAGITTAL SINUS|UNILATERAL||Y|VENDOR|1|Visit_1|10|5|WASHOUT|2021-01-25|10
e|FA|1497a00d-55b1-4e02-a957-cf15e3d15512|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^7/L|[?]|1|mg/g/min|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|UNILATERAL||Y|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2021-02-09|25
e|FA|1497a00d-55b1-4e02-a957-cf15e3d15512|4|SPEED|Speed|[?]|GERD|[?]|Sv|[?]|1|mEq/g|OPPONENS POLLICIS MUSCLE|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2021-02-09|25
e|FA|1497a00d-55b1-4e02-a957-cf15e3d15512|5|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|log10 CCID 50/dose|[?]|1|ug/m2/h|PERIURETHRAL REGION|BILATERAL|||STUDY SUBJECT|3|Visit_3|40|4|TREATMENT|2021-02-24|40
e|FA|1497a00d-55b1-4e02-a957-cf15e3d15512|6|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|mEq|GASTROINTESTINAL TRACT, LOWER|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|SCREENING|2021-02-24|40
e|FA|1497a00d-55b1-4e02-a957-cf15e3d15512|7|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|pkat/L|[?]|1|10^4 CFU/mL|INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|||INTERVIEWER|4|Visit_4|65|4|WASHOUT|2021-03-21|65
e|FA|1497a00d-55b1-4e02-a957-cf15e3d15512|8|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|PATCH|[?]|1|g/cage/day|EXTRAOCULAR MUSCLE|BILATERAL||Y|SIBLING|4|Visit_4|65|7|FOLLOW-UP|2021-03-21|65
e|FA|1497a00d-55b1-4e02-a957-cf15e3d15512|9|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|LB|[?]|1|QUANTITY SUFFICIENT|FIRST RIGHT POSTEROLATERAL ARTERY|LEFT|||FAMILY MEMBER|5|Visit_5|90|7|SCREENING|2021-04-15|90
e|FA|1497a00d-55b1-4e02-a957-cf15e3d15512|10|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|nmol/mol|[?]|1|%(v/v)|RADIUS|BILATERAL|Y||SPOUSE|5|Visit_5|90|5|TREATMENT|2021-04-15|90
e|FA|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|1|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|ug/m2/h|CHOROID|BILATERAL||Y|SIBLING|1|Visit_1|10|1|TREATMENT|2020-07-21|10
e|FA|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|2|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|pt_us|[?]|1|QUANTITY SUFFICIENT|FEMALE REPRODUCTIVE SYSTEM|UNILATERAL||Y|ADJUDICATOR|1|Visit_1|10|2|WASHOUT|2020-07-21|10
e|FA|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|3|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|CIGARETTE|[?]|1|mL/cm3/min|DISTAL INTERPHALANGEAL JOINT 5|UNILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|1|WASHOUT|2020-08-05|25
e|FA|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|10^8 PFU|[?]|1|mL/dose|PARA-AORTIC LYMPH NODE|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|6|SCREENING|2020-08-05|25
e|FA|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|5|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|L/h|[?]|1|mL/h|PARA-AORTIC LYMPH NODE|UNILATERAL|||FRIEND|3|Visit_3|40|4|TREATMENT|2020-08-20|40
e|FA|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|6|DFRUIT|Dietary Fruit|[?]|GERD|[?]|Weber|[?]|1|10^6 CFU/mL|DISTAL EXTRAHEPATIC BILE DUCT REGION|LATERAL|Y||VENDOR|3|Visit_3|40|3|TREATMENT|2020-08-20|40
e|FA|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|7|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|kHz|[?]|1|PACK|DISTAL PHALANX 3 OF THE HAND|LEFT|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-09-14|65
e|FA|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|8|LDIAM|Longest Diameter|[?]|GERD|[?]|vg/kg|[?]|1|Shock Wave|UVEA|BILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2020-09-14|65
e|FA|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|9|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|nmol/day|[?]|1|ug/m2/h|HYPOGLOSSAL NERVE|CONTRALATERAL||Y|PROXY|5|Visit_5|90|6|WASHOUT|2020-10-09|90
e|FA|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|10|DIAMETER|Diameter|[?]|GERD|[?]|/4.0 mL|[?]|1|cm|FRONTAL SINUS|BILATERAL|||PROXY|5|Visit_5|90|6|TREATMENT|2020-10-09|90
e|FA|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mU|[?]|1|CUP|GRACILIS MUSCLE|LEFT|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|FOLLOW-UP|2020-12-09|10
e|FA|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|2|CALBURN|Calories Burned|[?]|PRE-SPECIFIED AE|[?]|umol/day|[?]|1|/kg|MEDIAN NERVE|IPSILATERAL|||INTERVIEWER|1|Visit_1|10|4|SCREENING|2020-12-09|10
e|FA|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|3|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|MBP|[?]|1|umol|POPLITEAL ARTERY ABOVE KNEE|RIGHT|||CAREGIVER|2|Visit_2|25|6|WASHOUT|2020-12-24|25
e|FA|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|kBq/uL|[?]|1|mL/dose|TYMPANIC MEMBRANE|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-12-24|25
e|FA|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|ukat/L|[?]|1|U/mmol|LEFT VENTRICULAR MID ANTERIOR SEGMENT|BILATERAL|||FAMILY MEMBER|3|Visit_3|40|1|FOLLOW-UP|2021-01-08|40
e|FA|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|6|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|10^6 organisms/mg|[?]|1|mL/cm3/min|AORTIC VALVE, LEFT CORONARY CUSP|LEFT|||STUDY SUBJECT|3|Visit_3|40|5|TREATMENT|2021-01-08|40
e|FA|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|7|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|ft|[?]|1|g/L|MANDIBLE|LATERAL|Y||SIBLING|4|Visit_4|65|4|TREATMENT|2021-02-02|65
e|FA|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|8|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|IMPLANT|[?]|1|10^6 IU/mL|SKIN AROUND THE MOUTH|RIGHT|Y||SIGNIFICANT OTHER|4|Visit_4|65|2|SCREENING|2021-02-02|65
e|FA|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|9|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|Bq/kg|[?]|1|mg/dose|SPINAL ACCESSORY NERVE|BILATERAL|||STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2021-02-27|90
e|FA|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|Gravitational Unit|[?]|1|km|SKIN OF THE HEAD|LEFT|||SIGNIFICANT OTHER|5|Visit_5|90|4|WASHOUT|2021-02-27|90
e|FA|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|1|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|/500 WBC|[?]|1|uCi/kg|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|IPSILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|SCREENING|2020-11-05|10
e|FA|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|2|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|10^8 PFU|[?]|1|Gy/h|RADIUS-LUNATE JOINT|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-11-05|10
e|FA|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|3|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|V/sec|[?]|1|aMFI|BLADDER, DOME|CONTRALATERAL|Y||STUDY SUBJECT|2|Visit_2|25|3|FOLLOW-UP|2020-11-20|25
e|FA|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|4|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mg/kg/min|[?]|1|ug/kg/h|POPLITEAL ARTERY ABOVE KNEE|RIGHT|||CAREGIVER|2|Visit_2|25|7|TREATMENT|2020-11-20|25
e|FA|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|5|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|mg/g/min|[?]|1|mm/h|TIBIALIS ANTERIOR MUSCLE|UNILATERAL|Y|Y|PARENT|3|Visit_3|40|2|TREATMENT|2020-12-05|40
e|FA|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|6|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|pL|[?]|1|mL/mmHg/min/L|PELVIS|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-12-05|40
e|FA|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|7|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|BOWL|[?]|1|g/L|METATARSOPHALANGEAL JOINT 1|RIGHT|||ADJUDICATOR|4|Visit_4|65|4|TREATMENT|2020-12-30|65
e|FA|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|8|LOCONSET|Localization of Onset|[?]|GERD|[?]|U/g/h|[?]|1|g/L|FOOT DIGIT 4|LATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2020-12-30|65
e|FA|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|9|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|mm3/mm2/year|[?]|1|uCi/kg|OCCIPITAL SCALP|LEFT|||SIGNIFICANT OTHER|5|Visit_5|90|4|WASHOUT|2021-01-24|90
e|FA|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|10|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|ng/mol|[?]|1|mL/m2|BRACHIAL LYMPH NODE|BILATERAL||Y|CAREGIVER|5|Visit_5|90|1|WASHOUT|2021-01-24|90
e|FA|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|1|EVENTFRQ|Event Frequency|[?]|GERD|[?]|foz_us|[?]|1|ug/kg/h|SPLEEN, HILUM|UNILATERAL||Y|SPOUSE|1|Visit_1|10|1|TREATMENT|2020-05-27|10
e|FA|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|2|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|mEq/g|[?]|1|DROP|CECUM|LATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|SCREENING|2020-05-27|10
e|FA|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mol/L|[?]|1|%(v/v)|OCULOMOTOR NERVE|LATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-06-11|25
e|FA|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|4|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|mm/2h|[?]|1|Log10 ELISA unit|KNEE JOINT|RIGHT|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|SCREENING|2020-06-11|25
e|FA|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|5|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|mg|[?]|1|BOWL|HILAR LYMPH NODE|RIGHT||Y|SPOUSE|3|Visit_3|40|6|SCREENING|2020-06-26|40
e|FA|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|6|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|LB|[?]|1|/200 HPFs|METATARSAL BONE|BILATERAL|||SIBLING|3|Visit_3|40|7|FOLLOW-UP|2020-06-26|40
e|FA|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|7|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|KIT|[?]|1|BOWL|LARYNX|CONTRALATERAL|||INTERVIEWER|4|Visit_4|65|6|FOLLOW-UP|2020-07-21|65
e|FA|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|U/g|[?]|1|PFU/dose|AORTIC VALVE, RIGHT CORONARY CUSP|RIGHT|||PARENT|4|Visit_4|65|3|SCREENING|2020-07-21|65
e|FA|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mL/h|[?]|1|%(v/v)|ILIOTIBIAL BAND|BILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|5|WASHOUT|2020-08-15|90
e|FA|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|10|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|TRANSDUCING UNIT|[?]|1|HOURS|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|LEFT|||ADJUDICATION COMMITTEE|5|Visit_5|90|5|SCREENING|2020-08-15|90
e|FA|2216086b-197e-4780-8e10-28123eb090c5|1|DIAMETER|Diameter|[?]|GERD|[?]|um/s|[?]|1|cm|MESENTERIC ARTERY|LATERAL|Y||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|SCREENING|2020-12-12|10
e|FA|2216086b-197e-4780-8e10-28123eb090c5|2|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|oz eq|[?]|1|ug/m2/h|PERITONEUM|LATERAL|||VENDOR|1|Visit_1|10|3|TREATMENT|2020-12-12|10
e|FA|2216086b-197e-4780-8e10-28123eb090c5|3|EPMLDNUM|Number of Mild Episodes|[?]|PRE-SPECIFIED AE|[?]|LENS|[?]|1|g/cage/day|CEREBRAL ARTERY|LEFT|Y||INTERVIEWER|2|Visit_2|25|6|SCREENING|2020-12-27|25
e|FA|2216086b-197e-4780-8e10-28123eb090c5|4|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|dyn|[?]|1|10^9 CFU/mL|SUBMANDIBULAR GLAND|IPSILATERAL|Y||GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-12-27|25
e|FA|2216086b-197e-4780-8e10-28123eb090c5|5|OBJTYPE|Type of Object|[?]|GERD|[?]|IU/L|[?]|1|ng|TARSUS BONE|BILATERAL|Y||PARENT|3|Visit_3|40|3|TREATMENT|2021-01-11|40
e|FA|2216086b-197e-4780-8e10-28123eb090c5|6|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|cmH2O*s/mL|[?]|1|HOURS|CORNEA|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2021-01-11|40
e|FA|2216086b-197e-4780-8e10-28123eb090c5|7|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|m2|[?]|1|BAG|INTRAHEPATIC BILE DUCT|LEFT|||GUARDIAN|4|Visit_4|65|5|FOLLOW-UP|2021-02-05|65
e|FA|2216086b-197e-4780-8e10-28123eb090c5|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|ka_u/dL|[?]|1|%(v/v)|GLENOID FOSSA|LATERAL|||INTERVIEWER|4|Visit_4|65|7|SCREENING|2021-02-05|65
e|FA|2216086b-197e-4780-8e10-28123eb090c5|9|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|cm|ATRIOVENTRICULAR VALVE|LEFT|||INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2021-03-02|90
e|FA|2216086b-197e-4780-8e10-28123eb090c5|10|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mm3/mm2/year|[?]|1|ug/kg/h|MUSCULOSKELETAL SYSTEM|BILATERAL||Y|PROXY|5|Visit_5|90|6|FOLLOW-UP|2021-03-02|90
e|FA|7280f69c-a0f4-48b5-b714-1e272193168c|1|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|mol/mL|[?]|1|mg/h|THIRD DIAGONAL BRANCH ARTERY|IPSILATERAL||Y|INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-08-19|10
e|FA|7280f69c-a0f4-48b5-b714-1e272193168c|2|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|%/min|[?]|1|PACK|JUGULAR VEIN|LEFT||Y|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-08-19|10
e|FA|7280f69c-a0f4-48b5-b714-1e272193168c|3|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|ug/m2/h|COCCYX|BILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|6|SCREENING|2020-09-03|25
e|FA|7280f69c-a0f4-48b5-b714-1e272193168c|4|AGETRT1|Age At First Treatment|[?]|GERD|[?]|pt_us|[?]|1|mL/mmHg/min/L|INTERATRIAL SEPTUM|LEFT|Y||FRIEND|2|Visit_2|25|1|TREATMENT|2020-09-03|25
e|FA|7280f69c-a0f4-48b5-b714-1e272193168c|5|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|m2|[?]|1|uL/kg/day|PARASYMPATHETIC GANGLIA|BILATERAL||Y|FAMILY MEMBER|3|Visit_3|40|3|FOLLOW-UP|2020-09-18|40
e|FA|7280f69c-a0f4-48b5-b714-1e272193168c|6|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|/40 HPFs|[?]|1|IU/mg|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|BILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|1|FOLLOW-UP|2020-09-18|40
e|FA|7280f69c-a0f4-48b5-b714-1e272193168c|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mmol/day|[?]|1|U/mg|FINGER FLEXOR MUSCLES|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-10-13|65
e|FA|7280f69c-a0f4-48b5-b714-1e272193168c|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|/MBP|[?]|1|mg/g/min|PROFUNDA FEMORIS VEIN|IPSILATERAL|Y||SIGNIFICANT OTHER|4|Visit_4|65|2|WASHOUT|2020-10-13|65
e|FA|7280f69c-a0f4-48b5-b714-1e272193168c|9|EXTRSCT|Extent of Resection|[?]|GERD|[?]|mg/h|[?]|1|Weber|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LEFT|||FRIEND|5|Visit_5|90|6|TREATMENT|2020-11-07|90
e|FA|7280f69c-a0f4-48b5-b714-1e272193168c|10|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|mph|[?]|1|mm/h|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|LATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-11-07|90
e|FA|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|1|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|mIU/L|SKIN OF THE KNEE|LEFT||Y|DOMESTIC PARTNER|1|Visit_1|10|2|FOLLOW-UP|2020-08-01|10
e|FA|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|2|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|mOsm|[?]|1|DRUM|RAMUS INTERMEDIUS ARTERY|LEFT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-08-01|10
e|FA|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|3|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|uCi|[?]|1|U/mmol|PALPEBRAL FISSURE|IPSILATERAL|||INTERVIEWER|2|Visit_2|25|1|SCREENING|2020-08-16|25
e|FA|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|4|ESTWT|Estimated Weight|[?]|GERD|[?]|/wk|[?]|1|g/day|PALATINE BONE|IPSILATERAL|||FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2020-08-16|25
e|FA|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|5|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|nCi|[?]|1|L|NASAL BONE|UNILATERAL|||GUARDIAN|3|Visit_3|40|5|SCREENING|2020-08-31|40
e|FA|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|6|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|nkat/g Hb|[?]|1|umol|TRAPEZIAL BONE|UNILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-08-31|40
e|FA|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|7|DGRAIN|Dietary Grain|[?]|GERD|[?]|mol/mg|[?]|1|10^9 CFU/g|CHEST|CONTRALATERAL|Y|Y|FAMILY MEMBER|4|Visit_4|65|6|FOLLOW-UP|2020-09-25|65
e|FA|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|mPa|[?]|1|PFU/dose|FIRST RIGHT POSTEROLATERAL ARTERY|IPSILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-09-25|65
e|FA|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|9|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|JAR|[?]|1|10^6 U|HUMERUS SHAFT|IPSILATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|7|SCREENING|2020-10-20|90
e|FA|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|10|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|100 IU/mL|[?]|1|PFU/dose|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|LEFT|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-10-20|90
e|FA|25c6812b-9200-4dc4-a954-6879183a2c54|1|DISTANCE|Distance|[?]|GERD|[?]|nsec|[?]|1|BOWL|FOOT DIGIT 3|CONTRALATERAL|||DOMESTIC PARTNER|1|Visit_1|10|5|WASHOUT|2020-12-24|10
e|FA|25c6812b-9200-4dc4-a954-6879183a2c54|2|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|COAT|[?]|1|10^6 CFU|PERIPANCREATIC LYMPH NODE|BILATERAL|Y||ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-12-24|10
e|FA|25c6812b-9200-4dc4-a954-6879183a2c54|3|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|bel|[?]|1|vp/dose|SKIN OF THE BENDING JOINT|IPSILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2021-01-08|25
e|FA|25c6812b-9200-4dc4-a954-6879183a2c54|4|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|V/sec|[?]|1|L|PUPIL|BILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|2|SCREENING|2021-01-08|25
e|FA|25c6812b-9200-4dc4-a954-6879183a2c54|5|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|ug|[?]|1|BAG|CONJUNCTIVA|RIGHT|||INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2021-01-23|40
e|FA|25c6812b-9200-4dc4-a954-6879183a2c54|6|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|TUBE|[?]|1|gtt|DISTAL PHALANX 3 OF THE HAND|IPSILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|4|SCREENING|2021-01-23|40
e|FA|25c6812b-9200-4dc4-a954-6879183a2c54|7|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|dram|[?]|1|IU/mg|DENTAL ARCH|IPSILATERAL|||CHILD|4|Visit_4|65|3|TREATMENT|2021-02-17|65
e|FA|25c6812b-9200-4dc4-a954-6879183a2c54|8|SPEED|Speed|[?]|GERD|[?]|umol/h/mmol|[?]|1|mEq/g|HEART, LEFT ATRIUM|LEFT||Y|SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2021-02-17|65
e|FA|25c6812b-9200-4dc4-a954-6879183a2c54|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|RING|[?]|1|mL|UTERINE ARTERY|BILATERAL|||CHILD|5|Visit_5|90|3|WASHOUT|2021-03-14|90
e|FA|25c6812b-9200-4dc4-a954-6879183a2c54|10|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|s*kPa|[?]|1|Log10 ELISA unit|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|CONTRALATERAL|Y|Y|SPOUSE|5|Visit_5|90|3|TREATMENT|2021-03-14|90
e|FA|10dca475-f364-42f3-9192-faf762832adf|1|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|SACHET|[?]|1|SACHET|BRAIN VENTRICLE, LATERAL|RIGHT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-09-25|10
e|FA|10dca475-f364-42f3-9192-faf762832adf|2|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|SYRINGE|[?]|1|MPS U|CEREBRAL HEMISPHERE, RIGHT|UNILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|FOLLOW-UP|2020-09-25|10
e|FA|10dca475-f364-42f3-9192-faf762832adf|3|SEV|Severity/Intensity|[?]|GERD|[?]|IU/kg|[?]|1|Pa|ILEUM, TERMINAL|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|2|WASHOUT|2020-10-10|25
e|FA|10dca475-f364-42f3-9192-faf762832adf|4|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|L/min|[?]|1|mL/m2|ULNA SHAFT|RIGHT||Y|PROXY|2|Visit_2|25|4|FOLLOW-UP|2020-10-10|25
e|FA|10dca475-f364-42f3-9192-faf762832adf|5|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|mg2/dL2|[?]|1|ng/day|RECTO-UTERINE POUCH|IPSILATERAL||Y|SIBLING|3|Visit_3|40|5|TREATMENT|2020-10-25|40
e|FA|10dca475-f364-42f3-9192-faf762832adf|6|SEV|Severity/Intensity|[?]|GERD|[?]|Absorbance U|[?]|1|Pa|URINARY SYSTEM|BILATERAL|Y|Y|FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2020-10-25|40
e|FA|10dca475-f364-42f3-9192-faf762832adf|7|DPROT|Dietary Protein|[?]|GERD|[?]|/cmH2O|[?]|1|10^4 CFU/mL|SHOULDER JOINT|CONTRALATERAL|Y||INTERVIEWER|4|Visit_4|65|3|TREATMENT|2020-11-19|65
e|FA|10dca475-f364-42f3-9192-faf762832adf|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|umol/h/mmol|[?]|1|U/mmol|PALATE|RIGHT|||SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2020-11-19|65
e|FA|10dca475-f364-42f3-9192-faf762832adf|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|oz eq|[?]|1|mg/g/min|LEPTOMENINGES|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-12-14|90
e|FA|10dca475-f364-42f3-9192-faf762832adf|10|EXTRSCT|Extent of Resection|[?]|GERD|[?]|g|[?]|1|Weber|AMYGDALA|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|WASHOUT|2020-12-14|90
e|FA|caf54095-56c3-428f-8342-ce45c6c9a287|1|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|L/day|[?]|1|cm|GLUTEAL MUSCLE|BILATERAL|Y||PARENT|1|Visit_1|10|3|TREATMENT|2020-12-20|10
e|FA|caf54095-56c3-428f-8342-ce45c6c9a287|2|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|cmH2O/mL|[?]|1|km|AORTIC VALVE, RIGHT CORONARY CUSP|RIGHT||Y|INTERVIEWER|1|Visit_1|10|5|WASHOUT|2020-12-20|10
e|FA|caf54095-56c3-428f-8342-ce45c6c9a287|3|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|uL/kg/day|[?]|1|10^6 organisms/mL|GLUTEAL MUSCLE|LATERAL|||INTERVIEWER|2|Visit_2|25|4|TREATMENT|2021-01-04|25
e|FA|caf54095-56c3-428f-8342-ce45c6c9a287|4|ESTWT|Estimated Weight|[?]|GERD|[?]|mg/m2|[?]|1|g/day|TESTIS|CONTRALATERAL|||FAMILY MEMBER|2|Visit_2|25|7|TREATMENT|2021-01-04|25
e|FA|caf54095-56c3-428f-8342-ce45c6c9a287|5|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|BU|[?]|1|EIA unit|BILIARY TRACT|LATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2021-01-19|40
e|FA|caf54095-56c3-428f-8342-ce45c6c9a287|6|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|DRUM|[?]|1|umol|LATISSIMUS DORSI MUSCLE|CONTRALATERAL||Y|PARENT|3|Visit_3|40|4|WASHOUT|2021-01-19|40
e|FA|caf54095-56c3-428f-8342-ce45c6c9a287|7|DMEAT|Dietary Meat|[?]|GERD|[?]|LB|[?]|1|10^6 organisms/mL|PROFUNDA FEMORIS VEIN|BILATERAL||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2021-02-13|65
e|FA|caf54095-56c3-428f-8342-ce45c6c9a287|8|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mEq/L|[?]|1|ohm|ILIAC CREST|CONTRALATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2021-02-13|65
e|FA|caf54095-56c3-428f-8342-ce45c6c9a287|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|10^6 CFU/mL|[?]|1|mL|BRAIN|UNILATERAL|Y||PARENT|5|Visit_5|90|3|TREATMENT|2021-03-10|90
e|FA|caf54095-56c3-428f-8342-ce45c6c9a287|10|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|U/m2/min|[?]|1|mAmp|RIGHT ATRIAL ENDOCARDIUM|IPSILATERAL|Y||STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2021-03-10|90
e|FA|f833ca56-d426-420b-a6d3-fedeabc02734|1|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|DRUM|ENDOMETRIUM|LEFT|||ADJUDICATOR|1|Visit_1|10|5|FOLLOW-UP|2020-06-20|10
e|FA|f833ca56-d426-420b-a6d3-fedeabc02734|2|OBJNUM|Number of Objects|[?]|GERD|[?]|yd|[?]|1|mL/100g/min|FLANK|LATERAL|||CHILD|1|Visit_1|10|1|TREATMENT|2020-06-20|10
e|FA|f833ca56-d426-420b-a6d3-fedeabc02734|3|DVEG|Dietary Vegetable|[?]|GERD|[?]|kg|[?]|1|Ci/ug|SACRUM|LATERAL|||PROXY|2|Visit_2|25|3|SCREENING|2020-07-05|25
e|FA|f833ca56-d426-420b-a6d3-fedeabc02734|4|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|umol/mg/min|[?]|1|ohm|PARS COMPACTA|IPSILATERAL|||SIBLING|2|Visit_2|25|3|FOLLOW-UP|2020-07-05|25
e|FA|f833ca56-d426-420b-a6d3-fedeabc02734|5|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Ci/L|[?]|1|umol|MASTOID PROCESS|RIGHT|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|TREATMENT|2020-07-20|40
e|FA|f833ca56-d426-420b-a6d3-fedeabc02734|6|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|cmol/L|[?]|1|mL/dose|BRONCHUS|IPSILATERAL|||FRIEND|3|Visit_3|40|6|WASHOUT|2020-07-20|40
e|FA|f833ca56-d426-420b-a6d3-fedeabc02734|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|titer|[?]|1|Pa|LATERAL HUMERAL EPICONDYLE|LATERAL|||SIBLING|4|Visit_4|65|4|FOLLOW-UP|2020-08-14|65
e|FA|f833ca56-d426-420b-a6d3-fedeabc02734|8|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|10^6 CFU/mL|[?]|1|cmH2O/mL|CHOROID|CONTRALATERAL|Y||GUARDIAN|4|Visit_4|65|7|TREATMENT|2020-08-14|65
e|FA|f833ca56-d426-420b-a6d3-fedeabc02734|9|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|g/m2|[?]|1|ug/g/h|CORONARY VEIN|LATERAL||Y|PROXY|5|Visit_5|90|3|FOLLOW-UP|2020-09-08|90
e|FA|f833ca56-d426-420b-a6d3-fedeabc02734|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|mg/animal|[?]|1|10^6 U|THORACIC LYMPH NODE|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-09-08|90
e|FA|03c8e2c7-b70d-4d46-8064-c99370eab232|1|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|kUSP|[?]|1|ng/day|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|LEFT|Y||ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-11-29|10
e|FA|03c8e2c7-b70d-4d46-8064-c99370eab232|2|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|log10 PFU/mL|[?]|1|IU/mmol|PERIURETERAL REGION|RIGHT||Y|CAREGIVER|1|Visit_1|10|7|TREATMENT|2020-11-29|10
e|FA|03c8e2c7-b70d-4d46-8064-c99370eab232|3|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|MASK|[?]|1|PACK|BRONCHUS|RIGHT|||PROXY|2|Visit_2|25|6|FOLLOW-UP|2020-12-14|25
e|FA|03c8e2c7-b70d-4d46-8064-c99370eab232|4|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|L/h|[?]|1|mg/h|T9 VERTEBRA|CONTRALATERAL|Y||GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-12-14|25
e|FA|03c8e2c7-b70d-4d46-8064-c99370eab232|5|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|PRE-SPECIFIED AE|[?]|g/cage|[?]|1|QUANTITY SUFFICIENT|PELVIC LYMPH NODE|IPSILATERAL||Y|PARENT|3|Visit_3|40|7|SCREENING|2020-12-29|40
e|FA|03c8e2c7-b70d-4d46-8064-c99370eab232|6|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|V|[?]|1|DRUM|GENITAL TUBERCLE|BILATERAL|||FRIEND|3|Visit_3|40|4|TREATMENT|2020-12-29|40
e|FA|03c8e2c7-b70d-4d46-8064-c99370eab232|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|U/m2|[?]|1|U/mg|VENOUS SINUS|IPSILATERAL|||ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2021-01-23|65
e|FA|03c8e2c7-b70d-4d46-8064-c99370eab232|8|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|pm|[?]|1|Log10 ELISA unit|PROSTATE GLAND, POSTERIOR LOBE|LATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-01-23|65
e|FA|03c8e2c7-b70d-4d46-8064-c99370eab232|9|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|10^12 IU/L|[?]|1|%(v/v)|ULNA SHAFT|RIGHT||Y|VENDOR|5|Visit_5|90|5|FOLLOW-UP|2021-02-17|90
e|FA|03c8e2c7-b70d-4d46-8064-c99370eab232|10|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|CIGAR|[?]|1|AU/mL|GLOBUS PALLIDUS|IPSILATERAL|||GUARDIAN|5|Visit_5|90|4|TREATMENT|2021-02-17|90
e|FA|944617c7-c5e6-4e06-b114-499c3020dbbd|1|DFIBER|Dietary Fiber|[?]|GERD|[?]|mEq/kg|[?]|1|h*%|T5 VERTEBRA|LEFT||Y|STUDY SUBJECT|1|Visit_1|10|1|WASHOUT|2020-10-22|10
e|FA|944617c7-c5e6-4e06-b114-499c3020dbbd|2|RLDEV|Relationship to Device|[?]|GERD|[?]|log10 copies/mL|[?]|1|mL/min/mmHg|CAPITATE BONE|BILATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-10-22|10
e|FA|944617c7-c5e6-4e06-b114-499c3020dbbd|3|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|tsp eq|[?]|1|MPS U|HAIR BULB|IPSILATERAL||Y|FAMILY MEMBER|2|Visit_2|25|2|FOLLOW-UP|2020-11-06|25
e|FA|944617c7-c5e6-4e06-b114-499c3020dbbd|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|%(v/v)|[?]|1|U/mmol|EPIGASTRIC LYMPH NODE|LEFT|||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-11-06|25
e|FA|944617c7-c5e6-4e06-b114-499c3020dbbd|5|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|mL/cm H2O|[?]|1|ng/day|TOOTH CANAL|IPSILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-11-21|40
e|FA|944617c7-c5e6-4e06-b114-499c3020dbbd|6|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mL/kg/day|[?]|1|gtt|INTERNAL ILIAC ARTERY|UNILATERAL|||SPOUSE|3|Visit_3|40|3|TREATMENT|2020-11-21|40
e|FA|944617c7-c5e6-4e06-b114-499c3020dbbd|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|BLOCKS|[?]|1|U/mmol|EYELASH|LEFT|||GUARDIAN|4|Visit_4|65|4|FOLLOW-UP|2020-12-16|65
e|FA|944617c7-c5e6-4e06-b114-499c3020dbbd|8|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|cmH2O*s/mL|[?]|1|HOURS|LUMBAR SPINE|IPSILATERAL|||FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-12-16|65
e|FA|944617c7-c5e6-4e06-b114-499c3020dbbd|9|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|F|[?]|1|ohm|PERICARDIUM|RIGHT||Y|GUARDIAN|5|Visit_5|90|6|TREATMENT|2021-01-10|90
e|FA|944617c7-c5e6-4e06-b114-499c3020dbbd|10|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|kat|[?]|1|Weber|PARACOLIC GUTTER|BILATERAL|Y||CAREGIVER|5|Visit_5|90|1|TREATMENT|2021-01-10|90
e|FA|e4878c66-1e2b-49bb-838e-85139d160dd4|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|AMPULE|[?]|1|mg/g/min|DENTAL ARCH|LEFT||Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|FOLLOW-UP|2020-10-21|10
e|FA|e4878c66-1e2b-49bb-838e-85139d160dd4|2|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|10^8/L|[?]|1|umol|NASOPHARYNX|LATERAL|||FRIEND|1|Visit_1|10|7|TREATMENT|2020-10-21|10
e|FA|e4878c66-1e2b-49bb-838e-85139d160dd4|3|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|L|RETINAL PIGMENTED EPITHELIAL LAYER|BILATERAL|||CAREGIVER|2|Visit_2|25|4|FOLLOW-UP|2020-11-05|25
e|FA|e4878c66-1e2b-49bb-838e-85139d160dd4|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/kg|[?]|1|%(v/v)|SCAPULA|LEFT||Y|SIGNIFICANT OTHER|2|Visit_2|25|5|TREATMENT|2020-11-05|25
e|FA|e4878c66-1e2b-49bb-838e-85139d160dd4|5|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|mL/s/m2|[?]|1|L/h/m2|PERIHILAR LYMPH NODE|RIGHT|Y||GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-11-20|40
e|FA|e4878c66-1e2b-49bb-838e-85139d160dd4|6|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mU/L|[?]|1|Weber|RIB 9|IPSILATERAL|||SIBLING|3|Visit_3|40|1|FOLLOW-UP|2020-11-20|40
e|FA|e4878c66-1e2b-49bb-838e-85139d160dd4|7|TOXGR|Toxicity Grade|[?]|GERD|[?]|Linear ft*LB|[?]|1|aMFI|BUTTOCK|LEFT|||ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2020-12-15|65
e|FA|e4878c66-1e2b-49bb-838e-85139d160dd4|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|CCID 50/dose|[?]|1|mg/g/min|LUNG|UNILATERAL|Y||INTERVIEWER|4|Visit_4|65|1|WASHOUT|2020-12-15|65
e|FA|e4878c66-1e2b-49bb-838e-85139d160dd4|9|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|C|[?]|1|mL/100g/min|HEART, APEX|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|WASHOUT|2021-01-09|90
e|FA|e4878c66-1e2b-49bb-838e-85139d160dd4|10|STROKTYP|Stroke Type|[?]|GERD|[?]|Ci/uL|[?]|1|g/L|SKIN|LEFT||Y|CHILD|5|Visit_5|90|5|TREATMENT|2021-01-09|90
e|FA|6873e227-baef-4d6e-8600-0bb61d60fe49|1|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|kcal/day|[?]|1|ohm|ABDOMINAL LYMPH NODE|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|TREATMENT|2020-06-06|10
e|FA|6873e227-baef-4d6e-8600-0bb61d60fe49|2|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|deg/mm|[?]|1|m2|BLADDER, TRIGONE|UNILATERAL|||INTERVIEWER|1|Visit_1|10|4|TREATMENT|2020-06-06|10
e|FA|6873e227-baef-4d6e-8600-0bb61d60fe49|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ft3|[?]|1|mg/g/min|THIGH|CONTRALATERAL|Y||SPOUSE|2|Visit_2|25|3|TREATMENT|2020-06-21|25
e|FA|6873e227-baef-4d6e-8600-0bb61d60fe49|4|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|nsec|[?]|1|oz eq|DORSALIS PEDIS ARTERY|LEFT|||ADJUDICATOR|2|Visit_2|25|6|FOLLOW-UP|2020-06-21|25
e|FA|6873e227-baef-4d6e-8600-0bb61d60fe49|5|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|Hz/s|HUMERAL EPICONDYLE|UNILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|WASHOUT|2020-07-06|40
e|FA|6873e227-baef-4d6e-8600-0bb61d60fe49|6|TOXGR|Toxicity Grade|[?]|GERD|[?]|mL/m2/h|[?]|1|aMFI|PLACENTA|IPSILATERAL|||SPOUSE|3|Visit_3|40|1|WASHOUT|2020-07-06|40
e|FA|6873e227-baef-4d6e-8600-0bb61d60fe49|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|hr/day|[?]|1|mg/g/min|LEFT VENTRICULAR APICAL LATERAL SEGMENT|UNILATERAL|Y||CHILD|4|Visit_4|65|6|WASHOUT|2020-07-31|65
e|FA|6873e227-baef-4d6e-8600-0bb61d60fe49|8|DISTANCE|Distance|[?]|GERD|[?]|mol/day|[?]|1|BOWL|HEAD AND NECK|LEFT||Y|INVESTIGATOR|4|Visit_4|65|7|SCREENING|2020-07-31|65
e|FA|6873e227-baef-4d6e-8600-0bb61d60fe49|9|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|breaths/min|[?]|1|BOWL|METATARSOPHALANGEAL JOINT 3|CONTRALATERAL|||FRIEND|5|Visit_5|90|5|FOLLOW-UP|2020-08-25|90
e|FA|6873e227-baef-4d6e-8600-0bb61d60fe49|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|cs|[?]|1|U/mg|DISTAL PHALANX 5 OF THE HAND|RIGHT|||SIBLING|5|Visit_5|90|4|TREATMENT|2020-08-25|90
e|FA|bad01879-9b97-4d9c-9eec-58871168bd57|1|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|BU/mL|[?]|1|g/day|EPIGLOTTIS|LATERAL||Y|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|SCREENING|2020-10-15|10
e|FA|bad01879-9b97-4d9c-9eec-58871168bd57|2|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|Shock Wave|[?]|1|fmol|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|UNILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|WASHOUT|2020-10-15|10
e|FA|bad01879-9b97-4d9c-9eec-58871168bd57|3|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|ug/kg/day|[?]|1|cmH2O/mL|ENDOMETRIAL CAVITY|LEFT|||SIBLING|2|Visit_2|25|7|TREATMENT|2020-10-30|25
e|FA|bad01879-9b97-4d9c-9eec-58871168bd57|4|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mol/g|[?]|1|CUP|AORTIC VALVE ANNULUS|LATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|SCREENING|2020-10-30|25
e|FA|bad01879-9b97-4d9c-9eec-58871168bd57|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/dose|[?]|1|U/mmol|RIGHT VENTRICULAR BRANCH|UNILATERAL|||GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-11-14|40
e|FA|bad01879-9b97-4d9c-9eec-58871168bd57|6|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|Rad|[?]|1|MBq|TRICUSPID VALVE, POSTERIOR CUSP|UNILATERAL|||SIGNIFICANT OTHER|3|Visit_3|40|4|WASHOUT|2020-11-14|40
e|FA|bad01879-9b97-4d9c-9eec-58871168bd57|7|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|ms/mmHg|[?]|1|gtt|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|UNILATERAL|||FRIEND|4|Visit_4|65|5|TREATMENT|2020-12-09|65
e|FA|bad01879-9b97-4d9c-9eec-58871168bd57|8|CALBURN|Calories Burned|[?]|GERD|[?]|MHz|[?]|1|/kg|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|LATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|SCREENING|2020-12-09|65
e|FA|bad01879-9b97-4d9c-9eec-58871168bd57|9|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|km/h|[?]|1|10^6 CFU/mL|T4 VERTEBRA|RIGHT||Y|SIBLING|5|Visit_5|90|2|TREATMENT|2021-01-03|90
e|FA|bad01879-9b97-4d9c-9eec-58871168bd57|10|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|BAU/mL|[?]|1|BP|WRIST JOINT FLEXOR TENDONS|IPSILATERAL|||CHILD|5|Visit_5|90|3|SCREENING|2021-01-03|90
e|FA|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|1|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|umol/kg/min|[?]|1|uL/kg/day|MIDBRAIN|LEFT|Y||CLINICAL STUDY SPONSOR|1|Visit_1|10|1|SCREENING|2020-11-05|10
e|FA|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|2|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|ug|[?]|1|mmHg/L/min|PALPEBRAL CONJUNCTIVA|BILATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|3|WASHOUT|2020-11-05|10
e|FA|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|3|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|mg/g/min|[?]|1|mm/h|BLADDER WALL|BILATERAL|||CHILD|2|Visit_2|25|7|TREATMENT|2020-11-20|25
e|FA|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|4|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|deg/mm|[?]|1|IU/mmol|PLEURA|BILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|1|FOLLOW-UP|2020-11-20|25
e|FA|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Bq/g|[?]|1|mg/g/min|SKIN OF THE AXILLA|CONTRALATERAL||Y|FAMILY MEMBER|3|Visit_3|40|7|FOLLOW-UP|2020-12-05|40
e|FA|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|6|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|mg/dose|NAIL BED|UNILATERAL|||PARENT|3|Visit_3|40|2|TREATMENT|2020-12-05|40
e|FA|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|amol|[?]|1|mg/g/min|ANAL CANAL|BILATERAL|Y||STUDY SUBJECT|4|Visit_4|65|6|SCREENING|2020-12-30|65
e|FA|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|8|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|fg|[?]|1|umol|PROSTATE GLAND, LATERAL LOBE|LEFT||Y|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2020-12-30|65
e|FA|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|9|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|CONTAINER|[?]|1|L|HEART, LEFT VENTRICULAR OUTFLOW TRACT|RIGHT|Y||INTERVIEWER|5|Visit_5|90|2|FOLLOW-UP|2021-01-24|90
e|FA|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|10|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|10^7 PFU|[?]|1|PFU/dose|KNEE JOINT|UNILATERAL|||SIBLING|5|Visit_5|90|2|FOLLOW-UP|2021-01-24|90
e|FA|0df77775-6e65-4f77-9f8f-7faaa1471141|1|ACNDEV|Action Taken With Device|[?]|GERD|[?]|BEAM BREAKS|[?]|1|100 IU/mL|HILAR LYMPH NODE|RIGHT|Y||SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-08-24|10
e|FA|0df77775-6e65-4f77-9f8f-7faaa1471141|2|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|mL/min/1.73m2|[?]|1|mAmp|CARPOMETACARPAL JOINT|UNILATERAL|Y||GUARDIAN|1|Visit_1|10|1|FOLLOW-UP|2020-08-24|10
e|FA|0df77775-6e65-4f77-9f8f-7faaa1471141|3|ACNSBJ|Action Taken With Subject|[?]|GERD|[?]|10^9 CFU/g|[?]|1|Gy/h|INTERPHALANGEAL JOINT 5 OF THE FOOT|BILATERAL|Y||SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2020-09-08|25
e|FA|0df77775-6e65-4f77-9f8f-7faaa1471141|4|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|mL/m2/min|[?]|1|EIA unit|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|BILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-09-08|25
e|FA|0df77775-6e65-4f77-9f8f-7faaa1471141|5|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|PUFF|[?]|1|U/mmol|SYMPATHETIC GANGLIA|LEFT|||PROXY|3|Visit_3|40|3|TREATMENT|2020-09-23|40
e|FA|0df77775-6e65-4f77-9f8f-7faaa1471141|6|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|U/L|[?]|1|IU/mg|MASTOID PROCESS|IPSILATERAL||Y|SIGNIFICANT OTHER|3|Visit_3|40|2|SCREENING|2020-09-23|40
e|FA|0df77775-6e65-4f77-9f8f-7faaa1471141|7|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|kBq/uL|[?]|1|oz eq|FEMORAL NECK|CONTRALATERAL||Y|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2020-10-18|65
e|FA|0df77775-6e65-4f77-9f8f-7faaa1471141|8|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|PFU/mL|[?]|1|mEq|LEFT CIRCUMFLEX CORONARY ARTERY|LATERAL|||INTERVIEWER|4|Visit_4|65|1|WASHOUT|2020-10-18|65
e|FA|0df77775-6e65-4f77-9f8f-7faaa1471141|9|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|RFU|[?]|1|10^4 CFU/mL|CALF|CONTRALATERAL|||SIBLING|5|Visit_5|90|2|SCREENING|2020-11-12|90
e|FA|0df77775-6e65-4f77-9f8f-7faaa1471141|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|FFU|[?]|1|oz eq|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|BILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|FOLLOW-UP|2020-11-12|90
e|FA|adc5359a-f1d5-428b-97d8-fce67cfeeaea|1|TOXGR|Toxicity Grade|[?]|GERD|[?]|ug|[?]|1|aMFI|SKULL, BASE|IPSILATERAL|||PROXY|1|Visit_1|10|5|TREATMENT|2020-08-22|10
e|FA|adc5359a-f1d5-428b-97d8-fce67cfeeaea|2|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mOsm/kg|[?]|1|%(v/v)|SCAPHOID-RADIUS JOINT|CONTRALATERAL|||STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2020-08-22|10
e|FA|adc5359a-f1d5-428b-97d8-fce67cfeeaea|3|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|kg/m2|[?]|1|mL/100g/min|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|RIGHT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-09-06|25
e|FA|adc5359a-f1d5-428b-97d8-fce67cfeeaea|4|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|mg/m2/h|[?]|1|PFU/dose|VENA CAVA|IPSILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2020-09-06|25
e|FA|adc5359a-f1d5-428b-97d8-fce67cfeeaea|5|ACNDEV|Action Taken With Device|[?]|GERD|[?]|Pa|[?]|1|100 IU/mL|SCAPHOID-LUNATE JOINT|LATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|7|SCREENING|2020-09-21|40
e|FA|adc5359a-f1d5-428b-97d8-fce67cfeeaea|6|EVENTNUM|Number of Events|[?]|GERD|[?]|psi|[?]|1|U/10^12 RBC|PROCERUS MUSCLE|RIGHT||Y|FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-09-21|40
e|FA|adc5359a-f1d5-428b-97d8-fce67cfeeaea|7|DFATM|Dietary Fat, Monounsaturated|[?]|PRE-SPECIFIED AE|[?]|mm/2h|[?]|1|g/day|URETHRA, PROSTATIC|UNILATERAL|||PROXY|4|Visit_4|65|1|WASHOUT|2020-10-16|65
e|FA|adc5359a-f1d5-428b-97d8-fce67cfeeaea|8|LOCONSET|Localization of Onset|[?]|GERD|[?]|GBq/g|[?]|1|g/L|FIBULA SHAFT|CONTRALATERAL||Y|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2020-10-16|65
e|FA|adc5359a-f1d5-428b-97d8-fce67cfeeaea|9|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|m/sec2|[?]|1|10^6/L|SCAPHOID-LUNATE JOINT|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2020-11-10|90
e|FA|adc5359a-f1d5-428b-97d8-fce67cfeeaea|10|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|dB|[?]|1|gtt|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|||CAREGIVER|5|Visit_5|90|1|TREATMENT|2020-11-10|90
e|FA|cd68296c-95d4-489e-8b64-b2404f16316c|1|DFATT|Dietary Fat, Total|[?]|GERD|[?]|fmol|[?]|1|Bq/mg|PRONATOR TERES MUSCLE|LATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-12-20|10
e|FA|cd68296c-95d4-489e-8b64-b2404f16316c|2|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|/day|[?]|1|mL/h|GINGIVA|RIGHT||Y|FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-12-20|10
e|FA|cd68296c-95d4-489e-8b64-b2404f16316c|3|RLDEV|Relationship to Device|[?]|GERD|[?]|10^4/L|[?]|1|mL/min/mmHg|CORNEA|LATERAL|||SPOUSE|2|Visit_2|25|1|TREATMENT|2021-01-04|25
e|FA|cd68296c-95d4-489e-8b64-b2404f16316c|4|OBJTYPE|Type of Object|[?]|PRE-SPECIFIED AE|[?]|uEq|[?]|1|ng|PROXIMAL PHALANX 3 OF THE HAND|CONTRALATERAL|||CHILD|2|Visit_2|25|4|TREATMENT|2021-01-04|25
e|FA|cd68296c-95d4-489e-8b64-b2404f16316c|5|CALBURN|Calories Burned|[?]|GERD|[?]|PFU/dose|[?]|1|/kg|KIDNEY, CORTEX|LEFT|||PROXY|3|Visit_3|40|3|WASHOUT|2021-01-19|40
e|FA|cd68296c-95d4-489e-8b64-b2404f16316c|6|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|L/min/m2|[?]|1|g/L|INFERIOR VENA CAVA|UNILATERAL||Y|VENDOR|3|Visit_3|40|5|TREATMENT|2021-01-19|40
e|FA|cd68296c-95d4-489e-8b64-b2404f16316c|7|STRCTNUM|Number of Strictures|[?]|GERD|[?]|TRACE|[?]|1|SACHET|OMENTUM|IPSILATERAL||Y|ADJUDICATION COMMITTEE|4|Visit_4|65|5|WASHOUT|2021-02-13|65
e|FA|cd68296c-95d4-489e-8b64-b2404f16316c|8|DFATT|Dietary Fat, Total|[?]|GERD|[?]|POUCH|[?]|1|Bq/mg|ENDOCERVIX|UNILATERAL|Y|Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|TREATMENT|2021-02-13|65
e|FA|cd68296c-95d4-489e-8b64-b2404f16316c|9|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|g/cage/day|[?]|1|TRANSDUCING UNIT/mL|EYELASH|UNILATERAL|||STUDY SUBJECT|5|Visit_5|90|1|TREATMENT|2021-03-10|90
e|FA|cd68296c-95d4-489e-8b64-b2404f16316c|10|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|ft|[?]|1|mg/h|ABDUCTOR DIGITI QUINTI MUSCLE|BILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-03-10|90
e|FA|fe137506-d1ce-4b08-a043-9366d86c421e|1|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|pmol/10^9 cells|[?]|1|g/dL|RENAL ARTERY|IPSILATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|6|WASHOUT|2020-07-03|10
e|FA|fe137506-d1ce-4b08-a043-9366d86c421e|2|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|mmol/min/kPa|[?]|1|vp/dose|TEMPOROMANDIBULAR JOINT|UNILATERAL|Y||SIBLING|1|Visit_1|10|5|TREATMENT|2020-07-03|10
e|FA|fe137506-d1ce-4b08-a043-9366d86c421e|3|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|ppb|[?]|1|10^6 CFU|FEMALE REPRODUCTIVE SYSTEM|IPSILATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|WASHOUT|2020-07-18|25
e|FA|fe137506-d1ce-4b08-a043-9366d86c421e|4|EVENTNUM|Number of Events|[?]|GERD|[?]|PA|[?]|1|U/10^12 RBC|FACE|LEFT|||CAREGIVER|2|Visit_2|25|4|TREATMENT|2020-07-18|25
e|FA|fe137506-d1ce-4b08-a043-9366d86c421e|5|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|nmol/day|[?]|1|mL/cm3/min|BLADDER, FUNDUS|RIGHT|Y||SIGNIFICANT OTHER|3|Visit_3|40|7|FOLLOW-UP|2020-08-02|40
e|FA|fe137506-d1ce-4b08-a043-9366d86c421e|6|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|ka_u/dL|[?]|1|cmH2O/mL|PROXIMAL INTERPHALANGEAL JOINT 3|CONTRALATERAL|Y|Y|SIBLING|3|Visit_3|40|7|FOLLOW-UP|2020-08-02|40
e|FA|fe137506-d1ce-4b08-a043-9366d86c421e|7|EVENTNUM|Number of Events|[?]|GERD|[?]|mg/cm2|[?]|1|U/10^12 RBC|LESSER TROCHANTER|BILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|7|WASHOUT|2020-08-27|65
e|FA|fe137506-d1ce-4b08-a043-9366d86c421e|8|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|%/s|[?]|1|SACHET|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|CONTRALATERAL||Y|GUARDIAN|4|Visit_4|65|2|TREATMENT|2020-08-27|65
e|FA|fe137506-d1ce-4b08-a043-9366d86c421e|9|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|uSiemens|[?]|1|g/cage/day|NECK|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-09-21|90
e|FA|fe137506-d1ce-4b08-a043-9366d86c421e|10|EVENTFRQ|Event Frequency|[?]|GERD|[?]|dpm/0.5 mL|[?]|1|ug/kg/h|WRIST JOINT FLEXOR MUSCLES|UNILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|TREATMENT|2020-09-21|90
e|FA|b112c524-42c8-4e9e-8699-209e739972a7|1|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|%/min|[?]|1|Bq/L|SHIN|RIGHT||Y|VENDOR|1|Visit_1|10|5|FOLLOW-UP|2021-01-03|10
e|FA|b112c524-42c8-4e9e-8699-209e739972a7|2|STRCTNUM|Number of Strictures|[?]|GERD|[?]|PIXEL|[?]|1|SACHET|INTERPHALANGEAL JOINT OF THE HAND|LATERAL|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2021-01-03|10
e|FA|b112c524-42c8-4e9e-8699-209e739972a7|3|QOLIMP|QOL Impact|[?]|PRE-SPECIFIED AE|[?]|ug/animal|[?]|1|10^6/L|GLOSSOPHARYNGEAL NERVE|LATERAL|Y||ADJUDICATOR|2|Visit_2|25|2|WASHOUT|2021-01-18|25
e|FA|b112c524-42c8-4e9e-8699-209e739972a7|4|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|Weber|[?]|1|/500 WBC|RIB 12|RIGHT|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2021-01-18|25
e|FA|b112c524-42c8-4e9e-8699-209e739972a7|5|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/g|[?]|1|Coulomb|POPLITEAL LYMPH NODE|BILATERAL|||PROXY|3|Visit_3|40|5|FOLLOW-UP|2021-02-02|40
e|FA|b112c524-42c8-4e9e-8699-209e739972a7|6|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|CYLINDER|[?]|1|BOWL|CHEEK|CONTRALATERAL|Y||SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2021-02-02|40
e|FA|b112c524-42c8-4e9e-8699-209e739972a7|7|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|AU/mL|[?]|1|mg/h|GREAT VESSELS|LEFT|Y||PROXY|4|Visit_4|65|6|TREATMENT|2021-02-27|65
e|FA|b112c524-42c8-4e9e-8699-209e739972a7|8|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|ug/g/min|[?]|1|TRANSDUCING UNIT/mL|FIBULAR VEIN|RIGHT|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|FOLLOW-UP|2021-02-27|65
e|FA|b112c524-42c8-4e9e-8699-209e739972a7|9|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|mN|[?]|1|fmol|PLEURAL CAVITY|LATERAL|||CAREGIVER|5|Visit_5|90|7|FOLLOW-UP|2021-03-24|90
e|FA|b112c524-42c8-4e9e-8699-209e739972a7|10|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|10^6 CFU|[?]|1|Shock Wave|INFRACLAVICULAR LYMPH NODE|UNILATERAL|Y||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-03-24|90
e|FA|e6e32df8-8b66-49a5-a626-fd385297dd6f|1|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|/h|[?]|1|IU/mg|GINGIVA|BILATERAL|||VENDOR|1|Visit_1|10|4|TREATMENT|2020-09-02|10
e|FA|e6e32df8-8b66-49a5-a626-fd385297dd6f|2|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|uOsm|[?]|1|EIA unit|LATERAL RAMUS INTERMEDIUS ARTERY|UNILATERAL|||PARENT|1|Visit_1|10|3|FOLLOW-UP|2020-09-02|10
e|FA|e6e32df8-8b66-49a5-a626-fd385297dd6f|3|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|kBq|[?]|1|10^6 CFU/mL|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-09-17|25
e|FA|e6e32df8-8b66-49a5-a626-fd385297dd6f|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|mmol/s|[?]|1|%(v/v)|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|UNILATERAL|Y||GUARDIAN|2|Visit_2|25|2|FOLLOW-UP|2020-09-17|25
e|FA|e6e32df8-8b66-49a5-a626-fd385297dd6f|5|DCAL|Dietary Calories|[?]|GERD|[?]|mL/cage|[?]|1|EIA unit|SKIN OF THE NECK|UNILATERAL|||SIBLING|3|Visit_3|40|1|TREATMENT|2020-10-02|40
e|FA|e6e32df8-8b66-49a5-a626-fd385297dd6f|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|%(w/w)|[?]|1|Pa|ABDOMINAL WALL|LATERAL|Y||INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-10-02|40
e|FA|e6e32df8-8b66-49a5-a626-fd385297dd6f|7|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|copies/uL|[?]|1|mg/dose|CERVIX UTERI|LEFT|||DOMESTIC PARTNER|4|Visit_4|65|4|SCREENING|2020-10-27|65
e|FA|e6e32df8-8b66-49a5-a626-fd385297dd6f|8|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|EVENTS|[?]|1|ug/kg/h|EYE BULGE|LATERAL|||VENDOR|4|Visit_4|65|6|FOLLOW-UP|2020-10-27|65
e|FA|e6e32df8-8b66-49a5-a626-fd385297dd6f|9|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|eq|[?]|1|mEq/g|ILIOTIBIAL BAND|RIGHT|||SIGNIFICANT OTHER|5|Visit_5|90|6|WASHOUT|2020-11-21|90
e|FA|e6e32df8-8b66-49a5-a626-fd385297dd6f|10|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|mg/L FEU|[?]|1|mAmp|EXTRAHEPATIC BILE DUCT|RIGHT|Y||SIGNIFICANT OTHER|5|Visit_5|90|7|FOLLOW-UP|2020-11-21|90
e|FA|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|1|OCCUR|Occurrence Indicator|[?]|GERD|[?]|U/g Hb|[?]|1|mg/g/min|VERTEBRAL ARTERY|UNILATERAL|Y||SIBLING|1|Visit_1|10|4|TREATMENT|2020-09-18|10
e|FA|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|2|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|Bq/kg|[?]|1|IU/mmol|SKIN OF THE CHIN|LEFT||Y|STUDY SUBJECT|1|Visit_1|10|1|WASHOUT|2020-09-18|10
e|FA|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/kg/day|[?]|1|mg/g/min|POSTERIOR TIBIAL ARTERY|RIGHT|Y||CAREGIVER|2|Visit_2|25|7|WASHOUT|2020-10-03|25
e|FA|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|4|DPROT|Dietary Protein|[?]|GERD|[?]|pmol/L|[?]|1|10^4 CFU/mL|CARPAL BONE|LEFT|Y|Y|INTERVIEWER|2|Visit_2|25|6|FOLLOW-UP|2020-10-03|25
e|FA|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|5|ENDPTIND|Endpoint Event Indicator|[?]|GERD|[?]|mL/s|[?]|1|PACK|MITRAL VALVE, POSTERIOR CUSP|LEFT|Y|Y|GUARDIAN|3|Visit_3|40|7|SCREENING|2020-10-18|40
e|FA|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|6|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit/dose|[?]|1|ohm|SKIN OF THE NECK|IPSILATERAL|Y|Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-10-18|40
e|FA|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|7|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|/500 WBC|[?]|1|m2|OPPONENS POLLICIS MUSCLE|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-11-12|65
e|FA|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|8|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|Shock Wave|DISTAL PHALANX 4 OF THE HAND|BILATERAL|||SIBLING|4|Visit_4|65|7|SCREENING|2020-11-12|65
e|FA|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|9|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|ug/L DDU|[?]|1|ohm|LOWER GASTROINTESTINAL TRACT LYMPH NODE|CONTRALATERAL|||VENDOR|5|Visit_5|90|7|TREATMENT|2020-12-07|90
e|FA|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|10|HOSPNUM|Number Of Hospitalizations|[?]|PRE-SPECIFIED AE|[?]|Bq/g|[?]|1|IU/mg|ANUS|CONTRALATERAL|Y|Y|FAMILY MEMBER|5|Visit_5|90|6|WASHOUT|2020-12-07|90
e|FA|5002de57-45df-4525-a6b7-b6cc33c22229|1|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|IU/g|[?]|1|CUP|PROXIMAL CIRCUMFLEX ARTERY|UNILATERAL||Y|SIBLING|1|Visit_1|10|5|FOLLOW-UP|2021-01-12|10
e|FA|5002de57-45df-4525-a6b7-b6cc33c22229|2|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|L/h/m2|[?]|1|mg/dose|AMYGDALA|UNILATERAL|||CAREGIVER|1|Visit_1|10|1|TREATMENT|2021-01-12|10
e|FA|5002de57-45df-4525-a6b7-b6cc33c22229|3|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|mEq/kg|[?]|1|Log10 ELISA unit|LOCUS CERULEUS|LEFT|||SPOUSE|2|Visit_2|25|5|TREATMENT|2021-01-27|25
e|FA|5002de57-45df-4525-a6b7-b6cc33c22229|4|LENRSCT|Length of Resection|[?]|PRE-SPECIFIED AE|[?]|HOURS|[?]|1|psi|INSULAR CORTEX|LATERAL|||STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2021-01-27|25
e|FA|5002de57-45df-4525-a6b7-b6cc33c22229|5|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|P|[?]|1|Coulomb|DISTAL INTERPHALANGEAL JOINT 3|CONTRALATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|FOLLOW-UP|2021-02-11|40
e|FA|5002de57-45df-4525-a6b7-b6cc33c22229|6|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|mEq/ug|[?]|1|uCi/kg|FORELIMB|RIGHT|||VENDOR|3|Visit_3|40|2|TREATMENT|2021-02-11|40
e|FA|5002de57-45df-4525-a6b7-b6cc33c22229|7|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|g/m2/day|[?]|1|h*%|FINGERNAIL|IPSILATERAL|Y|Y|SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2021-03-08|65
e|FA|5002de57-45df-4525-a6b7-b6cc33c22229|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|km/h|[?]|1|Pa|PERINEUM|LATERAL||Y|PARENT|4|Visit_4|65|6|FOLLOW-UP|2021-03-08|65
e|FA|5002de57-45df-4525-a6b7-b6cc33c22229|9|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|Gravitational Unit|[?]|1|U/mmol|AORTIC ARCH|IPSILATERAL||Y|FAMILY MEMBER|5|Visit_5|90|7|FOLLOW-UP|2021-04-02|90
e|FA|5002de57-45df-4525-a6b7-b6cc33c22229|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|DRINK|[?]|1|Pa|VESTIBULOCOCHLEAR NERVE|CONTRALATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2021-04-02|90
e|FA|298f2081-bb11-4856-9e88-4be3b9b2250d|1|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mL/min|[?]|1|U/mg|DISTANT LYMPH NODE|IPSILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-10-05|10
e|FA|298f2081-bb11-4856-9e88-4be3b9b2250d|2|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mmHg/L/min|[?]|1|CUP|AORTA|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|3|FOLLOW-UP|2020-10-05|10
e|FA|298f2081-bb11-4856-9e88-4be3b9b2250d|3|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|pL|[?]|1|umol|MANDIBLE|UNILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-10-20|25
e|FA|298f2081-bb11-4856-9e88-4be3b9b2250d|4|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|nkat/L|[?]|1|10^6 CFU|THYROID GLAND, LEFT LOBE|IPSILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-10-20|25
e|FA|298f2081-bb11-4856-9e88-4be3b9b2250d|5|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|nL|[?]|1|PFU/dose|UPPER CERVICAL LYMPH NODE|RIGHT|Y||ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-11-04|40
e|FA|298f2081-bb11-4856-9e88-4be3b9b2250d|6|EXCINTSY|Exercise Intensity|[?]|PRE-SPECIFIED AE|[?]|tsp eq|[?]|1|AU/mL|FALLOPIAN TUBE|RIGHT|||SIGNIFICANT OTHER|3|Visit_3|40|3|FOLLOW-UP|2020-11-04|40
e|FA|298f2081-bb11-4856-9e88-4be3b9b2250d|7|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|L/s|[?]|1|10^6 CFU|PYRAMIDAL TRACTS, INTERNAL CAPSULE|LEFT|Y||PROXY|4|Visit_4|65|2|FOLLOW-UP|2020-11-29|65
e|FA|298f2081-bb11-4856-9e88-4be3b9b2250d|8|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|mEq|[?]|1|ug/m2/h|HEART, VENTRICLE|RIGHT|||STUDY SUBJECT|4|Visit_4|65|7|SCREENING|2020-11-29|65
e|FA|298f2081-bb11-4856-9e88-4be3b9b2250d|9|EXCDUR|Exercise Duration|[?]|GERD|[?]|10^9 CFU/g|[?]|1|mm|TRICUSPID VALVE ANNULUS|BILATERAL|||INTERVIEWER|5|Visit_5|90|7|FOLLOW-UP|2020-12-24|90
e|FA|298f2081-bb11-4856-9e88-4be3b9b2250d|10|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|Enzyme U/m2|[?]|1|mg/dose|INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL||Y|PARENT|5|Visit_5|90|5|SCREENING|2020-12-24|90
e|FA|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|1|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|BP|[?]|1|mL/animal/day|SKIN OF THE FINGER|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|4|WASHOUT|2020-12-29|10
e|FA|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|2|SEV|Severity/Intensity|[?]|GERD|[?]|Ci/mL|[?]|1|Pa|INTERNAL ILIAC ARTERY|IPSILATERAL|||CAREGIVER|1|Visit_1|10|6|FOLLOW-UP|2020-12-29|10
e|FA|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|3|VOL|Volume|[?]|GERD|[?]|kcal|[?]|1|vp/dose|POPLITEAL LYMPH NODE|LATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|6|SCREENING|2021-01-13|25
e|FA|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|4|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|FINGERTIP UNIT|[?]|1|Shock Wave|GUT-ASSOCIATED LYMPHOID TISSUE|LATERAL|Y||SPOUSE|2|Visit_2|25|2|TREATMENT|2021-01-13|25
e|FA|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|kat|[?]|1|Pa|HUMERUS|LATERAL|Y|Y|PARENT|3|Visit_3|40|4|WASHOUT|2021-01-28|40
e|FA|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|6|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|%/min|[?]|1|IU/mmol|SCAPHOID-RADIUS JOINT|BILATERAL|||SPOUSE|3|Visit_3|40|6|FOLLOW-UP|2021-01-28|40
e|FA|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|7|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|mg/dose|[?]|1|uCi/kg|T5 VERTEBRA|IPSILATERAL|Y|Y|FRIEND|4|Visit_4|65|1|TREATMENT|2021-02-22|65
e|FA|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cm H2O|[?]|1|mg/g/min|SKIN OF THE BACK|LEFT||Y|SIBLING|4|Visit_4|65|3|WASHOUT|2021-02-22|65
e|FA|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|9|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|CCID 50/mL|[?]|1|mL/100g/min|URETHRAL SPHINCTER|LEFT|||PARENT|5|Visit_5|90|4|FOLLOW-UP|2021-03-19|90
e|FA|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|10|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|mm/2h|[?]|1|Ci/ug|HAIR SHAFT|CONTRALATERAL|Y||CHILD|5|Visit_5|90|2|WASHOUT|2021-03-19|90
e|FA|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|1|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|fmol/L|[?]|1|mIU/L|JAW|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-05-12|10
e|FA|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|2|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|U/animal|[?]|1|mL/cm3/min|PANCREAS|RIGHT|||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|TREATMENT|2020-05-12|10
e|FA|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|3|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|km|[?]|1|mL/animal/day|INCUS|RIGHT||Y|PROXY|2|Visit_2|25|3|TREATMENT|2020-05-27|25
e|FA|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|4|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|ukat/10^12 RBC|[?]|1|BAG|SMALL INTESTINE|LEFT||Y|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-05-27|25
e|FA|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|5|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mgEq|[?]|1|mg/g/min|LEFT POSTERIOR DESCENDING ARTERY|RIGHT||Y|ADJUDICATION COMMITTEE|3|Visit_3|40|5|WASHOUT|2020-06-11|40
e|FA|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|6|EVENTFRQ|Event Frequency|[?]|PRE-SPECIFIED AE|[?]|10^3 copies/mL|[?]|1|ug/kg/h|SKIN OF THE LOWER LIMB|BILATERAL|||CAREGIVER|3|Visit_3|40|1|TREATMENT|2020-06-11|40
e|FA|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|7|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|pmol/dL|[?]|1|mL/m2|SUPERIOR VENA CAVA|RIGHT|Y|Y|VENDOR|4|Visit_4|65|4|SCREENING|2020-07-06|65
e|FA|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|8|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/kg/min|[?]|1|mg/g/min|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|WASHOUT|2020-07-06|65
e|FA|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|9|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|Joule|[?]|1|gtt|FALCIFORM LIGAMENT|BILATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2020-07-31|90
e|FA|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|10|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|ug/kg|[?]|1|MBq|BRACHIOCEPHALIC ARTERY|BILATERAL|||STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2020-07-31|90
e|FA|18c21176-db5e-4650-a1af-beb2042c31d8|1|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|nL|[?]|1|PFU/dose|TRIANGULAR-HAMATE JOINT|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-08-30|10
e|FA|18c21176-db5e-4650-a1af-beb2042c31d8|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|10^6 organisms/mg|[?]|1|TRANSDUCING UNIT/mL|ISCHIORECTAL FOSSA|LATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|6|SCREENING|2020-08-30|10
e|FA|18c21176-db5e-4650-a1af-beb2042c31d8|3|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|Gy|[?]|1|mL/m2|MESENTERY|LEFT|||INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-09-14|25
e|FA|18c21176-db5e-4650-a1af-beb2042c31d8|4|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|Rad|[?]|1|DROP|FASCIA|IPSILATERAL|Y||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|WASHOUT|2020-09-14|25
e|FA|18c21176-db5e-4650-a1af-beb2042c31d8|5|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|/2000 RBC|[?]|1|cm|ASCENDING AORTA, SINUS OF VALSALVA|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-09-29|40
e|FA|18c21176-db5e-4650-a1af-beb2042c31d8|6|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|dpm/mL|[?]|1|10^6 CFU|INTRAHEPATIC BILE DUCT|LEFT||Y|CHILD|3|Visit_3|40|6|SCREENING|2020-09-29|40
e|FA|18c21176-db5e-4650-a1af-beb2042c31d8|7|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|mol/mol|[?]|1|Bq/L|SUBSCAPULARIS MUSCLE|LEFT|Y||DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2020-10-24|65
e|FA|18c21176-db5e-4650-a1af-beb2042c31d8|8|DMEAT|Dietary Meat|[?]|PRE-SPECIFIED AE|[?]|APL U|[?]|1|10^6 organisms/mL|AORTOCAVAL LYMPH NODE|LEFT|||PARENT|4|Visit_4|65|1|WASHOUT|2020-10-24|65
e|FA|18c21176-db5e-4650-a1af-beb2042c31d8|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|cL|[?]|1|mg/g/min|FINGER|UNILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2020-11-18|90
e|FA|18c21176-db5e-4650-a1af-beb2042c31d8|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|APS U|[?]|1|mg/g/min|SPLEEN|RIGHT|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-11-18|90
e|FA|7808abd1-7d6f-4090-aa08-916a804c95f5|1|SEV|Severity/Intensity|[?]|GERD|[?]|DPM|[?]|1|Pa|MID-RIGHT CORONARY ARTERY CONDUIT|BILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-06-20|10
e|FA|7808abd1-7d6f-4090-aa08-916a804c95f5|2|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|10^6 DNA copies/mL|[?]|1|U/mmol|MITRAL VALVE, ANTERIOR CUSP|IPSILATERAL|||PARENT|1|Visit_1|10|6|SCREENING|2020-06-20|10
e|FA|7808abd1-7d6f-4090-aa08-916a804c95f5|3|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mmol/g|[?]|1|%(v/v)|HEART, VENTRICULAR WALL|UNILATERAL||Y|CAREGIVER|2|Visit_2|25|2|WASHOUT|2020-07-05|25
e|FA|7808abd1-7d6f-4090-aa08-916a804c95f5|4|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|mL/g/min|[?]|1|gtt|FLANK|LATERAL|||INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-07-05|25
e|FA|7808abd1-7d6f-4090-aa08-916a804c95f5|5|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|anti-Xa IU|[?]|1|10^9 CFU/mL|SUBMANDIBULAR LYMPH NODE|BILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|SCREENING|2020-07-20|40
e|FA|7808abd1-7d6f-4090-aa08-916a804c95f5|6|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|tuberculin unit/mL|[?]|1|gtt|NAVICULAR BONE|UNILATERAL|Y|Y|CHILD|3|Visit_3|40|7|TREATMENT|2020-07-20|40
e|FA|7808abd1-7d6f-4090-aa08-916a804c95f5|7|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mL/breath|[?]|1|Weber|LOWER GASTROINTESTINAL TRACT LYMPH NODE|RIGHT|Y||VENDOR|4|Visit_4|65|7|TREATMENT|2020-08-14|65
e|FA|7808abd1-7d6f-4090-aa08-916a804c95f5|8|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|NEEDLE GAUGE|[?]|1|oz eq|PENIS, GLANS|IPSILATERAL|||FRIEND|4|Visit_4|65|3|TREATMENT|2020-08-14|65
e|FA|7808abd1-7d6f-4090-aa08-916a804c95f5|9|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|TAMPON|[?]|1|uCi/kg|RIB 4|CONTRALATERAL|||CAREGIVER|5|Visit_5|90|2|SCREENING|2020-09-08|90
e|FA|7808abd1-7d6f-4090-aa08-916a804c95f5|10|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/dL|[?]|1|mg/g/min|SALIVARY GLAND|UNILATERAL||Y|ADJUDICATOR|5|Visit_5|90|2|TREATMENT|2020-09-08|90
e|FA|57553b78-e761-4577-aae2-5c693a2dc303|1|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|10^9 organisms/mg|[?]|1|10^9 CFU/mL|FEMALE GENITALIA|CONTRALATERAL|||SIBLING|1|Visit_1|10|3|FOLLOW-UP|2021-01-01|10
e|FA|57553b78-e761-4577-aae2-5c693a2dc303|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Hz|[?]|1|mg/g/min|ADDUCTOR BREVIS MUSCLE|LATERAL|||CAREGIVER|1|Visit_1|10|2|TREATMENT|2021-01-01|10
e|FA|57553b78-e761-4577-aae2-5c693a2dc303|3|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|mg/m2/day|[?]|1|cmH2O/mL|SEBACEOUS GLAND|LEFT|Y||DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2021-01-16|25
e|FA|57553b78-e761-4577-aae2-5c693a2dc303|4|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|umol/L|[?]|1|fmol|SKIN OF THE CHEST|UNILATERAL|Y||INDEPENDENT ASSESSOR|2|Visit_2|25|2|FOLLOW-UP|2021-01-16|25
e|FA|57553b78-e761-4577-aae2-5c693a2dc303|5|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|Gy/min|[?]|1|HOURS|ILIAC LYMPH NODE|BILATERAL|||SPOUSE|3|Visit_3|40|4|FOLLOW-UP|2021-01-31|40
e|FA|57553b78-e761-4577-aae2-5c693a2dc303|6|CALBURN|Calories Burned|[?]|GERD|[?]|mL/animal|[?]|1|/kg|MAIN BRONCHUS, RIGHT|LATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|5|SCREENING|2021-01-31|40
e|FA|57553b78-e761-4577-aae2-5c693a2dc303|7|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|Siemens|[?]|1|Bq/L|LIP, LOWER|RIGHT|||CLINICAL STUDY SPONSOR|4|Visit_4|65|5|FOLLOW-UP|2021-02-25|65
e|FA|57553b78-e761-4577-aae2-5c693a2dc303|8|TTIMPHAC|Total Time Physically Active|[?]|PRE-SPECIFIED AE|[?]|Antibody Unit|[?]|1|IU/mmol|COCCYGEAL VERTEBRA|LEFT|Y||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-02-25|65
e|FA|57553b78-e761-4577-aae2-5c693a2dc303|9|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|NEEDLE GAUGE|SPLEEN, HILUM|IPSILATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|FOLLOW-UP|2021-03-22|90
e|FA|57553b78-e761-4577-aae2-5c693a2dc303|10|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|Anson U|[?]|1|mL/m2|SUBGLOTTIS|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2021-03-22|90
e|FA|40883550-4627-4f92-974a-7eeb5bde74c5|1|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/m2/h|[?]|1|Pa|GINGIVA|CONTRALATERAL||Y|PROXY|1|Visit_1|10|6|TREATMENT|2020-10-13|10
e|FA|40883550-4627-4f92-974a-7eeb5bde74c5|2|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|/mm|[?]|1|mAmp|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|LATERAL|Y|Y|INVESTIGATOR|1|Visit_1|10|3|TREATMENT|2020-10-13|10
e|FA|40883550-4627-4f92-974a-7eeb5bde74c5|3|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|U.CARR|[?]|1|PFU/dose|CARPOMETACARPAL JOINT 2|IPSILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-10-28|25
e|FA|40883550-4627-4f92-974a-7eeb5bde74c5|4|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|%(v/v)|TOE|LEFT|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|WASHOUT|2020-10-28|25
e|FA|40883550-4627-4f92-974a-7eeb5bde74c5|5|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|L|[?]|1|g/L|METACARPOPHALANGEAL JOINT 4|LATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|SCREENING|2020-11-12|40
e|FA|40883550-4627-4f92-974a-7eeb5bde74c5|6|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|10^9 CFU/g|AXILLARY LYMPH NODE LEVEL II|LATERAL|||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-11-12|40
e|FA|40883550-4627-4f92-974a-7eeb5bde74c5|7|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Watt|[?]|1|umol|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2020-12-07|65
e|FA|40883550-4627-4f92-974a-7eeb5bde74c5|8|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|MAC50|[?]|1|g/dL|TOE|UNILATERAL|Y||INDEPENDENT ASSESSOR|4|Visit_4|65|2|TREATMENT|2020-12-07|65
e|FA|40883550-4627-4f92-974a-7eeb5bde74c5|9|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|Roentgen|[?]|1|10^6 U|SUPRACLAVICULAR FOSSA|LEFT|||VENDOR|5|Visit_5|90|4|TREATMENT|2021-01-01|90
e|FA|40883550-4627-4f92-974a-7eeb5bde74c5|10|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|TCID 50/dose|[?]|1|BAG|PERICARDIAL WALL|LATERAL|||FRIEND|5|Visit_5|90|4|WASHOUT|2021-01-01|90
e|FA|4199b549-d021-4bfd-97e6-95630d407183|1|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|nCi|[?]|1|Hz/s|MID-RIGHT CORONARY ARTERY CONDUIT|CONTRALATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|7|SCREENING|2020-12-02|10
e|FA|4199b549-d021-4bfd-97e6-95630d407183|2|EPSDNUM|Number of Episodes|[?]|GERD|[?]|Log10 ELISA unit/dose|[?]|1|%(v/v)|RECTOSIGMOID JUNCTION|BILATERAL|||INTERVIEWER|1|Visit_1|10|7|FOLLOW-UP|2020-12-02|10
e|FA|4199b549-d021-4bfd-97e6-95630d407183|3|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|kIU|[?]|1|L|POPLITEAL ARTERY ABOVE KNEE|UNILATERAL||Y|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2020-12-17|25
e|FA|4199b549-d021-4bfd-97e6-95630d407183|4|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|/month|[?]|1|mmHg/L/min|MEDULLA OBLONGATA|LEFT|||FRIEND|2|Visit_2|25|6|TREATMENT|2020-12-17|25
e|FA|4199b549-d021-4bfd-97e6-95630d407183|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|cGy|[?]|1|%(v/v)|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL||Y|INDEPENDENT ASSESSOR|3|Visit_3|40|5|SCREENING|2021-01-01|40
e|FA|4199b549-d021-4bfd-97e6-95630d407183|6|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|breaths/min|[?]|1|uL/kg/day|SCLERA|UNILATERAL|||HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2021-01-01|40
e|FA|4199b549-d021-4bfd-97e6-95630d407183|7|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|10^12 IU/L|[?]|1|U/10^12 RBC|ENDOCARDIUM|UNILATERAL|Y||FRIEND|4|Visit_4|65|4|TREATMENT|2021-01-26|65
e|FA|4199b549-d021-4bfd-97e6-95630d407183|8|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|ug|[?]|1|mm/h|MEDIAL FEMORAL CONDYLE|LATERAL||Y|INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2021-01-26|65
e|FA|4199b549-d021-4bfd-97e6-95630d407183|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ohm|[?]|1|Pa|LUNG, LEFT|LEFT|||SIGNIFICANT OTHER|5|Visit_5|90|6|FOLLOW-UP|2021-02-20|90
e|FA|4199b549-d021-4bfd-97e6-95630d407183|10|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|10^3 organisms/mL|[?]|1|10^6 IU/mL|MAIN BRONCHUS, RIGHT|CONTRALATERAL|||STUDY SUBJECT|5|Visit_5|90|1|FOLLOW-UP|2021-02-20|90
e|FA|6366647f-62fa-48dc-9d77-1677fce62fc7|1|SPEED|Speed|[?]|GERD|[?]|U|[?]|1|mEq/g|DISTAL CIRCUMFLEX ARTERY|LATERAL||Y|PROXY|1|Visit_1|10|6|TREATMENT|2020-07-14|10
e|FA|6366647f-62fa-48dc-9d77-1677fce62fc7|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|nkat/g Hb|[?]|1|Pa|SPHENOID SINUS|LEFT|||ADJUDICATOR|1|Visit_1|10|1|FOLLOW-UP|2020-07-14|10
e|FA|6366647f-62fa-48dc-9d77-1677fce62fc7|3|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|mL/g/h|[?]|1|ohm|STERNEBRA|UNILATERAL||Y|VENDOR|2|Visit_2|25|5|TREATMENT|2020-07-29|25
e|FA|6366647f-62fa-48dc-9d77-1677fce62fc7|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mL/kg/h|[?]|1|Pa|CLAVICLE|LEFT||Y|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-07-29|25
e|FA|6366647f-62fa-48dc-9d77-1677fce62fc7|5|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|ft|[?]|1|cm H2O|BLADDER, TRIGONE|CONTRALATERAL|||FAMILY MEMBER|3|Visit_3|40|1|SCREENING|2020-08-13|40
e|FA|6366647f-62fa-48dc-9d77-1677fce62fc7|6|EPMLDNUM|Number of Mild Episodes|[?]|GERD|[?]|EU|[?]|1|g/cage/day|WRIST JOINT EXTENSOR TENDONS|CONTRALATERAL|Y|Y|DOMESTIC PARTNER|3|Visit_3|40|3|WASHOUT|2020-08-13|40
e|FA|6366647f-62fa-48dc-9d77-1677fce62fc7|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|uIU/dL|[?]|1|U/mmol|EPIDIDYMIS|RIGHT||Y|DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2020-09-07|65
e|FA|6366647f-62fa-48dc-9d77-1677fce62fc7|8|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|RFU|[?]|1|mg/h|WAIST|LEFT|||ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-09-07|65
e|FA|6366647f-62fa-48dc-9d77-1677fce62fc7|9|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|/100 WBC|[?]|1|Shock Wave|AORTIC VALVE, RIGHT CORONARY CUSP|CONTRALATERAL|Y|Y|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2020-10-02|90
e|FA|6366647f-62fa-48dc-9d77-1677fce62fc7|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|mL/kg/day|[?]|1|10^6 U|CAPITATE-HAMATE JOINT|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-10-02|90
e|FA|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|1|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|APPLICATION|[?]|1|SCOOPFUL|GREAT SAPHENOUS VEIN|RIGHT||Y|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|WASHOUT|2020-05-13|10
e|FA|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|2|LDIAM|Longest Diameter|[?]|GERD|[?]|dyn|[?]|1|Shock Wave|VERTEBRAL COLUMN|BILATERAL|||DOMESTIC PARTNER|1|Visit_1|10|3|WASHOUT|2020-05-13|10
e|FA|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|3|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|Enzyme U/g Hb|[?]|1|NEEDLE GAUGE|MESENTERIC LYMPH NODE|CONTRALATERAL|||INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-05-28|25
e|FA|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|/HPF|[?]|1|mg/g/min|DISTAL EXTRAHEPATIC BILE DUCT REGION|IPSILATERAL||Y|GUARDIAN|2|Visit_2|25|2|TREATMENT|2020-05-28|25
e|FA|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|5|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|VOXEL|[?]|1|QUANTITY SUFFICIENT|PALPEBRAL CONJUNCTIVA|UNILATERAL|||FRIEND|3|Visit_3|40|3|TREATMENT|2020-06-12|40
e|FA|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|log10 PFU|[?]|1|%(v/v)|RENAL PELVIS|UNILATERAL|||INTERVIEWER|3|Visit_3|40|4|TREATMENT|2020-06-12|40
e|FA|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|7|TOXGR|Toxicity Grade|[?]|GERD|[?]|mV*min|[?]|1|aMFI|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|IPSILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|3|SCREENING|2020-07-07|65
e|FA|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|8|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|ug/m2/min|[?]|1|Log10 ELISA unit|STERNAL MANUBRIUM|RIGHT||Y|GUARDIAN|4|Visit_4|65|7|WASHOUT|2020-07-07|65
e|FA|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|GERD|[?]|Ci/uL|[?]|1|mL/dose|CAPITATE-HAMATE JOINT|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|WASHOUT|2020-08-01|90
e|FA|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|10|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg|[?]|1|mL/min/mmHg|MEDULLA OBLONGATA|CONTRALATERAL||Y|GUARDIAN|5|Visit_5|90|3|WASHOUT|2020-08-01|90
e|FA|637d7d5f-78d3-47fb-b6dc-d877d92b9001|1|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|dpm/mg|[?]|1|mm|LATISSIMUS DORSI MUSCLE|BILATERAL|||INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-06-03|10
e|FA|637d7d5f-78d3-47fb-b6dc-d877d92b9001|2|ICJRIND|Ileocecal Junction Removed Indicator|[?]|GERD|[?]|vp/mL|[?]|1|mL/animal/day|OSTIOMEATAL COMPLEX|RIGHT|||CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2020-06-03|10
e|FA|637d7d5f-78d3-47fb-b6dc-d877d92b9001|3|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|PRESSOR UNITS|[?]|1|EIA unit|OBTURATOR EXTERNUS MUSCLE|LATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-06-18|25
e|FA|637d7d5f-78d3-47fb-b6dc-d877d92b9001|4|OUNIMULT|Onset Unifocal or Multifocal|[?]|PRE-SPECIFIED AE|[?]|vp/dose|[?]|1|10^6 IU/mL|EPIDIDYMIS|LATERAL|Y||CLINICAL STUDY SPONSOR|2|Visit_2|25|6|FOLLOW-UP|2020-06-18|25
e|FA|637d7d5f-78d3-47fb-b6dc-d877d92b9001|5|DEVPNUM|Number of Devices Present|[?]|PRE-SPECIFIED AE|[?]|fmol|[?]|1|anti-Xa IU/mL|INTERVENTRICULAR SEPTUM|BILATERAL|Y||GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-07-03|40
e|FA|637d7d5f-78d3-47fb-b6dc-d877d92b9001|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|JAR|[?]|1|%(v/v)|VASTUS MEDIALIS MUSCLE|LATERAL|||STUDY SUBJECT|3|Visit_3|40|4|TREATMENT|2020-07-03|40
e|FA|637d7d5f-78d3-47fb-b6dc-d877d92b9001|7|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|LOZENGE|[?]|1|EIA unit|TEMPORAL LOBE|LEFT|||SIBLING|4|Visit_4|65|4|TREATMENT|2020-07-28|65
e|FA|637d7d5f-78d3-47fb-b6dc-d877d92b9001|8|STRCTNUM|Number of Strictures|[?]|PRE-SPECIFIED AE|[?]|Arbitrary U|[?]|1|SACHET|HAND PHALANX|LATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-07-28|65
e|FA|637d7d5f-78d3-47fb-b6dc-d877d92b9001|9|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|PIXEL|[?]|1|mAmp|RETROCRURAL LYMPH NODE|CONTRALATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|SCREENING|2020-08-22|90
e|FA|637d7d5f-78d3-47fb-b6dc-d877d92b9001|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|umol/mol|[?]|1|Pa|TIBIO-PERONEAL TRUNK|RIGHT|||FAMILY MEMBER|5|Visit_5|90|3|SCREENING|2020-08-22|90
e|FA|696cd04a-cde7-4481-b5e2-fad1877ec284|1|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|RING|[?]|1|MPS U|ANAL CANAL|RIGHT|||INDEPENDENT ASSESSOR|1|Visit_1|10|4|WASHOUT|2020-08-31|10
e|FA|696cd04a-cde7-4481-b5e2-fad1877ec284|2|EXCMPLNC|Exercise Compliance|[?]|GERD|[?]|mAmp|[?]|1|ohm|FOOT|LATERAL||Y|PARENT|1|Visit_1|10|1|SCREENING|2020-08-31|10
e|FA|696cd04a-cde7-4481-b5e2-fad1877ec284|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/cage|[?]|1|mg/g/min|THYROID GLAND ISTHMUS|LEFT|||INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-09-15|25
e|FA|696cd04a-cde7-4481-b5e2-fad1877ec284|4|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|log EID 50/dose|[?]|1|/500 WBC|LYMPH NODE|CONTRALATERAL|Y||HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-09-15|25
e|FA|696cd04a-cde7-4481-b5e2-fad1877ec284|5|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|OD Unit|[?]|1|uCi/kg|HEART, APEX|IPSILATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-09-30|40
e|FA|696cd04a-cde7-4481-b5e2-fad1877ec284|6|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|PIXEL|[?]|1|PFU/dose|SACRAL TUBEROSITY|BILATERAL|||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-09-30|40
e|FA|696cd04a-cde7-4481-b5e2-fad1877ec284|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|FIU|[?]|1|Pa|EYE, ANTERIOR SEGMENT|CONTRALATERAL|Y||FAMILY MEMBER|4|Visit_4|65|5|SCREENING|2020-10-25|65
e|FA|696cd04a-cde7-4481-b5e2-fad1877ec284|8|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|mg/L FEU|[?]|1|mg/dose|SUDORIFEROUS GLAND|LATERAL|Y||CAREGIVER|4|Visit_4|65|4|SCREENING|2020-10-25|65
e|FA|696cd04a-cde7-4481-b5e2-fad1877ec284|9|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|nmol/mL/min|[?]|1|BP|SHOULDER|BILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|5|SCREENING|2020-11-19|90
e|FA|696cd04a-cde7-4481-b5e2-fad1877ec284|10|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|BOTTLE|[?]|1|cmH2O/mL|DISTAL EXTRAHEPATIC BILE DUCT REGION|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|SCREENING|2020-11-19|90
e|FA|ce4699cb-66f1-4c13-8428-84064255b765|1|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|Log10 ELISA unit/dose|[?]|1|Weber|RENAL ARTERY|BILATERAL|Y||STUDY SUBJECT|1|Visit_1|10|2|FOLLOW-UP|2020-12-02|10
e|FA|ce4699cb-66f1-4c13-8428-84064255b765|2|STEPSTN|Number of Steps Taken|[?]|GERD|[?]|ag|[?]|1|mAmp|ANTECUBITAL FOSSA|LEFT||Y|CAREGIVER|1|Visit_1|10|5|TREATMENT|2020-12-02|10
e|FA|ce4699cb-66f1-4c13-8428-84064255b765|3|LESNUM|Number of Lesions|[?]|GERD|[?]|Henry|[?]|1|ng/day|ABDUCENS NERVE|LATERAL||Y|PARENT|2|Visit_2|25|4|WASHOUT|2020-12-17|25
e|FA|ce4699cb-66f1-4c13-8428-84064255b765|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|uIU/dL|[?]|1|mL/dose|SKIN OF THE BENDING JOINT|RIGHT||Y|DOMESTIC PARTNER|2|Visit_2|25|2|WASHOUT|2020-12-17|25
e|FA|ce4699cb-66f1-4c13-8428-84064255b765|5|PPTFCT|Precipitating Factor|[?]|PRE-SPECIFIED AE|[?]|nsec|[?]|1|EIA unit|INTERNAL ILIAC ARTERY|RIGHT|Y||CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2021-01-01|40
e|FA|ce4699cb-66f1-4c13-8428-84064255b765|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^3 organisms/mL|[?]|1|mg/g/min|INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|||DOMESTIC PARTNER|3|Visit_3|40|1|FOLLOW-UP|2021-01-01|40
e|FA|ce4699cb-66f1-4c13-8428-84064255b765|7|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|fg|[?]|1|cmH2O/mL|PARATRACHEAL LYMPH NODE|UNILATERAL|||FAMILY MEMBER|4|Visit_4|65|4|SCREENING|2021-01-26|65
e|FA|ce4699cb-66f1-4c13-8428-84064255b765|8|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|MAC50|[?]|1|Pa|PELVIC LYMPH NODE|UNILATERAL|||DOMESTIC PARTNER|4|Visit_4|65|2|WASHOUT|2021-01-26|65
e|FA|ce4699cb-66f1-4c13-8428-84064255b765|9|LONGCRSE|Longitudinal Course|[?]|PRE-SPECIFIED AE|[?]|CAPLET|[?]|1|10^6 CFU|GLENOID FOSSA|LEFT||Y|DOMESTIC PARTNER|5|Visit_5|90|2|TREATMENT|2021-02-20|90
e|FA|ce4699cb-66f1-4c13-8428-84064255b765|10|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|kg/cm2|[?]|1|Bq/mg|CAUDAL VERTEBRA|BILATERAL|||CAREGIVER|5|Visit_5|90|1|TREATMENT|2021-02-20|90
e|FA|015b391b-23c7-478d-b9d1-226d3cb9edcf|1|CALBURN|Calories Burned|[?]|GERD|[?]|dpm/mg|[?]|1|/kg|T8 VERTEBRA|LEFT|||CAREGIVER|1|Visit_1|10|1|FOLLOW-UP|2020-11-29|10
e|FA|015b391b-23c7-478d-b9d1-226d3cb9edcf|2|OBJNUM|Number of Objects|[?]|GERD|[?]|mL/cage|[?]|1|mL/100g/min|ASCENDING AORTA, SINOTUBULAR JUNCTION|CONTRALATERAL|||INDEPENDENT ASSESSOR|1|Visit_1|10|5|TREATMENT|2020-11-29|10
e|FA|015b391b-23c7-478d-b9d1-226d3cb9edcf|3|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|kDa|[?]|1|mg/h|INTERVENTRICULAR SEPTUM|IPSILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|WASHOUT|2020-12-14|25
e|FA|015b391b-23c7-478d-b9d1-226d3cb9edcf|4|DPROT|Dietary Protein|[?]|GERD|[?]|mmHg|[?]|1|10^4 CFU/mL|T12 VERTEBRA|BILATERAL|||INTERVIEWER|2|Visit_2|25|6|TREATMENT|2020-12-14|25
e|FA|015b391b-23c7-478d-b9d1-226d3cb9edcf|5|EPSDNUM|Number of Episodes|[?]|GERD|[?]|kPa/L/sec|[?]|1|%(v/v)|SKIN AROUND THE MOUTH|BILATERAL|||GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-12-29|40
e|FA|015b391b-23c7-478d-b9d1-226d3cb9edcf|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|/ms|[?]|1|%(v/v)|LUNG, RIGHT LOWER LOBE|CONTRALATERAL|Y||FRIEND|3|Visit_3|40|3|TREATMENT|2020-12-29|40
e|FA|015b391b-23c7-478d-b9d1-226d3cb9edcf|7|DCAL|Dietary Calories|[?]|GERD|[?]|cs|[?]|1|EIA unit|GLUTEAL MUSCLE|LATERAL|Y|Y|INDEPENDENT ASSESSOR|4|Visit_4|65|5|FOLLOW-UP|2021-01-23|65
e|FA|015b391b-23c7-478d-b9d1-226d3cb9edcf|8|DIAMETER|Diameter|[?]|GERD|[?]|ug/L DDU|[?]|1|cm|DURAL VENOUS SINUS|LATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|5|TREATMENT|2021-01-23|65
e|FA|015b391b-23c7-478d-b9d1-226d3cb9edcf|9|LENRSCT|Length of Resection|[?]|GERD|[?]|10^6 organisms/g|[?]|1|psi|EYE, VITREOUS CHAMBER|UNILATERAL|||GUARDIAN|5|Visit_5|90|3|TREATMENT|2021-02-17|90
e|FA|015b391b-23c7-478d-b9d1-226d3cb9edcf|10|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|Bq/ug|[?]|1|10^6 U|THORACIC AORTA|LATERAL|||CHILD|5|Visit_5|90|2|WASHOUT|2021-02-17|90
e|FA|b510a277-c5ee-4a32-b111-b2dbc72c8a27|1|SERVNUM|Number of Servings|[?]|GERD|[?]|tuberculin unit/mL|[?]|1|Hz/s|HEART, LEFT VENTRICULAR WALL|IPSILATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-06-07|10
e|FA|b510a277-c5ee-4a32-b111-b2dbc72c8a27|2|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|mol/day|[?]|1|uL/kg/day|ESOPHAGUS, CERVICAL|LEFT|||DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-06-07|10
e|FA|b510a277-c5ee-4a32-b111-b2dbc72c8a27|3|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|nsec|[?]|1|cmH2O/mL|MAIN BRONCHUS, LEFT|LEFT||Y|FRIEND|2|Visit_2|25|3|TREATMENT|2020-06-22|25
e|FA|b510a277-c5ee-4a32-b111-b2dbc72c8a27|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|anti-Xa IU|[?]|1|Pa|RETINA|LATERAL|||SPOUSE|2|Visit_2|25|4|WASHOUT|2020-06-22|25
e|FA|b510a277-c5ee-4a32-b111-b2dbc72c8a27|5|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|mg/h|[?]|1|10^4 CFU/mL|LUNATE BONE|LATERAL|Y||INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-07-07|40
e|FA|b510a277-c5ee-4a32-b111-b2dbc72c8a27|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mol/mL|[?]|1|%(v/v)|GLOBUS PALLIDUS|CONTRALATERAL|||GUARDIAN|3|Visit_3|40|2|SCREENING|2020-07-07|40
e|FA|b510a277-c5ee-4a32-b111-b2dbc72c8a27|7|AGETRT1|Age At First Treatment|[?]|GERD|[?]|VIAL|[?]|1|mL/mmHg/min/L|THYROID GLAND, LEFT LOBE|LEFT|||STUDY SUBJECT|4|Visit_4|65|1|SCREENING|2020-08-01|65
e|FA|b510a277-c5ee-4a32-b111-b2dbc72c8a27|8|DVEG|Dietary Vegetable|[?]|GERD|[?]|h/wk|[?]|1|Ci/ug|PULMONARY VALVE, RIGHT CUSP|LEFT|||SIBLING|4|Visit_4|65|6|TREATMENT|2020-08-01|65
e|FA|b510a277-c5ee-4a32-b111-b2dbc72c8a27|9|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|pmol/L|[?]|1|Pa|UTERINE ARTERY|UNILATERAL|||ADJUDICATOR|5|Visit_5|90|1|FOLLOW-UP|2020-08-26|90
e|FA|b510a277-c5ee-4a32-b111-b2dbc72c8a27|10|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|steps/min|[?]|1|QUANTITY SUFFICIENT|TRUNK|BILATERAL||Y|FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2020-08-26|90
e|FA|9e9acf6b-d29a-4c11-96d6-b580c721f462|1|DRSTAT|Drug Resistance Status|[?]|PRE-SPECIFIED AE|[?]|g/animal/wk|[?]|1|BOWL|PUPIL|LEFT|||FAMILY MEMBER|1|Visit_1|10|2|FOLLOW-UP|2020-08-20|10
e|FA|9e9acf6b-d29a-4c11-96d6-b580c721f462|2|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|mL/g/h|[?]|1|h*%|SKIN BETWEEN EYEBROWS|LATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-08-20|10
e|FA|9e9acf6b-d29a-4c11-96d6-b580c721f462|3|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|TRACE|[?]|1|U/mmol|RIB|IPSILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|TREATMENT|2020-09-04|25
e|FA|9e9acf6b-d29a-4c11-96d6-b580c721f462|4|ESTWT|Estimated Weight|[?]|GERD|[?]|vp/mL|[?]|1|g/day|ISCHIORECTAL FOSSA|CONTRALATERAL|Y||NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|SCREENING|2020-09-04|25
e|FA|9e9acf6b-d29a-4c11-96d6-b580c721f462|5|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|g/animal/wk|[?]|1|PFU/dose|VESTIBULOCOCHLEAR NERVE|LATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|6|WASHOUT|2020-09-19|40
e|FA|9e9acf6b-d29a-4c11-96d6-b580c721f462|6|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|10^4 CFU/mL|TRACHEA|LEFT|||STUDY SUBJECT|3|Visit_3|40|6|FOLLOW-UP|2020-09-19|40
e|FA|9e9acf6b-d29a-4c11-96d6-b580c721f462|7|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|nkat/g Hb|[?]|1|IU/mmol|COMMON FEMORAL ARTERY|CONTRALATERAL|Y|Y|INTERVIEWER|4|Visit_4|65|4|TREATMENT|2020-10-14|65
e|FA|9e9acf6b-d29a-4c11-96d6-b580c721f462|8|NWSYMP|New or Worsening Symptoms|[?]|PRE-SPECIFIED AE|[?]|PUFF|[?]|1|mL/m2|HAND DIGIT 3|IPSILATERAL|Y|Y|FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2020-10-14|65
e|FA|9e9acf6b-d29a-4c11-96d6-b580c721f462|9|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|oz|[?]|1|100 IU/mL|L2-L3 INTERVERTEBRAL SPACE|BILATERAL||Y|DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-11-08|90
e|FA|9e9acf6b-d29a-4c11-96d6-b580c721f462|10|DFRUIT|Dietary Fruit|[?]|GERD|[?]|NEEDLE GAUGE|[?]|1|10^6 CFU/mL|PERIRECTAL LYMPH NODE|UNILATERAL|Y||INDEPENDENT ASSESSOR|5|Visit_5|90|4|WASHOUT|2020-11-08|90
e|FA|da69b157-7dab-49c5-b8fb-bd312a21fcf0|1|TOTNUM|Total Number|[?]|GERD|[?]|mol/L|[?]|1|/200 HPFs|ANAL VERGE|LATERAL|||STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-07-18|10
e|FA|da69b157-7dab-49c5-b8fb-bd312a21fcf0|2|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|WEEKS|[?]|1|aMFI|ISCHIORECTAL FOSSA|RIGHT|||INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-07-18|10
e|FA|da69b157-7dab-49c5-b8fb-bd312a21fcf0|3|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ng|[?]|1|%(v/v)|DORSAL MOTOR NUCLEUS|LEFT|||ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-08-02|25
e|FA|da69b157-7dab-49c5-b8fb-bd312a21fcf0|4|AGETRT1|Age At First Treatment|[?]|GERD|[?]|L/L|[?]|1|mL/mmHg/min/L|EXTRAOCULAR MUSCLE|RIGHT|||VENDOR|2|Visit_2|25|1|TREATMENT|2020-08-02|25
e|FA|da69b157-7dab-49c5-b8fb-bd312a21fcf0|5|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|EID 50/mL|[?]|1|10^4 CFU/mL|MALE REPRODUCTIVE SYSTEM|BILATERAL||Y|INTERVIEWER|3|Visit_3|40|6|FOLLOW-UP|2020-08-17|40
e|FA|da69b157-7dab-49c5-b8fb-bd312a21fcf0|6|EPMODNUM|Number of Moderate Episodes|[?]|GERD|[?]|g|[?]|1|NEEDLE GAUGE|FIRST RIGHT POSTEROLATERAL ARTERY|UNILATERAL|||PARENT|3|Visit_3|40|3|TREATMENT|2020-08-17|40
e|FA|da69b157-7dab-49c5-b8fb-bd312a21fcf0|7|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|mL/g/h|[?]|1|Log10 ELISA unit|C1 VERTEBRA|RIGHT|||STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-09-11|65
e|FA|da69b157-7dab-49c5-b8fb-bd312a21fcf0|8|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|mL/cm H2O|[?]|1|km|GASTRIC CURVATURE LYMPH NODE|CONTRALATERAL|||CHILD|4|Visit_4|65|5|TREATMENT|2020-09-11|65
e|FA|da69b157-7dab-49c5-b8fb-bd312a21fcf0|9|SEV|Severity/Intensity|[?]|GERD|[?]|km/h|[?]|1|Pa|T8 VERTEBRA|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|TREATMENT|2020-10-06|90
e|FA|da69b157-7dab-49c5-b8fb-bd312a21fcf0|10|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|g/animal/wk|[?]|1|mmHg/L/min|PERIRECTAL LYMPH NODE|LEFT|||PARENT|5|Visit_5|90|2|TREATMENT|2020-10-06|90
e|FA|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|1|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|g/cage|[?]|1|10^9 CFU/mL|VAGINAL WALL|UNILATERAL|||GUARDIAN|1|Visit_1|10|2|SCREENING|2020-05-29|10
e|FA|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|2|TOXGR|Toxicity Grade|[?]|GERD|[?]|AMPULE|[?]|1|aMFI|SPINOUS PROCESS|CONTRALATERAL|||ADJUDICATOR|1|Visit_1|10|3|FOLLOW-UP|2020-05-29|10
e|FA|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|3|PRSUCIND|Procedure Success Indicator|[?]|PRE-SPECIFIED AE|[?]|mL/cage|[?]|1|mg/dose|NUCLEUS ACCUMBENS|RIGHT|||SPOUSE|2|Visit_2|25|5|TREATMENT|2020-06-13|25
e|FA|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|IU/kg|[?]|1|%(v/v)|AORTIC VALVE, LEFT CORONARY CUSP|UNILATERAL|Y||INTERVIEWER|2|Visit_2|25|7|SCREENING|2020-06-13|25
e|FA|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|5|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|PFU/mL|[?]|1|mIU/L|TIBIOTARSAL JOINT|RIGHT|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-06-28|40
e|FA|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|6|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|P|[?]|1|10^6 U|PARAPHARYNGEAL LYMPH NODE|IPSILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-06-28|40
e|FA|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|7|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|DAgU/mL|[?]|1|U/10^12 RBC|AXILLARY ARTERY|IPSILATERAL|Y||GUARDIAN|4|Visit_4|65|3|WASHOUT|2020-07-23|65
e|FA|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|8|PRUSTAT|Procedure Urgency Status Type|[?]|PRE-SPECIFIED AE|[?]|U/cL|[?]|1|gtt|DORSALIS PEDIS ARTERY|BILATERAL|||SPOUSE|4|Visit_4|65|5|WASHOUT|2020-07-23|65
e|FA|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|9|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|dpm/0.5 mL|[?]|1|/200 HPFs|INTRAHEPATIC LARGE BILE DUCT|BILATERAL|||PARENT|5|Visit_5|90|2|WASHOUT|2020-08-17|90
e|FA|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|10|DISTANCE|Distance|[?]|PRE-SPECIFIED AE|[?]|10^8 PFU|[?]|1|BOWL|COMMON ILIAC LYMPH NODE|BILATERAL|||ADJUDICATOR|5|Visit_5|90|4|SCREENING|2020-08-17|90
e|FA|77c97d1e-e223-4485-b2de-59daa4e5b01f|1|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|g/m2/day|[?]|1|PFU/dose|PHARYNX|LEFT|||FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-06-19|10
e|FA|77c97d1e-e223-4485-b2de-59daa4e5b01f|2|RLDEV|Relationship to Device|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU|[?]|1|mL/min/mmHg|ILIAC LYMPH NODE|BILATERAL|||STUDY SUBJECT|1|Visit_1|10|7|SCREENING|2020-06-19|10
e|FA|77c97d1e-e223-4485-b2de-59daa4e5b01f|3|DVEG|Dietary Vegetable|[?]|GERD|[?]|TRANSDUCING UNIT|[?]|1|Ci/ug|DIAPHRAGMATIC LYMPH NODE|RIGHT|||STUDY SUBJECT|2|Visit_2|25|5|FOLLOW-UP|2020-07-04|25
e|FA|77c97d1e-e223-4485-b2de-59daa4e5b01f|4|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|CFU/mL|[?]|1|mL/dose|ARM SKIN|LEFT|||STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-07-04|25
e|FA|77c97d1e-e223-4485-b2de-59daa4e5b01f|5|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|fmol/L|[?]|1|CUP|SCIATIC NERVE|BILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|2|WASHOUT|2020-07-19|40
e|FA|77c97d1e-e223-4485-b2de-59daa4e5b01f|6|LDIAM|Longest Diameter|[?]|PRE-SPECIFIED AE|[?]|GBq/mg|[?]|1|Shock Wave|LEFT VENTRICULAR MID INFERIOR SEGMENT|UNILATERAL|||VENDOR|3|Visit_3|40|2|SCREENING|2020-07-19|40
e|FA|77c97d1e-e223-4485-b2de-59daa4e5b01f|7|SEV|Severity/Intensity|[?]|GERD|[?]|cmol/L|[?]|1|Pa|HAND|CONTRALATERAL|||DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2020-08-13|65
e|FA|77c97d1e-e223-4485-b2de-59daa4e5b01f|8|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|log10 copies/mL|[?]|1|%(v/v)|PLACENTA|IPSILATERAL||Y|STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-08-13|65
e|FA|77c97d1e-e223-4485-b2de-59daa4e5b01f|9|DGRAIN|Dietary Grain|[?]|PRE-SPECIFIED AE|[?]|mL/mmHg/min/L|[?]|1|10^9 CFU/g|PANCREAS, EXOCRINE|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-09-07|90
e|FA|77c97d1e-e223-4485-b2de-59daa4e5b01f|10|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|mol/mg|[?]|1|km|SENSORIMOTOR CORTEX|CONTRALATERAL|Y||INVESTIGATOR|5|Visit_5|90|2|SCREENING|2020-09-07|90
e|FA|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|1|PRSUCIND|Procedure Success Indicator|[?]|GERD|[?]|Bq/uL|[?]|1|mg/dose|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|UNILATERAL|Y||PARENT|1|Visit_1|10|1|TREATMENT|2020-10-14|10
e|FA|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|2|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|PNU/mL|[?]|1|mmHg/L/min|OBTURATOR EXTERNUS MUSCLE|LATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|SCREENING|2020-10-14|10
e|FA|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|3|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|pkat/L|[?]|1|cmH2O/mL|SKIN OF THE BUTTOCK|CONTRALATERAL||Y|CHILD|2|Visit_2|25|1|FOLLOW-UP|2020-10-29|25
e|FA|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|4|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|mCi/kg|[?]|1|TRANSDUCING UNIT/mL|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|RIGHT|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-10-29|25
e|FA|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|5|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|pL|[?]|1|mAmp|PLEURAL CAVITY|LATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-11-13|40
e|FA|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|6|ACUTSTRS|Most Severe Acute Stressor|[?]|GERD|[?]|10^6 organisms|[?]|1|BAG|CEREBRUM|BILATERAL||Y|SPOUSE|3|Visit_3|40|1|SCREENING|2020-11-13|40
e|FA|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|7|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|mmol2/L2|[?]|1|U/mmol|POPLITEAL ARTERY ABOVE KNEE|BILATERAL|Y||FAMILY MEMBER|4|Visit_4|65|3|WASHOUT|2020-12-08|65
e|FA|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|8|DXCRITMT|Diagnostic Criteria Met|[?]|PRE-SPECIFIED AE|[?]|mEq/L|[?]|1|Shock Wave|CANINE TOOTH|IPSILATERAL||Y|CHILD|4|Visit_4|65|7|TREATMENT|2020-12-08|65
e|FA|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|9|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|gpELISA unit/mL|[?]|1|10^9 CFU/mL|APPENDICEAL TIP|UNILATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|7|SCREENING|2021-01-02|90
e|FA|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|10|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|10^3 copies/mL|[?]|1|mIU/L|FEMORAL CONDYLE|RIGHT|Y||INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2021-01-02|90
e|FA|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|1|SSDISC|Sign/Symptom Leading to Discontinuation|[?]|GERD|[?]|mg/dL|[?]|1|QUANTITY SUFFICIENT|CEREBRUM|LATERAL|||SPOUSE|1|Visit_1|10|4|WASHOUT|2020-11-01|10
e|FA|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|2|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|U/kg/min|[?]|1|gtt|POSTERIOR CERVICAL LYMPH NODE|RIGHT||Y|VENDOR|1|Visit_1|10|6|TREATMENT|2020-11-01|10
e|FA|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|3|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|/mm|[?]|1|Weber|PANCREAS, EXOCRINE|UNILATERAL||Y|INVESTIGATOR|2|Visit_2|25|6|SCREENING|2020-11-16|25
e|FA|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|4|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|/kg|[?]|1|mEq|NECK|UNILATERAL|Y||PARENT|2|Visit_2|25|2|SCREENING|2020-11-16|25
e|FA|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|5|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|GERD|[?]|gpELISA unit/mL|[?]|1|km|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|RIGHT|||PARENT|3|Visit_3|40|4|SCREENING|2020-12-01|40
e|FA|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Frames/s|[?]|1|mg/g/min|PINEAL GLAND|LATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|6|TREATMENT|2020-12-01|40
e|FA|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|7|EXCMPLNC|Exercise Compliance|[?]|PRE-SPECIFIED AE|[?]|pt_br|[?]|1|ohm|PARANASAL SINUS|UNILATERAL|Y||CHILD|4|Visit_4|65|1|FOLLOW-UP|2020-12-26|65
e|FA|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|10^4/hpf|[?]|1|mL|MIDDLE PHALANX 5 OF THE HAND|IPSILATERAL|Y||GUARDIAN|4|Visit_4|65|5|TREATMENT|2020-12-26|65
e|FA|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|9|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|umol/h/mmol|[?]|1|mL/h|HEART, VENTRICULAR WALL|UNILATERAL||Y|SIBLING|5|Visit_5|90|3|TREATMENT|2021-01-20|90
e|FA|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|10|LESNUM|Number of Lesions|[?]|GERD|[?]|IU/dL|[?]|1|ng/day|THORACIC VERTEBRA|BILATERAL|||INVESTIGATOR|5|Visit_5|90|6|WASHOUT|2021-01-20|90
e|FA|9eb6e591-d266-4e05-85b6-230e8a02d494|1|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|mL/m2/h|[?]|1|cm H2O|VERTEBRAL COLUMN|RIGHT|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|WASHOUT|2020-06-28|10
e|FA|9eb6e591-d266-4e05-85b6-230e8a02d494|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|GPL U/mL|[?]|1|mg/g/min|TRICUSPID VALVE, ANTERIOR CUSP|UNILATERAL|||FRIEND|1|Visit_1|10|5|FOLLOW-UP|2020-06-28|10
e|FA|9eb6e591-d266-4e05-85b6-230e8a02d494|3|DVEG|Dietary Vegetable|[?]|PRE-SPECIFIED AE|[?]|IMPLANT|[?]|1|Ci/ug|HEPATIC LYMPH NODE|UNILATERAL|Y||PARENT|2|Visit_2|25|7|TREATMENT|2020-07-13|25
e|FA|9eb6e591-d266-4e05-85b6-230e8a02d494|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|U/mg|[?]|1|%(v/v)|ANTECUBITAL FOSSA|RIGHT|Y||PROXY|2|Visit_2|25|5|SCREENING|2020-07-13|25
e|FA|9eb6e591-d266-4e05-85b6-230e8a02d494|5|DPROT|Dietary Protein|[?]|GERD|[?]|mL/sec/1.73m2|[?]|1|10^4 CFU/mL|ENDOCERVIX|UNILATERAL|Y||STUDY SUBJECT|3|Visit_3|40|4|SCREENING|2020-07-28|40
e|FA|9eb6e591-d266-4e05-85b6-230e8a02d494|6|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|CARTRIDGE|[?]|1|g/dL|PORTACAVAL LYMPH NODE|BILATERAL|||CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-07-28|40
e|FA|9eb6e591-d266-4e05-85b6-230e8a02d494|7|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|ugEq/L|[?]|1|U/mg|RECTO-UTERINE POUCH|LATERAL|Y|Y|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-08-22|65
e|FA|9eb6e591-d266-4e05-85b6-230e8a02d494|8|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|Ci/kg|[?]|1|mL/dose|RETINAL ARTERY|IPSILATERAL|Y||INVESTIGATOR|4|Visit_4|65|4|SCREENING|2020-08-22|65
e|FA|9eb6e591-d266-4e05-85b6-230e8a02d494|9|CALBURN|Calories Burned|[?]|GERD|[?]|cd|[?]|1|/kg|PRETRACHEAL LYMPH NODE|CONTRALATERAL|||PROXY|5|Visit_5|90|1|WASHOUT|2020-09-16|90
e|FA|9eb6e591-d266-4e05-85b6-230e8a02d494|10|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|mm/h|[?]|1|umol|NASOPHARYNX|RIGHT||Y|CAREGIVER|5|Visit_5|90|6|TREATMENT|2020-09-16|90
e|FA|6a6e040d-6a09-4004-9fab-f4f82ba00eae|1|DFATP|Dietary Fat, Polyunsaturated|[?]|PRE-SPECIFIED AE|[?]|nkat/g Hb|[?]|1|L|CELIAC LYMPH NODE|BILATERAL|Y||PARENT|1|Visit_1|10|6|TREATMENT|2020-06-30|10
e|FA|6a6e040d-6a09-4004-9fab-f4f82ba00eae|2|TTIMPHAC|Total Time Physically Active|[?]|GERD|[?]|U.CARR|[?]|1|IU/mmol|EPIDURAL SPACE|CONTRALATERAL|||INTERVIEWER|1|Visit_1|10|7|SCREENING|2020-06-30|10
e|FA|6a6e040d-6a09-4004-9fab-f4f82ba00eae|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|ELISA unit/mL|[?]|1|mg/g/min|OPTIC NERVE|CONTRALATERAL|||INVESTIGATOR|2|Visit_2|25|1|SCREENING|2020-07-15|25
e|FA|6a6e040d-6a09-4004-9fab-f4f82ba00eae|4|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|min/day|[?]|1|mL/100g/min|METACARPAL BONE 2|BILATERAL|||SIBLING|2|Visit_2|25|3|SCREENING|2020-07-15|25
e|FA|6a6e040d-6a09-4004-9fab-f4f82ba00eae|5|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|g/dL|[?]|1|L/h/m2|CALCARINE SULCUS|LATERAL|||FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-07-30|40
e|FA|6a6e040d-6a09-4004-9fab-f4f82ba00eae|6|DCAL|Dietary Calories|[?]|GERD|[?]|PATCH|[?]|1|EIA unit|AORTIC VALVE ANNULUS|LEFT|||SPOUSE|3|Visit_3|40|1|WASHOUT|2020-07-30|40
e|FA|6a6e040d-6a09-4004-9fab-f4f82ba00eae|7|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|kcal/day|[?]|1|uL/kg/day|RIB 8|BILATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|TREATMENT|2020-08-24|65
e|FA|6a6e040d-6a09-4004-9fab-f4f82ba00eae|8|OCCUR|Occurrence Indicator|[?]|GERD|[?]|10^6 CFU|[?]|1|mg/g/min|EPIGASTRIC REGION|IPSILATERAL|Y||CAREGIVER|4|Visit_4|65|2|WASHOUT|2020-08-24|65
e|FA|6a6e040d-6a09-4004-9fab-f4f82ba00eae|9|OBJNUM|Number of Objects|[?]|PRE-SPECIFIED AE|[?]|kPa|[?]|1|mL/100g/min|PATELLA|LATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|2|FOLLOW-UP|2020-09-18|90
e|FA|6a6e040d-6a09-4004-9fab-f4f82ba00eae|10|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|um/day|[?]|1|mL|AORTIC VALVE|IPSILATERAL|Y||GUARDIAN|5|Visit_5|90|5|TREATMENT|2020-09-18|90
e|FA|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|1|TOTNUM|Total Number|[?]|GERD|[?]|CIGAR|[?]|1|/200 HPFs|PERIUMBILICAL REGION|RIGHT|Y||ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-08-17|10
e|FA|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|2|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|mol/g|[?]|1|anti-Xa IU/mL|LUNG, RIGHT UPPER LOBE|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2020-08-17|10
e|FA|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|3|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|PRE-SPECIFIED AE|[?]|uEq|[?]|1|SCOOPFUL|LOCUS CERULEUS|UNILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-09-01|25
e|FA|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|4|SEV|Severity/Intensity|[?]|GERD|[?]|ugEq|[?]|1|Pa|DISTAL PHALANX 4 OF THE HAND|LEFT|||PROXY|2|Visit_2|25|1|FOLLOW-UP|2020-09-01|25
e|FA|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|mAmp|[?]|1|%(v/v)|L5 VERTEBRA|BILATERAL|||SPOUSE|3|Visit_3|40|1|WASHOUT|2020-09-16|40
e|FA|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|6|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|dL|[?]|1|mEq/g|SCAPHOID-LUNATE-CAPITATE JOINT|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|SCREENING|2020-09-16|40
e|FA|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|7|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|%/min|[?]|1|m2|PULMONARY VALVE|BILATERAL||Y|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-10-11|65
e|FA|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|8|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|/cmH2O|[?]|1|10^9 CFU/mL|FLEXOR DIGITORUM LONGUS MUSCLE|UNILATERAL||Y|INVESTIGATOR|4|Visit_4|65|3|SCREENING|2020-10-11|65
e|FA|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|9|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|PELLET|[?]|1|mmHg/L/min|SPLENIC VEIN|LATERAL|||ADJUDICATOR|5|Visit_5|90|6|SCREENING|2020-11-05|90
e|FA|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|10|STEPSTN|Number of Steps Taken|[?]|PRE-SPECIFIED AE|[?]|g/g|[?]|1|mAmp|LENS|UNILATERAL||Y|VENDOR|5|Visit_5|90|6|SCREENING|2020-11-05|90
e|FA|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|1|CALBURN|Calories Burned|[?]|GERD|[?]|mg/kg/week|[?]|1|/kg|ANAL VERGE|LEFT|||INDEPENDENT ASSESSOR|1|Visit_1|10|7|FOLLOW-UP|2021-01-19|10
e|FA|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|2|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|mL/breath|[?]|1|umol|BRACHIALIS MUSCLE|RIGHT||Y|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2021-01-19|10
e|FA|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|3|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|/sec|[?]|1|10^6 U|OMENTUM|LEFT|||SPOUSE|2|Visit_2|25|1|SCREENING|2021-02-03|25
e|FA|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|4|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|mg/m2/min|[?]|1|uCi/kg|LEFT MAIN CORONARY ARTERY BIFURCATION|LATERAL|Y|Y|PARENT|2|Visit_2|25|6|TREATMENT|2021-02-03|25
e|FA|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|5|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|10^3 RNA copies/mL|[?]|1|cmH2O/mL|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|||STUDY SUBJECT|3|Visit_3|40|6|TREATMENT|2021-02-18|40
e|FA|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|6|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|uCi/L|[?]|1|g/day|BODY OF STOMACH|IPSILATERAL|||PARENT|3|Visit_3|40|2|WASHOUT|2021-02-18|40
e|FA|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|7|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/g/h|[?]|1|Pa|PERIURETHRAL REGION|IPSILATERAL|||STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2021-03-15|65
e|FA|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|8|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|deg/mm|[?]|1|mL|SCAPHOID-RADIUS JOINT|IPSILATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|4|TREATMENT|2021-03-15|65
e|FA|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|9|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|ug/g/h|[?]|1|uL/kg/day|SKIN AROUND THE EYE|CONTRALATERAL||Y|FAMILY MEMBER|5|Visit_5|90|4|FOLLOW-UP|2021-04-09|90
e|FA|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|10|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|g/day|[?]|1|10^6 CFU/mL|MIDBRAIN|CONTRALATERAL||Y|CHILD|5|Visit_5|90|1|TREATMENT|2021-04-09|90
e|FA|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|1|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|mmAL|[?]|1|m2|PELVIC LYMPH NODE|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|FOLLOW-UP|2020-05-12|10
e|FA|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|2|TOXGR|Toxicity Grade|[?]|GERD|[?]|/min|[?]|1|aMFI|SEMINAL VESICLE|UNILATERAL|||PARENT|1|Visit_1|10|7|WASHOUT|2020-05-12|10
e|FA|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|3|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|DISK|[?]|1|cm H2O|VENA CAVA|UNILATERAL|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|2|SCREENING|2020-05-27|25
e|FA|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|4|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|Bq|[?]|1|h*%|MESENTERIC VEIN|CONTRALATERAL|||DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-05-27|25
e|FA|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|5|OUNIMULT|Onset Unifocal or Multifocal|[?]|GERD|[?]|vg/kg|[?]|1|10^6 IU/mL|SUDORIFEROUS GLAND|IPSILATERAL|Y||FRIEND|3|Visit_3|40|1|FOLLOW-UP|2020-06-11|40
e|FA|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|6|ISCDIND|Ischemic Discomfort Indicator|[?]|GERD|[?]|Enzyme U/m2|[?]|1|ug/m2/h|PANCREAS, EXOCRINE|RIGHT|||CHILD|3|Visit_3|40|5|WASHOUT|2020-06-11|40
e|FA|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|7|OBJNUM|Number of Objects|[?]|GERD|[?]|mL/animal/wk|[?]|1|mL/100g/min|SKIN OF THE BENDING JOINT|CONTRALATERAL||Y|STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2020-07-06|65
e|FA|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|8|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|log10 CFU/g|[?]|1|mL/m2|SCIATIC NERVE|CONTRALATERAL||Y|INTERVIEWER|4|Visit_4|65|5|FOLLOW-UP|2020-07-06|65
e|FA|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|9|SEV|Severity/Intensity|[?]|GERD|[?]|mmol/day|[?]|1|Pa|THYROID GLAND, RIGHT LOBE|IPSILATERAL|||GUARDIAN|5|Visit_5|90|6|FOLLOW-UP|2020-07-31|90
e|FA|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|10|CUMEXP|Cumulative Exposure|[?]|GERD|[?]|CIGARETTE|[?]|1|10^6 U|CORNEA|BILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-07-31|90
e|FA|ba99022a-d398-4c60-828c-876f119459e1|1|EXCINTSY|Exercise Intensity|[?]|GERD|[?]|ng/day|[?]|1|AU/mL|LATERAL HUMERAL EPICONDYLE|RIGHT|Y||STUDY SUBJECT|1|Visit_1|10|1|FOLLOW-UP|2020-12-01|10
e|FA|ba99022a-d398-4c60-828c-876f119459e1|2|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|SUPPOSITORY|[?]|1|mL/dose|STERNUM|LEFT|||ADJUDICATION COMMITTEE|1|Visit_1|10|1|WASHOUT|2020-12-01|10
e|FA|ba99022a-d398-4c60-828c-876f119459e1|3|LDIAM|Longest Diameter|[?]|GERD|[?]|10^3 copies/mL|[?]|1|Shock Wave|MEDIAN BASILIC VEIN|LATERAL|||INTERVIEWER|2|Visit_2|25|1|FOLLOW-UP|2020-12-16|25
e|FA|ba99022a-d398-4c60-828c-876f119459e1|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|um|[?]|1|Pa|FACIAL BONE|LEFT|Y|Y|PARENT|2|Visit_2|25|7|FOLLOW-UP|2020-12-16|25
e|FA|ba99022a-d398-4c60-828c-876f119459e1|5|EXCDUR|Exercise Duration|[?]|PRE-SPECIFIED AE|[?]|/5x10^4 WBC|[?]|1|mm|SCIATIC NERVE|LATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|SCREENING|2020-12-31|40
e|FA|ba99022a-d398-4c60-828c-876f119459e1|6|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Absorbance U/mL|[?]|1|umol|OPTIC NERVE|BILATERAL|Y||DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2020-12-31|40
e|FA|ba99022a-d398-4c60-828c-876f119459e1|7|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|mCi/kg|[?]|1|mEq|MESENTERIC VEIN|RIGHT|||SIBLING|4|Visit_4|65|7|SCREENING|2021-01-25|65
e|FA|ba99022a-d398-4c60-828c-876f119459e1|8|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|BAU|[?]|1|mEq/g|MAXILLARY SINUS|LATERAL|||INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2021-01-25|65
e|FA|ba99022a-d398-4c60-828c-876f119459e1|9|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/min/1.73m2|[?]|1|mg/g/min|DISTAL LAD ARTERY|LEFT||Y|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2021-02-19|90
e|FA|ba99022a-d398-4c60-828c-876f119459e1|10|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|MPS U|[?]|1|mg/h|MEDIASTINUM, ANTERIOR|UNILATERAL|Y||DOMESTIC PARTNER|5|Visit_5|90|2|FOLLOW-UP|2021-02-19|90
e|FA|d713869e-061c-4e95-8a50-da2e1ec47b3c|1|DFATP|Dietary Fat, Polyunsaturated|[?]|GERD|[?]|APS U|[?]|1|L|CARPOMETACARPAL JOINT 3|UNILATERAL||Y|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-06-06|10
e|FA|d713869e-061c-4e95-8a50-da2e1ec47b3c|2|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|GERD|[?]|U/g Hb|[?]|1|MBq|ANTERIOR TIBIAL ARTERY|IPSILATERAL|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2020-06-06|10
e|FA|d713869e-061c-4e95-8a50-da2e1ec47b3c|3|OCCUR|Occurrence Indicator|[?]|GERD|[?]|POINT|[?]|1|mg/g/min|PROXIMAL INTERPHALANGEAL JOINT 4|UNILATERAL||Y|ADJUDICATION COMMITTEE|2|Visit_2|25|7|SCREENING|2020-06-21|25
e|FA|d713869e-061c-4e95-8a50-da2e1ec47b3c|4|SEV|Severity/Intensity|[?]|GERD|[?]|scm|[?]|1|Pa|HIPPOCAMPUS|IPSILATERAL|||GUARDIAN|2|Visit_2|25|3|TREATMENT|2020-06-21|25
e|FA|d713869e-061c-4e95-8a50-da2e1ec47b3c|5|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|PUFF|[?]|1|BAG|BRAIN VENTRICLE|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-07-06|40
e|FA|d713869e-061c-4e95-8a50-da2e1ec47b3c|6|LOCONSET|Localization of Onset|[?]|GERD|[?]|GBq/g|[?]|1|g/L|WRIST JOINT FLEXOR TENDONS|RIGHT||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-07-06|40
e|FA|d713869e-061c-4e95-8a50-da2e1ec47b3c|7|NINVIMGC|Non-Invasive Imaging Change|[?]|PRE-SPECIFIED AE|[?]|MHz|[?]|1|Bq/L|ABDOMINAL SKIN|LEFT|Y||STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2020-07-31|65
e|FA|d713869e-061c-4e95-8a50-da2e1ec47b3c|8|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mOsm/L|[?]|1|Weber|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|BILATERAL||Y|PROXY|4|Visit_4|65|1|FOLLOW-UP|2020-07-31|65
e|FA|d713869e-061c-4e95-8a50-da2e1ec47b3c|9|EPSDNUM|Number of Episodes|[?]|GERD|[?]|ms/mmHg|[?]|1|%(v/v)|AORTOCAVAL LYMPH NODE|IPSILATERAL|||INTERVIEWER|5|Visit_5|90|4|TREATMENT|2020-08-25|90
e|FA|d713869e-061c-4e95-8a50-da2e1ec47b3c|10|EXCDUR|Exercise Duration|[?]|GERD|[?]|Bq/g|[?]|1|mm|HEART, LEFT VENTRICULAR OUTFLOW TRACT|LATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-08-25|90
e|FA|fcebb64c-e0e6-4f29-9c52-15fa91f60018|1|PCIAAC|PCI Acute Angiographic Complication|[?]|GERD|[?]|Gy|[?]|1|mL/h|L2-L3 INTERVERTEBRAL SPACE|UNILATERAL|||FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-07-11|10
e|FA|fcebb64c-e0e6-4f29-9c52-15fa91f60018|2|TOTNUM|Total Number|[?]|PRE-SPECIFIED AE|[?]|uCi/L|[?]|1|/200 HPFs|FOOT DIGIT 1|LATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|FOLLOW-UP|2020-07-11|10
e|FA|fcebb64c-e0e6-4f29-9c52-15fa91f60018|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|DRINK|[?]|1|Pa|PERICARDIAL WALL|IPSILATERAL|||VENDOR|2|Visit_2|25|1|FOLLOW-UP|2020-07-26|25
e|FA|fcebb64c-e0e6-4f29-9c52-15fa91f60018|4|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|nkat|[?]|1|mg/g/min|INTERPHALANGEAL JOINT 2|BILATERAL|||ADJUDICATION COMMITTEE|2|Visit_2|25|6|SCREENING|2020-07-26|25
e|FA|fcebb64c-e0e6-4f29-9c52-15fa91f60018|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|ug/g/min|[?]|1|Pa|ANAL CANAL|CONTRALATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-08-10|40
e|FA|fcebb64c-e0e6-4f29-9c52-15fa91f60018|6|DPROT|Dietary Protein|[?]|PRE-SPECIFIED AE|[?]|POUCH|[?]|1|10^4 CFU/mL|NAIL BED|IPSILATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|7|FOLLOW-UP|2020-08-10|40
e|FA|fcebb64c-e0e6-4f29-9c52-15fa91f60018|7|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|fraction of 1|[?]|1|Shock Wave|TIBIO-PERONEAL TRUNK|CONTRALATERAL|||CHILD|4|Visit_4|65|4|TREATMENT|2020-09-04|65
e|FA|fcebb64c-e0e6-4f29-9c52-15fa91f60018|8|EXCDUR|Exercise Duration|[?]|GERD|[?]|ug/m2/day|[?]|1|mm|ELBOW FLEXOR MUSCLES|CONTRALATERAL|||PARENT|4|Visit_4|65|7|TREATMENT|2020-09-04|65
e|FA|fcebb64c-e0e6-4f29-9c52-15fa91f60018|9|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|dram|[?]|1|mL/h|OPTIC NERVE|LEFT|||INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2020-09-29|90
e|FA|fcebb64c-e0e6-4f29-9c52-15fa91f60018|10|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|CFU/g|[?]|1|U/10^12 RBC|ADDUCTOR BREVIS MUSCLE|LEFT||Y|SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-09-29|90
e|FA|e443f82e-43a8-4710-bff4-fd2b2f4d512f|1|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|dpm/100mg|[?]|1|mEq|SCIATIC NERVE|BILATERAL|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2021-01-01|10
e|FA|e443f82e-43a8-4710-bff4-fd2b2f4d512f|2|ENDPTIND|Endpoint Event Indicator|[?]|PRE-SPECIFIED AE|[?]|/h|[?]|1|PACK|L2 VERTEBRA|CONTRALATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|1|FOLLOW-UP|2021-01-01|10
e|FA|e443f82e-43a8-4710-bff4-fd2b2f4d512f|3|ORCANIND|Origin of Cancer Known Ind|[?]|PRE-SPECIFIED AE|[?]|/2000 RBC|[?]|1|cmH2O/mL|AZYGOS VEIN|UNILATERAL||Y|SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2021-01-16|25
e|FA|e443f82e-43a8-4710-bff4-fd2b2f4d512f|4|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|PIXELS/in|[?]|1|Bq/mg|MIDDLE PHALANX 5 OF THE HAND|IPSILATERAL|Y|Y|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2021-01-16|25
e|FA|e443f82e-43a8-4710-bff4-fd2b2f4d512f|5|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|10^3 CFU/mL|[?]|1|EIA unit|PENIS, BODY|UNILATERAL|Y||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|WASHOUT|2021-01-31|40
e|FA|e443f82e-43a8-4710-bff4-fd2b2f4d512f|6|OBJTYPE|Type of Object|[?]|GERD|[?]|BAG|[?]|1|ng|POPLITEAL FOSSA|CONTRALATERAL||Y|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|SCREENING|2021-01-31|40
e|FA|e443f82e-43a8-4710-bff4-fd2b2f4d512f|7|OCCUR|Occurrence Indicator|[?]|GERD|[?]|Shock Wave|[?]|1|mg/g/min|HEART, BASE|IPSILATERAL|||SIBLING|4|Visit_4|65|1|TREATMENT|2021-02-25|65
e|FA|e443f82e-43a8-4710-bff4-fd2b2f4d512f|8|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|IU/mmol|[?]|1|m2|OPTIC DISC|BILATERAL|||FAMILY MEMBER|4|Visit_4|65|5|WASHOUT|2021-02-25|65
e|FA|e443f82e-43a8-4710-bff4-fd2b2f4d512f|9|QOLIMP|QOL Impact|[?]|GERD|[?]|Bq/g|[?]|1|10^6/L|ESOPHAGEAL LYMPH NODE|IPSILATERAL||Y|PROXY|5|Visit_5|90|1|FOLLOW-UP|2021-03-22|90
e|FA|e443f82e-43a8-4710-bff4-fd2b2f4d512f|10|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|U/mmol|[?]|1|L/h/m2|RAPHE|IPSILATERAL|||PARENT|5|Visit_5|90|4|TREATMENT|2021-03-22|90
e|FA|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|1|EVENTNUM|Number of Events|[?]|PRE-SPECIFIED AE|[?]|10^9 CFU/mL|[?]|1|U/10^12 RBC|PORTAL VEIN BIFURCATION|CONTRALATERAL|Y||FAMILY MEMBER|1|Visit_1|10|1|FOLLOW-UP|2020-06-22|10
e|FA|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|2|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|Siemens|[?]|1|DRUM|MITRAL VALVE|LEFT|||CAREGIVER|1|Visit_1|10|6|SCREENING|2020-06-22|10
e|FA|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|3|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|Ci/mL|[?]|1|HOURS|OVARIAN FOLLICLE|IPSILATERAL||Y|STUDY SUBJECT|2|Visit_2|25|4|SCREENING|2020-07-07|25
e|FA|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|4|EPSDNUM|Number of Episodes|[?]|GERD|[?]|DDU|[?]|1|%(v/v)|BILE DUCT|IPSILATERAL|||PROXY|2|Visit_2|25|7|TREATMENT|2020-07-07|25
e|FA|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|5|VOL|Volume|[?]|GERD|[?]|ppth|[?]|1|vp/dose|MEDIASTINUM, POSTERIOR|UNILATERAL|||CAREGIVER|3|Visit_3|40|3|WASHOUT|2020-07-22|40
e|FA|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|6|HOSPNUM|Number Of Hospitalizations|[?]|GERD|[?]|deg/mm|[?]|1|IU/mg|PROCERUS MUSCLE|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|5|SCREENING|2020-07-22|40
e|FA|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|7|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|Osm|[?]|1|gtt|FIBULA|RIGHT|Y||ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-08-16|65
e|FA|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|8|SBDEPIND|Substance Dependence Indicator|[?]|PRE-SPECIFIED AE|[?]|ug/g/h|[?]|1|10^9 CFU/mL|ESOPHAGUS|IPSILATERAL|Y||CAREGIVER|4|Visit_4|65|3|TREATMENT|2020-08-16|65
e|FA|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|9|DIAMETER|Diameter|[?]|GERD|[?]|L/kg|[?]|1|cm|ULNAR NERVE|LATERAL||Y|CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-09-10|90
e|FA|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|10|AGETRT1|Age At First Treatment|[?]|GERD|[?]|gtt|[?]|1|mL/mmHg/min/L|PUBIC BONE|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|TREATMENT|2020-09-10|90
e|FA|8a2147b1-2deb-410e-a298-d028a5efc555|1|LONGCRSE|Longitudinal Course|[?]|GERD|[?]|ug/min|[?]|1|10^6 CFU|LUMBAR SPINE|LEFT|||ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2020-10-30|10
e|FA|8a2147b1-2deb-410e-a298-d028a5efc555|2|SPEED|Speed|[?]|GERD|[?]|pmol/10^10 cells|[?]|1|mEq/g|TRICUSPID VALVE, POSTERIOR ANNULUS|CONTRALATERAL|||DOMESTIC PARTNER|1|Visit_1|10|2|SCREENING|2020-10-30|10
e|FA|8a2147b1-2deb-410e-a298-d028a5efc555|3|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|U/g Hb|[?]|1|SCOOPFUL|OBTURATOR INTERNUS MUSCLE|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|FOLLOW-UP|2020-11-14|25
e|FA|8a2147b1-2deb-410e-a298-d028a5efc555|4|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|10^7/L|[?]|1|Bq/L|TIBIA|BILATERAL|||SIBLING|2|Visit_2|25|1|TREATMENT|2020-11-14|25
e|FA|8a2147b1-2deb-410e-a298-d028a5efc555|5|DCAL|Dietary Calories|[?]|GERD|[?]|L/day|[?]|1|EIA unit|PROXIMAL PHALANX 5 OF THE HAND|CONTRALATERAL|||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|TREATMENT|2020-11-29|40
e|FA|8a2147b1-2deb-410e-a298-d028a5efc555|6|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|DAgU/mL|[?]|1|SCOOPFUL|SKIN OF THE NECK|LATERAL||Y|INVESTIGATOR|3|Visit_3|40|2|TREATMENT|2020-11-29|40
e|FA|8a2147b1-2deb-410e-a298-d028a5efc555|7|FNDOSAMT|Final Dose Amount|[?]|GERD|[?]|g/m2|[?]|1|umol|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LEFT||Y|CHILD|4|Visit_4|65|2|SCREENING|2020-12-24|65
e|FA|8a2147b1-2deb-410e-a298-d028a5efc555|8|SPEED|Speed|[?]|GERD|[?]|g/U|[?]|1|mEq/g|DISTAL INTERPHALANGEAL JOINT 4|UNILATERAL|Y||INTERVIEWER|4|Visit_4|65|2|SCREENING|2020-12-24|65
e|FA|8a2147b1-2deb-410e-a298-d028a5efc555|9|SEV|Severity/Intensity|[?]|GERD|[?]|PACKAGE|[?]|1|Pa|FLOOR OF MOUTH|UNILATERAL|||SIBLING|5|Visit_5|90|2|SCREENING|2021-01-18|90
e|FA|8a2147b1-2deb-410e-a298-d028a5efc555|10|OCCUR|Occurrence Indicator|[?]|GERD|[?]|DRINK|[?]|1|mg/g/min|C2 VERTEBRA|LATERAL|||SIBLING|5|Visit_5|90|4|SCREENING|2021-01-18|90
e|FA|033db3bf-17fb-4872-afdb-1eea3dac6d85|1|AGEHOSP1|Age At First Hospitalization|[?]|GERD|[?]|GBq/g|[?]|1|fmol|BRACHIAL ARTERY|UNILATERAL||Y|PARENT|1|Visit_1|10|1|TREATMENT|2020-07-05|10
e|FA|033db3bf-17fb-4872-afdb-1eea3dac6d85|2|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mm|[?]|1|CUP|ARM|LATERAL|Y||GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-07-05|10
e|FA|033db3bf-17fb-4872-afdb-1eea3dac6d85|3|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|10^9 organisms|[?]|1|Pa|OPTIC NERVE|LEFT|||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-07-20|25
e|FA|033db3bf-17fb-4872-afdb-1eea3dac6d85|4|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|g/cage|[?]|1|g/L|FLEXOR DIGITORUM PROFUNDUS MUSCLE|UNILATERAL|||PARENT|2|Visit_2|25|2|TREATMENT|2020-07-20|25
e|FA|033db3bf-17fb-4872-afdb-1eea3dac6d85|5|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mg/kg/h|[?]|1|Pa|FLOOR OF MOUTH|UNILATERAL||Y|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-08-04|40
e|FA|033db3bf-17fb-4872-afdb-1eea3dac6d85|6|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|PRE-SPECIFIED AE|[?]|mL/g/min|[?]|1|CUP|UNCINATE PROCESS OF PANCREAS|RIGHT|||CHILD|3|Visit_3|40|1|SCREENING|2020-08-04|40
e|FA|033db3bf-17fb-4872-afdb-1eea3dac6d85|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|gpELISA unit/mL|[?]|1|mg/g/min|THIRD RIGHT POSTEROLATERAL ARTERY|BILATERAL|Y||SPOUSE|4|Visit_4|65|7|TREATMENT|2020-08-29|65
e|FA|033db3bf-17fb-4872-afdb-1eea3dac6d85|8|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|h*%|[?]|1|PFU/dose|FOOT DIGIT 4|BILATERAL||Y|VENDOR|4|Visit_4|65|3|TREATMENT|2020-08-29|65
e|FA|033db3bf-17fb-4872-afdb-1eea3dac6d85|9|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|PIXELS/in|[?]|1|vp/dose|TRICUSPID VALVE|LEFT||Y|SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2020-09-23|90
e|FA|033db3bf-17fb-4872-afdb-1eea3dac6d85|10|CALBURN|Calories Burned|[?]|GERD|[?]|ng/L|[?]|1|/kg|FEMORAL CONDYLE|LATERAL|||SIGNIFICANT OTHER|5|Visit_5|90|6|SCREENING|2020-09-23|90
e|FA|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|1|CHRNSTRS|Most Severe Chronic Stressor|[?]|PRE-SPECIFIED AE|[?]|titer|[?]|1|mg/h|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|RIGHT|Y||SIBLING|1|Visit_1|10|4|TREATMENT|2020-06-19|10
e|FA|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|2|DFATM|Dietary Fat, Monounsaturated|[?]|GERD|[?]|APS U|[?]|1|g/day|STOMACH|BILATERAL|||FRIEND|1|Visit_1|10|3|FOLLOW-UP|2020-06-19|10
e|FA|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|3|LDIAM|Longest Diameter|[?]|GERD|[?]|POUCH|[?]|1|Shock Wave|LIMB, LOWER|CONTRALATERAL|||GUARDIAN|2|Visit_2|25|3|TREATMENT|2020-07-04|25
e|FA|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|4|AGETRT1|Age At First Treatment|[?]|GERD|[?]|mg/kg/day|[?]|1|mL/mmHg/min/L|THIRD POSTEROLATERAL DESCENDING ARTERY|IPSILATERAL|||SIGNIFICANT OTHER|2|Visit_2|25|5|SCREENING|2020-07-04|25
e|FA|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|5|DVEG|Dietary Vegetable|[?]|GERD|[?]|s^-1(%O2)^-1|[?]|1|Ci/ug|HEART, LEFT VENTRICULAR WALL|IPSILATERAL||Y|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|SCREENING|2020-07-19|40
e|FA|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|6|OCCUR|Occurrence Indicator|[?]|GERD|[?]|mL/m2|[?]|1|mg/g/min|LIVER, LEFT LOBE|LATERAL|Y||HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|WASHOUT|2020-07-19|40
e|FA|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|7|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Tesla|[?]|1|%(v/v)|VOMER|LATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|TREATMENT|2020-08-13|65
e|FA|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|8|SYMSTDTC|Symptom Onset Date|[?]|PRE-SPECIFIED AE|[?]|Tbsp|[?]|1|DROP|INTERPHALANGEAL JOINT 4 OF THE FOOT|BILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2020-08-13|65
e|FA|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|9|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|/kg|[?]|1|vp/dose|ASCENDING AORTA, AORTIC ROOT|LATERAL|Y||GUARDIAN|5|Visit_5|90|4|TREATMENT|2020-09-07|90
e|FA|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|10|DISTANCE|Distance|[?]|GERD|[?]|kg|[?]|1|BOWL|BRAIN|IPSILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-09-07|90
e|FA|8dd493b7-a892-4cab-8f69-701471c51d99|1|SERVNUM|Number of Servings|[?]|PRE-SPECIFIED AE|[?]|Siemens|[?]|1|Hz/s|L4 VERTEBRA|LATERAL||Y|CHILD|1|Visit_1|10|4|TREATMENT|2021-01-12|10
e|FA|8dd493b7-a892-4cab-8f69-701471c51d99|2|LOCONSET|Localization of Onset|[?]|GERD|[?]|GLOBULE|[?]|1|g/L|LIVER, LEFT LOBE|UNILATERAL||Y|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2021-01-12|10
e|FA|8dd493b7-a892-4cab-8f69-701471c51d99|3|AGEHOSP1|Age At First Hospitalization|[?]|PRE-SPECIFIED AE|[?]|umol/kg/min|[?]|1|fmol|COLON, ASCENDING|IPSILATERAL|||INDEPENDENT ASSESSOR|2|Visit_2|25|2|FOLLOW-UP|2021-01-27|25
e|FA|8dd493b7-a892-4cab-8f69-701471c51d99|4|SBDEPIND|Substance Dependence Indicator|[?]|GERD|[?]|dpm/mg|[?]|1|10^9 CFU/mL|NERVE|LATERAL||Y|ADJUDICATOR|2|Visit_2|25|4|FOLLOW-UP|2021-01-27|25
e|FA|8dd493b7-a892-4cab-8f69-701471c51d99|5|DEVPNUM|Number of Devices Present|[?]|GERD|[?]|mg/kg|[?]|1|anti-Xa IU/mL|HAND|UNILATERAL|Y||INVESTIGATOR|3|Visit_3|40|2|TREATMENT|2021-02-11|40
e|FA|8dd493b7-a892-4cab-8f69-701471c51d99|6|LDIAM|Longest Diameter|[?]|GERD|[?]|mL/dL|[?]|1|Shock Wave|SYMPATHETIC GANGLIA|CONTRALATERAL|||NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2021-02-11|40
e|FA|8dd493b7-a892-4cab-8f69-701471c51d99|7|MI12EXC|Exclusion of Type 1 and Type 2 MI|[?]|PRE-SPECIFIED AE|[?]|deg|[?]|1|MBq|THYROID GLAND ISTHMUS|LATERAL|Y||PROXY|4|Visit_4|65|7|TREATMENT|2021-03-08|65
e|FA|8dd493b7-a892-4cab-8f69-701471c51d99|8|DFRUIT|Dietary Fruit|[?]|PRE-SPECIFIED AE|[?]|copies/mL|[?]|1|10^6 CFU/mL|RENAL ARTERY|LEFT|||FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2021-03-08|65
e|FA|8dd493b7-a892-4cab-8f69-701471c51d99|9|DGRAIN|Dietary Grain|[?]|GERD|[?]|mU/L|[?]|1|10^9 CFU/g|TROCHLEAR NERVE|BILATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|SCREENING|2021-04-02|90
e|FA|8dd493b7-a892-4cab-8f69-701471c51d99|10|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|Farad|[?]|1|mL/cm3/min|TRIGEMINAL NERVE|BILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2021-04-02|90
e|FA|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|1|DMG|Dietary Magnesium|[?]|GERD|[?]|Hounsfield Unit|[?]|1|TRANSDUCING UNIT/mL|BICEPS BRACHII MUSCLE|IPSILATERAL|||INVESTIGATOR|1|Visit_1|10|5|TREATMENT|2020-11-07|10
e|FA|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|2|DCARBT|Dietary Total Carbohydrate|[?]|GERD|[?]|10^3 organisms|[?]|1|mL/cm3/min|EPICONDYLE|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|TREATMENT|2020-11-07|10
e|FA|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|3|TTIMPAUS|Total Time Paused|[?]|PRE-SPECIFIED AE|[?]|ms2|[?]|1|Log10 ELISA unit|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|IPSILATERAL|||INVESTIGATOR|2|Visit_2|25|7|WASHOUT|2020-11-22|25
e|FA|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|4|DFATS|Dietary Fat, Saturated|[?]|PRE-SPECIFIED AE|[?]|mL/s/m2|[?]|1|MPS U|LUNG, LEFT LOWER LOBE|IPSILATERAL||Y|CAREGIVER|2|Visit_2|25|2|WASHOUT|2020-11-22|25
e|FA|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|5|TRTSETT|Treatment Setting|[?]|PRE-SPECIFIED AE|[?]|deg/mm|[?]|1|Coulomb|L5 VERTEBRA|UNILATERAL|||STUDY SUBJECT|3|Visit_3|40|3|FOLLOW-UP|2020-12-07|40
e|FA|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|6|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|EVENTS|[?]|1|DRUM|BACK|UNILATERAL|||VENDOR|3|Visit_3|40|7|WASHOUT|2020-12-07|40
e|FA|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|7|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|ks|[?]|1|mEq/g|PROCERUS MUSCLE|CONTRALATERAL|||ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2021-01-01|65
e|FA|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|8|DFATS|Dietary Fat, Saturated|[?]|GERD|[?]|umol/dL|[?]|1|MPS U|SHIN|LATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|3|SCREENING|2021-01-01|65
e|FA|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|9|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|nmol/L|[?]|1|mL/m2|GLOMERULUS|LEFT|||INTERVIEWER|5|Visit_5|90|2|TREATMENT|2021-01-26|90
e|FA|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|10|ACUTSTRS|Most Severe Acute Stressor|[?]|PRE-SPECIFIED AE|[?]|mmol|[?]|1|BAG|VENOUS SINUS|RIGHT|Y|Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2021-01-26|90
e|FA|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|1|AGESYMST|Age Symptoms Started|[?]|GERD|[?]|kPa/L/sec|[?]|1|m2|C5 VERTEBRA|UNILATERAL|Y||SPOUSE|1|Visit_1|10|5|TREATMENT|2020-09-04|10
e|FA|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|2|EXCDUR|Exercise Duration|[?]|GERD|[?]|nmol/L/h|[?]|1|mm|CINGULATE CORTEX|CONTRALATERAL|||CLINICAL STUDY SPONSOR|1|Visit_1|10|4|SCREENING|2020-09-04|10
e|FA|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|3|LOCONSET|Localization of Onset|[?]|PRE-SPECIFIED AE|[?]|/min|[?]|1|g/L|LIVER|CONTRALATERAL|Y|Y|STUDY SUBJECT|2|Visit_2|25|6|FOLLOW-UP|2020-09-19|25
e|FA|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|4|STROKTYP|Stroke Type|[?]|GERD|[?]|mg/animal|[?]|1|g/L|DISTAL RADIOULNAR JOINT|UNILATERAL|Y||ADJUDICATOR|2|Visit_2|25|2|SCREENING|2020-09-19|25
e|FA|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|5|DCAL|Dietary Calories|[?]|GERD|[?]|g/m2|[?]|1|EIA unit|HEART, LEFT VENTRICULAR OUTFLOW TRACT|LATERAL|||SIBLING|3|Visit_3|40|1|SCREENING|2020-10-04|40
e|FA|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|6|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|m/sec|[?]|1|mEq|ACCESSORY RENAL ARTERY|UNILATERAL|Y||INTERVIEWER|3|Visit_3|40|2|WASHOUT|2020-10-04|40
e|FA|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|7|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|U/mL|[?]|1|mg/g/min|AORTIC ARCH|BILATERAL|Y||ADJUDICATION COMMITTEE|4|Visit_4|65|7|FOLLOW-UP|2020-10-29|65
e|FA|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|8|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|copies/uL|[?]|1|10^6 U|ENDOMETRIUM|UNILATERAL||Y|CAREGIVER|4|Visit_4|65|2|FOLLOW-UP|2020-10-29|65
e|FA|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|9|SEV|Severity/Intensity|[?]|GERD|[?]|dL|[?]|1|Pa|LEFT VENTRICULAR MID INFERIOR SEGMENT|CONTRALATERAL|||INTERVIEWER|5|Visit_5|90|3|WASHOUT|2020-11-23|90
e|FA|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|10|PROCPRFN|Number of Procedures Performed|[?]|PRE-SPECIFIED AE|[?]|10^6 copies/mL|[?]|1|L/h/m2|APPENDIX|UNILATERAL|||FRIEND|5|Visit_5|90|4|TREATMENT|2020-11-23|90
e|FA|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|1|DFATT|Dietary Fat, Total|[?]|GERD|[?]|Gravitational Unit|[?]|1|Bq/mg|SUBGLOTTIS|UNILATERAL|||VENDOR|1|Visit_1|10|3|TREATMENT|2020-11-20|10
e|FA|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|2|LESNUM|Number of Lesions|[?]|GERD|[?]|ukat|[?]|1|ng/day|DISTAL INTERPHALANGEAL JOINT 5|LATERAL|Y|Y|CHILD|1|Visit_1|10|5|TREATMENT|2020-11-20|10
e|FA|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|3|DRSTAT|Drug Resistance Status|[?]|GERD|[?]|BISCUIT|[?]|1|BOWL|PALPEBRAL FISSURE|RIGHT|||CAREGIVER|2|Visit_2|25|2|FOLLOW-UP|2020-12-05|25
e|FA|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|4|PROCPRFN|Number of Procedures Performed|[?]|GERD|[?]|um/day|[?]|1|L/h/m2|PALM|UNILATERAL|||DOMESTIC PARTNER|2|Visit_2|25|5|FOLLOW-UP|2020-12-05|25
e|FA|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|5|STRCTNUM|Number of Strictures|[?]|GERD|[?]|nmol|[?]|1|SACHET|CALF|RIGHT|||CHILD|3|Visit_3|40|7|SCREENING|2020-12-20|40
e|FA|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|6|LOCONSET|Localization of Onset|[?]|GERD|[?]|cmol|[?]|1|g/L|GRACILIS MUSCLE|CONTRALATERAL|||FAMILY MEMBER|3|Visit_3|40|5|SCREENING|2020-12-20|40
e|FA|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|7|OBJTYPE|Type of Object|[?]|GERD|[?]|%(w/v)|[?]|1|ng|ILIOTIBIAL BAND|IPSILATERAL|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-01-14|65
e|FA|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|8|PCIAAC|PCI Acute Angiographic Complication|[?]|PRE-SPECIFIED AE|[?]|ft3|[?]|1|mL/h|SUPRASPINATUS MUSCLE|UNILATERAL|||INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2021-01-14|65
e|FA|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|9|HFPEFNW|Heart Failure New/Worsening PE Findings|[?]|GERD|[?]|mMU/mL|[?]|1|SCOOPFUL|HUMERAL EPICONDYLE|UNILATERAL|||INDEPENDENT ASSESSOR|5|Visit_5|90|2|WASHOUT|2021-02-08|90
e|FA|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|kg/m2|[?]|1|%(v/v)|URETERIC ORIFICE|LEFT|||CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|FOLLOW-UP|2021-02-08|90
e|FA|b49ef90c-a17e-4554-9fa6-af72b4d56a06|1|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|uL|[?]|1|mEq|BRACHIAL ARTERY|BILATERAL|||FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2021-01-05|10
e|FA|b49ef90c-a17e-4554-9fa6-af72b4d56a06|2|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|mV/sec|[?]|1|DROP|THIRD POSTEROLATERAL DESCENDING ARTERY|LEFT||Y|INVESTIGATOR|1|Visit_1|10|5|FOLLOW-UP|2021-01-05|10
e|FA|b49ef90c-a17e-4554-9fa6-af72b4d56a06|3|DISTANCE|Distance|[?]|GERD|[?]|10^7 PFU|[?]|1|BOWL|FEMORAL CONDYLE|BILATERAL|||HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2021-01-20|25
e|FA|b49ef90c-a17e-4554-9fa6-af72b4d56a06|4|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|cg|[?]|1|umol|POSTERIOR POLE OF THE EYE|RIGHT|||ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2021-01-20|25
e|FA|b49ef90c-a17e-4554-9fa6-af72b4d56a06|5|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|Joule|[?]|1|%(v/v)|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|IPSILATERAL|||GUARDIAN|3|Visit_3|40|5|FOLLOW-UP|2021-02-04|40
e|FA|b49ef90c-a17e-4554-9fa6-af72b4d56a06|6|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|nkat|[?]|1|/500 WBC|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|IPSILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2021-02-04|40
e|FA|b49ef90c-a17e-4554-9fa6-af72b4d56a06|7|FNDOSAMT|Final Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ug/kg/h|[?]|1|umol|COCCYX|BILATERAL|||CHILD|4|Visit_4|65|3|TREATMENT|2021-03-01|65
e|FA|b49ef90c-a17e-4554-9fa6-af72b4d56a06|8|ESTWT|Estimated Weight|[?]|GERD|[?]|mPa|[?]|1|g/day|ENTORHINAL CORTEX|BILATERAL|||ADJUDICATOR|4|Visit_4|65|4|TREATMENT|2021-03-01|65
e|FA|b49ef90c-a17e-4554-9fa6-af72b4d56a06|9|EVENTNUM|Number of Events|[?]|GERD|[?]|L/h|[?]|1|U/10^12 RBC|FLEXOR HALLUCIS BREVIS MUSCLE|IPSILATERAL|Y|Y|CHILD|5|Visit_5|90|6|TREATMENT|2021-03-26|90
e|FA|b49ef90c-a17e-4554-9fa6-af72b4d56a06|10|EPSDNUM|Number of Episodes|[?]|GERD|[?]|CCID 50/dose|[?]|1|%(v/v)|KIDNEY, HILUM|LATERAL|||SIBLING|5|Visit_5|90|5|WASHOUT|2021-03-26|90
e|FA|df041193-ee4e-4835-8db9-5be9b832ded0|1|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|fmol/L/sec|[?]|1|PFU/dose|FOOT DIGIT 1|UNILATERAL|||PROXY|1|Visit_1|10|7|TREATMENT|2020-11-25|10
e|FA|df041193-ee4e-4835-8db9-5be9b832ded0|2|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|GERD|[?]|mg/mol|[?]|1|TRANSDUCING UNIT/mL|LINGULA OF THE LUNG|IPSILATERAL||Y|CAREGIVER|1|Visit_1|10|4|TREATMENT|2020-11-25|10
e|FA|df041193-ee4e-4835-8db9-5be9b832ded0|3|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|/LSQN|[?]|1|g/L|TRICUSPID VALVE, POSTERIOR CUSP|LATERAL||Y|PROXY|2|Visit_2|25|1|FOLLOW-UP|2020-12-10|25
e|FA|df041193-ee4e-4835-8db9-5be9b832ded0|4|ACNDEV|Action Taken With Device|[?]|PRE-SPECIFIED AE|[?]|g|[?]|1|100 IU/mL|CERVICAL SPINE|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|SCREENING|2020-12-10|25
e|FA|df041193-ee4e-4835-8db9-5be9b832ded0|5|DMEAT|Dietary Meat|[?]|GERD|[?]|/wk|[?]|1|10^6 organisms/mL|CORONARY SINUS|LEFT|||INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2020-12-25|40
e|FA|df041193-ee4e-4835-8db9-5be9b832ded0|6|EPSDNUM|Number of Episodes|[?]|GERD|[?]|amp|[?]|1|%(v/v)|SCAPHOID-LUNATE-CAPITATE JOINT|IPSILATERAL|||SPOUSE|3|Visit_3|40|5|WASHOUT|2020-12-25|40
e|FA|df041193-ee4e-4835-8db9-5be9b832ded0|7|DCARBT|Dietary Total Carbohydrate|[?]|PRE-SPECIFIED AE|[?]|Enzyme U/g Hb|[?]|1|mL/cm3/min|RIGHT POSTERIOR DESCENDING ARTERY|BILATERAL|||SIGNIFICANT OTHER|4|Visit_4|65|5|SCREENING|2021-01-19|65
e|FA|df041193-ee4e-4835-8db9-5be9b832ded0|8|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|mL/(min*100mL)|[?]|1|mm/h|T4 VERTEBRA|UNILATERAL|Y|Y|PROXY|4|Visit_4|65|6|TREATMENT|2021-01-19|65
e|FA|df041193-ee4e-4835-8db9-5be9b832ded0|9|NINVIMGC|Non-Invasive Imaging Change|[?]|GERD|[?]|pmol/dL|[?]|1|Bq/L|COLON, TRANSVERSE|UNILATERAL|Y||GUARDIAN|5|Visit_5|90|7|WASHOUT|2021-02-13|90
e|FA|df041193-ee4e-4835-8db9-5be9b832ded0|10|TRTSETT|Treatment Setting|[?]|GERD|[?]|SPRAY|[?]|1|Coulomb|FACIAL BONE|UNILATERAL|Y||ADJUDICATION COMMITTEE|5|Visit_5|90|4|FOLLOW-UP|2021-02-13|90
e|FA|e41a4505-a5aa-4cac-895b-04fe85737ca9|1|LDIAM|Longest Diameter|[?]|GERD|[?]|g/animal/wk|[?]|1|Shock Wave|SARTORIUS MUSCLE|BILATERAL|Y||ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2021-01-13|10
e|FA|e41a4505-a5aa-4cac-895b-04fe85737ca9|2|SEV|Severity/Intensity|[?]|GERD|[?]|kBq|[?]|1|Pa|RETROPHARYNGEAL LYMPH NODE|CONTRALATERAL|||CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|WASHOUT|2021-01-13|10
e|FA|e41a4505-a5aa-4cac-895b-04fe85737ca9|3|LENRSCT|Length of Resection|[?]|GERD|[?]|genEq|[?]|1|psi|CORPUS CALLOSUM|UNILATERAL|Y||ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2021-01-28|25
e|FA|e41a4505-a5aa-4cac-895b-04fe85737ca9|4|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|/HPF|[?]|1|mL/m2|PERICARDIUM|LATERAL|||GUARDIAN|2|Visit_2|25|1|TREATMENT|2021-01-28|25
e|FA|e41a4505-a5aa-4cac-895b-04fe85737ca9|5|AGETRT1|Age At First Treatment|[?]|GERD|[?]|mol/L|[?]|1|mL/mmHg/min/L|LATISSIMUS DORSI MUSCLE|UNILATERAL|||INDEPENDENT ASSESSOR|3|Visit_3|40|1|SCREENING|2021-02-12|40
e|FA|e41a4505-a5aa-4cac-895b-04fe85737ca9|6|ISCETYP|Ischemic Evidence Type|[?]|GERD|[?]|log10 TCID 50/dose|[?]|1|mm/h|TRICUSPID VALVE ANNULUS|BILATERAL||Y|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|WASHOUT|2021-02-12|40
e|FA|e41a4505-a5aa-4cac-895b-04fe85737ca9|7|ACMITYPE|Acute Myocardial Infarction Type|[?]|GERD|[?]|ELISA unit/dose|[?]|1|PFU/dose|L3-L4 INTERVERTEBRAL SPACE|UNILATERAL|||HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-03-09|65
e|FA|e41a4505-a5aa-4cac-895b-04fe85737ca9|8|DCDEPIND|Unable to Discon Dependent Indicator|[?]|GERD|[?]|nmol/mol|[?]|1|U/mmol|CANINE TOOTH|LATERAL|||CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2021-03-09|65
e|FA|e41a4505-a5aa-4cac-895b-04fe85737ca9|9|DMG|Dietary Magnesium|[?]|PRE-SPECIFIED AE|[?]|ppth|[?]|1|TRANSDUCING UNIT/mL|CAROTID ARTERY|BILATERAL|||DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2021-04-03|90
e|FA|e41a4505-a5aa-4cac-895b-04fe85737ca9|10|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|L/day|[?]|1|mIU/L|ESOPHAGUS, LOWER THIRD|LATERAL|||INTERVIEWER|5|Visit_5|90|2|WASHOUT|2021-04-03|90
e|FA|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|1|AGEEPSD1|Age At First Episode|[?]|GERD|[?]|GBq/ug|[?]|1|uCi/kg|ASCENDING AORTA, AORTIC ROOT|IPSILATERAL|||SPOUSE|1|Visit_1|10|5|FOLLOW-UP|2021-01-15|10
e|FA|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|2|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|DIP|[?]|1|10^6 U|L1 VERTEBRA|LEFT||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|5|TREATMENT|2021-01-15|10
e|FA|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|3|STRCTNUM|Number of Strictures|[?]|GERD|[?]|hr/day|[?]|1|SACHET|LIMB, UPPER|RIGHT|||INTERVIEWER|2|Visit_2|25|3|SCREENING|2021-01-30|25
e|FA|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|4|EPMODNUM|Number of Moderate Episodes|[?]|PRE-SPECIFIED AE|[?]|mU|[?]|1|NEEDLE GAUGE|KNEE JOINT TENDONS|LATERAL|||STUDY SUBJECT|2|Visit_2|25|7|FOLLOW-UP|2021-01-30|25
e|FA|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|5|ACNSBJ|Action Taken With Subject|[?]|PRE-SPECIFIED AE|[?]|ECL unit|[?]|1|Gy/h|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|RIGHT|||ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2021-02-14|40
e|FA|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|6|EPSDNUM|Number of Episodes|[?]|PRE-SPECIFIED AE|[?]|pg|[?]|1|%(v/v)|XIPHOID PROCESS|LATERAL|Y||CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2021-02-14|40
e|FA|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|7|HETYPE|Healthcare Encounter Type|[?]|PRE-SPECIFIED AE|[?]|pmol/L/h|[?]|1|mEq|SPINAL CORD|IPSILATERAL|Y||STUDY SUBJECT|4|Visit_4|65|3|SCREENING|2021-03-11|65
e|FA|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|8|HETYPE|Healthcare Encounter Type|[?]|GERD|[?]|ukat/L|[?]|1|mEq|SPLENIC VEIN|IPSILATERAL|Y|Y|STUDY SUBJECT|4|Visit_4|65|2|WASHOUT|2021-03-11|65
e|FA|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|9|CHRNSTRS|Most Severe Chronic Stressor|[?]|GERD|[?]|cg|[?]|1|mg/h|PULMONARY ARTERY BRANCH|CONTRALATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|4|SCREENING|2021-04-05|90
e|FA|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|10|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|/kg|[?]|1|mL/mmHg/min/L|JAW|UNILATERAL|||CAREGIVER|5|Visit_5|90|6|WASHOUT|2021-04-05|90
e|FA|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|1|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|uCi/L|[?]|1|Weber|VASTUS INTERMEDIUS MUSCLE|LEFT|||INDEPENDENT ASSESSOR|1|Visit_1|10|2|SCREENING|2020-12-12|10
e|FA|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|2|LOCONSET|Localization of Onset|[?]|GERD|[?]|sec|[?]|1|g/L|BODY|LATERAL|||FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2020-12-12|10
e|FA|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|3|ISCDIND|Ischemic Discomfort Indicator|[?]|PRE-SPECIFIED AE|[?]|U/kg/min|[?]|1|ug/m2/h|CAROTID ARTERY|LEFT|Y||INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-12-27|25
e|FA|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|4|DCDEPIND|Unable to Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|PIXEL|[?]|1|U/mmol|ADDUCTOR LONGUS MUSCLE|RIGHT||Y|SIBLING|2|Visit_2|25|6|WASHOUT|2020-12-27|25
e|FA|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|5|RLDEPIND|Relapse after Discon Dependent Indicator|[?]|PRE-SPECIFIED AE|[?]|fmol/g|[?]|1|km|ESOPHAGUS, MIDDLE THIRD|RIGHT||Y|GUARDIAN|3|Visit_3|40|5|SCREENING|2021-01-11|40
e|FA|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|6|PRUSTAT|Procedure Urgency Status Type|[?]|GERD|[?]|NFIU|[?]|1|gtt|PROXIMAL INTERPHALANGEAL JOINT 4|LEFT|||FAMILY MEMBER|3|Visit_3|40|3|SCREENING|2021-01-11|40
e|FA|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|7|ISCETYP|Ischemic Evidence Type|[?]|PRE-SPECIFIED AE|[?]|ELISA unit|[?]|1|mm/h|SUBMENTAL LYMPH NODE|BILATERAL|Y||SPOUSE|4|Visit_4|65|7|SCREENING|2021-02-05|65
e|FA|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|8|STROKTYP|Stroke Type|[?]|GERD|[?]|cL|[?]|1|g/L|LEFT ATRIOVENTRICULAR ARTERY|LATERAL||Y|GUARDIAN|4|Visit_4|65|6|TREATMENT|2021-02-05|65
e|FA|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|9|EXCDUR|Exercise Duration|[?]|GERD|[?]|g/cm2|[?]|1|mm|INTERPHALANGEAL JOINT 5 OF THE FOOT|CONTRALATERAL|||ADJUDICATION COMMITTEE|5|Visit_5|90|4|FOLLOW-UP|2021-03-02|90
e|FA|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|DROP|[?]|1|Pa|PAROTID GLAND LYMPH NODE|BILATERAL|||FAMILY MEMBER|5|Visit_5|90|7|WASHOUT|2021-03-02|90
e|FA|5abbbb78-2eeb-4d21-85ac-f5d18294c603|1|DADDSUG|Dietary Added Sugar|[?]|GERD|[?]|BLOCKS|[?]|1|cm H2O|SHOULDER JOINT TENDONS|BILATERAL|||STUDY SUBJECT|1|Visit_1|10|6|TREATMENT|2021-01-25|10
e|FA|5abbbb78-2eeb-4d21-85ac-f5d18294c603|2|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|NEEDLE GAUGE|[?]|1|PFU/dose|C1 VERTEBRA|CONTRALATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|3|TREATMENT|2021-01-25|10
e|FA|5abbbb78-2eeb-4d21-85ac-f5d18294c603|3|STCTIMNG|Stent Thrombosis, Coronary, ARC Timing|[?]|PRE-SPECIFIED AE|[?]|keV|[?]|1|TRANSDUCING UNIT/mL|FEMORAL CONDYLE|CONTRALATERAL|Y|Y|VENDOR|2|Visit_2|25|7|TREATMENT|2021-02-09|25
e|FA|5abbbb78-2eeb-4d21-85ac-f5d18294c603|4|DIAMETER|Diameter|[?]|GERD|[?]|RING|[?]|1|cm|JAW|UNILATERAL|||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2021-02-09|25
e|FA|5abbbb78-2eeb-4d21-85ac-f5d18294c603|5|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|mg/kg/dose|[?]|1|EIA unit|RIGHT ATRIAL ENDOCARDIUM|RIGHT|||INTERVIEWER|3|Visit_3|40|5|TREATMENT|2021-02-24|40
e|FA|5abbbb78-2eeb-4d21-85ac-f5d18294c603|6|NWSYMP|New or Worsening Symptoms|[?]|GERD|[?]|10^10/L|[?]|1|mL/m2|T2 VERTEBRA|LATERAL||Y|DOMESTIC PARTNER|3|Visit_3|40|5|SCREENING|2021-02-24|40
e|FA|5abbbb78-2eeb-4d21-85ac-f5d18294c603|7|SEV|Severity/Intensity|[?]|GERD|[?]|days/wk|[?]|1|Pa|FUNDUS OF THE EYE|LEFT|Y||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|SCREENING|2021-03-21|65
e|FA|5abbbb78-2eeb-4d21-85ac-f5d18294c603|8|DMEAT|Dietary Meat|[?]|GERD|[?]|DRUM|[?]|1|10^6 organisms/mL|ABDOMINAL LYMPH NODE|CONTRALATERAL|||PROXY|4|Visit_4|65|5|WASHOUT|2021-03-21|65
e|FA|5abbbb78-2eeb-4d21-85ac-f5d18294c603|9|EVENTNUM|Number of Events|[?]|GERD|[?]|BU|[?]|1|U/10^12 RBC|SUBLINGUAL REGION|LEFT|||FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-04-15|90
e|FA|5abbbb78-2eeb-4d21-85ac-f5d18294c603|10|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|Henry|[?]|1|oz eq|ESOPHAGUS, UPPER THIRD|BILATERAL|||VENDOR|5|Visit_5|90|2|WASHOUT|2021-04-15|90
e|FA|109fe46d-ac1f-47fe-8ecb-6049a577d38c|1|SYMSTDTC|Symptom Onset Date|[?]|GERD|[?]|mV2/Hz|[?]|1|DROP|INGUINAL REGION|UNILATERAL|||PARENT|1|Visit_1|10|2|TREATMENT|2020-05-20|10
e|FA|109fe46d-ac1f-47fe-8ecb-6049a577d38c|2|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|log10 PFU/mL|[?]|1|oz eq|NUCLEUS OF DIAGONAL BAND|LEFT|Y||INVESTIGATOR|1|Visit_1|10|3|WASHOUT|2020-05-20|10
e|FA|109fe46d-ac1f-47fe-8ecb-6049a577d38c|3|AGESYMST|Age Symptoms Started|[?]|PRE-SPECIFIED AE|[?]|oz|[?]|1|m2|CRANIAL CAVITY|UNILATERAL|||INTERVIEWER|2|Visit_2|25|7|SCREENING|2020-06-04|25
e|FA|109fe46d-ac1f-47fe-8ecb-6049a577d38c|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|uL/mL|[?]|1|Pa|RIGHT VENTRICULAR BRANCH|LEFT|||PROXY|2|Visit_2|25|7|FOLLOW-UP|2020-06-04|25
e|FA|109fe46d-ac1f-47fe-8ecb-6049a577d38c|5|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|100 IU/mL|[?]|1|mg/g/min|CARDIAC WALL|IPSILATERAL|||CLINICAL STUDY SPONSOR|3|Visit_3|40|7|FOLLOW-UP|2020-06-19|40
e|FA|109fe46d-ac1f-47fe-8ecb-6049a577d38c|6|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|um|[?]|1|mg/g/min|MUCOSA OF THE LIP|RIGHT|Y||FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-06-19|40
e|FA|109fe46d-ac1f-47fe-8ecb-6049a577d38c|7|ORCANIND|Origin of Cancer Known Ind|[?]|GERD|[?]|uU/L|[?]|1|cmH2O/mL|CEREBRAL VEIN|IPSILATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|5|SCREENING|2020-07-14|65
e|FA|109fe46d-ac1f-47fe-8ecb-6049a577d38c|8|SPEED|Speed|[?]|PRE-SPECIFIED AE|[?]|L/s/kPa|[?]|1|mEq/g|C1 VERTEBRA|LEFT|||NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-07-14|65
e|FA|109fe46d-ac1f-47fe-8ecb-6049a577d38c|9|DGRAIN|Dietary Grain|[?]|GERD|[?]|NFIU|[?]|1|10^9 CFU/g|PARACOLIC GUTTER|LATERAL|||CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2020-08-08|90
e|FA|109fe46d-ac1f-47fe-8ecb-6049a577d38c|10|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|GERD|[?]|Tesla|[?]|1|U/mg|T8 VERTEBRA|BILATERAL|Y||SIBLING|5|Visit_5|90|4|TREATMENT|2020-08-08|90
e|FA|cdb18d0a-5fca-4437-9b6e-0e46b0930521|1|STROKTYP|Stroke Type|[?]|GERD|[?]|Bq|[?]|1|g/L|METACARPOPHALANGEAL JOINT 2|LATERAL|||GUARDIAN|1|Visit_1|10|2|WASHOUT|2020-09-03|10
e|FA|cdb18d0a-5fca-4437-9b6e-0e46b0930521|2|SYMPINDC|Symptom Indicator|[?]|PRE-SPECIFIED AE|[?]|IU/dL|[?]|1|g/dL|PORTAL LYMPH NODE|RIGHT|||NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-09-03|10
e|FA|cdb18d0a-5fca-4437-9b6e-0e46b0930521|3|DVCINSN|Number of Devices Inserted|[?]|GERD|[?]|mL/breath|[?]|1|HOURS|FEMORAL ARTERY|BILATERAL|Y|Y|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-09-18|25
e|FA|cdb18d0a-5fca-4437-9b6e-0e46b0930521|4|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|mg/kg/week|[?]|1|mmHg/L/min|HAIR BULB|BILATERAL|Y|Y|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2020-09-18|25
e|FA|cdb18d0a-5fca-4437-9b6e-0e46b0930521|5|DIAMETER|Diameter|[?]|PRE-SPECIFIED AE|[?]|nmol BCE/L|[?]|1|cm|SOFT TISSUE|IPSILATERAL|Y||SIBLING|3|Visit_3|40|5|FOLLOW-UP|2020-10-03|40
e|FA|cdb18d0a-5fca-4437-9b6e-0e46b0930521|6|LESNUM|Number of Lesions|[?]|PRE-SPECIFIED AE|[?]|mU|[?]|1|ng/day|PINEAL GLAND|UNILATERAL|||GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-10-03|40
e|FA|cdb18d0a-5fca-4437-9b6e-0e46b0930521|7|RESCTIND|Resected Tumor Ind|[?]|PRE-SPECIFIED AE|[?]|/4.0 mL|[?]|1|mmHg/L/min|ILIAC LYMPH NODE|LEFT|||INDEPENDENT ASSESSOR|4|Visit_4|65|7|FOLLOW-UP|2020-10-28|65
e|FA|cdb18d0a-5fca-4437-9b6e-0e46b0930521|8|EVENTFRQ|Event Frequency|[?]|GERD|[?]|mmHg/sec|[?]|1|ug/kg/h|OSTIOMEATAL COMPLEX|IPSILATERAL||Y|GUARDIAN|4|Visit_4|65|6|TREATMENT|2020-10-28|65
e|FA|cdb18d0a-5fca-4437-9b6e-0e46b0930521|9|HFTHERIN|Heart Failure Therapy, Intensification|[?]|PRE-SPECIFIED AE|[?]|mol/mol|[?]|1|mL/dose|PRELARYNGEAL LYMPH NODE|IPSILATERAL|Y||PARENT|5|Visit_5|90|5|TREATMENT|2020-11-22|90
e|FA|cdb18d0a-5fca-4437-9b6e-0e46b0930521|10|AGEFTUSE|Age at Full-Time Use|[?]|PRE-SPECIFIED AE|[?]|mPa|[?]|1|DRUM|HAND DIGIT 5|CONTRALATERAL|Y|Y|SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2020-11-22|90
e|FA|e515b916-5d28-4236-8835-2ff43b498ab3|1|TTIMPAUS|Total Time Paused|[?]|GERD|[?]|keV|[?]|1|Log10 ELISA unit|SKIN AROUND THE MOUTH|UNILATERAL|Y||DOMESTIC PARTNER|1|Visit_1|10|6|FOLLOW-UP|2020-05-23|10
e|FA|e515b916-5d28-4236-8835-2ff43b498ab3|2|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/L/h|[?]|1|mg/g/min|SUPERIOR SAGITTAL SINUS|IPSILATERAL||Y|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-05-23|10
e|FA|e515b916-5d28-4236-8835-2ff43b498ab3|3|TOXGR|Toxicity Grade|[?]|GERD|[?]|uEq|[?]|1|aMFI|GLENOID FOSSA|RIGHT|Y||CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|TREATMENT|2020-06-07|25
e|FA|e515b916-5d28-4236-8835-2ff43b498ab3|4|AGEFTUSE|Age at Full-Time Use|[?]|GERD|[?]|L/h|[?]|1|DRUM|LENS|IPSILATERAL|||INTERVIEWER|2|Visit_2|25|3|SCREENING|2020-06-07|25
e|FA|e515b916-5d28-4236-8835-2ff43b498ab3|5|DFATT|Dietary Fat, Total|[?]|PRE-SPECIFIED AE|[?]|umol/L/sec|[?]|1|Bq/mg|INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT||Y|GUARDIAN|3|Visit_3|40|7|SCREENING|2020-06-22|40
e|FA|e515b916-5d28-4236-8835-2ff43b498ab3|6|TOXGR|Toxicity Grade|[?]|PRE-SPECIFIED AE|[?]|nmol|[?]|1|aMFI|CILIARY BODY|IPSILATERAL|Y||CHILD|3|Visit_3|40|4|TREATMENT|2020-06-22|40
e|FA|e515b916-5d28-4236-8835-2ff43b498ab3|7|ESTWT|Estimated Weight|[?]|PRE-SPECIFIED AE|[?]|mU|[?]|1|g/day|RESPIRATORY SYSTEM|UNILATERAL||Y|FRIEND|4|Visit_4|65|4|SCREENING|2020-07-17|65
e|FA|e515b916-5d28-4236-8835-2ff43b498ab3|8|HFLBFNW|Heart Failure New/Worsening Lab Findings|[?]|PRE-SPECIFIED AE|[?]|mm/sec|[?]|1|U/mg|TRAPEZOID BONE|LATERAL|||ADJUDICATION COMMITTEE|4|Visit_4|65|1|TREATMENT|2020-07-17|65
e|FA|e515b916-5d28-4236-8835-2ff43b498ab3|9|AGETRT1|Age At First Treatment|[?]|PRE-SPECIFIED AE|[?]|dyn|[?]|1|mL/mmHg/min/L|HEART, SEPTUM|RIGHT|||STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2020-08-11|90
e|FA|e515b916-5d28-4236-8835-2ff43b498ab3|10|ESTWT|Estimated Weight|[?]|GERD|[?]|10^6/hpf|[?]|1|g/day|SACRAL VERTEBRA|RIGHT||Y|FRIEND|5|Visit_5|90|2|WASHOUT|2020-08-11|90
e|FA|158af2a8-d447-45e5-8c58-3b950f1bd889|1|CATMTHID|Coronary Artery Thrombosis Method Ident|[?]|GERD|[?]|SACHET|[?]|1|ug/g/h|LEFT VENTRICULAR MID INFERIOR SEGMENT|LATERAL|Y||INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-05-30|10
e|FA|158af2a8-d447-45e5-8c58-3b950f1bd889|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|pkat|[?]|1|Pa|PLEURAL CAVITY|CONTRALATERAL||Y|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-05-30|10
e|FA|158af2a8-d447-45e5-8c58-3b950f1bd889|3|SEV|Severity/Intensity|[?]|GERD|[?]|gMFI|[?]|1|Pa|INFERIOR PUBIC RAMUS|UNILATERAL||Y|ADJUDICATOR|2|Visit_2|25|4|FOLLOW-UP|2020-06-14|25
e|FA|158af2a8-d447-45e5-8c58-3b950f1bd889|4|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|vg/kg|[?]|1|Pa|WRIST JOINT|RIGHT|||GUARDIAN|2|Visit_2|25|2|SCREENING|2020-06-14|25
e|FA|158af2a8-d447-45e5-8c58-3b950f1bd889|5|CLININD|Clinic Stay Indicator|[?]|PRE-SPECIFIED AE|[?]|umol/L/min|[?]|1|mIU/L|BUCCAL MUCOSA|LATERAL|||PROXY|3|Visit_3|40|4|TREATMENT|2020-06-29|40
e|FA|158af2a8-d447-45e5-8c58-3b950f1bd889|6|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|BAU/mL|[?]|1|Pa|JAW|UNILATERAL|||INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-06-29|40
e|FA|158af2a8-d447-45e5-8c58-3b950f1bd889|7|RESCTIND|Resected Tumor Ind|[?]|GERD|[?]|kg/mol|[?]|1|mmHg/L/min|HEART, LEFT VENTRICULAR OUTFLOW TRACT|BILATERAL|||STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2020-07-24|65
e|FA|158af2a8-d447-45e5-8c58-3b950f1bd889|8|VOC48IND|Vessel Occlusion After CABG 48 Ind|[?]|GERD|[?]|mL/m2/h|[?]|1|CUP|HAND DIGIT 1|CONTRALATERAL|Y||CLINICAL STUDY SPONSOR|4|Visit_4|65|4|WASHOUT|2020-07-24|65
e|FA|158af2a8-d447-45e5-8c58-3b950f1bd889|9|FNDOSFRQ|Frequency of Final Dose Amount|[?]|GERD|[?]|RFU|[?]|1|mL|FOOT PHALANX|BILATERAL|||CHILD|5|Visit_5|90|5|TREATMENT|2020-08-18|90
e|FA|158af2a8-d447-45e5-8c58-3b950f1bd889|10|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|INHALATION|[?]|1|Pa|BLADDER, TRIGONE|UNILATERAL|||VENDOR|5|Visit_5|90|7|WASHOUT|2020-08-18|90
e|FA|e9a930d5-ca57-4069-8251-c164273df082|1|DADDSUG|Dietary Added Sugar|[?]|PRE-SPECIFIED AE|[?]|U/g Hb|[?]|1|cm H2O|RIB|RIGHT|||HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|FOLLOW-UP|2020-05-21|10
e|FA|e9a930d5-ca57-4069-8251-c164273df082|2|SEV|Severity/Intensity|[?]|PRE-SPECIFIED AE|[?]|mmol|[?]|1|Pa|SKIN OF THE FOREARM|LATERAL|||FAMILY MEMBER|1|Visit_1|10|6|TREATMENT|2020-05-21|10
e|FA|e9a930d5-ca57-4069-8251-c164273df082|3|AGEEPSD1|Age At First Episode|[?]|PRE-SPECIFIED AE|[?]|uSiemens|[?]|1|uCi/kg|ESOPHAGEAL LYMPH NODE|UNILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2020-06-05|25
e|FA|e9a930d5-ca57-4069-8251-c164273df082|4|SEV|Severity/Intensity|[?]|GERD|[?]|mEq|[?]|1|Pa|COLON, TRANSVERSE|IPSILATERAL|||SIBLING|2|Visit_2|25|3|WASHOUT|2020-06-05|25
e|FA|e9a930d5-ca57-4069-8251-c164273df082|5|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|pL|[?]|1|EIA unit|ENDOCARDIUM|BILATERAL|||ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-06-20|40
e|FA|e9a930d5-ca57-4069-8251-c164273df082|6|VOL|Volume|[?]|PRE-SPECIFIED AE|[?]|L/min|[?]|1|vp/dose|CORONARY ARTERY, RIGHT|LEFT|Y||STUDY SUBJECT|3|Visit_3|40|5|SCREENING|2020-06-20|40
e|FA|e9a930d5-ca57-4069-8251-c164273df082|7|CUMEXP|Cumulative Exposure|[?]|PRE-SPECIFIED AE|[?]|MET|[?]|1|10^6 U|ACCESSORY RENAL ARTERY|UNILATERAL|||INTERVIEWER|4|Visit_4|65|6|SCREENING|2020-07-15|65
e|FA|e9a930d5-ca57-4069-8251-c164273df082|8|DXCRITMT|Diagnostic Criteria Met|[?]|GERD|[?]|/sec|[?]|1|Shock Wave|RENAL FOSSA|LATERAL|||CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-07-15|65
e|FA|e9a930d5-ca57-4069-8251-c164273df082|9|MXDOSAMT|Maximum Dose Amount|[?]|GERD|[?]|/VF|[?]|1|uL/kg/day|TOENAIL|RIGHT||Y|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|SCREENING|2020-08-09|90
e|FA|e9a930d5-ca57-4069-8251-c164273df082|10|STROKTYP|Stroke Type|[?]|PRE-SPECIFIED AE|[?]|MdFI|[?]|1|g/L|C1 VERTEBRA|IPSILATERAL||Y|INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-08-09|90
e|FA|e654e37e-1c95-4f25-83b1-9233186626c6|1|CLININD|Clinic Stay Indicator|[?]|GERD|[?]|km|[?]|1|mIU/L|ENDOMETRIAL CAVITY|CONTRALATERAL|Y||INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-08-04|10
e|FA|e654e37e-1c95-4f25-83b1-9233186626c6|2|CALBURN|Calories Burned|[?]|GERD|[?]|HOMEOPATHIC DILUTION|[?]|1|/kg|SUPERIOR VENA CAVA|CONTRALATERAL|||INTERVIEWER|1|Visit_1|10|6|WASHOUT|2020-08-04|10
e|FA|e654e37e-1c95-4f25-83b1-9233186626c6|3|DVEG|Dietary Vegetable|[?]|GERD|[?]|Absorbance U|[?]|1|Ci/ug|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|UNILATERAL|Y||DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-08-19|25
e|FA|e654e37e-1c95-4f25-83b1-9233186626c6|4|EPSEVNUM|Number of Severe Episodes|[?]|GERD|[?]|Bq|[?]|1|/500 WBC|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|BILATERAL|||CAREGIVER|2|Visit_2|25|2|SCREENING|2020-08-19|25
e|FA|e654e37e-1c95-4f25-83b1-9233186626c6|5|ICJRIND|Ileocecal Junction Removed Indicator|[?]|PRE-SPECIFIED AE|[?]|AFU|[?]|1|mL/animal/day|MITRAL VALVE|LATERAL|||FAMILY MEMBER|3|Visit_3|40|4|SCREENING|2020-09-03|40
e|FA|e654e37e-1c95-4f25-83b1-9233186626c6|6|LAPCOMPN|Number of Laps Completed|[?]|GERD|[?]|CUP|[?]|1|BP|DUCTUS ARTERIOSUS|UNILATERAL|||DOMESTIC PARTNER|3|Visit_3|40|4|FOLLOW-UP|2020-09-03|40
e|FA|e654e37e-1c95-4f25-83b1-9233186626c6|7|MXDOSAMT|Maximum Dose Amount|[?]|PRE-SPECIFIED AE|[?]|ugEq|[?]|1|uL/kg/day|JEJUNUM|UNILATERAL|Y||CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2020-09-28|65
e|FA|e654e37e-1c95-4f25-83b1-9233186626c6|8|DCAL|Dietary Calories|[?]|GERD|[?]|10^6 organisms/mL|[?]|1|EIA unit|PRIMARY VISUAL CORTEX|LEFT||Y|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|SCREENING|2020-09-28|65
e|FA|e654e37e-1c95-4f25-83b1-9233186626c6|9|ACMITYPE|Acute Myocardial Infarction Type|[?]|PRE-SPECIFIED AE|[?]|mL/kg/min|[?]|1|PFU/dose|TOENAIL|LATERAL|||HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|FOLLOW-UP|2020-10-23|90
e|FA|e654e37e-1c95-4f25-83b1-9233186626c6|10|DFIBER|Dietary Fiber|[?]|PRE-SPECIFIED AE|[?]|MBq/uL|[?]|1|h*%|5TH LUMBAR SPINOUS PROCESS|BILATERAL|Y||CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2020-10-23|90
e|FA|808ee0ac-e668-4e8e-aa0a-889476cbe631|1|EPSEVNUM|Number of Severe Episodes|[?]|PRE-SPECIFIED AE|[?]|Bq/mL|[?]|1|/500 WBC|PERITONEUM|CONTRALATERAL|||VENDOR|1|Visit_1|10|2|TREATMENT|2020-06-19|10
e|FA|808ee0ac-e668-4e8e-aa0a-889476cbe631|2|ACNDEV|Action Taken With Device|[?]|GERD|[?]|mmHg/sec|[?]|1|100 IU/mL|SCLERA|BILATERAL|||VENDOR|1|Visit_1|10|1|FOLLOW-UP|2020-06-19|10
e|FA|808ee0ac-e668-4e8e-aa0a-889476cbe631|3|OCCUR|Occurrence Indicator|[?]|PRE-SPECIFIED AE|[?]|Tbsp|[?]|1|mg/g/min|RIB 1|BILATERAL|||CLINICAL STUDY SPONSOR|2|Visit_2|25|3|FOLLOW-UP|2020-07-04|25
e|FA|808ee0ac-e668-4e8e-aa0a-889476cbe631|4|OCCUR|Occurrence Indicator|[?]|GERD|[?]|COAT|[?]|1|mg/g/min|ILIAC LYMPH NODE|LATERAL|||DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-07-04|25
e|FA|808ee0ac-e668-4e8e-aa0a-889476cbe631|5|DCAL|Dietary Calories|[?]|PRE-SPECIFIED AE|[?]|mL/cage/day|[?]|1|EIA unit|SECOND DIAGONAL BRANCH ARTERY|RIGHT||Y|INVESTIGATOR|3|Visit_3|40|3|WASHOUT|2020-07-19|40
e|FA|808ee0ac-e668-4e8e-aa0a-889476cbe631|6|DCAL|Dietary Calories|[?]|GERD|[?]|INHALATION|[?]|1|EIA unit|PARIETAL LOBE|UNILATERAL|||SPOUSE|3|Visit_3|40|6|TREATMENT|2020-07-19|40
e|FA|808ee0ac-e668-4e8e-aa0a-889476cbe631|7|LAPCOMPN|Number of Laps Completed|[?]|PRE-SPECIFIED AE|[?]|GBq/g|[?]|1|BP|TOOTH|LATERAL||Y|FAMILY MEMBER|4|Visit_4|65|7|TREATMENT|2020-08-13|65
e|FA|808ee0ac-e668-4e8e-aa0a-889476cbe631|8|MXDOSFRQ|Frequency of Maximum Dose Amount|[?]|GERD|[?]|BOX|[?]|1|oz eq|BRACHIALIS MUSCLE|CONTRALATERAL||Y|DOMESTIC PARTNER|4|Visit_4|65|6|SCREENING|2020-08-13|65
e|FA|808ee0ac-e668-4e8e-aa0a-889476cbe631|9|EXTRSCT|Extent of Resection|[?]|PRE-SPECIFIED AE|[?]|mg/kg/dose|[?]|1|Weber|GASTROCNEMIUS MUSCLE, LATERAL HEAD|IPSILATERAL|||VENDOR|5|Visit_5|90|4|WASHOUT|2020-09-07|90
e|FA|808ee0ac-e668-4e8e-aa0a-889476cbe631|10|DVCINSN|Number of Devices Inserted|[?]|PRE-SPECIFIED AE|[?]|U/g/min|[?]|1|HOURS|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|IPSILATERAL|||CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|TREATMENT|2020-09-07|90
